<SEC-DOCUMENT>0000849146-25-000068.txt : 20250904
<SEC-HEADER>0000849146-25-000068.hdr.sgml : 20250904
<ACCEPTANCE-DATETIME>20250904160610
ACCESSION NUMBER:		0000849146-25-000068
CONFORMED SUBMISSION TYPE:	10-K
PUBLIC DOCUMENT COUNT:		108
CONFORMED PERIOD OF REPORT:	20250630
FILED AS OF DATE:		20250904
DATE AS OF CHANGE:		20250904

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Lifevantage Corp
		CENTRAL INDEX KEY:			0000849146
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				900224471
		FISCAL YEAR END:			0630

	FILING VALUES:
		FORM TYPE:		10-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-35647
		FILM NUMBER:		251293415

	BUSINESS ADDRESS:	
		STREET 1:		3300 TRIUMPH BLVD
		STREET 2:		SUITE 700
		CITY:			LEHI
		STATE:			UT
		ZIP:			84043
		BUSINESS PHONE:		801-432-9000

	MAIL ADDRESS:	
		STREET 1:		3300 TRIUMPH BLVD
		STREET 2:		SUITE 700
		CITY:			LEHI
		STATE:			UT
		ZIP:			84043

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	LIFELINE THERAPEUTICS, INC.
		DATE OF NAME CHANGE:	20041019

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	YAAK RIVER RESOURCES INC
		DATE OF NAME CHANGE:	19920703

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	ANDRAPLEX CORP
		DATE OF NAME CHANGE:	19920406
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-K
<SEQUENCE>1
<FILENAME>lfvn-20250630.htm
<DESCRIPTION>10-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:60c7f1f2-d52d-4c01-b992-aaf8be1801ed,g:81eb96f2-7ea0-4e0b-9dac-655ac6c272fe,d:7a9d1ca723db478892511ede354648f3-->
<html xmlns:country="http://xbrl.sec.gov/country/2025" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:srt="http://fasb.org/srt/2025" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:us-gaap="http://fasb.org/us-gaap/2025" xmlns:lfvn="http://www.lifevantage.com/20250630" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:cyd="http://xbrl.sec.gov/cyd/2025" xmlns="http://www.w3.org/1999/xhtml" xmlns:ecd="http://xbrl.sec.gov/ecd/2025" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:dei="http://xbrl.sec.gov/dei/2025" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>lfvn-20250630</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="c-1" name="dei:EntityCentralIndexKey" id="f-33">0000849146</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="dei:AmendmentFlag" format="ixt:fixed-false" id="f-34">false</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="dei:DocumentFiscalYearFocus" id="f-35">2025</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="dei:DocumentFiscalPeriodFocus" id="f-36">FY</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="us-gaap:RevenueFromContractWithCustomerProductAndServiceExtensibleList" id="f-140">http://fasb.org/us-gaap/2025#ProductMember</ix:nonNumeric><ix:nonNumeric contextRef="c-8" name="us-gaap:RevenueFromContractWithCustomerProductAndServiceExtensibleList" id="f-141">http://fasb.org/us-gaap/2025#ProductMember</ix:nonNumeric><ix:nonNumeric contextRef="c-83" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" id="f-495">P3Y</ix:nonNumeric><ix:nonFraction unitRef="number" contextRef="c-109" decimals="4" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" scale="0" id="f-618">0.3333</ix:nonFraction><ix:nonFraction unitRef="number" contextRef="c-110" decimals="4" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" scale="0" id="f-619">0.0833</ix:nonFraction><ix:nonNumeric contextRef="c-113" name="us-gaap:LesseeOperatingLeaseTermOfContract" id="f-748">P1Y</ix:nonNumeric><ix:nonFraction unitRef="segment" contextRef="c-1" decimals="INF" name="us-gaap:NumberOfOperatingSegments" id="f-852">1</ix:nonFraction></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="lfvn-20250630.xsd"/></ix:references><ix:resources><xbrli:unit id="usd"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:unit id="shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:unit id="usdPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:unit id="number"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:unit id="lease"><xbrli:measure>lfvn:lease</xbrli:measure></xbrli:unit><xbrli:unit id="region"><xbrli:measure>lfvn:region</xbrli:measure></xbrli:unit><xbrli:unit id="productline"><xbrli:measure>lfvn:productLine</xbrli:measure></xbrli:unit><xbrli:unit id="segment"><xbrli:measure>lfvn:segment</xbrli:measure></xbrli:unit><xbrli:context id="c-1"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2024-07-01</xbrli:startDate><xbrli:endDate>2025-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-2"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-3"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2025-09-03</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-4"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:IndividualAxis">lfvn:MichaelBeindorffMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-04-01</xbrli:startDate><xbrli:endDate>2025-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-5"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:IndividualAxis">lfvn:MichaelBeindorffMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-6"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2025-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-7"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2024-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-8"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2023-07-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-9"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-10"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-11"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-12"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-13"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-14"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-07-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-15"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-07-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-16"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-07-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-17"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-07-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-18"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-19"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-20"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-21"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-22"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-07-01</xbrli:startDate><xbrli:endDate>2025-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-23"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-07-01</xbrli:startDate><xbrli:endDate>2025-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-24"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-07-01</xbrli:startDate><xbrli:endDate>2025-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-25"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-07-01</xbrli:startDate><xbrli:endDate>2025-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-26"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-27"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-28"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-29"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-30"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2018-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-31"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:InventoryValuationReserveMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-32"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:InventoryValuationReserveMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-33"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:InventoryValuationReserveMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-07-01</xbrli:startDate><xbrli:endDate>2025-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-34"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:InventoryValuationReserveMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-07-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-35"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:InventoryValuationReserveMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-36"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-37"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-38"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-39"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:VehiclesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-40"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">lfvn:CashAccountsHeldPrimarilyAtFinancialInstitutionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-07-01</xbrli:startDate><xbrli:endDate>2025-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-41"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">lfvn:CashAccountsHeldatOtherFinancialInstitutionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-07-01</xbrli:startDate><xbrli:endDate>2025-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-42"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:SalesReturnsAndAllowancesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-43"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:SalesReturnsAndAllowancesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-44"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:SalesReturnsAndAllowancesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-07-01</xbrli:startDate><xbrli:endDate>2025-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-45"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:SalesReturnsAndAllowancesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-07-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-46"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:SalesReturnsAndAllowancesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-47"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-48"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-49"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-50"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-51"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-52"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:VehiclesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-53"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:PatentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-54"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:PatentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-55"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-56"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-57"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">lfvn:March2016TermLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2016-03-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-58"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">lfvn:March2016RevolvingLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2016-03-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-59"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">lfvn:March2016RevolvingLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-04-12</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-60"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">lfvn:March2016RevolvingLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-61"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">lfvn:March2016RevolvingLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-62"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-63"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-07-01</xbrli:startDate><xbrli:endDate>2025-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-64"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-07-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-65"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">lfvn:EmployeeStockPurchasePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-07-01</xbrli:startDate><xbrli:endDate>2025-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-66"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">lfvn:EmployeeStockPurchasePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-07-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-67"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-02-17</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-68"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2023-08-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-69"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2024-07-01</xbrli:startDate><xbrli:endDate>2024-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-70"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2024-10-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-71"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-72"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2025-04-01</xbrli:startDate><xbrli:endDate>2025-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-73"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2023-09-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-74"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2023-10-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-75"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-76"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2023-07-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-77"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2024-04-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-78"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">lfvn:TwoThousandSeventeenLongTermIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-07-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-79"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">lfvn:TwoThousandSeventeenLongTermIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-11-09</xbrli:startDate><xbrli:endDate>2023-11-09</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-80"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">lfvn:TwoThousandSeventeenLongTermIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-81"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">lfvn:TwoThousandSeventeenLongTermIncentivePlanExcludingTwoThousandAndTenLongTermIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-02-02</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-82"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">lfvn:TwoThousandAndTenLongTermIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-02-02</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-83"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">lfvn:TwoThousandSeventeenLongTermIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-07-01</xbrli:startDate><xbrli:endDate>2025-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-84"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">lfvn:TwoThousandSeventeenLongTermIncentivePlanExcludingTwoThousandAndTenLongTermIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-02-16</xbrli:startDate><xbrli:endDate>2017-02-16</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-85"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">lfvn:EmployeeStockPurchasePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-08-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-86"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">lfvn:EmployeeStockPurchasePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-87"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">lfvn:TwoThousandAndTenAndTwoThousandSeventeenLongTermIncentivePlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-88"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">lfvn:TwoThousandAndTenAndTwoThousandSeventeenLongTermIncentivePlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-07-01</xbrli:startDate><xbrli:endDate>2025-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-89"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-90"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-91"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-92"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-93"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-11-03</xbrli:startDate><xbrli:endDate>2023-11-03</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-94"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-11-03</xbrli:startDate><xbrli:endDate>2023-11-03</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-95"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">lfvn:PerformanceStockUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-11-03</xbrli:startDate><xbrli:endDate>2023-11-03</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-96"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-97"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-07-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-98"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-99"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-07-01</xbrli:startDate><xbrli:endDate>2025-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-100"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-101"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">lfvn:PerformanceStockUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-102"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">lfvn:PerformanceStockUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-103"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">lfvn:PerformanceStockUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-104"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">lfvn:PerformanceStockUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-105"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">lfvn:PerformanceStockUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-07-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-106"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">lfvn:PerformanceStockUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-107"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">lfvn:PerformanceStockUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-07-01</xbrli:startDate><xbrli:endDate>2025-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-108"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">lfvn:PerformanceStockUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-109"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-110"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheTwoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-111"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-112"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-113"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-114"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-115"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lfvn:ReportableSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-07-01</xbrli:startDate><xbrli:endDate>2025-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-116"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lfvn:ReportableSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-07-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-117"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-118"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-119"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:JP</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-120"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:JP</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-121"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">lfvn:OtherForeignMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-122"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">lfvn:OtherForeignMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-123"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-124"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-125"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-07-01</xbrli:startDate><xbrli:endDate>2025-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-126"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-07-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-127"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:JP</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-07-01</xbrli:startDate><xbrli:endDate>2025-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-128"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:JP</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-07-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-129"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">lfvn:OtherForeignMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-07-01</xbrli:startDate><xbrli:endDate>2025-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">lfvn:OtherForeignMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-07-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-07-01</xbrli:startDate><xbrli:endDate>2025-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-132"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-07-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-133"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lfvn:ProtandimandTrueScienceProductLineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-07-01</xbrli:startDate><xbrli:endDate>2025-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-134"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lfvn:ProtandimandTrueScienceProductLineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-07-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-135"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lfvn:ProtandimMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-07-01</xbrli:startDate><xbrli:endDate>2025-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-136"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lfvn:ProtandimMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-07-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-137"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lfvn:LifeVantageTrueScienceSkinCareRegimenMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-07-01</xbrli:startDate><xbrli:endDate>2025-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-138"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lfvn:LifeVantageTrueScienceSkinCareRegimenMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-07-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-139"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lfvn:TrueScienceProductLineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-07-01</xbrli:startDate><xbrli:endDate>2025-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-140"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lfvn:TrueScienceProductLineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-07-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-141"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lfvn:AXIOProductLineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-07-01</xbrli:startDate><xbrli:endDate>2025-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-142"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lfvn:AXIOProductLineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-07-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-143"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lfvn:PhysIQProductLineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-07-01</xbrli:startDate><xbrli:endDate>2025-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-144"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lfvn:PhysIQProductLineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-07-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-145"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lfvn:PetandimProductLineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-07-01</xbrli:startDate><xbrli:endDate>2025-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-146"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lfvn:PetandimProductLineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-07-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-147"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-07-01</xbrli:startDate><xbrli:endDate>2025-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-148"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-07-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="i7a9d1ca723db478892511ede354648f3_1"></div><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:18pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:18pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">WASHINGTON, D.C. 20549</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6pt;font-weight:700;line-height:120%">________________________________________________________________________________</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:18pt;font-weight:700;line-height:120%">FORM <ix:nonNumeric contextRef="c-1" name="dei:DocumentType" id="f-1">10-K</ix:nonNumeric> </span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">(Mark One)</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:4.747%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:93.053%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:DocumentAnnualReport" format="ixt:fixed-true" id="f-2">&#9746;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></div></td></tr></table></div><div style="text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;For the fiscal year ended <ix:nonNumeric contextRef="c-1" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="f-4"><ix:nonNumeric contextRef="c-1" name="dei:CurrentFiscalYearEndDate" format="ixt:date-monthname-day-en" id="f-3">June&#160;30</ix:nonNumeric>, 2025</ix:nonNumeric> </span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:4.747%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:93.053%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:DocumentTransitionReport" format="ixt:fixed-false" id="f-5">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></div></td></tr></table></div><div style="text-align:center;text-indent:24.75pt"><span><br/></span></div><div style="text-align:center;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">For the transition period from __________ to __________ </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Commission file number <ix:nonNumeric contextRef="c-1" name="dei:EntityFileNumber" id="f-6">001-35647</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6pt;font-weight:700;line-height:120%">________________________________________________________________________________</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:24pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityRegistrantName" id="f-7">LIFEVANTAGE CORP</ix:nonNumeric>ORATION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">(Exact Name of Registrant as Specified in its Charter)</span></div><div style="margin-bottom:8pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:37.057%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:37.353%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen" id="f-8">Delaware</ix:nonNumeric></span></td><td colspan="6" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityTaxIdentificationNumber" id="f-9">90-0224471</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">(State or Other Jurisdiction of</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">Incorporation or Organization)</span></div></td><td colspan="6" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">(I.R.S. Employer</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">Identification No.)</span></div></td></tr></table></div><div style="margin-bottom:8pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:37.057%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:37.353%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressAddressLine1" id="f-10">3300 N. Triumph Blvd</ix:nonNumeric>, <ix:nonNumeric contextRef="c-1" name="dei:EntityAddressAddressLine2" id="f-11">Suite 700</ix:nonNumeric></span></div></td><td colspan="6" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">&#160;<ix:nonNumeric contextRef="c-1" name="dei:EntityAddressPostalZipCode" id="f-12">84043</ix:nonNumeric> </span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressCityOrTown" id="f-13">Lehi</ix:nonNumeric>, <ix:nonNumeric contextRef="c-1" name="dei:EntityAddressStateOrProvince" format="ixt-sec:stateprovnameen" id="f-14">Utah</ix:nonNumeric></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">(Address of Principal Executive Office)</span></td><td colspan="6" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">(Zip Code.)</span></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">(<ix:nonNumeric contextRef="c-1" name="dei:CityAreaCode" id="f-15">801</ix:nonNumeric>) <ix:nonNumeric contextRef="c-1" name="dei:LocalPhoneNumber" id="f-16">432-9000</ix:nonNumeric> </span></div><div style="margin-bottom:8pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:120%">Registrant's telephone number, including area code</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Securities registered pursuant to Section&#160;12(b) of the Act:</span></div><div style="margin-bottom:8pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:31.744%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:31.744%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:31.746%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:Security12bTitle" id="f-17">Common Stock, par value $0.0001</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:TradingSymbol" id="f-18">LFVN</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="f-19">The Nasdaq Stock Market LLC</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">Title of each class</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">Trading Symbol(s)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">Name of each exchange on which registered</span></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Securities registered pursuant to Section&#160;12(g) of the Act: None</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6pt;font-weight:700;line-height:120%">________________________________________________________________________________</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.    Yes&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9744;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="c-1" name="dei:EntityWellKnownSeasonedIssuer" id="f-20">No</ix:nonNumeric>&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9746;</span></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark if the registrant is not required to file reports pursuant to Section&#160;13 or Section&#160;15(d) of the Act.    Yes&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9744;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="c-1" name="dei:EntityVoluntaryFilers" id="f-21">No</ix:nonNumeric>&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9746;</span></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant (1)&#160;has filed all reports required to be filed by Section&#160;13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2)&#160;has been subject to such filing requirements for the past 90 days.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="c-1" name="dei:EntityCurrentReportingStatus" id="f-22">Yes</ix:nonNumeric>&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9746;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;No&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9744;</span></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="c-1" name="dei:EntityInteractiveDataCurrent" id="f-23">Yes</ix:nonNumeric>&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9746;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;No&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9744;</span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221; &#8220;smaller reporting company,&#8221; and &#8220;emerging growth company&#8221; in Rule 12b-2 of the Exchange Act.</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:42.613%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.285%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.502%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:42.613%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.287%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Large&#160;accelerated&#160;filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#9744;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityFilerCategory" format="ixt-sec:entityfilercategoryen" id="f-24">Accelerated filer</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#9746;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Non-accelerated filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#9744;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Smaller&#160;reporting&#160;company</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntitySmallBusiness" format="ixt:fixed-true" id="f-25">&#9746;</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Emerging growth company</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityEmergingGrowthCompany" format="ixt:fixed-false" id="f-26">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr></table></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9744;</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant has filed a report on and attestation to its management&#8217;s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report. </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:IcfrAuditorAttestationFlag" format="ixt:fixed-true" id="f-27">&#9746;</ix:nonNumeric></span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">If securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of the registrant included in the filing reflect the correction of an error to previously issued financial statements. </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:DocumentFinStmtErrorCorrectionFlag" format="ixt:fixed-false" id="f-28">&#9744;</ix:nonNumeric></span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive-based compensation received by any of the registrant&#8217;s executive officers during the relevant recovery period pursuant to &#167;240.10D-1(b). </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9744;</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act).&#160;&#160;&#160;&#160;Yes&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9744;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;No&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityShellCompany" format="ixt:fixed-false" id="f-29">&#9746;</ix:nonNumeric></span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The aggregate market value of the registrant&#8217;s common stock held by non-affiliates as of December&#160;31, 2024, the last business day of the registrant&#8217;s most recently completed second fiscal quarter, was approximately $<ix:nonFraction unitRef="usd" contextRef="c-2" decimals="-5" name="dei:EntityPublicFloat" scale="6" id="f-30">220.0</ix:nonFraction> million, based on a closing market price of $17.49 per share. </span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The number of shares of common stock (par value $0.0001) outstanding as of September&#160;3, 2025 was</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> <ix:nonFraction unitRef="shares" contextRef="c-3" decimals="INF" name="dei:EntityCommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-31">12,691,009</ix:nonFraction> s</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">hares.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6pt;font-weight:700;line-height:120%">________________________________________________________________________________</span></div><div style="text-align:center"><span><br/></span></div><div style="margin-bottom:8pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">DOCUMENTS INCORPORATED BY REFERENCE</span></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:DocumentsIncorporatedByReferenceTextBlock" id="f-32" escape="true">Portions of the registrant&#8217;s definitive proxy statement to be filed subsequent to the date hereof with the Securities and Exchange Commission pursuant to Regulation 14A in connection with the registrant&#8217;s fiscal year 2026 annual meeting of stockholders are incorporated by reference into Part III of this report. Such definitive proxy statement will be filed with the Commission not later than 120 days after the end of the registrant&#8217;s fiscal year ended June 30, 2025.</ix:nonNumeric> </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="i7a9d1ca723db478892511ede354648f3_7"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Certain statements contained in this report and the information incorporated by reference herein may contain &#8220;forward-looking statements&#8221; (as such term is defined in Section&#160;27A of the Securities Act of 1933, as amended, and Section&#160;21E of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;)). These statements, which involve risks and uncertainties, reflect our current expectations, intentions, or strategies regarding our possible future results of operations, performance, and achievements. Forward-looking statements include, without limitation: statements regarding future products or product development; statements regarding future selling, general and administrative costs and research and development spending; statements regarding the future performance of our network marketing efforts; statements regarding our expectations regarding ongoing litigation; statements regarding international growth; and statements regarding future financial performance, results of operations, capital expenditures and sufficiency of capital resources to fund our operating requirements. These forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 and applicable rules of the Securities and Exchange Commission (&#8220;SEC&#8221;) and common law.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">These forward-looking statements may be identified in this report and the information incorporated by reference by words such as &#8220;anticipate,&#8221; &#8220;believe,&#8221; &#8220;could,&#8221; &#8220;estimate,&#8221; &#8220;expect,&#8221; &#8220;intend,&#8221; &#8220;plan,&#8221; &#8220;predict,&#8221; &#8220;project,&#8221; &#8220;should&#8221; and similar terms and expressions, including references to assumptions and strategies. These statements reflect our current beliefs and are based on information currently available to us. Accordingly, these statements are subject to certain risks, uncertainties, and contingencies, which could cause our actual results, performance, or achievements to differ materially from those expressed in, or implied by, such statements.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The following factors are among those that may cause actual results to differ materially from our forward-looking statements:</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Inability to properly manage, motivate and retain our independent consultants (which we previously referred to as &#8220;distributors&#8221; in our prior filings) or to attract new customers and independent consultants on an ongoing basis;</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Non-compliance by our independent consultants with applicable legal requirements or our policies and procedures;</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Changes to our independent consultant compensation plans;</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Dependence upon a few products for revenue;</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Dependence on third parties to manufacture our products;</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Sourcing and pricing of high quality materials for our products;</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Disruptions to the transportation channels used to distribute our products;</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Risk of being subject to a product recall;</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Product liability claims against us;</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Competition in the dietary supplement and personal care markets;</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Unfavorable publicity on our business or products; </span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Actions by activist stockholders;</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Loss of or inability to attract key personnel;</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Risk of being held responsible for certain taxes or assessments and other obligations relating to the activity of our independent consultants;</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Risk related to Global Not For Resale program;</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Inability to comply with evolving laws, regulations, standards, policies, and contractual obligations related to data privacy and security, including cybersecurity; </span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Inability to manage existing markets, open new international markets or expand our operations;</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Inability of new products and technological innovations to gain customer or independent consultant or market acceptance;</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Inability to execute our product launch process due to increased pressure on our supply chain, information systems and management;</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">2</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Inability to appropriately manage our inventory;</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Disruptions in our information technology (&#8220;IT&#8221;) systems, including as a result of cybersecurity incidents;</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Inability to comply with financial covenants imposed by our credit facility and the impact of debt service obligations and restrictive debt covenants;</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">International trade or foreign exchange restrictions, increased tariffs, and foreign currency exchange fluctuations;</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Inability to raise additional capital or complete desired acquisitions;</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Strict government regulations on our business;</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Regulations governing the production or marketing of our products;</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Risk of investigatory and enforcement action;</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Risk of our direct selling program being found non-compliant with current or newly adopted laws or regulations in various markets;</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Laws and regulations prohibiting or severely restricting direct selling;</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">International regulatory and business risks, including failure to comply with anti-corruption laws;</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Inability to protect our intellectual property rights;</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Third party intellectual property infringement claims;</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Volatility of the market price of our common stock; </span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Risk of substantial sales of shares negatively impacting the market price of our common stock;</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Inability of share repurchase program enhancing long-term stockholder value;</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Risk of additional shares issued diluting voting power of current outstanding common stock or causing decline in stock price;</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Potential delisting of our common stock due to non-compliance with Nasdaq&#8217;s continued listing requirements;</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Risks related to being a smaller reporting company;</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Limitations for disputes, mergers, tender offers, or proxy contests under Delaware law;</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Expensive and time consuming legal proceedings;</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Ineffectiveness of internal controls over financial reporting;</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Challenges to tax positions or transfer pricing policies or change in laws;</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Economic, political, foreign exchange and other risks associated with international operations, including consumer discretionary spending habits;</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Unfavorable global economic conditions;</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Securities class action litigation; and</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Securities or industry analysts ceasing coverage or publishing inaccurate or unfavorable research.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">When considering these forward-looking statements, you should keep in mind the cautionary statements in this report and the documents incorporated by reference. Except as required by law, we have no obligation and do not undertake to update or revise any such forward-looking statements to reflect events or circumstances after the date of this report.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">SUMMARY OF RISKS ASSOCIATED WITH OUR BUSINESS</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We face risks and uncertainties associated with our business, many of which are beyond our control. Some of the more significant risks associated with our business that may cause actual results to differ materially from our forward-looking statements include the following:</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">An inability to properly motivate and incentivize sales from our independent consultants could harm our business.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">3</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">If we are unable to retain our existing customers and independent consultants or attract additional customers and independent consultants, our revenue will not increase and may decline further.</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our independent consultants could fail to comply with applicable legal requirements or our policies and procedures, which could result in claims against us that could harm our business.</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We primarily depend on a few products for our revenue.</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We are dependent upon third parties to manufacture our products.</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We are subject to evolving laws, policies, and contractual obligations related to data privacy and security, including cybersecurity, and our actual or perceived failure to comply with such obligations or the actual or perceived failure to maintain the integrity of our data could expose us to data loss or litigation, harm our reputation, subject us to significant fines and liability, or otherwise adversely affect our business, prospects, financial condition, and operating results.</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%"> </span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We are subject to risks related to product recalls.</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our business is susceptible to product liability claims.</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Many of the markets in which we compete for business, including the dietary supplement and personal care markets, are highly competitive. We may not be able to compete effectively, which may have a material adverse effect on our results of operations and financial condition.</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Actions of activist stockholders have, and could continue to, impact the pursuit of our business strategies, cause us to incur substantial costs, divert our management&#8217;s attention and resources, and adversely affect our business, results of operations, financial condition, and the trading price of our common stock.</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We are subject to risks related to a Global Not For Resale Program.</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">If we are able to expand our operations, we may experience difficulties in managing our future growth, which could adversely affect our business.</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Inability of new products and technological innovations to gain market acceptance by customers and/or independent consultants could harm our business.</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our business could be negatively impacted if we fail to execute our product launch process due to increased pressure on our supply chain, information systems and management.</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We rely on our IT systems to manage numerous aspects of our business, and a disruption in these systems, including as a result of cybersecurity incidents, could adversely affect our business.</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">A substantial portion of our business is conducted in foreign markets, exposing us to the risks of trade or foreign exchange restrictions, increased tariffs, foreign currency fluctuations, disruptions or conflicts with our third-party importers and similar risks associated with foreign operations.</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our business is subject to strict government regulations.</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our direct selling program could be found to be not in compliance with current or newly adopted laws or regulations in one or more markets, which could prevent us from conducting our business in these markets and harm our financial condition and operating results.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">4</span></div></div></div><div id="i7a9d1ca723db478892511ede354648f3_10"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">TABLE OF CONTENTS</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:91.128%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.672%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Page</span></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7a9d1ca723db478892511ede354648f3_13">PART I</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7a9d1ca723db478892511ede354648f3_16">Item&#160;1. Business</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7a9d1ca723db478892511ede354648f3_16">6</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7a9d1ca723db478892511ede354648f3_178">Item&#160;1A. Risk Factors</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7a9d1ca723db478892511ede354648f3_178">26</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7a9d1ca723db478892511ede354648f3_196">Item&#160;1B. Unresolved Staff Comments</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7a9d1ca723db478892511ede354648f3_196">43</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7a9d1ca723db478892511ede354648f3_199">Item&#160;1C. Cybersecurity</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7a9d1ca723db478892511ede354648f3_199">43</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7a9d1ca723db478892511ede354648f3_202">Item&#160;2. Properties</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7a9d1ca723db478892511ede354648f3_202">44</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7a9d1ca723db478892511ede354648f3_205">Item&#160;3. Legal Proceedings</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7a9d1ca723db478892511ede354648f3_205">44</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7a9d1ca723db478892511ede354648f3_208">Item&#160;4. Mine Safety Disclosures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7a9d1ca723db478892511ede354648f3_208">44</a></span></div></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7a9d1ca723db478892511ede354648f3_211">PART II</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7a9d1ca723db478892511ede354648f3_214">Item 5. Market for Registrant&#8217;s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7a9d1ca723db478892511ede354648f3_214">44</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7a9d1ca723db478892511ede354648f3_232">Item&#160;6. Reserved</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7a9d1ca723db478892511ede354648f3_232">46</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7a9d1ca723db478892511ede354648f3_235">Item&#160;7. Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7a9d1ca723db478892511ede354648f3_235">46</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7a9d1ca723db478892511ede354648f3_262">Item&#160;7A. Quantitative and Qualitative Disclosures About Market Risk</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7a9d1ca723db478892511ede354648f3_262">55</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7a9d1ca723db478892511ede354648f3_265">Item&#160;8. Financial Statements and Supplementary Data</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7a9d1ca723db478892511ede354648f3_265">55</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7a9d1ca723db478892511ede354648f3_268">Item&#160;9. Changes in and Disagreements with Accountants on Accounting and Financial Disclosure</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7a9d1ca723db478892511ede354648f3_268">55</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7a9d1ca723db478892511ede354648f3_271">Item&#160;9A. Controls and Procedures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7a9d1ca723db478892511ede354648f3_271">55</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7a9d1ca723db478892511ede354648f3_274">Item&#160;9B. Other Information</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7a9d1ca723db478892511ede354648f3_274">56</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7a9d1ca723db478892511ede354648f3_277">Item&#160;9C. Disclosure Regarding Foreign Jurisdictions that Prevent Inspections</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7a9d1ca723db478892511ede354648f3_277">56</a></span></div></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7a9d1ca723db478892511ede354648f3_280">PART III</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7a9d1ca723db478892511ede354648f3_283">Item&#160;10. Directors, Executive Officers and Corporate Governance</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7a9d1ca723db478892511ede354648f3_283">56</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7a9d1ca723db478892511ede354648f3_286">Item&#160;11. Executive Compensation</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7a9d1ca723db478892511ede354648f3_286">56</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7a9d1ca723db478892511ede354648f3_289">Item 12. Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7a9d1ca723db478892511ede354648f3_289">56</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7a9d1ca723db478892511ede354648f3_292">Item&#160;13. Certain Relationships and Related Transactions, and Director Independence</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7a9d1ca723db478892511ede354648f3_292">56</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7a9d1ca723db478892511ede354648f3_295">Item&#160;14. Principal Accountant Fees and Services</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7a9d1ca723db478892511ede354648f3_295">56</a></span></div></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7a9d1ca723db478892511ede354648f3_298">PART IV</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7a9d1ca723db478892511ede354648f3_301">Item&#160;15. Exhibits, Financial Statement Schedules</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7a9d1ca723db478892511ede354648f3_301">57</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7a9d1ca723db478892511ede354648f3_307">Signatures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7a9d1ca723db478892511ede354648f3_307">60</a></span></div></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">5</span></div></div></div><div id="i7a9d1ca723db478892511ede354648f3_13"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">PART I</span></div><div id="i7a9d1ca723db478892511ede354648f3_16"></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">ITEM&#160;1 &#8212; BUSINESS</span></div><div id="i7a9d1ca723db478892511ede354648f3_19"></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Overview</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">LifeVantage Corporation (the &#8220;Company,&#8221; &#8220;LifeVantage,&#8221; &#8220;we,&#8221; &#8220;us,&#8221; or &#8220;our&#8221;) is a company focused on nutrigenomics, the study of how nutrition and naturally occurring compounds affect human genes to support good health. LifeVantage is dedicated to helping people achieve their health, wellness and financial goals. We provide quality, scientifically validated products to customers and independent consultants as well as a financially rewarding commission-based direct sales opportunity to our independent consultants. We sell our products in the United States, Mexico, Japan, Australia, Hong Kong, Canada, Thailand, the United Kingdom, the Netherlands, Germany, Taiwan, Austria, Spain, Ireland, Belgium, New Zealand, and Singapore. We also sell our products in a number of countries to customers for personal consumption only. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We engage in the identification, research, development, formulation and sale of advanced nutrigenomic activators, dietary supplements, weight management products, pre- and pro-biotics, skin and hair care products, and nootropics. Our product lines include: Protandim</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">, our flagship line of scientifically validated dietary supplements; LifeVantage</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">, our line of dietary supplements that include the MindBody GLP-1 System</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#8482;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:1.41pt;vertical-align:baseline">,</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"> </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Omega+, ProBio, IC Bright</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">, the Rise AM &amp; Reset PM System</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">, D3+, and Daily Wellness; PhysIQ</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#8482;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">, our</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"> </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Fat Burn and Prebiotic dietary supplements; TrueScience</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">, our line of skin and hair care products and Liquid Collagen; Petandim</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">, our companion pet supplement formulated to combat oxidative stress in dogs; and AXIO</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">, our nootropic energy drink mixes.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We were incorporated in Colorado in June 1988 under the name Andraplex Corporation. We changed our corporate name to Yaak River Resources, Inc. in January 1992 and subsequently changed it again in October 2004 to Lifeline Therapeutics, Inc. In October 2004 and March 2005, we acquired all of the outstanding common stock of Lifeline Nutraceuticals Corporation. In November 2006, we changed our name to LifeVantage Corporation. From our fiscal year 2005 until our fiscal year 2009, we marketed and sold a single product, Protandim</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">, through traditional retail stores. In October 2008, we announced that we were transitioning our business model from a traditional retail model to a direct sales model in which Protandim</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> would be sold primarily through a network of independent consultants. Since entering direct sales, we have increased our geographic reach by entering new international markets and increased our product offering by introducing additional scientifically validated products.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In 2018, we reincorporated from the State of Colorado to the State of Delaware.</span></div><div id="i7a9d1ca723db478892511ede354648f3_22"></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Fiscal Year 2025 Highlights</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">New Product Offerings</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In fiscal year 2025, we launched the next evolution in activation, the patent-pending MindBody GLP-1 System</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#8482; </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">consisting of MB Core</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#8482;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> and MB Enhance</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#8482;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">. With ingredients backed by science and formulas designed to support the body&#8217;s natural production of the GLP-1 hormone, the MindBody GLP-1 System</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#8482; </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">helps balance signals along the gut-brain axis to turn down food noise, reduce hunger, and quiet cravings over time. The system is designed to help reshape relationships with food for a sustainable way to make the changes necessary to support wellness and weight loss goals. We also launched a new AXIO</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> limited-edition Tiger&#8217;s Blood flavor. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">A summary of the various product introductions by market in fiscal year 2025 is as follows:</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">In the United States, we introduced the MindBody GLP-1 System</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#8482; </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">and an event-exclusive AXIO</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> limited-edition Tiger&#8217;s Blood flavor at our Global Convention in Salt Lake City, Utah. The United States also reintroduced AXIO</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> Decaf Peach Nectarine as a permanent flavor, TrueScience</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> TruePout Hydrating Lip Oil as a limited-edition holiday item and Mother&#8217;s Day gift with purchase, Protandim</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> Tri-Synergizer</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> with an event-exclusive label for Global Convention, and TrueScience</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> Hand Cream in Coastal Breeze and Mango Blossom, available exclusively through the Rewards Circle loyalty program.</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">In Japan, we introduced the MB System</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#8482;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> (an international formulation of the MindBody GLP-1 System</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#8482; </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">) and reintroduced TrueScience</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> TrueProtect as a limited-edition item during the summer months.</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">In Australia and New Zealand, we introduced the MB System</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#8482;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> and TrueScience</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174; </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Hand Cream in Mango Blossom, available exclusively through the Rewards Circle loyalty program.</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">In Canada, we introduced Protandim</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> NAD Synergizer</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174; </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">and a clean, caffeinated AXIO</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> in Dragon Fruit flavor.</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">In Mexico, Europe, and Taiwan, we introduced the MB System</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#8482;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">. </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">6</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">In Thailand, we launched the MB Set</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#8482;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> (the Thai name for the MB System</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#8482;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">).</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Technology Innovation </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We continued to develop, enhance and improve the LifeVantage experience using technology. We pioneered new ways to interact with our independent consultants that give us and our independent consultant leaders valuable insight into the activities of the broader independent consultant base. We provided independent consultants with tools and communications that help simplify business activities, by providing step-by-step instruction for starting their business, and ways to improve the prospecting of potential consultants and customers. </span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Nutrigenomic Culture &amp; Activating Wellness </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We continue to own our message of activation by developing products that empower the body to work as designed with nutrients that activate internal processes to support vibrant health at any age. Nutrigenomics and cellular activation are cutting-edge trends in our industry that support our unique position in the market and leverage our core competencies and existing products. Activation is the guiding principle of our culture and is the key underlying message for our independent consultants and customers. We continue capitalizing on this message by highlighting how LifeVantage has used the concept of activation and expanded it to every aspect of our business, with our brand message of &#8220;activating wellness.&#8221; By focusing on wellness, we are able to apply activation not only to our products, which support physical, mental, and emotional health, but also our business opportunity, which supports financial, social, and spiritual health. The &#8220;activating wellness&#8221; message is featured across our communications with our independent consultants and in our brand and marketing materials. In fiscal year 2025, the brand message of activation and &#8220;activating wellness&#8221; was strengthened by introducing the innovative, patent-pending MindBody GLP-1</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"> </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">System</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#8482;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> consisting of MB Core</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#8482;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> and MB Enhance</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#8482;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">. Research from a cell culture study on the active ingredient blends in the MindBody GLP-1 System</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#8482;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> revealed that the two products work together to directly activate the GLP-1 pathway and encourage L-cells to produce more GLP-1 hormone naturally. MB Enhance</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#8482;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> also fuels GLP-1 production indirectly by creating an optimal environment in the gut microbiome. Additionally, when both products are used together, they have been shown to reduce the enzyme that breaks down GLP-1 and help promote an increase in GLP-1 cell receptors.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Red Carpet Program</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In fiscal year 2025, we continued to grow through our red-carpet program, which is designed to attract and incentivize experienced direct selling sales leaders to join LifeVantage. Red carpet leaders are identified by our independent consultants who facilitate the relationship between the potential red carpet leader and LifeVantage. Our corporate team does not actively engage in recruiting leaders for the red carpet program. We remain optimistic that this program will help drive long term revenue growth for our business. We have increased red carpet leadership enrollments and hope to see improved retention and active independent consultant and customer counts as a result of this program. </span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Rewards Circle Loyalty Program</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In March 2023, we launched our Rewards Circle customer loyalty program to drive retention in the United States, Australia, New Zealand, and Japan. In February 2024, Rewards Circle was expanded to Canada, Europe, and Mexico. Rewards Circle rewards customers who demonstrate loyalty through subscription purchases with discount credits to redeem on future purchases. In August 2024, Rewards Circle was expanded to also reward independent consultant subscription purchases in the United States, Australia, and New Zealand markets.</span></div><div id="i7a9d1ca723db478892511ede354648f3_25"></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Our Competitive Advantages</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We believe we have a competitive advantage in several key areas:</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;text-decoration:underline">Our Sales Compensation</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">: We believe our sales compensation plan engineered for our independent consultants is one of the more financially rewarding plans in the direct selling industry and in line with direct selling industry standards.  Our sales compensation plan also enables independent consultants to earn compensation early and often as they sell our products. Some elements of our sales compensation plan are calculated and paid daily to eligible independent consultants and others are calculated and paid weekly or monthly, allowing new independent consultants to receive their sales commissions more quickly. We believe the ease of more frequent sales commission payments helps us attract and then retain new independent consultants by allowing them to receive their commission payments as soon as possible after making qualified product sales. We also offer a variety of incentives to our independent consultants for achieving specified product sales goals. We believe our sales compensation plan provides motivation for our independent consultants to sell our products to customers and share the business opportunity with other entrepreneurs seeking to begin their own sales business. In 2023, we implemented a new compensation plan for our independent consultants in the United States, Australia, New Zealand and Japan markets. This compensation plan is known as our &#8220;Evolve Compensation Plan.&#8221; In February 2024, we launched the Evolve Compensation Plan for our independent </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">7</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">consultants in the Canada, Mexico, and Europe markets. In November 2024, we launched an optimized version of the Evolve Compensation Plan for our independent consultants in the United States, Japan, Australia, New Zealand, Canada, Mexico, and Europe markets. In March 2025, we launched the Evolve Compensation Plan for our independent consultants in other markets, including Taiwan, Hong Kong, and Singapore. We plan to roll out the Evolve Compensation Plan in Thailand once we receive the appropriate government approvals. </span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;text-decoration:underline">Our Products</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">: Our focus is on a differentiated approach to health activation through nutrigenomics and the study of how properly formulated and applied nutrition and naturally occurring compounds affect human genes to support good health. We have developed proprietary and exclusive scientifically validated activation products focused on helping individuals look, feel, and perform better. Our products are the Protandim</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> line of scientifically validated dietary supplements; the LifeVantage</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> line of dietary supplements that include the</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"> </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">new MindBody GLP-1 System</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#8482;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">,</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"> </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Omega+, ProBio, IC Bright</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">, the Rise AM &amp; Reset PM System</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">, D3+ and Daily Wellness; PhysIQ</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#8482;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> Fat Burn and Prebiotic dietary supplements; the TrueScience</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174; </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">line of skin and hair care products and Liquid Collagen; the Petandim</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174; </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">pet supplement formulated to combat oxidative stress in dogs; and the AXIO</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> line of nootropic energy drink mixes. We believe the significant number of customers who regularly and repeatedly purchase our products is a strong indicator of the health benefits of our products.</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">The Protandim</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> product line includes Protandim</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> NRF1 Synergizer</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">, Protandim</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> Nrf2 Synergizer</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">, and Protandim</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> NAD Synergizer</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">. The Protandim</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> NRF1 Synergizer</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> is formulated to increase cellular energy and performance by boosting mitochondria production to improve cellular repair and slow cellular aging. The Protandim</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> Nrf2 Synergizer</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> contains a proprietary blend of ingredients and has been shown to combat oxidative stress and enhance energy production by increasing the body&#8217;s natural antioxidant protection at the genetic level, inducing the production of naturally occurring protective antioxidant enzymes, including superoxide dismutase, catalase, and glutathione synthase. The Protandim</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> NAD Synergizer</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> was specifically formulated to target cell signaling pathways involved in the synthesis and recycling of a specific molecule called NAD (nicotinamide adenine dinucleotide), and it has been shown to double sirtuin activity, supporting increased health, focus, energy, mental clarity, and mood. Use of the three Protandim</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> products together (marketed as Protandim</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> Tri-Synergizer</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">) has been shown to produce &#8220;activation synergies&#8221; greater than using the individual products on their own. </span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">The LifeVantage</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> product line includes: the new MindBody GLP-1 System</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#8482;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">, a dietary supplement that combines two products, MB Core</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#8482;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> and MB Enhance</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#8482;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">, which are designed to support weight management and wellness by activating GLP-1 naturally and balancing signals along the gut-brain axis; Omega+, a dietary supplement that combines DHA and EPA omega-3 fatty acids, omega-7 fatty acids, and vitamin D3 to support cognitive health, cardiovascular health, skin health, and the immune system; ProBio, a dietary supplement designed to support optimal digestion and immune system function; Daily Wellness, a dietary supplement designed to support immune health; IC Bright</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">, a dietary supplement to help support eye and brain health, reduce eye fatigue and strain, support cognitive functions, and may help support normal sleep patterns; Rise AM &amp; Reset PM System</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">, a dietary supplement that uses Timewise Nutrient Delivery</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#8482;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> to provide the body with the right nutrients in the right amounts at the right time; and D3+, a dietary supplement that provides vitamin D3, vitamin K2, magnesium, calcium, and other trace minerals to support a balanced immune system, strong bones, and cardiovascular health.</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">PhysIQ</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#8482;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> Fat Burn is a dietary supplement designed to support weight-management. PhysIQ</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#8482;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> Prebiotic is a dietary supplement designed to support a healthy digestive tract. </span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Our TrueScience</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> line of skin and hair care products includes TrueScience</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> TrueClean Refining Cleanser, TrueScience</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> TrueRenew Daily Firming Complex, TrueScience</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> TrueLift Illuminating Eye Cream, TrueScience</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174; </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">TrueHydrate Brightening Moisturizer, TrueScience</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> TrueTone Perfecting Lotion, TrueScience</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> TrueProtect Daily Mineral Sunstick SPF 30, TrueScience</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> Perfecting Lotion, TrueScience</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> Hand Cream, TrueScience</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> Invigorating Shampoo, TrueScience</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> Nourishing Conditioner, TrueScience</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> Scalp Serum, and TrueScience</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174; </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Liquid Collagen. TrueScience</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174; </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Liquid Collagen activates, replenishes, and maintains collagen to support firmness and elasticity from within. It has been shown to have a synergistic effect with Protandim</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> Nrf2 Synergizer</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">, helping to break the cellular stress that prevents cells throughout the body from performing optimally. </span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Petandim</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> is a supplement specially formulated to combat oxidative stress in dogs through Nrf2 activation. </span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">AXIO</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> is our line of nootropic energy drink mixes formulated to promote alertness and support mental performance. </span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;text-decoration:underline">Technology-Enabled Consultant Training and Resources</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">: We are committed to providing our independent consultants with resources and training designed to promote productivity and their opportunity for successful sales and resulting </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">8</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">commissions. We are dedicated to using technology to facilitate a streamlined approach for independent consultants to manage their businesses and sell our products. The LifeVantage app, which is available for download on the Apple app store and Google Play store, is a custom-developed platform that provides new ways for us to interact with our independent consultants and gives us and our consultant leadership valuable insight into the sales activities of our consultant base. Ultimately, through artificial intelligence and machine learning, we expect that the app will be able to guide independent consultants on what to share, when to share it, and with whom to sell LifeVantage products. In addition, we provide other business and product training materials, and we encourage our independent consultants to participate in company-sponsored events, including conventions and sales promotions and incentives. </span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;text-decoration:underline">Our Culture</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">: We are committed to creating a culture for our independent consultants, their customers and our employees that focuses on ethical, legal, and transparent business practices. At enrollment, our independent consultants agree to abide by their contract with us, which includes our policies and procedures. These policies and procedures, when followed, are designed to ensure that our independent consultants comply with applicable laws and regulations. Our consultant compliance department monitors the activities of o</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">ur independent consultants </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">as part of our efforts to enforce our policies and procedures. Similarly, our code of business conduct and ethics sets forth guidelines and expectations for our employees. We believe our ethical, legal, and transparent culture attracts highly qualified employees and independent consultants who share our commitment to these principles.</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;text-decoration:underline">Global Customer Acquisition</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">: Our global customer acquisition program expands the number of countries where customers can purchase and use our products for personal consumption only. This program allows us to enter additional markets at low incremental cost and enables independent consultants to leverage customer sales through their international relationships outside of their home countries. The program initially launched in eight markets, many of which subsequently became fully open for business on-the-ground through a growing network of resident independent consultants. We have also entered into key strategic agreements with third parties based in the United States that helps customers ship LifeVantage products purchased in the U.S. throughout the world via their customer personal purchase and importation programs. We also expanded our Auto-Assigned Customer Program, which allows new customers to order directly through www.lifevantage.com without being required to go through an independent consultant on their initial order. At the initial order, new customers have an opportunity to be assigned to independent consultants, who may then benefit from the initial sale commission and are then incentivized to provide future product support and sales to the assigned customer. This program provides customers easier access to our innovative products while providing the opportunity of referrals to our independent consultant force.</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;text-decoration:underline">Our Employees</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">: We believe that our employees are an essential asset. We have a dedicated team of professionals that support our independent consultants, work to generate long-term value for our stockholders and contribute to the broader society through charitable programs, including the 501(c)(3) LifeVantage Legacy &#8211; an independent charitable organization focused on bettering the lives of children throughout the world. In turn, we offer competitive compensation and direct employee focus toward the short and long-term goals of our stockholders and independent consultants.</span></div><div id="i7a9d1ca723db478892511ede354648f3_28"></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Scientific Background</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The Normal Aging Process</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Aging in humans is a complex process driven by diverse changes in genetic, molecular, biochemical, and cellular events. This multifactorial process is ultimately characterized by a gradual decline in physiological functions and in the effectiveness of the intricate network of internal cellular communication referred to as cellular signaling. Theories as to why humans age include the oxidative stress theory, the mitochondrial theory, and the sirtuin theory. </span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Oxidative Stress Theory of Aging and the Nrf2 Pathway</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The oxidative stress theory of aging states that as humans age, we accumulate free radicals and other oxidants. If left unchecked, this oxidative stress can lead to serious consequences to the cell. Oxidative stress can ultimately lead to oxidative damage from attacks and damage to essential biological structures of the cell, which results in compromised cellular function.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Antioxidants are the cell&#8217;s primary defense against free radicals and other oxidants. There are two major classes of antioxidants: (1) dietary antioxidants obtained through food and nutritional supplements; and (2) endogenous antioxidants produced by the body. A 2013 review of the scientific literature led by the United States National Institutes of Health&#8217;s National Center for Complementary and Integrative Health concluded that &#8220;rigorous trials of antioxidant supplements in large numbers of people have not found that high doses of antioxidant supplements prevent disease.&#8221; Thus, much attention has shifted to the body&#8217;s endogenous antioxidant and detoxification systems. Endogenous antioxidants are antioxidants made by the body and are the primary line of defense against oxidative stress. In general, endogenous antioxidants either prevent oxidants from being formed, or remove them from the body. Endogenous antioxidants form a complex network of antioxidant metabolites and </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">9</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">enzymes. These networks work together, throughout the cell, to neutralize oxidants and protect important biological structures from oxidative damage.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Endogenous antioxidants can also be upregulated in times of increasing oxidative stress. The Nrf2 cellular signaling pathway is the primary pathway for upregulating endogenous antioxidant and other detoxification pathways. With age, the activity of this Nrf2 cellular signaling pathway has been shown to decrease &#8211; both in its ability to sense oxidative threats and ultimately upregulate its target genes.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Mitochondrial Theory of Aging and the NRF1 Pathway</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="background-color:#ffffff;color:#222222;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Mitochondria are membrane-bound cellular organelles that generate most of the chemical energy needed to power the cell's biochemical reactions. </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The mitochondria produce energy by breaking down food that has been ingested and capturing high-energy electrons in the process. When mitochondria are functioning properly, they harness the energy of these electrons to produce energy for the cell. At the end of this process, the mitochondria attach these electrons to molecular oxygen that ultimately get detoxified to water. However, this process is not perfectly efficient and, even in young, healthy mitochondria, electrons can escape, potentially forming free radicals and other oxidants. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The mitochondrial theory of aging states that as humans age, mitochondria function less efficiently, producing less energy and more free radicals and other oxidants. The reduction in energy production compromises cellular function. The increase in free radicals and other oxidants in turn damage structures of the cell, including the mitochondria. This mitochondrial damage goes on to further compromise mitochondrial function leading to a downward spiral of decreased mitochondrial efficiency and increased production of free radicals and other oxidants. This process ultimately contributes to an increase in the overall cellular burden of oxidative stress and otherwise compromises cellular function through decreased energy production.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">A major cellular signaling pathway believed to be involved in mitochondrial health is NRF1 (Nuclear Respiratory Factor-1). The </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">NRF1 </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">cellular signaling pathway directly or indirectly regulates a number of genes involved in mitochondrial health, turnover, and biogenesis. NRF1 is a protein believed to activate the expression of key genes involved in metabolism, cellular growth, energy production, and mitochondrial DNA transcription and replication. Together with Nrf2, Nrf1 also provides the essential function of coordinating gene expression between nuclear and mitochondrial genomes. An additional protein shown to support mitochondrial health is PGC1-alpha (peroxisome proliferator activated receptor gamma coactivator-1-alpha). PGC1-alpha has been shown to regulate energy metabolism and is the master regulator of mitochondrial biogenesis and turnover. </span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Sirtuin Theory of Aging and the NAD Pathway</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The sirtuin theory of aging developed from studies examining the health benefits of caloric restriction. Caloric restriction is the process whereby caloric intake is restricted by as much as 40 to 60 percent. In numerous experimental models, animals put on calorically restricted diets experienced significant increases in maximum lifespan. Numerous studies have concluded that a family of proteins called the &#8220;sirtuins&#8221; are required for the increase in lifespan brought on by caloric restriction.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">When the physiology of humans undergoing caloric restriction was examined, a number of health benefits were discovered. As researchers began to understand the molecular biology of these sirtuins, they found that the enzymatic activity for most of them required the molecule NAD</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">+</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> (nicotinamide adenine dinucleotide). NAD</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">+</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> is an essential molecule for many biochemical reactions, most notably metabolism of food for energy in the mitochondria.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Taken together, these findings are intriguing because they establish a direct link between metabolism and healthy longevity. When energy intake is normal, the primary role of NAD</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">+</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> is for energy production. However, when NAD</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">+</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> levels increase, either due to restricting calories or increasing the cellular production of NAD</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">+</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">, it becomes a signaling molecule to activate sirtuins and other health promoting mechanisms within the cell. </span></div><div id="i7a9d1ca723db478892511ede354648f3_31"></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Impacts of Aging - </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Collagen Depletion</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Collagen is a protein that serves as a key structural component in various connective tissues throughout the body.  There are 28 types of collagens, but Type I represents 80%-90% of all skin collagen in healthy adults. Type I collagen is produced by a type of cell called fibroblasts. From early adulthood, fibroblast cells become less active and collagen production declines by about 1.0-1.5% a year. Studies show that collagen reaches peak levels in an individual&#8217;s late 20&#8217;s to early 30&#8217;s, followed by a gradual decline that continues with age.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">This decline occurs as collagen fibers accumulate damage over time, decreasing their ability to function correctly. The density of the dermis is reduced as well, so it contains less collagen and elastin. The fibers that remain can become disorganized and abnormal in shape in aged skin compared to young and healthy skin. As a result, there is an upregulation of enzymes that break down and recycle collagen, contributing to declining levels. As collagen fibers become damaged and levels start to decline, collagen becomes more fragile and brittle, leading to a weakening of the skin&#8217;s structural support. The skin loses </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">10</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">volume and firmness, and it starts to thin and wrinkle. Hydration, elasticity, and suppleness of the skin also begin to decline. These changes are characteristic hallmarks associated with the appearance of aging. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In order to holistically address the decline of collagen that impacts structural integrity of both the skin and connective tissue throughout the body, there are three approaches that need to be taken. First, production of new collagen fibers must be activated within the extracellular matrix. Second, the collagen that has been lost must be replenished through supplementation. Third, collagen fibers already present must be maintained through slowing their breakdown or degradation.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Factors of Skin Aging</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In addition to declines in collagen, other factors impact the appearance of skin as it ages. Such factors, include skin dullness, hyperpigmentation, and under-eye puffiness and dark circles.</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Skin dullness can be caused by a buildup of dead skin and impurities caused by the slowdown of skin cell turnover with age, typically beginning in the 30&#8217;s and early 40&#8217;s.  </span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Hyperpigmentation is caused by excess melanin that can be triggered by factors like sun, pollution, stress, and hormones. Increased tyrosinase and signaling molecules like IL-6 and IL-8 from these factors ultimately lead to an increase of melanin and the appearance of age spots or uneven skin tone.  </span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Under-eye dark circles are caused by excess blood vessels under the eye that are more easily visible due to collagen decline and resulting skin thinning under the eye, as well as an increase in vasculature under the eye (angiogenesis triggered by binding of VEGF (vascular endothelial growth factor) on its receptor at the surface of blood vessels).</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Under-eye puffiness and bags are caused by fat accumulation from weakening tissues around the eye. </span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">All these factors lead to an aging appearance.  </span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">GLP-1</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Glucagon-like peptide-1 (GLP-1) is a naturally occurring hormone primarily secreted by cells in the colon in response to food intake. It plays a key role in regulating blood glucose levels and metabolic health. It also influences multiple physiological systems, including the pancreas, liver, brain, cardiovascular system, and gastrointestinal tract.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">GLP-1 activity contributes to appetite regulation and satiety by acting on specific regions of the brain, including reward centers, resulting in reduced food intake and prolonged gastric emptying. These mechanisms make GLP-1 a critical target for metabolic health and weight management.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">GLP-1 works by binding to GLP-1 receptors, which are expressed in various tissues. Activation of these receptors initiates signaling pathways that influence insulin release, appetite suppression, cardiovascular tone, and neuroendocrine function. The hormone&#8217;s activity is rapidly weakened by the enzyme dipeptidyl peptidase-4 (DPP-4), which breaks down GLP-1 and significantly shortens its half-life. Thus, regulating DPP-4 activity is helpful for maintaining more active GLP-1 in the body for sustained benefits.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In the gastrointestinal system, GLP-1 slows motility and plays a role in the gut-brain axis, potentially impacting mood, reward-related behavior, and cognitive performance. GLP-1 also has cardio and neuroprotective effects. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">A holistic approach is necessary to enhance the benefits of GLP-1 to support appetite control, metabolic health, and overall well-being: (1) directly activating GLP-1 production in L-cells; (2) indirect activation by optimizing the gut microbiome to generate short-chain fatty acids that fuel GLP-1 production; (3) creating more GLP-1 receptors on cells throughout the body; (4) reducing expression of DPP4 enzymes to extend the life of GLP-1; and (5) restoring clear and balanced hunger signals along the gut-brain axis through increased neuropeptide activity. </span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Research and Development</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Historically, we have focused our research and development efforts on creating and supporting scientifically validated products under the LifeVantage</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">, Protandim</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">, TrueScience</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">, Petandim</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">, AXIO</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">, and PhysIQ</span><span style="color:#008080;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#8482;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> federation of brands. We anticipate that our future research and development efforts will be focused on creating, developing, and evaluating new products that are consistent with our commitment to provide quality, scientifically validated products that activate and empower the body&#8217;s ability to work better. Through our lens of activation and nutrigenomics, we will explore what categories of products and benefits to target and research new ingredients and combinations thereof to develop new products. As we expand, we intend to build on our foundation of activation and nutrigenomics with products that either activate or support the activation of gene or cell pathways targeting specific benefit areas, provide real results, and are an essential and enjoyable part of everyday life. We also intend to continue exploring the synergies of our products to determine what, if any, enhanced or new benefits </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">11</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">appear when multiple products are combined as well as ways to expand our product delivery systems. We remain committed to helping people look and feel healthy and vibrant at any age by combating sources of premature aging or declining health.</span></div><div id="i7a9d1ca723db478892511ede354648f3_34"></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Product Overview</span></div><div id="i7a9d1ca723db478892511ede354648f3_37"></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Protandim</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-style:italic;font-weight:700;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174; </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Nrf2 Synergizer</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-style:italic;font-weight:700;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Protandim</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:700;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%"> Nrf2 Synergizer</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:700;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">is a dietary supplement that has been shown in clinical trials to reduce the age-dependent increase in markers of oxidative stress and has also been shown to provide substantial benefits to combat the variety of negative health effects linked to oxidative stress.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Protandim</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> Nrf2 Synergizer</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> combats oxidative stress by increasing the body&#8217;s natural antioxidant protection at the gene level. The unique blend of phytonutrients in Protandim</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> Nrf2 Synergizer</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> signals the activation of Nrf2 to increase production of antioxidant enzymes, specifically superoxide dismutase and catalase, and other cell-protective gene products. The body&#8217;s internally produced antioxidant enzymes provide a better defense against oxidative stress than externally derived sources of antioxidants such as vitamin C and vitamin E. Unlike externally derived sources of antioxidants, these enzymes are &#8220;catalytic,&#8221; which means these enzymes are not used up upon neutralizing free radicals.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We held multiple U.S. patents related to Protandim</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174; </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Nrf2 Synergizer</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174; </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">until their expiration in March 2025. We sell Protandim</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> Nrf2 Synergizer</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> in three formulas around the world.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Protandim</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> Nrf2 Synergizer</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> has been the subject of numerous independent scientific studies at various universities and research facilities including Ohio State University, Louisiana State University, University of Colorado Denver, Virginia Commonwealth University, Colorado State University, Texas Tech University and the National Institute on Aging. The results of these studies have been published in a variety of peer-reviewed scientific journals, including </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Free Radical Biology &amp; Medicine, Enzyme Research, Circulation-the scientific journal of the American Heart Association, American Journal of Physiology-Lung Cellular and Molecular Physiology, PLoS One, Journal of Dietary Supplements, Molecular Aspects of Medicine, Oxidative Medicine and Cell Longevity, Exercise &amp; Sports Science Reviews</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">, </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Clinical Pharmacology,</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">the FASEB Journal, and the Journal of Applied Physiology.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We also continue to perform our own research into Protandim</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> Nrf2 Synergizer</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174; </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">and the synergy with other products in our portfolio.  In fiscal year 2023, we received a patent for the combination of Protandim</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> Nrf2 Synergizer</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">, Protandim</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> NRF1 Synergizer</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">, and Protandim</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> NAD Synergizer</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> (marketed as Protandim</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> Tri-Synergizer</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">), continuing to show how our Protandim</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> product line is differentiated and unique in the marketplace.  We also filed a U.S. Patent application in fiscal year 2023 which, if granted, will protect the combined effects and synergistic benefits of the Protandim</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> Nrf2 Synergizer</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> and TrueScience</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> Liquid Collagen products when used together.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Protandim</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:700;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-style:italic;font-weight:700;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"> </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">NRF1 Synergizer</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:700;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Protandim</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:700;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%"> NRF1 Synergizer</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:700;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> is a dietary supplement which was formulated to strengthen the mitochondria, the powerhouse of all cells, for better cellular health. It is designed to work in tandem with our flagship Protandim</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> Nrf2 Synergizer</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> and further enhance the body&#8217;s internal ability to naturally produce antioxidants and reduce the effects of cellular stress. Protandim</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> NRF1 Synergizer</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> activates NRF1, a protein that regulates the expression of genes involved in mitochondrial DNA transcription, translation and repair. The unique blend of ingredients in Protandim</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> NRF1 Synergizer</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> supports the mitochondria to slow cellular aging and increase cellular energy.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Protandim</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:700;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-style:italic;font-weight:700;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"> </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">NAD Synergizer</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:700;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Protandim</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:700;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%"> NAD Synergizer</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:700;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> is a dietary supplement which was specifically formulated to target the biochemical pathways involved in the synthesis and recycling of a specific molecule called NAD (nicotinamide adenine dinucleotide) and has been shown to double sirtuin activity in just 24 hours. Sirtuin activity naturally declines by as much as 60 percent as humans age. Research has long shown that sirtuin activity can be increased by as much as 94 percent through drastic caloric restriction. Sirtuin activity has been linked to multiple health benefits. In addition to being responsible for cellular autophagy (cellular cleanup and renewal process), sirtuins help improve mental focus and concentration, support positive mood and motivation, boost mental and physical energy, aid in maintaining cholesterol levels already in a healthy range, support a healthy vascular system, and promote healthy longevity. A study on the active ingredients in NAD Synergizer</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:700;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> also demonstrated a significant increase in NAD+ associated metabolites.</span></div><div id="i7a9d1ca723db478892511ede354648f3_2939"></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">LifeVantage</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:700;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> MindBody GLP-1 System</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#8482;</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">LifeVantage</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:700;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%"> MindBody GLP-1 System</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:700;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#8482;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> is a U.S. patent-pending dietary supplement duo&#8212;MB Core</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#8482;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> and MB Enhance</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#8482;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;that is scientifically shown to increase GLP-1 and help bring balance to the gut-brain axis to reduce hunger, cravings, and food noise by activating the GLP-1 pathway, optimizing the gut microbiome to fuel production, and increasing </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">12</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">GLP-1 activity in the body.  We filed a U.S. Patent application in October 2025 which, if granted, will protect the combined effects of the MindBody GLP-1 System</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#8482;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div id="i7a9d1ca723db478892511ede354648f3_40"></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">LifeVantage</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-style:italic;font-weight:700;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> Omega+</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">LifeVantage</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.47pt;font-weight:700;line-height:120%;position:relative;top:-3.48pt;vertical-align:baseline">&#174; </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Omega+</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> is a dietary supplement that combines DHA and EPA omega-3 fatty acids, omega-7 fatty acids, and vitamin D3 to support cognitive health, cardiovascular health, skin health, and the immune system.</span></div><div id="i7a9d1ca723db478892511ede354648f3_43"></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">LifeVantage</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-style:italic;font-weight:700;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174; </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">ProBio</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">LifeVantage</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:700;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%"> ProBio</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> is a dietary supplement designed to support long-term gut health by restoring healthy gut bacteria to support digestive system health.</span></div><div id="i7a9d1ca723db478892511ede354648f3_46"></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">LifeVantage</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-style:italic;font-weight:700;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> IC Bright</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-style:italic;font-weight:700;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174; </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">LifeVantage</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:700;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%"> IC Bright</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.47pt;font-weight:700;line-height:120%;position:relative;top:-3.48pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">combines macular carotenoids with vitamins and key ingredients that effectively support eye and brain health.</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">It helps reduce eye fatigue and strain from use of digital devices, helps promote healthy levels of essential proteins for the brain, and may help support normal sleep patterns, which can be disrupted by blue light exposure. </span></div><div id="i7a9d1ca723db478892511ede354648f3_49"></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">LifeVantage</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-style:italic;font-weight:700;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174; </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Daily Wellness</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">LifeVantage</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.47pt;font-weight:700;line-height:120%;position:relative;top:-3.48pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%"> Daily Wellness </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">is a dietary supplement designed to strengthen immune health by supporting and balancing the three essential roles of the immune system: barrier, innate and adaptive.</span></div><div id="i7a9d1ca723db478892511ede354648f3_52"></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">LifeVantage</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-style:italic;font-weight:700;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174; </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Rise AM &amp; Reset PM System</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:700;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">LifeVantage</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:700;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%"> Rise AM &amp; Reset PM System</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:700;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174; </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">is an intelligent approach to a multivitamin that uses Timewise Nutrient Delivery</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#8482;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> to provide the body with the right nutrients in the right amounts at the right time.  Timewise Nutrient Delivery</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#8482;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> was developed in combination with experts in biochemistry, biophysics, and molecular biology and results in nutrition that allows your body to stay in sync with its natural rhythms, delivering energy and focus for a productive day and helping to calm the mind and body at night.</span></div><div id="i7a9d1ca723db478892511ede354648f3_55"></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">LifeVantage</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.47pt;font-style:italic;font-weight:700;line-height:120%;position:relative;top:-3.48pt;vertical-align:baseline">&#174; </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">D3</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.47pt;font-style:italic;font-weight:700;line-height:120%;position:relative;top:-3.48pt;vertical-align:baseline">+</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">LifeVantage</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.47pt;font-weight:700;line-height:120%;position:relative;top:-3.48pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%"> D3+</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.47pt;font-weight:400;line-height:120%;position:relative;top:-3.48pt;vertical-align:baseline"> </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">is a dietary supplement that provides vitamin D3, vitamin K2, magnesium, calcium, and other trace minerals to support a balanced immune system, strong bones, and cardiovascular health.</span></div><div id="i7a9d1ca723db478892511ede354648f3_58"></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">PhysIQ</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#8482;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> Fat Burn</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">PhysIQ</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#8482;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%"> Fat Burn </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">is</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">a dietary supplement containing naturally derived active ingredients to stimulate the breakdown of abdominal fat, increase energy and support long-term weight management.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">PhysIQ</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#8482;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> Prebiotic</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">PhysIQ</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#8482;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%"> Prebiotic </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">is</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">a dietary supplement designed to support the &#8220;good&#8221; bacteria in the gut and a healthy microbiome, resulting in a healthier digestive tract and a healthier metabolism.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">13</span></div></div></div><div id="i7a9d1ca723db478892511ede354648f3_61"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">TrueScience</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-style:italic;font-weight:700;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174; </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Skin Care</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Our line of activated anti-aging skin care products under our TrueScience</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> brand, consists of:</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">TrueScience</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:700;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%"> Liquid Collagen</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">: our first digestible liquid supplement in fully recyclable glass bottles that activates, replenishes, and maintains the body&#8217;s production of collagen on the cellular level to support skin firmness and elasticity for healthy, glowing skin.</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">TrueScience</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:700;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%"> TrueRenew Daily Firming Complex</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">: a</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">high-performance cosmetic retinol alternative that targets 11 visible signs of aging, providing a more youthful and vibrant complexion in as little as three weeks&#8212;with continued enhancements at six weeks.</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#616060;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">TrueScience</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:700;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%"> TrueClean Refining Cleanser</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">: a rich 2-in-1</span><span style="color:#2e3134;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">facial cleanser </span><span style="color:#2e3134;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">that cleanses and exfoliates leaving skin clean, soft, and smooth without making it feel tight or dry.</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#2e3134;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">TrueScience</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:700;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%"> TrueLift Illuminating Eye Cream</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">: a silky-smooth formula that targets dark circles and visibly lifts to reveal revitalized eyes. TrueLift supports the skin to improve seven visible signs of aging around the eyes, including dark circles, under eye bags, puffiness, fine lines, wrinkles, sagging eyelids, and crow&#8217;s feet.</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">TrueScience</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:700;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%"> TrueHydrate Brightening Moisturizer</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">: a moisturizing cream that provides hydration equivalent to two weeks&#8217; use of hyaluronic acid, enhanced brightness in seven days and a more even skin tone and visibly faded age spots with continued use.</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">TrueScience</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:700;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%"> TrueProtect Daily Mineral Sunstick SPF 30: </span><span style="color:#2e3134;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">A broad-spectrum mineral sunscreen that addresses the appearance of sun-induced hyperpigmentation and wrinkles as it protects against future damage for younger-looking, radiant skin.</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#2e3134;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">TrueScience</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:700;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%"> TrueTone Perfecting Lotion (Japan market only):</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> a toning lotion developed to meet the needs and concerns of Japanese skin care consumers that moisturizes the skin while minimizing the appearance of pores.</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">TrueScience</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:700;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%"> Perfecting Lotion: </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">a hybrid lotion formulated for smoother, radiant, and brighter looking skin.</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">TrueScience</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:700;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%"> Hand Cream:</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> a cream formulated with Nrf2 ingredients to moisturize skin and decrease the visible signs of premature aging on the hands.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Our TrueScience</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> Activated Skin Care Collection includes the following products in a TSA-compliant set: TrueScience</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174; </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">TrueClean Refining Cleanser, TrueScience</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> TrueRenew Daily Firming Complex, TrueScience</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">  TrueLift Illuminating Eye Cream, and TrueScience</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174; </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">TrueHydrate Brightening Moisturizer. The system varies slightly in some markets and additional products such as TrueScience</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> TrueProtect Daily Mineral Sunstick SPF 30 and TrueScience</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> Perfecting Lotion are available outside of the Collection.  </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We filed a U.S. Patent application in fiscal year 2023 which, if granted, will protect the combined effects and synergistic benefits of the Protandim</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> Nrf2 Synergizer</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> and TrueScience</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> Liquid Collagen products when used together. Our TrueScience</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174; </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">skin care products leverage our research on Nrf2 activation and oxidative stress in combination with other clinically tested activating ingredients that work multi-mechanistically to target skin concerns at the source through activation. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">TrueScience</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174; </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">TrueRenew Daily Firming Complex was also validated through a third-party clinical trial. Starting at three weeks and continuing over six weeks, subjects experienced significant improvements in 11 visible signs of aging.  </span></div><div id="i7a9d1ca723db478892511ede354648f3_64"></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">TrueScience</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-style:italic;font-weight:700;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174; </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Hair Care</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Our line of hair care products under our TrueScience</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> brand, consists of:</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">TrueScience</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:700;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%"> Invigorating Shampoo:</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> Mild surfactant and added amino acid blend that cleans hair without drying out the scalp.</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">TrueScience</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:700;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%"> Nourishing Conditioner: </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Deeply nourishing weightless conditioner that helps hair feel soft and smooth and look fuller and thicker.</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">TrueScience</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:700;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%"> Scalp Serum:</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> A serum that nourishes the scalp to support normal hair growth while soothing all scalp types.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">14</span></div></div></div><div id="i7a9d1ca723db478892511ede354648f3_67"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Petandim</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-style:italic;font-weight:700;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Petandim</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.47pt;font-weight:400;line-height:120%;position:relative;top:-3.48pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> is a supplement specially formulated to combat oxidative stress in dogs through Nrf2 activation. Petandim</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.47pt;font-weight:400;line-height:120%;position:relative;top:-3.48pt;vertical-align:baseline">&#174; </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">builds upon the active ingredients in Protandim</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> Nrf2 Synergizer</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> to reduce oxidative stress and support joint function, mobility and flexibility in dogs. Petandim</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.47pt;font-weight:400;line-height:120%;position:relative;top:-3.48pt;vertical-align:baseline">&#174; </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">received the Quality Seal from the National Animal Supplement Council (&#8220;NASC&#8221;).</span></div><div id="i7a9d1ca723db478892511ede354648f3_70"></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">AXIO</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-style:italic;font-weight:700;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">AXIO</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.47pt;font-weight:400;line-height:120%;position:relative;top:-3.48pt;vertical-align:baseline">&#174; </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">is our line of energy drink mixes, formulated as a nootropic to promote alertness and support mental performance. These energy drink powders deliver sustained energy, as well as improved mental focus and promote a positive mood. Available in regular and decaf formulas, AXIO</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.47pt;font-weight:400;line-height:120%;position:relative;top:-3.48pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> is derived from a unique combination of scientifically validated ingredients. </span></div><div id="i7a9d1ca723db478892511ede354648f3_73"></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Product Stacking</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">A stack consists of multiple products bundled together that are designed to achieve a specific result. By studying the effects of nutrients and natural compounds, we have developed scientifically backed nutrigenomics products that promote healthy aging on the cellular level. By stacking these products together, we have created a foundation for synergy from nutrigenomic products to promote a healthier life. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In fiscal year 2025, our stack strategy continued to focus on the brand message of activation. During the year, we introduced a number of new stacks to meet customer and independent consultant needs. Prior to the launch of our latest activator, the MindBody GLP-1 System</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#8482;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">, we introduced the Kickstart Bundle, which features a selection of products (varies by market) to help prepare the body for GLP-1 activation. Additionally, several stacks were introduced that incorporated the MindBody GLP-1 System</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#8482;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> to offer consumers support for weight management and wellness along with delivering other targeted benefits as part of their activated lifestyle. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We also introduced our Healthy Weight Stack, which includes the MindBody GLP-1 System</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#8482;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> and Protandim</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> Nrf2 Synergizer</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">. Results of an in vitro study were released that showed beneficial &#8220;activation synergies&#8221; when both products were used together, including enhanced fatty acid metabolism, improved defense against oxidative stress, and activation of 22 new genes that help cells make what they need to support organ strength, structure, and signaling. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We continue to offer other popular stacks with products that complement one another with inner activation power for internal benefits that can be felt, external benefits that can be seen, or both.</span></div><div id="i7a9d1ca723db478892511ede354648f3_76"></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Distribution of Products</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We believe our products are well suited for independent consultant to customer sales through our direct selling model. This model allows our independent consultants to educate our customers regarding the benefits of our unique products more thoroughly than other business models. Our direct selling model also allows our independent consultants to offer personalized customer service to our customers and encourage regular use of our products.</span></div><div id="i7a9d1ca723db478892511ede354648f3_79"></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Product Return Policy</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">All products purchased directly from us include a product guarantee. Subject to some exceptions based on local regulations, we will accept returns of opened and unopened products within 30 days of purchase for a full refund of the purchase price. In addition, our product return program allows independent consultants to return certain unopened, unexpired products for a refund of the purchase price less a 10% restocking fee and any paid commissions. The amount of inventory we will repurchase from an independent consultant is subject to specified policies and procedures.</span></div><div id="i7a9d1ca723db478892511ede354648f3_82"></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Accounts</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We generally categorize accounts as either independent consultants or customers, both of which may be consumers of our products.</span></div><div id="i7a9d1ca723db478892511ede354648f3_85"></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Independent Consultants</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">An independent consultant in our company is an independent contractor who participates in our direct sales opportunity by enrolling through the independent consultant contract process and selling our products. Independent consultants may purchase our products and sell them to others either directly or through our company. We believe our independent consultants are typically entrepreneurs, who believe in our products and desire to earn income through sales commissions and by building their own business. Many of our independent consultants are attracted by the opportunity to sell unique, scientifically validated products without incurring significant start-up costs. Independent consultants sign a contract with us that includes a requirement that they adhere to strict policies and procedures. Independent consultants may purchase product from us for individual and family consumption and for demonstrations, samples and retailing opportunities. </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">15</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">While we provide product development, shipping and logistics support, brochures, magazines, a website, the LifeVantage app and other sales and marketing materials, independent consultants are primarily responsible for their sales to customers and for attracting, enrolling, and educating new independent consultants about the benefits of our products and sales compensation plan. An independent consultant creates multiple levels of compensation by selling our products and enrolling new independent consultants who sell our products. These newly enrolled independent consultants form a &#8220;downline&#8221; or &#8220;group&#8221; for the independent consultant who enrolled them. If downline independent consultants enroll new independent consultants or customers who purchase our products, they create additional levels of compensation, and their downline independent consultants remain in the same downline network as the original enrolling independent consultant We pay commissions only upon the sale of our products. We do not pay commissions for enrolling independent consultants.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We define &#8220;active indepe</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">ndent consultants&#8221; as those independent consultants who have purchased product from us for retail sales or personal consumption during the prior three months.  We had approximately 51,000 and 49,000 active independent consultants</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">as of each of the fiscal years ended June&#160;30, 2025 and 2024, respectively.</span></div><div id="i7a9d1ca723db478892511ede354648f3_88"></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Independent Consultant Compensation</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In March 2025, we launched the Evolve Compensation Plan for our independent consultants in several markets including Taiwan, Hong Kong, and Singapore. In November 2024, we launched an optimized version of the Evolve Compensation Plan for our independent consultants in the United States, Japan, Australia, New Zealand, Canada, Mexico, and Europe markets. In February 2024, we launched the Evolve Compensation Plan for our independent consultants in the Mexico, Canada, and Europe markets. In March 2023, we launched the Evolve Compensation Plan for our independent consultants in the United States, Australia, New Zealand and Japan markets. We plan to roll out this new compensation plan to Thailand once we receive the appropriate government approval.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We believe our sales compensation plan is one of the more financially rewarding in the direct selling industry and in line with direct selling industry standards. Some elements of our sales compensation plan are paid daily, to eligible independent consultants, and others are paid weekly or monthly. We believe this gives us a competitive advantage and helps retain new independent consultants by allowing them to receive some sales commissions in a more timely manner from their sales efforts. Our sales compensation plan is intended to appeal to a broad cross-section of people, including those seeking to supplement family income, start a home-based business or pursue entrepreneurial opportunities full- or part-time. Through the Evolve Compensation Plan our independent consultants earn bonuses specifically for the sale of products to customers and by growing a customer subscription-based business, creating greater opportunities for independent consultants who are not interested in enrolling other consultants to sell products. Our independent consultants earn sales commissions on product sales to their personally enrolled customers and independent consultants and the product sales to customers and independent consultants within their sales organization, or &#8220;downline.&#8221; Our independent consultants can also earn money by purchasing product from us and selling that product to others at their chosen retail price. We pay sales commissions in the local currency of the independent consultant&#8217;s home country.</span></div><div id="i7a9d1ca723db478892511ede354648f3_91"></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Independent Consultant Motivation and Training</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Our revenue depends on the sales success and productivity of our independent consultants. We provide tools, training and technology designed to increase our independent consultants&#8217; sales productivity and increase their potential for sales success. We offer training and business development opportunities to our independent consultants, including the opportunities listed below.</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;text-decoration:underline">Consultant Communications Hub</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">: A consultant-specific website that has all the latest details on promotions, product launches, and onboarding to help each consultant build a LifeVantage business. Since the launch in October 2023, this site has been widely adopted as a centralized resource for our independent consultants. </span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;text-decoration:underline">Momentum Academy, Global Convention, and other Company-Sponsored Training</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">: We hold regularly occurring live and virtual company-sponsored events intended to provide sales training and motivation to our independent consultants.</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;text-decoration:underline">Promotions and Incentive Trips</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">: We hold special sales promotions, business incentives and incentive trips from time to time in order to motivate our independent consultants to accomplish specific sales goals.</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;text-decoration:underline">Mobile Application</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">: The LifeVantage app was designed to allow users to conduct their business on a single platform from anywhere in the world. Ultimately, through artificial intelligence and machine learning, we expect that the app will be able to guide users on what to share, when to share it, and with whom to maximize their sales potential. </span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;text-decoration:underline">Online Social Media Groups</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">: Through the use of social media platforms, we host online groups to support the success of our independent consultants. Important announcements, weekly trainings, calls, and documentation are also shared </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">16</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">through our social media groups to provide our independent consultants many opportunities to find the training and support. </span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;text-decoration:underline">Corporate Support Team</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">: The LifeVantage contact center, VIP Lines, and sales support team are designed to provide support, motivation, training, and resources to our independent consultants through their business journey. As independent consultants advance through the titles in our consultant path, they continue to receive more personalized support.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We continue to evaluate new ways in which to incorporate new technology and sales training opportunities to improve consultant product sales.</span></div><div id="i7a9d1ca723db478892511ede354648f3_94"></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Independent Consultant Compliance Activities</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Given that our independent consultants are independent contractors, we do not control or direct their promotional efforts. We do, however, require that our independent consultants abide by policies and procedures that require them to act in an ethical manner and in compliance with applicable laws and regulations. As a member of the United States Direct Selling Association (&#8220;US DSA&#8221;) and similar organizations in many of the markets where we do business, we are also subject to the ethical business practices and consumer service standards required by the industry&#8217;s code of ethics. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Independent consultants represent to us that their receipt of sales commissions is based on their product sales and by product sales of other LifeVantage consultants in their personal marketing organization.</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We must produce or pre-approve all sales aids used by independent consultants, such as brochures and online materials. Products may be promoted only through sales materials produced or approved by us. Independent consultants may not use our trademarks or other intellectual property without our written consent.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We monitor and systematically review alleged independent consultant misbehavior through our internal consultant compliance department. If we determine one of our independent consultants has violated any of our policies and procedures, we first attempt to educate, but may discipline or terminate the independent consultant&#8217;s rights to sell or distribute our products when appropriate. When necessary, we have brought legal action against independent consultants, or former consultants, to enforce our policies and procedures. Short of termination or legal action, and in addition to educating, we may impose sanctions against independent consultants whose actions are in violation of our policies and procedures. Such sanctions may include warnings, probation, withdrawal or denial of an award, suspension of privileges of a consultantship, fines and/or withholding of commissions until specified conditions are satisfied, or other appropriate injunctive relief.</span></div><div id="i7a9d1ca723db478892511ede354648f3_97"></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Customers</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Customers purchase products directly from us at either our retail (list) pricing for one-time purchases or our subscription price on a monthly subscription basis for personal consumption, without the ability to resell or earn commissions from the purchase or sale of such products. In eligible markets, customers who order their items on a subscription also automatically join our Rewards Circle loyalty program, a program that rewards customer loyalty through subscription purchases. A customer may decide to enroll as an independent consultant at any time if they become interested in selling our products. We believe our customers are a great source of word-of-mouth advertising for our products. We also believe our large base of customers validates the health benefits of our products.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We define an &#8220;active customer&#8221; as a customer who has purchased product from us within the prior three months. As of June&#160;30, 2025 and 2024, we had approximately 81,000 and 79,000 active customers, respectively.</span></div><div id="i7a9d1ca723db478892511ede354648f3_100"></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Sales of Our Products</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We accept orders for our products through our website at www.lifevantage.com and through personalized websites we provide to our independent consultants, which we refer to as &#8220;Referral Sites.&#8221; Orders placed through Referral Sites and through our website are processed daily at our fulfillment centers, where orders are shipped directly to the consumer.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We offer toll-free numbers for our independent consultants and our customers to order product or ask questions. Our customer service representatives assist customers in placing orders through our web order processing system, answer questions, track packages, and initiate refunds. The customer service representatives receive extensive training about our products and our direct selling business model. LifeVantage customers and independent consultants generally pay for products by credit card, prior to shipment, and as a result, we carry minimal accounts receivable.</span></div><div id="i7a9d1ca723db478892511ede354648f3_103"></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Seasonality</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In addition to general economic factors, we are impacted by seasonal factors and trends such as major cultural events and vacation patterns. We believe that direct selling in the United States and Japan is also generally negatively impacted during our </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">17</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">first fiscal quarter, from July 1 through September 30, when many individuals, including our independent consultants, traditionally take vacations. The timing and size of our training events and incentive trips can also cause revenue and expense to fluctuate in the periods that they are held.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Although our product launch process may vary by market, we may introduce new products to our customers and independent consultants through limited-time offers and promotions. The limited-time offers and promotions typically generate significant activity and a high level of sales and purchasing, which may result in a higher-than-normal increase in revenue during the quarter of the limited-time offer and skew year-over-year and sequential comparisons. Similarly, company events for independent consultants typically generate a higher-than-normal increase in revenue. The timing of these events can also skew year-over-year and sequential comparisons.</span></div><div id="i7a9d1ca723db478892511ede354648f3_106"></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Marketing</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We utilize our network of </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">i</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">ndependent </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">c</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">onsultants located throughout the United</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> States, Mexico, Japan, Australia, Hong Kong, Canada, Thailand, the United Kingdom, the Netherlands, Germany, Taiwan, Austria, Spain, Ireland, Belgium, New Zealand and Singapore to market and sell our products. We also have in-house sales, marketing, IT, and customer service groups dedicated to supporting our independent consultants. Support includes training and education, personalized assistance, in-person and digital events, recognition, incentives and promotions, digital and social media content, press coverage, regular communications, as well as a full suite of marketing assets, including content for their websites.</span></div><div id="i7a9d1ca723db478892511ede354648f3_109"></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Raw Materials and Manufacturing</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We outsource the primary manufacturing, fulfillment, and shipping components of our business to third-party companies we believe possess a high degree of expertise. We believe outsourcing provides us access to advanced manufacturing process capabilities and expertise without incurring fixed costs associated with manufacturing our own products in house.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We currently outsource the manufacture of our products to multiple third-party contract manufacturers. Our contract manufacturers have a legal obligation to comply with the current Good Manufacturing Practices (&#8220;GMP&#8221;) regulations that are applicable to those who manufacture, package, label and hold dietary supplements and personal care products. Additionally, we are subject to regulations that, among other things, obligate us to know what and how manufacturing activities are performed so that we can make decisions related to whether the packaged and labeled product conforms to our established specifications and whether to approve and release product for distribution to consumers. We maintain and qualify alternative manufacturing options in order to keep our costs low, maintain the quality of our products, and prepare for unanticipated spikes in demand or manufacturing failure. Our contract manufacturers deliver products to our fulfillment centers based on our purchase orders. We also have a Vendor Code of Conduct that we expect our contract manufacturers and/or vendors to adhere to. This Vendor Code of Conduct requires contract manufacturers and vendors to abide by certain human rights, labor rights, protection of the environment and fight against corruption standards outlined under the United Nations Global Compact. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We acquire raw materials for our products from third-party suppliers. Although we generally have good relationships with our suppliers, we believe we could replace any of our current suppliers without great difficulty or significant increase to our cost of goods sold. We also have ongoing relationships with secondary and tertiary suppliers. Please refer to &#8220;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Risk Factors - High quality material for our products may be difficult to obtain or expensive</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; for a discussion of the risks and uncertainties associated with our sourcing of raw materials.</span></div><div id="i7a9d1ca723db478892511ede354648f3_112"></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Geographic Information</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We sell our products in the United States, Mexico, Japan, Australia, Hong Kong, Canada, Thailand, the United Kingdom, the Netherlands, Germany, Taiwan, Austria, Spain, Ireland, Belgium, New Zealand and Singapore. On June 30, 2025, we ceased operations in the Philippines and closed that market. We also sell our products in a number of countries to customers for personal consumption only. In fiscal year 2025, revenue generated in the United States accounted for approximately</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> 78% of our total revenue and revenue generated from Japan accounted for approximately 11% of our total revenue. For reporting purposes, we generally divide our markets into two geographic regions: the Americas regio</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">n and the Asia/Pacific and Europe region. The following table sets forth net revenue information by region for the periods indicated (in thousands):</span></div><div style="margin-bottom:8pt;margin-top:8pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:38.724%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.394%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.394%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.394%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.398%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-bottom:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">For the fiscal years ended June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="9" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Americas</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">185,723&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">81.3&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">152,907&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">76.4&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Asia/Pacific &amp; Europe</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">42,807&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">18.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">47,257&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">23.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">228,530&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">200,164&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">18</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Additional comparative revenue and related financial information is presented in the section captioned &#8220;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Segment Information</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; in Note 13 to our consolidated financial statements.</span></div><div id="i7a9d1ca723db478892511ede354648f3_115"></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Product Liability and Other Insurance</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We have product liability insurance coverage for our products that we believe is adequate for our needs. We also maintain commercial property and liability coverage, directors&#8217; and officers&#8217; liability insurance, workers compensation coverage and cyber information security risk insurance policies as well as foreign and other miscellaneous coverage. </span></div><div id="i7a9d1ca723db478892511ede354648f3_118"></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Intellectual Property</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We use commercially reasonable efforts to protect our intellectual property through patent protection, trademarks, and trade secrets, licensed rights, and contractual protections, and intend to continue to develop a strong brand identity for our company and our products. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Protandim</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> Nrf2 Synergizer</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> is a proprietary, dietary supplement formulation for enhancing antioxidant enzymes including superoxide dismutase and catalase. The patents and patent applications protecting its formulations held by LifeVantage Corporation or our wholly owned subsidiary, Lifeline Nutraceuticals Corporation expired in March 2025. However, we continue to research and file, as appropriate, new composition and method patents in the U.S. for enhanced and improved product formulations that are intended to provide patent protection for a variety of product formulations and methods. During fiscal year 2018, we received patents for personal care or skin care products. These patents expire approximately February 2036. In fiscal year 2023, we received a patent for the combination of Protandim</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> Nrf2 Synergizer</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">, Protandim</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> NRF1 Synergizer</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">, and Protandim</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> NAD Synergizer</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">, collectively called the Tri-Synergizer</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> pack. In fiscal year 2023, we filed a U.S. patent application which, if granted, will protect the combined synergistic effects and benefits of the Protandim</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> Nrf2 Synergizer</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> and TrueScience</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> Liquid Collagen products when these two products are used together. In fiscal year 2025, we filed a U.S. patent application which, if granted, will protect the MindBody GLP-1 System</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#8482;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We continue to protect our products and brands using trademarks. We have filed and successfully procured registered trademarks for our key brands consisting of Protandim</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">, LifeVantage</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">, and TrueScience</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> in many countries around the world, and we have pending trademark applications for these and other marks in many other countries, including our newest key product the MindBody GLP-1 System</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#8482;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">, including MB Core</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#8482;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> and MB Enhance</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#8482;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">. We anticipate seeking protection in other countries, as we deem appropriate.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In order to protect the confidentiality of our intellectual property, including trade secrets, know-how and other proprietary technical and business information, it is our policy to limit access to such information to those who require access in order to perform their functions and to enter into agreements with employees, consultants and vendors to contractually protect such information.</span></div><div id="i7a9d1ca723db478892511ede354648f3_121"></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Competition</span></div><div id="i7a9d1ca723db478892511ede354648f3_124"></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Direct Selling Companies</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We compete with other direct selling companies, many of which have longer operating histories and greater visibility, name recognition and financial resources than we do. We also compete with newer direct selling companies that may attempt to solicit our independent consultants by offering the possibility of a more financially rewarding opportunity or by being among the company's early consultant base. We compete for new consultants with these companies on the basis of our business opportunity, product offerings, sales compensation plan, management and operations. In order to successfully compete in the direct selling industry and attract and retain quality consultants, we must maintain the attractiveness of our business opportunity, product offerings and sales compensation plan.</span></div><div id="i7a9d1ca723db478892511ede354648f3_127"></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Dietary Supplement Market</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We compete with other companies that sell dietary supplements. We believe the dietary supplement market is highly fragmented and competitive. We believe competition in the dietary supplement market is based primarily on quality, price, efficacy, brand name, and recognition of product benefits. In the dietary supplement industry, our competition includes numerous nutritional supplement companies, pharmaceutical companies and packaged food and beverage companies. Many of these companies have broader product lines, larger sales volumes, and greater financial resources than we do. Additionally, some of these companies are able to compete more effectively due to greater vertical integration. Increased competition in the dietary supplement market could have a material adverse effect on our results of operations and financial condition.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">19</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Nrf2 Activators</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In the last few years, we have seen the number of products marketed as Nrf2 activators increase. We anticipate the number of products that claim to activate Nrf2 will continue to increase as the technology becomes more popular and more broadly accepted. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Direct Antioxidants</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Vitamin C, vitamin E, other vitamin/mineral antioxidants, and other sources of externally derived antioxidants may be considered competitors of Protandim</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> Nrf2 Synergizer</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> but they are mechanistically distinct from Protandim</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> Nrf2 Synergizer</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">. These other sources of antioxidants do not increase the body&#8217;s elimination of oxidants using internal antioxidant enzymes. Our research indicates that Protandim</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> Nrf2 Synergizer</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> increases production of anti-fibrotic gene products, including antioxidant enzymes, such as superoxide dismutase and catalase, within the cells of the body. We believe that the body&#8217;s internally produced antioxidant enzymes provide a better defense against oxidative stress than externally derived sources of antioxidants.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Oral Superoxide Dismutase and Catalase</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">There are many companies performing research into antioxidants. Several companies sell oral forms of superoxide dismutase and catalase. Although we believe Protandim</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> Nrf2 Synergizer</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> is a superior alternative to oral forms of superoxide dismutase and catalase, these products do compete with Protandim</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> Nrf2 Synergizer</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> in the marketplace. We anticipate additional companies will likely develop, purchase or in-license products that are competitive with Protandim</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> Nrf2 Synergizer</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Omega Fatty Acid Products</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">There are many companies that market omega supplements, including omega-3. Although LifeVantage</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174; </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Omega+ contains a unique combination of DHA and EPA omega-3 fatty acids, omega-7 fatty acids, and vitamin D3, we anticipate additional companies will likely develop products that are competitive with LifeVantage</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174; </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Omega+. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Probiotic Products</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">There are many companies that market probiotic supplements, and we anticipate additional companies will likely continue to develop products that compete with our LifeVantage</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174; </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">ProBio supplement. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Eye Health and Vitamin Products</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">There are many companies that market eye health and other vitamin/mineral supplements and we anticipate additional companies will likely continue to develop products that are competitive with our IC Bright</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">, </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">LifeVantage</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174; </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Daily Wellness, the Rise AM &amp; Reset PM System</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">, and LifeVantage</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> D3+. </span></div><div id="i7a9d1ca723db478892511ede354648f3_130"></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Personal Skin Care Market</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In the personal skin care market, we compete principally with large, well-known cosmetics companies that manufacture and sell broad product lines through retail establishments. Many of these competitors have greater financial resources and brand recognition than we do. We believe, however, we can compete with these larger companies by leveraging our direct selling model and emphasizing our unique, science-based, Nrf2 formulas in our personal care products. We also now compete in the growing global liquid collagen market and believe we can compete with our triple-action formula that has been shown to deliver visible results in only 30 days as it activates, replenishes, and maintains collagen levels. Our TrueScience</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> Liquid Collagen product is a unique blend featuring sustainably sourced, hydrolyzed fish collagen that delivers 10 different types of peptides&#8211;significantly more than most competitive products&#8211;plus a unique red quinoa extract that has been shown to up regulate genes associated with collagen production and down regulate those that produce enzymes that break down collagen.  </span></div><div id="i7a9d1ca723db478892511ede354648f3_133"></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Personal Hair Care Market</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In the personal hair care market, we compete principally with large, well-known hair care companies that manufacture and sell broad product lines through retail establishments. Many of these competitors have greater financial resources and brand recognition than we do. We believe, however, we can compete with these larger companies by leveraging our direct selling model and emphasizing our unique, science-based hair care products.</span></div><div id="i7a9d1ca723db478892511ede354648f3_136"></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Animal Supplement Market</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We compete principally with large, well-known companies in the animal supplement market. Most of the companies we compete with in the animal supplement market have broad distribution channels that include retail establishments. Many of </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">20</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">these competitors have greater financial resources and brand recognition than we do. We believe, however, that we can compete with these larger companies by leveraging our direct selling model and emphasizing our unique, science-based animal supplement product.</span></div><div id="i7a9d1ca723db478892511ede354648f3_139"></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Energy Drink Market</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We compete with large, well-known companies in the energy drink market. Most of the companies we compete with in the energy drink market have broad distribution channels that include big box retail establishments. Many of these competitors have greater financial resources and brand recognition than we do. We intend to compete with these larger companies by leveraging our direct selling model and emphasizing our unique, science-based energy drink product. AXIO</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> is a no sugar, low-carbohydrate and low-calorie energy drink that is also non-GMO, gluten-free and vegan. </span></div><div id="i7a9d1ca723db478892511ede354648f3_142"></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Weight Management Market</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We compete with large, well-known companies in the weight management market, including those offering GLP-1 products. Most of the companies we compete with in the weight management market have broad distribution channels that include big box retail establishments. Many of these competitors have greater financial resources and brand recognition than we do. We intend to compete with these larger companies by leveraging our direct selling model and emphasizing our unique, science-based weight management products.</span></div><div id="i7a9d1ca723db478892511ede354648f3_145"></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Regulatory Environment</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The formulation, manufacturing, packaging, labeling, and advertising of our products in the United States are subject to regulation by the Food and Drug Administration (&#8220;FDA&#8221;) and the Federal Trade Commission (&#8220;FTC&#8221;), as well as comparable state laws.</span></div><div id="i7a9d1ca723db478892511ede354648f3_148"></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">FDA Regulations and DSHEA</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We market our Protandim</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> products as &#8220;dietary supplements&#8221; as defined in the Dietary Supplement Health and Education Act of 1994 (&#8220;DSHEA&#8221;). DSHEA is intended to promote access to safe, quality dietary supplements, and information about dietary supplements. DSHEA established a new framework governing the composition and labeling of dietary supplements. DSHEA does not apply to animal supplements like Petandim</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">. We are not required to obtain FDA pre-market approval to sell our products in the United States under current laws.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">DSHEA permits statements of nutritional support, called &#8220;structure-function&#8221; statements, to be included in labeling for dietary supplements without FDA marketing approval. Such statements may claim a benefit related to a classical nutrient deficiency disease and disclose the prevalence of such disease in the United States, describe the role of a nutrient or dietary ingredient intended to affect the structure or function in humans, characterize the documented mechanism by which a nutrient or dietary ingredient acts to maintain such structure or function, or describe general well-being from consumption of a nutrient or dietary ingredient. Such statements may not expressly o</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">r impliedly</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> claim that a dietary supplement is intended to diagnose, cure, mitigate, treat, or prevent a disease. A company that uses a structure-function statement in labeling must possess evidence substantiating that the statement is truthful and not misleading and is supported by competent and reliable scientific evidence. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The FDA may assert that a particular structure-function statement that a company is using is an illegal claim; that assertion, normally, is in the form of a warning letter to that company. We have a duty to send to the FDA a notice that lists each new structure-function statement made by us; we are obligated to send that notice within 30 days after the first marketing of a supplement with such a statement.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">DSHEA also permits certain scientific literature, for example a reprint of a peer-reviewed scientific publication, to be used in connection with the sale of a dietary supplement to consumers without the literature being subject to regulation as labeling. However, such literature must not be false or misleading, the literature may not promote a particular manufacturer or brand of dietary supplement and it must include a balanced view of the available scientific information on the subject matter, among other requirements.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The FDA&#8217;s Center for Veterinary Medicine (&#8220;CVM&#8221;) is responsible for enforcing the portion of the Federal Food, Drug, and Cosmetic Act (the &#8220;FFDCA&#8221;), that relates to animal supplements, like our Petandim</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> product. CVM&#8217;s primary responsibility in enforcing the FFDCA is to ensure that animal supplements are safe, effective, and can be manufactured to a consistent standard. CVM has taken the position that DSHEA does not apply to products intended for animals, but it is clear that products like Petandim</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> are under FDA jurisdiction.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Our Petandim</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> product follows the labeling rules of the NASC of which LifeVantage is a member. Under the NASC rules, Petandim</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> is classified as a dosage form animal health product.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">21</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">While we exercise care in our formulation, manufacturing, packaging, labeling, and advertising of our products, we cannot guarantee the FDA will never inform us that the FDA believes some violation of law has occurred either by us or by our independent consultants. Any allegations of our non-compliance may result in time-consuming and expensive defense of our activities. The FDA&#8217;s normal course of action is to issue a warning letter if it believes that a product is misbranded or adulterated. The responsive action requested by the FDA differs depending upon the nature of the product and claims in question. Typically, the FDA expects a written response within 15 working days of the receipt of a warning letter. The warning letter is public information posted on the FDA&#8217;s web site. That information could affect our relationships with our customers, investors, independent consultants, vendors, and employees. Warning letters also often spark private class action litigation under state consumer protection statutes. The FDA could also order compliance activities, such as an inspection of our facilities and products, and could file a civil lawsuit in which an arrest warrant (seizure) could be issued as to some or all of our products. In extraordinary cases, we could be named a defendant and sued for declaratory and injunctive relief.  There were no open letters from the FDA to us as of June 30, 2025.</span></div><div id="i7a9d1ca723db478892511ede354648f3_151"></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">FTC Regulations</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Advertising and marketing of our products in the United States are also subject to regulation by the FTC under the Federal Trade Commission Act (&#8220;FTC Act&#8221;). Among other things, the FTC Act prohibits unfair methods of competition and unfair false or deceptive acts or practices in or affecting commerce. The FTC Act also makes it illegal to disseminate or cause to be disseminated any false advertisement for &#8220;food, drugs, devices, services, or cosmetics.&#8221; The FTC Act provides that disseminating any false advertisement pertaining to foods, which would include dietary supplements, is an unfair or deceptive act or practice. An advertiser is required to have competent and reliable scientific evidence for all express and implied health-related product claims at the time the claims are first made. We are required to have adequate scientific substantiation for all material advertising claims made for our products in the United States. The FTC routinely reviews websites to identify questionable advertising claims and practices. Competitors sometimes inform the FTC when they believe other competitors are violating the FTC Act and consumers may also notify the FTC of what they believe may be wrongful advertising. The FTC may initiate a non-public investigation that focuses on our advertising claims, which usually involves non-public pre-lawsuit extensive formal discovery. Such an investigation may be very expensive to defend, be lengthy, and result in a publicly disclosed Consent Decree, which is a settlement agreement. If no settlement can be reached, the FTC may start an administrative proceeding or a federal court lawsuit against us and/or our principal officers. The FTC often seeks to recover from the defendants, whether in a Consent Decree or a proceeding, any or all of the following: (i) consumer redress in the form of monetary relief or disgorgement of profits; (ii) significant reporting requirements for several years; and (iii) injunctive relief. In addition, most, if not all, states have statutes prohibiting deceptive and unfair acts and practices. The requirements under these state statutes are similar to those of the FTC Act.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The National Advertising Division (&#8220;NAD&#8221;), of the national Better Business Bureau, a non-governmental not-for-profit organization through its Advertising Self-Regulatory Council, is also actively engaged in conducting investigations, called inquiries, which are focused on determining whether the requisite claim substantiation standard exists for advertising claims, including specific structure-function claims. Although the results of each inquiry or proceeding are not binding on the recipient, they are posted on NAD&#8217;s website, and the NAD often refers cases to the FTC, if the advertisers do not agree to modify their advertising in conformance with the NAD decision.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In January 2019, the Direct Selling Self-Regulatory Council (&#8220;DSSRC&#8221;) was introduced. T</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">his program monitors the entire direct selling channel</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">including the US DSA member companies and non-members. The DSSRC provides impartial monitoring, enforcement, and dispute resolution regarding product claims or income representations (including lifestyle claims) disseminated by </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">direct selling</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> companies and their </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">sales</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> force members (independent consultants). The failure of a company to resolve DSSRC complaints will ultimately result in the DSSRC reporting the matter to the FTC, which may or may not pursue enforcement action in any given case. </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">There were no open letters from the FTC to us as of June 30, 2025.</span></div><div id="i7a9d1ca723db478892511ede354648f3_154"></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Regulation of Direct Selling Activities</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Direct selling activities are regulated by the FTC, as well as various federal, state and local governmental agencies in the United States and foreign countries. These laws and regulations are generally intended to prevent fraudulent or deceptive schemes, often referred to as &#8220;pyramid&#8221; schemes, which compensate participants primarily for recruiting additional participants without sufficient emphasis on product sales. The laws and regulations may often:</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">require us or our independent consultants to register with governmental agencies;</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">impose caps on the amount or type of sales commission we can pay;</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">impose reporting requirements; and</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">22</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">require that we ensure, among other things, that our independent consultants maintain levels of product sales to qualify to receive sales commissions and that our independent consultants are being compensated primarily for sales of products and not primarily for recruiting additional participants.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The laws and regulations governing direct selling are modified from time to time, and, like other direct selling companies, we may be subject to government investigations related to our direct selling activities. This may require us to make changes to our business model and our sales compensation plan.</span></div><div id="i7a9d1ca723db478892511ede354648f3_157"></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">State Regulations</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In addition to United States federal regulation, each state has enacted its own food and drug laws. We may receive requests to supply information regarding our sales or advertising to state regulatory agencies. We remain subject to the risk that, in one or more of our present or future markets, our products, sales, and advertising could be found non-compliant with state laws and regulations. If we fail to comply with these laws and regulations, it could have a material adverse effect on our business in a particular market or in general. In addition, these laws and regulations could affect our ability to enter new markets.</span></div><div id="i7a9d1ca723db478892511ede354648f3_160"></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The FDA Food Safety Modernization Act</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The FDA Food Safety Modernization Act (&#8220;FSMA&#8221;) was enacted in 2011 and is now part of the FFDCA. The FSMA is a comprehensive set of laws that gives the FDA considerable authority with respect to the prevention of food contamination and the serious problems associated with such contamination. Among other things, it does the following:</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">gives the FDA explicit authority to compel a recall if the FDA believes there is a reasonable probability of serious adverse health consequences or death;</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">places strict obligations on food and dietary supplement importers to verify that food from foreign suppliers is not adulterated or misbranded; and</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">provides whistle blower protection for employees of conventional food or dietary supplement companies who provide information to governmental authorities about violations of the FFDCA.</span></div><div id="i7a9d1ca723db478892511ede354648f3_163"></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">International Regulations</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In addition to the regulations applicable to our activities in the United States, all other markets in which we operate our business regulate our products under a variety of statutory and regulatory schemes. We typically market our Protandim</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> line of products in international markets as foods, health foods or dietary supplements under applicable regulatory regimes. However, because of varied regulations, some products or ingredients that are recognized as a &#8220;food&#8221; in certain markets may be treated as a &#8220;pharmaceutical&#8221; or equivalent in other markets. In the event a product, or an ingredient in a product, is classified as a drug or pharmaceutical product in any market, we will generally not be able to distribute that product through our independent consultants because of pre-marketing approval requirements and strict regulations applicable to drug and pharmaceutical products. In Japan, for example, ashwagandha was determined to be inappropriate for inclusion in food products. Ashwagandha is one of the ingredients in Protandim</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174; </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Nrf2 Synergizer</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">. While we disagree with the assessment of ashwagandha by Japanese regulatory authorities, we are restricted from selling a formulation of Protandim</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> Nrf2 Synergizer</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> that contains ashwagandha in Japan. As such, we reformulated Protandim</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174; </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Nrf2 Synergizer</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> for the Japan market to exclude ashwagandha</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> and include black pepper extract</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">. This reformulated Protandim</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174; </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Nrf2 Synergizer</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> was introduced in Japan in fiscal year 2013.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Similarly, our other markets outside the United States regulate advertising and product claims regarding the efficacy of our products and require adequate substantiation of claims. As such, we are unable to claim that any of our products will diagnose, cure, mitigate, treat, or prevent diseases. For example, in Japan, Protandim</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> Nrf2 Synergizer</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> is considered a food product, which significantly limits our ability to make claims regarding the product. If marketing materials make claims that exceed the scope of allowed claims for dietary supplements, regulatory authorities could deem our products to be unapproved drugs and we could experience substantial harm.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Our business model is also subject to regulatory frameworks that may limit or significantly alter the way business is done in foreign markets vis-&#224;-vis the United States. For example, our marketing of products or business opportunity as a consultant in the United Kingdom differs significantly from marketing to United States customers and independent consultants. Consequently, we may experience additional costs and delays in entering or continuing to do business in foreign markets in order to comply with local regulations.</span></div><div id="i7a9d1ca723db478892511ede354648f3_166"></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Potential FDA and Other Regulation</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We could become subject to additional laws or regulations administered by the FDA, FTC, or other federal, state, local or international regulatory authorities, to the repeal or amendment of laws or regulations that we consider favorable, such as </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">23</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">DSHEA, or to more stringent interpretations of current laws or regulations. Because of negative publicity associated with some adulterated or misbranded supplements, including pharmaceutical drugs marketed as dietary supplements, there has been an increased movement in the United States and other markets to expand the regulation of dietary supplements, which could impose additional restrictions or requirements in the future. In recent years, there also has been increased pressure in the United States to further regulate cosmetics. In general, the regulatory environment is becoming more complex with increasingly strict regulations. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Dietary Supplement and Nonprescription Drug Consumer Protection Act requires us to report to the FDA all serious adverse events and to maintain for six years, records of all adverse events, whether or not serious. An adverse event is defined as any health-related event associated with the use of a dietary supplement that is adverse. In addition, this law requires the label of each dietary supplement, including our Protandim</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> products, to include a domestic address or telephone number by which the company selling the product may receive a report of a serious adverse event associated with such product. Our product labels comply with that statutory provision.</span></div><div id="i7a9d1ca723db478892511ede354648f3_169"></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Employees</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">As of June&#160;30, 2025, we had </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">238</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> employees, 232 of which were </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">full-time employees. As of June&#160;30, 2025, 176 of our employees were based in the United States and </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">62</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> were based in our international markets. We do not include our independent consultants in our number of employees because our independent consultants are independent contractors and not employees. We outsource our manufacturing, warehousing and shipping operations.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We believe that our employees are an essential asset. We have a dedicated team of professionals that support our customers and independent consultants, work to generate long-term value for our stockholders and contribute to the broader public through charitable programs, including LifeVantage Legacy &#8211; an independent charitable organization focused on bettering the lives of children throughout the world (&#8220;LifeVantage Legacy&#8221;). In turn, we offer competitive compensation and guide employees to focus on the long-term goals of our stockholders and independent consultants.  We have received many &#8216;best place to work&#8217; awards over the years, most recently being named as &#8220;Utah Top Workplaces&#8221; by the Salt Lake Tribune for the third year, &#8220;Top Places to Work in the Wellness Industry&#8221; by Energage, an industry leader in employee engagement for the third year, and &#8220;Best Place to Work&#8221; by USA Today.</span></div><div id="i7a9d1ca723db478892511ede354648f3_172"></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Corporate Responsibility and Sustainability</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We understand that long-term value creation for stockholders is our core responsibility. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We are investing in a number of sustainability initiatives, including reducing the environmental impact of our business activities and products, improving the global human condition, providing a positive working environment and engaging with our stakeholders regarding these initiatives.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Environment</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">: We are committed to reducing our impact on the environment and creating awareness about sustainability. We strive to improve our environmental footprint over time and to initiate additional projects and activities that will further reduce our impact on the environment. Our commitment to the environment extends to our customers, our independent consultants, our employees, and the global communities in which we operate. We comply with applicable environmental regulations and strive to prevent pollution whenever possible. We are increasing our efforts to train our employees and independent consultants on our environmental program and empower them to contribute and participate. We are committed to continually improving over time by striving to measure our environmental impacts and by setting goals to reduce these impacts each year. Some examples of our efforts include:</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">Launching our new MindBody GLP-1 System</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#8482;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> using only clean ingredients and packaging recyclable curbside in most locations;</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Launching a revamped TrueScience</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> Activated Skin Care Collection using only clean ingredients that also score low on the Think Dirty scale; </span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Using more easily recycled packaging in the relaunch of our TrueScience</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> Activated Skin Care Collection;</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Abiding by our environmental policy using the feedback from our stakeholders to help formalize our focus on sustainability;</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Using environmental auditing in our selection process for new partners;</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Switching to more easily recyclable bottles and cartons for product packaging, including replacing plastic bags with paper cartons for our energy drink products and using a fully recyclable glass bottle and cap for our TrueScience</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> Liquid Collagen product line;</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">24</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Sourcing shipping boxes made from Sustainable Forestry Initiative certified corrugate material; </span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Redesigning our shipping boxes to reduce the amount of waste created;</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Changing our shipping process to leverage lower CO2 emissions by 50%; </span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Creating sharable videos that our independent consultants can use when discussing our sustainability efforts;</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Focusing on working with fish oil suppliers and fisheries who are Marine Stewardship Council certified; and</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">  </span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Joining the Roundtable on Sustainable Palm Oil to support sustainable sources of Palm Oil.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Social/Community</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">: We believe that our legacy is not the past, it is the future we create. This belief informed our effort to sponsor the formation of LifeVantage Legacy. LifeVantage Legacy helps the leaders of tomorrow by touching a million lives across the world today. From helping a child in need to supporting initiatives that uplift entire communities, our goal is simple - give future generations the support and resources they need to live happier, healthier lives one child at a time. One of the best parts of LifeVantage is our commitment to leaving places better than we found them. Some examples of our efforts include:</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Partnering with local schools near where we host our events to provide weekend meals to underprivileged children;</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Partnered with a local school in South Africa supplementing their library, providing school supplies and uniforms for the local community;</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Hosting home building trips over the holidays with our independent consultants and their families in Puerto Penasco, Mexico, where we have built over 30 homes for families in need over the past several years;</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Partnering with local refugee foundations to provide help to repair fences, provide habitat upkeep, as well as helped procure needed items for kids and cleaning supplies for people's homes;</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Assembling backpacks during our company training events consisting of food items for children who have food insecurity over weekends.</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Hosting Company-sponsored incentive trips where attendees give back to the local communities, like creating over 1,000 school kits for the local community to aid children and their families in attending school and after-school education during a recent Company-sponsored trip to Punta Cana;</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Formalizing our auditing and commitment to align internationally with human rights philosophies in how we conduct business through our human rights policy and vendor code of conduct, including auditing our key partners each year to ensure we are partnering with those who share our values;</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Measuring our employees&#8217; engagement levels, requesting anonymous feedback during the fiscal year, and implementing changes to address their feedback; and</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Hosting monthly all hands staff meetings to ensure our employees feel informed and aligned on our priorities and to encourage transparent communication.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Governance</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">: We endeavor to continue to strengthen and improve our corporate governance and executive compensation practices. We have an equity ownership policy to reinforce our belief that executives and directors who believe in the future of our company should have meaningful equity holdings in LifeVantage. In addition, we have a majority standard for the election of directors on our board. </span></div><div id="i7a9d1ca723db478892511ede354648f3_175"></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Available Information</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Our principal offices are located at 3300 N. Triumph Blvd, Suite 700, Lehi, UT 84043. Our telephone number is (801)&#160;432-9000 and our fax number is (801)&#160;880-0699. Our website address is www.lifevantage.com; however, information found on our website is not incorporated by reference into this report. Our website address is included in this annual report as an inactive textual reference only.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The reports filed with the SEC, by us and by our officers, directors, and significant stockholders are available for review on the SEC&#8217;s website at www.sec.gov. </span><span style="background-color:#ffffff;color:#212529;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Such reports are</span><span style="color:#212529;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="background-color:#ffffff;color:#212529;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">also available free of charge through the investor relations section of our website at </span><span style="color:#212529;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">www.lifevantage.com</span><span style="background-color:#ffffff;color:#212529;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> and are accessible as soon as reasonably practicable after being electronically filed with or furnished to the SEC.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">25</span></div></div></div><div id="i7a9d1ca723db478892511ede354648f3_178"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">ITEM&#160;1A &#8212; RISK FACTORS</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Because of the following risks, as well as other risks affecting our financial condition and operating results, past financial performance should not be considered to be a reliable indicator of future performance, and investors should not use historical trends to anticipate results or trends in future periods. The risks described below are those we currently believe could materially affect us. The following risks are not necessarily all of the important factors that could cause our actual results of operations to differ materially from those expressed in the forward-looking statements in this report.</span></div><div id="i7a9d1ca723db478892511ede354648f3_181"></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Risks Relating to Our Business and Industry</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">An inability to properly motivate and incentivize sales from our independent consultants could harm our business.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Motivating our independent consultants and providing them with appropriate sales resources, including technology, tools, and training, are important to the growth and success of our business. We have faced, and may continue to face, challenges in motivating and incentivizing our independent consultants. In addition, actions we take from time to time to enforce our policies and procedures, may cause discord among some of our independent consultants. The loss of key independent consultants due to various factors including, but not limited to, voluntary termination or involuntary termination or suspension resulting from non-compliance with our policies and procedures, could distract our independent consultants and disrupt our business. For example, in the past, we have experienced discord among our leading independent consultants. If we fail to properly respond to any discord among our leading independent consultants in the United States and other markets, we could lose additional leaders, including to competing direct selling companies, which could have a significant negative impact on our revenue. Further, from time to time, we are involved in legal proceedings with former independent consultants. Such legal proceedings can be a distraction to our active independent consultants and can be expensive, time-consuming and cause a disruption to our business. Our inability to properly respond to these and other distractions may have a negative impact on our business.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If we are unable to retain our existing customers and independent consultants or attract additional customers and independent consultants, our revenue will not increase and may decline.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Our customers may cease purchasing our products at any time and for any reason. Our independent consultants may terminate their services at any time, and we can and have in the past terminated consultants for conduct violative of our policies and procedures. As such, like most direct selling companies, we have experienced and are likely to continue to experience turnover among both customers and independent consultants. In the past, we have experienced, and, in the future, we may experience, a decrease in the number of our independent consultants. The departure for any reason of one of our leading independent consultants can be a major disruption to other independent consultants and could have a significant negative impact on our sales and operating results. Independent consultants who join our company to purchase our products for personal consumption or for short-term income goals may only stay with us for a short time. While we take steps to help train, motivate, and retain independent consultants, we cannot accurately predict the number or sales productivity of our independent consultants.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Our operating results will be harmed if we and our independent consultant leaders do not generate sufficient interest in our business to retain existing customers and independent consultants and attract new customers and independent consultants. The number and sales productivity of our independent consultants could be harmed by several factors, including:</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">any adverse publicity regarding us, our products, our distribution channel, or our competitors;</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">non-compliance by our independent consultants with applicable legal requirements or our policies and procedures;</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">lack of interest in existing or new products or their failure to achieve desired sales results;</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">lack of a compelling business opportunity sufficient to generate the interest and commitment of new independent consultants;</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">any changes we might make to our independent consultant sales compensation plan;</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">any negative public perception of our company or our products or their ingredients;</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">any negative public perception of our independent consultants and direct selling business in general;</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our actions to enforce our policies and procedures;</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">any efforts to sell our products through competitive channels;</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">any regulatory actions or charges against us or others in our industry; and</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">general economic and business conditions.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">26</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our independent consultants could fail to comply with applicable legal requirements or our policies and procedures, which could result in claims against us that could harm our business.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Our independent consultants are independent contractors and, accordingly, we are not in a position to directly provide the same oversight, direction and motivation as we would if they were our employees. As a result, there can be no assurance that our independent consultants will comply with applicable laws or regulations or our independent consultant policies and procedures, participate in our marketing strategies or plans, or accept our introduction of new products. Despite their independent contractor status, activities by our independent consultants that allegedly violate applicable laws or regulations could result in government or third-party actions against us, which could harm our business. Our independent consultants agree to abide by our policies and procedures which are designed to ensure our independent consultants will comply with legal requirements. We have a consultant compliance department that addresses violations of our independent consultants when they become known to us. However, given the size of our independent consultant network, we experience problems with independent consultants violating our policies and procedures from time to time and are not always able to discover or remedy such violations.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">One of our most significant areas of risk with respect to independent consultant activities relates to improper product claims and claims regarding the consultant business opportunity of being an independent consultant. Any determination by the FDA, FTC, any state agency, or other similar governmental agency outside the United States that we or our independent consultants are not in compliance with applicable laws could materially harm our business. Even if governmental actions do not result in rulings or orders against us, they could create negative publicity that could detrimentally affect our efforts to recruit or motivate independent consultants and attract customers or lead to consumer lawsuits against us. When we experience growth in the number of our independent consultants, we have seen an increase in sales aids and promotional material being produced by independent consultants and/or consultant groups in some markets. This places an increased burden on us to monitor compliance of such materials and increases the risk that such materials could contain problematic product, marketing, or business opportunity claims in violation of our policies and applicable regulations. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Because we have expanded into foreign countries, our policies and procedures for our independent consultants differ slightly in some countries due to the different legal requirements of each country in which we do business. In addition, as we have expanded internationally, some of our independent consultants have carried or shipped our products into countries in which such products are not registered or that otherwise impose stringent restrictions on our direct selling model. While we have taken steps to stop or restrict these sales from occurring, including through our independent consultant policies and procedures, it can be difficult to enforce these policies and procedures because of the large number of independent consultants and their independent status. If relevant regulatory authorities determined that any such independent consultant activities are not compliant with all regulatory requirements, we could be subject to related fines, penalties, and other assessments or negative publicity, any of which could have an adverse impact on our business. In addition, violations by our independent consultants of our policies and procedures could reflect negatively on our products and operations and harm our business reputation. Further, it is possible that a court could hold us civilly or criminally accountable based on vicarious liability because of the actions of our independent consultants. In the past, some of our independent consultants have been investigated by government agencies for conduct alleged to have violated the law and our policies. This type of investigation can have an adverse effect on us even if we are not involved in the independent consultant&#8217;s activities.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may be adversely affected by changes to our independent consultant compensation plans. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We modify our compensation plans from time to time to keep them competitive and attractive to existing and potential independent consultants, to address changing market dynamics, to provide incentives to our independent consultants that we believe will help grow our business, to conform to local regulations and to address other business-related considerations.</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In fiscal year 2023, we launched our new Evolve Compensation Plan for our independent consultants in the United States, Australia, New Zealand, and Japan markets. In fiscal year 2024, we launched our new Evolve Compensation Plan for our independent consultants in the Canada, Mexico and Europe markets. In fiscal year 2025, we launched an optimized version of the Evolve Compensation Plan for our independent consultants in the United States, Japan, Australia, New Zealand, Canada, Mexico, and Europe markets and launched the Evolve Compensation plan in other markets, including Taiwan, Hong Kong, and Singapore. It is difficult to predict whether such changes will achieve their desired results in the various markets. Such changes could result in unintended or unforeseen negative economic and non-economic consequences to our business, such as higher than anticipated costs or difficulty in attracting and retaining independent consultants, either of which could have a material adverse effect on our results of operations and financial condition. In addition, if regulatory agencies such as the FTC or judicial cases lead to new industry standards or rules, our business could be impacted, and we may need to amend our compensation plan. If we are required to make changes, or if the FTC seeks to enforce similar measures in the industry, either through rulemaking or an enforcement action against our company, our business could be harmed. </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">27</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We primarily depend on a few products for a majority of our revenue.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We primarily rely on our Protandim</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">, LifeVantage</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:700;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">, and TrueScience</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> product lines</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:700;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"> </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">for a majority of our revenue, which collectively represent approximately 87.6% of total revenue for the fiscal year ended June 30, 2025. As such, any adverse impact we experience with respect to any of these products lines could negatively impact our overall revenue. For example, if we are unable to sustain or increase the price or sales levels of our Protandim</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">, LifeVantage</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:700;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">, or </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:700;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"> </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">TrueScience</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174; </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">product lines, our business could be harmed.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We are dependent upon third parties to manufacture our products.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We currently rely on third parties to manufacture our products. We are dependent on the uninterrupted and efficient operation of third-party manufacturers&#8217; facilities. We currently use multiple third-party manufacturers for our products. If any of our current manufacturers are unable or unwilling to fulfill our manufacturing requirements or seek to impose unfavorable terms, we will likely have to seek out other manufacturers, which could disrupt our operations and we may not be successful in finding alternative manufacturing resources. In addition, competitors who perform their own manufacturing may have an advantage over us with respect to pricing, availability of product, and in other areas through their control of the manufacturing process.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">High quality materials for our products may be difficult to obtain or expensive.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Raw materials account for a significant portion of our manufacturing costs, and we rely on third-party suppliers to provide raw materials. Suppliers may be unable or unwilling to provide the raw materials our manufacturers need in the quantities requested, at a price we are willing to pay, or that meet our quality standards. We are also subject to potential delays in the delivery of raw materials caused by events beyond our control, including labor disputes, transportation interruptions and changes in government regulations. Our business could be adversely affected if we are unable to obtain a reliable source of any of the raw materials used in the manufacturing of our products that meets our quality standards. Additionally, if demand for our products exceeds our forecasts, we may have difficulties in obtaining additional raw materials in time to meet the excess demand. Any significant delay in or disruption of the supply of raw materials could, among other things, substantially increase the cost of such materials, require reformulation or repackaging of products, require the qualification of new suppliers, or result in our inability to meet customer demands.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Disruptions to or significantly increased costs associated with transportation and other distribution channels for our products may adversely affect our margins and profitability.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We generally rely on the uninterrupted and efficient operation of third-party logistics companies to transport and deliver our products. These third-party logistics companies may experience disruptions to the transportation channels used to distribute our products, including disruptions caused by increased airport and shipping port congestion, a lack of transportation capacity, increased fuel expenses, and a shortage of manpower. Disruptions to the transportation channels experienced by our third-party logistics companies may result in increased costs, including the additional use of airfreight to meet demand. </span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We are subject to risks related to product recalls.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We have implemented measures in our manufacturing process that are designed to prevent and detect defects in our products, including contaminants. However, such measures may not prevent or reveal defects or detect contaminants in our products and such defects and contaminants may not become apparent until after our products have been sold into the market. Accordingly, there is a risk that product defects will occur, or that our products will contain foreign contaminants, and that such defects and contaminants will require a product recall. We do not maintain product recall insurance. In the past, we commenced a voluntary recall of certain lots of Protandim</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> Nrf2 Synergizer</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> to alleviate safety concerns related to certain batches of turmeric extract, an ingredient in Protandim</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> Nrf2 Synergizer</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> we purchase from third-party suppliers. Product recalls and subsequent remedial actions can be expensive to implement and could have a material adverse effect on our business, results of operations and financial condition. In addition, product recalls could result in negative publicity and public concerns regarding the safety of our products, either of which could harm the reputation of our products and our business and could cause the market value of our common stock to decline.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">A past voluntary product recall strained our relationships with some of our third-party manufacturers. Additionally, following the voluntary recall we implemented more stringent measures, including several redundant measures, in our manufacturing process to detect contaminants. Third-party manufacturers may be reluctant to implement these redundant measures, may refuse to manufacture our products, and additional safety measures such as these may increase our cost of goods sold and strain our relationships with manufacturers.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">28</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our business is susceptible to product liability claims.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The manufacture and sale of any product for human consumption raises the risk of product liability claims. These claims may derive from the product itself or a contaminant found in the product from the manufacturing, packaging, sales process or even due to tampering by unauthorized third parties. Our products consist of vitamins, minerals, herbs, and other ingredients that are classified as foods or dietary supplements and are not subject to pre-market regulatory approval in the United States. Our products could contain contaminated substances, and some of our products contain ingredients that do not have long histories of human consumption. Previously unknown adverse reactions resulting from human consumption of these ingredients could occur. In addition, third-party manufacturers produce all of the products we sell. As a distributor of products manufactured by third parties, we may also be liable for various product liability claims for these products despite not manufacturing them. We may be subject to various product liability claims, including, among others, that our products include inadequate instructions for use or inadequate warnings concerning possible side effects and interactions with other substances. Any product liability claim against us could result in increased costs and could adversely affect our reputation with our customers, which in turn could adversely affect our revenue and operating income. Although we maintain insurance coverage, there is a risk that our insurance will not cover our potential exposure completely or would fail to cover a particular claim, in which case we may not have the financial resources to satisfy such claim. In addition, certain types of damages, such as punitive damages, are not covered by our insurance policy.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Many of the markets in which we compete for business, including the dietary supplement and personal care markets, are highly competitive. We may not be able to compete effectively, which may have a material adverse effect on our results of operations and financial condition.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Many of the markets in which we compete for business, including the dietary supplement and personal care markets, are large, highly competitive, and fragmented. Our flagship product line, Protandim</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">, our LifeVantage</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> product line, and our TrueScience</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> Liquid Collagen compete in the dietary supplements market and our TrueScience</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174; </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Skin Care Collection competes in the personal care market. Participants include specialty retailers, supermarkets, drugstores, mass merchants, multi-level marketing organizations, online merchants, mail-order companies, and a variety of other smaller participants. Many of our competitors have greater financial and other resources available to them and possess better manufacturing, independent distribution, and marketing capabilities than we do. We believe some of these competitors with greater resources may develop and release products that will compete directly with Protandim</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">, LifeVantage</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">,</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"> </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">or TrueScience</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174; </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">and will be marketed as activation products. One or more of these products could significantly reduce the demand for Protandim</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">, LifeVantage</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">, or TrueScience</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174; </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">and have a material adverse effect on our revenue. We believe that the market is also highly sensitive to the introduction of new products, including various prescription drugs, which may rapidly capture a significant share of the market. Moreover, because of regulatory restrictions concerning claims about the efficacy of dietary supplements and personal care products, we may have difficulty differentiating our products from our competitors&#8217; products and competing products entering the dietary supplements and personal care markets could harm our revenue. In the United States and Japan, we also compete for sales with heavily advertised national brands manufactured by large pharmaceutical and food companies, as well as other retailers. In addition, as some products become more mainstream, we experience increased competition for those products as more participants enter the market. Our international competitors include large international pharmacy chains, major international supermarket chains, and other large U.S.-based companies with international operations. We may not be able to compete effectively and our attempt to do so may result in increased pricing pressure, which may result in lower margins and have a material adverse effect on our results of operations and financial condition.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Unfavorable publicity could materially harm our business.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We are highly dependent upon consumers&#8217; perceptions of the safety, quality, and efficacy of our products, as well as competitive products distributed by other companies. In the past, we have experienced negative publicity that has harmed our business. Critics of our industry and other individuals whose interests are not aligned with our interests, have in the past and may in the future utilize the Internet, the press, and other means to publish criticism of the industry, our company, our products, and our competitors, or make allegations regarding our business and operations, or the business and operations of our competitors. For instance, several prominent companies in our industry have been targeted by short sellers who profit if a company&#8217;s stock price decreases. One such company was targeted by a short seller who, after taking a significant short position, publicly made allegations regarding the legality of the company&#8217;s direct selling model. Short sellers have an incentive to publicly criticize our industry and business model and any such criticism may adversely affect our stock price.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Future scientific research or publicity may not be favorable to our industry or any particular product. Because of our dependence upon consumer perceptions, adverse publicity associated with illness or other adverse effects resulting or claimed to have resulted from the consumption or use of our products or any similar products distributed by other companies could have a material adverse impact on us. Such adverse publicity could arise even if the claims are unsubstantiated or if the adverse effects associated with such products resulted from failure to consume or use such products as directed. Adverse publicity could also increase our product liability exposure, result in increased regulatory scrutiny and lead to the initiation of private lawsuits.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">29</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Actions of activist stockholders have, and could continue to, impact the pursuit of our business strategies, cause us to incur substantial costs, divert our management&#8217;s attention and resources, and adversely affect our business, results of operations, financial condition, and the trading price of our common stock.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Publicly traded companies have increasingly become subject to campaigns by activist investors advocating for corporate actions such as financial restructurings, increased borrowings, special dividends, stock repurchases or even sales of assets or entire companies to third parties or the activists themselves. Responding to proxy contests and other actions by activist stockholders, including related litigation, has been and can be costly and time consuming, disrupt our operations and divert the attention of our board and senior management from the pursuit of business strategies, which could adversely affect our results of operations and financial condition. For example, in August 2023, we received notice from a stockholder, Bradley L. Radoff, of his intent to nominate three directors for election at our fiscal year 2024 annual meeting of stockholders. We and Mr. Radoff communicated throughout the proxy contest, but could not reach an agreement in connection with Mr. Radoff&#8217;s nomination. At our fiscal year 2024 annual meeting of stockholders, our stockholders elected the incumbent directors as the directors of our board, each to hold office until our fiscal year 2025 annual meeting of stockholders or until his or her respective successor is elected and qualified. On February 14, 2024, we entered into a cooperation agreement with Mr. Radoff and other relevant persons and entities (the &#8220;Cooperation Agreement&#8221;). Pursuant to the Cooperation Agreement, we increased the size of our board by one seat, appointed Mr. Dayton Judd to our board, and agreed to other terms and customary standstill provisions. The amount of time, attention, and resources that were required of our Company, board, and executive leadership team to address the proxy contest-related measures were substantial, and the residual impact on the Company&#8217;s business and financial performance is uncertain. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, perceived uncertainties as to our future direction as a result of future stockholder activism or further changes to the composition of our board may lead to the perception of a change in the direction of our business, instability or lack of continuity. These uncertainties may be more acute or heightened when an activist seeks to change a majority of the board or ultimately desires to acquire the company. If individuals are elected to our board with a specific agenda, it may adversely affect our ability to effectively implement our business strategy and create additional value for our stockholders. Additionally, actions by activist stockholders may be exploited by our competitors, cause concern to our current or potential independent consultants and customers, make it more difficult to attract and retain qualified personnel and may create adverse uncertainty for our employees. In addition, actions of activist stockholders may cause significant fluctuations in our stock price based on temporary or speculative market perceptions or other factors that do not necessarily reflect the underlying fundamentals and prospects of our business. It is possible that we could become engaged in future proxy contests with other activist stockholders, which could adversely affect our results of operations and financial condition.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The loss of or inability to attract key personnel could negatively impact our business.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Our future performance will depend, in part, upon our ability to attract, retain, and motivate our executive and senior management team and scientific staff. Our success depends to a significant extent both upon the continued services of our current executive and senior management team and scientific staff, as well as our ability to attract, hire, motivate, and retain additional qualified management and scientific staff in the future. Specifically, competition for executive and senior staff in the direct selling and dietary supplement markets is intense, and our operations could be adversely affected if we cannot attract and retain qualified personnel. Additionally, former members of our executive and senior management team have in the past, and could in the future, join or form companies that compete against us in the direct selling industry.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">All of our employees are &#8220;at will&#8221; employees, which means any employee may quit at any time and we may terminate any employee at any time. We do not carry &#8220;key person&#8221; insurance covering members of senior management or our employees.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may be held responsible for certain taxes or assessments and other obligations relating to the activities of our independent consultants, which could harm our financial condition and operating results.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Our independent consultants are subject to taxation, and in some instances, legislation or governmental agencies impose an obligation on us to collect or withhold taxes, such as value added taxes or income taxes, and to maintain appropriate records. In the event that local laws and regulations or the interpretation of local laws and regulations change to require us to treat our independent consultants as employees, or that our independent consultants are deemed by local regulatory authorities in one or more of the jurisdictions in which we operate to be our employees rather than independent contractors under existing laws and interpretations, or our independent consultants are deemed to be conducting business in countries outside of the country in which they are authorized to do business, we may be held responsible for social security, income, and other related taxes in those jurisdictions, plus any related assessments and penalties, which could harm our financial condition and operating results. If our independent consultants were deemed to be employees rather than independent contractors, we may be obligated to pay certain employee benefits, such as workers compensation and unemployment insurance. Further, if our independent consultants are misclassified as employees, we would also face the threat of increased vicarious liability for their actions. </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">30</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We are subject to risks related to a Global Not For Resale Program.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We have a Global Not For Resale program, which allows customers from around the world to purchase limited amounts of our products for their individual consumption. Under this program, customers from other countries are able to set up a U.S. customer account and associated U.S. address and payment method to drop-ship their order to a third-party vendor in the U.S., who will then ship the products to the customer&#8217;s global location with any customs and/or duties being the sole responsibility of the ordering customer.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">This program may raise questions from tax regulators about the appropriate sales tax jurisdiction due to the varied and complex tax regulations in the U.S. and around the world. Further, any regulatory review of our facilitation to ship U.S. product to our existing markets, where such product has not been registered, may raise issues against the local subsidiary from the foreign jurisdiction equivalents of the FDA or FTC or the relevant trade associations, should any agency or association perceive that we or our independent consultants are advertising and/or facilitating the sale of unregistered product in their country.</span></div><div id="i7a9d1ca723db478892511ede354648f3_184"></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Risks Relating to Our Company</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We are subject to evolving laws, policies, and contractual obligations related to data privacy and security, including cybersecurity, and our actual or perceived failure to comply with such obligations or perceived failure to maintain the integrity of our data could expose us to data loss or litigation, harm our reputation, subject us to significant fines and liability, or otherwise adversely affect our business, prospects, financial condition, and operating results. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We collect and retain large volumes of data relating to our business and from our customers, independent consultants and employees for business purposes, including for transactional and promotional purposes, and our various IT systems enter, process, summarize and report such data. The integrity and protection of this data is critical to our business. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We are subject to or affected by a number of national, state and local laws and regulations, as well as contractual obligations and industry standards, that impose certain obligations and restrictions with respect to data privacy and security, and govern our collection, storage, retention, protection, use, processing, transmission, sharing and disclosure of personal information, including that of our employees, customers and others. We are also subject to requirements imposed by the payment card industry. As we expand our operations, the CCPA, CPRA, and other laws and regulations relating to privacy and data security may increase our compliance costs and potential liability. Compliance with any applicable privacy and data security laws and regulations is a time-intensive and costly process, and we may be required to put in place additional processes to comply with existing and evolving laws and regulations and new laws and regulations as we expand our operations. Many jurisdictions have enacted laws requiring companies to notify individuals, regulatory authorities and others of security breaches involving certain types of data. In addition, our agreements with certain customers may require us to notify them in the event of a security breach or incident. Such mandatory disclosures can be costly and could lead to negative publicity, penalties, fines, litigation, and other proceedings or cause our customers to lose confidence in the effectiveness of our security measures and require us to expend significant capital and other resources to respond to and/or alleviate problems caused by the actual or perceived security breach or incident. We may not be able to monitor and react to all developments in a timely manner. Maintaining compliance with these evolving regulations and requirements could be difficult and may increase our expenses.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Many jurisdictions outside of the United States are considering or have enacted similar or more stringent legislation providing for local storage of data or otherwise imposing privacy, data protection, and data security obligations in connection with the collection, use, and other processing of personal data. Further, the global data protection landscape is rapidly evolving, and implementation standards and enforcement practices are likely to remain uncertain for the foreseeable future. As our international presence expands, we may become subject to additional obligations under laws and regulations in countries outside the United States, such as, for example, the European Union&#8217;s General Data Protection Regulation (&#8220;GDPR&#8221;), legislation in other countries implementing the GDPR or similar versions of the GDPR. As a general matter, compliance with laws, regulations, contractual obligations, industry standards, and any rules or guidance from self-regulatory organizations relating to privacy, data protection, and data security that apply, or are asserted to apply, to our operations may result in substantial costs and may necessitate changes to our business practices, which may compromise our growth strategy, adversely affect our ability to acquire customers, and otherwise adversely affect our business prospects, results of operations, and financial condition.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Despite the security measures we have in place to comply with applicable laws and rules and to protect our security and information systems, there can be no assurance that our cybersecurity risk management program and processes, including our policies, controls, or procedures will be fully implemented, complied with, or effective in protecting our systems and information Further, our vendors and third-party service providers (as well as their third-party service providers), may be vulnerable to security breaches, acts of cyber terrorism or sabotage, vandalism or theft, computer viruses, loss or corruption of data or programming or human errors or other similar events. While we have agreements requiring our third-party service providers to use best practices for data security, we have no operational control over them. Because such attacks are increasing </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">31</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">in sophistication and change frequently in nature, we and our third-party service providers may be unable to anticipate these attacks or implement adequate preventative measures, and any compromise of our systems, or those of our third-party vendors (as well as their third-party service providers), may not be discovered and remediated promptly. Changes in consumer behavior following a security breach or perceived security breach, act of cyber terrorism or sabotage, vandalism or theft, computer virus, loss or corruption of data or programming or human error or other similar event affecting a competitor, large retailer or financial institution may materially and adversely affect our business. While we carry cyber insurance, we cannot be certain that our coverage will be adequate for liabilities actually incurred, that insurance will continue to be available to us on commercially reasonable terms or at all, or that any insurer will not deny coverage as to any future claim. Any of the foregoing may have an adverse effect on our business, prospects, results of operations, and financial condition.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may not be successful in expanding our operations.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We may not be successful in expanding our operations. Although we have been selling our products through our direct selling network since fiscal year 2009, we still may have limited insight into trends, disruptions and other factors that may emerge and affect our business. For example, a widespread pandemic, such as the COVID-19 pandemic, and measures taken in response by governments and businesses worldwide to contain its spread, including quarantines, facility closures, travel and logistics restrictions, border controls, and shelter in place or stay at home and social distancing orders, may adversely impact our supply chain, manufacturing, logistics, workforce and operations, as well as the operations of our customers and suppliers globally. Such adverse impacts on our supply chain could limit our ability to sell our products on a timely and cost-effective basis, which could adversely affect our business and results of operations.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In addition, from time to time, we are compelled to terminate one or more of our independent consultants for actions contrary to their contractual obligations with us. In the past, some of these terminations have caused disruption among our independent consultants, and such terminations or resulting disruption in the future may negatively impact our revenue. Additionally, we may not be successful in keeping our leading independent consultants focused and motivated or in aligning their goals with our company goals. Although we are seeking to grow our business, if we fail to effectively manage operations in our existing markets and/or expand our operations into additional markets, we may be unable to generate consistent operating profit growth in future periods.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If we are able to expand our operations, including through acquisition of assets or businesses, we may experience difficulties in managing our future growth, which could adversely affect our business.</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">If we are able to expand our operations in the United States and in other countries where we believe our products will be successful, such expansion could place increased strain on our management, operational, financial and other resources. An inability to leverage our current resources in an efficient manner could have a material adverse effect on our business, operating margins, and results of operations. If we are able to expand our operations, we expect we will need additional managerial, operational, technical, sales, marketing, financial, legal, and other resources. </span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In addition, acquisitions of complementary businesses or assets involve numerous risks and uncertainties. These include challenges in integrating operations, systems, and personnel; difficulties in realizing the anticipated benefits of the transaction within the expected timeframe, or at all; disruption of ongoing business operations and relationships; exposure to unknown or contingent liabilities; and potential increases in costs, indebtedness, or dilution. If we are unable to successfully integrate acquired businesses or achieve the benefits we expect, our growth strategy and financial performance could be adversely affected.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">If we are successful in expanding our operations, our management may need to divert its attention away from its day-to-day activities and devote a substantial amount of time to managing these growth activities. We may not be able to effectively manage the expansion of our operations, which may result in weaknesses in our infrastructure and loss of business opportunities, among others. </span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may not succeed in growing our business in existing markets or opening new markets. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We sell our products in the United States, Mexico, Japan, Australia, Hong Kong, Canada, Thailand, the United Kingdom, the Netherlands, Germany, Taiwan, Austria, Spain, Ireland, Belgium, New Zealand, and Singapore. We also sell our products in a number of countries to customers for personal consumption only. In fiscal year 2025, we generated approximately 22% of our revenue from our international operations, a majority of which was generated in Japan. We believe that our ability to achieve future growth is dependent in part on our ability to effectively expand into new international markets and grow our existing markets. In some international markets, we have experienced difficulties which have resulted in adverse consequences to our business, including declining revenue in some markets, the closure of some markets, and occasional disruption to our business with supply chain and logistics delays in delivering product to certain markets in a timely manner.  Our business and financial results may be also negatively impacted if a particular market or new business model is not widely accepted and adopted. We must overcome significant regulatory and legal barriers before we can begin marketing in any international market. Also, before </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">32</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">marketing commences in a new country or market, it is difficult to assess the extent to which our products and sales techniques will be accepted or successful. In addition to significant regulatory barriers, we may also encounter problems conducting operations in new markets with different cultures and legal systems from those encountered elsewhere. We may be required to reformulate one or more of our products before commencing sales of that product in a given country. Once we have entered a market, we must adhere to the regulatory and legal requirements of that market. We may not be able to obtain and retain necessary permits and approvals in new markets, or we may have insufficient capital to finance our expansion efforts in a timely manner.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Inability of new products and technological innovations to gain market acceptance by customers and/or independent consultants could harm our business.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We believe our ability to introduce new products that gain acceptance among our customers and independent consultants is an important part of our ability to grow our revenue in future periods. However, any new products we introduce may not gain market acceptance by customers and/or independent consultants to the extent we anticipate or project. Factors that could affect our ability to introduce new products include, among others, government regulations, the inability to attract and retain qualified research and development staff, the termination of third-party research and collaborative arrangements, proprietary protections of competitors that may limit our ability to offer comparable products and the difficulties in anticipating changes in consumer tastes and buying preferences. In addition, new products we introduce may not be successful or generate substantial sales revenue. The introduction of a new product could also negatively impact other product lines to the extent our independent consultant leaders focus their sales efforts on the new product instead of an existing product. If any of our products fails to gain customer and/or independent consultant acceptance, we could see an increase in product returns.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In addition, we believe our ability to introduce new technologies that gain acceptance among our customers and independent consultants is an important part of our ability to grow our sales revenue in future periods. However, these or other new technologies that we introduce may not gain customer and/or independent consultant acceptance to the extent we anticipate or project. </span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our business could be negatively impacted if we fail to execute any product launch process due to increased pressure on our supply chain, information systems and management.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Although our product launch process may vary by market, we generally introduce new products to our customers and independent consultants through live events or cyber launches, limited-time offers and promotions. The limited-time offers typically generate significant activity and a high level of purchasing, which may result in a higher-than-normal increase in sales revenue during the quarter of the limited-time offer and skew year-over-year and sequential comparisons. We may experience difficulty effectively managing growth associated with these limited-time offers. In addition, the size and condensed schedule of these product launches increases pressure on our supply chain. If we are unable to accurately forecast sales levels in each market, obtain sufficient ingredients or produce a sufficient supply to meet demand, we may incur higher expedited shipping costs and we may temporarily run out of stock of certain products, which could negatively impact the enthusiasm of our independent consultants and their customers. Conversely, if demand does not meet our expectations for a product launch, we could incur increased inventory write-offs. Any inventory write-off would negatively impact our gross margins. In addition, our order processing systems could have difficulties handling the high volume of orders generated by limited-time offers. Although our previous limited-time offers have not materially affected our product return rate, these events may increase our product return rate in the future.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our business may be harmed if we are unable to appropriately manage our inventory.</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In the past, we have experienced difficulties in appropriately managing our inventory. For example, when we launched our MindBody GLP-1 System</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#8482;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> in October 2024, we experienced higher than expected demand and did not have sufficient inventory to meet demand. In the past, we have also experienced an inventory surplus, causing us to engage in a deliberate effort to manage down such inventory balances to levels we viewed as appropriate. We review all inventory items quarterly for obsolescence, and when items become obsolete or are expired, we write down our inventory accordingly. If we are unable to sell our inventory in a timely manner, we may experience additional inventory obsolescence charges, including for finished products in inventory that have expired. If we are unable to appropriately manage our inventory balances, our business may be harmed.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We rely on our IT systems to manage numerous aspects of our business, and a disruption in these systems, including as a result of cybersecurity incidents, could adversely affect our business.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We depend on our IT systems to manage numerous aspects of our business, including our finance and accounting transactions, to manage our independent consultant sales compensation plan and to provide analytical information to management. Our IT systems are an essential component of our business and growth strategies, and a serious disruption to our IT systems, including as a result of cybersecurity incidents, could significantly limit our ability to manage and operate our </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">33</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">business efficiently. These systems are vulnerable to, among other things, damage and interruption from power loss or natural disasters, computer system and network failures, loss of telecommunications services, physical and electronic loss of data, security breaches and computer viruses. Any disruption could cause our business and competitive position to suffer and adversely affect our business and operating results. In addition, if we experience future growth, we will need to scale or change some of our systems to accommodate the increasing number of independent consultants and their customers.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Inability to comply with financial covenants imposed by our credit facility and the impact of debt service obligations and restrictive covenants could impede our operations and flexibility.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In April 2024, we entered into a loan agreement, which provides for a revolving line of credit in an aggregate principal amount not to exceed $5.0 million (the &#8220;2024 Credit Facility&#8221;). </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">A</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">s of June&#160;30, 2025, there is no outstanding balance on the 2024 Credit Facility. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The principal amount of any borrowings under the 2024 Credit Facility is repayable, if drawn, on the maturity date of the facility (April 12, 2027). Interest will accrue on outstanding loans, payable monthly. We expect to generate the cash necessary to pay any future principal and interest on the 2024 Credit Facility, if any, from our cash flows provided by operating activities. However, our ability to meet our debt service obligations will depend on our future performance, which may be affected by financial, business, economic, demographic, and other factors. If we do not have enough money to pay our debt service obligations, we may be required to refinance all or part of our debt, sell assets, borrow more money, or raise cash through the sale of equity. In such an event, we may not be able to refinance our debt, sell assets, borrow more money, or raise cash through the sale of equity on terms acceptable to us or at all. Also, our ability to carry out any of these activities on favorable terms, if at all, may be further impacted by any financial or credit crisis which may limit access to the credit markets and increase the cost of capital. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The 2024 Credit Facility is secured by a lien on substantially all of our assets, and the assets of Lifeline Nutraceuticals, and by a pledge of membership interests of our subsidiaries, and contains customary covenants, both affirmative and negative covenants, that, among other things, restrict our ability to deal with our assets outside of the ordinary course, incur or guarantee additional indebtedness, grant liens on our assets, make certain investments, purchase or otherwise acquire all or substantially all the assets or equity interests of other companies, and enter into consolidations, mergers or other combinations. The 2024 Credit Facility requires that we maintain specified financial ratios and satisfy certain financial condition tests and comply with certain informational requirements in order to borrow under the revolving loan facility, if needed. Our ability to comply with these financial ratios and tests and informational requirements can be affected by events beyond our control and we may be unable to meet these ratios and tests and informational requirements. A breach of any of the representations, covenants (including compliance with financial ratios), or other restrictions imposed by the 2024 Credit Facility may result in a default or an event of default giving rise to lender's remedies thereunder, which could result in the lender declaring any portion or all amounts of principal, interest and other related costs and expenses outstanding under the 2024 Credit Facility to be immediately due and payable or limit our ability to draw on the revolving loan facility. Our assets may not be sufficient to repay the indebtedness if the lender accelerates our repayment of the indebtedness under the 2024 Credit Facility. In such circumstances, the lender's remedies would include the ability to foreclose on the collateral securing the loan. We were in compliance with all of the 2024 Credit Facility covenants at the end of fiscal year 2025.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">A substantial portion of our business is conducted in foreign markets, exposing us to the risks of trade or foreign exchange restrictions, increased tariffs, foreign currency fluctuations, disruptions or conflicts with our third-party importers and similar risks associated with foreign operations.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Global economic conditions continue to be challenging and unpredictable. A substantial portion of our sales are generated outside the United States. If we are successful in entering additional foreign markets, we anticipate that the percentage of our sales generated outside the United States will increase. There are substantial risks associated with foreign operations. For example, a foreign government may impose trade or foreign exchange restrictions, increased tariffs or other legal, tax, customs or other financial burdens on us or our independent consultants, due, for example, to the structure of our operations in various markets. Any such actions could negatively impact our operations and financial results. We are also exposed to risks associated with foreign currency fluctuations. For instance, in preparing our financial statements, we translate revenue and expenses in our markets outside the United States from their local currencies into U.S. Dollars using weighted average exchange rates. If the U.S. Dollar strengthens relative to local currencies, our reported revenue, gross profit, and net income will be likely reduced. Foreign currency fluctuations can also result in losses and gains resulting from translation of foreign currency denominated balances on our balance sheet. Additionally, purchases from suppliers are generally made in U.S. Dollars while sales to customers and independent consultants are generally made in local currencies. Accordingly, strengthening of the U.S. Dollar versus a foreign currency could have a negative impact on us. Specifically, because a significant percentage of our revenue is generated in Japan, strengthening of the U.S. Dollar versus the Japanese Yen has had and, in the future, could have an adverse impact on our financial results. Although we may engage in transactions intended to reduce our exposure to foreign currency fluctuations, there can be no assurance that these transactions will be effective. Given the complex global political and </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">34</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">economic dynamics that affect exchange rate fluctuations, it is difficult to predict future fluctuations and the effect these fluctuations may have upon future reported results or our overall financial condition.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, any major changes in tax or trade policy, such as the imposition of additional tariffs or duties on imported products, or trade sanctions, between the U.S. and countries from which we source products or ingredients, directly or indirectly, could require us to take certain actions, such as raising prices on our products or seeking alternative sources of supply from vendors with whom we have less familiarity, which could adversely affect our reputation, revenue, and our results of operations. U.S. trade policies continue to be in flux, and trade policies implemented by the U.S. federal government, or the consequences of such policies, could have an adverse effect on our business.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We cannot predict what changes to trade policy will be made by the U.S. federal government, or other governments, including whether existing tariff policies will be maintained or modified or whether the entry into new bilateral or multilateral trade agreements will occur, nor can we predict the effects that any such changes would have on our business or the global economy. Changes in U.S. trade policy, or threat of such changes, have resulted and could again result in reactions from U.S. trading partners, including adopting responsive trade policies making it more difficult or costly for us to export our products or import products or product ingredients from countries where we currently purchase products or product ingredients or sell our products.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We may be negatively impacted by conflicts with, or disruptions caused or faced by, third party importers, as well as conflicts between such importers and local governments or regulatory agencies. We are required to obtain import licenses in order to sell our products to consumers in countries outside the United States. Our inability to obtain and maintain import licenses could cause delays or disruptions to our business and financial condition. Our operations in some markets also may be adversely affected by political, economic, and social instability in foreign countries.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may require substantial additional funding, which may not be available to us on acceptable terms, or at all, and, if not available, may require us to delay, scale back, or cease our product development or growth plans.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Based on our current plans, we believe that our current cash and cash equivalents and our ongoing cash flow from operations will be sufficient to satisfy our anticipated cash requirements for at least 12 months from the date of this report. If our available cash resources and anticipated cash flows from operations are insufficient to satisfy our liquidity requirements, we may be required to raise significant additional capital to support our continued operations and the implementation of our business and growth plans. Future funding requirements will depend on many factors, including but not limited to:</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the costs associated with acquiring products from third-party vendors;</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the costs of the sales and marketing activities of our products;</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the costs associated with commissions and incentives for our independent consultants;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the costs associated with integrating any assets or businesses that we acquire;</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">litigation expenses we incur to defend against claims, including claims that we infringe the intellectual property of others or judgments we must pay to satisfy such claims;</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">contractual obligations to third parties;</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our rate of progress in developing, launching, and selling our current products and any new products we pursue;</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to control our operating costs;</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to satisfy our outstanding debt obligations; and</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the costs of responding to the other risks and uncertainties described in this report.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We may also be required to raise additional capital in the future to expand our business and operations to pursue strategic investments or for other reasons including but not limited to:</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">acquiring or investing in complementary businesses or assets;</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">increasing our sales and marketing efforts to drive market adoption of our products;</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">scaling up our customer support capabilities;</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">funding development and marketing efforts of additional products;</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">expanding our product portfolio into additional markets;</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">35</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">acquiring products through licensing rights; and</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">financing capital expenditures and general and administrative expenses.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We may seek required funding through issuances of equity or convertible debt securities or entering into additional loan facilities. Each of the various ways we could raise additional capital carry potential risks. If we raise funds by issuing equity securities, dilution to our stockholders would result. If we raise funds by issuing additional debt securities, those debt securities would have rights, preferences, and privileges senior to those of holders of our common stock. Our 2024 Credit Facility restricts our ability to pursue certain transactions that we may believe to be in our best interest, including incurring additional indebtedness without the prior written consent of the lender under the credit facility. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">If we are unable to obtain adequate financing or financing on terms satisfactory to us, if we require it, our ability to continue to pursue our business objectives and to respond to business opportunities, challenges, or unforeseen circumstances could be significantly limited and could have a material adverse effect on our business, financial condition, results of operations and prospects.</span></div><div id="i7a9d1ca723db478892511ede354648f3_187"></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Risks Related to Regulatory, Compliance, and Legal Matters </span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our business is subject to strict government regulations.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The manufacturing, packaging, labeling, advertising, sale, and distribution of our products are subject to federal laws and regulations by one or more federal agencies, including, in the United States, the FDA, the FTC, the Consumer Product Safety Commission, and the United States Department of Agriculture (the &#8220;U.S. DOA&#8221;). These activities are also regulated by various state, local, and international laws, and agencies of the states, localities, and countries in which our products are sold. For instance, the FDA regulates, among other things, the ingredients, composition, manufacture, safety, labeling, and marketing of dietary supplements (including vitamins, minerals, herbs and other dietary ingredients for human use) and cosmetic products. We and our suppliers must comply with FDA regulations with respect to current GMP, which require good manufacturing processes, including ingredient identification, manufacturing controls and record keeping. If our third-party suppliers or vendors are not able to comply with these regulations, we may experience increased cost or delays in obtaining certain raw materials and third-party products. Complying with applicable legislation could also raise our costs and negatively impact our business. In addition, government regulations may prevent or delay the introduction of our products or require us to reformulate our products or change the claims we make about them, which could result in lost revenue, increased costs, and delayed expansion into new international markets.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The FDA may determine that a particular dietary supplement or ingredient or a particular cosmetic product is adulterated or misbranded or both and may determine that a particular claim or statement of nutritional support that we make to support the marketing of a dietary supplement is an impermissible drug claim or is an unauthorized version of a &#8220;health claim,&#8221; or that a particular benefit claim that we make to support the marketing of a cosmetic product is an impermissible drug claim. The FDA, the FTC, or state attorneys general may also determine that a particular claim we make for our products is not substantiated. Determining whether a claim is improper frequently involves a degree of subjectivity by the regulatory agency or individual regulator. Any of these determinations by the FDA or other regulators could prevent us from marketing that particular dietary supplement product or cosmetic product, or making certain claims for that product. The FDA could also require us to remove a particular product from the market. Any future recall or removal would result in additional costs to us, including lost revenue from any product that we are required to remove from the market, which could be material. Any product recalls or removals could also lead to liability, substantial costs, and reduced growth prospects.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We may receive a warning letter from the FDA if it believes some violation of law has occurred either by us or by our independent consultants. Any allegations of our non-compliance may result in time-consuming and expensive defense of our activities. FDA warning letters are available to the public on the FDA&#8217;s website. That information could negatively affect our relationships with our customers, investors, independent consultants, vendors, employees, and consumers. Warning letters may also spark private class action litigation under state consumer protection statutes. The FDA could also order compliance activities, such as an inspection of our facilities and products, and could file a civil lawsuit in which an arrest warrant (seizure) could be issued as to some or all of our products. In extraordinary cases, we could be named a defendant and sued for declaratory and injunctive relief.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Additional or more stringent regulations of dietary supplements and other products have been considered from time to time. In recent years, there has been increased pressure in the United States and other markets to increase regulation of dietary supplements. New regulations, or new interpretations of those regulations, could impose additional restrictions, including requiring reformulation of some products to meet new standards, recalls or discontinuance of some products not able to be reformulated, additional record-keeping requirements, increased documentation of the properties of some products, additional or different labeling, additional scientific substantiation, additional adverse event reporting, or other new requirements. Any of these developments could increase our costs significantly. Our operations also could be harmed if new laws or regulations are </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">36</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">enacted that restrict our ability to market or distribute dietary supplements or impose additional burdens or requirements on dietary supplement companies or require us to reformulate our products.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In the United States, for example, some legislators and industry critics continue to push for increased regulatory authority by the FDA over dietary supplements and the FTC over the direct selling industry. The FTC may strengthen the regulation of business opportunity claims and direct selling companies, among other things. The FTC has in recent years investigated and taken enforcement action against direct selling companies for misleading representations relating to the earnings potential of an independent consultant within a company&#8217;s compensation plan, as well as appropriateness of the compensation plans themselves. Our business could be harmed if more restrictive legislation or regulation is successfully introduced and adopted in the future.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In December 2022, Congress passed the Modernization of Cosmetics Regulation Act, which added significant new requirements for cosmetic products marketed in the United States. For example, we now have to register cosmetic product manufacturing facilities and list all cosmetic products with the FDA, and need to report all &#8220;serious adverse events&#8221; to the FDA and maintain relevant records. We will need to comply with current GMP regulations and fragrance allergen declaration regulations once the FDA implements those requirements. Complying with these requirements could raise our costs and negatively impact our business. </span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Regulations governing the production and marketing of our products could harm our business.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We are subject to various domestic and foreign laws and regulations that regulate the production and marketing of our products. If, for example, a determination that our dietary supplement products are used to diagnose, treat, cure, or prevent any disease or illness, including due to improper marketing claims by our independent consultants, it may lead to a determination that the LifeVantage supplements require pre-market approval as a drug. Such regulations in any given market can limit our ability to import products and can delay product launches as we go through the registration and approval process for those products. Furthermore, if we fail to comply with these regulations, we could face enforcement action against us and we could be fined, forced to alter or stop selling our products and/or be required to adjust our operations. Our operations also could be harmed if new laws or regulations are enacted that restrict our ability to market or distribute our products or impose additional burdens or requirements on the contents of our products or require us to reformulate our products.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We are subject to the risk of investigatory and enforcement action.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We are subject to the risk of investigatory and enforcement action by various government agencies, both domestic and international. For instance, the FTC and state attorneys general may open an investigation or bring an enforcement action against us based on our advertising claims and marketing practices. The FTC routinely reviews product advertising, including websites, to identify significant questionable advertising claims and practices. The FTC has brought many actions against dietary supplement companies, including some actions that were brought jointly with state attorneys general, based upon allegations that applicable advertising claims or practices were deceptive or not substantiated. If the FTC initiates an investigation, the FTC can initiate pre-complaint discovery that may be nonpublic in nature. In addition, we are subject to the risk of investigatory and enforcement action by other agencies including, but not limited to, the FDA, including warning letters and other sanctions, enforcement actions by the SEC and by other international regulatory agencies. Any investigation may be very expensive to defend and may result in an adverse ruling or in a consent decree.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our direct selling program could be found to be not in compliance with current or newly adopted laws or regulations in one or more markets, which could prevent us from conducting our business in these markets and harm our financial condition and operating results.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Some of the legal and regulatory requirements concerning the direct selling business model are ambiguous and subject to interpretation. As a result, regulators and courts have discretion in their application of these laws and regulations, and the enforcement or interpretation of these laws and regulations by governmental agencies or courts can change. Allegations by short sellers regarding the legality of multi-level marketing companies generally have also created intense public scrutiny of our industry and could cause governmental agencies to change their enforcement and interpretation of applicable laws and regulations. The failure of our business to comply with current or newly adopted regulations or interpretations could negatively impact our business in a particular market or in general and may adversely affect our stock price.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Laws and regulations may prohibit or severely restrict direct selling and cause our revenue and profitability to decline, and regulators could adopt new regulations that negatively impact our business.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Various government agencies throughout the world regulate direct selling practices. The laws and regulations applicable to us and our independent consultants in Japan are particularly stringent. These laws and regulations are generally intended to prevent fraudulent or deceptive schemes, often referred to as &#8220;pyramid&#8221; schemes, which compensate participants primarily for recruiting additional participants without significant emphasis on the sale of product to end consumers. Government agencies, </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">37</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">such as the FTC in the United States and similar agencies in foreign jurisdictions, periodically investigate direct selling companies based on such schemes or other claims made by a direct selling company or its independent consultants. Generally, companies that are the subject of an FTC, or similar foreign agency, enforcement action are required to pay monetary fines and/or make updates or changes to their business model. The laws and regulations in some of our markets impose cancellations, product returns, inventory buy-backs and cooling-off rights for our independent consultants and/or customers. Excessive refunds and/or product returns pursuant to local laws and regulations, including being the target of an enforcement action or investigation by the FTC or a similar foreign agency in a foreign jurisdiction, could have a negative impact on our operating results. Complying with these rules and regulations can be difficult and requires the devotion of significant resources on our part. We may not be able to continue business in existing markets or commence operations in new markets if we are unable to comply with these laws or adjust to changes in these laws.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our financial condition and results of operations may be adversely affected by international regulatory and business risks. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">As a result of our operations, offering products or contracting with independent contractors and other service providers in various other countries, we are increasingly subject to varied and complex foreign and international laws and regulations. Compliance with these laws and regulations often involves significant costs and may require changes in our business practices that may result in reduced revenues and adversely affect our operating results.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We are subject to the Foreign Corrupt Practices Act, which prohibits companies and their intermediaries from making payments in violation of law to non-U.S. government officials for the purpose of obtaining or retaining business or securing any other improper advantage. Our reliance on independent consultants to market our products internationally demands a high degree of vigilance in maintaining our policy against participation in corrupt activity, because these independent consultants may be deemed to be our agents and we could be held responsible for their actions. We are also subject to similar anti-bribery laws in the jurisdictions in which we operate, including the United Kingdom&#8217;s Bribery Act of 2010, which also prohibits commercial bribery and makes it a crime for companies to fail to prevent bribery. These laws are complex and far-reaching in nature. Any violations of these laws, or allegations of such violations, could disrupt our operations, involve significant management distraction, involve significant costs and expenses, including legal fees, and we could be subject to severe penalties, including criminal and civil penalties, disgorgement, and other remedial measures, any of which could result in a material adverse effect on our business, prospects, financial condition, or results of operations. Any allegations that we are not in compliance with anti-corruption laws may require us to dedicate time and resources to an internal investigation of the allegations or may result in a government investigation. Any determination that our operations or activities are not in compliance with existing anti-corruption laws or regulations could result in the imposition of substantial fines, and other penalties. Although we have implemented anti-corruption policies and controls to protect against violation of these laws, we cannot be certain that these efforts will be effective. Operating internationally requires significant management attention and financial resources. We cannot be certain that the investment and additional resources required to increase international revenues or expand our international presence will produce desired levels of revenues or profitability.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our intellectual property rights are valuable, and any inability to protect them could reduce the value of our products and brand.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The loss of our intellectual property rights in our products could permit our competitors to manufacture their own version of our products. For example, the U.S. patents protecting our Protandim</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174; </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Nrf2 Synergizer</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174; </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">expired in March 2025, which could permit competitors to manufacture and sell their own version of this product and harm our business. We have attempted to protect our intellectual property rights in our products through a combination of patents, patent applications, trademarks, trade secrets, confidentiality agreements, non-compete agreements and other contractual protection mechanisms, and we will continue to do so. While we intend to defend against any threats to our intellectual property, our patents or various contractual protections may not adequately protect our intellectual property. In addition, we could be required to expend significant resources to defend our rights to proprietary information and may not be successful in such defense.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Moreover, our intellectual property rights are more limited outside of the United States than they are in the United States. As such, we may not be successful in preventing third parties from copying or misappropriating our intellectual property. There also can be no assurance that pending patent applications owned by us will result in patents being issued to us, that patents issued to or licensed by us in the past or in the future will not be challenged or circumvented by competitors or that such patents will be found to be valid or sufficiently broad to protect our products or to provide us with any competitive advantage. Third parties could also obtain patents that may require us to negotiate to obtain licenses to conduct our business, and any required licenses may not be available on reasonable terms or at all. We also rely on confidentiality and non-compete agreements with certain employees, independent consultants, consultants, and other parties to protect, in part, trade secrets and other proprietary rights. There can be no assurance that these agreements will not be breached, that we will have adequate remedies for any breach, that others will not independently develop substantially equivalent proprietary information or that third parties will not otherwise gain access to our trade secrets or proprietary knowledge. </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">38</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Third parties might claim that we infringe on their intellectual property rights.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Although the dietary supplement industry has historically been characterized by products with naturally occurring ingredients, it has become more common for suppliers and competitors to apply for patents or develop proprietary technologies and processes. Third parties may assert intellectual property infringement claims against us despite our efforts to avoid such infringement. Such claims could prevent us from offering competitive products or result in litigation or threatened litigation. </span></div><div id="i7a9d1ca723db478892511ede354648f3_190"></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Risks Related to Ownership of Our Common Stock </span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our stock price may experience future volatility.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The trading price of our common stock has historically been subject to wide fluctuations. The price of our common stock may fluctuate in the future in response to quarter-to-quarter variations in operating results, material announcements by us or competitors, governmental regulatory action, conditions in the dietary supplement industry, or other events or factors, many of which are beyond our control, and some of which do not have a strong correlation to our operating performance. We cannot predict the effect, if any, of future sales of our common stock, or the availability of our common stock for future sales, on the value of our common stock. Sales of substantial amounts of our common stock by any one or more of our stockholders, or the perception that such sales could occur, may adversely affect the market price of our common stock.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Substantial sales of shares of our common stock in the public market may impact the market price of our common stock. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> Sales of a substantial number of shares of our common stock in the public market could cause our stock price to decline. Sales of a substantial number of shares of our common stock in the public market could occur at any time. These sales, or the perception in the market that the holders of a large number of shares intend to sell shares, could reduce the market price of our common stock. These sales also might make it more difficult for us to sell equity or equity-related securities in the future at a time and price that we consider appropriate. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We have registered and intend to continue to register all shares of common stock that we may issue under our equity compensation plans. Once we register these shares, they can be freely sold in the public market upon issuance, subject to volume limitations applicable to affiliates. We cannot predict what effect, if any, sales of our shares in the public market or the availability of shares for sale will have on the market price of our common stock. However, future sales of substantial amounts of our common stock in the public market, including shares issued upon exercise of our outstanding warrant or options, or the perception that such sales may occur, could adversely affect the market price of our common stock. Significant additional capital may be required in the future to continue our planned operations. To the extent that we raise additional capital through the sale and issuance of shares or other securities convertible into shares, our stockholders will be diluted.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We cannot guarantee that our share repurchase program will be utilized to the full value approved or that it will enhance long-term stockholder value. Repurchases we consummate could increase the volatility of the price of our common stock and could have a negative impact on our available cash balance.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Our board of directors authorized a share repurchase program pursuant to which we may repurchase up to $60 million of our common stock on or before December 31, 2026. The manner, timing and amount of any share repurchases may fluctuate and will be determined by us based on a variety of factors, including the market price of our common stock, our priorities for the use of cash to support our business operations and plans, general business and market conditions, tax laws, and alternative investment opportunities. The share repurchase program authorization does not obligate us to acquire any specific number or dollar value of shares. Further, our share repurchases could have an impact on our share trading prices, increase the volatility of the price of our common stock, or reduce our available cash balance such that we will be required to seek financing to support our operations. Our share repurchase program may be modified, suspended, or terminated at any time, which may result in a decrease in the trading prices of our common stock. Even if our share repurchase program is fully implemented, it may not enhance long-term stockholder value. Additionally, repurchases are subject to the 1% Share Repurchase Excise Tax enacted by the Inflation Reduction Act, which may be offset by shares newly issued during that fiscal year (the &#8220;Share Repurchase Excise Tax&#8221;). We have and will continue to take the Share Repurchase Excise Tax into account with respect to our decisions to repurchase shares.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Additional shares that may be issued upon the exercise of currently outstanding options or upon future vesting of restricted stock units, would dilute the voting power of our currently outstanding common stock and could cause our stock price to decline.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">As of June&#160;30, 2025, we had 12.4 million shares of common stock outstanding. As of June&#160;30, 2025, we also had stock options outstanding for an aggregate of 0.1 million shares of common stock. As of June 30, 2025 we also had time-based and performance restricted stock units outstanding that, at target-level achievement, would result in the issuance of an aggregate 0.9 million shares of common stock, which would further increase the total number of outstanding shares of our common stock. </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">39</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The issuance of these shares will dilute the voting power of our currently outstanding common stock and could cause our stock price to decline. </span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If we are unable to maintain compliance with Nasdaq requirements for continued listing, our common stock could be delisted from trading.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">If our common stock was delisted from the Nasdaq Stock Market for failure to maintain compliance with its listing requirements, then there can be no assurance whether or when it would be listed again for trading on the Nasdaq or any other exchange. In addition, if our common stock were to be delisted, the market price of our shares would likely decline and become more volatile, and our stockholders may find that their ability to trade in our stock will be adversely affected. Furthermore, institutions whose charters do not allow them to hold securities in unlisted companies might sell our shares, which could have a further adverse effect on the price of our stock. </span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We are a &#8220;smaller reporting company&#8221; and may take advantage of certain scaled disclosures available to us. We cannot be certain if the reduced reporting requirements applicable to smaller reporting companies will make our common stock less attractive to investors. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We are a &#8220;smaller reporting company&#8221; as defined in the Exchange Act. As a smaller reporting company, we are permitted to comply with scaled disclosure obligations in our SEC filings as compared to other issuers who are not smaller reporting companies, including with respect to disclosure obligations regarding executive compensation in our periodic reports and proxy statements. We have elected to adopt the accommodations available to smaller reporting companies. Until we cease to be a smaller reporting company, the scaled disclosure in our SEC filings will result in less information about our company being available than for public companies that are not smaller reporting companies. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We will be able to take advantage of these scaled disclosures for so long as our voting and non-voting common stock held by non-affiliates is less than $250 million measured on the last business day of our second fiscal quarter, or (ii) our annual revenue is less than $100 million during the most recently completed fiscal year and the market value of our voting and non-voting common stock held by non-affiliates is less than $700 million as measured on the last business day of our second fiscal quarter.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We cannot predict if investors will find our common stock less attractive because we will rely on certain scaled disclosures that are available to smaller reporting companies. If some investors find our common stock less attractive as a result, there may be a less active trading market for our common stock and our stock price may be more volatile.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our certificate of incorporation provides that the Court of Chancery of the State of Delaware is the exclusive forum for substantially all disputes between us and our stockholders, which could limit our stockholders&#8217; ability to obtain a favorable judicial forum for disputes with us or our directors, officers, or employees.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Our certificate of incorporation provides that the Court of Chancery of the State of Delaware is the exclusive forum for any derivative action or proceeding brought on our behalf, any action asserting a breach of fiduciary duty, any action asserting a claim against us arising pursuant to the Delaware General Corporation Law, our certificate of incorporation or our amended and restated bylaws, or any action asserting a claim against us that is governed by the internal affairs doctrine. This choice of forum provision may limit a stockholder&#8217;s ability to bring a claim in a judicial forum that it finds favorable for disputes with us or our directors, officers or other employees and may discourage these types of lawsuits. Alternatively, if a court were to find the choice of forum provision contained in our certificate of incorporation to be inapplicable or unenforceable in an action, we may incur additional costs associated with resolving such action in other jurisdictions, which could harm our business, financial condition and results of operations.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Delaware law and provisions in our certificate of incorporation and amended and restated bylaws could make a merger, tender offer or proxy contest difficult, thereby depressing the trading price of our common stock.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Our status as a Delaware corporation and the anti-takeover provisions of the Delaware General Corporation Law may discourage, delay, or prevent a change in control by prohibiting us from engaging in a business combination with an interested stockholder for a period of three years after the person becomes an interested stockholder, even if a change of control would be beneficial to our existing stockholders. In addition, our certificate of incorporation and amended and restated bylaws contain provisions that may make the acquisition of our company more difficult, including the following:</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the ability of our board to issue shares of preferred stock and to determine the price and other terms of those shares, including preferences and voting rights, without stockholder approval, which could be used to significantly dilute the ownership of a hostile acquiror;</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">40</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the exclusive right of our board to elect a director to fill a vacancy created by the expansion of our board or the resignation, death, or removal of a director, which prevents stockholders from being able to fill vacancies on our board;</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">a prohibition on stockholder action by written consent, which forces stockholder action to be taken at an annual or special meeting of our stockholders;</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the requirement that a special meeting of stockholders may be called only by a majority vote of our entire board, the chairman of our board or our chief executive officer, or by stockholders holding at least 10% of the outstanding shares entitled to vote at such special meeting, which could delay the ability of our stockholders to force consideration of a proposal or to take action, including the removal of directors; and</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">advance notice procedures with which stockholders must comply to nominate candidates to our board or to propose matters to be acted upon at a stockholders&#8217; meeting, which may discourage or deter a potential acquiror from conducting a solicitation of proxies to elect the acquirer&#8217;s own slate of directors or otherwise attempting to obtain control of us.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In addition, as a Delaware corporation, we are subject to Section 203 of the Delaware General Corporation Law. These provisions may prohibit large stockholders, in particular those owning 15% or more of our outstanding voting stock, from merging or combining with us for a certain period of time. A Delaware corporation may opt out of this provision by express provision in its original certificate of incorporation or by amendment to its certificate of incorporation or bylaws approved by its stockholders. However, we have not opted out of this provision.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">These and other provisions in our certificate of incorporation, amended and restated bylaws and Delaware law could make it more difficult for stockholders or potential acquirers to obtain control of our board or initiate actions that are opposed by our then-current board, including delay or impede a merger, tender offer or proxy contest involving our company. The existence of these provisions could negatively affect the price of our common stock and limit opportunities for you to realize value in a corporate transaction. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In August 2023, we entered into a Rights Agreement, pursuant to which we declared a dividend of one preferred share purchase right (a &#8220;Right&#8221;) for each outstanding share of our common stock. The dividend was payable on September 11, 2023 to the stockholders of record at the close of business on September 11, 2023. Each Right initially entitled the registered holder to purchase from the Company one one-thousandth of a share of Series A Junior Participating Preferred Stock, par value $0.0001 per share, of the Company (the &#8220;Preferred Stock&#8221;) at a price of $20 per one one-thousandth of a share of Preferred Stock, subject to adjustment. Also called a &#8220;poison pill,&#8221; the Rights Agreement may have the effect of discouraging or preventing a change of control by, among other things, making it uneconomical for a third party to gain control of us through open market accumulation of shares without paying all stockholders an appropriate control premium or without the consent of our board. The Rights expired on August 28, 2024.</span></div><div id="i7a9d1ca723db478892511ede354648f3_193"></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">General Risk Factors</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may become involved in legal proceedings that are expensive, time-consuming and, if adversely adjudicated or settled, could adversely affect our financial results.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Litigation claims can be expensive and time-consuming to bring or defend against and could result in settlements or damages that could significantly affect our financial results. It is not possible to predict the final resolution of litigation to which we may become a party, and the impact of litigation proceedings on our business, results of operations and financial condition could be material.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, we are involved in various legal matters, both as a plaintiff and defendant. While we believe the suits against us are without merit, they are costly to defend, and we cannot be assured that we will ultimately prevail. If we do not prevail and are required to pay damages, it could harm our business.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If we fail to maintain proper and effective internal controls, our ability to produce accurate and timely financial statements could be impaired, which could result in sanctions or other penalties that would harm our business.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">As a public company, we are required to maintain internal controls over financial reporting and to report any material weaknesses in such internal controls. Section 404 of the Sarbanes-Oxley Act of 2002 (the &#8220;Sarbanes-Oxley Act&#8221;) requires, among other things, that we evaluate and determine the effectiveness of our internal controls over financial reporting and provide a management report on the internal controls over financial reporting.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We have implemented internal controls to help ensure the completeness and accuracy of our financial reporting and to detect and prevent fraudulent actions within our financial and accounting processes including the development and </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">41</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">implementation of control policies and procedures regarding the international business policies, practices, monitoring, and training for each country outside the U.S. in which we do business. However, we cannot be assured that significant deficiencies or material weaknesses in our internal control over financial reporting will not exist in the future. Any failure to maintain or implement required new or improved controls, or any difficulties we encounter in their implementation, could result in significant deficiencies or material weaknesses, cause us to fail to timely meet our periodic reporting obligations, or result in material misstatements in our financial statements. Any such failure could also adversely affect the results of periodic management evaluations and annual auditor attestation reports regarding disclosure controls and the effectiveness of our internal control over financial reporting required under the Sarbanes-Oxley Act and the rules promulgated thereunder. The existence of a material weakness could result in errors in our financial statements that could result in a restatement of financial statements, cause us to fail to timely meet our reporting obligations, or cause investors to lose confidence in our reported financial information, which could cause a decline in the market price of our stock and we could be subject to sanctions or investigations by the SEC or other regulatory authorities including equivalent foreign authorities. In fiscal year 2025, we did not experience any material weaknesses in our internal control and/or financial reporting processes.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Government authorities may question our tax positions or transfer pricing policies or change their laws in a manner that could increase our effective tax rate or otherwise harm our business.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">As a U.S. company doing business in international markets through subsidiaries, we are subject to various tax and intercompany pricing laws, including those relating to the flow of funds between our company and our subsidiaries. Tax authorities may disagree with certain positions that we have taken and assess additional taxes. From time to time, we are audited by tax regulators in the U.S. and in our foreign markets. If regulators challenge our tax positions, corporate structure, transfer pricing mechanisms or intercompany transfers, we may be subject to fines and payment of back taxes, our effective tax rate may increase, and our operations may be harmed. We regularly assess the likely outcomes of these audits in order to determine the appropriateness of our tax positions. However, there can be no assurance that we will accurately predict the outcomes of these audits, and the actual outcomes of these audits could have a material impact on our business, result of operations, financial condition, and cash flows. Tax rates vary from country to country, and, if tax authorities determine that our profits in one jurisdiction may need to be increased, we may not be able to fully utilize all foreign tax credits that are generated, which will increase our effective tax rate. The various customs, exchange control and transfer pricing laws are continually changing and are subject to the interpretation of government agencies. We may experience increased efforts by customs authorities in foreign countries to reclassify our products or otherwise increase the level of duties we pay on our products. Despite our efforts to be aware of and comply with such laws, and changes to and interpretations thereof, there is a risk that we may not continue to operate in compliance with such laws. We may need to adjust our operating procedures in response to such changes and, as a result, our business may suffer. In addition, due to the international nature of our business, from time to time, we are subject to reviews and audits by taxing authorities of other jurisdictions in which we conduct business throughout the world.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Economic, political, and other risks associated with our international operations could adversely affect our revenue and international growth prospects.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">As part of our business strategy, we intend to continue to expand and grow our international presence. Our international operations are subject to a number of risks inherent to operating in foreign countries, and any expansion or growth of our international operations will increase the effects of these risks. These risks include, among others:</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">political and economic instability of foreign markets;</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">foreign governments&#8217; restrictive trade policies;</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">major changes in tax or trade policy, such as the imposition of additional tariffs or duties on imported products;</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">lack of well-established or reliable legal systems in certain areas in which we operate;</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">inconsistent product regulation or sudden policy changes by foreign agencies or governments;</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the imposition of, or increase in, duties, taxes, government royalties, or non-tariff trade barriers;</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">difficulty in collecting international accounts receivable and potentially longer payment cycles;</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the possibility that a foreign government may limit our ability to repatriate cash;</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">increased costs in maintaining international marketing efforts;</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">problems entering international markets with different cultural bases and consumer preferences; and</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">fluctuations in foreign currency exchange rates.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">42</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Any of these risks could have a material adverse effect on our international operations and our growth strategy.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Unfavorable global economic conditions, including high inflation, tariffs, and other macroeconomic conditions or trends may have an adverse impact on our business, financial results, and prospects.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Ongoing geopolitical matters have contributed to difficult macroeconomic conditions and exacerbated supply chain issues, resulting in significant economic uncertainty as well as volatility in the financial markets, particularly in the United States. Such conditions may adversely impact our business, financial results, and prospects. We rely on consumer discretionary spending. If general economic conditions continue to deteriorate globally or in specific markets where we operate, including with respect to inflation, consumer discretionary spending may decline and demand for our products may be reduced. A decrease in consumer discretionary spending would cause sales in our products to decline and adversely impact our business. If our costs were to become subject to significant inflationary pressures, including, as a result of, increased tariffs, we may not be able to fully offset such higher costs through increases in revenue as increases in core inflation rates may also affect consumers&#8217; willingness to make discretionary purchases on our products. Our inability or failure to do so could harm our business, financial condition, and results of operations. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In addition, such macroeconomic conditions could impact our ability to access the public markets as and when appropriate or necessary to carry out our operations or our strategic goals. We cannot predict the ongoing extent, duration, or severity of these conditions, nor the extent to which we may be impacted.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">To the extent that there are health epidemics or outbreaks, or a resurgence in the COVID-19 pandemic, our operations could be disrupted and our business adversely impacted. Such disruptions or impacts may be similar to those we faced during the COVID-19 pandemic, such as mandated business closures in impacted areas, limitations due to stay at home orders or sickness of employees or their families, reduced demand for certain of our products, or supply constraints.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We could be subject to securities class action litigation. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In the past, securities class action litigation has often been brought against a company following a decline in the market price of its securities. This risk is especially relevant for us because dietary supplement companies have experienced significant stock price volatility in recent years. If we face such litigation, it could result in substantial costs and a diversion of management&#8217;s attention and resources, which could harm our business.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If securities or industry analysts cease publishing research or publish inaccurate or unfavorable research about our business, our stock price and trading volume could decline.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The trading market for our common stock will depend in part on the research and reports published by securities or industry analysts about us or our business. Securities and industry analysts currently publish research on our company. If analysts cease coverage of us, the trading price for our common stock could be negatively affected. If one or more of the analysts who cover us downgrade our common stock or publish inaccurate or unfavorable research about our business, our common stock price would likely decline. If one or more of these analysts cease coverage of us or fail to publish reports on us regularly, demand for our common stock could decrease, which might cause our common stock price and trading volume to decline. </span></div><div id="i7a9d1ca723db478892511ede354648f3_196"></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">ITEM&#160;1B &#8212; UNRESOLVED STAFF COMMENTS</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div id="i7a9d1ca723db478892511ede354648f3_199"></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 1C &#8212; CYBERSECURITY </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Risk Management and Strategy</span></div><ix:nonNumeric contextRef="c-1" name="cyd:CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" id="f-37" continuedAt="f-37-1" escape="true"><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="cyd:CybersecurityRiskManagementProcessesIntegratedTextBlock" id="f-38" escape="true">We have <ix:nonNumeric contextRef="c-1" name="cyd:CybersecurityRiskManagementProcessesIntegratedFlag" format="ixt:fixed-true" id="f-39">implemented</ix:nonNumeric> and maintain a cybersecurity risk management program through our security steering committee, which is designed to assess risks from cybersecurity threats, monitor our information systems for potential vulnerabilities, and test those systems pursuant to our cybersecurity policies, processes, and practices, which are integrated into our overall risk management program.</ix:nonNumeric> The members of our security steering committee represent the following functional areas: cybersecurity and infrastructure; corporate risk and privacy; personnel; and finance and fraud management. <ix:nonNumeric contextRef="c-1" name="cyd:CybersecurityRiskManagementThirdPartyEngagedFlag" format="ixt:fixed-true" id="f-40">The security steering committee collaborates with and manages third parties, as appropriate, to assess the effectiveness of our cybersecurity prevention and response systems and processes.</ix:nonNumeric> <ix:nonNumeric contextRef="c-1" name="cyd:CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag" format="ixt:fixed-true" id="f-41">These third parties may include cybersecurity assessors, consultants, and other external cybersecurity experts to assist in the identification, verification, and validation of cybersecurity risks, as well as to support associated mitigation plans when necessary.</ix:nonNumeric> To protect our information systems from cybersecurity threats, we also ask our employees to take periodic cybersecurity training and we use various security tools that are designed to help identify, escalate, investigate, resolve, and recover from security incidents in a timely manner.</span></div></ix:nonNumeric><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">43</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="f-37-1"><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="cyd:CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag" format="ixt:fixed-false" id="f-42">We have not identified risks from known cybersecurity threats to the business, including as a result of any prior cybersecurity incidents, that have materially affected or are reasonably likely to materially affect our Company, including our business strategy, results of operations, or financial condition.</ix:nonNumeric> See our risk factor &#8220;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">We are subject to evolving laws, policies, and contractual obligations related to data privacy and security, including cybersecurity, and our actual or perceived failure to comply with such obligations or perceived failure to maintain the integrity of our data could expose us to data loss or litigation, harm our reputation, subject us to significant fines and liability, or otherwise affect our business, prospects, financial condition, and operating results.</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; in Part I, Item 1A. (&#8220;Risk Factors&#8221;) for additional details regarding cybersecurity risks and potential impacts on our business.</span></div></ix:continuation><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Cybersecurity Governance</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="cyd:CybersecurityRiskBoardOfDirectorsOversightTextBlock" id="f-43" escape="true">Our board is actively involved in the assessment, oversight and management of the material risks that could affect the Company.</ix:nonNumeric> The board carries out its risk oversight and management responsibilities by monitoring risk directly as a full board and, where appropriate, through its committees. <ix:nonNumeric contextRef="c-1" name="cyd:CybersecurityRiskRoleOfManagementTextBlock" id="f-46" escape="true"><ix:nonNumeric contextRef="c-1" name="cyd:CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock" id="f-44" escape="true"><ix:nonNumeric contextRef="c-1" name="cyd:CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock" id="f-45" escape="true">Our board has delegated to the audit committee the oversight responsibility for risks and incidents relating to cybersecurity threats, including compliance with disclosure requirements, cooperation with law enforcement, and related effects on financial and other risks.</ix:nonNumeric> The audit committee reports any material or notable cybersecurity incidents, findings and recommendations, as appropriate, to the full board for consideration. <ix:nonNumeric contextRef="c-1" name="cyd:CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock" id="f-48" escape="true"><ix:nonNumeric contextRef="c-1" name="cyd:CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock" id="f-47" escape="true">Our <ix:nonNumeric contextRef="c-1" name="cyd:CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag" format="ixt:fixed-true" id="f-49">Chief Information and Innovation Officer (&#8220;CIIO&#8221;)</ix:nonNumeric> also presents to the audit committee and to the <ix:nonNumeric contextRef="c-1" name="cyd:CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag" format="ixt:fixed-true" id="f-50">board</ix:nonNumeric>, as appropriate, any updates, changes, or improvements on the Company&#8217;s cybersecurity risk management program.</ix:nonNumeric></ix:nonNumeric></ix:nonNumeric></ix:nonNumeric></span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="cyd:CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock" id="f-51" escape="true">Our CIIO, with over 40 years of experience in IT and operational technology security, has the primary responsibility of overseeing our cybersecurity risk management program and assessing and managing any material risks related to cybersecurity threats.</ix:nonNumeric> Our CIIO supervises efforts to help prevent, detect, mitigate, and remediate cybersecurity risks and incidents through various means, which may include briefings from internal information systems personnel and reports produced by security tools deployed in the technical environment.    </span></div><div id="i7a9d1ca723db478892511ede354648f3_202"></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">ITEM&#160;2 &#8212; PROPERTIES</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Corporate Offices</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In November 2019, we entered into a lease agreement with Traverse Ridge Center III LLC, a Utah limited liability company, for our new corporate headquarters located at 3300 N. Triumph Blvd., Suite 700, Lehi, Utah 84043. The lease is for approximately 51,674 square feet with a right of first refusal to lease certain additional space in the building when such space becomes available. The term of the lease began on January 1, 2021, and will continue for a period of eleven years.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In July 2023, our subsidiary, LifeVantage Japan K.K., entered into a lease agreement with Sumitomo Mitsui Trust Bank, Limited, for an office located in the Shinagawa Grand Central Tower in Tokyo, Japan.  The lease is for approximately 5,200 square feet and has a lease term from July 1, 2023 through June 30, 2026.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We believe that the facilities under our leases are sufficient to meet our needs for the foreseeable future.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Warehouse Facilities</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Since fiscal year 2010, Maersk E-Commerce Logistics (formerly Visible Supply Chain Management and IntegraCore, LLC) has provided fulfillment services to us, including services relating to procurement, warehousing, ordering, processing, and shipping. We have also entered into arrangements to receive similar services in each of our international markets.</span></div><div id="i7a9d1ca723db478892511ede354648f3_205"></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">ITEM&#160;3 &#8212; LEGAL PROCEEDINGS</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">See Note 14 of the Notes to the Consolidated Financial Statements contained within this Annual Report on Form 10-K for a discussion of the company's legal proceedings.</span></div><div id="i7a9d1ca723db478892511ede354648f3_208"></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">ITEM&#160;4 &#8212; MINE SAFETY DISCLOSURES</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Not applicable.</span></div><div id="i7a9d1ca723db478892511ede354648f3_211"></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">PART II</span></div><div id="i7a9d1ca723db478892511ede354648f3_214"></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">ITEM&#160;5 &#8212; MARKET FOR REGISTRANT&#8217;S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES</span></div><div id="i7a9d1ca723db478892511ede354648f3_217"></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Market Information and Holders</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Our common stock trades on the Nasdaq Capital Market under the symbol &#8220;LFVN&#8221;.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">44</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Our common stock is issued in registered form and the following infor</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">mation is taken from the records of our current transfer agent, Computershare Trust Company, Inc. As of June&#160;30, 2025, we had 79 stockholders of record and 12.4 million shares of common stock outstanding. This does not include an unknown number of persons who hold shares in street name </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">through brokers and dealers and who are not listed on our stockholder records.</span></div><div id="i7a9d1ca723db478892511ede354648f3_220"></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Dividends</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We paid quarterly cash dividends of $0.04 per share of common stock to stockholders of record in September 2024, December 2024, and March 2025, and </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">$0.045</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> per share of common stock to stockholders in June 2025, which were in the aggregate amount of </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">$2.1 million, or $</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">0.165 per share of common stock for the fiscal year ended June&#160;30, 2025</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">. For the fiscal year ended June&#160;30, 2024, w</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">e paid a one-time cash dividend of </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">$0.40 </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">per share of common stock to stockholders of record in September 2023, </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">$0.035</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> per share of common stock to stockholders of record in September 2023, December 2023 and March 2024, and </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">$0.04</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> per share of common stock to stockholders in June 2024, which were in the aggregate amount of</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> $6.9 million, or </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">$0.545</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> per share of common stock.  </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The declaration of dividends is subject to the discretion of our board and will depend upon various factors, including our earnings, financial condition, restrictions imposed by any indebtedness that may be outstanding, cash requirements, future prospects and other factors deemed relevant by our board of directors. </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We currently expect that a comparable cash dividend will be paid each quarter for the foreseeable future.</span></div><div id="i7a9d1ca723db478892511ede354648f3_223"></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Purchases of Equity Securities by the Issuer</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">On November&#160;27, 2017, our board approved a stock repurchase program. Under this program, we were initially authorized to repurchase up to $15.0 million of the outstanding shares through November&#160;27, 2020. On August&#160;27, 2020, our board approved an amendment to the stock repurchase program to increase the authorized share repurchase amount from $15.0&#160;million to $35.0&#160;million and to extend the duration of the program through </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">November&#160;30, 2023. Further, on February 17, 2022, our board approved an amendment to the stock repurchase program to increase the authorized share repurchase amount from </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">$35.0&#160;million to $60.0&#160;million</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">. </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">On June 13, 2023, our board approved an amendment to the stock repurchase program to extend the duration of the program through December 31, 2026. The stock repurchase program permits us to purchase shares from time to time through a variety of methods, including in the open market, through privately negotiated transactions or other means as determined by our management, in accordance with applicable securities laws. As part of the repurchase program, we may enter into a pre-arranged stock repurchase plan which operates in accordance with guidelines specified under Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. Accordingly, any transactions under such stock repurchase plan would be completed in accordance with the terms of the plan, including specified price, volume, and timing conditions. T</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">he stock repurchase program may be suspended or discontinued at any time. </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">During the&#160;three months ended June&#160;30, 2025, we repurchased 0.2 million shares of our common stock&#160;under the stock repurchase plan. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides information with respect to all purchases&#160;made by the company during the three months ended June 30, 2025. All purchases listed below were made at prevailing market prices.</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"><tr><td style="width:1.0%"/><td style="width:23.088%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.041%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.041%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.189%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.193%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Period</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Total Number of Shares Purchased</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Average Price Paid Per Share</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Total Number of Shares Purchased as Part of the Publicly Announced Plans or Programs</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Maximum Dollar Value of Shares that May Yet Be Purchased Under the Plans or Programs</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">April 1 - April 30</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">19,307,478&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">May 1 - May 31</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">99,653&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">12.77&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">99,653&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">18,034,641&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">June 1 - June 30</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">59,900&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">12.69&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">59,900&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">17,274,386&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">159,553&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">159,553&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr></table></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">On November&#160;27, 2017, our board approved a stock repurchase program. Under this program, we were initially authorized to repurchase up to $15.0 million of the outstanding shares through November&#160;27, 2020. On August&#160;27, 2020, our board approved an amendment to the stock repurchase program to increase the authorized share repurchase amount from $15.0&#160;million to $35.0&#160;million and to extend the duration of the program through </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">November&#160;30, 2023. Further, on February 17, 2022, our board approved an amendment to the stock repurchase program to increase the authorized share repurchase amount from </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">$35.0&#160;million to $60.0&#160;million</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">. </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">On June 13, 2023, our board approved an amendment to the stock repurchase program to extend the duration of the program through December 31, 2026. </span></div><div id="i7a9d1ca723db478892511ede354648f3_226"></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Recent Sale of Unregistered Securities</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div id="i7a9d1ca723db478892511ede354648f3_229"></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Equity Compensation Plan Information</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">45</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">This information is incorporated by reference to Part III, Item 12 of this report.</span></div><div id="i7a9d1ca723db478892511ede354648f3_232"></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">ITEM&#160;6 &#8212; [RESERVED]</span></div><div id="i7a9d1ca723db478892511ede354648f3_235"></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">ITEM&#160;7 &#8212; MANAGEMENT&#8217;S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The following discussion and analysis of our financial condition and results of operations should be read in conjunction with the consolidated financial statements and related notes, which are included in this Annual Report on Form 10-K.</span></div><div id="i7a9d1ca723db478892511ede354648f3_238"></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Overview</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We are a company focused on nutrigenomics, the study of how nutrition and naturally occurring compounds affect human genes to support good health. We are dedicated to helping people achieve their health, wellness, and financial goals. We provide quality, scientifically validated products to customers an</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">d independent consultants as </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">well as a financially rewarding commission-based direct sales opportunity to our independent consultants. We engage in the identification, research, development, formulation and sale of advanced nutrigenomic activators, dietary supplements, weight management products,  pre- and pro-biotics, skin and hair care products, and nootropics. We currently sell our products to customers and independent consultants in two geographic regions that we have classified as the Americas region and the Asia/Pacific and Europe region.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The success and growth of our business is primarily based on the effectiveness of our independent consultants to attract and </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">retain customers in order to sell our products and our ability to attract and retain independent consultants. When we are successful in attracting and retaining independent consultants and customers, it is largely because of:</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our products, including our flagship Protandim</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> family of scientifically validated dietary supplements,</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> our </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">LifeVantage</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174; </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">family of dietary supplements that include the</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"> </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">MindBody GLP-1 System</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#8482;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">, Omega+, ProBio, IC Bright</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">, the Rise AM &amp; Reset PM System</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">, D3+, and Daily Wellness, our PhysIQ</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#8482;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> Fat Burn and Prebiotic dietary supplements, our TrueScience</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> line of skin and hair care products and Liquid Collagen, Petandim</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">, our companion pet supplement formulated to combat oxidative stress in dogs; and AXIO</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">, our nootropic energy drink mixes;</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our sales compensation plan and other sales initiatives and incentives; and</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our delivery of superior customer service.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">As a result, it is vital to our success that we leverage our product development resources to develop and introduce compelling and innovative products and provide opportunities for our independent consultants to sell these products in a variety of markets. We sell our products in the United States, Mexico, Japan, Australia, Hong Kong, Canada, Thailand, the United Kingdom, the Netherlands, Germany, Taiwan, Austria, Spain, Ireland, Belgium, New Zealand and Singapore. In addition, we sell our products in a number of countries for personal consumption only. Entering a new market requires a considerable amount of time, resources and continued support. If we are unable to properly support an existing or new market, our revenue growth may be negatively impacted. On June 30, 2025, we ceased operations in the Philippines and closed that market.</span></div><div id="i7a9d1ca723db478892511ede354648f3_241"></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Our Products</span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Our products are: the Protandim</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"> line of scientifically validated dietary supplements; the LifeVantage</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"> line of dietary supplements that include the MindBody GLP-1 System</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">&#8482;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">, Omega+, ProBio, IC Bright</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.47pt;font-weight:400;line-height:112%;position:relative;top:-3.48pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">, the Rise AM &amp; Reset PM System</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.47pt;font-weight:400;line-height:112%;position:relative;top:-3.48pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">, D3+, and Daily Wellness; our PhysIQ Fat Burn and Prebiotic dietary supplements; the TrueScience</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">&#174; </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">line of skin and hair care products and Liquid Collagen; our Petandim</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">&#174; </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">companion pet supplement formulated to combat oxidative stress in dogs; and AXIO</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">, our nootropic energy drink mixes. We believe the significant number of customers who regularly and repeatedly purchase our products is a strong indicator of the health benefits of our products. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Protandim</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> product line includes Protandim</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> NRF1 Synergizer</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">, Protandim</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> Nrf2 Synergizer</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">, and Protandim</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> NAD Synergizer</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">. The Protandim</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> NRF1 Synergizer</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> is formulated to increase cellular energy and performance by boosting mitochondria production to improve cellular repair and slow cellular aging. The Protandim</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> Nrf2 Synergizer</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> contains a proprietary blend of ingredients and has been shown to combat oxidative stress and enhance energy production by increasing the body&#8217;s natural antioxidant protection at the genetic level, inducing the production of naturally occurring protective antioxidant enzymes, including superoxide dismutase, catalase, and glutathione synthase. The Protandim</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> NAD Synergizer</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> was specifically formulated to target cell signaling pathways involved in the synthesis and recycling of a specific molecule called NAD (nicotinamide adenine dinucleotide), and it has been shown to double sirtuin activity, supporting increased health, focus, energy, mental clarity, and mood. Use of the three Protandim</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> products together, marketed as the Protandim</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> Tri-Synergizer</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">, has been shown to produce synergistic benefits greater than using the single products on their own.  </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The LifeVantage</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> product line includes: the new MindBody GLP-1 System</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#8482;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">, a dietary supplement that combines two products MB Core</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#8482;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> and MB Enhance</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#8482;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> designed to support weight loss and wellness by activating GLP-1 naturally and </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">46</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">balancing signals along the gut-brain axis; Omega+, a dietary supplement that combines DHA and EPA Omega-3 fatty acids, omega-7 fatty acids, and vitamin D3 to support cognitive health, cardiovascular health, skin health, and the immune system; ProBio, a dietary supplement designed to support optimal digestion and immune system function; Daily Wellness, a dietary supplement designed to support immune health. IC Bright</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">, a dietary supplement to help support eye and brain health, reduce eye fatigue and strain, support cognitive functions, and may help support normal sleep patterns; the Rise AM &amp; Reset PM System</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">, a dietary supplement that uses Timewise Nutrient Delivery</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#8482;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> to provide the body with the right nutrients in the right amounts at the right time and D3+, a dietary supplement that provides vitamin D3, vitamin K2, magnesium, calcium, and other trace minerals to support a balanced immune system, strong bones, and cardiovascular health.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">PhysIQ</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#8482;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> Fat Burn is a dietary supplement designed to support weight management, and PhysIQ</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#8482; </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Prebiotic is a dietary supplement designed to support a healthy digestive tract. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Our TrueScience</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> line of skin and hair care products includes TrueScience</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> TrueClean Refining Cleanser, TrueScience</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> TrueRenew Daily Firming Complex, TrueScience</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> TrueLift Illuminating Eye Cream, TrueScience</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> TrueHydrate Brightening Moisturizer, TrueScience</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> TrueTone Perfecting Lotion, TrueScience</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> TrueProtect Daily Mineral Sunstick SPF 30, TrueScience</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> Perfecting Lotion, TrueScience</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> Hand Cream, TrueScience</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> Invigorating Shampoo, TrueScience</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> Nourishing Conditioner, TrueScience</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> Scalp Serum, and TrueScience</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> Liquid Collagen. TrueScience</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> Liquid Collagen activates, replenishes, and maintains collagen to support firmness and elasticity from within. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Petandim</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> is a supplement specially formulated to combat oxidative stress in dogs through Nrf2 activation. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">AXIO</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> is our line of our nootropic energy drink mixes formulated to promote alertness and support mental performance.  </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We sell our products both individually and in stacks. A stack consists of multiple products bundled together that are designed to achieve a specific result. </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In fiscal year 2025, our stack strategy continued to focus on the brand message of activation. During the year, we introduced a number of new stacks to meet customer and independent consultant needs. Prior to the launch of our latest activator, the MindBody GLP-1 System</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#8482;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> , we introduced the Kickstart Bundle, which features a selection of products (varies by market) to help prepare the body for GLP-1 activation. Additionally, several stacks were introduced that incorporated the MindBody GLP-1 System</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#8482;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> to offer consumers support for weight management and wellness along with delivering other targeted benefits as part of their activated lifestyle. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We also introduced our Healthy Weight Stack, which includes the MindBody GLP-1 System</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#8482;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> and Protandim</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> Nrf2 Synergizer</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">. Results of an in vitro study were released that showed beneficial &#8220;activation synergies&#8221; when both products were used together, including enhanced fatty acid metabolism, improved defense against oxidative stress, and activation of 22 new genes that help cells make what they need to support organ strength, structure, and signaling. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We continue to offer other popular stacks with products that complement one another with inner activation power for internal benefits that can be felt, external benefits that can be seen, or both.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The following table shows revenue by major product line for the fiscal years ended June&#160;30, 2025 and 2024.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:38.782%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.416%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.416%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.416%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.271%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-bottom:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Years ended June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="9" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Protandim</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">&#174; </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">product line</span></div></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">95,328&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">41.7&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">104,135&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">52.0&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">LifeVantage</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">&#174; </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">product line</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">56,225&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">24.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">15,675&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">7.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">TrueScience</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">&#174; </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">product line</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">48,712&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">21.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">56,252&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">28.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">28,265&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">12.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">24,102&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">12.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">228,530&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">200,164&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Our revenue for the fiscal year ended June 30, 2025 is largely attributed to three product lines, Protandim</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">, LifeVantage</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">, and TrueScience</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">. On a combined basis, these three product lines represent approximately 87.6% of our total net revenue for the fiscal year ended June&#160;30, 2025. Our revenue for the fiscal year ended June&#160;30, 2024 was largely attributed to two product lines, Protandim</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> and TrueScience</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">, which on a combined basis, represented approximately 80.1% of our total net revenue for that fiscal year. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We currently have additional products in development. Any delays or difficulties in introducing compelling products or attractive initiatives or tools into our markets may have a negative impact on our revenue and our ability to attract new independent consultants and customers.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">47</span></div></div></div><div id="i7a9d1ca723db478892511ede354648f3_244"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Accounts</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Because we primarily utilize a direct selling model for the distribution of a majority of our products, the success and growth of our business depends in large part on the effectiveness of our independent consultants to attract and retain customers to purchase our products, and our ability to attract new and retain existing independent consultants. Changes in our product sales are typically the result of variations in product sales volume relating to fluctuations in the number of active independent consultants and customers purchasing our products. The number of active independent consultants and customers is, therefore, used by management as a key non-financial measure.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The following tables summarize the changes in our active accounts by geographic region. These numbers have been rounded to the nearest thousand as of the dates indicated. For purposes of this report, we define &#8220;Active Accounts&#8221; as only those independent consultants and customers who have purchased from us at any time during the most recent three-month period, either for personal use or for resale. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:36.381%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.709%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.709%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.709%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.709%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.856%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.385%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.714%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">As of June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Change from Prior Year</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Percent Change</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Active Independent Consultants</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Americas</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">34,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">66.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">31,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">63.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">9.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Asia/Pacific &amp; Europe</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">17,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">33.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">18,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">36.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(1,000)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(5.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Total Active Independent Consultants</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">51,000&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">49,000&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2,000&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">4.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Active Customers</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Americas</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">66,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">81.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">63,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">79.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">4.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Asia/Pacific &amp; Europe</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">15,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">18.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">16,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">20.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(1,000)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(6.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Total Active Customers</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">81,000&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">79,000&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2,000&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Active Accounts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Americas</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">100,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">75.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">94,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">73.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">6,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">6.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Asia/Pacific &amp; Europe</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">32,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">24.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">34,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">26.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(2,000)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(5.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Total Active Accounts</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">132,000&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">128,000&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">4,000&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div id="i7a9d1ca723db478892511ede354648f3_247"></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Income Statement Presentation</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We report revenue in two geographic regions, and we translate revenue from each market&#8217;s local currency into U.S. Dollars using weighted-average exchange rates. Revenue consists primarily of product sales, fee revenue, and shipping and handling fees, net of applicable sales discounts. Revenue is recognized at the time of shipment, which is when the passage of title and risk of loss to customers occurs. Also reflected in revenue is a provision for product returns and allowances, which is estimated based on our historical experience. The following table sets forth net revenue information by region for the years indicated. The following table should be reviewed in connection with the tables presented under &#8220;Results of Operations&#8221; (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:38.724%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.394%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.394%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.394%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.398%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-bottom:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">For the fiscal years ended June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="9" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Americas</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">185,723&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">81.3&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">152,907&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">76.4&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Asia/Pacific &amp; Europe</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">42,807&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">18.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">47,257&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">23.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">228,530&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">200,164&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Cost of sales primarily consists of costs of products purchased from and manufactured by third-party vendors, shipping and order fulfillment costs, costs of adjustments to inventory carrying value, and costs of marketing materials which we sell to our independent consultant sales force, as well as freight, duties and taxes associated with the import and export of our products. As our international revenue increases as a percentage of total revenue, cost of sales as a percentage of revenue likely will increase as a result of additional duties, freight, and other factors, such as changes in currency exchange rates.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Commissions and incentives expenses are our most significant expenses and are classified as operating expenses. Commissions and incentives expenses include sales commissions paid to our independent consultants, special incentives and costs for incentive trips and other rewards. Commissions and incentives expenses do not include any amounts we pay to our </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">48</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">independent consultants related to their personal purchases. Commissions paid to independent consultants on personal purchases are considered a sales discount and are reported as a reduction to net revenue. Our sales compensation plan is an important factor in our ability to attract and retain our independent consultants. Under our sales compensation plan, independent consultants can earn commissions for product sales to their customers as well as the product sales made through the sales networks they have developed and trained. We do not pay commissions on marketing materials that are sold to our independent consultants. Commissions and incentives expenses, as a percentage of net revenue, may be impacted by the timing and magnitude of non-commissionable revenue derived from the sales of marketing materials, event tickets, and promotional items, investment in our red-carpet program, limited-time offers and the timing, magnitude and number of incentive trips and other promotional activities. From time to time, we make modifications and enhancements to our sales compensation plan in an effort to help motivate our sales force and develop leadership characteristics, which can have an impact on commissions and incentives expenses. In fiscal year 2023, we introduced our new compensation plan, called the Evolve Compensation Plan, in four markets &#8211; the United States, Japan, Australia, and New Zea</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">land.  In fiscal year 2024, we introduced the Evolve Compensation Plan to Canada, Mexico, and Europe. In fiscal year 2025, we introduced an optimized version of the Evolve Compensation Plan to the United States, Japan, Australia, New Zealand, Canada, Mexico, and Europe and introduced </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">the Evolve Compensation Plan in other markets, including Taiwan, Hong Kong, and Singapore.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Selling, general and administrative expenses include wages and benefits, stock compensation expenses, marketing and event costs, professional fees, rents and utilities, depreciation and amortization, research and development, travel costs and other operating expenses. Wages and benefits and stock compensation expenses represent the largest component of selling, general and administrative expenses. Marketing and event costs include costs of consultant conventions and events held in various markets worldwide, which we expense in the period in which they are incurred. For the fiscal year ended June 30, 2024 marketing and event costs also included expenses associated with our sponsorship of the Major League Soccer team, Real Salt Lake. Our agreement with Real Salt Lake ended in December 2023.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Sales to customers outside the United States are transacted in the respective local currencies and are translated to U.S. Dollars at weighted-average currency exchange rates for each monthly accounting period to which they relate. Consequently, our net sales and earnings are affected by changes in currency exchange rates. In general, sales and gross profit are affected positively by a weakening U.S. Dollar and negatively by a strengthening U.S. Dollar. Currency fluctuations, however, have the opposite effect on our commissions paid to independent consultants and selling, and general and administrative expenses. In our revenue discussions that follow, we approximate the impact of currency fluctuations on revenue by translating current year revenue at the average exchange rates in effect during the comparable prior year periods.</span></div><div id="i7a9d1ca723db478892511ede354648f3_250"></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Results of Operations</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">For the fiscal years ended June&#160;30, 2025 and 2024, we generated net revenue of $228.5 million and $200.2 million, respectively, recognized operating income of $12.2 million and $4.3 million, respectively, and recognized net income of $9.8 million and $2.9 million, respectively.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents certain consolidated earnings data as a percentage of net revenue for the years indicated:</span></div><div style="margin-bottom:8pt;margin-top:8pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:62.150%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.908%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.910%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">For&#160;the&#160;fiscal years&#160;ended June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Revenue, net</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Cost of sales</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">19.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">20.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Gross profit</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">80.4&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">79.3&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Operating expenses:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Commissions and incentives</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">44.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">42.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">30.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">34.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total operating expenses</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">75.0&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">77.1&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Operating income</span></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">5.4&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2.2&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Other income (expense):</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Interest income, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Other expense, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total other expense</span></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Income before income taxes</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">5.4&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2.2&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Income tax expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(1.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(0.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">4.3&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1.5&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">49</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Comparison of Fiscal Years Ended June&#160;30, 2025 and 2024 </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Net Revenue</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">.</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> We generated net revenue of $228.5 million and $200.2 million during the fiscal years ended June&#160;30, 2025 and 2024, respectively. The overall increase in revenue is attributed mainly to the launch of our new MindBody GLP-1 System</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#8482;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> which drove an increase in our total Active Accounts by 3.1% during fiscal year 2025. Total revenue from the MindBody GLP-1 System</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#8482;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> was $4</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">0.8 million, including the product when sold as part of a bundle. This increase was partially offset by a $4.7 million decrease in revenue from TrueScience</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> Liquid Collagen, a decrease of $8.8 million in sales from our </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Protandim</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> products, and the negative impacts of foreign currency fluctuations compared to fiscal year ended June&#160;30, 2024.  In fiscal year 2025, f</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">oreign currency fluctuations negatively impacted our net revenue $0.5 million or 0.3%. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Americas</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">. The following table sets forth revenue for the fiscal years ended June&#160;30, 2025 and 2024 for the Americas region (in thousands):</span></div><div style="margin-bottom:8pt;margin-top:8pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:52.938%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.731%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.731%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.732%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">For the fiscal years ended June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">% change</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">178,442&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">145,679&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">22.5&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">7,281&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">7,228&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Americas Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">185,723&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">152,907&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">21.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Revenue in the Americas region for the fiscal year ended June&#160;30, 2025 increased $32.8 million, or 21.5%, compared to the prior year.  Total Active Accounts increased 6.4% in the region compared to the prior fiscal year which contributed to the increase in revenue.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> The increase in revenue and Active Accounts is due primarily to the launch of </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">our new MindBody GLP-1 System</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#8482;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">. Total revenue related to the sale of our MindBody GLP-1 </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">System</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#8482;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> in the United States for the fiscal year ended </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">June&#160;30, 2025 was $37.3 million, including the product when sold as part of a bundle.  In Canada and Mexico, sales of our </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">MindBody GLP-1 </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">System</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#8482;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> were $0.9 million for the fiscal year ended </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">June&#160;30, 2025.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The increase in revenue in the Americas regions was partially offset by a decrease in revenue from </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">TrueScience</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> Liquid Collagen, which decreased approximately $2.4 million for the fiscal year ended </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">June&#160;30, 2025 compared to fiscal year ended </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">June&#160;30, 2024, and the</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> negative impacts of foreign currency of $0.5 million. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Asia/Pacific &amp; Europe</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">. The following table sets forth revenue for the fiscal years ended June&#160;30, 2025 and 2024 for the Asia/Pacific and Europe region and its principal markets (in thousands):</span></div><div style="margin-bottom:8pt;margin-top:8pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:52.938%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.731%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.731%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.732%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">For the fiscal years ended June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">% change</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Japan</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">25,394&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">26,989&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(5.9)</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">4,213&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3,653&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">15.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Australia &amp; New Zealand</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">6,494&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">8,020&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(19.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Other Asia/Pacific</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">6,706&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">8,595&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(22.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Asia/Pacific &amp; Europe Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">42,807&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">47,257&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(9.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Revenue in the Asia/Pacific and Europe region for the fiscal year ended June&#160;30, 2025 decreased</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> $4.5 million, or 9.4%, compared to the prior year. </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Revenue in the region was positively impacted approximately $16,000, or 0.0%, by foreign currency exchange rate fluctuations.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Revenue in our Japan market decreased 5.9% year over year on a U.S. Dollar basis and decreased 5.8% on a constant currency basis.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">  Total revenue related to the sale of our MindBody GLP-1 </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">System</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#8482;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> in Japan for the year ended </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">June&#160;30, 2025 was $1.3 million. The increase in revenue related to </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">our MindBody GLP-1 </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">System</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#8482;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> was offset by a decrease in sales of </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">TrueScience</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> Liquid Collagen, which decreased by $1.3 million for the </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">fiscal year ended June&#160;30, 2025 compared to the prior year.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">  </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">During the fiscal year ended June&#160;30, 2025, the Japanese Yen, on average, weakened against the U.S. Dollar, negatively impacting our revenue in this market by $27,000 or 0.1%. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Revenue in our Australia and New Zealand markets decreased $1.5 million, or 19.0%, during fiscal year 2025. The decrease in revenue in these markets primarily resulted from a 13.6% decrease in the number of Active Accounts. Total revenue related to the sale of our MindBody GLP-1 System</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#8482;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> in Australia and New Zealand for the year ended June&#160;30, 2025 was $0.6 million. The increase in revenue related to our MindBody GLP-1 System</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#8482;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> was offset by a decrease in sales of </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">TrueScience</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> Liquid Collagen, which decreased by $1.1 million for the </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">fiscal year ended June&#160;30, 2025 compared to the prior year.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">50</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Revenue in our Europe region increased</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> by 15.3% </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">year over year primarily due to </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">an 18.1% increase in our average number of Active Accounts within the market from fiscal year 2024 to fiscal year 2025. Total revenue related to the sale of our MindBody GLP-1 System</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#8482;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> in Europe for the year ended June&#160;30, 2025 was $0.6 million.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The decline in revenue in our other markets was driven by a decrease in revenue from the Philippines. Revenue from our Philippines market was $1.4 million during fiscal year </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">2025</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> compared to $2.6 million during fiscal year 2024.  Total Active Accounts in the Philippines decreased by 63.0% in the current fiscal year. On June 30, 2025, we ceased operations in the Philippines and closed that market.      </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Globally, our sales and marketing efforts continue to be directed toward strengthening our core business through our fiscal year initiatives and building our worldwide sales. We plan to continue the refinement and expansion of our product offerings internationally, including our MindBody GLP-1 System</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#8482;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">, during the fiscal year 2026 and beyond. We expect this expansion will continue to drive revenue growth globally through increased average order size and increased ability to attract and retain new independent consultants and customers with a compelling product lineup.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">During fiscal year 2026, our main focus will be to increase our average account base through concentrating our efforts on the enrollment of new independent consultants and customers, who will in turn help grow the business through incremental product sales, and on increasing the number of accounts that place an order in the month following their initial enrollment.  We also plan to continue investing in our red-carpet program, which we believe has increased our ability to attract and retain strong consultant leadership and is a significant opportunity to drive revenue growth throughout our markets. We remain committed to further expanding the functionality and availability of our digital tools, which we believe will aid independent consultants in initiating and expanding their businesses.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Cost of Sales</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">.</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> Cost of sales were $44.9 million for the fiscal year ended June&#160;30, 2025, and $41.4 million for the fiscal year ended June&#160;30, 2024, resulting in a gross margin of $183.7 million, or 80.4%, and $158.7 million, or 79.3%, respectively. The de</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">crease</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> in cost of sales</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> as a percentage of revenue is primarily due to shift in product mix and decreased inventory obsolescence costs during the</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> fiscal year ended June&#160;30, 2025</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Commissions and Incentives</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">.</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> Commissions and incentives expenses for the fiscal year ended June&#160;30, 2025 were $102.3 million or 44.7% o</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">f revenue compared to $85.9 million or 42.9% of revenue for the fiscal year ended June&#160;30, 2024. The increase in commissions as a percentage of revenue compared to the prior fiscal year is primarily due to higher qualifications within existing promotional and incentive programs and changes in the sales mix between our independent consultants and customers.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Commissions and incentives expenses, as a percentage of revenue, may fluctu</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">ate in future periods based on the timing of incentive trips and events and the timing and magnitude of compensation, incentive, and promotional programs.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Selling, General and Administrative</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">.</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> Selling, general and administrative expenses for the fiscal year ended June&#160;30, 2025 were $69.2 million or 30.3% of revenue compared to $68.5 million or 34.2% of revenue for the fiscal year ended June&#160;30, 2024. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The decrease</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> in selling, general, and administrative expenses as a percentage of revenue during fiscal year </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">2025 </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">primarily was due t</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">o decreased proxy contest related expenses and the termination of our endorsement agreement with Real Salt Lake in December 2023. These decreases were partially offset by increases in the variable portion of employee related compensation expenses.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Primary factors that may cause our selling, general and administrative expenses to fluctuate in the future include changes in the number of employees, the timing and number of events we hold, marketing and branding initiatives and costs related to legal matters, if and as they arise. A fluctuation in our stock price may also impact our stock-based compensation expense relating to equity awards made in future years.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Interest Income</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">. Interest income, net, was $0.4 million for each of the fiscal years ended June&#160;30, 2025 and June&#160;30, 2024.  </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Other Expense, Net</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">.</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> We recognized other expense, net, for the fiscal year ended June&#160;30, 2025 of $0.4 million as compared to $0.4 million for the fiscal year ended June&#160;30, 2024. Other expense, net, primarily consists of the impact of foreign currency fluctuations recognized during the fiscal year.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Income Tax Expense</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">. Our income tax expense for the fiscal year ended June&#160;30, 2025 was $2.4 million as compared to income tax expense of $1.4 million for the fiscal year ended June&#160;30, 2024. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The effective tax rate was&#160;19.9%&#160;of pre-tax income for the fiscal year ended June&#160;30, 2025, compared to&#160;32.5%&#160;for the fiscal year ended June&#160;30, 2024. The decrease in the effectiv</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">e tax rate for fiscal year 2025 compared to the prior year is mainly due to </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">the impact of permanent items in relation to pre-tax income.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">51</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Our provision for income taxes for the fiscal year ended June&#160;30, 2025 consisted prim</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">arily of federal, state, and foreign tax on anticipated fiscal year 2025 income which was partially offset by tax benefits. We expect our effective rate to fluctuate in future periods based on the impact of permanent items in relation to pre-tax income.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Net Income</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">.</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> As a result of the foregoing factors, net income for the fiscal year ended June&#160;30, 2025 in</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">creased </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">to $9.8 million compared to $2.9 million for the fiscal year ended June&#160;30, 2024.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Comparison of Fiscal Years Ended June&#160;30, 2024 and 2023</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">For a discussion of our results of operations for the fiscal year 2024 compared with fiscal year 2023, refer to &#8220;Part II. Item 7. Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8221; in our annual report on Form 10-K for the fiscal year ended June&#160;30, 2024, as filed with the SEC on August 28, 2024.</span></div><div id="i7a9d1ca723db478892511ede354648f3_253"></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Liquidity and Capital Resources</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We continually assess our capital allocation strategy to maximize stockholder value. Our current capital allocation strategy follows a balanced approach focused on supporting and re-investing in the business, as well as returning stockholder value through quarterly dividends and opportunistic share repurchases, where appropriate.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Liquidity</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Our primary liquidity and capital resource requirements are to service our debt, which includes any outstanding balances under the 2024 Credit Facility, and finance the cost of our planned operating expenses and working capital (principally inventory purchases), as well as capital expenditures. We have generally relied on cash flow from operations to fund operating activities and we have, at times, incurred long-term debt in order to fund stock repurchases and strategic transactions.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">At June&#160;30, 2025, our cash and cash equivalents were $20.2 million. This represented an increase of $3.3 million from the $16.9 million in cash and cash equivalents as of June&#160;30, 2024. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">During the fiscal year ended June&#160;30, 2025, our net cash provided by operating activities was $11.9 million as compared to $12.2 million during the fiscal year ended June&#160;30, 2024. The</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> decrease i</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">n cash provided by operating activities during the fiscal year ended June&#160;30, 2025</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> primarily was due to increases in inventory and deposits on future events offset primarily by increases in other accrued expenses which contain accrued incentive compensation to employees and accrued incentives and promotions to our independent consultants.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">During the fiscal year ended June&#160;30, 2025, our net cash used in investing activities was $1.4 million, as a result of the purchase of fixed assets, primarily from investing in changes to our Evolve Compensation Plan and Rewards Circle loyalty program through software, website, and mobile application development. During the fiscal year ended June&#160;30, 2024, our net cash used in investing activities was $2.2 million, which was attributable to capital expenditures including leasehold improvements related to moving our Tokyo, Japan office.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Cash used in financing activities during the fiscal year ended June&#160;30, 2025 was $7.6 million, as a result of the repurchase of company stock, payment of quarterly cash dividends, and shares purchased as payment of tax withholding upon vesting of employee equity awards, partially offset by proceeds from stock option exercises and proceeds from purchases of company stock under our employee stock purchase plan. Cash used in financing activities during the fiscal year ended June&#160;30, 2024 was $14.4 million, as a result of the payment of a one-time cash dividend in September 2023, quarterly cash dividends, the repurchase of company stock, and shares purchased as payment of tax withholding upon vesting of employee equity awards, partially offset by proceeds from purchases of company stock under our employee stock purchase plan.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">At June&#160;30, 2025 and 2024, the total amount of our foreign subsidiary cash was $6.4 million and $7.3 million, respectively. Under current U.S. tax law, in the future, if needed, we expect to be able to repatriate cash from foreign subsidiaries without paying additional U.S. taxes.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">At June&#160;30, 2025, we had working capital (current assets minus current liabilities) of $23.7 million compared to working capital of $15.3 million at June&#160;30, 2024. The in</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">crease</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> in working capital primarily was due to increases in cash, inventory, and prepaid expenses and decreases in accounts payable, partially offset by increases in commissions payable and other accrued expenses. We believe that our cash and cash equivalents balances and our ongoing cash flow from operations will be sufficient to satisfy our cash requirements for at least the next 12 months. The majority of our historical expenses have been variable in nature and as such, a potential reduction in the level of revenue would reduce our cash flow. In the event that our current cash balances and future cash flow from operations are not sufficient to meet our obligations or strategic needs, we would consider raising additional funds, which may not be available on terms that are acceptable to us, or at all. Our 2024 Credit Facility, however, contains covenants that in certain circumstances restrict our ability to incur additional indebtedness, make certain investments, purchase or otherwise acquire all or substantially all the assets or equity interests of other companies, or transfer </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">52</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">any part of the business. Additionally, our 2024 Credit Facility provides for a line of credit in an aggregate principal amount up to $5.0 million. We would also consider realigning our strategic plans including a reduction in capital spending and expenses.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Capital Resources</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Shelf Registration Statement</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">On March 31, 2023, we filed a shelf registration statement on Form S-3 (the &#8220;2023 Shelf Registration&#8221;) with the SEC that was declared effective on April 6, 2023, which permits us to offer up to $75 million of common stock, preferred stock, debt securities and warrants in one or more offerings and in any combination, including in units from time to time. Our 2023 Shelf Registration is intended to provide us with additional flexibility to access capital markets for general corporate purposes, which may include, among other purposes, working capital, capital expenditures, other corporate expenses and acquisitions of assets, licenses, products, technologies, or businesses.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2016 Credit Facility</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">On </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">March&#160;30, 2016</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">, we entered into a loan agreement (the &#8220;2016 Loan Agreement&#8221;) and a security agreement (the &#8220;2016 Security Agreement&#8221;). The 2016 Loan Agreement provided for a term loan in an aggregate principal amount of </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">$10.0 million</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> (the &#8220;2016 Term Loan&#8221;) and a revolving loan facility in an aggregate principal amount not to exceed </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">$2.0 million</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> (the &#8220;2016 Revolving Loan,&#8221; and collectively with the 2016 Term Loan, the 2016 Loan Agreement and the 2016 Security Agreement, and with the amendments described below, the &#8220;2016 Credit Facility&#8221;). The 2016 Credit Facility was subsequently amended, among other things, to increase the available borrowing under the revolving loan facility to $5.0 million. On March 31, 2024, the 2016 Credit Facility reached the maturity date and was terminated. As of March 31, 2024, there was no balance outstanding under the 2016 Credit Facility.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2024 Credit Facility</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">On April 12, 2024, we entered into a Loan Agreement (the &#8220;Loan Agreement&#8221;) with Bank of America, N.A., as Lender (the &#8220;Lender&#8221;). In connection with the Loan Agreement and on the same date, we, Lifeline Nutraceuticals Corporation, as Guarantor (the &#8220;Guarantor&#8221;), and the Lender also entered into a Continuing and Unconditional Guaranty (the &#8220;Continuing and Unconditional Guaranty&#8221;) and a Security and Pledge Agreement (the &#8220;Security and Pledge Agreement&#8221;). The Loan Agreement provides for a revolving line of credit in an aggregate principal amount not to exceed $5.0 million (the &#8220;Line of Credit&#8221;) and collectively with the Loan Agreement, the Continuing and Unconditional Guaranty and the Security and Pledge Agreement, the &#8220;2024 Credit Facility&#8221;). </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In the event we borrow under the Line of Credit, interest will be payable commencing May 31, 2024, and then on the last day of each month thereafter until payment in full of all principal outstanding under the Line of Credit, with all unpaid principal and interest due on April 12, 2027 (the &#8220;Expiration Date&#8221;). The Line of Credit will bear interest at a rate per year equal to the sum of (i) the greater of the Term SOFR Daily Floating Rate (as defined in the Loan Agreement) or 0.00%, plus (ii) 2.00%. Amounts under the Line of Credit may be repaid and re-borrowed from time to time until the Expiration Date. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Our obligations under the Loan Agreement are secured by a security interest in substantially all of the assets of the Company and the Guarantor, as further provided for in the Security and Pledge Agreement. Pursuant to the Continuing and Unconditional Guaranty, the Guarantor guarantees and promises to pay promptly to the Lender all indebtedness of the Company when due. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Loan Agreement contains customary covenants, including affirmative and negative covenants that in certain circumstances restrict our ability to incur additional indebtedness, make certain investments, purchase or otherwise acquire all or substantially all the assets or equity interests of other companies, or transfer any part of the business or any assets of the Company or the Guarantor. The Loan Agreement requires us to maintain specified financial ratios and satisfy certain financial condition tests. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Loan Agreement contains certain customary events of default, including, among other things, our failure to make required payments under the Loan Agreement, certain breaches of representations made by us or the Guarantor, insolvency or bankruptcy of the Company or the Guarantor, failure to have an enforceable first lien or security interest in any property given as security for the Loan Agreement, or our failure to comply with covenants set forth in the Loan Agreement. If an event of default occurs under the Loan Agreement, the obligation of the Lender to make any additional credit available to us may be terminated and the amounts outstanding may become immediately due and payable in the discretion of the Lender, provided that in the event of insolvency or bankruptcy of the Company or the Guarantor, all debts outstanding under the Loan Agreement will automatically become due and payable. Upon the occurrence of any default or after maturity, all amounts outstanding under the Loan Agreement will at the option of the Lender bear interest at a rate which is 2.00% higher than the rate of interest otherwise provided under the Loan Agreement. </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">53</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">As of June 30, 2025, there was no outstanding balance under the 2024 Credit Facility</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">. </span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Commitments and Obligations</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Please refer to Note 14 to the consolidated financial statements contained in this report for information regarding our contingent liabilities.</span></div><div id="i7a9d1ca723db478892511ede354648f3_256"></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Critical Accounting Policies and Estimates</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We prepare our financial statements in conformity with accounting principles generally accepted in the United States of America. As such, we are required to make certain estimates, judgments, and assumptions that we believe are reasonable based upon the information available. These estimates and assumptions affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the periods presented. Actual results could differ from these estimates. Our significant accounting policies are described in Note 2 to our consolidated financial statements. Certain of these significant accounting policies require us to make difficult, subjective, or complex judgments or estimates. We consider an accounting estimate to be critical if: (1)&#160;the accounting estimate requires us to make assumptions about matters that were highly uncertain at the time the accounting estimate was made and (2)&#160;changes in the estimate that are reasonably likely to occur from period to period, or use of different estimates that we reasonably could have used in the current period, would have a material impact on our financial condition or results of operations.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">There are other items within our financial statements that require estimation but are not deemed critical as defined above. Changes in estimates used in these and other items could have a material impact on our financial statements. Management has discussed the development and selection of these critical accounting estimates with our board, and the audit committee has reviewed the disclosures noted below.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Stock-Based Compensation</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We use the fair value approach to account for stock-based compensation in accordance with current accounting guidance. We recognize compensation costs for awards with performance conditions when we conclude it is probable that the performance conditions will be achieved. We reassess the probability of vesting at each balance sheet date and adjust compensation costs based on our probability assessment. For awards with market-based performance conditions, the cost of the awards is recognized as the requisite service is rendered by the employees, regardless of when, if ever, the market-based performance conditions are satisfied. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Historically, our estimates and underlying assumptions have not materially deviated from our actual reported results and rates. However, we base assumptions we use on our best estimates, which involves inherent uncertainties based on market conditions that are outside of our control. If actual results are not consistent with the assumptions we use, the stock-based compensation expense reported in our consolidated financial statements may not be representative of the actual economic cost of stock-based compensation. For example, if actual employee forfeitures significantly differ from our estimated forfeitures, we may be required to adjust our consolidated financial statements in future periods. </span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Income Taxes</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The provision for income taxes includes income from U.S. and foreign subsidiaries taxed at statutory rates, the accrual or release of amounts for tax uncertainties, and U.S. tax impacts of foreign income in the U.S.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Deferred tax assets and liabilities are recognized for the future tax consequences attributable to temporary differences between the carrying amounts of assets and liabilities on the financial statements and their respective tax bases. Deferred tax assets also are recognized for net operating losses and credit carryforwards. Deferred tax assets and liabilities are measured using the enacted rates applicable to taxable income in the years in which the temporary differences are expected to reverse and the credits are expected to be used. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. An assessment is made as to whether or not a valuation allowance is required to offset deferred tax assets. This assessment requires estimates as to future operating results, as well as an evaluation of the effectiveness of our tax planning strategies. These estimates are made on an ongoing basis based upon our business plans and growth strategies in each market and consequently, future material changes in the valuation allowance are possible. The valuation allowance reduces the deferred tax assets to an amount that management determined is more-likely-than-not to be realized.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We operate in and file income tax returns in the U.S. and numerous foreign jurisdictions with complex tax laws and regulations, which are subject to examination by tax authorities. The complexity of our global structure requires specialized knowledge and judgment in determining the application of tax laws in various jurisdictions. Years open to examination contain matters that could be subject to differing interpretations of applicable tax laws and regulations related to the amount and/or timing of income, deductions, and tax credits. We account for uncertain tax positions in accordance with Accounting Standards </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">54</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Codification (&#8220;ASC&#8221;) 740, Income Taxes. This guidance prescribes a minimum probability threshold that a tax position must meet before a financial statement benefit is recognized. The minimum threshold is defined as a tax position that is more likely than not to be sustained upon examination by the applicable taxing authority, including resolution of any related appeals or litigation processes, based on the technical merits of the position. The tax benefit to be recognized is measured as the largest amount of benefit that is greater than 50 percent likely of being realized upon ultimate settlement.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Interest and penalties related to tax contingency or settlement items are recorded as a component of the provision for income taxes in our Consolidated Statements of Operations and Comprehensive Income. We record accruals for tax contingencies as a component of accrued liabilities or other long-term liabilities on our Consolidated Balance Sheet.</span></div><div id="i7a9d1ca723db478892511ede354648f3_259"></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Recently Issued Accounting Standards</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Refer to &#8220;Item 8. Financial Statements and Supplementary Data&#8221; and Note 2 to our consolidated financial statements included in Part IV, Item 15 of this report for discussion regarding the impact of accounting standards that were recently issued but not yet effective, on our consolidated financial statements.</span></div><div id="i7a9d1ca723db478892511ede354648f3_262"></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">ITEM&#160;7A &#8212; QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Not required for smaller reporting companies.</span></div><div id="i7a9d1ca723db478892511ede354648f3_265"></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">ITEM&#160;8 &#8212; FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The information required by this Item&#160;8 is set forth in the consolidated financial statements included in Part IV, Item&#160;15 of this report and is incorporated into this Item&#160;8 by reference.</span></div><div id="i7a9d1ca723db478892511ede354648f3_268"></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">ITEM&#160;9 &#8212; CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div id="i7a9d1ca723db478892511ede354648f3_271"></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 9A &#8212; CONTROLS AND PROCEDURES</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Disclosure Controls and Procedures</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We maintain disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) of the Exchange Act) that are designed to ensure that the information required to be disclosed in the reports we file or submit under the Exchange Act is (a) recorded, processed, summarized and reported within the time periods specified in the rules and forms of the SEC and (b) accumulated and communicated to management, including our Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosure. As of June&#160;30, 2025, we carried out an evaluation, under the supervision and with the participation of our management, including our Chief Executive Officer and Chief Financial Officer, of the effectiveness and design and operation of such disclosure controls and procedures, as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange. Based on that evaluation, our Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures were designed and operating effectively as of&#160;June&#160;30, 2025.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Management&#8217;s Annual Report on Internal Control Over Financial Reporting</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Our management is responsible for establishing and maintaining adequate internal control over financial reporting, as defined in Exchange Act Rules 13a-15(f) and 15d-15(f). Our system of internal control over financial reporting is designed to provide reasonable assurance to our management and board of directors regarding the preparation and fair presentation of our consolidated and combined financial statements for external purposes in accordance with generally accepted accounting principles (&#8220;GAAP&#8221;).</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Our management, under the supervision of our Chief Executive Officer and Chief Financial Officer, assessed the effectiveness of our internal control over financial reporting as of June&#160;30, 2025. In making this assessment, we used the framework included in Internal Control - Integrated Framework published by the Committee of Sponsoring Organizations of the Treadway Commission 2013 (COSO). Based on that evaluation, our management has concluded that internal control over financing reporting was effective as of June&#160;30, 2025.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Auditor&#8217;s Attestation Report on Internal Control Over Financial Reporting</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Deloitte &amp; Touche LLP, </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">our independent registered public accounting firm, has audited our consolidated financial statements included in this annual report on Form 10-K and has issued an attestation report, included herein, on the effectiveness of our internal control over financial reporting as of June 30, 2025.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Changes in Internal Control over Financial Reporting</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">55</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">There were no changes in our internal control over financial reporting during the quarter ended June&#160;30, 2025 that have materially affected or are reasonably likely to materially affect our internal control over financial reporting.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Inherent Limitations on Effectiveness of Controls</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Our management, including our Chief Executive Officer and Chief Financial Officer, cannot provide absolute assurance that our disclosure controls or our internal control over financial reporting will prevent or detect all error and all fraud. A control system, no matter how well designed and operated, can provide only reasonable, not absolute, assurance that the control system&#8217;s objectives will be met. The design of a control system must reflect the fact that there are resource constraints, and the benefits of controls must be considered relative to their costs. Further, because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that misstatements due to error or fraud will not occur or that all control issues and instances of fraud, if any, have been detected. These inherent limitations include the realities that judgments in decision-making can be faulty and that breakdowns can occur because of simple error or mistake. Controls can also be circumvented by the individual acts of some persons, by collusion of two or more people, or by management override of the controls. The design of any system of controls is based in part on certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions. Projections of any evaluation of controls effectiveness to future periods are subject to risks. Over time, controls may become inadequate because of changes in conditions or deterioration in the degree of compliance with policies or procedures.</span></div><div id="i7a9d1ca723db478892511ede354648f3_274"></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">ITEM&#160;9B &#8212; OTHER INFORMATION</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">During the quarter ended June 30, 2025, none of our officers or directors, as defined in Rule 16a-1(f), informed us of the <ix:nonNumeric contextRef="c-1" name="ecd:NonRule10b51ArrAdoptedFlag" format="ixt:fixed-false" id="f-52">adoption</ix:nonNumeric> or <ix:nonNumeric contextRef="c-1" name="ecd:NonRule10b51ArrTrmntdFlag" format="ixt:fixed-false" id="f-53"><ix:nonNumeric contextRef="c-1" name="ecd:Rule10b51ArrTrmntdFlag" format="ixt:fixed-false" id="f-54">termination</ix:nonNumeric></ix:nonNumeric> of a Rule 10b5-1 trading arrangement or a non-Rule 10b5-1 trading arrangement, each as defined in Regulation S-K Item 408, other than as described below.</span></div><ix:nonNumeric contextRef="c-4" name="ecd:MtrlTermsOfTrdArrTextBlock" id="f-55" escape="true"><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">As previously reported, on <ix:nonNumeric contextRef="c-4" name="ecd:TrdArrAdoptionDate" id="f-56">February 10, 2025</ix:nonNumeric>, <ix:nonNumeric contextRef="c-4" name="ecd:TrdArrIndName" id="f-57">Michael Beindorff</ix:nonNumeric>, a <ix:nonNumeric contextRef="c-4" name="ecd:TrdArrIndTitle" id="f-58">director</ix:nonNumeric>, <ix:nonNumeric contextRef="c-4" name="ecd:Rule10b51ArrAdoptedFlag" format="ixt:fixed-true" id="f-59">adopted</ix:nonNumeric> a sales plan designed to comply with Rule 10b5-1 under the Exchange Act. The sales plan, which Mr. Beindorff adopted in compliance with restrictions imposed by our Insider Trading Policy, provided for sales of shares of LifeVantage Corporation common stock owned by Mr. Beindorff. Total sales on Mr. Beindorff&#8217;s behalf under the sales plan were limited to 1,000 shares per month, beginning in May 2025 and continuing through <ix:nonNumeric contextRef="c-4" name="ecd:TrdArrExpirationDate" id="f-60">October 2026</ix:nonNumeric>, and up to a maximum of <ix:nonFraction unitRef="shares" contextRef="c-5" decimals="-3" name="ecd:TrdArrSecuritiesAggAvailAmt" format="ixt:num-dot-decimal" id="f-61">18,000</ix:nonFraction> shares could be sold under the plan. On May 12, 2025, Mr. Beindorff terminated this 10b5-1 plan.</span></div></ix:nonNumeric><div id="i7a9d1ca723db478892511ede354648f3_277"></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">ITEM&#160;9C &#8212; DISCLOSURE REGARDING FOREIGN JURISDICTIONS THAT PREVENT INSPECTIONS</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div id="i7a9d1ca723db478892511ede354648f3_280"></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">PART III</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Certain information required by Part III of this report is omitted from this report pursuant to General Instruction G(3) of Form 10-K because we will file a definitive proxy statement pursuant to Regulation 14A for our fiscal year 2026 annual meeting of stockholders (the &#8220;Proxy Statement&#8221;) not later than 120 days after the end of the fiscal year covered by this report, and the information included in the Proxy Statement that is required by Part III of this report is incorporated herein by reference.</span></div><div id="i7a9d1ca723db478892511ede354648f3_283"></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">ITEM&#160;10 &#8212; DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Incorporated herein by reference to the information to be set forth in the Proxy Statement.</span></div><div id="i7a9d1ca723db478892511ede354648f3_286"></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">ITEM&#160;11 &#8212; EXECUTIVE COMPENSATION</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Incorporated herein by reference to the information to be set forth in the Proxy Statement.</span></div><div id="i7a9d1ca723db478892511ede354648f3_289"></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">ITEM&#160;12 &#8212; SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Incorporated herein by reference to the information to be set forth in the Proxy Statement.</span></div><div id="i7a9d1ca723db478892511ede354648f3_292"></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">ITEM&#160;13 &#8212; CERTAIN RELATIONSHIP AND RELATED TRANSACTIONS, AND DIRECTORS INDEPENDENCE</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Incorporated herein by reference to the information to be set forth in the Proxy Statement.</span></div><div id="i7a9d1ca723db478892511ede354648f3_295"></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">ITEM&#160;14 &#8212; PRINCIPAL ACCOUNTING FEES AND SERVICES</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Incorporated herein by reference to the information to be set forth in the Proxy Statement.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">56</span></div></div></div><div id="i7a9d1ca723db478892511ede354648f3_298"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">PART IV</span></div><div id="i7a9d1ca723db478892511ede354648f3_301"></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">ITEM&#160;15 &#8212; EXHIBITS, FINANCIAL STATEMENT SCHEDULES</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The following documents are being filed as part of this report:</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Financial Statements</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">(a)(1) Financial Statements. The following consolidated financial statements of LifeVantage Corporation and Report of Independent Registered Public Accounting Firm are included in a separate section of this Annual Report on Form&#160;10-K.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">(a)(2) All schedules for which provision is made in the applicable accounting regulations of the SEC are not required under the related instructions or are inapplicable, or because the required information is included in the financial statements or notes thereto, and therefore have been omitted.</span></div><div id="i7a9d1ca723db478892511ede354648f3_304"></div><div style="-sec-extract:summary;margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Exhibits</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">(a)(3) The following exhibits are filed as part of, or incorporated by reference into, the Annual Report on Form 10-K.</span></div><div style="margin-bottom:8pt;margin-top:13pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:7.857%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:43.687%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:43.688%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Exhibit<br/>No.</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Document Description</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Filed Herewith or Incorporated by Reference From</span></td></tr><tr style="height:9pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3.1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/849146/000084914618000046/ex31-certificateofincorpor.htm">Certificate of Incorporation</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Exhibit 3.1 to Form 8-K filed with the SEC on March 13, 2018.</span></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3.2</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/849146/000084914619000066/lifevantage-amendedandrest.htm">Amended and Restated Bylaws</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Exhibit 3.1 to Form 8-K filed with the SEC on August 15, 2019.</span></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3.3</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/849146/000084914623000114/lfvn-certificateofdesign.htm">Certificate of Designation of Series A Junior Participating Preferred Stock of the Company</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Exhibit 3.1 to Form 8-K filed with the SEC on August 31, 2023.</span></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3.4</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/849146/000084914624000146/lfvn-certificateofterminat.htm">Certificate of Elimination of Series A Junior Participating Preferred Stock of Registrant, filed November 18, 2024 </a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Exhibit 3.1 to Form 8-K filed with the SEC on November 19, 2024.</span></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">4.1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/849146/000084914618000046/exhibit41formofcommonsto.htm">Form of Common Stock Certificate</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Exhibit 4.1 to Form 8-K filed with the SEC on March 13, 2018.</span></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">4.2</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/849146/000084914622000058/ex42descriptionofcapitalst.htm">Description of Capital Stock</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Exhibit 4.2 to Form 10-K filed with the SEC on August 23, 2022.</span></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">4.3</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/849146/000084914623000115/lifevantage-rightsplanfi.htm">Rights Agreement, dated as of August 30, 2023, by and between the Company and Computershare Trust Company, N.A., as Rights Agent</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Exhibit 4.1 to Form 8-K filed with the SEC on August 31, 2023</span></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10.1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/849146/000084914624000021/lfvn-cooperationagreemen.htm">Cooperation Agreement, dated February 14, 2024, by and among the Company, the entities and persons listed on Exhibit A thereto, and the entities and persons listed on Exhibit B thereto</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Exhibit 10.1 to Form 8-K filed with the SEC on February 15, 2024.</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10.2#</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/849146/000084914622000058/lifevantagesalescompensa.htm">LifeVantage Sales Compensation Plan</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Exhibit 10.1 to Form 10-K filed with the SEC on August 23, 2022.</span></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10.2.1#</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/849146/000084914624000106/lfvnproxystatementfy2025.htm">LifeVantage Corporation 2017 Long-Term Incentive Plan, as amended</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Annex A to the Registrant&#8217;s Proxy Statement on Schedule 14A, filed with the SEC on September 20, 2024.</span></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10.2.2#</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/849146/000084914624000106/lfvnproxystatementfy2025.htm">LifeVantage Corporation 2019 Employee Stock Purchase Plan, as amended</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Annex B to the Registrant&#8217;s Proxy Statement on Schedule 14A, filed with the SEC on September 20, 2024.</span></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10.2.3#</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/849146/000084914625000014/evolvecompensationplanus.htm">Evolve Compensation Plan (United States), as amended on November 1, 2024</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Exhibit 10.3 to Form 10-Q filed for the fiscal quarter ended December 31, 2024 filed with the SEC on February 5, 2025.</span></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">57</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:8pt;margin-top:13pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:7.857%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:43.687%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:43.688%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Exhibit<br/>No.</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Document Description</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Filed Herewith or Incorporated by Reference From</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10.2.4#</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/849146/000084914625000014/evolvecompensationplanau.htm">Evolve Compensation Plan (Australia), as amended on November 1, 2024</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Exhibit 10.4 to Form 10-Q filed for the fiscal quarter ended December 31, 2024 filed with the SEC on February 5, 2025.</span></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10.2.5#</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/849146/000084914625000014/evolvecompensationplannz.htm">Evolve Compensation Plan (New Zealand), as amended on November 1, 2024</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Exhibit 10.5 to Form 10-Q filed for the fiscal quarter ended December 31, 2024 filed with the SEC on February 5, 2025.</span></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10.2.6#</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/849146/000084914625000014/evolvecompensationplanjp.htm">Evolve Compensation Plan (Japan), as amended on November 1, 2024</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Exhibit 10.6 to Form 10-Q filed for the fiscal quarter ended December 31, 2024 filed with the SEC on February 5, 2025.</span></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10.2.7#</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/849146/000084914625000014/evolvecompensationplanca.htm">Evolve Compensation Plan (Canada), as amended on November 1, 2024</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Exhibit 10.7 to Form 10-Q filed for the fiscal quarter ended December 31, 2024 filed with the SEC on February 5, 2025.</span></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10.2.8#</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/849146/000084914625000014/evolvecompensationplanmx.htm">Evolve Compensation Plan (Mexico), as amended on November 1, 2024</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Exhibit 10.8 to Form 10-Q filed for the fiscal quarter ended December 31, 2024 filed with the SEC on February 5, 2025.</span></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10.2.9#</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/849146/000084914625000014/evolvecompensationplanuk.htm">Evolve Compensation Plan (UK), as amended on November 1, 2024</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Exhibit 10.9 to Form 10-Q filed for the fiscal quarter ended December 31, 2024 filed with the SEC on February 5, 2025.</span></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10.2.10#</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/849146/000084914625000014/evolvecompensationplaneu.htm">Evolve Compensation Plan (EU), as amended on November 1, 2024</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Exhibit 10.10 to Form 10-Q filed for the fiscal quarter ended December 31, 2024 filed with the SEC on February 5, 2025.</span></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10.2.11#</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/849146/000084914625000039/evolvecompensationplanph.htm">Evolve Compensation Plan (Philippines)</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Exhibit 10.11 to Form 10-Q filed for the fiscal quarter ended March 31, 2025 filed with the SEC on May 6, 2025.</span></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10.2.12#</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/849146/000084914625000039/evolvecompensationplantw.htm">Evolve Compensation Plan (Taiwan)</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Exhibit 10.11 to Form 10-Q filed for the fiscal quarter ended March 31, 2025 filed with the SEC on May 6, 2025.</span></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10.2.13#</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/849146/000084914625000039/evolvecompensationplanhk.htm">Evolve Compensation Plan (Hong Kong)</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Exhibit 10.11 to Form 10-Q filed for the fiscal quarter ended March 31, 2025 filed with the SEC on May 6, 2025.</span></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10.2.14#</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/849146/000084914625000039/evolvecompensationplansg.htm">Evolve Compensation Plan (Singapore)</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Exhibit 10.11 to Form 10-Q filed for the fiscal quarter ended March 31, 2025 filed with the SEC on May 6, 2025.</span></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10.3#</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/849146/000084914617000064/ex992restrictedstockgranta.htm">Form of Restricted Stock Grant Agreement for the 2017 Long-Term Incentive Plan</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Exhibit 99.2 to the Registration Statement on Form S-8 filed with the SEC on March 27, 2017.</span></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10.4#</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/849146/000084914617000064/ex993stockunitagreement.htm">Form of Stock Unit Agreement for the 2017 Long-Term Incentive Plan</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Exhibit 99.3 to the Registration Statement on Form S-8 filed with the SEC on March 27, 2017.</span></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10.5#</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/849146/000084914624000106/lfvnproxystatementfy2025.htm">LifeVantage Corporation 2019 Employee Stock Purchase Plan, as amended</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Annex B to the Registrant&#8217;s Proxy Statement on Schedule 14A, filed with the SEC on September 20, 2024.</span></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10.6</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/849146/000084914618000046/ex991-indemnificationagree.htm">Form of Indemnification Agreement</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Exhibit to 99.1 to Form 8-K filed with the SEC on March 13, 2018.</span></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10.7#</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/849146/000084914621000047/lfvnstevefifeceoofferlet.htm">CEO Offer Letter, dated January 31, 2021, by and between the Company and Steven R. Fife</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Exhibit 10.1 to Form 10-Q filed for the fiscal quarter ended March 31, 2021 filed with the SEC on April 29, 2021.</span></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">58</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:8pt;margin-top:13pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:7.857%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:43.687%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:43.688%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Exhibit<br/>No.</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Document Description</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Filed Herewith or Incorporated by Reference From</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10.8#</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/849146/000084914624000073/ex109keyexecutivebenefit.htm">Form of Key Executive Benefits Agreement</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Exhibit 10.09# to Form 10-K for the fiscal year ended June 30, 2024 filed with the SEC on August 28, 2024.</span></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10.9</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/849146/000084914624000039/loanagreement.htm">Loan Agreement, dated April 12, 2024, by and between the Company and Bank of America, N.A.</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Exhibit 10.1 to Form 8-K filed with the SEC on April 16, 2024.</span></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10.1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/849146/000084914624000039/continuinganduncondition.htm">Continuing and Unconditional Guaranty, dated April 12, 2024, by and among the Company, as Borrower, Lifeline Nutraceuticals Corporation, as Guarantor, and Bank of America, N.A.</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Exhibit 10.2 to Form 8-K filed with the SEC on April 16, 2024.</span></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10.11</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/849146/000084914624000039/securityandpledgeagreeme.htm">Security and Pledge Agreement, dated April 12, 2024, by and among the Company, as Borrower, Lifeline Nutraceuticals Corporation, as Guarantor, and Bank of America, N.A.</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Exhibit 10.3 to Form 8-K filed with the SEC on April 16, 2024.</span></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10.12</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/849146/000084914616000165/exhibit101zfnb-lifevantage.htm">Loan Agreement, dated March 30, 2016, by and between Z.B., N.A., the Company and Lifeline Nutraceuticals Corporation</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Exhibit 10.1 to Form 8-K filed with the SEC on April 4, 2016.</span></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10.13</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/849146/000084914616000165/exhibit102zfnb-lifevantage.htm">Security Agreement, dated March 30, 2016, by and between Z.B., N.A., the Company and Lifeline Nutraceuticals Corporation</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Exhibit 10.2 to Form 8-K filed with the SEC on April 4, 2016.<br/></span></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10.14</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/849146/000084914618000057/ex101-loanmodification.htm">Amended No.1 to Loan Agreement, dated May 4, 2018, by and between Z.B., N.A., the Company and Lifeline Nutraceuticals Corporation</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Exhibit 10.1 to Form 10-Q filed for the fiscal quarter ended March 31, 2018 filed with the SEC on May 9, 2018.</span></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10.15</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/849146/000084914619000029/ex101loanmodification.htm">Second Loan Modification Agreement, dated February 1, 2019, by and between Zions Bank and the Company</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Exhibit 10.1 to Form 8-K filed with the SEC on February 4, 2019.</span></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10.16</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/849146/000084914621000047/loandocuments-lifevantag.htm">Change in Terms Agreement, dated April 1, 2021, by and between Zions Bank and the Company</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Exhibit 10.3 to Form 10-Q filed for the fiscal quarter ended March 31, 2021 filed with the SEC on April 29, 2021.</span></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10.17</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/849146/000084914622000076/a20220930-zionsrlocadden.htm">Change in Terms Agreement, dated September 30, 2022 by and between the Company and Zions Bank</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Exhibit 10.1 to Form 10-Q filed for the fiscal quarter ended September 30, 2022 filed with the SEC on November 2, 2022.</span></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10.18</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/849146/000084914620000040/lfvnleasetrciii.htm">Lease Agreement, dated November 14, 2019, by and between Traverse Ridge Center III and the Company</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Exhibit 10.1 to Form 10-Q filed for the fiscal quarter ended December 31, 2019 with the SEC on January 28, 2020.</span></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10.19</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/849146/000084914623000204/leaseagreementshinagawag.htm">Lease Agreement, dated May 26, 2023, by and between Sumitomo Mitsui Trust Bank, Limited and LifeVantage Japan in US/English Format</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Exhibit 10.1 to Form 10-Q filed for the fiscal quarter ended September 30, 2023 filed with the SEC on November 9, 2023.</span></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10.20*</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/849146/000084914614000027/dlimanufacturingagreement.htm">Commercial Supply Agreement, dated January 31, 2014, by and between the Company and Deseret Laboratories, Inc.</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Exhibit 10.1 to Form 10-Q for the fiscal quarter ended March 31, 2014 filed with the SEC on May 6, 2014.</span></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10.21*</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/849146/000084914614000062/integracoreservicesagreeme.htm">Service Agreement, dated June 1, 2014, by and between IntegraCore, LLC and the Company</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Exhibit 10.29 to Form 10-K for the fiscal year ended June 30, 2014 filed with the SEC on September 10, 2014. </span></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10.22*</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/849146/000084914614000062/wasatchmanufagreement.htm">Commercial Supply Agreement, dated May 30, 2014, by and between the Company and Wasatch Product Development</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Exhibit 10.30 to Form 10-K for the fiscal year ended June 30, 2014 filed with the SEC on September 10, 2014.</span></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">19.1</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="insidertradingpolicy.htm"><ix:nonNumeric contextRef="c-1" name="ecd:InsiderTrdPoliciesProcAdoptedFlag" format="ixt:fixed-true" id="f-62">Insider Trading Policy, amended and restated on April 29, 2025</ix:nonNumeric></a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Filed herewith.</span></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">59</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:8pt;margin-top:13pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:7.857%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:43.687%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:43.688%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Exhibit<br/>No.</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Document Description</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Filed Herewith or Incorporated by Reference From</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">21.1</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="ex211listofsubsidiaries063.htm">List of Subsidiaries</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Filed herewith.</span></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">23.1</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="ex231deloitteconsent063020.htm">Consent of Deloitte &amp; Touche, LLP</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Filed herewith.</span></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">24.1</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Power of Attorney</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Signature page to this report.</span></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">31.1</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="ex311ceosec302certificatio.htm">Certification of Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Filed herewith.</span></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">31.2</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="ex312cfosec302certificatio.htm">Certification of Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Filed herewith.</span></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">32.1</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="ex321ceosec906certificatio.htm">Certification of Chief Executive Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Furnished herewith.</span></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">32.2</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="ex322cfosec906certificatio.htm">Certification of Chief Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Furnished herewith.</span></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">97.1</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/849146/000084914624000073/clawbackpolicy.htm">Company Policy for the Recovery of Erroneously Awarded Compensation (Clawback Policy)</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Exhibit 97.1 to Form 10-K for the fiscal year ended June 30, 2024 filed with the SEC on August 28, 2024.</span></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">101</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">The following financial information from the registrant&#8217;s Annual Report on Form&#160;10-K for the year ended June 30, 2025 formatted in Inline XBRL (eXtensible Business Reporting Language): (i)&#160;Consolidated Balance Sheets; (ii)&#160;Consolidated Statements of Operations and Other Comprehensive Income; (iii)&#160;Consolidated Statement of Stockholders&#8217; Deficit; (iv)&#160;Consolidated Statements of Cash Flows; and (v)&#160;Notes to Consolidated Financial Statements, tagged as blocks of text.</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Filed herewith.</span></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">104</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Filed herewith.</span></td></tr></table></div><div style="margin-bottom:8pt;margin-top:8pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:7.844%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:89.223%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">#</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Management contract or compensatory plan.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">The company has been granted confidential treatment for portions of this agreement. Accordingly, certain portions of this agreement have been omitted in the version filed with this report and such confidential portions have been filed with the SEC.</span></td></tr></table></div><div id="i7a9d1ca723db478892511ede354648f3_307"></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">SIGNATURES</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of Section&#160;13 or 15(d) of the Securities Exchange Act of 1934, the registrant duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">60</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:8pt;margin-top:13pt;text-align:right;text-indent:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:56.871%"><tr><td style="width:1.0%"/><td style="width:14.581%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:83.219%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">LIFEVANTAGE CORPORATION</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">/s/&#160;&#160;&#160;&#160;Steven R. Fife</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Steven R. Fife</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">President and Chief Executive Officer</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Date:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">September 4, 2025</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">/s/&#160;&#160;&#160;&#160;Carl A. Aure</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Carl A. Aure</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Chief Financial Officer</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(Principal Financial Officer and Principal Accounting Officer)</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Date:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">September 4, 2025</span></td></tr></table></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Each person whose individual signature appears below hereby constitutes and appoints Steven R. Fife with full power of substitution and re-substitution and full power to act without the other, as his or her true and lawful attorney-in-fact and agent to act in his or her name, place and stead and to execute in the name and on behalf of each person, individually and in each capacity stated below, and to file any and all amendments to this report, and to file the same, with all exhibits thereto, and other documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorneys-in-fact and agents, and each of them, full power and authority to do and perform each and every act and thing, ratifying and confirming all that said attorneys-in-fact and agents or any of them or their or his substitute or substitutes may lawfully do or cause to be done by virtue thereof.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">61</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:8pt;margin-top:13pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:41.128%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.348%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:37.758%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Signature</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Date</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Title</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">/s/&#160;&#160;&#160;&#160;Steven R. Fife</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">September 4, 2025</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">President and Chief&#160;Executive&#160;Officer<br/>(Principal&#160;Executive&#160;Officer)</span></td></tr><tr style="height:14pt"><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Steven R. Fife</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">/s/&#160;&#160;&#160;&#160;Raymond B. Greer</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">September 4, 2025</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Chairman of the Board</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Raymond B. Greer</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">/s/&#160;&#160;&#160;&#160;Rajendran Anbalagan</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">September 4, 2025</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Rajendran Anbalagan</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">/s/&#160;&#160;&#160;&#160;Michael A. Beindorff</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">September 4, 2025</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Michael A. Beindorff</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">/s/&#160;&#160;&#160;&#160;Dayton Judd</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">September 4, 2025</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Dayton Judd</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">/s/&#160;&#160;&#160;&#160;Cynthia Latham</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">September 4, 2025</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Cynthia Latham</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">/s/&#160;&#160;&#160;&#160;Darwin K. Lewis</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">September 4, 2025</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Darwin K. Lewis</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">/s/&#160;&#160;&#160;&#160;Garry Mauro</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">September 4, 2025</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Garry Mauro</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr></table></div><div style="margin-bottom:8pt;margin-top:3pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">62</span></div></div></div><div id="i7a9d1ca723db478892511ede354648f3_310"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">LIFEVANTAGE CORPORATION</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Index to Consolidated Financial Statements</span></div><div style="margin-bottom:8pt;margin-top:13pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:87.186%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.756%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.758%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7a9d1ca723db478892511ede354648f3_313">Report</a><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7a9d1ca723db478892511ede354648f3_313">s</a><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7a9d1ca723db478892511ede354648f3_313"> of Independent Registered Public Accounting Firm (Deloitte &amp; Touche, LLP, Salt Lake City, UT, Auditor Firm ID: </a></span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:AuditorFirmId" id="f-63">34</ix:nonNumeric></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7a9d1ca723db478892511ede354648f3_313">64</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7a9d1ca723db478892511ede354648f3_316">Consolidated Financial Statements:</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7a9d1ca723db478892511ede354648f3_316">Consolidated Balance Sheets</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7a9d1ca723db478892511ede354648f3_316">66</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7a9d1ca723db478892511ede354648f3_319">Consolidated Statements of Operations and Comprehensive Income</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7a9d1ca723db478892511ede354648f3_319">67</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7a9d1ca723db478892511ede354648f3_322">Consolidated Statements of Stockholders&#8217; Equity</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7a9d1ca723db478892511ede354648f3_322">68</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7a9d1ca723db478892511ede354648f3_325">Consolidated Statements of Cash Flows</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7a9d1ca723db478892511ede354648f3_325">69</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7a9d1ca723db478892511ede354648f3_331">Notes to Consolidated Financial Statements</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7a9d1ca723db478892511ede354648f3_331">71</a></span></div></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">63</span></div></div></div><div id="i7a9d1ca723db478892511ede354648f3_313"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">To the stockholders and the Board of Directors of LifeVantage Corporation</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Opinions on the Financial Statements and Internal Control over Financial Reporting</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We have audited the accompanying consolidated balance sheets of LifeVantage Corporation and subsidiaries (the &#8220;Company&#8221;) as of June 30, 2025 and 2024, the related consolidated statements of operations and comprehensive income, stockholders&#8217; equity, and cash flows, for each of the two years in the period ended June 30, 2025, and the related notes (collectively referred to as the &#8220;financial statements&#8221;). We also have audited the Company&#8217;s internal control over financial reporting as of June 30, 2025, based on criteria established in </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Internal Control &#8212; Integrated Framework (2013)</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO).</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In our opinion, the financial statements referred to above present fairly, in all material respects, the financial position of the Company as of June 30, 2025 and 2024, and the results of its operations and its cash flows for each of the two years in the period ended June 30, 2025, in conformity with accounting principles generally accepted in the United States of America. Also, in our opinion, the Company maintained, in all material respects, effective internal control over financial reporting as of June 30, 2025, based on criteria established in </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Internal Control &#8212; Integrated Framework (2013)</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> issued by COSO.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Basis for Opinions</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s management is responsible for these financial statements, for maintaining effective internal control over financial reporting, and for its assessment of the effectiveness of internal control over financial reporting, included in the accompanying financial statements. Our responsibility is to express an opinion on these financial statements and an opinion on the Company&#8217;s internal control over financial reporting based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audits to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud, and whether effective internal control over financial reporting was maintained in all material respects.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Our audits of the financial statements included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures to respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. Our audit of internal control over financial reporting included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, and testing and evaluating the design and operating effectiveness of internal control based on the assessed risk. Our audits also included performing such other procedures as we considered necessary in the circumstances. We believe that our audits provide a reasonable basis for our opinions.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Definition and Limitations of Internal Control over Financial Reporting</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">A company&#8217;s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company&#8217;s internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company&#8217;s assets that could have a material effect on the financial statements.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Critical Audit Matter</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The critical audit matter communicated below is a matter arising from the current-period audit of the financial statements that was communicated or required to be communicated to the audit committee and that (1) relates to accounts or disclosures that </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">64</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">are material to the financial statements and (2) involved our especially challenging, subjective, or complex judgments. The communication of critical audit matters does not alter in any way our opinion on the financial statements, taken as a whole, and we are not, by communicating the critical audit matter below, providing a separate opinion on the critical audit matter or on the accounts or disclosures to which it relates.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Income Tax Expense-US Jurisdiction &#8211; Refer to Notes 2 and 11 to the financial statements</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Critical Audit Matter Description</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Company operates and is subject to income taxes in the United States (&#8220;U.S.&#8221;) and numerous foreign jurisdictions with complex tax laws and regulations.  The complexity of the Company&#8217;s global structure requires specialized knowledge, skills and judgment in determining the application of tax laws in various jurisdictions.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We identified income tax expense for the U.S. jurisdiction as a critical audit matter because of the complexity the application of tax laws in the U.S. jurisdiction. This required an increased extent of effort, including the need to involve our income tax specialists to evaluate the Company&#8217;s U.S income tax expense, especially the interpretation and application of tax laws in the U.S.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">How the Critical Audit Matter Was Addressed in the Audit</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Our audit procedures related to the calculation of U.S income tax expense, including the interpretation and application of tax laws in the U.S. included the following:</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Tested the effectiveness of controls over the calculation of the income tax expense, including management&#8217;s controls over the application of tax laws in the U.S. </span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Obtained an understanding of the Company&#8217;s overall legal entity structure by reading and evaluating the Company&#8217;s organizational charts and associated documentation, including legal documents.</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Evaluated the Company's U.S. income tax expense calculation, including: (1) testing the appropriateness of income tax rates applied by agreeing to applicable Federal and state tax laws, (2) testing the accuracy of income allocations and apportionment among the Federal and state taxing jurisdictions based on the Company's structure, (3) testing, on a sample basis, the completeness and accuracy of book to tax differences, and (4) testing the mathematical accuracy of the income tax expense calculation.  </span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">With the assistance of our income tax specialists, we evaluated management's application of relevant tax laws to its legal entity structure and the effect on the Company's U.S. income tax expense, including the Company's calculations of current period income tax expense, by examining and evaluating management's income tax calculations and assessing the Company's compliance with tax laws.</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">With the assistance of our income tax specialists, we evaluated management&#8217;s consideration of tax requirements in the </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">U.S. tax jurisdiction in which the Company operates.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span><br/></span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">/s/<ix:nonNumeric contextRef="c-1" name="dei:AuditorName" id="f-64">Deloitte &amp; Touche LLP</ix:nonNumeric></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:AuditorLocation" id="f-65">Salt Lake City, Utah</ix:nonNumeric></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">September&#160;4, 2025</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We have served as the Company's auditor since 2023.</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">65</span></div></div></div><div id="i7a9d1ca723db478892511ede354648f3_316"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">LIFEVANTAGE CORPORATION AND SUBSIDIARIES</span></div><div style="margin-bottom:8pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">CONSOLIDATED BALANCE SHEETS</span></div><div style="margin-bottom:8pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:62.150%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.908%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.910%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(In thousands, except per share data)</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">ASSETS</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="f-66">20,201</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="f-67">16,886</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:AccountsReceivableNetCurrent" format="ixt:num-dot-decimal" scale="3" id="f-68">3,294</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:AccountsReceivableNetCurrent" format="ixt:num-dot-decimal" scale="3" id="f-69">2,949</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Income tax receivable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:IncomeTaxesReceivable" scale="3" id="f-70">635</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:IncomeTaxesReceivable" scale="3" id="f-71">313</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Inventory</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="3" id="f-72">20,669</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="3" id="f-73">15,055</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="f-74">6,095</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="f-75">2,443</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total current assets</span></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="f-76">50,894</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="f-77">37,646</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="f-78">6,207</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="f-79">7,813</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Right-of-use assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="f-80">8,041</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="f-81">9,569</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="3" id="f-82">245</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="3" id="f-83">323</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income tax asset</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:DeferredIncomeTaxAssetsNet" format="ixt:num-dot-decimal" scale="3" id="f-84">5,970</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:DeferredIncomeTaxAssetsNet" format="ixt:num-dot-decimal" scale="3" id="f-85">4,268</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:OtherAssetsNoncurrent" scale="3" id="f-86">601</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:OtherAssetsNoncurrent" scale="3" id="f-87">680</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">TOTAL ASSETS</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="f-88">71,958</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="f-89">60,299</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">LIABILITIES AND STOCKHOLDERS&#8217; EQUITY</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Current liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:AccountsPayableCurrent" format="ixt:num-dot-decimal" scale="3" id="f-90">4,600</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:AccountsPayableCurrent" format="ixt:num-dot-decimal" scale="3" id="f-91">5,853</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Commissions payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:AccruedSalesCommissionCurrent" format="ixt:num-dot-decimal" scale="3" id="f-92">7,237</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:AccruedSalesCommissionCurrent" format="ixt:num-dot-decimal" scale="3" id="f-93">6,569</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Income tax payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:AccruedIncomeTaxesCurrent" format="ixt:fixed-zero" scale="3" id="f-94">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:AccruedIncomeTaxesCurrent" scale="3" id="f-95">202</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:OperatingLeaseLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="f-96">1,867</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:OperatingLeaseLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="f-97">1,811</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Other accrued expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:AccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-98">13,513</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:AccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-99">7,874</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total current liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-100">27,217</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-101">22,309</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Long-term lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-102">9,811</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-103">11,801</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:OtherLiabilitiesNoncurrent" scale="3" id="f-104">289</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:OtherLiabilitiesNoncurrent" scale="3" id="f-105">198</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="3" id="f-106">37,317</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="3" id="f-107">34,308</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Commitments and contingencies &#8212; Note 14</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="c-6" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="f-108"></ix:nonFraction></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="c-7" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="f-109"></ix:nonFraction></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Stockholders&#8217; equity</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:27pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Preferred stock &#8212; par value $<ix:nonFraction unitRef="usdPerShare" contextRef="c-7" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="f-110"><ix:nonFraction unitRef="usdPerShare" contextRef="c-6" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="f-111">0.0001</ix:nonFraction></ix:nonFraction> per share, <ix:nonFraction unitRef="shares" contextRef="c-7" decimals="INF" name="us-gaap:PreferredStockSharesAuthorized" format="ixt:num-dot-decimal" scale="3" id="f-112"><ix:nonFraction unitRef="shares" contextRef="c-6" decimals="INF" name="us-gaap:PreferredStockSharesAuthorized" format="ixt:num-dot-decimal" scale="3" id="f-113">5,000</ix:nonFraction></ix:nonFraction> shares authorized, <ix:nonFraction unitRef="shares" contextRef="c-7" decimals="INF" name="us-gaap:PreferredStockSharesOutstanding" format="ixt:fixed-zero" scale="3" id="f-114"><ix:nonFraction unitRef="shares" contextRef="c-6" decimals="INF" name="us-gaap:PreferredStockSharesIssued" format="ixt:fixed-zero" scale="3" id="f-115"><ix:nonFraction unitRef="shares" contextRef="c-7" decimals="INF" name="us-gaap:PreferredStockSharesIssued" format="ixt:fixed-zero" scale="3" id="f-116"><ix:nonFraction unitRef="shares" contextRef="c-6" decimals="INF" name="us-gaap:PreferredStockSharesOutstanding" format="ixt:fixed-zero" scale="3" id="f-117">no</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction> shares issued or outstanding</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:PreferredStockValue" format="ixt:fixed-zero" scale="3" id="f-118">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:PreferredStockValue" format="ixt:fixed-zero" scale="3" id="f-119">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:27pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Common stock &#8212; par value $<ix:nonFraction unitRef="usdPerShare" contextRef="c-7" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="f-120"><ix:nonFraction unitRef="usdPerShare" contextRef="c-6" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="f-121">0.0001</ix:nonFraction></ix:nonFraction> per share, <ix:nonFraction unitRef="shares" contextRef="c-7" decimals="INF" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="3" id="f-122"><ix:nonFraction unitRef="shares" contextRef="c-6" decimals="INF" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="3" id="f-123">40,000</ix:nonFraction></ix:nonFraction> shares authorized and <ix:nonFraction unitRef="shares" contextRef="c-6" decimals="INF" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="3" id="f-124"><ix:nonFraction unitRef="shares" contextRef="c-6" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="f-125">12,429</ix:nonFraction></ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="c-7" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="f-126"><ix:nonFraction unitRef="shares" contextRef="c-7" decimals="INF" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="3" id="f-127">12,510</ix:nonFraction></ix:nonFraction> issued and outstanding as of June&#160;30, 2025 and 2024, respectively</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:CommonStockValue" scale="3" id="f-128">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:CommonStockValue" scale="3" id="f-129">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Additional paid-in capital</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:AdditionalPaidInCapitalCommonStock" format="ixt:num-dot-decimal" scale="3" id="f-130">139,962</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:AdditionalPaidInCapitalCommonStock" format="ixt:num-dot-decimal" scale="3" id="f-131">136,644</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated deficit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" sign="-" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="3" id="f-132">104,147</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" sign="-" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="3" id="f-133">108,738</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated other comprehensive loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="f-134">1,175</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="f-135">1,916</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total stockholders&#8217; equity</span></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-136">34,641</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-137">25,991</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">TOTAL LIABILITIES AND STOCKHOLDERS&#8217; EQUITY</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-138">71,958</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-139">60,299</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:8pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these consolidated financial statements.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">66</span></div></div></div><div id="i7a9d1ca723db478892511ede354648f3_319"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">LIFEVANTAGE CORPORATION AND SUBSIDIARIES</span></div><div style="margin-bottom:8pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME</span></div><div style="margin-bottom:8pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:62.150%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.908%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.910%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">For the years ended June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(In thousands, except per share data)</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:f-140"><span style="-sec-ix-hidden:f-141">Revenue, net</span></span></span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-142">228,530</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-143">200,164</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Cost of sales</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="3" id="f-144">44,864</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-3" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="3" id="f-145">41,440</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Gross profit</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:GrossProfit" format="ixt:num-dot-decimal" scale="3" id="f-146">183,666</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-3" name="us-gaap:GrossProfit" format="ixt:num-dot-decimal" scale="3" id="f-147">158,724</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Operating expenses:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Commissions and incentives</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="lfvn:CommissionAndIncentives" format="ixt:num-dot-decimal" scale="3" id="f-148">102,260</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-3" name="lfvn:CommissionAndIncentives" format="ixt:num-dot-decimal" scale="3" id="f-149">85,920</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="f-150">69,207</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-3" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="f-151">68,472</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total operating expenses</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:OperatingExpenses" format="ixt:num-dot-decimal" scale="3" id="f-152">171,467</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-3" name="us-gaap:OperatingExpenses" format="ixt:num-dot-decimal" scale="3" id="f-153">154,392</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Operating income</span></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-154">12,199</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-155">4,332</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Other income (expense):</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Interest income, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:InterestRevenueExpenseNet" scale="3" id="f-156">431</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-3" name="us-gaap:InterestRevenueExpenseNet" scale="3" id="f-157">430</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Other expense, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="f-158">387</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-3" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="f-159">412</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total other income, net</span></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:NonoperatingIncomeExpense" scale="3" id="f-160">44</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-3" name="us-gaap:NonoperatingIncomeExpense" scale="3" id="f-161">18</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Income before income taxes</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-162">12,243</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-163">4,350</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Income tax expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="f-164">2,438</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="f-165">1,413</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-166">9,805</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-167">2,937</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Net income per share:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-168">0.80</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-8" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-169">0.24</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-170">0.75</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-8" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-171">0.23</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average shares outstanding:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-1" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="f-172">12,251</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-8" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="f-173">12,458</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-1" decimals="-3" name="us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment" format="ixt:num-dot-decimal" scale="3" id="f-174">12,987</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-8" decimals="-3" name="us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment" format="ixt:num-dot-decimal" scale="3" id="f-175">12,986</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss), net of tax:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation adjustment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="3" id="f-176">741</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="3" id="f-177">555</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss), net of tax:</span></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="3" id="f-178">741</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="3" id="f-179">555</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Comprehensive income</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-180">10,546</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-3" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-181">2,382</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:8pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these consolidated financial statements.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">67</span></div></div></div><div id="i7a9d1ca723db478892511ede354648f3_322"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">LIFEVANTAGE CORPORATION AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">CONSOLIDATED STATEMENTS OF STOCKHOLDERS&#8217; EQUITY</span></div><div style="margin-bottom:8pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">For the years ended June&#160;30, 2025 and 2024 </span></div><div style="margin-bottom:8pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"><tr><td style="width:1.0%"/><td style="width:32.626%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.062%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.062%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.062%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.062%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.682%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.064%"/><td style="width:0.1%"/></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Common Stock</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Additional<br/>Paid-In&#160;Capital</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Deficit</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Other<br/>Comprehensive<br/>Income (Loss)</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr style="height:24pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In thousands)</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:100%">Balances, June 30, 2023</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-9" decimals="-3" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="f-182">12,622</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="f-183">1</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-184">134,314</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-185">98,305</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-186">1,361</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-187">34,649</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="f-188">3,280</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="f-189">3,280</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">Common stock issued under employee stock purchase plan</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-15" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" scale="3" id="f-190">64</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="3" id="f-191">271</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="3" id="f-192">271</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">Common stock issued under equity award plans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-15" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" format="ixt:num-dot-decimal" scale="3" id="f-193">1,007</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">Shares canceled or surrendered as payment of tax withholding and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="c-15" decimals="-3" name="us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation" scale="3" id="f-194">206</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-3" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="f-195">1,221</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-3" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="f-196">1,221</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">Repurchase of company stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="c-15" decimals="-3" name="us-gaap:StockRepurchasedDuringPeriodShares" scale="3" id="f-197">977</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-16" decimals="-3" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodValue" format="ixt:num-dot-decimal" scale="3" id="f-198">6,430</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-3" name="us-gaap:StockRepurchasedDuringPeriodValue" format="ixt:num-dot-decimal" scale="3" id="f-199">6,430</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">Cash dividends</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-16" decimals="-3" name="us-gaap:DividendsCash" format="ixt:num-dot-decimal" scale="3" id="f-200">6,940</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-3" name="us-gaap:DividendsCash" format="ixt:num-dot-decimal" scale="3" id="f-201">6,940</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency translation adjustment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-17" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="3" id="f-202">555</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="3" id="f-203">555</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-16" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-204">2,937</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-205">2,937</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:100%">Balances, June 30, 2024</span></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-18" decimals="-3" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="f-206">12,510</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-18" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="f-207">1</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-19" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-208">136,644</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-209">108,738</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-21" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-210">1,916</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-211">25,991</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-22" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="f-212">5,702</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="f-213">5,702</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">Common stock issued under employee stock purchase plan</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-23" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" scale="3" id="f-214">44</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-22" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="3" id="f-215">280</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="3" id="f-216">280</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">Common stock issued under equity award plans</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-23" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" scale="3" id="f-217">376</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">Shares canceled or surrendered as payment of tax withholding and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="c-23" decimals="-3" name="us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation" scale="3" id="f-218">202</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-22" decimals="-3" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="f-219">2,664</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="f-220">2,664</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">Repurchase of company stock</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="c-23" decimals="-3" name="us-gaap:StockRepurchasedDuringPeriodShares" scale="3" id="f-221">299</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-24" decimals="-3" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodValue" format="ixt:num-dot-decimal" scale="3" id="f-222">3,147</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:StockRepurchasedDuringPeriodValue" format="ixt:num-dot-decimal" scale="3" id="f-223">3,147</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">Cash dividends</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-24" decimals="-3" name="us-gaap:DividendsCash" format="ixt:num-dot-decimal" scale="3" id="f-224">2,067</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:DividendsCash" format="ixt:num-dot-decimal" scale="3" id="f-225">2,067</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency translation adjustment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-25" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="3" id="f-226">741</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="3" id="f-227">741</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-24" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-228">9,805</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-229">9,805</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:100%">Balances, June 30, 2025</span></td><td colspan="2" style="border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-26" decimals="-3" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="f-230">12,429</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-26" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="f-231">1</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-232">139,962</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-28" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-233">104,147</ix:nonFraction>)</span></td><td style="border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-29" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-234">1,175</ix:nonFraction>)</span></td><td style="border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-235">34,641</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:8pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these consolidated financial statements.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">68</span></div></div></div><div id="i7a9d1ca723db478892511ede354648f3_325"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">LIFEVANTAGE CORPORATION AND SUBSIDIARIES</span></div><div style="margin-bottom:8pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">CONSOLIDATED STATEMENTS OF CASH FLOWS</span></div><div style="margin-bottom:8pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:62.336%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.961%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.669%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">For the years ended June&#160;30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In thousands)</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9.5pt;font-weight:700;line-height:100%">Cash Flows from Operating Activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9.5pt;font-weight:400;line-height:100%">Net income</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-236">9,805</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-237">2,937</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9.5pt;font-weight:400;line-height:100%">Adjustments to reconcile net income to net cash provided by operating activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9.5pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="3" id="f-238">3,156</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-3" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="3" id="f-239">3,581</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9.5pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="f-240">5,702</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="f-241">3,280</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9.5pt;font-weight:400;line-height:100%">Non-cash operating lease expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense" format="ixt:num-dot-decimal" scale="3" id="f-242">1,440</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense" format="ixt:num-dot-decimal" scale="3" id="f-243">1,287</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9.5pt;font-weight:400;line-height:100%">(Gain) loss on disposal of fixed assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:GainLossOnSaleOfPropertyPlantEquipment" scale="3" id="f-244">4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-3" sign="-" name="us-gaap:GainLossOnSaleOfPropertyPlantEquipment" scale="3" id="f-245">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9.5pt;font-weight:400;line-height:100%">Amortization of deferred financing fees</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:AmortizationOfFinancingCosts" scale="3" id="f-246">32</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-3" name="us-gaap:AmortizationOfFinancingCosts" scale="3" id="f-247">7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9.5pt;font-weight:400;line-height:100%">Deferred income tax </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:DeferredIncomeTaxesAndTaxCredits" format="ixt:num-dot-decimal" scale="3" id="f-248">1,703</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-3" sign="-" name="us-gaap:DeferredIncomeTaxesAndTaxCredits" format="ixt:num-dot-decimal" scale="3" id="f-249">1,277</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9.5pt;font-weight:400;line-height:100%">Changes in operating assets and liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9.5pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:IncreaseDecreaseInAccountsReceivable" scale="3" id="f-250">242</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-3" name="us-gaap:IncreaseDecreaseInAccountsReceivable" format="ixt:num-dot-decimal" scale="3" id="f-251">1,424</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9.5pt;font-weight:400;line-height:100%">Income tax receivable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:IncreaseDecreaseInIncomeTaxesReceivable" scale="3" id="f-252">322</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-3" name="us-gaap:IncreaseDecreaseInIncomeTaxesReceivable" scale="3" id="f-253">71</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9.5pt;font-weight:400;line-height:100%">Inventory</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:IncreaseDecreaseInInventories" format="ixt:num-dot-decimal" scale="3" id="f-254">5,216</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInInventories" scale="3" id="f-255">662</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9.5pt;font-weight:400;line-height:100%">Prepaid expenses and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:IncreaseDecreaseInPrepaidExpense" format="ixt:num-dot-decimal" scale="3" id="f-256">3,603</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInPrepaidExpense" format="ixt:num-dot-decimal" scale="3" id="f-257">2,280</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9.5pt;font-weight:400;line-height:100%">Other long-term assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInOtherNoncurrentAssets" scale="3" id="f-258">72</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-3" name="us-gaap:IncreaseDecreaseInOtherNoncurrentAssets" scale="3" id="f-259">55</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9.5pt;font-weight:400;line-height:100%">Accounts payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInAccountsPayable" format="ixt:num-dot-decimal" scale="3" id="f-260">1,295</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-3" name="us-gaap:IncreaseDecreaseInAccountsPayable" format="ixt:num-dot-decimal" scale="3" id="f-261">2,301</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9.5pt;font-weight:400;line-height:100%">Income tax payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable" scale="3" id="f-262">201</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-3" name="us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable" scale="3" id="f-263">202</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9.5pt;font-weight:400;line-height:100%">Other accrued expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:IncreaseDecreaseInAccruedLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-264">6,037</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInAccruedLiabilities" scale="3" id="f-265">176</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9.5pt;font-weight:400;line-height:100%">Lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInOperatingLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="f-266">1,843</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInOperatingLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="f-267">1,586</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9.5pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities" scale="3" id="f-268">63</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-3" name="us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities" scale="3" id="f-269">247</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9.5pt;font-weight:700;line-height:100%">Net Cash Provided by Operating Activities</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9.5pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="3" id="f-270">11,878</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9.5pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-3" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="3" id="f-271">12,197</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9.5pt;font-weight:700;line-height:100%">Cash Flows from Investing Activities:</span></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9.5pt;font-weight:400;line-height:100%">Purchase of equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="f-272">1,371</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-3" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="f-273">2,245</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9.5pt;font-weight:400;line-height:100%">Proceeds from sale of fixed assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment" scale="3" id="f-274">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-3" name="us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment" format="ixt:fixed-zero" scale="3" id="f-275">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9.5pt;font-weight:700;line-height:100%">Net Cash Used in Investing Activities</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9.5pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" format="ixt:num-dot-decimal" scale="3" id="f-276">1,367</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9.5pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" format="ixt:num-dot-decimal" scale="3" id="f-277">2,245</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9.5pt;font-weight:700;line-height:100%">Cash Flows from Financing Activities:</span></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9.5pt;font-weight:400;line-height:100%">Payment of deferred financing fees</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:PaymentsOfFinancingCosts" format="ixt:fixed-zero" scale="3" id="f-278">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-3" name="us-gaap:PaymentsOfFinancingCosts" scale="3" id="f-279">97</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9.5pt;font-weight:400;line-height:100%">Repurchase of company stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:PaymentsForRepurchaseOfCommonStock" format="ixt:num-dot-decimal" scale="3" id="f-280">3,147</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-3" name="us-gaap:PaymentsForRepurchaseOfCommonStock" format="ixt:num-dot-decimal" scale="3" id="f-281">6,430</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9.5pt;font-weight:400;line-height:100%">Payment of cash dividends</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:PaymentsOfDividends" format="ixt:num-dot-decimal" scale="3" id="f-282">2,067</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-3" name="us-gaap:PaymentsOfDividends" format="ixt:num-dot-decimal" scale="3" id="f-283">6,940</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9.5pt;font-weight:400;line-height:100%">Shares purchased as payment of tax withholding and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="f-284">2,664</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-3" name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="f-285">1,221</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9.5pt;font-weight:400;line-height:100%">Proceeds from common stock issued under employee stock purchase plan</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="lfvn:ProceedsFromIssuanceOfCommonStockUnderEmployeeStockPurchasePlan" scale="3" id="f-286">280</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-3" name="lfvn:ProceedsFromIssuanceOfCommonStockUnderEmployeeStockPurchasePlan" scale="3" id="f-287">271</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9.5pt;font-weight:700;line-height:100%">Net Cash Used in Financing Activities</span></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9.5pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="f-288">7,598</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9.5pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="f-289">14,417</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9.5pt;font-weight:700;line-height:100%">Foreign Currency Effect on Cash</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="f-290">402</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-3" sign="-" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="f-291">254</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9.5pt;font-weight:700;line-height:100%">Increase (Decrease) in Cash and Cash Equivalents</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9.5pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" format="ixt:num-dot-decimal" scale="3" id="f-292">3,315</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9.5pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-3" sign="-" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" format="ixt:num-dot-decimal" scale="3" id="f-293">4,719</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9.5pt;font-weight:400;line-height:100%">Cash and Cash Equivalents &#8212; beginning of period</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="f-294">16,886</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="f-295">21,605</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9.5pt;font-weight:700;line-height:100%">Cash and Cash Equivalents &#8212; end of period</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9.5pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9.5pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="f-296">20,201</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9.5pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9.5pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="f-297">16,886</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:8pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these consolidated financial statements.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">69</span></div></div></div><div id="i7a9d1ca723db478892511ede354648f3_328"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">LIFEVANTAGE CORPORATION AND SUBSIDIARIES</span></div><div style="margin-bottom:8pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">CONSOLIDATED STATEMENTS OF CASH FLOWS (CONTINUED)</span></div><div style="margin-bottom:8pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:62.150%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.908%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.910%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">For the years ended June&#160;30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In thousands)</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9.5pt;font-weight:700;line-height:100%">SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid for interest</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:InterestPaidNet" scale="3" id="f-298">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-3" name="us-gaap:InterestPaidNet" scale="3" id="f-299">21</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid for income taxes</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:IncomeTaxesPaid" format="ixt:num-dot-decimal" scale="3" id="f-300">4,918</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-3" name="us-gaap:IncomeTaxesPaid" format="ixt:num-dot-decimal" scale="3" id="f-301">2,306</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:8pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these consolidated financial statements.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">70</span></div></div></div><div id="i7a9d1ca723db478892511ede354648f3_331"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:8pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">LIFEVANTAGE CORPORATION AND SUBSIDIARIES</span></div><div style="margin-bottom:8pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></div><div style="margin-bottom:8pt;text-align:center"><span><br/></span></div><div id="i7a9d1ca723db478892511ede354648f3_334"></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Note 1 &#8212; <ix:nonNumeric contextRef="c-1" name="us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" id="f-302" continuedAt="f-302-1" escape="true">The Company</ix:nonNumeric></span></div><ix:continuation id="f-302-1" continuedAt="f-302-2"><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">LifeVantage Corporation (the &#8220;Company&#8221; or &#8220;we&#8221; or &#8220;our&#8221; or &#8220;us&#8221;) is a company focused on nutrigenomics, the study of how nutrition and naturally occurring compounds affect human genes to support good health. The Company is dedicated to helping people achieve their health, wellness, and financial goals. The Company provides quality, scientifically validated products to customers and independent consultants as well as a financially rewarding commission-based direct sales opportunity to its independent consultants. LifeVantage sells its products in the United States, Mexico, Japan, Australia, Hong Kong, Canada, Thailand, the United Kingdom, the Netherlands, Germany, Taiwan, Austria, Spain, Ireland, Belgium, New Zealand, and Singapore.  On June 30, 2025, the Company ceased operations in the Philippines and closed that marke</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">t.</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Company engages in the identification, research, development, formulation and sale of advanced nutrigenomic activators, dietary supplements, weight management products, pre- and pro-biotics, skin and hair care products and nootropics. The Company&#8217;s line of scientifically validated dietary supplements includes its flagship Protandim</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174; </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">family of products, its LifeVantage</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> line of dietary supplements that include the MindBody GLP-1 System</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#8482;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">,</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">  </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Omega+, ProBio, IC Bright</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">, the Rise AM &amp; Reset PM System</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">, D3+, and Daily Wellness, and PhysIQ</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#8482;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> Fat Burn and Prebiotic dietary supplements. TrueScience</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174; </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">is the Company&#8217;s line of skin and hair care products and Liquid Collagen. The Company also markets and sells Petandim</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">, its companion pet supplement formulated to combat oxidative stress in dogs; and AXIO</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">, its nootropic energy drink mixes.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Company was incorporated in Colorado in June 1988 under the name Andraplex Corporation. The Company changed its corporate name to Yaak River Resources, Inc. in January 1992, and subsequently changed it again in October 2004 to Lifeline Therapeutics, Inc. In October 2004 and March 2005, the Company acquired all of the outstanding common stock of Lifeline Nutraceuticals Corporation. In November 2006, the Company changed its name to LifeVantage Corporation.</span></div></ix:continuation><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="f-302-2">In March 2018, the Company reincorporated from the state of Colorado to the state of Delaware. All outstanding shares of common stock, options and share units of the Colorado corporation were converted into an equivalent share, option or share unit of the Delaware corporation and the par value of the Company&#8217;s common stock was adjusted to $<ix:nonFraction unitRef="usdPerShare" contextRef="c-30" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="f-303">0.0001</ix:nonFraction>.</ix:continuation> </span></div><div id="i7a9d1ca723db478892511ede354648f3_337"></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Note 2 &#8212; <ix:nonNumeric contextRef="c-1" name="us-gaap:SignificantAccountingPoliciesTextBlock" id="f-304" continuedAt="f-304-1" escape="true">Summary of Significant Accounting Policies</ix:nonNumeric></span></div><ix:continuation id="f-304-1" continuedAt="f-304-2"><ix:nonNumeric contextRef="c-1" name="us-gaap:ConsolidationPolicyTextBlock" id="f-305" continuedAt="f-305-1" escape="true"><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Consolidation</span></div></ix:nonNumeric><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="f-305-1">The consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries. All significant intercompany accounts and transactions are eliminated in consolidation.</ix:continuation> </span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:UseOfEstimates" id="f-306" escape="true"><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Company prepares the consolidated financial statements and related disclosures in conformity with accounting principles generally accepted in the United States of America (&#8220;GAAP&#8221;). In preparing these statements, the Company is required to use estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ materially from those estimates and assumptions. On an ongoing basis, the Company reviews its estimates, including, but not limited to, those related to inventory valuation and obsolescence, sales returns, income taxes and tax valuation reserves, transfer pricing methodology and positions, impairment of assets, stock-based compensation, and loss contingencies.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" id="f-307" escape="true"><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Foreign Currency Translation</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">A portion of the Company&#8217;s business operations occurs outside the United States.&#160;The local currency of each of the Company&#8217;s subsidiaries generally is its functional currency.&#160;All assets and liabilities are translated into U.S. Dollars at exchange rates existing at the balance sheet dates, revenue and expenses are translated at weighted-average exchange rates and stockholders&#8217; equity is recorded at historical exchange rates.&#160;The resulting foreign currency translation adjustments are recorded as a separate component of stockholders&#8217; equity in the consolidated balance sheets and as a component of comprehensive income. Transaction gains and losses are included in other expense, net in the consolidated statements of operations and comprehensive income.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="us-gaap:FairValueOfFinancialInstrumentsPolicy" id="f-308" continuedAt="f-308-1" escape="true"><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Fair Value of Financial Instruments</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Company accounts for assets and liabilities using a hierarchy of valuation techniques based on whether the inputs to those valuation techniques are observable or unobservable. Observable inputs reflect market data obtained from independent </span></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">71</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="f-304-2" continuedAt="f-304-3"><ix:continuation id="f-308-1" continuedAt="f-308-2"><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">sources, while unobservable inputs reflect the Company&#8217;s market assumptions. These two types of inputs have created the fair-value hierarchy below. This hierarchy requires the Company to minimize the use of unobservable inputs and to use observable market data, if available, when determining fair value.</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 1&#8212;Quoted prices for identical instruments in active markets; </span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 2&#8212;Quoted prices for similar instruments in active markets, quoted prices for identical or similar instruments in markets that are not active, and model-derived valuations in which all significant inputs and significant value drivers are observable in active markets; and</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 3&#8212;Valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable.</span></div></ix:continuation><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="f-308-2">Our financial instruments, consisting primarily of cash and cash equivalents, accounts receivable, and accounts payable, approximate fair value due to their short-term nature.</ix:continuation> </span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:CashAndCashEquivalentsPolicyTextBlock" id="f-309" escape="true"><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Cash and Cash Equivalents</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Company considers only its monetary liquid assets with original maturities of three months or less to be cash equivalents.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="us-gaap:ReceivablesPolicyTextBlock" id="f-310" continuedAt="f-310-1" escape="true"><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Accounts Receivable</span></div></ix:nonNumeric><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="f-310-1">The Company&#8217;s accounts receivable for the fiscal years ended June&#160;30, 2025 and 2024 consist primarily of credit card receivables. Based on the Company&#8217;s verification process for customer credit cards and historical information available, management has determined that an allowance for doubtful accounts on credit card sales related to its customer sales as of June&#160;30, 2025 or 2024 is not necessary.</ix:continuation> There was </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="INF" name="us-gaap:ProvisionForDoubtfulAccounts" format="ixt:fixed-zero" scale="0" id="f-311"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="INF" name="us-gaap:ProvisionForDoubtfulAccounts" format="ixt:fixed-zero" scale="0" id="f-312">no</ix:nonFraction></ix:nonFraction> b</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">ad debt expense for the fiscal years ended June&#160;30, 2025 and 2024. </span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Inventory</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfInventoryCurrentTableTextBlock" id="f-313" continuedAt="f-313-1" escape="true"><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Inventory consisted of (in thousands):</span></div><div style="margin-bottom:8pt;margin-top:13pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:38.724%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.394%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.394%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.394%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.398%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="21" style="border-bottom:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">June&#160;30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="9" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:InventoryFinishedGoods" format="ixt:num-dot-decimal" scale="3" id="f-314">17,739</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-6" decimals="3" name="lfvn:InventoryFinishedGoodsPercentOfTotalInventory" scale="-2" id="f-315">85.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:InventoryFinishedGoods" format="ixt:num-dot-decimal" scale="3" id="f-316">11,841</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-7" decimals="3" name="lfvn:InventoryFinishedGoodsPercentOfTotalInventory" scale="-2" id="f-317">78.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:InventoryRawMaterials" format="ixt:num-dot-decimal" scale="3" id="f-318">2,930</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-6" decimals="3" name="lfvn:RawMaterialsPercentOfTotalInventory" scale="-2" id="f-319">14.2</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:InventoryRawMaterials" format="ixt:num-dot-decimal" scale="3" id="f-320">3,214</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-7" decimals="3" name="lfvn:RawMaterialsPercentOfTotalInventory" scale="-2" id="f-321">21.3</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total inventory</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="3" id="f-322">20,669</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-6" decimals="INF" name="lfvn:InventoryPercentOfTotalInventory" scale="-2" id="f-323">100.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="3" id="f-324">15,055</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-7" decimals="INF" name="lfvn:InventoryPercentOfTotalInventory" scale="-2" id="f-325">100.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="us-gaap:InventoryPolicyTextBlock" id="f-326" escape="true">Inventories are carried at the lower of cost or net realizable value, using the first-in, first-out method</ix:nonNumeric>, which includes a reduction in inventory values of </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">$<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:InventoryAdjustments" scale="6" id="f-327">0.5</ix:nonFraction> million</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> and $<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:InventoryAdjustments" scale="6" id="f-328">1.3</ix:nonFraction> million at June&#160;30, 2025 and 2024, respectively, related to obsolete and slow-moving inventory. </span></div><ix:continuation id="f-313-1"><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Reserves of inventories consist of the following (in thousands):</span></div><div style="margin-bottom:8pt;margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:62.150%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.908%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.910%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Years ended June&#160;30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Beginning balance</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" name="us-gaap:ValuationAllowancesAndReservesBalance" format="ixt:num-dot-decimal" scale="3" id="f-329">1,301</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-32" decimals="-3" name="us-gaap:ValuationAllowancesAndReservesBalance" format="ixt:num-dot-decimal" scale="3" id="f-330">1,292</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Additions</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-33" decimals="-3" name="us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense" scale="3" id="f-331">214</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-34" decimals="-3" name="us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense" scale="3" id="f-332">901</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Write-offs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-33" decimals="-3" name="us-gaap:ValuationAllowancesAndReservesDeductions" format="ixt:num-dot-decimal" scale="3" id="f-333">1,049</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-34" decimals="-3" name="us-gaap:ValuationAllowancesAndReservesDeductions" scale="3" id="f-334">892</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Ending balance</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-35" decimals="-3" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="3" id="f-335">466</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" name="us-gaap:ValuationAllowancesAndReservesBalance" format="ixt:num-dot-decimal" scale="3" id="f-336">1,301</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div></ix:continuation><ix:nonNumeric contextRef="c-1" name="us-gaap:PropertyPlantAndEquipmentPolicyTextBlock" id="f-337" continuedAt="f-337-1" escape="true"><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Property and Equipment</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:PropertyPlantAndEquipmentTextBlock" id="f-338" continuedAt="f-338-1" escape="true"><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment are recorded at cost and depreciated using the straight-line method over the following useful lives:</span></div><div style="margin-bottom:8pt;margin-top:13pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:80.891%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.909%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Years</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Equipment (includes computer hardware and software)</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-36" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="f-339">3</ix:nonNumeric> - <ix:nonNumeric contextRef="c-37" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="f-340">5</ix:nonNumeric></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Furniture and fixtures</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-38" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="f-341">5</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Vehicles</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-39" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="f-342">5</ix:nonNumeric></span></td></tr></table></div></ix:nonNumeric></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">72</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="f-304-3" continuedAt="f-304-4"><ix:continuation id="f-337-1"><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Leasehold improvements are depreciated over the shorter of estimated useful life of the related asset or the lease term.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The cost of normal maintenance and repairs is charged to expense as incurred. When an asset is sold or otherwise disposed of, the cost and associated accumulated depreciation are removed from the accounts and the resulting gain or loss is recognized in the consolidated statements of operations and comprehensive income in other expense, net. Significant expenditures that increase the useful life of an asset are capitalized and depreciated over the estimated useful life of the asset. Property and equipment are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of such assets may not be recoverable.</span></div></ix:continuation><ix:nonNumeric contextRef="c-1" name="us-gaap:IntangibleAssetsFiniteLivedPolicy" id="f-343" continuedAt="f-343-1" escape="true"><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Intangible Assets</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Intangible assets are stated at cost less accumulated amortization. Finite-lived intangible assets are amortized over their related useful lives, using a straight-line method, consistent with the underlying expected future cash flows related to the specific intangible asset. Finite-lived intangible assets are reviewed for impairment whenever events or changes in circumstances exist that indicate the carrying amount of an asset may not be recoverable. When indicators of impairment exist, an estimate of undiscounted net cash flows is used in measuring whether the carrying amount of the asset or related asset group is recoverable. Measurement of the amount of impairment, if any, is based upon the difference between the asset&#8217;s carrying value and estimated fair value. </span></div></ix:nonNumeric><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="f-343-1">Indefinite-lived intangible assets are not amortized; however, they are tested at least annually for impairment or more frequently if events or changes in circumstances exist that may indicate impairment. An impairment loss is recognized if the carrying amount of the asset exceeds its fair value.</ix:continuation> Annual impairment tests on intangible assets were completed for the fiscal years ended June&#160;30, 2025 and 2024, resulting in <ix:nonFraction unitRef="usd" contextRef="c-8" decimals="INF" name="us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill" format="ixt:fixed-zero" scale="0" id="f-344"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="INF" name="us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill" format="ixt:fixed-zero" scale="0" id="f-345">no</ix:nonFraction></ix:nonFraction> impairment charges.</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" id="f-346" continuedAt="f-346-1" escape="true"><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Impairment of Long-Lived Assets</span></div></ix:nonNumeric><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="f-346-1">Pursuant to guidance established for impairment or disposal of assets, the Company assesses impairment whenever events or changes in circumstances indicate that the carrying amount of a long-lived asset may not be recoverable. When an assessment for impairment of long-lived assets, long-lived assets to be disposed of, and certain identifiable intangibles related to those assets is performed, the Company is required to compare the net carrying value of long-lived assets on the lowest level at which cash flows can be determined on a consistent basis to the related estimates of future undiscounted net cash flows for such assets. If the net carrying value exceeds the net cash flows, then an impairment is recognized to reduce the carrying value to the estimated fair value, generally equal to the future discounted net cash flow.</ix:continuation> For the fiscal years ended June&#160;30, 2025 and 2024, management has concluded that there are no indications of impairment.</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ConcentrationRiskCreditRisk" id="f-347" continuedAt="f-347-1" escape="true"><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Concentration of Credit Risk</span></div></ix:nonNumeric><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="f-347-1">Accounting guidance for financial instruments requires disclosure of significant concentrations of credit risk regardless of the degree of such risk. Financial instruments with significant credit risk include cash and cash equivalents.</ix:continuation> At June&#160;30, 2025, the Company</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> had $<ix:nonFraction unitRef="usd" contextRef="c-40" decimals="-5" name="us-gaap:ConcentrationRiskCreditRiskFinancialInstrumentMaximumExposure" scale="6" id="f-348">17.0</ix:nonFraction> million in cash and cash equivalent accounts at one financial institution and $<ix:nonFraction unitRef="usd" contextRef="c-41" decimals="-5" name="us-gaap:ConcentrationRiskCreditRiskFinancialInstrumentMaximumExposure" scale="6" id="f-349">3.2</ix:nonFraction> million i</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">n other financial institutions. As of June&#160;30, 2025 and 2024, and during the years then ended, the Company&#8217;s cash balances exceeded federally insured limits.</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:CommissionsExpensePolicyPolicyTextBlock" id="f-350" escape="true"><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Commissions and Incentives</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Commissions and incentives expenses are the Company&#8217;s most significant expenses and are classified as operating expenses. Commissions and incentives expenses include sales commissions paid to the Company&#8217;s independent consultants, special incentives, costs for incentive trips and other rewards. Commissions and incentives expenses do not include any amounts the Company pays to its independent consultants for personal purchases. Commissions paid to independent consultants on personal purchases are considered a sales discount and are reported as a reduction to net revenue.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="us-gaap:RevenueFromContractWithCustomerPolicyTextBlock" id="f-351" continuedAt="f-351-1" escape="true"><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Shipping and Handling</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Shipping and handling costs associated with inbound freight and freight out to customers, including independent consultants, are included in cost of sales. Shipping and handling fees charged to all customers are included in sales.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="us-gaap:ResearchAndDevelopmentExpensePolicy" id="f-352" continuedAt="f-352-1" escape="true"><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Research and Development Costs</span></div></ix:nonNumeric><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="f-352-1">The Company expenses all costs related to research and development activities as incurred.</ix:continuation> Research and development expenses for the fiscal years ended June&#160;30, 2025 and 2024 were </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">$<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:ResearchAndDevelopmentExpense" scale="6" id="f-353">1.4</ix:nonFraction> million and</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> $<ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-5" name="us-gaap:ResearchAndDevelopmentExpense" scale="6" id="f-354">0.7</ix:nonFraction> million, respectively.</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:LesseeLeasesPolicyTextBlock" id="f-355" continuedAt="f-355-1" escape="true"><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Leases</span></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">73</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="f-304-4" continuedAt="f-304-5"><ix:continuation id="f-355-1"><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Company accounts for leases in accordance with Accounting Standards Codification (&#8220;ASC&#8221;) 842. The Company reviews all contracts and determines if the arrangement is or contains a lease, at inception. Operating leases are included in right-of-use (&#8220;ROU&#8221;) assets, current lease liabilities and long-term lease liabilities on the consolidated balance sheets. The Company does <ix:nonFraction unitRef="lease" contextRef="c-1" decimals="INF" name="lfvn:NumberOfFinanceLeases" format="ixt:fixed-zero" scale="0" id="f-356">no</ix:nonFraction>t have any finance leases.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Operating lease ROU assets represent the Company&#8217;s right to use an underlying asset for the lease term and lease liabilities represent the Company&#8217;s obligation to make lease payments arising from the lease. ROU assets and lease liabilities are recognized at the lease commencement date based on the estimated present value of lease payments over the lease term. The Company uses its estimated incremental borrowing rate based on the information available at the commencement date in determining the present value of future payments. The operating lease ROU asset also includes any upfront lease payments made and excludes lease incentives and initial direct costs incurred. The Company&#8217;s lease terms may include options to extend or terminate the lease when it is reasonably certain that the Company will exercise that option. Lease expense for minimum lease payments is recognized on a straight-line basis over the lease term. Leases with a term of 12 months or less are not recorded on the balance sheet. The Company&#8217;s lease agreements do not contain any residual value guarantees.</span></div></ix:continuation><ix:nonNumeric contextRef="c-1" name="us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy" id="f-357" escape="true"><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Stock-Based Compensation</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognizes stock-based compensation by measuring the cost of services to be rendered based on the grant date fair value of the equity award. The Company recognizes stock-based compensation, net of any estimated forfeitures, over the period an employee is required to provide service in exchange for the award, generally referred to as the requisite service period. The Company estimates forfeitures based on historical information and other management assumptions. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Black-Scholes option pricing model is used to estimate the fair value of stock options and options under the Company&#8217;s 2019 Employee Stock Purchase Plan. The determination of the fair value of options is affected by the Company&#8217;s stock price and a number of assumptions, including expected volatility, expected life, risk-free interest rate and expected dividends. The Company uses historical data for estimating the expected volatility and expected life of stock options required in the Black-Scholes model. The risk-free interest rate assumption is based on observed interest rates appropriate for the expected terms of the stock options. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of restricted stock grants, including performance restricted stock units that include non-market based performance conditions, is based on the closing market price of the Company&#8217;s stock on the date of grant less the Company&#8217;s expected dividend yield. The Company recognizes compensation costs for awards with performance conditions when it concludes it is probable that the performance conditions will be achieved. The Company reassesses the probability of vesting at each balance sheet date and adjusts compensation costs accordingly.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="us-gaap:IncomeTaxPolicyTextBlock" id="f-358" escape="true"><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Income Taxes</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Income taxes are accounted for under the asset and liability method. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases and operating loss and tax credit carry forwards. Deferred tax assets and liabilities are measured using statutory tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled, updated as needed for changes in corporate tax rates. The effect on deferred tax assets and liabilities from a change in tax rates is recognized in income in the period that includes the effective date of the change. The Company recognizes tax liabilities or benefits from an uncertain position only if it is more likely than not that the position will be sustained upon examination by taxing authorities based on the technical merits of the issue. The amount recognized would be the largest liability or benefit that the Company believes has greater than a 50% likelihood of being realized upon settlement.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="us-gaap:EarningsPerSharePolicyTextBlock" id="f-359" escape="true"><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Income Per Share</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Basic income per common share is computed by dividing net income by the weighted-average number of common shares outstanding during the period, less unvested restricted stock awards. Diluted income per common share is computed by dividing net income by the weighted-average common shares and potentially dilutive common share equivalents using the treasury stock method.</span></div></ix:nonNumeric><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">For the fiscal years ended June&#160;30, 2025 and 2024, the effects of approximately <ix:nonFraction unitRef="shares" contextRef="c-1" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="f-360">30,000</ix:nonFraction></span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> and</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> <ix:nonFraction unitRef="shares" contextRef="c-8" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="f-361">13,000</ix:nonFraction> common shares, respectively, issuable upon exercise of options and non-vested shares of restricted stock, are not included in the computations as their effect was anti-dilutive.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">74</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="f-304-5"><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" id="f-362" escape="true"><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The following is a reconciliation of net income per share and the weighted-average common shares outstanding for purposes of computing basic and diluted net income per share (in thousands, except per share amounts):</span></div><div style="margin-bottom:8pt;margin-top:13pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:62.150%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.908%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.910%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Years ended June&#160;30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Numerator:</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-363">9,805</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-364">2,937</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Denominator:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Basic weighted-average common shares outstanding</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-1" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="f-365">12,251</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-8" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="f-366">12,458</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Effect of dilutive securities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Stock awards and options</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-1" decimals="-3" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="3" id="f-367">736</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-8" decimals="-3" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="3" id="f-368">528</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Diluted weighted-average common shares outstanding</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-1" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="f-369">12,987</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-8" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="f-370">12,986</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Net income per share, basic</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-371">0.80</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-8" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-372">0.24</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Net income per share, diluted</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-373">0.75</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-8" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-374">0.23</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div></ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock" id="f-375" escape="true"><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">New Accounting Pronouncements</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In November 2023, the Financial Accounting Standards Board (&#8220;FASB&#8221;) issued Accounting Standards Update (&#8220;ASU&#8221;) 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures (ASU 2023-07), expanding segment disclosure requirements. The amendments require enhanced disclosure for certain segment items and required disclosure on how management uses reported measures to assess segment performance. The amendments do not change how segments are determined, aggregated, or how thresholds are applied to determine reportable segments. ASU 2023-07 is effective for the Company&#8217;s annual periods beginning July 1, 2024, and for interim periods beginning July 1, 2025, with early adoption permitted. The Company adopted ASU 2023-07 for the fiscal year beginning July 1, 2024. See Note 13 for expanded segment disclosures.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In December 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures (&#8220;ASU 2023-09&#8221;). The guidance requires disclosure of disaggregated income taxes paid, prescribes standardized categories for the components of the effective tax rate reconciliation, and modifies other income tax-related disclosures. ASU 2023-09 is effective for the Company&#8217;s annual periods beginning July 1, 2025, with early adoption permitted. The Company is currently evaluating the potential effect that the updated standard will have on its financial statement disclosures.   </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In November 2024, the FASB issued ASU 2024-03, Income Statement&#8212;Reporting Comprehensive Income&#8212;Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses (&#8220;ASU 2024-03&#8221;). The guidance requires disclosure of specified information about certain costs and expenses at each interim and annual reporting period. ASU 2024-03 is effective for the Company&#8217;s annual periods beginning July 1, 2027, with early adoption permitted. The Company is currently evaluating the potential effect that the updated standard will have on its financial statement disclosures.   </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Other recently issued accounting pronouncements did not or are not believed by management to have a material impact on the Company&#8217;s present or future financial statements.</span></div></ix:nonNumeric></ix:continuation><div id="i7a9d1ca723db478892511ede354648f3_340"></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Note 3 &#8212; <ix:nonNumeric contextRef="c-1" name="us-gaap:RevenueFromContractWithCustomerTextBlock" id="f-376" continuedAt="f-376-1" escape="true"><ix:continuation id="f-351-1" continuedAt="f-351-2">Revenue</ix:continuation></ix:nonNumeric></span></div><ix:continuation id="f-376-1" continuedAt="f-376-2"><ix:continuation id="f-351-2" continuedAt="f-351-3"><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Revenue is recognized when control of the promised goods or services are transferred to the customer, in an amount that reflects the consideration the Company expects to be entitled to in exchange for those goods or services. Sales, value add, and other taxes the Company collects concurrent with revenue-producing activities are excluded from revenue.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Company generates the majority of its revenue through product sales to customers. These products include the Protandim</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174; </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">line of dietary supplements, the LifeVantage</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> line of dietary supplements that include the MindBody GLP-1 System</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#8482;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">, Omega+, ProBio, IC Bright</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">, the Rise AM &amp; Reset PM System</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">, D3+, and Daily Wellness, PhysIQ</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#8482;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> Fat Burn and Prebiotic dietary supplements, TrueScience</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> skin and hair care products and Liquid Collagen, Petandim</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">, our companion pet supplement formulated to combat oxidative stress in dogs, and AXIO</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#160;nootropic energy drink mixes. The Company ships most of its product directly to the consumer and receives substantially all payment for product sales in the form of credit card receipts. Revenue from direct product sales to customers is recognized upon shipment, which is when passage of title and risk of loss occurs. For items sold in packs and bundles, the Company determines the standalone selling price at contract inception for each distinct good and then allocates the transaction price on a relative standalone selling price basis. Any discounts are accounted for as a direct reduction to the transaction price. Shipping and handling revenue is recognized upon shipment when the performance obligation is completed.</span></div></ix:continuation></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">75</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="f-376-2"><ix:continuation id="f-351-3"><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Company also charges amounts to independent consultants to attend events that it holds. Tickets to events are sold as standalone items or included within packs. For event tickets sold in packs, the Company allocates a portion of the transaction price to the ticket on a relative standalone selling price basis, adjusted for the probability of the tickets being redeemed for attendance at a future event. Any discounts are accounted for as a direct reduction to the transaction price. Fee revenue associated with ticket sales is recorded in the month that the event is held, which is when the Company has performed its obligations under the contract.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Deferred Revenue</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Company launched its Rewards Circle loyalty program in the United States, Australia, New Zealand, and Japan in March 2023 and in Canada, Europe, and Mexico in February 2024.  Contract liabilities, recorded as deferred revenue, include these loyalty program credit deferrals with certain customers which are accounted for as a reduction in the transaction price and are generally recognized as credits are redeemed for additional products at a later date.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Company also records deferred revenue when cash payments are received or due in advance of performance, including amounts which are refundable. The Company pre-sells tickets to its events. When cash payments are received in advance of events, the cash received is recorded to deferred revenue until the event is held, at which time the Company has performed its obligations under the contract and the revenue is recognized.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> Deferred revenue is included in accrued expenses in the consolidated balance sheets.  The balance of deferred revenue related to contract liabilities, each less than twelve months, was $<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:ContractWithCustomerLiabilityCurrent" scale="6" id="f-377">0.7</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:ContractWithCustomerLiabilityCurrent" scale="6" id="f-378">0.9</ix:nonFraction> million as of June&#160;30, 2025 and 2024, respectively. The contract liabilities impact to revenue for the years ended June&#160;30, 2025 and 2024 was an increase of $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:ContractWithCustomerLiabilityRevenueRecognized" scale="6" id="f-379">0.2</ix:nonFraction> million and a decrease of $<ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-3" sign="-" name="us-gaap:ContractWithCustomerLiabilityRevenueRecognized" format="ixt:num-dot-decimal" scale="0" id="f-380">26,000</ix:nonFraction>, respectively.</span></div></ix:continuation><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Sales Returns and Allowances</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Estimated returns are recorded when product is shipped. Subject to some exceptions based on local regulations, the Company&#8217;s return policy is to provide a full refund for product returned within <ix:nonNumeric contextRef="c-1" name="lfvn:MoneyBackGuaranteePeriod" format="ixt-sec:durday" id="f-381">30</ix:nonNumeric> days. After 30 days of purchase, only unopened product that is in a resalable and restockable condition may be returned within twelve months of purchase and shall receive a 100% refund, less a <ix:nonFraction unitRef="number" contextRef="c-6" decimals="INF" name="lfvn:HandlingAndRestockingFeePercentage" scale="-2" id="f-382">10</ix:nonFraction>% handling and restocking fee and any shipping and handling costs. The Company establishes a refund liability reserve, and an asset reserve for its right to recover products, based on historical experience. The returns asset reserve and returns liability reserve are evaluated on a quarterly basis. As of June&#160;30, 2025 and 2024, the Company&#8217;s return liability reserve, net was </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">$<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="lfvn:ReturnLiabilityReserve" scale="6" id="f-383">0.2</ix:nonFraction> million </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">and $<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="lfvn:ReturnLiabilityReserve" scale="6" id="f-384">0.1</ix:nonFraction> million, respectively.</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:DisaggregationOfRevenueTableTextBlock" id="f-385" escape="true"><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Reserves for sales returns consist of the following (in thousands):</span></div><div style="margin-bottom:8pt;margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:62.150%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.908%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.910%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Years ended June&#160;30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Beginning balance</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-42" decimals="-3" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="3" id="f-386">133</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-43" decimals="-3" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="3" id="f-387">129</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Additions</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-44" decimals="-3" name="us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense" format="ixt:num-dot-decimal" scale="3" id="f-388">2,759</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-45" decimals="-3" name="us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense" format="ixt:num-dot-decimal" scale="3" id="f-389">1,622</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Returns</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-44" decimals="-3" name="us-gaap:ValuationAllowancesAndReservesDeductions" format="ixt:num-dot-decimal" scale="3" id="f-390">2,655</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-45" decimals="-3" name="us-gaap:ValuationAllowancesAndReservesDeductions" format="ixt:num-dot-decimal" scale="3" id="f-391">1,618</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Ending balance</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-46" decimals="-3" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="3" id="f-392">237</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-42" decimals="-3" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="3" id="f-393">133</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div></ix:nonNumeric></ix:continuation><div style="margin-bottom:8pt;margin-top:8pt"><span><br/></span></div><div id="i7a9d1ca723db478892511ede354648f3_343"></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Note 4 &#8212; <ix:nonNumeric contextRef="c-1" name="us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock" id="f-394" continuedAt="f-394-1" escape="true">Property and Equipment, Net</ix:nonNumeric></span></div><ix:continuation id="f-394-1" continuedAt="f-394-2"><ix:continuation id="f-338-1"><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment, net consist of (in thousands):</span></div><div style="margin-bottom:8pt;margin-top:13pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:62.150%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.908%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.910%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">June&#160;30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Equipment (includes computer hardware and software)</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-47" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="f-395">16,998</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-48" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="f-396">15,766</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Furniture and fixtures</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-38" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="f-397">1,469</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-49" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="f-398">1,466</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-50" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="f-399">5,101</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-51" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="f-400">5,040</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Vehicles</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-39" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="f-401">51</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-52" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="f-402">51</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated depreciation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="f-403">17,412</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="f-404">14,510</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total property and equipment, net</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="f-405">6,207</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="f-406">7,813</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:continuation></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">76</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="f-394-2"><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Depreciation expense totaled </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">$<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:Depreciation" scale="6" id="f-407">3.1</ix:nonFraction> million and</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> $<ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-5" name="us-gaap:Depreciation" scale="6" id="f-408">3.4</ix:nonFraction> million for the fiscal years ended June&#160;30, 2025 and 2024, respectively.</span></div></ix:continuation><div id="i7a9d1ca723db478892511ede354648f3_346"></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Note 5 &#8212; <ix:nonNumeric contextRef="c-1" name="us-gaap:IntangibleAssetsDisclosureTextBlock" id="f-409" continuedAt="f-409-1" escape="true">Intangible Assets, Net</ix:nonNumeric></span></div><ix:continuation id="f-409-1"><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" id="f-410" escape="true"><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Intangible assets, net consist of (in thousands):</span></div><div style="margin-bottom:8pt;margin-top:13pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:62.150%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.908%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.910%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">June&#160;30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Patent costs</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-53" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:fixed-zero" scale="3" id="f-411">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-54" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="f-412">2,330</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-53" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:fixed-zero" scale="3" id="f-413">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-54" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="f-414">2,252</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total finite-lived intangible assets, net</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-53" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:fixed-zero" scale="3" id="f-415">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-54" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="3" id="f-416">78</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Trademarks and other indefinite-lived intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-55" decimals="-3" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" scale="3" id="f-417">245</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-56" decimals="-3" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" scale="3" id="f-418">245</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total intangible assets, net</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="3" id="f-419">245</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="3" id="f-420">323</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">During the fiscal year ended June&#160;30, 2025, the patents included in intangible assets related to Protandim</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> Nrf2 Synergizer</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> reached expiration and entered the public domain. Amortization expense totaled </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">$<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="f-421">0.1</ix:nonFraction> million and</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> $<ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-5" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="f-422">0.1</ix:nonFraction> million for the fiscal years ended June&#160;30, 2025 and 2024, respectively. As of June&#160;30, 2025, the remaining weighted-average amortization period for finite-lived intangible assets is <ix:nonNumeric contextRef="c-6" name="us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" format="ixt-sec:durwordsen" id="f-423">zero years</ix:nonNumeric>. There is </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" format="ixt:fixed-zero" scale="6" id="f-424"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" format="ixt:fixed-zero" scale="6" id="f-425">no</ix:nonFraction></ix:nonFraction> a</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">nnual estimated amortization expense expected in the succeeding fiscal year.</span></div></ix:continuation><div id="i7a9d1ca723db478892511ede354648f3_349"></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Note 6 &#8212; <ix:nonNumeric contextRef="c-1" name="us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock" id="f-426" continuedAt="f-426-1" escape="true">Other Accrued Expenses</ix:nonNumeric></span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock" id="f-427" escape="true"><ix:continuation id="f-426-1"><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Other accrued expenses consist of (in thousands):</span></div><div style="margin-bottom:8pt;margin-top:13pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:62.150%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.908%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.910%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Accrued incentive compensation</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:AccruedBonusesCurrentAndNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-428">5,325</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:AccruedBonusesCurrentAndNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-429">1,521</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Accrued severance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:AccruedEmployeeBenefitsCurrentAndNoncurrent" scale="3" id="f-430">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:AccruedEmployeeBenefitsCurrentAndNoncurrent" scale="3" id="f-431">90</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Other taxes payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:TaxesPayableCurrent" format="ixt:num-dot-decimal" scale="3" id="f-432">2,189</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:TaxesPayableCurrent" format="ixt:num-dot-decimal" scale="3" id="f-433">2,258</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Accrued payable to vendors</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="lfvn:AccruedPayableToVendors" scale="3" id="f-434">459</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="lfvn:AccruedPayableToVendors" scale="3" id="f-435">434</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Deferred revenue</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:ContractWithCustomerLiabilityCurrent" scale="3" id="f-436">711</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:ContractWithCustomerLiabilityCurrent" scale="3" id="f-437">860</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Accrued incentives and promotions to consultants</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:AccruedMarketingCostsCurrent" format="ixt:num-dot-decimal" scale="3" id="f-438">3,284</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:AccruedMarketingCostsCurrent" format="ixt:num-dot-decimal" scale="3" id="f-439">1,454</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Accrued other expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:OtherAccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-440">1,540</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:OtherAccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-441">1,257</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total other accrued expenses</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:AccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-442">13,513</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:AccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-443">7,874</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:continuation></ix:nonNumeric><div id="i7a9d1ca723db478892511ede354648f3_352"></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Note 7 &#8212; <ix:nonNumeric contextRef="c-1" name="us-gaap:DebtDisclosureTextBlock" id="f-444" continuedAt="f-444-1" escape="true">Long-Term Debt</ix:nonNumeric></span></div><ix:continuation id="f-444-1" continuedAt="f-444-2"><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">On March&#160;30, 2016,</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> t</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">he Company entered into a loan agreement (the &#8220;2016 Loan Agreement&#8221;) and a security agreement (the &#8220;2016 Security Agreement&#8221;). The 2016 Loan Agreement provides for a term loan in an aggregate principal amount of $<ix:nonFraction unitRef="usd" contextRef="c-57" decimals="INF" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" scale="6" id="f-445">10.0</ix:nonFraction> million </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">(</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">the &#8220;2016 Term Loan&#8221;) and a revolving loan facility in an aggregate principal amount not to exceed $<ix:nonFraction unitRef="usd" contextRef="c-58" decimals="INF" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" scale="6" id="f-446">2.0</ix:nonFraction> million (the &#8220;2016 Revolving Loan,&#8221; and collectively with the 2016 Term Loan, the 2016 Loan Agreement, and the 2016 Security Agreement, and together with the amendments described below, the &#8220;2016 Credit Facility&#8221;). The 2016 Credit Facility was subsequently amended, among other things, to increase the available borrowing under the revolving loan facility to $<ix:nonFraction unitRef="usd" contextRef="c-59" decimals="INF" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" scale="6" id="f-447">5.0</ix:nonFraction> million. On March 31, 2024, the 2016 Credit Facility reached the maturity date and was terminated. As of March 31, 2024, there was <ix:nonFraction unitRef="usd" contextRef="c-60" decimals="INF" name="us-gaap:LineOfCredit" format="ixt:fixed-zero" scale="0" id="f-448">no</ix:nonFraction> balance outstanding under the 2016 Credit Facility.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">On April 12, 2024, the Company entered into a Loan Agreement (the &#8220;Loan Agreement&#8221;) with Bank of America, N.A., as Lender (the &#8220;Lender&#8221;). In connection with the Loan Agreement and on the same date, the Company, Lifeline Nutraceuticals Corporation, as Guarantor (the &#8220;Guarantor&#8221;), and the Lender also entered into a Continuing and Unconditional Guaranty (the &#8220;Continuing and Unconditional Guaranty&#8221;) and a Security and Pledge Agreement (the &#8220;Security and Pledge Agreement&#8221;). The Loan Agreement provides for a revolving line of credit in an aggregate principal amount not to exceed</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">$<ix:nonFraction unitRef="usd" contextRef="c-59" decimals="INF" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" scale="6" id="f-449">5.0</ix:nonFraction> million (the &#8220;Line of Credit&#8221; and collectively with the Loan Agreement, Continuing and Unconditional Guaranty, and the Security and Pledge Agreement, the &#8220;2024 Credit Facility&#8221;). </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">77</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="f-444-2" continuedAt="f-444-3"><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In the event the Company borrows under the Line of Credit, interest will be payable commencing May 31, 2024, and then on the last day of each month thereafter until payment in full of all principal outstanding under the Line of Credit, with all unpaid principal and interest due on April 12, 2027 (the &#8220;Expiration Date&#8221;). The Line of Credit will bear interest at a rate per year equal to the sum of (i) the greater of the Term SOFR Daily Floating Rate (as defined in the Loan Agreement) or </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="number" contextRef="c-61" decimals="INF" name="lfvn:DebtInstrumentFloorInterestRate" scale="-2" id="f-450">0.00</ix:nonFraction>%</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">, plus (ii) <ix:nonFraction unitRef="number" contextRef="c-61" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="f-451">2.00</ix:nonFraction>%. Amounts under the Line of Credit may be repaid and re-borrowed from time to time until the Expiration Date. As of June&#160;30, 2025, the effective interest rate is <ix:nonFraction unitRef="number" contextRef="c-62" decimals="4" name="us-gaap:DebtInstrumentInterestRateEffectivePercentage" scale="-2" id="f-452">6.45</ix:nonFraction>%.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s obligations under the Loan Agreement are secured by a security interest in substantially all of the assets of the Company and the Guarantor, and by a pledge of the membership interests of the Company&#8217;s subsidiaries, as further provided for in the Security and Pledge Agreement. Pursuant to the Continuing and Unconditional Guaranty, the Guarantor guarantees and promises to pay promptly to the Lender all indebtedness of the Company when due. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Loan Agreement contains customary covenants, both affirmative and negative, that, among other things, restrict the Company&#8217;s ability to deal with the Company&#8217;s assets outside of the ordinary course, incur additional indebtedness, grant liens on the Company's assets, make certain investments, purchase or otherwise acquire all or substantially all the assets or equity interests of other companies, and enter into consolidations, mergers or other combinations. The Loan Agreement requires that the Company maintain specified financial ratios and satisfy certain financial condition tests. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Loan Agreement contains certain customary events of default, including, among other things, failure of the Company to make required payments under the Loan Agreement, certain breaches of representations made by the Company or the Guarantor, insolvency or bankruptcy of the Company or the Guarantor, failure to have an enforceable first lien or security interest in any property given as security for the Loan Agreement, or failure of the Company to comply with covenants set forth in the Loan Agreement. If an event of default occurs under the Loan Agreement, the obligation of the Lender to make any additional credit available to the Company may be terminated and the amounts outstanding may become immediately due and payable in the discretion of the Lender, provided that in the event of insolvency or bankruptcy of the Company or the Guarantor, all debts outstanding under the Loan Agreement will automatically become due and payable. Upon the occurrence of any default or after maturity, all amounts outstanding under the Loan Agreement will, at the option of the Lender, bear interest at a rate which is <ix:nonFraction unitRef="number" contextRef="c-61" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="f-453">2.00</ix:nonFraction>% higher than the rate of interest otherwise provided under the Loan Agreement. </span></div></ix:continuation><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="f-444-3">As of June&#160;30, 2025, the Company was in compliance with its financial covenants under the 2024 Credit Facility.  As of June&#160;30, 2025, there was no balance outstanding on the 2024 Credit Facility.</ix:continuation>  </span></div><div id="i7a9d1ca723db478892511ede354648f3_355"></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Note 8 &#8212; <ix:nonNumeric contextRef="c-1" name="us-gaap:StockholdersEquityNoteDisclosureTextBlock" id="f-454" continuedAt="f-454-1" escape="true">Stockholders&#8217; Equity</ix:nonNumeric></span></div><ix:continuation id="f-454-1" continuedAt="f-454-2"><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">During the fiscal years ended June&#160;30, 2025 and 2024, the Company issued <ix:nonFraction unitRef="shares" contextRef="c-15" decimals="-3" name="lfvn:StockIssuedDuringPeriodSharesStockOptionsAndWarrantsExercised" format="ixt:fixed-zero" scale="0" id="f-455"><ix:nonFraction unitRef="shares" contextRef="c-23" decimals="0" name="lfvn:StockIssuedDuringPeriodSharesStockOptionsAndWarrantsExercised" format="ixt:fixed-zero" scale="0" id="f-456">zero</ix:nonFraction></ix:nonFraction> shares of common stock as a result of the exercise of options. During the fiscal years ended June&#160;30, 2025 and 2024, the Company issued </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-63" decimals="-5" name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" scale="6" id="f-457">0.4</ix:nonFraction> million and</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> <ix:nonFraction unitRef="shares" contextRef="c-64" decimals="-5" name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" scale="6" id="f-458">1.0</ix:nonFraction> million shares, respectively, under the Company&#8217;s equity incentive plans. During the fiscal years ended June&#160;30, 2025 and 2024, <ix:nonFraction unitRef="shares" contextRef="c-1" decimals="-3" name="us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation" scale="6" id="f-459">0.2</ix:nonFraction> million</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> and</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> <ix:nonFraction unitRef="shares" contextRef="c-8" decimals="0" name="us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation" scale="6" id="f-460">0.2</ix:nonFraction> million shares, respectively, of restricted stock were canceled or surrendered as payment of tax withholding upon vesting.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> During the fiscal years ended </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">June&#160;30, 2025 and 2024</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">, the Company sold <ix:nonFraction unitRef="shares" contextRef="c-65" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" format="ixt:num-dot-decimal" scale="0" id="f-461">44,000</ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="c-66" decimals="-5" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" scale="6" id="f-462">0.1</ix:nonFraction> million shares under its 2019 Employee Stock Purchase Plan, respectively. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">On November&#160;27, 2017, the Company&#8217;s board approved a stock repurchase program, which was subsequently amended on February&#160;1, 2019. Under the currently approved stock repurchase program, the Company is authorized to purchase up to $<ix:nonFraction unitRef="usd" contextRef="c-67" decimals="INF" name="srt:StockRepurchaseProgramAuthorizedAmount1" format="ixt:num-dot-decimal" scale="6" id="f-463">60</ix:nonFraction>&#160;million through December 31, 2026. The stock repurchase program permits the Company to purchase shares from time to time through a variety of methods, including in the open market, through privately negotiated transactions or other means as determined by the Company&#8217;s management, in accordance with applicable securities laws. As part of the stock repurchase program, the Company may enter into a pre-arranged stock repurchase plan which operates in accordance with guidelines specified under Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. Accordingly, any transactions under such stock repurchase plan would be completed in accordance with the terms of the plan, including specified price, volume, and timing conditions. T</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">he stock repurchase program may be suspended or discontinued at any time. During the year ended June&#160;30, 2025, the Company purchased <ix:nonFraction unitRef="shares" contextRef="c-1" decimals="-5" name="us-gaap:StockRepurchasedDuringPeriodShares" scale="6" id="f-464">0.3</ix:nonFraction> million&#160;shares of its common stock at an aggregate purchase price of $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:PaymentsForRepurchaseOfCommonStock" scale="6" id="f-465">3.1</ix:nonFraction> million under this repurchase program. During the fiscal year ended June&#160;30, 2024, the Company purchased <ix:nonFraction unitRef="shares" contextRef="c-8" decimals="-5" name="us-gaap:StockRepurchasedDuringPeriodShares" scale="6" id="f-466">1.0</ix:nonFraction> million&#160;shares of its common stock at an aggregate purchase price of $<ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-5" name="us-gaap:PaymentsForRepurchaseOfCommonStock" scale="6" id="f-467">6.4</ix:nonFraction> million under this repurchase program. At&#160;June&#160;30, 2025, there is&#160;$<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" scale="6" id="f-468">17.3</ix:nonFraction> million&#160;remaining under this stock repurch</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">ase program.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">On August 30, 2023, the board approved a stockholder rights agreement (the &#8220;Rights Plan&#8221;) and declared a dividend of <ix:nonFraction unitRef="shares" contextRef="c-68" decimals="INF" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" format="ixt-sec:numwordsen" scale="0" id="f-469">one</ix:nonFraction> right for each outstanding share of common stock to stockholders of record on September 11, 2023. Each right entitled holders to purchase <ix:nonFraction unitRef="shares" contextRef="c-68" decimals="INF" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" format="ixt-sec:numwordsen" scale="0" id="f-470">one</ix:nonFraction> newly issued share of preferred stock at an exercise price of $<ix:nonFraction unitRef="usdPerShare" contextRef="c-68" decimals="INF" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" scale="0" id="f-471">20</ix:nonFraction> per right, subject to adjustment. Initially, the rights were not exercisable and traded with shares of the Company&#8217;s common stock.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In general, the rights became exercisable following a public announcement that a person had acquired <ix:nonFraction unitRef="number" contextRef="c-68" decimals="INF" name="lfvn:ClassOfWarrantOrRightPercentOfCommonStockAcquisitionThatMakesRightsExercisable" scale="-2" id="f-472">12</ix:nonFraction>% (or, in the case of passive investors, <ix:nonFraction unitRef="number" contextRef="c-68" decimals="INF" name="lfvn:ClassOfWarrantOrRightPercentOfCommonStockAcquisitionThatMakesRightsExercisablePassiveInvestors" scale="-2" id="f-473">20</ix:nonFraction>%) or more of the outstanding shares of the Company&#8217;s common stock. If a person became an acquiring </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">78</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="f-454-2"><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">person, each holder of rights (except the acquiring person) would have the right to purchase, for the purchase price, a number of shares of the Company&#8217;s common stock at a <ix:nonFraction unitRef="number" contextRef="c-68" decimals="INF" name="lfvn:ClassOfWarrantsOrRightDiscount" scale="-2" id="f-474">50</ix:nonFraction>% discount to the then-current trading price. Rather than allowing the rights to be exercised in those circumstances, the board had the right to exchange each right, other than the rights owned by the acquiring person, for a share of the Company&#8217;s common stock. The agreement provided for exceptions and additional terms for other certain situations and circumstances.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Rights Plan was intended to protect the interests of the Company and its stockholders by reducing the likelihood that any entity, person or group gains control of the Company through open-market accumulation or other means without payment of an adequate control premium and expired on August 28, 2024. There was no impact to the Company&#8217;s Consolidated Financial Statements.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s Certificate of Incorporation authorizes the designation and issuance of shares of preferred stock. However, as of June&#160;30, 2025, no shares of preferred stock have been designated by the Board nor are any shares of preferred stock outstanding.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Dividends</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Company paid quarterly cash dividends of $<ix:nonFraction unitRef="usdPerShare" contextRef="c-69" decimals="INF" name="us-gaap:CommonStockDividendsPerShareCashPaid" scale="0" id="f-475"><ix:nonFraction unitRef="usdPerShare" contextRef="c-70" decimals="INF" name="us-gaap:CommonStockDividendsPerShareCashPaid" scale="0" id="f-476"><ix:nonFraction unitRef="usdPerShare" contextRef="c-71" decimals="INF" name="us-gaap:CommonStockDividendsPerShareCashPaid" scale="0" id="f-477">0.04</ix:nonFraction></ix:nonFraction></ix:nonFraction> per share of common stock to stockholders of record in September 2024, December 2024 and March 2025, and </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">$<ix:nonFraction unitRef="usdPerShare" contextRef="c-72" decimals="INF" name="us-gaap:CommonStockDividendsPerShareCashPaid" scale="0" id="f-478">0.045</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> per share of common stock to stockholders of record in June 2025 which were in the aggregate amount of </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">$<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:DividendsCommonStockCash" scale="6" id="f-479">2.1</ix:nonFraction> million, or $<ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="INF" name="us-gaap:CommonStockDividendsPerShareCashPaid" scale="0" id="f-480">0.165</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> per share of common stock for the fiscal year ended June&#160;30, 2025</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">. </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Company paid a one-time cash dividend of $<ix:nonFraction unitRef="usdPerShare" contextRef="c-73" decimals="INF" name="lfvn:CommonStockDividendsPerShareCashPaidOneTimeDividend" scale="0" id="f-481">0.40</ix:nonFraction></span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">per share of common stock to stockholders of record in September 2023, quarterly cash dividends of $<ix:nonFraction unitRef="usdPerShare" contextRef="c-74" decimals="INF" name="us-gaap:CommonStockDividendsPerShareCashPaid" scale="0" id="f-482"><ix:nonFraction unitRef="usdPerShare" contextRef="c-75" decimals="INF" name="us-gaap:CommonStockDividendsPerShareCashPaid" scale="0" id="f-483"><ix:nonFraction unitRef="usdPerShare" contextRef="c-76" decimals="INF" name="us-gaap:CommonStockDividendsPerShareCashPaid" scale="0" id="f-484">0.035</ix:nonFraction></ix:nonFraction></ix:nonFraction> per share of common stock to stockholders of record in September 2023, December 2023 and March 2024, and $<ix:nonFraction unitRef="usdPerShare" contextRef="c-77" decimals="INF" name="us-gaap:CommonStockDividendsPerShareCashPaid" scale="0" id="f-485">0.04</ix:nonFraction> per share of common stock to stockholders of record in June 2024 which were in the aggregate amount of </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">$<ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-5" name="us-gaap:DividendsCommonStockCash" scale="6" id="f-486">6.9</ix:nonFraction> million, or </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">$<ix:nonFraction unitRef="usdPerShare" contextRef="c-8" decimals="INF" name="us-gaap:CommonStockDividendsPerShareCashPaid" scale="0" id="f-487">0.545</ix:nonFraction></span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">per share of common stock for the fiscal year ended </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">June&#160;30, 2024. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The declaration of dividends is subject to the discretion of the board and will depend upon various factors, including the Company&#8217;s earnings, financial condition, restrictions imposed by any indebtedness that may be outstanding, cash requirements, future prospects, and other factors deemed relevant by the board.</span></div></ix:continuation><div id="i7a9d1ca723db478892511ede354648f3_358"></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Note 9 &#8212; <ix:nonNumeric contextRef="c-1" name="us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" id="f-488" continuedAt="f-488-1" escape="true">Stock-Based Compensation</ix:nonNumeric></span></div><ix:continuation id="f-488-1" continuedAt="f-488-2"><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Long-Term Incentive Plans</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Equity-Settled Plans</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Company adopted, and the stockholders approved, the 2017 Long-Term Incentive Plan (the &#8220;2017 Plan&#8221;), effective February&#160;16, 2017, to provide incentives to eligible employees, directors, and consultants. T</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">he initial share pool approved was <ix:nonFraction unitRef="shares" contextRef="c-78" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="f-489">650,000</ix:nonFraction> shares. On November 9, 2023, the stockholders approved amendments to the 2017 Plan to increase the number of shares of the Company&#8217;s common stock that are available for issuance under the 2017 plan by </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-79" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="f-490">1,138,000</ix:nonFraction></span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> shares. </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">As of&#160;June&#160;30, 2025, a maximum of&#160;<ix:nonFraction unitRef="shares" contextRef="c-80" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="f-491">5,105,000</ix:nonFraction>&#160;shares of the Company&#8217;s common stock can be issued under the 2017 Plan in connection with the grant of awards which is calculated as the sum of (i)&#160;<ix:nonFraction unitRef="shares" contextRef="c-81" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="f-492">4,630,000</ix:nonFraction>&#160;shares and (ii) up to&#160;<ix:nonFraction unitRef="shares" contextRef="c-82" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="f-493">475,000</ix:nonFraction>&#160;shares previously reserved for issuance under the Company&#8217;s prior 2010 Long Term Incentive Plan, including shares returned upon cancellation, termination or forfeiture of awards that were previously granted under that plan. Outstanding stock options awarded under the 2017 Plan have exercise prices of&#160;$<ix:nonFraction unitRef="usdPerShare" contextRef="c-80" decimals="2" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="f-494">4.44</ix:nonFraction>&#160;per share, vest over a&#160;<span style="-sec-ix-hidden:f-495">three&#160;year</span> vesting period, and have a contractual term of <ix:nonNumeric contextRef="c-84" name="lfvn:SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsOutstandingContractualTerm" format="ixt-sec:durwordsen" id="f-496">ten years</ix:nonNumeric>. Awards expire in accordance with the terms of each award and, upon expiration of the award, the shares subject to the award are added back to the 2017 Plan. As of June&#160;30, 2025, under the 2017 Plan, there were stock option awards outstanding, net of awards expired, for an aggregate of <ix:nonFraction unitRef="shares" contextRef="c-80" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" scale="6" id="f-497">0.1</ix:nonFraction> million shares of the Company&#8217;s common stock.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Employee Stock Purchase Plan</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">General.</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;The Company&#8217;s 2019 Employee Stock Purchase Plan (&#8220;ESPP&#8221;) was adopted by the board in September 2018 and the Company&#8217;s stockholders approved it in November 2018.  In August 2024, the board approved an amendment to the ESPP to increase the share reserve thereunder by <ix:nonFraction unitRef="shares" contextRef="c-85" decimals="-5" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" scale="6" id="f-498">0.4</ix:nonFraction> million shares, which amendment and increase was approved by the Company&#8217;s stockholders in November 2024. The ESPP is intended to qualify under Section 423 of the Internal Revenue Code.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Share Reserve.</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;The Company has reserved <ix:nonFraction unitRef="shares" contextRef="c-86" decimals="INF" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" scale="6" id="f-499">0.8</ix:nonFraction> million shares of its common stock for issuance under the ESPP. As of June&#160;30, 2025, <ix:nonFraction unitRef="shares" contextRef="c-86" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" scale="6" id="f-500">0.4</ix:nonFraction> million shares were available for issuance. The number of shares reserved under the ESPP will automatically be adjusted in the event of a stock split, stock dividend or a reverse stock split (including an adjustment to the per-purchase period share limit).</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Purchase Price.</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;Employees may purchase each share of common stock under the ESPP at a price equal to <ix:nonFraction unitRef="number" contextRef="c-65" decimals="INF" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" scale="-2" id="f-501">85</ix:nonFraction>% of the lower of the fair market values of the stock as of the beginning or the end of the six-month offering periods. An employee&#8217;s contributions to the ESPP are limited to <ix:nonFraction unitRef="number" contextRef="c-86" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate" scale="-2" id="f-502">15</ix:nonFraction>% of the compensation, and up to a maximum of <ix:nonFraction unitRef="shares" contextRef="c-65" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee" format="ixt:num-dot-decimal" scale="0" id="f-503">3,000</ix:nonFraction> shares may be purchased by </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">79</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="f-488-2" continuedAt="f-488-3"><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">an employee during any offering period. A participant shall not be granted an option under the ESPP if such option would permit the participant&#8217;s rights to purchase stock to accrue at a rate exceeding $<ix:nonFraction unitRef="usd" contextRef="c-86" decimals="INF" name="lfvn:ShareBasedCompensationArrangementByShareBasedPaymentAwardAmountInExcessOfFairMarketValueOfStockForOptionNotToBeGranted" format="ixt:num-dot-decimal" scale="0" id="f-504">25,000</ix:nonFraction> fair market value of stock for each calendar year in which such option is outstanding at any time.&#160;</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Offering Periods.</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;Unless otherwise determined by the compensation committee, the ESPP will be operated through a series of successive <ix:nonNumeric contextRef="c-65" name="lfvn:ShareBasedCompensationArrangementByShareBasedPaymentAwardOfferingPeriod" format="ixt-sec:durwordsen" id="f-505">six-month</ix:nonNumeric> offering periods, which will begin each year on March 1 and September 1.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">During the fiscal years ended June&#160;30, 2025 and 2024, <ix:nonFraction unitRef="shares" contextRef="c-65" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" format="ixt:num-dot-decimal" scale="0" id="f-506">44,000</ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="c-66" decimals="-5" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" scale="6" id="f-507">0.1</ix:nonFraction> million shares of common stock were purchased under the ESPP, respectively. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Stock-Based Compensation</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In accordance with accounting guidance for stock-based compensation, payments in equity instruments for goods or services are accounted for by the fair value method. For the fiscal year ended June&#160;30, 2025 and 2024, stock-based compensation of $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="f-508">5.7</ix:nonFraction> million</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> and $<ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="f-509">3.3</ix:nonFraction> million, respectively, was reflected as an increase to additional paid in capital. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">At June&#160;30, 2025, there was $<ix:nonFraction unitRef="usd" contextRef="c-87" decimals="-5" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" scale="6" id="f-510">3.5</ix:nonFraction> million of unrecognized compensation cost related to non-vested stock-based compensation arrangements under the 2017 Plan, based on management&#8217;s estimate of the shares that will ultimately vest. The Company expects to recognize such costs over a weighted-average period of <ix:nonNumeric contextRef="c-88" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" format="ixt-sec:duryear" id="f-511">1.43</ix:nonNumeric> years. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Stock Options</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">There were <ix:nonFraction unitRef="shares" contextRef="c-1" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" format="ixt:fixed-zero" scale="0" id="f-512"><ix:nonFraction unitRef="shares" contextRef="c-8" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" format="ixt:fixed-zero" scale="0" id="f-513"><ix:nonFraction unitRef="shares" contextRef="c-89" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" format="ixt:fixed-zero" scale="0" id="f-514">no</ix:nonFraction></ix:nonFraction></ix:nonFraction> stock option grants during the fiscal years ended June&#160;30, 2025 and 2024. </span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" id="f-515" escape="true"><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The following is a summary of stock option activity for the fiscal years ended June&#160;30, 2025 and 2024:</span></div><div style="margin-bottom:8pt;margin-top:13pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:38.724%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.394%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.394%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.394%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.398%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Options (in thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Weighted<br/>Average<br/>Exercise&#160;Price</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Weighted<br/>Average&#160;Remaining<br/>Contractual Term (in years)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Aggregate Intrinsic Value (in thousands)</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at June 30, 2023</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-13" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" scale="3" id="f-516">72</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-13" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="f-517">4.44</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-8" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" format="ixt:fixed-zero" scale="3" id="f-518">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-8" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" format="ixt:fixed-zero" scale="0" id="f-519">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-8" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" format="ixt:fixed-zero" scale="3" id="f-520">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-8" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" format="ixt:fixed-zero" scale="0" id="f-521">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" format="ixt:fixed-zero" scale="3" id="f-522">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-8" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" format="ixt:fixed-zero" scale="3" id="f-523">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-8" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" format="ixt:fixed-zero" scale="0" id="f-524">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Expired or Canceled</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-8" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" format="ixt:fixed-zero" scale="3" id="f-525">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-8" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" format="ixt:fixed-zero" scale="0" id="f-526">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at June 30, 2024</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-7" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" scale="3" id="f-527">72</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-7" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="f-528">4.44</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-1" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" format="ixt:fixed-zero" scale="3" id="f-529">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" format="ixt:fixed-zero" scale="0" id="f-530">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-1" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" format="ixt:fixed-zero" scale="3" id="f-531">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" format="ixt:fixed-zero" scale="0" id="f-532">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" format="ixt:fixed-zero" scale="3" id="f-533">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-1" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" format="ixt:fixed-zero" scale="3" id="f-534">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" format="ixt:fixed-zero" scale="0" id="f-535">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Expired or Canceled</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-1" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" format="ixt:fixed-zero" scale="3" id="f-536">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" format="ixt:fixed-zero" scale="0" id="f-537">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at June 30, 2025</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-6" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" scale="3" id="f-538">72</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-6" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="f-539">4.44</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" format="ixt-sec:duryear" id="f-540">2.59</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" scale="3" id="f-541">618</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Exercisable at June 30, 2025</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-6" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" scale="3" id="f-542">72</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-6" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" scale="0" id="f-543">4.44</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" format="ixt-sec:duryear" id="f-544">2.59</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" scale="3" id="f-545">618</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">80</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="f-488-3" continuedAt="f-488-4"><div style="margin-bottom:8pt;margin-top:3pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Restricted Stock Awards</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:NonvestedRestrictedStockSharesActivityTableTextBlock" id="f-546" escape="true"><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The following is a summary of restricted stock award activity during the fiscal years ended June&#160;30, 2025 and 2024:</span></div><div style="margin-bottom:8pt;margin-top:13pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:61.418%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.908%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.910%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Shares<br/>(in thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Weighted Average Grant Date Fair Value</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Nonvested at June 30, 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-90" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="3" id="f-547">117</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-90" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="f-548">3.85</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-64" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="3" id="f-549">392</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-64" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="f-550">4.74</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Vested </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="c-64" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" scale="3" id="f-551">117</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-64" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" scale="0" id="f-552">3.85</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-64" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" format="ixt:fixed-zero" scale="3" id="f-553">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-64" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" format="ixt:fixed-zero" scale="0" id="f-554">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Nonvested at June 30, 2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-91" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="3" id="f-555">392</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-91" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="f-556">4.74</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-63" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="3" id="f-557">58</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-63" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="f-558">13.54</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="c-63" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" scale="3" id="f-559">294</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-63" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" scale="0" id="f-560">4.77</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-63" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" format="ixt:fixed-zero" scale="3" id="f-561">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-63" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" format="ixt:fixed-zero" scale="0" id="f-562">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Nonvested at June 30, 2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-92" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="3" id="f-563">156</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-92" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="f-564">7.92</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center;text-indent:22.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.836%"><tr><td style="width:1.0%"/><td style="width:2.679%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:95.121%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">(1)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">Includes <ix:nonFraction unitRef="shares" contextRef="c-93" decimals="INF" name="lfvn:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInExchange" format="ixt:num-dot-decimal" scale="0" id="f-565">125,732</ix:nonFraction> shares of restricted stock that were granted in exchange for the cancellation of <ix:nonFraction unitRef="shares" contextRef="c-94" decimals="INF" name="lfvn:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsCancelledInPeriod" format="ixt:num-dot-decimal" scale="0" id="f-566">48,026</ix:nonFraction> shares of stock units and <ix:nonFraction unitRef="shares" contextRef="c-95" decimals="INF" name="lfvn:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsCancelledInPeriod" format="ixt:num-dot-decimal" scale="0" id="f-567">77,706</ix:nonFraction> shares of performance restricted stock units on November 6, 2023.</span></div></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The total vesting date fair value of restricted shares that vested during the fiscal years ended June 30, 2025 and 2024 w</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">as $<ix:nonFraction unitRef="usd" contextRef="c-63" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" scale="6" id="f-568">4.4</ix:nonFraction> million and</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> $<ix:nonFraction unitRef="usd" contextRef="c-64" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" scale="6" id="f-569">0.7</ix:nonFraction> million, respectively.  </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Restricted Stock Units</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfUnvestedRestrictedStockUnitsRollForwardTableTextBlock" id="f-570" escape="true"><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The following is a summary of restricted stock units activity during the fiscal years ended June&#160;30, 2025 and 2024:</span></div><div style="margin-bottom:8pt;margin-top:13pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:61.418%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.908%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.910%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Number of Units (in thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Weighted Average Grant Date Fair Value</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Nonvested at June 30, 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-96" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="3" id="f-571">538</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-96" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="f-572">4.90</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-97" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="3" id="f-573">214</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-97" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="f-574">4.90</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="c-97" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" scale="3" id="f-575">331</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-97" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" scale="0" id="f-576">5.05</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="c-97" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" scale="3" id="f-577">84</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-97" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" scale="0" id="f-578">4.48</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Nonvested at June 30, 2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-98" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="3" id="f-579">337</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-98" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="f-580">4.86</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-99" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="3" id="f-581">224</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-99" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="f-582">10.08</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="c-99" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" scale="3" id="f-583">224</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-99" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" scale="0" id="f-584">4.87</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="c-99" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" scale="3" id="f-585">47</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-99" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" scale="0" id="f-586">6.12</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Nonvested at June 30, 2025</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-100" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="3" id="f-587">290</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-100" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="f-588">8.68</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center;text-indent:22.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.836%"><tr><td style="width:1.0%"/><td style="width:2.679%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:95.121%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">(1)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">Includes <ix:nonFraction unitRef="shares" contextRef="c-94" decimals="INF" name="lfvn:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsCancelledInPeriod" format="ixt:num-dot-decimal" scale="0" id="f-589">48,026</ix:nonFraction> shares of restricted stock units that were canceled in exchange for restricted stock awards on November 6, 2023.</span></div></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The total vesting date fair value of restricted stock units that vested during the fiscal years ended June 30, 2025 and 2024 was $<ix:nonFraction unitRef="usd" contextRef="c-99" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" scale="6" id="f-590">2.6</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-97" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" scale="6" id="f-591">1.9</ix:nonFraction> million, respectively. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Performance Restricted Stock Units</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">During the fiscal years ended June 30, 2025 and 2024 , the Company awarded performance restricted stock units (the &#8220;FY 2025 PRSUs&#8221; and &#8220;FY 2024 PRSUs,&#8221; respectively) to certain employees (the &#8220;Recipients&#8221;). Each performance restricted stock unit represents a contingent right for the Recipients to receive a distribution of shares of common stock of the Company equal to <ix:nonFraction unitRef="number" contextRef="c-101" decimals="INF" name="lfvn:SharebasedCompensationArrangementbySharebasedPaymentAwardDistributionPercentage" scale="-2" id="f-592">0</ix:nonFraction>% to <ix:nonFraction unitRef="number" contextRef="c-102" decimals="INF" name="lfvn:SharebasedCompensationArrangementbySharebasedPaymentAwardDistributionPercentage" scale="-2" id="f-593">200</ix:nonFraction>% of the target number of performance restricted stock units subject to the award. The actual number of shares distributed will be based on the Company&#8217;s achievement of specified financial performance metrics. For FY 2025 PRSUs, the performance period for 50% of the FY 2025 PRSUs ended on June&#160;30, 2025, the performance period for 30% of the FY 2025 PRSUs ends on June 30, 2026, and the performance period for the remaining 20% of the FY 2025 PRSUs ends on June 30, 2027. For FY 2024 PRSUs, the performance period for 50% of the FY 2024 PRSUs ended on June 30, 2024, the performance period for 30% of the FY 2024 PRSUs ended on June&#160;30, 2025, and the performance period for the remaining 20% of the FY </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">81</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="f-488-4" continuedAt="f-488-5"><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">2024 PRSUs ends on June 30, 2026. The financial performance metrics for the fiscal year ended June&#160;30, 2025, were deemed achieved at the <ix:nonFraction unitRef="number" contextRef="c-102" decimals="INF" name="lfvn:SharebasedCompensationArrangementbySharebasedPaymentAwardDistributionPercentage" scale="-2" id="f-594">200.00</ix:nonFraction>% achievement level. The financial performance metrics for the fiscal year ended June 30, 2024, were deemed achieved at the <ix:nonFraction unitRef="number" contextRef="c-103" decimals="INF" name="lfvn:SharebasedCompensationArrangementbySharebasedPaymentAwardDistributionPercentage" scale="-2" id="f-595">0</ix:nonFraction>% achievement level. The FY 2025 PRSUs and FY 2024 PRSUs will vest only to the extent the specified financial performance criteria are achieved and subject to the Recipient&#8217;s continued service with the Company, as follows: (i) a portion of the earned award will vest on the first anniversary of the grant date and (ii) an additional portion of the earned award will vest thereafter in a series of quarterly installments. The fair values of the performance restricted stock units are based on the grant date fair value which is the closing price of the Company's common stock on the date of grant.</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock" id="f-596" escape="true"><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The following is a summary of performance restricted stock units activity during the fiscal years ended June&#160;30, 2025 and 2024:</span></div><div style="margin-bottom:8pt;margin-top:13pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:61.418%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.908%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.910%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Number of Units (in thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Weighted Average Grant Date Fair Value</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Nonvested at June 30, 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-104" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="3" id="f-597">492</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-104" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="f-598">4.24</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-105" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="3" id="f-599">350</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-105" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="f-600">4.89</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="c-105" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" scale="3" id="f-601">284</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-105" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" scale="0" id="f-602">4.24</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="c-105" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" scale="3" id="f-603">274</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-105" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" scale="0" id="f-604">4.68</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Nonvested at June 30, 2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-106" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="3" id="f-605">284</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-106" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="f-606">4.62</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-107" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="3" id="f-607">509</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-107" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="f-608">8.30</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="c-107" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" scale="3" id="f-609">94</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-107" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" scale="0" id="f-610">4.24</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="c-107" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" scale="3" id="f-611">45</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-107" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" scale="0" id="f-612">6.67</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Nonvested at June 30, 2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-108" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="3" id="f-613">654</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-108" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="f-614">7.40</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center;text-indent:22.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.836%"><tr><td style="width:1.0%"/><td style="width:2.679%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:95.121%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">(1)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">Includes <ix:nonFraction unitRef="shares" contextRef="c-95" decimals="INF" name="lfvn:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsCancelledInPeriod" format="ixt:num-dot-decimal" scale="0" id="f-615">77,706</ix:nonFraction> shares of performance restricted stock units that were canceled in exchange for restricted stock awards on November 6, 2023.</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">(2)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">Includes shares added based on achievement of performance goals in excess of target.</span></div></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="margin-bottom:8pt;margin-top:3pt;text-indent:18pt"><ix:continuation id="f-488-5" continuedAt="f-488-6"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The total vesting date fair value of performance restricted stock units that vested during the fiscal years ended June 30, 2025 and 2024 was approximately $<ix:nonFraction unitRef="usd" contextRef="c-107" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" scale="6" id="f-616">1.1</ix:nonFraction> million</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> and</span></ix:continuation><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="f-488-6"> $<ix:nonFraction unitRef="usd" contextRef="c-105" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" scale="6" id="f-617">1.6</ix:nonFraction> million, respectively.</ix:continuation> </span></div><div id="i7a9d1ca723db478892511ede354648f3_364"></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Note 10 &#8212; <ix:nonNumeric contextRef="c-1" name="us-gaap:OtherIncomeAndOtherExpenseDisclosureTextBlock" id="f-620" continuedAt="f-620-1" escape="true">Other Expense, Net</ix:nonNumeric></span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock" id="f-621" escape="true"><ix:continuation id="f-620-1"><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Other expense, net consists of the following (in thousands):</span></div><div style="margin-bottom:8pt;margin-top:13pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:62.150%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.908%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.910%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Years ended June&#160;30,</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency transaction loss, net</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:ForeignCurrencyTransactionGainLossBeforeTax" scale="3" id="f-622">380</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-3" sign="-" name="us-gaap:ForeignCurrencyTransactionGainLossBeforeTax" scale="3" id="f-623">429</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Other income (expense), net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="lfvn:OtherMiscellaneousIncomeExpensesNet" scale="3" id="f-624">7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-3" name="lfvn:OtherMiscellaneousIncomeExpensesNet" scale="3" id="f-625">17</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;Total other expense, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="f-626">387</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-3" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="f-627">412</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div></ix:continuation></ix:nonNumeric><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">82</span></div></div></div><div id="i7a9d1ca723db478892511ede354648f3_367"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Note 11 &#8212; <ix:nonNumeric contextRef="c-1" name="us-gaap:IncomeTaxDisclosureTextBlock" id="f-628" continuedAt="f-628-1" escape="true">Income Taxes</ix:nonNumeric></span></div><ix:continuation id="f-628-1" continuedAt="f-628-2"><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" id="f-629" escape="true"><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The income tax expense for the fiscal years ended June&#160;30, 2025 and 2024 consists of the following (in thousands):</span></div><div style="margin-bottom:8pt;margin-top:13pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:62.150%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.908%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.910%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Years ended June 30,</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Income before income taxes:</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Domestic</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" format="ixt:num-dot-decimal" scale="3" id="f-630">10,397</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" format="ixt:num-dot-decimal" scale="3" id="f-631">2,940</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">International</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" format="ixt:num-dot-decimal" scale="3" id="f-632">1,846</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" format="ixt:num-dot-decimal" scale="3" id="f-633">1,410</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td style="border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-634">12,243</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-635">4,350</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Current taxes:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Federal</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:CurrentFederalTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="f-636">2,925</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-3" name="us-gaap:CurrentFederalTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="f-637">1,457</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">State</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:CurrentStateAndLocalTaxExpenseBenefit" scale="3" id="f-638">708</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-3" name="us-gaap:CurrentStateAndLocalTaxExpenseBenefit" scale="3" id="f-639">246</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:CurrentForeignTaxExpenseBenefit" scale="3" id="f-640">491</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-3" name="us-gaap:CurrentForeignTaxExpenseBenefit" scale="3" id="f-641">984</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total current income tax provision</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:CurrentIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="f-642">4,124</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-3" name="us-gaap:CurrentIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="f-643">2,687</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Deferred taxes:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Federal</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:DeferredFederalIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="f-644">1,464</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-3" sign="-" name="us-gaap:DeferredFederalIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="f-645">1,281</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">State</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit" scale="3" id="f-646">341</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-3" sign="-" name="us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit" scale="3" id="f-647">151</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:DeferredForeignIncomeTaxExpenseBenefit" scale="3" id="f-648">119</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-3" name="us-gaap:DeferredForeignIncomeTaxExpenseBenefit" scale="3" id="f-649">158</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total deferred income tax provision</span></td><td style="border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:DeferredIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="f-650">1,686</ix:nonFraction>)</span></td><td style="border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-3" sign="-" name="us-gaap:DeferredIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="f-651">1,274</ix:nonFraction>)</span></td><td style="border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Net income tax provision</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="f-652">2,438</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="f-653">1,413</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div></ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" id="f-654" escape="true"><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The effective income tax rate for the fiscal years ended June&#160;30, 2025 and 2024 differs from the U.S. Federal statutory income tax rate due to the following:</span></div><div style="margin-bottom:8pt;margin-top:13pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:62.150%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.908%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.910%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Years ended June 30,</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Federal statutory income tax rate</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1" decimals="INF" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" scale="-2" id="f-655">21.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-8" decimals="INF" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" scale="-2" id="f-656">21.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">State income taxes, net of federal benefit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" scale="-2" id="f-657">3.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-8" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" scale="-2" id="f-658">1.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Foreign tax rate difference</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="c-1" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" scale="-2" id="f-659">0.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-8" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" scale="-2" id="f-660">8.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Tax return to provision true-up</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1" decimals="3" name="lfvn:EffectiveIncomeTaxRateReconciliationTaxReturnToProvisionsTrueUp" scale="-2" id="f-661">0.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="c-8" decimals="3" sign="-" name="lfvn:EffectiveIncomeTaxRateReconciliationTaxReturnToProvisionsTrueUp" scale="-2" id="f-662">4.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Limit on future stock compensation due to 162(m)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1" decimals="3" sign="-" name="lfvn:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseLimitationOnFutureStockBasedCompensationExpensePercent" scale="-2" id="f-663">4.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-8" decimals="3" sign="-" name="lfvn:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseLimitationOnFutureStockBasedCompensationExpensePercent" scale="-2" id="f-664">2.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Foreign withholding tax</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1" decimals="3" name="lfvn:EffectiveIncomeTaxRateReconciliationForeignWithholdingTaxPercent" scale="-2" id="f-665">0.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-8" decimals="3" name="lfvn:EffectiveIncomeTaxRateReconciliationForeignWithholdingTaxPercent" scale="-2" id="f-666">2.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Other differences</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments" scale="-2" id="f-667">0.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-8" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments" scale="-2" id="f-668">1.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Revalue of deferred for change in federal tax rate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate" scale="-2" id="f-669">0.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-8" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate" scale="-2" id="f-670">0.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Permanent differences:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212; stock-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="c-1" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost" scale="-2" id="f-671">6.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="c-8" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost" scale="-2" id="f-672">8.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212; current year section 162(m) limitation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1" decimals="3" name="lfvn:EffectiveIncomeTaxRateReconciliationCurrentYearSection162mLimitationPercent" scale="-2" id="f-673">0.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-8" decimals="3" name="lfvn:EffectiveIncomeTaxRateReconciliationCurrentYearSection162mLimitationPercent" scale="-2" id="f-674">7.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212; foreign derived intangible income deduction</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="c-1" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationFdiiPercent" scale="-2" id="f-675">1.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="c-8" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationFdiiPercent" scale="-2" id="f-676">0.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212; tax credits</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="c-1" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationTaxCredits" scale="-2" id="f-677">4.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="c-8" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationTaxCredits" scale="-2" id="f-678">12.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212; meals and entertainment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseMealsAndEntertainment" scale="-2" id="f-679">0.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-8" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseMealsAndEntertainment" scale="-2" id="f-680">1.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212; removal of additional permanent reinvestment assertions</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1" decimals="3" name="lfvn:EffectiveIncomeTaxRateReconciliationRemovalOfPermanentReinvestmentAssertion" scale="-2" id="f-681">0.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-8" decimals="3" name="lfvn:EffectiveIncomeTaxRateReconciliationRemovalOfPermanentReinvestmentAssertion" scale="-2" id="f-682">1.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212; change in uncertain tax positions</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="c-1" decimals="INF" sign="-" name="lfvn:EffectiveIncomeTaxRateReconciliationChangeInUncertainTaxPositions" scale="-2" id="f-683">0.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-8" decimals="INF" name="lfvn:EffectiveIncomeTaxRateReconciliationChangeInUncertainTaxPositions" scale="-2" id="f-684">1.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212; accrual for foreign tax audits</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1" decimals="INF" name="us-gaap:EffectiveIncomeTaxRateReconciliationTaxSettlementsForeign" scale="-2" id="f-685">0.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-8" decimals="INF" name="us-gaap:EffectiveIncomeTaxRateReconciliationTaxSettlementsForeign" scale="-2" id="f-686">7.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212; other permanent differences</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther" scale="-2" id="f-687">0.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-8" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther" scale="-2" id="f-688">1.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Change in valuation allowance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="c-1" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" scale="-2" id="f-689">0.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-8" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" scale="-2" id="f-690">0.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Net income tax provision </span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="f-691">19.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-8" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="f-692">32.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">83</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="f-628-2" continuedAt="f-628-3"><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" id="f-693" escape="true"><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The components of the deferred tax assets and liabilities as of June&#160;30, 2025 and 2024 are as follows (in thousands):</span></div><div style="margin-bottom:8pt;margin-top:13pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:62.150%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.908%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.910%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Federal, state, and foreign net operating loss carryovers</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwards" scale="3" id="f-694">234</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwards" scale="3" id="f-695">271</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Stock option compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" scale="3" id="f-696">628</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" scale="3" id="f-697">360</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Section 174 costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:DeferredTaxAssetsInProcessResearchAndDevelopment" format="ixt:num-dot-decimal" scale="3" id="f-698">2,798</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:DeferredTaxAssetsInProcessResearchAndDevelopment" format="ixt:num-dot-decimal" scale="3" id="f-699">2,578</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Lease liability</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="lfvn:DeferredTaxAssetsLeasingArrangements" format="ixt:num-dot-decimal" scale="3" id="f-700">2,798</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="lfvn:DeferredTaxAssetsLeasingArrangements" format="ixt:num-dot-decimal" scale="3" id="f-701">3,223</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Accrued vacation, allowance for returns, bonuses&#160;&amp; other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals" format="ixt:num-dot-decimal" scale="3" id="f-702">2,819</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals" format="ixt:num-dot-decimal" scale="3" id="f-703">2,119</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Gross deferred tax asset</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:DeferredTaxAssetsGross" format="ixt:num-dot-decimal" scale="3" id="f-704">9,277</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:DeferredTaxAssetsGross" format="ixt:num-dot-decimal" scale="3" id="f-705">8,551</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Patents and trademarks</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets" scale="3" id="f-706">16</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets" scale="3" id="f-707">30</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Property&#160;&amp; equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment" scale="3" id="f-708">239</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment" scale="3" id="f-709">798</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Right of use asset</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:DeferredTaxLiabilitiesLeasingArrangements" format="ixt:num-dot-decimal" scale="3" id="f-710">1,942</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:DeferredTaxLiabilitiesLeasingArrangements" format="ixt:num-dot-decimal" scale="3" id="f-711">2,263</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:DeferredTaxLiabilitiesOther" scale="3" id="f-712">468</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:DeferredTaxLiabilitiesOther" scale="3" id="f-713">472</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Gross deferred tax liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:DeferredIncomeTaxLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-714">2,665</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:DeferredIncomeTaxLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-715">3,563</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Less: valuation allowance</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:DeferredTaxAssetsValuationAllowance" scale="3" id="f-716">642</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:DeferredTaxAssetsValuationAllowance" scale="3" id="f-717">720</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax assets, net</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:DeferredTaxAssetsLiabilitiesNet" format="ixt:num-dot-decimal" scale="3" id="f-718">5,970</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:DeferredTaxAssetsLiabilitiesNet" format="ixt:num-dot-decimal" scale="3" id="f-719">4,268</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Company has adopted accounting guidance for uncertain tax positions (&#8220;UTPs&#8221;) which provides that in order to recognize an uncertain tax benefit, the taxpayer must be more likely than not of sustaining the position. The measurement of the benefit is calculated as the largest amount that is more than 50% likely to be realized upon recognition of the benefit. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In the fiscal year ended June&#160;30, 2024, the Company began recording a withholding tax obligation on certain rebalanced commission payments to the U.S. parent company it had not obtained treaty rates for. The withholding tax recorded in the fiscal year ended June&#160;30, 2024 has been reversed during the fiscal year ended June&#160;30, 2025 as the Company no longer expects to pay that liability</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Company has been undergoing income tax audits in foreign jurisdictions. For the fiscal year ended June&#160;30, 2025, the Company accrued a total $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="lfvn:UnrecognizedTaxPositionIncreaseResultingFromForeignTaxAudits" scale="6" id="f-720">0.4</ix:nonFraction> million related to foreign income tax audits. In fiscal year 2025, the Company made payments or deemed payments totaling $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="lfvn:UnrecognizedTaxPositionIncreaseResultingFromForeignTaxAudits" scale="6" id="f-721">0.4</ix:nonFraction> million related to these foreign income tax audits. The UTP related to foreign tax audits is now zero. The Company does not have any other foreign tax audits as of June&#160;30, 2025.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The change in the liability for uncertain tax positions were as follows (in thousands):</span></div><div style="margin-bottom:8pt;margin-top:8pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:62.204%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.882%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.884%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Years ended June&#160;30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Beginning balance</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:UnrecognizedTaxBenefits" scale="3" id="f-722">389</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-3" name="us-gaap:UnrecognizedTaxBenefits" format="ixt:fixed-zero" scale="3" id="f-723">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Gross increases - tax positions in prior year</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" scale="3" id="f-724">51</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-3" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" format="ixt:fixed-zero" scale="3" id="f-725">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Gross decreases - tax positions in prior year</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" scale="3" id="f-726">53</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-3" name="us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" format="ixt:fixed-zero" scale="3" id="f-727">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Gross increases - tax positions in current year</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" format="ixt:fixed-zero" scale="3" id="f-728">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-3" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" scale="3" id="f-729">389</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Settlement</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" scale="3" id="f-730">381</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-3" name="us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" format="ixt:fixed-zero" scale="3" id="f-731">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Currency adjustment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromForeignCurrencyTranslation" scale="3" id="f-732">6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-3" name="us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromForeignCurrencyTranslation" format="ixt:fixed-zero" scale="3" id="f-733">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Ending balance</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:UnrecognizedTaxBenefits" format="ixt:fixed-zero" scale="3" id="f-734">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:UnrecognizedTaxBenefits" scale="3" id="f-735">389</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In fiscal year 2022, the Company removed its permanent reinvestment assertion in Japan. In fiscal year 2024, the Company removed its permanent reinvestment assertions in Taiwan and Australia and recorded the tax effects of that change. In fiscal year 2025, the Company removed its permanent reinvestment assertion on all other entities. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The tax years open for examination by the Internal Revenue Service (&#8220;IRS&#8221;) include returns for fiscal years June 30, 2021 through present and the open tax years by state tax authorities include returns for fiscal years June 30, 2020 through present. In addition, the IRS and state tax authorities may examine net operating losses (&#8220;NOLs&#8221;) for any previous years if utilized by the Company.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">84</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="f-628-3"><ix:nonNumeric contextRef="c-1" name="us-gaap:SummaryOfValuationAllowanceTextBlock" id="f-736" escape="true"><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The change in the valuation allowance were as follows (in thousands):</span></div><div style="margin-bottom:8pt;margin-top:8pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:62.150%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.908%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.910%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Years ended June&#160;30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Beginning balance</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:DeferredTaxAssetsValuationAllowance" scale="3" id="f-737">720</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-3" name="us-gaap:DeferredTaxAssetsValuationAllowance" scale="3" id="f-738">704</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Increases</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount" scale="3" id="f-739">78</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-3" name="us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount" scale="3" id="f-740">16</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Ending balance</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:DeferredTaxAssetsValuationAllowance" scale="3" id="f-741">642</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:DeferredTaxAssetsValuationAllowance" scale="3" id="f-742">720</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div></ix:nonNumeric><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The change in valuation allowance during the fiscal year ended </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">June&#160;30, 2025</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> related to current year income in entities with a full valuation allowance along with a change to the United States valuation allowance based on the Company converting from a blended rate to a state-by-state provision. During the fiscal year ended June&#160;30, 2024, the change in valuation allowance related to current year income in entities with a full valuation allowance along with a change to the United States valuation allowance based on updated projections and changes to the blended rate.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">As of June&#160;30, 2025, the Company had utilized all of its Federal NOL carry-forwards.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> As of June&#160;30, 2025, state NOLs were $<ix:nonFraction unitRef="usd" contextRef="c-111" decimals="-5" name="us-gaap:OperatingLossCarryforwards" scale="6" id="f-743">4.8</ix:nonFraction> million and foreign NOLs were $<ix:nonFraction unitRef="usd" contextRef="c-112" decimals="-5" name="us-gaap:OperatingLossCarryforwards" scale="6" id="f-744">0.4</ix:nonFraction> million.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The total recognized tax benefit from settlement of stock-based awards for the fiscal years ended June&#160;30, 2025 and 2024, was $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount" scale="6" id="f-745">0.8</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-3" name="us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount" scale="6" id="f-746">0.2</ix:nonFraction> million, respectively.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Company has reflected all changes in tax laws including the changes resulting from expiring Tax Cuts and Jobs Act provisions. The Company will reflect the changes from the One Big Beautiful Bill Act in fiscal year 2026, when the law was enacted.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Company conducts its business globally. As a result, the Company and its subsidiaries file income tax returns in the U.S. federal jurisdiction and various state and foreign jurisdictions, and are subject to examination for the open tax years of June 30, 2021 through June 30, 2025.</span></div></ix:continuation><div id="i7a9d1ca723db478892511ede354648f3_370"></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Note 12 &#8212; <ix:nonNumeric contextRef="c-1" name="us-gaap:LesseeOperatingLeasesTextBlock" id="f-747" continuedAt="f-747-1" escape="true">Leases</ix:nonNumeric></span></div><ix:continuation id="f-747-1" continuedAt="f-747-2"><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Company has operating leases for current corporate offices and certain equipment. These leases have remaining terms of approximately <span style="-sec-ix-hidden:f-748">one</span> to <ix:nonNumeric contextRef="c-114" name="us-gaap:LesseeOperatingLeaseTermOfContract" format="ixt-sec:duryear" id="f-749">6.5</ix:nonNumeric> years. As of June&#160;30, 2025, the weighted average remaining lease term and weighted average discount rate for operating leases was <ix:nonNumeric contextRef="c-6" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" format="ixt-sec:duryear" id="f-750">5.91</ix:nonNumeric> years and <ix:nonFraction unitRef="number" contextRef="c-6" decimals="4" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" scale="-2" id="f-751">3.17</ix:nonFraction>%, respectively. As of June&#160;30, 2024, the weighted average remaining lease term and weighted average discount rate for operating leases was <ix:nonNumeric contextRef="c-7" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" format="ixt-sec:duryear" id="f-752">6.90</ix:nonNumeric> years and <ix:nonFraction unitRef="number" contextRef="c-7" decimals="4" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" scale="-2" id="f-753">3.46</ix:nonFraction>%, respectively.</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:LeaseCostTableTextBlock" id="f-754" escape="true"><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The components of lease expense for the fiscal years ended June&#160;30, 2025 and 2024, were as follows (in thousands):</span></div><div style="margin-bottom:8pt;margin-top:8pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:62.150%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.908%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.910%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Years ended June 30,</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease expense</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease cost</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:OperatingLeaseCost" format="ixt:num-dot-decimal" scale="3" id="f-755">1,881</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-3" name="us-gaap:OperatingLeaseCost" format="ixt:num-dot-decimal" scale="3" id="f-756">1,913</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Variable lease cost</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:VariableLeaseCost" scale="3" id="f-757">154</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-3" name="us-gaap:VariableLeaseCost" scale="3" id="f-758">174</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Short-term lease cost</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:ShortTermLeaseCost" scale="3" id="f-759">11</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-3" name="us-gaap:ShortTermLeaseCost" scale="3" id="f-760">47</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total lease expense</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:LeaseCost" format="ixt:num-dot-decimal" scale="3" id="f-761">2,046</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-3" name="us-gaap:LeaseCost" format="ixt:num-dot-decimal" scale="3" id="f-762">2,134</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Supplemental cash flow information related to operating leases was as follows (in thousands):</span></div><div style="margin-bottom:8pt;margin-top:8pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:62.150%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.908%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.910%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2025</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash outflows from operating leases</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:OperatingLeasePayments" format="ixt:num-dot-decimal" scale="3" id="f-763">2,284</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-3" name="us-gaap:OperatingLeasePayments" format="ixt:num-dot-decimal" scale="3" id="f-764">2,187</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Right-of-use assets obtained in exchange for lease obligations</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" format="ixt:fixed-zero" scale="3" id="f-765">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-3" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="f-766">2,475</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock" id="f-767" continuedAt="f-767-1" escape="true"><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Maturity of lease liabilities at June&#160;30, 2025 are as follows (in thousands):</span></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">85</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="f-767-1"><ix:continuation id="f-747-2"><div style="margin-bottom:8pt;margin-top:8pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:80.159%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.909%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Year ended June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" format="ixt:num-dot-decimal" scale="3" id="f-768">2,214</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" format="ixt:num-dot-decimal" scale="3" id="f-769">2,195</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2028</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree" format="ixt:num-dot-decimal" scale="3" id="f-770">2,073</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2029</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour" format="ixt:num-dot-decimal" scale="3" id="f-771">1,772</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2030</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive" format="ixt:num-dot-decimal" scale="3" id="f-772">1,817</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" format="ixt:num-dot-decimal" scale="3" id="f-773">2,805</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue" format="ixt:num-dot-decimal" scale="3" id="f-774">12,876</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Less: imputed interest</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" format="ixt:num-dot-decimal" scale="3" id="f-775">1,198</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Present value of lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:OperatingLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="f-776">11,678</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr></table></div></ix:continuation></ix:continuation><div id="i7a9d1ca723db478892511ede354648f3_2884"></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Note 13 &#8212; <ix:nonNumeric contextRef="c-1" name="us-gaap:SegmentReportingDisclosureTextBlock" id="f-777" continuedAt="f-777-1" escape="true">Segment Information</ix:nonNumeric></span></div><ix:continuation id="f-777-1" continuedAt="f-777-2"><ix:nonNumeric contextRef="c-1" name="us-gaap:SegmentReportingPolicyPolicyTextBlock" id="f-778" escape="true"><div style="margin-bottom:8pt;margin-top:3pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Company operates in a single operating segment by selling products directly to customers through an international network of independent consultants that operates in an integrated manner from market to market. The Company manages its business primarily by managing its international network of independent consultants through similar commission plans. Most products available to customers in the United States are available to customers across all markets.  These products are purchased through third-party manufacturers by the US Corporate office and sold to each international market. Pricing for all products is determined at the US Corporate office. Accordingly, for disclosure purposes, the Company has a single reporting segment, which is reported on the Company&#8217;s consolidated financial statements.</span></div></ix:nonNumeric><div style="margin-bottom:8pt;margin-top:3pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Chief Operating Decision Maker (&#8220;CODM&#8221;) is the Company&#8217;s Chief Executive Officer. The CODM regularly reviews consolidated financial information and performance used to make decisions about the Company as a whole and without distinguishing or grouping of operations based on asset type, revenue, geographic location, tenant or other factors.  </span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The CODM evaluates performance through consolidated financial budget-to-actual variances on a monthly and quarterly basis and allocates resources based on net income as reported in the consolidated statements of operations. The measure of segment assets is reported on the balance sheet as total consolidated assets. Total expenditures for long-lived assets are reported on the consolidated statements of cash flows.</span></div><div style="text-indent:18pt"><span><br/></span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock" id="f-779" continuedAt="f-779-1" escape="true"><div style="text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The following table presents the Company&#8217;s segment revenue and expenses and segment net income for the fiscal years ended June 30, 2025 and 2024 (in thousands):</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:62.150%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.908%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.910%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Years ended June&#160;30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Revenue, net</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-115" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-780">228,530</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-116" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-781">200,164</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Cost of sales</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-115" decimals="-3" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="3" id="f-782">44,864</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-116" decimals="-3" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="3" id="f-783">41,440</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Consultant commissions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-115" decimals="-3" name="lfvn:ConsultantCommissions" format="ixt:num-dot-decimal" scale="3" id="f-784">95,920</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-116" decimals="-3" name="lfvn:ConsultantCommissions" format="ixt:num-dot-decimal" scale="3" id="f-785">80,900</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Consultant incentives, promotions, and recognition</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-115" decimals="-3" name="lfvn:ConsultantIncentivesPromotionsAndRecognitionExpense" format="ixt:num-dot-decimal" scale="3" id="f-786">6,340</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-116" decimals="-3" name="lfvn:ConsultantIncentivesPromotionsAndRecognitionExpense" format="ixt:num-dot-decimal" scale="3" id="f-787">5,020</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Labor and benefits</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-115" decimals="-3" name="us-gaap:LaborAndRelatedExpense" format="ixt:num-dot-decimal" scale="3" id="f-788">31,216</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-116" decimals="-3" name="us-gaap:LaborAndRelatedExpense" format="ixt:num-dot-decimal" scale="3" id="f-789">27,202</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Stock compensation</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-115" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="f-790">5,702</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-116" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="f-791">3,280</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Events</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-115" decimals="-3" name="lfvn:EventsExpense" format="ixt:num-dot-decimal" scale="3" id="f-792">3,791</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-116" decimals="-3" name="lfvn:EventsExpense" format="ixt:num-dot-decimal" scale="3" id="f-793">4,321</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-115" decimals="-3" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="3" id="f-794">3,156</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-116" decimals="-3" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="3" id="f-795">3,581</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Credit card and bank processing fees</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-115" decimals="-3" name="lfvn:CreditCardAndBankingProcessingFees" format="ixt:num-dot-decimal" scale="3" id="f-796">6,694</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-116" decimals="-3" name="lfvn:CreditCardAndBankingProcessingFees" format="ixt:num-dot-decimal" scale="3" id="f-797">6,051</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Other segment items</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-115" decimals="-3" name="us-gaap:SegmentReportingOtherItemAmount" format="ixt:num-dot-decimal" scale="3" id="f-798">19,035</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-116" decimals="-3" name="us-gaap:SegmentReportingOtherItemAmount" format="ixt:num-dot-decimal" scale="3" id="f-799">24,449</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Interest income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-115" decimals="-3" name="us-gaap:InvestmentIncomeInterest" scale="3" id="f-800">466</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-116" decimals="-3" name="us-gaap:InvestmentIncomeInterest" scale="3" id="f-801">451</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-115" decimals="-3" name="us-gaap:InterestExpenseNonoperating" scale="3" id="f-802">35</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-116" decimals="-3" name="us-gaap:InterestExpenseNonoperating" scale="3" id="f-803">21</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Income tax expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-115" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="f-804">2,438</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-116" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="f-805">1,413</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-115" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-806">9,805</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-116" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-807">2,937</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">(1) Other general and administrative expenses include legal, professional services, rent, utilities, and other miscellaneous expenses.</span></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">86</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="f-777-2"><ix:nonNumeric contextRef="c-1" name="us-gaap:LongLivedAssetsByGeographicAreasTableTextBlock" id="f-808" escape="true"><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the Company&#8217;s long-lived assets for its most significant geographic markets (in thousands):</span></div><div style="margin-bottom:8pt;margin-top:13pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:62.150%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.908%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.910%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">June&#160;30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-117" decimals="-3" name="us-gaap:NoncurrentAssets" format="ixt:num-dot-decimal" scale="3" id="f-809">18,446</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-118" decimals="-3" name="us-gaap:NoncurrentAssets" format="ixt:num-dot-decimal" scale="3" id="f-810">19,216</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Foreign:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Japan</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-119" decimals="-3" name="us-gaap:NoncurrentAssets" format="ixt:num-dot-decimal" scale="3" id="f-811">1,901</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-120" decimals="-3" name="us-gaap:NoncurrentAssets" format="ixt:num-dot-decimal" scale="3" id="f-812">1,925</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Other foreign markets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-121" decimals="-3" name="us-gaap:NoncurrentAssets" scale="3" id="f-813">472</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-122" decimals="-3" name="us-gaap:NoncurrentAssets" scale="3" id="f-814">612</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total foreign markets</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-123" decimals="-3" name="us-gaap:NoncurrentAssets" format="ixt:num-dot-decimal" scale="3" id="f-815">2,373</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-124" decimals="-3" name="us-gaap:NoncurrentAssets" format="ixt:num-dot-decimal" scale="3" id="f-816">2,537</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total long-lived assets</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:NoncurrentAssets" format="ixt:num-dot-decimal" scale="3" id="f-817">20,819</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:NoncurrentAssets" format="ixt:num-dot-decimal" scale="3" id="f-818">21,753</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Company has identified <ix:nonFraction unitRef="region" contextRef="c-1" decimals="INF" name="lfvn:NumberOfGeographicSegments" format="ixt-sec:numwordsen" scale="0" id="f-819">two</ix:nonFraction> major markets with revenues exceeding 10% of consolidated total revenue: United States and Japan.  There are 16 other markets, each of which individually is less than 10% of consolidated total revenue. Sales are recorded in the market in which the transaction occurred. <ix:nonNumeric contextRef="c-1" name="us-gaap:RevenueFromExternalCustomersByGeographicAreasTableTextBlock" id="f-820" continuedAt="f-820-1" escape="true">The following table presents the Company&#8217;s revenue disaggregated by these markets (in thousands):</ix:nonNumeric></span></div><ix:continuation id="f-820-1"><div style="margin-bottom:8pt;margin-top:13pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:62.150%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.908%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.910%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Years ended June&#160;30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-125" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-821">178,442</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-126" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-822">145,679</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Foreign:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Japan</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-127" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-823">25,394</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-128" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-824">26,989</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Other foreign markets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-129" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-825">24,694</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-130" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-826">27,496</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total foreign markets</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-131" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-827">50,088</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-132" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-828">54,485</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total revenue, net</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-829">228,530</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-830">200,164</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div></ix:continuation><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Major Products</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s revenue for the fiscal year ended June 30, 2025 is largely attributed to <ix:nonFraction unitRef="productline" contextRef="c-1" decimals="INF" name="lfvn:NumberOfProductLines" format="ixt-sec:numwordsen" scale="0" id="f-831">three</ix:nonFraction> product lines, Protandim</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">, LifeVantage</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">, and TrueScience</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">. On a combined basis, these <ix:nonFraction unitRef="productline" contextRef="c-1" decimals="INF" name="lfvn:NumberOfProductLines" format="ixt-sec:numwordsen" scale="0" id="f-832">three</ix:nonFraction> product lines represent approximately </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="number" contextRef="c-133" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-833">87.6</ix:nonFraction>% o</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">f the Company&#8217;s total net revenue for the fiscal year ended June&#160;30, 2025. Total revenue for the fiscal year ended June&#160;30, 2024 was largely attributed to <ix:nonFraction unitRef="productline" contextRef="c-8" decimals="INF" name="lfvn:NumberOfProductLines" format="ixt-sec:numwordsen" scale="0" id="f-834">two</ix:nonFraction> product lines, Protandim</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> and TrueScience</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">, which on a combined basis represented approximately <ix:nonFraction unitRef="number" contextRef="c-134" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-835">80.1</ix:nonFraction>% of total net revenue for that fiscal year. <ix:continuation id="f-779-1" continuedAt="f-779-2">The following table shows revenue by product line for the fiscal years ended June&#160;30, 2025 and 2024 (in thousands):</ix:continuation></span></div><ix:continuation id="f-779-2"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:62.243%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.788%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.936%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Years ended June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Protandim</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">&#174; </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">product line</span></div></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-135" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-836">95,328</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-136" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-837">104,135</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">LifeVantage</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">&#174; </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">product line</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-137" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-838">56,225</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-138" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-839">15,675</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">TrueScience</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">&#174; </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">product line</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-139" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-840">48,712</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-140" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-841">56,252</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">AXIO</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> product line</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-141" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-842">15,312</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-142" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-843">13,375</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">PhysIQ</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">&#8482;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> product line</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-143" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-844">5,102</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-144" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-845">3,827</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Petandim</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> product line</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-145" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-846">2,117</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-146" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-847">2,398</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Other</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-147" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-848">5,734</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-148" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-849">4,502</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total revenue, net</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-850">228,530</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-851">200,164</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">(1) Other revenue includes shipping and handling revenue, event related revenue, and other revenues impracticable to allocate to a specific product line.</span></div></ix:continuation></ix:continuation><div id="i7a9d1ca723db478892511ede354648f3_373"></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Note 14 &#8212; <ix:nonNumeric contextRef="c-1" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock" id="f-853" continuedAt="f-853-1" escape="true">Commitments and Contingencies</ix:nonNumeric></span></div><ix:continuation id="f-853-1" continuedAt="f-853-2"><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contingencies</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Company accounts for contingent liabilities in accordance with ASC 450, </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contingencies</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">. This guidance requires management to assess potential contingent liabilities that may exist as of the date of the financial statements to determine the probability and amount of loss that may have occurred, which inherently involves an exercise of judgment. If the assessment of a contingency indicates that it is probable that a material loss has been incurred and the amount of the liability can be estimated, </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">87</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="f-853-2" continuedAt="f-853-3"><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">then the estimated liability would be accrued in the Company&#8217;s financial statements. If the assessment indicates that a potential material loss contingency is not probable but is reasonably possible, or is probable but cannot be estimated, then the nature of the contingent liability, and an estimate of the range of possible losses, if determinable and material, would be disclosed. For loss contingencies considered remote, no accrual or disclosures are generally made. Management has assessed potential contingent liabilities as of June&#160;30, 2025, and based on the assessment there are no probable loss contingencies requiring accrual or disclosures within its financial statements.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Legal Accruals</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In addition to commitments and obligations in the ordinary course of business, from time to time, the Company is subject to various claims, pending and potential legal actions, investigations relating to governmental laws and regulations and other matters arising out of the normal conduct of its business. Management assesses contingencies to determine the degree of probability and range of possible loss for potential accrual in the consolidated financial statements. An estimated loss contingency is accrued in the consolidated financial statements if it is probable that a liability has been incurred and the amount of the loss can be reasonably estimated. Because evaluating legal claims and litigation results are inherently unpredictable and unfavorable results could occur, assessing contingencies is highly subjective and requires judgments about future events. When evaluating contingencies, management may be unable to provide a meaningful estimate due to a number of factors, including the procedural status of the matter in question, the presence of complex or novel legal theories, and/or the ongoing discovery and development of information important to the matters. In addition, damage amounts claimed or asserted against the Company may be unsupported, exaggerated, or unrelated to possible outcomes, and as such are not meaningful indicators of a potential liability. Management regularly reviews contingencies to determine the adequacy of financial statement accruals and related disclosures. The amount of ultimate loss may differ from these estimates. It is possible that cash flows or results of operations could be materially affected in any particular period by the unfavorable publicity or resolution of one or more of these contingencies. Whether any losses finally determined in any claim, action, investigation or proceeding or publicity related to such could reasonably have a material effect on the Company's business, financial condition, results of operations or cash flows will depend on a number of variables, including: the timing and amount of such losses; the structure and type of any remedies; the significance of the impact of any such losses, damages or remedies may have on the consolidated financial statements; and the unique facts and circumstances of the particular matter that may give rise to additional factors.</span></div></ix:continuation><div style="margin-bottom:8pt;margin-top:8pt"><ix:continuation id="f-853-3" continuedAt="f-853-4"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Other Matters</span></ix:continuation><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"><ix:continuation id="f-853-4">.   The Company may become involved in other litigation and regulatory matters incidental to its business and the matters disclosed in this annual report on Form 10-K, including, but not limited to, product liability claims, regulatory actions, employment matters and commercial disputes. The Company intends to defend itself in any such matters and does not currently believe that the outcome of any such matters will have a material adverse effect on the Company's business, financial condition, results of operations and cash flows.</ix:continuation> </span></div><div id="i7a9d1ca723db478892511ede354648f3_2946"></div><ix:nonNumeric contextRef="c-1" name="us-gaap:SubsequentEventsTextBlock" id="f-854" escape="true"><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Note 15 &#8212; Subsequent Events</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">On September 3, 2025, the Company entered into an Asset Purchase Agreement to acquire critical assets of a Global Organics Merchants, LLC, dba LoveBiome.  The transaction is expected to close by mid-October 2025, subject to satisfaction of customary closing conditions and regulatory requirements.  The Company has not yet determined the accounting purchase price allocation of the purchase consideration described above, which includes evaluating the fair value of the acquired assets and the valuation of contingent consideration to be transferred.</span></div></ix:nonNumeric><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">88</span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-19.1
<SEQUENCE>2
<FILENAME>insidertradingpolicy.htm
<DESCRIPTION>EX-19.1
<TEXT>
<HTML>
<HEAD><!-- Document generated by Workiva Inc -->
<TITLE>insidertradingpolicy</TITLE>
</HEAD>
<BODY bgcolor="white">
<DIV align="center">
<DIV style="margin-left:1em;width:1055;"><!-- insidertradingpolicy001.jpg -->
<DIV style="padding-top:2em;">
<IMG src="insidertradingpolicy001.jpg" title="slide1" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white"> 1  Insider Trading Policy   Amended and Restated on April 29, 2025  Introduction  LifeVantage Corporation (referred to herein as &#8220;LifeVantage&#8221; or the &#8220;Company&#8221;) is a  publicly traded company and is subject to United States securities laws which contain very strict  prohibitions regarding trading in securities. Trading in securities of publicly held companies while  in possession of Material Non-Public Information is against the law and can result in criminal  and civil fines, injunctive actions, jail and dismissal from the Company.  LifeVantage intends to comply with the spirit as well as the letter of the insider trading  laws. LifeVantage believes it is important to avoid even the appearance of insider trading, whether  or not the conduct is literally a violation of the law. For that reason, we have developed this written  policy (the &#8220;Policy&#8221;) to protect our officers, directors, employees, consultants and anyone else  associated with LifeVantage.  Material Non-Public Information  Information is material if there is a substantial likelihood that a reasonable investor would  consider it important to an investment decision. Information is important if it would be expected  to significantly alter the total mix of information in the marketplace about the issuer. Either positive  or negative information may be material.  While it is not possible to define all categories of material information, LifeVantage  generally regards information about the following matters to be material:  o financial results or expectations for the quarter or the year;  o unannounced proposed acquisitions;  o new product, discovery or invention;  o new market launches;  o notice of issuance of patents;  o confidential internal financial information or projections of future business  results;  o unannounced changes in the level of actual or anticipated income or  expenses, or financial or liquidity problems;  o planned stock splits, stock dividends and stock repurchases;  o defaults on securities, bankruptcy or liquidation;        </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- insidertradingpolicy002.jpg -->
<DIV style="padding-top:2em;">
<IMG src="insidertradingpolicy002.jpg" title="slide2" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">   2  o changes in relationships with significant independent Consultants;  o change in auditors or auditor notification that the Company may no longer  rely on an auditor&#8217;s audit report;  o unannounced decisions to issue dividends or to change the Company&#8217;s  dividend policy;  o unannounced Company financings, including new equity or debt offerings  or other financings;  o unannounced significant personnel changes;  o the existence of a special blackout period in which you may not trade  LifeVantage securities;  o significant cybersecurity incident, such as a data breach, or any other  significant disruption, loss, potential loss, breach or unauthorized access of  LifeVantage property or assets, whether at LifeVantage&#8217;s facilities or  through LifeVantage&#8217;s information technology infrastructure;  o unannounced significant litigation; and  o substantial changes in the Company&#8217;s accounting methods.  It is irrelevant how you obtain material non-public information. Liability may be imposed  whether the information is obtained during the course of your employment, from outside of  LifeVantage, or even accidentally or inadvertently such as overhearing a conversation.  In the event of a dispute concerning whether particular information is material, a court will  determine the materiality of the information in question after the fact, with the benefit of hindsight.  Therefore, if you are in doubt about whether the information you possess is material you should  assume the information is material and contact the LifeVantage&#8217;s Insider Trading Compliance  Official. Now and until further notice, the &#8220;Insider Trading Compliance Official&#8221; shall mean: (i)  with respect to members of the Company&#8217;s Board of Directors, General Counsel, all C-Suite  executive officers and then-current Section 16 officers, the Chair of the Audit Committee of the  Company&#8217;s Board of Directors and (ii) for all other persons subject to this Policy, the Company&#8217;s  General Counsel.  Non-public information is information that has not yet been made generally available to  all investors by distribution of a press release, a public filing with the Securities and Exchange  Commission or another broadly disseminated means of communication. Unless you have seen  material information publicly disseminated, you should assume the information is non-public. As  a general rule information is non-public until after the second trading day after the information has  been generally made available to all investors by distribution of a press release, a public filing with  the Securities and Exchange Commission or another broadly disseminated means of  communication. If, for example, LifeVantage were to make an announcement after the close of the  trading day on a Monday afternoon, you should not trade in LifeVantage securities until the  beginning of the trading day on the following Thursday when the market opens. Any questions as  to whether information is non-public should be directed to the Insider Trading Compliance Officer.  </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- insidertradingpolicy003.jpg -->
<DIV style="padding-top:2em;">
<IMG src="insidertradingpolicy003.jpg" title="slide3" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">   3  In order to prevent misuse, material non-public information may be disclosed only within  LifeVantage on a need to know basis or to LifeVantage&#8217;s designated advisors and/or attorneys  involved in the specific matter or transaction. If you have material non-public information about  LifeVantage or its business, you must keep this information in the highest confidence. If there are  rumors that are widespread and accurate, this does not constitute public information and you will  not be relieved from your obligations to treat such information as confidential. You must refrain  from disclosing or discussing such information with family members, friends or acquaintances.    Except for the Chief Executive Officer and the Chief Financial Officer, or another person  designated in writing by either of them, no employee, officer or director of LifeVantage shall discuss  the advantages or disadvantages of investing in LifeVantage with any other person or entity unless  the discussion is pursuant to the disclosing individual&#8217;s responsibilities for and on behalf of  LifeVantage. Any and all inquiries of or contacts with analysts or shareholders must be referred to  the LifeVantage Investor Relations Contact, the Chief Executive Officer or the Chief Financial  Officer. No other person is authorized to provide information to analysts. You must immediately  contact the Chief Executive Officer or the Chief Financial Officer if you discover that you  inadvertently disclosed information to an analyst.  The unauthorized posting of material non-public information in chat-rooms, in  communications with independent Consultants or via other electronic communications is expressly  prohibited under this Policy. This Policy also applies to information relating to any other company,  including current or prospective independent Consultants, customers, vendors or suppliers of  LifeVantage obtained in the course of your employment by or service to LifeVantage.  General Trading Policy  This Policy applies to all officers, directors, employees and consultants of LifeVantage, as  well as their family members. For purposes of this Insider Trading Policy, the term &#8220;family  member&#8221; shall mean a person&#8217;s spouse, parents, children, siblings, mothers- and fathers-in-law,  sons- and daughters-in-law, brothers- and sisters-in-law, and anyone (other than domestic  employees) who shares such person&#8217;s home. For clarity, certain independent Consultants are  covered by this Policy. It applies to all transactions of LifeVantage securities beneficially owned  by any of the above-named persons, including those securities held indirectly through any other  person or entity, such as a trust, corporation, partnership, or other association. This Policy applies  to any and all transactions in the common stock or any other securities (including notes, options  and warrants) that LifeVantage may issue.  It is the policy of LifeVantage that any of the above-named persons who possesses material  non-public information about LifeVantage may not buy or sell securities of LifeVantage nor engage  in any other action to take advantage of, or pass on to others, that information at any time.  Prohibited Transactions  Trading on Material Non-Public Information. You may not trade or otherwise engage in  any transaction involving a purchase or sale of LifeVantage securities, including but not limited to,  any offer to purchase or offer to sell, during any period commencing with the date that you possess  the material non-public information concerning LifeVantage, and ending at the end of the second  business day following the date of public disclosure of that information, or at such earlier time as  such non-public information is no longer material.  </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- insidertradingpolicy004.jpg -->
<DIV style="padding-top:2em;">
<IMG src="insidertradingpolicy004.jpg" title="slide4" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">   4  Tipping. You may not disclose (&#8220;tip&#8221;) material non-public information to any other person  (including family members) where such information may be used by such person for his or her  profit by trading in securities of the companies to which such information relates. You may not  make recommendations or express opinions based on material non-public information as to trading  in LifeVantage securities.    No Short Sales. Because short sales represent a bet that the price of LifeVantage stock will  decline, LifeVantage prohibits all persons subject to this Policy from shorting LifeVantage stock.    Derivative Securities. You may not participate in transactions in publicly-traded options,  such as puts and calls, and other derivative securities with respect to LifeVantage securities. This  prohibition extends to any hedging or similar transaction designed to decrease the risks associated  with holding LifeVantage securities. Stock options, restricted stock units, restricted stock, stock  appreciation rights and other securities issued pursuant to the LifeVantage benefit plans or other  compensatory arrangements with LifeVantage are not subject to this prohibition. Transactions in  derivative securities may reflect a short-term and speculative interest in LifeVantage securities and  may create the appearance of impropriety, even where a transaction does not involve trading on  material non-public information. Trading in derivatives may also focus attention on short-term  performance at the expense of LifeVantage&#8217;s long-term objectives. In addition, the application of  securities laws to derivatives transactions can be complex, and persons engaging in derivatives  transactions run an increased risk of violating securities laws.    LifeVantage also prohibits all persons subject to this Policy from acquiring any security or  position which would increase in value if the price of LifeVantage stock declines, such as a put  option. Any questions whether a transaction is a prohibited short sale should be directed to the  appropriate Insider Trading Compliance Official.  Trading Black Out Periods  In order to abide by the spirit and the letter of the laws prohibiting insider trading, no officer,  director or employee of the Company, together with their family members or other members of  their household, may purchase or sell any securities of LifeVantage during &#8220;black out periods.&#8221;  Periodic black out periods begin on the 15th day of the last month of each quarter, and end at the  end of the second business day after the date of filing with the Securities and Exchange  Commission of the quarterly or annual report that includes LifeVantage&#8217;s financial statements for  the most recently completed fiscal quarter or fiscal year. If, for example, LifeVantage were to  release results for a completed fiscal quarter on a Monday after market close, you should not trade  in LifeVantage securities until the following Thursday when the market opens. LifeVantage may  in its sole discretion implement other &#8220;black out periods&#8221; at other times when there is material non- public information. LifeVantage will evaluate potentially significant corporate events as they  develop and will notify you when a non-standard black out period commences and is terminated.  Except as discussed under the heading &#8220;Limited Exceptions&#8221; on Appendix A, this Policy,  including the restrictions on trading during &#8220;black out periods,&#8221; applies to all transactions involving  the securities of LifeVantage.  Even if outside a black out period, you may not trade in LifeVantage securities while in  possession of material non-public information. Trading in LifeVantage securities outside of a black  </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- insidertradingpolicy005.jpg -->
<DIV style="padding-top:2em;">
<IMG src="insidertradingpolicy005.jpg" title="slide5" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">   5  out period should not be considered a &#8220;safe harbor,&#8221; and all persons subject to this Policy should  use good judgment at all times.    Pre-Clearance Procedures  All directors and executive officers, together with their family members or other members  of their household, are strictly prohibited from purchasing or selling any securities of LifeVantage  at any time, unless they (a) have prior approval from the appropriate Insider Trading Compliance  Official (or the Chief Executive Officer in the case of a proposed purchase or sale by the appropriate  Insider Trading Compliance Official) or (b) are trading pursuant to an approved Rule 10b5-1 trading  plan (a &#8220;Trading Plan&#8221;) that has been pre-approved by the appropriate Insider Trading Compliance  Official.  A purchase or sale of LifeVantage securities pursuant to a Trading Plan that complies with  the requirements set forth in Appendix A hereto provides an affirmative defense against a claim  that such purchase or sale violated insider trading laws (e.g., that the trade was made on the basis  of material non-public information). This defense effectively serves as a safe harbor from liability  for insider trading when the Trading Plan is properly structured and followed.  All Trading Plans must be pre-approved by the appropriate Insider Trading Compliance  Official and must comply with the requirements set forth in Appendix A hereto. A request for  approval of a Trading Plan should be submitted at least five business days in advance of the date     proposed for entry into such Trading Plan. A request for approval of a trade other than pursuant to  an approved Trading Plan should be submitted at least two business days in advance of the proposed  transaction. Such written approval will expire at the end of the fifth trading day following the date of  the written approval or the beginning of the next black out period, whichever is earlier. Accordingly,  individuals should not request permission to enter into a Trading Plan or to trade unless there is an  intention to execute the Trading Plan or the trade immediately.                                                                                     The appropriate Insider Trading Compliance Official is under no obligation to approve a  proposed trade or Trading Plan and may determine not to grant approval in his or her sole  discretion. In the event that a trade request is denied by the appropriate Insider Trading Compliance  Official or Chief Executive Officer, as the case may be, an individual may make a one-time written  appeal to the Board of Directors for reconsideration. Any reconsideration decision by the Board of  Directors shall be final and non-appealable. In determining whether to grant approval, the  appropriate Insider Trading Compliance Official or the Board of Directors must determine that, to  the best of his, her or their knowledge and judgment, the individual requesting to trade does not  have knowledge of any material non-public information concerning LifeVantage and that the  individual does not have access to any material non-public information.  Holding Securities in Margin Accounts. You may not hold LifeVantage securities in margin  accounts without the approval of the appropriate Insider Trading Compliance Officer (or the Chief  Executive Officer, in the case of proposed purchases and sales by the appropriate Insider Trading  Compliance Official). Under typical margin arrangements, if you fail to meet a margin call, the  broker may be entitled to sell securities held in the margin account without your consent. The sale,  even though not initiated at your request, is still considered a sale for your benefit. If made at a  time when you are aware of material non-public information or are otherwise not permitted to trade  in LifeVantage securities, the sale may result in inadvertent insider trading violations, Section 16  violations (for officers and directors), violations of this Policy and unfavorable publicity for you  </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- insidertradingpolicy006.jpg -->
<DIV style="padding-top:2em;">
<IMG src="insidertradingpolicy006.jpg" title="slide6" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">   6  and LifeVantage. For these reasons, even if you are permitted to hold LifeVantage securities in  margin accounts, you should exercise caution when doing so.  Potential Criminal and Civil Liability and/or Disciplinary Action  Liability for Insider Trading. Engaging in transactions in securities at a time when you have  knowledge of material non-public information regarding the subject company can result in  penalties of up to $5,000,000 and up to twenty years in jail.  Liability for Tipping. You may also be liable for improper transactions by any person  (commonly referred to as a &#8220;tippee&#8221;) to whom you have disclosed material non-public information  regarding LifeVantage or to whom you have made recommendations or expressed opinions based  on such information as to trading in LifeVantage securities. The Securities and Exchange  Commission has imposed large penalties even when the disclosing person did not profit from the  trading. The Securities and Exchange Commission, the stock exchanges and the Financial Industry  Regulatory Authority, use sophisticated electronic surveillance techniques to uncover insider  trading.  Disciplinary Actions. A violation of this Policy could result in disciplinary action, which  may include, in addition to other sanctions, ineligibility for future participation in LifeVantage  equity incentive plans or termination of employment.  Controlling Persons.  As of the date of this Policy, the penalty for insider trading violations  of controlling persons is a civil fine of up to the greater of $1 million or three times the profit gained  or loss avoided as a result of the insider trading violations, as well as potential criminal fines and  imprisonment.    Stop Transfer Order. LifeVantage may in its discretion impose or maintain stop transfer  orders on securities held by subject persons during a Blackout Period.  In the event you learn of any violation of this Policy, including violations by yourself  (which may be inadvertent) or violations of others, you must immediately report such violation(s)  to the Chief Executive Officer, the Chief Financial Officer, the General Counsel or the appropriate  Insider Trading Compliance Official.  Post-Termination Transactions  This Policy continues to apply to your transactions in LifeVantage securities even after  your employment, directorship or consulting relationship with LifeVantage has been terminated.  If you are in possession of material non-public information when your employment or other such  relationship terminates, you may not trade in LifeVantage securities until after the end of the second  business day following the date of public disclosure of that information, or at such earlier time as  such non-public information is no longer material.  Additional Information - Directors and Executive Officers  Directors and executive officers of LifeVantage must also comply with the reporting  obligations and limitations on short-swing transactions set forth in Section 16 of the Securities  Exchange Act of 1934, as amended (&#8220;Section 16&#8221;). The practical effect of these provisions is that  </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- insidertradingpolicy007.jpg -->
<DIV style="padding-top:2em;">
<IMG src="insidertradingpolicy007.jpg" title="slide7" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">   7  directors and executive officers who purchase and sell LifeVantage securities within a six-month  period must disgorge all profits to LifeVantage whether or not they had knowledge of any material  non-public information. Under these provisions, and so long as certain other criteria are met, in  most cases neither the receipt of an option under LifeVantage&#8217;s equity incentive plans, nor the  exercise of that option is deemed a purchase under Section 16; however, the sale of any such shares  is a sale under Section 16. The exercise of options by directors and executive officers, although not  subject to short-swing liability, must be disclosed on a Form 4 filed within two business days after  the exercise occurs. LifeVantage has provided, or will provide, separate memoranda and other  appropriate materials to its executive officers and directors regarding compliance with Section 16  and its related rules.  To facilitate timely reporting of transactions pursuant to Section 16 requirements, if you  are subject to Section 16 reporting requirements you must provide, or must ensure that your broker  provides, LifeVantage with detailed information (e.g., trade date, number of shares, exact price,  etc.) regarding your transactions involving LifeVantage securities, including gifts, transfers,  pledges and transactions pursuant to a trading plan, both prior to the transaction (to confirm  compliance with pre-clearance procedures, if applicable) and on the date of the transaction.  The obligation to file Section 16 reports, and to otherwise comply with Section 16, is  personal. LifeVantage is not responsible for the failure to comply with Section 16 requirements.  Additional Information and Inquiries About Insider Trading  The Policy and the above restrictions are in addition to the legal requirements relating to  LifeVantage securities that may otherwise apply to the directors, officers, employees and  consultants of LifeVantage. Please direct your questions regarding insider trading to the  appropriate Insider Trading Compliance Official. All decisions of the appropriate Insider Trading  Compliance Official or the Board of Directors concerning this Policy are final and binding.  </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- insidertradingpolicy008.jpg -->
<DIV style="padding-top:2em;">
<IMG src="insidertradingpolicy008.jpg" title="slide8" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">    Appendix A  Requirements for Rule 10b5-1 Trading Plans  A Rule 10b5-1 &#8220;trading plan&#8221; involving purchases or sales of LifeVantage securities must comply  with the requirements of Rule 10b5-1 and must meet the following requirements:  1. The trading plan must be in writing and signed by the person adopting the trading plan.  2. The trading plan must be adopted at a time when:  &#8226; the person adopting the trading plan is not aware of any material non-public  information (&#8220;MNPI&#8221;); and  &#8226; there is no quarterly, special or other trading blackout in effect with respect to the  person adopting the trading plan.  3. The trading plan must be entered in good faith and not as part of a plan or scheme to evade  the prohibitions of Rule 10b5-1 and the individual adopting the trading plan must act in  good faith with respect to the plan during its duration.    4. In addition, directors and Section 16 Officers of the Company must represent in a trading  plan at the time of its adoption (or modification) that (i) they are not aware of any MNPI  about the Company or its securities, and (ii) they are adopting (or modifying) the trading  plan in good faith and not as part of a plan or scheme to evade the prohibitions of Rule  10b5-1.  5. The individual adopting the trading plan may not have entered into or altered a  corresponding or hedging transaction or position with respect to the securities subject to  the trading plan and must agree not to enter into any such transaction while the trading plan  is in effect.  6. The first trade under the trading plan may not occur until   &#8226; for directors and Section 16 officers of the Company, the later of (i) 90 calendar  days after adoption of the trading plan, or (ii) two business days following the filing  of the Form 10-Q or Form 10-K for the fiscal quarter in which the plan was adopted  (but in any event, no more than 120 calendar days after the adoption of the trading  plan);  &#8226; for all other persons, 30 days after the adoption of the trading plan.  7. The trading plan must have a minimum term of one year and a maximum term of two years  (each starting from the time when trades may first occur in accordance with these  requirements). There is a limitation of one single-trade plan during any consecutive 12- month period.  </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- insidertradingpolicy009.jpg -->
<DIV style="padding-top:2em;">
<IMG src="insidertradingpolicy009.jpg" title="slide9" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">    8. All transactions during the term of the trading plan (except for the other &#8220;Limited  Exceptions&#8221; identified in LifeVantage&#8217;s insider trading policy) must be conducted through  the trading plan.  9. The trading plan cannot overlap with another Rule 10b5-1 trading plan, unless one of the  following exceptions applies:   &#8226; Eligible &#8220;sell-to-cover&#8221; transactions (i.e., authorizing the sale of securities as  necessary to satisfy tax withholding obligations arising exclusively from the vesting  of a compensatory award where the insider doesn&#8217;t otherwise exercise control over  the timing of such sales) are not considered separate plans that count against this  prohibition.  &#8226; A series of separate contracts with different broker-dealers that effectively function  as a single trading plan are not considered overlapping plans.  &#8226; Trades under an existing trading plan can continue to run during the cooling-off  period for a new trading plan if the following conditions are met: (i) trading under  the new trading plan may not begin until after all trades under the existing trading  plan are completed or expire without execution, and (ii) the applicable cooling off  period under the new trading plan, running from the date of its adoption, has been  met; provided, however, if the existing trading plan is terminated early (i.e., before  its scheduled completion date), then the applicable cooling-off period for the new  trading plan must run from the date of the termination of the existing trading plan.  10. Regarding material modifications (where such modifications change the amount, price or  timing of the purchase or sale of securities pursuant to the plan, but does not include  immaterial modifications):  &#8226; The trading plan may only be modified when the person modifying the trading  plan is not aware of MNPI.  &#8226; The trading plan may only be modified when there is no quarterly, special or other  blackout in effect with respect to the person modifying the plan.  &#8226; The first trade under the modified trading plan may only occur in accordance with  the cooling off periods noted in item 6 above. The existing plan would remain in  effect until the modified plan comes into effect.  &#8226; The modified trading plan must have a minimum duration of one year and a  maximum term of two years (each starting from the time when trades may first  occur under the modified plan in accordance with these requirements).  11. A person may only modify a trading plan once in a one-year period.  12. If the person that adopted the trading plan terminates the plan prior to its stated duration,  he or she may not trade in LifeVantage&#8217;s securities until the cooling off periods noted in  item 6 above have been met.  13. LifeVantage must be promptly notified of any modification or termination of the trading  plan, including any suspension of trading under the plan.  </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- insidertradingpolicy010.jpg -->
<DIV style="padding-top:2em;">
<IMG src="insidertradingpolicy010.jpg" title="slide10" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">    14. If the trading plan grants discretion to a stockbroker or other person with respect to the  execution of trades under the plan:  &#8226; trades made under the trading plan must be executed by someone other than the  stockbroker or other person that executes trades in other securities for the person  adopting the trading plan;  &#8226; the person adopting the trading plan may not confer with the person administering  the trading plan regarding LifeVantage or its securities; and  &#8226; the person administering the trading plan must provide prompt notice to  LifeVantage of the execution of a transaction pursuant to the plan.  15. All transactions under the trading plan must be in accordance with applicable law.  16. The trading plan (including any modified trading plan) must meet such other requirements  as the appropriate Insider Trading Compliance Official may determine.  17. The appropriate Insider Trading Compliance Official must approve and keep a copy of each  adopted trading plan.  LIMITED EXCEPTIONS  The following are certain limited exceptions to the restrictions imposed by LifeVantage under this  Policy. Please be aware that even if a transaction is subject to an exception to this Policy, you will  need to separately assess whether the transaction complies with applicable law. For example, even  if a transaction is indicated as exempt from this Policy, you may need to comply with the &#8220;short- swing&#8221; trading restrictions under Section 16 of the Exchange Act, if applicable. You are  responsible for complying with applicable law at all times.  A. Transactions Pursuant to a Trading Plan that Complies with SEC Rules  The Securities and Exchange Commission has enacted rules that provide an affirmative  defense against alleged violations of U.S. federal insider trading laws for transactions pursuant to  trading plans that meet certain </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- insidertradingpolicy011.jpg -->
<DIV style="padding-top:2em;">
<IMG src="insidertradingpolicy011.jpg" title="slide11" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">    requirements. In general, these rules, as set forth in Rule 10b5-1 under the Exchange Act, provide  for an affirmative defense if you enter into a contract, provide instructions or adopt a written plan  for trading securities when you are not aware of material non-public information. The contract,  instructions or plan must (i) specify the amount, price and date of the transaction, (ii) specify an  objective method for determining the amount, price and date of the transaction and/or (iii) place any  subsequent discretion for determining the amount, price and date of the transaction in another person  who is not, at the time of the transaction, aware of material non-public information.  Transactions made pursuant to a written trading plan that (i) complies with the affirmative  defense set forth in Rule 10b5-1, (ii) complies with the requirements set forth in this Appendix A  and (iii) is approved by the appropriate Insider Trading Compliance Official, are not subject to the  restrictions in this Policy against trades made while aware of material non-public information or to  the preclearance procedures or blackout periods established under this Policy. In approving a  trading plan, the appropriate Insider Trading Compliance Official may, in furtherance of the  objectives expressed in this Policy, impose criteria in addition to those set forth in Rule 10b5-1.  The Securities and Exchange Commission rules regarding trading plans are complex, and  you must comply with them completely for your trading plan to be effective. The description  provided above is only a summary, and LifeVantage strongly advises that you consult with your  personal legal advisor if you intend to adopt a trading plan. While trading plans are subject to  LifeVantage review and approval, you are ultimately responsible for compliance with Rule 10b5- 1 and this Policy.  The appropriate Insider Trading Compliance Official must keep a copy of each adopted trading  plan. LifeVantage may publicly disclose information regarding trading plans that you may enter  (including but not limited to information required by Regulation S-K Item 408) and you, or the  Company on your behalf, will identify as Rule 10b5-1 transactions as such on Form 4 and 5, if  applicable.  B. Receipt and Vesting of Stock Options, Restricted Stock Units, Restricted Stock and Stock  Appreciation Rights  The trading restrictions under this Policy do not apply to the grant or award of stock options,  restricted stock units, restricted stock or stock appreciation rights issued or offered by LifeVantage.  The trading restrictions under this Policy also do not apply to the vesting, cancellation or forfeiture of  stock options, restricted stock units, restricted stock or stock appreciation rights in accordance with  applicable plans and agreements. The trading restrictions do apply, however, to any subsequent sales  of any such securities or the common stock underlying such securities, including discretionary &#8220;sell  to cover taxes&#8221; for restricted stock units or &#8220;net exercises&#8221; of stock options and any other market sale  for the purpose of generating cash needed to pay withholding taxes related to the settlement of  restricted units or stock option exercises.  C. Cash or Cashless Net Exercise of Stock Options   The trading restrictions under this Policy do not apply to the exercise of stock options for  cash under LifeVantage&#8217;s equity incentive plans. Likewise, the trading restrictions under this  Policy do not apply to the exercise of stock options in a stock-for-stock exercise with LifeVantage  or an election to have LifeVantage withhold securities to cover tax obligations in connection with  an option exercise. However, the trading restrictions under this Policy do apply to (i) the sale of  </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- insidertradingpolicy012.jpg -->
<DIV style="padding-top:2em;">
<IMG src="insidertradingpolicy012.jpg" title="slide12" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">    any securities issued upon the exercise of a stock option, (ii) a cashless exercise of a stock option  through a broker, because this involves selling a portion of the underlying shares to cover the costs  of exercise, and (iii) any other market sale for the purpose of generating the cash needed to pay the  exercise price of an option.  D. Purchases from the Employee Stock Purchase Plan  The trading restrictions in this Policy do not apply to elections with respect to participation in  LifeVantage&#8217;s employee stock purchase plan or to purchases of securities under the plan. However,  the trading restrictions do apply to any subsequent sales of any such securities acquired therefrom.  E. Stock Splits, Stock Dividends and Similar Transactions  The trading restrictions under this Policy do not apply to a change in the number of  securities held as a result of a stock split or stock dividend applying equally to all securities of a  class, or similar transactions.  F. Bona Fide Gifts and Inheritance  The trading restrictions under this Policy do not apply to bona fide gifts involving  LifeVantage securities or transfers by will or the laws of descent and distribution. However, (i) if  you have reason to believe that the recipient intends to sell Company securities while you are aware  of material nonpublic information or, (ii) if (A) you are subject to the trading restrictions specified  above under the heading &#8220;Trading Blackout Periods,&#8221; and (B) you have reason to believe that the  recipient intends to sell Company securities during a blackout period, then the trading restrictions  apply. In addition, the trading restrictions under this Policy do apply to the sale of any gifted or  inherited securities if the recipient, for example, an immediate family member, is subject to this  Policy. In other words, you cannot use a gift to conduct a transaction that otherwise would be  prohibited under this Policy.  G. Change in Form of Ownership  Transactions that involve merely a change in the form in which you own securities are not  subject to the trading restrictions under this Policy. For example, you may transfer shares to an  inter vivos trust of which you are the sole beneficiary during your lifetime.  H. Other Exceptions  Any other exception from this Policy must be approved by the appropriate Insider Trading  Compliance Official, in consultation with the Board of Directors or an independent committee of  the Board of Directors.    </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
</DIV>
</DIV>
</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-21.1
<SEQUENCE>3
<FILENAME>ex211listofsubsidiaries063.htm
<DESCRIPTION>EX-21.1
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2025 Workiva -->
<title>Document</title></head><body><div id="i312c283fe30442bf94030a6a320d3a27_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:130%">Exhibit 21.1</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">SUBSIDIARIES OF LIFEVANTAGE CORPORATION</font></div><div style="text-align:center"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Set forth below is a list of all subsidiaries of LifeVantage Corporation, a Delaware corporation, and the state or country of incorporation of each as of June 30, 2025.</font></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:18.372%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:30.964%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.410%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:22.326%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:22.328%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Name</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">State or Country of Incorporation</font></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Dinng Creative, Inc.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Utah</font></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Importadora LifeVantage S. de R.L. de C.V.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Mexico</font></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">LFVN Malaysia SDN. BHD.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Malaysia</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">LifeLine Nutraceuticals Corporation</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Colorado</font></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">LifeVantage Asia Pte. Ltd.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Singapore</font></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">LifeVantage Australia Pty. Ltd.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Australia</font></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">LifeVantage Canada Ltd.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Canada</font></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">LifeVantage de Mexico S. de R.L. de C.V.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Mexico</font></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">LifeVantage Hong Kong Limited</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Hong Kong</font></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">LifeVantage Japan Kabushiki Kaisha (KK)</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Japan</font></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">LifeVantage Netherlands B.V.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Netherlands</font></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">LifeVantage New Zealand Limited</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">New Zealand</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">LifeVantage Singapore Pte. Ltd.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Singapore</font></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">LifeVantage Taiwan Pte. Ltd.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Taiwan</font></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">LifeVantage Thailand Company Limited</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Thailand</font></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">LifeVantage UK Limited</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">United Kingdom</font></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Protandum Philippines Corporation</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Philippines</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Puyoujian (Guangzhou) Technology Co., Ltd.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">China</font></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>4
<FILENAME>ex231deloitteconsent063020.htm
<DESCRIPTION>EX-23.1
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2025 Workiva -->
<title>Document</title></head><body><div id="if4130fdeb78d45fd8b96a5301bfea8b5_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:130%">Exhibit 23.1</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</font></div><div style="text-align:center"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:130%">We consent to the incorporation by reference in Registration Statement Nos. 333-252013, 333-228627, 333-216957, 333-200363, 333-183461, 333-175104, 333-158704, and 333-144247 on Form S-8, and the Registration Statement No. 333-271061 on Form S-3 of our report dated September&#160;4, 2025, relating to the financial statements of LifeVantage Corporation and the effectiveness of LifeVantage Corporation's internal control over financial reporting, appearing in the Annual Report on Form 10-K of LifeVantage Corporation for the year ended June&#160;30, 2025.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:130%">&#47;s&#47; Deloitte &#38; Touche, LLP</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:130%">Salt Lake City, Utah</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:130%">September&#160;4, 2025</font></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>5
<FILENAME>ex311ceosec302certificatio.htm
<DESCRIPTION>EX-31.1
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2025 Workiva -->
<title>Document</title></head><body><div id="id3be4c7517074f7980933e87bfa37057_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">EXHIBIT 31.1</font></div><div style="margin-top:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO SECURITIES EXCHANGE ACT RULES 13a-14(a) AND 15(d)-14(a)</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="margin-top:14pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">I, Steven R. Fife, certify that&#58;</font></div><div style="margin-top:14pt;padding-left:22.5pt;text-indent:-22.5pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15pt">I have reviewed this Annual Report on Form 10-K of LifeVantage Corporation&#59;</font></div><div style="margin-top:14pt;padding-left:22.5pt;text-indent:-22.5pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="margin-top:14pt;padding-left:22.5pt;text-indent:-22.5pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="margin-top:14pt;padding-left:22.5pt;text-indent:-22.5pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15pt">The registrant&#8217;s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="margin-top:14pt;padding-left:36pt;text-indent:-13.5pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.57pt">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="margin-top:14pt;padding-left:36pt;text-indent:-13.5pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">b.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6pt">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="margin-top:14pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">c.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.07pt">Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="margin-top:14pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">d.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div><div style="margin-top:14pt;padding-left:22.5pt;text-indent:-22.5pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15pt">The registrant&#8217;s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="margin-top:14pt;padding-left:36pt;text-indent:-13.5pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.57pt">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="margin-top:14pt;padding-left:36pt;text-indent:-13.5pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">b.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6pt">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.760%"><tr><td style="width:1.0%"></td><td style="width:59.968%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:37.832%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">September 4, 2025</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Steven R. Fife</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Steven R. Fife</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">President&#160;&#38; Chief Executive Officer<br>(Principal Executive Officer)</font></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>6
<FILENAME>ex312cfosec302certificatio.htm
<DESCRIPTION>EX-31.2
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2025 Workiva -->
<title>Document</title></head><body><div id="ib0f7eb57f0484e638798a4e9938b3030_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">EXHIBIT 31.2</font></div><div style="margin-top:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO SECURITIES EXCHANGE ACT RULES 13a-14(a) AND 15(d)-14(a)</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="margin-top:9pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">I, Carl A. Aure, certify that&#58;</font></div><div style="margin-top:9pt;padding-left:22.5pt;text-indent:-22.5pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15pt">I have reviewed this Annual Report on Form 10-K of LifeVantage Corporation&#59;</font></div><div style="margin-top:9pt;padding-left:22.5pt;text-indent:-22.5pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="margin-top:9pt;padding-left:22.5pt;text-indent:-22.5pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="margin-top:9pt;padding-left:22.5pt;text-indent:-22.5pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15pt">The registrant&#8217;s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="margin-top:9pt;padding-left:40.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.07pt">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="margin-top:9pt;padding-left:40.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">b.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="margin-top:9pt;padding-left:40.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">c.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.07pt">Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="margin-top:9pt;padding-left:40.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">d.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div><div style="margin-top:9pt;padding-left:22.5pt;text-indent:-22.5pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15pt">The registrant&#8217;s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="margin-top:9pt;padding-left:58.5pt;text-indent:-22.5pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.57pt">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="margin-top:9pt;padding-left:58.5pt;text-indent:-22.5pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">b.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15pt">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:89.327%"><tr><td style="width:1.0%"></td><td style="width:64.366%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:33.434%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">September 4, 2025</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Carl A. Aure</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Carl A. Aure<br>Chief Financial Officer<br>(Principal Financial Officer and Principal Accounting Officer)</font></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>7
<FILENAME>ex321ceosec906certificatio.htm
<DESCRIPTION>EX-32.1
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2025 Workiva -->
<title>Document</title></head><body><div id="i622dfcd99e6f476db83f2c7b5a247874_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">EXHIBIT 32.1</font></div><div style="margin-top:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="margin-top:9pt;text-indent:24.75pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the filing of this annual report on Form 10-K of LifeVantage Corporation (the &#8220;Company&#8221;) for the period ended June&#160;30, 2025, with the Securities and Exchange Commission on the date hereof (the &#8220;Report&#8221;), I, Steven R. Fife, President and Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. Section&#160;1350, as adopted pursuant to Section&#160;906 of the Sarbanes-Oxley Act of 2002, that&#58;</font></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The Report fully complies with the requirements of Section&#160;13(a) or 15(d) of the Securities Exchange Act of 1934&#59; and</font></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:90.643%"><tr><td style="width:1.0%"></td><td style="width:64.061%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:33.739%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">September 4, 2025</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Steven R. Fife</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Steven R. Fife<br>President&#160;&#38; Chief Executive Officer<br>(Principal Executive Officer)</font></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.2
<SEQUENCE>8
<FILENAME>ex322cfosec906certificatio.htm
<DESCRIPTION>EX-32.2
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2025 Workiva -->
<title>Document</title></head><body><div id="ide970e9381254530a2e803e9cb8df1b2_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">EXHIBIT 32.2</font></div><div style="margin-top:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="margin-top:9pt;text-indent:24.75pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the filing of this annual report on Form 10-K of LifeVantage Corporation (the &#8220;Company&#8221;) for the period ended June&#160;30, 2025, with the Securities and Exchange Commission on the date hereof (the &#8220;Report&#8221;), I, Carl A. Aure, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section&#160;1350, as adopted pursuant to Section&#160;906 of the Sarbanes-Oxley Act of 2002, that&#58;</font></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The Report fully complies with the requirements of Section&#160;13(a) or 15(d) of the Securities Exchange Act of 1934&#59; and</font></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:86.549%"><tr><td style="width:1.0%"></td><td style="width:66.974%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:30.826%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">September 4, 2025</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Carl A. Aure</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:9pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Carl A. Aure</font></div><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Chief Financial Officer</font></div><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(Principal Financial Officer and Principal Accounting Officer)</font></div></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>9
<FILENAME>lfvn-20250630.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:60c7f1f2-d52d-4c01-b992-aaf8be1801ed,g:81eb96f2-7ea0-4e0b-9dac-655ac6c272fe-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:lfvn="http://www.lifevantage.com/20250630" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2024-01-31" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.lifevantage.com/20250630">
  <xs:import namespace="http://fasb.org/srt/2025" schemaLocation="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd"/>
  <xs:import namespace="http://fasb.org/us-gaap/2025" schemaLocation="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2024-01-31" schemaLocation="https://www.xbrl.org/dtr/type/2024-01-31/types.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/country/2025" schemaLocation="https://xbrl.sec.gov/country/2025/country-2025.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/cyd-af-sub/2025" schemaLocation="https://xbrl.sec.gov/cyd/2025/cyd-af-sub-2025.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2025" schemaLocation="https://xbrl.sec.gov/dei/2025/dei-2025.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/ecd/2025" schemaLocation="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="lfvn-20250630_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="lfvn-20250630_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="lfvn-20250630_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="lfvn-20250630_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="CoverPage" roleURI="http://www.lifevantage.com/role/CoverPage">
        <link:definition>0000001 - Document - Cover Page</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AuditInformation" roleURI="http://www.lifevantage.com/role/AuditInformation">
        <link:definition>0000002 - Document - Audit Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDBALANCESHEETS" roleURI="http://www.lifevantage.com/role/CONSOLIDATEDBALANCESHEETS">
        <link:definition>9952151 - Statement - CONSOLIDATED BALANCE SHEETS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDBALANCESHEETSParenthetical" roleURI="http://www.lifevantage.com/role/CONSOLIDATEDBALANCESHEETSParenthetical">
        <link:definition>9952152 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOME" roleURI="http://www.lifevantage.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOME">
        <link:definition>9952153 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" roleURI="http://www.lifevantage.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY">
        <link:definition>9952154 - Statement - CONSOLIDATED STATEMENTS OF STOCKHOLDERS&#8217; EQUITY</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDSTATEMENTSOFCASHFLOWS" roleURI="http://www.lifevantage.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS">
        <link:definition>9952155 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="TheCompany" roleURI="http://www.lifevantage.com/role/TheCompany">
        <link:definition>9952156 - Disclosure - The Company</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPolicies" roleURI="http://www.lifevantage.com/role/SummaryofSignificantAccountingPolicies">
        <link:definition>9952157 - Disclosure - Summary of Significant Accounting Policies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Revenue" roleURI="http://www.lifevantage.com/role/Revenue">
        <link:definition>9952158 - Disclosure - Revenue</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PropertyandEquipmentNet" roleURI="http://www.lifevantage.com/role/PropertyandEquipmentNet">
        <link:definition>9952159 - Disclosure - Property and Equipment, Net</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IntangibleAssetsNet" roleURI="http://www.lifevantage.com/role/IntangibleAssetsNet">
        <link:definition>9952160 - Disclosure - Intangible Assets, Net</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtherAccruedExpenses" roleURI="http://www.lifevantage.com/role/OtherAccruedExpenses">
        <link:definition>9952161 - Disclosure - Other Accrued Expenses</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LongTermDebt" roleURI="http://www.lifevantage.com/role/LongTermDebt">
        <link:definition>9952162 - Disclosure - Long-Term Debt</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquity" roleURI="http://www.lifevantage.com/role/StockholdersEquity">
        <link:definition>9952163 - Disclosure - Stockholders' Equity</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareBasedCompensation" roleURI="http://www.lifevantage.com/role/ShareBasedCompensation">
        <link:definition>9952164 - Disclosure - Share-Based Compensation</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtherExpenseNet" roleURI="http://www.lifevantage.com/role/OtherExpenseNet">
        <link:definition>9952165 - Disclosure - Other Expense, Net</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxes" roleURI="http://www.lifevantage.com/role/IncomeTaxes">
        <link:definition>9952166 - Disclosure - Income Taxes</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Leases" roleURI="http://www.lifevantage.com/role/Leases">
        <link:definition>9952167 - Disclosure - Leases</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentInformation" roleURI="http://www.lifevantage.com/role/SegmentInformation">
        <link:definition>9952168 - Disclosure - Segment Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingencies" roleURI="http://www.lifevantage.com/role/CommitmentsandContingencies">
        <link:definition>9952169 - Disclosure - Commitments and Contingencies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SubsequentEvents" roleURI="http://www.lifevantage.com/role/SubsequentEvents">
        <link:definition>9952170 - Disclosure - Subsequent Events</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesPolicies" roleURI="http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesPolicies">
        <link:definition>9955511 - Disclosure - Summary of Significant Accounting Policies (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesTables" roleURI="http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesTables">
        <link:definition>9955512 - Disclosure - Summary of Significant Accounting Policies (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueTables" roleURI="http://www.lifevantage.com/role/RevenueTables">
        <link:definition>9955513 - Disclosure - Revenue (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PropertyandEquipmentNetTables" roleURI="http://www.lifevantage.com/role/PropertyandEquipmentNetTables">
        <link:definition>9955514 - Disclosure - Property and Equipment, Net (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IntangibleAssetsNetTables" roleURI="http://www.lifevantage.com/role/IntangibleAssetsNetTables">
        <link:definition>9955515 - Disclosure - Intangible Assets, Net (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtherAccruedExpensesTables" roleURI="http://www.lifevantage.com/role/OtherAccruedExpensesTables">
        <link:definition>9955516 - Disclosure - Other Accrued Expenses (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareBasedCompensationTables" roleURI="http://www.lifevantage.com/role/ShareBasedCompensationTables">
        <link:definition>9955517 - Disclosure - Share-Based Compensation (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtherExpenseNetTables" roleURI="http://www.lifevantage.com/role/OtherExpenseNetTables">
        <link:definition>9955518 - Disclosure - Other Expense, Net (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesTables" roleURI="http://www.lifevantage.com/role/IncomeTaxesTables">
        <link:definition>9955519 - Disclosure - Income Taxes (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesTables" roleURI="http://www.lifevantage.com/role/LeasesTables">
        <link:definition>9955520 - Disclosure - Leases (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentInformationTables" roleURI="http://www.lifevantage.com/role/SegmentInformationTables">
        <link:definition>9955521 - Disclosure - Segment Information (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="TheCompanyDetails" roleURI="http://www.lifevantage.com/role/TheCompanyDetails">
        <link:definition>9955522 - Disclosure - The Company (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesNarrativeDetails" roleURI="http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails">
        <link:definition>9955523 - Disclosure - Summary of Significant Accounting Policies - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesInventoryDetails" roleURI="http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesInventoryDetails">
        <link:definition>9955524 - Disclosure - Summary of Significant Accounting Policies - Inventory (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesScheduleOfInventoryValuationReserveDetails" roleURI="http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesScheduleOfInventoryValuationReserveDetails">
        <link:definition>9955525 - Disclosure - Summary of Significant Accounting Policies - Schedule Of Inventory Valuation Reserve (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesPropertyandEquipmentDetails" roleURI="http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesPropertyandEquipmentDetails">
        <link:definition>9955526 - Disclosure - Summary of Significant Accounting Policies - Property and Equipment (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesComputationofNetIncomePerShareDetails" roleURI="http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesComputationofNetIncomePerShareDetails">
        <link:definition>9955527 - Disclosure - Summary of Significant Accounting Policies - Computation of Net Income Per Share (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesSegmentInformationDetails" roleURI="http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesSegmentInformationDetails">
        <link:definition>9955528 - Disclosure - Summary of Significant Accounting Policies - Segment Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueNarrativeDetails" roleURI="http://www.lifevantage.com/role/RevenueNarrativeDetails">
        <link:definition>9955529 - Disclosure - Revenue - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueSalesReturnDetails" roleURI="http://www.lifevantage.com/role/RevenueSalesReturnDetails">
        <link:definition>9955530 - Disclosure - Revenue - Sales Return (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueMajorProductsDetails" roleURI="http://www.lifevantage.com/role/RevenueMajorProductsDetails">
        <link:definition>9955531 - Disclosure - Revenue - Major Products (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PropertyandEquipmentNetDetails" roleURI="http://www.lifevantage.com/role/PropertyandEquipmentNetDetails">
        <link:definition>9955532 - Disclosure - Property and Equipment, Net (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IntangibleAssetsNetDetails" roleURI="http://www.lifevantage.com/role/IntangibleAssetsNetDetails">
        <link:definition>9955533 - Disclosure - Intangible Assets, Net (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtherAccruedExpensesDetails" roleURI="http://www.lifevantage.com/role/OtherAccruedExpensesDetails">
        <link:definition>9955534 - Disclosure - Other Accrued Expenses (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LongTermDebtDetails" roleURI="http://www.lifevantage.com/role/LongTermDebtDetails">
        <link:definition>9955535 - Disclosure - Long-Term Debt (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquityDetails" roleURI="http://www.lifevantage.com/role/StockholdersEquityDetails">
        <link:definition>9955536 - Disclosure - Stockholders' Equity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareBasedCompensationEquitySettledPlansNarrativeDetails" roleURI="http://www.lifevantage.com/role/ShareBasedCompensationEquitySettledPlansNarrativeDetails">
        <link:definition>9955537 - Disclosure - Share-Based Compensation - Equity-Settled Plans, Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareBasedCompensationEmployeeStockPurchasePlanNarrativeDetails" roleURI="http://www.lifevantage.com/role/ShareBasedCompensationEmployeeStockPurchasePlanNarrativeDetails">
        <link:definition>9955538 - Disclosure - Share-Based Compensation - Employee Stock Purchase Plan, Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareBasedCompensationStockBasedCompensationNarrativeDetails" roleURI="http://www.lifevantage.com/role/ShareBasedCompensationStockBasedCompensationNarrativeDetails">
        <link:definition>9955539 - Disclosure - Share-Based Compensation - Stock-Based Compensation, Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareBasedCompensationStockOptionsNarrativeDetails" roleURI="http://www.lifevantage.com/role/ShareBasedCompensationStockOptionsNarrativeDetails">
        <link:definition>9955540 - Disclosure - Share-Based Compensation - Stock Options, Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareBasedCompensationStockOptionsDetails" roleURI="http://www.lifevantage.com/role/ShareBasedCompensationStockOptionsDetails">
        <link:definition>9955541 - Disclosure - Share-Based Compensation - Stock Options (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareBasedCompensationRestrictedSharesDetails" roleURI="http://www.lifevantage.com/role/ShareBasedCompensationRestrictedSharesDetails">
        <link:definition>9955542 - Disclosure - Share-Based Compensation - Restricted Shares (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareBasedCompensationRestrictedStockNarrativeDetails" roleURI="http://www.lifevantage.com/role/ShareBasedCompensationRestrictedStockNarrativeDetails">
        <link:definition>9955543 - Disclosure - Share-Based Compensation - Restricted Stock, Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareBasedCompensationPerformanceRestrictedStockUnitsNarrativeDetails" roleURI="http://www.lifevantage.com/role/ShareBasedCompensationPerformanceRestrictedStockUnitsNarrativeDetails">
        <link:definition>9955544 - Disclosure - Share-Based Compensation - Performance Restricted Stock Units, Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareBasedCompensationPerformanceRestrictedStockUnitsDetails" roleURI="http://www.lifevantage.com/role/ShareBasedCompensationPerformanceRestrictedStockUnitsDetails">
        <link:definition>9955545 - Disclosure - Share-Based Compensation - Performance Restricted Stock Units (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtherExpenseNetDetails" roleURI="http://www.lifevantage.com/role/OtherExpenseNetDetails">
        <link:definition>9955546 - Disclosure - Other Expense, Net (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesIncomeTaxExpenseDetails" roleURI="http://www.lifevantage.com/role/IncomeTaxesIncomeTaxExpenseDetails">
        <link:definition>9955547 - Disclosure - Income Taxes - Income Tax Expense (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesEffectiveIncomeTaxRateDetails" roleURI="http://www.lifevantage.com/role/IncomeTaxesEffectiveIncomeTaxRateDetails">
        <link:definition>9955548 - Disclosure - Income Taxes - Effective Income Tax Rate (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails" roleURI="http://www.lifevantage.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails">
        <link:definition>9955549 - Disclosure - Income Taxes - Deferred Tax Assets and Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesNarrativeDetails" roleURI="http://www.lifevantage.com/role/IncomeTaxesNarrativeDetails">
        <link:definition>9955550 - Disclosure - Income Taxes - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesScheduleofUnrecognizedTaxBenefitDetails" roleURI="http://www.lifevantage.com/role/IncomeTaxesScheduleofUnrecognizedTaxBenefitDetails">
        <link:definition>9955551 - Disclosure - Income Taxes - Schedule of Unrecognized Tax Benefit (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesDeferredTaxAssetsValuationAllowanceScheduleDetails" roleURI="http://www.lifevantage.com/role/IncomeTaxesDeferredTaxAssetsValuationAllowanceScheduleDetails">
        <link:definition>9955552 - Disclosure - Income Taxes - Deferred Tax Assets, Valuation Allowance Schedule (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesNarrativeDetails" roleURI="http://www.lifevantage.com/role/LeasesNarrativeDetails">
        <link:definition>9955553 - Disclosure - Leases - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesScheduleofLeaseCostDetails" roleURI="http://www.lifevantage.com/role/LeasesScheduleofLeaseCostDetails">
        <link:definition>9955554 - Disclosure - Leases - Schedule of Lease Cost (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesSupplementalCashFlowInformationDetails" roleURI="http://www.lifevantage.com/role/LeasesSupplementalCashFlowInformationDetails">
        <link:definition>9955555 - Disclosure - Leases - Supplemental Cash Flow Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesMaturityofLeaseLiabilitiesDetails" roleURI="http://www.lifevantage.com/role/LeasesMaturityofLeaseLiabilitiesDetails">
        <link:definition>9955556 - Disclosure - Leases - Maturity of Lease Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesMaturityofLeaseLiabilitiesDetails_1" roleURI="http://www.lifevantage.com/role/LeasesMaturityofLeaseLiabilitiesDetails_1">
        <link:definition>9955556 - Disclosure - Leases - Maturity of Lease Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentInformationScheduleofSegmentRevenueandExpenseDetails" roleURI="http://www.lifevantage.com/role/SegmentInformationScheduleofSegmentRevenueandExpenseDetails">
        <link:definition>9955557 - Disclosure - Segment Information - Schedule of Segment Revenue and Expense (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentInformationScheduleofLongLivedAssetsDetails" roleURI="http://www.lifevantage.com/role/SegmentInformationScheduleofLongLivedAssetsDetails">
        <link:definition>9955558 - Disclosure - Segment Information - Schedule of Long-Lived Assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentInformationNarrativeDetails" roleURI="http://www.lifevantage.com/role/SegmentInformationNarrativeDetails">
        <link:definition>9955559 - Disclosure - Segment Information - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentInformationScheduleOfRevenueDisaggregationByMarketDetails" roleURI="http://www.lifevantage.com/role/SegmentInformationScheduleOfRevenueDisaggregationByMarketDetails">
        <link:definition>9955560 - Disclosure - Segment Information - Schedule Of Revenue Disaggregation By Market (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentInformationScheduleofMajorProductsLinesDetails" roleURI="http://www.lifevantage.com/role/SegmentInformationScheduleofMajorProductsLinesDetails">
        <link:definition>9955561 - Disclosure - Segment Information - Schedule of Major Products Lines (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:element id="lfvn_AuditorInformationAbstract" abstract="true" name="AuditorInformationAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="lfvn_CommissionAndIncentives" abstract="false" name="CommissionAndIncentives" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lfvn_ProceedsFromIssuanceOfCommonStockUnderEmployeeStockPurchasePlan" abstract="false" name="ProceedsFromIssuanceOfCommonStockUnderEmployeeStockPurchasePlan" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lfvn_CashAccountsHeldPrimarilyAtFinancialInstitutionMember" abstract="true" name="CashAccountsHeldPrimarilyAtFinancialInstitutionMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lfvn_CashAccountsHeldatOtherFinancialInstitutionsMember" abstract="true" name="CashAccountsHeldatOtherFinancialInstitutionsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lfvn_SummaryOfSignificantAccountingPoliciesTextualAbstract" abstract="true" name="SummaryOfSignificantAccountingPoliciesTextualAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="lfvn_NumberOfFinanceLeases" abstract="false" name="NumberOfFinanceLeases" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="lfvn_NumberOfGeographicSegments" abstract="false" name="NumberOfGeographicSegments" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="lfvn_InventoryFinishedGoodsPercentOfTotalInventory" abstract="false" name="InventoryFinishedGoodsPercentOfTotalInventory" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="lfvn_RawMaterialsPercentOfTotalInventory" abstract="false" name="RawMaterialsPercentOfTotalInventory" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="lfvn_InventoryPercentOfTotalInventory" abstract="false" name="InventoryPercentOfTotalInventory" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="lfvn_ProtandimandTrueScienceProductLineMember" abstract="true" name="ProtandimandTrueScienceProductLineMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lfvn_MoneyBackGuaranteePeriod" abstract="false" name="MoneyBackGuaranteePeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="lfvn_HandlingAndRestockingFeePercentage" abstract="false" name="HandlingAndRestockingFeePercentage" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="lfvn_ReturnLiabilityReserve" abstract="false" name="ReturnLiabilityReserve" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lfvn_NumberOfProductLines" abstract="false" name="NumberOfProductLines" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="lfvn_ProtandimMember" abstract="true" name="ProtandimMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lfvn_LifeVantageTrueScienceSkinCareRegimenMember" abstract="true" name="LifeVantageTrueScienceSkinCareRegimenMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lfvn_AccruedPayableToVendors" abstract="false" name="AccruedPayableToVendors" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lfvn_March2016RevolvingLoanMember" abstract="true" name="March2016RevolvingLoanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lfvn_March2016TermLoanMember" abstract="true" name="March2016TermLoanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lfvn_DebtInstrumentFloorInterestRate" abstract="false" name="DebtInstrumentFloorInterestRate" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="lfvn_CommonStockDividendsPerShareCashPaidOneTimeDividend" abstract="false" name="CommonStockDividendsPerShareCashPaidOneTimeDividend" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:perShareItemType"/>
  <xs:element id="lfvn_EmployeeStockPurchasePlanMember" abstract="true" name="EmployeeStockPurchasePlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lfvn_StockIssuedDuringPeriodSharesStockOptionsAndWarrantsExercised" abstract="false" name="StockIssuedDuringPeriodSharesStockOptionsAndWarrantsExercised" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="lfvn_ClassOfWarrantOrRightPercentOfCommonStockAcquisitionThatMakesRightsExercisable" abstract="false" name="ClassOfWarrantOrRightPercentOfCommonStockAcquisitionThatMakesRightsExercisable" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="lfvn_ClassOfWarrantOrRightPercentOfCommonStockAcquisitionThatMakesRightsExercisablePassiveInvestors" abstract="false" name="ClassOfWarrantOrRightPercentOfCommonStockAcquisitionThatMakesRightsExercisablePassiveInvestors" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="lfvn_ClassOfWarrantsOrRightDiscount" abstract="false" name="ClassOfWarrantsOrRightDiscount" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="lfvn_TwoThousandAndTenLongTermIncentivePlanMember" abstract="true" name="TwoThousandAndTenLongTermIncentivePlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lfvn_TwoThousandSeventeenLongTermIncentivePlanMember" abstract="true" name="TwoThousandSeventeenLongTermIncentivePlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lfvn_TwoThousandSeventeenLongTermIncentivePlanExcludingTwoThousandAndTenLongTermIncentivePlanMember" abstract="true" name="TwoThousandSeventeenLongTermIncentivePlanExcludingTwoThousandAndTenLongTermIncentivePlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lfvn_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsOutstandingContractualTerm" abstract="false" name="SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsOutstandingContractualTerm" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="lfvn_ShareBasedCompensationArrangementByShareBasedPaymentAwardAmountInExcessOfFairMarketValueOfStockForOptionNotToBeGranted" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardAmountInExcessOfFairMarketValueOfStockForOptionNotToBeGranted" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lfvn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOfferingPeriod" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardOfferingPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="lfvn_TwoThousandAndTenAndTwoThousandSeventeenLongTermIncentivePlanMember" abstract="true" name="TwoThousandAndTenAndTwoThousandSeventeenLongTermIncentivePlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lfvn_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermAbstract" abstract="true" name="SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="lfvn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsCancelledInPeriod" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsCancelledInPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="lfvn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInExchange" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInExchange" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="lfvn_PerformanceStockUnitsMember" abstract="true" name="PerformanceStockUnitsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lfvn_SharebasedCompensationArrangementbySharebasedPaymentAwardDistributionPercentage" abstract="false" name="SharebasedCompensationArrangementbySharebasedPaymentAwardDistributionPercentage" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="lfvn_OtherMiscellaneousIncomeExpensesNet" abstract="false" name="OtherMiscellaneousIncomeExpensesNet" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lfvn_EffectiveIncomeTaxRateReconciliationTaxReturnToProvisionsTrueUp" abstract="false" name="EffectiveIncomeTaxRateReconciliationTaxReturnToProvisionsTrueUp" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="lfvn_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseLimitationOnFutureStockBasedCompensationExpensePercent" abstract="false" name="EffectiveIncomeTaxRateReconciliationNondeductibleExpenseLimitationOnFutureStockBasedCompensationExpensePercent" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="lfvn_EffectiveIncomeTaxRateReconciliationForeignWithholdingTaxPercent" abstract="false" name="EffectiveIncomeTaxRateReconciliationForeignWithholdingTaxPercent" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="lfvn_PermanentDifferencesAbstract" abstract="true" name="PermanentDifferencesAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="lfvn_EffectiveIncomeTaxRateReconciliationCurrentYearSection162mLimitationPercent" abstract="false" name="EffectiveIncomeTaxRateReconciliationCurrentYearSection162mLimitationPercent" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="lfvn_EffectiveIncomeTaxRateReconciliationRemovalOfPermanentReinvestmentAssertion" abstract="false" name="EffectiveIncomeTaxRateReconciliationRemovalOfPermanentReinvestmentAssertion" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="lfvn_EffectiveIncomeTaxRateReconciliationChangeInUncertainTaxPositions" abstract="false" name="EffectiveIncomeTaxRateReconciliationChangeInUncertainTaxPositions" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="lfvn_DeferredTaxAssetsLeasingArrangements" abstract="false" name="DeferredTaxAssetsLeasingArrangements" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lfvn_UnrecognizedTaxPositionIncreaseResultingFromForeignTaxAudits" abstract="false" name="UnrecognizedTaxPositionIncreaseResultingFromForeignTaxAudits" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lfvn_ReportableSegmentMember" abstract="true" name="ReportableSegmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lfvn_ConsultantCommissions" abstract="false" name="ConsultantCommissions" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lfvn_ConsultantIncentivesPromotionsAndRecognitionExpense" abstract="false" name="ConsultantIncentivesPromotionsAndRecognitionExpense" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lfvn_EventsExpense" abstract="false" name="EventsExpense" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lfvn_CreditCardAndBankingProcessingFees" abstract="false" name="CreditCardAndBankingProcessingFees" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lfvn_OtherForeignMember" abstract="true" name="OtherForeignMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lfvn_TrueScienceProductLineMember" abstract="true" name="TrueScienceProductLineMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lfvn_AXIOProductLineMember" abstract="true" name="AXIOProductLineMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lfvn_PhysIQProductLineMember" abstract="true" name="PhysIQProductLineMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lfvn_PetandimProductLineMember" abstract="true" name="PetandimProductLineMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lfvn_MichaelBeindorffMember" abstract="true" name="MichaelBeindorffMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>10
<FILENAME>lfvn-20250630_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:60c7f1f2-d52d-4c01-b992-aaf8be1801ed,g:81eb96f2-7ea0-4e0b-9dac-655ac6c272fe-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.lifevantage.com/role/CONSOLIDATEDBALANCESHEETS" xlink:type="simple" xlink:href="lfvn-20250630.xsd#CONSOLIDATEDBALANCESHEETS"/>
  <link:calculationLink xlink:role="http://www.lifevantage.com/role/CONSOLIDATEDBALANCESHEETS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_377ec04b-3ebc-47a6-804a-f2bc35af39c5" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_7f23fa67-654f-4e43-8ad3-8b0fe0483f45" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PreferredStockValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_377ec04b-3ebc-47a6-804a-f2bc35af39c5" xlink:to="loc_us-gaap_PreferredStockValue_7f23fa67-654f-4e43-8ad3-8b0fe0483f45" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_cc4b0cb5-fab1-44d4-94dd-e5d2b8f66226" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_377ec04b-3ebc-47a6-804a-f2bc35af39c5" xlink:to="loc_us-gaap_CommonStockValue_cc4b0cb5-fab1-44d4-94dd-e5d2b8f66226" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock_624dea1b-cec1-412f-8cbe-2551e87f4d6b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_377ec04b-3ebc-47a6-804a-f2bc35af39c5" xlink:to="loc_us-gaap_AdditionalPaidInCapitalCommonStock_624dea1b-cec1-412f-8cbe-2551e87f4d6b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_3e220838-1c38-46f0-b071-385924e5ce7b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_377ec04b-3ebc-47a6-804a-f2bc35af39c5" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_3e220838-1c38-46f0-b071-385924e5ce7b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_92e62de3-e2a0-41d1-b3e5-e5a3c6756c3f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_377ec04b-3ebc-47a6-804a-f2bc35af39c5" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_92e62de3-e2a0-41d1-b3e5-e5a3c6756c3f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_9fc29007-75fb-4709-95b9-2c4e97d9c24b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_43a5a849-bed0-46d8-80c8-3faf71598bef" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetsCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_9fc29007-75fb-4709-95b9-2c4e97d9c24b" xlink:to="loc_us-gaap_AssetsCurrent_43a5a849-bed0-46d8-80c8-3faf71598bef" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_940b200e-a5f1-4ab2-8387-03bfb34a9246" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_9fc29007-75fb-4709-95b9-2c4e97d9c24b" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_940b200e-a5f1-4ab2-8387-03bfb34a9246" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_98132913-2c81-4e24-94e6-b6e7e7e8f7f0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_9fc29007-75fb-4709-95b9-2c4e97d9c24b" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_98132913-2c81-4e24-94e6-b6e7e7e8f7f0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_2c71f7be-87ff-4aa7-a62d-709f07efeb76" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_9fc29007-75fb-4709-95b9-2c4e97d9c24b" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_2c71f7be-87ff-4aa7-a62d-709f07efeb76" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet_943bb6f6-df7a-4a14-bb3a-4f53fc1f8c13" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_9fc29007-75fb-4709-95b9-2c4e97d9c24b" xlink:to="loc_us-gaap_DeferredIncomeTaxAssetsNet_943bb6f6-df7a-4a14-bb3a-4f53fc1f8c13" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_31711431-8210-4fe6-b375-cdf597430087" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_9fc29007-75fb-4709-95b9-2c4e97d9c24b" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_31711431-8210-4fe6-b375-cdf597430087" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_86309fba-abdc-4b93-8dd5-b7786a59a724" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_73f1b6e5-b6cd-4c59-9951-74a7a0731db7" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Liabilities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_86309fba-abdc-4b93-8dd5-b7786a59a724" xlink:to="loc_us-gaap_Liabilities_73f1b6e5-b6cd-4c59-9951-74a7a0731db7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_76cc3917-0a51-4687-9a8e-ad92ecf624d1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_86309fba-abdc-4b93-8dd5-b7786a59a724" xlink:to="loc_us-gaap_CommitmentsAndContingencies_76cc3917-0a51-4687-9a8e-ad92ecf624d1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_bb5c81ad-0075-4b55-9d25-eee506e5ad31" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockholdersEquity"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_86309fba-abdc-4b93-8dd5-b7786a59a724" xlink:to="loc_us-gaap_StockholdersEquity_bb5c81ad-0075-4b55-9d25-eee506e5ad31" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_3b23b416-12ab-4507-b0e1-a5362eeab716" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_cf15ad54-c8c0-42f4-8731-ac9ed2d7500c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_3b23b416-12ab-4507-b0e1-a5362eeab716" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_cf15ad54-c8c0-42f4-8731-ac9ed2d7500c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_1fe71cf1-fd19-41fe-862a-674e3ae9bcc9" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_3b23b416-12ab-4507-b0e1-a5362eeab716" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_1fe71cf1-fd19-41fe-862a-674e3ae9bcc9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesReceivable_99289ffc-4012-4b7d-ba79-b772816ed1f0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxesReceivable"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_3b23b416-12ab-4507-b0e1-a5362eeab716" xlink:to="loc_us-gaap_IncomeTaxesReceivable_99289ffc-4012-4b7d-ba79-b772816ed1f0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_599f08b0-cc1f-494f-9ff8-98f556681cee" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InventoryNet"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_3b23b416-12ab-4507-b0e1-a5362eeab716" xlink:to="loc_us-gaap_InventoryNet_599f08b0-cc1f-494f-9ff8-98f556681cee" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_9eb65103-15ac-4c02-ba69-ecc4c5287a25" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_3b23b416-12ab-4507-b0e1-a5362eeab716" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_9eb65103-15ac-4c02-ba69-ecc4c5287a25" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_c72d444d-37cd-4f79-94fd-a6f7b4351713" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Liabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_e2960814-126e-4584-bbd1-955935406e49" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_c72d444d-37cd-4f79-94fd-a6f7b4351713" xlink:to="loc_us-gaap_LiabilitiesCurrent_e2960814-126e-4584-bbd1-955935406e49" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_ae2126e7-27d7-4372-8e36-02d02d02c083" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_c72d444d-37cd-4f79-94fd-a6f7b4351713" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_ae2126e7-27d7-4372-8e36-02d02d02c083" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_450c7697-bdfe-4cf0-a006-2fc5210b8431" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_c72d444d-37cd-4f79-94fd-a6f7b4351713" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_450c7697-bdfe-4cf0-a006-2fc5210b8431" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_62435829-a825-4f0c-9cce-b6fac4230918" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_77f5147c-6824-4209-a869-81cce3e3edf8" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_62435829-a825-4f0c-9cce-b6fac4230918" xlink:to="loc_us-gaap_AccountsPayableCurrent_77f5147c-6824-4209-a869-81cce3e3edf8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedSalesCommissionCurrent_83a21426-9ea6-4be6-aec4-ca1d67f1a7c0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccruedSalesCommissionCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_62435829-a825-4f0c-9cce-b6fac4230918" xlink:to="loc_us-gaap_AccruedSalesCommissionCurrent_83a21426-9ea6-4be6-aec4-ca1d67f1a7c0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesCurrent_de10df98-b2d6-4abb-b582-fd39d6ceb7b7" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccruedIncomeTaxesCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_62435829-a825-4f0c-9cce-b6fac4230918" xlink:to="loc_us-gaap_AccruedIncomeTaxesCurrent_de10df98-b2d6-4abb-b582-fd39d6ceb7b7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_67ae2f35-388f-465b-aca0-8bdd65c63d69" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_62435829-a825-4f0c-9cce-b6fac4230918" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_67ae2f35-388f-465b-aca0-8bdd65c63d69" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_2f37a053-c9bb-40b5-b611-861957747ddb" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_62435829-a825-4f0c-9cce-b6fac4230918" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_2f37a053-c9bb-40b5-b611-861957747ddb" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.lifevantage.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOME" xlink:type="simple" xlink:href="lfvn-20250630.xsd#CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOME"/>
  <link:calculationLink xlink:role="http://www.lifevantage.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOME" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_8988116c-0da5-45da-bbdc-15e9fd0d70ac" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_3f1c29e0-a951-4beb-8a69-3c44808d98c2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_8988116c-0da5-45da-bbdc-15e9fd0d70ac" xlink:to="loc_us-gaap_NetIncomeLoss_3f1c29e0-a951-4beb-8a69-3c44808d98c2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_ec8e63cf-a79b-49dd-93f8-29ae19e2c117" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_8988116c-0da5-45da-bbdc-15e9fd0d70ac" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_ec8e63cf-a79b-49dd-93f8-29ae19e2c117" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_968cf089-fd6c-48bb-b549-f49bd4ac60d9" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_a6dc28e9-a9c9-4f76-8bc7-4662ac46d726" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GrossProfit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_968cf089-fd6c-48bb-b549-f49bd4ac60d9" xlink:to="loc_us-gaap_GrossProfit_a6dc28e9-a9c9-4f76-8bc7-4662ac46d726" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_6e3d7ed8-10b7-4f2a-83df-1a29054b2f86" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingExpenses"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_968cf089-fd6c-48bb-b549-f49bd4ac60d9" xlink:to="loc_us-gaap_OperatingExpenses_6e3d7ed8-10b7-4f2a-83df-1a29054b2f86" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_f96d7a94-1bcc-4c46-9f21-442acb57a258" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_3afdc951-0bb4-4de9-ae0c-d10baaa2c77f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_f96d7a94-1bcc-4c46-9f21-442acb57a258" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_3afdc951-0bb4-4de9-ae0c-d10baaa2c77f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_1ca3f4cf-e31d-427b-9b57-167b914963f5" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_f96d7a94-1bcc-4c46-9f21-442acb57a258" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_1ca3f4cf-e31d-427b-9b57-167b914963f5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_ffc1e39a-2ea4-445d-8827-2145f4bd4f31" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_254ea5b8-2b6d-4012-a1e3-f452fb86d417" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_ffc1e39a-2ea4-445d-8827-2145f4bd4f31" xlink:to="loc_us-gaap_OperatingIncomeLoss_254ea5b8-2b6d-4012-a1e3-f452fb86d417" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_da230e04-89b5-45ad-9b03-ccdb09e84f2f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_ffc1e39a-2ea4-445d-8827-2145f4bd4f31" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_da230e04-89b5-45ad-9b03-ccdb09e84f2f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_0baa284d-e752-4fd8-b4cf-d784f347f212" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_7ac6c111-dac4-4c19-8169-ddf066e0b96d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_0baa284d-e752-4fd8-b4cf-d784f347f212" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_7ac6c111-dac4-4c19-8169-ddf066e0b96d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_099f3c06-5e25-48f5-a523-f9d7f7831c3a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingExpenses"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_CommissionAndIncentives_78a56019-4ae5-485a-88d8-97aa5dabf8ac" xlink:href="lfvn-20250630.xsd#lfvn_CommissionAndIncentives"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_099f3c06-5e25-48f5-a523-f9d7f7831c3a" xlink:to="loc_lfvn_CommissionAndIncentives_78a56019-4ae5-485a-88d8-97aa5dabf8ac" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_d53a8184-7e60-48c8-884c-e08e9b66bb97" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_099f3c06-5e25-48f5-a523-f9d7f7831c3a" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_d53a8184-7e60-48c8-884c-e08e9b66bb97" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_833b60ec-4644-4192-847a-42f051c2bedc" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRevenueExpenseNet_ecd35c6a-2e22-4015-bb9f-57dd4e85935a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InterestRevenueExpenseNet"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_833b60ec-4644-4192-847a-42f051c2bedc" xlink:to="loc_us-gaap_InterestRevenueExpenseNet_ecd35c6a-2e22-4015-bb9f-57dd4e85935a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_28ffa94b-3a69-447e-b7a5-b440cb99b494" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_833b60ec-4644-4192-847a-42f051c2bedc" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_28ffa94b-3a69-447e-b7a5-b440cb99b494" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_fc1b7594-01f7-4b0e-94de-a9cebea076ed" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GrossProfit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_86550a57-9a87-477c-90d3-621ed44098b5" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossProfit_fc1b7594-01f7-4b0e-94de-a9cebea076ed" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_86550a57-9a87-477c-90d3-621ed44098b5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_4c8848de-8786-4696-9202-fd6eb851b9c7" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossProfit_fc1b7594-01f7-4b0e-94de-a9cebea076ed" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_4c8848de-8786-4696-9202-fd6eb851b9c7" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.lifevantage.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="simple" xlink:href="lfvn-20250630.xsd#CONSOLIDATEDSTATEMENTSOFCASHFLOWS"/>
  <link:calculationLink xlink:role="http://www.lifevantage.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_dfff9cce-f7b9-4485-a343-ce1c6a19e18d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_9cc79a0b-9465-4e96-931b-f61281c3b7d1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_dfff9cce-f7b9-4485-a343-ce1c6a19e18d" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_9cc79a0b-9465-4e96-931b-f61281c3b7d1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_30a75ca8-cb87-42ab-8df4-0e2ff852461b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_dfff9cce-f7b9-4485-a343-ce1c6a19e18d" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_30a75ca8-cb87-42ab-8df4-0e2ff852461b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_7ce96b9a-44a8-438d-91e1-2719ae5ef751" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_dfff9cce-f7b9-4485-a343-ce1c6a19e18d" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_7ce96b9a-44a8-438d-91e1-2719ae5ef751" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_aace0cc5-fed4-43ae-8792-9889accb5368" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_dfff9cce-f7b9-4485-a343-ce1c6a19e18d" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_aace0cc5-fed4-43ae-8792-9889accb5368" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_3fa76be7-ab00-4f0e-b4a5-dc980e697df7" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_87434fe6-1b7c-4247-83bf-2b2d4cce18fa" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_3fa76be7-ab00-4f0e-b4a5-dc980e697df7" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_87434fe6-1b7c-4247-83bf-2b2d4cce18fa" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_ddaa0c44-b858-4f3f-8b73-c7b898b6732c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_3fa76be7-ab00-4f0e-b4a5-dc980e697df7" xlink:to="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_ddaa0c44-b858-4f3f-8b73-c7b898b6732c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_0d543b87-0bb2-4fc2-9cc6-8f22ceb12646" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_6e7707f6-3aa4-4515-8cf4-a99dd4a9c644" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_0d543b87-0bb2-4fc2-9cc6-8f22ceb12646" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_6e7707f6-3aa4-4515-8cf4-a99dd4a9c644" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_27790c3c-d0ab-4fe3-85bb-9840ac136727" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_0d543b87-0bb2-4fc2-9cc6-8f22ceb12646" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_27790c3c-d0ab-4fe3-85bb-9840ac136727" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_70eb65a5-43f1-4198-a09c-7dff439ff75c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensation"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_0d543b87-0bb2-4fc2-9cc6-8f22ceb12646" xlink:to="loc_us-gaap_ShareBasedCompensation_70eb65a5-43f1-4198-a09c-7dff439ff75c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_3d09aa19-6243-49a3-9be3-ecf906e35147" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_0d543b87-0bb2-4fc2-9cc6-8f22ceb12646" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_3d09aa19-6243-49a3-9be3-ecf906e35147" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_a31e1e03-09ba-45ca-8ced-cdd43ca6339a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_0d543b87-0bb2-4fc2-9cc6-8f22ceb12646" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_a31e1e03-09ba-45ca-8ced-cdd43ca6339a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_fe60f20d-d0de-424e-9928-d9a6a5dc6369" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_0d543b87-0bb2-4fc2-9cc6-8f22ceb12646" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_fe60f20d-d0de-424e-9928-d9a6a5dc6369" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInIncomeTaxesReceivable_a101d511-a8cb-47b1-88c9-4708a173a558" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInIncomeTaxesReceivable"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_0d543b87-0bb2-4fc2-9cc6-8f22ceb12646" xlink:to="loc_us-gaap_IncreaseDecreaseInIncomeTaxesReceivable_a101d511-a8cb-47b1-88c9-4708a173a558" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_ed89292f-46ed-43f0-8e3c-606cea822888" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentAssets"/>
    <link:calculationArc order="8" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_0d543b87-0bb2-4fc2-9cc6-8f22ceb12646" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_ed89292f-46ed-43f0-8e3c-606cea822888" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_dda28a1f-2828-496f-8ebe-ae935e2308d7" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInOperatingLeaseLiability"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_0d543b87-0bb2-4fc2-9cc6-8f22ceb12646" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_dda28a1f-2828-496f-8ebe-ae935e2308d7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_2ffd7a05-5ea0-4509-8145-f995dd9286ac" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable"/>
    <link:calculationArc order="10" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_0d543b87-0bb2-4fc2-9cc6-8f22ceb12646" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_2ffd7a05-5ea0-4509-8145-f995dd9286ac" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxesAndTaxCredits_939bfb64-655c-45a9-b242-997e8f0fff4a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredIncomeTaxesAndTaxCredits"/>
    <link:calculationArc order="11" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_0d543b87-0bb2-4fc2-9cc6-8f22ceb12646" xlink:to="loc_us-gaap_DeferredIncomeTaxesAndTaxCredits_939bfb64-655c-45a9-b242-997e8f0fff4a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidExpense_e3127d7d-8b88-42e4-8c94-081f98c61927" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInPrepaidExpense"/>
    <link:calculationArc order="12" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_0d543b87-0bb2-4fc2-9cc6-8f22ceb12646" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidExpense_e3127d7d-8b88-42e4-8c94-081f98c61927" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_6f6828fc-9aad-4af8-a477-c48d61dcc3e7" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="13" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_0d543b87-0bb2-4fc2-9cc6-8f22ceb12646" xlink:to="loc_us-gaap_NetIncomeLoss_6f6828fc-9aad-4af8-a477-c48d61dcc3e7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_e1e23167-e31a-4a3d-b6c8-fc800fafd08a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GainLossOnSaleOfPropertyPlantEquipment"/>
    <link:calculationArc order="14" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_0d543b87-0bb2-4fc2-9cc6-8f22ceb12646" xlink:to="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_e1e23167-e31a-4a3d-b6c8-fc800fafd08a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities_da9ae7e0-f42e-4e5c-a011-1ef4922c0737" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities"/>
    <link:calculationArc order="15" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_0d543b87-0bb2-4fc2-9cc6-8f22ceb12646" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities_da9ae7e0-f42e-4e5c-a011-1ef4922c0737" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_1212252c-f3da-4e48-bdb5-01d19c786338" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:calculationArc order="16" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_0d543b87-0bb2-4fc2-9cc6-8f22ceb12646" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_1212252c-f3da-4e48-bdb5-01d19c786338" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCosts_d74e32a7-76f3-438f-af82-0ef00f4f4334" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AmortizationOfFinancingCosts"/>
    <link:calculationArc order="17" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_0d543b87-0bb2-4fc2-9cc6-8f22ceb12646" xlink:to="loc_us-gaap_AmortizationOfFinancingCosts_d74e32a7-76f3-438f-af82-0ef00f4f4334" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_ba64890f-570c-4542-a221-41426db75f42" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_aa2e6d4d-cfa3-47e4-a209-1d672b02da10" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_ba64890f-570c-4542-a221-41426db75f42" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_aa2e6d4d-cfa3-47e4-a209-1d672b02da10" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_ProceedsFromIssuanceOfCommonStockUnderEmployeeStockPurchasePlan_d1973f18-71dd-4118-a7e2-f07b6ab9a25c" xlink:href="lfvn-20250630.xsd#lfvn_ProceedsFromIssuanceOfCommonStockUnderEmployeeStockPurchasePlan"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_ba64890f-570c-4542-a221-41426db75f42" xlink:to="loc_lfvn_ProceedsFromIssuanceOfCommonStockUnderEmployeeStockPurchasePlan_d1973f18-71dd-4118-a7e2-f07b6ab9a25c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_8514fa9e-69fd-459b-8cad-7e731a867a3d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_ba64890f-570c-4542-a221-41426db75f42" xlink:to="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_8514fa9e-69fd-459b-8cad-7e731a867a3d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividends_e9f6222d-27b0-4cb2-b1b8-1e45cb15c9c0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PaymentsOfDividends"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_ba64890f-570c-4542-a221-41426db75f42" xlink:to="loc_us-gaap_PaymentsOfDividends_e9f6222d-27b0-4cb2-b1b8-1e45cb15c9c0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfFinancingCosts_22f3154b-73eb-4e2e-9e9a-f5aa45627ac1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PaymentsOfFinancingCosts"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_ba64890f-570c-4542-a221-41426db75f42" xlink:to="loc_us-gaap_PaymentsOfFinancingCosts_22f3154b-73eb-4e2e-9e9a-f5aa45627ac1" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesInventoryDetails" xlink:type="simple" xlink:href="lfvn-20250630.xsd#SummaryofSignificantAccountingPoliciesInventoryDetails"/>
  <link:calculationLink xlink:role="http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesInventoryDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_InventoryPercentOfTotalInventory_72e6cf73-2df2-4b62-b65a-df62b97970cb" xlink:href="lfvn-20250630.xsd#lfvn_InventoryPercentOfTotalInventory"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_InventoryFinishedGoodsPercentOfTotalInventory_098f7092-2262-46c8-b409-da0390df47ed" xlink:href="lfvn-20250630.xsd#lfvn_InventoryFinishedGoodsPercentOfTotalInventory"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_lfvn_InventoryPercentOfTotalInventory_72e6cf73-2df2-4b62-b65a-df62b97970cb" xlink:to="loc_lfvn_InventoryFinishedGoodsPercentOfTotalInventory_098f7092-2262-46c8-b409-da0390df47ed" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_RawMaterialsPercentOfTotalInventory_48415e32-a202-46fc-b14e-dbfffe82703f" xlink:href="lfvn-20250630.xsd#lfvn_RawMaterialsPercentOfTotalInventory"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_lfvn_InventoryPercentOfTotalInventory_72e6cf73-2df2-4b62-b65a-df62b97970cb" xlink:to="loc_lfvn_RawMaterialsPercentOfTotalInventory_48415e32-a202-46fc-b14e-dbfffe82703f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_a2ff1b1d-75a5-45aa-92ac-fd345c70406c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InventoryNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoods_5cad3141-596d-40c2-91a1-c78842458553" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InventoryFinishedGoods"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_a2ff1b1d-75a5-45aa-92ac-fd345c70406c" xlink:to="loc_us-gaap_InventoryFinishedGoods_5cad3141-596d-40c2-91a1-c78842458553" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterials_6bbfa8bf-4495-4718-9340-d15df2fed0b6" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InventoryRawMaterials"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_a2ff1b1d-75a5-45aa-92ac-fd345c70406c" xlink:to="loc_us-gaap_InventoryRawMaterials_6bbfa8bf-4495-4718-9340-d15df2fed0b6" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesComputationofNetIncomePerShareDetails" xlink:type="simple" xlink:href="lfvn-20250630.xsd#SummaryofSignificantAccountingPoliciesComputationofNetIncomePerShareDetails"/>
  <link:calculationLink xlink:role="http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesComputationofNetIncomePerShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_1b4541ec-d04a-4c00-8fc1-fc03b05481db" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_bdd038d9-b184-453c-9fcb-ee81dd700730" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_1b4541ec-d04a-4c00-8fc1-fc03b05481db" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_bdd038d9-b184-453c-9fcb-ee81dd700730" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_c8f4b64a-be03-4f05-8a38-3144a577eb5e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_1b4541ec-d04a-4c00-8fc1-fc03b05481db" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_c8f4b64a-be03-4f05-8a38-3144a577eb5e" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.lifevantage.com/role/PropertyandEquipmentNetDetails" xlink:type="simple" xlink:href="lfvn-20250630.xsd#PropertyandEquipmentNetDetails"/>
  <link:calculationLink xlink:role="http://www.lifevantage.com/role/PropertyandEquipmentNetDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_32cf0e3f-21ba-4006-8601-829beb76f043" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_4c1270a5-1aeb-4169-95be-b3b1bb8b8fcc" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_32cf0e3f-21ba-4006-8601-829beb76f043" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_4c1270a5-1aeb-4169-95be-b3b1bb8b8fcc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_5a7452c0-d915-4bb6-a6a6-7db1a4e6bc2c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_32cf0e3f-21ba-4006-8601-829beb76f043" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_5a7452c0-d915-4bb6-a6a6-7db1a4e6bc2c" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.lifevantage.com/role/IntangibleAssetsNetDetails" xlink:type="simple" xlink:href="lfvn-20250630.xsd#IntangibleAssetsNetDetails"/>
  <link:calculationLink xlink:role="http://www.lifevantage.com/role/IntangibleAssetsNetDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_731c668d-6626-4997-bce8-2a762507168b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_0d3be02f-e9fb-49d6-beae-05e6c202d439" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_731c668d-6626-4997-bce8-2a762507168b" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_0d3be02f-e9fb-49d6-beae-05e6c202d439" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_88d30db6-f437-41f7-80df-ba5f7a82065f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_731c668d-6626-4997-bce8-2a762507168b" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_88d30db6-f437-41f7-80df-ba5f7a82065f" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.lifevantage.com/role/OtherAccruedExpensesDetails" xlink:type="simple" xlink:href="lfvn-20250630.xsd#OtherAccruedExpensesDetails"/>
  <link:calculationLink xlink:role="http://www.lifevantage.com/role/OtherAccruedExpensesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_d68b6a8d-42c2-4ee6-ab6f-d2d5b1ef8944" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedBonusesCurrentAndNoncurrent_99ac22fe-ac7e-4ad5-9d20-919595a4dc88" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccruedBonusesCurrentAndNoncurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_d68b6a8d-42c2-4ee6-ab6f-d2d5b1ef8944" xlink:to="loc_us-gaap_AccruedBonusesCurrentAndNoncurrent_99ac22fe-ac7e-4ad5-9d20-919595a4dc88" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedEmployeeBenefitsCurrentAndNoncurrent_bfcde2b1-3259-4bcb-bde4-0287254b0648" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccruedEmployeeBenefitsCurrentAndNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_d68b6a8d-42c2-4ee6-ab6f-d2d5b1ef8944" xlink:to="loc_us-gaap_AccruedEmployeeBenefitsCurrentAndNoncurrent_bfcde2b1-3259-4bcb-bde4-0287254b0648" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxesPayableCurrent_e6402788-8968-412d-8f67-49c0f0241872" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TaxesPayableCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_d68b6a8d-42c2-4ee6-ab6f-d2d5b1ef8944" xlink:to="loc_us-gaap_TaxesPayableCurrent_e6402788-8968-412d-8f67-49c0f0241872" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_b0cf5c80-46fc-4b83-a715-8d20d9f2d041" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_d68b6a8d-42c2-4ee6-ab6f-d2d5b1ef8944" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrent_b0cf5c80-46fc-4b83-a715-8d20d9f2d041" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_AccruedPayableToVendors_bbe71af0-70e2-4338-b59f-6d8194ba11d9" xlink:href="lfvn-20250630.xsd#lfvn_AccruedPayableToVendors"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_d68b6a8d-42c2-4ee6-ab6f-d2d5b1ef8944" xlink:to="loc_lfvn_AccruedPayableToVendors_bbe71af0-70e2-4338-b59f-6d8194ba11d9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent_ae14f7be-9fe7-4f27-aadb-eed60c63539f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_d68b6a8d-42c2-4ee6-ab6f-d2d5b1ef8944" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCurrent_ae14f7be-9fe7-4f27-aadb-eed60c63539f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedMarketingCostsCurrent_4586a9d3-16f4-4171-9149-f1b514d884d2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccruedMarketingCostsCurrent"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_d68b6a8d-42c2-4ee6-ab6f-d2d5b1ef8944" xlink:to="loc_us-gaap_AccruedMarketingCostsCurrent_4586a9d3-16f4-4171-9149-f1b514d884d2" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.lifevantage.com/role/OtherExpenseNetDetails" xlink:type="simple" xlink:href="lfvn-20250630.xsd#OtherExpenseNetDetails"/>
  <link:calculationLink xlink:role="http://www.lifevantage.com/role/OtherExpenseNetDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_bb669565-0a7c-4591-a81a-e3a5b45bfc43" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_4c0907ae-5c8a-4388-aaf9-25397bd799c8" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ForeignCurrencyTransactionGainLossBeforeTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense_bb669565-0a7c-4591-a81a-e3a5b45bfc43" xlink:to="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_4c0907ae-5c8a-4388-aaf9-25397bd799c8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_OtherMiscellaneousIncomeExpensesNet_64a90fb6-ae4a-400a-8360-06b92389c113" xlink:href="lfvn-20250630.xsd#lfvn_OtherMiscellaneousIncomeExpensesNet"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense_bb669565-0a7c-4591-a81a-e3a5b45bfc43" xlink:to="loc_lfvn_OtherMiscellaneousIncomeExpensesNet_64a90fb6-ae4a-400a-8360-06b92389c113" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.lifevantage.com/role/IncomeTaxesIncomeTaxExpenseDetails" xlink:type="simple" xlink:href="lfvn-20250630.xsd#IncomeTaxesIncomeTaxExpenseDetails"/>
  <link:calculationLink xlink:role="http://www.lifevantage.com/role/IncomeTaxesIncomeTaxExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_6200f7b7-1ea2-4cd1-bfd5-091002005ad1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_92cade35-8781-4ff5-94b0-d92581ea283b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_6200f7b7-1ea2-4cd1-bfd5-091002005ad1" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_92cade35-8781-4ff5-94b0-d92581ea283b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_919f3468-727d-4838-a9b8-d6ee03b6cf53" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_6200f7b7-1ea2-4cd1-bfd5-091002005ad1" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_919f3468-727d-4838-a9b8-d6ee03b6cf53" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_02507902-a532-43a1-9828-71fb7dcfc4ed" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_55f7d472-16b3-4a0f-89a5-5378def88ed6" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredForeignIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_02507902-a532-43a1-9828-71fb7dcfc4ed" xlink:to="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_55f7d472-16b3-4a0f-89a5-5378def88ed6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_ab2aea8a-b33a-4d01-8f3f-b0d2159e73a0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_02507902-a532-43a1-9828-71fb7dcfc4ed" xlink:to="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_ab2aea8a-b33a-4d01-8f3f-b0d2159e73a0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_57fa623c-d548-442a-a4c7-e7b66d8ca05b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_02507902-a532-43a1-9828-71fb7dcfc4ed" xlink:to="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_57fa623c-d548-442a-a4c7-e7b66d8ca05b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_bf703bd0-83a5-4583-ba2c-b720276ccd20" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_7a955bb2-9c61-4e91-b44e-ad0915944ee1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_bf703bd0-83a5-4583-ba2c-b720276ccd20" xlink:to="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_7a955bb2-9c61-4e91-b44e-ad0915944ee1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_c4d9a871-00be-43f2-985f-8c890b13b6ae" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_bf703bd0-83a5-4583-ba2c-b720276ccd20" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_c4d9a871-00be-43f2-985f-8c890b13b6ae" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_372a04e6-c1bf-4b64-8e49-723ccf931398" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentForeignTaxExpenseBenefit_b625d880-da3b-46cb-ae91-712e7d4a35a6" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CurrentForeignTaxExpenseBenefit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_372a04e6-c1bf-4b64-8e49-723ccf931398" xlink:to="loc_us-gaap_CurrentForeignTaxExpenseBenefit_b625d880-da3b-46cb-ae91-712e7d4a35a6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentFederalTaxExpenseBenefit_0cd25127-6737-4af0-8671-62fdd63a4545" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CurrentFederalTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_372a04e6-c1bf-4b64-8e49-723ccf931398" xlink:to="loc_us-gaap_CurrentFederalTaxExpenseBenefit_0cd25127-6737-4af0-8671-62fdd63a4545" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_1bf2826d-b6b8-4066-b9c5-6a25cb43f769" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_372a04e6-c1bf-4b64-8e49-723ccf931398" xlink:to="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_1bf2826d-b6b8-4066-b9c5-6a25cb43f769" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.lifevantage.com/role/IncomeTaxesEffectiveIncomeTaxRateDetails" xlink:type="simple" xlink:href="lfvn-20250630.xsd#IncomeTaxesEffectiveIncomeTaxRateDetails"/>
  <link:calculationLink xlink:role="http://www.lifevantage.com/role/IncomeTaxesEffectiveIncomeTaxRateDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_288d8183-fd6f-4a5c-9b18-46cf4e1df1d5" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_ee67cf66-56d3-444b-b7cd-fb38d7448458" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_288d8183-fd6f-4a5c-9b18-46cf4e1df1d5" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_ee67cf66-56d3-444b-b7cd-fb38d7448458" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_332a824f-dc5c-4475-97e0-6a70b31b93ff" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_288d8183-fd6f-4a5c-9b18-46cf4e1df1d5" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_332a824f-dc5c-4475-97e0-6a70b31b93ff" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_7cd2fd1b-303f-4759-b2c5-7bd2fa881450" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_288d8183-fd6f-4a5c-9b18-46cf4e1df1d5" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_7cd2fd1b-303f-4759-b2c5-7bd2fa881450" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_EffectiveIncomeTaxRateReconciliationTaxReturnToProvisionsTrueUp_4667d56e-9abb-4792-85e7-8e9e4868f9df" xlink:href="lfvn-20250630.xsd#lfvn_EffectiveIncomeTaxRateReconciliationTaxReturnToProvisionsTrueUp"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_288d8183-fd6f-4a5c-9b18-46cf4e1df1d5" xlink:to="loc_lfvn_EffectiveIncomeTaxRateReconciliationTaxReturnToProvisionsTrueUp_4667d56e-9abb-4792-85e7-8e9e4868f9df" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseLimitationOnFutureStockBasedCompensationExpensePercent_c77c3614-83e2-4f24-9a10-dccc2daaf1e4" xlink:href="lfvn-20250630.xsd#lfvn_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseLimitationOnFutureStockBasedCompensationExpensePercent"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_288d8183-fd6f-4a5c-9b18-46cf4e1df1d5" xlink:to="loc_lfvn_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseLimitationOnFutureStockBasedCompensationExpensePercent_c77c3614-83e2-4f24-9a10-dccc2daaf1e4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_EffectiveIncomeTaxRateReconciliationForeignWithholdingTaxPercent_0ced9f08-731f-4da2-88b5-b24b22c56c2d" xlink:href="lfvn-20250630.xsd#lfvn_EffectiveIncomeTaxRateReconciliationForeignWithholdingTaxPercent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_288d8183-fd6f-4a5c-9b18-46cf4e1df1d5" xlink:to="loc_lfvn_EffectiveIncomeTaxRateReconciliationForeignWithholdingTaxPercent_0ced9f08-731f-4da2-88b5-b24b22c56c2d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_10429ce1-bb9e-4699-940e-173972859313" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_288d8183-fd6f-4a5c-9b18-46cf4e1df1d5" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_10429ce1-bb9e-4699-940e-173972859313" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate_cb4e83f9-b305-488e-99c0-37473895ee6a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_288d8183-fd6f-4a5c-9b18-46cf4e1df1d5" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate_cb4e83f9-b305-488e-99c0-37473895ee6a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost_7f12cdc8-427d-4faa-a786-94f5c38e415b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_288d8183-fd6f-4a5c-9b18-46cf4e1df1d5" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost_7f12cdc8-427d-4faa-a786-94f5c38e415b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_EffectiveIncomeTaxRateReconciliationCurrentYearSection162mLimitationPercent_e4b0928c-bca1-44f1-b52b-87635f215c23" xlink:href="lfvn-20250630.xsd#lfvn_EffectiveIncomeTaxRateReconciliationCurrentYearSection162mLimitationPercent"/>
    <link:calculationArc order="10" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_288d8183-fd6f-4a5c-9b18-46cf4e1df1d5" xlink:to="loc_lfvn_EffectiveIncomeTaxRateReconciliationCurrentYearSection162mLimitationPercent_e4b0928c-bca1-44f1-b52b-87635f215c23" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationFdiiPercent_f9ff041e-9989-4e39-9b84-3061340899d4" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationFdiiPercent"/>
    <link:calculationArc order="11" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_288d8183-fd6f-4a5c-9b18-46cf4e1df1d5" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationFdiiPercent_f9ff041e-9989-4e39-9b84-3061340899d4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits_ccec4326-28e8-4346-ac0e-3bb26421dd0c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits"/>
    <link:calculationArc order="12" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_288d8183-fd6f-4a5c-9b18-46cf4e1df1d5" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits_ccec4326-28e8-4346-ac0e-3bb26421dd0c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseMealsAndEntertainment_2a78602a-8554-4b60-920d-158477784335" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseMealsAndEntertainment"/>
    <link:calculationArc order="13" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_288d8183-fd6f-4a5c-9b18-46cf4e1df1d5" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseMealsAndEntertainment_2a78602a-8554-4b60-920d-158477784335" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_EffectiveIncomeTaxRateReconciliationRemovalOfPermanentReinvestmentAssertion_739e1daa-78f3-4184-992c-70d7101afb01" xlink:href="lfvn-20250630.xsd#lfvn_EffectiveIncomeTaxRateReconciliationRemovalOfPermanentReinvestmentAssertion"/>
    <link:calculationArc order="14" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_288d8183-fd6f-4a5c-9b18-46cf4e1df1d5" xlink:to="loc_lfvn_EffectiveIncomeTaxRateReconciliationRemovalOfPermanentReinvestmentAssertion_739e1daa-78f3-4184-992c-70d7101afb01" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_EffectiveIncomeTaxRateReconciliationChangeInUncertainTaxPositions_63c098a8-8f33-40cf-996e-89633b923a36" xlink:href="lfvn-20250630.xsd#lfvn_EffectiveIncomeTaxRateReconciliationChangeInUncertainTaxPositions"/>
    <link:calculationArc order="15" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_288d8183-fd6f-4a5c-9b18-46cf4e1df1d5" xlink:to="loc_lfvn_EffectiveIncomeTaxRateReconciliationChangeInUncertainTaxPositions_63c098a8-8f33-40cf-996e-89633b923a36" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxSettlementsForeign_74ac300f-b219-45ee-990d-497b40e5017a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTaxSettlementsForeign"/>
    <link:calculationArc order="16" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_288d8183-fd6f-4a5c-9b18-46cf4e1df1d5" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxSettlementsForeign_74ac300f-b219-45ee-990d-497b40e5017a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther_e676c614-05a9-407e-b147-a198215b3305" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther"/>
    <link:calculationArc order="17" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_288d8183-fd6f-4a5c-9b18-46cf4e1df1d5" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther_e676c614-05a9-407e-b147-a198215b3305" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_b2d79d5f-b7fa-4673-ba13-674a73cbb753" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <link:calculationArc order="18" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_288d8183-fd6f-4a5c-9b18-46cf4e1df1d5" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_b2d79d5f-b7fa-4673-ba13-674a73cbb753" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.lifevantage.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails" xlink:type="simple" xlink:href="lfvn-20250630.xsd#IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails"/>
  <link:calculationLink xlink:role="http://www.lifevantage.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities_0914095e-25e3-4b35-a83b-64059b36f273" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets_60c3cd00-dd53-4ae8-9191-37a6aa499274" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities_0914095e-25e3-4b35-a83b-64059b36f273" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets_60c3cd00-dd53-4ae8-9191-37a6aa499274" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesLeasingArrangements_32afe2c8-35e1-4f5e-a0bc-b57beccc08ef" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxLiabilitiesLeasingArrangements"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities_0914095e-25e3-4b35-a83b-64059b36f273" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesLeasingArrangements_32afe2c8-35e1-4f5e-a0bc-b57beccc08ef" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesOther_8c5a39e4-b38a-4ed4-b8d0-dc9d80c0b467" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxLiabilitiesOther"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities_0914095e-25e3-4b35-a83b-64059b36f273" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesOther_8c5a39e4-b38a-4ed4-b8d0-dc9d80c0b467" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_db1f6011-e58f-4bd7-992b-69662922c159" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities_0914095e-25e3-4b35-a83b-64059b36f273" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_db1f6011-e58f-4bd7-992b-69662922c159" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_f76831dc-b5c2-46a5-86b8-71652add2561" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_3ea07659-f9ad-461b-b709-16cf57f42d78" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_f76831dc-b5c2-46a5-86b8-71652add2561" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_3ea07659-f9ad-461b-b709-16cf57f42d78" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities_93c32ed6-45bb-4816-9b41-8ff5d7e8fc74" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_f76831dc-b5c2-46a5-86b8-71652add2561" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilities_93c32ed6-45bb-4816-9b41-8ff5d7e8fc74" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross_c66916dd-6100-4439-9d24-599f11397d4e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_f76831dc-b5c2-46a5-86b8-71652add2561" xlink:to="loc_us-gaap_DeferredTaxAssetsGross_c66916dd-6100-4439-9d24-599f11397d4e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross_9449a2c0-35fa-451e-80a1-818949e5e206" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_e57a9794-abf8-4868-b619-ea98cfd17d61" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_9449a2c0-35fa-451e-80a1-818949e5e206" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_e57a9794-abf8-4868-b619-ea98cfd17d61" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals_4a3e5aa1-d3d8-4387-b826-cde8fa322179" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_9449a2c0-35fa-451e-80a1-818949e5e206" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals_4a3e5aa1-d3d8-4387-b826-cde8fa322179" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_DeferredTaxAssetsLeasingArrangements_690db1a8-2781-4a74-84c7-ec4ccf28cacc" xlink:href="lfvn-20250630.xsd#lfvn_DeferredTaxAssetsLeasingArrangements"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_9449a2c0-35fa-451e-80a1-818949e5e206" xlink:to="loc_lfvn_DeferredTaxAssetsLeasingArrangements_690db1a8-2781-4a74-84c7-ec4ccf28cacc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment_776ecdd7-c430-4b6f-8068-4f3b09194c19" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_9449a2c0-35fa-451e-80a1-818949e5e206" xlink:to="loc_us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment_776ecdd7-c430-4b6f-8068-4f3b09194c19" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_d3b38ad4-b2e5-4551-9843-1f2967f91016" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_9449a2c0-35fa-451e-80a1-818949e5e206" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_d3b38ad4-b2e5-4551-9843-1f2967f91016" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.lifevantage.com/role/LeasesScheduleofLeaseCostDetails" xlink:type="simple" xlink:href="lfvn-20250630.xsd#LeasesScheduleofLeaseCostDetails"/>
  <link:calculationLink xlink:role="http://www.lifevantage.com/role/LeasesScheduleofLeaseCostDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCost_b727a6e5-d554-4b66-a4b8-c9ee4c239efc" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LeaseCost"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseCost_5a6fdb87-c381-439f-8305-be79f8dbd1bb" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseCost"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LeaseCost_b727a6e5-d554-4b66-a4b8-c9ee4c239efc" xlink:to="loc_us-gaap_OperatingLeaseCost_5a6fdb87-c381-439f-8305-be79f8dbd1bb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermLeaseCost_290d1aec-c0e6-4c73-8524-a90516ff0773" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShortTermLeaseCost"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LeaseCost_b727a6e5-d554-4b66-a4b8-c9ee4c239efc" xlink:to="loc_us-gaap_ShortTermLeaseCost_290d1aec-c0e6-4c73-8524-a90516ff0773" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableLeaseCost_d44d052a-d382-4715-b566-ef4448394823" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_VariableLeaseCost"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LeaseCost_b727a6e5-d554-4b66-a4b8-c9ee4c239efc" xlink:to="loc_us-gaap_VariableLeaseCost_d44d052a-d382-4715-b566-ef4448394823" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.lifevantage.com/role/LeasesMaturityofLeaseLiabilitiesDetails" xlink:type="simple" xlink:href="lfvn-20250630.xsd#LeasesMaturityofLeaseLiabilitiesDetails"/>
  <link:calculationLink xlink:role="http://www.lifevantage.com/role/LeasesMaturityofLeaseLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_f24a1374-e8a5-4fe8-be9d-02ff07e58830" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_684ece95-a060-4c1d-9205-ae04f5508574" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_f24a1374-e8a5-4fe8-be9d-02ff07e58830" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_684ece95-a060-4c1d-9205-ae04f5508574" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_6be4ce91-fbc6-45ed-805d-4e378a9e0c26" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_f24a1374-e8a5-4fe8-be9d-02ff07e58830" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_6be4ce91-fbc6-45ed-805d-4e378a9e0c26" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_0cc0ff66-0956-4c3b-94e8-e0ff1e62d681" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_f24a1374-e8a5-4fe8-be9d-02ff07e58830" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_0cc0ff66-0956-4c3b-94e8-e0ff1e62d681" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_b6274b4a-83c2-43ad-8c76-275aa33a32bf" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_f24a1374-e8a5-4fe8-be9d-02ff07e58830" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_b6274b4a-83c2-43ad-8c76-275aa33a32bf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_7584661a-ae44-4cbf-8b87-53a470a9ee03" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_f24a1374-e8a5-4fe8-be9d-02ff07e58830" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_7584661a-ae44-4cbf-8b87-53a470a9ee03" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_b05a4cad-1975-4953-b3b4-8d9315355750" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_f24a1374-e8a5-4fe8-be9d-02ff07e58830" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_b05a4cad-1975-4953-b3b4-8d9315355750" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.lifevantage.com/role/LeasesMaturityofLeaseLiabilitiesDetails_1" xlink:type="simple" xlink:href="lfvn-20250630.xsd#LeasesMaturityofLeaseLiabilitiesDetails_1"/>
  <link:calculationLink xlink:role="http://www.lifevantage.com/role/LeasesMaturityofLeaseLiabilitiesDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_19e9c09e-7f11-4b01-992f-c615336ac3a4" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_0c5fd243-df99-4296-8e5a-9644d7058207" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_19e9c09e-7f11-4b01-992f-c615336ac3a4" xlink:to="loc_us-gaap_OperatingLeaseLiability_0c5fd243-df99-4296-8e5a-9644d7058207" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_2a48459c-dcd8-4336-b0cf-66275deb8527" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_19e9c09e-7f11-4b01-992f-c615336ac3a4" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_2a48459c-dcd8-4336-b0cf-66275deb8527" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.lifevantage.com/role/SegmentInformationScheduleofSegmentRevenueandExpenseDetails" xlink:type="simple" xlink:href="lfvn-20250630.xsd#SegmentInformationScheduleofSegmentRevenueandExpenseDetails"/>
  <link:calculationLink xlink:role="http://www.lifevantage.com/role/SegmentInformationScheduleofSegmentRevenueandExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_4899f16e-1b3f-45c2-86ed-6e0076b1ce04" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_053645bf-7806-43ff-8a58-b11782af1370" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_4899f16e-1b3f-45c2-86ed-6e0076b1ce04" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_053645bf-7806-43ff-8a58-b11782af1370" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_a0892c51-accf-400b-9b99-a3aab39ae5c2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_4899f16e-1b3f-45c2-86ed-6e0076b1ce04" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_a0892c51-accf-400b-9b99-a3aab39ae5c2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_ConsultantCommissions_b96a7903-3028-47b0-bf00-7d0396e369b3" xlink:href="lfvn-20250630.xsd#lfvn_ConsultantCommissions"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_4899f16e-1b3f-45c2-86ed-6e0076b1ce04" xlink:to="loc_lfvn_ConsultantCommissions_b96a7903-3028-47b0-bf00-7d0396e369b3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_ConsultantIncentivesPromotionsAndRecognitionExpense_5454ba72-f48a-46c3-a344-55b06c5982d3" xlink:href="lfvn-20250630.xsd#lfvn_ConsultantIncentivesPromotionsAndRecognitionExpense"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_4899f16e-1b3f-45c2-86ed-6e0076b1ce04" xlink:to="loc_lfvn_ConsultantIncentivesPromotionsAndRecognitionExpense_5454ba72-f48a-46c3-a344-55b06c5982d3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LaborAndRelatedExpense_789c07ce-e271-4d6c-a24a-0bfcc5c98e9f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LaborAndRelatedExpense"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_4899f16e-1b3f-45c2-86ed-6e0076b1ce04" xlink:to="loc_us-gaap_LaborAndRelatedExpense_789c07ce-e271-4d6c-a24a-0bfcc5c98e9f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_d6b4e128-b840-441f-ae26-4fba74940846" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensation"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_4899f16e-1b3f-45c2-86ed-6e0076b1ce04" xlink:to="loc_us-gaap_ShareBasedCompensation_d6b4e128-b840-441f-ae26-4fba74940846" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_EventsExpense_4496da49-8e10-4018-8cd7-f6e149cb434a" xlink:href="lfvn-20250630.xsd#lfvn_EventsExpense"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_4899f16e-1b3f-45c2-86ed-6e0076b1ce04" xlink:to="loc_lfvn_EventsExpense_4496da49-8e10-4018-8cd7-f6e149cb434a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_2fb45cfd-f703-4b95-b9a9-30b5e08f794e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:calculationArc order="8" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_4899f16e-1b3f-45c2-86ed-6e0076b1ce04" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_2fb45cfd-f703-4b95-b9a9-30b5e08f794e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_CreditCardAndBankingProcessingFees_6693cc6b-34d4-4f87-82ff-ef66cbadb09e" xlink:href="lfvn-20250630.xsd#lfvn_CreditCardAndBankingProcessingFees"/>
    <link:calculationArc order="9" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_4899f16e-1b3f-45c2-86ed-6e0076b1ce04" xlink:to="loc_lfvn_CreditCardAndBankingProcessingFees_6693cc6b-34d4-4f87-82ff-ef66cbadb09e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingOtherItemAmount_07574bf3-89da-4aba-a7c1-7f77d059ab88" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SegmentReportingOtherItemAmount"/>
    <link:calculationArc order="10" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_4899f16e-1b3f-45c2-86ed-6e0076b1ce04" xlink:to="loc_us-gaap_SegmentReportingOtherItemAmount_07574bf3-89da-4aba-a7c1-7f77d059ab88" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterest_c2e94e6f-5c49-4bec-ae92-0bb4bff9d843" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InvestmentIncomeInterest"/>
    <link:calculationArc order="11" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_4899f16e-1b3f-45c2-86ed-6e0076b1ce04" xlink:to="loc_us-gaap_InvestmentIncomeInterest_c2e94e6f-5c49-4bec-ae92-0bb4bff9d843" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseNonoperating_119431a1-e4ee-4302-83a7-3b8c64808e93" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InterestExpenseNonoperating"/>
    <link:calculationArc order="12" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_4899f16e-1b3f-45c2-86ed-6e0076b1ce04" xlink:to="loc_us-gaap_InterestExpenseNonoperating_119431a1-e4ee-4302-83a7-3b8c64808e93" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_a651b20a-9975-40fc-b438-b71f4a18a013" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:calculationArc order="13" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_4899f16e-1b3f-45c2-86ed-6e0076b1ce04" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_a651b20a-9975-40fc-b438-b71f4a18a013" xlink:type="arc"/>
  </link:calculationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>11
<FILENAME>lfvn-20250630_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:60c7f1f2-d52d-4c01-b992-aaf8be1801ed,g:81eb96f2-7ea0-4e0b-9dac-655ac6c272fe-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://www.lifevantage.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" xlink:type="simple" xlink:href="lfvn-20250630.xsd#CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"/>
  <link:definitionLink xlink:role="http://www.lifevantage.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_cde4e02c-c63b-42a7-abbe-327a6950055a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_2da2c356-67ae-49a7-8cba-e6e3aec0c79d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_cde4e02c-c63b-42a7-abbe-327a6950055a" xlink:to="loc_us-gaap_StatementTable_2da2c356-67ae-49a7-8cba-e6e3aec0c79d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_4fd6067b-9b69-40e4-abd4-9dcdda247a4f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_2da2c356-67ae-49a7-8cba-e6e3aec0c79d" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_4fd6067b-9b69-40e4-abd4-9dcdda247a4f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_4fd6067b-9b69-40e4-abd4-9dcdda247a4f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_4fd6067b-9b69-40e4-abd4-9dcdda247a4f" xlink:to="loc_us-gaap_EquityComponentDomain_4fd6067b-9b69-40e4-abd4-9dcdda247a4f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_54575689-c1be-4dba-a406-a6ed4a44d0c5" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_4fd6067b-9b69-40e4-abd4-9dcdda247a4f" xlink:to="loc_us-gaap_EquityComponentDomain_54575689-c1be-4dba-a406-a6ed4a44d0c5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_573666f0-a793-45f8-94a5-8dc3d886be13" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_54575689-c1be-4dba-a406-a6ed4a44d0c5" xlink:to="loc_us-gaap_CommonStockMember_573666f0-a793-45f8-94a5-8dc3d886be13" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_b25354a5-578f-4044-9d9d-4433f1ff3048" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_54575689-c1be-4dba-a406-a6ed4a44d0c5" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_b25354a5-578f-4044-9d9d-4433f1ff3048" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_cf0f81ef-d8ac-4661-9419-055519ee936a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_54575689-c1be-4dba-a406-a6ed4a44d0c5" xlink:to="loc_us-gaap_RetainedEarningsMember_cf0f81ef-d8ac-4661-9419-055519ee936a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_11f01954-7381-463e-8fa5-0e24396d7bae" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_54575689-c1be-4dba-a406-a6ed4a44d0c5" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_11f01954-7381-463e-8fa5-0e24396d7bae" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_94946c27-d0f7-4e8c-82e5-16a1045a4cb3" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_cde4e02c-c63b-42a7-abbe-327a6950055a" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_94946c27-d0f7-4e8c-82e5-16a1045a4cb3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_f4826a77-a6bb-4092-b5f9-48970ab2b3d2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_94946c27-d0f7-4e8c-82e5-16a1045a4cb3" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_f4826a77-a6bb-4092-b5f9-48970ab2b3d2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_2d9897f9-9062-4489-9e10-ef2631dd4444" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockholdersEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_94946c27-d0f7-4e8c-82e5-16a1045a4cb3" xlink:to="loc_us-gaap_StockholdersEquity_2d9897f9-9062-4489-9e10-ef2631dd4444" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_77b115f4-3513-4cc7-9410-f4605d00c581" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_94946c27-d0f7-4e8c-82e5-16a1045a4cb3" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_77b115f4-3513-4cc7-9410-f4605d00c581" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_654ba936-779f-42b0-a0f8-73fa55abc3cf" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_94946c27-d0f7-4e8c-82e5-16a1045a4cb3" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_654ba936-779f-42b0-a0f8-73fa55abc3cf" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_472877af-0b6e-4b0d-b60c-79e068c33a49" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_94946c27-d0f7-4e8c-82e5-16a1045a4cb3" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_472877af-0b6e-4b0d-b60c-79e068c33a49" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_f25973a2-94bf-4cfe-a1b1-cb054c028639" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_94946c27-d0f7-4e8c-82e5-16a1045a4cb3" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_f25973a2-94bf-4cfe-a1b1-cb054c028639" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_d0aa29e6-bd5b-4a09-9f0e-e6eb7c380619" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_94946c27-d0f7-4e8c-82e5-16a1045a4cb3" xlink:to="loc_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_d0aa29e6-bd5b-4a09-9f0e-e6eb7c380619" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_1177665e-f1c3-48c2-a3e9-6e42f0dfc310" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_94946c27-d0f7-4e8c-82e5-16a1045a4cb3" xlink:to="loc_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_1177665e-f1c3-48c2-a3e9-6e42f0dfc310" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue_7239f0fd-66ab-4803-865d-9c15ab89d84d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_94946c27-d0f7-4e8c-82e5-16a1045a4cb3" xlink:to="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue_7239f0fd-66ab-4803-865d-9c15ab89d84d" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodShares_c98b1c2e-f276-45ab-96bf-30b75a7ffce2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockRepurchasedDuringPeriodShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_94946c27-d0f7-4e8c-82e5-16a1045a4cb3" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodShares_c98b1c2e-f276-45ab-96bf-30b75a7ffce2" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodValue_1c153e0c-7118-4e12-9596-70ed2659e9c4" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockRepurchasedDuringPeriodValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_94946c27-d0f7-4e8c-82e5-16a1045a4cb3" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodValue_1c153e0c-7118-4e12-9596-70ed2659e9c4" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCash_0e295ab6-aa6b-4a6b-a5e7-904792b9a700" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DividendsCash"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_94946c27-d0f7-4e8c-82e5-16a1045a4cb3" xlink:to="loc_us-gaap_DividendsCash_0e295ab6-aa6b-4a6b-a5e7-904792b9a700" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_1c706376-40ba-453c-83c2-0c84e0df0e86" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_94946c27-d0f7-4e8c-82e5-16a1045a4cb3" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_1c706376-40ba-453c-83c2-0c84e0df0e86" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_11bed733-28c1-4855-aced-4487da26193e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_94946c27-d0f7-4e8c-82e5-16a1045a4cb3" xlink:to="loc_us-gaap_NetIncomeLoss_11bed733-28c1-4855-aced-4487da26193e" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_42effda0-5c7e-4988-9ef8-0c96434a3515" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_7d37f78b-62a4-44bf-bc22-b4bc64d2e315" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockholdersEquity"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" xlink:type="simple" xlink:href="lfvn-20250630.xsd#SummaryofSignificantAccountingPoliciesNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskLineItems_a3c39f41-975a-4a50-8c6a-faa4f195d538" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConcentrationRiskLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTable_9f9ceed0-ab72-4722-92c2-9f3575678116" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConcentrationRiskTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_a3c39f41-975a-4a50-8c6a-faa4f195d538" xlink:to="loc_us-gaap_ConcentrationRiskTable_9f9ceed0-ab72-4722-92c2-9f3575678116" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_00954ec1-da36-4937-a2c8-405959efa0b3" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ConcentrationRiskTable_9f9ceed0-ab72-4722-92c2-9f3575678116" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_00954ec1-da36-4937-a2c8-405959efa0b3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_00954ec1-da36-4937-a2c8-405959efa0b3_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_00954ec1-da36-4937-a2c8-405959efa0b3" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_00954ec1-da36-4937-a2c8-405959efa0b3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_b2b73c0a-6e6d-42c9-a0dc-11a89a5ca109" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_00954ec1-da36-4937-a2c8-405959efa0b3" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_b2b73c0a-6e6d-42c9-a0dc-11a89a5ca109" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_CashAccountsHeldPrimarilyAtFinancialInstitutionMember_7970ce70-af82-4d99-a1ea-1cee3750ed80" xlink:href="lfvn-20250630.xsd#lfvn_CashAccountsHeldPrimarilyAtFinancialInstitutionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_b2b73c0a-6e6d-42c9-a0dc-11a89a5ca109" xlink:to="loc_lfvn_CashAccountsHeldPrimarilyAtFinancialInstitutionMember_7970ce70-af82-4d99-a1ea-1cee3750ed80" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_CashAccountsHeldatOtherFinancialInstitutionsMember_d22e4db2-2d57-4607-bacb-e019ec37c29f" xlink:href="lfvn-20250630.xsd#lfvn_CashAccountsHeldatOtherFinancialInstitutionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_b2b73c0a-6e6d-42c9-a0dc-11a89a5ca109" xlink:to="loc_lfvn_CashAccountsHeldatOtherFinancialInstitutionsMember_d22e4db2-2d57-4607-bacb-e019ec37c29f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_SummaryOfSignificantAccountingPoliciesTextualAbstract_85ffac6b-5c1d-4e46-8496-d6c7d86e7d59" xlink:href="lfvn-20250630.xsd#lfvn_SummaryOfSignificantAccountingPoliciesTextualAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_a3c39f41-975a-4a50-8c6a-faa4f195d538" xlink:to="loc_lfvn_SummaryOfSignificantAccountingPoliciesTextualAbstract_85ffac6b-5c1d-4e46-8496-d6c7d86e7d59" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProvisionForDoubtfulAccounts_51b2d5e5-3c33-4827-a4a2-4f4a2e4aaac5" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProvisionForDoubtfulAccounts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lfvn_SummaryOfSignificantAccountingPoliciesTextualAbstract_85ffac6b-5c1d-4e46-8496-d6c7d86e7d59" xlink:to="loc_us-gaap_ProvisionForDoubtfulAccounts_51b2d5e5-3c33-4827-a4a2-4f4a2e4aaac5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryAdjustments_2f76650b-0c02-48e6-82c5-fd78b720c7b2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InventoryAdjustments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lfvn_SummaryOfSignificantAccountingPoliciesTextualAbstract_85ffac6b-5c1d-4e46-8496-d6c7d86e7d59" xlink:to="loc_us-gaap_InventoryAdjustments_2f76650b-0c02-48e6-82c5-fd78b720c7b2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_ff0efdac-2717-48cd-9b24-1d2a82b22902" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lfvn_SummaryOfSignificantAccountingPoliciesTextualAbstract_85ffac6b-5c1d-4e46-8496-d6c7d86e7d59" xlink:to="loc_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_ff0efdac-2717-48cd-9b24-1d2a82b22902" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskCreditRiskFinancialInstrumentMaximumExposure_c9df6e07-ec7d-4418-9d13-92b3d22194bb" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConcentrationRiskCreditRiskFinancialInstrumentMaximumExposure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lfvn_SummaryOfSignificantAccountingPoliciesTextualAbstract_85ffac6b-5c1d-4e46-8496-d6c7d86e7d59" xlink:to="loc_us-gaap_ConcentrationRiskCreditRiskFinancialInstrumentMaximumExposure_c9df6e07-ec7d-4418-9d13-92b3d22194bb" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_08cda668-3e54-4e73-811b-fefe08b95098" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lfvn_SummaryOfSignificantAccountingPoliciesTextualAbstract_85ffac6b-5c1d-4e46-8496-d6c7d86e7d59" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_08cda668-3e54-4e73-811b-fefe08b95098" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_NumberOfFinanceLeases_0d39d712-f7d7-410f-a81e-90629568760e" xlink:href="lfvn-20250630.xsd#lfvn_NumberOfFinanceLeases"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lfvn_SummaryOfSignificantAccountingPoliciesTextualAbstract_85ffac6b-5c1d-4e46-8496-d6c7d86e7d59" xlink:to="loc_lfvn_NumberOfFinanceLeases_0d39d712-f7d7-410f-a81e-90629568760e" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_cc42a5b5-616e-419a-9419-dfdc441f98ca" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lfvn_SummaryOfSignificantAccountingPoliciesTextualAbstract_85ffac6b-5c1d-4e46-8496-d6c7d86e7d59" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_cc42a5b5-616e-419a-9419-dfdc441f98ca" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_NumberOfGeographicSegments_76221c26-b9e4-433a-af6e-d5203a159f6f" xlink:href="lfvn-20250630.xsd#lfvn_NumberOfGeographicSegments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lfvn_SummaryOfSignificantAccountingPoliciesTextualAbstract_85ffac6b-5c1d-4e46-8496-d6c7d86e7d59" xlink:to="loc_lfvn_NumberOfGeographicSegments_76221c26-b9e4-433a-af6e-d5203a159f6f" xlink:type="arc" order="8"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesScheduleOfInventoryValuationReserveDetails" xlink:type="simple" xlink:href="lfvn-20250630.xsd#SummaryofSignificantAccountingPoliciesScheduleOfInventoryValuationReserveDetails"/>
  <link:definitionLink xlink:role="http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesScheduleOfInventoryValuationReserveDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryLineItems_7d19c451-b9f6-4984-942e-46ea5969a56c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InventoryLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryCurrentTable_c041bf9d-b855-47c7-ba42-8a75da5271cf" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InventoryCurrentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_InventoryLineItems_7d19c451-b9f6-4984-942e-46ea5969a56c" xlink:to="loc_us-gaap_InventoryCurrentTable_c041bf9d-b855-47c7-ba42-8a75da5271cf" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_2b3a3c85-0410-43c1-a7a8-c7699d371748" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ValuationAllowancesAndReservesTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_InventoryCurrentTable_c041bf9d-b855-47c7-ba42-8a75da5271cf" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_2b3a3c85-0410-43c1-a7a8-c7699d371748" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesDomain_2b3a3c85-0410-43c1-a7a8-c7699d371748_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ValuationAllowancesAndReservesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_2b3a3c85-0410-43c1-a7a8-c7699d371748" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesDomain_2b3a3c85-0410-43c1-a7a8-c7699d371748_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesDomain_a79fa1bb-a66d-4079-9d1a-f6e72f84f772" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ValuationAllowancesAndReservesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_2b3a3c85-0410-43c1-a7a8-c7699d371748" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesDomain_a79fa1bb-a66d-4079-9d1a-f6e72f84f772" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryValuationReserveMember_2babcb57-5cef-4531-b5ee-7315cb44cc08" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InventoryValuationReserveMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesDomain_a79fa1bb-a66d-4079-9d1a-f6e72f84f772" xlink:to="loc_us-gaap_InventoryValuationReserveMember_2babcb57-5cef-4531-b5ee-7315cb44cc08" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_893f8ec6-b666-49b2-9296-1319670ac26f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MovementInValuationAllowancesAndReservesRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InventoryLineItems_7d19c451-b9f6-4984-942e-46ea5969a56c" xlink:to="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_893f8ec6-b666-49b2-9296-1319670ac26f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesBalance_7b9bd6a9-7f7b-49d5-8468-ab37b4188c53" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ValuationAllowancesAndReservesBalance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_893f8ec6-b666-49b2-9296-1319670ac26f" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesBalance_7b9bd6a9-7f7b-49d5-8468-ab37b4188c53" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_8036b1b5-60af-4993-b3fd-3ca1a5401772" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_893f8ec6-b666-49b2-9296-1319670ac26f" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_8036b1b5-60af-4993-b3fd-3ca1a5401772" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesDeductions_a45b0161-afe6-4d88-8bab-94b9447fc63f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ValuationAllowancesAndReservesDeductions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_893f8ec6-b666-49b2-9296-1319670ac26f" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesDeductions_a45b0161-afe6-4d88-8bab-94b9447fc63f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesBalance_752969c7-ca4b-4916-a454-8c2e2dabd42d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ValuationAllowancesAndReservesBalance"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesPropertyandEquipmentDetails" xlink:type="simple" xlink:href="lfvn-20250630.xsd#SummaryofSignificantAccountingPoliciesPropertyandEquipmentDetails"/>
  <link:definitionLink xlink:role="http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesPropertyandEquipmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_4454b07b-cb8d-4660-95a7-6835b8a4b0a9" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_523adbfa-624b-40eb-af2e-73cb1bb1b79a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_4454b07b-cb8d-4660-95a7-6835b8a4b0a9" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_523adbfa-624b-40eb-af2e-73cb1bb1b79a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_4bd83661-d8c5-4214-a5ee-122687be742d" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_523adbfa-624b-40eb-af2e-73cb1bb1b79a" xlink:to="loc_srt_RangeAxis_4bd83661-d8c5-4214-a5ee-122687be742d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_4bd83661-d8c5-4214-a5ee-122687be742d_default" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_4bd83661-d8c5-4214-a5ee-122687be742d" xlink:to="loc_srt_RangeMember_4bd83661-d8c5-4214-a5ee-122687be742d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_7ebfa872-435e-4638-9695-69a95896e061" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_4bd83661-d8c5-4214-a5ee-122687be742d" xlink:to="loc_srt_RangeMember_7ebfa872-435e-4638-9695-69a95896e061" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_b01356d5-3eae-4854-8360-77f7078d808b" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_7ebfa872-435e-4638-9695-69a95896e061" xlink:to="loc_srt_MinimumMember_b01356d5-3eae-4854-8360-77f7078d808b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_4b371096-1df2-473a-85a4-5db50cf60e66" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_7ebfa872-435e-4638-9695-69a95896e061" xlink:to="loc_srt_MaximumMember_4b371096-1df2-473a-85a4-5db50cf60e66" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_39a0bcc8-8198-48a0-bc6e-e93d56105b88" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_523adbfa-624b-40eb-af2e-73cb1bb1b79a" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_39a0bcc8-8198-48a0-bc6e-e93d56105b88" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_39a0bcc8-8198-48a0-bc6e-e93d56105b88_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_39a0bcc8-8198-48a0-bc6e-e93d56105b88" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_39a0bcc8-8198-48a0-bc6e-e93d56105b88_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_1def108b-2c93-4bd7-afce-ffe0734c2a9e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_39a0bcc8-8198-48a0-bc6e-e93d56105b88" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_1def108b-2c93-4bd7-afce-ffe0734c2a9e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquipmentMember_e73dc512-00fe-4c3d-937b-19f4c65c3139" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_1def108b-2c93-4bd7-afce-ffe0734c2a9e" xlink:to="loc_us-gaap_EquipmentMember_e73dc512-00fe-4c3d-937b-19f4c65c3139" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesMember_b77b1edc-b859-43cb-8740-1dbea13a5e54" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FurnitureAndFixturesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_1def108b-2c93-4bd7-afce-ffe0734c2a9e" xlink:to="loc_us-gaap_FurnitureAndFixturesMember_b77b1edc-b859-43cb-8740-1dbea13a5e54" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VehiclesMember_d8ab8764-5a76-4fa9-b84e-c72e58cf7f0d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_VehiclesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_1def108b-2c93-4bd7-afce-ffe0734c2a9e" xlink:to="loc_us-gaap_VehiclesMember_d8ab8764-5a76-4fa9-b84e-c72e58cf7f0d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_f983ae04-2e17-4601-9774-60243d5d8efb" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_4454b07b-cb8d-4660-95a7-6835b8a4b0a9" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_f983ae04-2e17-4601-9774-60243d5d8efb" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesSegmentInformationDetails" xlink:type="simple" xlink:href="lfvn-20250630.xsd#SummaryofSignificantAccountingPoliciesSegmentInformationDetails"/>
  <link:definitionLink xlink:role="http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesSegmentInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_499ae2a0-4f4d-4338-bbbc-59bdd3b55b6c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_ff0622bd-c781-471b-b655-2268f5320919" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_499ae2a0-4f4d-4338-bbbc-59bdd3b55b6c" xlink:to="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_ff0622bd-c781-471b-b655-2268f5320919" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_f3787ae0-d1c1-4e08-bda6-083d72a72e8f" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_ff0622bd-c781-471b-b655-2268f5320919" xlink:to="loc_srt_StatementGeographicalAxis_f3787ae0-d1c1-4e08-bda6-083d72a72e8f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_f3787ae0-d1c1-4e08-bda6-083d72a72e8f_default" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_f3787ae0-d1c1-4e08-bda6-083d72a72e8f" xlink:to="loc_srt_SegmentGeographicalDomain_f3787ae0-d1c1-4e08-bda6-083d72a72e8f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_c30c83c1-154c-4f85-bc05-3bed8ef5cafa" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_f3787ae0-d1c1-4e08-bda6-083d72a72e8f" xlink:to="loc_srt_SegmentGeographicalDomain_c30c83c1-154c-4f85-bc05-3bed8ef5cafa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_f08ec60f-fadc-4052-8b59-6bead6b99287" xlink:href="https://xbrl.sec.gov/country/2025/country-2025.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_c30c83c1-154c-4f85-bc05-3bed8ef5cafa" xlink:to="loc_country_US_f08ec60f-fadc-4052-8b59-6bead6b99287" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_JP_fd307ac3-bd29-414f-bbb2-e09f41324e1c" xlink:href="https://xbrl.sec.gov/country/2025/country-2025.xsd#country_JP"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_c30c83c1-154c-4f85-bc05-3bed8ef5cafa" xlink:to="loc_country_JP_fd307ac3-bd29-414f-bbb2-e09f41324e1c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncurrentAssets_576f9f3c-9c29-48ad-a3ee-5aa0d8afff1a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NoncurrentAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_499ae2a0-4f4d-4338-bbbc-59bdd3b55b6c" xlink:to="loc_us-gaap_NoncurrentAssets_576f9f3c-9c29-48ad-a3ee-5aa0d8afff1a" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.lifevantage.com/role/RevenueNarrativeDetails" xlink:type="simple" xlink:href="lfvn-20250630.xsd#RevenueNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.lifevantage.com/role/RevenueNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems_bc76da81-6a56-4544-b7ca-4965f1694c32" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable_3904ecf1-eed5-4c81-ae90-5388b7909337" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems_bc76da81-6a56-4544-b7ca-4965f1694c32" xlink:to="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable_3904ecf1-eed5-4c81-ae90-5388b7909337" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_ee792df3-2e39-4c34-b2c3-70558c2894d5" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable_3904ecf1-eed5-4c81-ae90-5388b7909337" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_ee792df3-2e39-4c34-b2c3-70558c2894d5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_ee792df3-2e39-4c34-b2c3-70558c2894d5_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_ee792df3-2e39-4c34-b2c3-70558c2894d5" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_ee792df3-2e39-4c34-b2c3-70558c2894d5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_27eabdba-af84-47bd-9d69-2ffdddbe4d8d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_ee792df3-2e39-4c34-b2c3-70558c2894d5" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_27eabdba-af84-47bd-9d69-2ffdddbe4d8d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductConcentrationRiskMember_ae47fc5a-6298-4ce6-979f-f325a1fd818d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProductConcentrationRiskMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_27eabdba-af84-47bd-9d69-2ffdddbe4d8d" xlink:to="loc_us-gaap_ProductConcentrationRiskMember_ae47fc5a-6298-4ce6-979f-f325a1fd818d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_f4f4f055-7c13-4686-8884-5644303ee977" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable_3904ecf1-eed5-4c81-ae90-5388b7909337" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_f4f4f055-7c13-4686-8884-5644303ee977" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_f4f4f055-7c13-4686-8884-5644303ee977_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_f4f4f055-7c13-4686-8884-5644303ee977" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_f4f4f055-7c13-4686-8884-5644303ee977_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_6bd37139-adb6-48fc-9e50-523933aeccdd" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_f4f4f055-7c13-4686-8884-5644303ee977" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_6bd37139-adb6-48fc-9e50-523933aeccdd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesRevenueNetMember_e20c037a-1ef6-4d70-8299-492285c378d3" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SalesRevenueNetMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_6bd37139-adb6-48fc-9e50-523933aeccdd" xlink:to="loc_us-gaap_SalesRevenueNetMember_e20c037a-1ef6-4d70-8299-492285c378d3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_4b8334e4-7ce7-4c11-9430-fafaa986b58c" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable_3904ecf1-eed5-4c81-ae90-5388b7909337" xlink:to="loc_srt_ProductOrServiceAxis_4b8334e4-7ce7-4c11-9430-fafaa986b58c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_4b8334e4-7ce7-4c11-9430-fafaa986b58c_default" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_4b8334e4-7ce7-4c11-9430-fafaa986b58c" xlink:to="loc_srt_ProductsAndServicesDomain_4b8334e4-7ce7-4c11-9430-fafaa986b58c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_8285d17b-8e84-4521-afaf-9021c259e4df" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_4b8334e4-7ce7-4c11-9430-fafaa986b58c" xlink:to="loc_srt_ProductsAndServicesDomain_8285d17b-8e84-4521-afaf-9021c259e4df" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_ProtandimandTrueScienceProductLineMember_749e1d2e-9aed-4cec-8775-ebd417ff7df1" xlink:href="lfvn-20250630.xsd#lfvn_ProtandimandTrueScienceProductLineMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_8285d17b-8e84-4521-afaf-9021c259e4df" xlink:to="loc_lfvn_ProtandimandTrueScienceProductLineMember_749e1d2e-9aed-4cec-8775-ebd417ff7df1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_MoneyBackGuaranteePeriod_90b7f589-9c82-4490-828d-1626c0f81400" xlink:href="lfvn-20250630.xsd#lfvn_MoneyBackGuaranteePeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems_bc76da81-6a56-4544-b7ca-4965f1694c32" xlink:to="loc_lfvn_MoneyBackGuaranteePeriod_90b7f589-9c82-4490-828d-1626c0f81400" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_HandlingAndRestockingFeePercentage_f41eed20-8824-4c7a-b035-977765c74f42" xlink:href="lfvn-20250630.xsd#lfvn_HandlingAndRestockingFeePercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems_bc76da81-6a56-4544-b7ca-4965f1694c32" xlink:to="loc_lfvn_HandlingAndRestockingFeePercentage_f41eed20-8824-4c7a-b035-977765c74f42" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_ReturnLiabilityReserve_085702ec-5a03-496b-9f7f-321f5216d3f6" xlink:href="lfvn-20250630.xsd#lfvn_ReturnLiabilityReserve"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems_bc76da81-6a56-4544-b7ca-4965f1694c32" xlink:to="loc_lfvn_ReturnLiabilityReserve_085702ec-5a03-496b-9f7f-321f5216d3f6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_NumberOfGeographicSegments_e0e33af5-2e5d-476d-907c-ab786e1c6691" xlink:href="lfvn-20250630.xsd#lfvn_NumberOfGeographicSegments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems_bc76da81-6a56-4544-b7ca-4965f1694c32" xlink:to="loc_lfvn_NumberOfGeographicSegments_e0e33af5-2e5d-476d-907c-ab786e1c6691" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_NumberOfProductLines_f9c770d7-0cbf-48f2-b49c-af2434ad8a40" xlink:href="lfvn-20250630.xsd#lfvn_NumberOfProductLines"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems_bc76da81-6a56-4544-b7ca-4965f1694c32" xlink:to="loc_lfvn_NumberOfProductLines_f9c770d7-0cbf-48f2-b49c-af2434ad8a40" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_368f7656-df4c-4e65-a8e7-face47b97202" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems_bc76da81-6a56-4544-b7ca-4965f1694c32" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_368f7656-df4c-4e65-a8e7-face47b97202" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent_a6192c6f-a07e-4345-9a65-897d31ff0b63" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems_bc76da81-6a56-4544-b7ca-4965f1694c32" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCurrent_a6192c6f-a07e-4345-9a65-897d31ff0b63" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_fcf5ee30-6da1-4a27-89d2-0d546dd43ce3" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ContractWithCustomerLiabilityRevenueRecognized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems_bc76da81-6a56-4544-b7ca-4965f1694c32" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_fcf5ee30-6da1-4a27-89d2-0d546dd43ce3" xlink:type="arc" order="7"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.lifevantage.com/role/RevenueSalesReturnDetails" xlink:type="simple" xlink:href="lfvn-20250630.xsd#RevenueSalesReturnDetails"/>
  <link:definitionLink xlink:role="http://www.lifevantage.com/role/RevenueSalesReturnDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_d9b7fd88-c2ba-413d-afda-d600eedeea0c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_b68e3040-af79-4c43-bee3-a39f94d77645" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_d9b7fd88-c2ba-413d-afda-d600eedeea0c" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_b68e3040-af79-4c43-bee3-a39f94d77645" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_80a040f2-e3d0-47e9-a465-e1213877bf98" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ValuationAllowancesAndReservesTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_b68e3040-af79-4c43-bee3-a39f94d77645" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_80a040f2-e3d0-47e9-a465-e1213877bf98" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesDomain_80a040f2-e3d0-47e9-a465-e1213877bf98_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ValuationAllowancesAndReservesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_80a040f2-e3d0-47e9-a465-e1213877bf98" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesDomain_80a040f2-e3d0-47e9-a465-e1213877bf98_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesDomain_a78b2acf-2f22-472c-a79b-a646e3220769" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ValuationAllowancesAndReservesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_80a040f2-e3d0-47e9-a465-e1213877bf98" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesDomain_a78b2acf-2f22-472c-a79b-a646e3220769" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesReturnsAndAllowancesMember_c472a68d-f699-41e0-821f-b60bde2f3f25" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SalesReturnsAndAllowancesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesDomain_a78b2acf-2f22-472c-a79b-a646e3220769" xlink:to="loc_us-gaap_SalesReturnsAndAllowancesMember_c472a68d-f699-41e0-821f-b60bde2f3f25" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_7d14c504-9d82-48a0-90da-19d96afb0c27" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MovementInValuationAllowancesAndReservesRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_d9b7fd88-c2ba-413d-afda-d600eedeea0c" xlink:to="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_7d14c504-9d82-48a0-90da-19d96afb0c27" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesBalance_d896106b-3add-4c6e-8adc-a1a36d2b6303" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ValuationAllowancesAndReservesBalance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_7d14c504-9d82-48a0-90da-19d96afb0c27" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesBalance_d896106b-3add-4c6e-8adc-a1a36d2b6303" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_233d1180-c81a-4ab2-8189-630423eeaab1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_7d14c504-9d82-48a0-90da-19d96afb0c27" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_233d1180-c81a-4ab2-8189-630423eeaab1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesDeductions_63feff55-50a5-4f1b-926c-d98feddc21ec" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ValuationAllowancesAndReservesDeductions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_7d14c504-9d82-48a0-90da-19d96afb0c27" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesDeductions_63feff55-50a5-4f1b-926c-d98feddc21ec" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesBalance_06d994da-b011-4b33-ab66-f73ed6f373ca" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ValuationAllowancesAndReservesBalance"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.lifevantage.com/role/RevenueMajorProductsDetails" xlink:type="simple" xlink:href="lfvn-20250630.xsd#RevenueMajorProductsDetails"/>
  <link:definitionLink xlink:role="http://www.lifevantage.com/role/RevenueMajorProductsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems_33541627-231a-4f98-a929-88114bf4328e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable_e94212f6-5ee2-4293-97a3-ac237836aac8" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems_33541627-231a-4f98-a929-88114bf4328e" xlink:to="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable_e94212f6-5ee2-4293-97a3-ac237836aac8" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_212c737e-36da-41ee-b29e-c4a52f24032c" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable_e94212f6-5ee2-4293-97a3-ac237836aac8" xlink:to="loc_srt_ProductOrServiceAxis_212c737e-36da-41ee-b29e-c4a52f24032c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_212c737e-36da-41ee-b29e-c4a52f24032c_default" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_212c737e-36da-41ee-b29e-c4a52f24032c" xlink:to="loc_srt_ProductsAndServicesDomain_212c737e-36da-41ee-b29e-c4a52f24032c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_b3ab0286-71f2-401d-be1e-b6651e310bd7" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_212c737e-36da-41ee-b29e-c4a52f24032c" xlink:to="loc_srt_ProductsAndServicesDomain_b3ab0286-71f2-401d-be1e-b6651e310bd7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_ProtandimMember_9cdf5045-fede-47ba-bbbb-d38a90277400" xlink:href="lfvn-20250630.xsd#lfvn_ProtandimMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_b3ab0286-71f2-401d-be1e-b6651e310bd7" xlink:to="loc_lfvn_ProtandimMember_9cdf5045-fede-47ba-bbbb-d38a90277400" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_LifeVantageTrueScienceSkinCareRegimenMember_e749419f-8fc1-4743-bfd2-7a26bba47a85" xlink:href="lfvn-20250630.xsd#lfvn_LifeVantageTrueScienceSkinCareRegimenMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_b3ab0286-71f2-401d-be1e-b6651e310bd7" xlink:to="loc_lfvn_LifeVantageTrueScienceSkinCareRegimenMember_e749419f-8fc1-4743-bfd2-7a26bba47a85" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductAndServiceOtherMember_0ee293a0-023d-4662-8ee2-549cbd9717cb" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProductAndServiceOtherMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_b3ab0286-71f2-401d-be1e-b6651e310bd7" xlink:to="loc_us-gaap_ProductAndServiceOtherMember_0ee293a0-023d-4662-8ee2-549cbd9717cb" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_e072e12d-fd3b-4eb8-b4d7-8552201df5ed" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable_e94212f6-5ee2-4293-97a3-ac237836aac8" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_e072e12d-fd3b-4eb8-b4d7-8552201df5ed" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_e072e12d-fd3b-4eb8-b4d7-8552201df5ed_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_e072e12d-fd3b-4eb8-b4d7-8552201df5ed" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_e072e12d-fd3b-4eb8-b4d7-8552201df5ed_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_b9f170cc-e122-41f5-a437-c01f3100cf34" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_e072e12d-fd3b-4eb8-b4d7-8552201df5ed" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_b9f170cc-e122-41f5-a437-c01f3100cf34" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductConcentrationRiskMember_fbbfb9ed-a9c8-4df6-91fa-0675bf2411cd" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProductConcentrationRiskMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_b9f170cc-e122-41f5-a437-c01f3100cf34" xlink:to="loc_us-gaap_ProductConcentrationRiskMember_fbbfb9ed-a9c8-4df6-91fa-0675bf2411cd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_e2100664-fa62-4b02-a135-1937d238147c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable_e94212f6-5ee2-4293-97a3-ac237836aac8" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_e2100664-fa62-4b02-a135-1937d238147c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_e2100664-fa62-4b02-a135-1937d238147c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_e2100664-fa62-4b02-a135-1937d238147c" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_e2100664-fa62-4b02-a135-1937d238147c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_04dc1f1b-7ade-471b-89c8-fe00420b5c0f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_e2100664-fa62-4b02-a135-1937d238147c" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_04dc1f1b-7ade-471b-89c8-fe00420b5c0f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesRevenueNetMember_20d466ba-0429-4486-a90e-ecdb9b147490" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SalesRevenueNetMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_04dc1f1b-7ade-471b-89c8-fe00420b5c0f" xlink:to="loc_us-gaap_SalesRevenueNetMember_20d466ba-0429-4486-a90e-ecdb9b147490" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_a0bd36ee-059b-493c-8db1-d6923c34af4b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems_33541627-231a-4f98-a929-88114bf4328e" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_a0bd36ee-059b-493c-8db1-d6923c34af4b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_34a4b8ce-7043-49a8-8b1f-52323d20ca31" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems_33541627-231a-4f98-a929-88114bf4328e" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_34a4b8ce-7043-49a8-8b1f-52323d20ca31" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.lifevantage.com/role/PropertyandEquipmentNetDetails" xlink:type="simple" xlink:href="lfvn-20250630.xsd#PropertyandEquipmentNetDetails"/>
  <link:definitionLink xlink:role="http://www.lifevantage.com/role/PropertyandEquipmentNetDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_3c7a43f4-6425-47ed-9b29-7feef4e9c03d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_d9daaab5-ecbf-44ae-b4fb-b4770a8ca856" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_3c7a43f4-6425-47ed-9b29-7feef4e9c03d" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_d9daaab5-ecbf-44ae-b4fb-b4770a8ca856" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_9cd9b2a8-4fde-4199-ac11-1b2cdf4b6411" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_d9daaab5-ecbf-44ae-b4fb-b4770a8ca856" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_9cd9b2a8-4fde-4199-ac11-1b2cdf4b6411" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_9cd9b2a8-4fde-4199-ac11-1b2cdf4b6411_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_9cd9b2a8-4fde-4199-ac11-1b2cdf4b6411" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_9cd9b2a8-4fde-4199-ac11-1b2cdf4b6411_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_a74a1d23-0d48-4bcd-afa8-2365014f85ef" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_9cd9b2a8-4fde-4199-ac11-1b2cdf4b6411" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_a74a1d23-0d48-4bcd-afa8-2365014f85ef" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquipmentMember_f039f524-27f3-47a4-b085-6fabfc69dc13" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_a74a1d23-0d48-4bcd-afa8-2365014f85ef" xlink:to="loc_us-gaap_EquipmentMember_f039f524-27f3-47a4-b085-6fabfc69dc13" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesMember_9fe29ea6-b5c6-4d79-9d43-31998c8ebd9f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FurnitureAndFixturesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_a74a1d23-0d48-4bcd-afa8-2365014f85ef" xlink:to="loc_us-gaap_FurnitureAndFixturesMember_9fe29ea6-b5c6-4d79-9d43-31998c8ebd9f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsMember_a70b06e0-9509-41f5-b6cd-ef862e003cae" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_a74a1d23-0d48-4bcd-afa8-2365014f85ef" xlink:to="loc_us-gaap_LeaseholdImprovementsMember_a70b06e0-9509-41f5-b6cd-ef862e003cae" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VehiclesMember_16bd67b1-2739-42a0-930a-260f8fd0d348" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_VehiclesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_a74a1d23-0d48-4bcd-afa8-2365014f85ef" xlink:to="loc_us-gaap_VehiclesMember_16bd67b1-2739-42a0-930a-260f8fd0d348" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_ba34d636-65e3-419d-94c1-0ac6c039ad15" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_3c7a43f4-6425-47ed-9b29-7feef4e9c03d" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_ba34d636-65e3-419d-94c1-0ac6c039ad15" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_9e2c3850-4980-4b82-9c55-ee4add70b846" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_3c7a43f4-6425-47ed-9b29-7feef4e9c03d" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_9e2c3850-4980-4b82-9c55-ee4add70b846" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_92a9f95b-d748-4a8a-b158-d5fd738afd7b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_3c7a43f4-6425-47ed-9b29-7feef4e9c03d" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_92a9f95b-d748-4a8a-b158-d5fd738afd7b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_cb2135db-33af-4ea2-b654-42e651715da1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Depreciation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_3c7a43f4-6425-47ed-9b29-7feef4e9c03d" xlink:to="loc_us-gaap_Depreciation_cb2135db-33af-4ea2-b654-42e651715da1" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.lifevantage.com/role/IntangibleAssetsNetDetails" xlink:type="simple" xlink:href="lfvn-20250630.xsd#IntangibleAssetsNetDetails"/>
  <link:definitionLink xlink:role="http://www.lifevantage.com/role/IntangibleAssetsNetDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_81224552-b863-49a1-a271-9e01ea5a084d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_909b1a96-592f-4072-aa19-570cb61c2c7e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_81224552-b863-49a1-a271-9e01ea5a084d" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_909b1a96-592f-4072-aa19-570cb61c2c7e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_ffc28564-b540-413d-975c-6ad4948269a0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_909b1a96-592f-4072-aa19-570cb61c2c7e" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_ffc28564-b540-413d-975c-6ad4948269a0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_ffc28564-b540-413d-975c-6ad4948269a0_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_ffc28564-b540-413d-975c-6ad4948269a0" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_ffc28564-b540-413d-975c-6ad4948269a0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_140829f5-dbda-4ab9-8b3d-230ec43a7a57" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_ffc28564-b540-413d-975c-6ad4948269a0" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_140829f5-dbda-4ab9-8b3d-230ec43a7a57" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PatentsMember_4a7aef89-341a-4192-ae1a-d7912c973cf8" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PatentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_140829f5-dbda-4ab9-8b3d-230ec43a7a57" xlink:to="loc_us-gaap_PatentsMember_4a7aef89-341a-4192-ae1a-d7912c973cf8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_cc847770-6edf-4b76-ad08-111bb5cf18cb" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_81224552-b863-49a1-a271-9e01ea5a084d" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_cc847770-6edf-4b76-ad08-111bb5cf18cb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_0afd29d6-8266-49a9-b428-ee661d828213" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_81224552-b863-49a1-a271-9e01ea5a084d" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_0afd29d6-8266-49a9-b428-ee661d828213" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_9b97ef73-6a4c-4d98-8013-b1334048d403" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_81224552-b863-49a1-a271-9e01ea5a084d" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_9b97ef73-6a4c-4d98-8013-b1334048d403" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_ed2ae5e1-8d64-41b7-862d-993b77da1ed7" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_0d97c067-155e-4e45-bfb2-490ef385ab11" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_ed2ae5e1-8d64-41b7-862d-993b77da1ed7" xlink:to="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_0d97c067-155e-4e45-bfb2-490ef385ab11" xlink:type="arc" order="2" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_932ed912-862c-43b3-bfda-dc7a2e2082d8" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_0d97c067-155e-4e45-bfb2-490ef385ab11" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_932ed912-862c-43b3-bfda-dc7a2e2082d8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_932ed912-862c-43b3-bfda-dc7a2e2082d8_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_932ed912-862c-43b3-bfda-dc7a2e2082d8" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_932ed912-862c-43b3-bfda-dc7a2e2082d8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_46e44976-c7c7-44d7-afe2-6278304d7fea" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_932ed912-862c-43b3-bfda-dc7a2e2082d8" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_46e44976-c7c7-44d7-afe2-6278304d7fea" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TrademarksMember_5c9ea9ac-a7d9-4a30-b01c-9bbab5d6440b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TrademarksMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_46e44976-c7c7-44d7-afe2-6278304d7fea" xlink:to="loc_us-gaap_TrademarksMember_5c9ea9ac-a7d9-4a30-b01c-9bbab5d6440b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_85f7ffe0-d7a2-4874-9547-2c085f0eb781" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_ed2ae5e1-8d64-41b7-862d-993b77da1ed7" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_85f7ffe0-d7a2-4874-9547-2c085f0eb781" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.lifevantage.com/role/LongTermDebtDetails" xlink:type="simple" xlink:href="lfvn-20250630.xsd#LongTermDebtDetails"/>
  <link:definitionLink xlink:role="http://www.lifevantage.com/role/LongTermDebtDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLineItems_cc044abf-578d-4db0-81e0-a48c91d97afd" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LineOfCreditFacilityLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityTable_f3b70e66-6fb4-4c1e-a586-9e9c69621eec" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LineOfCreditFacilityTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_cc044abf-578d-4db0-81e0-a48c91d97afd" xlink:to="loc_us-gaap_LineOfCreditFacilityTable_f3b70e66-6fb4-4c1e-a586-9e9c69621eec" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_4e997df3-ce74-41be-a37d-4c37bb8d1356" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_f3b70e66-6fb4-4c1e-a586-9e9c69621eec" xlink:to="loc_us-gaap_DebtInstrumentAxis_4e997df3-ce74-41be-a37d-4c37bb8d1356" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_4e997df3-ce74-41be-a37d-4c37bb8d1356_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_4e997df3-ce74-41be-a37d-4c37bb8d1356" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_4e997df3-ce74-41be-a37d-4c37bb8d1356_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_e4a767f9-3cc7-4bf3-8d90-8a246dceb37b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_4e997df3-ce74-41be-a37d-4c37bb8d1356" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_e4a767f9-3cc7-4bf3-8d90-8a246dceb37b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_March2016RevolvingLoanMember_b98b51d5-dc64-4164-988f-2460d3961553" xlink:href="lfvn-20250630.xsd#lfvn_March2016RevolvingLoanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_e4a767f9-3cc7-4bf3-8d90-8a246dceb37b" xlink:to="loc_lfvn_March2016RevolvingLoanMember_b98b51d5-dc64-4164-988f-2460d3961553" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_March2016TermLoanMember_4d37361b-52d7-4c91-a391-451bc639f42b" xlink:href="lfvn-20250630.xsd#lfvn_March2016TermLoanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_e4a767f9-3cc7-4bf3-8d90-8a246dceb37b" xlink:to="loc_lfvn_March2016TermLoanMember_4d37361b-52d7-4c91-a391-451bc639f42b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_73a13568-90a2-448f-921d-64c1aa66b64a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_f3b70e66-6fb4-4c1e-a586-9e9c69621eec" xlink:to="loc_us-gaap_CreditFacilityAxis_73a13568-90a2-448f-921d-64c1aa66b64a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_73a13568-90a2-448f-921d-64c1aa66b64a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditFacilityAxis_73a13568-90a2-448f-921d-64c1aa66b64a" xlink:to="loc_us-gaap_CreditFacilityDomain_73a13568-90a2-448f-921d-64c1aa66b64a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_3e350aaf-b95a-41c7-b3a3-b6c708d7cd3a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditFacilityAxis_73a13568-90a2-448f-921d-64c1aa66b64a" xlink:to="loc_us-gaap_CreditFacilityDomain_3e350aaf-b95a-41c7-b3a3-b6c708d7cd3a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_15e26b70-e7a9-40cb-99ab-5d9c08f75527" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_3e350aaf-b95a-41c7-b3a3-b6c708d7cd3a" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_15e26b70-e7a9-40cb-99ab-5d9c08f75527" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebtMember_055c8973-e767-4296-8977-ccd0cfcd1c54" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SecuredDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_3e350aaf-b95a-41c7-b3a3-b6c708d7cd3a" xlink:to="loc_us-gaap_SecuredDebtMember_055c8973-e767-4296-8977-ccd0cfcd1c54" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_9c7c81af-22c9-42bd-8af2-aff400c2cfde" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_f3b70e66-6fb4-4c1e-a586-9e9c69621eec" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_9c7c81af-22c9-42bd-8af2-aff400c2cfde" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_9c7c81af-22c9-42bd-8af2-aff400c2cfde_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_9c7c81af-22c9-42bd-8af2-aff400c2cfde" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_9c7c81af-22c9-42bd-8af2-aff400c2cfde_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_2caf71fb-ed2f-4333-82be-91b7fb912b4f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_9c7c81af-22c9-42bd-8af2-aff400c2cfde" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_2caf71fb-ed2f-4333-82be-91b7fb912b4f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_71fea916-e9b7-49d0-820d-c63b81deb2af" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LineOfCreditMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_2caf71fb-ed2f-4333-82be-91b7fb912b4f" xlink:to="loc_us-gaap_LineOfCreditMember_71fea916-e9b7-49d0-820d-c63b81deb2af" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_db95a510-f098-48b0-bce4-e09f1485cb31" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_cc044abf-578d-4db0-81e0-a48c91d97afd" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_db95a510-f098-48b0-bce4-e09f1485cb31" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_e4d3a401-64ff-470b-a071-7d42e0d7e0fa" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_cc044abf-578d-4db0-81e0-a48c91d97afd" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_e4d3a401-64ff-470b-a071-7d42e0d7e0fa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_DebtInstrumentFloorInterestRate_89917b9d-71a9-4967-a6dc-eca5ed14e6e3" xlink:href="lfvn-20250630.xsd#lfvn_DebtInstrumentFloorInterestRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_cc044abf-578d-4db0-81e0-a48c91d97afd" xlink:to="loc_lfvn_DebtInstrumentFloorInterestRate_89917b9d-71a9-4967-a6dc-eca5ed14e6e3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_CommonStockDividendsPerShareCashPaidOneTimeDividend_6de1d761-4669-4124-a3cb-871c978644bf" xlink:href="lfvn-20250630.xsd#lfvn_CommonStockDividendsPerShareCashPaidOneTimeDividend"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_cc044abf-578d-4db0-81e0-a48c91d97afd" xlink:to="loc_lfvn_CommonStockDividendsPerShareCashPaidOneTimeDividend_6de1d761-4669-4124-a3cb-871c978644bf" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage_2124128d-2db6-445c-94ee-2b2ea33e312f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentInterestRateEffectivePercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_cc044abf-578d-4db0-81e0-a48c91d97afd" xlink:to="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage_2124128d-2db6-445c-94ee-2b2ea33e312f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit_56552daa-16f8-4d82-a24a-4078315644bd" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LineOfCredit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_cc044abf-578d-4db0-81e0-a48c91d97afd" xlink:to="loc_us-gaap_LineOfCredit_56552daa-16f8-4d82-a24a-4078315644bd" xlink:type="arc" order="5"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.lifevantage.com/role/StockholdersEquityDetails" xlink:type="simple" xlink:href="lfvn-20250630.xsd#StockholdersEquityDetails"/>
  <link:definitionLink xlink:role="http://www.lifevantage.com/role/StockholdersEquityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems_f1981530-56cd-4aa9-8571-75a4c18e972d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_1bea9198-c8c5-4010-a47c-fd4eeb70f24d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ClassOfStockLineItems_f1981530-56cd-4aa9-8571-75a4c18e972d" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_1bea9198-c8c5-4010-a47c-fd4eeb70f24d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_7b21ba5d-6864-48bb-9a44-48d240b5a34b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_1bea9198-c8c5-4010-a47c-fd4eeb70f24d" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_7b21ba5d-6864-48bb-9a44-48d240b5a34b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_7b21ba5d-6864-48bb-9a44-48d240b5a34b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_7b21ba5d-6864-48bb-9a44-48d240b5a34b" xlink:to="loc_us-gaap_EquityComponentDomain_7b21ba5d-6864-48bb-9a44-48d240b5a34b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_2aad7f7a-c387-4a88-9700-4021f166bd43" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_7b21ba5d-6864-48bb-9a44-48d240b5a34b" xlink:to="loc_us-gaap_EquityComponentDomain_2aad7f7a-c387-4a88-9700-4021f166bd43" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_df186b6f-0342-4193-b15d-ba3a13de6696" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_2aad7f7a-c387-4a88-9700-4021f166bd43" xlink:to="loc_us-gaap_CommonStockMember_df186b6f-0342-4193-b15d-ba3a13de6696" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_e6ad5800-7120-4512-835f-23809bd70134" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_1bea9198-c8c5-4010-a47c-fd4eeb70f24d" xlink:to="loc_us-gaap_AwardTypeAxis_e6ad5800-7120-4512-835f-23809bd70134" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_e6ad5800-7120-4512-835f-23809bd70134_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_e6ad5800-7120-4512-835f-23809bd70134" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_e6ad5800-7120-4512-835f-23809bd70134_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_9c39719b-fadd-48fb-adda-41cfef58c266" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_e6ad5800-7120-4512-835f-23809bd70134" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_9c39719b-fadd-48fb-adda-41cfef58c266" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_39f1d66f-8c1b-4598-8949-5e09fb719f71" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RestrictedStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_9c39719b-fadd-48fb-adda-41cfef58c266" xlink:to="loc_us-gaap_RestrictedStockMember_39f1d66f-8c1b-4598-8949-5e09fb719f71" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_d18751db-7b73-4676-94d9-27ea091c994b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PlanNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_1bea9198-c8c5-4010-a47c-fd4eeb70f24d" xlink:to="loc_us-gaap_PlanNameAxis_d18751db-7b73-4676-94d9-27ea091c994b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_d18751db-7b73-4676-94d9-27ea091c994b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PlanNameAxis_d18751db-7b73-4676-94d9-27ea091c994b" xlink:to="loc_us-gaap_PlanNameDomain_d18751db-7b73-4676-94d9-27ea091c994b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_98c18fba-17d8-4171-83ad-b018a7ea541f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PlanNameAxis_d18751db-7b73-4676-94d9-27ea091c994b" xlink:to="loc_us-gaap_PlanNameDomain_98c18fba-17d8-4171-83ad-b018a7ea541f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_EmployeeStockPurchasePlanMember_2cd0b4cb-8472-4467-a214-8cfdcf7c17df" xlink:href="lfvn-20250630.xsd#lfvn_EmployeeStockPurchasePlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_98c18fba-17d8-4171-83ad-b018a7ea541f" xlink:to="loc_lfvn_EmployeeStockPurchasePlanMember_2cd0b4cb-8472-4467-a214-8cfdcf7c17df" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_StockIssuedDuringPeriodSharesStockOptionsAndWarrantsExercised_e85008d1-7928-47e3-9c44-a7e8483ec3d1" xlink:href="lfvn-20250630.xsd#lfvn_StockIssuedDuringPeriodSharesStockOptionsAndWarrantsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_f1981530-56cd-4aa9-8571-75a4c18e972d" xlink:to="loc_lfvn_StockIssuedDuringPeriodSharesStockOptionsAndWarrantsExercised_e85008d1-7928-47e3-9c44-a7e8483ec3d1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_882e3a2f-b793-4bb0-bffb-198671364379" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_f1981530-56cd-4aa9-8571-75a4c18e972d" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_882e3a2f-b793-4bb0-bffb-198671364379" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_2157019b-2d55-421a-b4fc-5269c234a8af" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_f1981530-56cd-4aa9-8571-75a4c18e972d" xlink:to="loc_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_2157019b-2d55-421a-b4fc-5269c234a8af" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_8c310c73-fc53-4f6c-92f2-96e1524ab8eb" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_f1981530-56cd-4aa9-8571-75a4c18e972d" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_8c310c73-fc53-4f6c-92f2-96e1524ab8eb" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StockRepurchaseProgramAuthorizedAmount1_d64e401d-cfb5-4efd-bfb7-04f11f1f635d" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_f1981530-56cd-4aa9-8571-75a4c18e972d" xlink:to="loc_srt_StockRepurchaseProgramAuthorizedAmount1_d64e401d-cfb5-4efd-bfb7-04f11f1f635d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodShares_c400ff44-840d-4edd-a231-d7a97551b42e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockRepurchasedDuringPeriodShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_f1981530-56cd-4aa9-8571-75a4c18e972d" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodShares_c400ff44-840d-4edd-a231-d7a97551b42e" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_d221c22b-9796-40ab-b1ec-5aad18520d9c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_f1981530-56cd-4aa9-8571-75a4c18e972d" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_d221c22b-9796-40ab-b1ec-5aad18520d9c" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_8e7f4322-9091-497c-97fb-d396e0a107ce" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_f1981530-56cd-4aa9-8571-75a4c18e972d" xlink:to="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_8e7f4322-9091-497c-97fb-d396e0a107ce" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCommonStockCash_dd6d8e5a-b406-4227-88c9-aef4711d44f5" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DividendsCommonStockCash"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_f1981530-56cd-4aa9-8571-75a4c18e972d" xlink:to="loc_us-gaap_DividendsCommonStockCash_dd6d8e5a-b406-4227-88c9-aef4711d44f5" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareCashPaid_b6c94c4e-e084-42a0-91d2-408729418473" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockDividendsPerShareCashPaid"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_f1981530-56cd-4aa9-8571-75a4c18e972d" xlink:to="loc_us-gaap_CommonStockDividendsPerShareCashPaid_b6c94c4e-e084-42a0-91d2-408729418473" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_CommonStockDividendsPerShareCashPaidOneTimeDividend_03fd3e8f-2915-4f5b-8458-36e0c6599a49" xlink:href="lfvn-20250630.xsd#lfvn_CommonStockDividendsPerShareCashPaidOneTimeDividend"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_f1981530-56cd-4aa9-8571-75a4c18e972d" xlink:to="loc_lfvn_CommonStockDividendsPerShareCashPaidOneTimeDividend_03fd3e8f-2915-4f5b-8458-36e0c6599a49" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_bed4b543-1b96-451d-be7e-c85f2ac31ec1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_f1981530-56cd-4aa9-8571-75a4c18e972d" xlink:to="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_bed4b543-1b96-451d-be7e-c85f2ac31ec1" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_9fc0b219-3be3-43a4-93ff-1c3e8f5cd0c3" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_f1981530-56cd-4aa9-8571-75a4c18e972d" xlink:to="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_9fc0b219-3be3-43a4-93ff-1c3e8f5cd0c3" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_ClassOfWarrantOrRightPercentOfCommonStockAcquisitionThatMakesRightsExercisable_c7d3f818-6afc-4aa1-a997-b6c8764509ac" xlink:href="lfvn-20250630.xsd#lfvn_ClassOfWarrantOrRightPercentOfCommonStockAcquisitionThatMakesRightsExercisable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_f1981530-56cd-4aa9-8571-75a4c18e972d" xlink:to="loc_lfvn_ClassOfWarrantOrRightPercentOfCommonStockAcquisitionThatMakesRightsExercisable_c7d3f818-6afc-4aa1-a997-b6c8764509ac" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_ClassOfWarrantOrRightPercentOfCommonStockAcquisitionThatMakesRightsExercisablePassiveInvestors_4640df29-9b95-4776-a083-a9899b9a72e4" xlink:href="lfvn-20250630.xsd#lfvn_ClassOfWarrantOrRightPercentOfCommonStockAcquisitionThatMakesRightsExercisablePassiveInvestors"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_f1981530-56cd-4aa9-8571-75a4c18e972d" xlink:to="loc_lfvn_ClassOfWarrantOrRightPercentOfCommonStockAcquisitionThatMakesRightsExercisablePassiveInvestors_4640df29-9b95-4776-a083-a9899b9a72e4" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_ClassOfWarrantsOrRightDiscount_3f2f27ba-659e-4214-aa31-5c5c605d84da" xlink:href="lfvn-20250630.xsd#lfvn_ClassOfWarrantsOrRightDiscount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_f1981530-56cd-4aa9-8571-75a4c18e972d" xlink:to="loc_lfvn_ClassOfWarrantsOrRightDiscount_3f2f27ba-659e-4214-aa31-5c5c605d84da" xlink:type="arc" order="15"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.lifevantage.com/role/ShareBasedCompensationEquitySettledPlansNarrativeDetails" xlink:type="simple" xlink:href="lfvn-20250630.xsd#ShareBasedCompensationEquitySettledPlansNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.lifevantage.com/role/ShareBasedCompensationEquitySettledPlansNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1481ecc0-72e2-4796-ab55-2e598c253b36" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_11c30ef7-fe0b-4c56-b1c0-79986de214e9" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1481ecc0-72e2-4796-ab55-2e598c253b36" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_11c30ef7-fe0b-4c56-b1c0-79986de214e9" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_83d4afee-6bd6-4c8a-bd79-e359269e897f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PlanNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_11c30ef7-fe0b-4c56-b1c0-79986de214e9" xlink:to="loc_us-gaap_PlanNameAxis_83d4afee-6bd6-4c8a-bd79-e359269e897f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_83d4afee-6bd6-4c8a-bd79-e359269e897f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PlanNameAxis_83d4afee-6bd6-4c8a-bd79-e359269e897f" xlink:to="loc_us-gaap_PlanNameDomain_83d4afee-6bd6-4c8a-bd79-e359269e897f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_b530a334-70ac-4af0-ae4f-21c545c5592a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PlanNameAxis_83d4afee-6bd6-4c8a-bd79-e359269e897f" xlink:to="loc_us-gaap_PlanNameDomain_b530a334-70ac-4af0-ae4f-21c545c5592a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_TwoThousandAndTenLongTermIncentivePlanMember_9b28b0a7-0cd9-4e35-ba74-e54cf2b9601f" xlink:href="lfvn-20250630.xsd#lfvn_TwoThousandAndTenLongTermIncentivePlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_b530a334-70ac-4af0-ae4f-21c545c5592a" xlink:to="loc_lfvn_TwoThousandAndTenLongTermIncentivePlanMember_9b28b0a7-0cd9-4e35-ba74-e54cf2b9601f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_TwoThousandSeventeenLongTermIncentivePlanMember_33346479-124a-444a-a4ef-482037160ff6" xlink:href="lfvn-20250630.xsd#lfvn_TwoThousandSeventeenLongTermIncentivePlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_b530a334-70ac-4af0-ae4f-21c545c5592a" xlink:to="loc_lfvn_TwoThousandSeventeenLongTermIncentivePlanMember_33346479-124a-444a-a4ef-482037160ff6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_TwoThousandSeventeenLongTermIncentivePlanExcludingTwoThousandAndTenLongTermIncentivePlanMember_f1102ba6-a746-4d72-8b46-1449ce9cc7df" xlink:href="lfvn-20250630.xsd#lfvn_TwoThousandSeventeenLongTermIncentivePlanExcludingTwoThousandAndTenLongTermIncentivePlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_b530a334-70ac-4af0-ae4f-21c545c5592a" xlink:to="loc_lfvn_TwoThousandSeventeenLongTermIncentivePlanExcludingTwoThousandAndTenLongTermIncentivePlanMember_f1102ba6-a746-4d72-8b46-1449ce9cc7df" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_694beb1f-f741-464f-8ec0-77094fadfa3c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1481ecc0-72e2-4796-ab55-2e598c253b36" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_694beb1f-f741-464f-8ec0-77094fadfa3c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_bd925365-063e-49e9-8789-9964aefa5fdd" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1481ecc0-72e2-4796-ab55-2e598c253b36" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_bd925365-063e-49e9-8789-9964aefa5fdd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_739c31d5-2147-4b8d-80ed-3ca71c7aa942" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1481ecc0-72e2-4796-ab55-2e598c253b36" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_739c31d5-2147-4b8d-80ed-3ca71c7aa942" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_e973af33-6c14-42a1-a0da-7d8cdf55f6e5" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1481ecc0-72e2-4796-ab55-2e598c253b36" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_e973af33-6c14-42a1-a0da-7d8cdf55f6e5" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsOutstandingContractualTerm_64723c0f-2217-482a-a0ca-f43884a62b61" xlink:href="lfvn-20250630.xsd#lfvn_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsOutstandingContractualTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1481ecc0-72e2-4796-ab55-2e598c253b36" xlink:to="loc_lfvn_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsOutstandingContractualTerm_64723c0f-2217-482a-a0ca-f43884a62b61" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_fc786c56-9dc3-4831-adf7-21f01c7916ee" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1481ecc0-72e2-4796-ab55-2e598c253b36" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_fc786c56-9dc3-4831-adf7-21f01c7916ee" xlink:type="arc" order="5"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.lifevantage.com/role/ShareBasedCompensationEmployeeStockPurchasePlanNarrativeDetails" xlink:type="simple" xlink:href="lfvn-20250630.xsd#ShareBasedCompensationEmployeeStockPurchasePlanNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.lifevantage.com/role/ShareBasedCompensationEmployeeStockPurchasePlanNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0361f077-afca-469d-b77f-e91f014e2b6a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_189116e0-24a4-4007-8b64-19487f28525c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0361f077-afca-469d-b77f-e91f014e2b6a" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_189116e0-24a4-4007-8b64-19487f28525c" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_9cb81e79-30da-408c-8ef7-890a778e0e06" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PlanNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_189116e0-24a4-4007-8b64-19487f28525c" xlink:to="loc_us-gaap_PlanNameAxis_9cb81e79-30da-408c-8ef7-890a778e0e06" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_9cb81e79-30da-408c-8ef7-890a778e0e06_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PlanNameAxis_9cb81e79-30da-408c-8ef7-890a778e0e06" xlink:to="loc_us-gaap_PlanNameDomain_9cb81e79-30da-408c-8ef7-890a778e0e06_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_f1ba49cf-3232-4cd1-8159-39f47afac75a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PlanNameAxis_9cb81e79-30da-408c-8ef7-890a778e0e06" xlink:to="loc_us-gaap_PlanNameDomain_f1ba49cf-3232-4cd1-8159-39f47afac75a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_EmployeeStockPurchasePlanMember_70791e2f-0657-49eb-b0d1-53bf76b495ae" xlink:href="lfvn-20250630.xsd#lfvn_EmployeeStockPurchasePlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_f1ba49cf-3232-4cd1-8159-39f47afac75a" xlink:to="loc_lfvn_EmployeeStockPurchasePlanMember_70791e2f-0657-49eb-b0d1-53bf76b495ae" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_f00968c8-1348-49db-af0b-d9aef1974a9f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0361f077-afca-469d-b77f-e91f014e2b6a" xlink:to="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_f00968c8-1348-49db-af0b-d9aef1974a9f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_a642c1ca-b7be-4897-a3ea-efdf626d8b7b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0361f077-afca-469d-b77f-e91f014e2b6a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_a642c1ca-b7be-4897-a3ea-efdf626d8b7b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_81fe4afe-fa05-4773-81b8-8327d0d68c7d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0361f077-afca-469d-b77f-e91f014e2b6a" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_81fe4afe-fa05-4773-81b8-8327d0d68c7d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate_b1925a43-5574-4b95-9a16-f4942ac78b8f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0361f077-afca-469d-b77f-e91f014e2b6a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate_b1925a43-5574-4b95-9a16-f4942ac78b8f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee_b7c558fd-f4ec-4bb3-892c-a83eebbfbd58" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0361f077-afca-469d-b77f-e91f014e2b6a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee_b7c558fd-f4ec-4bb3-892c-a83eebbfbd58" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_ShareBasedCompensationArrangementByShareBasedPaymentAwardAmountInExcessOfFairMarketValueOfStockForOptionNotToBeGranted_ca66096c-2bff-4d3f-84aa-aa5f64bec9e9" xlink:href="lfvn-20250630.xsd#lfvn_ShareBasedCompensationArrangementByShareBasedPaymentAwardAmountInExcessOfFairMarketValueOfStockForOptionNotToBeGranted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0361f077-afca-469d-b77f-e91f014e2b6a" xlink:to="loc_lfvn_ShareBasedCompensationArrangementByShareBasedPaymentAwardAmountInExcessOfFairMarketValueOfStockForOptionNotToBeGranted_ca66096c-2bff-4d3f-84aa-aa5f64bec9e9" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOfferingPeriod_cac7c9eb-4fc2-40d6-8afa-385c9bcc690d" xlink:href="lfvn-20250630.xsd#lfvn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOfferingPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0361f077-afca-469d-b77f-e91f014e2b6a" xlink:to="loc_lfvn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOfferingPeriod_cac7c9eb-4fc2-40d6-8afa-385c9bcc690d" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_e2034732-a72d-45cb-a6a1-64f2830e15d9" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0361f077-afca-469d-b77f-e91f014e2b6a" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_e2034732-a72d-45cb-a6a1-64f2830e15d9" xlink:type="arc" order="7"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.lifevantage.com/role/ShareBasedCompensationStockBasedCompensationNarrativeDetails" xlink:type="simple" xlink:href="lfvn-20250630.xsd#ShareBasedCompensationStockBasedCompensationNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.lifevantage.com/role/ShareBasedCompensationStockBasedCompensationNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6a799a40-a0aa-4512-8933-244fe3220684" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_d5a78dac-9606-4509-8d9c-cc7c2b098b96" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6a799a40-a0aa-4512-8933-244fe3220684" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_d5a78dac-9606-4509-8d9c-cc7c2b098b96" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_00d21672-33a5-46fc-a2ca-80273819faaa" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_d5a78dac-9606-4509-8d9c-cc7c2b098b96" xlink:to="loc_us-gaap_AwardTypeAxis_00d21672-33a5-46fc-a2ca-80273819faaa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_00d21672-33a5-46fc-a2ca-80273819faaa_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_00d21672-33a5-46fc-a2ca-80273819faaa" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_00d21672-33a5-46fc-a2ca-80273819faaa_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2f4360e2-1d59-49a2-b473-f592817fb5d6" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_00d21672-33a5-46fc-a2ca-80273819faaa" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2f4360e2-1d59-49a2-b473-f592817fb5d6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_0cdc0028-fa0a-457c-b854-1b88f1d14607" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RestrictedStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2f4360e2-1d59-49a2-b473-f592817fb5d6" xlink:to="loc_us-gaap_RestrictedStockMember_0cdc0028-fa0a-457c-b854-1b88f1d14607" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_ee18d173-2047-44d1-99c5-4615bb5456a9" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PlanNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_d5a78dac-9606-4509-8d9c-cc7c2b098b96" xlink:to="loc_us-gaap_PlanNameAxis_ee18d173-2047-44d1-99c5-4615bb5456a9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_ee18d173-2047-44d1-99c5-4615bb5456a9_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PlanNameAxis_ee18d173-2047-44d1-99c5-4615bb5456a9" xlink:to="loc_us-gaap_PlanNameDomain_ee18d173-2047-44d1-99c5-4615bb5456a9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_8aeefbc5-ecdd-4aa0-a5ce-23337f4fc2ab" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PlanNameAxis_ee18d173-2047-44d1-99c5-4615bb5456a9" xlink:to="loc_us-gaap_PlanNameDomain_8aeefbc5-ecdd-4aa0-a5ce-23337f4fc2ab" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_TwoThousandAndTenAndTwoThousandSeventeenLongTermIncentivePlanMember_d09290e0-0b19-45b2-9e0c-aa191e52f179" xlink:href="lfvn-20250630.xsd#lfvn_TwoThousandAndTenAndTwoThousandSeventeenLongTermIncentivePlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_8aeefbc5-ecdd-4aa0-a5ce-23337f4fc2ab" xlink:to="loc_lfvn_TwoThousandAndTenAndTwoThousandSeventeenLongTermIncentivePlanMember_d09290e0-0b19-45b2-9e0c-aa191e52f179" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_de83d78a-f36b-449b-842a-acbe0afd336a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6a799a40-a0aa-4512-8933-244fe3220684" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_de83d78a-f36b-449b-842a-acbe0afd336a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_9dab49b1-3321-4a5e-881c-dfc6b72c9b12" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6a799a40-a0aa-4512-8933-244fe3220684" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_9dab49b1-3321-4a5e-881c-dfc6b72c9b12" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_f87f6d87-d617-47a2-a022-93634a971b2f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6a799a40-a0aa-4512-8933-244fe3220684" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_f87f6d87-d617-47a2-a022-93634a971b2f" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.lifevantage.com/role/ShareBasedCompensationStockOptionsNarrativeDetails" xlink:type="simple" xlink:href="lfvn-20250630.xsd#ShareBasedCompensationStockOptionsNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.lifevantage.com/role/ShareBasedCompensationStockOptionsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_d7144524-a862-4033-93e3-3ad318d4964d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_fc02d65c-973e-46ae-8ae3-58ce72fe98b3" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_d7144524-a862-4033-93e3-3ad318d4964d" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_fc02d65c-973e-46ae-8ae3-58ce72fe98b3" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingAxis_3d4f89b8-3840-4150-bf1d-370fbf5ea077" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_VestingAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_fc02d65c-973e-46ae-8ae3-58ce72fe98b3" xlink:to="loc_us-gaap_VestingAxis_3d4f89b8-3840-4150-bf1d-370fbf5ea077" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingDomain_3d4f89b8-3840-4150-bf1d-370fbf5ea077_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_VestingDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_VestingAxis_3d4f89b8-3840-4150-bf1d-370fbf5ea077" xlink:to="loc_us-gaap_VestingDomain_3d4f89b8-3840-4150-bf1d-370fbf5ea077_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingDomain_638cd577-8bf7-4cc3-909a-6941a2256841" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_VestingDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_VestingAxis_3d4f89b8-3840-4150-bf1d-370fbf5ea077" xlink:to="loc_us-gaap_VestingDomain_638cd577-8bf7-4cc3-909a-6941a2256841" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationAwardTrancheOneMember_64bc805b-31fc-4b74-ad50-c40ff18e1a75" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationAwardTrancheOneMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VestingDomain_638cd577-8bf7-4cc3-909a-6941a2256841" xlink:to="loc_us-gaap_ShareBasedCompensationAwardTrancheOneMember_64bc805b-31fc-4b74-ad50-c40ff18e1a75" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationAwardTrancheTwoMember_ea64ff54-dedb-4ebb-ba6e-8bcf4a5c28b9" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationAwardTrancheTwoMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VestingDomain_638cd577-8bf7-4cc3-909a-6941a2256841" xlink:to="loc_us-gaap_ShareBasedCompensationAwardTrancheTwoMember_ea64ff54-dedb-4ebb-ba6e-8bcf4a5c28b9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_6015b020-d7a1-46bc-9e95-a5079798fde0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_fc02d65c-973e-46ae-8ae3-58ce72fe98b3" xlink:to="loc_us-gaap_AwardTypeAxis_6015b020-d7a1-46bc-9e95-a5079798fde0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_6015b020-d7a1-46bc-9e95-a5079798fde0_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_6015b020-d7a1-46bc-9e95-a5079798fde0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_6015b020-d7a1-46bc-9e95-a5079798fde0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_78a767b1-b71c-4406-ba45-a8d322d57d36" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_6015b020-d7a1-46bc-9e95-a5079798fde0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_78a767b1-b71c-4406-ba45-a8d322d57d36" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_5e6f204b-1502-4734-acba-5e091775bfd7" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_78a767b1-b71c-4406-ba45-a8d322d57d36" xlink:to="loc_us-gaap_EmployeeStockOptionMember_5e6f204b-1502-4734-acba-5e091775bfd7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_ac7dc795-a689-4fab-abb2-9b1ca1ab5a83" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_d7144524-a862-4033-93e3-3ad318d4964d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_ac7dc795-a689-4fab-abb2-9b1ca1ab5a83" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_9dddd3a9-e473-4942-8a05-66484fd8ca26" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_d7144524-a862-4033-93e3-3ad318d4964d" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_9dddd3a9-e473-4942-8a05-66484fd8ca26" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_57659526-2828-480b-9fc7-38adcbc7a997" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_d7144524-a862-4033-93e3-3ad318d4964d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_57659526-2828-480b-9fc7-38adcbc7a997" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.lifevantage.com/role/ShareBasedCompensationRestrictedSharesDetails" xlink:type="simple" xlink:href="lfvn-20250630.xsd#ShareBasedCompensationRestrictedSharesDetails"/>
  <link:definitionLink xlink:role="http://www.lifevantage.com/role/ShareBasedCompensationRestrictedSharesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_22ca40e9-a1e0-4c7e-9660-ef4e5aaf333e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_8a8401b0-2380-45bb-8167-aec37c2fde04" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_22ca40e9-a1e0-4c7e-9660-ef4e5aaf333e" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_8a8401b0-2380-45bb-8167-aec37c2fde04" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_415ca3a2-967c-4c88-98d1-238be5a0ba1c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_8a8401b0-2380-45bb-8167-aec37c2fde04" xlink:to="loc_us-gaap_AwardTypeAxis_415ca3a2-967c-4c88-98d1-238be5a0ba1c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_415ca3a2-967c-4c88-98d1-238be5a0ba1c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_415ca3a2-967c-4c88-98d1-238be5a0ba1c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_415ca3a2-967c-4c88-98d1-238be5a0ba1c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_799fd31e-a5f3-4e52-8548-137a3597fa67" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_415ca3a2-967c-4c88-98d1-238be5a0ba1c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_799fd31e-a5f3-4e52-8548-137a3597fa67" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_673665e9-a848-48b3-bf85-16674c228763" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RestrictedStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_799fd31e-a5f3-4e52-8548-137a3597fa67" xlink:to="loc_us-gaap_RestrictedStockMember_673665e9-a848-48b3-bf85-16674c228763" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_8b8dc0a6-503f-46b6-ae88-e25891c29e64" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_799fd31e-a5f3-4e52-8548-137a3597fa67" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_8b8dc0a6-503f-46b6-ae88-e25891c29e64" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_ba1a26fd-a0a8-41d1-a050-e3e8a8fe6464" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_22ca40e9-a1e0-4c7e-9660-ef4e5aaf333e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_ba1a26fd-a0a8-41d1-a050-e3e8a8fe6464" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_b033025c-5205-4949-b10e-f4f41aa0c14a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_ba1a26fd-a0a8-41d1-a050-e3e8a8fe6464" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_b033025c-5205-4949-b10e-f4f41aa0c14a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_58c385c1-fb3e-4aac-86da-cb7a56740bf7" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_ba1a26fd-a0a8-41d1-a050-e3e8a8fe6464" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_58c385c1-fb3e-4aac-86da-cb7a56740bf7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_7267aba3-e2b3-4589-b3e9-7762d3e25030" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_ba1a26fd-a0a8-41d1-a050-e3e8a8fe6464" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_7267aba3-e2b3-4589-b3e9-7762d3e25030" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_530f6a6c-9d61-427f-acb7-a45f6535c387" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_ba1a26fd-a0a8-41d1-a050-e3e8a8fe6464" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_530f6a6c-9d61-427f-acb7-a45f6535c387" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_d9e5aa3a-5802-4ce6-a847-8e54b3a48baf" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_a757bd3b-1145-42ed-9d7a-a54d21e8452a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_22ca40e9-a1e0-4c7e-9660-ef4e5aaf333e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_a757bd3b-1145-42ed-9d7a-a54d21e8452a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_33d0b129-4ad5-47d9-a35d-29abf5b39b94" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_a757bd3b-1145-42ed-9d7a-a54d21e8452a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_33d0b129-4ad5-47d9-a35d-29abf5b39b94" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_73c35a3e-985e-441e-8f2a-945f579c348b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_a757bd3b-1145-42ed-9d7a-a54d21e8452a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_73c35a3e-985e-441e-8f2a-945f579c348b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_10d95066-b6ce-4c4d-b6d3-c50a50fc5469" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_a757bd3b-1145-42ed-9d7a-a54d21e8452a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_10d95066-b6ce-4c4d-b6d3-c50a50fc5469" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_c5e861fb-21b8-4995-ab8f-c960459bc9d7" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_a757bd3b-1145-42ed-9d7a-a54d21e8452a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_c5e861fb-21b8-4995-ab8f-c960459bc9d7" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_e02cf916-fd12-4c0d-8aa0-f6494a0546a2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsCancelledInPeriod_3b49f749-5c48-4de4-8a6d-9d2fa7765e09" xlink:href="lfvn-20250630.xsd#lfvn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsCancelledInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_22ca40e9-a1e0-4c7e-9660-ef4e5aaf333e" xlink:to="loc_lfvn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsCancelledInPeriod_3b49f749-5c48-4de4-8a6d-9d2fa7765e09" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInExchange_c594d3f3-2cdd-46b2-a1a8-280d5f30f7d5" xlink:href="lfvn-20250630.xsd#lfvn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInExchange"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_22ca40e9-a1e0-4c7e-9660-ef4e5aaf333e" xlink:to="loc_lfvn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInExchange_c594d3f3-2cdd-46b2-a1a8-280d5f30f7d5" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.lifevantage.com/role/ShareBasedCompensationRestrictedStockNarrativeDetails" xlink:type="simple" xlink:href="lfvn-20250630.xsd#ShareBasedCompensationRestrictedStockNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.lifevantage.com/role/ShareBasedCompensationRestrictedStockNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_d794265c-1a87-4413-8246-298921cc4104" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_fde8c7f6-5642-4c28-b98f-712c15cba69e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_d794265c-1a87-4413-8246-298921cc4104" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_fde8c7f6-5642-4c28-b98f-712c15cba69e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_33520d58-2e0b-4b2e-b549-c3aed41bbfd2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_fde8c7f6-5642-4c28-b98f-712c15cba69e" xlink:to="loc_us-gaap_AwardTypeAxis_33520d58-2e0b-4b2e-b549-c3aed41bbfd2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_33520d58-2e0b-4b2e-b549-c3aed41bbfd2_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_33520d58-2e0b-4b2e-b549-c3aed41bbfd2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_33520d58-2e0b-4b2e-b549-c3aed41bbfd2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_32effecc-edd3-420a-b3aa-9efdbb14f76e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_33520d58-2e0b-4b2e-b549-c3aed41bbfd2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_32effecc-edd3-420a-b3aa-9efdbb14f76e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_61195b8c-1bf4-48af-8c3c-0392eb9f5d9e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RestrictedStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_32effecc-edd3-420a-b3aa-9efdbb14f76e" xlink:to="loc_us-gaap_RestrictedStockMember_61195b8c-1bf4-48af-8c3c-0392eb9f5d9e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_2c3219a7-80c5-4ff6-b6ad-5c6bc4a548bb" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_32effecc-edd3-420a-b3aa-9efdbb14f76e" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_2c3219a7-80c5-4ff6-b6ad-5c6bc4a548bb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_52e30840-ef69-4728-a1f8-0384ede912f3" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_d794265c-1a87-4413-8246-298921cc4104" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_52e30840-ef69-4728-a1f8-0384ede912f3" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.lifevantage.com/role/ShareBasedCompensationPerformanceRestrictedStockUnitsNarrativeDetails" xlink:type="simple" xlink:href="lfvn-20250630.xsd#ShareBasedCompensationPerformanceRestrictedStockUnitsNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.lifevantage.com/role/ShareBasedCompensationPerformanceRestrictedStockUnitsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3933982c-0031-4a19-8c65-21af3d988c2c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_43ac31be-bcf8-4cea-acff-4c575fd99895" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3933982c-0031-4a19-8c65-21af3d988c2c" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_43ac31be-bcf8-4cea-acff-4c575fd99895" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_6cb5c0e8-469b-4d26-b7ff-71ed34acae9a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_43ac31be-bcf8-4cea-acff-4c575fd99895" xlink:to="loc_us-gaap_AwardTypeAxis_6cb5c0e8-469b-4d26-b7ff-71ed34acae9a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_6cb5c0e8-469b-4d26-b7ff-71ed34acae9a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_6cb5c0e8-469b-4d26-b7ff-71ed34acae9a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_6cb5c0e8-469b-4d26-b7ff-71ed34acae9a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_cf782522-1d2b-4beb-b383-f789bdbdab1f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_6cb5c0e8-469b-4d26-b7ff-71ed34acae9a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_cf782522-1d2b-4beb-b383-f789bdbdab1f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_PerformanceStockUnitsMember_45712cad-c0c6-4877-8857-a04b84de9055" xlink:href="lfvn-20250630.xsd#lfvn_PerformanceStockUnitsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_cf782522-1d2b-4beb-b383-f789bdbdab1f" xlink:to="loc_lfvn_PerformanceStockUnitsMember_45712cad-c0c6-4877-8857-a04b84de9055" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_5554f411-3365-4415-bf74-4295978f19d3" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_43ac31be-bcf8-4cea-acff-4c575fd99895" xlink:to="loc_srt_RangeAxis_5554f411-3365-4415-bf74-4295978f19d3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_5554f411-3365-4415-bf74-4295978f19d3_default" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_5554f411-3365-4415-bf74-4295978f19d3" xlink:to="loc_srt_RangeMember_5554f411-3365-4415-bf74-4295978f19d3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_7ca95660-aa81-40c7-a3ea-5f7a71ac2bec" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_5554f411-3365-4415-bf74-4295978f19d3" xlink:to="loc_srt_RangeMember_7ca95660-aa81-40c7-a3ea-5f7a71ac2bec" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_0ef6889f-a756-4b12-b8b3-4dbc682d0b2d" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_7ca95660-aa81-40c7-a3ea-5f7a71ac2bec" xlink:to="loc_srt_MinimumMember_0ef6889f-a756-4b12-b8b3-4dbc682d0b2d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_25f524fd-c81f-4ff8-bace-9b7ba5a901e9" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_7ca95660-aa81-40c7-a3ea-5f7a71ac2bec" xlink:to="loc_srt_MaximumMember_25f524fd-c81f-4ff8-bace-9b7ba5a901e9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_SharebasedCompensationArrangementbySharebasedPaymentAwardDistributionPercentage_0c6b90b4-aed7-40c7-9434-81c3969889a4" xlink:href="lfvn-20250630.xsd#lfvn_SharebasedCompensationArrangementbySharebasedPaymentAwardDistributionPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3933982c-0031-4a19-8c65-21af3d988c2c" xlink:to="loc_lfvn_SharebasedCompensationArrangementbySharebasedPaymentAwardDistributionPercentage_0c6b90b4-aed7-40c7-9434-81c3969889a4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_584a1890-7f74-4a00-af95-8d0fd63e24fe" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3933982c-0031-4a19-8c65-21af3d988c2c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_584a1890-7f74-4a00-af95-8d0fd63e24fe" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.lifevantage.com/role/ShareBasedCompensationPerformanceRestrictedStockUnitsDetails" xlink:type="simple" xlink:href="lfvn-20250630.xsd#ShareBasedCompensationPerformanceRestrictedStockUnitsDetails"/>
  <link:definitionLink xlink:role="http://www.lifevantage.com/role/ShareBasedCompensationPerformanceRestrictedStockUnitsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e033d7bc-9101-454b-8a65-a2d4fc070a88" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_7f8917b4-1a5c-4792-82a1-c649711fab65" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e033d7bc-9101-454b-8a65-a2d4fc070a88" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_7f8917b4-1a5c-4792-82a1-c649711fab65" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_fc7cbd4c-7ff9-4ac8-8336-b70afc3c82f8" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_7f8917b4-1a5c-4792-82a1-c649711fab65" xlink:to="loc_us-gaap_AwardTypeAxis_fc7cbd4c-7ff9-4ac8-8336-b70afc3c82f8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_fc7cbd4c-7ff9-4ac8-8336-b70afc3c82f8_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_fc7cbd4c-7ff9-4ac8-8336-b70afc3c82f8" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_fc7cbd4c-7ff9-4ac8-8336-b70afc3c82f8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2de88098-fa9c-47c5-8179-543ae8781ced" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_fc7cbd4c-7ff9-4ac8-8336-b70afc3c82f8" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2de88098-fa9c-47c5-8179-543ae8781ced" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_PerformanceStockUnitsMember_f56df465-0041-49b5-a367-a309aeb759d9" xlink:href="lfvn-20250630.xsd#lfvn_PerformanceStockUnitsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2de88098-fa9c-47c5-8179-543ae8781ced" xlink:to="loc_lfvn_PerformanceStockUnitsMember_f56df465-0041-49b5-a367-a309aeb759d9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsCancelledInPeriod_94fecb31-8470-46f0-b6bd-e5944cc80eab" xlink:href="lfvn-20250630.xsd#lfvn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsCancelledInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e033d7bc-9101-454b-8a65-a2d4fc070a88" xlink:to="loc_lfvn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsCancelledInPeriod_94fecb31-8470-46f0-b6bd-e5944cc80eab" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_4bdb9e1b-c9d7-4c36-9bdf-4acfefcf8967" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e033d7bc-9101-454b-8a65-a2d4fc070a88" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_4bdb9e1b-c9d7-4c36-9bdf-4acfefcf8967" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_f7d14e1a-e4ce-447e-b052-1bde478f52a3" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_4bdb9e1b-c9d7-4c36-9bdf-4acfefcf8967" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_f7d14e1a-e4ce-447e-b052-1bde478f52a3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_5b2fe561-b7d3-4bc4-b2ed-e4150e5029e6" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_4bdb9e1b-c9d7-4c36-9bdf-4acfefcf8967" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_5b2fe561-b7d3-4bc4-b2ed-e4150e5029e6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_f6aa6cb0-72d8-4a88-bf80-e49556e0de22" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_4bdb9e1b-c9d7-4c36-9bdf-4acfefcf8967" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_f6aa6cb0-72d8-4a88-bf80-e49556e0de22" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_c08f52af-49ea-45ef-9e7b-645b93224ae2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_4bdb9e1b-c9d7-4c36-9bdf-4acfefcf8967" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_c08f52af-49ea-45ef-9e7b-645b93224ae2" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_991d3aed-9e64-47db-9ea3-f6f381d39916" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_92af6bf1-d011-4281-a1dc-01661f045362" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e033d7bc-9101-454b-8a65-a2d4fc070a88" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_92af6bf1-d011-4281-a1dc-01661f045362" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_b5d8f57e-0536-4dba-85c0-c13d214037d2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_92af6bf1-d011-4281-a1dc-01661f045362" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_b5d8f57e-0536-4dba-85c0-c13d214037d2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_87538fc5-1589-407c-b276-ba72886de886" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_92af6bf1-d011-4281-a1dc-01661f045362" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_87538fc5-1589-407c-b276-ba72886de886" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_59d7919e-dd21-4267-9cd5-4803e891ce73" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_92af6bf1-d011-4281-a1dc-01661f045362" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_59d7919e-dd21-4267-9cd5-4803e891ce73" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_11bb05ca-cf99-42fb-a51e-6f9ad8e00028" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_92af6bf1-d011-4281-a1dc-01661f045362" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_11bb05ca-cf99-42fb-a51e-6f9ad8e00028" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_124f964e-5b5c-4ad3-881b-46a67241a048" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.lifevantage.com/role/IncomeTaxesNarrativeDetails" xlink:type="simple" xlink:href="lfvn-20250630.xsd#IncomeTaxesNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.lifevantage.com/role/IncomeTaxesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsLineItems_0c3163ba-ec81-41d3-8cd8-e86eecac692c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLossCarryforwardsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsTable_1b5fc874-7685-464e-b196-7dd60c12b3d8" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLossCarryforwardsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_0c3163ba-ec81-41d3-8cd8-e86eecac692c" xlink:to="loc_us-gaap_OperatingLossCarryforwardsTable_1b5fc874-7685-464e-b196-7dd60c12b3d8" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis_5002d842-63ad-48f8-858c-2c52ae8b4063" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable_1b5fc874-7685-464e-b196-7dd60c12b3d8" xlink:to="loc_us-gaap_IncomeTaxAuthorityAxis_5002d842-63ad-48f8-858c-2c52ae8b4063" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_5002d842-63ad-48f8-858c-2c52ae8b4063_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_5002d842-63ad-48f8-858c-2c52ae8b4063" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_5002d842-63ad-48f8-858c-2c52ae8b4063_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_96b0cad2-1337-4b57-bd00-da727d21a7a8" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_5002d842-63ad-48f8-858c-2c52ae8b4063" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_96b0cad2-1337-4b57-bd00-da727d21a7a8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StateAndLocalJurisdictionMember_420a2323-c32d-4875-be44-f349d2f2b95f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StateAndLocalJurisdictionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_96b0cad2-1337-4b57-bd00-da727d21a7a8" xlink:to="loc_us-gaap_StateAndLocalJurisdictionMember_420a2323-c32d-4875-be44-f349d2f2b95f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCountryMember_736751e7-6057-46be-adcc-70eff5098e61" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ForeignCountryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_96b0cad2-1337-4b57-bd00-da727d21a7a8" xlink:to="loc_us-gaap_ForeignCountryMember_736751e7-6057-46be-adcc-70eff5098e61" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_UnrecognizedTaxPositionIncreaseResultingFromForeignTaxAudits_b3f3f4d0-9436-48ba-b605-132e8aa66d12" xlink:href="lfvn-20250630.xsd#lfvn_UnrecognizedTaxPositionIncreaseResultingFromForeignTaxAudits"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_0c3163ba-ec81-41d3-8cd8-e86eecac692c" xlink:to="loc_lfvn_UnrecognizedTaxPositionIncreaseResultingFromForeignTaxAudits_b3f3f4d0-9436-48ba-b605-132e8aa66d12" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwards_64bbdf03-e148-4ed7-b3f0-aaf1a7bef1bc" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLossCarryforwards"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_0c3163ba-ec81-41d3-8cd8-e86eecac692c" xlink:to="loc_us-gaap_OperatingLossCarryforwards_64bbdf03-e148-4ed7-b3f0-aaf1a7bef1bc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount_bfeaaf6a-7c59-4def-8abb-df61febd4f1f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_0c3163ba-ec81-41d3-8cd8-e86eecac692c" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount_bfeaaf6a-7c59-4def-8abb-df61febd4f1f" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.lifevantage.com/role/LeasesNarrativeDetails" xlink:type="simple" xlink:href="lfvn-20250630.xsd#LeasesNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.lifevantage.com/role/LeasesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems_06b6ceac-d226-482a-abc4-374a7236d522" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable_03cf1588-5e0c-4201-b6b7-68f087c6c8f7" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_06b6ceac-d226-482a-abc4-374a7236d522" xlink:to="loc_us-gaap_LesseeLeaseDescriptionTable_03cf1588-5e0c-4201-b6b7-68f087c6c8f7" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_240a6e2a-123e-4cf2-856d-674f6f2942af" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_03cf1588-5e0c-4201-b6b7-68f087c6c8f7" xlink:to="loc_srt_RangeAxis_240a6e2a-123e-4cf2-856d-674f6f2942af" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_240a6e2a-123e-4cf2-856d-674f6f2942af_default" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_240a6e2a-123e-4cf2-856d-674f6f2942af" xlink:to="loc_srt_RangeMember_240a6e2a-123e-4cf2-856d-674f6f2942af_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_048e2c1d-c491-44c5-9a00-4e5e43b69e53" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_240a6e2a-123e-4cf2-856d-674f6f2942af" xlink:to="loc_srt_RangeMember_048e2c1d-c491-44c5-9a00-4e5e43b69e53" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_3519f8e9-6b97-4076-9beb-592b47db77d8" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_048e2c1d-c491-44c5-9a00-4e5e43b69e53" xlink:to="loc_srt_MinimumMember_3519f8e9-6b97-4076-9beb-592b47db77d8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_1287d0e7-1783-48ea-9d6f-8a4206c88c52" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_048e2c1d-c491-44c5-9a00-4e5e43b69e53" xlink:to="loc_srt_MaximumMember_1287d0e7-1783-48ea-9d6f-8a4206c88c52" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseTermOfContract_df3230de-d8ce-4401-8375-3e35b7a730cf" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseTermOfContract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_06b6ceac-d226-482a-abc4-374a7236d522" xlink:to="loc_us-gaap_LesseeOperatingLeaseTermOfContract_df3230de-d8ce-4401-8375-3e35b7a730cf" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_7cba3230-9df3-4dcd-9fb3-359491653235" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_06b6ceac-d226-482a-abc4-374a7236d522" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_7cba3230-9df3-4dcd-9fb3-359491653235" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_2bf74371-45b8-45ab-8fa8-d1b79042378b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_06b6ceac-d226-482a-abc4-374a7236d522" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_2bf74371-45b8-45ab-8fa8-d1b79042378b" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.lifevantage.com/role/SegmentInformationScheduleofSegmentRevenueandExpenseDetails" xlink:type="simple" xlink:href="lfvn-20250630.xsd#SegmentInformationScheduleofSegmentRevenueandExpenseDetails"/>
  <link:definitionLink xlink:role="http://www.lifevantage.com/role/SegmentInformationScheduleofSegmentRevenueandExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_07c4af5c-bc91-4c37-a94d-481164bbd7a1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_8d7cd929-26d7-4485-8f22-28e2977b8700" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_07c4af5c-bc91-4c37-a94d-481164bbd7a1" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_8d7cd929-26d7-4485-8f22-28e2977b8700" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_22130ace-aa5c-4023-8bab-38497a4133f9" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_8d7cd929-26d7-4485-8f22-28e2977b8700" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_22130ace-aa5c-4023-8bab-38497a4133f9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_22130ace-aa5c-4023-8bab-38497a4133f9_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_22130ace-aa5c-4023-8bab-38497a4133f9" xlink:to="loc_us-gaap_SegmentDomain_22130ace-aa5c-4023-8bab-38497a4133f9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_f5b416ed-149e-4937-ba9c-3d6571aa443a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_22130ace-aa5c-4023-8bab-38497a4133f9" xlink:to="loc_us-gaap_SegmentDomain_f5b416ed-149e-4937-ba9c-3d6571aa443a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_ReportableSegmentMember_805ec5f0-89b8-49e5-95ed-d445fdee44d4" xlink:href="lfvn-20250630.xsd#lfvn_ReportableSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_f5b416ed-149e-4937-ba9c-3d6571aa443a" xlink:to="loc_lfvn_ReportableSegmentMember_805ec5f0-89b8-49e5-95ed-d445fdee44d4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_b157567f-d637-43c5-ad8d-6ba2f213224e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_07c4af5c-bc91-4c37-a94d-481164bbd7a1" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_b157567f-d637-43c5-ad8d-6ba2f213224e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_cdf2e625-a19c-4f68-ae3d-92c295afa97b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_07c4af5c-bc91-4c37-a94d-481164bbd7a1" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_cdf2e625-a19c-4f68-ae3d-92c295afa97b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_ConsultantCommissions_094a0f1d-e2ee-4c0a-a731-0f7a2ee61b26" xlink:href="lfvn-20250630.xsd#lfvn_ConsultantCommissions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_07c4af5c-bc91-4c37-a94d-481164bbd7a1" xlink:to="loc_lfvn_ConsultantCommissions_094a0f1d-e2ee-4c0a-a731-0f7a2ee61b26" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_ConsultantIncentivesPromotionsAndRecognitionExpense_e4384835-a3ca-4f11-9549-6939dec8977f" xlink:href="lfvn-20250630.xsd#lfvn_ConsultantIncentivesPromotionsAndRecognitionExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_07c4af5c-bc91-4c37-a94d-481164bbd7a1" xlink:to="loc_lfvn_ConsultantIncentivesPromotionsAndRecognitionExpense_e4384835-a3ca-4f11-9549-6939dec8977f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LaborAndRelatedExpense_4ef9f7a2-4d11-4856-84ce-5e6d5679e0d0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LaborAndRelatedExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_07c4af5c-bc91-4c37-a94d-481164bbd7a1" xlink:to="loc_us-gaap_LaborAndRelatedExpense_4ef9f7a2-4d11-4856-84ce-5e6d5679e0d0" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_1db3187b-be61-4c12-a9a1-1e9d3fe1a635" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_07c4af5c-bc91-4c37-a94d-481164bbd7a1" xlink:to="loc_us-gaap_ShareBasedCompensation_1db3187b-be61-4c12-a9a1-1e9d3fe1a635" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_EventsExpense_1c5dda0e-b397-4f42-bc78-fcc0146a2b66" xlink:href="lfvn-20250630.xsd#lfvn_EventsExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_07c4af5c-bc91-4c37-a94d-481164bbd7a1" xlink:to="loc_lfvn_EventsExpense_1c5dda0e-b397-4f42-bc78-fcc0146a2b66" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_524f0cb2-6182-4342-8584-1ae6895892df" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_07c4af5c-bc91-4c37-a94d-481164bbd7a1" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_524f0cb2-6182-4342-8584-1ae6895892df" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_CreditCardAndBankingProcessingFees_69b44005-018d-42d5-8921-a3ad09ea1534" xlink:href="lfvn-20250630.xsd#lfvn_CreditCardAndBankingProcessingFees"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_07c4af5c-bc91-4c37-a94d-481164bbd7a1" xlink:to="loc_lfvn_CreditCardAndBankingProcessingFees_69b44005-018d-42d5-8921-a3ad09ea1534" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingOtherItemAmount_287e0603-8a98-46d0-b6e8-622e861c8f39" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SegmentReportingOtherItemAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_07c4af5c-bc91-4c37-a94d-481164bbd7a1" xlink:to="loc_us-gaap_SegmentReportingOtherItemAmount_287e0603-8a98-46d0-b6e8-622e861c8f39" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterest_5280b6bd-2f77-4c8e-934d-e1570f58565a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InvestmentIncomeInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_07c4af5c-bc91-4c37-a94d-481164bbd7a1" xlink:to="loc_us-gaap_InvestmentIncomeInterest_5280b6bd-2f77-4c8e-934d-e1570f58565a" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseNonoperating_b7e6ed7d-57b1-4bd6-a420-bbafd9a74510" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InterestExpenseNonoperating"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_07c4af5c-bc91-4c37-a94d-481164bbd7a1" xlink:to="loc_us-gaap_InterestExpenseNonoperating_b7e6ed7d-57b1-4bd6-a420-bbafd9a74510" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_e3696b7e-98ca-447a-a54f-9af7ac52e74d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_07c4af5c-bc91-4c37-a94d-481164bbd7a1" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_e3696b7e-98ca-447a-a54f-9af7ac52e74d" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_9082d3ac-0f46-4ba8-9421-2d27ccab2dbf" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_07c4af5c-bc91-4c37-a94d-481164bbd7a1" xlink:to="loc_us-gaap_NetIncomeLoss_9082d3ac-0f46-4ba8-9421-2d27ccab2dbf" xlink:type="arc" order="13"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.lifevantage.com/role/SegmentInformationScheduleofLongLivedAssetsDetails" xlink:type="simple" xlink:href="lfvn-20250630.xsd#SegmentInformationScheduleofLongLivedAssetsDetails"/>
  <link:definitionLink xlink:role="http://www.lifevantage.com/role/SegmentInformationScheduleofLongLivedAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_1df63075-7862-4261-a5ac-79deda47ffc3" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_40121676-28cc-4ca0-8827-5c5a7a2b4e34" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_1df63075-7862-4261-a5ac-79deda47ffc3" xlink:to="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_40121676-28cc-4ca0-8827-5c5a7a2b4e34" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_f843eaa2-77c3-4fb1-b9ab-7a41c618c0c1" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_40121676-28cc-4ca0-8827-5c5a7a2b4e34" xlink:to="loc_srt_StatementGeographicalAxis_f843eaa2-77c3-4fb1-b9ab-7a41c618c0c1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_f843eaa2-77c3-4fb1-b9ab-7a41c618c0c1_default" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_f843eaa2-77c3-4fb1-b9ab-7a41c618c0c1" xlink:to="loc_srt_SegmentGeographicalDomain_f843eaa2-77c3-4fb1-b9ab-7a41c618c0c1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_3d0a77e8-c4f8-472a-bc24-be8a5bc74bea" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_f843eaa2-77c3-4fb1-b9ab-7a41c618c0c1" xlink:to="loc_srt_SegmentGeographicalDomain_3d0a77e8-c4f8-472a-bc24-be8a5bc74bea" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_230cb850-8622-46a2-b619-bc781595905b" xlink:href="https://xbrl.sec.gov/country/2025/country-2025.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_3d0a77e8-c4f8-472a-bc24-be8a5bc74bea" xlink:to="loc_country_US_230cb850-8622-46a2-b619-bc781595905b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonUsMember_a109c279-ca88-427d-b357-87222c7058c0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NonUsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_3d0a77e8-c4f8-472a-bc24-be8a5bc74bea" xlink:to="loc_us-gaap_NonUsMember_a109c279-ca88-427d-b357-87222c7058c0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_JP_b97f17e7-c86a-4a93-9eed-a4f0934d6411" xlink:href="https://xbrl.sec.gov/country/2025/country-2025.xsd#country_JP"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NonUsMember_a109c279-ca88-427d-b357-87222c7058c0" xlink:to="loc_country_JP_b97f17e7-c86a-4a93-9eed-a4f0934d6411" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_OtherForeignMember_bb795a5a-65d8-445b-8a28-be893b2b2f33" xlink:href="lfvn-20250630.xsd#lfvn_OtherForeignMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NonUsMember_a109c279-ca88-427d-b357-87222c7058c0" xlink:to="loc_lfvn_OtherForeignMember_bb795a5a-65d8-445b-8a28-be893b2b2f33" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncurrentAssets_acfc1859-2240-4032-97db-d761a93a733d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NoncurrentAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_1df63075-7862-4261-a5ac-79deda47ffc3" xlink:to="loc_us-gaap_NoncurrentAssets_acfc1859-2240-4032-97db-d761a93a733d" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.lifevantage.com/role/SegmentInformationNarrativeDetails" xlink:type="simple" xlink:href="lfvn-20250630.xsd#SegmentInformationNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.lifevantage.com/role/SegmentInformationNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_225e4bb1-2c5d-4e7d-b45b-c98ccc56a631" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_62bec139-4285-46cd-aa39-288e0850b05d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_225e4bb1-2c5d-4e7d-b45b-c98ccc56a631" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_62bec139-4285-46cd-aa39-288e0850b05d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_6403694a-8a29-4d6c-8fee-2f64dbf1fcff" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_62bec139-4285-46cd-aa39-288e0850b05d" xlink:to="loc_srt_ProductOrServiceAxis_6403694a-8a29-4d6c-8fee-2f64dbf1fcff" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_6403694a-8a29-4d6c-8fee-2f64dbf1fcff_default" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_6403694a-8a29-4d6c-8fee-2f64dbf1fcff" xlink:to="loc_srt_ProductsAndServicesDomain_6403694a-8a29-4d6c-8fee-2f64dbf1fcff_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_5c8ebcab-efea-4d5b-b1a8-a26b73134c8b" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_6403694a-8a29-4d6c-8fee-2f64dbf1fcff" xlink:to="loc_srt_ProductsAndServicesDomain_5c8ebcab-efea-4d5b-b1a8-a26b73134c8b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_ProtandimandTrueScienceProductLineMember_5be2da21-4f40-4496-a130-d162bc99dcdb" xlink:href="lfvn-20250630.xsd#lfvn_ProtandimandTrueScienceProductLineMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_5c8ebcab-efea-4d5b-b1a8-a26b73134c8b" xlink:to="loc_lfvn_ProtandimandTrueScienceProductLineMember_5be2da21-4f40-4496-a130-d162bc99dcdb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_658214cc-c641-4552-858d-1dfe0411a1f2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_62bec139-4285-46cd-aa39-288e0850b05d" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_658214cc-c641-4552-858d-1dfe0411a1f2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_658214cc-c641-4552-858d-1dfe0411a1f2_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_658214cc-c641-4552-858d-1dfe0411a1f2" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_658214cc-c641-4552-858d-1dfe0411a1f2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_2e7cf73f-7bda-451e-a28c-78fd122a33a9" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_658214cc-c641-4552-858d-1dfe0411a1f2" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_2e7cf73f-7bda-451e-a28c-78fd122a33a9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesRevenueNetMember_c2b1fb73-a6bd-4729-88b9-19d06b0da1cb" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SalesRevenueNetMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_2e7cf73f-7bda-451e-a28c-78fd122a33a9" xlink:to="loc_us-gaap_SalesRevenueNetMember_c2b1fb73-a6bd-4729-88b9-19d06b0da1cb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_e6ef6e94-fe02-485d-ad2d-97d41faaf82a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_62bec139-4285-46cd-aa39-288e0850b05d" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_e6ef6e94-fe02-485d-ad2d-97d41faaf82a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_e6ef6e94-fe02-485d-ad2d-97d41faaf82a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_e6ef6e94-fe02-485d-ad2d-97d41faaf82a" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_e6ef6e94-fe02-485d-ad2d-97d41faaf82a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_615e0319-fef2-4f99-9f10-0c180012126a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_e6ef6e94-fe02-485d-ad2d-97d41faaf82a" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_615e0319-fef2-4f99-9f10-0c180012126a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductConcentrationRiskMember_2fbc060d-5742-456f-9c07-ddd370bb8432" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProductConcentrationRiskMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_615e0319-fef2-4f99-9f10-0c180012126a" xlink:to="loc_us-gaap_ProductConcentrationRiskMember_2fbc060d-5742-456f-9c07-ddd370bb8432" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_NumberOfProductLines_0ab1f43b-2d80-4e94-a9ac-4f301e3dad61" xlink:href="lfvn-20250630.xsd#lfvn_NumberOfProductLines"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_225e4bb1-2c5d-4e7d-b45b-c98ccc56a631" xlink:to="loc_lfvn_NumberOfProductLines_0ab1f43b-2d80-4e94-a9ac-4f301e3dad61" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_025eb825-a021-44c5-8d36-104c3a421b2f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_225e4bb1-2c5d-4e7d-b45b-c98ccc56a631" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_025eb825-a021-44c5-8d36-104c3a421b2f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_NumberOfGeographicSegments_fea22474-99dc-4e41-b725-d923a951d040" xlink:href="lfvn-20250630.xsd#lfvn_NumberOfGeographicSegments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_225e4bb1-2c5d-4e7d-b45b-c98ccc56a631" xlink:to="loc_lfvn_NumberOfGeographicSegments_fea22474-99dc-4e41-b725-d923a951d040" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfOperatingSegments_fa6a2b8a-dcff-4a3e-ba75-c50ac365f521" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NumberOfOperatingSegments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_225e4bb1-2c5d-4e7d-b45b-c98ccc56a631" xlink:to="loc_us-gaap_NumberOfOperatingSegments_fa6a2b8a-dcff-4a3e-ba75-c50ac365f521" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.lifevantage.com/role/SegmentInformationScheduleOfRevenueDisaggregationByMarketDetails" xlink:type="simple" xlink:href="lfvn-20250630.xsd#SegmentInformationScheduleOfRevenueDisaggregationByMarketDetails"/>
  <link:definitionLink xlink:role="http://www.lifevantage.com/role/SegmentInformationScheduleOfRevenueDisaggregationByMarketDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_c2eb85ef-f363-42b4-b918-a38e6431de56" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_e7f3c8e7-309c-4ef0-85b4-88fddc704cde" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_c2eb85ef-f363-42b4-b918-a38e6431de56" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_e7f3c8e7-309c-4ef0-85b4-88fddc704cde" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_f6097e94-5637-451c-aaa8-bd11df7409cd" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_e7f3c8e7-309c-4ef0-85b4-88fddc704cde" xlink:to="loc_srt_StatementGeographicalAxis_f6097e94-5637-451c-aaa8-bd11df7409cd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_f6097e94-5637-451c-aaa8-bd11df7409cd_default" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_f6097e94-5637-451c-aaa8-bd11df7409cd" xlink:to="loc_srt_SegmentGeographicalDomain_f6097e94-5637-451c-aaa8-bd11df7409cd_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_f1cc58a4-a828-4719-b04b-b1e25893b744" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_f6097e94-5637-451c-aaa8-bd11df7409cd" xlink:to="loc_srt_SegmentGeographicalDomain_f1cc58a4-a828-4719-b04b-b1e25893b744" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_9093a131-4169-4526-a522-85cd0b726d33" xlink:href="https://xbrl.sec.gov/country/2025/country-2025.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_f1cc58a4-a828-4719-b04b-b1e25893b744" xlink:to="loc_country_US_9093a131-4169-4526-a522-85cd0b726d33" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonUsMember_f1b8fda6-2874-4f88-b032-a4fcf0f570ac" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NonUsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_f1cc58a4-a828-4719-b04b-b1e25893b744" xlink:to="loc_us-gaap_NonUsMember_f1b8fda6-2874-4f88-b032-a4fcf0f570ac" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_JP_8573fc48-9c56-4bc0-abe2-054450fed452" xlink:href="https://xbrl.sec.gov/country/2025/country-2025.xsd#country_JP"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NonUsMember_f1b8fda6-2874-4f88-b032-a4fcf0f570ac" xlink:to="loc_country_JP_8573fc48-9c56-4bc0-abe2-054450fed452" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_OtherForeignMember_4c43136b-d853-41dd-ba64-c3a5f2430ac1" xlink:href="lfvn-20250630.xsd#lfvn_OtherForeignMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NonUsMember_f1b8fda6-2874-4f88-b032-a4fcf0f570ac" xlink:to="loc_lfvn_OtherForeignMember_4c43136b-d853-41dd-ba64-c3a5f2430ac1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_6fb5d87f-114d-4da2-a3ca-65989d6912c2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_c2eb85ef-f363-42b4-b918-a38e6431de56" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_6fb5d87f-114d-4da2-a3ca-65989d6912c2" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.lifevantage.com/role/SegmentInformationScheduleofMajorProductsLinesDetails" xlink:type="simple" xlink:href="lfvn-20250630.xsd#SegmentInformationScheduleofMajorProductsLinesDetails"/>
  <link:definitionLink xlink:role="http://www.lifevantage.com/role/SegmentInformationScheduleofMajorProductsLinesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_5b282037-af4a-43bf-b889-708fcd90bfa7" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_644172e2-f719-46a2-8aa7-4e9595160160" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_5b282037-af4a-43bf-b889-708fcd90bfa7" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_644172e2-f719-46a2-8aa7-4e9595160160" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_e75bb562-c478-47af-af03-6680a0359165" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_644172e2-f719-46a2-8aa7-4e9595160160" xlink:to="loc_srt_ProductOrServiceAxis_e75bb562-c478-47af-af03-6680a0359165" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_e75bb562-c478-47af-af03-6680a0359165_default" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_e75bb562-c478-47af-af03-6680a0359165" xlink:to="loc_srt_ProductsAndServicesDomain_e75bb562-c478-47af-af03-6680a0359165_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_dc6c6749-997b-404c-876b-4297815418a9" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_e75bb562-c478-47af-af03-6680a0359165" xlink:to="loc_srt_ProductsAndServicesDomain_dc6c6749-997b-404c-876b-4297815418a9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_ProtandimMember_626204c7-d94d-4c5a-a228-a036f9d9866f" xlink:href="lfvn-20250630.xsd#lfvn_ProtandimMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_dc6c6749-997b-404c-876b-4297815418a9" xlink:to="loc_lfvn_ProtandimMember_626204c7-d94d-4c5a-a228-a036f9d9866f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_LifeVantageTrueScienceSkinCareRegimenMember_19c19e24-be7f-4881-88ad-d867075ca38f" xlink:href="lfvn-20250630.xsd#lfvn_LifeVantageTrueScienceSkinCareRegimenMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_dc6c6749-997b-404c-876b-4297815418a9" xlink:to="loc_lfvn_LifeVantageTrueScienceSkinCareRegimenMember_19c19e24-be7f-4881-88ad-d867075ca38f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_TrueScienceProductLineMember_deabf640-ced1-43b2-b91e-142c7c5b6dd9" xlink:href="lfvn-20250630.xsd#lfvn_TrueScienceProductLineMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_dc6c6749-997b-404c-876b-4297815418a9" xlink:to="loc_lfvn_TrueScienceProductLineMember_deabf640-ced1-43b2-b91e-142c7c5b6dd9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_AXIOProductLineMember_7187bd77-4035-4387-afa9-2ce33070c7d2" xlink:href="lfvn-20250630.xsd#lfvn_AXIOProductLineMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_dc6c6749-997b-404c-876b-4297815418a9" xlink:to="loc_lfvn_AXIOProductLineMember_7187bd77-4035-4387-afa9-2ce33070c7d2" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_PhysIQProductLineMember_b7e84147-ad94-43cb-89bd-d952e4f25a19" xlink:href="lfvn-20250630.xsd#lfvn_PhysIQProductLineMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_dc6c6749-997b-404c-876b-4297815418a9" xlink:to="loc_lfvn_PhysIQProductLineMember_b7e84147-ad94-43cb-89bd-d952e4f25a19" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_PetandimProductLineMember_34b10341-21b8-4c48-b229-b6f04973536f" xlink:href="lfvn-20250630.xsd#lfvn_PetandimProductLineMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_dc6c6749-997b-404c-876b-4297815418a9" xlink:to="loc_lfvn_PetandimProductLineMember_34b10341-21b8-4c48-b229-b6f04973536f" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductAndServiceOtherMember_db4fa8c6-76b2-4313-9219-247011a03298" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProductAndServiceOtherMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_dc6c6749-997b-404c-876b-4297815418a9" xlink:to="loc_us-gaap_ProductAndServiceOtherMember_db4fa8c6-76b2-4313-9219-247011a03298" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_2a154a91-f1fe-403d-b361-2744af8bf020" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_5b282037-af4a-43bf-b889-708fcd90bfa7" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_2a154a91-f1fe-403d-b361-2744af8bf020" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/IndividualsOnly" xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#IndividualsOnly"/>
  <link:definitionLink xlink:role="http://xbrl.sec.gov/ecd/role/IndividualsOnly" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllIndividualsMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AllIndividualsMember"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_MichaelBeindorffMember_bbcbbab7-20cc-4d61-93cc-a0f41a6ddfc5" xlink:href="lfvn-20250630.xsd#lfvn_MichaelBeindorffMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ecd_AllIndividualsMember" xlink:to="loc_lfvn_MichaelBeindorffMember_bbcbbab7-20cc-4d61-93cc-a0f41a6ddfc5" xlink:type="arc" order="2"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>12
<FILENAME>lfvn-20250630_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:60c7f1f2-d52d-4c01-b992-aaf8be1801ed,g:81eb96f2-7ea0-4e0b-9dac-655ac6c272fe-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_lfvn_EffectiveIncomeTaxRateReconciliationCurrentYearSection162mLimitationPercent_40631016-de0d-46df-a98d-d38c5e1b487d_terseLabel_en-US" xlink:label="lab_lfvn_EffectiveIncomeTaxRateReconciliationCurrentYearSection162mLimitationPercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">&#8212; current year section 162(m) limitation</link:label>
    <link:label id="lab_lfvn_EffectiveIncomeTaxRateReconciliationCurrentYearSection162mLimitationPercent_label_en-US" xlink:label="lab_lfvn_EffectiveIncomeTaxRateReconciliationCurrentYearSection162mLimitationPercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Current Year Section 162(m) Limitation, Percent</link:label>
    <link:label id="lab_lfvn_EffectiveIncomeTaxRateReconciliationCurrentYearSection162mLimitationPercent_documentation_en-US" xlink:label="lab_lfvn_EffectiveIncomeTaxRateReconciliationCurrentYearSection162mLimitationPercent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Current Year Section 162(m) Limitation, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_EffectiveIncomeTaxRateReconciliationCurrentYearSection162mLimitationPercent" xlink:href="lfvn-20250630.xsd#lfvn_EffectiveIncomeTaxRateReconciliationCurrentYearSection162mLimitationPercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfvn_EffectiveIncomeTaxRateReconciliationCurrentYearSection162mLimitationPercent" xlink:to="lab_lfvn_EffectiveIncomeTaxRateReconciliationCurrentYearSection162mLimitationPercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockDividendsPerShareCashPaid_9aace7c6-43f3-400c-b7f8-dd51cabc000e_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockDividendsPerShareCashPaid" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash dividend, common stock (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockDividendsPerShareCashPaid_label_en-US" xlink:label="lab_us-gaap_CommonStockDividendsPerShareCashPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock, Dividends, Per Share, Cash Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareCashPaid" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockDividendsPerShareCashPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockDividendsPerShareCashPaid" xlink:to="lab_us-gaap_CommonStockDividendsPerShareCashPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_fcdb2114-81e9-478a-8aef-35a9c6430e16_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Accumulated amortization</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Assets, Accumulated Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SignificantAccountingPoliciesTextBlock_44732be0-e796-42b3-b83b-0fe0b6a61c68_verboseLabel_en-US" xlink:label="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Summary of Significant Accounting Policies</link:label>
    <link:label id="lab_us-gaap_SignificantAccountingPoliciesTextBlock_label_en-US" xlink:label="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Significant Accounting Policies [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:to="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeMember_f772ca87-75b0-4c0b-a41b-116019cc900f_terseLabel_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:label id="lab_srt_RangeMember_label_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeMember" xlink:to="lab_srt_RangeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_57255aea-4b1c-49cc-9414-5a89b526c964_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Thereafter</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, after Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardTmgPredtrmndFlag_terseLabel_en-US" xlink:label="lab_ecd_AwardTmgPredtrmndFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Award Timing Predetermined</link:label>
    <link:label id="lab_ecd_AwardTmgPredtrmndFlag_label_en-US" xlink:label="lab_ecd_AwardTmgPredtrmndFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Timing Predetermined [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgPredtrmndFlag" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardTmgPredtrmndFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardTmgPredtrmndFlag" xlink:to="lab_ecd_AwardTmgPredtrmndFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_lfvn_EventsExpense_cd98f8ee-4af0-4a43-bede-1165daf6ac83_negatedTerseLabel_en-US" xlink:label="lab_lfvn_EventsExpense" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Events</link:label>
    <link:label id="lab_lfvn_EventsExpense_label_en-US" xlink:label="lab_lfvn_EventsExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Events Expense</link:label>
    <link:label id="lab_lfvn_EventsExpense_documentation_en-US" xlink:label="lab_lfvn_EventsExpense" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Events Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_EventsExpense" xlink:href="lfvn-20250630.xsd#lfvn_EventsExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfvn_EventsExpense" xlink:to="lab_lfvn_EventsExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_413002c0-8676-480a-a933-c2706352fbea_terseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Indefinite-lived Intangible Assets [Axis]</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Indefinite-Lived Intangible Assets [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_2842d4f8-3d38-4256-9d3b-9b2e0a47bc1e_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_2e5ca5f1-0811-45eb-aa73-52e737b3d75f_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Additional Paid-In&#160;Capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:to="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsOfFinancingCosts_3175db4c-5cf1-47f7-b0fa-b883332be961_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfFinancingCosts" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Payment of deferred financing fees</link:label>
    <link:label id="lab_us-gaap_PaymentsOfFinancingCosts_label_en-US" xlink:label="lab_us-gaap_PaymentsOfFinancingCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payments of Financing Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfFinancingCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PaymentsOfFinancingCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfFinancingCosts" xlink:to="lab_us-gaap_PaymentsOfFinancingCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_f17beb42-74cf-406d-a49c-a6f0ce21d378_verboseLabel_en-US" xlink:label="lab_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Impairment of Long-Lived Assets</link:label>
    <link:label id="lab_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:to="lab_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock_5aed9604-2837-4352-b84d-4c5fdca23eb1_terseLabel_en-US" xlink:label="lab_us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other Expense, Net</link:label>
    <link:label id="lab_us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Income and Other Expense Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock" xlink:to="lab_us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TabularListTableTextBlock_terseLabel_en-US" xlink:label="lab_ecd_TabularListTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Tabular List, Table</link:label>
    <link:label id="lab_ecd_TabularListTableTextBlock_label_en-US" xlink:label="lab_ecd_TabularListTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Tabular List [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TabularListTableTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TabularListTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TabularListTableTextBlock" xlink:to="lab_ecd_TabularListTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeasesAbstract_label_en-US" xlink:label="lab_us-gaap_LeasesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Leases [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LeasesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeasesAbstract" xlink:to="lab_us-gaap_LeasesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_1dfe45eb-4833-4f20-ac2d-99aef40732f0_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Gross increases - tax positions in prior year</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasicAbstract_ea90d5e8-1d14-4bc3-b46a-c47d295d33e0_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Reconciliation of earnings per share and the weighted-average common shares outstanding for purposes of computing basic and diluted net income per share</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasicAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Earnings Per Share, Basic [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EarningsPerShareBasicAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasicAbstract" xlink:to="lab_us-gaap_EarningsPerShareBasicAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_ba35e48f-a256-4420-a795-f1af0066ac85_verboseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">New Accounting Pronouncements</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">New Accounting Pronouncements, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayable_78108342-b28f-4982-9152-c24ffb050030_verboseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Accounts Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_e3df7c92-9d39-4791-8786-85cb4df61f34_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Shares canceled or surrendered as payment of tax withholding and other</link:label>
    <link:label id="lab_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Decrease for Tax Withholding Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:to="lab_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TradingArrByIndTable_terseLabel_en-US" xlink:label="lab_ecd_TradingArrByIndTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Trading Arrangements, by Individual</link:label>
    <link:label id="lab_ecd_TradingArrByIndTable_label_en-US" xlink:label="lab_ecd_TradingArrByIndTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Arrangements, by Individual [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TradingArrByIndTable" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TradingArrByIndTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TradingArrByIndTable" xlink:to="lab_ecd_TradingArrByIndTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_f3fe6b52-09b5-47f4-b6c7-2104c8d9f463_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Basic (dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_dd36fd09-4754-47e7-8527-ef71b750b802_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income per share, basic (dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Earnings Per Share, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasic" xlink:to="lab_us-gaap_EarningsPerShareBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AdjToCompAxis_terseLabel_en-US" xlink:label="lab_ecd_AdjToCompAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Adjustment to Compensation:</link:label>
    <link:label id="lab_ecd_AdjToCompAxis_label_en-US" xlink:label="lab_ecd_AdjToCompAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustment to Compensation [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToCompAxis" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AdjToCompAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AdjToCompAxis" xlink:to="lab_ecd_AdjToCompAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NamedExecutiveOfficersFnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_NamedExecutiveOfficersFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Named Executive Officers, Footnote</link:label>
    <link:label id="lab_ecd_NamedExecutiveOfficersFnTextBlock_label_en-US" xlink:label="lab_ecd_NamedExecutiveOfficersFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Named Executive Officers, Footnote [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NamedExecutiveOfficersFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_NamedExecutiveOfficersFnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NamedExecutiveOfficersFnTextBlock" xlink:to="lab_ecd_NamedExecutiveOfficersFnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_72b5e912-3d69-4f9d-b4f8-48cca90b4673_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of shares of common stock subject for purchase</link:label>
    <link:label id="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_label_en-US" xlink:label="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock, Capital Shares Reserved for Future Issuance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:to="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerTextBlock_6b720ac5-d729-4a91-b38a-b7c80dd5ca7f_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Revenue</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revenue from Contract with Customer [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_3ef541b0-e495-4224-a1eb-0a94d0cc3eb8_verboseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Stock option compensation</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-Based Compensation Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsGross_b5d42476-4dd1-432a-a139-c586d844150f_totalLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsGross" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Gross deferred tax asset</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsGross_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Assets, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsGross" xlink:to="lab_us-gaap_DeferredTaxAssetsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfStockByClassTable_7644ed43-e750-4b29-b840-30bf5f038863_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfStockByClassTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Stock by Class [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfStockByClassTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfStockByClassTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock, Class of Stock [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable" xlink:to="lab_us-gaap_ScheduleOfStockByClassTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_3335e75b-b9c6-4302-86f2-927fed665af9_totalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Other comprehensive income (loss), net of tax:</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_00266dab-d6a4-4114-bf9e-13a2694970ce_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_e069b4df-65ec-468f-9f40-7f954730ea5d_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Indefinite-Lived Intangible Assets [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Intangible Asset, Indefinite-Lived [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable" xlink:to="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_d11c9e3c-817c-4c4a-922c-270f571e4549_verboseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Common stock issued under equity award plans (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_b22e6f2e-350f-4643-ba12-338c99f7d404_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restricted common stock to employees (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_58b55685-d9f6-491b-b2fe-5655e81434e2_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common stock issued under employee stock purchase plan (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Issued During Period, Shares, Employee Stock Purchase Plans</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentIncomeTaxExpenseBenefit_01adf2c9-a9c5-4c76-be2e-f75ca02412ab_totalLabel_en-US" xlink:label="lab_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total current income tax provision</link:label>
    <link:label id="lab_us-gaap_CurrentIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Current Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_lfvn_AuditorInformationAbstract_label_en-US" xlink:label="lab_lfvn_AuditorInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Auditor Information [Abstract]</link:label>
    <link:label id="lab_lfvn_AuditorInformationAbstract_documentation_en-US" xlink:label="lab_lfvn_AuditorInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Auditor Information</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_AuditorInformationAbstract" xlink:href="lfvn-20250630.xsd#lfvn_AuditorInformationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfvn_AuditorInformationAbstract" xlink:to="lab_lfvn_AuditorInformationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AdjToCompAmt_terseLabel_en-US" xlink:label="lab_ecd_AdjToCompAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Adjustment to Compensation, Amount</link:label>
    <link:label id="lab_ecd_AdjToCompAmt_label_en-US" xlink:label="lab_ecd_AdjToCompAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustment to Compensation Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AdjToCompAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AdjToCompAmt" xlink:to="lab_ecd_AdjToCompAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskPercentage1_59a99b12-ed9e-428a-9fb2-c8b6b58a7cb7_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskPercentage1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Concentration risk</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskPercentage1_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskPercentage1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Concentration Risk, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskPercentage1" xlink:to="lab_us-gaap_ConcentrationRiskPercentage1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConsolidationPolicyTextBlock_974c6dbb-22dd-43d7-abad-acf437e48829_verboseLabel_en-US" xlink:label="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Consolidation</link:label>
    <link:label id="lab_us-gaap_ConsolidationPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Consolidation, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConsolidationPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConsolidationPolicyTextBlock" xlink:to="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensation_ecb7fff9-1bf9-44e4-b18b-83ac51510279_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Stock-based compensation</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensation_c37719d0-cdc1-45c7-825b-0af7e6116ed0_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Stock compensation</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Noncash Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensation" xlink:to="lab_us-gaap_ShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_3d4c84af-cefb-45a2-8efd-c3a294ca282e_terseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Indefinite-lived Intangible Assets [Line Items]</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Indefinite-Lived Intangible Assets [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_cbe6177e-ad68-4bdf-83ff-72177ca300a8_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Employee Stock Option</link:label>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_label_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Option [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeStockOptionMember" xlink:to="lab_us-gaap_EmployeeStockOptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardTmgMnpiDiscTextBlock_terseLabel_en-US" xlink:label="lab_ecd_AwardTmgMnpiDiscTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Award Timing MNPI Disclosure</link:label>
    <link:label id="lab_ecd_AwardTmgMnpiDiscTextBlock_label_en-US" xlink:label="lab_ecd_AwardTmgMnpiDiscTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Timing MNPI Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgMnpiDiscTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardTmgMnpiDiscTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardTmgMnpiDiscTextBlock" xlink:to="lab_ecd_AwardTmgMnpiDiscTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_0a8a836b-2bea-419d-8480-4aa0bf32b973_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Property, Plant and Equipment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_lfvn_SummaryOfSignificantAccountingPoliciesTextualAbstract_18277db4-aa8b-444f-b646-e562a1a93cfe_verboseLabel_en-US" xlink:label="lab_lfvn_SummaryOfSignificantAccountingPoliciesTextualAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Summary of Significant Accounting Policies Additional Information [Abstract]</link:label>
    <link:label id="lab_lfvn_SummaryOfSignificantAccountingPoliciesTextualAbstract_label_en-US" xlink:label="lab_lfvn_SummaryOfSignificantAccountingPoliciesTextualAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Summary of Significant Accounting Policies (Textual) [Abstract]</link:label>
    <link:label id="lab_lfvn_SummaryOfSignificantAccountingPoliciesTextualAbstract_documentation_en-US" xlink:label="lab_lfvn_SummaryOfSignificantAccountingPoliciesTextualAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Summary of significant accounting policies.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_SummaryOfSignificantAccountingPoliciesTextualAbstract" xlink:href="lfvn-20250630.xsd#lfvn_SummaryOfSignificantAccountingPoliciesTextualAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfvn_SummaryOfSignificantAccountingPoliciesTextualAbstract" xlink:to="lab_lfvn_SummaryOfSignificantAccountingPoliciesTextualAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpensePolicy_8d4cfd85-6074-402e-999e-aacea642b128_verboseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Research and Development Costs</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpensePolicy_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Research and Development Expense, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock_f265d925-0390-41d3-bd7b-136813815048_verboseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Cash and Cash Equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash and Cash Equivalents, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:to="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxesPaid_72d63dc8-82c6-4c26-bc96-5e19c00631c9_verboseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaid" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Cash paid for income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxesPaid_label_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Taxes Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaid" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxesPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxesPaid" xlink:to="lab_us-gaap_IncomeTaxesPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_2cf09150-ac5b-4975-a9b4-9096760d3c8d_verboseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">The effective income tax rate differs from the U.S. Federal statutory income tax rate</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Percent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DividendsCommonStockCash_f10f7578-c294-4bc3-a2bc-14ec9a103ba2_terseLabel_en-US" xlink:label="lab_us-gaap_DividendsCommonStockCash" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash dividend, common stock</link:label>
    <link:label id="lab_us-gaap_DividendsCommonStockCash_label_en-US" xlink:label="lab_us-gaap_DividendsCommonStockCash" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Dividends, Common Stock, Cash</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCommonStockCash" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DividendsCommonStockCash"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DividendsCommonStockCash" xlink:to="lab_us-gaap_DividendsCommonStockCash" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquity_853e12dd-e578-484c-95db-5b399ca4fdcd_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total stockholders&#8217; equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_96963a7e-60c9-436a-9ed5-2d2e3c66591f_periodStartLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Beginning balances</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_9a325441-6013-4285-a151-52c8dd199232_periodEndLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Ending balances</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_label_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquity" xlink:to="lab_us-gaap_StockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_daf3aba0-f040-4149-9924-efe33c920776_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Other comprehensive income (loss), net of tax:</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_InsiderTradingPoliciesProcLineItems_label_en-US" xlink:label="lab_ecd_InsiderTradingPoliciesProcLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Insider Trading Policies and Procedures [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTradingPoliciesProcLineItems" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_InsiderTradingPoliciesProcLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_InsiderTradingPoliciesProcLineItems" xlink:to="lab_ecd_InsiderTradingPoliciesProcLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_lfvn_ProceedsFromIssuanceOfCommonStockUnderEmployeeStockPurchasePlan_2ef2f104-f1b4-4354-90d3-d7e569ce4b3c_terseLabel_en-US" xlink:label="lab_lfvn_ProceedsFromIssuanceOfCommonStockUnderEmployeeStockPurchasePlan" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Proceeds from common stock issued under employee stock purchase plan</link:label>
    <link:label id="lab_lfvn_ProceedsFromIssuanceOfCommonStockUnderEmployeeStockPurchasePlan_label_en-US" xlink:label="lab_lfvn_ProceedsFromIssuanceOfCommonStockUnderEmployeeStockPurchasePlan" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proceeds From Issuance of Common Stock Under Employee Stock Purchase Plan</link:label>
    <link:label id="lab_lfvn_ProceedsFromIssuanceOfCommonStockUnderEmployeeStockPurchasePlan_documentation_en-US" xlink:label="lab_lfvn_ProceedsFromIssuanceOfCommonStockUnderEmployeeStockPurchasePlan" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Proceeds From Issuance of Common Stock Under Employee Stock Purchase Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_ProceedsFromIssuanceOfCommonStockUnderEmployeeStockPurchasePlan" xlink:href="lfvn-20250630.xsd#lfvn_ProceedsFromIssuanceOfCommonStockUnderEmployeeStockPurchasePlan"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfvn_ProceedsFromIssuanceOfCommonStockUnderEmployeeStockPurchasePlan" xlink:to="lab_lfvn_ProceedsFromIssuanceOfCommonStockUnderEmployeeStockPurchasePlan" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_54d72e0d-a6e6-4f10-84d9-6d664972cc05_verboseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Property and Equipment</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_51913e22-76f8-4123-9b77-e88c43236db2_verboseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Common stock, shares authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesAuthorized" xlink:to="lab_us-gaap_CommonStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_1fa7f4d3-d1a7-485f-b000-2f6e0800020c_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PatentsMember_e06098d8-d4cb-4f27-9b69-d1b0bbe6dad7_terseLabel_en-US" xlink:label="lab_us-gaap_PatentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Patents</link:label>
    <link:label id="lab_us-gaap_PatentsMember_label_en-US" xlink:label="lab_us-gaap_PatentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Patents [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PatentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PatentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PatentsMember" xlink:to="lab_us-gaap_PatentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_4442665a-88c0-4c3d-bccd-055173b9a63d_verboseLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Assets, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrentAbstract" xlink:to="lab_us-gaap_AssetsCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_79129f13-6906-4e84-a0c5-4f09c5e717cf_negatedLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Forfeited (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_e81bc93e-d200-4a8c-acc7-da652b26c514_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">TOTAL LIABILITIES AND STOCKHOLDERS&#8217; EQUITY</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liabilities and Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_4327eb07-0f2a-46f1-ad75-ec96b3e6632d_verboseLabel_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Foreign Currency Translation</link:label>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Foreign Currency Transactions and Translations Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:to="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_c4476b2c-cb33-4d43-af71-f56720008a25_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Options (in thousands)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskByBenchmarkAxis_6bdee132-684a-4d8f-b58a-19791a1dd21f_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Concentration Risk Benchmark [Axis]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskByBenchmarkAxis_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Concentration Risk Benchmark [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:to="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskCreditRisk_7b776212-0e8c-4205-8552-cfe02679de5c_verboseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskCreditRisk" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Concentration of Credit Risk</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskCreditRisk_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskCreditRisk" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Concentration Risk, Credit Risk, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskCreditRisk" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConcentrationRiskCreditRisk"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskCreditRisk" xlink:to="lab_us-gaap_ConcentrationRiskCreditRisk" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_bea7012b-48fa-4b5f-b760-996915e119f4_verboseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">LIABILITIES AND STOCKHOLDERS&#8217; EQUITY</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liabilities and Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StateAndLocalJurisdictionMember_10d2fc51-8e1b-4810-81f7-0d95de88ddd2_terseLabel_en-US" xlink:label="lab_us-gaap_StateAndLocalJurisdictionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">State and Local Jurisdiction</link:label>
    <link:label id="lab_us-gaap_StateAndLocalJurisdictionMember_label_en-US" xlink:label="lab_us-gaap_StateAndLocalJurisdictionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">State and Local Jurisdiction [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StateAndLocalJurisdictionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StateAndLocalJurisdictionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StateAndLocalJurisdictionMember" xlink:to="lab_us-gaap_StateAndLocalJurisdictionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_5ac7175d-657d-4fbb-8309-cf5bc6969f81_terseLabel_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MaximumMember_3a928a7a-e923-49ea-aae3-5849aac925da_terseLabel_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Maximum</link:label>
    <link:label id="lab_srt_MaximumMember_label_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Maximum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_MaximumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MaximumMember" xlink:to="lab_srt_MaximumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_lfvn_CommissionAndIncentives_ed244f03-da8a-4229-9e29-07c24b01c6c1_verboseLabel_en-US" xlink:label="lab_lfvn_CommissionAndIncentives" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Commissions and incentives</link:label>
    <link:label id="lab_lfvn_CommissionAndIncentives_label_en-US" xlink:label="lab_lfvn_CommissionAndIncentives" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Commission And Incentives</link:label>
    <link:label id="lab_lfvn_CommissionAndIncentives_documentation_en-US" xlink:label="lab_lfvn_CommissionAndIncentives" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Expenses related to commissions and other incentives earned by independent distributors. Commission and incentive expenses include sales commissions paid to our independent distributors, special incentives, costs for incentive trip and other rewards</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_CommissionAndIncentives" xlink:href="lfvn-20250630.xsd#lfvn_CommissionAndIncentives"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfvn_CommissionAndIncentives" xlink:to="lab_lfvn_CommissionAndIncentives" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_f77ec3c4-24b6-44f8-8fb6-e63a0dc58856_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Exercisable (dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_f5e1008c-a172-4b0f-b6b7-01a29e2ab0ea_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_label_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingPoliciesAbstract" xlink:to="lab_us-gaap_AccountingPoliciesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_lfvn_CommonStockDividendsPerShareCashPaidOneTimeDividend_7420d032-63d0-4ef1-a4df-42e393f9cbf0_terseLabel_en-US" xlink:label="lab_lfvn_CommonStockDividendsPerShareCashPaidOneTimeDividend" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">One time dividend (dollars per share)</link:label>
    <link:label id="lab_lfvn_CommonStockDividendsPerShareCashPaidOneTimeDividend_label_en-US" xlink:label="lab_lfvn_CommonStockDividendsPerShareCashPaidOneTimeDividend" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock, Dividends, Per Share, Cash Paid, One Time Dividend</link:label>
    <link:label id="lab_lfvn_CommonStockDividendsPerShareCashPaidOneTimeDividend_documentation_en-US" xlink:label="lab_lfvn_CommonStockDividendsPerShareCashPaidOneTimeDividend" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Common Stock, Dividends, Per Share, Cash Paid, One Time Dividend</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_CommonStockDividendsPerShareCashPaidOneTimeDividend" xlink:href="lfvn-20250630.xsd#lfvn_CommonStockDividendsPerShareCashPaidOneTimeDividend"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfvn_CommonStockDividendsPerShareCashPaidOneTimeDividend" xlink:to="lab_lfvn_CommonStockDividendsPerShareCashPaidOneTimeDividend" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_f7cd6534-8e7b-4da4-aa5e-e25f06c1bcca_totalLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total finite-lived intangible assets, net</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_d319283d-dd7e-432f-9528-8ca17d49a7a9_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Lessee, Operating Lease, Liability, Maturity</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Maturity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedStockMember_d1815390-3d89-4d50-8175-d2034bae5719_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restricted Stock</link:label>
    <link:label id="lab_us-gaap_RestrictedStockMember_7f9e4c5c-7477-4f54-a295-af8962d4e613_verboseLabel_en-US" xlink:label="lab_us-gaap_RestrictedStockMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Restricted Shares</link:label>
    <link:label id="lab_us-gaap_RestrictedStockMember_label_en-US" xlink:label="lab_us-gaap_RestrictedStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restricted Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RestrictedStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedStockMember" xlink:to="lab_us-gaap_RestrictedStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskTypeDomain_6c933bf3-3b8c-4234-b9bd-36e24e9ebf46_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Concentration Risk Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskTypeDomain_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Concentration Risk Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain" xlink:to="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NonPeoNeoAvgTotalCompAmt_terseLabel_en-US" xlink:label="lab_ecd_NonPeoNeoAvgTotalCompAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-PEO NEO Average Total Compensation Amount</link:label>
    <link:label id="lab_ecd_NonPeoNeoAvgTotalCompAmt_label_en-US" xlink:label="lab_ecd_NonPeoNeoAvgTotalCompAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-PEO NEO Average Total Compensation Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonPeoNeoAvgTotalCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_NonPeoNeoAvgTotalCompAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NonPeoNeoAvgTotalCompAmt" xlink:to="lab_ecd_NonPeoNeoAvgTotalCompAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_00571189-14b9-4d0b-9a45-d3b2a4885ffc_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_a3fc7056-46f8-42ab-aa4b-887f289c8d0e_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair value of vested awards</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AdjToNonPeoNeoCompFnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Adjustment to Non-PEO NEO Compensation Footnote</link:label>
    <link:label id="lab_ecd_AdjToNonPeoNeoCompFnTextBlock_label_en-US" xlink:label="lab_ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustment to Non-PEO NEO Compensation Footnote [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AdjToNonPeoNeoCompFnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:to="lab_ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PayVsPerformanceDisclosureLineItems_label_en-US" xlink:label="lab_ecd_PayVsPerformanceDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pay vs Performance Disclosure [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PayVsPerformanceDisclosureLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="lab_ecd_PayVsPerformanceDisclosureLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_890ed536-c2c9-41f2-b1da-386ca802e8f0_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Present value of lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Lease, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiability" xlink:to="lab_us-gaap_OperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt_terseLabel_en-US" xlink:label="lab_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Forgone Recovery due to Disqualification of Tax Benefits, Amount</link:label>
    <link:label id="lab_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt_label_en-US" xlink:label="lab_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Forgone Recovery due to Disqualification of Tax Benefits, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:to="lab_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SummaryOfValuationAllowanceTextBlock_c6698a52-b097-4ead-b9f6-7aa1b0853e3e_terseLabel_en-US" xlink:label="lab_us-gaap_SummaryOfValuationAllowanceTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Summary of Valuation Allowance</link:label>
    <link:label id="lab_us-gaap_SummaryOfValuationAllowanceTextBlock_label_en-US" xlink:label="lab_us-gaap_SummaryOfValuationAllowanceTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Summary of Valuation Allowance [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SummaryOfValuationAllowanceTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SummaryOfValuationAllowanceTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SummaryOfValuationAllowanceTextBlock" xlink:to="lab_us-gaap_SummaryOfValuationAllowanceTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NonRule10b51ArrTrmntdFlag_terseLabel_en-US" xlink:label="lab_ecd_NonRule10b51ArrTrmntdFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-Rule 10b5-1 Arrangement Terminated</link:label>
    <link:label id="lab_ecd_NonRule10b51ArrTrmntdFlag_label_en-US" xlink:label="lab_ecd_NonRule10b51ArrTrmntdFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-Rule 10b5-1 Arrangement Terminated [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonRule10b51ArrTrmntdFlag" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_NonRule10b51ArrTrmntdFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NonRule10b51ArrTrmntdFlag" xlink:to="lab_ecd_NonRule10b51ArrTrmntdFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_lfvn_ShareBasedCompensationArrangementByShareBasedPaymentAwardAmountInExcessOfFairMarketValueOfStockForOptionNotToBeGranted_61b2a97f-b089-47aa-8e02-bfa97cf679ac_terseLabel_en-US" xlink:label="lab_lfvn_ShareBasedCompensationArrangementByShareBasedPaymentAwardAmountInExcessOfFairMarketValueOfStockForOptionNotToBeGranted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Amount in excess of fair market value of stock for option not to be granted</link:label>
    <link:label id="lab_lfvn_ShareBasedCompensationArrangementByShareBasedPaymentAwardAmountInExcessOfFairMarketValueOfStockForOptionNotToBeGranted_label_en-US" xlink:label="lab_lfvn_ShareBasedCompensationArrangementByShareBasedPaymentAwardAmountInExcessOfFairMarketValueOfStockForOptionNotToBeGranted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Amount In Excess Of Fair Market Value Of Stock For Option Not To Be Granted</link:label>
    <link:label id="lab_lfvn_ShareBasedCompensationArrangementByShareBasedPaymentAwardAmountInExcessOfFairMarketValueOfStockForOptionNotToBeGranted_documentation_en-US" xlink:label="lab_lfvn_ShareBasedCompensationArrangementByShareBasedPaymentAwardAmountInExcessOfFairMarketValueOfStockForOptionNotToBeGranted" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Amount In Excess Of Fair Market Value Of Stock For Option Not To Be Granted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_ShareBasedCompensationArrangementByShareBasedPaymentAwardAmountInExcessOfFairMarketValueOfStockForOptionNotToBeGranted" xlink:href="lfvn-20250630.xsd#lfvn_ShareBasedCompensationArrangementByShareBasedPaymentAwardAmountInExcessOfFairMarketValueOfStockForOptionNotToBeGranted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfvn_ShareBasedCompensationArrangementByShareBasedPaymentAwardAmountInExcessOfFairMarketValueOfStockForOptionNotToBeGranted" xlink:to="lab_lfvn_ShareBasedCompensationArrangementByShareBasedPaymentAwardAmountInExcessOfFairMarketValueOfStockForOptionNotToBeGranted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_39aa69d0-2d54-440d-a473-ea405f1c9bf7_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Income before income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityShellCompany_0bc0e56f-e165-4799-84da-0040f73e7224_terseLabel_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Shell Company</link:label>
    <link:label id="lab_dei_EntityShellCompany_label_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Shell Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityShellCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityShellCompany" xlink:to="lab_dei_EntityShellCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_lfvn_CashAccountsHeldPrimarilyAtFinancialInstitutionMember_f5d61498-a8dc-47f5-8cca-9a42f9eace9e_terseLabel_en-US" xlink:label="lab_lfvn_CashAccountsHeldPrimarilyAtFinancialInstitutionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash Accounts Held Primarily At Financial Institution</link:label>
    <link:label id="lab_lfvn_CashAccountsHeldPrimarilyAtFinancialInstitutionMember_label_en-US" xlink:label="lab_lfvn_CashAccountsHeldPrimarilyAtFinancialInstitutionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash Accounts Held Primarily At Financial Institution [Member]</link:label>
    <link:label id="lab_lfvn_CashAccountsHeldPrimarilyAtFinancialInstitutionMember_documentation_en-US" xlink:label="lab_lfvn_CashAccountsHeldPrimarilyAtFinancialInstitutionMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Cash Accounts Held Primarily At Financial Institution [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_CashAccountsHeldPrimarilyAtFinancialInstitutionMember" xlink:href="lfvn-20250630.xsd#lfvn_CashAccountsHeldPrimarilyAtFinancialInstitutionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfvn_CashAccountsHeldPrimarilyAtFinancialInstitutionMember" xlink:to="lab_lfvn_CashAccountsHeldPrimarilyAtFinancialInstitutionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_f1bc146d-701a-4cdc-8232-8c748a44d57c_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other long-term liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Liabilities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:to="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_1291a737-c267-4ad6-9b10-075b0e63632e_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Proceeds from sale of fixed assets</link:label>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proceeds from Sale of Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:to="lab_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_0c88651d-9a0e-4f95-8cea-f8be2353cb24_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_af6e6d34-4ced-4da2-9514-6b7055123b68_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:to="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_CoSelectedMeasureAmt_terseLabel_en-US" xlink:label="lab_ecd_CoSelectedMeasureAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Company Selected Measure Amount</link:label>
    <link:label id="lab_ecd_CoSelectedMeasureAmt_label_en-US" xlink:label="lab_ecd_CoSelectedMeasureAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Company Selected Measure Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CoSelectedMeasureAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_CoSelectedMeasureAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_CoSelectedMeasureAmt" xlink:to="lab_ecd_CoSelectedMeasureAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_20046b55-ae9a-4ae8-8234-e77a742f026c_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2028</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardTmgMnpiCnsdrdFlag_terseLabel_en-US" xlink:label="lab_ecd_AwardTmgMnpiCnsdrdFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Award Timing MNPI Considered</link:label>
    <link:label id="lab_ecd_AwardTmgMnpiCnsdrdFlag_label_en-US" xlink:label="lab_ecd_AwardTmgMnpiCnsdrdFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Timing MNPI Considered [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgMnpiCnsdrdFlag" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardTmgMnpiCnsdrdFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardTmgMnpiCnsdrdFlag" xlink:to="lab_ecd_AwardTmgMnpiCnsdrdFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityTable_cb8d19d3-e603-430a-955b-efd09fc6b5f7_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Line of Credit Facility [Table]</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityTable_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Line of Credit Facility [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityTable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LineOfCreditFacilityTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityTable" xlink:to="lab_us-gaap_LineOfCreditFacilityTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities_1dbb11e2-cc92-49ac-aff8-28dc1cb6e0bf_verboseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Other liabilities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Other Noncurrent Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_ead7af75-43d1-4e29-b3b8-6ae5ba3e3983_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Expired or Canceled (dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_MeasureName_terseLabel_en-US" xlink:label="lab_ecd_MeasureName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Name</link:label>
    <link:label id="lab_ecd_MeasureName_label_en-US" xlink:label="lab_ecd_MeasureName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Measure Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MeasureName" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_MeasureName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_MeasureName" xlink:to="lab_ecd_MeasureName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_20272ce0-c6b9-4abd-a6e2-e9721f69672d_verboseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Domestic</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Domestic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:type="arc" order="1"/>
    <link:label id="lab_lfvn_ProtandimMember_16d91b99-d44c-4ac7-a77e-d4fa8e3a99da_terseLabel_en-US" xlink:label="lab_lfvn_ProtandimMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Protandim&#174; product line</link:label>
    <link:label id="lab_lfvn_ProtandimMember_label_en-US" xlink:label="lab_lfvn_ProtandimMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Protandim [Member]</link:label>
    <link:label id="lab_lfvn_ProtandimMember_documentation_en-US" xlink:label="lab_lfvn_ProtandimMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Protandim [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_ProtandimMember" xlink:href="lfvn-20250630.xsd#lfvn_ProtandimMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfvn_ProtandimMember" xlink:to="lab_lfvn_ProtandimMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SecuredDebtMember_0e298aa2-fd3d-486b-93ce-440186bfda43_terseLabel_en-US" xlink:label="lab_us-gaap_SecuredDebtMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Secured Debt</link:label>
    <link:label id="lab_us-gaap_SecuredDebtMember_label_en-US" xlink:label="lab_us-gaap_SecuredDebtMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Secured Debt [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebtMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SecuredDebtMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SecuredDebtMember" xlink:to="lab_us-gaap_SecuredDebtMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_437d0b3f-82da-4cc9-bef7-99e3d0ffc107_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Lease, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfStockLineItems_9854f60c-7d11-4e1b-a45e-e68b873ba1c5_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfStockLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Class of Stock [Line Items]</link:label>
    <link:label id="lab_us-gaap_ClassOfStockLineItems_label_en-US" xlink:label="lab_us-gaap_ClassOfStockLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Class of Stock [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfStockLineItems" xlink:to="lab_us-gaap_ClassOfStockLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_118db59a-b571-4d10-a9d8-df4e12e60a1f_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalPeriodFocus" xlink:to="lab_dei_DocumentFiscalPeriodFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_lfvn_ProtandimandTrueScienceProductLineMember_75c5dd7b-78ef-444f-afa8-4da754f9148a_terseLabel_en-US" xlink:label="lab_lfvn_ProtandimandTrueScienceProductLineMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Protandim and TrueScience Product Line</link:label>
    <link:label id="lab_lfvn_ProtandimandTrueScienceProductLineMember_label_en-US" xlink:label="lab_lfvn_ProtandimandTrueScienceProductLineMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Protandim and TrueScience Product Line [Member]</link:label>
    <link:label id="lab_lfvn_ProtandimandTrueScienceProductLineMember_documentation_en-US" xlink:label="lab_lfvn_ProtandimandTrueScienceProductLineMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Protandim and TrueScience Product Line [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_ProtandimandTrueScienceProductLineMember" xlink:href="lfvn-20250630.xsd#lfvn_ProtandimandTrueScienceProductLineMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfvn_ProtandimandTrueScienceProductLineMember" xlink:to="lab_lfvn_ProtandimandTrueScienceProductLineMember" xlink:type="arc" order="1"/>
    <link:label id="lab_lfvn_LifeVantageTrueScienceSkinCareRegimenMember_4f10583b-0e75-4bbd-ae3d-67dec18bd8a4_terseLabel_en-US" xlink:label="lab_lfvn_LifeVantageTrueScienceSkinCareRegimenMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">LifeVantage&#174; product line</link:label>
    <link:label id="lab_lfvn_LifeVantageTrueScienceSkinCareRegimenMember_label_en-US" xlink:label="lab_lfvn_LifeVantageTrueScienceSkinCareRegimenMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">LifeVantage TrueScience Skin Care Regimen [Member]</link:label>
    <link:label id="lab_lfvn_LifeVantageTrueScienceSkinCareRegimenMember_documentation_en-US" xlink:label="lab_lfvn_LifeVantageTrueScienceSkinCareRegimenMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">LifeVantage TrueScience Skin Care Regimen [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_LifeVantageTrueScienceSkinCareRegimenMember" xlink:href="lfvn-20250630.xsd#lfvn_LifeVantageTrueScienceSkinCareRegimenMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfvn_LifeVantageTrueScienceSkinCareRegimenMember" xlink:to="lab_lfvn_LifeVantageTrueScienceSkinCareRegimenMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReceivablesPolicyTextBlock_766e1e95-860f-4f82-9aa1-772154fc9483_verboseLabel_en-US" xlink:label="lab_us-gaap_ReceivablesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Accounts Receivable</link:label>
    <link:label id="lab_us-gaap_ReceivablesPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ReceivablesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Receivable [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ReceivablesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReceivablesPolicyTextBlock" xlink:to="lab_us-gaap_ReceivablesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardTmgMethodTextBlock_terseLabel_en-US" xlink:label="lab_ecd_AwardTmgMethodTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Award Timing Method</link:label>
    <link:label id="lab_ecd_AwardTmgMethodTextBlock_label_en-US" xlink:label="lab_ecd_AwardTmgMethodTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Timing Method [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgMethodTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardTmgMethodTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardTmgMethodTextBlock" xlink:to="lab_ecd_AwardTmgMethodTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FurnitureAndFixturesMember_31685ec7-5e9f-438b-a74f-75da22b60fa2_terseLabel_en-US" xlink:label="lab_us-gaap_FurnitureAndFixturesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Furniture and fixtures</link:label>
    <link:label id="lab_us-gaap_FurnitureAndFixturesMember_label_en-US" xlink:label="lab_us-gaap_FurnitureAndFixturesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Furniture and Fixtures [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FurnitureAndFixturesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FurnitureAndFixturesMember" xlink:to="lab_us-gaap_FurnitureAndFixturesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AwardTypeAxis_e8f78d74-2692-4eca-bf52-2c2be81a98b9_terseLabel_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:label id="lab_us-gaap_AwardTypeAxis_label_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AwardTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AwardTypeAxis" xlink:to="lab_us-gaap_AwardTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Assets_13601205-f7c0-4754-89a9-d8b93087665f_totalLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">TOTAL ASSETS</link:label>
    <link:label id="lab_us-gaap_Assets_label_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Assets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Assets" xlink:to="lab_us-gaap_Assets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock_15758da9-633a-460f-90a8-3bab46d7fac5_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Summary of Nonvested Restricted Stock Units</link:label>
    <link:label id="lab_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Nonvested Restricted Stock Units Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_7c1b43ef-a53c-482e-80a8-62303dd67e6f_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Stock-Based Compensation</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:to="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_99776f7c-c12a-4732-b085-ff27b72762fe_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_7ec07582-5814-4516-aea3-a9420cad3b39_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_69f1b158-23a3-4889-84fe-74a26b573b57_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2029</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_0f315f7f-f4e6-4c28-9103-15e7206a0131_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Vested (dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_SegmentGeographicalDomain_2c14bae8-534b-4d30-b3f2-27568f7570c6_terseLabel_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:label id="lab_srt_SegmentGeographicalDomain_label_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_SegmentGeographicalDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_SegmentGeographicalDomain" xlink:to="lab_srt_SegmentGeographicalDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLossCarryforwardsTable_83f2cac3-5ae0-405d-95a7-54912f71352f_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwardsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating Loss Carryforwards [Table]</link:label>
    <link:label id="lab_us-gaap_OperatingLossCarryforwardsTable_label_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwardsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Loss Carryforwards [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLossCarryforwardsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable" xlink:to="lab_us-gaap_OperatingLossCarryforwardsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_33c89292-7642-43e9-9a25-3aea12e87459_verboseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Change in valuation allowance</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxPolicyTextBlock_d7e23274-d89b-4f37-a82b-1b1d5cd06ce9_verboseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Income Taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Tax, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxPolicyTextBlock" xlink:to="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_9c2b1b56-7480-4020-9e70-c648ecc17c12_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract_e228f50a-b670-4fd0-8ea9-63b186f9ec4a_verboseLabel_en-US" xlink:label="lab_us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">The components of the deferred tax assets and liabilities</link:label>
    <link:label id="lab_us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract_label_en-US" xlink:label="lab_us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Components of Deferred Tax Assets and Liabilities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract" xlink:to="lab_us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_lfvn_NumberOfFinanceLeases_ef2f7e07-7cde-4735-83ae-17f7ba99d5b9_terseLabel_en-US" xlink:label="lab_lfvn_NumberOfFinanceLeases" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of finance leases</link:label>
    <link:label id="lab_lfvn_NumberOfFinanceLeases_label_en-US" xlink:label="lab_lfvn_NumberOfFinanceLeases" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Number of Finance Leases</link:label>
    <link:label id="lab_lfvn_NumberOfFinanceLeases_documentation_en-US" xlink:label="lab_lfvn_NumberOfFinanceLeases" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Number of Finance Leases</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_NumberOfFinanceLeases" xlink:href="lfvn-20250630.xsd#lfvn_NumberOfFinanceLeases"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfvn_NumberOfFinanceLeases" xlink:to="lab_lfvn_NumberOfFinanceLeases" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_e40d3601-ccdb-42a0-a586-5c687a2c1166_verboseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Cash Flows from Operating Activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash Provided by (Used in) Operating Activity, Including Discontinued Operation [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryAdjustments_1a476553-9fc9-4dbb-9b4b-2dcd25ead116_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryAdjustments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Reduction in inventory</link:label>
    <link:label id="lab_us-gaap_InventoryAdjustments_label_en-US" xlink:label="lab_us-gaap_InventoryAdjustments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Inventory Adjustments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryAdjustments" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InventoryAdjustments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryAdjustments" xlink:to="lab_us-gaap_InventoryAdjustments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingOtherItemAmount_7191706e-b32d-4e2f-b854-3c1b25a627b0_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingOtherItemAmount" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Other segment items</link:label>
    <link:label id="lab_us-gaap_SegmentReportingOtherItemAmount_label_en-US" xlink:label="lab_us-gaap_SegmentReportingOtherItemAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Segment Reporting, Other Segment Item, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingOtherItemAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SegmentReportingOtherItemAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingOtherItemAmount" xlink:to="lab_us-gaap_SegmentReportingOtherItemAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsDisclosureTextBlock_9c3957a7-8294-4f9a-aa48-0801e47363ba_terseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Intangible Assets, Net</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Intangible Assets Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IntangibleAssetsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:to="lab_us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_276181f9-2f70-4c46-be2a-2824ebf1ff47_terseLabel_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Foreign Currency Effect on Cash</link:label>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effect of Exchange Rate on Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskByTypeAxis_843a18e9-e3a6-4c59-b182-a5e1deef65af_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Concentration Risk Type [Axis]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskByTypeAxis_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Concentration Risk Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis" xlink:to="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NonPeoNeoAvgCompActuallyPaidAmt_terseLabel_en-US" xlink:label="lab_ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-PEO NEO Average Compensation Actually Paid Amount</link:label>
    <link:label id="lab_ecd_NonPeoNeoAvgCompActuallyPaidAmt_label_en-US" xlink:label="lab_ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-PEO NEO Average Compensation Actually Paid Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_NonPeoNeoAvgCompActuallyPaidAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:to="lab_ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_754e1eb9-a64d-4bc1-aa26-ca249a6b3dce_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restricted Stock Units (RSUs)</link:label>
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_label_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restricted Stock Units (RSUs) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:to="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_CompActuallyPaidVsOtherMeasureTextBlock_terseLabel_en-US" xlink:label="lab_ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Compensation Actually Paid vs. Other Measure</link:label>
    <link:label id="lab_ecd_CompActuallyPaidVsOtherMeasureTextBlock_label_en-US" xlink:label="lab_ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Compensation Actually Paid vs. Other Measure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_CompActuallyPaidVsOtherMeasureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:to="lab_ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_lfvn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsCancelledInPeriod_b1f4a1da-4ee3-4c4f-a6b5-eb9e056afad8_terseLabel_en-US" xlink:label="lab_lfvn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsCancelledInPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cancelled in period (in shares)</link:label>
    <link:label id="lab_lfvn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsCancelledInPeriod_label_en-US" xlink:label="lab_lfvn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsCancelledInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Cancelled In Period</link:label>
    <link:label id="lab_lfvn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsCancelledInPeriod_documentation_en-US" xlink:label="lab_lfvn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsCancelledInPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Cancelled In Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsCancelledInPeriod" xlink:href="lfvn-20250630.xsd#lfvn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsCancelledInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfvn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsCancelledInPeriod" xlink:to="lab_lfvn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsCancelledInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities_38d6996c-f609-4ee3-bbca-d5a0e3746416_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Settlement</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Unrecognized Tax Benefits, Decrease Resulting from Settlements with Taxing Authorities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_7065a846-84a2-4980-a11d-4b0ccaaf182c_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_df155126-9dac-4694-8449-39c39a4be3a0_terseLabel_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_label_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCommonStockSharesOutstanding" xlink:to="lab_dei_EntityCommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_8bf8edd0-75e3-49ce-a474-e1deb0a23c8e_terseLabel_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Right-of-use assets obtained in exchange for lease obligations</link:label>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Right-of-Use Asset Obtained in Exchange for Operating Lease Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:to="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_5d387ee2-c1e6-4449-bd9b-9cc33bc52177_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Company's common stock purchased in aggregate (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_eb167314-bbe3-4d2d-be7b-6d402c1837a7_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Outstanding beginning balance (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_75a31a8e-734a-42fd-9d6d-21067f711e61_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Outstanding ending balance (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember_terseLabel_en-US" xlink:label="lab_ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year</link:label>
    <link:label id="lab_ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember_label_en-US" xlink:label="lab_ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember" xlink:to="lab_ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFinStmtErrorCorrectionFlag_be0da826-7c38-4dea-815a-06b8d7208f67_terseLabel_en-US" xlink:label="lab_dei_DocumentFinStmtErrorCorrectionFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Financial Statement Error Correction [Flag]</link:label>
    <link:label id="lab_dei_DocumentFinStmtErrorCorrectionFlag_label_en-US" xlink:label="lab_dei_DocumentFinStmtErrorCorrectionFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Financial Statement Error Correction [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFinStmtErrorCorrectionFlag" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFinStmtErrorCorrectionFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFinStmtErrorCorrectionFlag" xlink:to="lab_dei_DocumentFinStmtErrorCorrectionFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_lfvn_HandlingAndRestockingFeePercentage_5401b712-8fb1-4108-a237-f604f38e45c7_terseLabel_en-US" xlink:label="lab_lfvn_HandlingAndRestockingFeePercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Handling and restocking fee, percentage</link:label>
    <link:label id="lab_lfvn_HandlingAndRestockingFeePercentage_label_en-US" xlink:label="lab_lfvn_HandlingAndRestockingFeePercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Handling and Restocking Fee, Percentage</link:label>
    <link:label id="lab_lfvn_HandlingAndRestockingFeePercentage_documentation_en-US" xlink:label="lab_lfvn_HandlingAndRestockingFeePercentage" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Handling and Restocking Fee, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_HandlingAndRestockingFeePercentage" xlink:href="lfvn-20250630.xsd#lfvn_HandlingAndRestockingFeePercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfvn_HandlingAndRestockingFeePercentage" xlink:to="lab_lfvn_HandlingAndRestockingFeePercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock_terseLabel_en-US" xlink:label="lab_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Insider Trading Policies and Procedures Not Adopted</link:label>
    <link:label id="lab_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock_label_en-US" xlink:label="lab_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Insider Trading Policies and Procedures Not Adopted [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:to="lab_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedEmployeeBenefitsCurrentAndNoncurrent_5f4cab64-182f-479c-936a-3f81adc0e226_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedEmployeeBenefitsCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accrued severance</link:label>
    <link:label id="lab_us-gaap_AccruedEmployeeBenefitsCurrentAndNoncurrent_label_en-US" xlink:label="lab_us-gaap_AccruedEmployeeBenefitsCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accrued Employee Benefits</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedEmployeeBenefitsCurrentAndNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccruedEmployeeBenefitsCurrentAndNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedEmployeeBenefitsCurrentAndNoncurrent" xlink:to="lab_us-gaap_AccruedEmployeeBenefitsCurrentAndNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_6eb05444-5811-4ba2-b89e-90f17cfcc10f_terseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Trademarks and other indefinite-lived intangible assets</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Indefinite-Lived Intangible Assets (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_lfvn_MichaelBeindorffMember_label_en-US" xlink:label="lab_lfvn_MichaelBeindorffMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Michael Beindorff [Member]</link:label>
    <link:label id="lab_lfvn_MichaelBeindorffMember_documentation_en-US" xlink:label="lab_lfvn_MichaelBeindorffMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Michael Beindorff</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_MichaelBeindorffMember" xlink:href="lfvn-20250630.xsd#lfvn_MichaelBeindorffMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfvn_MichaelBeindorffMember" xlink:to="lab_lfvn_MichaelBeindorffMember" xlink:type="arc" order="1"/>
    <link:label id="lab_lfvn_PerformanceStockUnitsMember_0b7d3a5b-27e5-4675-bdd9-3f5183996081_terseLabel_en-US" xlink:label="lab_lfvn_PerformanceStockUnitsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Performance Restricted Stock Units</link:label>
    <link:label id="lab_lfvn_PerformanceStockUnitsMember_label_en-US" xlink:label="lab_lfvn_PerformanceStockUnitsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Performance Stock Units [Member]</link:label>
    <link:label id="lab_lfvn_PerformanceStockUnitsMember_documentation_en-US" xlink:label="lab_lfvn_PerformanceStockUnitsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Performance Stock Units [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_PerformanceStockUnitsMember" xlink:href="lfvn-20250630.xsd#lfvn_PerformanceStockUnitsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfvn_PerformanceStockUnitsMember" xlink:to="lab_lfvn_PerformanceStockUnitsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_a8bfbec8-641c-49a9-86f6-e25139c867e5_verboseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Common stock, shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_94fd227e-c1a0-4dc9-ba80-034bde10f9a1_periodStartLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Beginning balances (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_c790430b-dad3-4be8-aa9d-451f220f80cf_periodEndLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Ending balances (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock, Shares, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesOutstanding" xlink:to="lab_us-gaap_CommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProvisionForDoubtfulAccounts_c6b548a0-7f7e-4bb9-8bfd-8186241a17b4_verboseLabel_en-US" xlink:label="lab_us-gaap_ProvisionForDoubtfulAccounts" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Recorded bad debt expense</link:label>
    <link:label id="lab_us-gaap_ProvisionForDoubtfulAccounts_label_en-US" xlink:label="lab_us-gaap_ProvisionForDoubtfulAccounts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounts Receivable, Credit Loss Expense (Reversal)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProvisionForDoubtfulAccounts" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProvisionForDoubtfulAccounts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProvisionForDoubtfulAccounts" xlink:to="lab_us-gaap_ProvisionForDoubtfulAccounts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_fe2be5fc-0821-49a4-9f7a-6c6fbd04c0bd_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Components of Income Tax Expense</link:label>
    <link:label id="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_lfvn_TwoThousandSeventeenLongTermIncentivePlanExcludingTwoThousandAndTenLongTermIncentivePlanMember_02a54f13-4496-44bc-b4aa-8e6c78a84cd1_terseLabel_en-US" xlink:label="lab_lfvn_TwoThousandSeventeenLongTermIncentivePlanExcludingTwoThousandAndTenLongTermIncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2017 Long Term Incentive Plan Excluding 2010 Long Term Incentive Plan</link:label>
    <link:label id="lab_lfvn_TwoThousandSeventeenLongTermIncentivePlanExcludingTwoThousandAndTenLongTermIncentivePlanMember_label_en-US" xlink:label="lab_lfvn_TwoThousandSeventeenLongTermIncentivePlanExcludingTwoThousandAndTenLongTermIncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Two Thousand Seventeen Long Term Incentive Plan, Excluding Two Thousand And Ten Long Term Incentive Plan [Member]</link:label>
    <link:label id="lab_lfvn_TwoThousandSeventeenLongTermIncentivePlanExcludingTwoThousandAndTenLongTermIncentivePlanMember_documentation_en-US" xlink:label="lab_lfvn_TwoThousandSeventeenLongTermIncentivePlanExcludingTwoThousandAndTenLongTermIncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Two Thousand Seventeen Long Term Incentive Plan, Excluding Two Thousand And Ten Long Term Incentive Plan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_TwoThousandSeventeenLongTermIncentivePlanExcludingTwoThousandAndTenLongTermIncentivePlanMember" xlink:href="lfvn-20250630.xsd#lfvn_TwoThousandSeventeenLongTermIncentivePlanExcludingTwoThousandAndTenLongTermIncentivePlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfvn_TwoThousandSeventeenLongTermIncentivePlanExcludingTwoThousandAndTenLongTermIncentivePlanMember" xlink:to="lab_lfvn_TwoThousandSeventeenLongTermIncentivePlanExcludingTwoThousandAndTenLongTermIncentivePlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanNameAxis_8f530441-d9b7-4f74-bd23-174da99cb027_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:label id="lab_us-gaap_PlanNameAxis_label_en-US" xlink:label="lab_us-gaap_PlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PlanNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameAxis" xlink:to="lab_us-gaap_PlanNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_1c36d73c-7190-4330-b92e-dc19f6dcf62e_verboseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Property and Equipment</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PeoMember_terseLabel_en-US" xlink:label="lab_ecd_PeoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">PEO</link:label>
    <link:label id="lab_ecd_PeoMember_label_en-US" xlink:label="lab_ecd_PeoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">PEO [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PeoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PeoMember" xlink:to="lab_ecd_PeoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_799d7cff-f9e8-4309-80a3-950e52b15761_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Disaggregation of Revenue</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disaggregation of Revenue [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:to="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentIncomeInterest_dbaa60a1-bbeb-466e-bf96-90a3f8231853_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentIncomeInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Interest income</link:label>
    <link:label id="lab_us-gaap_InvestmentIncomeInterest_label_en-US" xlink:label="lab_us-gaap_InvestmentIncomeInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Investment Income, Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InvestmentIncomeInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentIncomeInterest" xlink:to="lab_us-gaap_InvestmentIncomeInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets_e0489211-65a4-441c-84ab-7ac9c468610f_negatedLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Patents and trademarks</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Liabilities, Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_3babdc52-e0eb-493a-9f07-e7378a2caae7_verboseLabel_en-US" xlink:label="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Current taxes:</link:label>
    <link:label id="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_label_en-US" xlink:label="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Current Income Tax Expense (Benefit), Continuing Operations [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_09f1aefd-7ad1-4811-9b88-82821dcadef5_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Increases</link:label>
    <link:label id="lab_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_label_en-US" xlink:label="lab_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:to="lab_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedIncomeTaxesCurrent_eedddc16-20a2-4aa2-9c1e-045095682733_verboseLabel_en-US" xlink:label="lab_us-gaap_AccruedIncomeTaxesCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Income tax payable</link:label>
    <link:label id="lab_us-gaap_AccruedIncomeTaxesCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedIncomeTaxesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accrued Income Taxes, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccruedIncomeTaxesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedIncomeTaxesCurrent" xlink:to="lab_us-gaap_AccruedIncomeTaxesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_country_US_5de27736-09e7-45fc-9881-05625c3d0ddc_terseLabel_en-US" xlink:label="lab_country_US" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">United States</link:label>
    <link:label id="lab_country_US_label_en-US" xlink:label="lab_country_US" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">UNITED STATES</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_US" xlink:href="https://xbrl.sec.gov/country/2025/country-2025.xsd#country_US"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_US" xlink:to="lab_country_US" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_79ce282b-bf07-4488-923b-cf9a49071943_verboseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Changes in operating assets and liabilities:</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity, Increase (Decrease) in Operating Capital [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember_terseLabel_en-US" xlink:label="lab_ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year</link:label>
    <link:label id="lab_ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember_label_en-US" xlink:label="lab_ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember" xlink:to="lab_ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_1802d701-5f4d-4dee-b072-3d6629b03534_negatedLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Property&#160;&amp; equipment</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Liabilities, Property, Plant and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_lfvn_RawMaterialsPercentOfTotalInventory_09aeae14-099c-4dd1-9a8b-453b97681020_terseLabel_en-US" xlink:label="lab_lfvn_RawMaterialsPercentOfTotalInventory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Raw materials</link:label>
    <link:label id="lab_lfvn_RawMaterialsPercentOfTotalInventory_label_en-US" xlink:label="lab_lfvn_RawMaterialsPercentOfTotalInventory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Raw Materials, Percent Of Total Inventory</link:label>
    <link:label id="lab_lfvn_RawMaterialsPercentOfTotalInventory_documentation_en-US" xlink:label="lab_lfvn_RawMaterialsPercentOfTotalInventory" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Raw Materials, Percent Of Total Inventory</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_RawMaterialsPercentOfTotalInventory" xlink:href="lfvn-20250630.xsd#lfvn_RawMaterialsPercentOfTotalInventory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfvn_RawMaterialsPercentOfTotalInventory" xlink:to="lab_lfvn_RawMaterialsPercentOfTotalInventory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsFiniteLivedPolicy_76bd69a6-5ddf-4807-a655-33e61a53bcf6_verboseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsFiniteLivedPolicy" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Intangible Assets</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsFiniteLivedPolicy_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsFiniteLivedPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Intangible Assets, Finite-Lived, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsFiniteLivedPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IntangibleAssetsFiniteLivedPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsFiniteLivedPolicy" xlink:to="lab_us-gaap_IntangibleAssetsFiniteLivedPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsMember_c1d9f6ef-59d6-4f17-8dd1-83ee8d1b6ecc_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accumulated Deficit</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsMember_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Retained Earnings [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RetainedEarningsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsMember" xlink:to="lab_us-gaap_RetainedEarningsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_e51279ea-a8fe-4d35-bb34-54e4e28eb9a6_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Prepaid expenses and other</link:label>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Prepaid Expense and Other Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityAxis_1b427ff1-8d75-493c-8d1b-da72223a50b8_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income Tax Authority [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityAxis_label_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Tax Jurisdiction [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis" xlink:to="lab_us-gaap_IncomeTaxAuthorityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_08216431-5b64-4e06-b4e3-d8a5e43f8af8_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Shares</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateEffectivePercentage_b6eb8f59-575a-4c6f-bfd7-a306b9632fa8_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt instrument, effective interest rate</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateEffectivePercentage_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument, Interest Rate, Effective Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentInterestRateEffectivePercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:to="lab_us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_911e4c65-c7d8-4994-9cae-a4c67dfcb5dc_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Other Accrued Expenses</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Accrued Liabilities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_8262d7c1-1da2-4538-a8d6-127d5062a48d_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_RestatementDeterminationDate_terseLabel_en-US" xlink:label="lab_ecd_RestatementDeterminationDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restatement Determination Date</link:label>
    <link:label id="lab_ecd_RestatementDeterminationDate_label_en-US" xlink:label="lab_ecd_RestatementDeterminationDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restatement Determination Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RestatementDeterminationDate" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_RestatementDeterminationDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_RestatementDeterminationDate" xlink:to="lab_ecd_RestatementDeterminationDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_9496b887-e30d-456c-b932-5907c5bc5009_terseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share-based Payment Arrangement [Abstract]</link:label>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_5ce133a3-4c64-491d-bbee-7ea23c3acecd_periodStartLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Cash and Cash Equivalents &#8212; beginning of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_4d050d4e-66fd-4f9b-8818-a2dc39072682_periodEndLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Cash and Cash Equivalents &#8212; end of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_11436764-eb67-4722-a595-31acc357be75_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementAbstract" xlink:to="lab_us-gaap_IncomeStatementAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_8a8ce1d7-a7e1-442e-ab04-92244fe18b4a_negatedLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Income tax expense</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_6e21816e-b9a8-4733-a0c8-902f42e91bc7_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net income tax provision</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_6af70330-6638-4a59-93c3-f2b7dc28fa27_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Income tax expense</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_c12b08d8-e408-4b3b-96e2-37d6cbd6fda5_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Basis spread on variable rate</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument, Basis Spread on Variable Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:to="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TaxesPayableCurrent_fe950a46-8fb0-452b-b84f-a52b6a965e27_terseLabel_en-US" xlink:label="lab_us-gaap_TaxesPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other taxes payable</link:label>
    <link:label id="lab_us-gaap_TaxesPayableCurrent_label_en-US" xlink:label="lab_us-gaap_TaxesPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Taxes Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxesPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TaxesPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TaxesPayableCurrent" xlink:to="lab_us-gaap_TaxesPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_377b48c8-49e0-4577-a9b4-e6113fb12925_verboseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Preferred stock, shares issued (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Preferred Stock, Shares Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesIssued" xlink:to="lab_us-gaap_PreferredStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_b4bfd78c-086c-4d5a-907f-26cbc53e0030_verboseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Intangible assets, net</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_cf643eb1-2422-4971-8578-0af1e6943d0b_terseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total intangible assets, net</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Intangible Assets, Net (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:to="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PnsnAdjsSvcCstMember_terseLabel_en-US" xlink:label="lab_ecd_PnsnAdjsSvcCstMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pension Adjustments Service Cost</link:label>
    <link:label id="lab_ecd_PnsnAdjsSvcCstMember_label_en-US" xlink:label="lab_ecd_PnsnAdjsSvcCstMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pension Adjustments Service Cost [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PnsnAdjsSvcCstMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PnsnAdjsSvcCstMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PnsnAdjsSvcCstMember" xlink:to="lab_ecd_PnsnAdjsSvcCstMember" xlink:type="arc" order="1"/>
    <link:label id="lab_lfvn_InventoryFinishedGoodsPercentOfTotalInventory_de5d535c-6cbe-482e-9b5d-441ba2b99086_terseLabel_en-US" xlink:label="lab_lfvn_InventoryFinishedGoodsPercentOfTotalInventory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Finished goods</link:label>
    <link:label id="lab_lfvn_InventoryFinishedGoodsPercentOfTotalInventory_label_en-US" xlink:label="lab_lfvn_InventoryFinishedGoodsPercentOfTotalInventory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Inventory, Finished Goods, Percent Of Total Inventory</link:label>
    <link:label id="lab_lfvn_InventoryFinishedGoodsPercentOfTotalInventory_documentation_en-US" xlink:label="lab_lfvn_InventoryFinishedGoodsPercentOfTotalInventory" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Inventory, Finished Goods, Percent Of Total Inventory</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_InventoryFinishedGoodsPercentOfTotalInventory" xlink:href="lfvn-20250630.xsd#lfvn_InventoryFinishedGoodsPercentOfTotalInventory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfvn_InventoryFinishedGoodsPercentOfTotalInventory" xlink:to="lab_lfvn_InventoryFinishedGoodsPercentOfTotalInventory" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductsAndServicesDomain_fa9f1b09-863a-4a11-a41e-df35ac32ec42_terseLabel_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:label id="lab_srt_ProductsAndServicesDomain_label_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ProductsAndServicesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductsAndServicesDomain" xlink:to="lab_srt_ProductsAndServicesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentGross_cc33a8e3-efd9-4b2f-9424-7d3c565dda06_verboseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Property and equipment, gross</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentGross_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentGross" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_RestatementDoesNotRequireRecoveryTextBlock_terseLabel_en-US" xlink:label="lab_ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restatement does not require Recovery</link:label>
    <link:label id="lab_ecd_RestatementDoesNotRequireRecoveryTextBlock_label_en-US" xlink:label="lab_ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restatement Does Not Require Recovery [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_RestatementDoesNotRequireRecoveryTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:to="lab_ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_1d5f6863-d1ee-4fbd-ac0f-b1e24b531bc0_terseLabel_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_lfvn_MoneyBackGuaranteePeriod_88d78ae1-d71d-4712-af63-fbc5054d158c_terseLabel_en-US" xlink:label="lab_lfvn_MoneyBackGuaranteePeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Money back guarantee period</link:label>
    <link:label id="lab_lfvn_MoneyBackGuaranteePeriod_label_en-US" xlink:label="lab_lfvn_MoneyBackGuaranteePeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Money Back Guarantee Period</link:label>
    <link:label id="lab_lfvn_MoneyBackGuaranteePeriod_documentation_en-US" xlink:label="lab_lfvn_MoneyBackGuaranteePeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Money Back Guarantee Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_MoneyBackGuaranteePeriod" xlink:href="lfvn-20250630.xsd#lfvn_MoneyBackGuaranteePeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfvn_MoneyBackGuaranteePeriod" xlink:to="lab_lfvn_MoneyBackGuaranteePeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherIncomeAndExpensesAbstract_44602549-8a92-4e3d-8bcf-4b517722e4ae_terseLabel_en-US" xlink:label="lab_us-gaap_OtherIncomeAndExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other Income and Expenses [Abstract]</link:label>
    <link:label id="lab_us-gaap_OtherIncomeAndExpensesAbstract_label_en-US" xlink:label="lab_us-gaap_OtherIncomeAndExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Income and Expenses [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIncomeAndExpensesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherIncomeAndExpensesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherIncomeAndExpensesAbstract" xlink:to="lab_us-gaap_OtherIncomeAndExpensesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_3095fd6b-87ac-4925-b689-b5807b30a9e8_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-cash operating lease expense</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Lease, Right-of-Use Asset, Periodic Reduction</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock_terseLabel_en-US" xlink:label="lab_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Compensation Actually Paid vs. Company Selected Measure</link:label>
    <link:label id="lab_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock_label_en-US" xlink:label="lab_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Compensation Actually Paid vs. Company Selected Measure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:to="lab_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MovementInValuationAllowancesAndReservesRollForward_1d876391-7a1e-434c-a6d5-2455fb925e0c_terseLabel_en-US" xlink:label="lab_us-gaap_MovementInValuationAllowancesAndReservesRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_MovementInValuationAllowancesAndReservesRollForward_label_en-US" xlink:label="lab_us-gaap_MovementInValuationAllowancesAndReservesRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MovementInValuationAllowancesAndReservesRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward" xlink:to="lab_us-gaap_MovementInValuationAllowancesAndReservesRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_ebeff3e9-b7ff-4f99-9a85-542823738acb_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardTmgHowMnpiCnsdrdTextBlock_terseLabel_en-US" xlink:label="lab_ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Award Timing, How MNPI Considered</link:label>
    <link:label id="lab_ecd_AwardTmgHowMnpiCnsdrdTextBlock_label_en-US" xlink:label="lab_ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Timing, How MNPI Considered [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardTmgHowMnpiCnsdrdTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:to="lab_ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AllTradingArrangementsMember_terseLabel_en-US" xlink:label="lab_ecd_AllTradingArrangementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">All Trading Arrangements</link:label>
    <link:label id="lab_ecd_AllTradingArrangementsMember_label_en-US" xlink:label="lab_ecd_AllTradingArrangementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">All Trading Arrangements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllTradingArrangementsMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AllTradingArrangementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AllTradingArrangementsMember" xlink:to="lab_ecd_AllTradingArrangementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_EqtyAwrdsAdjFnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_EqtyAwrdsAdjFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity Awards Adjustments, Footnote</link:label>
    <link:label id="lab_ecd_EqtyAwrdsAdjFnTextBlock_label_en-US" xlink:label="lab_ecd_EqtyAwrdsAdjFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Awards Adjustments, Footnote [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_EqtyAwrdsAdjFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_EqtyAwrdsAdjFnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_EqtyAwrdsAdjFnTextBlock" xlink:to="lab_ecd_EqtyAwrdsAdjFnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TotalShareholderRtnVsPeerGroupTextBlock_terseLabel_en-US" xlink:label="lab_ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total Shareholder Return Vs Peer Group</link:label>
    <link:label id="lab_ecd_TotalShareholderRtnVsPeerGroupTextBlock_label_en-US" xlink:label="lab_ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Total Shareholder Return Vs Peer Group [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TotalShareholderRtnVsPeerGroupTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:to="lab_ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_f4bbf10c-cf89-42b2-bd93-cc1e2d29150c_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other accrued expenses</link:label>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_fea2bb31-e453-4776-95cc-3ab48bc3b3c5_totalLabel_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total other accrued expenses</link:label>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_lfvn_TwoThousandSeventeenLongTermIncentivePlanMember_60fecf98-cf4e-45f6-b31c-f3b6df4a42e6_terseLabel_en-US" xlink:label="lab_lfvn_TwoThousandSeventeenLongTermIncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2017 Long-Term Incentive Plan</link:label>
    <link:label id="lab_lfvn_TwoThousandSeventeenLongTermIncentivePlanMember_label_en-US" xlink:label="lab_lfvn_TwoThousandSeventeenLongTermIncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Two Thousand Seventeen Long Term Incentive Plan [Member]</link:label>
    <link:label id="lab_lfvn_TwoThousandSeventeenLongTermIncentivePlanMember_documentation_en-US" xlink:label="lab_lfvn_TwoThousandSeventeenLongTermIncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Two Thousand Seventeen Long Term Incentive Plan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_TwoThousandSeventeenLongTermIncentivePlanMember" xlink:href="lfvn-20250630.xsd#lfvn_TwoThousandSeventeenLongTermIncentivePlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfvn_TwoThousandSeventeenLongTermIncentivePlanMember" xlink:to="lab_lfvn_TwoThousandSeventeenLongTermIncentivePlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesAbstract_3b83c14f-f589-4421-ada2-fce6273656ec_verboseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Deferred tax liabilities:</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesAbstract_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Liabilities, Gross [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxLiabilitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesAbstract" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_lfvn_OtherMiscellaneousIncomeExpensesNet_fe2fd5b5-0018-4d29-90b3-f0316daa8d3e_terseLabel_en-US" xlink:label="lab_lfvn_OtherMiscellaneousIncomeExpensesNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other income (expense), net</link:label>
    <link:label id="lab_lfvn_OtherMiscellaneousIncomeExpensesNet_label_en-US" xlink:label="lab_lfvn_OtherMiscellaneousIncomeExpensesNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Miscellaneous Income (Expenses), Net</link:label>
    <link:label id="lab_lfvn_OtherMiscellaneousIncomeExpensesNet_documentation_en-US" xlink:label="lab_lfvn_OtherMiscellaneousIncomeExpensesNet" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Other Miscellaneous Income (Expenses), Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_OtherMiscellaneousIncomeExpensesNet" xlink:href="lfvn-20250630.xsd#lfvn_OtherMiscellaneousIncomeExpensesNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfvn_OtherMiscellaneousIncomeExpensesNet" xlink:to="lab_lfvn_OtherMiscellaneousIncomeExpensesNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_caec49e6-f14a-443f-aceb-eceaf5df631f_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Nonvested beginning period (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_087b9148-ea5e-45d8-a804-734d2394bdb4_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Nonvested ending period (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_9929c89e-c49c-4e71-99ec-1aedb67c550b_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_f9c0c064-3a4d-46c6-a36d-fa92300302b5_verboseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Cash Flows from Investing Activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash Provided by (Used in) Investing Activity, Including Discontinued Operation [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncurrentAssets_50dbaaa1-7eb2-455b-b8e3-adf010b9cb45_terseLabel_en-US" xlink:label="lab_us-gaap_NoncurrentAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Long-lived assets</link:label>
    <link:label id="lab_us-gaap_NoncurrentAssets_label_en-US" xlink:label="lab_us-gaap_NoncurrentAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-Lived Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncurrentAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NoncurrentAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncurrentAssets" xlink:to="lab_us-gaap_NoncurrentAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromForeignCurrencyTranslation_22ad2f9d-75d7-49a6-9b04-0e50e7f91420_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromForeignCurrencyTranslation" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Currency adjustment</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromForeignCurrencyTranslation_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromForeignCurrencyTranslation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Unrecognized Tax Benefits, Decrease Resulting from Foreign Currency Translation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromForeignCurrencyTranslation" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromForeignCurrencyTranslation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromForeignCurrencyTranslation" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromForeignCurrencyTranslation" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PvpTable_terseLabel_en-US" xlink:label="lab_ecd_PvpTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pay vs Performance Disclosure</link:label>
    <link:label id="lab_ecd_PvpTable_label_en-US" xlink:label="lab_ecd_PvpTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pay vs Performance Disclosure [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PvpTable" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PvpTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PvpTable" xlink:to="lab_ecd_PvpTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_9de5358b-de44-41b0-88e9-fc81b93fe6ab_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net Cash Provided by Operating Activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash Provided by (Used in) Operating Activity, Including Discontinued Operation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_lfvn_TrueScienceProductLineMember_2cf9e137-a704-4d4a-94f2-a00c86a4d4d7_terseLabel_en-US" xlink:label="lab_lfvn_TrueScienceProductLineMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">TrueScience&#174; product line</link:label>
    <link:label id="lab_lfvn_TrueScienceProductLineMember_label_en-US" xlink:label="lab_lfvn_TrueScienceProductLineMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">TrueScience Product Line [Member]</link:label>
    <link:label id="lab_lfvn_TrueScienceProductLineMember_documentation_en-US" xlink:label="lab_lfvn_TrueScienceProductLineMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">TrueScience Product Line</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_TrueScienceProductLineMember" xlink:href="lfvn-20250630.xsd#lfvn_TrueScienceProductLineMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfvn_TrueScienceProductLineMember" xlink:to="lab_lfvn_TrueScienceProductLineMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesDomain_81d5e0d2-e565-4b2b-8de6-6f765a75d8e4_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves [Domain]</link:label>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesDomain_label_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ValuationAllowancesAndReservesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesDomain" xlink:to="lab_us-gaap_ValuationAllowancesAndReservesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife_d82c1e9e-03de-4c94-9cb0-67025cbd66b0_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Estimated service lives of property and equipment</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment, Useful Life</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_e27d1cb6-8de4-49c5-a9e6-5c51ae708ed2_verboseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Preferred stock, par value (dollars per share)</link:label>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Preferred Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_d6d0f274-5bba-45d4-a728-81c5aae17d44_terseLabel_en-US" xlink:label="lab_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Revenues from External Customers and Long-Lived Assets [Line Items]</link:label>
    <link:label id="lab_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_label_en-US" xlink:label="lab_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revenues from External Customers and Long-Lived Assets [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:to="lab_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseCost_d57dddb4-9c84-42b4-a52f-0cb174811a8a_totalLabel_en-US" xlink:label="lab_us-gaap_LeaseCost" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total lease expense</link:label>
    <link:label id="lab_us-gaap_LeaseCost_label_en-US" xlink:label="lab_us-gaap_LeaseCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lease, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCost" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LeaseCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseCost" xlink:to="lab_us-gaap_LeaseCost" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_EquityValuationAssumptionDifferenceFnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity Valuation Assumption Difference, Footnote</link:label>
    <link:label id="lab_ecd_EquityValuationAssumptionDifferenceFnTextBlock_label_en-US" xlink:label="lab_ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Valuation Assumption Difference, Footnote [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_EquityValuationAssumptionDifferenceFnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:to="lab_ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_lfvn_EffectiveIncomeTaxRateReconciliationTaxReturnToProvisionsTrueUp_a8a25c0b-2a0a-4963-8594-039046ecf4a5_verboseLabel_en-US" xlink:label="lab_lfvn_EffectiveIncomeTaxRateReconciliationTaxReturnToProvisionsTrueUp" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Tax return to provision true-up</link:label>
    <link:label id="lab_lfvn_EffectiveIncomeTaxRateReconciliationTaxReturnToProvisionsTrueUp_label_en-US" xlink:label="lab_lfvn_EffectiveIncomeTaxRateReconciliationTaxReturnToProvisionsTrueUp" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation Tax Return To Provisions True Up</link:label>
    <link:label id="lab_lfvn_EffectiveIncomeTaxRateReconciliationTaxReturnToProvisionsTrueUp_documentation_en-US" xlink:label="lab_lfvn_EffectiveIncomeTaxRateReconciliationTaxReturnToProvisionsTrueUp" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Effective income tax rate reconciliation tax return to provisions true up.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_EffectiveIncomeTaxRateReconciliationTaxReturnToProvisionsTrueUp" xlink:href="lfvn-20250630.xsd#lfvn_EffectiveIncomeTaxRateReconciliationTaxReturnToProvisionsTrueUp"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfvn_EffectiveIncomeTaxRateReconciliationTaxReturnToProvisionsTrueUp" xlink:to="lab_lfvn_EffectiveIncomeTaxRateReconciliationTaxReturnToProvisionsTrueUp" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseCostTableTextBlock_494a4c5d-7e39-4082-968a-df9fd54c26a9_terseLabel_en-US" xlink:label="lab_us-gaap_LeaseCostTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Lease, Cost</link:label>
    <link:label id="lab_us-gaap_LeaseCostTableTextBlock_label_en-US" xlink:label="lab_us-gaap_LeaseCostTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lease, Cost [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCostTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LeaseCostTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseCostTableTextBlock" xlink:to="lab_us-gaap_LeaseCostTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PeoTotalCompAmt_terseLabel_en-US" xlink:label="lab_ecd_PeoTotalCompAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">PEO Total Compensation Amount</link:label>
    <link:label id="lab_ecd_PeoTotalCompAmt_label_en-US" xlink:label="lab_ecd_PeoTotalCompAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">PEO Total Compensation Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoTotalCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PeoTotalCompAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PeoTotalCompAmt" xlink:to="lab_ecd_PeoTotalCompAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_6bf1f182-516d-4ec8-b4b4-083d7687c570_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-Term Debt, Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeAxis" xlink:to="lab_us-gaap_LongtermDebtTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Depreciation_ed11847d-7570-4333-b08d-2197da081e4c_verboseLabel_en-US" xlink:label="lab_us-gaap_Depreciation" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Depreciation expense</link:label>
    <link:label id="lab_us-gaap_Depreciation_label_en-US" xlink:label="lab_us-gaap_Depreciation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Depreciation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Depreciation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Depreciation" xlink:to="lab_us-gaap_Depreciation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract_371092c7-d818-4349-9fa6-1bad9aabce21_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted-average shares outstanding:</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_1055f49e-0aec-49c4-ad29-41996f6e666e_verboseLabel_en-US" xlink:label="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Federal</link:label>
    <link:label id="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Federal Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_60c67ddc-248e-461b-9ffb-dba2043e9bc7_terseLabel_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementEquityComponentsAxis" xlink:to="lab_us-gaap_StatementEquityComponentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NonUsMember_0b82b815-90f9-4d25-8d32-48e7a4d6e415_terseLabel_en-US" xlink:label="lab_us-gaap_NonUsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total foreign markets</link:label>
    <link:label id="lab_us-gaap_NonUsMember_label_en-US" xlink:label="lab_us-gaap_NonUsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-US [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonUsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NonUsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonUsMember" xlink:to="lab_us-gaap_NonUsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentLineItems_233d1709-0a9b-497f-bd37-87d7095392c8_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentLineItems_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_b01fc97f-c8e1-4941-8918-ea364ad75c04_terseLabel_en-US" xlink:label="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Unrecognized Tax Benefits [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_label_en-US" xlink:label="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Unrecognized Tax Benefits [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:to="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AuditorName_79f0d4f4-64bb-4e5c-892e-854b9b0915cb_terseLabel_en-US" xlink:label="lab_dei_AuditorName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Auditor Name</link:label>
    <link:label id="lab_dei_AuditorName_label_en-US" xlink:label="lab_dei_AuditorName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Auditor Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorName" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AuditorName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AuditorName" xlink:to="lab_dei_AuditorName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount_de794820-722d-4542-92a7-d98f58d06b3c_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Tax benefit from settlement of stock based awards</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-Based Payment Arrangement, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NonRule10b51ArrAdoptedFlag_terseLabel_en-US" xlink:label="lab_ecd_NonRule10b51ArrAdoptedFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-Rule 10b5-1 Arrangement Adopted</link:label>
    <link:label id="lab_ecd_NonRule10b51ArrAdoptedFlag_label_en-US" xlink:label="lab_ecd_NonRule10b51ArrAdoptedFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-Rule 10b5-1 Arrangement Adopted [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonRule10b51ArrAdoptedFlag" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_NonRule10b51ArrAdoptedFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NonRule10b51ArrAdoptedFlag" xlink:to="lab_ecd_NonRule10b51ArrAdoptedFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskTable_88b31123-7baf-4001-8d75-058986947f57_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Concentration Risk [Table]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskTable_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Concentration Risk [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConcentrationRiskTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskTable" xlink:to="lab_us-gaap_ConcentrationRiskTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquipmentMember_5506390f-62c1-465e-8ece-0b4de3c6c7ff_verboseLabel_en-US" xlink:label="lab_us-gaap_EquipmentMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Equipment (includes computer hardware and software)</link:label>
    <link:label id="lab_us-gaap_EquipmentMember_f34c2cbb-3b17-40fb-bb8d-8e9dc1a9f978_terseLabel_en-US" xlink:label="lab_us-gaap_EquipmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equipment (includes computer hardware and software)</link:label>
    <link:label id="lab_us-gaap_EquipmentMember_label_en-US" xlink:label="lab_us-gaap_EquipmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equipment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquipmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquipmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquipmentMember" xlink:to="lab_us-gaap_EquipmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_f81c8b7a-dfc6-454f-8763-ad3da9b8f8a3_negatedLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Expired or Canceled (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Expirations in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_ba5402b6-a21d-49f2-bb39-5ad7a18e2d50_verboseLabel_en-US" xlink:label="lab_us-gaap_ComponentsOfDeferredTaxAssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Deferred tax assets:</link:label>
    <link:label id="lab_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_label_en-US" xlink:label="lab_us-gaap_ComponentsOfDeferredTaxAssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Components of Deferred Tax Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ComponentsOfDeferredTaxAssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract" xlink:to="lab_us-gaap_ComponentsOfDeferredTaxAssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_0a77620d-dd55-4d0c-b412-f319bd07fd2a_verboseLabel_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION</link:label>
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_label_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Supplemental Cash Flow Information [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems_f1c0d38f-2779-4752-b774-9814e5e133a7_terseLabel_en-US" xlink:label="lab_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Revenue from External Customer [Line Items]</link:label>
    <link:label id="lab_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems_label_en-US" xlink:label="lab_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revenue from External Customer [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems" xlink:to="lab_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_OtherPerfMeasureAmt_terseLabel_en-US" xlink:label="lab_ecd_OtherPerfMeasureAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other Performance Measure, Amount</link:label>
    <link:label id="lab_ecd_OtherPerfMeasureAmt_label_en-US" xlink:label="lab_ecd_OtherPerfMeasureAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Performance Measure, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OtherPerfMeasureAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_OtherPerfMeasureAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_OtherPerfMeasureAmt" xlink:to="lab_ecd_OtherPerfMeasureAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_144a1176-9fa7-487c-aac7-1d0e662686f8_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted Average Exercise&#160;Price</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryLineItems_de54350a-78e2-4e52-b8fd-f328e0d54b59_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Inventory [Line Items]</link:label>
    <link:label id="lab_us-gaap_InventoryLineItems_label_en-US" xlink:label="lab_us-gaap_InventoryLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Inventory [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InventoryLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryLineItems" xlink:to="lab_us-gaap_InventoryLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_e49502af-931d-4094-86db-203f2c256bfd_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_lfvn_StockIssuedDuringPeriodSharesStockOptionsAndWarrantsExercised_831f452b-4a6a-4e78-bb9a-a07aca33e064_terseLabel_en-US" xlink:label="lab_lfvn_StockIssuedDuringPeriodSharesStockOptionsAndWarrantsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common stock issued (in shares)</link:label>
    <link:label id="lab_lfvn_StockIssuedDuringPeriodSharesStockOptionsAndWarrantsExercised_label_en-US" xlink:label="lab_lfvn_StockIssuedDuringPeriodSharesStockOptionsAndWarrantsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Issued During Period Shares Stock Options and Warrants Exercised</link:label>
    <link:label id="lab_lfvn_StockIssuedDuringPeriodSharesStockOptionsAndWarrantsExercised_documentation_en-US" xlink:label="lab_lfvn_StockIssuedDuringPeriodSharesStockOptionsAndWarrantsExercised" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Exercise of options and warrants, shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_StockIssuedDuringPeriodSharesStockOptionsAndWarrantsExercised" xlink:href="lfvn-20250630.xsd#lfvn_StockIssuedDuringPeriodSharesStockOptionsAndWarrantsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfvn_StockIssuedDuringPeriodSharesStockOptionsAndWarrantsExercised" xlink:to="lab_lfvn_StockIssuedDuringPeriodSharesStockOptionsAndWarrantsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_afd97934-cf23-40d1-978f-fc9f5faa7a0d_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="lab_us-gaap_LiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxSettlementsForeign_7b16a253-c62e-41b9-a29a-a6f468bc36a0_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxSettlementsForeign" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">&#8212; accrual for foreign tax audits</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxSettlementsForeign_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxSettlementsForeign" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Tax Settlement, Foreign, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxSettlementsForeign" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTaxSettlementsForeign"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxSettlementsForeign" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxSettlementsForeign" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_IndividualAxis_terseLabel_en-US" xlink:label="lab_ecd_IndividualAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Individual:</link:label>
    <link:label id="lab_ecd_IndividualAxis_label_en-US" xlink:label="lab_ecd_IndividualAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Individual [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_IndividualAxis" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_IndividualAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_IndividualAxis" xlink:to="lab_ecd_IndividualAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VestingAxis_6326784e-e1e1-49d0-aa90-1a1ebd263de5_terseLabel_en-US" xlink:label="lab_us-gaap_VestingAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Vesting [Axis]</link:label>
    <link:label id="lab_us-gaap_VestingAxis_label_en-US" xlink:label="lab_us-gaap_VestingAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Vesting [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_VestingAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VestingAxis" xlink:to="lab_us-gaap_VestingAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueOfFinancialInstrumentsPolicy_22d0bf7e-2c19-4eca-8ecc-24b24e901085_verboseLabel_en-US" xlink:label="lab_us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Fair Value of Financial Instruments</link:label>
    <link:label id="lab_us-gaap_FairValueOfFinancialInstrumentsPolicy_label_en-US" xlink:label="lab_us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value of Financial Instruments, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:to="lab_us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityDomain_f22dbfb4-a8df-49d2-9a9c-396044afce8a_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income Tax Authority [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityDomain_label_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Tax Jurisdiction [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain" xlink:to="lab_us-gaap_IncomeTaxAuthorityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerProductAndServiceExtensibleList_9a40fc7f-af5e-45d3-98e3-5c51a5027778_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerProductAndServiceExtensibleList" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Revenue from Contract with Customer, Product and Service [Extensible Enumeration]</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerProductAndServiceExtensibleList_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerProductAndServiceExtensibleList" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revenue from Contract with Customer, Product and Service [Extensible Enumeration]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerProductAndServiceExtensibleList" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RevenueFromContractWithCustomerProductAndServiceExtensibleList"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerProductAndServiceExtensibleList" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerProductAndServiceExtensibleList" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentAnnualReport_5cfb74b9-edcf-4ebe-884d-0b2d55968995_terseLabel_en-US" xlink:label="lab_dei_DocumentAnnualReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Annual Report</link:label>
    <link:label id="lab_dei_DocumentAnnualReport_label_en-US" xlink:label="lab_dei_DocumentAnnualReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Annual Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentAnnualReport" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentAnnualReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentAnnualReport" xlink:to="lab_dei_DocumentAnnualReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalCommonStock_cbc52578-4e81-420b-b434-67cc20c65dcc_verboseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Additional paid-in capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalCommonStock_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Additional Paid in Capital, Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:to="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedMarketingCostsCurrent_87335fcb-35b0-4155-806b-04b671fc6ace_verboseLabel_en-US" xlink:label="lab_us-gaap_AccruedMarketingCostsCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Accrued incentives and promotions to consultants</link:label>
    <link:label id="lab_us-gaap_AccruedMarketingCostsCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedMarketingCostsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accrued Marketing Costs, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedMarketingCostsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccruedMarketingCostsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedMarketingCostsCurrent" xlink:to="lab_us-gaap_AccruedMarketingCostsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_8b54e1fc-b4b9-4e40-9480-896092c09cc7_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net Cash Used in Investing Activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash Provided by (Used in) Investing Activity, Including Discontinued Operation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember_terseLabel_en-US" xlink:label="lab_ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table</link:label>
    <link:label id="lab_ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember_label_en-US" xlink:label="lab_ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember" xlink:to="lab_ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestPaidNet_f53d5916-63e6-4776-a052-9c8cbc9b0ba1_terseLabel_en-US" xlink:label="lab_us-gaap_InterestPaidNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash paid for interest</link:label>
    <link:label id="lab_us-gaap_InterestPaidNet_label_en-US" xlink:label="lab_us-gaap_InterestPaidNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Interest Paid, Excluding Capitalized Interest, Operating Activity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InterestPaidNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestPaidNet" xlink:to="lab_us-gaap_InterestPaidNet" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalYearFocus_e952cf20-4994-447e-b04d-a5f09881e355_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalYearFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalYearFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalYearFocus" xlink:to="lab_dei_DocumentFiscalYearFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_lfvn_ReturnLiabilityReserve_24767e3d-7587-4a3c-8ee7-a92f0e32221d_terseLabel_en-US" xlink:label="lab_lfvn_ReturnLiabilityReserve" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Return liability reserve</link:label>
    <link:label id="lab_lfvn_ReturnLiabilityReserve_label_en-US" xlink:label="lab_lfvn_ReturnLiabilityReserve" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Return Liability Reserve</link:label>
    <link:label id="lab_lfvn_ReturnLiabilityReserve_documentation_en-US" xlink:label="lab_lfvn_ReturnLiabilityReserve" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Return Liability Reserve</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_ReturnLiabilityReserve" xlink:href="lfvn-20250630.xsd#lfvn_ReturnLiabilityReserve"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfvn_ReturnLiabilityReserve" xlink:to="lab_lfvn_ReturnLiabilityReserve" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_4d136830-e0d6-48b7-859e-735b3148222e_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Right-of-use assets</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Lease, Right-of-Use Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock_terseLabel_en-US" xlink:label="lab_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Forgone Recovery, Explanation of Impracticability</link:label>
    <link:label id="lab_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock_label_en-US" xlink:label="lab_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Forgone Recovery, Explanation of Impracticability [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:to="lab_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment_2dd4fd9b-2f9c-43c2-9c72-2cb4a6a9d475_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Section 174 costs</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Asset, In-Process Research and Development</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment" xlink:to="lab_us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_3d5cc614-60dc-44dc-8107-9a5a40d680bb_totalLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net income tax provision</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_4d9696d0-bed6-42bd-baf1-b829697e00e4_terseLabel_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_label_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInteractiveDataCurrent" xlink:to="lab_dei_EntityInteractiveDataCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseCost_3a073cb1-e49f-4670-ba36-ddc7355abb25_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating lease cost</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseCost_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Lease, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseCost" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseCost" xlink:to="lab_us-gaap_OperatingLeaseCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_01460809-a771-4de6-92f1-447aa7d34fd7_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Gross decreases - tax positions in prior year</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanNameDomain_7c0391ec-8940-4602-8ad5-9860a0661042_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Plan Name [Domain]</link:label>
    <link:label id="lab_us-gaap_PlanNameDomain_label_en-US" xlink:label="lab_us-gaap_PlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Plan Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameDomain" xlink:to="lab_us-gaap_PlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_lfvn_ConsultantIncentivesPromotionsAndRecognitionExpense_de15b832-ddfa-48da-87b6-7220b04e2188_negatedTerseLabel_en-US" xlink:label="lab_lfvn_ConsultantIncentivesPromotionsAndRecognitionExpense" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Consultant incentives, promotions, and recognition</link:label>
    <link:label id="lab_lfvn_ConsultantIncentivesPromotionsAndRecognitionExpense_label_en-US" xlink:label="lab_lfvn_ConsultantIncentivesPromotionsAndRecognitionExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Consultant Incentives, Promotions And Recognition Expense</link:label>
    <link:label id="lab_lfvn_ConsultantIncentivesPromotionsAndRecognitionExpense_documentation_en-US" xlink:label="lab_lfvn_ConsultantIncentivesPromotionsAndRecognitionExpense" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Consultant Incentives, Promotions And Recognition Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_ConsultantIncentivesPromotionsAndRecognitionExpense" xlink:href="lfvn-20250630.xsd#lfvn_ConsultantIncentivesPromotionsAndRecognitionExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfvn_ConsultantIncentivesPromotionsAndRecognitionExpense" xlink:to="lab_lfvn_ConsultantIncentivesPromotionsAndRecognitionExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_bfcddcb5-a897-4229-92dd-c59bcfc64b53_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Period for recognition of unrecognized compensation cost</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_29a01803-b8d9-4fc2-9a2b-f55a4c7266e3_negatedLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Exercised (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsValuationAllowance_a1f4bc8c-5960-42ab-83b8-ccee90f49873_negatedLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Less: valuation allowance</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsValuationAllowance_cba4b76a-4175-4ecb-a035-29115cf2770e_periodStartLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsValuationAllowance_1a630eda-ba3a-4d47-bcc4-d0829add59eb_periodEndLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsValuationAllowance_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Assets, Valuation Allowance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:to="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityAbstract_0fd2c082-cc19-45cc-a718-a2f96f698cd3_terseLabel_en-US" xlink:label="lab_us-gaap_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_EquityAbstract_label_en-US" xlink:label="lab_us-gaap_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityAbstract" xlink:to="lab_us-gaap_EquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_b2d34620-0e8e-4a90-9d4a-f75aacb289dc_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Shipping and Handling, Revenue And Deferred Revenue</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revenue from Contract with Customer [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_d02100b4-2ab5-46b8-92e5-62b315bdefa9_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Exercisable</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_6eca09e1-d1e5-49fa-9f9b-35f433a58753_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Segment Information</link:label>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Segment Reporting Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:to="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_79a3f719-c021-4770-a121-936ea0b4ad4f_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Definite-lived intangible assets weighted-average amortization period</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Assets, Remaining Amortization Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTable_b90dbb50-89de-489f-a700-0dea915eb194_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disaggregation of Revenue [Table]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTable_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disaggregation of Revenue [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable" xlink:to="lab_us-gaap_DisaggregationOfRevenueTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_980fbd42-a2c8-439f-96e7-adbdb56eda66_verboseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Federal, state, and foreign net operating loss carryovers</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Assets, Operating Loss Carryforwards</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:to="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TrademarksMember_9fd264a2-ee56-4b3a-bda4-72245b4f8bee_terseLabel_en-US" xlink:label="lab_us-gaap_TrademarksMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Trademarks</link:label>
    <link:label id="lab_us-gaap_TrademarksMember_label_en-US" xlink:label="lab_us-gaap_TrademarksMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trademarks [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TrademarksMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TrademarksMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TrademarksMember" xlink:to="lab_us-gaap_TrademarksMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentFederalTaxExpenseBenefit_a25db29d-2a33-4b3e-b404-32de55538537_verboseLabel_en-US" xlink:label="lab_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Federal</link:label>
    <link:label id="lab_us-gaap_CurrentFederalTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Current Federal Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CurrentFederalTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:to="lab_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_cac36b6a-a976-4845-93ee-fd3eaa6f73cf_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment by Type [Axis]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-Lived Tangible Asset [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_911e76f8-83ac-4b2d-a378-c09453d23d1b_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems_08e35c8c-323d-4790-bfed-6188c61986a4_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Assets [Line Items]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Assets [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Compensation Actually Paid vs. Total Shareholder Return</link:label>
    <link:label id="lab_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock_label_en-US" xlink:label="lab_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Compensation Actually Paid vs. Total Shareholder Return [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:to="lab_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_11505a3e-d93e-486c-a84e-4a87b7848ffa_terseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Amortization of intangible assets</link:label>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_label_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Amortization of Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:to="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeLeasesPolicyTextBlock_45d4cc1f-6fef-4fc7-a723-b8ff9ddeac70_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeLeasesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Leases</link:label>
    <link:label id="lab_us-gaap_LesseeLeasesPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeLeasesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Leases [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeasesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeLeasesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeasesPolicyTextBlock" xlink:to="lab_us-gaap_LesseeLeasesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_3f344e86-0725-44d3-a943-9b34391b4422_terseLabel_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Selling, general and administrative</link:label>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_label_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Selling, General and Administrative Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:to="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesBalance_bdc07e08-e469-4444-8be0-d6e9c8bb6faf_periodStartLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesBalance" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesBalance_871da148-d9be-45d8-b449-ba9a16a33c26_periodEndLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesBalance" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesBalance_label_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesBalance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesBalance" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ValuationAllowancesAndReservesBalance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesBalance" xlink:to="lab_us-gaap_ValuationAllowancesAndReservesBalance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxAssetsNet_c6b6d99f-bd1d-4735-bc00-053af19f2a95_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Deferred income tax asset</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxAssetsNet_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Income Tax Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxAssetsNet" xlink:to="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchasedDuringPeriodValue_11474a14-a4e8-46b9-9509-c576ec48fc99_negatedLabel_en-US" xlink:label="lab_us-gaap_StockRepurchasedDuringPeriodValue" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Repurchase of company stock</link:label>
    <link:label id="lab_us-gaap_StockRepurchasedDuringPeriodValue_label_en-US" xlink:label="lab_us-gaap_StockRepurchasedDuringPeriodValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Repurchased During Period, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodValue" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockRepurchasedDuringPeriodValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchasedDuringPeriodValue" xlink:to="lab_us-gaap_StockRepurchasedDuringPeriodValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_4cfe9829-9de0-4943-a562-05b222f3a150_verboseLabel_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_76126219-ccf2-4600-93bf-3caf20d3b8cd_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_label_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Depreciation, Depletion and Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:to="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInIncomeTaxesReceivable_d1de2914-e09a-4284-9fc6-38ccac1614f7_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInIncomeTaxesReceivable" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Income tax receivable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInIncomeTaxesReceivable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInIncomeTaxesReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Income Taxes Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInIncomeTaxesReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInIncomeTaxesReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInIncomeTaxesReceivable" xlink:to="lab_us-gaap_IncreaseDecreaseInIncomeTaxesReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_lfvn_ConsultantCommissions_e57e7d10-56c5-4609-b644-12e056be77ee_negatedTerseLabel_en-US" xlink:label="lab_lfvn_ConsultantCommissions" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Consultant commissions</link:label>
    <link:label id="lab_lfvn_ConsultantCommissions_label_en-US" xlink:label="lab_lfvn_ConsultantCommissions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Consultant Commissions</link:label>
    <link:label id="lab_lfvn_ConsultantCommissions_documentation_en-US" xlink:label="lab_lfvn_ConsultantCommissions" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Consultant Commissions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_ConsultantCommissions" xlink:href="lfvn-20250630.xsd#lfvn_ConsultantCommissions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfvn_ConsultantCommissions" xlink:to="lab_lfvn_ConsultantCommissions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_b8f9098e-e228-4f66-8225-cef8dec06d44_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other long-term assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Assets, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsNoncurrent" xlink:to="lab_us-gaap_OtherAssetsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_09111192-4b73-44b8-94ef-63ed408dc647_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryValuationReserveMember_e9d7952d-4239-4236-8634-7e48ddeef79a_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryValuationReserveMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">SEC Schedule, 12-09, Reserve, Inventory</link:label>
    <link:label id="lab_us-gaap_InventoryValuationReserveMember_label_en-US" xlink:label="lab_us-gaap_InventoryValuationReserveMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">SEC Schedule, 12-09, Reserve, Inventory [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryValuationReserveMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InventoryValuationReserveMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryValuationReserveMember" xlink:to="lab_us-gaap_InventoryValuationReserveMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PeoName_terseLabel_en-US" xlink:label="lab_ecd_PeoName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">PEO Name</link:label>
    <link:label id="lab_ecd_PeoName_label_en-US" xlink:label="lab_ecd_PeoName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">PEO Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoName" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PeoName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PeoName" xlink:to="lab_ecd_PeoName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommissionsExpensePolicyPolicyTextBlock_1bc6272a-9596-46e3-b85b-7472ff033204_terseLabel_en-US" xlink:label="lab_us-gaap_CommissionsExpensePolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Commissions and Incentives</link:label>
    <link:label id="lab_us-gaap_CommissionsExpensePolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_CommissionsExpensePolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Commissions Expense, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommissionsExpensePolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommissionsExpensePolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommissionsExpensePolicyPolicyTextBlock" xlink:to="lab_us-gaap_CommissionsExpensePolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_d6542a13-543c-4aa9-8807-844741fbff80_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Revenues from External Customers and Long-Lived Assets [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Revenues from External Customers and Long-Lived Assets [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:to="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_lfvn_TwoThousandAndTenAndTwoThousandSeventeenLongTermIncentivePlanMember_9f739cb7-0c03-471f-85af-1cff07d04044_terseLabel_en-US" xlink:label="lab_lfvn_TwoThousandAndTenAndTwoThousandSeventeenLongTermIncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2010 and 2017 Long Term Incentive Plan</link:label>
    <link:label id="lab_lfvn_TwoThousandAndTenAndTwoThousandSeventeenLongTermIncentivePlanMember_label_en-US" xlink:label="lab_lfvn_TwoThousandAndTenAndTwoThousandSeventeenLongTermIncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Two Thousand And Ten and Two Thousand Seventeen Long Term Incentive Plan [Member]</link:label>
    <link:label id="lab_lfvn_TwoThousandAndTenAndTwoThousandSeventeenLongTermIncentivePlanMember_documentation_en-US" xlink:label="lab_lfvn_TwoThousandAndTenAndTwoThousandSeventeenLongTermIncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Two Thousand And Ten and Two Thousand Seventeen Long Term Incentive Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_TwoThousandAndTenAndTwoThousandSeventeenLongTermIncentivePlanMember" xlink:href="lfvn-20250630.xsd#lfvn_TwoThousandAndTenAndTwoThousandSeventeenLongTermIncentivePlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfvn_TwoThousandAndTenAndTwoThousandSeventeenLongTermIncentivePlanMember" xlink:to="lab_lfvn_TwoThousandAndTenAndTwoThousandSeventeenLongTermIncentivePlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember_terseLabel_en-US" xlink:label="lab_ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year</link:label>
    <link:label id="lab_ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember_label_en-US" xlink:label="lab_ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember" xlink:to="lab_ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryFinishedGoods_248b54eb-de00-4639-af7f-36d299a90bc8_verboseLabel_en-US" xlink:label="lab_us-gaap_InventoryFinishedGoods" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Finished goods</link:label>
    <link:label id="lab_us-gaap_InventoryFinishedGoods_label_en-US" xlink:label="lab_us-gaap_InventoryFinishedGoods" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Inventory, Finished Goods, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoods" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InventoryFinishedGoods"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryFinishedGoods" xlink:to="lab_us-gaap_InventoryFinishedGoods" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_OutstandingAggtErrCompAmt_terseLabel_en-US" xlink:label="lab_ecd_OutstandingAggtErrCompAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Outstanding Aggregate Erroneous Compensation Amount</link:label>
    <link:label id="lab_ecd_OutstandingAggtErrCompAmt_label_en-US" xlink:label="lab_ecd_OutstandingAggtErrCompAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Outstanding Aggregate Erroneous Compensation Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OutstandingAggtErrCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_OutstandingAggtErrCompAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_OutstandingAggtErrCompAmt" xlink:to="lab_ecd_OutstandingAggtErrCompAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevolvingCreditFacilityMember_8b51d19d-d489-44c3-a60a-c325b04c6b13_terseLabel_en-US" xlink:label="lab_us-gaap_RevolvingCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Revolving Credit Facility</link:label>
    <link:label id="lab_us-gaap_RevolvingCreditFacilityMember_label_en-US" xlink:label="lab_us-gaap_RevolvingCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revolving Credit Facility [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevolvingCreditFacilityMember" xlink:to="lab_us-gaap_RevolvingCreditFacilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TrdArrDuration_terseLabel_en-US" xlink:label="lab_ecd_TrdArrDuration" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Arrangement Duration</link:label>
    <link:label id="lab_ecd_TrdArrDuration_label_en-US" xlink:label="lab_ecd_TrdArrDuration" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Arrangement Duration</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrDuration" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TrdArrDuration"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TrdArrDuration" xlink:to="lab_ecd_TrdArrDuration" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_accc663c-7c4a-42c2-8dc1-6c80466a257c_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationAwardTrancheOneMember_461d91ed-3730-4630-866b-a8d9c07c0212_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationAwardTrancheOneMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Vesting on January 1, 2019</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationAwardTrancheOneMember_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationAwardTrancheOneMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Tranche One [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationAwardTrancheOneMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationAwardTrancheOneMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationAwardTrancheOneMember" xlink:to="lab_us-gaap_ShareBasedCompensationAwardTrancheOneMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityCurrent_a7e049d3-125b-4ac7-94d6-20ff6094eb07_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Deferred revenue</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Contract with Customer, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:to="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_ddf18049-a638-4acd-9032-14bcc0b3aef8_terseLabel_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Segments [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Segments [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:to="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_32948c10-9b50-4840-a46a-991058f28c7b_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Exercise price of rights (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_label_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Class of Warrant or Right, Exercise Price of Warrants or Rights</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:to="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:type="arc" order="1"/>
    <link:label id="lab_lfvn_InventoryPercentOfTotalInventory_ee8a284c-840c-4c2c-a416-03f86fc4651b_totalLabel_en-US" xlink:label="lab_lfvn_InventoryPercentOfTotalInventory" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total inventory</link:label>
    <link:label id="lab_lfvn_InventoryPercentOfTotalInventory_label_en-US" xlink:label="lab_lfvn_InventoryPercentOfTotalInventory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Inventory, Percent Of Total Inventory</link:label>
    <link:label id="lab_lfvn_InventoryPercentOfTotalInventory_documentation_en-US" xlink:label="lab_lfvn_InventoryPercentOfTotalInventory" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Inventory, Percent Of Total Inventory</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_InventoryPercentOfTotalInventory" xlink:href="lfvn-20250630.xsd#lfvn_InventoryPercentOfTotalInventory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfvn_InventoryPercentOfTotalInventory" xlink:to="lab_lfvn_InventoryPercentOfTotalInventory" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardExrcPrice_terseLabel_en-US" xlink:label="lab_ecd_AwardExrcPrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Exercise Price</link:label>
    <link:label id="lab_ecd_AwardExrcPrice_label_en-US" xlink:label="lab_ecd_AwardExrcPrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardExrcPrice" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardExrcPrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardExrcPrice" xlink:to="lab_ecd_AwardExrcPrice" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFilerCategory_c91d7949-4634-450b-9ca1-bedaaf72a72b_terseLabel_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Filer Category</link:label>
    <link:label id="lab_dei_EntityFilerCategory_label_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Filer Category</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFilerCategory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFilerCategory" xlink:to="lab_dei_EntityFilerCategory" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_bb06cd96-eecf-4c6c-b810-24a23290230c_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_Additional402vDisclosureTextBlock_terseLabel_en-US" xlink:label="lab_ecd_Additional402vDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Additional 402(v) Disclosure</link:label>
    <link:label id="lab_ecd_Additional402vDisclosureTextBlock_label_en-US" xlink:label="lab_ecd_Additional402vDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Additional 402(v) Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_Additional402vDisclosureTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_Additional402vDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_Additional402vDisclosureTextBlock" xlink:to="lab_ecd_Additional402vDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_fee52956-5139-402a-a233-2d24f2c727d6_verboseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Federal statutory income tax rate</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryCurrentTable_a6070790-18c6-4f9b-a884-7aea27de2933_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryCurrentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Inventory, Current [Table]</link:label>
    <link:label id="lab_us-gaap_InventoryCurrentTable_label_en-US" xlink:label="lab_us-gaap_InventoryCurrentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Inventory, Current [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryCurrentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InventoryCurrentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryCurrentTable" xlink:to="lab_us-gaap_InventoryCurrentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_dcba9443-f1ba-4a2c-84b9-628b33a8b870_terseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share-Based Compensation</link:label>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsAbstract_04d4cee1-1089-47a3-aeaf-c8f2e24f0284_verboseLabel_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">ASSETS</link:label>
    <link:label id="lab_us-gaap_AssetsAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="lab_us-gaap_AssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityAxis_b4976f1e-ebae-4e8d-9d5f-5ae482fedf6a_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityAxis_label_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CreditFacilityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityAxis" xlink:to="lab_us-gaap_CreditFacilityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_UndrlygSecurityMktPriceChngPct_terseLabel_en-US" xlink:label="lab_ecd_UndrlygSecurityMktPriceChngPct" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Underlying Security Market Price Change</link:label>
    <link:label id="lab_ecd_UndrlygSecurityMktPriceChngPct_label_en-US" xlink:label="lab_ecd_UndrlygSecurityMktPriceChngPct" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Underlying Security Market Price Change, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_UndrlygSecurityMktPriceChngPct" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_UndrlygSecurityMktPriceChngPct"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_UndrlygSecurityMktPriceChngPct" xlink:to="lab_ecd_UndrlygSecurityMktPriceChngPct" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VestingDomain_c536f38a-fb1e-48e7-a6e2-e242c5509cb0_terseLabel_en-US" xlink:label="lab_us-gaap_VestingDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Vesting [Domain]</link:label>
    <link:label id="lab_us-gaap_VestingDomain_label_en-US" xlink:label="lab_us-gaap_VestingDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Vesting [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_VestingDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VestingDomain" xlink:to="lab_us-gaap_VestingDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_26b418c7-e610-46ec-9e9a-f07c92f0ebba_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentAxis" xlink:to="lab_us-gaap_DebtInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_d683ec05-e06c-4cc0-aac1-75ce0a8ba64d_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Forfeited (dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityDomain_caeceb12-f50f-4fa4-8219-3e4995e1cc5e_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityDomain_label_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CreditFacilityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityDomain" xlink:to="lab_us-gaap_CreditFacilityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_3a400377-3689-4841-bdc6-07de3d11ea80_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Patent costs</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Assets, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_2982a445-2e3f-43b5-9101-f89e81a2450a_verboseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Stockholders&#8217; equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity, Attributable to Parent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityAbstract" xlink:to="lab_us-gaap_StockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember_terseLabel_en-US" xlink:label="lab_ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year</link:label>
    <link:label id="lab_ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember_label_en-US" xlink:label="lab_ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember" xlink:to="lab_ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_e96363e5-f03d-49ce-a650-d7e515567b5a_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Vesting right percentage</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Rights, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_acdea08e-8ef2-48ff-bfd6-2e3c4928ff24_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine2_d7e0ba7f-fbe8-4e9b-a9aa-ab71c4705229_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line Two</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine2_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine2" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine2"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine2" xlink:to="lab_dei_EntityAddressAddressLine2" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_99c14abe-4760-4d89-88cd-999170c044a2_verboseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Research and development</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Research and Development Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_e7aaf0f9-4279-402f-9559-0a74f553a54b_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss)</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">AOCI Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseMealsAndEntertainment_a46ff9f4-8a11-45cf-b48a-d8823033c785_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseMealsAndEntertainment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">&#8212; meals and entertainment</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseMealsAndEntertainment_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseMealsAndEntertainment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Nondeductible Expense, Meals and Entertainment, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseMealsAndEntertainment" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseMealsAndEntertainment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseMealsAndEntertainment" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseMealsAndEntertainment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_447174bf-d4ea-48e5-ae41-b6301ddfaa1a_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Shares canceled or surrendered as payment of tax withholding and other (in shares)</link:label>
    <link:label id="lab_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_63912533-35e8-4d6b-b113-5d3150f9d7f0_terseLabel_en-US" xlink:label="lab_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Shares canceled or surrendered as payment of tax withholding and other (in shares)</link:label>
    <link:label id="lab_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Shares Withheld for Tax Withholding Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation" xlink:to="lab_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_a118a01d-9505-411e-9166-56e6e967a4bf_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Long-term lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Lease, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityVoluntaryFilers_db9827fa-8de0-4c78-8b2c-fad609acddd7_terseLabel_en-US" xlink:label="lab_dei_EntityVoluntaryFilers" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Voluntary Filers</link:label>
    <link:label id="lab_dei_EntityVoluntaryFilers_label_en-US" xlink:label="lab_dei_EntityVoluntaryFilers" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Voluntary Filers</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityVoluntaryFilers" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityVoluntaryFilers"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityVoluntaryFilers" xlink:to="lab_dei_EntityVoluntaryFilers" xlink:type="arc" order="1"/>
    <link:label id="lab_lfvn_PermanentDifferencesAbstract_82709437-936e-4bf5-86a4-a3461d6195e1_verboseLabel_en-US" xlink:label="lab_lfvn_PermanentDifferencesAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Permanent differences:</link:label>
    <link:label id="lab_lfvn_PermanentDifferencesAbstract_label_en-US" xlink:label="lab_lfvn_PermanentDifferencesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Permanent Differences [Abstract]</link:label>
    <link:label id="lab_lfvn_PermanentDifferencesAbstract_documentation_en-US" xlink:label="lab_lfvn_PermanentDifferencesAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Permanent differences.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_PermanentDifferencesAbstract" xlink:href="lfvn-20250630.xsd#lfvn_PermanentDifferencesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfvn_PermanentDifferencesAbstract" xlink:to="lab_lfvn_PermanentDifferencesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComponentsOfIncomeTaxExpenseBenefitContinuingOperationsAbstract_243388f8-eacb-4409-b2a4-d7e55d3b8cd0_verboseLabel_en-US" xlink:label="lab_us-gaap_ComponentsOfIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Components of income tax expense (benefit)</link:label>
    <link:label id="lab_us-gaap_ComponentsOfIncomeTaxExpenseBenefitContinuingOperationsAbstract_label_en-US" xlink:label="lab_us-gaap_ComponentsOfIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Components of Income Tax Expense (Benefit), Continuing Operations [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComponentsOfIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ComponentsOfIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComponentsOfIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="lab_us-gaap_ComponentsOfIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardGrantDateFairValue_terseLabel_en-US" xlink:label="lab_ecd_AwardGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value as of Grant Date</link:label>
    <link:label id="lab_ecd_AwardGrantDateFairValue_label_en-US" xlink:label="lab_ecd_AwardGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardGrantDateFairValue" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardGrantDateFairValue" xlink:to="lab_ecd_AwardGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAbstract_bc8d7558-1247-47dc-b7f0-b0848d01637a_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment [Abstract]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAbstract_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_0ba3e541-d00e-4db5-a8a1-e6ad90f295c9_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_64743c1b-34b6-4425-a349-dde775376f85_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Other long-term assets</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Other Noncurrent Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_StkPrcOrTsrEstimationMethodTextBlock_terseLabel_en-US" xlink:label="lab_ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock Price or TSR Estimation Method</link:label>
    <link:label id="lab_ecd_StkPrcOrTsrEstimationMethodTextBlock_label_en-US" xlink:label="lab_ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Price or TSR Estimation Method [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_StkPrcOrTsrEstimationMethodTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:to="lab_ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock_899a2a08-da08-4e57-a842-3b3ef7a7ba29_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Other Expense, Net</link:label>
    <link:label id="lab_us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Other Nonoperating Income (Expense) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLossCarryforwards_f8556ee0-e1c5-4faa-b4e6-835624babbee_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Net operating loss carryforwards</link:label>
    <link:label id="lab_us-gaap_OperatingLossCarryforwards_label_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Loss Carryforwards</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwards" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLossCarryforwards"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLossCarryforwards" xlink:to="lab_us-gaap_OperatingLossCarryforwards" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LaborAndRelatedExpense_988533c7-3213-4307-b17b-6188af1f350d_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_LaborAndRelatedExpense" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Labor and benefits</link:label>
    <link:label id="lab_us-gaap_LaborAndRelatedExpense_label_en-US" xlink:label="lab_us-gaap_LaborAndRelatedExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Labor and Related Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LaborAndRelatedExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LaborAndRelatedExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LaborAndRelatedExpense" xlink:to="lab_us-gaap_LaborAndRelatedExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_lfvn_ClassOfWarrantOrRightPercentOfCommonStockAcquisitionThatMakesRightsExercisablePassiveInvestors_0bbf9d05-8b7e-4836-adda-4082d418df18_terseLabel_en-US" xlink:label="lab_lfvn_ClassOfWarrantOrRightPercentOfCommonStockAcquisitionThatMakesRightsExercisablePassiveInvestors" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Percent of common stock acquisition that makes rights exercisable, passive investors</link:label>
    <link:label id="lab_lfvn_ClassOfWarrantOrRightPercentOfCommonStockAcquisitionThatMakesRightsExercisablePassiveInvestors_label_en-US" xlink:label="lab_lfvn_ClassOfWarrantOrRightPercentOfCommonStockAcquisitionThatMakesRightsExercisablePassiveInvestors" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Class of Warrant or Right, Percent Of Common Stock Acquisition That Makes Rights Exercisable, Passive Investors</link:label>
    <link:label id="lab_lfvn_ClassOfWarrantOrRightPercentOfCommonStockAcquisitionThatMakesRightsExercisablePassiveInvestors_documentation_en-US" xlink:label="lab_lfvn_ClassOfWarrantOrRightPercentOfCommonStockAcquisitionThatMakesRightsExercisablePassiveInvestors" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Class of Warrant or Right, Percent Of Common Stock Acquisition That Makes Rights Exercisable, Passive Investors</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_ClassOfWarrantOrRightPercentOfCommonStockAcquisitionThatMakesRightsExercisablePassiveInvestors" xlink:href="lfvn-20250630.xsd#lfvn_ClassOfWarrantOrRightPercentOfCommonStockAcquisitionThatMakesRightsExercisablePassiveInvestors"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfvn_ClassOfWarrantOrRightPercentOfCommonStockAcquisitionThatMakesRightsExercisablePassiveInvestors" xlink:to="lab_lfvn_ClassOfWarrantOrRightPercentOfCommonStockAcquisitionThatMakesRightsExercisablePassiveInvestors" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_52388230-7d1c-45d9-afe3-0a54f432c731_terseLabel_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock awards and options (in shares)</link:label>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_label_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Incremental Common Shares Attributable to Dilutive Effect of Share-Based Payment Arrangements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:to="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_afebb506-249f-4f1a-bdf7-140b7d79d56c_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Granted (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_7a960ccf-1c9e-486f-af3e-2b00e525a641_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Granted (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_lfvn_DeferredTaxAssetsLeasingArrangements_52e48db8-4791-4bca-804e-bced8c2466b4_terseLabel_en-US" xlink:label="lab_lfvn_DeferredTaxAssetsLeasingArrangements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Lease liability</link:label>
    <link:label id="lab_lfvn_DeferredTaxAssetsLeasingArrangements_label_en-US" xlink:label="lab_lfvn_DeferredTaxAssetsLeasingArrangements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Assets, Leasing Arrangements</link:label>
    <link:label id="lab_lfvn_DeferredTaxAssetsLeasingArrangements_documentation_en-US" xlink:label="lab_lfvn_DeferredTaxAssetsLeasingArrangements" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Deferred Tax Assets, Leasing Arrangements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_DeferredTaxAssetsLeasingArrangements" xlink:href="lfvn-20250630.xsd#lfvn_DeferredTaxAssetsLeasingArrangements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfvn_DeferredTaxAssetsLeasingArrangements" xlink:to="lab_lfvn_DeferredTaxAssetsLeasingArrangements" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_dea51ae9-28c5-4350-a2f3-90c7972e864e_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Forfeited (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_a7c24772-5626-4f8d-99ef-fc2ca48802ed_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Unrecognized compensation cost</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxesAndTaxCredits_45d78ecd-c998-4d4f-8d0e-49f61b92fa53_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxesAndTaxCredits" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Deferred income tax</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxesAndTaxCredits_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxesAndTaxCredits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Income Taxes and Tax Credits</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxesAndTaxCredits" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredIncomeTaxesAndTaxCredits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxesAndTaxCredits" xlink:to="lab_us-gaap_DeferredIncomeTaxesAndTaxCredits" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ChangedPeerGroupFnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_ChangedPeerGroupFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Changed Peer Group, Footnote</link:label>
    <link:label id="lab_ecd_ChangedPeerGroupFnTextBlock_label_en-US" xlink:label="lab_ecd_ChangedPeerGroupFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Changed Peer Group, Footnote [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ChangedPeerGroupFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ChangedPeerGroupFnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ChangedPeerGroupFnTextBlock" xlink:to="lab_ecd_ChangedPeerGroupFnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfOperatingSegments_479f9706-959f-4a75-a1e5-838915226e6a_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfOperatingSegments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of operating segments</link:label>
    <link:label id="lab_us-gaap_NumberOfOperatingSegments_label_en-US" xlink:label="lab_us-gaap_NumberOfOperatingSegments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Number of Operating Segments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfOperatingSegments" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NumberOfOperatingSegments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfOperatingSegments" xlink:to="lab_us-gaap_NumberOfOperatingSegments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_e9eb4767-6f45-4538-afa9-ea8b3a5501b0_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2027</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AdjToPeoCompFnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_AdjToPeoCompFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Adjustment To PEO Compensation, Footnote</link:label>
    <link:label id="lab_ecd_AdjToPeoCompFnTextBlock_label_en-US" xlink:label="lab_ecd_AdjToPeoCompFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustment To PEO Compensation, Footnote [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToPeoCompFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AdjToPeoCompFnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AdjToPeoCompFnTextBlock" xlink:to="lab_ecd_AdjToPeoCompFnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_d4f0e2cd-c520-44ec-b091-2e6e43acb4f1_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Outstanding</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesTypeAxis_cda778fc-8d1c-42c8-be88-c6dcbe05b3a6_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves Type [Axis]</link:label>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesTypeAxis_label_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ValuationAllowancesAndReservesTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis" xlink:to="lab_us-gaap_ValuationAllowancesAndReservesTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c1ddb780-c207-4775-a3f3-553754529a0b_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Granted (dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TrdArrIndTitle_terseLabel_en-US" xlink:label="lab_ecd_TrdArrIndTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Title</link:label>
    <link:label id="lab_ecd_TrdArrIndTitle_label_en-US" xlink:label="lab_ecd_TrdArrIndTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Arrangement, Individual Title</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrIndTitle" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TrdArrIndTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TrdArrIndTitle" xlink:to="lab_ecd_TrdArrIndTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PeerGroupTotalShareholderRtnAmt_terseLabel_en-US" xlink:label="lab_ecd_PeerGroupTotalShareholderRtnAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Peer Group Total Shareholder Return Amount</link:label>
    <link:label id="lab_ecd_PeerGroupTotalShareholderRtnAmt_label_en-US" xlink:label="lab_ecd_PeerGroupTotalShareholderRtnAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Peer Group Total Shareholder Return Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeerGroupTotalShareholderRtnAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PeerGroupTotalShareholderRtnAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PeerGroupTotalShareholderRtnAmt" xlink:to="lab_ecd_PeerGroupTotalShareholderRtnAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_751a27f0-3a3e-4464-ac2a-72da5303bbe0_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Intangible Assets, Net</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_RestatementDateAxis_terseLabel_en-US" xlink:label="lab_ecd_RestatementDateAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restatement Determination Date:</link:label>
    <link:label id="lab_ecd_RestatementDateAxis_label_en-US" xlink:label="lab_ecd_RestatementDateAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restatement Determination Date [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RestatementDateAxis" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_RestatementDateAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_RestatementDateAxis" xlink:to="lab_ecd_RestatementDateAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NonPeoNeoMember_terseLabel_en-US" xlink:label="lab_ecd_NonPeoNeoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-PEO NEO</link:label>
    <link:label id="lab_ecd_NonPeoNeoMember_label_en-US" xlink:label="lab_ecd_NonPeoNeoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-PEO NEO [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonPeoNeoMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_NonPeoNeoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NonPeoNeoMember" xlink:to="lab_ecd_NonPeoNeoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_fe8f6242-1bdb-44e2-93ea-fab6e0b61ddb_verboseLabel_en-US" xlink:label="lab_us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Foreign</link:label>
    <link:label id="lab_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Foreign Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredForeignIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_6988fe83-616b-4234-9fd6-365af43f6917_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Outstanding</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_fa798196-c3bb-4468-b7e1-2f5a6dde65ff_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common stock issued under employee stock purchase plan</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Issued During Period, Value, Employee Stock Purchase Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesLeasingArrangements_ab7e943f-7610-4d61-8beb-9d6360cf8d32_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesLeasingArrangements" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Right of use asset</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesLeasingArrangements_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesLeasingArrangements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Liabilities, Leasing Arrangements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesLeasingArrangements" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxLiabilitiesLeasingArrangements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesLeasingArrangements" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesLeasingArrangements" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TrdArrIndName_terseLabel_en-US" xlink:label="lab_ecd_TrdArrIndName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Name</link:label>
    <link:label id="lab_ecd_TrdArrIndName_label_en-US" xlink:label="lab_ecd_TrdArrIndName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Arrangement, Individual Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrIndName" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TrdArrIndName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TrdArrIndName" xlink:to="lab_ecd_TrdArrIndName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_7ffd894a-9082-417f-9e60-6768f83b430c_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_42964b1a-5802-4207-9e09-a5aaf9a87d5e_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2026</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_EqtyAwrdsAdjsMember_terseLabel_en-US" xlink:label="lab_ecd_EqtyAwrdsAdjsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity Awards Adjustments</link:label>
    <link:label id="lab_ecd_EqtyAwrdsAdjsMember_label_en-US" xlink:label="lab_ecd_EqtyAwrdsAdjsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Awards Adjustments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_EqtyAwrdsAdjsMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_EqtyAwrdsAdjsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_EqtyAwrdsAdjsMember" xlink:to="lab_ecd_EqtyAwrdsAdjsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseholdImprovementsMember_9d07ec89-4f47-4a89-9509-09a4811dd7b7_terseLabel_en-US" xlink:label="lab_us-gaap_LeaseholdImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Leasehold improvements</link:label>
    <link:label id="lab_us-gaap_LeaseholdImprovementsMember_label_en-US" xlink:label="lab_us-gaap_LeaseholdImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Leasehold Improvements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseholdImprovementsMember" xlink:to="lab_us-gaap_LeaseholdImprovementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PnsnBnftsAdjFnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_PnsnBnftsAdjFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pension Benefits Adjustments, Footnote</link:label>
    <link:label id="lab_ecd_PnsnBnftsAdjFnTextBlock_label_en-US" xlink:label="lab_ecd_PnsnBnftsAdjFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pension Benefits Adjustments, Footnote [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PnsnBnftsAdjFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PnsnBnftsAdjFnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PnsnBnftsAdjFnTextBlock" xlink:to="lab_ecd_PnsnBnftsAdjFnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueLineItems_cc73e2f8-4610-4a09-8a0b-3281688211b3_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disaggregation of Revenue [Line Items]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueLineItems_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disaggregation of Revenue [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems" xlink:to="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_OutstandingRecoveryCompAmt_terseLabel_en-US" xlink:label="lab_ecd_OutstandingRecoveryCompAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Compensation Amount</link:label>
    <link:label id="lab_ecd_OutstandingRecoveryCompAmt_label_en-US" xlink:label="lab_ecd_OutstandingRecoveryCompAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Outstanding Recovery Compensation Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OutstandingRecoveryCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_OutstandingRecoveryCompAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_OutstandingRecoveryCompAmt" xlink:to="lab_ecd_OutstandingRecoveryCompAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_d04f3043-f3a8-4678-b22b-c91cbf7223fc_verboseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Deferred taxes:</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Income Tax Expense (Benefit), Continuing Operations [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="lab_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_lfvn_ClassOfWarrantOrRightPercentOfCommonStockAcquisitionThatMakesRightsExercisable_92ceb306-a5c4-474a-96b8-edf46f693150_terseLabel_en-US" xlink:label="lab_lfvn_ClassOfWarrantOrRightPercentOfCommonStockAcquisitionThatMakesRightsExercisable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Percent of common stock acquisition that makes rights exercisable</link:label>
    <link:label id="lab_lfvn_ClassOfWarrantOrRightPercentOfCommonStockAcquisitionThatMakesRightsExercisable_label_en-US" xlink:label="lab_lfvn_ClassOfWarrantOrRightPercentOfCommonStockAcquisitionThatMakesRightsExercisable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Class of Warrant or Right, Percent Of Common Stock Acquisition That Makes Rights Exercisable</link:label>
    <link:label id="lab_lfvn_ClassOfWarrantOrRightPercentOfCommonStockAcquisitionThatMakesRightsExercisable_documentation_en-US" xlink:label="lab_lfvn_ClassOfWarrantOrRightPercentOfCommonStockAcquisitionThatMakesRightsExercisable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Class of Warrant or Right, Percent Of Common Stock Acquisition That Makes Rights Exercisable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_ClassOfWarrantOrRightPercentOfCommonStockAcquisitionThatMakesRightsExercisable" xlink:href="lfvn-20250630.xsd#lfvn_ClassOfWarrantOrRightPercentOfCommonStockAcquisitionThatMakesRightsExercisable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfvn_ClassOfWarrantOrRightPercentOfCommonStockAcquisitionThatMakesRightsExercisable" xlink:to="lab_lfvn_ClassOfWarrantOrRightPercentOfCommonStockAcquisitionThatMakesRightsExercisable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_1ded7eda-e37d-431a-957d-915fad62cbfc_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentNameDomain" xlink:to="lab_us-gaap_DebtInstrumentNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_RecoveryOfErrCompDisclosureLineItems_label_en-US" xlink:label="lab_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Recovery of Erroneously Awarded Compensation Disclosure [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_RecoveryOfErrCompDisclosureLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="lab_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_e4434238-7964-4398-ab19-6eb39914544c_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Increase in revenue from recognition of deferred revenue</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Contract with Customer, Liability, Revenue Recognized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ContractWithCustomerLiabilityRevenueRecognized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:to="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_529be043-10de-421b-9510-be273c758f8e_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Additions</link:label>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_label_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves, Additions, Charge to Cost and Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense" xlink:to="lab_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_MnpiDiscTimedForCompValFlag_terseLabel_en-US" xlink:label="lab_ecd_MnpiDiscTimedForCompValFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">MNPI Disclosure Timed for Compensation Value</link:label>
    <link:label id="lab_ecd_MnpiDiscTimedForCompValFlag_label_en-US" xlink:label="lab_ecd_MnpiDiscTimedForCompValFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">MNPI Disclosure Timed for Compensation Value [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MnpiDiscTimedForCompValFlag" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_MnpiDiscTimedForCompValFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_MnpiDiscTimedForCompValFlag" xlink:to="lab_ecd_MnpiDiscTimedForCompValFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardsCloseToMnpiDiscIndName_terseLabel_en-US" xlink:label="lab_ecd_AwardsCloseToMnpiDiscIndName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Name</link:label>
    <link:label id="lab_ecd_AwardsCloseToMnpiDiscIndName_label_en-US" xlink:label="lab_ecd_AwardsCloseToMnpiDiscIndName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Awards Close in Time to MNPI Disclosures, Individual Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardsCloseToMnpiDiscIndName" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardsCloseToMnpiDiscIndName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardsCloseToMnpiDiscIndName" xlink:to="lab_ecd_AwardsCloseToMnpiDiscIndName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_25257b19-aeb5-4654-b886-bdb3e3ac8974_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Foreign tax rate difference</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" xlink:type="arc" order="1"/>
    <link:label id="lab_lfvn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInExchange_eb5f37d7-3de5-4f84-b58d-b94a51e692a9_terseLabel_en-US" xlink:label="lab_lfvn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInExchange" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Granted in exchange (in shares)</link:label>
    <link:label id="lab_lfvn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInExchange_label_en-US" xlink:label="lab_lfvn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInExchange" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Exchange</link:label>
    <link:label id="lab_lfvn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInExchange_documentation_en-US" xlink:label="lab_lfvn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInExchange" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Exchange</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInExchange" xlink:href="lfvn-20250630.xsd#lfvn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInExchange"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfvn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInExchange" xlink:to="lab_lfvn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInExchange" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock_316e7a14-34d8-48ec-a739-96926e0d3f49_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other Accrued Expenses</link:label>
    <link:label id="lab_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock_label_en-US" xlink:label="lab_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounts Payable, Accrued Liabilities, and Other Liabilities Disclosure, Current [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock" xlink:to="lab_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_da07719c-c399-475e-b837-9dddb4157fee_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Exercise price of outstanding stock options (dollars per share)</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Option, Nonvested, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_98408a9a-692e-453b-8f84-863c4d17d5b7_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Nonvested beginning period (dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_6cc78930-21db-4845-a111-62aa1c993afa_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Nonvested ending period (dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AggtErrCompNotYetDeterminedTextBlock_terseLabel_en-US" xlink:label="lab_ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Aggregate Erroneous Compensation Not Yet Determined</link:label>
    <link:label id="lab_ecd_AggtErrCompNotYetDeterminedTextBlock_label_en-US" xlink:label="lab_ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Aggregate Erroneous Compensation Not Yet Determined [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AggtErrCompNotYetDeterminedTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:to="lab_ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_IcfrAuditorAttestationFlag_5a629704-3454-4143-a296-bb34b212f597_terseLabel_en-US" xlink:label="lab_dei_IcfrAuditorAttestationFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">ICFR Auditor Attestation Flag</link:label>
    <link:label id="lab_dei_IcfrAuditorAttestationFlag_label_en-US" xlink:label="lab_dei_IcfrAuditorAttestationFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">ICFR Auditor Attestation Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_IcfrAuditorAttestationFlag" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_IcfrAuditorAttestationFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_IcfrAuditorAttestationFlag" xlink:to="lab_dei_IcfrAuditorAttestationFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentsIncorporatedByReferenceTextBlock_3e15e8de-b7f1-462c-8905-28796d21bb2e_terseLabel_en-US" xlink:label="lab_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Documents Incorporated by Reference</link:label>
    <link:label id="lab_dei_DocumentsIncorporatedByReferenceTextBlock_label_en-US" xlink:label="lab_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentsIncorporatedByReferenceTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="lab_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee_61b37a62-9cb1-47d2-920f-c1271fa68923_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Maximum number of shares that can be purchased during any offering period</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Maximum Number of Shares Per Employee</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_de9b6aa1-50c5-4665-aaa9-e9a0f6f204d4_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock-based compensation</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">APIC, Share-Based Payment Arrangement, Increase for Cost Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_f855f726-0fa9-4d24-b7ab-ef46335309a6_verboseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Accumulated other comprehensive loss</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_lfvn_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermAbstract_cb159df4-0899-45b3-a488-962fc35a71ce_terseLabel_en-US" xlink:label="lab_lfvn_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted Average&#160;Remaining Contractual Term (in years)</link:label>
    <link:label id="lab_lfvn_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermAbstract_label_en-US" xlink:label="lab_lfvn_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term [Abstract]</link:label>
    <link:label id="lab_lfvn_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermAbstract_documentation_en-US" xlink:label="lab_lfvn_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermAbstract" xlink:href="lfvn-20250630.xsd#lfvn_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfvn_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermAbstract" xlink:to="lab_lfvn_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_lfvn_ReportableSegmentMember_0cbe6b48-8792-40b5-841d-60709cdc93b6_terseLabel_en-US" xlink:label="lab_lfvn_ReportableSegmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Reportable Segment</link:label>
    <link:label id="lab_lfvn_ReportableSegmentMember_label_en-US" xlink:label="lab_lfvn_ReportableSegmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Reportable Segment [Member]</link:label>
    <link:label id="lab_lfvn_ReportableSegmentMember_documentation_en-US" xlink:label="lab_lfvn_ReportableSegmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Reportable Segment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_ReportableSegmentMember" xlink:href="lfvn-20250630.xsd#lfvn_ReportableSegmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfvn_ReportableSegmentMember" xlink:to="lab_lfvn_ReportableSegmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCountryMember_a8c6a32d-fde1-4b87-900c-60afd1944c98_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignCountryMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Foreign Tax Authority</link:label>
    <link:label id="lab_us-gaap_ForeignCountryMember_label_en-US" xlink:label="lab_us-gaap_ForeignCountryMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Foreign Tax Jurisdiction [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCountryMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ForeignCountryMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCountryMember" xlink:to="lab_us-gaap_ForeignCountryMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilities_bdf13a5b-8c42-4560-8b44-6d520540ed29_negatedTotalLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilities" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xml:lang="en-US">Gross deferred tax liabilities</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilities_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Liabilities, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities" xlink:to="lab_us-gaap_DeferredIncomeTaxLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AuditorFirmId_ba964932-6dab-43e4-abd6-c04a84bbfcb5_terseLabel_en-US" xlink:label="lab_dei_AuditorFirmId" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Auditor Firm ID</link:label>
    <link:label id="lab_dei_AuditorFirmId_label_en-US" xlink:label="lab_dei_AuditorFirmId" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Auditor Firm ID</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorFirmId" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AuditorFirmId"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AuditorFirmId" xlink:to="lab_dei_AuditorFirmId" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentDomain_9a37f3d9-953b-4cc0-8e45-47262fb13858_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Segments [Domain]</link:label>
    <link:label id="lab_us-gaap_SegmentDomain_label_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Segments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SegmentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentDomain" xlink:to="lab_us-gaap_SegmentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_982c3a8c-3691-4be9-8a12-f025c7432331_verboseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">International</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Foreign</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:type="arc" order="1"/>
    <link:label id="lab_lfvn_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsOutstandingContractualTerm_c7aeb8b8-63ce-470d-b681-aab083aeae09_terseLabel_en-US" xlink:label="lab_lfvn_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsOutstandingContractualTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Contractual term of stock options granted</link:label>
    <link:label id="lab_lfvn_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsOutstandingContractualTerm_label_en-US" xlink:label="lab_lfvn_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsOutstandingContractualTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Contractual Term</link:label>
    <link:label id="lab_lfvn_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsOutstandingContractualTerm_documentation_en-US" xlink:label="lab_lfvn_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsOutstandingContractualTerm" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsOutstandingContractualTerm" xlink:href="lfvn-20250630.xsd#lfvn_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsOutstandingContractualTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfvn_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsOutstandingContractualTerm" xlink:to="lab_lfvn_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsOutstandingContractualTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AggtPnsnAdjsSvcCstMember_terseLabel_en-US" xlink:label="lab_ecd_AggtPnsnAdjsSvcCstMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Aggregate Pension Adjustments Service Cost</link:label>
    <link:label id="lab_ecd_AggtPnsnAdjsSvcCstMember_label_en-US" xlink:label="lab_ecd_AggtPnsnAdjsSvcCstMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Aggregate Pension Adjustments Service Cost [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AggtPnsnAdjsSvcCstMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AggtPnsnAdjsSvcCstMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AggtPnsnAdjsSvcCstMember" xlink:to="lab_ecd_AggtPnsnAdjsSvcCstMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_46a7886f-f422-4709-8941-6a7d9746cfce_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Inventory</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Inventories</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInInventories" xlink:to="lab_us-gaap_IncreaseDecreaseInInventories" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryNet_9d319b59-891a-4c77-a4ed-27f9bb5d8577_verboseLabel_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Inventory</link:label>
    <link:label id="lab_us-gaap_InventoryNet_717a1834-72eb-4cb0-ae65-46d586d7101b_totalLabel_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total inventory</link:label>
    <link:label id="lab_us-gaap_InventoryNet_label_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Inventory, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InventoryNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryNet" xlink:to="lab_us-gaap_InventoryNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedBonusesCurrentAndNoncurrent_32af27fd-0eda-4b05-a3c1-30cecad74fd1_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedBonusesCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accrued incentive compensation</link:label>
    <link:label id="lab_us-gaap_AccruedBonusesCurrentAndNoncurrent_label_en-US" xlink:label="lab_us-gaap_AccruedBonusesCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accrued Bonuses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedBonusesCurrentAndNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccruedBonusesCurrentAndNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedBonusesCurrentAndNoncurrent" xlink:to="lab_us-gaap_AccruedBonusesCurrentAndNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_45de3326-02aa-4cc3-ac70-7d07cd70dc8f_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MinimumMember_64ddfcc0-8803-4645-a8f7-41219db614d4_terseLabel_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Minimum</link:label>
    <link:label id="lab_srt_MinimumMember_label_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Minimum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_MinimumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MinimumMember" xlink:to="lab_srt_MinimumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsNoncurrentAbstract_53672a29-e337-4ba3-b508-0253959209f4_verboseLabel_en-US" xlink:label="lab_us-gaap_AssetsNoncurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Non-current assets</link:label>
    <link:label id="lab_us-gaap_AssetsNoncurrentAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsNoncurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Assets, Noncurrent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsNoncurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetsNoncurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsNoncurrentAbstract" xlink:to="lab_us-gaap_AssetsNoncurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_fcac498c-5d89-462c-880a-0cee05ba3db5_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Accumulated depreciation</link:label>
    <link:label id="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerSharePolicyTextBlock_b8b176c5-9bdc-471e-914c-1f58a3de8034_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Income Per Share</link:label>
    <link:label id="lab_us-gaap_EarningsPerSharePolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Earnings Per Share, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerSharePolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EarningsPerSharePolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerSharePolicyTextBlock" xlink:to="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_CoSelectedMeasureName_terseLabel_en-US" xlink:label="lab_ecd_CoSelectedMeasureName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Company Selected Measure Name</link:label>
    <link:label id="lab_ecd_CoSelectedMeasureName_label_en-US" xlink:label="lab_ecd_CoSelectedMeasureName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Company Selected Measure Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CoSelectedMeasureName" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_CoSelectedMeasureName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_CoSelectedMeasureName" xlink:to="lab_ecd_CoSelectedMeasureName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_656209d4-2543-4316-ba3b-7329a3843ab9_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Long-Term Debt</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureTextBlock" xlink:to="lab_us-gaap_DebtDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockValue_a33e2db9-3488-44db-8e2b-917219d1483f_verboseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Preferred stock &#8212; par value $0.0001 per share, 5,000 shares authorized, no shares issued or outstanding</link:label>
    <link:label id="lab_us-gaap_PreferredStockValue_label_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Preferred Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PreferredStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockValue" xlink:to="lab_us-gaap_PreferredStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TrdArrSecuritiesAggAvailAmt_terseLabel_en-US" xlink:label="lab_ecd_TrdArrSecuritiesAggAvailAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Aggregate Available</link:label>
    <link:label id="lab_ecd_TrdArrSecuritiesAggAvailAmt_label_en-US" xlink:label="lab_ecd_TrdArrSecuritiesAggAvailAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Arrangement, Securities Aggregate Available Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrSecuritiesAggAvailAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TrdArrSecuritiesAggAvailAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TrdArrSecuritiesAggAvailAmt" xlink:to="lab_ecd_TrdArrSecuritiesAggAvailAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_371ba61b-a1fb-46b0-a3d9-2212567721a5_verboseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounts Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableCurrent" xlink:to="lab_us-gaap_AccountsPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeasePayments_93e928b0-497a-41d7-8b7e-6b69642a8e34_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeasePayments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating cash outflows from operating leases</link:label>
    <link:label id="lab_us-gaap_OperatingLeasePayments_label_en-US" xlink:label="lab_us-gaap_OperatingLeasePayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Lease, Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasePayments" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeasePayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeasePayments" xlink:to="lab_us-gaap_OperatingLeasePayments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockAppreciationRightsSARSMember_terseLabel_en-US" xlink:label="lab_us-gaap_StockAppreciationRightsSARSMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock Appreciation Rights (SARs)</link:label>
    <link:label id="lab_us-gaap_StockAppreciationRightsSARSMember_label_en-US" xlink:label="lab_us-gaap_StockAppreciationRightsSARSMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Appreciation Rights (SARs) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockAppreciationRightsSARSMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockAppreciationRightsSARSMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockAppreciationRightsSARSMember" xlink:to="lab_us-gaap_StockAppreciationRightsSARSMember" xlink:type="arc" order="1"/>
    <link:label id="lab_lfvn_DebtInstrumentFloorInterestRate_27eb7e90-950e-4329-80b3-630c805082e7_terseLabel_en-US" xlink:label="lab_lfvn_DebtInstrumentFloorInterestRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Floor interest rate</link:label>
    <link:label id="lab_lfvn_DebtInstrumentFloorInterestRate_label_en-US" xlink:label="lab_lfvn_DebtInstrumentFloorInterestRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument, Floor Interest Rate</link:label>
    <link:label id="lab_lfvn_DebtInstrumentFloorInterestRate_documentation_en-US" xlink:label="lab_lfvn_DebtInstrumentFloorInterestRate" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Debt Instrument, Floor Interest Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_DebtInstrumentFloorInterestRate" xlink:href="lfvn-20250630.xsd#lfvn_DebtInstrumentFloorInterestRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfvn_DebtInstrumentFloorInterestRate" xlink:to="lab_lfvn_DebtInstrumentFloorInterestRate" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AllExecutiveCategoriesMember_terseLabel_en-US" xlink:label="lab_ecd_AllExecutiveCategoriesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">All Executive Categories</link:label>
    <link:label id="lab_ecd_AllExecutiveCategoriesMember_label_en-US" xlink:label="lab_ecd_AllExecutiveCategoriesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">All Executive Categories [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllExecutiveCategoriesMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AllExecutiveCategoriesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AllExecutiveCategoriesMember" xlink:to="lab_ecd_AllExecutiveCategoriesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_425753c2-1b77-4f75-b5e8-065a5874e3ed_terseLabel_en-US" xlink:label="lab_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Impairment of intangible assets</link:label>
    <link:label id="lab_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Impairment of Intangible Assets (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill" xlink:to="lab_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_51a6c3c4-70b1-49c7-b877-07e5cefe705c_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Schedule of The Components of the Deferred Tax Assets and Liabilities</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Deferred Tax Assets and Liabilities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_lfvn_AXIOProductLineMember_30569456-2a93-4f64-8fd7-f1b694451e1a_terseLabel_en-US" xlink:label="lab_lfvn_AXIOProductLineMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">AXIO&#174; product line</link:label>
    <link:label id="lab_lfvn_AXIOProductLineMember_label_en-US" xlink:label="lab_lfvn_AXIOProductLineMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">AXIO Product Line [Member]</link:label>
    <link:label id="lab_lfvn_AXIOProductLineMember_documentation_en-US" xlink:label="lab_lfvn_AXIOProductLineMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">AXIO Product Line</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_AXIOProductLineMember" xlink:href="lfvn-20250630.xsd#lfvn_AXIOProductLineMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfvn_AXIOProductLineMember" xlink:to="lab_lfvn_AXIOProductLineMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockValue_f9aeb601-7f24-43b3-bafe-d8b2bad907eb_verboseLabel_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Common stock &#8212; par value $0.0001 per share, 40,000 shares authorized and 12,429 and 12,510 issued and outstanding as of June&#160;30, 2025 and 2024, respectively</link:label>
    <link:label id="lab_us-gaap_CommonStockValue_label_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockValue" xlink:to="lab_us-gaap_CommonStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentForeignTaxExpenseBenefit_338d5624-43fe-4fb6-98f7-efecc921fcd6_verboseLabel_en-US" xlink:label="lab_us-gaap_CurrentForeignTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Foreign</link:label>
    <link:label id="lab_us-gaap_CurrentForeignTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_CurrentForeignTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Current Foreign Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentForeignTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CurrentForeignTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentForeignTaxExpenseBenefit" xlink:to="lab_us-gaap_CurrentForeignTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract_660b81fc-d89d-435b-b0ab-5e372cb3ace0_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Assets, Amortization Expense, Maturity Schedule [Abstract]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Assets, Amortization Expense, Maturity Schedule [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_5d547d14-1d69-4dd8-9f84-9ed3ff0574be_verboseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Commitments and Contingencies Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationAwardTrancheTwoMember_34429746-f631-4146-9788-5020c2359daa_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationAwardTrancheTwoMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Vesting on the last day of each fiscal quarter following January 1, 2019</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationAwardTrancheTwoMember_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationAwardTrancheTwoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Tranche Two [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationAwardTrancheTwoMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationAwardTrancheTwoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationAwardTrancheTwoMember" xlink:to="lab_us-gaap_ShareBasedCompensationAwardTrancheTwoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_88074655-a67f-4a65-903a-0b95c1014340_totalLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Diluted weighted-average common shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock_cc46eeb6-5e59-4363-ae69-ac5ab9ab08fa_verboseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Segment Information</link:label>
    <link:label id="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Segment Reporting, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SegmentReportingPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:to="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_e9b3fea9-e1ef-4809-960b-29bdacde687e_verboseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Commitments and contingencies &#8212; Note 14</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingencies" xlink:to="lab_us-gaap_CommitmentsAndContingencies" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NonGaapMeasureDescriptionTextBlock_terseLabel_en-US" xlink:label="lab_ecd_NonGaapMeasureDescriptionTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-GAAP Measure Description</link:label>
    <link:label id="lab_ecd_NonGaapMeasureDescriptionTextBlock_label_en-US" xlink:label="lab_ecd_NonGaapMeasureDescriptionTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-GAAP Measure Description [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonGaapMeasureDescriptionTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_NonGaapMeasureDescriptionTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NonGaapMeasureDescriptionTextBlock" xlink:to="lab_ecd_NonGaapMeasureDescriptionTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_e112f927-fe93-488c-a9f9-85a5c9f04db9_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Comprehensive income</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskCreditRiskFinancialInstrumentMaximumExposure_c855431c-2b1b-4d2e-b10c-d49f718ac972_verboseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskCreditRiskFinancialInstrumentMaximumExposure" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Concentration of credit risk</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskCreditRiskFinancialInstrumentMaximumExposure_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskCreditRiskFinancialInstrumentMaximumExposure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Concentration Risk, Credit Risk, Financial Instrument, Maximum Exposure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskCreditRiskFinancialInstrumentMaximumExposure" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConcentrationRiskCreditRiskFinancialInstrumentMaximumExposure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskCreditRiskFinancialInstrumentMaximumExposure" xlink:to="lab_us-gaap_ConcentrationRiskCreditRiskFinancialInstrumentMaximumExposure" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitySmallBusiness_6f518ef9-2cff-4b0f-bf00-05cc26b16c7f_terseLabel_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Small Business</link:label>
    <link:label id="lab_dei_EntitySmallBusiness_label_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Small Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntitySmallBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitySmallBusiness" xlink:to="lab_dei_EntitySmallBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock_af1b0c36-cc8f-40d2-973f-b13e9840a15f_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Revenue from External Customers by Geographic Areas</link:label>
    <link:label id="lab_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revenue from External Customers by Geographic Areas [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock" xlink:to="lab_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_lfvn_EffectiveIncomeTaxRateReconciliationForeignWithholdingTaxPercent_3496450a-58a3-46d7-acd5-b753d480a6d2_terseLabel_en-US" xlink:label="lab_lfvn_EffectiveIncomeTaxRateReconciliationForeignWithholdingTaxPercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Foreign withholding tax</link:label>
    <link:label id="lab_lfvn_EffectiveIncomeTaxRateReconciliationForeignWithholdingTaxPercent_label_en-US" xlink:label="lab_lfvn_EffectiveIncomeTaxRateReconciliationForeignWithholdingTaxPercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Foreign Withholding Tax, Percent</link:label>
    <link:label id="lab_lfvn_EffectiveIncomeTaxRateReconciliationForeignWithholdingTaxPercent_documentation_en-US" xlink:label="lab_lfvn_EffectiveIncomeTaxRateReconciliationForeignWithholdingTaxPercent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Foreign Withholding Tax, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_EffectiveIncomeTaxRateReconciliationForeignWithholdingTaxPercent" xlink:href="lfvn-20250630.xsd#lfvn_EffectiveIncomeTaxRateReconciliationForeignWithholdingTaxPercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfvn_EffectiveIncomeTaxRateReconciliationForeignWithholdingTaxPercent" xlink:to="lab_lfvn_EffectiveIncomeTaxRateReconciliationForeignWithholdingTaxPercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_b46d9bc2-53e7-48fe-a7aa-b790634d03ad_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:to="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_lfvn_ClassOfWarrantsOrRightDiscount_14967726-fc3c-482d-8322-5e53a8dd8bba_terseLabel_en-US" xlink:label="lab_lfvn_ClassOfWarrantsOrRightDiscount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Discount percent</link:label>
    <link:label id="lab_lfvn_ClassOfWarrantsOrRightDiscount_label_en-US" xlink:label="lab_lfvn_ClassOfWarrantsOrRightDiscount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Class Of Warrants Or Right, Discount</link:label>
    <link:label id="lab_lfvn_ClassOfWarrantsOrRightDiscount_documentation_en-US" xlink:label="lab_lfvn_ClassOfWarrantsOrRightDiscount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Class Of Warrants Or Right, Discount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_ClassOfWarrantsOrRightDiscount" xlink:href="lfvn-20250630.xsd#lfvn_ClassOfWarrantsOrRightDiscount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfvn_ClassOfWarrantsOrRightDiscount" xlink:to="lab_lfvn_ClassOfWarrantsOrRightDiscount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesOutstanding_89725379-2a62-47b6-9cba-8dbc08cdb26c_verboseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Preferred stock, shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Preferred Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesOutstanding" xlink:to="lab_us-gaap_PreferredStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_89c12964-fe81-4a7d-b584-3f2845a906df_verboseLabel_en-US" xlink:label="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">State</link:label>
    <link:label id="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Current State and Local Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:to="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentTransitionReport_cd7a81a1-c2b7-48b4-ae49-349c43966cc9_terseLabel_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Transition Report</link:label>
    <link:label id="lab_dei_DocumentTransitionReport_label_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Transition Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentTransitionReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentTransitionReport" xlink:to="lab_dei_DocumentTransitionReport" xlink:type="arc" order="1"/>
    <link:label id="lab_lfvn_UnrecognizedTaxPositionIncreaseResultingFromForeignTaxAudits_0141e402-39fd-4aa2-97bf-4a80ab983bf9_terseLabel_en-US" xlink:label="lab_lfvn_UnrecognizedTaxPositionIncreaseResultingFromForeignTaxAudits" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Increase resulting from foreign tax audits</link:label>
    <link:label id="lab_lfvn_UnrecognizedTaxPositionIncreaseResultingFromForeignTaxAudits_label_en-US" xlink:label="lab_lfvn_UnrecognizedTaxPositionIncreaseResultingFromForeignTaxAudits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Unrecognized Tax Position, Increase Resulting From Foreign Tax Audits</link:label>
    <link:label id="lab_lfvn_UnrecognizedTaxPositionIncreaseResultingFromForeignTaxAudits_documentation_en-US" xlink:label="lab_lfvn_UnrecognizedTaxPositionIncreaseResultingFromForeignTaxAudits" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Unrecognized Tax Position, Increase Resulting From Foreign Tax Audits</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_UnrecognizedTaxPositionIncreaseResultingFromForeignTaxAudits" xlink:href="lfvn-20250630.xsd#lfvn_UnrecognizedTaxPositionIncreaseResultingFromForeignTaxAudits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfvn_UnrecognizedTaxPositionIncreaseResultingFromForeignTaxAudits" xlink:to="lab_lfvn_UnrecognizedTaxPositionIncreaseResultingFromForeignTaxAudits" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract_fa5ad0bf-9eb8-4052-9110-b953c72c36c9_verboseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Numerator:</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Income (Loss) Available to Common Stockholders, Basic [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract" xlink:to="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardUndrlygSecuritiesAmt_terseLabel_en-US" xlink:label="lab_ecd_AwardUndrlygSecuritiesAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Underlying Securities</link:label>
    <link:label id="lab_ecd_AwardUndrlygSecuritiesAmt_label_en-US" xlink:label="lab_ecd_AwardUndrlygSecuritiesAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Underlying Securities Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardUndrlygSecuritiesAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardUndrlygSecuritiesAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardUndrlygSecuritiesAmt" xlink:to="lab_ecd_AwardUndrlygSecuritiesAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskLineItems_3d72e859-8845-4c44-aff3-baf1320cfe73_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Concentration Risk [Line Items]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskLineItems_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Concentration Risk [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConcentrationRiskLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskLineItems" xlink:to="lab_us-gaap_ConcentrationRiskLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsLiabilitiesNet_1bb474bf-3f8b-46f1-a315-ba47bb1f977c_totalLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Deferred tax assets, net</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsLiabilitiesNet_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:to="lab_us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityComponentDomain_41be3726-1637-47b7-afc0-39ecc4b916de_terseLabel_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:label id="lab_us-gaap_EquityComponentDomain_label_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityComponentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityComponentDomain" xlink:to="lab_us-gaap_EquityComponentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_3ae59c02-0516-41f0-8a36-8da4e105372e_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock_bb70aeef-55d1-475c-87db-eabe62e8a830_terseLabel_en-US" xlink:label="lab_us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Long-lived Assets by Geographic Areas</link:label>
    <link:label id="lab_us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock_label_en-US" xlink:label="lab_us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-Lived Assets by Geographic Areas [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock" xlink:to="lab_us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PeoActuallyPaidCompAmt_terseLabel_en-US" xlink:label="lab_ecd_PeoActuallyPaidCompAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">PEO Actually Paid Compensation Amount</link:label>
    <link:label id="lab_ecd_PeoActuallyPaidCompAmt_label_en-US" xlink:label="lab_ecd_PeoActuallyPaidCompAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">PEO Actually Paid Compensation Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoActuallyPaidCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PeoActuallyPaidCompAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PeoActuallyPaidCompAmt" xlink:to="lab_ecd_PeoActuallyPaidCompAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_lfvn_NumberOfProductLines_bc8bf16b-5b63-4064-8c06-5f537df699d7_terseLabel_en-US" xlink:label="lab_lfvn_NumberOfProductLines" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of product lines</link:label>
    <link:label id="lab_lfvn_NumberOfProductLines_label_en-US" xlink:label="lab_lfvn_NumberOfProductLines" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Number Of Product Lines</link:label>
    <link:label id="lab_lfvn_NumberOfProductLines_documentation_en-US" xlink:label="lab_lfvn_NumberOfProductLines" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Number Of Product Lines</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_NumberOfProductLines" xlink:href="lfvn-20250630.xsd#lfvn_NumberOfProductLines"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfvn_NumberOfProductLines" xlink:to="lab_lfvn_NumberOfProductLines" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_357b4690-020d-4b23-9b70-9e8fbe48f44c_verboseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Income Taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Tax Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardsCloseToMnpiDiscTableTextBlock_terseLabel_en-US" xlink:label="lab_ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Awards Close in Time to MNPI Disclosures, Table</link:label>
    <link:label id="lab_ecd_AwardsCloseToMnpiDiscTableTextBlock_label_en-US" xlink:label="lab_ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Awards Close in Time to MNPI Disclosures [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardsCloseToMnpiDiscTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:to="lab_ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerAbstract_db2455df-00c7-4ec8-94a5-4b6c0f720756_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Revenue from Contract with Customer [Abstract]</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerAbstract_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revenue from Contract with Customer [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortTermLeaseCost_9065c8ad-9448-40f2-bd2e-364148e4222b_terseLabel_en-US" xlink:label="lab_us-gaap_ShortTermLeaseCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Short-term lease cost</link:label>
    <link:label id="lab_us-gaap_ShortTermLeaseCost_label_en-US" xlink:label="lab_us-gaap_ShortTermLeaseCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Short-Term Lease, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermLeaseCost" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShortTermLeaseCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortTermLeaseCost" xlink:to="lab_us-gaap_ShortTermLeaseCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_09f9c91f-ccdb-4e98-b330-795b2fcbf1f5_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Exercisable</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_48b32387-49ed-4d1b-92fc-7cfba182b748_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Lease liabilities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Operating Lease Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInOperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals_dac98214-6767-44f3-ae72-15c1fd953961_verboseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Accrued vacation, allowance for returns, bonuses&#160;&amp; other</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_f9ea91a9-1647-458e-a0f0-0a473e708ab0_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_OutstandingRecoveryIndName_terseLabel_en-US" xlink:label="lab_ecd_OutstandingRecoveryIndName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Name</link:label>
    <link:label id="lab_ecd_OutstandingRecoveryIndName_label_en-US" xlink:label="lab_ecd_OutstandingRecoveryIndName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Outstanding Recovery, Individual Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OutstandingRecoveryIndName" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_OutstandingRecoveryIndName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_OutstandingRecoveryIndName" xlink:to="lab_ecd_OutstandingRecoveryIndName" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductOrServiceAxis_680ac3c4-f7da-40e2-aa8f-a8b05965d970_terseLabel_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:label id="lab_srt_ProductOrServiceAxis_label_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ProductOrServiceAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductOrServiceAxis" xlink:to="lab_srt_ProductOrServiceAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableLeaseCost_a07c182d-85ec-4f4e-9372-97680a3fccaf_terseLabel_en-US" xlink:label="lab_us-gaap_VariableLeaseCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Variable lease cost</link:label>
    <link:label id="lab_us-gaap_VariableLeaseCost_label_en-US" xlink:label="lab_us-gaap_VariableLeaseCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Variable Lease, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableLeaseCost" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_VariableLeaseCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableLeaseCost" xlink:to="lab_us-gaap_VariableLeaseCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_c8b19e12-a62e-4e43-ad62-6115953dd7fb_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Revenue, net</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revenue from Contract with Customer, Excluding Assessed Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="arc" order="1"/>
    <link:label id="lab_lfvn_NumberOfGeographicSegments_64f93295-2649-4c85-a08c-7689cbc06b25_terseLabel_en-US" xlink:label="lab_lfvn_NumberOfGeographicSegments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of geographic segments</link:label>
    <link:label id="lab_lfvn_NumberOfGeographicSegments_label_en-US" xlink:label="lab_lfvn_NumberOfGeographicSegments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Number Of Geographic Segments</link:label>
    <link:label id="lab_lfvn_NumberOfGeographicSegments_documentation_en-US" xlink:label="lab_lfvn_NumberOfGeographicSegments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Number of geographic segments.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_NumberOfGeographicSegments" xlink:href="lfvn-20250630.xsd#lfvn_NumberOfGeographicSegments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfvn_NumberOfGeographicSegments" xlink:to="lab_lfvn_NumberOfGeographicSegments" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AllIndividualsMember_terseLabel_en-US" xlink:label="lab_ecd_AllIndividualsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">All Individuals</link:label>
    <link:label id="lab_ecd_AllIndividualsMember_label_en-US" xlink:label="lab_ecd_AllIndividualsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">All Individuals [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllIndividualsMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AllIndividualsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AllIndividualsMember" xlink:to="lab_ecd_AllIndividualsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_51ffdb2b-559f-4732-b587-c1f07731ee44_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Long-term Debt, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-Term Debt, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeDomain" xlink:to="lab_us-gaap_LongtermDebtTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_8beafd95-61d8-4cae-af70-5b84b4ded16d_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Purchase of equipment</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ForgoneRecoveryIndName_terseLabel_en-US" xlink:label="lab_ecd_ForgoneRecoveryIndName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Name</link:label>
    <link:label id="lab_ecd_ForgoneRecoveryIndName_label_en-US" xlink:label="lab_ecd_ForgoneRecoveryIndName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Forgone Recovery, Individual Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryIndName" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ForgoneRecoveryIndName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ForgoneRecoveryIndName" xlink:to="lab_ecd_ForgoneRecoveryIndName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrent_44f71e1c-e38e-4d5f-9bbb-8b8cf76bdc29_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrent_label_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="lab_us-gaap_AssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeAxis_c88aed4d-a005-4238-81c8-0263a0b853e2_terseLabel_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:label id="lab_srt_RangeAxis_label_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeAxis" xlink:to="lab_srt_RangeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember_terseLabel_en-US" xlink:label="lab_ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested</link:label>
    <link:label id="lab_ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember_label_en-US" xlink:label="lab_ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember" xlink:to="lab_ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_lfvn_CreditCardAndBankingProcessingFees_7f61077e-9886-4341-8db1-4b73f50fc1ed_negatedTerseLabel_en-US" xlink:label="lab_lfvn_CreditCardAndBankingProcessingFees" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Credit card and bank processing fees</link:label>
    <link:label id="lab_lfvn_CreditCardAndBankingProcessingFees_label_en-US" xlink:label="lab_lfvn_CreditCardAndBankingProcessingFees" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Credit Card And Banking Processing Fees</link:label>
    <link:label id="lab_lfvn_CreditCardAndBankingProcessingFees_documentation_en-US" xlink:label="lab_lfvn_CreditCardAndBankingProcessingFees" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Credit Card And Banking Processing Fees</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_CreditCardAndBankingProcessingFees" xlink:href="lfvn-20250630.xsd#lfvn_CreditCardAndBankingProcessingFees"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfvn_CreditCardAndBankingProcessingFees" xlink:to="lab_lfvn_CreditCardAndBankingProcessingFees" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_StockRepurchaseProgramAuthorizedAmount1_9fda95bc-e0f0-4cee-b278-34074289ffd0_terseLabel_en-US" xlink:label="lab_srt_StockRepurchaseProgramAuthorizedAmount1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Repurchase common stock amount authorized (up to)</link:label>
    <link:label id="lab_srt_StockRepurchaseProgramAuthorizedAmount1_label_en-US" xlink:label="lab_srt_StockRepurchaseProgramAuthorizedAmount1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share Repurchase Program, Authorized, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StockRepurchaseProgramAuthorizedAmount1" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_StockRepurchaseProgramAuthorizedAmount1" xlink:to="lab_srt_StockRepurchaseProgramAuthorizedAmount1" xlink:type="arc" order="1"/>
    <link:label id="lab_lfvn_OtherForeignMember_855ca5c0-31a9-4628-8661-af25ef53632b_terseLabel_en-US" xlink:label="lab_lfvn_OtherForeignMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other foreign markets</link:label>
    <link:label id="lab_lfvn_OtherForeignMember_label_en-US" xlink:label="lab_lfvn_OtherForeignMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Foreign [Member]</link:label>
    <link:label id="lab_lfvn_OtherForeignMember_documentation_en-US" xlink:label="lab_lfvn_OtherForeignMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Other Foreign</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_OtherForeignMember" xlink:href="lfvn-20250630.xsd#lfvn_OtherForeignMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfvn_OtherForeignMember" xlink:to="lab_lfvn_OtherForeignMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VehiclesMember_dcd5c222-c9a4-4781-bf9d-c11ceded6105_terseLabel_en-US" xlink:label="lab_us-gaap_VehiclesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Vehicles</link:label>
    <link:label id="lab_us-gaap_VehiclesMember_label_en-US" xlink:label="lab_us-gaap_VehiclesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Vehicles [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VehiclesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_VehiclesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VehiclesMember" xlink:to="lab_us-gaap_VehiclesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AggtErrCompAmt_terseLabel_en-US" xlink:label="lab_ecd_AggtErrCompAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Aggregate Erroneous Compensation Amount</link:label>
    <link:label id="lab_ecd_AggtErrCompAmt_label_en-US" xlink:label="lab_ecd_AggtErrCompAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Aggregate Erroneous Compensation Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AggtErrCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AggtErrCompAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AggtErrCompAmt" xlink:to="lab_ecd_AggtErrCompAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_ac069b57-41cd-4b00-881f-0d45ae395ce2_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Purchase price of stock fair market value</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Purchase Price of Common Stock, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_70cfb0a4-32bf-482e-be9a-98091ae5cf8f_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Exercised</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period, Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_8c9a150a-418f-429c-bfee-d70f145d1a7a_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Shares purchased as payment of tax withholding and other</link:label>
    <link:label id="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payment, Tax Withholding, Share-Based Payment Arrangement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:to="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PeerGroupIssuersFnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_PeerGroupIssuersFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Peer Group Issuers, Footnote</link:label>
    <link:label id="lab_ecd_PeerGroupIssuersFnTextBlock_label_en-US" xlink:label="lab_ecd_PeerGroupIssuersFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Peer Group Issuers, Footnote [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeerGroupIssuersFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PeerGroupIssuersFnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PeerGroupIssuersFnTextBlock" xlink:to="lab_ecd_PeerGroupIssuersFnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ErrCompAnalysisTextBlock_terseLabel_en-US" xlink:label="lab_ecd_ErrCompAnalysisTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Erroneous Compensation Analysis</link:label>
    <link:label id="lab_ecd_ErrCompAnalysisTextBlock_label_en-US" xlink:label="lab_ecd_ErrCompAnalysisTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Erroneous Compensation Analysis [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ErrCompAnalysisTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ErrCompAnalysisTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ErrCompAnalysisTextBlock" xlink:to="lab_ecd_ErrCompAnalysisTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_a5771939-a761-46e2-b829-d9554f99cb37_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Intangible Asset, Finite-Lived [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_0a840bf8-0317-447b-8ab3-2aa4c6d77340_verboseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liabilities, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:to="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_3f3347b9-a2ca-46e7-9b90-1815ec341890_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Aggregate Intrinsic Value (in thousands)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityLineItems_b70b7eb5-35af-43bc-a3c3-dc404e651e67_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Line of Credit Facility [Line Items]</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityLineItems_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Line of Credit Facility [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LineOfCreditFacilityLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems" xlink:to="lab_us-gaap_LineOfCreditFacilityLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_StatementGeographicalAxis_68b6078b-7c03-496d-a9d3-9bf0fe1cb7d3_terseLabel_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:label id="lab_srt_StatementGeographicalAxis_label_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_StatementGeographicalAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_StatementGeographicalAxis" xlink:to="lab_srt_StatementGeographicalAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionLineItems_5196ccdf-8894-4db5-ac46-8c655459b26e_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Lessee, Lease, Description [Line Items]</link:label>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionLineItems_label_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Lease, Description [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestRevenueExpenseNet_d8945c3c-9dfd-46c7-a475-66cc2640dbdf_terseLabel_en-US" xlink:label="lab_us-gaap_InterestRevenueExpenseNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Interest income, net</link:label>
    <link:label id="lab_us-gaap_InterestRevenueExpenseNet_label_en-US" xlink:label="lab_us-gaap_InterestRevenueExpenseNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Interest Income (Expense), Operating and Nonoperating</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRevenueExpenseNet" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InterestRevenueExpenseNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestRevenueExpenseNet" xlink:to="lab_us-gaap_InterestRevenueExpenseNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingExpenses_2f9ca662-1724-44e2-a439-69bb0af6a521_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingExpenses" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total operating expenses</link:label>
    <link:label id="lab_us-gaap_OperatingExpenses_label_en-US" xlink:label="lab_us-gaap_OperatingExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpenses" xlink:to="lab_us-gaap_OperatingExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_Rule10b51ArrTrmntdFlag_terseLabel_en-US" xlink:label="lab_ecd_Rule10b51ArrTrmntdFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Rule 10b5-1 Arrangement Terminated</link:label>
    <link:label id="lab_ecd_Rule10b51ArrTrmntdFlag_label_en-US" xlink:label="lab_ecd_Rule10b51ArrTrmntdFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Rule 10b5-1 Arrangement Terminated [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_Rule10b51ArrTrmntdFlag" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_Rule10b51ArrTrmntdFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_Rule10b51ArrTrmntdFlag" xlink:to="lab_ecd_Rule10b51ArrTrmntdFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCredit_70728b4c-bcb0-425e-a56f-5e94cfc24a9c_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCredit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Long-Term Line of Credit</link:label>
    <link:label id="lab_us-gaap_LineOfCredit_label_en-US" xlink:label="lab_us-gaap_LineOfCredit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-Term Line of Credit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LineOfCredit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCredit" xlink:to="lab_us-gaap_LineOfCredit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_60624ced-9466-443f-91e9-654cffafb10f_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Foreign currency transaction loss, net</link:label>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_label_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Gain (Loss), Foreign Currency Transaction, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ForeignCurrencyTransactionGainLossBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:to="lab_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities_a4537659-aa45-47f7-a83a-5cdcaf5d75c9_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other accrued expenses</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Accrued Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_dc27016f-626f-44d7-9a4c-7d12ed2f6037_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Diluted (dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_904f4d81-3297-458d-a315-e9370d353f84_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Income per share, diluted (dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Earnings Per Share, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDiluted" xlink:to="lab_us-gaap_EarningsPerShareDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ErrCompRecoveryTable_terseLabel_en-US" xlink:label="lab_ecd_ErrCompRecoveryTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Erroneously Awarded Compensation Recovery</link:label>
    <link:label id="lab_ecd_ErrCompRecoveryTable_label_en-US" xlink:label="lab_ecd_ErrCompRecoveryTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Erroneously Awarded Compensation Recovery [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ErrCompRecoveryTable" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ErrCompRecoveryTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ErrCompRecoveryTable" xlink:to="lab_ecd_ErrCompRecoveryTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_f1fa8420-fd83-4329-8c79-af748f80181a_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accounts receivable</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounts Receivable, after Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableNetCurrent" xlink:to="lab_us-gaap_AccountsReceivableNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskBenchmarkDomain_ac40cf23-aaaa-4bfd-8d91-fb18f52dcc5f_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Concentration Risk Benchmark [Domain]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskBenchmarkDomain_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Concentration Risk Benchmark [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:to="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_3ee444f9-9d2f-4170-8f05-e0a9541c44d2_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionTable_ba38c419-5b62-419c-83a6-54927673c05a_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Lessee, Lease, Description [Table]</link:label>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionTable_label_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Lease, Description [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable" xlink:to="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedSalesCommissionCurrent_d52e6f81-959b-4140-a7bf-182b95255e3b_verboseLabel_en-US" xlink:label="lab_us-gaap_AccruedSalesCommissionCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Commissions payable</link:label>
    <link:label id="lab_us-gaap_AccruedSalesCommissionCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedSalesCommissionCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accrued Sales Commission, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedSalesCommissionCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccruedSalesCommissionCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedSalesCommissionCurrent" xlink:to="lab_us-gaap_AccruedSalesCommissionCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_8bae7f1f-7119-4e91-a540-429fb146264d_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net income per share:</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareAbstract" xlink:to="lab_us-gaap_EarningsPerShareAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_5a44ab52-9613-4f5e-a6c8-72070cb5e429_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2030</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpense_c02a1474-6e30-4eec-be3c-2e6d487de9d6_totalLabel_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total other income, net</link:label>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonoperatingIncomeExpense" xlink:to="lab_us-gaap_NonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AuditorLocation_b403ba7d-a376-42f5-85de-d0f8fa7235f0_terseLabel_en-US" xlink:label="lab_dei_AuditorLocation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Auditor Location</link:label>
    <link:label id="lab_dei_AuditorLocation_label_en-US" xlink:label="lab_dei_AuditorLocation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Auditor Location</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorLocation" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AuditorLocation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AuditorLocation" xlink:to="lab_dei_AuditorLocation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidExpense_1d22e72d-7177-40cc-bf23-19b990db2b31_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidExpense" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Prepaid expenses and other</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidExpense_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Prepaid Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInPrepaidExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInPrepaidExpense" xlink:to="lab_us-gaap_IncreaseDecreaseInPrepaidExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationFdiiPercent_92612e8e-746f-4b7b-84e4-5461aba635e3_negatedLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationFdiiPercent" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">&#8212; foreign derived intangible income deduction</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationFdiiPercent_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationFdiiPercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation, FDII, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationFdiiPercent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationFdiiPercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationFdiiPercent" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationFdiiPercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GrossProfit_9556ca41-4841-4f01-a801-5d5b3f588c71_totalLabel_en-US" xlink:label="lab_us-gaap_GrossProfit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Gross profit</link:label>
    <link:label id="lab_us-gaap_GrossProfit_label_en-US" xlink:label="lab_us-gaap_GrossProfit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Gross Profit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GrossProfit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GrossProfit" xlink:to="lab_us-gaap_GrossProfit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue_170bc61d-2cd5-405c-be6d-daca746be200_negatedLabel_en-US" xlink:label="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Repurchase of company stock</link:label>
    <link:label id="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue_label_en-US" xlink:label="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Repurchased and Retired During Period, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue" xlink:to="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_18026798-0ae6-4452-ba01-5cf864003e86_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Less: imputed interest</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Liability, Undiscounted Excess Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther_1a36de55-1cc8-4d24-973a-c9f47b1640d3_verboseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">&#8212; other permanent differences</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_815c0318-d41d-405e-b085-91b99ba0c8d1_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Exercised (dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock_0dfa14c6-dee5-4954-86ed-f8e3d7914074_terseLabel_en-US" xlink:label="lab_us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Nonvested Restricted Shares</link:label>
    <link:label id="lab_us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Nonvested Restricted Stock Shares Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock" xlink:to="lab_us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_bb1be4ff-7f69-4f12-8766-8dbc6b4dd98a_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardTmgDiscLineItems_label_en-US" xlink:label="lab_ecd_AwardTmgDiscLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Timing Disclosures [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgDiscLineItems" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardTmgDiscLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="lab_ecd_AwardTmgDiscLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLossCarryforwardsLineItems_5436888b-c096-4108-8428-c6984773786b_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwardsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating Loss Carryforwards [Line Items]</link:label>
    <link:label id="lab_us-gaap_OperatingLossCarryforwardsLineItems_label_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwardsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Loss Carryforwards [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLossCarryforwardsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems" xlink:to="lab_us-gaap_OperatingLossCarryforwardsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_1211f219-f640-434f-9f51-d39670d3afd8_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Components of Inventory</link:label>
    <link:label id="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Inventory, Current [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_589fe15b-02c9-444f-a5f5-dfccb51caef2_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Granted (dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityWellKnownSeasonedIssuer_4ce2e358-ba9e-452d-86ad-e6c5f78e3ee6_terseLabel_en-US" xlink:label="lab_dei_EntityWellKnownSeasonedIssuer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
    <link:label id="lab_dei_EntityWellKnownSeasonedIssuer_label_en-US" xlink:label="lab_dei_EntityWellKnownSeasonedIssuer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityWellKnownSeasonedIssuer" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityWellKnownSeasonedIssuer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityWellKnownSeasonedIssuer" xlink:to="lab_dei_EntityWellKnownSeasonedIssuer" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_d6c9f69a-a47e-4981-a129-541cc8048782_verboseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Property and Equipment, Net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_0eb567c0-693e-489b-be6a-97fdcac3ada8_totalLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_a9df1581-bce5-44df-9dd7-d30dec0a8f1c_verboseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Stockholders' Equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_55d12c3d-0cf6-4e2a-a612-c73870c57b41_verboseLabel_en-US" xlink:label="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">State</link:label>
    <link:label id="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred State and Local Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLoss_23dd44b0-3913-4c82-bce3-5a2a3c220dc5_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net income</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_76799bf3-c12f-4972-ba79-cfde5ad47b36_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net income</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_label_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Income (Loss) Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss" xlink:to="lab_us-gaap_NetIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TrdArrExpirationDate_terseLabel_en-US" xlink:label="lab_ecd_TrdArrExpirationDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Expiration Date</link:label>
    <link:label id="lab_ecd_TrdArrExpirationDate_label_en-US" xlink:label="lab_ecd_TrdArrExpirationDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Arrangement Expiration Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrExpirationDate" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TrdArrExpirationDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TrdArrExpirationDate" xlink:to="lab_ecd_TrdArrExpirationDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAccruedLiabilitiesCurrent_947fb567-cef5-4018-aaa0-a48c5860e00c_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accrued other expenses</link:label>
    <link:label id="lab_us-gaap_OtherAccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SalesReturnsAndAllowancesMember_2eb3f270-8336-4244-8823-8ffb73ad106c_terseLabel_en-US" xlink:label="lab_us-gaap_SalesReturnsAndAllowancesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Sales Returns and Allowances</link:label>
    <link:label id="lab_us-gaap_SalesReturnsAndAllowancesMember_label_en-US" xlink:label="lab_us-gaap_SalesReturnsAndAllowancesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Sales Returns and Allowances [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesReturnsAndAllowancesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SalesReturnsAndAllowancesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SalesReturnsAndAllowancesMember" xlink:to="lab_us-gaap_SalesReturnsAndAllowancesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_204e078c-4d23-4279-a512-dc9c72c9597e_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Schedule of The Effective Income Tax Rate Differs from the U.S. Federal Statutory Income Tax Rate</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_cecb6374-f49f-4ea1-8f60-c474c0c96f48_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Vesting period</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_60ef88f4-b94a-4702-9454-28eba9dd7196_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other differences</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Other Adjustments, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesDeductions_a925979e-e605-47b5-b1c0-0058377e71c2_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesDeductions" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Write-offs</link:label>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesDeductions_f6f18ac6-b9e7-4598-8c5f-2c12eb4eb100_negatedLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesDeductions" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Returns</link:label>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesDeductions_label_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesDeductions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves, Deduction</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesDeductions" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ValuationAllowancesAndReservesDeductions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesDeductions" xlink:to="lab_us-gaap_ValuationAllowancesAndReservesDeductions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_7572c84b-290c-4f62-b64d-2a41e9b2b40f_verboseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Property and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_fac0fc59-e89b-4f67-9129-36674ca4f2c9_totalLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total property and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_14c10cb5-c872-4905-9ea4-8eb71dd47733_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_label_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems" xlink:to="lab_us-gaap_SegmentReportingInformationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_b35d9d6a-9558-4fe3-9aa3-219b0baaa598_verboseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Preferred stock, shares authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Preferred Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesAuthorized" xlink:to="lab_us-gaap_PreferredStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_93685aa1-3eef-4e1b-aa0e-d29889f42d26_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Repurchase of company stock</link:label>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_d6e046ef-c705-47b3-81b4-8576d7690adb_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Payments for repurchase of common stock</link:label>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_label_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payments for Repurchase of Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:to="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TrdArrAdoptionDate_terseLabel_en-US" xlink:label="lab_ecd_TrdArrAdoptionDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Adoption Date</link:label>
    <link:label id="lab_ecd_TrdArrAdoptionDate_label_en-US" xlink:label="lab_ecd_TrdArrAdoptionDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Arrangement Adoption Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrAdoptionDate" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TrdArrAdoptionDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TrdArrAdoptionDate" xlink:to="lab_ecd_TrdArrAdoptionDate" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_CompActuallyPaidVsNetIncomeTextBlock_terseLabel_en-US" xlink:label="lab_ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Compensation Actually Paid vs. Net Income</link:label>
    <link:label id="lab_ecd_CompActuallyPaidVsNetIncomeTextBlock_label_en-US" xlink:label="lab_ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Compensation Actually Paid vs. Net Income [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_CompActuallyPaidVsNetIncomeTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:to="lab_ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_051d48ef-318a-41ee-880f-e59699c89b4e_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Accounts receivable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Accounts Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryPolicyTextBlock_5d8dd639-e922-455c-a537-77a235f5422f_verboseLabel_en-US" xlink:label="lab_us-gaap_InventoryPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_InventoryPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_InventoryPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Inventory, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InventoryPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryPolicyTextBlock" xlink:to="lab_us-gaap_InventoryPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCurrentReportingStatus_ba1a8cef-fa7c-453c-a977-df6329bf82bc_terseLabel_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:label id="lab_dei_EntityCurrentReportingStatus_label_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCurrentReportingStatus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCurrentReportingStatus" xlink:to="lab_dei_EntityCurrentReportingStatus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseTermOfContract_239e83d9-edf3-4224-a656-16987bbbd0cd_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Lease term</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseTermOfContract_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Term of Contract</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseTermOfContract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:to="lab_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:type="arc" order="1"/>
    <link:label id="lab_lfvn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOfferingPeriod_2786be61-dab8-41a3-b23e-2f3de3fd887a_terseLabel_en-US" xlink:label="lab_lfvn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOfferingPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Offering period</link:label>
    <link:label id="lab_lfvn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOfferingPeriod_label_en-US" xlink:label="lab_lfvn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOfferingPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Offering Period</link:label>
    <link:label id="lab_lfvn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOfferingPeriod_documentation_en-US" xlink:label="lab_lfvn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOfferingPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Offering Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOfferingPeriod" xlink:href="lfvn-20250630.xsd#lfvn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOfferingPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfvn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOfferingPeriod" xlink:to="lab_lfvn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOfferingPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardsCloseToMnpiDiscTable_terseLabel_en-US" xlink:label="lab_ecd_AwardsCloseToMnpiDiscTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Awards Close in Time to MNPI Disclosures</link:label>
    <link:label id="lab_ecd_AwardsCloseToMnpiDiscTable_label_en-US" xlink:label="lab_ecd_AwardsCloseToMnpiDiscTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Awards Close in Time to MNPI Disclosures [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardsCloseToMnpiDiscTable" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardsCloseToMnpiDiscTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardsCloseToMnpiDiscTable" xlink:to="lab_ecd_AwardsCloseToMnpiDiscTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable_df0392f3-6774-4af3-8119-23ceae564f12_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Revenue from External Customers by Products and Services [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Segment Reporting, Revenue from External Customer, Product and Service [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable" xlink:to="lab_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_c5d002d4-6586-41f6-a593-751c6f100699_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Operating income</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_label_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingIncomeLoss" xlink:to="lab_us-gaap_OperatingIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditMember_7063d1e9-c8e8-4192-8e3f-cb1ddf0d9cbc_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Line of Credit</link:label>
    <link:label id="lab_us-gaap_LineOfCreditMember_label_en-US" xlink:label="lab_us-gaap_LineOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Line of Credit [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LineOfCreditMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditMember" xlink:to="lab_us-gaap_LineOfCreditMember" xlink:type="arc" order="1"/>
    <link:label id="lab_country_JP_5cd6f74f-4dfa-4032-8259-2aaad2adaf76_terseLabel_en-US" xlink:label="lab_country_JP" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Japan</link:label>
    <link:label id="lab_country_JP_label_en-US" xlink:label="lab_country_JP" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">JAPAN</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_JP" xlink:href="https://xbrl.sec.gov/country/2025/country-2025.xsd#country_JP"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_JP" xlink:to="lab_country_JP" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_aae7227c-b9fd-43c4-b9f1-8752f6fa71ba_verboseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Accumulated deficit</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_e396fa6f-c0bf-4646-a339-b2c0164b47e5_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">(Gain) loss on disposal of fixed assets</link:label>
    <link:label id="lab_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_label_en-US" xlink:label="lab_us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Gain (Loss) on Disposition of Property Plant Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GainLossOnSaleOfPropertyPlantEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:to="lab_us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_lfvn_March2016RevolvingLoanMember_4a38fd55-b9b0-4bc0-946b-c0a53017c9a5_terseLabel_en-US" xlink:label="lab_lfvn_March2016RevolvingLoanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">March 2016 Revolving Loan</link:label>
    <link:label id="lab_lfvn_March2016RevolvingLoanMember_label_en-US" xlink:label="lab_lfvn_March2016RevolvingLoanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">March 2016 Revolving Loan [Member]</link:label>
    <link:label id="lab_lfvn_March2016RevolvingLoanMember_documentation_en-US" xlink:label="lab_lfvn_March2016RevolvingLoanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">March 2016 Revolving Loan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_March2016RevolvingLoanMember" xlink:href="lfvn-20250630.xsd#lfvn_March2016RevolvingLoanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfvn_March2016RevolvingLoanMember" xlink:to="lab_lfvn_March2016RevolvingLoanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_141d854f-674e-4737-9de9-bda3b7f4afae_verboseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Adjustments to reconcile net income to net cash provided by operating activities:</link:label>
    <link:label id="lab_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity, Noncash Item [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_f499a3bf-3b9f-405f-a06b-4c226aaf3f17_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:to="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember_terseLabel_en-US" xlink:label="lab_ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested</link:label>
    <link:label id="lab_ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember_label_en-US" xlink:label="lab_ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember" xlink:to="lab_ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ExecutiveCategoryAxis_terseLabel_en-US" xlink:label="lab_ecd_ExecutiveCategoryAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Executive Category:</link:label>
    <link:label id="lab_ecd_ExecutiveCategoryAxis_label_en-US" xlink:label="lab_ecd_ExecutiveCategoryAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Executive Category [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ExecutiveCategoryAxis" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ExecutiveCategoryAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ExecutiveCategoryAxis" xlink:to="lab_ecd_ExecutiveCategoryAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost_226bb10c-a426-4367-add1-6890d2395d87_verboseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">&#8212; stock-based compensation</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-Based Payment Arrangement, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:type="arc" order="1"/>
    <link:label id="lab_lfvn_CashAccountsHeldatOtherFinancialInstitutionsMember_7ae45271-717d-4855-92dd-fa34c5f075ef_terseLabel_en-US" xlink:label="lab_lfvn_CashAccountsHeldatOtherFinancialInstitutionsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash Accounts Held at Other Financial Institutions</link:label>
    <link:label id="lab_lfvn_CashAccountsHeldatOtherFinancialInstitutionsMember_label_en-US" xlink:label="lab_lfvn_CashAccountsHeldatOtherFinancialInstitutionsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash Accounts Held at Other Financial Institutions [Member]</link:label>
    <link:label id="lab_lfvn_CashAccountsHeldatOtherFinancialInstitutionsMember_documentation_en-US" xlink:label="lab_lfvn_CashAccountsHeldatOtherFinancialInstitutionsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Cash Accounts Held At Other Financial Institutions [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_CashAccountsHeldatOtherFinancialInstitutionsMember" xlink:href="lfvn-20250630.xsd#lfvn_CashAccountsHeldatOtherFinancialInstitutionsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfvn_CashAccountsHeldatOtherFinancialInstitutionsMember" xlink:to="lab_lfvn_CashAccountsHeldatOtherFinancialInstitutionsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_6b1a5d23-fb45-4c34-8bb7-f7a9cf825447_verboseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">State income taxes, net of federal benefit</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_b6020837-d10c-4863-9cca-42fbf68b6873_terseLabel_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_label_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CurrentFiscalYearEndDate" xlink:to="lab_dei_CurrentFiscalYearEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_f34963e3-56b1-44e6-aede-be0b49f3eda8_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of rights</link:label>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_label_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Class of Warrant or Right, Number of Securities Called by Each Warrant or Right</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" xlink:to="lab_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" xlink:type="arc" order="1"/>
    <link:label id="lab_lfvn_EmployeeStockPurchasePlanMember_da0e1243-4ae3-43a5-9773-e2bcaec278f6_terseLabel_en-US" xlink:label="lab_lfvn_EmployeeStockPurchasePlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">ESPP</link:label>
    <link:label id="lab_lfvn_EmployeeStockPurchasePlanMember_label_en-US" xlink:label="lab_lfvn_EmployeeStockPurchasePlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Employee Stock Purchase Plan [Member]</link:label>
    <link:label id="lab_lfvn_EmployeeStockPurchasePlanMember_documentation_en-US" xlink:label="lab_lfvn_EmployeeStockPurchasePlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Employee Stock Purchase Plan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_EmployeeStockPurchasePlanMember" xlink:href="lfvn-20250630.xsd#lfvn_EmployeeStockPurchasePlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfvn_EmployeeStockPurchasePlanMember" xlink:to="lab_lfvn_EmployeeStockPurchasePlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_da954ab0-faec-45c1-b60a-564d85c7de14_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember_terseLabel_en-US" xlink:label="lab_ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table</link:label>
    <link:label id="lab_ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember_label_en-US" xlink:label="lab_ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember" xlink:to="lab_ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesOther_d63c06bc-c9bd-4005-8ea4-b06e79b9a3ee_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesOther" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesOther_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Liabilities, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesOther" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxLiabilitiesOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesOther" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesOther" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterestAbstract_febb6ed5-f28c-48b3-88f8-4d30e0170c04_verboseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterestAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Income before income taxes:</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterestAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterestAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterestAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterestAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterestAbstract" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterestAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PayablesAndAccrualsAbstract_5ff1b7ce-70be-4b9e-be0d-21dde9f52f35_terseLabel_en-US" xlink:label="lab_us-gaap_PayablesAndAccrualsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Payables and Accruals [Abstract]</link:label>
    <link:label id="lab_us-gaap_PayablesAndAccrualsAbstract_label_en-US" xlink:label="lab_us-gaap_PayablesAndAccrualsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payables and Accruals [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PayablesAndAccrualsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PayablesAndAccrualsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract" xlink:to="lab_us-gaap_PayablesAndAccrualsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_ea3241af-8e95-4ced-a7ca-4355e30958e7_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted Average Grant Date Fair Value</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_67a3f2a4-4002-4604-aff6-57414a671e20_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of shares available for issuance</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementTable_2dccaeb5-ce6a-40e9-a2e7-90c4bcdeae05_terseLabel_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Statement [Table]</link:label>
    <link:label id="lab_us-gaap_StatementTable_label_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementTable" xlink:to="lab_us-gaap_StatementTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_b25aae9c-0066-46ff-aeb3-67b0be6af422_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Other expense, net</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_63a9f3e5-04bf-4efe-bf6e-dc1e9ca41642_totalLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total other expense, net</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:to="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_f1e66c41-65e3-4aa0-8034-007520c5dd85_totalLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total deferred income tax provision</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate_585142cb-f663-456e-ae35-b3ad84613749_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Maximum percentage of employee compensation</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Maximum Employee Subscription Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_b8440793-cee1-43ae-9f9d-294b6f1b37a2_verboseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Cash Flows from Financing Activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash Provided by (Used in) Financing Activity, Including Discontinued Operation [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember_terseLabel_en-US" xlink:label="lab_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity Awards Adjustments, Excluding Value Reported in Compensation Table</link:label>
    <link:label id="lab_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember_label_en-US" xlink:label="lab_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Awards Adjustments, Excluding Value Reported in the Compensation Table [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:to="lab_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SalesRevenueNetMember_ee0f988a-b784-4247-9092-95aac97e2894_terseLabel_en-US" xlink:label="lab_us-gaap_SalesRevenueNetMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Revenue benchmark</link:label>
    <link:label id="lab_us-gaap_SalesRevenueNetMember_label_en-US" xlink:label="lab_us-gaap_SalesRevenueNetMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revenue Benchmark [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesRevenueNetMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SalesRevenueNetMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SalesRevenueNetMember" xlink:to="lab_us-gaap_SalesRevenueNetMember" xlink:type="arc" order="1"/>
    <link:label id="lab_lfvn_EffectiveIncomeTaxRateReconciliationChangeInUncertainTaxPositions_aa1d0e91-cfbb-4ea5-89f5-3b1ad9c7ede8_terseLabel_en-US" xlink:label="lab_lfvn_EffectiveIncomeTaxRateReconciliationChangeInUncertainTaxPositions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">&#8212; change in uncertain tax positions</link:label>
    <link:label id="lab_lfvn_EffectiveIncomeTaxRateReconciliationChangeInUncertainTaxPositions_label_en-US" xlink:label="lab_lfvn_EffectiveIncomeTaxRateReconciliationChangeInUncertainTaxPositions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Change In UncertainTax Positions</link:label>
    <link:label id="lab_lfvn_EffectiveIncomeTaxRateReconciliationChangeInUncertainTaxPositions_documentation_en-US" xlink:label="lab_lfvn_EffectiveIncomeTaxRateReconciliationChangeInUncertainTaxPositions" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Change In UncertainTax Positions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_EffectiveIncomeTaxRateReconciliationChangeInUncertainTaxPositions" xlink:href="lfvn-20250630.xsd#lfvn_EffectiveIncomeTaxRateReconciliationChangeInUncertainTaxPositions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfvn_EffectiveIncomeTaxRateReconciliationChangeInUncertainTaxPositions" xlink:to="lab_lfvn_EffectiveIncomeTaxRateReconciliationChangeInUncertainTaxPositions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate_ad8b5384-996a-4763-8fe8-e5d5d22dca98_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Revalue of deferred for change in federal tax rate</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate" xlink:type="arc" order="1"/>
    <link:label id="lab_lfvn_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseLimitationOnFutureStockBasedCompensationExpensePercent_b1cb8165-172d-461f-b42e-9677a3292bbb_negatedTerseLabel_en-US" xlink:label="lab_lfvn_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseLimitationOnFutureStockBasedCompensationExpensePercent" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Limit on future stock compensation due to 162(m)</link:label>
    <link:label id="lab_lfvn_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseLimitationOnFutureStockBasedCompensationExpensePercent_label_en-US" xlink:label="lab_lfvn_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseLimitationOnFutureStockBasedCompensationExpensePercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Nondeductible Expense, Limitation On Future Stock Based Compensation Expense, Percent</link:label>
    <link:label id="lab_lfvn_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseLimitationOnFutureStockBasedCompensationExpensePercent_documentation_en-US" xlink:label="lab_lfvn_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseLimitationOnFutureStockBasedCompensationExpensePercent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Nondeductible Expense, Limitation On Future Stock Based Compensation Expense, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseLimitationOnFutureStockBasedCompensationExpensePercent" xlink:href="lfvn-20250630.xsd#lfvn_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseLimitationOnFutureStockBasedCompensationExpensePercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfvn_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseLimitationOnFutureStockBasedCompensationExpensePercent" xlink:to="lab_lfvn_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseLimitationOnFutureStockBasedCompensationExpensePercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_356d9942-0940-4392-ab96-5284c0ef50e2_verboseLabel_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">The Company</link:label>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_add616b8-bdaa-46ae-8105-73e5df7455a9_periodStartLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Unrecognized Tax Benefits, Beginning Balance</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_cad5f7ed-ee10-453a-8d90-c41f01319dbc_periodEndLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Unrecognized Tax Benefits, Ending Balance</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Unrecognized Tax Benefits</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefits" xlink:to="lab_us-gaap_UnrecognizedTaxBenefits" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_40c162f2-2823-408f-a12f-a1c61fa88579_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Denominator:</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_8fd222b6-e1b9-4ee7-ba31-f8b3aa40e665_verboseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Number of antidilutive securities (in shares)</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AllAdjToCompMember_terseLabel_en-US" xlink:label="lab_ecd_AllAdjToCompMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">All Adjustments to Compensation</link:label>
    <link:label id="lab_ecd_AllAdjToCompMember_label_en-US" xlink:label="lab_ecd_AllAdjToCompMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">All Adjustments to Compensation [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllAdjToCompMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AllAdjToCompMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AllAdjToCompMember" xlink:to="lab_ecd_AllAdjToCompMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_025248bf-6e5a-40fe-88a3-1ea62e5c94be_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_4184b724-f7d2-4d9d-b569-d66280ca2dd5_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Maximum common stock issued under Long-Term Incentive Plan (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeasesTextBlock_16eaca4a-7759-42c2-82ba-a5cf4db69c29_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Leases</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeasesTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Leases [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeasesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeasesTextBlock" xlink:to="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TrdArrTerminationDate_terseLabel_en-US" xlink:label="lab_ecd_TrdArrTerminationDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Termination Date</link:label>
    <link:label id="lab_ecd_TrdArrTerminationDate_label_en-US" xlink:label="lab_ecd_TrdArrTerminationDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Arrangement Termination Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrTerminationDate" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TrdArrTerminationDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TrdArrTerminationDate" xlink:to="lab_ecd_TrdArrTerminationDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_e48d54f9-3b26-4227-8f58-b4c33188f071_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net Cash Used in Financing Activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash Provided by (Used in) Financing Activity, Including Discontinued Operation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_InsiderTrdPoliciesProcAdoptedFlag_terseLabel_en-US" xlink:label="lab_ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Insider Trading Policies and Procedures Adopted</link:label>
    <link:label id="lab_ecd_InsiderTrdPoliciesProcAdoptedFlag_label_en-US" xlink:label="lab_ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Insider Trading Policies and Procedures Adopted [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_InsiderTrdPoliciesProcAdoptedFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:to="lab_ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_MeasureAxis_terseLabel_en-US" xlink:label="lab_ecd_MeasureAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Measure:</link:label>
    <link:label id="lab_ecd_MeasureAxis_label_en-US" xlink:label="lab_ecd_MeasureAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Measure [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MeasureAxis" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_MeasureAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_MeasureAxis" xlink:to="lab_ecd_MeasureAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_99e389cc-8bcc-40fd-86c0-59ec510ca96e_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted average discount rate</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Lease, Weighted Average Discount Rate, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:to="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_bc0deef7-48be-44e1-9865-5f814102681b_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Summary of Stock Option Activity</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Option, Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_22098231-fd8e-441b-9b76-38279087454e_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-Lived Tangible Asset [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_6f4ecd94-3cea-4ecb-b7a4-1f16f8b7d2d0_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Basic (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_7bb53b00-755f-4630-86b5-334457b06ad9_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Basic weighted-average common shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_44b51c2c-bdfe-4bc3-9e55-b2cdae7cfa4d_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Remaining authorized amount of common stock repurchase program</link:label>
    <link:label id="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_label_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share Repurchase Program, Remaining Authorized, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:to="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_2c50fbb1-74df-4b94-9044-a096921e56fa_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cost of sales</link:label>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_5d48adfb-2912-45fc-a14b-fc5056375f76_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Cost of sales</link:label>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_label_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cost of Product and Service Sold</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfGoodsAndServicesSold" xlink:to="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_dcf2b9ab-50c5-4c82-b30c-a08a42fb3061_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Summary of Computation of Net Income Per Share</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_5edae89a-7a1f-416b-a846-87cdac7ebfcb_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Exercisable (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventsAbstract_label_en-US" xlink:label="lab_us-gaap_SubsequentEventsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Subsequent Events [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsequentEventsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventsAbstract" xlink:to="lab_us-gaap_SubsequentEventsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_label_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingAbstract" xlink:to="lab_us-gaap_SegmentReportingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PvpTableTextBlock_terseLabel_en-US" xlink:label="lab_ecd_PvpTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pay vs Performance Disclosure, Table</link:label>
    <link:label id="lab_ecd_PvpTableTextBlock_label_en-US" xlink:label="lab_ecd_PvpTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pay vs Performance [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PvpTableTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PvpTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PvpTableTextBlock" xlink:to="lab_ecd_PvpTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_a5437b96-5085-4ca0-92b2-fc37e61498c0_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureAbstract" xlink:to="lab_us-gaap_DebtDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt_terseLabel_en-US" xlink:label="lab_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Forgone Recovery due to Violation of Home Country Law, Amount</link:label>
    <link:label id="lab_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt_label_en-US" xlink:label="lab_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Forgone Recovery due to Violation of Home Country Law, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:to="lab_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfUnvestedRestrictedStockUnitsRollForwardTableTextBlock_c9b412c2-7310-499c-ba39-7644d9e96f5f_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfUnvestedRestrictedStockUnitsRollForwardTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Unvested Restricted Stock Units Roll Forward</link:label>
    <link:label id="lab_us-gaap_ScheduleOfUnvestedRestrictedStockUnitsRollForwardTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfUnvestedRestrictedStockUnitsRollForwardTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Unvested Restricted Stock Units Roll Forward [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfUnvestedRestrictedStockUnitsRollForwardTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfUnvestedRestrictedStockUnitsRollForwardTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfUnvestedRestrictedStockUnitsRollForwardTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfUnvestedRestrictedStockUnitsRollForwardTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfFinancingCosts_5d97e162-ecf2-4038-acff-8fb10c38be69_terseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfFinancingCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Amortization of deferred financing fees</link:label>
    <link:label id="lab_us-gaap_AmortizationOfFinancingCosts_label_en-US" xlink:label="lab_us-gaap_AmortizationOfFinancingCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Amortization of Debt Issuance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AmortizationOfFinancingCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfFinancingCosts" xlink:to="lab_us-gaap_AmortizationOfFinancingCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpenseAbstract_96b428bd-76e7-4a1e-8233-3077beb6f135_verboseLabel_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Other income (expense):</link:label>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpenseAbstract_label_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Nonoperating Income (Expense) [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NonoperatingIncomeExpenseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:to="lab_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_40a4d043-1747-4d4b-984d-85cebec0ab45_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits_cf6684f3-e671-4ad5-91d6-b4c749a11c39_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">&#8212; tax credits</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Tax Credit, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits" xlink:type="arc" order="1"/>
    <link:label id="lab_lfvn_SharebasedCompensationArrangementbySharebasedPaymentAwardDistributionPercentage_8a2bf676-509f-4f61-880b-01e26bcf2209_terseLabel_en-US" xlink:label="lab_lfvn_SharebasedCompensationArrangementbySharebasedPaymentAwardDistributionPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Distribution percentage of target number of Performance Stock Units</link:label>
    <link:label id="lab_lfvn_SharebasedCompensationArrangementbySharebasedPaymentAwardDistributionPercentage_label_en-US" xlink:label="lab_lfvn_SharebasedCompensationArrangementbySharebasedPaymentAwardDistributionPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Distribution Percentage</link:label>
    <link:label id="lab_lfvn_SharebasedCompensationArrangementbySharebasedPaymentAwardDistributionPercentage_documentation_en-US" xlink:label="lab_lfvn_SharebasedCompensationArrangementbySharebasedPaymentAwardDistributionPercentage" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Distribution Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_SharebasedCompensationArrangementbySharebasedPaymentAwardDistributionPercentage" xlink:href="lfvn-20250630.xsd#lfvn_SharebasedCompensationArrangementbySharebasedPaymentAwardDistributionPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfvn_SharebasedCompensationArrangementbySharebasedPaymentAwardDistributionPercentage" xlink:to="lab_lfvn_SharebasedCompensationArrangementbySharebasedPaymentAwardDistributionPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DividendsCash_f7b15925-0334-4c77-9633-1e21acbe7e40_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DividendsCash" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Cash dividends</link:label>
    <link:label id="lab_us-gaap_DividendsCash_label_en-US" xlink:label="lab_us-gaap_DividendsCash" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Dividends, Cash</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCash" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DividendsCash"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DividendsCash" xlink:to="lab_us-gaap_DividendsCash" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryNetAbstract_8ad20193-ca3b-4ad8-af2c-da095794e47b_verboseLabel_en-US" xlink:label="lab_us-gaap_InventoryNetAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Components of Inventory</link:label>
    <link:label id="lab_us-gaap_InventoryNetAbstract_label_en-US" xlink:label="lab_us-gaap_InventoryNetAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Inventory, Net [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNetAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InventoryNetAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryNetAbstract" xlink:to="lab_us-gaap_InventoryNetAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_59f81853-85c9-4ca9-9840-0c02fb9722cf_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Outstanding beginning balance (dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_fe69405d-3040-4654-8cd8-1123bea5748d_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Outstanding ending balance (dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt_terseLabel_en-US" xlink:label="lab_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Forgone Recovery due to Expense of Enforcement, Amount</link:label>
    <link:label id="lab_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt_label_en-US" xlink:label="lab_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Forgone Recovery due to Expense of Enforcement, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:to="lab_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1ed0cf06-0cda-4cf1-a3bf-3bf2eaea1e7b_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_eb243afc-f493-4a5e-98b9-c27dbb7f3226_verboseLabel_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Common stock, par value (dollars per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_lfvn_TwoThousandAndTenLongTermIncentivePlanMember_bd4d60dd-f0da-480f-9632-bd600555102a_verboseLabel_en-US" xlink:label="lab_lfvn_TwoThousandAndTenLongTermIncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">2010 Long-Term Incentive Plan</link:label>
    <link:label id="lab_lfvn_TwoThousandAndTenLongTermIncentivePlanMember_label_en-US" xlink:label="lab_lfvn_TwoThousandAndTenLongTermIncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Two Thousand And Ten Long Term Incentive Plan [Member]</link:label>
    <link:label id="lab_lfvn_TwoThousandAndTenLongTermIncentivePlanMember_documentation_en-US" xlink:label="lab_lfvn_TwoThousandAndTenLongTermIncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Two thousand and ten long term incentive plan.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_TwoThousandAndTenLongTermIncentivePlanMember" xlink:href="lfvn-20250630.xsd#lfvn_TwoThousandAndTenLongTermIncentivePlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfvn_TwoThousandAndTenLongTermIncentivePlanMember" xlink:to="lab_lfvn_TwoThousandAndTenLongTermIncentivePlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_42dbab24-48f0-43e7-b863-3a789f847b31_verboseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Common stock, shares issued (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock, Shares, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesIssued" xlink:to="lab_us-gaap_CommonStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxesReceivable_add79b84-7163-4479-b44e-933db93b61b3_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxesReceivable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income tax receivable</link:label>
    <link:label id="lab_us-gaap_IncomeTaxesReceivable_label_en-US" xlink:label="lab_us-gaap_IncomeTaxesReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Taxes Receivable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxesReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxesReceivable" xlink:to="lab_us-gaap_IncomeTaxesReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_9b23a165-b849-4031-9c05-c598cc8851a8_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted average remaining lease term</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Lease, Weighted Average Remaining Lease Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:to="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DilutiveSecuritiesAbstract_5e173a84-7f01-4fb9-8202-538fd8f99984_verboseLabel_en-US" xlink:label="lab_us-gaap_DilutiveSecuritiesAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Effect of dilutive securities:</link:label>
    <link:label id="lab_us-gaap_DilutiveSecuritiesAbstract_label_en-US" xlink:label="lab_us-gaap_DilutiveSecuritiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Dilutive Securities, Effect on Basic Earnings Per Share [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DilutiveSecuritiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DilutiveSecuritiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DilutiveSecuritiesAbstract" xlink:to="lab_us-gaap_DilutiveSecuritiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_9ad8b9a0-8c68-4ee4-9ea9-26bc0c525e45_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Options granted (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_5dd16823-a171-470b-9346-fa386bfce7c3_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Granted (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:type="arc" order="1"/>
    <link:label id="lab_lfvn_AccruedPayableToVendors_280813f3-2cd1-4c45-9c17-cf0e8cb43721_terseLabel_en-US" xlink:label="lab_lfvn_AccruedPayableToVendors" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accrued payable to vendors</link:label>
    <link:label id="lab_lfvn_AccruedPayableToVendors_label_en-US" xlink:label="lab_lfvn_AccruedPayableToVendors" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accrued Payable to Vendors</link:label>
    <link:label id="lab_lfvn_AccruedPayableToVendors_documentation_en-US" xlink:label="lab_lfvn_AccruedPayableToVendors" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Accrued Payable to Vendors</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_AccruedPayableToVendors" xlink:href="lfvn-20250630.xsd#lfvn_AccruedPayableToVendors"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfvn_AccruedPayableToVendors" xlink:to="lab_lfvn_AccruedPayableToVendors" xlink:type="arc" order="1"/>
    <link:label id="lab_lfvn_March2016TermLoanMember_f9332a0e-bcbe-4c67-9bd6-de744d7ef223_terseLabel_en-US" xlink:label="lab_lfvn_March2016TermLoanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">March 2016 Term Loan</link:label>
    <link:label id="lab_lfvn_March2016TermLoanMember_label_en-US" xlink:label="lab_lfvn_March2016TermLoanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">March 2016 Term Loan [Member]</link:label>
    <link:label id="lab_lfvn_March2016TermLoanMember_documentation_en-US" xlink:label="lab_lfvn_March2016TermLoanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">March 2016 Term Loan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_March2016TermLoanMember" xlink:href="lfvn-20250630.xsd#lfvn_March2016TermLoanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfvn_March2016TermLoanMember" xlink:to="lab_lfvn_March2016TermLoanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UseOfEstimates_50e3edab-0145-478f-91fb-9197ef0ceb3d_verboseLabel_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Use of Estimates</link:label>
    <link:label id="lab_us-gaap_UseOfEstimates_label_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Use of Estimates, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_UseOfEstimates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UseOfEstimates" xlink:to="lab_us-gaap_UseOfEstimates" xlink:type="arc" order="1"/>
    <link:label id="lab_lfvn_EffectiveIncomeTaxRateReconciliationRemovalOfPermanentReinvestmentAssertion_adb5bd72-3a8d-4308-b704-d7e2e5bb6094_terseLabel_en-US" xlink:label="lab_lfvn_EffectiveIncomeTaxRateReconciliationRemovalOfPermanentReinvestmentAssertion" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">&#8212; removal of additional permanent reinvestment assertions</link:label>
    <link:label id="lab_lfvn_EffectiveIncomeTaxRateReconciliationRemovalOfPermanentReinvestmentAssertion_label_en-US" xlink:label="lab_lfvn_EffectiveIncomeTaxRateReconciliationRemovalOfPermanentReinvestmentAssertion" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Removal Of Permanent Reinvestment Assertion</link:label>
    <link:label id="lab_lfvn_EffectiveIncomeTaxRateReconciliationRemovalOfPermanentReinvestmentAssertion_documentation_en-US" xlink:label="lab_lfvn_EffectiveIncomeTaxRateReconciliationRemovalOfPermanentReinvestmentAssertion" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Removal Of Permanent Reinvestment Assertion</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_EffectiveIncomeTaxRateReconciliationRemovalOfPermanentReinvestmentAssertion" xlink:href="lfvn-20250630.xsd#lfvn_EffectiveIncomeTaxRateReconciliationRemovalOfPermanentReinvestmentAssertion"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfvn_EffectiveIncomeTaxRateReconciliationRemovalOfPermanentReinvestmentAssertion" xlink:to="lab_lfvn_EffectiveIncomeTaxRateReconciliationRemovalOfPermanentReinvestmentAssertion" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsOfDividends_ae88e70e-4998-4914-89cf-5a0c5f25d195_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfDividends" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Payment of cash dividends</link:label>
    <link:label id="lab_us-gaap_PaymentsOfDividends_label_en-US" xlink:label="lab_us-gaap_PaymentsOfDividends" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payments of Dividends</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividends" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PaymentsOfDividends"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfDividends" xlink:to="lab_us-gaap_PaymentsOfDividends" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityPublicFloat_3117eef0-14be-401b-9434-4fef86453d04_terseLabel_en-US" xlink:label="lab_dei_EntityPublicFloat" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Public Float</link:label>
    <link:label id="lab_dei_EntityPublicFloat_label_en-US" xlink:label="lab_dei_EntityPublicFloat" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Public Float</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityPublicFloat" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityPublicFloat"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityPublicFloat" xlink:to="lab_dei_EntityPublicFloat" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpenseNonoperating_05e127ee-e52c-4cf9-9b70-ffc1a413f23e_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_InterestExpenseNonoperating" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Interest expense</link:label>
    <link:label id="lab_us-gaap_InterestExpenseNonoperating_label_en-US" xlink:label="lab_us-gaap_InterestExpenseNonoperating" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Interest Expense, Nonoperating</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseNonoperating" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InterestExpenseNonoperating"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpenseNonoperating" xlink:to="lab_us-gaap_InterestExpenseNonoperating" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TradingArrAxis_terseLabel_en-US" xlink:label="lab_ecd_TradingArrAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Trading Arrangement:</link:label>
    <link:label id="lab_ecd_TradingArrAxis_label_en-US" xlink:label="lab_ecd_TradingArrAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Arrangement [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TradingArrAxis" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TradingArrAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TradingArrAxis" xlink:to="lab_ecd_TradingArrAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_336a49f2-4f9a-4583-8b65-15337035961b_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income tax payable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Income Taxes Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TotalShareholderRtnAmt_terseLabel_en-US" xlink:label="lab_ecd_TotalShareholderRtnAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total Shareholder Return Amount</link:label>
    <link:label id="lab_ecd_TotalShareholderRtnAmt_label_en-US" xlink:label="lab_ecd_TotalShareholderRtnAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Total Shareholder Return Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TotalShareholderRtnAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TotalShareholderRtnAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TotalShareholderRtnAmt" xlink:to="lab_ecd_TotalShareholderRtnAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventsTextBlock_a1d757ad-e847-4c61-8a4b-26cafda7fa4b_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Subsequent Events</link:label>
    <link:label id="lab_us-gaap_SubsequentEventsTextBlock_label_en-US" xlink:label="lab_us-gaap_SubsequentEventsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Subsequent Events [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsequentEventsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventsTextBlock" xlink:to="lab_us-gaap_SubsequentEventsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_760e18a9-0dd0-4200-a184-314cbbc81b8e_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Foreign currency translation adjustment</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_f748e288-f11b-4e7e-b5d2-fbef1aee6ebc_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Foreign currency translation adjustment</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_InsiderTradingArrLineItems_label_en-US" xlink:label="lab_ecd_InsiderTradingArrLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Insider Trading Arrangements [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTradingArrLineItems" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_InsiderTradingArrLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="lab_ecd_InsiderTradingArrLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_929ed6f9-874f-4419-8eb8-2e72bab1fa08_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_8448dc81-116c-42b5-8f9c-3c9a2d392442_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Forfeited (dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProductAndServiceOtherMember_71ff3502-41a5-4747-8ecb-473fc23aeb89_terseLabel_en-US" xlink:label="lab_us-gaap_ProductAndServiceOtherMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_ProductAndServiceOtherMember_label_en-US" xlink:label="lab_us-gaap_ProductAndServiceOtherMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Product and Service, Other [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductAndServiceOtherMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProductAndServiceOtherMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProductAndServiceOtherMember" xlink:to="lab_us-gaap_ProductAndServiceOtherMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryRawMaterials_fe9fc06a-e8a9-4c14-b149-92a9318bcc6f_verboseLabel_en-US" xlink:label="lab_us-gaap_InventoryRawMaterials" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Raw materials</link:label>
    <link:label id="lab_us-gaap_InventoryRawMaterials_label_en-US" xlink:label="lab_us-gaap_InventoryRawMaterials" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Inventory, Raw Materials, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterials" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InventoryRawMaterials"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryRawMaterials" xlink:to="lab_us-gaap_InventoryRawMaterials" xlink:type="arc" order="1"/>
    <link:label id="lab_lfvn_PhysIQProductLineMember_4b7116e1-d9fa-4b86-b893-adf758519ed6_terseLabel_en-US" xlink:label="lab_lfvn_PhysIQProductLineMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">PhysIQ&#8482; product line</link:label>
    <link:label id="lab_lfvn_PhysIQProductLineMember_label_en-US" xlink:label="lab_lfvn_PhysIQProductLineMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">PhysIQ Product Line [Member]</link:label>
    <link:label id="lab_lfvn_PhysIQProductLineMember_documentation_en-US" xlink:label="lab_lfvn_PhysIQProductLineMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">PhysIQ Product Line</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_PhysIQProductLineMember" xlink:href="lfvn-20250630.xsd#lfvn_PhysIQProductLineMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfvn_PhysIQProductLineMember" xlink:to="lab_lfvn_PhysIQProductLineMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Liabilities_3f3ff2b9-e5b8-41c1-8022-4dafc663bafb_totalLabel_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total liabilities</link:label>
    <link:label id="lab_us-gaap_Liabilities_label_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Liabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Liabilities" xlink:to="lab_us-gaap_Liabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProductConcentrationRiskMember_7b1c056b-20e7-4cda-8b2c-e305fcdda4c8_terseLabel_en-US" xlink:label="lab_us-gaap_ProductConcentrationRiskMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Product concentration risk</link:label>
    <link:label id="lab_us-gaap_ProductConcentrationRiskMember_label_en-US" xlink:label="lab_us-gaap_ProductConcentrationRiskMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Product Concentration Risk [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductConcentrationRiskMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProductConcentrationRiskMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProductConcentrationRiskMember" xlink:to="lab_us-gaap_ProductConcentrationRiskMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_9664f9cd-fd71-48ff-99c7-4964d496601e_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Maximum borrowing capacity</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Line of Credit Facility, Maximum Borrowing Capacity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:to="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PnsnAdjsPrrSvcCstMember_terseLabel_en-US" xlink:label="lab_ecd_PnsnAdjsPrrSvcCstMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pension Adjustments Prior Service Cost</link:label>
    <link:label id="lab_ecd_PnsnAdjsPrrSvcCstMember_label_en-US" xlink:label="lab_ecd_PnsnAdjsPrrSvcCstMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pension Adjustments Prior Service Cost [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PnsnAdjsPrrSvcCstMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PnsnAdjsPrrSvcCstMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PnsnAdjsPrrSvcCstMember" xlink:to="lab_ecd_PnsnAdjsPrrSvcCstMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_ebe3212e-aa30-475b-9cce-ae138ff3d99f_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Gross increases - tax positions in current year</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:type="arc" order="1"/>
    <link:label id="lab_lfvn_PetandimProductLineMember_5bca2b6c-72fb-4677-98de-83798a9cab94_terseLabel_en-US" xlink:label="lab_lfvn_PetandimProductLineMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Petandim&#174; product line</link:label>
    <link:label id="lab_lfvn_PetandimProductLineMember_label_en-US" xlink:label="lab_lfvn_PetandimProductLineMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Petandim Product Line [Member]</link:label>
    <link:label id="lab_lfvn_PetandimProductLineMember_documentation_en-US" xlink:label="lab_lfvn_PetandimProductLineMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Petandim Product Line</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_PetandimProductLineMember" xlink:href="lfvn-20250630.xsd#lfvn_PetandimProductLineMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfvn_PetandimProductLineMember" xlink:to="lab_lfvn_PetandimProductLineMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchasedDuringPeriodShares_c060d6d2-91f2-4950-abfd-513e3f11dad2_negatedLabel_en-US" xlink:label="lab_us-gaap_StockRepurchasedDuringPeriodShares" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Repurchase of company stock (in shares)</link:label>
    <link:label id="lab_us-gaap_StockRepurchasedDuringPeriodShares_6a442da1-a89a-49ad-a835-92d4cb84bb8c_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchasedDuringPeriodShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock repurchased during period (in shares)</link:label>
    <link:label id="lab_us-gaap_StockRepurchasedDuringPeriodShares_label_en-US" xlink:label="lab_us-gaap_StockRepurchasedDuringPeriodShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Repurchased During Period, Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodShares" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockRepurchasedDuringPeriodShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchasedDuringPeriodShares" xlink:to="lab_us-gaap_StockRepurchasedDuringPeriodShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_00961db5-fff1-4b9a-9394-5c856704e339_terseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Indefinite-lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Indefinite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingExpensesAbstract_81edcfb1-d861-4617-8002-036517eb8a92_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Operating expenses:</link:label>
    <link:label id="lab_us-gaap_OperatingExpensesAbstract_label_en-US" xlink:label="lab_us-gaap_OperatingExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Expenses [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpensesAbstract" xlink:to="lab_us-gaap_OperatingExpensesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_MtrlTermsOfTrdArrTextBlock_terseLabel_en-US" xlink:label="lab_ecd_MtrlTermsOfTrdArrTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Material Terms of Trading Arrangement</link:label>
    <link:label id="lab_ecd_MtrlTermsOfTrdArrTextBlock_label_en-US" xlink:label="lab_ecd_MtrlTermsOfTrdArrTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Material Terms of Trading Arrangement [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MtrlTermsOfTrdArrTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_MtrlTermsOfTrdArrTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_MtrlTermsOfTrdArrTextBlock" xlink:to="lab_ecd_MtrlTermsOfTrdArrTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementLineItems_fe76a7d7-92ce-4197-917c-a4afdfd1834a_terseLabel_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:label id="lab_us-gaap_StatementLineItems_label_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementLineItems" xlink:to="lab_us-gaap_StatementLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_Rule10b51ArrAdoptedFlag_terseLabel_en-US" xlink:label="lab_ecd_Rule10b51ArrAdoptedFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Rule 10b5-1 Arrangement Adopted</link:label>
    <link:label id="lab_ecd_Rule10b51ArrAdoptedFlag_label_en-US" xlink:label="lab_ecd_Rule10b51ArrAdoptedFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Rule 10b5-1 Arrangement Adopted [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_Rule10b51ArrAdoptedFlag" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_Rule10b51ArrAdoptedFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_Rule10b51ArrAdoptedFlag" xlink:to="lab_ecd_Rule10b51ArrAdoptedFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_d344878c-1179-4835-ae5f-05e0a928dd98_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash and Cash Equivalent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_fa988107-b4bd-4470-b69c-4c94da1b2b5d_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of additional shares authorized</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Additional Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockMember_830426d0-bc6d-4b14-9da0-21ad1eb02a77_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common Stock</link:label>
    <link:label id="lab_us-gaap_CommonStockMember_label_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockMember" xlink:to="lab_us-gaap_CommonStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_f183379c-6503-41d7-82bd-5e715a34dd5d_negatedLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Vested (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_75c89010-fa85-47c2-9b3c-cafe1c20b243_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NonNeosMember_terseLabel_en-US" xlink:label="lab_ecd_NonNeosMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-NEOs</link:label>
    <link:label id="lab_ecd_NonNeosMember_label_en-US" xlink:label="lab_ecd_NonNeosMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-NEOs [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonNeosMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_NonNeosMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NonNeosMember" xlink:to="lab_ecd_NonNeosMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_ca8f7fed-9804-447e-a1a6-cf537344fa4f_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Cash and Cash Equivalents</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Period Increase (Decrease), Including Exchange Rate Effect and Discontinued Operation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_22d22dcf-bc2d-42d8-85a8-2c1dc5cdb480_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Diluted (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted, Adjustment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:to="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProductMember_label_en-US" xlink:label="lab_us-gaap_ProductMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Product [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProductMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProductMember" xlink:to="lab_us-gaap_ProductMember" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>13
<FILENAME>lfvn-20250630_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:60c7f1f2-d52d-4c01-b992-aaf8be1801ed,g:81eb96f2-7ea0-4e0b-9dac-655ac6c272fe-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.lifevantage.com/role/CoverPage" xlink:type="simple" xlink:href="lfvn-20250630.xsd#CoverPage"/>
  <link:presentationLink xlink:role="http://www.lifevantage.com/role/CoverPage" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_839bb3b5-2128-46e4-93b2-111d35a8b8ac" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_07939b06-40c7-4b84-8a09-5627cfe1f6d5" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_839bb3b5-2128-46e4-93b2-111d35a8b8ac" xlink:to="loc_dei_DocumentType_07939b06-40c7-4b84-8a09-5627cfe1f6d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentAnnualReport_3d9aecb2-f434-4197-a458-b5e035d7be4d" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentAnnualReport"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_839bb3b5-2128-46e4-93b2-111d35a8b8ac" xlink:to="loc_dei_DocumentAnnualReport_3d9aecb2-f434-4197-a458-b5e035d7be4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_da8b3cf4-6d5f-4ec8-bf8e-4ec8a3325298" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_839bb3b5-2128-46e4-93b2-111d35a8b8ac" xlink:to="loc_dei_DocumentPeriodEndDate_da8b3cf4-6d5f-4ec8-bf8e-4ec8a3325298" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_eab431f4-1d21-46b8-8191-c34b148ebeec" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_839bb3b5-2128-46e4-93b2-111d35a8b8ac" xlink:to="loc_dei_CurrentFiscalYearEndDate_eab431f4-1d21-46b8-8191-c34b148ebeec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_cbf9a343-4a88-48fe-992c-64e1b58072a5" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentTransitionReport"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_839bb3b5-2128-46e4-93b2-111d35a8b8ac" xlink:to="loc_dei_DocumentTransitionReport_cbf9a343-4a88-48fe-992c-64e1b58072a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_44ac8e9c-ed23-479e-9579-f5cdc8ba5053" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_839bb3b5-2128-46e4-93b2-111d35a8b8ac" xlink:to="loc_dei_EntityFileNumber_44ac8e9c-ed23-479e-9579-f5cdc8ba5053" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_8e2990e5-ee45-464c-b20f-34bd972be4db" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_839bb3b5-2128-46e4-93b2-111d35a8b8ac" xlink:to="loc_dei_EntityRegistrantName_8e2990e5-ee45-464c-b20f-34bd972be4db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_1c33d85a-c413-4c49-96ff-cd6728e480f5" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_839bb3b5-2128-46e4-93b2-111d35a8b8ac" xlink:to="loc_dei_EntityIncorporationStateCountryCode_1c33d85a-c413-4c49-96ff-cd6728e480f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_2598035d-b266-4485-b19d-044e08959425" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_839bb3b5-2128-46e4-93b2-111d35a8b8ac" xlink:to="loc_dei_EntityTaxIdentificationNumber_2598035d-b266-4485-b19d-044e08959425" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_a260d508-a4b0-4f25-8719-93035594e125" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_839bb3b5-2128-46e4-93b2-111d35a8b8ac" xlink:to="loc_dei_EntityAddressAddressLine1_a260d508-a4b0-4f25-8719-93035594e125" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine2_0773b22f-bf5c-45c3-83da-4e15147b72e9" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine2"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_839bb3b5-2128-46e4-93b2-111d35a8b8ac" xlink:to="loc_dei_EntityAddressAddressLine2_0773b22f-bf5c-45c3-83da-4e15147b72e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_ab0436f3-d543-42cb-94b9-40fb8e577376" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_839bb3b5-2128-46e4-93b2-111d35a8b8ac" xlink:to="loc_dei_EntityAddressCityOrTown_ab0436f3-d543-42cb-94b9-40fb8e577376" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_0f6ceec8-9dfc-44cd-b450-c55c001b5b05" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_839bb3b5-2128-46e4-93b2-111d35a8b8ac" xlink:to="loc_dei_EntityAddressStateOrProvince_0f6ceec8-9dfc-44cd-b450-c55c001b5b05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_085df177-01c4-4c0b-a30b-d2b225bdf28c" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_839bb3b5-2128-46e4-93b2-111d35a8b8ac" xlink:to="loc_dei_EntityAddressPostalZipCode_085df177-01c4-4c0b-a30b-d2b225bdf28c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_b8ec211a-0fff-4e6f-afc7-bb2355401f2b" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_839bb3b5-2128-46e4-93b2-111d35a8b8ac" xlink:to="loc_dei_CityAreaCode_b8ec211a-0fff-4e6f-afc7-bb2355401f2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_43c2de41-b824-42ec-a975-a6862fc3fc7f" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_839bb3b5-2128-46e4-93b2-111d35a8b8ac" xlink:to="loc_dei_LocalPhoneNumber_43c2de41-b824-42ec-a975-a6862fc3fc7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_b8a14456-b397-444d-9b8b-3bb4d4c69eca" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_839bb3b5-2128-46e4-93b2-111d35a8b8ac" xlink:to="loc_dei_Security12bTitle_b8a14456-b397-444d-9b8b-3bb4d4c69eca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_804857b7-5bc6-4031-a2a7-6d5438794d98" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_839bb3b5-2128-46e4-93b2-111d35a8b8ac" xlink:to="loc_dei_TradingSymbol_804857b7-5bc6-4031-a2a7-6d5438794d98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_a7f479be-109b-49ea-b679-57f62f0e4845" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_839bb3b5-2128-46e4-93b2-111d35a8b8ac" xlink:to="loc_dei_SecurityExchangeName_a7f479be-109b-49ea-b679-57f62f0e4845" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityWellKnownSeasonedIssuer_ccbf1eec-569c-4ace-a3f8-9cb14a4388be" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityWellKnownSeasonedIssuer"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_839bb3b5-2128-46e4-93b2-111d35a8b8ac" xlink:to="loc_dei_EntityWellKnownSeasonedIssuer_ccbf1eec-569c-4ace-a3f8-9cb14a4388be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityVoluntaryFilers_d0cbdf36-db6d-4fca-ba59-140f651ad39c" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityVoluntaryFilers"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_839bb3b5-2128-46e4-93b2-111d35a8b8ac" xlink:to="loc_dei_EntityVoluntaryFilers_d0cbdf36-db6d-4fca-ba59-140f651ad39c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_a8ed5be4-564b-4dfb-b96d-be7cd5936a8f" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCurrentReportingStatus"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_839bb3b5-2128-46e4-93b2-111d35a8b8ac" xlink:to="loc_dei_EntityCurrentReportingStatus_a8ed5be4-564b-4dfb-b96d-be7cd5936a8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_6a272e14-3abf-49ac-908a-b1422aa34997" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_839bb3b5-2128-46e4-93b2-111d35a8b8ac" xlink:to="loc_dei_EntityInteractiveDataCurrent_6a272e14-3abf-49ac-908a-b1422aa34997" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_56fab336-9de1-4762-b6c9-84053b3a6b10" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFilerCategory"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_839bb3b5-2128-46e4-93b2-111d35a8b8ac" xlink:to="loc_dei_EntityFilerCategory_56fab336-9de1-4762-b6c9-84053b3a6b10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_a883c4ad-7c6d-4fbe-9beb-228ec1325478" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntitySmallBusiness"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_839bb3b5-2128-46e4-93b2-111d35a8b8ac" xlink:to="loc_dei_EntitySmallBusiness_a883c4ad-7c6d-4fbe-9beb-228ec1325478" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_5e19c936-da5d-4fcd-a02a-c42e15a62500" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_839bb3b5-2128-46e4-93b2-111d35a8b8ac" xlink:to="loc_dei_EntityEmergingGrowthCompany_5e19c936-da5d-4fcd-a02a-c42e15a62500" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_IcfrAuditorAttestationFlag_2b31abaf-3a92-4c70-98cc-3399138aeda7" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_IcfrAuditorAttestationFlag"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_839bb3b5-2128-46e4-93b2-111d35a8b8ac" xlink:to="loc_dei_IcfrAuditorAttestationFlag_2b31abaf-3a92-4c70-98cc-3399138aeda7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_76a1fd21-9aec-4e6a-93a8-b3aa1ada2940" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityShellCompany"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_839bb3b5-2128-46e4-93b2-111d35a8b8ac" xlink:to="loc_dei_EntityShellCompany_76a1fd21-9aec-4e6a-93a8-b3aa1ada2940" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityPublicFloat_a069b254-8911-414e-844e-4f6e83ee2673" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityPublicFloat"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_839bb3b5-2128-46e4-93b2-111d35a8b8ac" xlink:to="loc_dei_EntityPublicFloat_a069b254-8911-414e-844e-4f6e83ee2673" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_611b48b3-e320-4216-b34b-9b1e852bce93" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_839bb3b5-2128-46e4-93b2-111d35a8b8ac" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_611b48b3-e320-4216-b34b-9b1e852bce93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentsIncorporatedByReferenceTextBlock_52647590-3d3e-4f53-99ea-0a16d96f4134" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentsIncorporatedByReferenceTextBlock"/>
    <link:presentationArc order="31" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_839bb3b5-2128-46e4-93b2-111d35a8b8ac" xlink:to="loc_dei_DocumentsIncorporatedByReferenceTextBlock_52647590-3d3e-4f53-99ea-0a16d96f4134" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_7f76b22e-bf10-447b-b0c2-5d1f81584370" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="32" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_839bb3b5-2128-46e4-93b2-111d35a8b8ac" xlink:to="loc_dei_EntityCentralIndexKey_7f76b22e-bf10-447b-b0c2-5d1f81584370" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_279862f4-0b11-455d-8140-b7403c237277" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="33" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_839bb3b5-2128-46e4-93b2-111d35a8b8ac" xlink:to="loc_dei_AmendmentFlag_279862f4-0b11-455d-8140-b7403c237277" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_3afb1f16-d285-4102-88bd-373ee49a1f61" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalYearFocus"/>
    <link:presentationArc order="34" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_839bb3b5-2128-46e4-93b2-111d35a8b8ac" xlink:to="loc_dei_DocumentFiscalYearFocus_3afb1f16-d285-4102-88bd-373ee49a1f61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_10c9fac4-ba73-481d-9609-4a1b14d685b4" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:presentationArc order="35" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_839bb3b5-2128-46e4-93b2-111d35a8b8ac" xlink:to="loc_dei_DocumentFiscalPeriodFocus_10c9fac4-ba73-481d-9609-4a1b14d685b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFinStmtErrorCorrectionFlag_23db0d24-adc1-48cb-9bfb-fc7519d8e609" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFinStmtErrorCorrectionFlag"/>
    <link:presentationArc order="36" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_839bb3b5-2128-46e4-93b2-111d35a8b8ac" xlink:to="loc_dei_DocumentFinStmtErrorCorrectionFlag_23db0d24-adc1-48cb-9bfb-fc7519d8e609" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.lifevantage.com/role/AuditInformation" xlink:type="simple" xlink:href="lfvn-20250630.xsd#AuditInformation"/>
  <link:presentationLink xlink:role="http://www.lifevantage.com/role/AuditInformation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_AuditorInformationAbstract_2db9b230-b3a0-492b-861e-59b223b49e9c" xlink:href="lfvn-20250630.xsd#lfvn_AuditorInformationAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorName_b1d15925-7208-4705-a959-b52e725045f1" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AuditorName"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lfvn_AuditorInformationAbstract_2db9b230-b3a0-492b-861e-59b223b49e9c" xlink:to="loc_dei_AuditorName_b1d15925-7208-4705-a959-b52e725045f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorLocation_40e7bc9e-a448-41b9-a38b-93785afa5984" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AuditorLocation"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lfvn_AuditorInformationAbstract_2db9b230-b3a0-492b-861e-59b223b49e9c" xlink:to="loc_dei_AuditorLocation_40e7bc9e-a448-41b9-a38b-93785afa5984" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorFirmId_09dbb02a-bb95-4791-8074-aa51fbfd0490" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AuditorFirmId"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lfvn_AuditorInformationAbstract_2db9b230-b3a0-492b-861e-59b223b49e9c" xlink:to="loc_dei_AuditorFirmId_09dbb02a-bb95-4791-8074-aa51fbfd0490" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.lifevantage.com/role/CONSOLIDATEDBALANCESHEETS" xlink:type="simple" xlink:href="lfvn-20250630.xsd#CONSOLIDATEDBALANCESHEETS"/>
  <link:presentationLink xlink:role="http://www.lifevantage.com/role/CONSOLIDATEDBALANCESHEETS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_9e8b2f2b-0624-4b38-acea-dc2f73467cca" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_e5fae47d-1536-4bc4-9017-d653c6c4775f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_9e8b2f2b-0624-4b38-acea-dc2f73467cca" xlink:to="loc_us-gaap_AssetsAbstract_e5fae47d-1536-4bc4-9017-d653c6c4775f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract_56c455ec-1bad-460c-8b2d-f62456dea180" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_e5fae47d-1536-4bc4-9017-d653c6c4775f" xlink:to="loc_us-gaap_AssetsCurrentAbstract_56c455ec-1bad-460c-8b2d-f62456dea180" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_f7cad36c-8b8a-4fab-b4f0-80122ba322e8" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_56c455ec-1bad-460c-8b2d-f62456dea180" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_f7cad36c-8b8a-4fab-b4f0-80122ba322e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_c7182240-7f28-48f9-a4d8-c0eec100bea8" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_56c455ec-1bad-460c-8b2d-f62456dea180" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_c7182240-7f28-48f9-a4d8-c0eec100bea8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesReceivable_45698846-3357-42ab-a0eb-0a6cf80b23a8" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxesReceivable"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_56c455ec-1bad-460c-8b2d-f62456dea180" xlink:to="loc_us-gaap_IncomeTaxesReceivable_45698846-3357-42ab-a0eb-0a6cf80b23a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_c6a2497d-0a40-4e77-9fe4-69bf82fa0809" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_56c455ec-1bad-460c-8b2d-f62456dea180" xlink:to="loc_us-gaap_InventoryNet_c6a2497d-0a40-4e77-9fe4-69bf82fa0809" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_db6dd4c7-4ac3-40d3-b8af-e7f91ae89a32" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_56c455ec-1bad-460c-8b2d-f62456dea180" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_db6dd4c7-4ac3-40d3-b8af-e7f91ae89a32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_4dcc8af9-7972-4936-a8d1-ef2512cb61af" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetsCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_56c455ec-1bad-460c-8b2d-f62456dea180" xlink:to="loc_us-gaap_AssetsCurrent_4dcc8af9-7972-4936-a8d1-ef2512cb61af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsNoncurrentAbstract_74c671ad-19c1-4cae-8c4e-286b77f5dab6" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetsNoncurrentAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_e5fae47d-1536-4bc4-9017-d653c6c4775f" xlink:to="loc_us-gaap_AssetsNoncurrentAbstract_74c671ad-19c1-4cae-8c4e-286b77f5dab6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_be031932-2540-4e6a-ad5d-5a6ba473ee3c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsNoncurrentAbstract_74c671ad-19c1-4cae-8c4e-286b77f5dab6" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_be031932-2540-4e6a-ad5d-5a6ba473ee3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_3477c4e4-5d0f-42c5-8a5f-20928aca9910" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsNoncurrentAbstract_74c671ad-19c1-4cae-8c4e-286b77f5dab6" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_3477c4e4-5d0f-42c5-8a5f-20928aca9910" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_18521f23-15ba-41fc-86b2-9761fc6b0a89" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsNoncurrentAbstract_74c671ad-19c1-4cae-8c4e-286b77f5dab6" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_18521f23-15ba-41fc-86b2-9761fc6b0a89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet_2899b6a9-20c5-4679-b6f1-efc62935bb2a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsNoncurrentAbstract_74c671ad-19c1-4cae-8c4e-286b77f5dab6" xlink:to="loc_us-gaap_DeferredIncomeTaxAssetsNet_2899b6a9-20c5-4679-b6f1-efc62935bb2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_1f42ba48-69f2-4cb8-9133-cfcc6a0e07ae" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsNoncurrentAbstract_74c671ad-19c1-4cae-8c4e-286b77f5dab6" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_1f42ba48-69f2-4cb8-9133-cfcc6a0e07ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_584fe300-cf21-4c5a-a040-0f207ba84ccb" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Assets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_e5fae47d-1536-4bc4-9017-d653c6c4775f" xlink:to="loc_us-gaap_Assets_584fe300-cf21-4c5a-a040-0f207ba84ccb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_0fd98fea-6e13-4313-b203-5a049b1cac38" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_9e8b2f2b-0624-4b38-acea-dc2f73467cca" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_0fd98fea-6e13-4313-b203-5a049b1cac38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_840b8383-0234-42f8-84ae-c34e35e2033b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_0fd98fea-6e13-4313-b203-5a049b1cac38" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_840b8383-0234-42f8-84ae-c34e35e2033b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_4ea7e536-6e73-4e06-af8d-7fe8a3e1185a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_840b8383-0234-42f8-84ae-c34e35e2033b" xlink:to="loc_us-gaap_AccountsPayableCurrent_4ea7e536-6e73-4e06-af8d-7fe8a3e1185a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedSalesCommissionCurrent_4760d59b-1309-4e02-a87c-4a1ce86371df" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccruedSalesCommissionCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_840b8383-0234-42f8-84ae-c34e35e2033b" xlink:to="loc_us-gaap_AccruedSalesCommissionCurrent_4760d59b-1309-4e02-a87c-4a1ce86371df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesCurrent_0a210ff0-b810-485b-8b1e-f26191c8ad73" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccruedIncomeTaxesCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_840b8383-0234-42f8-84ae-c34e35e2033b" xlink:to="loc_us-gaap_AccruedIncomeTaxesCurrent_0a210ff0-b810-485b-8b1e-f26191c8ad73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_c265a3b8-0e44-408d-9a40-e079da701214" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_840b8383-0234-42f8-84ae-c34e35e2033b" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_c265a3b8-0e44-408d-9a40-e079da701214" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_ce22edb0-e4f3-40bf-bf50-7fa95e69b8b5" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_840b8383-0234-42f8-84ae-c34e35e2033b" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_ce22edb0-e4f3-40bf-bf50-7fa95e69b8b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_845d07a0-ac03-4bae-adb8-a99d8051e565" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_840b8383-0234-42f8-84ae-c34e35e2033b" xlink:to="loc_us-gaap_LiabilitiesCurrent_845d07a0-ac03-4bae-adb8-a99d8051e565" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_72891f2e-5aa2-43ce-8d9f-10adfea74d65" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_840b8383-0234-42f8-84ae-c34e35e2033b" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_72891f2e-5aa2-43ce-8d9f-10adfea74d65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_80e856c6-6d22-4fc9-b49a-7f4ee95bb7e9" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_840b8383-0234-42f8-84ae-c34e35e2033b" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_80e856c6-6d22-4fc9-b49a-7f4ee95bb7e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_e042c59b-88cf-451f-acef-33e57be233fe" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Liabilities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_0fd98fea-6e13-4313-b203-5a049b1cac38" xlink:to="loc_us-gaap_Liabilities_e042c59b-88cf-451f-acef-33e57be233fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_3bbb2d25-ce7e-420a-9787-1e8e497c421a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_0fd98fea-6e13-4313-b203-5a049b1cac38" xlink:to="loc_us-gaap_CommitmentsAndContingencies_3bbb2d25-ce7e-420a-9787-1e8e497c421a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract_c62f194b-7e23-490b-8220-858bf1a7f6f3" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_0fd98fea-6e13-4313-b203-5a049b1cac38" xlink:to="loc_us-gaap_StockholdersEquityAbstract_c62f194b-7e23-490b-8220-858bf1a7f6f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_3267ab80-39a2-47fb-b61e-8428d05184b8" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PreferredStockValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_c62f194b-7e23-490b-8220-858bf1a7f6f3" xlink:to="loc_us-gaap_PreferredStockValue_3267ab80-39a2-47fb-b61e-8428d05184b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_053a02e8-8a03-400d-9c39-6702cdde1778" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_c62f194b-7e23-490b-8220-858bf1a7f6f3" xlink:to="loc_us-gaap_CommonStockValue_053a02e8-8a03-400d-9c39-6702cdde1778" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock_f07fcd66-b190-4557-96ba-408ec182c0b1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_c62f194b-7e23-490b-8220-858bf1a7f6f3" xlink:to="loc_us-gaap_AdditionalPaidInCapitalCommonStock_f07fcd66-b190-4557-96ba-408ec182c0b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_49404244-000a-4342-ad1c-cc14f3015562" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_c62f194b-7e23-490b-8220-858bf1a7f6f3" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_49404244-000a-4342-ad1c-cc14f3015562" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_cbc84d42-3ed8-41df-8328-710ab98423ec" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_c62f194b-7e23-490b-8220-858bf1a7f6f3" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_cbc84d42-3ed8-41df-8328-710ab98423ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_eac8bec9-1d07-46bd-a127-78499beab423" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_c62f194b-7e23-490b-8220-858bf1a7f6f3" xlink:to="loc_us-gaap_StockholdersEquity_eac8bec9-1d07-46bd-a127-78499beab423" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_97d08b8c-3ea9-4abc-8d85-63e4ac7966ea" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_0fd98fea-6e13-4313-b203-5a049b1cac38" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_97d08b8c-3ea9-4abc-8d85-63e4ac7966ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.lifevantage.com/role/CONSOLIDATEDBALANCESHEETSParenthetical" xlink:type="simple" xlink:href="lfvn-20250630.xsd#CONSOLIDATEDBALANCESHEETSParenthetical"/>
  <link:presentationLink xlink:role="http://www.lifevantage.com/role/CONSOLIDATEDBALANCESHEETSParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_fe6e36ae-382a-4299-bc93-5493baf4f2d8" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_783627a8-c017-41b9-9251-f285ff5c4412" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_fe6e36ae-382a-4299-bc93-5493baf4f2d8" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_783627a8-c017-41b9-9251-f285ff5c4412" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_c1ee1b84-e984-4113-95e5-8e0e3271f4b9" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_fe6e36ae-382a-4299-bc93-5493baf4f2d8" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_c1ee1b84-e984-4113-95e5-8e0e3271f4b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued_efdd533b-6bb2-4244-a03e-e273f3c4d975" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_fe6e36ae-382a-4299-bc93-5493baf4f2d8" xlink:to="loc_us-gaap_PreferredStockSharesIssued_efdd533b-6bb2-4244-a03e-e273f3c4d975" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding_8d2cdc5c-3e17-4b19-85ab-df6d2b457b3a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_fe6e36ae-382a-4299-bc93-5493baf4f2d8" xlink:to="loc_us-gaap_PreferredStockSharesOutstanding_8d2cdc5c-3e17-4b19-85ab-df6d2b457b3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_a29906cd-25f7-4599-bdbc-96f67c6cbe2c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_fe6e36ae-382a-4299-bc93-5493baf4f2d8" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_a29906cd-25f7-4599-bdbc-96f67c6cbe2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_13210733-cc5f-4bf0-8479-1db9e461cb35" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_fe6e36ae-382a-4299-bc93-5493baf4f2d8" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_13210733-cc5f-4bf0-8479-1db9e461cb35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_7367b2c3-bcd9-4bd5-b49d-42bf631e054d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_fe6e36ae-382a-4299-bc93-5493baf4f2d8" xlink:to="loc_us-gaap_CommonStockSharesIssued_7367b2c3-bcd9-4bd5-b49d-42bf631e054d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_e0bbc452-3e4c-4f6c-814f-0c74a76bc23f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_fe6e36ae-382a-4299-bc93-5493baf4f2d8" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_e0bbc452-3e4c-4f6c-814f-0c74a76bc23f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.lifevantage.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOME" xlink:type="simple" xlink:href="lfvn-20250630.xsd#CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOME"/>
  <link:presentationLink xlink:role="http://www.lifevantage.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOME" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract_be99a055-50db-42f1-9696-6bc1c1305111" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerProductAndServiceExtensibleList_48d44e23-b8e6-4ece-842e-8edcf61e05ca" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RevenueFromContractWithCustomerProductAndServiceExtensibleList"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_be99a055-50db-42f1-9696-6bc1c1305111" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerProductAndServiceExtensibleList_48d44e23-b8e6-4ece-842e-8edcf61e05ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_bbf443cf-7610-4bb0-9a4f-77dc46761e8d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_be99a055-50db-42f1-9696-6bc1c1305111" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_bbf443cf-7610-4bb0-9a4f-77dc46761e8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_027369d0-15cb-4625-a4c8-fdafe40519eb" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_be99a055-50db-42f1-9696-6bc1c1305111" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_027369d0-15cb-4625-a4c8-fdafe40519eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_d6c2b268-b5e8-4a2c-9bf8-b2a18821104d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GrossProfit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_be99a055-50db-42f1-9696-6bc1c1305111" xlink:to="loc_us-gaap_GrossProfit_d6c2b268-b5e8-4a2c-9bf8-b2a18821104d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract_9f163d05-0234-4979-bf3f-a41e8b29e9ae" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_be99a055-50db-42f1-9696-6bc1c1305111" xlink:to="loc_us-gaap_OperatingExpensesAbstract_9f163d05-0234-4979-bf3f-a41e8b29e9ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_CommissionAndIncentives_4093705b-32d6-409c-b9a6-1908b1ee6eb6" xlink:href="lfvn-20250630.xsd#lfvn_CommissionAndIncentives"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_9f163d05-0234-4979-bf3f-a41e8b29e9ae" xlink:to="loc_lfvn_CommissionAndIncentives_4093705b-32d6-409c-b9a6-1908b1ee6eb6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_3a5bb3d7-e7a5-4c2d-a8f3-a8f02b7e1c52" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_9f163d05-0234-4979-bf3f-a41e8b29e9ae" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_3a5bb3d7-e7a5-4c2d-a8f3-a8f02b7e1c52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_87832203-a470-4220-9ad4-bfc21fdf5af8" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingExpenses"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_9f163d05-0234-4979-bf3f-a41e8b29e9ae" xlink:to="loc_us-gaap_OperatingExpenses_87832203-a470-4220-9ad4-bfc21fdf5af8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_9043899b-e4fa-4b8b-aa8d-1b91a5c5b0f1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_be99a055-50db-42f1-9696-6bc1c1305111" xlink:to="loc_us-gaap_OperatingIncomeLoss_9043899b-e4fa-4b8b-aa8d-1b91a5c5b0f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpenseAbstract_9e076a02-c8f6-417a-9119-c823757c5634" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NonoperatingIncomeExpenseAbstract"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_be99a055-50db-42f1-9696-6bc1c1305111" xlink:to="loc_us-gaap_NonoperatingIncomeExpenseAbstract_9e076a02-c8f6-417a-9119-c823757c5634" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRevenueExpenseNet_6e83ffa2-7225-4725-b53d-1481a213579c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InterestRevenueExpenseNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_9e076a02-c8f6-417a-9119-c823757c5634" xlink:to="loc_us-gaap_InterestRevenueExpenseNet_6e83ffa2-7225-4725-b53d-1481a213579c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_9e8a7cc8-1d92-4bfe-b0b5-0cb6f3787913" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_9e076a02-c8f6-417a-9119-c823757c5634" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_9e8a7cc8-1d92-4bfe-b0b5-0cb6f3787913" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_63d1f3b2-6725-4626-be37-0e288ae4fcc5" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_9e076a02-c8f6-417a-9119-c823757c5634" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_63d1f3b2-6725-4626-be37-0e288ae4fcc5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_5596e37c-0739-428a-897c-d1d639a3218a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_be99a055-50db-42f1-9696-6bc1c1305111" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_5596e37c-0739-428a-897c-d1d639a3218a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_09af01b8-5a7d-462a-9ddc-8af14494538d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_be99a055-50db-42f1-9696-6bc1c1305111" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_09af01b8-5a7d-462a-9ddc-8af14494538d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_3a517fa5-c026-438c-b990-daa4a7f5953d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_be99a055-50db-42f1-9696-6bc1c1305111" xlink:to="loc_us-gaap_NetIncomeLoss_3a517fa5-c026-438c-b990-daa4a7f5953d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_c79142c6-1a3c-427b-9202-049d57b72843" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_be99a055-50db-42f1-9696-6bc1c1305111" xlink:to="loc_us-gaap_EarningsPerShareAbstract_c79142c6-1a3c-427b-9202-049d57b72843" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_997c95a4-8830-48ca-be80-e5f6fd7abc3f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_c79142c6-1a3c-427b-9202-049d57b72843" xlink:to="loc_us-gaap_EarningsPerShareBasic_997c95a4-8830-48ca-be80-e5f6fd7abc3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_14095c9a-94e2-4fcd-8287-0b332991621d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_c79142c6-1a3c-427b-9202-049d57b72843" xlink:to="loc_us-gaap_EarningsPerShareDiluted_14095c9a-94e2-4fcd-8287-0b332991621d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract_4e140dc7-6c66-442e-bd7d-d4a606b0836a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_be99a055-50db-42f1-9696-6bc1c1305111" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract_4e140dc7-6c66-442e-bd7d-d4a606b0836a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_7c1b3c3b-52c2-4151-a613-e9bc7bcd2d4f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract_4e140dc7-6c66-442e-bd7d-d4a606b0836a" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_7c1b3c3b-52c2-4151-a613-e9bc7bcd2d4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_4a665882-82d5-406c-bd64-13aee04539d4" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract_4e140dc7-6c66-442e-bd7d-d4a606b0836a" xlink:to="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_4a665882-82d5-406c-bd64-13aee04539d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_be9952ae-d8c1-4cdd-9ff0-bfe66062bf18" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_be99a055-50db-42f1-9696-6bc1c1305111" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_be9952ae-d8c1-4cdd-9ff0-bfe66062bf18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_0d6965bc-5054-4c15-9bfa-5df263ecf263" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_be9952ae-d8c1-4cdd-9ff0-bfe66062bf18" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_0d6965bc-5054-4c15-9bfa-5df263ecf263" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_a381685f-209f-4752-8d05-2141f7847337" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_be9952ae-d8c1-4cdd-9ff0-bfe66062bf18" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_a381685f-209f-4752-8d05-2141f7847337" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_984f930b-b0c7-4420-9219-72ea377a7b89" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_be99a055-50db-42f1-9696-6bc1c1305111" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_984f930b-b0c7-4420-9219-72ea377a7b89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.lifevantage.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" xlink:type="simple" xlink:href="lfvn-20250630.xsd#CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"/>
  <link:presentationLink xlink:role="http://www.lifevantage.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_913373a8-c71d-481d-99ab-7c04448680f7" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_2da2c356-67ae-49a7-8cba-e6e3aec0c79d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_913373a8-c71d-481d-99ab-7c04448680f7" xlink:to="loc_us-gaap_StatementTable_2da2c356-67ae-49a7-8cba-e6e3aec0c79d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_4fd6067b-9b69-40e4-abd4-9dcdda247a4f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_2da2c356-67ae-49a7-8cba-e6e3aec0c79d" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_4fd6067b-9b69-40e4-abd4-9dcdda247a4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_54575689-c1be-4dba-a406-a6ed4a44d0c5" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_4fd6067b-9b69-40e4-abd4-9dcdda247a4f" xlink:to="loc_us-gaap_EquityComponentDomain_54575689-c1be-4dba-a406-a6ed4a44d0c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_573666f0-a793-45f8-94a5-8dc3d886be13" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_54575689-c1be-4dba-a406-a6ed4a44d0c5" xlink:to="loc_us-gaap_CommonStockMember_573666f0-a793-45f8-94a5-8dc3d886be13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_b25354a5-578f-4044-9d9d-4433f1ff3048" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_54575689-c1be-4dba-a406-a6ed4a44d0c5" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_b25354a5-578f-4044-9d9d-4433f1ff3048" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_cf0f81ef-d8ac-4661-9419-055519ee936a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_54575689-c1be-4dba-a406-a6ed4a44d0c5" xlink:to="loc_us-gaap_RetainedEarningsMember_cf0f81ef-d8ac-4661-9419-055519ee936a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_11f01954-7381-463e-8fa5-0e24396d7bae" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_54575689-c1be-4dba-a406-a6ed4a44d0c5" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_11f01954-7381-463e-8fa5-0e24396d7bae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_cde4e02c-c63b-42a7-abbe-327a6950055a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_2da2c356-67ae-49a7-8cba-e6e3aec0c79d" xlink:to="loc_us-gaap_StatementLineItems_cde4e02c-c63b-42a7-abbe-327a6950055a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_94946c27-d0f7-4e8c-82e5-16a1045a4cb3" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_cde4e02c-c63b-42a7-abbe-327a6950055a" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_94946c27-d0f7-4e8c-82e5-16a1045a4cb3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_f4826a77-a6bb-4092-b5f9-48970ab2b3d2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_94946c27-d0f7-4e8c-82e5-16a1045a4cb3" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_f4826a77-a6bb-4092-b5f9-48970ab2b3d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_2d9897f9-9062-4489-9e10-ef2631dd4444" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_94946c27-d0f7-4e8c-82e5-16a1045a4cb3" xlink:to="loc_us-gaap_StockholdersEquity_2d9897f9-9062-4489-9e10-ef2631dd4444" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_77b115f4-3513-4cc7-9410-f4605d00c581" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_94946c27-d0f7-4e8c-82e5-16a1045a4cb3" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_77b115f4-3513-4cc7-9410-f4605d00c581" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_654ba936-779f-42b0-a0f8-73fa55abc3cf" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_94946c27-d0f7-4e8c-82e5-16a1045a4cb3" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_654ba936-779f-42b0-a0f8-73fa55abc3cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_472877af-0b6e-4b0d-b60c-79e068c33a49" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_94946c27-d0f7-4e8c-82e5-16a1045a4cb3" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_472877af-0b6e-4b0d-b60c-79e068c33a49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_f25973a2-94bf-4cfe-a1b1-cb054c028639" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_94946c27-d0f7-4e8c-82e5-16a1045a4cb3" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_f25973a2-94bf-4cfe-a1b1-cb054c028639" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_d0aa29e6-bd5b-4a09-9f0e-e6eb7c380619" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_94946c27-d0f7-4e8c-82e5-16a1045a4cb3" xlink:to="loc_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_d0aa29e6-bd5b-4a09-9f0e-e6eb7c380619" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_1177665e-f1c3-48c2-a3e9-6e42f0dfc310" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_94946c27-d0f7-4e8c-82e5-16a1045a4cb3" xlink:to="loc_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_1177665e-f1c3-48c2-a3e9-6e42f0dfc310" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue_7239f0fd-66ab-4803-865d-9c15ab89d84d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodValue"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_94946c27-d0f7-4e8c-82e5-16a1045a4cb3" xlink:to="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue_7239f0fd-66ab-4803-865d-9c15ab89d84d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodShares_c98b1c2e-f276-45ab-96bf-30b75a7ffce2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockRepurchasedDuringPeriodShares"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_94946c27-d0f7-4e8c-82e5-16a1045a4cb3" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodShares_c98b1c2e-f276-45ab-96bf-30b75a7ffce2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodValue_1c153e0c-7118-4e12-9596-70ed2659e9c4" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockRepurchasedDuringPeriodValue"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_94946c27-d0f7-4e8c-82e5-16a1045a4cb3" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodValue_1c153e0c-7118-4e12-9596-70ed2659e9c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCash_0e295ab6-aa6b-4a6b-a5e7-904792b9a700" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DividendsCash"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_94946c27-d0f7-4e8c-82e5-16a1045a4cb3" xlink:to="loc_us-gaap_DividendsCash_0e295ab6-aa6b-4a6b-a5e7-904792b9a700" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_1c706376-40ba-453c-83c2-0c84e0df0e86" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_94946c27-d0f7-4e8c-82e5-16a1045a4cb3" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_1c706376-40ba-453c-83c2-0c84e0df0e86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_11bed733-28c1-4855-aced-4487da26193e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_94946c27-d0f7-4e8c-82e5-16a1045a4cb3" xlink:to="loc_us-gaap_NetIncomeLoss_11bed733-28c1-4855-aced-4487da26193e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_42effda0-5c7e-4988-9ef8-0c96434a3515" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_94946c27-d0f7-4e8c-82e5-16a1045a4cb3" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_42effda0-5c7e-4988-9ef8-0c96434a3515" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_7d37f78b-62a4-44bf-bc22-b4bc64d2e315" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_94946c27-d0f7-4e8c-82e5-16a1045a4cb3" xlink:to="loc_us-gaap_StockholdersEquity_7d37f78b-62a4-44bf-bc22-b4bc64d2e315" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.lifevantage.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="simple" xlink:href="lfvn-20250630.xsd#CONSOLIDATEDSTATEMENTSOFCASHFLOWS"/>
  <link:presentationLink xlink:role="http://www.lifevantage.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_fb3751fa-34ea-4644-b642-3aa6f002d6cf" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_958b178e-243e-43a1-a33f-20b13dc1da7a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_fb3751fa-34ea-4644-b642-3aa6f002d6cf" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_958b178e-243e-43a1-a33f-20b13dc1da7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_068423ab-9b34-4b3e-9854-0fad0a85ea78" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_958b178e-243e-43a1-a33f-20b13dc1da7a" xlink:to="loc_us-gaap_NetIncomeLoss_068423ab-9b34-4b3e-9854-0fad0a85ea78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_8bff7770-029d-4ccf-9c33-3768a2d48f26" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_958b178e-243e-43a1-a33f-20b13dc1da7a" xlink:to="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_8bff7770-029d-4ccf-9c33-3768a2d48f26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_3ce2daf6-056e-4dd6-a88b-531e2e6c5648" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_8bff7770-029d-4ccf-9c33-3768a2d48f26" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_3ce2daf6-056e-4dd6-a88b-531e2e6c5648" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_ead422e6-740f-4841-90c6-4bfa214d3c75" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_8bff7770-029d-4ccf-9c33-3768a2d48f26" xlink:to="loc_us-gaap_ShareBasedCompensation_ead422e6-740f-4841-90c6-4bfa214d3c75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_8cfafba0-37f0-45ad-aeb4-9b84946545f3" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_8bff7770-029d-4ccf-9c33-3768a2d48f26" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_8cfafba0-37f0-45ad-aeb4-9b84946545f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_5368145d-1a59-44a2-89a1-8e7f88ac8378" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GainLossOnSaleOfPropertyPlantEquipment"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_8bff7770-029d-4ccf-9c33-3768a2d48f26" xlink:to="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_5368145d-1a59-44a2-89a1-8e7f88ac8378" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCosts_61626128-079e-4365-9e5e-6e4fe652ce43" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AmortizationOfFinancingCosts"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_8bff7770-029d-4ccf-9c33-3768a2d48f26" xlink:to="loc_us-gaap_AmortizationOfFinancingCosts_61626128-079e-4365-9e5e-6e4fe652ce43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxesAndTaxCredits_a060ee86-f185-4a66-81c6-1bc05ff54adf" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredIncomeTaxesAndTaxCredits"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_8bff7770-029d-4ccf-9c33-3768a2d48f26" xlink:to="loc_us-gaap_DeferredIncomeTaxesAndTaxCredits_a060ee86-f185-4a66-81c6-1bc05ff54adf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_31b36ae5-1d39-4e88-a22a-07597e62276e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_8bff7770-029d-4ccf-9c33-3768a2d48f26" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_31b36ae5-1d39-4e88-a22a-07597e62276e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_6ff25c4f-3092-4b21-a270-f53442b0de9d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_31b36ae5-1d39-4e88-a22a-07597e62276e" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_6ff25c4f-3092-4b21-a270-f53442b0de9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInIncomeTaxesReceivable_24216933-7e0b-4cfa-bd1b-a2e2893ead24" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInIncomeTaxesReceivable"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_31b36ae5-1d39-4e88-a22a-07597e62276e" xlink:to="loc_us-gaap_IncreaseDecreaseInIncomeTaxesReceivable_24216933-7e0b-4cfa-bd1b-a2e2893ead24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_d969142f-9252-4955-a30c-01af90c0119a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_31b36ae5-1d39-4e88-a22a-07597e62276e" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_d969142f-9252-4955-a30c-01af90c0119a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidExpense_95a7fe8e-c431-44b4-b4d5-ada4313aed1c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInPrepaidExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_31b36ae5-1d39-4e88-a22a-07597e62276e" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidExpense_95a7fe8e-c431-44b4-b4d5-ada4313aed1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_08e3887d-6b2c-4ec6-ab76-7b80b372768a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentAssets"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_31b36ae5-1d39-4e88-a22a-07597e62276e" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_08e3887d-6b2c-4ec6-ab76-7b80b372768a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_b7898bd0-b122-4e47-9435-0629af9c4b86" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_31b36ae5-1d39-4e88-a22a-07597e62276e" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_b7898bd0-b122-4e47-9435-0629af9c4b86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_2330e08b-a8d9-4482-bf83-f1bbac2610a7" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_31b36ae5-1d39-4e88-a22a-07597e62276e" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_2330e08b-a8d9-4482-bf83-f1bbac2610a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_fd9ee65b-645a-430f-8c23-687dc24299f2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_31b36ae5-1d39-4e88-a22a-07597e62276e" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_fd9ee65b-645a-430f-8c23-687dc24299f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_800788d6-b140-45d4-931d-4724330c8d3e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInOperatingLeaseLiability"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_31b36ae5-1d39-4e88-a22a-07597e62276e" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_800788d6-b140-45d4-931d-4724330c8d3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities_bef9a619-8920-4080-9ee2-ad3bcafc23dd" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_31b36ae5-1d39-4e88-a22a-07597e62276e" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities_bef9a619-8920-4080-9ee2-ad3bcafc23dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_21a4a293-543a-4867-a8eb-8a21dbbab349" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_958b178e-243e-43a1-a33f-20b13dc1da7a" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_21a4a293-543a-4867-a8eb-8a21dbbab349" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_c618cdd8-91ac-431b-9fa4-1997b35bf71d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_fb3751fa-34ea-4644-b642-3aa6f002d6cf" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_c618cdd8-91ac-431b-9fa4-1997b35bf71d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_d541d2f7-af7e-4208-afec-c2c1cfcc8d1e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_c618cdd8-91ac-431b-9fa4-1997b35bf71d" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_d541d2f7-af7e-4208-afec-c2c1cfcc8d1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_37efe2ae-8820-455d-9406-5d070e014db9" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_c618cdd8-91ac-431b-9fa4-1997b35bf71d" xlink:to="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_37efe2ae-8820-455d-9406-5d070e014db9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_79e96e11-fbbd-4ff5-b649-7cb23cb1c59f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_c618cdd8-91ac-431b-9fa4-1997b35bf71d" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_79e96e11-fbbd-4ff5-b649-7cb23cb1c59f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_c3458207-da64-4ab5-abac-a6179f9a2585" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_fb3751fa-34ea-4644-b642-3aa6f002d6cf" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_c3458207-da64-4ab5-abac-a6179f9a2585" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfFinancingCosts_29d6f669-0c31-4c18-93c3-2b7cd3fb2190" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PaymentsOfFinancingCosts"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_c3458207-da64-4ab5-abac-a6179f9a2585" xlink:to="loc_us-gaap_PaymentsOfFinancingCosts_29d6f669-0c31-4c18-93c3-2b7cd3fb2190" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_2a89f3ec-cca6-4b9b-88f6-f399f9f120d0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_c3458207-da64-4ab5-abac-a6179f9a2585" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_2a89f3ec-cca6-4b9b-88f6-f399f9f120d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividends_3e2149a0-0e71-4d2a-9e0a-a6f2a806422f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PaymentsOfDividends"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_c3458207-da64-4ab5-abac-a6179f9a2585" xlink:to="loc_us-gaap_PaymentsOfDividends_3e2149a0-0e71-4d2a-9e0a-a6f2a806422f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_69a73ea2-5fdd-4300-9a24-79d68e138e15" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_c3458207-da64-4ab5-abac-a6179f9a2585" xlink:to="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_69a73ea2-5fdd-4300-9a24-79d68e138e15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_ProceedsFromIssuanceOfCommonStockUnderEmployeeStockPurchasePlan_8d750f45-c1fa-4373-b052-f48e1069a40b" xlink:href="lfvn-20250630.xsd#lfvn_ProceedsFromIssuanceOfCommonStockUnderEmployeeStockPurchasePlan"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_c3458207-da64-4ab5-abac-a6179f9a2585" xlink:to="loc_lfvn_ProceedsFromIssuanceOfCommonStockUnderEmployeeStockPurchasePlan_8d750f45-c1fa-4373-b052-f48e1069a40b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_bd159b24-3cfb-4374-a3b8-bf94e8ee9297" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_c3458207-da64-4ab5-abac-a6179f9a2585" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_bd159b24-3cfb-4374-a3b8-bf94e8ee9297" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_638a4807-acfd-46fd-a04e-ed8c0ee64fe0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_fb3751fa-34ea-4644-b642-3aa6f002d6cf" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_638a4807-acfd-46fd-a04e-ed8c0ee64fe0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_65ae444d-0af7-4ff8-9c0e-4331e075fe2b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_fb3751fa-34ea-4644-b642-3aa6f002d6cf" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_65ae444d-0af7-4ff8-9c0e-4331e075fe2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_4d7816f3-2cf7-4234-9e53-8fa02d555cfe" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_fb3751fa-34ea-4644-b642-3aa6f002d6cf" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_4d7816f3-2cf7-4234-9e53-8fa02d555cfe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_3adcdcca-6e53-49ef-aea1-207320950c25" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_fb3751fa-34ea-4644-b642-3aa6f002d6cf" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_3adcdcca-6e53-49ef-aea1-207320950c25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract_e2beabc5-2825-4882-a79f-965a5f28132f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_fb3751fa-34ea-4644-b642-3aa6f002d6cf" xlink:to="loc_us-gaap_SupplementalCashFlowInformationAbstract_e2beabc5-2825-4882-a79f-965a5f28132f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet_69b76349-547a-4436-86fc-9920937b9a22" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InterestPaidNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_e2beabc5-2825-4882-a79f-965a5f28132f" xlink:to="loc_us-gaap_InterestPaidNet_69b76349-547a-4436-86fc-9920937b9a22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaid_ab91cbb0-3ace-4961-9723-0016f5b136fc" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxesPaid"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_e2beabc5-2825-4882-a79f-965a5f28132f" xlink:to="loc_us-gaap_IncomeTaxesPaid_ab91cbb0-3ace-4961-9723-0016f5b136fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.lifevantage.com/role/TheCompany" xlink:type="simple" xlink:href="lfvn-20250630.xsd#TheCompany"/>
  <link:presentationLink xlink:role="http://www.lifevantage.com/role/TheCompany" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_cdb3efbc-b62c-4ae3-9953-f1de2bacf70c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_9ec16f91-2fa0-4fd6-80d1-87cbc10b7833" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_cdb3efbc-b62c-4ae3-9953-f1de2bacf70c" xlink:to="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_9ec16f91-2fa0-4fd6-80d1-87cbc10b7833" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.lifevantage.com/role/SummaryofSignificantAccountingPolicies" xlink:type="simple" xlink:href="lfvn-20250630.xsd#SummaryofSignificantAccountingPolicies"/>
  <link:presentationLink xlink:role="http://www.lifevantage.com/role/SummaryofSignificantAccountingPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_0b0d9382-cf0e-471f-8d38-b7ae1bea5e0b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantAccountingPoliciesTextBlock_0554044f-7052-431a-8c2a-be67e300bd8d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0b0d9382-cf0e-471f-8d38-b7ae1bea5e0b" xlink:to="loc_us-gaap_SignificantAccountingPoliciesTextBlock_0554044f-7052-431a-8c2a-be67e300bd8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.lifevantage.com/role/Revenue" xlink:type="simple" xlink:href="lfvn-20250630.xsd#Revenue"/>
  <link:presentationLink xlink:role="http://www.lifevantage.com/role/Revenue" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_fc7b9fd3-8239-443b-a18e-659f35651da3" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerTextBlock_c56a02cc-516e-4d82-8707-714b0973dece" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_fc7b9fd3-8239-443b-a18e-659f35651da3" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerTextBlock_c56a02cc-516e-4d82-8707-714b0973dece" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.lifevantage.com/role/PropertyandEquipmentNet" xlink:type="simple" xlink:href="lfvn-20250630.xsd#PropertyandEquipmentNet"/>
  <link:presentationLink xlink:role="http://www.lifevantage.com/role/PropertyandEquipmentNet" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_6c0182ec-4c0d-45b3-816c-08842f05b6b0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_f8b51332-e076-4fbe-96c5-8f610f0b1e8d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_6c0182ec-4c0d-45b3-816c-08842f05b6b0" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_f8b51332-e076-4fbe-96c5-8f610f0b1e8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.lifevantage.com/role/IntangibleAssetsNet" xlink:type="simple" xlink:href="lfvn-20250630.xsd#IntangibleAssetsNet"/>
  <link:presentationLink xlink:role="http://www.lifevantage.com/role/IntangibleAssetsNet" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_0cf94321-8082-4fe9-8c24-b18e62fcb44d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsDisclosureTextBlock_060102a3-6c23-43ec-8231-7107d58ed26f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IntangibleAssetsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_0cf94321-8082-4fe9-8c24-b18e62fcb44d" xlink:to="loc_us-gaap_IntangibleAssetsDisclosureTextBlock_060102a3-6c23-43ec-8231-7107d58ed26f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.lifevantage.com/role/OtherAccruedExpenses" xlink:type="simple" xlink:href="lfvn-20250630.xsd#OtherAccruedExpenses"/>
  <link:presentationLink xlink:role="http://www.lifevantage.com/role/OtherAccruedExpenses" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PayablesAndAccrualsAbstract_3872001b-8d3e-4f40-9732-2af586dfaae0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PayablesAndAccrualsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock_82538fd7-8fd7-408e-872d-b318f8f0eb3d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_3872001b-8d3e-4f40-9732-2af586dfaae0" xlink:to="loc_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock_82538fd7-8fd7-408e-872d-b318f8f0eb3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.lifevantage.com/role/LongTermDebt" xlink:type="simple" xlink:href="lfvn-20250630.xsd#LongTermDebt"/>
  <link:presentationLink xlink:role="http://www.lifevantage.com/role/LongTermDebt" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_04c52875-ca87-4a16-8bd0-7a89aa715f69" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock_aeddfd4f-ff6d-4657-ba73-896cbda4f3ee" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_04c52875-ca87-4a16-8bd0-7a89aa715f69" xlink:to="loc_us-gaap_DebtDisclosureTextBlock_aeddfd4f-ff6d-4657-ba73-896cbda4f3ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.lifevantage.com/role/StockholdersEquity" xlink:type="simple" xlink:href="lfvn-20250630.xsd#StockholdersEquity"/>
  <link:presentationLink xlink:role="http://www.lifevantage.com/role/StockholdersEquity" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_89ec3a39-e852-43d5-ba5f-13fbfa121143" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_3daae564-4ccd-4251-a116-df64c156e29e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_89ec3a39-e852-43d5-ba5f-13fbfa121143" xlink:to="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_3daae564-4ccd-4251-a116-df64c156e29e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.lifevantage.com/role/ShareBasedCompensation" xlink:type="simple" xlink:href="lfvn-20250630.xsd#ShareBasedCompensation"/>
  <link:presentationLink xlink:role="http://www.lifevantage.com/role/ShareBasedCompensation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_c3ebd014-83be-45b0-95b4-d1ed93ac1a17" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_051bbbf2-b626-4927-9c00-5c174503f7e1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_c3ebd014-83be-45b0-95b4-d1ed93ac1a17" xlink:to="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_051bbbf2-b626-4927-9c00-5c174503f7e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.lifevantage.com/role/OtherExpenseNet" xlink:type="simple" xlink:href="lfvn-20250630.xsd#OtherExpenseNet"/>
  <link:presentationLink xlink:role="http://www.lifevantage.com/role/OtherExpenseNet" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIncomeAndExpensesAbstract_95fc4fb8-dfc8-4f30-89a9-5e9afaae6c3c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherIncomeAndExpensesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock_eb48a25a-d1c9-479e-83f9-b70e96ff2a71" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherIncomeAndExpensesAbstract_95fc4fb8-dfc8-4f30-89a9-5e9afaae6c3c" xlink:to="loc_us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock_eb48a25a-d1c9-479e-83f9-b70e96ff2a71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.lifevantage.com/role/IncomeTaxes" xlink:type="simple" xlink:href="lfvn-20250630.xsd#IncomeTaxes"/>
  <link:presentationLink xlink:role="http://www.lifevantage.com/role/IncomeTaxes" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_d121a2d9-a65c-4c0c-8f5c-3a67a0b380d5" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock_7d009d87-099b-42fb-9ebd-dd0bfa1dd384" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_d121a2d9-a65c-4c0c-8f5c-3a67a0b380d5" xlink:to="loc_us-gaap_IncomeTaxDisclosureTextBlock_7d009d87-099b-42fb-9ebd-dd0bfa1dd384" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.lifevantage.com/role/Leases" xlink:type="simple" xlink:href="lfvn-20250630.xsd#Leases"/>
  <link:presentationLink xlink:role="http://www.lifevantage.com/role/Leases" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_1d543d15-b41b-428c-b6bc-0542634490dc" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeasesTextBlock_e0449794-de11-41b2-98d8-ef1b71d48383" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_1d543d15-b41b-428c-b6bc-0542634490dc" xlink:to="loc_us-gaap_LesseeOperatingLeasesTextBlock_e0449794-de11-41b2-98d8-ef1b71d48383" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.lifevantage.com/role/SegmentInformation" xlink:type="simple" xlink:href="lfvn-20250630.xsd#SegmentInformation"/>
  <link:presentationLink xlink:role="http://www.lifevantage.com/role/SegmentInformation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_70c41714-dc0d-4ec5-a30b-4737cfcff0e3" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock_95d2fdd3-4fa0-487b-89b4-6c96be2ac2b8" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_70c41714-dc0d-4ec5-a30b-4737cfcff0e3" xlink:to="loc_us-gaap_SegmentReportingDisclosureTextBlock_95d2fdd3-4fa0-487b-89b4-6c96be2ac2b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.lifevantage.com/role/CommitmentsandContingencies" xlink:type="simple" xlink:href="lfvn-20250630.xsd#CommitmentsandContingencies"/>
  <link:presentationLink xlink:role="http://www.lifevantage.com/role/CommitmentsandContingencies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_2d4ecb7f-d579-4052-920d-70178e6e30d1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_5845a083-b132-4103-9e3e-b5c442493f1d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_2d4ecb7f-d579-4052-920d-70178e6e30d1" xlink:to="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_5845a083-b132-4103-9e3e-b5c442493f1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.lifevantage.com/role/SubsequentEvents" xlink:type="simple" xlink:href="lfvn-20250630.xsd#SubsequentEvents"/>
  <link:presentationLink xlink:role="http://www.lifevantage.com/role/SubsequentEvents" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsAbstract_b9b1dd6b-3bbb-4ca8-bcbd-9117dec7ca82" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsequentEventsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsTextBlock_5f37d3a7-2adb-47fd-9831-8956aef9ea3a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsequentEventsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventsAbstract_b9b1dd6b-3bbb-4ca8-bcbd-9117dec7ca82" xlink:to="loc_us-gaap_SubsequentEventsTextBlock_5f37d3a7-2adb-47fd-9831-8956aef9ea3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesPolicies" xlink:type="simple" xlink:href="lfvn-20250630.xsd#SummaryofSignificantAccountingPoliciesPolicies"/>
  <link:presentationLink xlink:role="http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_c6cb5c89-72d4-4bec-9b06-95ce8f95c55d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationPolicyTextBlock_4c575ba9-f040-43fe-a2af-fa6c832a70e4" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConsolidationPolicyTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_c6cb5c89-72d4-4bec-9b06-95ce8f95c55d" xlink:to="loc_us-gaap_ConsolidationPolicyTextBlock_4c575ba9-f040-43fe-a2af-fa6c832a70e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates_a891e112-9c95-42c8-bde0-357ffe0d8da6" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_UseOfEstimates"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_c6cb5c89-72d4-4bec-9b06-95ce8f95c55d" xlink:to="loc_us-gaap_UseOfEstimates_a891e112-9c95-42c8-bde0-357ffe0d8da6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_cf511c88-3687-4bde-9165-430d650b212d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_c6cb5c89-72d4-4bec-9b06-95ce8f95c55d" xlink:to="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_cf511c88-3687-4bde-9165-430d650b212d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueOfFinancialInstrumentsPolicy_be2f9df0-a33f-4f7f-83da-f7d6c9c30802" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_c6cb5c89-72d4-4bec-9b06-95ce8f95c55d" xlink:to="loc_us-gaap_FairValueOfFinancialInstrumentsPolicy_be2f9df0-a33f-4f7f-83da-f7d6c9c30802" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock_dd449473-5cde-403a-a27e-69d170c2a893" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_c6cb5c89-72d4-4bec-9b06-95ce8f95c55d" xlink:to="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock_dd449473-5cde-403a-a27e-69d170c2a893" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesPolicyTextBlock_c544c15f-bdaa-441b-9c84-0e1216dc0eda" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ReceivablesPolicyTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_c6cb5c89-72d4-4bec-9b06-95ce8f95c55d" xlink:to="loc_us-gaap_ReceivablesPolicyTextBlock_c544c15f-bdaa-441b-9c84-0e1216dc0eda" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryPolicyTextBlock_99eba071-24f9-4510-b0ba-7e97f783348e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InventoryPolicyTextBlock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_c6cb5c89-72d4-4bec-9b06-95ce8f95c55d" xlink:to="loc_us-gaap_InventoryPolicyTextBlock_99eba071-24f9-4510-b0ba-7e97f783348e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_22e5627f-8d20-49ea-95f2-b07267a3893f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_c6cb5c89-72d4-4bec-9b06-95ce8f95c55d" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_22e5627f-8d20-49ea-95f2-b07267a3893f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsFiniteLivedPolicy_6cb3ed43-0c38-4fb6-b7f9-a0dcaf8ed83d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IntangibleAssetsFiniteLivedPolicy"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_c6cb5c89-72d4-4bec-9b06-95ce8f95c55d" xlink:to="loc_us-gaap_IntangibleAssetsFiniteLivedPolicy_6cb3ed43-0c38-4fb6-b7f9-a0dcaf8ed83d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_6f18755f-3965-43b6-a25f-463155e9876b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_c6cb5c89-72d4-4bec-9b06-95ce8f95c55d" xlink:to="loc_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_6f18755f-3965-43b6-a25f-463155e9876b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskCreditRisk_09406f16-cfe1-4092-b94c-8f29aae780ec" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConcentrationRiskCreditRisk"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_c6cb5c89-72d4-4bec-9b06-95ce8f95c55d" xlink:to="loc_us-gaap_ConcentrationRiskCreditRisk_09406f16-cfe1-4092-b94c-8f29aae780ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommissionsExpensePolicyPolicyTextBlock_9617430a-9035-4055-943a-e2dd07da2da4" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommissionsExpensePolicyPolicyTextBlock"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_c6cb5c89-72d4-4bec-9b06-95ce8f95c55d" xlink:to="loc_us-gaap_CommissionsExpensePolicyPolicyTextBlock_9617430a-9035-4055-943a-e2dd07da2da4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_6de7db05-4e87-46d8-b305-2c91d5a380e8" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_c6cb5c89-72d4-4bec-9b06-95ce8f95c55d" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_6de7db05-4e87-46d8-b305-2c91d5a380e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpensePolicy_cadeac0d-8fdd-48f1-8e05-ec1ce79a2f51" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_c6cb5c89-72d4-4bec-9b06-95ce8f95c55d" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpensePolicy_cadeac0d-8fdd-48f1-8e05-ec1ce79a2f51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeasesPolicyTextBlock_3ec4be70-ffa4-4f4b-a35a-d9cc2a13bf8f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeLeasesPolicyTextBlock"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_c6cb5c89-72d4-4bec-9b06-95ce8f95c55d" xlink:to="loc_us-gaap_LesseeLeasesPolicyTextBlock_3ec4be70-ffa4-4f4b-a35a-d9cc2a13bf8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_c4e1f0ef-ae90-4dcd-ab2f-28ea8f6b4af1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_c6cb5c89-72d4-4bec-9b06-95ce8f95c55d" xlink:to="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_c4e1f0ef-ae90-4dcd-ab2f-28ea8f6b4af1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxPolicyTextBlock_69095ef5-596f-4cf4-aa06-fa61e75a402a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxPolicyTextBlock"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_c6cb5c89-72d4-4bec-9b06-95ce8f95c55d" xlink:to="loc_us-gaap_IncomeTaxPolicyTextBlock_69095ef5-596f-4cf4-aa06-fa61e75a402a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerSharePolicyTextBlock_83d97f7d-c965-4642-ac0d-470927f705f6" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EarningsPerSharePolicyTextBlock"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_c6cb5c89-72d4-4bec-9b06-95ce8f95c55d" xlink:to="loc_us-gaap_EarningsPerSharePolicyTextBlock_83d97f7d-c965-4642-ac0d-470927f705f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingPolicyPolicyTextBlock_a1dc4b5e-28a7-4880-9ea7-d3ade91fda95" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SegmentReportingPolicyPolicyTextBlock"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_c6cb5c89-72d4-4bec-9b06-95ce8f95c55d" xlink:to="loc_us-gaap_SegmentReportingPolicyPolicyTextBlock_a1dc4b5e-28a7-4880-9ea7-d3ade91fda95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_7ccd6bce-5666-423a-9b65-482925941d54" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_c6cb5c89-72d4-4bec-9b06-95ce8f95c55d" xlink:to="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_7ccd6bce-5666-423a-9b65-482925941d54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesTables" xlink:type="simple" xlink:href="lfvn-20250630.xsd#SummaryofSignificantAccountingPoliciesTables"/>
  <link:presentationLink xlink:role="http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_6e7e1ce4-151a-4516-b616-f8bfadd62ad0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_a17794c2-0a7e-4914-ab29-3fb0404bf5df" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_6e7e1ce4-151a-4516-b616-f8bfadd62ad0" xlink:to="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_a17794c2-0a7e-4914-ab29-3fb0404bf5df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_fb799eac-a195-4934-891e-13ba3d1db10c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_6e7e1ce4-151a-4516-b616-f8bfadd62ad0" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_fb799eac-a195-4934-891e-13ba3d1db10c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_ed25b3e8-4634-4f50-81f8-25fa2e05633b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_6e7e1ce4-151a-4516-b616-f8bfadd62ad0" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_ed25b3e8-4634-4f50-81f8-25fa2e05633b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock_cc1b98b8-aa66-48db-8797-7b76a74ebbee" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_6e7e1ce4-151a-4516-b616-f8bfadd62ad0" xlink:to="loc_us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock_cc1b98b8-aa66-48db-8797-7b76a74ebbee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.lifevantage.com/role/RevenueTables" xlink:type="simple" xlink:href="lfvn-20250630.xsd#RevenueTables"/>
  <link:presentationLink xlink:role="http://www.lifevantage.com/role/RevenueTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_3f1b4755-f01e-4c6a-8258-833825eb69a2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_fd3cc821-f5b2-48e5-89fc-75f9c09351a0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_3f1b4755-f01e-4c6a-8258-833825eb69a2" xlink:to="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_fd3cc821-f5b2-48e5-89fc-75f9c09351a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.lifevantage.com/role/PropertyandEquipmentNetTables" xlink:type="simple" xlink:href="lfvn-20250630.xsd#PropertyandEquipmentNetTables"/>
  <link:presentationLink xlink:role="http://www.lifevantage.com/role/PropertyandEquipmentNetTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_098661fa-55d3-46e1-b0b5-3d18d7c91ce5" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_779f756d-535f-416a-90d3-95343951801c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_098661fa-55d3-46e1-b0b5-3d18d7c91ce5" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_779f756d-535f-416a-90d3-95343951801c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.lifevantage.com/role/IntangibleAssetsNetTables" xlink:type="simple" xlink:href="lfvn-20250630.xsd#IntangibleAssetsNetTables"/>
  <link:presentationLink xlink:role="http://www.lifevantage.com/role/IntangibleAssetsNetTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_0077a836-793c-4a8f-967c-0a7e61008235" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_25cdb9c6-8e8c-44d3-961d-6911fd3ee793" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_0077a836-793c-4a8f-967c-0a7e61008235" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_25cdb9c6-8e8c-44d3-961d-6911fd3ee793" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.lifevantage.com/role/OtherAccruedExpensesTables" xlink:type="simple" xlink:href="lfvn-20250630.xsd#OtherAccruedExpensesTables"/>
  <link:presentationLink xlink:role="http://www.lifevantage.com/role/OtherAccruedExpensesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PayablesAndAccrualsAbstract_6c2057ea-536b-4a55-9a01-7b77a5494912" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PayablesAndAccrualsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_c0220716-7778-4ac5-949b-f2d20c7c9d11" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_6c2057ea-536b-4a55-9a01-7b77a5494912" xlink:to="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_c0220716-7778-4ac5-949b-f2d20c7c9d11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.lifevantage.com/role/ShareBasedCompensationTables" xlink:type="simple" xlink:href="lfvn-20250630.xsd#ShareBasedCompensationTables"/>
  <link:presentationLink xlink:role="http://www.lifevantage.com/role/ShareBasedCompensationTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_2950f368-2642-4465-8cff-7177fe07c71d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_549f960d-12d4-4644-914b-80cb81c1d0e3" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_2950f368-2642-4465-8cff-7177fe07c71d" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_549f960d-12d4-4644-914b-80cb81c1d0e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock_78b0650c-4977-44e6-a063-ce64add11671" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_2950f368-2642-4465-8cff-7177fe07c71d" xlink:to="loc_us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock_78b0650c-4977-44e6-a063-ce64add11671" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfUnvestedRestrictedStockUnitsRollForwardTableTextBlock_fe736617-1906-4d2c-b8e8-33865a60bbb5" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfUnvestedRestrictedStockUnitsRollForwardTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_2950f368-2642-4465-8cff-7177fe07c71d" xlink:to="loc_us-gaap_ScheduleOfUnvestedRestrictedStockUnitsRollForwardTableTextBlock_fe736617-1906-4d2c-b8e8-33865a60bbb5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock_60cece1b-b972-4f71-a971-bc7ca6a02499" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_2950f368-2642-4465-8cff-7177fe07c71d" xlink:to="loc_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock_60cece1b-b972-4f71-a971-bc7ca6a02499" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.lifevantage.com/role/OtherExpenseNetTables" xlink:type="simple" xlink:href="lfvn-20250630.xsd#OtherExpenseNetTables"/>
  <link:presentationLink xlink:role="http://www.lifevantage.com/role/OtherExpenseNetTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIncomeAndExpensesAbstract_83866507-0daf-49ae-83b3-70065f2d87d0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherIncomeAndExpensesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock_12a8f452-7e79-48c5-bba7-774efccfa7a6" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherIncomeAndExpensesAbstract_83866507-0daf-49ae-83b3-70065f2d87d0" xlink:to="loc_us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock_12a8f452-7e79-48c5-bba7-774efccfa7a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.lifevantage.com/role/IncomeTaxesTables" xlink:type="simple" xlink:href="lfvn-20250630.xsd#IncomeTaxesTables"/>
  <link:presentationLink xlink:role="http://www.lifevantage.com/role/IncomeTaxesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_73297d20-0445-4250-be26-87b79e826015" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_670f3c77-a2af-4288-9e86-4b671b1c833e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_73297d20-0445-4250-be26-87b79e826015" xlink:to="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_670f3c77-a2af-4288-9e86-4b671b1c833e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_1203886b-ecb3-45f3-a29d-10a13b6db273" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_73297d20-0445-4250-be26-87b79e826015" xlink:to="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_1203886b-ecb3-45f3-a29d-10a13b6db273" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_a5e06f3a-fda5-439d-abe5-4c1c364ebb06" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_73297d20-0445-4250-be26-87b79e826015" xlink:to="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_a5e06f3a-fda5-439d-abe5-4c1c364ebb06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SummaryOfValuationAllowanceTextBlock_5a595428-f0c1-4b99-9aa4-30e0f2d2d51d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SummaryOfValuationAllowanceTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_73297d20-0445-4250-be26-87b79e826015" xlink:to="loc_us-gaap_SummaryOfValuationAllowanceTextBlock_5a595428-f0c1-4b99-9aa4-30e0f2d2d51d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.lifevantage.com/role/LeasesTables" xlink:type="simple" xlink:href="lfvn-20250630.xsd#LeasesTables"/>
  <link:presentationLink xlink:role="http://www.lifevantage.com/role/LeasesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_f81b923f-26ba-4295-ac24-e518354429af" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCostTableTextBlock_bfa4f59a-6a5a-4ed9-b865-34fbbd34e994" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LeaseCostTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_f81b923f-26ba-4295-ac24-e518354429af" xlink:to="loc_us-gaap_LeaseCostTableTextBlock_bfa4f59a-6a5a-4ed9-b865-34fbbd34e994" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_2993e47b-5649-46d3-8512-a9d942ab0939" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_f81b923f-26ba-4295-ac24-e518354429af" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_2993e47b-5649-46d3-8512-a9d942ab0939" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.lifevantage.com/role/SegmentInformationTables" xlink:type="simple" xlink:href="lfvn-20250630.xsd#SegmentInformationTables"/>
  <link:presentationLink xlink:role="http://www.lifevantage.com/role/SegmentInformationTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_0e46f616-cb23-4f56-910c-e8188c8cb214" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_d9e4b7c1-6ad9-4dc6-a948-d150b4a51eb6" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_0e46f616-cb23-4f56-910c-e8188c8cb214" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_d9e4b7c1-6ad9-4dc6-a948-d150b4a51eb6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock_aaca811a-2106-4a35-aa98-f5dc70c83ee5" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_0e46f616-cb23-4f56-910c-e8188c8cb214" xlink:to="loc_us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock_aaca811a-2106-4a35-aa98-f5dc70c83ee5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock_4bd6da5e-0626-49c8-ba79-bc2fee207688" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_0e46f616-cb23-4f56-910c-e8188c8cb214" xlink:to="loc_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock_4bd6da5e-0626-49c8-ba79-bc2fee207688" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.lifevantage.com/role/TheCompanyDetails" xlink:type="simple" xlink:href="lfvn-20250630.xsd#TheCompanyDetails"/>
  <link:presentationLink xlink:role="http://www.lifevantage.com/role/TheCompanyDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_220c37fa-9ebf-410e-85db-d6886ab6664f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_593d70cc-5569-48e1-982f-87d640149989" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_220c37fa-9ebf-410e-85db-d6886ab6664f" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_593d70cc-5569-48e1-982f-87d640149989" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" xlink:type="simple" xlink:href="lfvn-20250630.xsd#SummaryofSignificantAccountingPoliciesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_6c01765d-c3f7-4ece-a9a3-df3998bb894b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTable_9f9ceed0-ab72-4722-92c2-9f3575678116" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConcentrationRiskTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_6c01765d-c3f7-4ece-a9a3-df3998bb894b" xlink:to="loc_us-gaap_ConcentrationRiskTable_9f9ceed0-ab72-4722-92c2-9f3575678116" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_00954ec1-da36-4937-a2c8-405959efa0b3" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_9f9ceed0-ab72-4722-92c2-9f3575678116" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_00954ec1-da36-4937-a2c8-405959efa0b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_b2b73c0a-6e6d-42c9-a0dc-11a89a5ca109" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_00954ec1-da36-4937-a2c8-405959efa0b3" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_b2b73c0a-6e6d-42c9-a0dc-11a89a5ca109" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_CashAccountsHeldPrimarilyAtFinancialInstitutionMember_7970ce70-af82-4d99-a1ea-1cee3750ed80" xlink:href="lfvn-20250630.xsd#lfvn_CashAccountsHeldPrimarilyAtFinancialInstitutionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_b2b73c0a-6e6d-42c9-a0dc-11a89a5ca109" xlink:to="loc_lfvn_CashAccountsHeldPrimarilyAtFinancialInstitutionMember_7970ce70-af82-4d99-a1ea-1cee3750ed80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_CashAccountsHeldatOtherFinancialInstitutionsMember_d22e4db2-2d57-4607-bacb-e019ec37c29f" xlink:href="lfvn-20250630.xsd#lfvn_CashAccountsHeldatOtherFinancialInstitutionsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_b2b73c0a-6e6d-42c9-a0dc-11a89a5ca109" xlink:to="loc_lfvn_CashAccountsHeldatOtherFinancialInstitutionsMember_d22e4db2-2d57-4607-bacb-e019ec37c29f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskLineItems_a3c39f41-975a-4a50-8c6a-faa4f195d538" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConcentrationRiskLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_9f9ceed0-ab72-4722-92c2-9f3575678116" xlink:to="loc_us-gaap_ConcentrationRiskLineItems_a3c39f41-975a-4a50-8c6a-faa4f195d538" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_SummaryOfSignificantAccountingPoliciesTextualAbstract_85ffac6b-5c1d-4e46-8496-d6c7d86e7d59" xlink:href="lfvn-20250630.xsd#lfvn_SummaryOfSignificantAccountingPoliciesTextualAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_a3c39f41-975a-4a50-8c6a-faa4f195d538" xlink:to="loc_lfvn_SummaryOfSignificantAccountingPoliciesTextualAbstract_85ffac6b-5c1d-4e46-8496-d6c7d86e7d59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProvisionForDoubtfulAccounts_51b2d5e5-3c33-4827-a4a2-4f4a2e4aaac5" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProvisionForDoubtfulAccounts"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lfvn_SummaryOfSignificantAccountingPoliciesTextualAbstract_85ffac6b-5c1d-4e46-8496-d6c7d86e7d59" xlink:to="loc_us-gaap_ProvisionForDoubtfulAccounts_51b2d5e5-3c33-4827-a4a2-4f4a2e4aaac5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryAdjustments_2f76650b-0c02-48e6-82c5-fd78b720c7b2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InventoryAdjustments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lfvn_SummaryOfSignificantAccountingPoliciesTextualAbstract_85ffac6b-5c1d-4e46-8496-d6c7d86e7d59" xlink:to="loc_us-gaap_InventoryAdjustments_2f76650b-0c02-48e6-82c5-fd78b720c7b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_ff0efdac-2717-48cd-9b24-1d2a82b22902" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lfvn_SummaryOfSignificantAccountingPoliciesTextualAbstract_85ffac6b-5c1d-4e46-8496-d6c7d86e7d59" xlink:to="loc_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_ff0efdac-2717-48cd-9b24-1d2a82b22902" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskCreditRiskFinancialInstrumentMaximumExposure_c9df6e07-ec7d-4418-9d13-92b3d22194bb" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConcentrationRiskCreditRiskFinancialInstrumentMaximumExposure"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lfvn_SummaryOfSignificantAccountingPoliciesTextualAbstract_85ffac6b-5c1d-4e46-8496-d6c7d86e7d59" xlink:to="loc_us-gaap_ConcentrationRiskCreditRiskFinancialInstrumentMaximumExposure_c9df6e07-ec7d-4418-9d13-92b3d22194bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_08cda668-3e54-4e73-811b-fefe08b95098" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lfvn_SummaryOfSignificantAccountingPoliciesTextualAbstract_85ffac6b-5c1d-4e46-8496-d6c7d86e7d59" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_08cda668-3e54-4e73-811b-fefe08b95098" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_NumberOfFinanceLeases_0d39d712-f7d7-410f-a81e-90629568760e" xlink:href="lfvn-20250630.xsd#lfvn_NumberOfFinanceLeases"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lfvn_SummaryOfSignificantAccountingPoliciesTextualAbstract_85ffac6b-5c1d-4e46-8496-d6c7d86e7d59" xlink:to="loc_lfvn_NumberOfFinanceLeases_0d39d712-f7d7-410f-a81e-90629568760e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_cc42a5b5-616e-419a-9419-dfdc441f98ca" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lfvn_SummaryOfSignificantAccountingPoliciesTextualAbstract_85ffac6b-5c1d-4e46-8496-d6c7d86e7d59" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_cc42a5b5-616e-419a-9419-dfdc441f98ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_NumberOfGeographicSegments_76221c26-b9e4-433a-af6e-d5203a159f6f" xlink:href="lfvn-20250630.xsd#lfvn_NumberOfGeographicSegments"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lfvn_SummaryOfSignificantAccountingPoliciesTextualAbstract_85ffac6b-5c1d-4e46-8496-d6c7d86e7d59" xlink:to="loc_lfvn_NumberOfGeographicSegments_76221c26-b9e4-433a-af6e-d5203a159f6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesInventoryDetails" xlink:type="simple" xlink:href="lfvn-20250630.xsd#SummaryofSignificantAccountingPoliciesInventoryDetails"/>
  <link:presentationLink xlink:role="http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesInventoryDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_07d018eb-c369-4f3e-aa62-618d8303b853" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNetAbstract_d363fe04-1bf4-4713-bfa9-373ef56c7ef4" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InventoryNetAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_07d018eb-c369-4f3e-aa62-618d8303b853" xlink:to="loc_us-gaap_InventoryNetAbstract_d363fe04-1bf4-4713-bfa9-373ef56c7ef4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoods_744dcc3f-449c-4f61-ad36-7e56d39f2e0f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InventoryFinishedGoods"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryNetAbstract_d363fe04-1bf4-4713-bfa9-373ef56c7ef4" xlink:to="loc_us-gaap_InventoryFinishedGoods_744dcc3f-449c-4f61-ad36-7e56d39f2e0f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterials_437cb8b1-19ab-48f7-8898-b1f84b344100" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InventoryRawMaterials"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryNetAbstract_d363fe04-1bf4-4713-bfa9-373ef56c7ef4" xlink:to="loc_us-gaap_InventoryRawMaterials_437cb8b1-19ab-48f7-8898-b1f84b344100" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_edfa025a-641d-4243-9c2c-f5013e085490" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryNetAbstract_d363fe04-1bf4-4713-bfa9-373ef56c7ef4" xlink:to="loc_us-gaap_InventoryNet_edfa025a-641d-4243-9c2c-f5013e085490" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_InventoryFinishedGoodsPercentOfTotalInventory_33525fd0-04db-4b26-9d6e-dd1957184a50" xlink:href="lfvn-20250630.xsd#lfvn_InventoryFinishedGoodsPercentOfTotalInventory"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryNetAbstract_d363fe04-1bf4-4713-bfa9-373ef56c7ef4" xlink:to="loc_lfvn_InventoryFinishedGoodsPercentOfTotalInventory_33525fd0-04db-4b26-9d6e-dd1957184a50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_RawMaterialsPercentOfTotalInventory_1cb57723-6763-4513-837a-c73022803b38" xlink:href="lfvn-20250630.xsd#lfvn_RawMaterialsPercentOfTotalInventory"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryNetAbstract_d363fe04-1bf4-4713-bfa9-373ef56c7ef4" xlink:to="loc_lfvn_RawMaterialsPercentOfTotalInventory_1cb57723-6763-4513-837a-c73022803b38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_InventoryPercentOfTotalInventory_ac71ff39-ac91-4a53-a87a-f8c431066429" xlink:href="lfvn-20250630.xsd#lfvn_InventoryPercentOfTotalInventory"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryNetAbstract_d363fe04-1bf4-4713-bfa9-373ef56c7ef4" xlink:to="loc_lfvn_InventoryPercentOfTotalInventory_ac71ff39-ac91-4a53-a87a-f8c431066429" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesScheduleOfInventoryValuationReserveDetails" xlink:type="simple" xlink:href="lfvn-20250630.xsd#SummaryofSignificantAccountingPoliciesScheduleOfInventoryValuationReserveDetails"/>
  <link:presentationLink xlink:role="http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesScheduleOfInventoryValuationReserveDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_a8a7db8a-e0bc-4acd-9f28-5888a268e419" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryCurrentTable_c041bf9d-b855-47c7-ba42-8a75da5271cf" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InventoryCurrentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_a8a7db8a-e0bc-4acd-9f28-5888a268e419" xlink:to="loc_us-gaap_InventoryCurrentTable_c041bf9d-b855-47c7-ba42-8a75da5271cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_2b3a3c85-0410-43c1-a7a8-c7699d371748" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ValuationAllowancesAndReservesTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryCurrentTable_c041bf9d-b855-47c7-ba42-8a75da5271cf" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_2b3a3c85-0410-43c1-a7a8-c7699d371748" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesDomain_a79fa1bb-a66d-4079-9d1a-f6e72f84f772" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ValuationAllowancesAndReservesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_2b3a3c85-0410-43c1-a7a8-c7699d371748" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesDomain_a79fa1bb-a66d-4079-9d1a-f6e72f84f772" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryValuationReserveMember_2babcb57-5cef-4531-b5ee-7315cb44cc08" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InventoryValuationReserveMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesDomain_a79fa1bb-a66d-4079-9d1a-f6e72f84f772" xlink:to="loc_us-gaap_InventoryValuationReserveMember_2babcb57-5cef-4531-b5ee-7315cb44cc08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryLineItems_7d19c451-b9f6-4984-942e-46ea5969a56c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InventoryLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryCurrentTable_c041bf9d-b855-47c7-ba42-8a75da5271cf" xlink:to="loc_us-gaap_InventoryLineItems_7d19c451-b9f6-4984-942e-46ea5969a56c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_893f8ec6-b666-49b2-9296-1319670ac26f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MovementInValuationAllowancesAndReservesRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryLineItems_7d19c451-b9f6-4984-942e-46ea5969a56c" xlink:to="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_893f8ec6-b666-49b2-9296-1319670ac26f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesBalance_7b9bd6a9-7f7b-49d5-8468-ab37b4188c53" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ValuationAllowancesAndReservesBalance"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_893f8ec6-b666-49b2-9296-1319670ac26f" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesBalance_7b9bd6a9-7f7b-49d5-8468-ab37b4188c53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_8036b1b5-60af-4993-b3fd-3ca1a5401772" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_893f8ec6-b666-49b2-9296-1319670ac26f" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_8036b1b5-60af-4993-b3fd-3ca1a5401772" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesDeductions_a45b0161-afe6-4d88-8bab-94b9447fc63f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ValuationAllowancesAndReservesDeductions"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_893f8ec6-b666-49b2-9296-1319670ac26f" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesDeductions_a45b0161-afe6-4d88-8bab-94b9447fc63f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesBalance_752969c7-ca4b-4916-a454-8c2e2dabd42d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ValuationAllowancesAndReservesBalance"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_893f8ec6-b666-49b2-9296-1319670ac26f" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesBalance_752969c7-ca4b-4916-a454-8c2e2dabd42d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesPropertyandEquipmentDetails" xlink:type="simple" xlink:href="lfvn-20250630.xsd#SummaryofSignificantAccountingPoliciesPropertyandEquipmentDetails"/>
  <link:presentationLink xlink:role="http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesPropertyandEquipmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_cc68fc53-b62d-4c2d-9486-951a09b89dcd" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_523adbfa-624b-40eb-af2e-73cb1bb1b79a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_cc68fc53-b62d-4c2d-9486-951a09b89dcd" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_523adbfa-624b-40eb-af2e-73cb1bb1b79a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_4bd83661-d8c5-4214-a5ee-122687be742d" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_523adbfa-624b-40eb-af2e-73cb1bb1b79a" xlink:to="loc_srt_RangeAxis_4bd83661-d8c5-4214-a5ee-122687be742d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_7ebfa872-435e-4638-9695-69a95896e061" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_4bd83661-d8c5-4214-a5ee-122687be742d" xlink:to="loc_srt_RangeMember_7ebfa872-435e-4638-9695-69a95896e061" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_b01356d5-3eae-4854-8360-77f7078d808b" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_7ebfa872-435e-4638-9695-69a95896e061" xlink:to="loc_srt_MinimumMember_b01356d5-3eae-4854-8360-77f7078d808b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_4b371096-1df2-473a-85a4-5db50cf60e66" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_7ebfa872-435e-4638-9695-69a95896e061" xlink:to="loc_srt_MaximumMember_4b371096-1df2-473a-85a4-5db50cf60e66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_39a0bcc8-8198-48a0-bc6e-e93d56105b88" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_523adbfa-624b-40eb-af2e-73cb1bb1b79a" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_39a0bcc8-8198-48a0-bc6e-e93d56105b88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_1def108b-2c93-4bd7-afce-ffe0734c2a9e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_39a0bcc8-8198-48a0-bc6e-e93d56105b88" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_1def108b-2c93-4bd7-afce-ffe0734c2a9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquipmentMember_e73dc512-00fe-4c3d-937b-19f4c65c3139" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquipmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_1def108b-2c93-4bd7-afce-ffe0734c2a9e" xlink:to="loc_us-gaap_EquipmentMember_e73dc512-00fe-4c3d-937b-19f4c65c3139" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesMember_b77b1edc-b859-43cb-8740-1dbea13a5e54" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FurnitureAndFixturesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_1def108b-2c93-4bd7-afce-ffe0734c2a9e" xlink:to="loc_us-gaap_FurnitureAndFixturesMember_b77b1edc-b859-43cb-8740-1dbea13a5e54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VehiclesMember_d8ab8764-5a76-4fa9-b84e-c72e58cf7f0d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_VehiclesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_1def108b-2c93-4bd7-afce-ffe0734c2a9e" xlink:to="loc_us-gaap_VehiclesMember_d8ab8764-5a76-4fa9-b84e-c72e58cf7f0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_4454b07b-cb8d-4660-95a7-6835b8a4b0a9" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_523adbfa-624b-40eb-af2e-73cb1bb1b79a" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentLineItems_4454b07b-cb8d-4660-95a7-6835b8a4b0a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_f983ae04-2e17-4601-9774-60243d5d8efb" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_4454b07b-cb8d-4660-95a7-6835b8a4b0a9" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_f983ae04-2e17-4601-9774-60243d5d8efb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesComputationofNetIncomePerShareDetails" xlink:type="simple" xlink:href="lfvn-20250630.xsd#SummaryofSignificantAccountingPoliciesComputationofNetIncomePerShareDetails"/>
  <link:presentationLink xlink:role="http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesComputationofNetIncomePerShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_7434ba3e-b7ec-4d18-9362-407ee819c0ec" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAbstract_1ab5b18a-1547-486f-b30a-5cfcead4731e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EarningsPerShareBasicAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_7434ba3e-b7ec-4d18-9362-407ee819c0ec" xlink:to="loc_us-gaap_EarningsPerShareBasicAbstract_1ab5b18a-1547-486f-b30a-5cfcead4731e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract_eefacb78-afe6-4040-bfff-1ffe4342384f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAbstract_1ab5b18a-1547-486f-b30a-5cfcead4731e" xlink:to="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract_eefacb78-afe6-4040-bfff-1ffe4342384f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_123d90a0-7808-46dc-aa45-f1d27b540665" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract_eefacb78-afe6-4040-bfff-1ffe4342384f" xlink:to="loc_us-gaap_NetIncomeLoss_123d90a0-7808-46dc-aa45-f1d27b540665" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_81f4524a-ad52-4f16-beb3-bf18cca254da" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAbstract_1ab5b18a-1547-486f-b30a-5cfcead4731e" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_81f4524a-ad52-4f16-beb3-bf18cca254da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_40b96a4c-8681-4fd0-ba3e-2abf07c867de" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_81f4524a-ad52-4f16-beb3-bf18cca254da" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_40b96a4c-8681-4fd0-ba3e-2abf07c867de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DilutiveSecuritiesAbstract_7393a2d8-289e-4962-8752-a08b07addff8" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DilutiveSecuritiesAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAbstract_1ab5b18a-1547-486f-b30a-5cfcead4731e" xlink:to="loc_us-gaap_DilutiveSecuritiesAbstract_7393a2d8-289e-4962-8752-a08b07addff8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_a171f175-4696-401b-8f63-35096bee7a04" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DilutiveSecuritiesAbstract_7393a2d8-289e-4962-8752-a08b07addff8" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_a171f175-4696-401b-8f63-35096bee7a04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_ece81f7f-d1b1-48ec-aaca-2a8ad9bbe72d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAbstract_1ab5b18a-1547-486f-b30a-5cfcead4731e" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_ece81f7f-d1b1-48ec-aaca-2a8ad9bbe72d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_ad68efc6-2d1b-4f28-b35c-8a177d20bad1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAbstract_1ab5b18a-1547-486f-b30a-5cfcead4731e" xlink:to="loc_us-gaap_EarningsPerShareBasic_ad68efc6-2d1b-4f28-b35c-8a177d20bad1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_4a3df024-1811-4643-948c-e6505f0d1f64" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAbstract_1ab5b18a-1547-486f-b30a-5cfcead4731e" xlink:to="loc_us-gaap_EarningsPerShareDiluted_4a3df024-1811-4643-948c-e6505f0d1f64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesSegmentInformationDetails" xlink:type="simple" xlink:href="lfvn-20250630.xsd#SummaryofSignificantAccountingPoliciesSegmentInformationDetails"/>
  <link:presentationLink xlink:role="http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesSegmentInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_987beb8f-ba2f-434d-95cf-4a9268733750" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_ff0622bd-c781-471b-b655-2268f5320919" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_987beb8f-ba2f-434d-95cf-4a9268733750" xlink:to="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_ff0622bd-c781-471b-b655-2268f5320919" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_f3787ae0-d1c1-4e08-bda6-083d72a72e8f" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_ff0622bd-c781-471b-b655-2268f5320919" xlink:to="loc_srt_StatementGeographicalAxis_f3787ae0-d1c1-4e08-bda6-083d72a72e8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_c30c83c1-154c-4f85-bc05-3bed8ef5cafa" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_f3787ae0-d1c1-4e08-bda6-083d72a72e8f" xlink:to="loc_srt_SegmentGeographicalDomain_c30c83c1-154c-4f85-bc05-3bed8ef5cafa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_f08ec60f-fadc-4052-8b59-6bead6b99287" xlink:href="https://xbrl.sec.gov/country/2025/country-2025.xsd#country_US"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_c30c83c1-154c-4f85-bc05-3bed8ef5cafa" xlink:to="loc_country_US_f08ec60f-fadc-4052-8b59-6bead6b99287" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_JP_fd307ac3-bd29-414f-bbb2-e09f41324e1c" xlink:href="https://xbrl.sec.gov/country/2025/country-2025.xsd#country_JP"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_c30c83c1-154c-4f85-bc05-3bed8ef5cafa" xlink:to="loc_country_JP_fd307ac3-bd29-414f-bbb2-e09f41324e1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_499ae2a0-4f4d-4338-bbbc-59bdd3b55b6c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_ff0622bd-c781-471b-b655-2268f5320919" xlink:to="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_499ae2a0-4f4d-4338-bbbc-59bdd3b55b6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncurrentAssets_576f9f3c-9c29-48ad-a3ee-5aa0d8afff1a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NoncurrentAssets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_499ae2a0-4f4d-4338-bbbc-59bdd3b55b6c" xlink:to="loc_us-gaap_NoncurrentAssets_576f9f3c-9c29-48ad-a3ee-5aa0d8afff1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.lifevantage.com/role/RevenueNarrativeDetails" xlink:type="simple" xlink:href="lfvn-20250630.xsd#RevenueNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.lifevantage.com/role/RevenueNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_0190afba-4c77-4220-89dd-f08caad1e561" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable_3904ecf1-eed5-4c81-ae90-5388b7909337" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_0190afba-4c77-4220-89dd-f08caad1e561" xlink:to="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable_3904ecf1-eed5-4c81-ae90-5388b7909337" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_ee792df3-2e39-4c34-b2c3-70558c2894d5" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable_3904ecf1-eed5-4c81-ae90-5388b7909337" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_ee792df3-2e39-4c34-b2c3-70558c2894d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_27eabdba-af84-47bd-9d69-2ffdddbe4d8d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_ee792df3-2e39-4c34-b2c3-70558c2894d5" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_27eabdba-af84-47bd-9d69-2ffdddbe4d8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductConcentrationRiskMember_ae47fc5a-6298-4ce6-979f-f325a1fd818d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProductConcentrationRiskMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_27eabdba-af84-47bd-9d69-2ffdddbe4d8d" xlink:to="loc_us-gaap_ProductConcentrationRiskMember_ae47fc5a-6298-4ce6-979f-f325a1fd818d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_f4f4f055-7c13-4686-8884-5644303ee977" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable_3904ecf1-eed5-4c81-ae90-5388b7909337" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_f4f4f055-7c13-4686-8884-5644303ee977" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_6bd37139-adb6-48fc-9e50-523933aeccdd" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_f4f4f055-7c13-4686-8884-5644303ee977" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_6bd37139-adb6-48fc-9e50-523933aeccdd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesRevenueNetMember_e20c037a-1ef6-4d70-8299-492285c378d3" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SalesRevenueNetMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_6bd37139-adb6-48fc-9e50-523933aeccdd" xlink:to="loc_us-gaap_SalesRevenueNetMember_e20c037a-1ef6-4d70-8299-492285c378d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_4b8334e4-7ce7-4c11-9430-fafaa986b58c" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable_3904ecf1-eed5-4c81-ae90-5388b7909337" xlink:to="loc_srt_ProductOrServiceAxis_4b8334e4-7ce7-4c11-9430-fafaa986b58c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_8285d17b-8e84-4521-afaf-9021c259e4df" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_4b8334e4-7ce7-4c11-9430-fafaa986b58c" xlink:to="loc_srt_ProductsAndServicesDomain_8285d17b-8e84-4521-afaf-9021c259e4df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_ProtandimandTrueScienceProductLineMember_749e1d2e-9aed-4cec-8775-ebd417ff7df1" xlink:href="lfvn-20250630.xsd#lfvn_ProtandimandTrueScienceProductLineMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_8285d17b-8e84-4521-afaf-9021c259e4df" xlink:to="loc_lfvn_ProtandimandTrueScienceProductLineMember_749e1d2e-9aed-4cec-8775-ebd417ff7df1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems_bc76da81-6a56-4544-b7ca-4965f1694c32" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable_3904ecf1-eed5-4c81-ae90-5388b7909337" xlink:to="loc_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems_bc76da81-6a56-4544-b7ca-4965f1694c32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_MoneyBackGuaranteePeriod_90b7f589-9c82-4490-828d-1626c0f81400" xlink:href="lfvn-20250630.xsd#lfvn_MoneyBackGuaranteePeriod"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems_bc76da81-6a56-4544-b7ca-4965f1694c32" xlink:to="loc_lfvn_MoneyBackGuaranteePeriod_90b7f589-9c82-4490-828d-1626c0f81400" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_HandlingAndRestockingFeePercentage_f41eed20-8824-4c7a-b035-977765c74f42" xlink:href="lfvn-20250630.xsd#lfvn_HandlingAndRestockingFeePercentage"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems_bc76da81-6a56-4544-b7ca-4965f1694c32" xlink:to="loc_lfvn_HandlingAndRestockingFeePercentage_f41eed20-8824-4c7a-b035-977765c74f42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_ReturnLiabilityReserve_085702ec-5a03-496b-9f7f-321f5216d3f6" xlink:href="lfvn-20250630.xsd#lfvn_ReturnLiabilityReserve"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems_bc76da81-6a56-4544-b7ca-4965f1694c32" xlink:to="loc_lfvn_ReturnLiabilityReserve_085702ec-5a03-496b-9f7f-321f5216d3f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_NumberOfGeographicSegments_e0e33af5-2e5d-476d-907c-ab786e1c6691" xlink:href="lfvn-20250630.xsd#lfvn_NumberOfGeographicSegments"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems_bc76da81-6a56-4544-b7ca-4965f1694c32" xlink:to="loc_lfvn_NumberOfGeographicSegments_e0e33af5-2e5d-476d-907c-ab786e1c6691" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_NumberOfProductLines_f9c770d7-0cbf-48f2-b49c-af2434ad8a40" xlink:href="lfvn-20250630.xsd#lfvn_NumberOfProductLines"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems_bc76da81-6a56-4544-b7ca-4965f1694c32" xlink:to="loc_lfvn_NumberOfProductLines_f9c770d7-0cbf-48f2-b49c-af2434ad8a40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_368f7656-df4c-4e65-a8e7-face47b97202" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems_bc76da81-6a56-4544-b7ca-4965f1694c32" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_368f7656-df4c-4e65-a8e7-face47b97202" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent_a6192c6f-a07e-4345-9a65-897d31ff0b63" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems_bc76da81-6a56-4544-b7ca-4965f1694c32" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCurrent_a6192c6f-a07e-4345-9a65-897d31ff0b63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_fcf5ee30-6da1-4a27-89d2-0d546dd43ce3" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ContractWithCustomerLiabilityRevenueRecognized"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems_bc76da81-6a56-4544-b7ca-4965f1694c32" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_fcf5ee30-6da1-4a27-89d2-0d546dd43ce3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.lifevantage.com/role/RevenueSalesReturnDetails" xlink:type="simple" xlink:href="lfvn-20250630.xsd#RevenueSalesReturnDetails"/>
  <link:presentationLink xlink:role="http://www.lifevantage.com/role/RevenueSalesReturnDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_8fc301c6-384b-42a9-b039-4505f3a33908" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_b68e3040-af79-4c43-bee3-a39f94d77645" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_8fc301c6-384b-42a9-b039-4505f3a33908" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_b68e3040-af79-4c43-bee3-a39f94d77645" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_80a040f2-e3d0-47e9-a465-e1213877bf98" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ValuationAllowancesAndReservesTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_b68e3040-af79-4c43-bee3-a39f94d77645" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_80a040f2-e3d0-47e9-a465-e1213877bf98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesDomain_a78b2acf-2f22-472c-a79b-a646e3220769" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ValuationAllowancesAndReservesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_80a040f2-e3d0-47e9-a465-e1213877bf98" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesDomain_a78b2acf-2f22-472c-a79b-a646e3220769" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesReturnsAndAllowancesMember_c472a68d-f699-41e0-821f-b60bde2f3f25" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SalesReturnsAndAllowancesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesDomain_a78b2acf-2f22-472c-a79b-a646e3220769" xlink:to="loc_us-gaap_SalesReturnsAndAllowancesMember_c472a68d-f699-41e0-821f-b60bde2f3f25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_d9b7fd88-c2ba-413d-afda-d600eedeea0c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_b68e3040-af79-4c43-bee3-a39f94d77645" xlink:to="loc_us-gaap_DisaggregationOfRevenueLineItems_d9b7fd88-c2ba-413d-afda-d600eedeea0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_7d14c504-9d82-48a0-90da-19d96afb0c27" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MovementInValuationAllowancesAndReservesRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_d9b7fd88-c2ba-413d-afda-d600eedeea0c" xlink:to="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_7d14c504-9d82-48a0-90da-19d96afb0c27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesBalance_d896106b-3add-4c6e-8adc-a1a36d2b6303" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ValuationAllowancesAndReservesBalance"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_7d14c504-9d82-48a0-90da-19d96afb0c27" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesBalance_d896106b-3add-4c6e-8adc-a1a36d2b6303" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_233d1180-c81a-4ab2-8189-630423eeaab1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_7d14c504-9d82-48a0-90da-19d96afb0c27" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_233d1180-c81a-4ab2-8189-630423eeaab1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesDeductions_63feff55-50a5-4f1b-926c-d98feddc21ec" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ValuationAllowancesAndReservesDeductions"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_7d14c504-9d82-48a0-90da-19d96afb0c27" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesDeductions_63feff55-50a5-4f1b-926c-d98feddc21ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesBalance_06d994da-b011-4b33-ab66-f73ed6f373ca" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ValuationAllowancesAndReservesBalance"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_7d14c504-9d82-48a0-90da-19d96afb0c27" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesBalance_06d994da-b011-4b33-ab66-f73ed6f373ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.lifevantage.com/role/RevenueMajorProductsDetails" xlink:type="simple" xlink:href="lfvn-20250630.xsd#RevenueMajorProductsDetails"/>
  <link:presentationLink xlink:role="http://www.lifevantage.com/role/RevenueMajorProductsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_02609e1d-17e5-4ae1-8542-c4a4cdd09da7" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable_e94212f6-5ee2-4293-97a3-ac237836aac8" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_02609e1d-17e5-4ae1-8542-c4a4cdd09da7" xlink:to="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable_e94212f6-5ee2-4293-97a3-ac237836aac8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_212c737e-36da-41ee-b29e-c4a52f24032c" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable_e94212f6-5ee2-4293-97a3-ac237836aac8" xlink:to="loc_srt_ProductOrServiceAxis_212c737e-36da-41ee-b29e-c4a52f24032c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_b3ab0286-71f2-401d-be1e-b6651e310bd7" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_212c737e-36da-41ee-b29e-c4a52f24032c" xlink:to="loc_srt_ProductsAndServicesDomain_b3ab0286-71f2-401d-be1e-b6651e310bd7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_ProtandimMember_9cdf5045-fede-47ba-bbbb-d38a90277400" xlink:href="lfvn-20250630.xsd#lfvn_ProtandimMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_b3ab0286-71f2-401d-be1e-b6651e310bd7" xlink:to="loc_lfvn_ProtandimMember_9cdf5045-fede-47ba-bbbb-d38a90277400" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_LifeVantageTrueScienceSkinCareRegimenMember_e749419f-8fc1-4743-bfd2-7a26bba47a85" xlink:href="lfvn-20250630.xsd#lfvn_LifeVantageTrueScienceSkinCareRegimenMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_b3ab0286-71f2-401d-be1e-b6651e310bd7" xlink:to="loc_lfvn_LifeVantageTrueScienceSkinCareRegimenMember_e749419f-8fc1-4743-bfd2-7a26bba47a85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductAndServiceOtherMember_0ee293a0-023d-4662-8ee2-549cbd9717cb" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProductAndServiceOtherMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_b3ab0286-71f2-401d-be1e-b6651e310bd7" xlink:to="loc_us-gaap_ProductAndServiceOtherMember_0ee293a0-023d-4662-8ee2-549cbd9717cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_e072e12d-fd3b-4eb8-b4d7-8552201df5ed" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable_e94212f6-5ee2-4293-97a3-ac237836aac8" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_e072e12d-fd3b-4eb8-b4d7-8552201df5ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_b9f170cc-e122-41f5-a437-c01f3100cf34" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_e072e12d-fd3b-4eb8-b4d7-8552201df5ed" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_b9f170cc-e122-41f5-a437-c01f3100cf34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductConcentrationRiskMember_fbbfb9ed-a9c8-4df6-91fa-0675bf2411cd" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProductConcentrationRiskMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_b9f170cc-e122-41f5-a437-c01f3100cf34" xlink:to="loc_us-gaap_ProductConcentrationRiskMember_fbbfb9ed-a9c8-4df6-91fa-0675bf2411cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_e2100664-fa62-4b02-a135-1937d238147c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable_e94212f6-5ee2-4293-97a3-ac237836aac8" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_e2100664-fa62-4b02-a135-1937d238147c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_04dc1f1b-7ade-471b-89c8-fe00420b5c0f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_e2100664-fa62-4b02-a135-1937d238147c" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_04dc1f1b-7ade-471b-89c8-fe00420b5c0f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesRevenueNetMember_20d466ba-0429-4486-a90e-ecdb9b147490" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SalesRevenueNetMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_04dc1f1b-7ade-471b-89c8-fe00420b5c0f" xlink:to="loc_us-gaap_SalesRevenueNetMember_20d466ba-0429-4486-a90e-ecdb9b147490" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems_33541627-231a-4f98-a929-88114bf4328e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable_e94212f6-5ee2-4293-97a3-ac237836aac8" xlink:to="loc_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems_33541627-231a-4f98-a929-88114bf4328e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_a0bd36ee-059b-493c-8db1-d6923c34af4b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems_33541627-231a-4f98-a929-88114bf4328e" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_a0bd36ee-059b-493c-8db1-d6923c34af4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_34a4b8ce-7043-49a8-8b1f-52323d20ca31" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems_33541627-231a-4f98-a929-88114bf4328e" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_34a4b8ce-7043-49a8-8b1f-52323d20ca31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.lifevantage.com/role/PropertyandEquipmentNetDetails" xlink:type="simple" xlink:href="lfvn-20250630.xsd#PropertyandEquipmentNetDetails"/>
  <link:presentationLink xlink:role="http://www.lifevantage.com/role/PropertyandEquipmentNetDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_92de6b19-26b5-499f-8f6a-91d252647ee9" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_d9daaab5-ecbf-44ae-b4fb-b4770a8ca856" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_92de6b19-26b5-499f-8f6a-91d252647ee9" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_d9daaab5-ecbf-44ae-b4fb-b4770a8ca856" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_9cd9b2a8-4fde-4199-ac11-1b2cdf4b6411" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_d9daaab5-ecbf-44ae-b4fb-b4770a8ca856" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_9cd9b2a8-4fde-4199-ac11-1b2cdf4b6411" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_a74a1d23-0d48-4bcd-afa8-2365014f85ef" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_9cd9b2a8-4fde-4199-ac11-1b2cdf4b6411" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_a74a1d23-0d48-4bcd-afa8-2365014f85ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquipmentMember_f039f524-27f3-47a4-b085-6fabfc69dc13" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquipmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_a74a1d23-0d48-4bcd-afa8-2365014f85ef" xlink:to="loc_us-gaap_EquipmentMember_f039f524-27f3-47a4-b085-6fabfc69dc13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesMember_9fe29ea6-b5c6-4d79-9d43-31998c8ebd9f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FurnitureAndFixturesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_a74a1d23-0d48-4bcd-afa8-2365014f85ef" xlink:to="loc_us-gaap_FurnitureAndFixturesMember_9fe29ea6-b5c6-4d79-9d43-31998c8ebd9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsMember_a70b06e0-9509-41f5-b6cd-ef862e003cae" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_a74a1d23-0d48-4bcd-afa8-2365014f85ef" xlink:to="loc_us-gaap_LeaseholdImprovementsMember_a70b06e0-9509-41f5-b6cd-ef862e003cae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VehiclesMember_16bd67b1-2739-42a0-930a-260f8fd0d348" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_VehiclesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_a74a1d23-0d48-4bcd-afa8-2365014f85ef" xlink:to="loc_us-gaap_VehiclesMember_16bd67b1-2739-42a0-930a-260f8fd0d348" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_3c7a43f4-6425-47ed-9b29-7feef4e9c03d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_d9daaab5-ecbf-44ae-b4fb-b4770a8ca856" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentLineItems_3c7a43f4-6425-47ed-9b29-7feef4e9c03d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_ba34d636-65e3-419d-94c1-0ac6c039ad15" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_3c7a43f4-6425-47ed-9b29-7feef4e9c03d" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_ba34d636-65e3-419d-94c1-0ac6c039ad15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_9e2c3850-4980-4b82-9c55-ee4add70b846" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_3c7a43f4-6425-47ed-9b29-7feef4e9c03d" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_9e2c3850-4980-4b82-9c55-ee4add70b846" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_92a9f95b-d748-4a8a-b158-d5fd738afd7b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_3c7a43f4-6425-47ed-9b29-7feef4e9c03d" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_92a9f95b-d748-4a8a-b158-d5fd738afd7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_cb2135db-33af-4ea2-b654-42e651715da1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Depreciation"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_3c7a43f4-6425-47ed-9b29-7feef4e9c03d" xlink:to="loc_us-gaap_Depreciation_cb2135db-33af-4ea2-b654-42e651715da1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.lifevantage.com/role/IntangibleAssetsNetDetails" xlink:type="simple" xlink:href="lfvn-20250630.xsd#IntangibleAssetsNetDetails"/>
  <link:presentationLink xlink:role="http://www.lifevantage.com/role/IntangibleAssetsNetDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_327097f3-8bc2-4c2e-8b29-1f2e00d23f67" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_909b1a96-592f-4072-aa19-570cb61c2c7e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_327097f3-8bc2-4c2e-8b29-1f2e00d23f67" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_909b1a96-592f-4072-aa19-570cb61c2c7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_ffc28564-b540-413d-975c-6ad4948269a0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_909b1a96-592f-4072-aa19-570cb61c2c7e" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_ffc28564-b540-413d-975c-6ad4948269a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_140829f5-dbda-4ab9-8b3d-230ec43a7a57" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_ffc28564-b540-413d-975c-6ad4948269a0" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_140829f5-dbda-4ab9-8b3d-230ec43a7a57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PatentsMember_4a7aef89-341a-4192-ae1a-d7912c973cf8" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PatentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_140829f5-dbda-4ab9-8b3d-230ec43a7a57" xlink:to="loc_us-gaap_PatentsMember_4a7aef89-341a-4192-ae1a-d7912c973cf8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_81224552-b863-49a1-a271-9e01ea5a084d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_909b1a96-592f-4072-aa19-570cb61c2c7e" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_81224552-b863-49a1-a271-9e01ea5a084d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_cc847770-6edf-4b76-ad08-111bb5cf18cb" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_81224552-b863-49a1-a271-9e01ea5a084d" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_cc847770-6edf-4b76-ad08-111bb5cf18cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_0afd29d6-8266-49a9-b428-ee661d828213" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_81224552-b863-49a1-a271-9e01ea5a084d" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_0afd29d6-8266-49a9-b428-ee661d828213" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_9b97ef73-6a4c-4d98-8013-b1334048d403" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_81224552-b863-49a1-a271-9e01ea5a084d" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_9b97ef73-6a4c-4d98-8013-b1334048d403" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_0d97c067-155e-4e45-bfb2-490ef385ab11" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_327097f3-8bc2-4c2e-8b29-1f2e00d23f67" xlink:to="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_0d97c067-155e-4e45-bfb2-490ef385ab11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_932ed912-862c-43b3-bfda-dc7a2e2082d8" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_0d97c067-155e-4e45-bfb2-490ef385ab11" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_932ed912-862c-43b3-bfda-dc7a2e2082d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_46e44976-c7c7-44d7-afe2-6278304d7fea" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_932ed912-862c-43b3-bfda-dc7a2e2082d8" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_46e44976-c7c7-44d7-afe2-6278304d7fea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TrademarksMember_5c9ea9ac-a7d9-4a30-b01c-9bbab5d6440b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TrademarksMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_46e44976-c7c7-44d7-afe2-6278304d7fea" xlink:to="loc_us-gaap_TrademarksMember_5c9ea9ac-a7d9-4a30-b01c-9bbab5d6440b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_ed2ae5e1-8d64-41b7-862d-993b77da1ed7" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_0d97c067-155e-4e45-bfb2-490ef385ab11" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_ed2ae5e1-8d64-41b7-862d-993b77da1ed7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_85f7ffe0-d7a2-4874-9547-2c085f0eb781" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_ed2ae5e1-8d64-41b7-862d-993b77da1ed7" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_85f7ffe0-d7a2-4874-9547-2c085f0eb781" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_74327fca-1b94-4dd1-9f5f-c16b812344c3" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_327097f3-8bc2-4c2e-8b29-1f2e00d23f67" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_74327fca-1b94-4dd1-9f5f-c16b812344c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_de6d112b-6473-4700-9a12-8e839d050de7" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_327097f3-8bc2-4c2e-8b29-1f2e00d23f67" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_de6d112b-6473-4700-9a12-8e839d050de7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_cc66eb97-0187-4b91-abc9-5320b99ed663" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_327097f3-8bc2-4c2e-8b29-1f2e00d23f67" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_cc66eb97-0187-4b91-abc9-5320b99ed663" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract_36dcf85f-b914-430e-b9f0-f35a55ef9ac0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_327097f3-8bc2-4c2e-8b29-1f2e00d23f67" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract_36dcf85f-b914-430e-b9f0-f35a55ef9ac0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_b7815c9e-3834-4b88-ba9e-589f1c7841b0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract_36dcf85f-b914-430e-b9f0-f35a55ef9ac0" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_b7815c9e-3834-4b88-ba9e-589f1c7841b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_8f69529c-9999-4615-bdd1-a3e3dda27aa5" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract_36dcf85f-b914-430e-b9f0-f35a55ef9ac0" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_8f69529c-9999-4615-bdd1-a3e3dda27aa5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.lifevantage.com/role/OtherAccruedExpensesDetails" xlink:type="simple" xlink:href="lfvn-20250630.xsd#OtherAccruedExpensesDetails"/>
  <link:presentationLink xlink:role="http://www.lifevantage.com/role/OtherAccruedExpensesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PayablesAndAccrualsAbstract_45900825-b767-4d04-9a12-19891f41020b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PayablesAndAccrualsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedBonusesCurrentAndNoncurrent_e865a7d2-30e6-48b3-944b-0ab7d36579ef" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccruedBonusesCurrentAndNoncurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_45900825-b767-4d04-9a12-19891f41020b" xlink:to="loc_us-gaap_AccruedBonusesCurrentAndNoncurrent_e865a7d2-30e6-48b3-944b-0ab7d36579ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedEmployeeBenefitsCurrentAndNoncurrent_416a8daa-4bad-4436-adb1-f02d349a3cff" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccruedEmployeeBenefitsCurrentAndNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_45900825-b767-4d04-9a12-19891f41020b" xlink:to="loc_us-gaap_AccruedEmployeeBenefitsCurrentAndNoncurrent_416a8daa-4bad-4436-adb1-f02d349a3cff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxesPayableCurrent_e9e70752-24e9-44bf-b49c-bd45ab670ab1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TaxesPayableCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_45900825-b767-4d04-9a12-19891f41020b" xlink:to="loc_us-gaap_TaxesPayableCurrent_e9e70752-24e9-44bf-b49c-bd45ab670ab1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_AccruedPayableToVendors_2393fb53-2cc9-4423-b7cb-f962143009c9" xlink:href="lfvn-20250630.xsd#lfvn_AccruedPayableToVendors"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_45900825-b767-4d04-9a12-19891f41020b" xlink:to="loc_lfvn_AccruedPayableToVendors_2393fb53-2cc9-4423-b7cb-f962143009c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent_6529d9db-c18a-4f87-aae9-84423802b754" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_45900825-b767-4d04-9a12-19891f41020b" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCurrent_6529d9db-c18a-4f87-aae9-84423802b754" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedMarketingCostsCurrent_debdf1b0-9ad4-4262-a154-8b00b24607ca" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccruedMarketingCostsCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_45900825-b767-4d04-9a12-19891f41020b" xlink:to="loc_us-gaap_AccruedMarketingCostsCurrent_debdf1b0-9ad4-4262-a154-8b00b24607ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_91b6a1e6-fdd6-42da-9129-95933323516c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_45900825-b767-4d04-9a12-19891f41020b" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrent_91b6a1e6-fdd6-42da-9129-95933323516c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_90708904-3b57-4716-85a0-467983ed0fd5" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_45900825-b767-4d04-9a12-19891f41020b" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_90708904-3b57-4716-85a0-467983ed0fd5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.lifevantage.com/role/LongTermDebtDetails" xlink:type="simple" xlink:href="lfvn-20250630.xsd#LongTermDebtDetails"/>
  <link:presentationLink xlink:role="http://www.lifevantage.com/role/LongTermDebtDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_e8257980-2f5c-4f11-8196-15746e28eac5" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityTable_f3b70e66-6fb4-4c1e-a586-9e9c69621eec" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LineOfCreditFacilityTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_e8257980-2f5c-4f11-8196-15746e28eac5" xlink:to="loc_us-gaap_LineOfCreditFacilityTable_f3b70e66-6fb4-4c1e-a586-9e9c69621eec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_4e997df3-ce74-41be-a37d-4c37bb8d1356" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_f3b70e66-6fb4-4c1e-a586-9e9c69621eec" xlink:to="loc_us-gaap_DebtInstrumentAxis_4e997df3-ce74-41be-a37d-4c37bb8d1356" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_e4a767f9-3cc7-4bf3-8d90-8a246dceb37b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_4e997df3-ce74-41be-a37d-4c37bb8d1356" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_e4a767f9-3cc7-4bf3-8d90-8a246dceb37b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_March2016RevolvingLoanMember_b98b51d5-dc64-4164-988f-2460d3961553" xlink:href="lfvn-20250630.xsd#lfvn_March2016RevolvingLoanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_e4a767f9-3cc7-4bf3-8d90-8a246dceb37b" xlink:to="loc_lfvn_March2016RevolvingLoanMember_b98b51d5-dc64-4164-988f-2460d3961553" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_March2016TermLoanMember_4d37361b-52d7-4c91-a391-451bc639f42b" xlink:href="lfvn-20250630.xsd#lfvn_March2016TermLoanMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_e4a767f9-3cc7-4bf3-8d90-8a246dceb37b" xlink:to="loc_lfvn_March2016TermLoanMember_4d37361b-52d7-4c91-a391-451bc639f42b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_73a13568-90a2-448f-921d-64c1aa66b64a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CreditFacilityAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_f3b70e66-6fb4-4c1e-a586-9e9c69621eec" xlink:to="loc_us-gaap_CreditFacilityAxis_73a13568-90a2-448f-921d-64c1aa66b64a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_3e350aaf-b95a-41c7-b3a3-b6c708d7cd3a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CreditFacilityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_73a13568-90a2-448f-921d-64c1aa66b64a" xlink:to="loc_us-gaap_CreditFacilityDomain_3e350aaf-b95a-41c7-b3a3-b6c708d7cd3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_15e26b70-e7a9-40cb-99ab-5d9c08f75527" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_3e350aaf-b95a-41c7-b3a3-b6c708d7cd3a" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_15e26b70-e7a9-40cb-99ab-5d9c08f75527" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebtMember_055c8973-e767-4296-8977-ccd0cfcd1c54" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SecuredDebtMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_3e350aaf-b95a-41c7-b3a3-b6c708d7cd3a" xlink:to="loc_us-gaap_SecuredDebtMember_055c8973-e767-4296-8977-ccd0cfcd1c54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_9c7c81af-22c9-42bd-8af2-aff400c2cfde" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_f3b70e66-6fb4-4c1e-a586-9e9c69621eec" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_9c7c81af-22c9-42bd-8af2-aff400c2cfde" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_2caf71fb-ed2f-4333-82be-91b7fb912b4f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_9c7c81af-22c9-42bd-8af2-aff400c2cfde" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_2caf71fb-ed2f-4333-82be-91b7fb912b4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_71fea916-e9b7-49d0-820d-c63b81deb2af" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LineOfCreditMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_2caf71fb-ed2f-4333-82be-91b7fb912b4f" xlink:to="loc_us-gaap_LineOfCreditMember_71fea916-e9b7-49d0-820d-c63b81deb2af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLineItems_cc044abf-578d-4db0-81e0-a48c91d97afd" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LineOfCreditFacilityLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_f3b70e66-6fb4-4c1e-a586-9e9c69621eec" xlink:to="loc_us-gaap_LineOfCreditFacilityLineItems_cc044abf-578d-4db0-81e0-a48c91d97afd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_db95a510-f098-48b0-bce4-e09f1485cb31" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_cc044abf-578d-4db0-81e0-a48c91d97afd" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_db95a510-f098-48b0-bce4-e09f1485cb31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_e4d3a401-64ff-470b-a071-7d42e0d7e0fa" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_cc044abf-578d-4db0-81e0-a48c91d97afd" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_e4d3a401-64ff-470b-a071-7d42e0d7e0fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_DebtInstrumentFloorInterestRate_89917b9d-71a9-4967-a6dc-eca5ed14e6e3" xlink:href="lfvn-20250630.xsd#lfvn_DebtInstrumentFloorInterestRate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_cc044abf-578d-4db0-81e0-a48c91d97afd" xlink:to="loc_lfvn_DebtInstrumentFloorInterestRate_89917b9d-71a9-4967-a6dc-eca5ed14e6e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_CommonStockDividendsPerShareCashPaidOneTimeDividend_6de1d761-4669-4124-a3cb-871c978644bf" xlink:href="lfvn-20250630.xsd#lfvn_CommonStockDividendsPerShareCashPaidOneTimeDividend"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_cc044abf-578d-4db0-81e0-a48c91d97afd" xlink:to="loc_lfvn_CommonStockDividendsPerShareCashPaidOneTimeDividend_6de1d761-4669-4124-a3cb-871c978644bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage_2124128d-2db6-445c-94ee-2b2ea33e312f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentInterestRateEffectivePercentage"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_cc044abf-578d-4db0-81e0-a48c91d97afd" xlink:to="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage_2124128d-2db6-445c-94ee-2b2ea33e312f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit_56552daa-16f8-4d82-a24a-4078315644bd" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LineOfCredit"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_cc044abf-578d-4db0-81e0-a48c91d97afd" xlink:to="loc_us-gaap_LineOfCredit_56552daa-16f8-4d82-a24a-4078315644bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.lifevantage.com/role/StockholdersEquityDetails" xlink:type="simple" xlink:href="lfvn-20250630.xsd#StockholdersEquityDetails"/>
  <link:presentationLink xlink:role="http://www.lifevantage.com/role/StockholdersEquityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_46cdb9eb-9bce-43e9-be19-4e851f425c86" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_1bea9198-c8c5-4010-a47c-fd4eeb70f24d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_46cdb9eb-9bce-43e9-be19-4e851f425c86" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_1bea9198-c8c5-4010-a47c-fd4eeb70f24d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_7b21ba5d-6864-48bb-9a44-48d240b5a34b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_1bea9198-c8c5-4010-a47c-fd4eeb70f24d" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_7b21ba5d-6864-48bb-9a44-48d240b5a34b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_2aad7f7a-c387-4a88-9700-4021f166bd43" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_7b21ba5d-6864-48bb-9a44-48d240b5a34b" xlink:to="loc_us-gaap_EquityComponentDomain_2aad7f7a-c387-4a88-9700-4021f166bd43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_df186b6f-0342-4193-b15d-ba3a13de6696" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_2aad7f7a-c387-4a88-9700-4021f166bd43" xlink:to="loc_us-gaap_CommonStockMember_df186b6f-0342-4193-b15d-ba3a13de6696" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_e6ad5800-7120-4512-835f-23809bd70134" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_1bea9198-c8c5-4010-a47c-fd4eeb70f24d" xlink:to="loc_us-gaap_AwardTypeAxis_e6ad5800-7120-4512-835f-23809bd70134" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_9c39719b-fadd-48fb-adda-41cfef58c266" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_e6ad5800-7120-4512-835f-23809bd70134" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_9c39719b-fadd-48fb-adda-41cfef58c266" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_39f1d66f-8c1b-4598-8949-5e09fb719f71" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RestrictedStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_9c39719b-fadd-48fb-adda-41cfef58c266" xlink:to="loc_us-gaap_RestrictedStockMember_39f1d66f-8c1b-4598-8949-5e09fb719f71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_d18751db-7b73-4676-94d9-27ea091c994b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PlanNameAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_1bea9198-c8c5-4010-a47c-fd4eeb70f24d" xlink:to="loc_us-gaap_PlanNameAxis_d18751db-7b73-4676-94d9-27ea091c994b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_98c18fba-17d8-4171-83ad-b018a7ea541f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_d18751db-7b73-4676-94d9-27ea091c994b" xlink:to="loc_us-gaap_PlanNameDomain_98c18fba-17d8-4171-83ad-b018a7ea541f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_EmployeeStockPurchasePlanMember_2cd0b4cb-8472-4467-a214-8cfdcf7c17df" xlink:href="lfvn-20250630.xsd#lfvn_EmployeeStockPurchasePlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_98c18fba-17d8-4171-83ad-b018a7ea541f" xlink:to="loc_lfvn_EmployeeStockPurchasePlanMember_2cd0b4cb-8472-4467-a214-8cfdcf7c17df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems_f1981530-56cd-4aa9-8571-75a4c18e972d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_1bea9198-c8c5-4010-a47c-fd4eeb70f24d" xlink:to="loc_us-gaap_ClassOfStockLineItems_f1981530-56cd-4aa9-8571-75a4c18e972d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_StockIssuedDuringPeriodSharesStockOptionsAndWarrantsExercised_e85008d1-7928-47e3-9c44-a7e8483ec3d1" xlink:href="lfvn-20250630.xsd#lfvn_StockIssuedDuringPeriodSharesStockOptionsAndWarrantsExercised"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_f1981530-56cd-4aa9-8571-75a4c18e972d" xlink:to="loc_lfvn_StockIssuedDuringPeriodSharesStockOptionsAndWarrantsExercised_e85008d1-7928-47e3-9c44-a7e8483ec3d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_882e3a2f-b793-4bb0-bffb-198671364379" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_f1981530-56cd-4aa9-8571-75a4c18e972d" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_882e3a2f-b793-4bb0-bffb-198671364379" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_2157019b-2d55-421a-b4fc-5269c234a8af" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_f1981530-56cd-4aa9-8571-75a4c18e972d" xlink:to="loc_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_2157019b-2d55-421a-b4fc-5269c234a8af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_8c310c73-fc53-4f6c-92f2-96e1524ab8eb" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_f1981530-56cd-4aa9-8571-75a4c18e972d" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_8c310c73-fc53-4f6c-92f2-96e1524ab8eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StockRepurchaseProgramAuthorizedAmount1_d64e401d-cfb5-4efd-bfb7-04f11f1f635d" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_f1981530-56cd-4aa9-8571-75a4c18e972d" xlink:to="loc_srt_StockRepurchaseProgramAuthorizedAmount1_d64e401d-cfb5-4efd-bfb7-04f11f1f635d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodShares_c400ff44-840d-4edd-a231-d7a97551b42e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockRepurchasedDuringPeriodShares"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_f1981530-56cd-4aa9-8571-75a4c18e972d" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodShares_c400ff44-840d-4edd-a231-d7a97551b42e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_d221c22b-9796-40ab-b1ec-5aad18520d9c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_f1981530-56cd-4aa9-8571-75a4c18e972d" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_d221c22b-9796-40ab-b1ec-5aad18520d9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_8e7f4322-9091-497c-97fb-d396e0a107ce" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_f1981530-56cd-4aa9-8571-75a4c18e972d" xlink:to="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_8e7f4322-9091-497c-97fb-d396e0a107ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCommonStockCash_dd6d8e5a-b406-4227-88c9-aef4711d44f5" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DividendsCommonStockCash"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_f1981530-56cd-4aa9-8571-75a4c18e972d" xlink:to="loc_us-gaap_DividendsCommonStockCash_dd6d8e5a-b406-4227-88c9-aef4711d44f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareCashPaid_b6c94c4e-e084-42a0-91d2-408729418473" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockDividendsPerShareCashPaid"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_f1981530-56cd-4aa9-8571-75a4c18e972d" xlink:to="loc_us-gaap_CommonStockDividendsPerShareCashPaid_b6c94c4e-e084-42a0-91d2-408729418473" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_CommonStockDividendsPerShareCashPaidOneTimeDividend_03fd3e8f-2915-4f5b-8458-36e0c6599a49" xlink:href="lfvn-20250630.xsd#lfvn_CommonStockDividendsPerShareCashPaidOneTimeDividend"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_f1981530-56cd-4aa9-8571-75a4c18e972d" xlink:to="loc_lfvn_CommonStockDividendsPerShareCashPaidOneTimeDividend_03fd3e8f-2915-4f5b-8458-36e0c6599a49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_bed4b543-1b96-451d-be7e-c85f2ac31ec1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_f1981530-56cd-4aa9-8571-75a4c18e972d" xlink:to="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_bed4b543-1b96-451d-be7e-c85f2ac31ec1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_9fc0b219-3be3-43a4-93ff-1c3e8f5cd0c3" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_f1981530-56cd-4aa9-8571-75a4c18e972d" xlink:to="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_9fc0b219-3be3-43a4-93ff-1c3e8f5cd0c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_ClassOfWarrantOrRightPercentOfCommonStockAcquisitionThatMakesRightsExercisable_c7d3f818-6afc-4aa1-a997-b6c8764509ac" xlink:href="lfvn-20250630.xsd#lfvn_ClassOfWarrantOrRightPercentOfCommonStockAcquisitionThatMakesRightsExercisable"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_f1981530-56cd-4aa9-8571-75a4c18e972d" xlink:to="loc_lfvn_ClassOfWarrantOrRightPercentOfCommonStockAcquisitionThatMakesRightsExercisable_c7d3f818-6afc-4aa1-a997-b6c8764509ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_ClassOfWarrantOrRightPercentOfCommonStockAcquisitionThatMakesRightsExercisablePassiveInvestors_4640df29-9b95-4776-a083-a9899b9a72e4" xlink:href="lfvn-20250630.xsd#lfvn_ClassOfWarrantOrRightPercentOfCommonStockAcquisitionThatMakesRightsExercisablePassiveInvestors"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_f1981530-56cd-4aa9-8571-75a4c18e972d" xlink:to="loc_lfvn_ClassOfWarrantOrRightPercentOfCommonStockAcquisitionThatMakesRightsExercisablePassiveInvestors_4640df29-9b95-4776-a083-a9899b9a72e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_ClassOfWarrantsOrRightDiscount_3f2f27ba-659e-4214-aa31-5c5c605d84da" xlink:href="lfvn-20250630.xsd#lfvn_ClassOfWarrantsOrRightDiscount"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_f1981530-56cd-4aa9-8571-75a4c18e972d" xlink:to="loc_lfvn_ClassOfWarrantsOrRightDiscount_3f2f27ba-659e-4214-aa31-5c5c605d84da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.lifevantage.com/role/ShareBasedCompensationEquitySettledPlansNarrativeDetails" xlink:type="simple" xlink:href="lfvn-20250630.xsd#ShareBasedCompensationEquitySettledPlansNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.lifevantage.com/role/ShareBasedCompensationEquitySettledPlansNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_c12e2e42-52ee-48f9-9c57-28421f897bab" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_11c30ef7-fe0b-4c56-b1c0-79986de214e9" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_c12e2e42-52ee-48f9-9c57-28421f897bab" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_11c30ef7-fe0b-4c56-b1c0-79986de214e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_83d4afee-6bd6-4c8a-bd79-e359269e897f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PlanNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_11c30ef7-fe0b-4c56-b1c0-79986de214e9" xlink:to="loc_us-gaap_PlanNameAxis_83d4afee-6bd6-4c8a-bd79-e359269e897f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_b530a334-70ac-4af0-ae4f-21c545c5592a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_83d4afee-6bd6-4c8a-bd79-e359269e897f" xlink:to="loc_us-gaap_PlanNameDomain_b530a334-70ac-4af0-ae4f-21c545c5592a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_TwoThousandAndTenLongTermIncentivePlanMember_9b28b0a7-0cd9-4e35-ba74-e54cf2b9601f" xlink:href="lfvn-20250630.xsd#lfvn_TwoThousandAndTenLongTermIncentivePlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_b530a334-70ac-4af0-ae4f-21c545c5592a" xlink:to="loc_lfvn_TwoThousandAndTenLongTermIncentivePlanMember_9b28b0a7-0cd9-4e35-ba74-e54cf2b9601f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_TwoThousandSeventeenLongTermIncentivePlanMember_33346479-124a-444a-a4ef-482037160ff6" xlink:href="lfvn-20250630.xsd#lfvn_TwoThousandSeventeenLongTermIncentivePlanMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_b530a334-70ac-4af0-ae4f-21c545c5592a" xlink:to="loc_lfvn_TwoThousandSeventeenLongTermIncentivePlanMember_33346479-124a-444a-a4ef-482037160ff6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_TwoThousandSeventeenLongTermIncentivePlanExcludingTwoThousandAndTenLongTermIncentivePlanMember_f1102ba6-a746-4d72-8b46-1449ce9cc7df" xlink:href="lfvn-20250630.xsd#lfvn_TwoThousandSeventeenLongTermIncentivePlanExcludingTwoThousandAndTenLongTermIncentivePlanMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_b530a334-70ac-4af0-ae4f-21c545c5592a" xlink:to="loc_lfvn_TwoThousandSeventeenLongTermIncentivePlanExcludingTwoThousandAndTenLongTermIncentivePlanMember_f1102ba6-a746-4d72-8b46-1449ce9cc7df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1481ecc0-72e2-4796-ab55-2e598c253b36" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_11c30ef7-fe0b-4c56-b1c0-79986de214e9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1481ecc0-72e2-4796-ab55-2e598c253b36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_694beb1f-f741-464f-8ec0-77094fadfa3c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1481ecc0-72e2-4796-ab55-2e598c253b36" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_694beb1f-f741-464f-8ec0-77094fadfa3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_bd925365-063e-49e9-8789-9964aefa5fdd" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1481ecc0-72e2-4796-ab55-2e598c253b36" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_bd925365-063e-49e9-8789-9964aefa5fdd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_739c31d5-2147-4b8d-80ed-3ca71c7aa942" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1481ecc0-72e2-4796-ab55-2e598c253b36" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_739c31d5-2147-4b8d-80ed-3ca71c7aa942" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_e973af33-6c14-42a1-a0da-7d8cdf55f6e5" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1481ecc0-72e2-4796-ab55-2e598c253b36" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_e973af33-6c14-42a1-a0da-7d8cdf55f6e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsOutstandingContractualTerm_64723c0f-2217-482a-a0ca-f43884a62b61" xlink:href="lfvn-20250630.xsd#lfvn_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsOutstandingContractualTerm"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1481ecc0-72e2-4796-ab55-2e598c253b36" xlink:to="loc_lfvn_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsOutstandingContractualTerm_64723c0f-2217-482a-a0ca-f43884a62b61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_fc786c56-9dc3-4831-adf7-21f01c7916ee" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1481ecc0-72e2-4796-ab55-2e598c253b36" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_fc786c56-9dc3-4831-adf7-21f01c7916ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.lifevantage.com/role/ShareBasedCompensationEmployeeStockPurchasePlanNarrativeDetails" xlink:type="simple" xlink:href="lfvn-20250630.xsd#ShareBasedCompensationEmployeeStockPurchasePlanNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.lifevantage.com/role/ShareBasedCompensationEmployeeStockPurchasePlanNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_6b9d0a14-0cee-4131-8ed9-d78167d62206" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_189116e0-24a4-4007-8b64-19487f28525c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_6b9d0a14-0cee-4131-8ed9-d78167d62206" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_189116e0-24a4-4007-8b64-19487f28525c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_9cb81e79-30da-408c-8ef7-890a778e0e06" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PlanNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_189116e0-24a4-4007-8b64-19487f28525c" xlink:to="loc_us-gaap_PlanNameAxis_9cb81e79-30da-408c-8ef7-890a778e0e06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_f1ba49cf-3232-4cd1-8159-39f47afac75a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_9cb81e79-30da-408c-8ef7-890a778e0e06" xlink:to="loc_us-gaap_PlanNameDomain_f1ba49cf-3232-4cd1-8159-39f47afac75a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_EmployeeStockPurchasePlanMember_70791e2f-0657-49eb-b0d1-53bf76b495ae" xlink:href="lfvn-20250630.xsd#lfvn_EmployeeStockPurchasePlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_f1ba49cf-3232-4cd1-8159-39f47afac75a" xlink:to="loc_lfvn_EmployeeStockPurchasePlanMember_70791e2f-0657-49eb-b0d1-53bf76b495ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0361f077-afca-469d-b77f-e91f014e2b6a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_189116e0-24a4-4007-8b64-19487f28525c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0361f077-afca-469d-b77f-e91f014e2b6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_f00968c8-1348-49db-af0b-d9aef1974a9f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0361f077-afca-469d-b77f-e91f014e2b6a" xlink:to="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_f00968c8-1348-49db-af0b-d9aef1974a9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_a642c1ca-b7be-4897-a3ea-efdf626d8b7b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0361f077-afca-469d-b77f-e91f014e2b6a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_a642c1ca-b7be-4897-a3ea-efdf626d8b7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_81fe4afe-fa05-4773-81b8-8327d0d68c7d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0361f077-afca-469d-b77f-e91f014e2b6a" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_81fe4afe-fa05-4773-81b8-8327d0d68c7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate_b1925a43-5574-4b95-9a16-f4942ac78b8f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0361f077-afca-469d-b77f-e91f014e2b6a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate_b1925a43-5574-4b95-9a16-f4942ac78b8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee_b7c558fd-f4ec-4bb3-892c-a83eebbfbd58" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0361f077-afca-469d-b77f-e91f014e2b6a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee_b7c558fd-f4ec-4bb3-892c-a83eebbfbd58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_ShareBasedCompensationArrangementByShareBasedPaymentAwardAmountInExcessOfFairMarketValueOfStockForOptionNotToBeGranted_ca66096c-2bff-4d3f-84aa-aa5f64bec9e9" xlink:href="lfvn-20250630.xsd#lfvn_ShareBasedCompensationArrangementByShareBasedPaymentAwardAmountInExcessOfFairMarketValueOfStockForOptionNotToBeGranted"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0361f077-afca-469d-b77f-e91f014e2b6a" xlink:to="loc_lfvn_ShareBasedCompensationArrangementByShareBasedPaymentAwardAmountInExcessOfFairMarketValueOfStockForOptionNotToBeGranted_ca66096c-2bff-4d3f-84aa-aa5f64bec9e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOfferingPeriod_cac7c9eb-4fc2-40d6-8afa-385c9bcc690d" xlink:href="lfvn-20250630.xsd#lfvn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOfferingPeriod"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0361f077-afca-469d-b77f-e91f014e2b6a" xlink:to="loc_lfvn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOfferingPeriod_cac7c9eb-4fc2-40d6-8afa-385c9bcc690d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_e2034732-a72d-45cb-a6a1-64f2830e15d9" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0361f077-afca-469d-b77f-e91f014e2b6a" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_e2034732-a72d-45cb-a6a1-64f2830e15d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.lifevantage.com/role/ShareBasedCompensationStockBasedCompensationNarrativeDetails" xlink:type="simple" xlink:href="lfvn-20250630.xsd#ShareBasedCompensationStockBasedCompensationNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.lifevantage.com/role/ShareBasedCompensationStockBasedCompensationNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_8e1bf96e-ced7-452e-8190-4f8f033f055d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_d5a78dac-9606-4509-8d9c-cc7c2b098b96" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_8e1bf96e-ced7-452e-8190-4f8f033f055d" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_d5a78dac-9606-4509-8d9c-cc7c2b098b96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_00d21672-33a5-46fc-a2ca-80273819faaa" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_d5a78dac-9606-4509-8d9c-cc7c2b098b96" xlink:to="loc_us-gaap_AwardTypeAxis_00d21672-33a5-46fc-a2ca-80273819faaa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2f4360e2-1d59-49a2-b473-f592817fb5d6" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_00d21672-33a5-46fc-a2ca-80273819faaa" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2f4360e2-1d59-49a2-b473-f592817fb5d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_0cdc0028-fa0a-457c-b854-1b88f1d14607" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RestrictedStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2f4360e2-1d59-49a2-b473-f592817fb5d6" xlink:to="loc_us-gaap_RestrictedStockMember_0cdc0028-fa0a-457c-b854-1b88f1d14607" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_ee18d173-2047-44d1-99c5-4615bb5456a9" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PlanNameAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_d5a78dac-9606-4509-8d9c-cc7c2b098b96" xlink:to="loc_us-gaap_PlanNameAxis_ee18d173-2047-44d1-99c5-4615bb5456a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_8aeefbc5-ecdd-4aa0-a5ce-23337f4fc2ab" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_ee18d173-2047-44d1-99c5-4615bb5456a9" xlink:to="loc_us-gaap_PlanNameDomain_8aeefbc5-ecdd-4aa0-a5ce-23337f4fc2ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_TwoThousandAndTenAndTwoThousandSeventeenLongTermIncentivePlanMember_d09290e0-0b19-45b2-9e0c-aa191e52f179" xlink:href="lfvn-20250630.xsd#lfvn_TwoThousandAndTenAndTwoThousandSeventeenLongTermIncentivePlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_8aeefbc5-ecdd-4aa0-a5ce-23337f4fc2ab" xlink:to="loc_lfvn_TwoThousandAndTenAndTwoThousandSeventeenLongTermIncentivePlanMember_d09290e0-0b19-45b2-9e0c-aa191e52f179" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6a799a40-a0aa-4512-8933-244fe3220684" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_d5a78dac-9606-4509-8d9c-cc7c2b098b96" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6a799a40-a0aa-4512-8933-244fe3220684" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_de83d78a-f36b-449b-842a-acbe0afd336a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6a799a40-a0aa-4512-8933-244fe3220684" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_de83d78a-f36b-449b-842a-acbe0afd336a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_9dab49b1-3321-4a5e-881c-dfc6b72c9b12" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6a799a40-a0aa-4512-8933-244fe3220684" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_9dab49b1-3321-4a5e-881c-dfc6b72c9b12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_f87f6d87-d617-47a2-a022-93634a971b2f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6a799a40-a0aa-4512-8933-244fe3220684" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_f87f6d87-d617-47a2-a022-93634a971b2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.lifevantage.com/role/ShareBasedCompensationStockOptionsNarrativeDetails" xlink:type="simple" xlink:href="lfvn-20250630.xsd#ShareBasedCompensationStockOptionsNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.lifevantage.com/role/ShareBasedCompensationStockOptionsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_c65c27ac-7ec6-4a90-98e6-4f3c81ce1434" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_fc02d65c-973e-46ae-8ae3-58ce72fe98b3" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_c65c27ac-7ec6-4a90-98e6-4f3c81ce1434" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_fc02d65c-973e-46ae-8ae3-58ce72fe98b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingAxis_3d4f89b8-3840-4150-bf1d-370fbf5ea077" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_VestingAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_fc02d65c-973e-46ae-8ae3-58ce72fe98b3" xlink:to="loc_us-gaap_VestingAxis_3d4f89b8-3840-4150-bf1d-370fbf5ea077" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingDomain_638cd577-8bf7-4cc3-909a-6941a2256841" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_VestingDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VestingAxis_3d4f89b8-3840-4150-bf1d-370fbf5ea077" xlink:to="loc_us-gaap_VestingDomain_638cd577-8bf7-4cc3-909a-6941a2256841" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationAwardTrancheOneMember_64bc805b-31fc-4b74-ad50-c40ff18e1a75" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationAwardTrancheOneMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VestingDomain_638cd577-8bf7-4cc3-909a-6941a2256841" xlink:to="loc_us-gaap_ShareBasedCompensationAwardTrancheOneMember_64bc805b-31fc-4b74-ad50-c40ff18e1a75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationAwardTrancheTwoMember_ea64ff54-dedb-4ebb-ba6e-8bcf4a5c28b9" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationAwardTrancheTwoMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VestingDomain_638cd577-8bf7-4cc3-909a-6941a2256841" xlink:to="loc_us-gaap_ShareBasedCompensationAwardTrancheTwoMember_ea64ff54-dedb-4ebb-ba6e-8bcf4a5c28b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_6015b020-d7a1-46bc-9e95-a5079798fde0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_fc02d65c-973e-46ae-8ae3-58ce72fe98b3" xlink:to="loc_us-gaap_AwardTypeAxis_6015b020-d7a1-46bc-9e95-a5079798fde0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_78a767b1-b71c-4406-ba45-a8d322d57d36" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_6015b020-d7a1-46bc-9e95-a5079798fde0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_78a767b1-b71c-4406-ba45-a8d322d57d36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_5e6f204b-1502-4734-acba-5e091775bfd7" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_78a767b1-b71c-4406-ba45-a8d322d57d36" xlink:to="loc_us-gaap_EmployeeStockOptionMember_5e6f204b-1502-4734-acba-5e091775bfd7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_d7144524-a862-4033-93e3-3ad318d4964d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_fc02d65c-973e-46ae-8ae3-58ce72fe98b3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_d7144524-a862-4033-93e3-3ad318d4964d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_ac7dc795-a689-4fab-abb2-9b1ca1ab5a83" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_d7144524-a862-4033-93e3-3ad318d4964d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_ac7dc795-a689-4fab-abb2-9b1ca1ab5a83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_9dddd3a9-e473-4942-8a05-66484fd8ca26" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_d7144524-a862-4033-93e3-3ad318d4964d" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_9dddd3a9-e473-4942-8a05-66484fd8ca26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_57659526-2828-480b-9fc7-38adcbc7a997" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_d7144524-a862-4033-93e3-3ad318d4964d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_57659526-2828-480b-9fc7-38adcbc7a997" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.lifevantage.com/role/ShareBasedCompensationStockOptionsDetails" xlink:type="simple" xlink:href="lfvn-20250630.xsd#ShareBasedCompensationStockOptionsDetails"/>
  <link:presentationLink xlink:role="http://www.lifevantage.com/role/ShareBasedCompensationStockOptionsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_b1be541d-49c0-42f6-abd1-643e2e5c48c9" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_b6ee36b2-844d-4384-8b25-b69a4c4150a7" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_b1be541d-49c0-42f6-abd1-643e2e5c48c9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_b6ee36b2-844d-4384-8b25-b69a4c4150a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_756db33b-d60c-4999-9455-183664833558" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_b6ee36b2-844d-4384-8b25-b69a4c4150a7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_756db33b-d60c-4999-9455-183664833558" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_b412123a-6240-4bcb-9273-0e957c84f344" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_b6ee36b2-844d-4384-8b25-b69a4c4150a7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_b412123a-6240-4bcb-9273-0e957c84f344" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_d937ce6a-2125-49c8-b0d7-e81af1586618" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_b6ee36b2-844d-4384-8b25-b69a4c4150a7" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_d937ce6a-2125-49c8-b0d7-e81af1586618" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_e044ccc5-f48a-41fa-ab66-39da3774fc6a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_b6ee36b2-844d-4384-8b25-b69a4c4150a7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_e044ccc5-f48a-41fa-ab66-39da3774fc6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_94f479a7-7d96-4983-8740-c718293274f6" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_b6ee36b2-844d-4384-8b25-b69a4c4150a7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_94f479a7-7d96-4983-8740-c718293274f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_409ff571-813e-4c43-992a-9b67d30b6bfe" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_b6ee36b2-844d-4384-8b25-b69a4c4150a7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_409ff571-813e-4c43-992a-9b67d30b6bfe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_94da966c-d67e-4206-ae30-1668a3fe73de" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_b1be541d-49c0-42f6-abd1-643e2e5c48c9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_94da966c-d67e-4206-ae30-1668a3fe73de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_ef6cafee-997c-4b0d-986c-5b24efb8efaa" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_b1be541d-49c0-42f6-abd1-643e2e5c48c9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_ef6cafee-997c-4b0d-986c-5b24efb8efaa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_4ea81ea0-189b-4b33-ad88-03f198f2ae85" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_ef6cafee-997c-4b0d-986c-5b24efb8efaa" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_4ea81ea0-189b-4b33-ad88-03f198f2ae85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_08c7ba5c-f9d4-43f1-8676-5e6ef93d9ec1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_ef6cafee-997c-4b0d-986c-5b24efb8efaa" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_08c7ba5c-f9d4-43f1-8676-5e6ef93d9ec1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_6aed492d-8a11-4b99-b00c-ead295b2ed3c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_ef6cafee-997c-4b0d-986c-5b24efb8efaa" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_6aed492d-8a11-4b99-b00c-ead295b2ed3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_1d5ce924-6021-4b07-9cd9-7c6f83dd9e2e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_ef6cafee-997c-4b0d-986c-5b24efb8efaa" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_1d5ce924-6021-4b07-9cd9-7c6f83dd9e2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_3ba78cfc-2046-4c5b-8865-973aeb133413" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_ef6cafee-997c-4b0d-986c-5b24efb8efaa" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_3ba78cfc-2046-4c5b-8865-973aeb133413" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_9fa6a88f-9f62-4eef-b0c2-d2b22a06db23" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_ef6cafee-997c-4b0d-986c-5b24efb8efaa" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_9fa6a88f-9f62-4eef-b0c2-d2b22a06db23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_c174c810-cc0b-439c-87bd-66aa03695b9f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_b1be541d-49c0-42f6-abd1-643e2e5c48c9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_c174c810-cc0b-439c-87bd-66aa03695b9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermAbstract_79456574-b488-4eec-8af4-3e00bbe7c6be" xlink:href="lfvn-20250630.xsd#lfvn_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermAbstract"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_b1be541d-49c0-42f6-abd1-643e2e5c48c9" xlink:to="loc_lfvn_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermAbstract_79456574-b488-4eec-8af4-3e00bbe7c6be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_24b3c752-0028-4ec8-b9e1-952c3da6ac01" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lfvn_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermAbstract_79456574-b488-4eec-8af4-3e00bbe7c6be" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_24b3c752-0028-4ec8-b9e1-952c3da6ac01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_f0edc560-ea58-4d28-9fd2-fe045ebec8a8" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lfvn_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermAbstract_79456574-b488-4eec-8af4-3e00bbe7c6be" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_f0edc560-ea58-4d28-9fd2-fe045ebec8a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_5d53007f-6210-4385-9a31-05b4b06ffa19" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_b1be541d-49c0-42f6-abd1-643e2e5c48c9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_5d53007f-6210-4385-9a31-05b4b06ffa19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_41d0d723-bc47-43e0-bf65-4ce7ff915438" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_5d53007f-6210-4385-9a31-05b4b06ffa19" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_41d0d723-bc47-43e0-bf65-4ce7ff915438" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_73836dfd-7ef7-4ae0-bece-5bdef2f7956e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_5d53007f-6210-4385-9a31-05b4b06ffa19" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_73836dfd-7ef7-4ae0-bece-5bdef2f7956e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_db43c675-bc93-4d6a-a2c9-999505b42e91" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_5d53007f-6210-4385-9a31-05b4b06ffa19" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_db43c675-bc93-4d6a-a2c9-999505b42e91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.lifevantage.com/role/ShareBasedCompensationRestrictedSharesDetails" xlink:type="simple" xlink:href="lfvn-20250630.xsd#ShareBasedCompensationRestrictedSharesDetails"/>
  <link:presentationLink xlink:role="http://www.lifevantage.com/role/ShareBasedCompensationRestrictedSharesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_2657a79d-6542-485d-a1e6-e138664c643a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_8a8401b0-2380-45bb-8167-aec37c2fde04" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_2657a79d-6542-485d-a1e6-e138664c643a" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_8a8401b0-2380-45bb-8167-aec37c2fde04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_415ca3a2-967c-4c88-98d1-238be5a0ba1c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_8a8401b0-2380-45bb-8167-aec37c2fde04" xlink:to="loc_us-gaap_AwardTypeAxis_415ca3a2-967c-4c88-98d1-238be5a0ba1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_799fd31e-a5f3-4e52-8548-137a3597fa67" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_415ca3a2-967c-4c88-98d1-238be5a0ba1c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_799fd31e-a5f3-4e52-8548-137a3597fa67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_673665e9-a848-48b3-bf85-16674c228763" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RestrictedStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_799fd31e-a5f3-4e52-8548-137a3597fa67" xlink:to="loc_us-gaap_RestrictedStockMember_673665e9-a848-48b3-bf85-16674c228763" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_8b8dc0a6-503f-46b6-ae88-e25891c29e64" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_799fd31e-a5f3-4e52-8548-137a3597fa67" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_8b8dc0a6-503f-46b6-ae88-e25891c29e64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_22ca40e9-a1e0-4c7e-9660-ef4e5aaf333e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_8a8401b0-2380-45bb-8167-aec37c2fde04" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_22ca40e9-a1e0-4c7e-9660-ef4e5aaf333e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_ba1a26fd-a0a8-41d1-a050-e3e8a8fe6464" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_22ca40e9-a1e0-4c7e-9660-ef4e5aaf333e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_ba1a26fd-a0a8-41d1-a050-e3e8a8fe6464" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_b033025c-5205-4949-b10e-f4f41aa0c14a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_ba1a26fd-a0a8-41d1-a050-e3e8a8fe6464" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_b033025c-5205-4949-b10e-f4f41aa0c14a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_58c385c1-fb3e-4aac-86da-cb7a56740bf7" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_ba1a26fd-a0a8-41d1-a050-e3e8a8fe6464" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_58c385c1-fb3e-4aac-86da-cb7a56740bf7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_7267aba3-e2b3-4589-b3e9-7762d3e25030" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_ba1a26fd-a0a8-41d1-a050-e3e8a8fe6464" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_7267aba3-e2b3-4589-b3e9-7762d3e25030" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_530f6a6c-9d61-427f-acb7-a45f6535c387" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_ba1a26fd-a0a8-41d1-a050-e3e8a8fe6464" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_530f6a6c-9d61-427f-acb7-a45f6535c387" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_d9e5aa3a-5802-4ce6-a847-8e54b3a48baf" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_ba1a26fd-a0a8-41d1-a050-e3e8a8fe6464" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_d9e5aa3a-5802-4ce6-a847-8e54b3a48baf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_a757bd3b-1145-42ed-9d7a-a54d21e8452a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_22ca40e9-a1e0-4c7e-9660-ef4e5aaf333e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_a757bd3b-1145-42ed-9d7a-a54d21e8452a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_33d0b129-4ad5-47d9-a35d-29abf5b39b94" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_a757bd3b-1145-42ed-9d7a-a54d21e8452a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_33d0b129-4ad5-47d9-a35d-29abf5b39b94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_73c35a3e-985e-441e-8f2a-945f579c348b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_a757bd3b-1145-42ed-9d7a-a54d21e8452a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_73c35a3e-985e-441e-8f2a-945f579c348b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_10d95066-b6ce-4c4d-b6d3-c50a50fc5469" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_a757bd3b-1145-42ed-9d7a-a54d21e8452a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_10d95066-b6ce-4c4d-b6d3-c50a50fc5469" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_c5e861fb-21b8-4995-ab8f-c960459bc9d7" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_a757bd3b-1145-42ed-9d7a-a54d21e8452a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_c5e861fb-21b8-4995-ab8f-c960459bc9d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_e02cf916-fd12-4c0d-8aa0-f6494a0546a2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_a757bd3b-1145-42ed-9d7a-a54d21e8452a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_e02cf916-fd12-4c0d-8aa0-f6494a0546a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsCancelledInPeriod_3b49f749-5c48-4de4-8a6d-9d2fa7765e09" xlink:href="lfvn-20250630.xsd#lfvn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsCancelledInPeriod"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_22ca40e9-a1e0-4c7e-9660-ef4e5aaf333e" xlink:to="loc_lfvn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsCancelledInPeriod_3b49f749-5c48-4de4-8a6d-9d2fa7765e09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInExchange_c594d3f3-2cdd-46b2-a1a8-280d5f30f7d5" xlink:href="lfvn-20250630.xsd#lfvn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInExchange"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_22ca40e9-a1e0-4c7e-9660-ef4e5aaf333e" xlink:to="loc_lfvn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInExchange_c594d3f3-2cdd-46b2-a1a8-280d5f30f7d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.lifevantage.com/role/ShareBasedCompensationRestrictedStockNarrativeDetails" xlink:type="simple" xlink:href="lfvn-20250630.xsd#ShareBasedCompensationRestrictedStockNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.lifevantage.com/role/ShareBasedCompensationRestrictedStockNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_af905b78-148d-48e1-b73b-74f708fa6e62" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_fde8c7f6-5642-4c28-b98f-712c15cba69e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_af905b78-148d-48e1-b73b-74f708fa6e62" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_fde8c7f6-5642-4c28-b98f-712c15cba69e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_33520d58-2e0b-4b2e-b549-c3aed41bbfd2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_fde8c7f6-5642-4c28-b98f-712c15cba69e" xlink:to="loc_us-gaap_AwardTypeAxis_33520d58-2e0b-4b2e-b549-c3aed41bbfd2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_32effecc-edd3-420a-b3aa-9efdbb14f76e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_33520d58-2e0b-4b2e-b549-c3aed41bbfd2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_32effecc-edd3-420a-b3aa-9efdbb14f76e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_61195b8c-1bf4-48af-8c3c-0392eb9f5d9e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RestrictedStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_32effecc-edd3-420a-b3aa-9efdbb14f76e" xlink:to="loc_us-gaap_RestrictedStockMember_61195b8c-1bf4-48af-8c3c-0392eb9f5d9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_2c3219a7-80c5-4ff6-b6ad-5c6bc4a548bb" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_32effecc-edd3-420a-b3aa-9efdbb14f76e" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_2c3219a7-80c5-4ff6-b6ad-5c6bc4a548bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_d794265c-1a87-4413-8246-298921cc4104" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_fde8c7f6-5642-4c28-b98f-712c15cba69e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_d794265c-1a87-4413-8246-298921cc4104" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_52e30840-ef69-4728-a1f8-0384ede912f3" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_d794265c-1a87-4413-8246-298921cc4104" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_52e30840-ef69-4728-a1f8-0384ede912f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.lifevantage.com/role/ShareBasedCompensationPerformanceRestrictedStockUnitsNarrativeDetails" xlink:type="simple" xlink:href="lfvn-20250630.xsd#ShareBasedCompensationPerformanceRestrictedStockUnitsNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.lifevantage.com/role/ShareBasedCompensationPerformanceRestrictedStockUnitsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_88220609-0901-4377-8d28-87be804980e9" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_43ac31be-bcf8-4cea-acff-4c575fd99895" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_88220609-0901-4377-8d28-87be804980e9" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_43ac31be-bcf8-4cea-acff-4c575fd99895" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_6cb5c0e8-469b-4d26-b7ff-71ed34acae9a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_43ac31be-bcf8-4cea-acff-4c575fd99895" xlink:to="loc_us-gaap_AwardTypeAxis_6cb5c0e8-469b-4d26-b7ff-71ed34acae9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_cf782522-1d2b-4beb-b383-f789bdbdab1f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_6cb5c0e8-469b-4d26-b7ff-71ed34acae9a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_cf782522-1d2b-4beb-b383-f789bdbdab1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_PerformanceStockUnitsMember_45712cad-c0c6-4877-8857-a04b84de9055" xlink:href="lfvn-20250630.xsd#lfvn_PerformanceStockUnitsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_cf782522-1d2b-4beb-b383-f789bdbdab1f" xlink:to="loc_lfvn_PerformanceStockUnitsMember_45712cad-c0c6-4877-8857-a04b84de9055" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_5554f411-3365-4415-bf74-4295978f19d3" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_43ac31be-bcf8-4cea-acff-4c575fd99895" xlink:to="loc_srt_RangeAxis_5554f411-3365-4415-bf74-4295978f19d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_7ca95660-aa81-40c7-a3ea-5f7a71ac2bec" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_5554f411-3365-4415-bf74-4295978f19d3" xlink:to="loc_srt_RangeMember_7ca95660-aa81-40c7-a3ea-5f7a71ac2bec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_0ef6889f-a756-4b12-b8b3-4dbc682d0b2d" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_7ca95660-aa81-40c7-a3ea-5f7a71ac2bec" xlink:to="loc_srt_MinimumMember_0ef6889f-a756-4b12-b8b3-4dbc682d0b2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_25f524fd-c81f-4ff8-bace-9b7ba5a901e9" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_7ca95660-aa81-40c7-a3ea-5f7a71ac2bec" xlink:to="loc_srt_MaximumMember_25f524fd-c81f-4ff8-bace-9b7ba5a901e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3933982c-0031-4a19-8c65-21af3d988c2c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_43ac31be-bcf8-4cea-acff-4c575fd99895" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3933982c-0031-4a19-8c65-21af3d988c2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_SharebasedCompensationArrangementbySharebasedPaymentAwardDistributionPercentage_0c6b90b4-aed7-40c7-9434-81c3969889a4" xlink:href="lfvn-20250630.xsd#lfvn_SharebasedCompensationArrangementbySharebasedPaymentAwardDistributionPercentage"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3933982c-0031-4a19-8c65-21af3d988c2c" xlink:to="loc_lfvn_SharebasedCompensationArrangementbySharebasedPaymentAwardDistributionPercentage_0c6b90b4-aed7-40c7-9434-81c3969889a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_584a1890-7f74-4a00-af95-8d0fd63e24fe" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3933982c-0031-4a19-8c65-21af3d988c2c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_584a1890-7f74-4a00-af95-8d0fd63e24fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.lifevantage.com/role/ShareBasedCompensationPerformanceRestrictedStockUnitsDetails" xlink:type="simple" xlink:href="lfvn-20250630.xsd#ShareBasedCompensationPerformanceRestrictedStockUnitsDetails"/>
  <link:presentationLink xlink:role="http://www.lifevantage.com/role/ShareBasedCompensationPerformanceRestrictedStockUnitsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_dde10ffe-b85e-488b-9218-90adde624bab" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_7f8917b4-1a5c-4792-82a1-c649711fab65" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_dde10ffe-b85e-488b-9218-90adde624bab" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_7f8917b4-1a5c-4792-82a1-c649711fab65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_fc7cbd4c-7ff9-4ac8-8336-b70afc3c82f8" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_7f8917b4-1a5c-4792-82a1-c649711fab65" xlink:to="loc_us-gaap_AwardTypeAxis_fc7cbd4c-7ff9-4ac8-8336-b70afc3c82f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2de88098-fa9c-47c5-8179-543ae8781ced" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_fc7cbd4c-7ff9-4ac8-8336-b70afc3c82f8" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2de88098-fa9c-47c5-8179-543ae8781ced" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_PerformanceStockUnitsMember_f56df465-0041-49b5-a367-a309aeb759d9" xlink:href="lfvn-20250630.xsd#lfvn_PerformanceStockUnitsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2de88098-fa9c-47c5-8179-543ae8781ced" xlink:to="loc_lfvn_PerformanceStockUnitsMember_f56df465-0041-49b5-a367-a309aeb759d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e033d7bc-9101-454b-8a65-a2d4fc070a88" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_7f8917b4-1a5c-4792-82a1-c649711fab65" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e033d7bc-9101-454b-8a65-a2d4fc070a88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsCancelledInPeriod_94fecb31-8470-46f0-b6bd-e5944cc80eab" xlink:href="lfvn-20250630.xsd#lfvn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsCancelledInPeriod"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e033d7bc-9101-454b-8a65-a2d4fc070a88" xlink:to="loc_lfvn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsCancelledInPeriod_94fecb31-8470-46f0-b6bd-e5944cc80eab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_4bdb9e1b-c9d7-4c36-9bdf-4acfefcf8967" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e033d7bc-9101-454b-8a65-a2d4fc070a88" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_4bdb9e1b-c9d7-4c36-9bdf-4acfefcf8967" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_f7d14e1a-e4ce-447e-b052-1bde478f52a3" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_4bdb9e1b-c9d7-4c36-9bdf-4acfefcf8967" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_f7d14e1a-e4ce-447e-b052-1bde478f52a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_5b2fe561-b7d3-4bc4-b2ed-e4150e5029e6" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_4bdb9e1b-c9d7-4c36-9bdf-4acfefcf8967" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_5b2fe561-b7d3-4bc4-b2ed-e4150e5029e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_f6aa6cb0-72d8-4a88-bf80-e49556e0de22" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_4bdb9e1b-c9d7-4c36-9bdf-4acfefcf8967" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_f6aa6cb0-72d8-4a88-bf80-e49556e0de22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_c08f52af-49ea-45ef-9e7b-645b93224ae2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_4bdb9e1b-c9d7-4c36-9bdf-4acfefcf8967" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_c08f52af-49ea-45ef-9e7b-645b93224ae2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_991d3aed-9e64-47db-9ea3-f6f381d39916" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_4bdb9e1b-c9d7-4c36-9bdf-4acfefcf8967" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_991d3aed-9e64-47db-9ea3-f6f381d39916" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_92af6bf1-d011-4281-a1dc-01661f045362" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e033d7bc-9101-454b-8a65-a2d4fc070a88" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_92af6bf1-d011-4281-a1dc-01661f045362" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_b5d8f57e-0536-4dba-85c0-c13d214037d2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_92af6bf1-d011-4281-a1dc-01661f045362" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_b5d8f57e-0536-4dba-85c0-c13d214037d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_87538fc5-1589-407c-b276-ba72886de886" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_92af6bf1-d011-4281-a1dc-01661f045362" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_87538fc5-1589-407c-b276-ba72886de886" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_59d7919e-dd21-4267-9cd5-4803e891ce73" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_92af6bf1-d011-4281-a1dc-01661f045362" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_59d7919e-dd21-4267-9cd5-4803e891ce73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_11bb05ca-cf99-42fb-a51e-6f9ad8e00028" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_92af6bf1-d011-4281-a1dc-01661f045362" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_11bb05ca-cf99-42fb-a51e-6f9ad8e00028" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_124f964e-5b5c-4ad3-881b-46a67241a048" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_92af6bf1-d011-4281-a1dc-01661f045362" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_124f964e-5b5c-4ad3-881b-46a67241a048" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.lifevantage.com/role/OtherExpenseNetDetails" xlink:type="simple" xlink:href="lfvn-20250630.xsd#OtherExpenseNetDetails"/>
  <link:presentationLink xlink:role="http://www.lifevantage.com/role/OtherExpenseNetDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIncomeAndExpensesAbstract_7361b111-2831-404f-af7a-24d4ed575f94" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherIncomeAndExpensesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_9341be36-6499-4aa6-9152-7c633db715ee" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ForeignCurrencyTransactionGainLossBeforeTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherIncomeAndExpensesAbstract_7361b111-2831-404f-af7a-24d4ed575f94" xlink:to="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_9341be36-6499-4aa6-9152-7c633db715ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_OtherMiscellaneousIncomeExpensesNet_1451eef1-5184-4ae6-aaa5-241ce6b14549" xlink:href="lfvn-20250630.xsd#lfvn_OtherMiscellaneousIncomeExpensesNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherIncomeAndExpensesAbstract_7361b111-2831-404f-af7a-24d4ed575f94" xlink:to="loc_lfvn_OtherMiscellaneousIncomeExpensesNet_1451eef1-5184-4ae6-aaa5-241ce6b14549" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_cb286ccb-e864-48be-a81a-1f41fe0a4535" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherIncomeAndExpensesAbstract_7361b111-2831-404f-af7a-24d4ed575f94" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_cb286ccb-e864-48be-a81a-1f41fe0a4535" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.lifevantage.com/role/IncomeTaxesIncomeTaxExpenseDetails" xlink:type="simple" xlink:href="lfvn-20250630.xsd#IncomeTaxesIncomeTaxExpenseDetails"/>
  <link:presentationLink xlink:role="http://www.lifevantage.com/role/IncomeTaxesIncomeTaxExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_14f5131d-a0bf-47c6-b4d0-6ec5301486be" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComponentsOfIncomeTaxExpenseBenefitContinuingOperationsAbstract_f0855c1d-572a-4ac4-8a40-e7323f647eee" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ComponentsOfIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_14f5131d-a0bf-47c6-b4d0-6ec5301486be" xlink:to="loc_us-gaap_ComponentsOfIncomeTaxExpenseBenefitContinuingOperationsAbstract_f0855c1d-572a-4ac4-8a40-e7323f647eee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterestAbstract_597e2b2f-1afd-46c2-9dfe-06cf40072182" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterestAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfIncomeTaxExpenseBenefitContinuingOperationsAbstract_f0855c1d-572a-4ac4-8a40-e7323f647eee" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterestAbstract_597e2b2f-1afd-46c2-9dfe-06cf40072182" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_a1784c7e-2f32-483c-950e-c5b8ef132a1c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterestAbstract_597e2b2f-1afd-46c2-9dfe-06cf40072182" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_a1784c7e-2f32-483c-950e-c5b8ef132a1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_5cabf172-f216-4ff5-afbe-266e5ef3c51d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterestAbstract_597e2b2f-1afd-46c2-9dfe-06cf40072182" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_5cabf172-f216-4ff5-afbe-266e5ef3c51d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_21d3e8f6-612d-445a-aa46-216815bb50c9" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterestAbstract_597e2b2f-1afd-46c2-9dfe-06cf40072182" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_21d3e8f6-612d-445a-aa46-216815bb50c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_bfe5e7ec-3bc5-44f1-a28c-043ee41d1d95" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfIncomeTaxExpenseBenefitContinuingOperationsAbstract_f0855c1d-572a-4ac4-8a40-e7323f647eee" xlink:to="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_bfe5e7ec-3bc5-44f1-a28c-043ee41d1d95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentFederalTaxExpenseBenefit_91c1ed6e-1e17-4f33-b410-bdc0faea1820" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CurrentFederalTaxExpenseBenefit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_bfe5e7ec-3bc5-44f1-a28c-043ee41d1d95" xlink:to="loc_us-gaap_CurrentFederalTaxExpenseBenefit_91c1ed6e-1e17-4f33-b410-bdc0faea1820" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_8dab6dd4-24dc-4fad-960d-bf527de77205" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_bfe5e7ec-3bc5-44f1-a28c-043ee41d1d95" xlink:to="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_8dab6dd4-24dc-4fad-960d-bf527de77205" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentForeignTaxExpenseBenefit_dc03c1c4-b4a8-4646-86ab-592d29a1f9f3" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CurrentForeignTaxExpenseBenefit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_bfe5e7ec-3bc5-44f1-a28c-043ee41d1d95" xlink:to="loc_us-gaap_CurrentForeignTaxExpenseBenefit_dc03c1c4-b4a8-4646-86ab-592d29a1f9f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_aca0e189-9553-4e59-8a4e-69dfe3785909" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_bfe5e7ec-3bc5-44f1-a28c-043ee41d1d95" xlink:to="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_aca0e189-9553-4e59-8a4e-69dfe3785909" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_272d10f4-c9e0-44a7-b995-e04d58ddfec2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfIncomeTaxExpenseBenefitContinuingOperationsAbstract_f0855c1d-572a-4ac4-8a40-e7323f647eee" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_272d10f4-c9e0-44a7-b995-e04d58ddfec2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_ed92cf06-a653-4ade-a1db-994fc0e286a6" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_272d10f4-c9e0-44a7-b995-e04d58ddfec2" xlink:to="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_ed92cf06-a653-4ade-a1db-994fc0e286a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_0c96b108-3e06-4ef5-9568-ce11571c2d4b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_272d10f4-c9e0-44a7-b995-e04d58ddfec2" xlink:to="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_0c96b108-3e06-4ef5-9568-ce11571c2d4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_e4d3d17a-b506-478a-a51a-4f930020dc58" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredForeignIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_272d10f4-c9e0-44a7-b995-e04d58ddfec2" xlink:to="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_e4d3d17a-b506-478a-a51a-4f930020dc58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_06cdceb0-6c99-47d3-ad22-f35a83172514" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_272d10f4-c9e0-44a7-b995-e04d58ddfec2" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_06cdceb0-6c99-47d3-ad22-f35a83172514" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_13cd4066-e95e-4aa7-bb56-e999cef305c1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfIncomeTaxExpenseBenefitContinuingOperationsAbstract_f0855c1d-572a-4ac4-8a40-e7323f647eee" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_13cd4066-e95e-4aa7-bb56-e999cef305c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.lifevantage.com/role/IncomeTaxesEffectiveIncomeTaxRateDetails" xlink:type="simple" xlink:href="lfvn-20250630.xsd#IncomeTaxesEffectiveIncomeTaxRateDetails"/>
  <link:presentationLink xlink:role="http://www.lifevantage.com/role/IncomeTaxesEffectiveIncomeTaxRateDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_e2e1e0cd-5029-430d-b01b-b4d2ae12854c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_3ea3d7af-58d0-45ac-8ee6-2e74d4090ce5" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_e2e1e0cd-5029-430d-b01b-b4d2ae12854c" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_3ea3d7af-58d0-45ac-8ee6-2e74d4090ce5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_7e91ad4e-61c9-4be3-ac5b-db83bf82ddee" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_3ea3d7af-58d0-45ac-8ee6-2e74d4090ce5" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_7e91ad4e-61c9-4be3-ac5b-db83bf82ddee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_9c5fe7ad-1813-4735-8316-c873a9b2d5a6" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_3ea3d7af-58d0-45ac-8ee6-2e74d4090ce5" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_9c5fe7ad-1813-4735-8316-c873a9b2d5a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_f4e47a5f-a839-42c3-abd8-28a734546a9b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_3ea3d7af-58d0-45ac-8ee6-2e74d4090ce5" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_f4e47a5f-a839-42c3-abd8-28a734546a9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_EffectiveIncomeTaxRateReconciliationTaxReturnToProvisionsTrueUp_a7b75e53-ea85-4e8a-b39b-4ce2d55c142a" xlink:href="lfvn-20250630.xsd#lfvn_EffectiveIncomeTaxRateReconciliationTaxReturnToProvisionsTrueUp"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_3ea3d7af-58d0-45ac-8ee6-2e74d4090ce5" xlink:to="loc_lfvn_EffectiveIncomeTaxRateReconciliationTaxReturnToProvisionsTrueUp_a7b75e53-ea85-4e8a-b39b-4ce2d55c142a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseLimitationOnFutureStockBasedCompensationExpensePercent_10a33507-86fe-4e58-9223-e565f20e5e3c" xlink:href="lfvn-20250630.xsd#lfvn_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseLimitationOnFutureStockBasedCompensationExpensePercent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_3ea3d7af-58d0-45ac-8ee6-2e74d4090ce5" xlink:to="loc_lfvn_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseLimitationOnFutureStockBasedCompensationExpensePercent_10a33507-86fe-4e58-9223-e565f20e5e3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_EffectiveIncomeTaxRateReconciliationForeignWithholdingTaxPercent_cababf01-b7e8-49f7-8bfa-106a1156dfa4" xlink:href="lfvn-20250630.xsd#lfvn_EffectiveIncomeTaxRateReconciliationForeignWithholdingTaxPercent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_3ea3d7af-58d0-45ac-8ee6-2e74d4090ce5" xlink:to="loc_lfvn_EffectiveIncomeTaxRateReconciliationForeignWithholdingTaxPercent_cababf01-b7e8-49f7-8bfa-106a1156dfa4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_47ac4a1d-928e-43be-ad57-aa3dc843dfc8" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_3ea3d7af-58d0-45ac-8ee6-2e74d4090ce5" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_47ac4a1d-928e-43be-ad57-aa3dc843dfc8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate_dca19b09-c0ed-41fb-8816-451a966751d2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_3ea3d7af-58d0-45ac-8ee6-2e74d4090ce5" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate_dca19b09-c0ed-41fb-8816-451a966751d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_PermanentDifferencesAbstract_793dfc90-dfaf-423b-8b8c-a2bb47f85deb" xlink:href="lfvn-20250630.xsd#lfvn_PermanentDifferencesAbstract"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_3ea3d7af-58d0-45ac-8ee6-2e74d4090ce5" xlink:to="loc_lfvn_PermanentDifferencesAbstract_793dfc90-dfaf-423b-8b8c-a2bb47f85deb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost_cb39043a-cd1b-4317-b095-e76908bfc8e7" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lfvn_PermanentDifferencesAbstract_793dfc90-dfaf-423b-8b8c-a2bb47f85deb" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost_cb39043a-cd1b-4317-b095-e76908bfc8e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_EffectiveIncomeTaxRateReconciliationCurrentYearSection162mLimitationPercent_afec2056-7d48-4405-9fba-d4072cd383a4" xlink:href="lfvn-20250630.xsd#lfvn_EffectiveIncomeTaxRateReconciliationCurrentYearSection162mLimitationPercent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lfvn_PermanentDifferencesAbstract_793dfc90-dfaf-423b-8b8c-a2bb47f85deb" xlink:to="loc_lfvn_EffectiveIncomeTaxRateReconciliationCurrentYearSection162mLimitationPercent_afec2056-7d48-4405-9fba-d4072cd383a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationFdiiPercent_e8047ee8-fbad-4aa3-a3db-b0fb90251905" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationFdiiPercent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lfvn_PermanentDifferencesAbstract_793dfc90-dfaf-423b-8b8c-a2bb47f85deb" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationFdiiPercent_e8047ee8-fbad-4aa3-a3db-b0fb90251905" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits_37b6600a-6d4e-4184-b7e9-59ec9f670b0e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lfvn_PermanentDifferencesAbstract_793dfc90-dfaf-423b-8b8c-a2bb47f85deb" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits_37b6600a-6d4e-4184-b7e9-59ec9f670b0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseMealsAndEntertainment_1054501d-0d93-413d-889e-22e63f7d5c9d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseMealsAndEntertainment"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lfvn_PermanentDifferencesAbstract_793dfc90-dfaf-423b-8b8c-a2bb47f85deb" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseMealsAndEntertainment_1054501d-0d93-413d-889e-22e63f7d5c9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_EffectiveIncomeTaxRateReconciliationRemovalOfPermanentReinvestmentAssertion_53cefd8c-f84a-45d4-beb1-9ff67c5fabb2" xlink:href="lfvn-20250630.xsd#lfvn_EffectiveIncomeTaxRateReconciliationRemovalOfPermanentReinvestmentAssertion"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lfvn_PermanentDifferencesAbstract_793dfc90-dfaf-423b-8b8c-a2bb47f85deb" xlink:to="loc_lfvn_EffectiveIncomeTaxRateReconciliationRemovalOfPermanentReinvestmentAssertion_53cefd8c-f84a-45d4-beb1-9ff67c5fabb2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_EffectiveIncomeTaxRateReconciliationChangeInUncertainTaxPositions_830c7a4b-4a7e-4995-b8a6-8d69acf9f4b8" xlink:href="lfvn-20250630.xsd#lfvn_EffectiveIncomeTaxRateReconciliationChangeInUncertainTaxPositions"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lfvn_PermanentDifferencesAbstract_793dfc90-dfaf-423b-8b8c-a2bb47f85deb" xlink:to="loc_lfvn_EffectiveIncomeTaxRateReconciliationChangeInUncertainTaxPositions_830c7a4b-4a7e-4995-b8a6-8d69acf9f4b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxSettlementsForeign_eb85a39c-fced-410d-965a-32e8ebdb7893" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTaxSettlementsForeign"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lfvn_PermanentDifferencesAbstract_793dfc90-dfaf-423b-8b8c-a2bb47f85deb" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxSettlementsForeign_eb85a39c-fced-410d-965a-32e8ebdb7893" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther_c2f0e920-3649-4071-85c7-b19ab18a279c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lfvn_PermanentDifferencesAbstract_793dfc90-dfaf-423b-8b8c-a2bb47f85deb" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther_c2f0e920-3649-4071-85c7-b19ab18a279c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_e44e7e10-dcba-40c9-b68c-1b895aeba8b4" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_3ea3d7af-58d0-45ac-8ee6-2e74d4090ce5" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_e44e7e10-dcba-40c9-b68c-1b895aeba8b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_bb82f5bc-e460-4fe2-bbe9-275f398c97c6" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_3ea3d7af-58d0-45ac-8ee6-2e74d4090ce5" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_bb82f5bc-e460-4fe2-bbe9-275f398c97c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.lifevantage.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails" xlink:type="simple" xlink:href="lfvn-20250630.xsd#IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://www.lifevantage.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_98677650-745b-4280-b23a-3720a459291c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract_61f9e989-5768-4d77-9d5b-a806edc44695" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_98677650-745b-4280-b23a-3720a459291c" xlink:to="loc_us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract_61f9e989-5768-4d77-9d5b-a806edc44695" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_00745850-1bbb-4031-95f2-d45fc9ac7525" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ComponentsOfDeferredTaxAssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract_61f9e989-5768-4d77-9d5b-a806edc44695" xlink:to="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_00745850-1bbb-4031-95f2-d45fc9ac7525" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_1a229ca2-919f-4274-9bdd-bf358276f087" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_00745850-1bbb-4031-95f2-d45fc9ac7525" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_1a229ca2-919f-4274-9bdd-bf358276f087" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_f6bc5ea8-4d37-48e1-b0b1-42d0a9e224ac" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_00745850-1bbb-4031-95f2-d45fc9ac7525" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_f6bc5ea8-4d37-48e1-b0b1-42d0a9e224ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment_1d83e6d9-e035-463f-9be1-7ee1f3e045d3" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_00745850-1bbb-4031-95f2-d45fc9ac7525" xlink:to="loc_us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment_1d83e6d9-e035-463f-9be1-7ee1f3e045d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_DeferredTaxAssetsLeasingArrangements_66bbe107-b0ad-4f9a-ac12-e0e2deba52bf" xlink:href="lfvn-20250630.xsd#lfvn_DeferredTaxAssetsLeasingArrangements"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_00745850-1bbb-4031-95f2-d45fc9ac7525" xlink:to="loc_lfvn_DeferredTaxAssetsLeasingArrangements_66bbe107-b0ad-4f9a-ac12-e0e2deba52bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals_5c31e562-6bb5-4f60-8be0-6c49901b0bf0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_00745850-1bbb-4031-95f2-d45fc9ac7525" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals_5c31e562-6bb5-4f60-8be0-6c49901b0bf0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross_4fd9f7fb-707d-411a-8c5f-beb51579f150" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_00745850-1bbb-4031-95f2-d45fc9ac7525" xlink:to="loc_us-gaap_DeferredTaxAssetsGross_4fd9f7fb-707d-411a-8c5f-beb51579f150" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesAbstract_5e7f074b-5882-4706-9e6f-736e220b58d2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxLiabilitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract_61f9e989-5768-4d77-9d5b-a806edc44695" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesAbstract_5e7f074b-5882-4706-9e6f-736e220b58d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets_607a9b03-1571-4889-b1f2-abc2d4f146e2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesAbstract_5e7f074b-5882-4706-9e6f-736e220b58d2" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets_607a9b03-1571-4889-b1f2-abc2d4f146e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_ebadd542-b969-4ecb-9c10-5b2502557e29" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesAbstract_5e7f074b-5882-4706-9e6f-736e220b58d2" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_ebadd542-b969-4ecb-9c10-5b2502557e29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesLeasingArrangements_18c03ce8-a577-4d4e-be0e-787c008d367f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxLiabilitiesLeasingArrangements"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesAbstract_5e7f074b-5882-4706-9e6f-736e220b58d2" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesLeasingArrangements_18c03ce8-a577-4d4e-be0e-787c008d367f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesOther_df4955c8-69b1-4d1c-a949-0be8bcd6f42a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxLiabilitiesOther"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesAbstract_5e7f074b-5882-4706-9e6f-736e220b58d2" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesOther_df4955c8-69b1-4d1c-a949-0be8bcd6f42a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities_3a521ff6-188c-49f0-9710-fc6c2cc56804" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesAbstract_5e7f074b-5882-4706-9e6f-736e220b58d2" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilities_3a521ff6-188c-49f0-9710-fc6c2cc56804" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_ee5dc99d-2020-4e95-8c5d-1be36fa44113" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract_61f9e989-5768-4d77-9d5b-a806edc44695" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_ee5dc99d-2020-4e95-8c5d-1be36fa44113" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_9f2e0c45-ea10-4c62-bbc3-a2fa16ad33a5" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract_61f9e989-5768-4d77-9d5b-a806edc44695" xlink:to="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_9f2e0c45-ea10-4c62-bbc3-a2fa16ad33a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.lifevantage.com/role/IncomeTaxesNarrativeDetails" xlink:type="simple" xlink:href="lfvn-20250630.xsd#IncomeTaxesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.lifevantage.com/role/IncomeTaxesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_0d8e52dd-9957-40a4-abdb-25f904f21fef" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsTable_1b5fc874-7685-464e-b196-7dd60c12b3d8" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLossCarryforwardsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_0d8e52dd-9957-40a4-abdb-25f904f21fef" xlink:to="loc_us-gaap_OperatingLossCarryforwardsTable_1b5fc874-7685-464e-b196-7dd60c12b3d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis_5002d842-63ad-48f8-858c-2c52ae8b4063" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable_1b5fc874-7685-464e-b196-7dd60c12b3d8" xlink:to="loc_us-gaap_IncomeTaxAuthorityAxis_5002d842-63ad-48f8-858c-2c52ae8b4063" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_96b0cad2-1337-4b57-bd00-da727d21a7a8" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_5002d842-63ad-48f8-858c-2c52ae8b4063" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_96b0cad2-1337-4b57-bd00-da727d21a7a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StateAndLocalJurisdictionMember_420a2323-c32d-4875-be44-f349d2f2b95f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StateAndLocalJurisdictionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_96b0cad2-1337-4b57-bd00-da727d21a7a8" xlink:to="loc_us-gaap_StateAndLocalJurisdictionMember_420a2323-c32d-4875-be44-f349d2f2b95f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCountryMember_736751e7-6057-46be-adcc-70eff5098e61" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ForeignCountryMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_96b0cad2-1337-4b57-bd00-da727d21a7a8" xlink:to="loc_us-gaap_ForeignCountryMember_736751e7-6057-46be-adcc-70eff5098e61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsLineItems_0c3163ba-ec81-41d3-8cd8-e86eecac692c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLossCarryforwardsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable_1b5fc874-7685-464e-b196-7dd60c12b3d8" xlink:to="loc_us-gaap_OperatingLossCarryforwardsLineItems_0c3163ba-ec81-41d3-8cd8-e86eecac692c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_UnrecognizedTaxPositionIncreaseResultingFromForeignTaxAudits_b3f3f4d0-9436-48ba-b605-132e8aa66d12" xlink:href="lfvn-20250630.xsd#lfvn_UnrecognizedTaxPositionIncreaseResultingFromForeignTaxAudits"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_0c3163ba-ec81-41d3-8cd8-e86eecac692c" xlink:to="loc_lfvn_UnrecognizedTaxPositionIncreaseResultingFromForeignTaxAudits_b3f3f4d0-9436-48ba-b605-132e8aa66d12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwards_64bbdf03-e148-4ed7-b3f0-aaf1a7bef1bc" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLossCarryforwards"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_0c3163ba-ec81-41d3-8cd8-e86eecac692c" xlink:to="loc_us-gaap_OperatingLossCarryforwards_64bbdf03-e148-4ed7-b3f0-aaf1a7bef1bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount_bfeaaf6a-7c59-4def-8abb-df61febd4f1f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_0c3163ba-ec81-41d3-8cd8-e86eecac692c" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount_bfeaaf6a-7c59-4def-8abb-df61febd4f1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.lifevantage.com/role/IncomeTaxesScheduleofUnrecognizedTaxBenefitDetails" xlink:type="simple" xlink:href="lfvn-20250630.xsd#IncomeTaxesScheduleofUnrecognizedTaxBenefitDetails"/>
  <link:presentationLink xlink:role="http://www.lifevantage.com/role/IncomeTaxesScheduleofUnrecognizedTaxBenefitDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_eb8cdf6f-1c24-4384-9b5d-6a5767200d58" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_2df2978b-b26f-4b5f-b342-0ba5b2472749" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_eb8cdf6f-1c24-4384-9b5d-6a5767200d58" xlink:to="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_2df2978b-b26f-4b5f-b342-0ba5b2472749" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_ce6974f3-ad31-4a4c-ad85-b99527aed97b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_2df2978b-b26f-4b5f-b342-0ba5b2472749" xlink:to="loc_us-gaap_UnrecognizedTaxBenefits_ce6974f3-ad31-4a4c-ad85-b99527aed97b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_17cf5707-75bb-4dd4-9416-cccc126fe198" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_2df2978b-b26f-4b5f-b342-0ba5b2472749" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_17cf5707-75bb-4dd4-9416-cccc126fe198" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_6c9f2bd0-d632-43c8-85d0-aa0b639b51f8" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_2df2978b-b26f-4b5f-b342-0ba5b2472749" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_6c9f2bd0-d632-43c8-85d0-aa0b639b51f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_1a3a95ec-8e4d-4532-9cf6-5e72c3c0cca5" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_2df2978b-b26f-4b5f-b342-0ba5b2472749" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_1a3a95ec-8e4d-4532-9cf6-5e72c3c0cca5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities_ad9a2984-eb17-4652-9f16-26f384df1afd" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_2df2978b-b26f-4b5f-b342-0ba5b2472749" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities_ad9a2984-eb17-4652-9f16-26f384df1afd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromForeignCurrencyTranslation_57a61ead-1302-426b-915a-4c920426fd52" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromForeignCurrencyTranslation"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_2df2978b-b26f-4b5f-b342-0ba5b2472749" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromForeignCurrencyTranslation_57a61ead-1302-426b-915a-4c920426fd52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_69194ed7-c2b9-4790-9552-6651d614aa43" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_2df2978b-b26f-4b5f-b342-0ba5b2472749" xlink:to="loc_us-gaap_UnrecognizedTaxBenefits_69194ed7-c2b9-4790-9552-6651d614aa43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.lifevantage.com/role/IncomeTaxesDeferredTaxAssetsValuationAllowanceScheduleDetails" xlink:type="simple" xlink:href="lfvn-20250630.xsd#IncomeTaxesDeferredTaxAssetsValuationAllowanceScheduleDetails"/>
  <link:presentationLink xlink:role="http://www.lifevantage.com/role/IncomeTaxesDeferredTaxAssetsValuationAllowanceScheduleDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_f935eed4-42b3-4328-962b-e44e353d570a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_97cdb284-98fc-4247-aaf6-5df16fb90e1a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MovementInValuationAllowancesAndReservesRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_f935eed4-42b3-4328-962b-e44e353d570a" xlink:to="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_97cdb284-98fc-4247-aaf6-5df16fb90e1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_3a26c5b8-8c95-45c7-824d-ca9fdf59621c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_97cdb284-98fc-4247-aaf6-5df16fb90e1a" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_3a26c5b8-8c95-45c7-824d-ca9fdf59621c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_367bd5f8-e3f9-4d84-b64f-0236ea7a3dba" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_97cdb284-98fc-4247-aaf6-5df16fb90e1a" xlink:to="loc_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_367bd5f8-e3f9-4d84-b64f-0236ea7a3dba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_ca842789-70fc-4e6a-8768-7ed13e52b047" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_97cdb284-98fc-4247-aaf6-5df16fb90e1a" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_ca842789-70fc-4e6a-8768-7ed13e52b047" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.lifevantage.com/role/LeasesNarrativeDetails" xlink:type="simple" xlink:href="lfvn-20250630.xsd#LeasesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.lifevantage.com/role/LeasesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_0d3d590c-4993-4d91-8ce6-5cbe8af35d11" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable_03cf1588-5e0c-4201-b6b7-68f087c6c8f7" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_0d3d590c-4993-4d91-8ce6-5cbe8af35d11" xlink:to="loc_us-gaap_LesseeLeaseDescriptionTable_03cf1588-5e0c-4201-b6b7-68f087c6c8f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_240a6e2a-123e-4cf2-856d-674f6f2942af" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_03cf1588-5e0c-4201-b6b7-68f087c6c8f7" xlink:to="loc_srt_RangeAxis_240a6e2a-123e-4cf2-856d-674f6f2942af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_048e2c1d-c491-44c5-9a00-4e5e43b69e53" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_240a6e2a-123e-4cf2-856d-674f6f2942af" xlink:to="loc_srt_RangeMember_048e2c1d-c491-44c5-9a00-4e5e43b69e53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_3519f8e9-6b97-4076-9beb-592b47db77d8" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_048e2c1d-c491-44c5-9a00-4e5e43b69e53" xlink:to="loc_srt_MinimumMember_3519f8e9-6b97-4076-9beb-592b47db77d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_1287d0e7-1783-48ea-9d6f-8a4206c88c52" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_048e2c1d-c491-44c5-9a00-4e5e43b69e53" xlink:to="loc_srt_MaximumMember_1287d0e7-1783-48ea-9d6f-8a4206c88c52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems_06b6ceac-d226-482a-abc4-374a7236d522" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_03cf1588-5e0c-4201-b6b7-68f087c6c8f7" xlink:to="loc_us-gaap_LesseeLeaseDescriptionLineItems_06b6ceac-d226-482a-abc4-374a7236d522" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseTermOfContract_df3230de-d8ce-4401-8375-3e35b7a730cf" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseTermOfContract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_06b6ceac-d226-482a-abc4-374a7236d522" xlink:to="loc_us-gaap_LesseeOperatingLeaseTermOfContract_df3230de-d8ce-4401-8375-3e35b7a730cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_7cba3230-9df3-4dcd-9fb3-359491653235" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_06b6ceac-d226-482a-abc4-374a7236d522" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_7cba3230-9df3-4dcd-9fb3-359491653235" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_2bf74371-45b8-45ab-8fa8-d1b79042378b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_06b6ceac-d226-482a-abc4-374a7236d522" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_2bf74371-45b8-45ab-8fa8-d1b79042378b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.lifevantage.com/role/LeasesScheduleofLeaseCostDetails" xlink:type="simple" xlink:href="lfvn-20250630.xsd#LeasesScheduleofLeaseCostDetails"/>
  <link:presentationLink xlink:role="http://www.lifevantage.com/role/LeasesScheduleofLeaseCostDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_677d9ae5-1424-4a91-b290-cc1e4f226a7c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseCost_b3de2c0f-b59e-49a9-b0c6-e8bec5142c29" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseCost"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_677d9ae5-1424-4a91-b290-cc1e4f226a7c" xlink:to="loc_us-gaap_OperatingLeaseCost_b3de2c0f-b59e-49a9-b0c6-e8bec5142c29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableLeaseCost_30778ca8-9045-4a4d-a671-9e67b458c4f7" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_VariableLeaseCost"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_677d9ae5-1424-4a91-b290-cc1e4f226a7c" xlink:to="loc_us-gaap_VariableLeaseCost_30778ca8-9045-4a4d-a671-9e67b458c4f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermLeaseCost_a209d4a4-8f4d-4c5d-aae6-ce2988966b48" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShortTermLeaseCost"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_677d9ae5-1424-4a91-b290-cc1e4f226a7c" xlink:to="loc_us-gaap_ShortTermLeaseCost_a209d4a4-8f4d-4c5d-aae6-ce2988966b48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCost_98b49231-a825-4987-a03e-5543ebe137db" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LeaseCost"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_677d9ae5-1424-4a91-b290-cc1e4f226a7c" xlink:to="loc_us-gaap_LeaseCost_98b49231-a825-4987-a03e-5543ebe137db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.lifevantage.com/role/LeasesSupplementalCashFlowInformationDetails" xlink:type="simple" xlink:href="lfvn-20250630.xsd#LeasesSupplementalCashFlowInformationDetails"/>
  <link:presentationLink xlink:role="http://www.lifevantage.com/role/LeasesSupplementalCashFlowInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_af1db504-4e34-45bf-8e38-a41c6d84e19c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasePayments_c358c049-8563-41ce-8f1d-b7609bfd2db7" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeasePayments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_af1db504-4e34-45bf-8e38-a41c6d84e19c" xlink:to="loc_us-gaap_OperatingLeasePayments_c358c049-8563-41ce-8f1d-b7609bfd2db7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_a9c0ee5f-cc57-4fe2-a2dd-b93693d91034" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_af1db504-4e34-45bf-8e38-a41c6d84e19c" xlink:to="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_a9c0ee5f-cc57-4fe2-a2dd-b93693d91034" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.lifevantage.com/role/LeasesMaturityofLeaseLiabilitiesDetails" xlink:type="simple" xlink:href="lfvn-20250630.xsd#LeasesMaturityofLeaseLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://www.lifevantage.com/role/LeasesMaturityofLeaseLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_b097106e-4087-46eb-a1dc-0c76efcae89f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_ad8c3372-2e52-4513-8cae-81c533a468cf" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_b097106e-4087-46eb-a1dc-0c76efcae89f" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_ad8c3372-2e52-4513-8cae-81c533a468cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_5979ecea-91de-4895-a985-4aa3cbe53f23" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_b097106e-4087-46eb-a1dc-0c76efcae89f" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_5979ecea-91de-4895-a985-4aa3cbe53f23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_ceebfb27-3357-4428-bf1b-ee59473da534" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_b097106e-4087-46eb-a1dc-0c76efcae89f" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_ceebfb27-3357-4428-bf1b-ee59473da534" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_30032187-eabb-4ba7-87b2-9209a7f4de82" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_b097106e-4087-46eb-a1dc-0c76efcae89f" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_30032187-eabb-4ba7-87b2-9209a7f4de82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_5bbe174f-1819-4e5b-8a28-2629974f3c17" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_b097106e-4087-46eb-a1dc-0c76efcae89f" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_5bbe174f-1819-4e5b-8a28-2629974f3c17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_62a55a02-5ce0-42f4-b8f7-e79f27ce9ca5" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_b097106e-4087-46eb-a1dc-0c76efcae89f" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_62a55a02-5ce0-42f4-b8f7-e79f27ce9ca5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_7b7dcb6e-e834-4ca9-94ef-a160cdbf639f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_b097106e-4087-46eb-a1dc-0c76efcae89f" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_7b7dcb6e-e834-4ca9-94ef-a160cdbf639f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_1dbfbe04-1fad-4f4d-b19c-18f3c76cfa98" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_b097106e-4087-46eb-a1dc-0c76efcae89f" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_1dbfbe04-1fad-4f4d-b19c-18f3c76cfa98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_c9f11da8-9b08-4dd8-a6f9-baf40f00dd8d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_b097106e-4087-46eb-a1dc-0c76efcae89f" xlink:to="loc_us-gaap_OperatingLeaseLiability_c9f11da8-9b08-4dd8-a6f9-baf40f00dd8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.lifevantage.com/role/SegmentInformationScheduleofSegmentRevenueandExpenseDetails" xlink:type="simple" xlink:href="lfvn-20250630.xsd#SegmentInformationScheduleofSegmentRevenueandExpenseDetails"/>
  <link:presentationLink xlink:role="http://www.lifevantage.com/role/SegmentInformationScheduleofSegmentRevenueandExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_5f38e96e-6ec6-4f63-a44a-8ba273516db9" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_8d7cd929-26d7-4485-8f22-28e2977b8700" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_5f38e96e-6ec6-4f63-a44a-8ba273516db9" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_8d7cd929-26d7-4485-8f22-28e2977b8700" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_22130ace-aa5c-4023-8bab-38497a4133f9" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_8d7cd929-26d7-4485-8f22-28e2977b8700" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_22130ace-aa5c-4023-8bab-38497a4133f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_f5b416ed-149e-4937-ba9c-3d6571aa443a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_22130ace-aa5c-4023-8bab-38497a4133f9" xlink:to="loc_us-gaap_SegmentDomain_f5b416ed-149e-4937-ba9c-3d6571aa443a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_ReportableSegmentMember_805ec5f0-89b8-49e5-95ed-d445fdee44d4" xlink:href="lfvn-20250630.xsd#lfvn_ReportableSegmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_f5b416ed-149e-4937-ba9c-3d6571aa443a" xlink:to="loc_lfvn_ReportableSegmentMember_805ec5f0-89b8-49e5-95ed-d445fdee44d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_07c4af5c-bc91-4c37-a94d-481164bbd7a1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_8d7cd929-26d7-4485-8f22-28e2977b8700" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_07c4af5c-bc91-4c37-a94d-481164bbd7a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_b157567f-d637-43c5-ad8d-6ba2f213224e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_07c4af5c-bc91-4c37-a94d-481164bbd7a1" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_b157567f-d637-43c5-ad8d-6ba2f213224e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_cdf2e625-a19c-4f68-ae3d-92c295afa97b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_07c4af5c-bc91-4c37-a94d-481164bbd7a1" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_cdf2e625-a19c-4f68-ae3d-92c295afa97b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_ConsultantCommissions_094a0f1d-e2ee-4c0a-a731-0f7a2ee61b26" xlink:href="lfvn-20250630.xsd#lfvn_ConsultantCommissions"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_07c4af5c-bc91-4c37-a94d-481164bbd7a1" xlink:to="loc_lfvn_ConsultantCommissions_094a0f1d-e2ee-4c0a-a731-0f7a2ee61b26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_ConsultantIncentivesPromotionsAndRecognitionExpense_e4384835-a3ca-4f11-9549-6939dec8977f" xlink:href="lfvn-20250630.xsd#lfvn_ConsultantIncentivesPromotionsAndRecognitionExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_07c4af5c-bc91-4c37-a94d-481164bbd7a1" xlink:to="loc_lfvn_ConsultantIncentivesPromotionsAndRecognitionExpense_e4384835-a3ca-4f11-9549-6939dec8977f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LaborAndRelatedExpense_4ef9f7a2-4d11-4856-84ce-5e6d5679e0d0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LaborAndRelatedExpense"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_07c4af5c-bc91-4c37-a94d-481164bbd7a1" xlink:to="loc_us-gaap_LaborAndRelatedExpense_4ef9f7a2-4d11-4856-84ce-5e6d5679e0d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_1db3187b-be61-4c12-a9a1-1e9d3fe1a635" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_07c4af5c-bc91-4c37-a94d-481164bbd7a1" xlink:to="loc_us-gaap_ShareBasedCompensation_1db3187b-be61-4c12-a9a1-1e9d3fe1a635" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_EventsExpense_1c5dda0e-b397-4f42-bc78-fcc0146a2b66" xlink:href="lfvn-20250630.xsd#lfvn_EventsExpense"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_07c4af5c-bc91-4c37-a94d-481164bbd7a1" xlink:to="loc_lfvn_EventsExpense_1c5dda0e-b397-4f42-bc78-fcc0146a2b66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_524f0cb2-6182-4342-8584-1ae6895892df" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_07c4af5c-bc91-4c37-a94d-481164bbd7a1" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_524f0cb2-6182-4342-8584-1ae6895892df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_CreditCardAndBankingProcessingFees_69b44005-018d-42d5-8921-a3ad09ea1534" xlink:href="lfvn-20250630.xsd#lfvn_CreditCardAndBankingProcessingFees"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_07c4af5c-bc91-4c37-a94d-481164bbd7a1" xlink:to="loc_lfvn_CreditCardAndBankingProcessingFees_69b44005-018d-42d5-8921-a3ad09ea1534" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingOtherItemAmount_287e0603-8a98-46d0-b6e8-622e861c8f39" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SegmentReportingOtherItemAmount"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_07c4af5c-bc91-4c37-a94d-481164bbd7a1" xlink:to="loc_us-gaap_SegmentReportingOtherItemAmount_287e0603-8a98-46d0-b6e8-622e861c8f39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterest_5280b6bd-2f77-4c8e-934d-e1570f58565a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InvestmentIncomeInterest"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_07c4af5c-bc91-4c37-a94d-481164bbd7a1" xlink:to="loc_us-gaap_InvestmentIncomeInterest_5280b6bd-2f77-4c8e-934d-e1570f58565a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseNonoperating_b7e6ed7d-57b1-4bd6-a420-bbafd9a74510" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InterestExpenseNonoperating"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_07c4af5c-bc91-4c37-a94d-481164bbd7a1" xlink:to="loc_us-gaap_InterestExpenseNonoperating_b7e6ed7d-57b1-4bd6-a420-bbafd9a74510" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_e3696b7e-98ca-447a-a54f-9af7ac52e74d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_07c4af5c-bc91-4c37-a94d-481164bbd7a1" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_e3696b7e-98ca-447a-a54f-9af7ac52e74d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_9082d3ac-0f46-4ba8-9421-2d27ccab2dbf" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_07c4af5c-bc91-4c37-a94d-481164bbd7a1" xlink:to="loc_us-gaap_NetIncomeLoss_9082d3ac-0f46-4ba8-9421-2d27ccab2dbf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.lifevantage.com/role/SegmentInformationScheduleofLongLivedAssetsDetails" xlink:type="simple" xlink:href="lfvn-20250630.xsd#SegmentInformationScheduleofLongLivedAssetsDetails"/>
  <link:presentationLink xlink:role="http://www.lifevantage.com/role/SegmentInformationScheduleofLongLivedAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_78989ba4-7e43-478e-9f99-73107e4d24e3" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_40121676-28cc-4ca0-8827-5c5a7a2b4e34" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_78989ba4-7e43-478e-9f99-73107e4d24e3" xlink:to="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_40121676-28cc-4ca0-8827-5c5a7a2b4e34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_f843eaa2-77c3-4fb1-b9ab-7a41c618c0c1" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_40121676-28cc-4ca0-8827-5c5a7a2b4e34" xlink:to="loc_srt_StatementGeographicalAxis_f843eaa2-77c3-4fb1-b9ab-7a41c618c0c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_3d0a77e8-c4f8-472a-bc24-be8a5bc74bea" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_f843eaa2-77c3-4fb1-b9ab-7a41c618c0c1" xlink:to="loc_srt_SegmentGeographicalDomain_3d0a77e8-c4f8-472a-bc24-be8a5bc74bea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_230cb850-8622-46a2-b619-bc781595905b" xlink:href="https://xbrl.sec.gov/country/2025/country-2025.xsd#country_US"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_3d0a77e8-c4f8-472a-bc24-be8a5bc74bea" xlink:to="loc_country_US_230cb850-8622-46a2-b619-bc781595905b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonUsMember_a109c279-ca88-427d-b357-87222c7058c0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NonUsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_3d0a77e8-c4f8-472a-bc24-be8a5bc74bea" xlink:to="loc_us-gaap_NonUsMember_a109c279-ca88-427d-b357-87222c7058c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_JP_b97f17e7-c86a-4a93-9eed-a4f0934d6411" xlink:href="https://xbrl.sec.gov/country/2025/country-2025.xsd#country_JP"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonUsMember_a109c279-ca88-427d-b357-87222c7058c0" xlink:to="loc_country_JP_b97f17e7-c86a-4a93-9eed-a4f0934d6411" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_OtherForeignMember_bb795a5a-65d8-445b-8a28-be893b2b2f33" xlink:href="lfvn-20250630.xsd#lfvn_OtherForeignMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonUsMember_a109c279-ca88-427d-b357-87222c7058c0" xlink:to="loc_lfvn_OtherForeignMember_bb795a5a-65d8-445b-8a28-be893b2b2f33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_1df63075-7862-4261-a5ac-79deda47ffc3" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_40121676-28cc-4ca0-8827-5c5a7a2b4e34" xlink:to="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_1df63075-7862-4261-a5ac-79deda47ffc3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncurrentAssets_acfc1859-2240-4032-97db-d761a93a733d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NoncurrentAssets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_1df63075-7862-4261-a5ac-79deda47ffc3" xlink:to="loc_us-gaap_NoncurrentAssets_acfc1859-2240-4032-97db-d761a93a733d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.lifevantage.com/role/SegmentInformationNarrativeDetails" xlink:type="simple" xlink:href="lfvn-20250630.xsd#SegmentInformationNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.lifevantage.com/role/SegmentInformationNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_14333712-1805-4e48-8c6f-2a8db91c51a2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_62bec139-4285-46cd-aa39-288e0850b05d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_14333712-1805-4e48-8c6f-2a8db91c51a2" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_62bec139-4285-46cd-aa39-288e0850b05d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_6403694a-8a29-4d6c-8fee-2f64dbf1fcff" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_62bec139-4285-46cd-aa39-288e0850b05d" xlink:to="loc_srt_ProductOrServiceAxis_6403694a-8a29-4d6c-8fee-2f64dbf1fcff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_5c8ebcab-efea-4d5b-b1a8-a26b73134c8b" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_6403694a-8a29-4d6c-8fee-2f64dbf1fcff" xlink:to="loc_srt_ProductsAndServicesDomain_5c8ebcab-efea-4d5b-b1a8-a26b73134c8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_ProtandimandTrueScienceProductLineMember_5be2da21-4f40-4496-a130-d162bc99dcdb" xlink:href="lfvn-20250630.xsd#lfvn_ProtandimandTrueScienceProductLineMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_5c8ebcab-efea-4d5b-b1a8-a26b73134c8b" xlink:to="loc_lfvn_ProtandimandTrueScienceProductLineMember_5be2da21-4f40-4496-a130-d162bc99dcdb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_658214cc-c641-4552-858d-1dfe0411a1f2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_62bec139-4285-46cd-aa39-288e0850b05d" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_658214cc-c641-4552-858d-1dfe0411a1f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_2e7cf73f-7bda-451e-a28c-78fd122a33a9" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_658214cc-c641-4552-858d-1dfe0411a1f2" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_2e7cf73f-7bda-451e-a28c-78fd122a33a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesRevenueNetMember_c2b1fb73-a6bd-4729-88b9-19d06b0da1cb" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SalesRevenueNetMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_2e7cf73f-7bda-451e-a28c-78fd122a33a9" xlink:to="loc_us-gaap_SalesRevenueNetMember_c2b1fb73-a6bd-4729-88b9-19d06b0da1cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_e6ef6e94-fe02-485d-ad2d-97d41faaf82a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_62bec139-4285-46cd-aa39-288e0850b05d" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_e6ef6e94-fe02-485d-ad2d-97d41faaf82a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_615e0319-fef2-4f99-9f10-0c180012126a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_e6ef6e94-fe02-485d-ad2d-97d41faaf82a" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_615e0319-fef2-4f99-9f10-0c180012126a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductConcentrationRiskMember_2fbc060d-5742-456f-9c07-ddd370bb8432" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProductConcentrationRiskMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_615e0319-fef2-4f99-9f10-0c180012126a" xlink:to="loc_us-gaap_ProductConcentrationRiskMember_2fbc060d-5742-456f-9c07-ddd370bb8432" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_225e4bb1-2c5d-4e7d-b45b-c98ccc56a631" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_62bec139-4285-46cd-aa39-288e0850b05d" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_225e4bb1-2c5d-4e7d-b45b-c98ccc56a631" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_NumberOfProductLines_0ab1f43b-2d80-4e94-a9ac-4f301e3dad61" xlink:href="lfvn-20250630.xsd#lfvn_NumberOfProductLines"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_225e4bb1-2c5d-4e7d-b45b-c98ccc56a631" xlink:to="loc_lfvn_NumberOfProductLines_0ab1f43b-2d80-4e94-a9ac-4f301e3dad61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_025eb825-a021-44c5-8d36-104c3a421b2f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_225e4bb1-2c5d-4e7d-b45b-c98ccc56a631" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_025eb825-a021-44c5-8d36-104c3a421b2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_NumberOfGeographicSegments_fea22474-99dc-4e41-b725-d923a951d040" xlink:href="lfvn-20250630.xsd#lfvn_NumberOfGeographicSegments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_225e4bb1-2c5d-4e7d-b45b-c98ccc56a631" xlink:to="loc_lfvn_NumberOfGeographicSegments_fea22474-99dc-4e41-b725-d923a951d040" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfOperatingSegments_fa6a2b8a-dcff-4a3e-ba75-c50ac365f521" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NumberOfOperatingSegments"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_225e4bb1-2c5d-4e7d-b45b-c98ccc56a631" xlink:to="loc_us-gaap_NumberOfOperatingSegments_fa6a2b8a-dcff-4a3e-ba75-c50ac365f521" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.lifevantage.com/role/SegmentInformationScheduleOfRevenueDisaggregationByMarketDetails" xlink:type="simple" xlink:href="lfvn-20250630.xsd#SegmentInformationScheduleOfRevenueDisaggregationByMarketDetails"/>
  <link:presentationLink xlink:role="http://www.lifevantage.com/role/SegmentInformationScheduleOfRevenueDisaggregationByMarketDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_41df6413-9021-4f62-aa95-79fd16aff63a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_e7f3c8e7-309c-4ef0-85b4-88fddc704cde" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_41df6413-9021-4f62-aa95-79fd16aff63a" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_e7f3c8e7-309c-4ef0-85b4-88fddc704cde" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_f6097e94-5637-451c-aaa8-bd11df7409cd" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_e7f3c8e7-309c-4ef0-85b4-88fddc704cde" xlink:to="loc_srt_StatementGeographicalAxis_f6097e94-5637-451c-aaa8-bd11df7409cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_f1cc58a4-a828-4719-b04b-b1e25893b744" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_f6097e94-5637-451c-aaa8-bd11df7409cd" xlink:to="loc_srt_SegmentGeographicalDomain_f1cc58a4-a828-4719-b04b-b1e25893b744" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_9093a131-4169-4526-a522-85cd0b726d33" xlink:href="https://xbrl.sec.gov/country/2025/country-2025.xsd#country_US"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_f1cc58a4-a828-4719-b04b-b1e25893b744" xlink:to="loc_country_US_9093a131-4169-4526-a522-85cd0b726d33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonUsMember_f1b8fda6-2874-4f88-b032-a4fcf0f570ac" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NonUsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_f1cc58a4-a828-4719-b04b-b1e25893b744" xlink:to="loc_us-gaap_NonUsMember_f1b8fda6-2874-4f88-b032-a4fcf0f570ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_JP_8573fc48-9c56-4bc0-abe2-054450fed452" xlink:href="https://xbrl.sec.gov/country/2025/country-2025.xsd#country_JP"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonUsMember_f1b8fda6-2874-4f88-b032-a4fcf0f570ac" xlink:to="loc_country_JP_8573fc48-9c56-4bc0-abe2-054450fed452" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_OtherForeignMember_4c43136b-d853-41dd-ba64-c3a5f2430ac1" xlink:href="lfvn-20250630.xsd#lfvn_OtherForeignMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonUsMember_f1b8fda6-2874-4f88-b032-a4fcf0f570ac" xlink:to="loc_lfvn_OtherForeignMember_4c43136b-d853-41dd-ba64-c3a5f2430ac1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_c2eb85ef-f363-42b4-b918-a38e6431de56" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_e7f3c8e7-309c-4ef0-85b4-88fddc704cde" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_c2eb85ef-f363-42b4-b918-a38e6431de56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_6fb5d87f-114d-4da2-a3ca-65989d6912c2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_c2eb85ef-f363-42b4-b918-a38e6431de56" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_6fb5d87f-114d-4da2-a3ca-65989d6912c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.lifevantage.com/role/SegmentInformationScheduleofMajorProductsLinesDetails" xlink:type="simple" xlink:href="lfvn-20250630.xsd#SegmentInformationScheduleofMajorProductsLinesDetails"/>
  <link:presentationLink xlink:role="http://www.lifevantage.com/role/SegmentInformationScheduleofMajorProductsLinesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_3069067d-3761-4f16-b5ca-2f5b3062c03d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_644172e2-f719-46a2-8aa7-4e9595160160" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_3069067d-3761-4f16-b5ca-2f5b3062c03d" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_644172e2-f719-46a2-8aa7-4e9595160160" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_e75bb562-c478-47af-af03-6680a0359165" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_644172e2-f719-46a2-8aa7-4e9595160160" xlink:to="loc_srt_ProductOrServiceAxis_e75bb562-c478-47af-af03-6680a0359165" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_dc6c6749-997b-404c-876b-4297815418a9" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_e75bb562-c478-47af-af03-6680a0359165" xlink:to="loc_srt_ProductsAndServicesDomain_dc6c6749-997b-404c-876b-4297815418a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_ProtandimMember_626204c7-d94d-4c5a-a228-a036f9d9866f" xlink:href="lfvn-20250630.xsd#lfvn_ProtandimMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_dc6c6749-997b-404c-876b-4297815418a9" xlink:to="loc_lfvn_ProtandimMember_626204c7-d94d-4c5a-a228-a036f9d9866f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_LifeVantageTrueScienceSkinCareRegimenMember_19c19e24-be7f-4881-88ad-d867075ca38f" xlink:href="lfvn-20250630.xsd#lfvn_LifeVantageTrueScienceSkinCareRegimenMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_dc6c6749-997b-404c-876b-4297815418a9" xlink:to="loc_lfvn_LifeVantageTrueScienceSkinCareRegimenMember_19c19e24-be7f-4881-88ad-d867075ca38f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_TrueScienceProductLineMember_deabf640-ced1-43b2-b91e-142c7c5b6dd9" xlink:href="lfvn-20250630.xsd#lfvn_TrueScienceProductLineMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_dc6c6749-997b-404c-876b-4297815418a9" xlink:to="loc_lfvn_TrueScienceProductLineMember_deabf640-ced1-43b2-b91e-142c7c5b6dd9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_AXIOProductLineMember_7187bd77-4035-4387-afa9-2ce33070c7d2" xlink:href="lfvn-20250630.xsd#lfvn_AXIOProductLineMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_dc6c6749-997b-404c-876b-4297815418a9" xlink:to="loc_lfvn_AXIOProductLineMember_7187bd77-4035-4387-afa9-2ce33070c7d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_PhysIQProductLineMember_b7e84147-ad94-43cb-89bd-d952e4f25a19" xlink:href="lfvn-20250630.xsd#lfvn_PhysIQProductLineMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_dc6c6749-997b-404c-876b-4297815418a9" xlink:to="loc_lfvn_PhysIQProductLineMember_b7e84147-ad94-43cb-89bd-d952e4f25a19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_PetandimProductLineMember_34b10341-21b8-4c48-b229-b6f04973536f" xlink:href="lfvn-20250630.xsd#lfvn_PetandimProductLineMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_dc6c6749-997b-404c-876b-4297815418a9" xlink:to="loc_lfvn_PetandimProductLineMember_34b10341-21b8-4c48-b229-b6f04973536f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductAndServiceOtherMember_db4fa8c6-76b2-4313-9219-247011a03298" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProductAndServiceOtherMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_dc6c6749-997b-404c-876b-4297815418a9" xlink:to="loc_us-gaap_ProductAndServiceOtherMember_db4fa8c6-76b2-4313-9219-247011a03298" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_5b282037-af4a-43bf-b889-708fcd90bfa7" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_644172e2-f719-46a2-8aa7-4e9595160160" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_5b282037-af4a-43bf-b889-708fcd90bfa7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_2a154a91-f1fe-403d-b361-2744af8bf020" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_5b282037-af4a-43bf-b889-708fcd90bfa7" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_2a154a91-f1fe-403d-b361-2744af8bf020" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#AwardTimingDisclosure"/>
  <link:presentationLink xlink:role="http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgDiscLineItems" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardTmgDiscLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgMnpiDiscTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardTmgMnpiDiscTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardTmgMnpiDiscTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgMethodTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardTmgMethodTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardTmgMethodTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgPredtrmndFlag" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardTmgPredtrmndFlag"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardTmgPredtrmndFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgMnpiCnsdrdFlag" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardTmgMnpiCnsdrdFlag"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardTmgMnpiCnsdrdFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardTmgHowMnpiCnsdrdTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MnpiDiscTimedForCompValFlag" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_MnpiDiscTimedForCompValFlag"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_MnpiDiscTimedForCompValFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardsCloseToMnpiDiscTableTextBlock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardsCloseToMnpiDiscTable" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardsCloseToMnpiDiscTable"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardsCloseToMnpiDiscTable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_IndividualAxis" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_IndividualAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardsCloseToMnpiDiscTable" xlink:to="loc_ecd_IndividualAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllIndividualsMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AllIndividualsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_IndividualAxis" xlink:to="loc_ecd_AllIndividualsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardsCloseToMnpiDiscTable" xlink:to="loc_us-gaap_AwardTypeAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaap_EmployeeStockOptionMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockAppreciationRightsSARSMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockAppreciationRightsSARSMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaap_StockAppreciationRightsSARSMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardsCloseToMnpiDiscIndName" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardsCloseToMnpiDiscIndName"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardsCloseToMnpiDiscIndName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardUndrlygSecuritiesAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardUndrlygSecuritiesAmt"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardUndrlygSecuritiesAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardExrcPrice" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardExrcPrice"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardExrcPrice" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardGrantDateFairValue" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardGrantDateFairValue"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardGrantDateFairValue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_UndrlygSecurityMktPriceChngPct" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_UndrlygSecurityMktPriceChngPct"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_UndrlygSecurityMktPriceChngPct" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ErrCompDisclosure"/>
  <link:presentationLink xlink:role="http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_RecoveryOfErrCompDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ErrCompRecoveryTable" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ErrCompRecoveryTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_ErrCompRecoveryTable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RestatementDateAxis" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_RestatementDateAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_ErrCompRecoveryTable" xlink:to="loc_ecd_RestatementDateAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_IndividualAxis" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_IndividualAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_ErrCompRecoveryTable" xlink:to="loc_ecd_IndividualAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllIndividualsMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AllIndividualsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_IndividualAxis" xlink:to="loc_ecd_AllIndividualsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonNeosMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_NonNeosMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AllIndividualsMember" xlink:to="loc_ecd_NonNeosMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RestatementDeterminationDate" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_RestatementDeterminationDate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_RestatementDeterminationDate" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AggtErrCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AggtErrCompAmt"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_AggtErrCompAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ErrCompAnalysisTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ErrCompAnalysisTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_ErrCompAnalysisTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_StkPrcOrTsrEstimationMethodTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OutstandingAggtErrCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_OutstandingAggtErrCompAmt"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_OutstandingAggtErrCompAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AggtErrCompNotYetDeterminedTextBlock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryIndName" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ForgoneRecoveryIndName"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_ForgoneRecoveryIndName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OutstandingRecoveryIndName" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_OutstandingRecoveryIndName"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_OutstandingRecoveryIndName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OutstandingRecoveryCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_OutstandingRecoveryCompAmt"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_OutstandingRecoveryCompAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_RestatementDoesNotRequireRecoveryTextBlock"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/PvpDisclosure" xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#PvpDisclosure"/>
  <link:presentationLink xlink:role="http://xbrl.sec.gov/ecd/role/PvpDisclosure" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PayVsPerformanceDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PvpTable" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PvpTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PvpTable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ExecutiveCategoryAxis" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ExecutiveCategoryAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PvpTable" xlink:to="loc_ecd_ExecutiveCategoryAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllExecutiveCategoriesMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AllExecutiveCategoriesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_ExecutiveCategoryAxis" xlink:to="loc_ecd_AllExecutiveCategoriesMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PeoMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AllExecutiveCategoriesMember" xlink:to="loc_ecd_PeoMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonPeoNeoMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_NonPeoNeoMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AllExecutiveCategoriesMember" xlink:to="loc_ecd_NonPeoNeoMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_IndividualAxis" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_IndividualAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PvpTable" xlink:to="loc_ecd_IndividualAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllIndividualsMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AllIndividualsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_IndividualAxis" xlink:to="loc_ecd_AllIndividualsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToCompAxis" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AdjToCompAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PvpTable" xlink:to="loc_ecd_AdjToCompAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllAdjToCompMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AllAdjToCompMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AdjToCompAxis" xlink:to="loc_ecd_AllAdjToCompMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AllAdjToCompMember" xlink:to="loc_ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AggtPnsnAdjsSvcCstMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AggtPnsnAdjsSvcCstMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AllAdjToCompMember" xlink:to="loc_ecd_AggtPnsnAdjsSvcCstMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PnsnAdjsSvcCstMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PnsnAdjsSvcCstMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AggtPnsnAdjsSvcCstMember" xlink:to="loc_ecd_PnsnAdjsSvcCstMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PnsnAdjsPrrSvcCstMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PnsnAdjsPrrSvcCstMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AggtPnsnAdjsSvcCstMember" xlink:to="loc_ecd_PnsnAdjsPrrSvcCstMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_EqtyAwrdsAdjsMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_EqtyAwrdsAdjsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AllAdjToCompMember" xlink:to="loc_ecd_EqtyAwrdsAdjsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_EqtyAwrdsAdjsMember" xlink:to="loc_ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_EqtyAwrdsAdjsMember" xlink:to="loc_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:to="loc_ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:to="loc_ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:to="loc_ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:to="loc_ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:to="loc_ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:to="loc_ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MeasureAxis" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_MeasureAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PvpTable" xlink:to="loc_ecd_MeasureAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PvpTableTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PvpTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PvpTableTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CoSelectedMeasureName" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_CoSelectedMeasureName"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_CoSelectedMeasureName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NamedExecutiveOfficersFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_NamedExecutiveOfficersFnTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_NamedExecutiveOfficersFnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeerGroupIssuersFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PeerGroupIssuersFnTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PeerGroupIssuersFnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ChangedPeerGroupFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ChangedPeerGroupFnTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_ChangedPeerGroupFnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoTotalCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PeoTotalCompAmt"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PeoTotalCompAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoActuallyPaidCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PeoActuallyPaidCompAmt"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PeoActuallyPaidCompAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToPeoCompFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AdjToPeoCompFnTextBlock"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_AdjToPeoCompFnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonPeoNeoAvgTotalCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_NonPeoNeoAvgTotalCompAmt"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_NonPeoNeoAvgTotalCompAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_NonPeoNeoAvgCompActuallyPaidAmt"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AdjToNonPeoNeoCompFnTextBlock"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_EquityValuationAssumptionDifferenceFnTextBlock"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_CompActuallyPaidVsNetIncomeTextBlock"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TotalShareholderRtnVsPeerGroupTextBlock"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_CompActuallyPaidVsOtherMeasureTextBlock"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TabularListTableTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TabularListTableTextBlock"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_TabularListTableTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TotalShareholderRtnAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TotalShareholderRtnAmt"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_TotalShareholderRtnAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeerGroupTotalShareholderRtnAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PeerGroupTotalShareholderRtnAmt"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PeerGroupTotalShareholderRtnAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CoSelectedMeasureAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_CoSelectedMeasureAmt"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_CoSelectedMeasureAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OtherPerfMeasureAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_OtherPerfMeasureAmt"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_OtherPerfMeasureAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AdjToCompAmt"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_AdjToCompAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoName" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PeoName"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PeoName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MeasureName" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_MeasureName"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_MeasureName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonGaapMeasureDescriptionTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_NonGaapMeasureDescriptionTextBlock"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_NonGaapMeasureDescriptionTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_Additional402vDisclosureTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_Additional402vDisclosureTextBlock"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_Additional402vDisclosureTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PnsnBnftsAdjFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PnsnBnftsAdjFnTextBlock"/>
    <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PnsnBnftsAdjFnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_EqtyAwrdsAdjFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_EqtyAwrdsAdjFnTextBlock"/>
    <link:presentationArc order="31" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_EqtyAwrdsAdjFnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#InsiderTradingArrangements"/>
  <link:presentationLink xlink:role="http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTradingArrLineItems" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_InsiderTradingArrLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TradingArrByIndTable" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TradingArrByIndTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TradingArrByIndTable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TradingArrAxis" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TradingArrAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_TradingArrByIndTable" xlink:to="loc_ecd_TradingArrAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllTradingArrangementsMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AllTradingArrangementsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_TradingArrAxis" xlink:to="loc_ecd_AllTradingArrangementsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_IndividualAxis" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_IndividualAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_TradingArrByIndTable" xlink:to="loc_ecd_IndividualAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllIndividualsMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AllIndividualsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_IndividualAxis" xlink:to="loc_ecd_AllIndividualsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_MichaelBeindorffMember" xlink:href="lfvn-20250630.xsd#lfvn_MichaelBeindorffMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AllIndividualsMember" xlink:to="loc_lfvn_MichaelBeindorffMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MtrlTermsOfTrdArrTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_MtrlTermsOfTrdArrTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_MtrlTermsOfTrdArrTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrIndName" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TrdArrIndName"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TrdArrIndName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrIndTitle" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TrdArrIndTitle"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TrdArrIndTitle" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_Rule10b51ArrAdoptedFlag" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_Rule10b51ArrAdoptedFlag"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_Rule10b51ArrAdoptedFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonRule10b51ArrAdoptedFlag" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_NonRule10b51ArrAdoptedFlag"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_NonRule10b51ArrAdoptedFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrAdoptionDate" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TrdArrAdoptionDate"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TrdArrAdoptionDate" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_Rule10b51ArrTrmntdFlag" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_Rule10b51ArrTrmntdFlag"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_Rule10b51ArrTrmntdFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonRule10b51ArrTrmntdFlag" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_NonRule10b51ArrTrmntdFlag"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_NonRule10b51ArrTrmntdFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrTerminationDate" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TrdArrTerminationDate"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TrdArrTerminationDate" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrExpirationDate" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TrdArrExpirationDate"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TrdArrExpirationDate" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrDuration" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TrdArrDuration"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TrdArrDuration" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrSecuritiesAggAvailAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TrdArrSecuritiesAggAvailAmt"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TrdArrSecuritiesAggAvailAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc" xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#InsiderTradingPoliciesProc"/>
  <link:presentationLink xlink:role="http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTradingPoliciesProcLineItems" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_InsiderTradingPoliciesProcLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_InsiderTrdPoliciesProcAdoptedFlag"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingPoliciesProcLineItems" xlink:to="loc_ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingPoliciesProcLineItems" xlink:to="loc_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>14
<FILENAME>insidertradingpolicy001.jpg
<TEXT>
begin 644 insidertradingpolicy001.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M;G0!F4N2 >/E].XZ=: .^HH'2B@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MLUTLUP\GFR8<[CN)P?E'3 ';%=S_ ,*S\*?\(W_PCWV";^RO.\_[-]KEQO\
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M 4444 %%%% !1110 4444 %%%% !1110 4444 %([K&C.[!549))P *6N?\
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M-K=3CGVYKH;/PU<^)/"%_:7/@^S\/ZG/ISVCW12+?)(0,;2F3Y>1DY]L ]:
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M>4Z%L*0WRELXKM?"+^&M2U.]UKP]'<SF>)(Y]0FDG(E(^Z@\T\E1U(Z9 ]<
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MG(ZA< OOZ8[T >B:AXX\,Z5<W-O>ZQ;Q36Q03)RQ0N<*#@'T/T[UOLP12QZ
M9.!FN"T=[<_&'7E>2.24Z9:QJQQ\S*7+@>X^4D?2N^H \WUSQN=:^'_B?4-&
MGO+"XTXS+%+Y!5CY> <[UP,G/'##CI75:/XITC4+F'2H]1CEU(6XD:/!^8
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M\GE2J\;1LC[0V"K $<,#^-.U#4K/2[=9[V<1([K&G!9G=C@*JC)8GT S7,>
M[W5IVU>TU2>UU 6LZ+%JUM&$6\!0') XW+PIQQV[4OQ U2+2[;1I)[>+RGU*
M-3>RQ>8MB=K8EQ_>_A!/ +9.>A .BTS6+#6(YFL9_,\B4PS(R,CQN.JLK %3
MR.HJ]7GOP_N(_P#A+_&4(DNI6DNX9EDGA92Z^2@W'Y0!D]!@<=!BO0J "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MLEPR2,J*6*QH68^P4<D^U<CI/Q'TBZ\)V^OZB9K&">4HOF6TFT;I"J#=MP>
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MNZ6MNA>5TB:0JHZG"@G ^E9Q\7:*)=)C^TS;M77?8XM9<3#&[KMP..><<<T
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M*D996';OTJCI]PUUXT\)W\*:K*LFG7,#SR64D<<4K"/"*FT*BK@\XQQ]XD4
M:GQ-\4PQ^!M6?2[Z^AN()%A6ZM$=4$@<!D\P#'J#SC/&<\5TL]]I@\;6UL^I
M7J:BEE(XLEWB!X\KER,;2P. .<\GBO+IKJ>'X(W_ (1NM/OUU^S_ ',ENMI(
M_FGSPPD5@,,&!SG/7\,]M=W"R_%G1;L17 MQI$Z-(\#J$9G1E5B1\I(!X/-
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MO58M/CUBX@2\5I!<01A8]H7Y2R8Z8QQS2VFHRZ-XUTC7+^TO1I%[H4=C'/\
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M%@@B:20J,9;:H.!R!D]R!UKD_!]Q]I^(/C*Y2WNTM[IK-X99;:2-9 L(!P6
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M "2N"2.&4X;!P>E '045Q7@!I?[0\7PO//,D.MND?G2M(57RHR "Q)QS7:T
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M!]K\-Q\O)Q\V/7H0:]EHH \,TW3=6TNP^)MM<:-J)EUR>X&G!+5W$^YI4!R
M0H^8'+8XY'%1:WX/UG2/"?PZTE;"[O+C3;T7-X;:!Y1"#('8$J".,D?A7O%%
M 'C_ /8>I:A\:/%=PME>P66HZ*UE!>O;2+'YA2,?>QVVMS[5-\*YM1TS1;/P
MIKGA34%O]+N'\FZDM@8%1F+%Q*>,C<P^7)(QCJ<>M44 0W<RV]I+*RR,%4G$
M<;.Q^BJ"37BOPGTG5=%^&GBC3M2TC4;:\F\UXHI+20&0&$*-O')R,8ZU[A10
M!\X/X>UT?"OP=IO]AZH;VRUAY[B$6<FZ--['<>.F&'Z^AKO-?LKZ?X]^&=6B
MTZ^DTZVLGBFN5M9#&C,LN 3C_:7Z9YKU.B@#PR;P[J^AP?$O3)-.O;J;79/-
MTZ2"W>19P[/P6 (4KO&=Q'<]*77O">K:?9_"_3FT^[O6TFX62_>W@>5(5WQD
M@E00<88?05[E10!YI\<=-O\ 6? *66F6%U>W+WD;B.WA9R% ;).!QU'6J$UG
M?O\ ';1-973-0_LV+2!!)<_8Y-J.5D.T_+U^8?B<5ZU10!X-X8L=?T?X9>,H
MAX7GN[V?4#-!97MDQ65&*C>$8?/C!..N0*M^&-*UN+XM:)K%SHNLI;2:0(I9
M[J(823!SD*=L:^B<8&,"O;J* /'_  1INJ:#=^/[.^TC4%-Y=33P2K;LT<B$
M/@JP^\3D<#)YZ<''*VG@S7YOA#HD7]EWR7ND:P;J>RD@99'C)ZJI'S$>@]Z^
MBJ* /+-/TF^OOB[KOBU;6[BTF/3!;1-);NCW#[5)"H0&(&#VZXQFO.7\,>(/
M^%%P:*-!U3^TEUOSS;_8Y-PC\L_-TZ9.*^F:* &0N)((W 8!E! 92I''<'D'
MV->;P6V^^\?_ &_0[^[L;ZX@*P_99%-Q%Y:1N4.!DC!(QSQGWKTNB@#A?!5E
MJ>EZY>V45]J%]X=6V1[:74HF6:&3<<Q!G 9U"\\CC('K5[QI>:A:W6ABWLKN
M;3WNF%[/90&6>%=AV[0 2H8G!8#(&<$9KK** /'?[.D3P9\0+"_T35DBN-1:
MYMU;[\@81>659B=[;ES@$YQCJ0*VM&UBTO?%]IJ&J1:O'J@M38VAN])EM(26
M.YLL2PWL5'<#L!DUVFOZ%!XATY;.>XN;<I*D\4UM)L>.1#E6'!!P>Q!%0:?H
M%Q!-'+J6N7VJM$VZ);A(D1&Z;L1HNX\]\XZ@ T >:[M8U"T\*WUWH6M?VC9Z
MTLE]"MJR0VZXD&(TX4KR/G /^TW-=' EQ%XU\<W+V%^(+JQMD@D%I(5E9$D#
M!2!R06'3KVKT*B@#R5+2^3P%\/;0Z9J/VBPU*SDNHA9REH5C5@[,-O &1]>U
M6=2TZ\AU^?5O#*:K8:L^HJMU826\C6=\GF!3*21M4[/FW @\8ZD$^HT4 <5H
M4=W8_$SQ6)K"[$&H-:RP7(B/DE4AVME^F0PQCKSTQDU-\2[.[O?!4RV5K-=2
MQ7-M,884W.RI,C-M ZG )Q77T4 <)++/=?%'1]2&G:BEH-*GB:1[1P$9G0J&
M(& 2%)P>G0X/%<L^DZO)X>U.ZM]%NKB2S\63:I]AGMVC-W;$D?(& R2&) ]N
MF<5[)10!RGA633]0O)-1T_PM+I \GRWGN[(6\TAR#L ZE1CDGC.,9YQ7^)4-
MQ<Z#816MI=7,BZG:RLMO TA")(&8G:#@ "NSHH \Q\4R:IJ5[XKTV32=4>&7
M3-NF&S@98[AC$VXRN,996. C'IT4DU/?Z?J,_P ._#6J6&FW(UG0Q;3Q6LB;
M)9 JA)8\=1N4MU]!7H]% 'F]IX6U;3_&JQ\S:;K$*7NJ2Y)5;J%]Q"^@<L@Q
M_=0^E>D444 >-73:SJ6G:-<WNA:R-2LO$,4]W!%;,L$$2RL?W2C <8(.\!CD
MG) (KI=.%Q'XQ\=74NGWZ0W=O:B!C:2$2E(F5@I (8@D#CKVS7H%% 'CNC6N
MK:%:> M9GTG49;;3K&6QO[=+9S-;,X7#B/&YAE<$@'CUKJ?"+7$OC[QA>OIU
M];VMZUH]O-<6[1B0+"%.-V#G/;KZX.17<T4 <1XY34M/U_PWXELM/N-0MM-D
MGCN[:U3?+Y<JA=ZK_$5*]!ZU'K^MZM<^'/[1TS0;V*&2]@$@>T#78AW?O)EB
M.?F&%"Y&>"<8Q7=T4 >4V]O=0:MX\>/1]9^SZEI< M9)H9)&E*Q2J1DDMN)9
M?EZC/( %2M;W@T#X:1?V=J'F:?+;&[46<N8 MN4;=\O&&('Z]*]1HH J:JVS
M2;P[)'/DN L:%V)QT  )-><1:-JUY\#=,T^VT^7^U+!+>1K&ZB,9E:&17,9#
M 9R%X[&O4J* //K"YTW5K*\OK;P%<VTD-C,LRWE@(99,J?W$?\3;N02./Q-0
M>&M(O].UE[#2+G4YO#<UA)^XU2%U:QERH1$=P&((S\O.-O7D5Z110!XS:_VD
MW@?P5I7]@ZN+K2-6M#>JUHP""-FW$$_>&.<KD>I&1GK]/BN#\4]>N&L[M+>X
MTZWABG>W<1LZERP#XQQN'>NWHH XWX7)=6O@+3=-O;"[L[FQC\F5;F(IE@S9
MVY^\.AR..>#UPWQ+%._Q'\&W$=I=RV]K]L\^:.W=DBWQ!5W,!@9/_P!>NTHH
M \K6VO#X6^)-O_9NH>;J%U=-:(;.7,P>%44K\O.6!KT'PYN'AG2U>.6)TM(D
M9)8RC*P4 @@@$<BM.B@#S;1+[4O"^J:]H5_X>U*_%YJ,]Y97%O!OAF24[MKN
M>$(/!W=OUTK9+H?%][J6SN1 VAQVQN%MI/)\X3,Q4/C'0YZ_K7;T4 >?VZW$
M/CGQO<O8WP@N+*V2"06DA65D20,%.WG!8=.O:L1;.^3X;^ K-M,U'[38ZG92
M7,(LY2T2QMEV(V] /S[9KUNB@#B(?-3XN7]^UG>BS.BQ0B?[))L,BRNQ4';R
M<$?RZUR5I8ZA%\*_"]B^E:D+NVUJ*::#[%+OCC6Y:0L1MZ;2#7LE% 'GFI'4
MD^(>L:CI^EW-P?\ A'/)MC+;.(99UD=Q&6( Y!'?OBLK3Q?7'BGP1JATC77,
M4%S%>R7%LT:Q2/&@"A#@1H"",@!3Q@DUZQ10!Q?@6.>'5O%IGM+N!;G5WN(6
MGMWC$D9C10P+ 9Y4UVE%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MFZC X^P, "JQ,X!Y8XV@D8R?2@#TNN<2^TAOB#-;B2\&K1Z9N=7WK (/,^\
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M7$OD0/*(I)=HSLC&6;Z"O*(K>_/@GX=6[:1J:3:?J-J]S&;1RT:1QNK,P )
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MZ9J/VFQU&RDNHA9R%H5CSO9AMZ#/X]LT =]HWBBQUK4;W3XH;NVO+0*\D%W
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH @:TA>\2
M[=2TR*50DDA0>N!T!/KUJ>BB@ K"U?PRNM7;F[U*\.GRQHDVG#9Y,FUMP/*[
MAGH<'D5NT4 %%%% !1110 4444 %%%% !1110 4444 %%%% !01D$?RHHH K
M16,-O9O;6Y>$/N)=6R^YNK9.<MDYR<UG:-X=32[DWMQ?7.HZ@;=+8W5R$#^4
MK,P7Y0!U8DGJ:VJ* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@##?PX'\91^)/MTHFCM
M#9B#8NPQE@Q[9SD#G-;E%% !1110!AZ)X:72+J>[FU/4-2N9-RI)>RAS#&6W
M%$P  ,@9[G ]!6Y110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M\3^(-"T+Q+8ZC;P2RNES=-+J$C0R0G.^+R=FQ<= 0<@KR3R:JS#5KU/B!O\
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M9:58P,BQW+I),\FXES("&.T  #.,DYSQBQX U74+^RUBQU*9KF;2=4FL$NF
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M*DNC32W#%C;2L45TY^ZA5GSU*XS0!V\7B-9/&DOALV4T<L=B+T3LR[74OLP
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M,"6.>?\ (KHSTZ9KF=&\47FMZ7KL]OI(%[IEY/9QVIN!^_>-01\^,+DG'?%
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M:%O]G%Y'Y@BW[MO)&,X&>GI0!CCX<:2OA[^PDO-233Q,LR1B<'R]K[U5<J<
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MI^P><?LXDW;LA/3=SM^[GG%37_A/2]1UR/6)1<I=B$02>3</&LT8.0LBJ0&
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MI<<E\P D<.ZK+CIO4$*__ @:T)= TV;7(M:DA<ZA#&8HY?.<!4/5=H.W!^E
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MSJLC1R[B-Q)Y*J3[BI=-M].B\(^ ;%1(T][;Q3+IZ$".\86P+&4G^!<ACUY
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M9_+"[4./F.>.*]UHH \E\#>&=8U7X6^'+:VU[4= GLQ<+/'%" SEI20&#<C
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MES;/*JHIN%CE*#>,>F,XQTH ]'TWQ =0U22PDTG4+-A MQ'+/&ICD0G'#*Q
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M>^3CD]"<=L27.HZ]H?Q9\&>'IM;FO(9[%_MC.B@3NJ2?-C!*YVKP#VH ]8K
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M,\CKD\T =7JVH-I>ES7J6-U?-$!BWM$#2OD@?*"1G&<]>@-7:Y+XF:CJ&C^
M=2U+2[U[2ZMPA5T16R"ZJ1\P/8GIS5#QEXANM"UO_B8RZC8Z%):J(=2LHA(E
MO<;F#&88)QC9C(QUZ]@#O**J6,IDTFVE%Q'.6@5O/4Y23Y1\P/H>M>>6.OZO
M!K/A(-JDM^NI3S07LR(HM)B(V8>3D!L*5&& P1W)H ].HK$\6W.JVGAR>XT:
MWEN+I'C+10X\UHMX\S9GC?LW8]ZX74_%KS?#WQ'K.@>(+WS[(QE(;F)1/9MD
M!HY%9>0>3DY[\\4 >INVQ&;:6P"=J]3]*RO#GB&V\3:4=0M89X8Q-)#LG4!@
MR,5.0">X/>LG4-3O[;XD>'[".\D^Q7UG=/-;E5*EHPFT@XR/O'O7":7%KUE\
M.-6U_2->DM'TV]O[E;/R4:&94F=G#Y!8D@$#!&..,\T >T4PRQB58BZB1E+*
MF>2!@$X]!D?F*\UUWQ?>6TB7.I3:AI&EW^GPO8ZC;QB2&WG=26$_RDCDKC(Q
M@=CDU<6&6X^-,3)JET83H G54=3&1YX! RI^5L DCD^M 'H-%>83^(-8L[G0
M;A=5DO7NM=%C=R0(/L9C=G C3(!+* OS+GD,"3TJ=YM?U'Q!XWL%\1W=M!IB
M026IAABW*6A+X)*G*YZ\9.!SZ@'HKRQQE [JI=MJ@G&XX)P/? /Y55BU!Y-8
MN-/-C=(D422"Z9!Y,A8D;5.<EACGCO7FDMY?^(;CX8:A/J%S!-?+(\H@*A?,
M^S,2X4J1DY(YS@$XQ726VIZHGQ \0Z:VHA[6WTR&XMEN%54A=BX))4 D?*,Y
MH [2L?0_$5MKUSJD$%O<0OIUS]EF$Z@9;:&R,$\885QVE:[JD7BCPE;-J5S>
MP:I;7 NYGC403R)&K[X1@,%SG!P%*D8SUK4\#?\ (Q^-_P#L,?\ M&.@#=OO
M$=M8>)=*T.6WN#/J0E,,JJ/+'EKN8$YSG&.W>FWGB);&#6;BXTS4%@TM0[2"
M-<7"[-Q,?S?-CD'..16)XF_Y*=X%^M__ .B16=+J.H7,7Q+L+R]>Y@L;?;;!
MT5?+5[8N1\H&>3WYH [O2M0CU?1[+4H4=(KNWCN$5\;@KJ& .._-6Z\Y^'FJ
MR>(-.TVV@OY[*+1]/MH9K/:H>X9H4(D;<I(CQG;M/S<DXQ@I_:7BCQ-I-[J6
M@320W<5]+%:HTD8MPL4I0K(I!8[@I)/4$C&!0!UZ>([9_%S^&_L]PMTMG]M\
MUE'EM'O"<'.<Y/IVJEJOC*'1?#U_K5]I.IQ06=PT#(8E#N P42+\V-A)&#^E
M9:%Y/C1&6PDC>&<G:<A3]H'0]ZY;7=2U#4O@[XR_M&\:ZEM=5FM4D=54[([A
M%484 =O2@#V*BN%?4-3T+XA6]G=:M<7UC>Z9/=20R1H!%)$R_P"KV@$##$8)
M/U-94WB#6Y?A<OCNVU%Q=JGVPV9"FW,6_!BQC/"_Q9SD>G% 'I]%<3IVLW'B
MSQ/K6G17ESI]KIMO:E1!M$C23(9-Q)!X4;0!TSG.>,8FF>-]7U"WTG0[B81:
MI/K%SI=Q?1H!N2W!9G52" S#:.F 22!TH [FU\16UWXHO= 6WN$N;2!)W=U
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MT5YEI^OZO#KWA&-M4FOH]3>>*]F"*+69A&S@PY ; *\,!@CN:Z#XEZCJ&D>
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MN]3GBFEAM8FFD6%06VJ,G ) Z ]ZDTR_CU32K/4(E9([J!)T5^H#*& /OS7
MS:E?W>A_$NRO+N2XAL8YHK?>J@HAM=V,J!GDGK4NE:Q<2KX+\,VT[VRW&C)>
M7$R8WE$C15120<9)R3UPO&,YH ZO2/$5MK.J:MI\-O<0S:9*D4WG* &++N!7
M!/&".N.M;%<%X%MY+7QKXYAEN9+EEO+;][+C<1Y"D X S@8&>^*[V@ HHHH
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MADTN1Y(8XPNUF92IW9!/W21P156?P@EXOV>]U&XN; 7_ -O6WD1,J_F&0*'
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MG#JM]%)H;YM+E/+\S:5*%6!4J<J<9Q5B;P7:7.KZK?SWMU(NIV/V"> E=HB
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MFV!E4G*[NC$8! />J5GX$M;738-'?4+J?1;:99H;&4*0-K;U0OC<R*V" >>
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M56RW"[MX(!SG'L!Q7:CPFB:UK6J)J5TLVK0I!*NU-L:H"%V_+G(#'KGK5,>
M;<:%H6D+JEZ(-%N([BV;$>YFCSM#?+@CD] * *8UR]T#QQK%AK&H7$]A-8?;
MM-!1 5"9$L8PH+-DJ1G/!HEU#6(-5TCPU+<7$]W+I\E[=RQ/&CLP9%V*2  H
M+-T&>!SUKHM8\-6&N7VD7EXK&;2[C[1"5XR=I&#[9VGZJ*J>)_"%OXDFL;Q;
MZ[T[4[!F-M>VC .@;AE(((93@<'_ !H YZXO/&>C>'-^HPW%^L&IGS6L2CW;
M6!5BIP  9 VT':,D XYYK(\0ZE'KO@BPO=.\17=Y;/KULBN $=094_=R+M'*
M'H".>"<UW2>%Y(;2T6+6;_[9!<&Y>[DV.UPQ0H0XQC;@]% Q@8YYJK=> K"[
MT:]LFNKB.XO+]=1DNX@JL+A2I#*I!4 ; ,$'WR3F@#/NGUAOB5!H$>OWD=C+
MHLEPV(XO,#B5%W*=F,D'N"!DX ZCG)=6\2K\/_$&J_\ "1W/VOP_?7-O"1#%
MBY$4F 9OE^;(X^7;Z\FN]C\*A/$T&O'5+R2ZALC98D$95T+!R3A1R6 /& .@
M %43X MF\.:SHC:I>FWU>YEN;A\1[PTARX7Y< $^QQ0!7N=9U#6O$EWH]H;J
M&.UL()V-K+&CEY=_.7!X4*, =R<YXK+N+WQC:/X-LM2U6.WO[N[EM;W[/'&Z
M2 1NRORO#8 X'&>Q'%;FJ> X[Z_L=3M-:U#3M5M;<6K7EJ4!GB'.UU*E3SR.
M/Z5:N/!EO/-HLHU&]5])F:>-B5<S2,"&:0E3DG<>F.O':@#C]2N]5&@_$G1;
MC6;RX72;82VUTVQ9MKVYD*$JH&,CL <&N\\)P/!X4TM7N)9RUK$P:7;E047@
M8 X'YU2/@JTDNO$<T][=2KK\(ANXSL 51&8QLPN0=I[YK5T/2CHND06!OKB\
M\E0@EN-N[:  !\H P !V]SDF@# M=1NO$GBSQ!IT5_/96VD>5 @M]H9Y73>7
M8D'(' "]#@YSQCD?!6L7EGX'\%Z+;%_-U)[TO)$55RL4CL0I;@$DCGT!QSR.
MXN?!R'Q1-KVFZK>:;<W<:QWJ0!&2X"\*2'4X8#C([5FCX8Z<OA:PT5=3U%)-
M.G:XLKU'59K=R23M(7D$L>#GZ]* *-SJWBCPY93V^HSKLOM5MK/3;F9DDE@C
MF;#&3 "DK@[2<YR,YQ721Z9K5GJ%^1KCR:=+:@P+*JM/#,/O,"5P5(QP0>?2
MJ\_@6SU'PY=:3K%_?:C)=%6DO97"S*RG*%-H 7:<D #N<YR:M:3X9GTZWE^U
M:[J&HW;Q&%+FYV9B3T50H&3@$D@DX&>E '(6/B;77^&_AC6YTO[^*;+ZK)8H
MIN-F&PRJ!T#;<[><#TS4NJ>([D^ M/U?1/$DEXDFJQ1&X\M SQ/.%\MP5&UE
M4@< 'CWKHM+\&_V+I.E6&G:Q>1C3 ZQ.ZHWF(W5'&T9'?C!X'-177@&QN=$;
M31>W,(EU#^TIY8@@:2?>'S@J0!D#@#H/KD 9%J5SXA\:^(-$2^N+*WTB&W4?
M9]H>2252^\D@\* H Z9SG/&.5;Q9XCNM TS_ (F/D:A;>*$T2[E2!"ERHDP6
M*XR,C&0I'?\ #NKCPLI\0'7;&_FLM0D@%O<LB*R7"#[I92/O#L1].156Z\"V
M,^F:=8PWEU;I97ZZEYB;"\UP&+[W)4YRQ). /P'% %;0+O4[/X@:SH-WJEQJ
M-JME!>0O<J@>-F9U90451CY0<8XKLZP%\+JGB6\UT:E="YNK06C( @5$4DJ5
M^7.X%B<Y-:>DV,FFZ5;64M[<7LD*!6N;@@R2'U8CO0!QNL_\EL\,?]@V[_\
M9:RY[SQ%=6_CME\2W</]BRN]IY<,0/RP"0*V4P5SV !/<FNQO?"B7OBZR\1G
M4;J.YLXGABA54\O:WWLY7)_/M4"^"HDB\0Q_VG>$:Z6-S\L?R938=GR\?+QS
MF@#F/%$ESK6F?#O4I+R>"2\U&S=TA";5=X)&+#*GGG'/&.U;EI?W>N^+M<T$
M:E=6T&BP6T>^+8))I94+&1CMQP ,  #.<@\ 6;CP1%<:=X?LCJMZL>AR12VQ
M58\NT:E5W_+S\I(XQ5JX\+*?$)UVPOYK+4)8!;W+(BLEPH^Z64C[P[$?3D4
M<*_BSQ'=>'M,QJ/V?4;?Q.NB7<J0ILN0),%]I'&1C(4CO^&O?IX@TCQ9X7T8
M>*+RXAU%[WSGEMX=V%CW)C"CD9/MP..,5LW?@2QGTO3K"&\N[=+*^&H^8FPO
M-<!B^]RRG.6))P!^ XJ]J7AM-2\0:1K#WUQ'-I?F>3&@38YD7:V[()Z>A&*
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MX](UN\OM+U-K^3R(Y8Q]DOK?<VQ8GP0#M*]PQ(QWQ7?WBR/9S+#,T,A0[9%
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M=+=74ETWVC;\KNV6QM4?KF@#FO$-I<WWQ:TJWM;^6Q=]%N0T\**SJOFQ_=W
M@'W(/?ZC,MO%NO:3'J&@7UV;V^M]:M]-@O\ 8B.T<R^8"1C;O"@C)&,D9![]
MQJGAM;_7;/6[:^GL]0M87@5D571XV()5E8>H!R"#52]\":1J'A^\TJZ:X<WD
M_P!JFNPX6<S\8D# 8!&   , #&* &Z#!XDMO$=XM](SZ++ KP+<RH\T4P.&
M*CE"#GG.#3_%6M75EJ6AZ39[Q+J<\BL\;*'"1QER%+< DX&?3..<$6?#_AV7
M1MTMYK-_JUUL\M9KQES&G7:H4 <X&2<DX'/%'BGPM9^*K"&"XFN+6>VF$]K=
MVS[)8)!T93^/(H Q[/3O%\MKKEE-JKV:DK)I-TQCEGCRIW+(-NUE#8P>N#UJ
MO\/]<U'Q3;RW-YJ+Q36,:V=Q:)Y;!I@,F?.W[K9!7'RX&>>VQ%X2D&CW%G<:
M[J-S<W.T7%Y(4\QXUS^[ V[57DYP,_,>>:D?PQ:V_BL^)8;Z:TD%LMO/#&$6
M&6-<D%P1G(['(P..E ' +J'B^Y^'NH^)XO$\HN]*N+IE@-O%Y<\<4C B3Y<Y
M*K@;<8^O-=!'K^I^*=1OK.P^UVJVUE:R@6TL:,LDT9<,V\'( P .G#9SQC.\
M!Z(-=\(:A87.HS"QGU&Y:XM J@LAF8A=V,A''7N03@BNFUGP-#J&N1:UINJW
M^C:@L(MY9+(KMFB'165@0<=CCC\J ,W3M6U^YU;1/#.M7,=KJ+:=+>7\UF1^
M]*2"-54X^7.2S8&>,# K-\86.M6OAW2;?4M<EGD7Q%;)'+ %0M"TRE!(,89U
MZ],9P2#71ZOX#L]1CTR6UU"^T_4=-+?9[^%PTIW_ ']^X$/N.2<]S]:FO_!=
MMJ'A]-,FU&^,ZW,=Y]O+*9C.A!5SE=O8#&,8 &* ,VYO]3U+Q'JF@6EQ>A=-
MM8,S021)(TD@8[VW#! "C   SNSGC%>RUCQ%+J7AWPOK-Q%;ZG-:S76HSVA!
M\Q8VVJJ'& 6R"V!Q@@8SQI:KX#2^U:VU>SUS4].U6. 6\UW;LA-S'G.)%*[2
M<YQ@#'IP,2:EX&M+O^RI[2_O;+4M,+F"^C8/(V__ %@DW APQR3D=>F* ,SP
M+;R6OC3QS#+<R7++>V_[V7&XCR%(!P!G P,]\5WM<_H7A9=#U?5=3_M.\NY]
M2:-YQ.(PNY$"@@*HP<#Z>W%=!0 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !4=Q/%:VTMQ/(L<,2%Y
M'8X"J!DD_A4E<-\8(O,^%^L-YDJ&-48>7(5S\ZC!QU'/0\4 =S17%W-W(_C^
MQ\(BZNX[)-,DU"1Q<.))V\T(J^9G< /F/!';L,4_P=J-_P#\)%XG\/7MQ)=1
M:3/";:XE.7,<T>\(Q_B*],GD@C- '8U26\N6UJ2R.GRK:K LJWI==C.6(*8S
MG( SGIS7!^(-=N=(\1WD>O/J5CI\]Q%_9VK6LC&VB7" Q3*IPI+!\LP.0W48
M%;%K>7Z_%G4=/:]GELQH\5Q';N0$1S*RG&!Z*.3DT =C17DEMJ>NZIH.@O!J
M=_%XEFU7R-4MHG_U46]Q+^[8%455 PV/3DD\[$=MJ6J^/?$VCR^(=4BLX+.U
MDB$,BHR,PDS@A>.F>.3QDXXH [;4KRYLDMVMM/EO3+<)$ZQ,J^4C'F0Y/('H
M.:JZIK@L;^WTVUM_M>I7,4DT4'F!!L3&XECTY90..2?3)'GT7B'6;SX=^!-5
M;4YTNKK5+2WNC'@>>AE*G=QGD+S@C.36OJ.G)-\:=-)N+M=^CSR?)<,N")8Q
M@8/ ]1T- '3^'=<O-<BFENM!OM*5-H07FT-)D?-@ DC!XYZ\&MJO+[WQ1JF@
M'XCW1NY;LZ6;;[&L^"L1DB4]  ,!GS[@5UD&D75EJMCJ$/B&9K,V[I<PW3F1
M;ER,K(I)PA&"2% !'88H Z2BO+++5M1M]6\'2QZG>WL>H7,L-W>.Q%O> QNP
M,<1)V@%1@@*"/4&HIVUBZTSX@3MXCU1'T>XF>S\N14VE(%D .%Y7/&T8')SD
M] #U22>**6*.215>9BL:D\L0"3C\ 361I/B--5\0:UI LYK>72C"':1E(D\Q
M2P*[2>, =>>>@KBYU?6/&_P_OKBXN5EO=*N)I1%.R*&\N)N #@<L<XZ\9Z5?
MTNS>_P#'OQ"M8[F:UDE2Q5)X6P\;>0<,/H>W>@#T"BO.?#NL7NM:-I6@W%U<
MQZW:WCPZHZS,' @Y=L]U?=&/3$G'2NF\7W#V^FV@34FL1+>PQL(T+2W"D\PQ
MXY#-CJ.@R>.H -75+_\ LO2KJ_-O+<"WB:4Q1%=S #)QN('ZU6TC7+?5= TO
M5B/LZ:A#%)'&[9(+J"%]SS^E<9I>H7TJ?$#3+EKK[/8H#;Q74OFR1+);;RI?
M)R,\]3C.,UC+:+<:#\)MT]R@;R4(BF9!_P >K'. >O'7KU]: /8**\\EEUKQ
M/>>);+3KIK>739Q9VCC4)(6B81*PD=50^9EF/WB00N,#DFO=)K][XOT/1KSQ
M#<6YNM&F:\.G.JIYR%%+QDKD'))R0<<@8H ](FFCMX))IG5(HU+N[' 4 9)-
M8U_XECL/$NBZ,;.9SJOF^5<AEV+Y:%R",YSC';'/6L+XFV9B^$>KP/=7,C6]
MF 9C(5>4C RY7&<]QT/I5'Q!8%?%W@"TAN[F,L;S]\7WR &WYP6S]/:@#T>B
MO*AXCU/P_I7BNS_M":Y-CJ]O9VMS>2;GACG\O)9R#G;O8@D'MUZ5U.E:9X@L
M/%0GENXET:>W*/:37TES)YX.0Z%T! QG*YQWQ0!U#SQ1RQ1/(JR2DB-2>6P,
MG'X5)7 :]8K/\7_#A:>Z4/I]V2J3NH&TQXP <#.>?7C/2H+&]O\ Q5X9\1:S
M%J=W9WMK=W,5DL,I5(!#PH9/NOG&6W _>XQ@4 >A23Q12Q1/(JR2DK&I/+$
MDX_ &I*\GL[J3Q/XM\ :O=/<P37^DW,TL<4[HH8+'RH!X!R?J,9SBG^(]8U&
MRM+[4[+5;R[GM];BB$\+E+:&(RHAMRA.)" 2"P4\D\@C% '=+XC0^-#X:-G,
MDOV$WHN&*[&4.$P "3G)[XZ5MUQ3_P#);X?^Q<?_ -*%I?&<^HQ>*/"=O9ZI
M<VD-Y>20SQQ;<,!$[9Y'7COD>U ':52U&\N;,VGV;3Y;SSKA(I/+=5\E#G,A
MR>0,=!SS7 V%EJ-UKWC#07\1:N+/3Q!-;.)_WRM+$6(,F,E05R![\YJNOB#6
M+SP9\/-4;4ITGOM1M(+P1X43JP;=NXSSM'0@<GB@#U.BO-/&M_J/AGQ-!<1Z
MM,-+U6(VTRRRL5TYV95%P,?P_,!@X )'(!X]#AC6QL%0233"%/OR,7=\#J3W
M)H L5EZKK2:==V5C'%Y]_?%Q;P[]@;8NYB6[ #'8\D<5Y^-8U34?A,_CFWU.
MXBU54DO502DP!$=OW)C^Z1M7;G&[/.:M:O NK?$/P/>/)=P&]LKN5D2X9?+_
M '41P,'CKSCK0!UT6NWT_AB35%T"^6]3</[-D*K*S*VT@$G:0>H/<5MJ2R E
M2I(R0>U<G\3;N]T_X=:Q>Z?>SV=S;P[TEA(#=0,9(..O;!]ZH:N^HW'Q&T73
M(]8O;>RN],GDEBA91RI09!QD$[CR<D=L=: .VN[J"PLI[RYD$=O!&TLKGHJJ
M,D_D*Q]*\0W.I7UO$^BW4%I=6@NK>\W!D*G'R/C[CX(..0>>>*X<RW=]\*_'
M5G?7]W<_V5/J-M#,\I\QXTC)4.P^]][!SUJ_!?2V">!/#L-U<QPZQ"TMQ,9F
M+[8K=6\M&/*@DCI@@ XQF@#T>BO-=0U'5=)USQ1X?AU&[-LFB'5;*=G\R6V8
M%E*;V!+ E<C.2.>:S-576K#X0#Q/'XHU8W\^F63E3(OEJS%,D#;D$AN2#D]:
M /7:*\^U"WU*T^(VEZ9'K^I&UU:RN&N5:13M:,H08^,1D[B.!T]^:I:?J=_%
MX;\1V,_B">'[!KOV&"[G!EG:(F,^6N.6<[V4'KR/2@#TZLZ\U22/38+W3K-]
M269XPJP.H^1B 7R3@@ YK@XKN]N+SQWH\TNHPV=OIT-Q;Q3W1::$O')NQ(&)
M )0'&XX]LXJGOO-(^#WA*ZT_4KR!Y&TX2 2Y#*YC5EYR57!Z*10!ZS17&6][
M+XC\=>(]&FNKJWM=(AMDB2VF:%G>5"YD+*03C@ =.#D&N3/B'Q#=>']*CDU:
MXAO+3Q6FC3W$2J!=1K)C<PQZ8! P#@Y% 'K]4KF\N8=4LK6/3Y9H+@2>;=*Z
MA;?: 5W G)W'@8]*Y;P_)>Z?\1=:T.34KR]LQ8P7D?VN3>T;LSJP4X& =H..
M@[8J77;R^MOB5X3M8KZ=;.\CO/.M@0$8I&"IZ9/+'J2.E '8T5Y#/+K4WA?Q
MY?GQ)JBS:+J-R;,I(JX\N)& ;"\KVV\#D\9->C2NVI^#C+*[QO<6/F,T+E&!
M*9.".1^% $&N^*[?1;73KE+>6\@OKV*S66%EVHSOM!.3DC.>@/2M^O%EM3'\
M'?!+1SS>9-J.G-ND<N$/F#H#P![5T%QJ^H>$_$OBB 7]WJ-M;:#_ &K''>2;
MRLJM(" 0!A3M' X';% 'I-%<'IMGXEEN=!UFWU&$6DJ*U^)K]Y4ND=1@HAC"
MHV2"-N!SBK/CZYU"TN?"_P!AU*XM!=:S#:S+%MPZ,KDYR/\ 9'MZ@T =G17G
M5A8W\_CC7_#C^(=7_L]+6WND(G'G([[P0LF,A?E!P._MD&MH.MW^J^"?"<U]
MJ\YN+BXFCFA@!%Q?B,R*%5E(VXVJS-D# Y(SR >G5B>(/$:>'YM)CDLYIEU&
M^CLED0J%C9\X+9.>QZ ].U><WVN:XGPP\8SIJ=[;76E:O);6SF0/*D0:/",_
M).-Y&<YZ<UI^.K"XT*UT2Z>^U+5I)/$EI.(964D$*_R1#  !(X&<<T >G45Y
M]%XC9/A[JWC:VO)+JX:VDGCM3(WE6KJ,>5L/=2/F)ZG., @5:M=,\1#5]+OX
M=2C&F2Q,E\LFHR3?: R_(\8,8"-GGY<#!Z4 =G#/%/O\J17V.4;:<X8=1]:D
M/ Z9]J\3MVO-'^#&O:GINJ7]O=PZA<!9!.7R/M17^+/)!Y(P3ZUU5XNL>&O'
M_AXKK=]J%GK4DMO=VUR5*HZH75X@ -@&#D>GKUH Z?PWXC3Q''J3)9S6IL+^
M2Q=)BI8L@4D_*2,?-ZGI6W7ENDW$EKX;\<21:HNF.?$LZBY,9<C+1 JJCDLP
MRHQSDBGGQ-J.@:KXP*I>&UL-(CO[:UOIO-9'PX/S;F(4[02-QQ[=* /3Z*Y/
M3=-O6.A:U%XAG:)X-U]',QD2\WH"I4$[8R&.1M R#BN<TR;Q1XH\-Z9XETR^
M@MKB2;[1(TU_)Y!A#$-$T(CVC &,_>R,YH ]/K.UW5AH6A7NJO;2W,=I"\SQ
MQ%0Q5023\Q Z"J/B^X>WT:/9J9T_S+J&,NB%I)5+C,48'.]AD CD=>.HXJ;4
M+Z33OB=I=PUVMK9Z8)+:"[F\V2+S+:0L-^6)!*@XW'&: /2M,O5U/2K._5"B
MW,"3!"<E0R@X_6K5>4;-7\-Z7X*UJTUN^N$O);*RNK"8J8&CE4#Y% &TKQSU
M/<]<Z5C>W_BOPWXBU>/4KNSO;6[N8;(0RE4@$/"AD^Z^2,MN!^]@8P* /1:C
MN)XK6WEN)Y%CAB0N[L<!5 R2?PKSK1/$FH:QXA\%W4DLL,>K:1//=6P<^6TB
MA,, >GWB1CUK!\27%U?_  T\>)=7UW*+#6W@M\S-E8PT.$)SEE^8\'- 'L]8
M'B'Q7;Z#I4.HK;RWD$ETEJ6A9<(S2>7DY/0-QP#TK3-BBZ7)9^=<E"C+YAG;
MS.?]O.X'WSQ7CD%N4^ .B2K-,9)KNT),DA<*?M0Z GC\.M 'M]%>=RZE?^&/
M'&KVW]H7NH6@\/OJGE74@;$L<A7Y< ;01V'%.TJ#Q/?Q>'->M=1@6*;RI;_S
M;^22.YBD R%BV;48$C;M(]"30!VNJ7ES8V8FM=/EOI#*B&&)U4A2P!;+$# !
MS^%7:X_XD7E]I_ARWNK"^GM9%O[:-O*(&]7E52"<9Q@]B*R/&>LWFD:O?'53
MJEMHLUND=IJFG2,4L9<'<9D4YZE3D@C& .] 'H]%>;>,-<N=.U&[GOWU*+0;
MFU1;/5M,E9DLI"#EI40Y(.5()!&, =36M:W\T_Q2N;".]FDTV;0H[M8Q*2N]
MI67>ISQE0.E '9T5Y3H_B;5I?#7A^S>[>6XU/5[NT>XFG*,8XVE*IO )!.Q5
MR!G&<8/(L>((?%.@>%/%MP^L&&V6W%SIRQW;3W$! PZEW0$H3@CN/6@#TZJF
MIWPTS3;B^:"6=((VD9(MNXJ!DXW$#MZUG^'-,N+*%[NYU>^OGO(XI"EPP*1,
M%Y\L #:#GH2>E6?$7_(LZK_UYS?^@&@#(M/&K7_A^/7+7PYJ\MC)!]H1E-ON
M*8SG;YN<X[=:VY+ZX75+.VBT^66VGC=WNPRA(2,84C.3G)Z>E<-X$MO$4GPX
M\,-9W]B+<);,\7V5A)Y(=2X\SS,9VY_AYZ5JZG?7:?$_P]:PZA,;"\LKIWMU
M8>62@3:W R?O'J30!M:[XA@T30M3U00R7BZ<K-/% R[EPH8YW$#[I!]>>E:%
MC="^T^VNU4H)XEE"DYQN ./UKR6TLE@^'/Q*D$]S(4N]3A EG9P0%&"03RW'
M7K6S9-?Z/XC\#*FJWDT&K6LD5S;RN#$-D ="B@?*01C/4CJ30!Z317F%K/XG
M\5^'!KVD7T%I>_:Y&C>:_D6%(TE*F*2$(5QM7DGG/.1TJW!;:IK7Q"\3::_B
M/5+:TLTL9X4MW1=I8.Q4';]TXP1C)XR>* /1**XOXA76I6G_  C?]G:G/9&Z
MUJWM9?+"D,CAB<Y&3]T<9QZ@US]_K&L> O$>MVW]HWFKV/\ 8<NJ0+>N'>&9
M&"D;@!\AR#CMVH ]4HKS;5[[4M!\-^'/$MKJ5W=3SSVJ7T4DI>.Z2; ;:G1"
M"P*[0/0YI+[7;G3?%3VOB!]2L(Y]2C.G:E!*S6<D09<0.H.$8X93N'4DYQ0!
MWL%Y<RZM=6CZ?+%;PHC1W;.I28MG*@ Y&,#KZU'?ZI)#I)OM-LWU-MZJL4#J
M"PW!206('')_"N3BFO;KQIXTTRXU&[>TCL+:2%!)L\DN)-VPK@CH.>OO7,P2
M7FD? '2M1T[4KVWN-EH25ESD-*J%1G.T88_=Q0!['17%:]=W.@>/]$OI[VX_
ML740]E+$TI\J&Y(W1OC_ &@&7'3.#UJI?ZM?VEGHPBGE#>(=3*J9KAD\J H[
MHBMABA8*HX&06;&, @ ] HKF/#FGZ]INLZDFH7D4FF3A9+.W:[>XFA8<.-[J
M"5)((R3BNGH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ K.UW1;/Q%HEWI%^'-K=)L?8VUASD$'U!
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ML5S-<V\EI<+=6\]M($DBD7(!!((Z$C!!ZU3?Q8\EVPT_2;F_LX;_ .P7$\#
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MUI@UY%,R[2P  *[5!4@ 8Y[ ]:E\.^$+;PZVY=2U74'5/+B;4+GS?)3CY4&
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M1M*M].CNKFXB@4)&]RP9PHX ) &<>_-7J* .7C\":9#;W-C%<7B:3<S&:73
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M #W-_/YLA49PN<  #)X [FMBBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "N7\>Z[<Z#X?A>T?RI
MKR]@LA/@'R1(X#/@\9 SC/?%=15#6M%L?$&D7&EZE#YMK.,,N<$$'(((Z$$
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MWES"S%0C,%]2 ._TQ5?0/ MEX>*_9]4U>X2)2EK'=W7FI: C'[M2,9 . 3G
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M''84 =-13)I5@A>5PY5 6(1"YQ[  D_A7(1?%'PQ+'8SK/=BSO9/*CO&M)!
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M!P58'D$'@@U8NKJ"QM)KJZE2&WA0R22.<*J@9))H FHKSK6-<-Y\0_!*V_\
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M<6W@M+>ZM+JUG2[N6,=S \38:9V4X8#.00:Z766*Z)?$)(Y^SN D:%V8E2
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MX7UGP9=2:S8,L7G26I:U<(?EG$I^7&.?7/ YKUNB@#D/B1H=SJ_A1KG35/\
M:VERKJ%B5&3YD?.T>NX9&/4BM;PW:7-KHBSWD874;QFN[E,_=D?G9GT4;4!]
M%%;-% 'C!FU/4+'PM>W6B:RE_9ZXDE[;1V3I!:K^\&(T "L.0=XW=>6&0*W[
M9+A=5^(TK:?J"I>)']F)LY?WV+8(=GR_-\W'&?RKTBB@#RFT@O;&S^&%[+I>
MHLFFV[V]W&EI(9(7:V"#<F,@;AC/3WJCXP.JZQH/C&PET75EO5N@;2WM+5EA
MEA!CQ*67B5R <@EB,# X)KV2B@#S7Q!JO]F>/K36;:SU5)9M(\J9DTU[I2AD
M)0,B$,C ACD]0<8R#C*EM;9/!VAS^';2^U:'0M3:;4+&6W:*XD\Q7\QA&P!R
M/-W #C'?BN[OO"UQ)KMQJ^F:_?Z;/=(B7$:)'+'($&%(5U.T\GH?PK8T[3ET
M^)P9YKF>5M\UQ,1OD; &3M  X &  * ,+PH^FWUQ<ZGIOA^;34D14>XNK8P3
M3D=L'YMJ^IXR>.AKJ:** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH *J:GJ5GH^FSZA?SK!:P+NDD;
M)P/H.2<\ #DDU;KEOB/;0W?P_P!6AF@N)@T:%$ML>9O#J4*CN0P!QWQCO0!<
MB\6:>VN1Z+-%>V^HRQ"9('M7;,9.-Y9 RJ,\')&#UIDOC+28+BT64SI;7<_V
M:"\,1\B27) 4-[D$ XP>Q-<MI&JV&J^+X+S49M3AU9[)K"U,^D36<?S'<QRQ
M8%SM&!D=, 9K.\)10Q:78^%]8\%W,FLV#+#YTEINM6"'"SB4_+C'/KG@4 =?
M=?$/0[8ZF-NH3-IC[;M8K*0F(;=Q9ACA0.<GKVS6O-K]DD-H\!DNWO(O.MXK
M==S21X!+C. %^9>20.0.I%<1"EP)/B2387X%YS;9LY?W_P#HX3Y/E^;YACC^
M594<5UHT?A#6+_0-0O\ 34T*/3;R".U=IK250IWF,@,1D%3CT^F0#N&^(7AU
M-+M=1:YF$%Q=_8A_H[YCGS@I(,?(0?7\,U+!XUTVZ,$4%OJ#7<[2B.S>V:.8
MB,@.Q5\8 R.2><X'/%<EK]M$VAZ++I?AN[LH7\0VU\T$-B_FF-2-\LJ*#M)Q
MWYP!WX&YXCOKN/Q?I4#V%^=*FM),W5C;,\IE++B)G4;HD(&2<KD@9( - %#Q
MQKD&K_#>'7-&O;E(VN[<(\3O$3FX6-U8<?[0(-7M0EF@^+VE(D]R8)=)N9'M
MQ*Q0LKH 0F< X/6N+2SU%/@N=).C:HM[%JH/DFT=G(%YYA(P"2 G.[H>Q-=E
M?>;)\6=$NTM+QK5=+GB:<6LGEJ[LA4%MN <*>O3O0!LV'B[2]2T6_P!6@^T"
MUL&D2X,D)1D:,9<;3SD5KQW2262W?ERJC)YFQHSO QG&T<Y]NM<%?:'>6_Q#
MDT^T53HVOH+V^7/^K> J'P/20&-3^->A.XCC9VSA02=JDG\ .30!S&F_$'0-
M6\M[9[K[.\<TAN9+5TBC$1(?>Y&%/&<'G&.F15VW\5:?/K-OI4B75K=7432V
MJW,)07"K][;GN 02IP0.U<1HFBZEJ?P3U+0XK6YM=2<W6R*ZA:$L6F=U'S <
M,"!GWYK5\,7NGZY?V,H\&7>GZE:AC/->V9C%J2I#"-V^\2<#Y>W)QTH V;CQ
MUHMK;I=R-<FPDN3:1W<5NTD;S E=JA06/S @'&"1@&I+_P 9Z58&\W+=2BQM
MTN;TQ0'-M&X)4N#@@X!.T D <@5YI876FQ:'%HFHPZY;Z+:ZF]U''_9$LF$6
M9G5?/3*LF[G(7..,]ZVO$]U>ZO-XML1INHR0SZ8#I;6%NWEWNZ%LL\J_>()P
M$)QCH&)H [#4O&VBZ7=65M*]S+->P-/;+!;22><JKN.T@?,<$<#GGG%//BC3
M[N"*."&^GEN+07300Q,LT43=&89!4]<#.XX. <5Q]H;F3Q!\.IVTS4HX[33I
MXKAGLI (6:*-5#''RY*MU_&K]O<77AKXF^()]0L;Z:PUF.V>TNK:V>=5:-"C
M1-L!*G)R,\=>: $^'&OJGP]TB6ZGNKVZO+JZC@#,7FF(EE/5CV52<L1T^E=K
MINI0ZK:&X@29%61XF69"C*RL58$'W!^M>5Z'I4-WX"T?3=9T_6[":.^NI8KR
MVAD2:S<R.R/E0?E*MC/(Y_$=WX&;6CH,J:W(9Y8KJ6."Y>'R7N(0?ED9.Q//
MU ![T *FHZ2/&]]&L^H'4X-/5IH-DIB$6\X94QAF)R,KGIBJUM\2/#UW!I]Q
M"]X;2_F^SQ7)M'$2R%BJJS$84DCI[C.,U50RQ?&"]O6M+S[)_8D< G%K(8S(
MLKN5#!<$X(Z5R$%I?)\&-$T]M+U(7L.IQR26_P!AE\Q56Z,A)&W.-O.: .IU
M[6#>_$*S\.7$%^VG'3YII4@5U,C[T56RI!*J"W/3)]0*T;?7]+\,Z.]M)=ZE
M?VFEMY%UJ,JF;RCUQ(P +;01D@''?O5.Y>0_%_3[L6=\;0:/+ UP+23RUD:5
M&"EMN <*?I63HR7>B>&?$WAG4=/O9[R2>[:U:.W=TO4FR5(<#:#EB&!(QWXH
M ZS5/&^BZ3>P6<KW,UQ<6[7,"6UL\OG(H!^0@88X(X&?4X%0)X_T::>6W@BU
M*:ZCMH[HVR6,OFE'&1A2,_4]!TSFN:TS2+S0_%/@:RG@NYQIVD36MQ<QV\CQ
M)(PCP"X& /E(Z]N:U[(RP_%G6[M[2\%JVF01+/\ 99-C.C.6 ;;@G##IU[4
M6X_B-X>EM+"\BDNGLKUUC6Z6U?RHG8[0LC8PISQCMWQFKNJ>,-+TJ:_CE%Q+
M_9T2S7S01;Q;(P)!;OT!.!DX&<5YP+2^'P,BTS^R]2^WC4 QMOL,OF!?MOFY
MV[<XV<Y_K6GXJFU'5)?&&G/I.J;9-.QIHL[5U2ZS"<M)( ,LK';L8CC@*2:
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M(LD9) 93D'!P?U% $E%-=UC1G=@J*"68G  ]:I7FHRPBP:TL9KV.ZF5&>%E
MA0@GS&R1E>!TYYH OT444 %%%% !16?K&L6^C6T,DX9WN)TMH(UQF25SA5YX
M'<D]@#3-&U2YU(7:7>EW.GS6TQB*S8*R# (>-APRD'KQSD4 :=%%% !16;JV
MM0:5I.HZ@(I+H:?&TD\,!7> %WD?,0,[2#UZ&IM)U!=6T:QU)$,:7=O'.J,<
ME0ZAL'\Z +E%%% !1110 4444 %%1RSQ0F,2R*AD<(F3]YCV'OP:DH ****
M"BBB@ HJ.>>*V@DGGD6.*-2SNQP% ZDUD7'B..W\767AY[.?S;NWDG2XROEX
M3&1USGYAU _&@#;HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M\5LWW@>PU#1;?39[V_W07GVU+M603^=N+;MVSKD]ATXZ5AFSN)_C%+)'>ZA
MJ:'';_:TA7;)()7+*2R%,X(/ '\Q0!DZ/XIU[[):^'KR[\^\&OW.DM?._E--
M%%&9!\P4[6;Y5R!GKWY&AJM]XF\':9K$]U?VYL[FXMHM/WW#7$MGYCJDC,SH
M-RC.Y<YYX-=%?> M%U#PX-&E6X5%N#=K=1R[9UN"2QF#_P!\DGG&.<8Q2Q^!
M]-?0;W2=3N;[5DO4$<\]_/OE91RH!  7:>1@#GGK0 VXT*\M;R[=-=N_[-GL
M6B:UDE9I1.,GS$D)RORY!4<=QBN2\+%[/X5^%&35[BW^UR0B6,%GEN%^8F&'
M'*EN.1C !.1UKM=!\)0:&IWZGJ>IN(S#&^H7'F&.,XRJX '.!D]3@<UFQ_#;
M2X=(T_3H=2U:,:=<">RG%POF6^,C:N5V[<,1R"3W)P* .2U2]O[WP/\ $:PN
MKB^2/3G;[.LL^98T,*OY;."=PR3U)X."2*W=7DO=&M/ ZV>IWBQ76I6]O/&S
MAA(C1LQ!)&[&5'&<5LQ^ =)1==1[B_FCUJ/9=I+<%AG8$++Q]X@#DYQVP.*=
M-X)M;BSTBWEU34W_ +*N$N8)&D1F:1054ME,< D8  _'F@#.TRYN?&&I>*(C
MJ%W9?V=>&QM%MI"AC*H"96 ^^2S'ALC"CCJ3SECXFU[7['P%=/J4]E-J%U<6
MMZL"ILD,:R#> 1U)3./N@]N*[N7PG;C6KS5;&_O=.N+Y%6[%L4VS%1A6(96P
MP'&5Q3)?!>FL^A_9I;FSBT4DVD4!7:"5*DMN4DY!/?OGKS0!S-I=>(K<^.=%
MTV^N+^YTZ2W:P:[E7S,2QJ[)O(QGJ%)Z$BM?P3KMGJ]_J4<,VIV]Q"D2SZ5J
M98RVK?/E@6))5LCG)^[VSBKK^"K5KS6+L:EJ*3:J\,DS(\8*-%CRRGR<8V@=
M\]ZT+#08;+59]4EN)KN_FA2W:>8("(U)(4!%4=6)Z9_  4 <M\2K,3W?A%S/
M<)NUZWCQ'*5 RLAW ?WO>K-G=2ZYXUUSP_)>7D-IHUM;(@BG9))7E5F,C..3
M@!0!TSG(/&-O7O#<'B"73I+B\NX/[/NENX5@* >:N<$[E.>">.G-,N_"UO/K
MB:U;7MW9:EY'V>6>WV?OXP<@.K*5)!Y! !'TXH \]D\1^(KGPY91-JTT-[9>
M*TT6:YC1 +J,2@;F&/0C(! .#FO3]'TR72K)K>74KS4"96<37;*S@$YVY '
M[5DWG@?3;K2['3TN+RWBM+P7ZO"Z[Y)PQ?S'+*<G<2?Q]*Z500H!8L0.IZF@
M#R?2[+RO#OQ.E-U=2%+J^C EF9@1]F3D@]3VSZ<5-I4FHZ,/AU/'JUW+#J4$
M=K<6CE?)V?9MR[5 X(*CG.3WKK7\#V!?7/+OM0ABUG<;F&.5=@9U".R@J<$J
M,<YQVQ2MX*M&BT&,ZA?[=#*FTYC[+L&[Y.?EX[?GS0!S4<WB?Q;H][J>BWL5
MI?17\T5LTEZZQ1+%*5V20B,ALJN23DY;@@8%=MK6K-H_A:_UAXTE:TLWN2B-
ME6*H6P#Z''6L1_AUI?\ ;=WJ-O?ZK:17LGFWEA;76RWN'/4LN,\]\$9KJKBV
M@NK26UGB62"5#&\9'#*1@CZ8H \YU:?4K/0?"6L1ZS>M>:CJ-BEV5E_=2I*P
M+*$^ZJ]AC!QU)R:OV5[>R>(?'U@]]<FWLH[=[4>:<PEH"YVGK][G].E8OB/P
MC#X9T_P_;65[K-];P:W:216TKM,EK"KY; 5<[0.[9P.E=C=^#+*]UJ\U:._U
M"V.H0+%=P6\H6.X"@A2WR[@0#C@C/?OD YW2M5O=2\-^"Y+O5+B26\LVEN+2
MV)6XO7V#!#@KL522220.5&>QQY-?U]_AD+M=6N8;VVUS[#YIVLSQ_:1&%<XY
MP#C((SCK780?#K3+2+11::AJEO+I,30031SKO>)L91LJ01P.@&.U,/PVTK^R
M+C2TU#5$M9K[[<5\]6*R;]X +*> W/J>Y- &%XCT"6R\3^$8IM<U:\^T:M,V
MZ:< Q@P,<+M '!!QQP"1TJY+-KGBB?Q);:7=FVFTVY-G9O\ ;GB,3K&K!W4(
MWF LQ^]D8&  <D]3K?AJVUU=.:XNKN&XT^<3P7-NZK(&VE3GY2,$$YX^F*S+
M_P"'VGW>NOK%KJ6K:9<S(L=U]ANS&+D*,#?D$D@<;@0??O0!AW(\0W_C+2-&
MNO$,]J;K0Y9+O^SV78)E9%+1DKD<D]<X&0,5UNOZE+X8\%7VH!GNYM/LF<-+
MUE95X+8QU(R<>]-_X1.S3Q#8ZS#<W4,EE;&TA@0IY0B.,J05)_A'.<\5LW-O
M#=VLMM<1K+!,ACDC89#*1@@^Q% 'GFKW^IZ#X<\.^);?4KJZEGGM4OHI'W1W
M*38!VIT0@L"NW'OFI=*M]6UCQSXFM)?$FI1VNEWUH\$<110P:(.R-\O*G)&!
MCW)K>L/!5E8V]C:->WUU8:?*);.TN'1DA9<[.0H9@N?E#$XX]!BWI?AN#2M<
MU35HKR[EGU-D>X24ILRB[5P H(PHQU^M '/_ !=A,GP\NW$TT9CN+;_5R%0V
M9XU(..HP3QZX/:JVN:>[?$WPQ917UU$/[.O09P^Z7&8^C-G!]\=.F.H[#Q!H
M5IXET.YTB^,JV]QMW-$VUU*L&4@\\@J#^%4AX2@_MO3M6?4M1DNK&%X8S(Z,
M'#D%]WR9)) Z8QCC H XNR\3:M8>'[NP:^DN)T\4'18+NY<!Q$2""S;3\V"5
M#8/4'%=7H>G^(-/\2W9N[N%M%GMPT-M)>/<313 @,59T!V$'H2<'&.M-;X?:
M/-I&KZ9=RW=U;:K=->3>:ZADF./G0JHVGY1[<>YJ_P"'_#$>@AF;4]3U.<KY
M8GU&X\UT3^ZN  !P,\9.!DG P 9'CRXO=$?2_$4-Y<KIUE<HNIVT;D*\#';Y
MF!SE&(/'49STJIKNOW6GZ5K_ (BM+IO(6>&PM-\F8D/F+')-CD<,Q'0C]WTY
M.=CQ9J@6)]!71[V_GU.VDCC*6Y:W&1MQ*_11SD^WOBKD?A72_P#A#X_#$T F
MTU;9;9D;@L .N1WSSGUYH Q8K#Q)IFN/>'4K:#1WLY%FCN[Y[@I, 6652R+@
M8!W+D#'('%8VEZKJ,/B?P? E_?W%OJEK<"[N9V_=W;I$'$L4;',8SG'"@@C@
MBNBTOP#8:?8W%E<ZEJVJ02V[VJ)?W7F"&)AM94P!C(XSR<<9J.U^'EA;2Z-*
M=6UB:71]RVKR7(R$9=NPX4#&._!]2: ,SP9!JVKZCJMW>>(]2=-,UVZMXX 4
M"2QJ  K@+R.1TQC'O79:-ITVE::EI<:C<ZA(K.QN+D@N06) . .F<?A570O#
M<'A_^T3;WEY,+^Y>[E$Q0XE?[Q7:HQG XZ5'X1TB[T32'M+J]OKL&=GA:^F$
MLR(<?*SC@G(8^V[':@#>HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M0^[9''KZU%(+;PIXC\*:HFEW%AX82VNK94*.WV1Y'#*[CEEW@=^F<'%>K44
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M4<=N/2I=7CM-/M]#\1:-I5XFA0ZVU[>Y25I)@\>W[24?Y\!B>HR<9QS7K-%
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH *Q[O2;U-2EO\ 2;Z*UEG51<1W$!FCD*C
M; 92&QQG." .. :V** ,[2M+;3_M$UQ<FZO;IP\\Y38#@8"JO.U0.@R>I)))
M)K1HHH **** "BBB@!KABC!"%?'READ ^XXS7#?\*\N#X%;PO_;*>4UU]I\_
M[)\V?.\[&-^/O?I^==W10!QNH>"]1;Q))KVB>(GTF[NXDCOT%JLT5QL&%8*Q
M^5@.,Y/'XYTM:\*6^M>%?[$DNKA"&21+O.95E5P_F9X^8D$\8ZFN@HH Y[_A
M#M.3Q3IVNP@Q/8V1LTA7[I7^ G_=!<#_ '_:MVXD2&VDDE=415)9F. ![FI*
M1E5E*L 0>H(H \L^'FAR>(_A1H=C=ZC#+I7#RV\</[QMDI81L^[&-P&?E!QQ
MGO7::?X<GLO&&J:\;])%U"**)K<6^-@C!VX;<>?F.>.?:MY(TC&$15'HHQ3J
M ./B\$36,&KZ=IVJ_9](U22226W:WWR0F08D\I]P"@\X!5L&EN_ _D:UIVK>
M'M072KFSLQ8,CP>=%-;KRJ,NY3D'H0<UU]% '"_\*Y:3PWKVD7&M32'5KYK\
M3"!5,,N]7!Q_%RB\<=^E7(/!UY)XFM]<U/6_M<R6+V4T*6JQQR(S!B ,D@<#
MU/7G' ZZB@#B_#W@:^T#RK!?$ES/H-O)YEM8/ H= &W*C2]64'G&!TQTX-A?
M"UYI=SXCO+#7);9-4+7"HMH)&@F*!-XZEQ\H(7 Y]:ZRB@#,\.IJ4>@6::O,
M9KX)B64H$+\G!91P&QC('&<US,G@"[@77[/2]=-II6M>:\UH]J)3%+(I#M&^
MX8![J0?;'6NYHH Y >"KA7\+,NKAO^$?4JF^V!,V8_+YPPQ\OZ^M27W@^?51
M'!J6I17-G#J/V^'-KB:/$GF*@DW\ 'Y<[<[>/>NKHH XN/P+>V.N:A<Z/XDN
M-/TS4IS<7=BMNKGS&^^T<AY0MWX/MVQ>?PI):>)I-<T2]CLIKBW2WNH9H#+%
M,$X1L!E(91QG.,=N]=-10!CZ5X;LM,T2?3"#<)=/+)=O(!F=Y23(2!ZY/'88
M%5=&\'6.E>#/^$9E>2[M7A>":24_-(K#;R?9<*/0 >E=%10!R'AWPAJ^BB&V
MN_%-QJ.G6@Q:6TELB%<#">8X.9 O8<<@>@J?1-,C\#:)JL^HZFDMF;B:_EE^
MSE/*WDL_ 9L@=N_UKJ*" 001D'M0!Q?A:QTO5/%>J^,--WM;7D4<,,A!5)6
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M>>?:J@\#W(T?Q/IQU>,KK\TLTK_9#F(R($8+\_/ &,]_6NSHH Y1M-UVQO\
MPY;V>KLUK:1^3>0"S CG0+@.7))0C P 3DGTS75T44 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %075Y:V,7FW=S#;QYQOFD"#/IDU/7,Q+8OXRU$:J(
M6N@B?8!/C'D;1OV9[^9NW8YQLSQB@#I$=9$5T8,C#*LIR"*=7.>&?LXO]873
M-G]DB9?)\O\ U8EQ^]\O'&W.W..-V_OFNCH **** "BBB@!&8*I9B H&23T%
M9B^)=":6VB76M/,ETQ2W47*9E8':0O/S$$$<=^*TV574JX#*1@@C((KPQ(+&
M+X#/=1QVZ2KJX995 !!%_@$'V7]* /9]0UG3-)"G4=1M+0-ROGS*F1Z\GW%*
MVKZ8MXEFVHV@NI$WI 9UWLN,Y"YR1CO7G=WJFG6WC[Q1I?B36FTJ&]AA-JTI
MB2*XM_*VLH:13T<OQD?>/O3]8LK3PSX>\+>)-*6Z>ST.41,9@6E>QE.QN.IQ
ME& [ =!0!WL6NZ//:SW4.JV,EO;_ .NE2X0I%_O$' _&KBSPM;BX66,P%=XD
M##:5QG.>F,=Z\MTRUU*R\47_ (;NK=A;>)2NK,%7Y;<$_P"DQ-ZY C3/J^:]
M4D5'C99%5D(^8,.,>] &:GB70I)K6%-9T]I;O/V=!<H3-@D'8,_-R"..XJ:R
MUG2]3GN(+#4;2ZFMCMFC@F5VC/HP!XZ'K7C-O;V ^ &A2^5 &_M*$[\#.?M9
M&<^NW(^E=?J+V6F?%EW$"B)/"TS20P *SJLP(  QSC.* .VMM<TF\NS:6NIV
M<UR 3Y4<ZLV <$X!SP>#Z5$^OZ1)(+6'6=/%U+(UO$OGHQ,H )4+GE@""1UY
M'K7E6GZMICZM\-KB"^L8;)1.L=I#)O%HC6Y"QNY)+/G YQDC@5TWP_T_2YM5
M\7RM:6DDT'B*9HV,:DQXC3!']WDMR/>@#2\$>*&O? NG:IX@U*UCN;F::(RR
MLD*NRRNJJHX&<*..O%=%?:WI6F!#?ZE9VHD&4\^=4W#ID9/2O'_A[JQT>T\/
MW&MM#)HEV]Q!I]SG"V=UY\N0_.,NO1^V". 23N7&I:9%XR\7:/XGUM]+2\\M
MH1,T21W%J80NU6=3T;?P#U8X&<T =K?^,-&T[Q#9:+<7UNEW=(TF'E"A% X)
M)[DD #OSZ5/XIN[NP\*:M>V,J175M:2S1NZ;P"JENF?:N'!T[0_&G@=%GD@T
M]-*NX;=[UL.P_=;0<]R,8'7VS7:>,V"^!O$!8@#^S;CD_P#7-J &Z/KL(\):
M+J.KWT$,MW9PR-)*ZQ[W:,,V!P/4X%7O[;TG[/;7']IV7DW3!;>3SUVS$\ (
M<_,?I7GMKJVG6R> 899+:UO&T7?#J-U(1'$GE1AU5<A6<\=3P 3STKG+:[MA
M\+H2+E&2P\4K).Q('E)]L)#,/X1SGMUH ]I_M33_ +3-;?;K;[1 GF2Q><NZ
M-?[S#.0/<U7B\1Z'-<VUM%K%A)/=*6MXUN4+2@9!*C/S#@]/0UQD>IZ5??&:
MY"7=K/#)X=5 =ZLKD3N2 >C8'7'3GTKE-.ALX/@]X#NDCA27^V;-C*  V[SR
M"<^N./H* /8[[6=+TQU2_P!1M+5F&5$\RH2,XSR>F>*YR_\ $-SIOQ'@L;O4
M+>'16TF6[?S%5 C+(B[F<GIACZ#FL&QUG0X->\;Z'XON;>WDN[G>HNY/+%Q9
MM$JHJ'(SC#<+SDGO5H6]BWQ6\.0+;".*+P](8()QEH@)(PH(.3D#/OP: .Z@
MU33[G31J,%];26)4N+E)5,>T=3NSC%,M=9TN^MY[BTU&TGA@)$TD<RLL>!D[
MB#QQSS7CRWO]F>%;FY222+2K'QK.;MK=0WD0!VPVT@C:KE&Z'H*Z*[M?">J0
MZ]J%OXDGN&O;2*"\U&"6-HH?G41%M@"[@3GGG:#G&10!W\&M:5=1W$EOJ5I*
MELN^=DF4B)<$Y;GY1@$\^E6;:Y@O+6*YM9HYX)5#QRQL&5U/0@CJ*X70]3O;
M/5M;T[Q>FG7!M].CFEU:!=L<]MF0 2H<A6^^<#@@FNQT>?3;G1[271V@;3FC
M'V?[. (]G0!0.@'3':@"]1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M2AVMPH)49&< 'C%54\":II>E>%!I=Y:S7V@RS,%NV<1O'*K*R!@"PVA@%XZ
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MH 9-#'/$T4J*\;C#*PR"*KZ=I=AI%J+73;*"SMP21%!&$4$^PXJW10 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M>WTMY<:?$\\RA)FY F4=!(!PX'^T#4UQHFFW6I6^HS6B/>6P(@FR=T8/4+Z
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MA</+9WRN<]0%3'\S^=<3<Z%ILG@#XAW;VJM<6.KWKVDC$DV[+L(*?W3TY')
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M(M)GTRU?3X2IBM_+ 1"O0@=L>U.30=*CU.+4DLHDO(HA#'*N04C'\ ]%]NE
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MP:WG3YPDL9 [_,"#SP/0UW%4['2[/3C*UM#MDEQYDCNSN^.!EF)) [#/%7*
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MN:A%\3(]"=K?^S7TF2]&(R) ZR(G+9P1@GL*\TGFM(?@+=6\DD*2QZPR+&2
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M1@RL/4$=:?0 4444 %%1I<0R320QS1M+%CS$5@63/3([9P:DH ***0D*"20
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MCO<I&DBLQ')P=H^4^I]@.:33_&IU?P_HFI:?I4\DNJRM"(F8A+=DW;S(X!P
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M/FYYY^GOQ0 FI_$VQT^V;4$BMKC38[G[/*4O%^T@!]AD6''S*&_V@<<XQ7=
M@@$'(->>:!8>,_#/G^';;3[.YTOSY'L]5:Z"F"-V+8>+!+LI8XQ@'@9'6O0^
MU &5KFN0Z+%:AHS-<WEPMK:P@X\R1LGD]@ "2>P'0G K.B\62QZW=Z'?::8M
M3BM?MD$<,XD2YBS@[78+A@>""!ZC-1^-= OM672-1TKRVU#2+Y;N.&1MJSK@
MATSV)!X/K43:1>ZEXJ'B2XT^6W^R:<]I;6CR1F61W8%F)5BH   'S=STP,@$
MOA+Q;?\ BJ"TOAH$MIIEU:F9+I[E&^<-C9L^]TR=W3CZ$]57,_#_ $N^T/P/
MI>E:E;^3=6D7E. ZNK<DY!!Z<UTU !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MM3\2+XG^&WC998(!)IT-W:LT,GF1R%8=P=3CN&''8CK78>&O^15T?_KQA_\
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M"(M-EEFW[PQ7;C;G Z_A5?2/",UKXQAU^#3K;1W-M)'J$-K-NBO)#C:0H
M.X[B 3GIWKN:",C!Z4 87A34M6U/2YGUJUM8+R*X>$_9'+Q.!CE2>>"2I]U-
M;M(JJB!$4*JC  & !2T %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 445S9MAKOB#4K>]N+E+>Q,<<5
MM!</"&W(&,C%""V22H!.!L/>@#I**PM">6#4=4THW$MS;V;1F&29R[H'7)C9
MCRQ& <GG#C.>M;M !1110 4444 %%-DC$L31L6"L""58J?P(Y'X5X9'I+/\
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M:RI:0?#?0U4Q:9JMN9;O:Q F=+92B,?0DY([[0.F: /4Z;(7$;&-59\':&;
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M2,[I@C;O+;MN">,XY/K2GP7H.-+Q9R Z4I6Q9;J4- I ! (;., #![<5OT4
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M !1110 4444 %%%% !112%@H)8@ =2: %HHHZ#)H **1'610R,&4]"#D&EH
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M7S%?<0[#Y#@]SBN:;P_XC/@6\TYM"G-X_B$WRHDT15HOM D+ EAV!Z@$\<4
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M<VAW'DW4*PS7/FI_H\JIPI4$[L[3R#P!GUKJJ "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MN  .@'GR5V5 !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4V0.8V
M$;*KX^4LN0#[C(S^=.HH P_"6@2^&/#T.DR7BW8A:1EE$/ED[W9SD;CW8UN4
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
3!1110 4444 %%%% !1110!__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>15
<FILENAME>insidertradingpolicy002.jpg
<TEXT>
begin 644 insidertradingpolicy002.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MKF9_!OB";X<^(= ^SVJWFHW\MQ$WVCY%6242?,=N<@#'2M'5- \27VOZI/\
M9[&>TOM.%O:M<7!SI[[6#[5"G=N+ Y!!X /2@"U/XYN&G\*+8Z/]HC\0P--$
M7N AC(A\T!AM/'3)STS@'@%L'CTVNB>)+O6M/6WN= D*7$5M+YJR J&0HQ53
MSN Y Q5#3_#'B&!O 37%M9_\2"!XKD1W!.08/)&W*C)_B/3T!/6HM3TV_P!*
ML_'%W>PV"QZV\:62SR;U9S&L*HXQU+8]1SSTH W6\5:G;>)](T6ZTJW+:G T
M\<L5T<1A,>8I!3D@,"#QGVK/N_B.L5K%J=I:0W>FM<^2R0SEKG9OV>:(PN",
MC.,YV\\=!5T=-9T35=.EU7PO$$ 33XKQ=8-R\*,0 %1U!QD L1S@9.0*E\/:
M+XR\-HWAVW&G2Z*DKFUU%Y6$T$+,6VF/;AG&2 <@=,^E '?N6",44,P' )QD
M_6O/8O'3:?X"EU^U\.V\*IJ+VTMI#.% 8S^67R% 8ECD\#KUKT-B0I*KN('
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M*@@_,.?8\53D^(-PG@"X\4?V3&3;W;6TMM]J/:;RMRMLYYYP0* .Y9@JEF(
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M "BBB@ K.UC0=*U^V2WU6QANXT;>GF#E&]5(Y4^XK1HH SM*T+3-$1UTZS2
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M2+:JICGBFVS91T=G8X) Z!O3M7:5F:QX=T?Q +8:OIT%X+:3S8A,N0K?3O\
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M-C'!XY%>BT4 <=9^&[[3O'UGJ%M!%_9%MHJZ6A,W[P8<,&VXQC QUS78T44
M>?Q>$+ZY\2:1K<FGV^FZO;3$ZA?6DWRWL6TC:5 &XL=I.X<8.">*W?&VF:MJ
MV@+;Z.\?G+<Q2RP2R&-;F)6R\18 D!AQ^G>NCHH X&R\*ZTVN^(IKBWT^TL=
M8TV*V5;>5F,!1'7:!M (^?.>.F,'K5&#PUXMETSP=:3V6FQ'P_<Q;S]K9O.2
M.)H]X(3Y<@CC!Y/;'/IE% 'G$?ACQ+H]KXHT6PM[.\TS5WN;BVGDN3&]N\RG
M<C+M.X9Z$'ZX[3IX8UY8/ J/!9EM" ^U%+@D,!"8ODRHR><\X],FO0** .5T
M71=5TOQKX@O&2U;3-3EBN%E\T^8I6((4V;<=1G.>G;T/%FCZGJFK>'+FPAA>
M/3;_ .U3>9+L)78RX7@Y/S9YQTKJJ* .*U[1_$=CXP3Q+X;CL[OS[5;2]L;J
M4Q!PK%D=7 ."-Q'(Z5F^+?[6BU+P1)=+;SZBVKL[0QN5C7]R_P BL1DX'<CD
M\\ \>CUFZCH.FZM=VEU>P/)-:-OMV$SIY;?W@%(&>V: .4UGP++XLEU^ZU/%
MG)J&GII]LBL',2(YDWOC@DN1P#T7KSQ8DT/6O$,&@6NN6]O;C2[N*\N)HIMX
MN)(E(78, @%CN.[!&,8.<CM:* .5\):/J>E:IXBFOH84BU'4#=P&.7>0I15V
ML,#!^7/&>M9>BZ?XF\'^!KZRB@TJ2>SFEDM9)KEA'*CS,Y9_E&S"L>,G)';O
MWU-=$D7:Z*P!!PPSR#D&@"OIMS+>:59W5Q;M;S30)))"W6-BH)4_0G%6J**
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MQ]F*E(U::7()9@> !S\S=.M 'J%%>'Q)]I^%?AU99Y&:#Q(D$;1RL-J?:V4
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MF>J@+A0O3&*Z7QQ!=V^I:KJDNEV^O:(;18;R!6"W5@ I8O%G@@JV[C!R!Z4
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M06 P"K XX///TKT2@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH *S+_P_INHW/VF>%UG*A&E@G>%G4=%8HP+#D\'(Y-:=% $
M5K:V]E:QVUK#'#!$NU(XU"JH] *EHHH **** "BBB@ (!!!&0>U<Y#X!\*P1
MQQ1Z':^7'.+A$8%E5QG! )X W'Y>G/2NCKG/%7B"\T*XT-;:"WEBU#4X;&9I
M&.Y ^>5 ]E/4_@: +B^&-'22_D6T*OJ VW9$KCSAC W<\\<?3CI4#^"_#DD=
MA')I,#I8 K:ALGRE/51S]W_9/'M6C VIG5[L3K:#3@B?9BC-YI;G?O!XQTQC
MWJ[0!@?\(3X;%M]G728$A^T?:MB%E'FYR'X/4'IZ9XQ5I_#>E2:C)J#VS&\D
MA^SO-YS[FC_N$YZ=\>O-6(3J?]KW0F6T&FB-/L[(S><7YW[@>,=,8]ZR?%OB
M"\T Z,;6"WE2^U2WL9C*QRBR-C*@=3C/4_G0!/\ \(AH/]G6FG_8 +.TE$UO
M")'VQ..0RC/!!Z>F3CK4UYX:TB_O3>3VF;EH_)>5)'0RQ_W7VD;U]FR*UL@4
M4 9>J>'=(UFQ@LK^PBEM[=E>%!E/**C *E<%<#CBJW_"&^' EZJZ1;J+U%CN
M=@*^:BJ%"G!^[@#CI6[7.1^(+P_$5_#KP6XM!IGVY)E8ER?-"8/8#KZ]N: +
MI\,Z0TMA(UH2^GC%HQE?,(QCY>>../IQTJ!O!?AM_$']NMH]J=3W!_/V\EAT
M8CH6]\9K=HH P=8\%^&_$&H0W^JZ/:W5U$,++(O)'H<?>'L<BK&J^&=&UN2U
MDU"PCEEM3F"0$H\?J RD$#VZ5K9KF]'\07M_XR\0Z+<6]O'%IJ6SPO&Q+.)0
MY^;/3[HX ]>30!IZ3H&DZ$)QI>GP6@N)#++Y2XWL>I/^'05H.BR(R.H96&"I
M&01Z53TDZDVEPG6%M%O^?-%HS&(<G&TMSTQU[YJZ#D9% '-0_#_PI (@FB6V
MR*;SXD;++&_/*J3@#GH!CIQP*FU#P3X9U76(]6OM%M)[^/&)F7DXZ;AT;&!U
M!Z5OT4 8FM^$/#_B2>"?5]*M[N:#B.1P0P'ID8R/8\58N_#^E7TEE)/9J6L2
M#:[69!"0, J 0!QQ]*TZ* ,D>&=(%T]Q]D^:2?[2Z&1_+:7.0Y3.TMD YQG@
M>@J:#0].MM6N-4AMMM]<J%FFWL3(!T!YP0.P[=JT** ,>R\+:+ITZ2VE@D7E
MR-+'&'8QQ.<Y9(R=J$Y/*@=3ZTX>&M)6XO[A;4B;4 %NW$K@S # #<\X' ]!
MQTK6HH Q4\)Z)#':1PVC0BS1H[<PSR1M$C8RJE6!"G XZ<5IVEG;V%I':VD*
M0P1C"1H, "IZ* *NHZ=9ZMI\UAJ%O'<6DZ[9(I!D,*IS^&-&N+6SMVL45+(E
MK9HV:-X2>I5U(8$]^>>]:U% %>RL;73K86]I"L4>XL0.K,3DL3U))Y)/)J:1
M!+&R-NVL,':Q4_F.13J* ,2+PCH4&GV]C#8"*VMIC/ D<KKY,ASED(.5/S-T
M]3ZU*_AG2)+:*W:T^6*<W*.)'$@F((,F\'<6P2,YS6M10!E3>&M&N='N-*GL
M(Y;*X;?-'(2QD;(.YF)W%L@<YSP/2F6/A70M-OH[ZTTR".[CA\A)L$N$R3C)
M[DDY/4]ZV** ,'3?!/AK1]7DU73M&M;:^DSF6-<8SUVCHN?8"MZBB@#'U'PM
MHFK:E#J-]IT4MY$NQ9LE6*_W6P1N7V.14*^"_#B:9#IL>E0I9PR^<D*%E DS
MD,<'E@>A/2MZB@"M=Z?:7UO'!=P+/''(DJK)SAT8,K?4$ U#JNBZ?K<$<&I6
MPN(HW$BHS, &'0\'J.WI5^B@#'U'PKHFJWMO>WVGQS75NFR.8LP?;_=)!RP]
MCD<FHAX,\-C0Y=%&C6G]G2MO>#9PS9SNSUS[]:W:* ,&'P7X=M]!?0X=*A33
M)&WR6ZD@2'U8YRW0=2>@]*M'P]I;7]G?-;,UU9J4MY6E<M&IZ@9/0]_7O6I1
M0!SEQX"\+74UW)-HMNQO&WW"_,$D;.=Q4'&[WQD\^M6I?"NB2R2.;%5\V-8I
M4CD9$D0# 1E4@,N,C!!')]:V:* $5510J@*H&  , "J>IZ18:S:K;:A;)/&K
MB1-V04<=&4CE6'J"#5VB@#,_X1[2SIUS8-:[K>ZS]H#2,S39&/G8G<W'')/'
M'2K=A86VF645G9Q^5;PJ$CCW$A%'0#/8>E6** $95=2K %2,$$<$5C1>$/#T
M.C2:1'I-LNGR-O:#;QNSD$=P0>F.G:MJB@"E8:39:9YAM8B))<>9+)(TDCXZ
M NQ+$#MD\5=HHH PG\%^&Y-?_MU]'M3J>X/Y^WDL.C$="P]<9JR/#NEKJ%W?
MK;,MW>*$N)5E<-(HZ X/0=O3M6I10!@-X)\-O965FVDP&WL7+VJ$MB$GJ%YX
M![CH?2AO!/AIK:YMO['ME@NIA//&@*K(X.02 >QY Z \UOT4 9%SH%I]L.J6
MT"G5XK<PV]Q-*YVC'"GG[N<$COUZUYUI_@"*6V2WNO B6>J;</J46I!(O,[R
MJ(V##GD+M'IQ7KE% '/ZIX)\/:]):SZSID%_=6R!%GF'SL!_>(QD=3@Y')K>
M1$CC6.-55% "JHP !V IU% %+5=)L-;L&LM2M8[FV9@QC<=P<@CN"#WJO'X:
MTB'4%OX;,1720?9EECD92L7]P8/"]\>O/6M6B@#%'A'0!H]QI!TR%M/N&+RV
M[Y968G);!/!SSD<YYJ?0_#VD>&[(V>CV$5G S;F6,'+'U)/)_&M.B@ K&NO"
MFBWFI/J+V9BO7 $D]M,\#R =-Q1AN_'-;-% %)](TZ32WTR2R@>QD4J\#("C
M \G([Y/.?7FHK'0--TW<;6!U=H_*\QYG=P@Z*&8EE4>@( K2HH PO^$.T#^R
M&TG^SE_LYI/,:V\Q]A;.[.,^O/UYZU9ET+3AJ$.JFTDFO[:,I#)YS%PO=02V
M.>^>O>M2B@#@O 'A#^S_  U;P:WI4D-[%=2SM')<!XV8RLZ/M5RA8 KR1D$#
MT%='>>$?#^H:C/J%WI-M-=3Q>3+(ZY\Q<8P1T)QP#U%;5% &+!X2T*UEL);?
M3TB?3U*6A1F7R0>H7![]_7OFJ]W8/X;M;F]\-:$M]?74ZO<0F\\KS,_><L^0
M6 _$UT5% &5H&F2:=8RM<)$M[=SO=77E?=\QST!P,A0%7..=N>]7[NT@O[.>
MSNHEEMYXVCEC;HRD8(/U%344 9]CHFGZ;-YUM PE\L1!Y)7D94SG8I8DJN>P
MP.!6A110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% &+XPU&[TGP;K.H6*YN[:SEEBXSA@I(..^
M.OX5Y_JNFZ2-#^'>J6<<3SS:O8EKL<R3;U8L7;JQ+#)SWKUEE#J58 J1@@C@
MBN;B^'_A.$(J:':[(YO/CC()1'YY52<*.>@&.G' H Q=)T^UN?B=XULYXO-M
MY[.R\R.0E@=PESUZ?A69X3A62W_X0&]B62;1]09YV= ?-ME(DA<^[%D4^H#U
MZ%;Z'IMIJMQJ<%L$O;A0LTH=LN!T!YQ@=AV[58CL;6*_GOHX$6ZG1(Y90/F=
M4SM!^FX_G0!YQ=W,^B^,/B#?:>K-<P:+!<1*26'F!92, ]L@<5GZEI^E2>$?
MA]J]ND<EU-J^G/)>=9)F=LN7;JQ+9R#T(]J]/AT/38-6N-4CM@+VX4)--O8F
M11T!R<$#L.U92?#[PG&,+H=KL$PG6,@E%?U52<+] ,4 <DMBGC6^\7Z=J%[8
MP7=K>M$AGMB\]I"$7RY(F\P;!U;('7.<TZ+2+/4?B9IEM>SOJ4$OAC=*\A8+
M<D2H-S)G&#U(Z=/2NQU3P3X9UK4H=1U'1;2XNX@%61TZ@= 0.& ]#FKSZ%IL
MFKC5FMS]O$7DB<2,&$?]T8/ SSCUYZT >36>H/I_A/2](:5X])D\63:;*2YP
MML)7*Q$]E) !]LCO7566FV.F_&^1+&VBMEE\.[VCB4*I/V@#.!QT _*NF'A'
M0/[*NM+.F0O8W;F2>!R65W)R6Y/#9YR.<TEAX1T#3+Z.^M-,A2[CB\E)VR[A
M<YQN8D_CUQQTH Y[XEVR3R^$@TDR>9KUO"QCE9#M97R.#UX'/7TKFM7M9_ W
MB?Q(GA2-X;:3PY)?/;*2R17"OM60 YP2NXX[[377_$#1[W7!X?AM=,DO8;75
MH;NYVR1IMB57!QN8'/S#&*Z6QTJRL/.:" B2?!FDE=I)),# #,Q)( Z#/% '
MG.KVMO8^%O"&O^'U5=2>ZLT$\?W[M)<!UD/5\Y+'.3D9K:T6%+CXH>-X9 2C
MVVGJP!(R-DG<5T5AX7T73)HY+.Q6+RF9X4WL8X6;.3&A.U"<G[H'4U+'H&F1
M:A=ZA';E+N\4+<3+*X:0#@ G/;MZ=J /*/#^I"V\!?#RTOI2NE7U_-%>LY^6
M0YE,:.>ZL^,@]<<\9KM+WP+H=[:>(M'M9GB;4%28VZD".SDVE5DC4 ;"2,GG
MG'H:V_\ A$= .@-H1TN!M*)S]E;)13G.5!/R\\\8YYJ!]._X1'P\8?"?AZ"X
M<2*?LBSB'?D@,Q=LY('KZ4 <WX1OAXL?28;RSCBN/#R,M]%L "78)B4#MC"N
M^.VZ,UV6CZ7I>FF_.F*H-U=O<7.V4OF9L;NI.#P.!C'I3/#^FRV%I/-=1Q)?
M7L[75T(CE0[8 4' SM557.!G;GO4.@>&[30;K4[BU@BMS?S^<\41)4'GYN>K
M$DD]!T';) -RBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***QKC7I!>SVNG
M:7=:@UN0L[Q-&B(Q .S+L,M@@X' R,D4 ;-%5--U*#5+,7$ =<,4>.1=KQNI
MPRL.Q!_Q&00:MT %%%% !1110 455U*Z>QTRYNXXA,T$;2>67V[@!DC.#VKG
M?^$WC.D^&-3%@_V?7IH8$'F#="TBEAD8Y& >AH ZRBN+N?'EVMUX@MK/PY=7
M$NB%3.&N(T#*4WY!R>=O0#/OBM%?%9O8M%;2M/DN3JMJ;R-I6,<44853\[A6
MPQW@ 8/>@#HZ*XEOB-;_ /"+:9KD>E74D=[?"Q:)73,,GF&,Y.?F&0<8'/'2
MKMGXOGEUC4])O-$N+:^M+5;R*(31N9XF)7(.0%.5(()_$T =317"V/Q':[LM
M U%]"N8=,UB>.V2Y:9"4E<D(-G4J2,9X^A&"=B?Q--+<:I%I&F_VA_99"7/[
MX1EI-H8QQ\'<P!&<[1D@9ZX .BHKE+;QW97T_AIK*!IK/7_,$$^_!C9$+,KK
MC_9(X/4&H[KQT+.W\4/)I4SOX?VF9(I5/F*8_,W G& %Z]_K0!U]%<G9^-99
MM;T>QNM&GM(-8A:2SN&E5MS*@<JRCE?EY!/7T%+/XSD^QG4['2+B^TI;O[*T
MT#%I6(?RV=(PIW(&R,Y!X) QR0#JZ*Y'7/'EKI+:F(([>Y.F#-TCWBQ2$[0Y
M6-2#O8*0>PR< DY LQ>+K?59+&VT:!;V>]LA?[99/*2.!N 7.&())P  >AZ8
MH Z*.:*7?Y<B/L;:VU@=K>A]#3ZX'X4@+I7B$"U%IC7[S_1QC$7S#Y>...G%
M)XNOIM4^('A[P<)'CL+F*6]OPC%3,B [8\C^$L/F'<<4 =XDT3[MDB-M.#A@
M<'TI]8&H>#]'NX+<6UE;V4UM-%-#+;1B,J8W5PIVXRIVX(/'X@5%<>*97.JM
MI.F'4(M*<Q73"8(S2!0S)&,'<P!&<E1DXSUH Z2BN0?X@6DLOAW^SM/N;Z#7
M4D:VF1D4 HA8J03G/&#G '//%5X_'>H2Q:Q#'X9G;4=(?%W;_:D"!"@=663^
M(E>@QVYQQD [>BN.G^($.?#GV+2+R[&O0--;%&1<$1[]IR>#T!)P!R<\4RS^
M(2R66N"^T2]M=4T8I]HTY")G</\ <*%>&!]>U ':45S=MXIF;7;_ $6ZTTKJ
M%K9I>*EO.)%EC8E<!F"X8$=#^=9%E\2&N]/T+5'T&YATO5KA+9;EID)CD=BJ
M_)U*Y&">/Q') .[HKG].\2O>>*]4T">Q^RS6,23J[39$\;D@,@QT!!!ST/'-
M7]#U.36-(AU![80+-EHU\S?N3/RMG X8<CV(H NSW$-K"TUQ-'#$OWGD8*H^
MI--ANK>Y)$%Q%*5 8A'#8!Y!X]>U</XEO-1?XF^';!;&*>T^SW<JQ//A96"H
MNXC:<%0S =?O'I2Z#<Z'X=O_ !79:-X8:SDTF.&6?RF3=<AP[K@EN !G&3QG
M&!C% '>T5Q-E\07N5\.W,^AW%OIVN%(H;EIE.V5T+*I0<X."-W'3IC!J?5?'
M)TJ"_OI-*E_LVPO4LIIGDV2,S%1OC0KAT!<<[AG!P.* .OHKE[WQ=<P^*I_#
MMGH=Q=7D=D+Q&,R(CJ7V]23@9!Z\^W>F:?XYM=1\/Z9J$5I*MWJ-PUI#9,PW
M"9"P<%NFU=C$MZ#ID@4 =3)(D4;22.J(H+,S'  '4DTJ.LB*Z,&5AD,#D$>M
M<CJ'B4G0_$J:OX=N&73(3]HA!#PW431EB8W8*&&,@C&1TP::?&$6G#PM86FA
M3LFL6I:V2%T"Q!8=X3DCH,#/  Y[8H [&BN1MO'MLFBZ]?:M8RV$NAR&.[@#
MB4_=#*488!W!ACIS4Q\6W,'B/3-%O-&D6?483-"\-PCJJKC?OW;2"H(.%W9'
M3- '445S>D^*7UIK6>RL4ETZXN);?STN,O$4#\R)M^7)3'4GYAG%=)0 R2:*
M$H)940R-L0,P&YO0>IX-/KF?%>I6-CJ'AZ&_TC[;]IU*.*VF;;MMYB&(?GG.
M W0?C52X\;W?]JZ]IMCX=N;FYTA8W?=<1HLBNK-D')QP.!R3GG&* .QIDLT4
M$32S2)'&HRSNP  ]R:YVV\8VVHV.B2Z= TUUK,!GMX)&V;$"@LSM@X R!P#D
MD8'<<K\0=1_M[X4>(7O=)EL[FQN%A*3ID;UE3]Y$Q W*0>&P.] 'I]%8;>(2
MGC%?#C6G[R2Q:]BG$GRD*ZH5(QD'+>_%9]MX[MI=$N+^6SDCFCU)M+CME<,T
MUP'V!5/ P3SDXP 2: .I,T0F$)D3S2I8)N&X@<$X].1^=$4T4Z%X94D4,5)1
M@1D'!''<&O/+9K@?&_S+G3(K>X/AZ0DP2B03?OTQ\Q"\CIR/3G%2VGC73M'\
M#3ZY9>'9;>U749();:)D!60S;"[8]6/;- 'H-%<WI_BF6Y\5RZ!?:3-83FT^
MV6[O*KB6,,%.=OW6!(XR>O6LV3XB1KHMAKD.E2W&E:A=BTMY(YE$K,7**Q5L
M *S*>=V1D9 [ ';44Q78PAS$P8KDQY&0?3KC/XXK@Y/B9)'HE[K)\.W8L-/O
M7M;V1IXPT05PA8#G<03R!Q[GG !W]%<WK'BZ#3K^;3[86DUY! L\B7-XMNN&
MSM4$@Y8[3QC XR1D9S[#XAVNICPW<6MC)]AUUGBCN)) ODRH&)C<8/)VD#!Y
M([4 =I17*VGC(W!\21S6"P3:$<31F?<9/DWJ1A> 1T[Y[5TMK)++:Q23P^3*
MR@O%NW;#Z9[T 2T5Q.M?$BPTF"\O$C@N+.QN#!<;;M5GR&VN4B(^8*<@Y()P
M< CD[#>(VO+^:RT6U2_FMX8YIV>;RHT#C*+G:26(YQC !&2,B@#>HKB[3X@Q
MW>C:!J@TR5+?6-0-@JM*-\+[W4%AC!'[LG@_GUK4A\2&?Q!K.BG3G>;3X(YQ
MLD4B=9-V -V,'Y3G)Q[T ;L,T5Q$LL,B2QL,JZ,&!^A%/KS(^+)+?P/X2N_#
M.CP65CJ>HP6RP&0+Y2-*?E "X^;:03VR>M=7;^)IV\8+X=O--%M,]G]KCF\_
M<DB@A65?E&2">>G'- '145FZ-J<FJP7$QMA#%'<201L)-WFA&*EAP,#(./I4
M%[KICUM-%L+=;K43;FZ=9)?+2./=M!9L,<DY  !Z'I0!LT5Q%U\2+6U\,WFK
MG2[II;"\%C>VFY=UO*75>3GYE)8$%0<@UTNCW]_?QW+7^D2Z:8YBD2RRI(94
MP"'^4G'7&.V* -*F1313*6BD2102I*L" 1P1]:QKW6S+K$^B:?91WUU%;B:Z
M667RXXT?(52=K99L-@8Q@<D<9XOX?:]::#\/;4S1I!)=:I=06]O)(L85O-D;
M#-T4*JG)YZ<9) (!Z;++'!$TLTBQQH,L[G  ]233P<C(Z5Y+XV\4V/B?P!XQ
MTR:V@%]I44;MY<JSQ,&(*21N ,]P> 1750>-)[?7[#2-3T*ZL(]01A874DJ,
MLSJN=K!2?+)'(!H ["BN1\#:]JVO+K$NI6L,2P:E/;)Y<VX)Y9";0-HR."=W
M<GH*V=8UR+2I["S6(SWVH2F*U@#;=Q52S,3V55!).#VP"30!JU#]LM?M?V3[
M3#]IV[O)WC?CUV]<5AV'B>2\U34M%DL!!K-E&LOV<S9CFC;HZ/MY&<@Y4$'M
M7G^C_:;_ .$S^(KG2X)=3LQ?7MO?&X(D67=-N?@9XX&TD@X'3 H ]<BO+6>>
M6"*YADFB_P!9&C@LGU':IJ\XT6XTO2-#\+ZI?:=:0:S-8I:V<K7(021F)79I
M'(  XR<ACD\9)JQ-\4;6#0M=OCIKS7&BRI'=0VUPDB$/]QUDXW*?ID8/% '>
M2S10*&FE2-2P4%V !). .>Y-/KAO$'B/;IP?7?",S6G]I6\-OYTL3!BS+LE(
MR2I!/3!-:%WXNNH_%%WX?LM"N+J\@M%ND8SI&DBLQ7J2<#(/7GVQS0!U-%<E
M;>/;.Z\+:3K"6LJRZI=+906KL 1.692K-T !1B3Z#IGBC_A.5M]0UVRO]+GA
M;1;;[5=2Q2))&8RA=2N2K$D*1]W@C\: .MHK&TG6;K49H1)91+;3VWVB&ZM[
MGSHV&0-N=HYYSW'H3SC9H **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "N=B.HZ%=7L46DSZC:W$[7$3VTD09"_+*XD=?XLD$
M$\'! QST5% &5H5E<VL5W<WJHEU?7)N9(HVW+'\JHJ@]R%1<GN<UJT44 %%%
M% !1110!7O[8WFG7-J&"F:)HP3VR"/ZUYC!H7BM_#7@[2WT%(I-"U&W>=FO(
MR)4C1UWKC/'(Z\Y/3J:]6HH X.WTC6(]5\=7+:7+LU9(Q9XFB^<K!Y9S\W'/
M//;WXJA8:+XFM+/PG97&D"\TZRT[[+>637,:JMPH4+(_)#I@' YQG.,@5Z71
M0!Y-!X5\2P>"['2'T=/.M=>%[^ZN8R&B%P921DC'!  Z^H%=+-IVJ_\ "Q;W
M6ETN9K*315LD82Q9,HD9\8W],-C/K^==I3)9HH(FEFD2.->6=V  ^I- 'F,/
MAG7X?A_X/T@Z4YO-*U&VN+E!/%@)$Y8D'=SD'@?GBMK2--UCPMX@\0-!IDFH
M:?JMS]O@:*6-6AF90'20.PXR!@KGCM7;T4 >91^"]5\-Z1X-;3[5=3N-%N9I
M;J"*58R_G*^\H7(&%9^ <9 I+GP_XDN8?B!OTE VNPHEH$ND/S>0(\'., 'J
M?8X!ZUZ=10!P<^D:Q+JW@6Y72Y?+TE)!>9EBRA:'RQCYOFYYX[>_%5_#-AXO
M\,13>&8=+@GTY;B5[/5C<J!%$[E\/']YF4L>!P>F0.:[I=2L'D,:7MLSK((B
MHE4D.>BXSUX/'M5J@#@4M?%?ACQ5J[Z7H\6L:3JTXNU)NU@>UF*JK;MP.5.T
M'@$BG3Z5XBT;QU%XBM[(:M%>:>EG?Q02)$\4B,6#H'(!7DC&<]^:[RB@#D?
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M0U;0;S3;C[)J$TKZ?,?XGM9$8RCCNH7<IZ CWKMHHHX(4AB0)&BA551@ #@
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M(5@Q)4C!P0#6CXGT35M>\%%"(4UV"1;ZT$;?+%.C;T0,<9X^0L<9R3Q76T4
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MK>J0WGV<2H!#'&\9568G&[:A)QGEL=!FO38V+QJS1M&2,E&QE?8X)'Y&G44
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M,UNKG&#TW<XZ5ZE<^'M*O+NQNIK4>=8#%H4=D$/&#M"D <<?3BJTG@_0IAJ
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M.U2W) ]3U.3QG%;5 !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%9%WX@C@O9;2UL;V_F@QYXM44B
M+(R S,RC."#M!)P0<<B@#7HJKI^H6VIV:75JY:-B5(92K*P."K*>00000>1B
MK5 !1110 4444 %&<=:J:G>2:?I=U>16S7+PQ,XA5@I? SC)X%>7:UK,^O>!
M/!NN:A:30SMK%A*2,$.&?)V*A)(] 1GCI0!ZY17.:?XPM;K4-4L;ZRNM+GTZ
M!;J07>S#0'.) 49ACY3GN*C3QM:#5M,L;JRNK5=5!^Q3R%"LC ;MK ,2A(Y
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M'L83I&)9')'383\@P>3C)(XXKI)HQ-!)$20'4J2.HR*?10!Y;9Z'K<7PON?
M<^F2F^5'LXKL ?9WB9R1-NSQA3ROWLC@5LW^F7EMX[\)R6]C=3V&EV=Q;S7(
M (4NB!.,Y/W.<#O7<T4 %<%XBM]=OO$>I64VDW-]I4VGA=/\J5%A68AMYF!8
M$G[N."!C@9KO:* .<\!6][9^!=&L]0LI+.YMK2.!XI"I;*J 3\I(Y(__ %=*
M?XPL;?4](BLKW1WU2RFG5;B*/[\2;6(D7D'(8+TYP3C-= "",@YHR,XSS0!X
MYK]AJVC_  \U*WN9[V\L(]8LSI8O6'V@Q>;%\K$]MV0N[!QUQ75ZMHDWBWQ3
MI][]GN+.TL+&[B,LR;'>2= FT+UPH!)/3)&,\XZ'Q%X>MO$VGI8WD]S% LJ2
MX@902R,&7)(/0@&M5%*HJEV<@ %FQD^YQQ0!YQX/@UBSMK#0=1\&0PWMCLB?
M5=L1MWC3 $BG[Q<@=,=3DXI_AO\ X2;PJ]]X;_L">\C:\FFL-221! (Y'+_O
M<G<"I8Y !)[>M>C44 <3/9ZJ/BC/J=O8R&#^POLD=RX C,XE+@'G.,8YQBN:
MM]/\175SX0U.\\.Z@^IV5XQU*>>:(LS-&ZY3Y\"($YP, <8!->MT4 <?X;L[
MVW\>>+KRXL9X;6^DMFMIG VR".((W0Y'/KC-=A110!Y?8Z/K"?#_ %;P@^DS
MI?7<UU&L[[3 (YI&(DW@] K9V_>R,8[UKC2+RR^(NC2V]G/)I]EHSV)NB!M#
MED*YYST7D@5W-% 'D+Z?XGU"T\.WFH^';Z;6K#6DGOIFEB(9!Y@Q"-^!'@K_
M '1P.IR:VM(/B/PGKNMZ<OAZXU.TU*_DO[.[@E0(AEP624L05"GN 21T!KT2
MB@#R_P 4>%-4U_QRMT%NK=K?1T2WU*%<(EXDWF+\N<E?8@CGUJSJ<7B3Q!HW
MAW6I=%FMM9T:]2XN=/+KB=<%7\MLXS@Y )'I]?1Z* .,_LBXUWQNFO&VFM+6
MVTR2SC^T+L>221LGY>H50.^,D\=,UR5MIOB+_A"_".C'PW?"YT75;5[DL\05
MUC9B6C.[YACG)P.0.:]@HH XW2+/4K#XD^(KF339C9:I':O%=!TV)Y<95E;G
M.<XP #7944A&00"1[CM0!Y=X>N+A],\>Z=;Z;<7,]SK5]'!M4>6[,JKAFSA0
M.ISV/&3Q3#X:U+P;J>D7,6A_\)%IZZ1#IMU'$J&6*2(DB1%? *G<1BN]T+P[
M;^'VOS;7-S+]NNGNYA,5/[U\;F&%&,X''2MB@#SW6['4[G_A%9H= : 6VKK>
MSVUL$_T>+8Z_,00&;Y@2%SW SC)TO$5G>W'C_P (WMO8SRVEBUT;F9 ,1^9%
ML7J<GGTSBNPHH \YTC3M7\.Z/XB\.R:7<7GVFXN9=/N(]ICF2;)"N2?D*DG.
M>W3-5=/\.:MX&\0:%?064^K6*:*FDW0M<&2*17WB0*Q&5))'M7J%% '&^ K3
M4K.X\3-J&F7%FMYK$MY 960[D944?=8\_*?;T)KKY9/*B>38S[1G:@R3["GT
M4 >1V6A:W!\-_!VER:/=_;=.U>"XNHAM)CC25G+9S@\,.AS75V5I>_\ "U;_
M %)K&X2PFTN&V2X8 *9%=V(QG/1ASBNQHH *X.]\'W%WXUU.)XU;PWK$$<]\
MF?O3Q@H% [;@48G_ *9^]=Y10!QO@;2=5T7P](=;#37L"_8XM@RSV\)98C]6
MR6_X$,URUMH6MP_"SPOI#:/=_;['4H)KB$;<HB3%V.<X/!'0UZW10!P-YHM]
MJOCO7F:TN(;#4-!&GI=E1M$F7)XSG@..W:I/!M_XF@TS3O#^H^'9K6XL$2">
M_:1&MY(T  9,'<S, .,#&<D\8KNJ* /+3I&KMX,\?V/]DW8N=5O[J6SC(7]Z
MDB*JG.<#E3UQ7HFC"1=#L$EB>*1+=%>-Q@J0H!!J]10!D>*-$M_$7AJ_TJX?
MRTGB.V7IY3CE7'^ZP!_"N3L_#^J>*?A7?)J4T::SKEH'>09"@A (QZA2%!(]
M7:NJUWPS9>(9;1KV>]5+8MF&WN7B28, "L@4_,O'0^I]36PJA5"J  !@ =J
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M'&YBS$DY+,QY)))))Y))- %JN*T^VOK7XB>)]2DTZZ^QW-I;1P2A01(T8?<
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M,%U'/7G\=J@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH *Y_4O"%EJ&KMJL5YJ-A?.BQRRV5R8_-5<[0R\J<
M9.#C/-=!10!3T[3;?3(&CA,KLYW22S2&220XQEF/)X'T'05<HHH **** "BB
MB@ HHHH **** "BBB@")+:%+B2X6,>=( &<\D@=![#V]R>]2T44 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MG#R*Q=E)!R6 ( .UCD'L*[FN<L/!]O8^(UUYM3U*YOC:BUE,TJ[95!)!954
M$9/ P.^,\UT= 'F<&CW>L_$3QS!;:U>Z7C["1)9A Q;R#C)8'Y1Z#&?6LZS\
M1>(]7TKP4\NK2VMQ>:C/87K01IMF\L2#S!E>"=F?[N>QZ5WLOA2/^W+_ %:R
MU.^L9]01$NU@,9638NU2-RDJ0.,@C\ZBN/!.G2KHB6T]U90Z-)YEK%;E-N[!
M!+;E8G()SSSDGKS0!B1-JC:_-X474;R[6PL(YVN'NA!/,TCR88LJ\A JCC Y
MYS2QR>(;2QT#3_$&L1R7IEF2X@T\GS[X!<Q[6 79@$%S\HZ<C/.SXA\%6>O:
MK:ZM'?ZAIFJ6\9B6[L)0CM&3G8V005SSTZTVY\#64TVDW$.H:E:WFF^9LNHI
ME:2428\SS"ZL&W$9Z<=L4 <IIWBW54\-V]K<74JW%QXG?15N9=IDBB#MC)Y4
MOM7:#SR0>:W/$.F7^F^'?%QDU9[G39])F:WM9R7DA<1,'(<G)4Y'!Z'TJ8_#
M71'T74M*EGU"6WOKQKT%[C+V\Q.[=&V,@YYR<GU)JW%X,B&B7VG7>LZK>R7L
M!MI;NXE1I1$0057Y=J]3DXR>YX& #E=+FU+1Y_A\Z:M=36^IVZVUQ:.%\D*+
M;>I4 9!!4<Y)->H5S+>"[5AH .I:A_Q(\?9>8OFPFSY_DY^7CC'YU/X?TF]T
M[5-9GFO[^XM+N<2017DH<Q'+;MF/NQ\J O\ LD]Z -^O,K?6-5U[X;:CXQM=
M3N+6_B^TW%M"I_=1QPNP$3)T;<J<D\Y;@@8KTVN6'@6QCCU&TM[V]@TO49&E
MN=/C9/*8M]\*2NY5;N 1U.,4 <V-0UCQ-XJTBVAUJ]TRSU3PX;YH8 F89"T?
MW25SGYNISQG&,\>DV\30VT43RO,Z(%:5\;G('4XXR>M8S>%K;_A*+;7H[NZB
MFMK4VD=NGEB$1$@E<;<]0._:MV@#F_$]Q+'J&CVZW[Q0S2R"2SM@?M%WA#M5
M&&-H!P6.0,8R1WX6Z\0Z^/AEK5VFJ74%[INN-91R.$9S$+A$"N<') 8C*D$X
MZUZ#KGA>WUO4]-U+[;>V5[IQD\F:U902K@!U8,K @X';-9,GPVTQ](U+2QJ6
MJK:ZA>_;95\Y6*R;P_!93QN4'G)XZT 00G4;'XE'19=9O;JSO](DN6$I4&*5
M9%7,>U1M&&Z>U9^DZOJG]E:CX6O-2N7\20:D+1;HL [Q.3(DP&, ")7.,8RA
M!ZUU5UH$$.OIXGDO+^6YM+-X!$BH5>/AF&T)DL2H/!Z]*SM AM/$7BAO%Z:9
M<VFVR6S@:[A,4LF6+,2IZ < 'OENV* .O1-D:H"QV@#+')/U-<OXJUJXM==\
M-Z';RM;C5[F199T^\L<<9<JI[%CM&>H&<<X(ZJLC7_#MGXBM[=+EYH9[6=;B
MVN8&"R0R+T9201[$$$'TH X_4;S4+'Q'KWA=K^[EL9M#?4K68R'SK9E8HR!^
MI!X().1SS6&]K)'\,/AUY=U*9)M2TQE:0[Q&2O8>@]*]*MO#EM'/>75W-->W
M=Y +:6>;:#Y0SA%"@!1EF/J2>3TQD)\/;)-&TK2_[7U5H-+N8KFV+21DJ8_]
M6OW,;1],GN3Q0!B3Z_J7A/5O&,#W]SJ<%CI,>I6XNRI9)#O!7*@?*2H..W:M
M2SL_%']J:1J$&HJ=/EC(OQ/=^8)@RC8\2[,(P/88!!QBM<^$;*77=0U6YN+F
MX:_M!9W%O+L\IHAGC 4'^(]^]4_#_@*U\/21B'6-7N;6WS]DM;JX#Q6V00-H
MV\X!(&[.* ,KP%'K&KB35+_Q%?S"SU*\MOLY6,1S(KE5WX7J.HQ@<=.N?0:Q
MO#GAR#PU:W-O;7EU<1W%P]RWV@H2KN<MC:J\$G-;- !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%4M7-\-%OCIFS[?]GD^S>9]WS=IVYSVSBN.\(ZXFKZI-I[W>KZ;JT5F1=:
M;?\ S.K[E_?1E@59>HXXY' SR =CI-]-J6F0W=Q87%A+)NW6UQMWI@D<[21S
MC/7O5VO*].\2ZX?A)H&JRW<LDMQ?K%J5[@;XK<W#J[CC P !G' .>U:NGRZK
M=>)_$,=CKEZVAVUK&UK(ACE19F5MZB1U8OC"G[W&<&@#OZI17TTFL7-DUA<1
MPPQ(ZW;;?+E+9RJ\YR,<\=Z\PT[5-=C\+^!?$,NNWD\^H7UM:7,#[?)>.4L#
MD8SNZ'.?R'%=5IUU?S_$CQ)I4VHW#V:6-O)!'\J^27+@[< >@Y.30!9O?&9A
M$LNGZ)J.JVT-TUG))9A6(F7@C:2#M#?*6Z ^W-=%93O=6-O<2V\EM)+&KM!+
MC=&2,E3CC(Z5YCX6AN;+X>>*[ZTU.\AN8;K4FC;<K!61V(;#*1DXY/N:U-,U
MV\U*3P;HLUY+']OT87]U.K;9)V5(QL#=1DLS$CG@<]: /0:*XF^CU71='6UO
M/$P8/JRB-Q$3</;,<BW7&2TAP1OZXR>,9K!DUS6HM ^(44=]?6LFC_O;-IF2
M2:(& 2;"WS C/?).#UH ]4ID<T4KRI'(K-$VR0 _=; ;!]\$'\:\]@NM6T_Q
M/X,:36KNZCUJWE2[@EV^6"L'F*R #*D$=223WJ?X:6C13^*9&N[J8IKUU#B6
M4L"!LP3GO@8SZ4 =]6!9>*$O[_7[&'3KL7.C; \;;,S%D+J$PQ'(QC)'7M5/
M7M6GD\::)X9AGDMXKN&:ZN)(SM=TC  C5NHR3DD<X7@C-<QIT-UINK?$\6VH
MW*W$"02Q7+;7D7%MN498$'' R1G ZYYH ]*L+B2\T^WN9;:6UDEC5V@EQOC)
M&2IQQD=*L5YM+KNKV_@_PAJUQ;ZC?Z=+IR2:HU@Q^T!VB0K)@$,R@[RP'J#V
MQ45YJ]W>0^"GT;Q1<S6>I7LL,EPJ)F5-LC G*Y#KC&.@(Y7C% 'IU%<'IXU'
M2?B'I^@2ZU?7]J^C33R-<L"SR"90K9 &"%;''IZUSUUKVO)X(U.ZAUFX2YM?
M$S6,<C*K9A^T*@5N,X /8@^] 'KM4+_4S;:1<WUE:RZB\.X""V(+R,K;2HR0
M,@@Y^AKC&&LZ%\1--TB;7;[4--UVUN-PGV![:6(!BR%5&T$-C&.*YO2YM0TK
M]GFXU:PU:]@O$2:19-X?!%PX.-P.,YR3USWH ]E4ED5BI4D9VGJ*6N-DU6?5
M/'T?AHW$T%K!I(OI3"Y1YG9]@&X<A5P3QC)(STP>3UCQ'X@L_"GBVS759UO-
M"U&"&"]"INFAE=,*_'+!7()7!/'OD ]>HKB+:74M*^*$&ER:M=7MG?Z9+<O'
M<;<1RI(H!3:!M&&(Q7;T 8LOB.*'Q?;>'6M+@33VKW*3G;Y952 0.<YRW<"M
MJN)U,X^,>AGTTB[_ /0XZQ8M:U;6/A9=>.+74IX-0C6>\BA#9A6.)V_<LG0Y
M5,$GYLG((X% 'J%%>8Z[XJO(?)U'5$U2PT2^TV&2VO['++8SN"6,RCD_>3!(
M(XZ9)J?Q3X@N-+O?/OYM1CT">QC%KJ^FDNEM,=VYY57D@@H02"O'3DT >CT5
M!9R+-8V\J3+,CQJRRJ<AP1]X'T/6N7^)E_J.E^"Y[[3+Z2TN8YX%#(JD,'E1
M"#D9QACT(/O0!U]%><WMYK/@_P =Z8DVL7FJZ;JUO=--!<*F89(8_,W1[5&
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M2/'%,NWRT*H6(;G.<#T_&L3X=?>\6_\ 8QW?\DH\8?\ ([^!?^O^X_\ 2=Z
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M,M;Z?Q-XP\2:2U[=6EMI @BB6VD\MB\B%S(3U..  >.#D'-<K_PDWB*_\/:
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M;?S'B7SV7<S*=IX4GC(/Y4 <OKWAZ#PSX1TC0;>37I-+BOO-DO;0"2>T +2
M[43+ N1_"<9SV%6?#UI>7=VRV7B3Q!?:9+"Z3OJ5JL>PD?*8R\2DM^!7&<\X
MKLKZZO+>XLH[73VNHYIMD\@E5/LZ8)WD'[W( P.>:S]5\0RVNIOI6FV(O]22
MT-XT#3>4/+#;0 V#\S'( QC@Y([@&>/ %BN@Z/HRZEJ0MM(N8[FV(:+=N0Y3
M<?+Y R>WUK2M_#,-MXDOM=2_O#=7D"02(QCV!5SMP-F<C)[GKS6EI]T][IUM
M=26LUJ\T:NT$P >,D9VMCN*Q+7Q<MQXVG\+2:;<P74-O]J\Z1D\N2+.T,N#D
M\G'3CF@!MCX*M;#0-3T:/4]1:VU%IGE9S$74RYWE2$P,Y/8XS4%]\/M.O=(T
M>S6_U"WN=&4)8W\,BK/$H4+MR%VD$  @CG%:][K3VFOV&DII\\[7:/)YR,H6
M)4*ABP)SCYEZ \FM:@#EKSP+97NFVEN^HZDMW:W8O4U 3*9S,!MW$E2I&WC&
MW& !BH7^'FGNNNJ=3U7&MQK'=YF4YP@0D94X) _#MBNOJ*:YAMVA6:14:9_+
MC!_B;!.!^ )_"@#"?P?;R7>A7+:C?^9HJLMMS%ALIL._Y.?EXXQ^=3Z1X9M=
M%U34KVUNKLKJ$[7,EL\@,22MC<R@#.3M'4G';%;=% &#XB\*6GB&>PO#<W5C
MJ.GN7M;RT91)'N&&7Y@05(Z@BJD'@:U@DUR4ZKJ<DVM1K'=2.\>>$V94;, X
MSVQSP!@5U-% '.VOA-;"VTF&RU?4(?[,MC:Q']VV^,[  X*8.-BX(P>OK5?_
M (0+3E32%@O+Z :7<O=Q>68_GE<L79\H<YW-P,#G@#BNJHH P=9\+0ZMK-CJ
M\>H7MA?6D;PB6U9!YD3$%D8,K#&0#D8(KBO&GA:U\/\ @FZL;"?4)C?ZQ%>,
MA8RNA,ZLY7 S@#G)STY->IT4 8]EHD(U./6+B\FO[I8##!+*$ CC8@MM"J!E
ML+D^PZ"L@?#O3E\*WOAM=1U,:;=,Q\OS4)B5G+E$RG W$\G)]ZZ^B@#G[SPG
M;W6H:?J<=]=V^J6,1@2\CV;Y(SU1P5VL,\]!@\C%07_@;3M1\/W>D2W5XB7M
MP+F[N(V02SR!E8%B5('W5&  , #I73T4 8<GAF&7Q+:Z\^H7IN[:V:V5?W>Q
MD8@MD;,Y) /!'2F^$=)O=&TF6UO+^^O 9V>%[^42SK&0.&8<'D,1Z!@.U;-O
M<PW2,\$BR*KM&2O9E)5A^!!'X5+0!C7'AN"Y\56GB!KR[6YM8&@2)2GEE&(+
M @KGD@=^U9R> ]/BM[ZPAO+R+2+Z5I9].5D\HECEU4[=RJW=0V.3C&:ZJB@#
M!OO#"7LE]MU*\M[>^@$$]M&(S&5"E?E#*2IP<9!]/05'+X0@,4]O:ZA>VME/
M:)9O:Q[&C\M5V#&Y20=IQG/IZ"NBHH YF/P]-9^*-,N-/O+Z#3;.R%J]F9@;
M8HH(0!.N_.WYO1<=ZS?BTAG^']U:QK*\TT]OM2%2SD"9&8@ 9X )_"NXHH Q
M;30X'U&#5[F]FU&XC@:*WDF"!8T?!8J%4#+87)]!@8YK.MO 6G6M@VE)=WAT
M1IO.&F,4,2G=OV [=^S=SMW>W3BNKHH Q)?#%K)XJ7Q"MU=Q7)MUMI8HW CF
M16++N&,\$GH1GH<BLK2?AUIVC7Q>SU+55TWSO/32C<?Z*CYW<+C.,\[<XSZU
MV%1&YA6[2U,BB=XVD6/N54@$_FR_G0!SR^"K5(]?0:EJ&-<)-UDQ<978=GR<
M?+QSG\Z:_@>R:+0574-1CET2-HK::.1%=HV0(48A<$%5 R #QD'-=110!S%Q
MX&TZ[NM?FN;J]E778%@NXF9 H55*KMPH((!/<^^:CM/ EM;:EI.HR:QJ]S=:
M;$T,;S3K\\;;?E8!0,#:.F"?XB:ZNB@#&T#PY!X>;43;WEW/]ONWO)1<%#B1
M\;B-JC X'%&K^&X-8U;2M1EO+N&73)&E@6$IM+,I4[MRDG@D=16O(Q2-F5"[
M $A5QEO;GBL;PIXA'BC04U1;1[4--+%Y3N&(*2,G)''\- %9_!MLFH:E<V.H
M7M@FJ'=>P6Y39(^,%QN4E&(X)4C/7KS5C_A&HK>6V;3+VYTZ.WM5M$@@"&,Q
MK]W*NIY'8_SS6Y44MS##-!#)(JR3L5B4]6(4L<?@": ,&S\(6^E1V<>DZA>6
M,=K;?9A''L99%W%LL&4_-DDY&.I['%5#X2;3KCP[!HMYJ%K:Z8S;XDF AE1C
MEO-7'SL3G&. 6)XP!6CH/B/^V]3UJR-C):OI=PL#>8X8OE V>.!P1W-;M %3
M5--MM9TF[TR\5FMKJ)H90K8)5A@X/:LNQ\*PVTE@]WJ%YJ']G#%FMSY8$1V[
M=V$5=S!<C)SC)[DFM^B@##T3PQ;:&^J-'=W5RNI7+W4\=SY97S& #$;5'!
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M')C<,"&7//3(/(-4M0\"Z=J/A^ZT>2ZO8X[RY%U=3QL@EGE#*P9B5('*KP
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MU?5;J^MK8VIDGF7$R%@V&"J!P0.F,]\\UG-\,M.;2Y-+_M;5ET[[4+J"V65
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M506PI(&?QR0#19^#[>W.EBYU"]OHM*;?9I<[/D;:4!+*H+84D#/XY(&.CHH
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M>:VU C:3+$V2N1@G  P&([<>CUB6/ABTL[FQN)+F[O'L(VCM/M+AO)#  X(
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MY3X :%4*MD#)W9SN[8 '6R^$;*:XTFXDN[]YM+9GMY'GW,78$,S$@EB0<<\
M= *IW?P\T2ZUZXU99+^UDNB#>06MV\4-T1_ST0=??IGOU- '-^*-6U#3;JYN
M-9-^=&N+2)(M5T>X<I82[?F9XU8$J20P8@\8%>FQ2)-$DL3AXW4,K*<@@]"*
MQ+WPK:7KWX:ZO([?4$$=W:QR 12J$"8P02N5&"5()_*MN*-(8DBB0)&BA54#
M  '04 <O\0M<N= \+&XM)##+/<PVOGX!\D2.%9^>,@$XSWQ6?JK7?AWQQX<M
M["\O)++5S-:W-O/</-M98]ZRH7)*D8.>Q':NNU;2K'7-*N-,U*W6XM+A=DD;
M=Q]1R"#@@CH15&R\-V]I<07,MY>7MS;1-#;373JS0JV,[<* 2<#+-DG'7K0!
MRWP^L;S4EEU6^UW5IWLM4O8(X6N?W4B!R@#KCYL=1TQ@8KT.LG0/#UIX<M[B
M"SEN'CGG>X<3.&_>.<L1QW/..E:U !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M0LLBEB2K#:<D8R*YRZU34D^$?BN\74[X7=AJEU';3_:7\Q%28*J[LY( XP:
M/7JPO%/B/_A&;&UNC8R723W45L=KA1&9&"@G//?L/RK'UB]G7QW9V>I7$]OH
M<NER/$\4KQAKD. VYD(/"$;<G&2>^*Y+48-9'PJT^36;J]:^FUBV*M=??6/[
M2!&2I'!*[20?QH ]BK!\7>*(_"&B-JUQ93W5LCJCB KN4LP5>&(SR16+I/VG
M2OBI>:.NHWUS97&CI?%+N<R[)1,4)7/W01V&![5#\9O^297_ /UWMO\ T>E
M'=0/)) KRPF%R.4+!MOXCBJUO=7DNJ7MM-I[0VL(C,%T9587!8$L HY7:<#G
MKFK<DB0QM)(P1%&68G  KB]">YNO'_C33;F^O);2..R,*&=E\G>CEMA4C;D]
MQSTH T+;Q5<:A<6\NG:1)=Z5+>26;7<<PWQLC%2YC(_U>Y2,[L]\5T-S++#;
M220P-/(HRL2L%+^P)X_.O(?#UX_AWX4PWMI-,DUUJS6;22W3[(D>\968 [@A
MVY^8#.3DYKM](TG6M.\5O<2WT::5<6VPV,E]+=-YP.?,1I%! V\$#CO0!=\(
M>*8?%^C'4[>TGM8Q*\/ESE=X93A@0"<<U9TC6GU6[U"'^SYK=+*<P&9W4K*P
M )VX).!D=<<Y'8UPK:@/A]\0-:M2A:PUZ%M0L(AP&O5PKQ+[N2I_$5T>K6QT
M'X?-;-K#:?<802WT<9=WE>0&3:HYW.S,!CD%O:@#K:*\YTZYU!?%WB32O.U"
MTM?[*ANH8IKHS20N2ZDAB6VYVC@$COUK%TZYU.W\*^ -?;6]3FO+V^M;6Y66
MY9HI(I=P8%.A/0[CDY[], 'K:7,+W4MLLBF>)5=T'50V=I/UVG\JEKS71[6"
MS\<?$.Z%]-:&V%O(MQ+<2/'%NMBQ=E+88 DD ],8&*9I-]?6OB_P?#'=:C):
M:E87(GENYV/VQD2-A*(F8^7DL2!P<-@@8H ]-HKR74;W7;S0]>2*[U"/Q5#J
MYBLX()7"^5O79A1\IC\LDEB.#DDYK=FEO=4\6ZCX<2:5X=/L8&3=J,EK*[2;
M]TFZ-26QA1V /8YX .C\3>(&\-Z='??V9=WT/FA9OLH!,*8),A!/08_6MJL'
MPYIU^OAJSLO$-Y;ZG?6SD23QDE796.TMTRP&,Y'49ZUSGC74K_2=8FN[VWU.
M;P\;-4-QI=PRR6$N6W2/&I!92"ISSC:>.3D ]!JEIUU>70NOMFGM9>5</%"&
ME5_.C&-LG'3/H>1BG:;-%=:1:307/VB*6!&2X'_+12H(;GUZUY3?ZEJT?PQ\
M=7":QJ N;#6;F*"X\X^8J*Z*%SV&">F* /8:YF_\57$=SJ$6DZ1)JG]FRQQ7
MBQ3!) 6 ;$:D8<A6!()7KQFLDI=Z/\3-%MDU2_N(-5L;EKF*XG+)OCV%61>B
M'YB/E %86FR+X;7XCZS:_:I9].N7>%)+J5U8BW0@N"V&Y[G)QWH ]9HKS35[
MF^T3POX;\2V.I7ES=2SVBW:23L\=VDV PV$[5.6!7:!CITJ72].O=9\<^*;6
MX\0:Q';Z=>VDEO'!<[0,Q!RIXP4))&W&.?I@ ]&HKQBYDU3_ (5QXHUG^W]6
M^W:3J=V+1Q=, !'*  P'#C'&&R/0#FNID^UZ1\1?#"QZI?SQZQ;W7VN*><O&
M3&B.K*GW4()(^4#B@#OJB6Y@>ZEM5D4SQ(KN@/*JV0I/UVM^5>62ZG?0-X;U
M"SU6^O1=>(!;3:@962"YC=I 8TAW$;5  #8'*Y!.<UK>&=,A_P"%F>."LUVK
M(]IM(NI#@O 2<@D@XSQD';VQ0!VNDW5Y>Z>D]_I[:?<EF#6[2K(5 8@'<O'(
M /MFKM>1Z/XDU-? ?A*WGO[EYM7UJ6RN+UY"9/+$\ORANH)"A01T&<8P*Z"1
M[W2OB+'H5O>WCZ9JFFRS[9)VD>VEC8#<COD@$,!CIGD4 =Y17C.EW>JIX$\$
M^)'US4Y;ZXU&V@F$ERQCDBDE*,K)T;CN<D>N, >H>)X$N/"NK1.9 IM)3F.1
MD/"D]5(- &C;7,-Y:Q7-M(LL$JAXW7HRGH14M>4Z->3:=X2^'^E6DD@76($,
MQEO9$SLM]P17^8Q@G'"@=,#&:LZI<:_X/T[4!<ZK&+2^U"TAM<W+W$MA'*^R
M5B\@!(X)7/0_2@#T/4KQM/TVYO%@><P1M)Y2$ M@9P"2!5;P[K"^(/#FG:NL
M)@6]@281%MQ3<,XSWK(NM%DTR?5+F+6+E[*?370:=<2M-B10<RJ[L2." 5''
M0UP^C+=Z/X5^&^IVVIWV^[N+6RF@,Q\AH9(GX\O[N1M&&QGWH ]BHKRR6WOM
M0U'X@P2Z]JZ1Z<4>T$-TT?EL;<2<%<<!C]WH>X/&+6D^(;W7=0\':3>W$T<=
M]H0U*Y>)S&UQ+M0!=RX( RS$ C/':@#N->U4Z'H-]JOV9[D6D#SM$C!254$G
MD^PJ72KX:IH]CJ C\L75O'/LSG;N4-C/?K7G=U>WT%C\2?#L]Q-=66GZ<9K2
M6=R[HLL#L8RQY;!!P3DX/6K.G:G-<7_@KPV9I8+.?1!=RF*0QM,RHBJFY2"
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M&#C&1SR<GC&I8>$6U;1GL]5O]:DL5NDN;5;Z93<*5P068#.-PR%//KZ#MZ*
M,=/#ELGB8>(#<7+WWV7[(2S+M,6[=C:!_>YSU_#BD\2^&K+Q7I9TW49+@6C,
M&>.%]FX@@C)QG@C/!K9HH P#X4@DEMVN-4U:X2"5)1%+=$HS*05W  ;AD X/
MI4UKX;MK/6M3U>"ZNEN]25%G8LI'R A, K@8!/\ 7-;-% '-VO@;1K;PS<^'
M9%FNM*N"Q>"X?=@LVXD-@$'<<]>#TJ7P[X1L?#>6@NM0NY-GEI)?733&*/\
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M[5&!QC')SCZ'ILKZE:3Z3?\ C1#'*IF36'<0>7GYE*RC+$C(&W.#@YQ7I%%
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MR7.DF-HO)N&W80\XSP>IR.XJ#0/!>G>' QMKG4KHK&8H?M=VTOD(?X8P>%'
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MH<*X! ="K#Z@\C\: 'T444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MU'7+JZN-058[F]>)%;8IR%1% 51U['J?; !4AOM9TKQYH>G7.J&\LM6LYW:
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M#>Z1->JBW\=O&CI.5& P#@A&QQGG^>>JM;:.SM(K:$'RXE"+N))P/4GDGWH
MX#X*.;CX?"]F.Z^N[ZXFO&/WC*7(.?? 6M[QIK"^%M"N]9M88S?SM!:([C*Y
M9]JEO4+O8^_2FQ>#Y-*U:\O_  _JCZ<E](9KFS> 30/(>KJN058]\'!]*MZE
MX4L];T.]TS5IIKO[:H66;A&7:<KL &%VGD=>>N: ,C4]2U7PUXKT"UDU&6_L
M-7=[603QQAX9@NY74HJY!P00?PKFI]>\5?\ "$>)M<77REQHNI7442+:Q;9D
MB<+M?(S@C^[@\\D]NZMO#<S7NGWFJZD=0GTY&%JQA$8#,NTR. 3N?&1D8')X
MK-/@$-X8UO0FU60PZO<RW,TODC>AE.YPO.,9Z9SCGKV *[ZEKFG^-_#UM-JI
MN;36X+@O;- BI;O'&'4H0-V.2"&8_P"& NJ>-+WPCKVN6WB*..?1KV[5(/L<
M96XCA8Y5SC(RHP,8/J3GCM;KPR\VKZ%JLVI[7T5) @\D!9 Z;6+<\?*.V,'\
MJY#P1II\0:#XEL!JRC3[O6+P3PQH#(8VD/W7S\JNO<@]3@CL :5[XAU/4+2*
M]M]1:TCN-$2]MK2SC62<2L"Q:3>I"Q@;0"2 3GVJM_PDWB#4+7X?SV]_%;'6
MT(NU%NK MY!?(SR.1D ?J.*W[CP/$VMW-_9:G=6,%W9)97-K"B%71 0FTL"4
MP&(X_0\U7L_ )LK?PW$NLSR#06+0&2%?GRFS!QC@*<#OGDDT 4=/N?$UV_C'
M0(-;>34=+DB-C>R01!F\R(2!'4+M(SQD 'FK6A>([KQ)IOAH6E[-%=2AY=2S
M''N41#9(C KA3YI4# '&35N2VL_!=YK_ (JU+49#;W[0M<*ML6$94"--H7+8
MP1GKZ\4O@[2+."ZUK7[6VD@76;KST212I\L* &VGE=[;WQU^89H WIK3R7O+
MZVC\V^>+:GF-Q\H)51Z#)R?K[#''>"_%#ZSJL5I=ZI=PZI!:M]OTB_MTBD67
M*8DCPHR@^<<$\%:[B\M_M=C<6Q=D\Z-H]Z]5R,9%8EMX8<ZSIVJ:E??;;K3H
M9(;>00"-B' #-(03N.!VVCD\>@ _Q3=W=I!8&VOXK**2[5+ARNZ9TPQV0KM;
M<Y('&#QFN0MO&VJ6>AZZ+B1I+FVUM-,M);J-59%E\O:T@3 .W>3VS@ ]ZZ_Q
M'X:_MZ?2[N'4)K"]TV<S031HKCE2K JW!!!-9#?#>QN++7[.]U*]NK?691/(
M&V*T4H"_O%(4?-E 1V'3% $^J7.M>%(]6UFXU$:CHUMIKS+!.JK.+A<G@HBC
M81USD@].*EL(/$32Z+J?]LQ7%E-"7U&"6-0OS("IAVKD8;C#,<CU-/TWPE*E
ME/;:]K5UK@EMVM1]HC2-5B88880#+$8RQ)/ICG,/ASP7<:#]GMYO$-_J&G6?
M%E9SH@$0Z#<P&Y]HZ9.!Z<# !@KXDUS4OAK/XYL-0,4D:S7<=@T:&$P1NP\M
MCMW[BJDDAA\QXXXK4TKQ#?:GX[BLTNI%TV\\/QZE'"R)NBD>3;P=N>!V.>:F
MA\!16VF7VB6^HRQZ!>2.[V/EC<BN<O&DF?E1CGC!(R<$5<U#PD9_$5GK6G:G
M-IL\-H;*18HD=9(-VX* P(4@]#S]* .-;Q5XC;P+9:C'JBB\.O\ V!Y'MT/F
M1?:3& 0  .!SC!^E;EM=:U!XWU7PY=:U/<P2Z2M_#.(8DDMV,C(57"X(X!&X
M$CU-.3X<)%H$>D)K-UY,>I?VBK/&K$.)/,"COC=UR23ZBME?#;?\)BWB*2]W
M2/8BQ: 183RPQ?(.<YW$_AV[T >>Z?J>LZ-\ ;36[+5Y_M?EQ/F:.-]NZ8*P
M'RYYW$Y;)S75ZG>:Y-\2XM"M=7-I83Z1)<D);HSHXE1<J6!YP>X(Y/'3#1\.
M5'@5_"7]MW;6)*B-VB3?'&K[U48 &<XR3G(]*V&\-S/XN@\1'4!]HBLC9>4(
M?D*E@Q/7.=P'?I^= '(Q>,-<MOA]=7<\XFO+/6'TV>_\I1LA6?8TY4#;D*?3
M&>36WI=]J\GQ%O=+35'O-'M[*.Y+-%&2LCEAY9=0.P#COSZ8K'\0:,/"WA:6
MR?4[];?4M7^U3WT%L&^R%F,C%U (,9*A<$8^;DD5;\(S7QU2W73_ !2FN:8=
M_P!H5=-CA2(;20PD0 %MVT;>>"3QB@#2\>:IJNE1Z"^EWB6YNM8MK28-$'#I
M(V".>G3M@^XK.@D\1-XZU+PRWB2<VYL(KZ.Y^RP^="6=D*+\NW&5!RRDXX]Z
MZ/Q+X=/B)-.0WC6PL;V*]0K&&W/&<J#D]/7^8IB>')4\7S^(A?CSY;);/R3#
M\@16+ ]<YW$]^G'O0!R>C^,]6N_#?AVWF=YM3U&^N;26X@2-798#)EE5R$#$
M(O7CDX'055\7'Q5#X"\8IJ-Q=164<*R6%PS0BX=",212>6"-N>A&"0>36X?A
MI;-X8AT<ZK=)-:WC7UG?1*$E@E9F8D=B,L>/2K[^#&OO#>I:7K.LW>HSZA#Y
M$MVZ)&449VA$4;1@G/<D]3TP 87B"UNU\7> ((]0D:=FO,7,T:,R@V_8*%7(
M'3CZYJNWC/5M T7Q3#=W8U"[TS4HK.TN9XE4D3!-I<( #MWD\ 9Q73-X1N)=
M2T&_GUJ:>XT?S"C/"H\TNFQMP&,#;T QZG-0R^ +.]B\10:C=/<V^NR++,BH
M$,3J %*')QC:IYSR* (M2U/5/#/BKP_;RZA+J&G:M*]I*L\<8>*4+N5U**O!
MP00<^U<GXFU*_P#%GP5UCQ(-1E@@N5D:&S2-#&(5EV!6)7<6(7).1@GIC@^@
M6OAN4WVG7>K:DVHS::K"U)A$>&9=ID?!.Y]N1D8')XK!E^&0&B:IH%IKUW;:
M'?,SBR$*-Y!9MS!'(SMSV_7KD C\4>)[G1-5%OJ%[>:1IDUG&++4HK=9(%N#
MN#"8E6V_P8Z#&[GT[VV8O:PN9%D+(IWH<AN.H]C7/W?A>[N8;RV.LO):7MLM
MM/%<6Z29 4J77&T!B#W!' XJ[9:$^G7MB;74;A-.L[$6:6! *-C&URW7< ,?
MYY -BBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M+_$74+_2? .KZCIEVUK=VT/F)(J*W?IA@1WK2TWQ%I.H7ATVWU.UGU&&(/-
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MB5TW8(C/1\'^$_WNE9NF:[I=EH[7=YXIM;Z"2[D2.[=XT7);B)=O#%>G')H
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MW@&T_>#]^",C9_>R.>* -"BO/]"\:VVG7WB&#Q-X@MXQ!J[VMH;EDB.P1QG
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MN@ =\7&1E/O D=..>U9 \4Z?KGAK2=0@U^+2&NY8' +(S,3M8P8;J3D XY%
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M*BF9$T&8I,!URK@9QD<'FN#\%^.;-M%MX?$6OVO]JSWEQ%&)G2-Y LS(ORC
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M2"Q(QDXKU8*H4*  H&  .,4T11J%"QH HP %' ]* /#8[C3X_@(CI+;+)_;
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M4N-K9\EA;NI5S_"<]CSP:]DBBCAC"1QI&H_A08 I%@A3[D2+\Q;A0.3U/UH
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M+!:-<J QSL7R-J$GMDX )ZF@#K-.\2Z-JNFW&HV=_&UK;.R3R.#'Y3+R0P8
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MVJ"3@$G'T'6LO1O$FEZ_-?PZ?.TDEA.;>X5HV0JX)'<#(R#R/0UJLP52S$
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBN.^*&IZCH?P_U+5M*OI+2\M0C(RHC YD52"&![$T
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M+OR[BVB\Z6*XB>!EC_OX< E?]H<4VR\4Z-J%REO!>?O9(#<QB6)XQ)$.KH6
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M&@#3HK!;QIX=33'U%]5BCMDG^SN9%9727.-C(1N#<C@C/-.MO&.@WJR&SO\
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M+-96DBNVU 20&8YPV/X2<CIZ54^)D-Z=!TZ\M(99XM/U6VO;N&)2S201MEL
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MF-DC<;E(Y!XQT.:Q+SQ)XSM/AE_PE_\ :6FGS=.MYEMOL9)5W*AFW;NX;/3
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MF>0I9L +@\$Y.<  [.BO,K?QQK?B >"YM*>TLXM>2Y69)H#(8I(D;)!W#(#
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M1C@=N30!W%IK^GWNNWNC0/(;VR1))T:)E #9VX) #=#R,BM.N*TK_DL'B/\
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M1W!Y!H YA/ BV5WX7;3+Y+>UT!9%CADMS(TWF)M8LP<8)R3TZG\*T#X<NO\
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M))"P4$$!E.[Y0<YZYS71:=J2ZB;O;:W=O]FN'MS]HB*>85Q\Z?WD.>&[U=H
M\_G^'%W/X=U_1_[?&S5]0^W/*]F&:,[D;'# '/EKZ#KQ6]XD\.7.OVVE,FH1
MVM]IU['>1S?9]Z,RJRD%-P."&/\ %5SQ'XALO"^CR:G?K.UNC*I\F,N<L0H]
MAR1R2*UJ &1*R1(CR&1E4 N0 6/KQQ7,CP+IK:GXANIF:2+6HO+D@/W8MR!9
M"ON^U"3ZJ*W#J2C6UTO[+=EFMS/]H$1\D -MVE^F_G./2KM '.VOA8V7@/\
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MCY@01D<Y!/ QCG.G:>!1!H]MH-QJ<EUH5M,DD5K)$/,*HV](WDS\R @<;0>
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M &]6 55'IDD^W/-?\)GKO]E1+)=*E_8>)HM&NY$B79=1EU&_!!VDJPZ$8.:
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MQI8UE2)G42."54GD@8SC\Q^= %32=.;3+(0R7<UW.[%YKF; :5SW(  '
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M' )QD>O- &5!X7GM]=UW58]1'F:O''&Z-!D1"-2JE?FYX8YSU/ITJ[X8T/\
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M] 8:PFKZG=+>WT=N;:)DA\I(T)!8A<GYF(&3GL, <YVZ* . B^&;QZ+8Z/\
M\)%>?8-.O4NK)%AC#1!'+A2<?.03U/'L>W?*"% +%B!U/4TM% '++X0DG;2E
MU'4A>1Z5<?:;5FMPLN\ A0S[N5&>@ )P,D]Z;^ &D\,Z[H;ZLQAUBZENII1;
M@,AD.6"_-C&0,9SCGKVZC5]231](N]2EAFFBM8FE=(0"Y51DXR0.@]:IP>(/
MM6EZ+J%MIUY/%JGE,/+52;='3<&DYX X!QGK0!2D\)RQZY;ZY8ZB+;4UM1:7
M#&#?%<Q@Y&Y-P(8'H0WMR*AO? =I=>')--BO)H;J2^&I&^"J7-T'#[RO0C(
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M!CY@6;&.F%]>:H/:WLGQ:T1;K5)VF&A2/+Y# 1%Q)$&VJ0<*QY/?ISQ6Q=^
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MM7EDM(7G""9HU,@C.5#8YP>XS7#>-?\ DHOP_P#^ONZ_]$UWD<:11I'&H5$
M55 P !T%<]K_ (137]8TS4VU6^M)],=WMOLXBPK,,,3O1L\4 =!)@IL\SRV?
M*JPQG..V>_?\*\HNKS4=9^!WB*XU#4KB:XA:^0R@(ID5'=0K +C& .@%=];^
M'[A-2CO;K7M1O6A1EBBF6%41F&-^$C7+ 9 SG@GUK.C\ VL?A&_\-C5+\V=[
M)(\LA\KS/WA+. =F,$D]J ,YK^]M+GP[X=MKBYF^V64EU)(TJ)(518P(U;;P
M/G)X&?EZUIZ+I.KW>BZOHWBEX[JVG>2.W)<-*;9Q@+(0 -PY&>]+K'@:UUC3
MM,ADU*_@OM+.;/48&5)H^ I'"X(( R,<UL:-I T>T:)KRYO;B1MTUU=,&DD.
M,=@  !T  'XDF@#SSPOJ5U-X6D\!WDI.K6=X=)F;.&-J 6\T>@,(*@^N/6NO
M\132P:GH]I#?-!:R>:'LK4'[1<D*-@0C[JKDECD ?+DU>A\-:=!XLN?$B18U
M"XM4M7;MM4DY^I^4?114.L^%HM6UK3]7CU"]L+VR5XUDMBGSQOC<K!U8=ASU
M% '!-XE\0R?#RVO5U2:&]AUX:>TCQQEI(_M'E@/@=0, E2,XZUO0/JEKX]U/
MP]-K=]=6EQHPOEDDV+)!)YA0["J@ $8[<58_X5K8+I,NFIJVJ+;/J/\ :(!=
M&*2!]X +(>-W/.2>YK87PS%_PEG_  D+WUT]R;+["8B$\LQ[MW9<YW<YS0!P
M_A*6[M/A3X8F76Y8!=2Q"8.-\LB$OF*$*I.]CCGDXW'(ZU9MO$?B&#0?'*VD
M=Q<WFDS8L(KD*\J*T2O@[2=^W)(Y)/0UK1?#6SM]'T[3[?6=5C.F7(N+"??&
M6M_O?( 4VLN&/W@2>.<#%4_$'A9-"T/Q'>6LVM7SZP(TNHXG#O&"%1Y555!)
M"@MM&1Q@  T %EJ-[>>,=#AT;7KF\TF>Q:YOBICE 92NPLQ4[-^6&T8Z<8P:
MK6&H>*_$OA_3O$>CSB*:6?SC'-<*+<P!R&B*[200!][.<@\XX#]!:ZEU*T;1
M?%FN:G$)5\^"_P!/"1"+/S;G,2$-CH <YQQC.-:Q^'5EINHSR6>K:I#I<\QG
MDTE9A]G+DY(QC<%)ZJ#@]#QQ0!U?V2'[;]L*DSB/RU8L3M4G) '09(&<=<#/
M05P'ASQ'<S>([+2=<NK_ $W71)*9K2X4?9[Y-K8,# 8P/E. 0>#G)YKT:N;M
M/!\4+:2+O4;J^CTE_,LQ.$W*VTH"S*H+84D#]<D"@#I*\_T)&D^+_CA%D:)F
MM+$!T ROR-R,@C\Q7H%<Y9>$DL?$VIZ]%JEZ;K48TCF1A'L 083:-F1CZ_6@
M#@;/6O$:_#O1/%4WB"ZENO[16&6 QQB*:-KIHB' 7.<="" ,# [G;\1>([G2
M?$E[:ZS=7^E6DTD0TO4HE#6@&U=R2\':Q?<,MV(P1C)U%^'=FOA&W\-#5=1^
MQ6]P+A'_ '7F;A)Y@!.S&-W/2KNH>#TU.'4;6[U2[EL-196N;5E3'"J"%.W*
MAM@S[DD8H R[O7[W2OB#K4<]W+/IEIH']HK;;5 5A(X." ">$[YZUSGB+[;J
MGP]\-Z]=ZE.\][?V%S+"I'DXDD5@BKCC;D<]3CDG-=\?"EJWBB?7)+F>1Y[(
M6+VK!/),.2<8VYZD]^]88^&5LNCQZ,NOZL-*@N$N+6VW1'R"K[P Y0L0#T!)
MQ^5 $-S?Z]XDN?$D&D3S6TVG7)M+1HYT14D$:MOD4J2P+-C'3 X&<FJ]Q+XG
MO_&.F:)/KLE@UUH<DUR+-(V6.=712T9*YZGOGC.,'D;5]X!@N/$$NLV.M:KI
M=S<HB7HLY55;G:,!F!4X;'&1BKR^$K:+Q)9:U!>743V=H;.*W788_*)!(.5+
M$Y4'.>U &W;1/#:PQ2S-/(B*K2L "Y Y8@<9/7BN9^)2@?#3Q)@ 9L9"<=^*
MZNLKQ%H<?B30KK2)[F>WM[I#'*T&W<5/498$#\J *-OYJ_#JVEMYV@N(M+1X
MIE56*,(@00&!'Z5RNERZ\WP_L?$5SXN>*:]L;8.+B%3'&69=S(%4L9&4E0.<
MLW3H!W,6BB+PV-%%[<&,6_V83D)Y@3;M_N[<X]JR)? EE+X-L_#;:A?"*Q:)
M[6Z#()HFC(*$$+M.,=Q0!SA\8W^@7?C-I1=S6FF6$%Y:07I!<,X<8)!)VDJI
MPW(YZ=*3Q%9723> ;VYU2XNI9M7@,ZOM\MG:)SN4 ?*!R !V/.2,UTB> K!]
M2U"]O;^_OCJ-FMI>1SNNR8 , Q"J,'#'A< =<9YJK'\.D6VTFUF\1:O-;Z3<
MI<62N8LQ[5(52=F6 !QSG@8XH I'5-8&K?$.U&K3XTVV@ELF\N/,!:%W( VX
M(R.X)QW[U1LM3URUMO &K3:Y<W/]L&&WN[9T01$/ 7W#"[MP*YSGDD]!Q75-
MX,A-[X@NAJ=\'UR)8KD 1X150H-GR<':2.<U&W@:W-AX?L_[4OQ'H3H]J0(L
ML44HN_Y.?E)'&* .:UKQ%JHM_&.[4I;#6-.G TJU3'[V/:IC(0@^9YC;AT..
M@P17H6DI=)I%J+Z:26[,8,K2!0VX\D': .,XX':O,A()==U6277_ !/H6H3W
MKM]ACL3.K 81&0^4VX,J@\' SCMD^DZ$-0&BVPU20R7@4[W*!&89.TL%X#;<
M9 XSG% '%>-'9OBSX @N3_H!DNI%!^Z9Q'\F?<<8^M>A7$,-Q;R0W"*\+J5=
M6Z$=ZS?$/AS3_$U@EI?K(#%(LT$\+[)8)%Z.C=B*BMM"NPBQ:CKEYJ$"X_=R
M1Q(),?WRB@M]. >X- &+I][>^+=4\30Q:E<Z>NF77V&U$&T%7" F5L@[LLV
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MN6'/3I]<T ?2-%>7ZQXAU:;Q]X8L;ZZDT[P[>:>;B6>*0PK+/L8[#)P5QA2
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MG:?+E <[DP!M'RCCIR?:N-T&^N],\%?$^_L+F2VNK?5&>.6,X(.\CZ$8)X-
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MW,^I37,%RR-#;.BA;8!<$*1R<GGF@">_O[?3;4W%RY"[E15 RSNQPJJ.Y)(
M%0-J4ZZE;6?]F7>)H&E:<;3'$PQ\C'/WCGMD<5R_B"Y>X^*OA+36)^S1PW5Z
M5[-($V*?P#-^=6KW4-0@^*FDZ>M]*=/N=.N)7MBJ[0Z,@!SC=_$>I- '1:?J
M4&I1RF+<LD,ABFA<8>)Q@[6'T(((X((()!JY7#I<26?QMEM(R1!?Z$L\JC_G
MI',55O\ OEB/P%=Q0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MW&X-N3" 8R!P0:[*B@#F;/P9'9ZY=:P-8U.2\NK5;>9I&CPY7=A]H3 (W'@
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M516*/\VV5F))(PV 0#CBK'PX\,>?\/-%M-7.I*MNWF2:;=1^6@D60LN0R!R
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M!15(9HU0APQ))W9R#@8Q44T&LZMX\M]&NO$=[;QS^'1<3G3I0B";S54O$=O
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MH(0T@9=C8W!L@DYP.<]N,557P)HGV;6+65+B>SU:1Y;BUEF)C5W(9B@_A)8
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M'J.E6FH(I2.Y@2<!^JAE#<_G5+2M?BUQS)IUO)+8!BHO6(6.0C@^7W89XS@
M]B:XGQ?=W5I\ HFM)#&\NGV<#2#^!'\M&/\ WRQ'XUH2R:IX.\2^%],@OFO-
M&O\ =8FVDAC4V[)'N1HRB@[<*00V>.] '>T5F>(]4?1/#.J:K'%YKV=I+.J'
MHQ520#[<5PFJW^HZ/X&T'Q=::E=W-X[6DEW&\S-%=),5#*(\[4Y<%2H&,=Z
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M40>(5GN8;Z*#[-^Z90DD><[7&.1G\NV*@GUW6K32Y=3G\..8(XS*;>*Z5[D
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MJ[J5(0$)QMSP"><\YYS6U10!BZ-X9L]$344AFN)X]0N'N;A+@JRM(_WS@*,
MXZ=/:LW0_A[I/A^Z$EE=ZH;6-B]O8S7;/;V['NB'N,G&<XZ]:ZRB@#ECX#TU
MM#U71VN[YK35;A[FZ!=-S.YR^#MX!..!^&*MR>$[&76-/U5KB\%Y9V_V8.DV
MSSHLAML@ &1D \8]\UO5@WGB*2T\::9X?-EF.^@FF6Y\WIY>W(VX_P!H<YH
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M& 0 HQP ./2KNL:5::YH]WI=\A>UNHC%(%.#@^A[&KM% '.+X-LUO=(O&O\
M49)]*#_9WDF#D[UVL6RO.5 'MVQ36\"Z1-!K<%V9[N#67$EY',PP6  #+@ J
M1@8QZ"NEK$TW7KB]\1:II-SI,]I]C"/#.[JRW$;$C<,?=Y4\&@"/P[X2M/#A
M+1W^IW\@3RHY-0NC,8DX^5.@4<#MDX'H*WZ** "BBB@ HHHH **** "BBB@
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !7E_Q6L/$\EQ9W7A/5+ZWO8+::ZEMHIWVSK&T0
MP$SMS\Y.,<XQS7J%8%W=;/&VFI]FO&1;.XC:9+61HE9WA*@N!M&0C=^,<XH
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M44V,E6&[?CW"D>]5?%?Q FT7QSH/AVTT^YF^V,TLTD:!B\85L+&">3D D\8
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MJ5C/97T\S7*R,L;1K*R+!M&0RX"C:!DGIR>=FQ\V+XJZU?/9WJVDFF01I/\
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MS+;,R)\_EXW$;EP<#@<\U'KVCWE[!X^UFVLKPIJFGQV5I MN_F3NL; OLQN
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MDM:O^YW0!%WX!VY(Z'D=\57E;6+34?B/>:=H]Q<7%P(&LDN+1_+N-D"HV-P
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MY77=Q@-N7.UL9 Z=JKW/Q$L8!K'E:1J]P=(?;>"*!1L7;N+_ #,,C'..I]*
M.QHK%F\46"G28[<274VK1F6TBB !>,*&+DL0  ".OJ*J6'CC3+ZSU"X,%Y;B
MPG^RSK-$,B?<%\I<$AF)90,==PH Z6BL*P\4VUWXAET&XM+JQU%+<7217&PB
M6+.W<K(S#@\$9S6[0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M^&O@K3_[+O#>:??V4EU"(CNC6)LN3V/'3'7MWKHC#<K\6VU4V5U]@&A_9OM
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M2.:M:C8^)(I_#WB2S\/_ &B:SM'LKS2I9X_,:)MAWJV2F0R9QDY&.G('I-%
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M[=[110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M\O(SSVI+;2O$&A>(="U^+1Y[R(Z+'I5]9QRQ>= R'<'7+A6&<@X;WH M_"W
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MEMI^;:N&!QE2.^:OZIK-W:ZK%IUEIOGR/;R7+SSR&&"-5(&TN%;YB3TQT!-
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M!U..3GH.*N44 <CI&G:I:?$'Q%JTVGL+*_AMHX'$J%LQ*X.1GC.[C]<5@?\
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M'#Z1N4S;)MOV-)&SNVA3E%W8XY QQ6B/%4,6C:GK=Y"L.D6FXPW*2;S<HO\
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M'#%B3N'7C)P *M6NBZ[_ ,)#X/O;C352/2["6VNO+N$;:SJBC&<9QLY^O&:
M+D'Q @3PKJ^L:CI\EK/I5XUC<6J2"3,P*A0K8 (.]>2!U]JMKXJNHO%T/AV\
MTE8YY;4W8GAN@\8C#;6SN53D$C@ \'-<I?:1?V?A?QA:7VFP-)KFK&2QAN)U
M F\SRU5<J25D&PL#T! .< U?THZE%KT+Z]X7NX9;R'^STU!]2BN2B8+;-JA2
M <$EL$Y STX ++_$RR4Z;=)#;S:;?W"P))#>![B,-PLCP[>$/^]D C(SP.ZK
M@/"=GXUT*SMO#-Q8V4EC9D10ZP+D9, / \G&=^WCDX[\XY[^@ KSO2I1XO\
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M8O[F-%(!=LXR2Q)QG' &>M &L/&5W%"DE]H4EK]LF@@TQ3<HQNFD!/(',84
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MEW?)M=BI.$.TL".5'7- &]<^+EM(].@N;>WM-3O8GE^SWET(DB5" VZ3![L
M, YSZ FL?_A9L9T$ZBND2R2Q:FNF7$4<ZLB.6"AT?'SJ=P(('/M5%/#/B_0H
M/#NKV3QZMJNGVTMG>6MS<;3/ [AE D(QN3:HR>N/ST?$NG>)?$'AJU273HDO
M#J-O=&UCN%98(HW5B"YQN8X/08YQVR0"V/&&J_\ "1W.@-X<(U 6HO+4?;5*
M21;MI+MM^0@X& &Z\9ZUGZIXVL[WX;W>M:AX=%U%!<&UO-.FD1E21)0ARQ&&
M ;!! _"M(Z=J9^)R:[]@?[ -'-D6\R/=YAE$G3=TP,9]?;FN:N/"GB";X<>(
M-#730+Z_U22ZA!GCV[&G$O)SP0 1CUQ0!U>H^*[NU\7+X=M-%DN;B2Q:[BE-
MPJ(V'5<'@D#YNO7T!S4-AXVEU#P]%?1:-<&^;4#ILEFK[EAF#E6+2 <(,9+8
M_"DDT[4Y/B5::Z-.D%BFDO:.3+'N$C2*_3=T 7&?7VYKGH_#OBJVT*X@@L1F
M7Q#)J%Q:?:E3[5:2,6,>\'@Y*Y!X(&,D$B@#7OO'%[_8'BV2TL;9-4T!&\Q3
M<%XF'E^8&5@H).,_*0.1C(ZU9MO%DEAHFAQZE]C74K^W#Q^=>;(V544L[N5X
M.6 P >6';)&-%X2UR7_A.K<Z?8V=OKEFL=IY4^51A;^4%P%& #U/Y9I]SHOB
MR&U\,ZW8:?:_VKI$#6D^FR70Q<0LJ!L28PK;D!';^5 &C9?$6SN=+NII+0K?
M07ZZ<MM%*)%GF<X3RY, %3UW$# !R.*H6GVD_'%&O-/M[69M D)>"7S!*//3
MDDJIR.G(].:G\1:+XG\2:'8Z@;>UL]7T[4(;^UT\S[T/EY!1Y !\S!CR!@8
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M'JVF,Y_Y9R*/-3/^R^3CT)->E:BL\FG7$=K&DDSQLJ*[[5)(QR<''Y5Q>K>
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M6ABUB*%+8"X.04B,?S_)QG.>,UF:=X*UO2;;PEJ$ M'U31+5K*YM_./EW,+
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MG:?>K$4TZ*3>B2+NWR =%SE1@?W?P'47ML+RPN+4MM$T31EO3((S^M '*?\
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MCH._34 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MR 1]['':FVWA#7)/$&E:A>OI$5O;Z;)IUQ:VJ2;0C%3\A.,YV]\8S_%7>T4
M>7R> _%0\"2^#H[[2I+&&6,VEY*9!*8UE60*Z 8!&,9!.< 8&<CIVT+5CX_@
M\0DV301Z6UBR>8RLS%P^X#:0!D8QD^OM6]INJ6.L68N]/N8[BW+LGF(>-RDJ
MP_ @U;H \W?P+K;_  XOO#/FZ>+BYO6N1-YK[%!G$V,;,YXQ^OM3-;34];\=
M7*Z3+H;76GV4=O<074\T3QM)EV >+#.A&S[PQZ<YKTNL77=#\-WL;ZCKNE:=
M<+:QEVGNK='*(HR>2"< 9- $/A"ZN9M(>UN;*PM6L9?LR#3I"]NRA5(*$@8
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M>,5R]O\ #W5=%M_#=WHU_;/J6CK-"T5VS^3-!*Q8Q[@"PV<!3@]!D=J]'HH
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 5QOQ&O]4L--TC^S;F* 7&K6EO,70L65I5X!!&!QSZCCBNRKG?
M&>@7?B#2+:&PF@CN[6]@O(O/SL8QN&VMCD ^U $?]N:A>^(+G0+![-;NPM8Y
MKRXEB9D#R9V(J!@>0I));CCKGB;PCXD;Q)IUT\]L+:^L;N2RO(5;<JRH>=I[
MJ001]:H?\(YJ]AXN?Q'I\EE--?6J6^H6LKO$C,GW)$8*Q! )7!'([BM3PSH'
M]@VEX9)%DN[^\EOKIT&%\QST7/.  H'KC/>@#"D\6:Q#)XLM)(K!;W18EN+=
M"KA;F%D+ _>X)*E>.A'?-7]&\2W.N6'ARYLVM7_M*!KFY^1OW<:@;@OS=0[*
MG.>I/;%/U?PF-2\8:7KB7'E)!"T-W$/^7A RR1 ^RNN[].YI/"OA/_A&+C5W
MCF$L5S<M):19PL$1)?RQQQ^\>0\=L>E '"Z/X@U?PQX.UK6+2ULI=/L]<NC<
MI*[>;(C7&T[,<+C/?.>>!W[;5?$]T-7O]+TI4%Q8PI)(\EG-<*SN"53$?W>
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MGCF3SF+.95525^3MMSSUSVJO9>$+R6Y\61ZK]E:Q\0-RL$K%XE\KR\<J 3@
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M_:[='8L8TQ\IY)PQ/&<X/2@#2G\0ZQJ(UMO#MM:S?V3,;?RIP=UU,JJS(IW
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MM<:?/'KT=DDS2.JBR=RIB/W<E@"&ZYKD/&<$5MXS^'L$$:QQ1WTJ(BC 4"'
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MI%GI&C6^E6L*+:01"()M&",8.?4GJ?7-8?VN/0=0TKP?HJ1)+)#+.IF4LEO
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M9B.P*@\BNAK$T7PGI'A^YEN+"*Y\Z1-C/<7<LY"YS@>8S8Y].N!6W0 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
-10 4444 %%%% '__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>16
<FILENAME>insidertradingpolicy003.jpg
<TEXT>
begin 644 insidertradingpolicy003.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *XSQ7J^JZ?XQ\
M+:=97QAM=5GEBN%\I&(")N&TD<$\]<UV=>=^.KRVA^(O@%9;B)&6[N2P9P,
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M??RW<2VHTRYA,[-\ID\F(;<]VR",=<C'6@#T>\\0:1I]TMM>:E;03,RIMDD
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MYL;2!9%!(/(Z''(SVK)DN]"\2Q7.K^%M4N]4\01Z3<);.LG, 9#M#@ 8)?&
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M;6+6&X"[0KQ,^&#$C(&/0CWK7TGQ;H&NR74>FZI;SO:#,Z@E2@_O<X^7WZ4
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M!ER.1D<T 7%BC1BR1HI/4A0*;%;00!Q#!'&'.6V(!N/OCK2SQM+ \:3/"S#
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M[+8*0!AD,>&) SC(]17I5% 'CVF:M:77BSX?WL5V\T)M;F'9!;,L%NQB0"%
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MTE-8@\1:.+%I+:_P//M!N0"*5EX.[@C."=AXXKT6BB@ HHHH **** "BBB@
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MI:K>6:>(M%M9-;>TNGDD:.QC(_TL;#D,,$X&"<\<BL'X12H_P^MHU5U,=S=
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M7*C4K:+XB^&=0<RBUNM#EMX9#$_[R3S(SM QG) )^G-8.IP76K:'\2[71_\
M2+I]1BF6&,Y,T:K%O"^N0K#CKTH ]2M/$FDWMXMI#=XN&B,R)+&T9DC'5TW
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MV>HS.VT2I;O DA182K#8V0!G WY]ZZ^'7--UNZNM&BN;JVOTA$K1O&\$P0G
MD7<!D9XR,\\'TH VZ*X;X:ZE?S6FKZ1K=[-=:UI5\\%Q)*WWT/,3@= "O\JN
M:-J$6GZ1J'B+5-4N#I]Q<,]J)G+K'!NVQ[0!EBY^8=3\X% '6T5BQ^*](<:C
MOFEA?3D62[BE@=7C1@2&VD9((!Y&>AJK9>._#VH76G6]O>2,=17=:R&WD6.0
M[=VT.5V[L?PYSVZT =)17*Z9XXLK_5M>MIHI[6WTEMKS3V[HN F]V9B,*,'@
M'!(&>]:6G>*-*U._2Q@EF6YDMQ=11S0/$9(L@;UW 9&2/<9'% &Q17/W/C70
M;1!+-=N+=K@VJW"P2-$TP)!0, 03D$>F01UXJQ?^*-+TZ%I9I)W6.$7$ODVT
MDABC.<,X525'!Z\\'T- &Q14-I=V]_9PW=I,DUO,@DCD0Y5E(R"*R[_Q7I&F
MM<_:)Y?+M"!=2Q0/)' 2 ?G900O!!/H""<"@#:HK!U/QGH.D7,%O=WI\V>%K
MB%8H7D\Q ,DJ5!#<$<#GFM6RO[?4--@U"V<M;3Q+-&Q4J2I&0<$9'':@"S7.
M:7X=N[#QCK.N27D$D6I)"GD+"08_*# '=N.<[CG@5BW'C'2_#W@S6-;T^[U'
M5D2^E3]^KOY4S,!Y?(!6-20/T&3BNGD\1Z?%L!%V9&B,QB6SE,BQ@X+,FW<!
MD'&1SVS0!K45#:74-_907=N^Z">-98VQC*L,@X/L:\XT'QM8>'I_%$>OZK>2
MK!K<L<;R1R3^3%LCQNVJ0B9)QG SGWH ]-HK*3Q'I4FJVVFI=%[JZMS<P!8W
M*RQ#&65\;3U'0]ZB@\5Z-<V=Q=0W+M';W9LI%,$BN)\@>6$*AB?F'04 ;5%<
MMKWB'19_"VK2WFHZAIMM;M]GN;B&*2*>!]JM\ORYZ,O(!'-7+OQ;HFEWT&F7
M-W+]LD@,T<0@D=Y$&.FU3N;D<#)]J -VBL:Q\4Z/J.BG5K>[)M%D,+;HF5UD
M#;?+*$;M^[ VXR21CK38/%NC3?V@K7+P2Z>H>ZBN(7CDC4_=;:P!(/8C.>G6
M@#;HK(7Q+IFV],KS6YLHDFG$]N\95&+!2,CYLE2.,\C'6K%AK%KJ%U<6L0G2
MXMT1Y(YH'C(5]VTC<!D':W3/2@"_1165IGB32]7NK^VLIII)M/?R[E&MI$,;
M8SCYE&3CGC- &K16.GBC29;*RNH9II%O@3:QK;R>9,!R2$V[L8QSC'(YY%5Y
M/&N@0Z)/K$EZZV5O*8;AOL\A:"0$ JZ!=R')'4#J* .@HK/?6]/BUV'17F=;
M^:)IHXS$^'1<;B&QMXR.,YYI-<US3O#FE2ZGJDY@M(OOR"-GQ^"@F@#1HKG6
M\<^'TU%K![N5+CRC+&&MI0)U! /E';B4Y(X3.>U(/'?A[^PKC6GNYH[*UF,%
MRSVLH>"0$#:Z;=R]1U'<4 ='16=)KFGQ:Y!HTDS+?SQ--%&8GPZ+C<0V-O&1
MQG/-5X/%&EW,L"0O<.+A7:"06LA28*"24;;@\#C'7MF@#9HKG/"'BN+Q983W
M4=M<0!+B6-5E@=/E5RH^8C:6XR0"<=*H:[<W=O\ $[PE!%>W"VUU%>^=;A\1
MN4C4J2.Y&X]: .RHK)M_$FE7-C<7L<\@M8'*/+)!(BE@VW"EE&_YN!MSD\"F
MV?B?2KR\N[,3O!=6D0FFANHFA98S_'AP,KQU' [XH V**PX?%NCRZA'8F::*
MXFA:>!9[:2/ST7EBA91NP.<#G'.,5FCXF^$66TD&J'R;J0Q1SFWD$8;<5PS[
M<(20<;B..>G- '744V2011/(P8JH+$*I8\>@')/L*\L\2>-)M?\ A3J^L:=)
MJ&F3V\Y6-E1XCM%P(^7Q@DC.0IX)H ]5HK%L?%FCZCJ\VEV]Q)]KBA\_:\#H
M)(\X+HS !USQE<BJ6AZUHL.D7E[;:M>WMNVH21EKD.[B9F \E%*AL G  '%
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M]X(_XB@&0/4 ]JZNB@#RBWG6/Q9XJG":I-!>Z'%Y-S<VT@\X@2@GE0%Y( 7
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M3(^;E3TZD>] 'IUMXFTRYU#^S_,F@NS$9TAN+=XFDC'5E# ;L=P.1W%9UO\
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M9@JECG &>!D_E7F6O>,Y->^'7BJ\T]M0TV?3WF2&18I(F'ED*<N1@$G/R@Y
MQ[UZ=7C=QYT?PZ\?:.UE>B]?4+UXX_LSXD$DF4VG&&W Y&,\ T >AZ1XMTF]
MO;?24N93?-;"9/,AD59E &XHY&U\$\[2:AT;6M%BM-9OH-6O;J!-1:.?[3O8
MPS'8/)C4J#C+* H!Y;BL2_E67QWX"GB21H8K6[65Q&VV/?$@4,<?+D@C![BL
MJQ@L;K0O&=MJMO??9+KQ$9%>"-UD5&,02="!DA67=D9^Z: /2;#5K74I;B&$
M3++;%1*DT+1E2PR/O 9X[C(IVHZI::7'$UU(09I!%%&B%WD<Y.U5 ))P"?8
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M5[3O%FCZG?7=E!<21W%K&)I$N8)(#Y1S^\&\#<G!^8<5YA;12Q_!'PQ9/:W
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M7^J63RO;[260&+:D8'7I@X]6-<[.6'@KX9Q>3/YEK?6+7">2V80D+*Y<8^4
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MK=6SP?:(QU:,L!D#\#0!T=%>7Z/J%E:^ /%;Z[=ZD]A%J][ \L4DLDRQA\*
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MV4A\II/NLW'"\CD\<\9H ZBBN>N/&>E6LML9A<+9W-Q]EBOO+_<-+D@+NSD
MD$!L;3ZTV\\;Z19-=-)]H:UL[I;.ZNTCS%!,VT!6YSU=02 0,\F@#HZ*YC_A
M*Y&^(#^&QI]SY<5D+AIM@(8L^T$<\*,-D^OTYW[^^MM,T^XOKR416UO&TLKG
M^%0,DT 6**PYO%%O;1WCW5C?P?9+;[7*KQ GRN<L,,0<8.1G(].12GQ7IB_V
M(Q,WEZT%^QR>7PQ9-X!_NG;SS0!MT5SNI^--)TF.YN+CSVLK298+J\CCW10.
M2!ACG)P6 .T'&><5SHUD:-\4?$&\ZC>1'3;:6.U@#W!!+/N*)DA1P/0=.Y%
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M.S$-G!7CD<'GITYR:K1_$70)K?3KJ)KM[*_=(H[L6S>2CN<*CMC .>/8]<4
M=9161#XCL[C4]4TV..X-YIJ))/%LY*N"5*G.#D*:@M/%VFZAIVFWE@)[K^TE
M=[6)$"NZK]XX8@ #CJ>X]: %D\/W-SXC.HW>LW,VGJR20:88T$<<BC 8L!N;
MGY@"< \]AC=KCM6\=+:/H(M-.O)1J=ZUN2T6#'LW[EVDYW90C'ID^F>O5\Q!
MRK#(S@CD?AZT .HKE[+Q]HVHWWV2V2_<K=26DLALW5(9$7)\PD?(.O7'0]N:
ML1^,=,;4-/M9$N8%U+/V&XEBVQ7! SA3G()'(W 9[9H Z"BO,7OD\4>(O%5E
MJ:ZS;6U@8%M9;0.LEK^Z\QG 3/S$GT.1@=*WK3XD>'Y]-^W!K\6*VOVG[7):
M.(W&\)M#8P7W$#:.Y]<B@#L**QK/Q+9W=_>V#PW5O>V<2SRV\L67,;9VLNPL
M&'!'&3D=*PM)\6^&M&\':/=V]QJ#Z9>W)MK66X225R[2LOSL<X&<XW'H/PH
M[:BL71_%%AK6I7FG0QW<%Y:*KO#=0-$S(V=KJ&ZJ<'W]<5M4 %%%% !1110
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M XP2.N1QSQ5?Q:-8UC0O%5G-HFK&]BU!6M8;6V80/;K+&1*"N!*[*"3G<1V
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MQ?OKS[)=K:2:/% MPULZQF1978KN(QG#"NTHHH **** "BBB@ HHHH ****
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M6"[>U81;R"0A;^\<'@9YXZUT6JMLTB\.R1SY+@+&A=B<'@  DUY>MI?)\-O
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ML_L]L[^:%7) XY;MMZ@]<5+_ ,)II[6,EY%::A)%!;I<7($&'MU8;@'4D-G
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M.WU&7R;.\>/]S.YY"J<YYP=I( ;L35&?XDZ%#;7]P(]1DBT^X:"[9+*3]P5
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MUR*Z>@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MI7,:!K/A#Q'JFG:I:0W\FI6"2-(UY-<?\2\,A#AS(=N3PN.<]>V:M_"'R?\
MA6FE1H%$L?FB1<89296/(ZC(P?RH ["_U"TTNT:ZO9UAA4A=S=R3@  <DDD
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M@LQ(ZC .3[&M5=0T2PUWQ+H7BY-0!U*\>>T\I[@Q7T$BJ JB,X9@!MQCT]*
M/6E970.C!E89!!R"*XU=;OO$GC?4M!TZ[>RT_1XX_MMQ$JF66:0$K&I8$*H
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M#Q<E]:V^J&*6SDADG\F9/)6-H<1=2"I&,<Y^E '<7_C;PUIK[+K6+9&-M]J
M4E\Q<?,-H.0<C'KVK:M;F&]M(;JWD$D$R+)&XZ,I&0?R->;V<6FV'Q*\,6MO
M:BSMX=%GBAMY6+-"6="B$DDABN>"<]17;V/B32]0UV_T2VG8W^GA3/$8V4 $
M C!(P>HZ>HH T;FY@L[:6YN9DA@B4O))(P554=22>@K/M?$FDW=U):I=>7<1
MQ>>T5Q$\+>7_ 'P' RON.*P_B?:W]UX+E;3X)+AK>Y@N9K>,9::*.1690._
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M7FH@TC3?&/P^MK"T-C8P1Z@8H)F8M$) NPMOY4MR0&YYQVQ7J0 4    = *
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M 4444 %%%% !1110 4444 %%%5=1U*TTJT-S>2^7%N5!A2S,S'"JJC)8DG
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MI3=6I*SQ/ Z&(C'!)&,\COR#D<5S.OZU_8GQ/TQKF^NQ8RZ7<.UK'OD5Y%=
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MN>5<Y5%QEL8.2,@8//!J.T\5Z/>6=U<QW+*+286]Q%)$RRQR$@!"A&XDDC
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MJL@R26"D[3G ]#0!W%%<E;:MI?A#3[J*[U35+VW@D,LDUQ').;-'P51W"D@
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M6:VYB8^<[.2DJMC!3Y@Q;.!@YK;FB>P^(OA&&4S3"RTJ>WGN1$Q0.1'C<V,
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MSZ9(Y:2QU67P=K-A::?>O?:=XCDU&2V,#*+B);CS J$C#DCY@ 3]WW&?9Z*
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M-)%;P1-([*N-S8 X R.3W..M9?A(:5<-?:GI&EW%K#=E-US<HZ27+*",D/\
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M8YCITT/FA(_E4*4ZMM7+[?4D5FV-TB_$@ZDJZO<VEQX?:,7ES:2*'<3;CQM
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MI9:3[7)$9E40N5V X)+8VCD]"<T[4-1M-+M?M-Y*(X]RH."Q9F.%55&2Q).
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M<.C12W U!8!<&&6SFB(CSC=EE QGCKUXJY8:I::F;D6K2-]FF:"0O$Z .O4
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M>>^#8M0T[Q*-.M-4GUCPZ+(O%->1?OK)]R@0ER 6R,G:>1M&<=_0J "BBB@
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M3X@LM7NKRSB$L%]9,JW-K.NV2/<,J>"001T()!K3D?RXG?:S[5)VJ,D^P]Z
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M]LQN(Y JA4)'S1HW.6&#P,D#-9HT_4X_A]>:8=#U6.X7Q'YZQFV9R8_M(DW
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MI'AC1%*L778V[(ST/;%;M '!ZFLOC'4?"LUO8WUH=/O1?W;7-L\1A"HP\O+
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M8[)O+!3C!(W#IU[9H Q?#]Y;^(;6]U[69-3LI=/U6>5+J-RBB..38L& 3N!
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MQHY'C$D;2#*LN1GIT(XQ42W.I'5=)LKC2=5_LUM&C5&M;=D=[@'#1ROP8P
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MH/,;139R?OPUN(QM^7GYAC]>E '=W'B"RA:SC@\R[N+V,S6\%N 6DC !+\D
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M:9JTC17QD16LTA2,B-61RP/WB0H(.X\DFNP7Q5:3:Y:Z%J&GW=E/J$+O:_:
MA6<*,NHVL<, <X..* .CHKSOP4K>'_'?B/PQ=S32M(5U'3Y9Y6=FMVX* L3P
MC#'XYK5T^2QLY?$/B^ZDD2S5G"?.S*L4(P[A,XRSA^0.0%]: );+P7+IC-#8
M>)=8M]/:1I/L8,+A2Q+$*[1EP,D_Q9YZUTMM;0V=M';0)LBC4*JYS@?4]?K6
M'8^+K>\U6+39;"]M;F>R^W0+*$/FQ @'&UCAAD<'UK*C^)NF2:9#J@TO5ETY
M[HVLUTT*!+=_,\L;_FSC=_=!QGG!XH [:BN43Q1?2?$:;P\-+G^RPV23F8/'
M\V]]H<Y;(4;2,#GKQTIUGX\TZ\DTMEM+Q+/59WM[.[=4V2.N[@@-N4':V,CM
MSB@#J:*YO4/&EC8+JTB6MW=0:1C[=+ JD1';N(P6!8JI!..@]3Q4\?BBWN+>
MR>TL[N>XO86GAM@$5_*&!O.Y@H7YEQSSN&.^ #8N83<VDT EDA,B,@DB.'3(
MQE3V(ZBLW0- 30K5T-[>7]S)CS;N\DWRR8&%!(   YP!ZD]232^'?$5EXFTZ
M2[LQ+&89WMYX9E DAE0X9& )&1QT)'-<M\65*:'I,L4DL4K:O:PL\4C(Q1FP
MRD@C@^E '?T5S=]XKL]*U^/P]%IE_/>&T:YA2WB7:ZJ0NT$L #SWP..O2JDG
MQ$TV+PHWB%K#4?LL5P;:ZB")YEM('V$."X&-V.03UH Z^BL^?5XX-2MK)[>;
M=/"\YD!39$B;<ESNSU8= ?TK(/C>PCNM*6>TO(+/59!%97KJGERNPR@P&W+N
M'3*C\* .GHK!M_%,%W+$;:QNY;26[>T6[388Q(A96R-VX#<I&<=?8@G*T'QK
M)>MXEN-5L9;"QTJ\DB,TCQE8TCC0D-M8DL26;@$8(&2: .SHKGD\76R:AIUI
M?6-[8#4N+.6X5-DC8SL.UB58CD!@,].O%5;+QW;:CJLMA::/J\KP7WV&XD%N
M-D#;0=['=PO/7KQR!QD ZNBF2Q1SQ-%*@=&&"I[UX-I=]:_\*F>>'6+T^*S/
M,MDEO>R/<R.LS!%\L,2RX !R,8YH ]\K#T+PXNAW^JW:WLTYU*X^TRK(J@*^
M ORX'3 '!S3H=6GT[0=*?5XV;5;F.*)K>$#=)<%-SJN2!QACDD  &N>U_P 1
M6>O>$?&.G&&ZL]1TRPE:>WE8*ZYB9HW#(Q!4XSU[<B@#NZ*Y'1M?AT[P_P"%
MM-6WGNKZ]TV-XH8=H^5(DW,68@ ?,HZYY^M4]8^(!'A33=8T?3[B87NH1V3+
M)L5H&\W8ZL"V"V0P&#C/).* .ZHKEIM1TJ7QUI%O=:9>Q:RUG,]O(Y&R./Y=
MZG:Y4G[O0'ZTZ[\<6%I8W&I?9+V;2;:8PSW\2JT:%6VLV-V]E5L@D*>AZ@9H
M Z>BN:O/&EG;:^NBP6%_>7<ED;V'[-&I29-RK\K%@/XNIP..O3)9>-].OM$M
M-1B@N5>ZNS8I:2!5E%P"P,9RVT$;&/7H.,GB@#I:*HZ9J7]HI<;K2XM9+>8P
MO'.%SG:K9&TD$$,,'-<QX_UR]L[G0/#^FSM;7>N7GD-<I]Z&%<&0KZ-@@ ]L
MT =K17,ZEX*L+C1;FTT]I[&\DA9([R*=Q+NQP7?.7'J&SFKMUXA2'4)]/M+*
MYU"\MH5FN(K;9^Z#9V@EV4;CM.!UXYQD4 ;-%<G+\0]%32=)U.)+RXMM3NEM
M(C%#EHY22-KKG(((;@ GCCM3HO&T<T>MQ+H^H1:AI,(G>RN/+1I$8$JRL'*X
M.TYYR,=,\4 =517&Z+XV>;PKH%_J-A<B^U81QP11B/\ ?.R;R5^;"J "?FP>
M.F:T+;QGIDVE:C?S)/:_V==&SN(95!D$P*@*H4D-NW+C!YR* .BHKF9/&*Q7
M=_8/I%_'J-K9?;DMI#&/.BSC*N'*@@\$$Y],U-X*UN[\1>%-/U.\M)();B%9
M"6*;7W#.5VL3CZX/M0!T%%%<$/$5YK\GC'2[G3+FWMK!3"CB5!M_=;\L5?=E
MLC&,C&,XYH [VBO.? _BZWL?"W@_3;JQOT2^M8K>&^:-?):;R\[/O;LG!P=N
M#ZUT6K^-+/2+>]NVL[RYL;"3R[NY@"%83QNX+!FVY&=H..>X( !TE%1P317-
MO'/"X>*50Z.O1E(R"*X2PO)/&?C_ %ZRN9)!HVA>7;K:HY5;B=@2S28^\%Q@
M*>.^* ._HKG_ /A%K>'6(+JSEF@M/(E@FLDF=8F#;2&50<*PVXXQP37%?#SQ
M=!HW@'PS;WEEJ#0W4S6IOP@,22O,^T,2VXY/\0!&3USF@#U6BN9@O]&;XA7T
M'V2XBU>'34:6YD)$36^\X ^;'WMW.!TZTA\<6$=SI0GM+R&SU640V5ZX3RY7
M8908#;EW#IE1^% '3T5YKM7Q?X[\2Z-K.CW<ME;P6L4&YXA]DW"1C("'R&8X
MP5R?E&<5Z&+2+[$MHX:6)4"?O&+%@!W)Y)]Z )Z*\;\":EX;7X>K=Z_J#RWB
M27 </>2>:P$K!0/FSG& *[^\UZU\(+H>DWD-_-'<-'917QV%/,Q@>8Q8$$XS
MG'/UH LP^&D7Q'+K%QJ>H766WP6DTH,%LVW:610.N"1R3]X^M;E8L/B:TDT>
M?598+F"TCE,4;2*I-P=VQ3&%8Y#-@+TSD=C5>'QC8_VS<:3J$%QIMW#:&]Q=
M%-KP X9PR,PX/4'!_"@#HJ*YN+QE;27^F6KZ=J$*ZHCO8S2(FV;:N[!PV4)7
MD;@/?!XJ"3Q_IL7A2\\1-97_ -DL[A[>XC"1^8C*^QCC?@C=Z$T =717*2^*
M+Y?B/'X=32YVM?[/-TTJM'\Q,BJ&P6!"K\P/<D].,FI8>)-$TW3?%&KV&DZD
M%LK^0ZD@ ,C2*BEW56?[H7' QTZ4 =M160GB"&6VTB>*UN95U3'DA-A* H7W
M-\V,;1U&>P[BL[4/'6G:; E[/;79TIKG[,VHJ$,2ONV9(W;]NX$;MN/PYH Z
MBBBO/?"=Q_PGFI:]JFI[I=.M+]]/L;(L?*"Q@;I&7HS,6[YQC H ]"HK@(]1
MF\+?$ZT\.Q/+-I.KV<D]M;NY8V\\>2RH6/",H^[G /3 K-TE!XOO?$<NK:)J
M$T]EJY6UFBEA22V$21[8D;S 5.2Q./E.X\T >HT5XS8C1];^'!\4>*]&U&:2
M%KF:>ZMY%5[A#+(ICRCAMBJ ,-@#:,<5Z6=<M;46%C9VL]S<SVWG16L17<L0
M &YBS  9(')R2>,X- &W17.V/C+3]1TJUO;>"Z,MS.]M'9L@6;S4SO4Y.T;0
MI).<<=>15"Y^(^E66DZS>W-G?QS:/(L=[:;$:6/=]QN&VE3G@YH [&BLO2-9
M_M=[L#3;^T2!PJ/=Q;!.I&0R<G(^N".XIVIZU;Z;<VEH8Y;B]O"P@MH<;G"C
M+-EB % QDD]P.20* -*BN6D\>:;!I6LWD]K>QS:-_P ?UF8U,T0QN#<-M*D<
M@@XK0T+Q"NO-,8],U"UA1(Y(Y[J$(DZN"04.3G&.<XZCUH V:*Y;QAXEO- N
M-#@M-/EN?[1U".V:1&0;1@L5 9A\Q"D=@.><XKGX]0?2_BIKLT6FZA=RRZ3:
MR_9(2'<,6?/+-L&,#^+'IF@#TFBN?L_&&G:CHFF:G9)/.-3R+6W"@2,0"6!R
M0!MVMDDXXZG(S/H/B6TUZ6_MHX9[:]T^80W5M.%WQDC*G*D@@CD$&@#9HKC?
MB+X@O=(T_2].TN7R=0UF_BL(I\ ^0&/S. >X'3Z^U:$_@S3'TN6UMVNK>Z>,
MH+]+A_M.XC[QDSEO7!X]J .BHKS62671?BO:DV]U?7)\-8:&V.XR2"9 2-Q"
MJ..I('XUH:UXK\.ZQ\.Y-6U+3[^;2WF6*>V"[)8Y%E"[6PPQAP.AH [JBLG4
M-=6SNY+.VLKF_NXH1/)#;% 40DA22[*,DJV!G)P:X[Q5XS75/!NC:AH<5U-9
M:KJ%M \B%$.TS!7B(9@0QP5].N2!0!Z/16-H.A6&D?:KFQLI;#[<XEEM&<;(
MV Q\JJ2JD]3M/-<5XAETZU^,=E#J5V;?3YM'>5T:X:.-I1+@-@$#=C- 'IU%
M<#=R^&+;P1K6L[+Z^T"[1DG@BE=\B-G1F0E@5!QV(Z9[UKW7BZPTJ_TK2$T_
M4)9KVV:6U6&(,&5%!VY+=>1R>/4B@#IZ*Y:#QYIDOA^[U66VO+<VEY]AFM)$
M7SEGW*H3ABIR67!SCGK4\?C"UWZU#/8WL-UI$237%N55F9&4LK(58@C"GN,8
MH Z*BN1LOB#87LNB'^S=2@M=9"BUNYHE$9D*;Q&?FW X!YQ@D<$U9U3QK8Z9
M;W]W]CO+JRTZ417ES;JI6)N,C!8,VW<,[0<<]P0 #I:*Y@W^C3?$.VMC9W)U
M?^S'DBNCD1&#>N5QNY.XC^'MUIMKX\TZZ?3'6TO%LM3N7M;2\94\N21=W&-V
MX [&P2.W:@#J:*X?PW&(OBKXT52Y4P6#89RV"5E)QGI]*[B@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "N2^(=A>WVB6$EA:2W<EGJEK=O#%C>R1R MM!(R<=JZVB@#B(TO7^*D>L
M2Z9>161T,VS2&/<%E,P?8=N>=O<9&>,FN4C\/:XGA:UNHM$:YN],UZYOFTVY
M4#[3!(9 =N>-VU\CT(]<9]BHH YSPNXN_-O(_#)T.%E"A)X8XYY#W)"$X4=L
MG)YX&.6?$*VN;[P'K%A96TUS=75L\,442Y)8C\@/<UTU% '':?KNH6'ABQM8
MO#6K/?16L<(C>-%0.% ^9MW"@]2,\4U+6]3XMMJ+VEPUD-#6T-T(CL,PF+D>
MO0]>G;.:[.B@#R^V\/:GJWA;QUI!M9[.XU/4KBZLGN(\+(I";"3VR4Q@\X/2
MMCPK<7%_=6OVCP,-%NK<'[5<RPQ!-VTC$+*=S9/?  &>3Q7<44 </X_\/:K?
M7>BZWX=81ZQ8W'D;R./(F^1R1WVY#?@:VM8M;_2O!%U:>&H5:^MK/RK*-\')
M5<#KP3]>">M;U% 'F6F6FH)XZT36AH&JQVYTR:"YGNV5Y1(61B7^8G'!P!]
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M_:+(<+(R'E">P(_4"KUGXDN;V!4'A_5(+XC#07$05$;WER5*^X)..@[5T%%
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M>06B03LGR.T:N' /U8=>O:NQHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M38 "=S#@$@$9Q6WX8M_#&@>)M9T_3[*\L[JUMDFN9;J4F)82SLJIEB J_-T
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M\&TJ3RKVS$:F:%NV1NVD'((8$@CO535;6^M?'^E>++:SN;FP>PDT^[A2,^;
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MQ;&>,CDYZ8Z[7AV;Q!H'AWR[ZWU'6<ZEY%HTFT7 M"0%DESCD?,3GG&,XYP
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ML%^4G<1G@G&/K77:WXXM=)_M)H;<72Z8,W8%PD;#Y0Y5%8_.P4@D<#G ).0
M#JJ*JZ;J-MJVEVNHV;[[:ZB6:)L8RK#(X[=:Y'XC:U>VBZ%H>GW#VMQKFH):
M/<QG#Q0]9"I[-@@ ^YH [C(SUIN]=X3<-Y&=N><>M<[>^!M N='GL(+"*T>6
M)HUNH%VSJ2,;O,'S$^N2<]\YKFI6ETGXPS/9Z:][>2>'(RT<!5/,<3L"S,Q
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M"*2Y()'0COSCWJA\.=+MM4\-^']>O]-"ZI#;EX[[S/GF,H.\MM/.<YPV>>:
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MVUT@W$9!*NZ#E48#(.>XR!0!T]%<M=^,TALM2U*TTV>\TW397BNIXG4-E/\
M6&-3]\+SGD=#C-2-XQMCKNBZ?%;/+;ZS"TUG>JX\MPJAR,=<X.0,<_G0!TM%
M8%UXI@LDOY;J!DBMKI+2)Q(O^D2MMPJYP!C< 22 ,-Z&LU?B#:K=:O93V,C7
MNFV?VXQ6TT<JS0#JR-D#(/!!P?3- '8T5SWAKQ+/XBCBN!HMY9V4]I%<PW,S
M)MDWC)4 '((]QSU],[5Y-+;V4TT$/GRHA9(MP7<?3)Z?6@"5W6-=SL%7IDG
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MV(M*\ZXMM7M[ZYCMY8PD,:,Q*@LR[B 0,@<D$\5W",616*E21DJ<9'MQ2T4
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M8R6;Z-+)%<0S2+NRB[B>,C:01@]ZH75AK%WXY\*ZH=(E2VL[2YCN6$T1\II
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "HKFWCN[6:VEW&.9&C
M?:Q4X(P<$<CZBI:* ,O0?#^G>&[#['IT;JA.YWED:1W.,99F))X  ] *U***
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MZIYVRX#*$3RT+D8SDGIV YZU=UK4O[&T6]U(VTEPMK"TS11%0Q"C)QN('04
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MI8 OEN, <XJ[0 4444 %%%8WBOQ OA;PW>:R]G+=I:IN:.)E4X]<D]/ID^U
M&S138W\R)'QC<H.*=0 45$MQ"]S);K(IFC56= >5#9P3]=I_*I: "BBB@ HH
MHH **** "BBB@ HH/3IFJ6DW=U?:7!<WNGR:?<R E[6217:/DCDKP>,'\: +
MM%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !6+XO\ ^1*U[_L'7'_H
MMJVJI:MIL>L:7<Z=--+%#<QM%*8B Q1@01D@XR#]: ,CX??\DY\-?]@VW_\
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M,K+W..<G)'; P*Z+6=1NSXB\4V>H7MW9I!812:/]GE9-Y*-N8!?OOY@ VG/
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MEM(RNXA8*6*L&')![@'CTJ*7PW!-XAM-<DO+LWEK T$?*!2C8+9&WN0#_+%
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M0& 'S+VV].O&3FO2KWP[;7WB'3];DN+E;JP5T@5&78 X ?(*\YP._;C%9_\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M%.1D#C.*I75I?:''X(\0V6K:E-=7]U:6=[#/<L\4\<J<_(?E4KC(P/4G)YH
M]8HKRVUBUCQGH6H:A:ZG'8:C!J,Z)=?:I ;3RI2 AC'RXV 9!Z[LFKD.GMK7
MQ'U[3KS4M1:R.FVLWDP7DD:!V+Y*X(*CC. 0/7- 'HU8.F^(I+_Q=K.A267D
M_P!G10R+-YN[S1)NQQCY<;?4]:X#P_XBU#4=#^'FDWU[.5U9KH7=QYA6258
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M6;&X%S;-.[")H@I$BDG*$[MIP1GKUYH U_$OBZ/1/#+ZW96RZA EP+=]LNP
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M]]@(&?S(_P BO*O%5]<0Z1K>KZ;J%Y=3VFLQ*+XS-$EO^]C0V\: D.!DAL@
M[CU(K<BTVW?XX7LF9PQT2&8[;AQEO.<<@'D8 XZ>U '9Z=<7]Q]K^WV"VGEW
M#QP;9A)YT0QMD.!\I//R]L5=KR Z_J.C>#?%,D=]=%AXH>P6ZFE,C6\+/&I(
M9LXPI('H2*Z/5XYO#WCGPS%ID]U]DU5IK6\MGG>0-MC+K*-Q)5A@Y8=1UH [
MRBO$;D7D/PQU[7AJ^JMJ&EZM/]DD:]DP@2X"X(SAP5X^;/'3%=-XWN[_ $W5
M-0O+ZTOKOP^]JL1NM-N&$VF. Q9S&",@AE;<.0!SQ0!Z.Q(4E1DXX&<9JII5
MQ?76EP3:E9+8WCKF6V682B,YZ;@ #1NAU'1P\,[F"> ,DT3E&*D9# CD<5YG
MHMSK]Y\+O"=_:))J\J[IKVS>Z*37<?S@D.3\Q4LIP>#@>U 'K%%<WX&U*QU3
MP\9K"2^*+<RI)#?;O.MY-Q)B;<2?ER .>F*Y*VBUCQIHVIWUKJ:6&H6^I3QI
M<_:I ;/RI2 AC'RXV 9!Z[LF@#U&BO+_ !S/>^']4LM<M-4NFM[JV:#4H$EE
M>.WB; -VB9PNPD?7/'<U=\7V[6D?@RWTW5]0C@GU2*W:9+QW::-HW;+,2=Q.
M 03F@#T.BO*IK6\\/^*/$>A6FJ:E)IDV@/J4?FW<CR6TRL5^20G< <9Z]JAB
M>?1/A[X?UX:K?O=ZM#IUI=2W-X_EQHY7<X_N''R[ASSGKDT >MT5P4N@Z]87
M>KR66LV]C'>Z9)'!:/<22K'<CI.K/]T?, 0!UP>M9^E:E<W;ZOI/D7OA[Q,N
ME.%@NKAI;<GHMQ&Y)!PQ&3C/3.<4 >DSM(D#M%'YD@!*H6V[CZ9[5D>$?$'_
M  E7A6PUO[-]F^UJS>3OW[<,1UP,]/2N<\&ZJLOB.73=0T_4-(UJ*SS+93SM
M-!.H8#SHG)(//!/7D9SBN:T6POY_@1H6HZ5/=I>Z8INUA@N'C%RB2L7B8*1D
M,H/XXH ]CHKEM U"#Q1K#Z[8W,S:;%:QPP*)6"22.!(Y*9VDJK(N<9!WCM74
MT %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 5F:_P"'],\3:6VG:K;">W+!QABK(PZ,K#D$>HK3HH P
M[/PCH]IHUUI;P27=O=KMN6O)FF>88P S,2>.WIVQ3]/\,6&G2V\JO<SR6L9B
MMFN9VD,"' (7/?  R<G'&:V:* .<'@?11I&HZ5LN39ZE,\]U&;E_WCORQSG(
MSW JQ+X5TV:]TN\D-T;C2U9;1_M#_(&&UL\_-D<<YK:)(4D#)QP/6L+PKXBD
M\1VVHRRV8M'LM0FL602^9DQD MG ZF@",>"-&&E:GIFVZ-IJ<SS7:&Y?]X[_
M 'CG.1GN!BIY/"FFRW>E73FY:;2@19M]H?Y,C:<\_-E>.<\5=N+G4(]5MH(+
M!9;)XY&FN3.%,3#&U0F/FW<\]L5G^%?$3^)+*^GELQ:/:7\UDT8E\S)C.TG.
M!U.: *EY\/?#]\^I^=%=>3J;%[FW6Z<0LYQE]@. QP.<?K5Z/PIID.K6NIQ_
M:A=VMM]EA<W+MMBX)7!)SR <G)XJ]/<7Z:M9P0V*RV4BR&XN3,%,) &T!,9;
M=S],5-;WEO=27$<$JNUM+Y4H'\#[5;'Y,I_&@#!?P'H<FC:AI#QW+66H7!N;
MJ,W+_O)"=Q.<Y&2 2 <<4_6O!.CZ])93W:W2W=DNR&[M[EXI@IZJ74@D'WKH
MJP/%?B*3PU8VETEE]J6>\AM6_>[-GF.%#=#GKTH 2[\%Z)=KI@\B>!M,+?99
M+:YDBD0-]\%U(8[N^3DU"/ /AU=*U/3!9R"TU*;SYX_/?A]P;*<_)\P!XQTK
MIJ* ,1O"FF/?Z7>M]J:XTP.+5VN7)7>,.6R?F+#J6S4<W@[2);J^F5)X4U Y
MO8(9V2*X.,$LH/4C@XQGOFM^D.0"0,GTH R9O#>G3:U9ZN4E2[LHC#;F.5E1
M$.,J%'&#@=NPJI'X*TB&.Y2(WB&XO/M\CK=.&\_^^#GCMQTXZ5)X6\12>(X-
M3>6R%H]CJ$UBR"7S-QCP"V<#J36]0!0T[2+739+F:+>]S=.'N)Y6W/(0-HR>
MF !@ 8'YFEO](L=3N;"XN[=99;"?[1;L?X'VE<_DQ_$ ]JO55>^B^TSVD+++
M>11+*8=V#M8L%)/8$JWY4 1VND6-EJ=_J-O J75^4-Q(.K[%VK^0JG!X5TJW
MN-6F$<KMJXQ>K),S+*-NWH3Q\O'&.*;X0\0GQ5X7M-:-K]E-P9!Y._?MVR,G
M7 S]W/2KXN+_ /MMK8V*C3A;AQ>><,F7=@Q[,9QCG=GVH QT\":)'::;:J+P
MQZ;*LUKNO)&*.HVJ<D\X7@ \ =JT+/P]86.N7NLPB;[;>JBW#-,Q5PF0HVDX
M&,G&/6M6N=\7>*'\*6-K=FP-W'<7,=J DH1@[G"]1C&?>@"[>>'K"^URQUB?
MSC>V*NMNRS,JH' #?*#@Y &<^E4AX(T8:;JFG[;HVNJRO->(;E_WKM]XYSD9
MP,XQTIEGXOC;Q0OAO4[";3]2E@,]N&=9(YT'7:P[C!R"!72T <[>>"M'O9=.
MG;[7#=Z?'Y-O=07+QS"/^X7!RR_6HT\ ^'%TC4M*>RDFL]2F:XN8YKB1]TA.
M=PR?E/ Y&#P*GC\1R-X[E\-/9!%33Q?+<^;G>#)LV[<<<Y[UI:9<7]S#,VH6
M*V<BSND:K,)-\8/ROD 8R.<=J .4U?PE9Z'X!\06>DP7UW=WEA+;H9))+F5R
M48(@)SA03TX S5_POX>MH]&T.XN5O'GLK9!%#=LW^C/LVMA6[]0"<X!(!P:Z
MFB@#EI_A[X=N->FU@VTR3W#![F**X=(;AAWDC!VM^(P>^:TD\-V$>MW>L1FY
M2^NXA#+()VP4&=H S@8R<8'>M>N9UOQ/?:1%JUTFAR3V.F1&66<W"IO CWL%
M4C)P#^= #6^'WAX^'[71!;SK:6DWGVK+</YMO)DG<CYW Y)[]ZL6?@S1K.^O
M+SR[BXN+V 6]RUS<R2B9 ",,&.#U/4=^,56L/%.IWUII]V/#SK;:A;^=!(+I
M2!F/S%5AC*Y'?FM#PGKW_"4>%M/UO[/]F^V1F3RM^_9R1C.!GIZ4 4M"\!:%
MX<F:33DNEPK+"DMU)(MN&Z^6K$A?J.:/^$"T(^'GT$QW7]FO-Y[0_:I.7W[\
M[LY^]SUZULQW%^VLSV[V*I8+"K1W?G EW).Y-F,C P<YYS5V@#'D\,Z9+KT&
MM.DQOX8!!Y@G=1(@.X!U!PV"21D=:MZKI-AKFG2Z?J=K'<VDHP\;C@^A'<$=
MB.163XL\4R>%UTU_[/-VM_>1V,>V8(5E?.W.1C;QUS^%)IWBZ*X\3R>&]0L9
MM/U40?:8D=E>.>/."R..N#G((!H LV?A>TM!&C7>HW4,9!CANKMY47'3()^;
M'^UGI3KSPSI]WJ_]K*;BUOVB\F2>UF,9ECZA6QP<=CU'8BMFL"U\1R7'C:^\
M.O9>6+:SCNEG\W=Y@9BN-N./NGO0 ZY\(:/<VNF6Q@DB@TR59[1(9F0)(,X8
MX/S'D]<YR<]:2?P?I-S>ZE=RK<M-J4(@NB+AQO09V@ 'Y<9.",'FM'2[B_N;
M,R:E8K93^8ZB)9A*-@8A6R .HP<=LU=H R;?P[8PW$MQ+YUW/);_ &4R7+[V
M\G.2GT)Z]SQDG K)M_ASX>MXK"()?2)I\PFM!)?2DP$ @*AW951GH.N!G.*Z
MRB@#'M_#.FVVJZEJ2)*UQJ:JEWOE9ED5054;2<# )'%9H^'GA]-.L;)([Q%L
M)?,M95O91+#QC:K[LA<<;0<5O:M>R:;I%W?10?:'MXFE$6_;NVC.,\XZ5#X=
MU8Z[X;TW5C#Y)O;:.X\K=NV;E!QG SC/I0!D/\/?#LEGJ=H;:X%OJ;A[N,74
MF'(QG^+C.T$D<G'.:T9/#.GRZMI^J2-<O>:>C1V[F=OE5@ P(S@YP,Y]*V**
M .<7P/HD<=['%'=1+>7/VIQ'=R*$EWA]R#=\F64$XQG'I6GI^CVNG7-S=(9)
M;NYVB:XF;<[A00H] !D\ #J3U)K0HH Q[[PU87NKKJP,]MJ B\AKBVE,;21Y
MSM;'##/3/([$5#=^#M&N['3[)H)8[?3YUN+9(9W3;*"2')!RQR2<G.2236]1
M0 @& !DG'<U2&CV UTZU]G7^T#;?93-W\O=NV_G69H_B2?5=7\0:<=/$4VDR
M)&O[[=YQ=-X[?+P1ZUKZ9->7&F6\VH6BV=XZ S6ZRB01MW&X<'ZT 4I/#6FS
M:^^MR)*]Z]L;1B96V&$G)39G&,\]*RH/AQX<MX;&%(;PI83>=:A[V5O)X(VK
MEN%Y.5'![YKK** *.KZ/8:[IDNG:E;K/:RXW(2000<@@CD$'D$<U%I^A6FGW
M1N]]Q<W?E"$7%S*9'$><[03T&>3W.!G.!5P7EN;YK(2J;E8Q*T?<(20"?J0?
MR-3T <L?A[X>_L>?21#="PFF\YH!=R;5(?> OS?*-WS8&!FM(^'+ Z_#K;&X
M:_A@-LDAF;'ED@E2N<') /2M29I$AD:)!)(%)5"V-QQP,]J@TV:[N--MIK^T
M6TNWC#36ZRB01MW7<.#]: ,#3/A[X=T?56O[&VFBS(9EMOM#FW20_P :Q9V@
M^G'';%:FD^';#1+J^N;/SQ)?2^=<>9,SAY.!NP3@'  X]*U:Y?3?%%_K#V%Y
MI^CBXT6[FEA^U+< 21A&91(T9 &TE3T8GD<<XH O^(_"VD^*K.*VU2!G\F02
MPRQR&.2)_P"\K#D57E\$Z+/X;ET"6*XDL9V#S[[ES),W'+R9W'H._8#H,5T-
M% '.:YX(T;Q ]G->K<B[LQM@NX+AXIE4]1O4@D?6G:EX(T'5-%M=*GM&6"T?
MS+9XY666)^N\2 [MQ))))Y/)S70T4 8+^#M&E\-SZ#+!++9W!#S-).[2R.""
M':0G<6!5><]@.@IR>$]+CU6QU,&[-W91M%#(UU(WRL<L&R?FR>23DFMRL^?4
M6ETR]N-)B2_N8/,C2'S-@>5>"FX\#GC/:@"M>>&-/N]7;54-Q:WSQ"&6:UF,
M9E0= V.#CL>H[&H[GPCH]S!I<'D210Z7();1(9601N,@-P>3R>N<Y/K6S TK
MV\3S1B*5D!>,-NVMCD9[X]:DH Q5\+:<NIZCJ*FY6ZU&-8KEQ<-\RJ"% &<#
M )QC'6J<_@+P_<^&K;0);:4V-HP>U_?OYD##H4?.X8^M=-10!G:-HMGH5F;:
MS$K!FWR2SRM+)(V,99V)). !]!69JO@30M8UK^UYXKF*]9!',]K<R0^>@Z+)
ML(W#_P#5725@>+O$<GAC28K]++[4K7,4##S=FSS'"!NASR>E $]_X9TR_N;*
MZ\M[:[L5,=M/:N8VC0C!3C@K_LD$5#>>#M&OM#DT>>&4V<LWGS!9W#RR;@VY
MW!W$[@#U[#TK>J">\M[>>V@FE5);ES'"IZNP4L0/^ J3^% &?)X;L)=<MM9=
MKEKZVA,,4GGM@(<9!7.#G SD5GR^ ="FTW4-.D2Z:UU&Y^UW2?:I/WDN0=V<
MY'*KP,#@5M07%^^K7<$UBL=C&B&"Z$P8RL<[@4QE<<<]\U=H R)/#=A-K=IK
M$C7+7UI$8H9#.V C8W C.#G SD=JJ#P1H?\ 9NK:>\$TEKJTK37B23NV^0XR
MXR?E/RKTQT%=%10!SEKX(TBUU*VU(-?2W]O"T*7,UY(\A5NNXD_-TZ'@>E,_
MX0+0CX>?03'=?V:\WGM#]JDY??OSNSG[W/7K6_;7EO=F86\JR>1*8I-O\+@#
M(_#-3T 9(\.6 \01ZZ3<-J$=O]E60S-CRLY*E<X.2,],YK.L/ 'A_3-7?4+2
MWGC+2^?]F%P_V=9?[XBSMW>G'';%=/10!REU\.?#EVFHQRV]SY.H3?:)H5NY
M%C$NX,9%4-A6) Y'-:+^%=*?6;75O+F6\MH!;JZW#C?&#N <9^?#<_-GGFMJ
MB@#!@\&Z)!I^J6!MGFM-4E>:[BGE:022-C<W)X)P.F,8&*FL/#=C8313"2ZN
M)H(C#!)<SM(T*'&0I/3.!D]3@9-;%% '--X#T)M!O-$:.Y.GWDQGGB-R_P [
MEMQ.<Y&3S@&K-QX5L+F2Y9Y[T"[B$-T@N6VS(!MPP[''!(P3ZU>N=2CC%[%;
M!;B[M(A*\ ?;PV=H)[9VFJOA77/^$E\+Z?K7V?[/]LB$OE;]VS)Z9P,_E0!H
MFTB%E]DC!BA$?EJ(CMVKC  QTXK%M/!FE6&G:?9637=M%IS,UH8[E]T>[J,D
MG<.3PV170T4 4],TNUTFW>&U0@22M-*[,6:21CEF8GJ3_P#6' K"N?A[X=N=
M>FUAK:9)[A@US%%<.D-PP[R1@[6_'@]\UU-% &8^@V,DNI22"5VU&(0W&^5B
M"@! 50?NC#-P/4UQ7BCPO#86GA+2-*M=2DL;'5HYW,32RFWB".,A^2,$C S^
M&*](HH QQX:T]H+]9#/++J$8BN;AY3YKH 0%R,;0 3P,=2>I)I!X5T<^%_\
MA&Y;8SZ2(A"()I&?"#H Q.>,#'.1@8K9HH YG3O >AZ;IEW81I=S174)MY&N
M+N21Q%_<5B<H/]W'Z5:?PGILZ7(NS<W3SVK6;2S3,76$]4##!&3R3U.!D\"M
MRB@#)M_#MI;W+71ENIKKR#;)<33%I(XR<E5/;) )/4X&2<"LLQ#P-I%AI.@:
M!J&HVS.R1QQ3!A!GD;FD;(4DGGG'/L#U5% &5X:T6+P]X>L],B2-?)3+^4N%
M,C$LY [ L3@5JT44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M?S?-OY1+-OE9AN"A?E!.%&!VIVKZ5;:WI<^G7OF&UN$,<JQR%"ZD8*DCG!%
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M"/[6 DZW/GFZD,S2@8#&0G<>.,$XQQC'%:&G:1:Z;)<S1;WN+IP]Q/*VYY"
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M<R*EPH&!YB@@,0">2*3_ (0;0OL.E6@AN532CFT=;N02("NTC>&W$%>,9Q@
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M &W&"#D@G)K6L8K;QCKOC#2]8D8W%H\=O;*/E:VB:($2Q@_=8L6.[KPHZ 4
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M]3MC$;RQ=@8DR&VO$PX*M@],<CWS0!VU%%<;\2=,EG\.#5[.,O>Z/*E\L8)
MFC0YDC;U!7/'J!0!V5%>>:QK/VCPMXA\:Z,=VS3_ "["95SP%R\H'J"Q'/\
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M2I$0/N*8$R!^9KT&@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MGP[#!/##IRPI/<"Z?RI70^:.C J05QVQC&!6_10!D2>&-'FTZ^L9[/SX+_\
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MV[O+*&6.>[?S+AC<2/YC=,D,Q&<5J444 %%%% !1110 4444 %%%% !1110
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MW\FIW%S)*][I^IB*WDW,=K<2JR\8S\A/!/)-=?/X%TC6-&TRT\06_P!ON;%
M$N&F<2*>^) 0Q'0<GG&3S0!;\'Z9-HV@)ID^L-JK6LKQBX9"I SD(<LV=N<9
MSVQVKF=$@@\8W'C%-9!^U6NIRV<!+$-:0JB^6\9_@).6W#J?I7>6-C:Z990V
M5E D%M"NV.-!@**S[OPMH][J$U]+;.MS<1B*=X9Y(O/4=!($8!\#CYL\<=*
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MK%<03/#(JGJNY"#M/ITIEUX9T:\T%M$GL(VTYN3#DCG=NW;@<[MW.[.<\YH
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MZ]M8I[.5-CPNORD=N/;C'I4.GZ%I^F3&:WCE:;RQ%YL\[S.$!SM#.20,\X%
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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ME;64\,S-(FY6D*D<;N0-O/Z9K)\,Z?XS\-0?\(Q'86<^F12.+35S= &*%F)
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MP(8>S8/N#]*P=0L/$^@^-K[6M"TZ#5K#58HEN;9[H0/#+&-H<,005*XR.O\
M7LB]II\$:%H+:'<$0$A%W$\ >Y/:K% '%ZCI6NW7BGPCJ4MJDPTYKF2\:*10
MJ>;&454!(+!<XR0,@9ZG%0VNCZO#J/C>X;3GV:N$-H!+'EML(BPWS<<C/T]^
M*[6WN8+N%9K::.:)L@/&P93@X/(]P14M 'DRVNHZ'JGPNL9[!GO+*WNH)8$E
M3+;;=5)4YP?49(_"MZZ\-:C=Q^,=4-IMO=:LA96MJ9%RB+&R@NV=N2SDG!.
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M2R^P7EB\XA8J'+JZ,>,@D@@]OKQVU1FX@%RML9HQ.REUB+#<5'!('7'(Y]Z
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M9P BCGC))S[<@%&V^(EQ)X?AUZ[T%K/2I[>"2&ZENTV^9)(J!6&,JHW9+XZ
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M-^Y$?S?-QR,_3WXJK)X=UL^&? MBNG$SZ+=6TMV/.CQMBC9&VG=R23D=/?%
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MQ%B2,G'# ]^G(KIK#Q+J;^,)_#VHZ9;P2M8F_M7AN2X9 X0J^5&&R1TR.>]
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MF& (&<D$\\8Y/077B:ZDUS5M*TNTAEGTJUCN)C/(5$C.&*QK@''"G+=LC@T
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M'HEEJNFO:7-I;2[T>=CD3!0 HVC@="<G('?T:B@#D?#47C9!;6>O_P!F+!:
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M11-CYF4$<GC@]N1W5O;P6EO';VT,<,,8VI'&H55'H .E/**75RH++G!(Y&:
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MSQQ1$ &W+X) (W'(!P3WZGH#H>H7_B0^(KNVAAGM]/>SM+7SMV6=LLS,!@=
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M&94"D-NR,\@\ 9P*S-.\)>([:S\#Q3PV!.@EO/V7#?,OE&,;?DY/.>WISUH
MT[?QXUG8^)'U^RCMKG09$65+64RI,)%#1["0IR=P7!'6LW6GU23XD^ WU&SM
M(MTEV08)2Y0_9VRAR!GZCKSP.YJO@/5-=?QK%</;VT6MFVDM)4E+M&\"J%WC
M:."5!X)XJU)I7B_5M=\+:GJ%CI<#Z3+,UQLO&82[XC&64>7QUR <^Y'< [VL
M'Q-XDA\/?V<LSP0_;[G[,MQ<OMBB.QFRQ]]N ..3UK>K$\165SJ$,%NNG6>H
MV#LRWEK=$#>F."N01N!QUQWYZ4 8_B3Q%>:9X5^WZCH=G<XOHX&B:;='M:55
M25<I\W56QQCUXJQJ?BV:'7[[1=/BM)-0M;5;B.VN9C&]WN#?+'P>FWKSR<8'
M6N?F\!:M#X!G\/Z?Y.)-36[MX)[EBEI LJ.(@VTD_=/T+'DXR=+Q=X7N_%,5
M[;7>DV4^8P=.O//V36<NT9)(7.T,,\$YZ$=* )7UC7&^+":0JVW]GII/VG89
M&!^:959C\IRPVD =,$\\U6G^(S?9K74[.QCO--FN1$8X6=K@1EBOFA0N".^W
M.<'.<\"XGAW6K/QOINL0RVUW"NDKIMW)/(R2960.9  "&)YXR.>]4/#>@^,?
M#<(\.02:;)H<4C?9K]I&^T10EB=GEXPS#) .<#@\]* +L?BO7KSQ/JVC6.@V
MTG]F7%NDTKWNT&*5=Q8?)]X#^'V/)XJ?0/%LWB*:"6RAM)+1KF6"Y19CY]IM
M#X,BXZDJ!CC&X?>ZT_0M&U2Q\:^)=5NHK<6>J-;F$I,6=?+CV'<-H'/7@FLF
M+PA?77B/1];GL;33M6M)2;Z^M)N+R+:1L*@#)8[2=W3!P3Q0!V_VR*0.MM+!
M-,%)5/-')]\9Q^5<%;>.Y;7P!I^NVGA^WB2XU VCVD,X41$W#1[E^4!B2,_P
M\FNIL/"/A_1;M[_2M#L;:\VL!)%$$8YZC('>N-C\%>(4^'ECH!BL#=V^J"\9
MOM+;"@N#-@'9G/..GO0!TVF>);^3Q==Z!J]A;6LB62W\$L%P9%,1<H0V57#
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M-&UU_I!PVV$Q_)\G/7/.* (O%>NW6N^"/%KZ;9VTNGVD%U:M)-(0TK(A$C(
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M72M>G+K&5#&/Y.3R3SM'3KVWI_%%S;^,=+TB6RA6PU.W>6VO#,<LZ@,8RFW
M.#D<\@&N??PAK[^#O&&D&*R%QK5]<7$#?:&VHLN/O'9G(QV!J]XRL6N_!MI:
MBXAMM>LY;:2QV.'*7(8*F.A*G)!XZ$GM0!>NO&#V<$\LEG&XDU-=,TX+,?\
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M6T^>.0R"-]RL@<;1_<P<9Z^U '76&I:R=?ETW4=*1+?[,)X[ZW<M$6W8,1R
M=PZY[CTK;K T!O$]PXF\00V%IY:;!#9RM)YK\9<D@;1QPO/7D\"M^@ HHHH
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MV^O6W7@5H)V_O/&Q0M^.W/XT =317/>-=:U#P[X:N-8L((9Q:E7GCD5B?*R
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MTY/[/OI=,M8[J"X@9HXI@P;*GE\$%3R"<^U4]/\ &^N'PS9^(M1T^P2QOK>
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MX3UE;+QG 389U]I&A(F?]UNB$?S?)S@#/'T]ZZ?P_97&F>'=-T^Z\HSVMM'
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M]AEOK= \T"-EHP3@;O2KM !1110 4444 %%%% !1110 4444 %%%% !1110
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M"759+.U+.[(P\Q <GKD\'+<=>AKT'4;3^T-+N[+?L^T0O%NQG;N4C/ZUPO\
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MVMO',SQKN.YG9R@.3@# 7@ ]<\8D?@C6HO!7AC0Q)IYFT:^@N7D,KA9%B8L
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MG_=?NA%\WR>@SQ]/>@"<^,S>KI,-A&8KC4-.7469[:2X$,;;=H*1X))+$9R
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MWB%P\-A-/%+<.F_:,$;4P5ZG)W=L<SZ?XHU;5KO2](:R72]5GT]KZ]2X0OY
M#B,*J@C)9LG)/ '?- '95GG7--&O+H?VD?VDT!N!!M.?+! )SC'4CO7"^)[[
MQ8FB^'UOI+2PNY?$%O:RB%"Z3IYN4?[^5!V@E<Y/3(Z5H7*SCXOZ2KR1FX_L
M"X!D6,A2WFQ\[<YQGMG\: .ZHKA-.\7:PVC>(H=0%B-?TNZ^RQ010NL<C/@0
M-@N20Y8=QCGTKMX!,MO&+AT>8*-[1J54GO@$G _$T ,O;VWTZRFO+N416\*E
MY'()V@=^*;IVH6VJZ;;:A92>;:W,:RQ/M(W*PR#@\CCUKS_3;C5[F]^(*WM_
M#/#;LT(3[.5(7[."H4[\ #<>,')R<\U5\,ZYK>B>&_ 'F&Q?2M2CM[ PK&WG
M(6A)5]^[!^[RNWC/4]: /4Z*X6QU[Q3J7B76K&)](AM-(OH4F>2.0M) R!V
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M9M0.G+;VL$;;9;AE 6-D0G.[>%]>1Z UZ%4+VEM)=1W3V\+7$0*QRL@+H#U
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M/J2:=JMEJ$U_:2)%NAA\S.Z$(3_J]O'ZXYQ7H=% &3H=GJ]O#)-K=_#=7LN
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M&<@<ANX..N#TK(B^'>JV6A>&Q8:U;Q:WH*M'!<&V/DRQ. &C==V2.!R"/H*
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M5Y&?YN3DY8],#V[ELOAV_C\<R>(;*^@2*>R2UGMY82S'8S,I5@>,[L'(/M[
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M-A;=C8-@QQD"M75_#6JZS8WFGW\VFWUG=VRQE)X&'D2X(,B#)]1A<@C'WN:
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M#O*[D*D_-PI&>.O2@#KY8DFA>*1=R.I5AZ@]:X/QFBQ_$#X?(BA56[N0 !@
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M=CR:ZRN7T[PL\7B\^)+I+."\-F;606:D"X)96\Q\]QMP!SC)Y/&.HH ****
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MWC971<_>PWWN!P!GG.,')L_'.J0^'EANVMYM6;Q V@QW'E[49@^/-* ]E!.
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MW*,<YYH [NBN.\&^)H_$5RSVVM?:TC@Q<V=Q L-Q;39'#* #MZCOR.I[=C0
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M]NE9+_#74AX4E\+1>)0-'69)+4/9;IH5642!"^_# 8X^4'IS@8KT6B@#G/\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MC5/#_A==1TJ[$%P+F&$AHE=6#N%/!&<C/K0!V-%1PQM%"J/,\S <R. "WUP
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ME$B_D&Z2=#)_J(5/RELC<>&)R !WKNPJJ20H!8Y) ZTA1&=695++]TD<CZ4
M>%Z'>Z=/X-^&$,L]NYBU0K(DA'RD++P<^A*_F*[31H]/U/XC^/\ 39FAEANH
M+))8@P.\&)U;CZ$ _A7?^5&  (TP.@Q5+6+?49=+G719[:UU$X\J:>+>@Y&<
M@$'D9'XT <5X(CU*:]CT'5(Y&7PJ[PK.XXN2RX@<?2%FS[L#6G\4HKZ7X?W_
M -AB>8H\4D\,8RTD*R*TB@=_E!R/3-=#HNFR:;9N+FX%S>W$AFN9PFP22$ <
M+DX  50,GA1R:T: //\ 6I[7Q#XP\%7V@W45Q)#++/+- P;9:M'AMV.@8[0
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M2UQ]KMP=Q.WD!T 4D#@<=N:U+AO!&O0:MJT.K7=VLNF?9;S4(I3BWA+@J#P
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MXHYF3]Y)(4Y^^/LRKQZ_,,<=^*IV>KIX<?P)KVH"0Z(-!&GS3HA=;2<B,Y<
M$C.S;^% 'J6EZM8:U9_:].N5GAWLA*@@JP."K \J1W!&:RTU33(_%&I,VOLS
MVUHAN+%G'E6X#']YTX8].O;I5GP[-IUU9W%WI5BMM:7-PTPD$/E?:6(&Z7:0
M#R<C)ZXST(KEUN[:+XMZ[))/&B#1(4+,P W*[EAGU (./>@#?MO'/AF\N+&"
MWU:&1[XXM\*V'/9=V,!CC@$@GM6+JFO?VKX\E\+B\O[.!-/\P2VL<B/Y[2E
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ME\%<7 M2_EN8UF/2,R8VAN1P3GFJL/C&QE\7WV@;)D:S@2229X7"[F+<9Q@
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MI3J>D?%5+6"X=IO+EC4P."RB!.1D>V<=<5ZOHFH6VI:-:W5K(7@:-=KE2H/
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MOOE,7_+,/'(&^5@V5.#C[O% '1#Q!IC:?!?)<EX)V*P[(W9Y&&<A4 W$C:>
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MK7DKL<#"M(2K'V*XP>XKD].E6W^%7P\N)=RQ6.LP-=':3Y(!E!+ <C[R_F*
M/3;;4+"Z\8-'!K<SW(T\,VE]$12X/FD8R'Y"X)Z=JL)XHT:34(+$7H$UPS+
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M11]QDQN4_4#'6L'P3+>:_8Z/XB.LWHDEM0U]9O$1#*[KD;-P&W:>Z]0.<]2
M:>H:!K?_  D,VKZ/KL-N;B&.&6VO+/[1& A;!3#H5^\<C)!K5TO3'L3//<7
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M+>W!RSL9"-@P!G#?* !S@8S0!T5%9,/B;1YTO&%ZL1L@&N4G1H7B4\@LK@$
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M(_FBNI3)N"$C[VU!DXY (%0V6IV<WC_1;T74]_;3Z'<1!TM6CB+;HSY<8"\
M 'J3CN>*];&<<]:* /)O#\TFEWMAI]AJ0U_PS-93LL$R@W6F(L>0C,.=IX3#
M8(.!VJWX/DNM-\0Z5IFFZNFN^'YK:0P^<H-SIBJ!A'8?PGA<, <C':O3J* .
M'\=M/8>(?"6MR*[:387DOVTJ"1%YD11)6'95).3VS6+KB17OB+Q1K]A/&^E?
M\(R]G+/&P,<]P2Y4*1PQ"X'&?O 5ZE10!Y*US:IHOPK EB4PRP>8 0/+_P!&
M96W>GS'!SWKJ_BE!-<_#'7XH(GDD-L2$09)PP)X^@-=?10!YQ-K$,'Q&T?Q'
M-*1X?N](>RANY%*QQ3^8'RQ8#:&50 3U(K3\&6;CQ3XNU>#_ )!>H7<)M2/N
MR,D0$DB^H+'&>^VNTHH X%+P:!\5]8N-9E6WL=3L;<6-U,VV)3%N#Q;CP&)8
MMCO7*SV$VE^&EU*6.6/37\:IJ4(*']U:^:/GQU"D@L/9AZU[110!Y_9ZA93?
M&2\NQ,BQG0(E5Y/EP1*[$<]#M()'7%<7I-V-,\(>$M6N$NWTG3[^_34!:,ZR
M6XEDD\N0A"&"@'\F]Z]THH \=\6GPY<_#SQ'J&A03/'J,MGONIFE8WCI,N=H
MDY.U>I P>?[IKJO&<6GWMUHTL&O-HNH!9I;#4HRIAZ(&1P?E8,"O!/\ #QZ5
MW%% '#^'?&4=IHNCQ>(Q%::AJ5W-;0-;PMY5PPD($@X^4.2"">N[/2M#XCP2
MW/PX\0PP1O)(UC)M1!DGC/ K?O+&.^,(F9S'%(LOE@C:[*0RD]^" 1SU'.:L
MT >97>JZ?J'B_P"'5Q#,KPHMUEW4J!FW 4\],MP#W(P*R;K5K>P'CF;[)!>Q
M-K5J_P"\C,L<2[8P9RHY8(PSQW'6O8Z* /*]+N$N/'7BE(+B[O6OM%A\B:2
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M(21C9\IQG;^?H5% &9X=TDZ#X;TW23.UP;.V2 RMQOV@#/M]*TZ** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M\TJZO+I+N2[CM5C6Y=;9K>;S \0QAFX&&SG(YQBK<%U;W2LUO/%,JG:3&X8
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M20 X'?&!7=T %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M/,T8B^?>A0#+9Z?-V _&M*PO/(.JSWVMV5Q;Q7)VE0J"T3:/W;G)Y'7)QUH
ML'1-),21'2[(QH2R)]G3"GU QQ7)3^%]9;5[^2YTGPUK5M<W!DBGOU9984P
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MP+N!R#$8\*2QVA5 !S\HKOM=M+X_#V_M-)6:.]_LUX[=&;,@;R\ 9_O=L^M
M&A!K^D7-ZME#J5K)<ONV1K(,OM^]M_O8[XZ5!+XK\/0W)MY-;L%F$RVY0W"Y
M$C=$Z_>..E>?:C/::_\ #CPC;Z+)'_:D5U9"VB0_O+>2,@2Y'5=JA]U;'AB/
M3;OXG>.0R6LTJS63*"%8C;".1]&'YB@#O+FY@L[=[BYFCAA09>21@JJ/<FJM
MKK>EWD5S);W]O(MK_P ?&'&8N,_,.J\<\URWQ(FFLQX;U"0$Z7::Q#+?D#A$
MP0KM_LJQ!/X'M3=B7?Q>M]2TV:-[:+1W34)8V!0Y<&)6(XW?>(]A[T 4;'Q9
M)KL=[JT'B:WL(M/U*1&M"L;QRVL;A.<_,&?J&#8!(&*M^%=<N]=T[3?$TGB6
M".T:)GU'3W6,QQ;\^6%889"#@?,3FJO@._LSX-\2R"ZA\M-4U!V;S!@*78@G
MV((_.N?AU 6?PC\"ZD)93IUC<0/J#VWS-$FQUWD8/"N5)X["@#U)/$VAO97%
MX-6LQ;VS;)Y'F51$WHV?NGV-2Z?KFE:K/<0:?J%M=2VX4S)#(&,>X97('3->
M<:XWAB[\*^,]9TC47U":YTEXKF\,H:)F"'RTZ %_IR.,]17>>%(+%?#6F3V<
M4 $EE"#)$H^8!!C)'7&3^9H CL_%^DWOBJ^\/PW,9NK-(RV6QN=M^44=RH4$
MX]?:KJZ_I#WZV*ZE:FY=RB1^8,LPZJ/5AW Y%<0;EX?B+XXL[>X2'5+W3+7^
MST9L-(XCE&5'< XR>U8ES+!K'P,TO2]/95UZ$VMO!;YQ/%>1R*&.WJI&'8GT
MR: /89IHK>%YII$CBC4L[NV%4#DDD]!52SUC3M0DFCM+R&62%5:5 WS(&S@D
M=0#@X]<51\7QV$WA'48=4N9+:SDBV2W$1P8@2!O_  )!^@KSS4[CQ,^C^*=#
MG>VUB]328YH-4L5VO<0[V_=2*,@.1YA&.H)H ]-M->TK4KF2SL=2MI;E8_,V
M(X+;3P' [KGN.*X!O$NOCX6>)]5&J'^TM.O;N.*X\A/N1R;0-N,=/:KV@ZCX
M2\3Z[H^K:?JEUJ&HVL4AC0O@VJ,F'\U0!@< 8/?&/6N9-W;/\%_'16XB(.HW
MX&''.Z7Y?S[4 >QV;M)902.<LT:DGU)%+<W,%G;R7%S-'#!&-SR2,%51ZDGI
M61:>(]'AGTG27U"$7U[;"2VASDRJ%Y(/3L>_8U@_$VZ>PM?#]],&_LFVUB"7
M4"!D)&,[68?W0^T_4"@!;7Q69_B;<V*ZO%)H\6C_ &IXRJJ(9?-"Y8XW?=P>
M?7-=1_;^C_9K.Y_M2S\B]<1VLGG+MF8G "'.&)/85Q5OJNE7_P :C)97UI.)
MO#IC5X958.WGYV@CJ<<X]*X^SUG34^%'@NR:]A%U9:O9_:H=WS6^V<[O,'\'
MXXH ]>N?%?AZSGE@N-;L(I8I$BD1KA04=\[5//!.T\>QJO9:O86\FLWESXGM
M+FSBG&0SQJEE\H_=E@>23SSSS7.Z$NF7WQ:\8K(+2=S;6&T-M8G"N3@>Q"'\
MJPY[FS.E_%Q1-!C]Y@;AU^R@?^A<?6@#TJU\2Z)?:B-.M=6LYKTQB40),I?8
M1G./H0?QIUWX@TBPF>*[U*U@9&57\R0*$+?=#$\*3V!ZUYZ\MA!??"HQ26\?
MRN 491PUJ0?S;'XUE7]WI+VWC3PI/X@TBW74=5>0S7]SY4D);87^0CY@I7"G
M(SCL "0#V6WN(+N!)[::.:%QE9(V#*P]B.#5&V\0Z/>7BV=OJ5M+</N*(L@)
M?;][;_>QWQG%2&6W@T,S0YNK=+<NOE$,95"Y^7'7(_G7D%AK>ES7/PZN[>^M
M(;2.XD5;*W;<MD&@<+&[G+&3/')&3T6@#U*?QCX:MD9YM>TU$6;R"QN4P),
ME<YZC(SZ9JZ^M:7'JD>F/J%JM_(N]+8RKYC+ZA>I'O7E@?3F\,_%E]UL7:XN
MANRN3_HZ[?\ Q[./>M?6(Y(?!/ACQCIX\^[T2VBGDV')FMFC G3/^[\WL5H
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MFN'"(8TW>:JL>,[V!(Z\4 7O WB=KSP<VJ:UJD,O^G3P)<MM17 E94 VX!R
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M@  'Y) (SP:@@NKJ ZKHGB2^M]7THZ%-*FM60"S+;'"LL@!*[B.5(Z[3UYP
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M;%!##_JHHX_E"_(H' Z#Z<FN.\#:WJUYJ_B+1]>O%EU'3+L(BI$L:M;LN8Y
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M7L-P\!"RHC?-&3R-PZC/;UH M/;P20>0\,;0XQY94%<?2GJJH@1%"JHP !@
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MVD* EY6^]([$LSGW9B2?K7,>(?%<$7B[3_#::M'8":":6YN$=/,C*A0B#<"
M3O)Y'85LQ74OAOPN;GQ'JB7+VD;-<7BP^7O )P=@SSC P.IZ4 :HMH%N#<"&
M,3,,&0*-Q'IGK2M!$\J2O$C2)G8Y4$KGK@]JX+5?&4MYIO@_5])U!(;;4=2M
MH+R$;'VK)&79&8C@C '&*['2]=TG6XYI-+U&UO$A?9*8)0X0^AQ0!>1%BC"1
MHJJHPJ@8 ]JY?PSX:N=*U'6KK4([*7[=J#WT+1DLT)957;RH_NCD?E6S9Z_I
M&H7IL[34;::Y">9Y22 L4Z;AZCW'%6[JZ@LK=KBYF2&%<9=S@#)P!^)('XT
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MRW"(U[I=F;56.&F :3.T=3C//IWKNC;PDN3#&=Y!?Y1\Q'3/K3BB%PY5=X&
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MH@G:6&1/*<@$!@5RN=R]?453\<PZ?<Z#'#J5[/81O=1>5>P-M:VE!RCYZ8!
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MF2P37UQ+/MA0\B(^8<%BW.!TP?49 .NTKQ9H6N7GV33-2AN;C[.MSL3.?*.
M&Y'N/?FJVL^+[+1O$>E:+,DS37WF.66%V5$12>H!R<[1@= <G'&:GPR\@_#?
M0!$$W1V:1R!0,JX'S ^ASUJCXON8]/\ B)X+OKG>MLHOHC($+ .\:;5X'4X.
M!WH V;75]*BUK7KAO$0F2U2$W-L[KY5CPW0XX+8)()/2G1^.?#,LUI$FL6^Z
M[3? S957&-WWB, XYP2#BN5M[RU3QM\16>>)5:RM0"6 !*PN&QZX) /H2*PS
M-9CX9_#:)WA!BU2P,J$CY-N=Y8=L9YSTSS0!ZCI/B31]<DNH].OHYY+4@3I@
MJ4SR"00.#@X/0TEKXFT>\U&*PAO0;F9#) K(R"=1U:-B ) /52:X#7TEU+QM
MXPLM,F0WEUX96&$(XR\N9/E!_O8(^F15GPSJGA3Q/<Z*8;;49=<T\AC:SR7&
M;!]N'+;CM XP!WX&/0 ]$OKZUTRRDO+V=(+>(9>1S@#G _$D@ =R:J6GB#2[
MTW@BNPCV0#723HT30J1D,RN 0" 3DC'!K(^(>H1Z9X2DN)K&*[B%Q '\Z,O'
M"/,7]ZRCDA/O8'H*XR&\TR7Q9XO%]<WE_8WF@Q%I?)(,T0$N\IM4#&#@$<$X
MY)H ]-LM<T_4+HVUO+)YXC\WRY(7C)3. PW 9&>XK0KSSP;<ZC;>)QI)U>#Q
M#I*V!EMM2 'GVXW*!%*R\-D<@\$[37H= !1110 4444 %%%% !1110 4444
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MQR2?_K<#@#@59HHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !11574+^+3;0W$D<TISM2*",N\C'H%4=3_ " ). *
M+5%8WA_Q+9>(X[K[-%<V\]I+Y-S;747ERQ-@$9'H00002#6S0 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %(P8HP0@-C@D9 /TI:HZKI-OK%LD%
MQ)<QB.02H]M</"X8=/F0@XY/!XH YGP<VI6OBKQ/INK1VLMUYD-Y]NMD*"9)
M%9%5E).TJ(MH&>G/7)/:54L=-MM.606Z-OE;=))([.\AQC+,Q)/ Q[=JMT %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
00 4444 %%%% !1110!__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>17
<FILENAME>insidertradingpolicy004.jpg
<TEXT>
begin 644 insidertradingpolicy004.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MX B9A.IV1XSG R>2Q'.3Z/TS3[K3O$UUX%%N_P#8SW(U:WD ^1+8L6>'_O\
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M2&;_ ,=!H 9>^)=4L?#6G:W+8WLRW\\9DM[*W$TEK"RLRX7^)L[%8G(!8X'
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M%UXL\/6(N?M.MV$7V5E2?=.O[MFS@'G@_*>.O%<[\(XW7P,)#D0S7UU+ /\
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M4SPS>%;SRI4?&JWA.U@<9F8C\QS0!TEYXET/3IIX;S5[*"6WC\R9'G4-&N0
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M6&2PD?MZ@$?ABN[H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MU:!9X8S*RMD94'!*DC#<G&!DYXJ6U\5:'>Z-/J\&I0FQMW,<TK97RV& 58$
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MR2-)CD C&[%='+;PS[/.ACDV'<N]0=I]1FHKV_M=.M_/NYEBC+!%SR68\!5
MY)/8#DU3B\2Z--:7ES]OBCCLCBZ\X&)H.,_.K %<CID<]J -)H8F;<T:%AW*
MC-->UMY)5ED@B:1#E79 2I]C69I/BO0]<NS:Z9J4-S.+=+DHF<^6WW6Y'O\
M4=ZQO'^HWFE+X=N+74)+6*76K:WN5&T+)$S'<&)&0..Q'?- '6S6\%RH6>&.
M50<@.H8 ^O-*\4<F-\:MCIN&<5G:5XCT?6WNDTZ^CG>T($Z@%2F1D$@@<$ X
M/0TRW\4:+<WR6<=\@GDC:6(2(R+,@ZM&S !P!SE2>.: -00Q*^]8T#>H49I]
M8-EXU\-ZC?VUC9ZO;SW-RTBPHA)WE,[L'&.,'ZX.*WJ "BBB@ HHHH ****
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M)"[AS&PE'[O<<Y;;[Y(YK/U2XETK7+V_\.ZI'<F75$6^\.78#-+)YBKYD/\
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MG *^U6-671O%7AOQ#J/@M;V^U.72FMGO&DG.4W!O)'F'EB-W Y'3^(9]:HH
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MU>6(^2$\P,1^[(MBO/IAL#GO71^%)X7^)?CD1R(=\EFR[3][$ 5B/7!X/H:
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M-H..3G('J0?2MVO)+GPSJ5XWB7P1;+)!9),=6L;D<*GF9:.(>F)U9N.RD=Z
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M^)OC.SFWI/<S6TT*E#\Z"W4%LXQC((SZ\=:[N@ HHHH **** "BBB@ HHHH
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M''U% %SQAJ5SKWP]N=>\':M.EQ:J9E\G*F0(?WD;(PR&P#P1G(%:=YK45_\
M#V/4=*GFWWUO&MDXD._S9,+&"?4,1GZ'-7/"MMI\>DRR:;IDEC:7,[3*DRLK
MR[@,R,K<@L0>#SC!/6N2\&>'M2TKQ-?:%/$1H.CW3WNFN>C>>#M0>HCS+^+
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% &7XA
MT4:_I1LOMEQ9N)8YHYX"-R.C!E.""&&0.".:JV6AZD9(VUG7&U%(G$B1+:I"
MA8'(9L9)(/(Y SSCI6]10 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M=5CG4YC4D%OH"#S[5/9:_I.HW$MO::A;RS1()'C#_,$/1L=U]^E>3:-;K/\
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MBT;7Q,=)U2TO?(;;+Y$H?8??'\ZYGXH"$:?X=DN@GV2+7[1[AI -BQY;);/
M7GOQ6#XJTV?5O$VN7OA<*\@\-SVUS+;$8EF8@QQY'!?:#[@%?44 >AP^)-%N
M+IK:+5+5IEC,NT2#E!U8?W@.Y&15;PQXLTWQ79S7.GR@K'-)'M)^;:KE0Q'4
M XR,UR/AW4O"7BF]T"ZM;V\NM6L@6BM"Y#6>5VR;U &%&-O/!. .M7_A5>6[
M>'+G3UF4WEMJ%WY\(/S19G<C<.V0>,]?PH W=7\7Z5HVOZ;H]U.B7%[O;+'
MC15)R3[G  ]_:L'1?&$6G:KXEA\2:[!'#:ZD+>U:X*184QHV!@#."W6E\87E
MOIWQ'\$W=Y,D%N%OXS(YPNYHTVKGU.#@=ZYY;C3I+#XLN9;9F8RC<67)'V8
M#_OK(^M 'IU]K6FZ:(_M=Y%$9%+HI.2RCJP YP,C)Z#-9>L>-M%T@:27O(95
MU294MW1P4*$9+[AQMP/Q-<9I6O::NH>&K9[B"QNI?#<)_M)CO>=25!@B!RI;
M<N3PQZ "L+1-1LX?A[\-[F:YC2"SU@)<RNV%A.V888G@=1U]10![<US"EJ;I
MI5$ 3S#)GC;C.?IBO.]>\>_VI\/I=>\.Z@;>6*]2(J%5F,9N?)R0P^7<N6'<
M9KT>.198DD0Y1U#*2,<&O"VU&P_X4')ILMS#]JM]2V7$#,-T9.H%L,.QV\X/
M;F@#V73]?TC5;RYL]/U*UN;BV_UT<4H9D^H%)%XAT>;45T^/4;=KM]VR(.,O
MM^\%_O$=P.G>N%UR17^)[6^ESPI>3>%;F*W\MP/G\Q3&!_,51\+7WA7Q!IWA
MJTFNKV36M,DAVZ8SLLEM-& KDJ ,(!G.>"..O% 'J5[?VFFVCW=]=0VUO&,O
M+,X15^I-4+7Q5H%]J9TRUUBRFO@GF>0DRE]N,YQ].:I?$$ _#GQ)D _\2VX/
M/_7,UQU[:Z?J>G_#K^QOL[7]O=V\^ZWQF.W6,F<MCHIX!S_$0.M '=+XP\-M
M.D*Z[I[222/$H%PIRZ@%AU[ C-)H>H6L7AM;V?Q##J=N)),ZB=B(W[P@+\OR
M\'Y>.N*YCX<G2Y[CQ=,#:221^(;F3?\ *2JX7#9[#EN?<^]<?I.IQZ=X!\)Z
ML3YND:?KUP]_Y7S")6DF"2,!V4LK?E[4 >R6FMZ9?07$UO?0/';$BX._'DD#
M/S@_=XYY[4EAKFF:I/-!97T,TT(!DB5OF4'H2.N#V/0UP'BR]TK4?#FKZWX8
MA^V_Z19SZE=60S]ICBD!**>C%4!SCH#S6MX;N?"NO>)HM:T;4;C4[]+,PO/Y
MC%8HB<A'&  2W(!YX)[4 =G=75O96SW%U/'#"GWI)&"J.W4U5MM=TJ[AN98+
M^!EM?^/CYL&'C/S \KQSS7+_ !%FFLIO#.HR _V59ZM')?D#B-2I59&_V58@
MD]N#3$6.Z^+JZKI\\;6<.C&._FC<&,L9,QJ2.-V-Q]A]10 SPUK5]XQ9-3L?
M$"VQAU"42Z>(TD1[59"@!XW!B &W9ZGICBK?C[5]5T>;P[_9M\;<:AJ\&GS*
M8D<;)-V6&1PW'T]JK_"6ZM[CP:XAGCD*ZA=DA&!P#.Y'Y@@_C53XKW]I:2>#
MC<W4,.SQ%:2OYCA=J#?ECGHH[GI0!Z(@,<8#2%RHY=L GW.,"N8C\0V>F:%K
MFKOK\.JP07$SH5*!82%#"W!7J1ZGGFKO_"7Z#->VMC9ZK97EW<OLCAMKA9&P
M 2S'!. %!.3].IKA=&OK)?!WQ+874 7^T]1.?,&.8AC\SF@#>\-:M<7MAIGB
M.Y\3QO9SV:?;;)XTV).ZJP$; !E()(VG<3QWYK2UK4[K5O"=_>^$-3A>^MU<
MQ[%60-(HR8V4C(/;'!!(KA[C5H=/\,?#C5I[F5=%MK98KVXMCN^SR-;JJ,V
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MBR%LTODB1I@ 9,XV<\[L]NM$/BG0KF)I;?5;6=%F: ^2^\[U&67 R3@$$^U
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M2ZA=K'-*2-T,.UF+#((R2H7)'<TFF>)-+T:"ZM]7\8V-\R7 \N21HT>-)/\
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M.&2SE+[8;B#R@C(&P>0V[C_:->H>5&0 8UXZ<4CP12[/,B1]ARNY0=I]1Z4
M<TOAC3-5^')\.0PS0Z=/:&&!;C)>->J,=W((^4@'D< UD?#:;5=8M([[7('B
MN]*B;20'_CD1L2R>^[;&,^JMZUZ!2!0HP !SGB@#Q[QIJ]A/!\0;".2+3[M+
M8"6$#=<7Y$(P^#G$8''RC/&216E8WVFWOQ+\*S+<6\O_ !3TA1RP/S;DP1GO
M@-CVS7IIBC9BQ12Q7:21R1Z?2CRH\@[%R/:@#Q&>YMO^$!\1R1S1FWMO&)E<
MHP*QQ_:D.[CHN.<]*Z+7/$.DW?B36K:"X@LY9='7;= ;Y=10^9M2$'*E0<Y(
M!+;N, 9KTSRH]I7RUPW!&.M*8T+ARB[E& <<@4 >,V>L:=8>'/AEK+:G;1FS
MMW@*W#E(6S %?,@!"LI  X.22..<37AM_P#A"_$&K:1J5KJC3:U#J=];Z7,)
M3%")$+(.Y.U-Q) SSQQ7>Z[H>L7&K6FH:/>V2K! \#65];EX6#$'>-I!5N .
M_%6M&T22SNY=0O?L7VZ6,1$6=OY4:H"3CDDL<GJ3Z8 YR 87ANY\*Z]XFCUK
M1=0N-3OULS#)<>8Q6*(L&"., !BW(!YX/I4/CEK./QYX$>^,(A%U= M-C:&\
MGY>O^UC'OBN[BAB@4K%&D:DY(10 3ZUSFO\ A^]U7Q/H&IPFU^SZ6\SO'*3F
M7S(RA' (& <]\^U 'GOBBUMXE^)>HV9B33;C3H8692!'+=!6W;>Q8 J#CN?7
M-;GB-H+"P\$ZQ;I#_8MO>0-?2PJ-JKY92-V(_A1CU[<5Z2L,21K&L:"->BA1
M@?A2[%V%-HVGC&.* /.-6\J?Q_J>KV-Q$;"+PY)%?3HX,9D+$QJ3TW8W'U Q
MZBL&&XL(/ 'PM9)K>-EU2SW$,H(S'('S^)&??K7L:0111"*.)$C'\"J /RI?
M*CQCRT_[Y% 'EL\L-QK_ ,6(+=TDF?3( L<9!9B+:0$ #J<D"HI+?3]8\)_#
M^VT8VTNIV]Q93*;8J6@1%!G9L=!P0<]6('6O6 B*VX(H/J!38X(HF=HXD1G.
M6*J 6/OZT >5RRPW%U\78;9TDD>U7:D9!)/V/!P![\?6I1/:ZQHO@^;1/$T.
MGZU;Z>RVLKA7@FPD/FPN#U.=G3D8/<5ZB$13D(H)[@4Q[:"2,1R0QO&/X60$
M?E0!A>!]2GU;PG:WEU916<[/*)(X"3$S"1@70G^%CEA['O7E^OZYIMUX>U P
M3P:=]G\1H\VG+S(I%RN^:8MDKN/(QM49 R:]R    & .U,,,1+$QI\^"WRCG
M'3- '"6U_:2_&N=DN8B&\.Q$98 _Z]FZ?0@_2I?A/<0S^#I?*E23;J-V3M8'
M&9W(_,'-=OY:%MQ1<^N*%14^ZH7Z#% 'GMI)I<7QB\3?;VM$9M,M2OG[1E?G
MW]>V,9KD--+>%;#PUJ%^]U:>&O[0U#RY8P1]FCE8?9W88.%(#\^C^]>EVGAN
MZC\<:KK=T+.6TO888EB.69/*W8;D8).X_3U-=,Z)(A1U5D88*L,@B@#QWQ<O
MAD>!=:OM)N3<07^I6;S74LNZ.XD$R;]F>#A>I''Y''5>++*!]7TB71=;M]&U
MORIY;1V13!=)^[$B..^<1G(Y &>U=N(8@BH(T"*,*H48'TI)+>&9-DL,;I_=
M9010!Y/I^MW3ZYX+US5[2*PTZ1+VV<QG_1X[IG($@)Z+(%.TG^][\U?%<2"V
M^)FI6\L?]E7-E!$'##RY;I4(;:>A(&T''?CJ*]D>*.2,QNBM&1@JPR"/I2"*
M-8Q&(U"+T4#@?A0!YS>W&GQ^._AR()K95-K=JHC90-IA3 X[$CCWJEX:NKC2
MM4\/6VG:C;ZYX<OIG^QI(!]KTX^6Y.2/O* 64YY&0/3/J?E1Y!V+QTXI$MX8
MY&D2*-7889E4 GZF@#F?'=O;7-CID4FL/I%Y]O4V%Z I5)Q'(0&#<%2NX8[D
MBN&U;5+^X\)-<:U!:)+I?B:T^UWUIGR)U1H\S#/3 (#=@0?I7L,D:2H4D174
M]0PR*00Q"'R1$GE8V[-HVX],4 >93:M8:E\3M7-C=Q7"S>&-D+1-N64B63(0
MCAOPST/H:R([:PU?X2>$=-TO[-)K:2VC0+#@R02HZF5VQRNU0^XGO[D5[(D4
M<?W$5> O QP.@^E5KRVF^R73:;]G@OY$.R:2+<N_'!8 @D?C0!YMK%M>W6O_
M !.@TQ6-Y+I%HL:I]YCY<O ]R.!4VE:CX8\6OI-WI5]=W.NVD,AMH&D(:Q9H
M]K^8   HP%YX)QBNRT+0Y['4=1U?4)89-2U%85F^SJ1&HC4@!<\]2QY]0.V3
MM)#%&[ND:*SG+E5 +'W]: /+_!6N>&]2\*Z!H6HPK)KVF31J=.D4^?%<QD@R
MD>G)<MTY/?BM?P->6\7BGQEISS*MZVL-.("?G\LQ1X?']WCKTKN1#$LK2B-!
M(PPSA1DCW-."J&+!1N/4XY- '">,+RWT[XC^";N\F2"W5;^,RN<+N:--JY]3
M@X'?M65H5[:6^C>.-(\121QWIOKN6:.8@-/#(O[ME!^\"H"C'H!7J!56QN4'
M!R,CH:8\$4DB2/$C2)]UBH)7Z'M0!A>!+2_L/ >AVNJ;_ML5G&LJO]Y>.%/N
M!@?A7E]]J-G'\(_'>G/<Q+>1ZE>;X"V&7=<?+D=L]O7!QT->XTTQQG.44Y.3
MQU- 'GVH7.GQ_%#P6+>:V5&T^\0"-E *[8RHX[<''T-86E'2[_PYXC@EUG^S
MBWBVX:VO864B"7S T3$'@J2,<\'/XUZ[Y4>0?+7CVH,,14J8TP>HVCF@#DO
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M]M=Q2?&#Q!!;W4(NCHT"(-XR'#R<8]1D?G7?F-#C**<=..E'EINW;%W=<XH
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M:<'</E'!]: 'T444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MQ3)<21IY.=K(IVAN>>2"?8$#GJ=)'610R,&4]"IR#0 ZBF"6-E9@ZE5SN(/
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M* )Z*K+J%DTD4:WEN7FSY:B09?'7 SSC%+-?V=O.L$UW!%,PRL;R!6(]0":
M+%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M/I[K<LK3AK9")2HPI;CD@=,]*?\ V'I/VF"Y_LNR\^W&V&7[.FZ(>BG&1^%
M'G>@2WNA:IX<L[^*UU;1[F20Z1K%O\LZ%HW?;*O?*[LD=P">:Q_M^GR:9X&O
MM/EM[?3W\0;X$EDWW)5C+YCR/GC)/*X.,C+=J];LM!TC3I1+8Z79VSJ"%:&!
M4VYZXP.,]_6HE\,: @<+H>F@/,+AP+5/FE&<.>.6&3SUYH X/2[K0=9_X3?2
MO%-Q!'.=1D$HGE"/]E 4P,A/.T 9&.Y)[\W8H["/XQVS21I&K>&T,?V@ /N^
MT #.>=_0>M=G=:!H]]J,.HW>E64][!CRKB6!6D3'3#$9&*GGTRPNKV"\N+*V
MENK?/DSR1*SQ9Z[6(R/PH \>O'ETOP+\0_[-C,44?B%A,MN,%8"(?-P!T^7=
MGVS76>([:$>,/!-YHBQ!YI)(9/( "RV7E;FSC@H/EQV!(QUKLK71],L3.;33
MK2W^T$F;RH%3S,]=V!S^--L-#TG2]WV#3+2UW+M;R853*]<<#I[4 >-76CZ8
MOPL\>W*V5N)[75[T6\@0;H=LJE0A_AQ[8KJ_%,>J0W^H:OI@L=6M_P"S(XM5
MTB[.US" [!HWZ D,_!&#CUKMAX;T(6LML-%TX6\S[Y8OLJ;';U88P3[FB7PY
MH<SJ\FCV#,J",$VZ9V#HO3[OMTH FT:ZAOM#T^\MTD2">VCEC20895900#[X
M-<+:V-FWQ ^($#6T)BFTZT>5"@VN2DN21W->C@   # %9YT+2&N+BX;2K$SW
M*[9Y#;INE'HQQEA]: /)+#3K&U\ _#348+:*.^?5;%&N0H\QE8,&4MU((XQT
MP!Z5[2Z)+&T<B*Z,"K*PR"#V(K./AS0S;PVYT73C! V^*/[*FV-O51C /N*T
M7)2(E$+%1P@P,^U 'A=OX=T6X^!^IWWV.$:E;7%T;6X1?WT4BW#>6B-U7)(
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MNF%/F,>?GQO(4#'?! YKF_/B;X/?$&!+F"7R]2O=HA("[2ZD%5R<*221SWH
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M+R(E&UX 5^;S"3SD].!7!-)8S>,_ 5W</;.DFD7)>60J0S*D74GJ1S].:O\
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M;@>QK@?'?A_1;#X63WEKIUK%<2FQ=YUC&]V$L8#%NI.&;GJ<GUK5N4LH_C?
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MKFM0_P!EBSL%WV\$MO(\DJA5R2PD 'S%@.#P!4AU#Q7'I/\ :#2Z3)#)I[W
M*6LBF*0*&4$&4[E(W#@@YQ1\4CCX7^(<_P#/HW\Q5\D?\*]SGC^RNO\ VRH
M7PEKW]L^&=&N;RXMQJ-[8QW+Q*P!.Y020N<XS5^U:]_MK4%FO+62T"1&"WC7
M$L7!W%SGD$CC@=#7E5II]E9>%/A;J%O;117LE]:1O<*H\QU>!PRENI!P!CV
MK8BM+(>+OB= \PL+>;3[3SIX@ 8]T,VZ3CN,YH ]%M[^SO&9;:[@G*YR(I V
M/R-6*X#PM<ZI9>+DT7Q!I]FU^NG%K75+#Y8[F!748=/X6!*GTY.*[^@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M[]:MQ:G87$4DL-];21Q'$CI*I"'T)!XI1J%DP0K>6Y$C;4(E'S'T'/)Y'YT
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M5\W'INQG%2W5[:6**]W=0VZL=JM+($!/H,T]YX8E1I)4178*I9@ Q/0#U)H
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MCC\*M-J%DMW]E:[MQ<\?N3(-_/3C.:66_LX+F.VFNX(YY?\ 5Q/( S_0'DT
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M/IFKVJ6NI:?:WENC!EBN(5=5(Z$ BHG\.Z)(DZ/H]@ZW!!F5K9")"!@;N.<
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M$65L+XIY9N1$OF%/[N[&<>U5[3P_HUA>SWMGI-C;W5QD2S16ZJ\F>N2!DYH
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MZ4 <AH\5@OQ;\6)/';!I+6QV+(JY8D2AL9ZYSS7'P3_V=\-K)44)I(\6-'J
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ME_(\D.L^$O"VJW$DKN^K2MM>3<Q.YH_*)R,] V., B@"2XT+2/\ A<6GVO\
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MB#1KF\BLX-6L9;J:,2Q0I<(SNA&0P4')&.<UPFN60E\?>(IK94>R?PTPU
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M]* .T.LZ6-0&GG4;07I.!;^<OF$XSC;G.<<U0TOQ=HVL:W?Z597L$EQ9,(V
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M0PG:=S'.&ZC)SR*HQWVBWEUXP\/^*]=DTYY[^1VMY3$GVBW8+Y3(60LQV@
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M.3G&"< >N>.E:5WK.EZ?.L%YJ5G;2MC:DTZHQR<#@GN>*\WCUFRFUOX::I)
MFEV<FGW@2*5\+$/*C"J&/48''J,5;\/3VLVG>/M/\0M&MP+^Y>Z6; )MF0")
MN?X=@P/I0!Z'>7UII\/G7MU#;Q$[0\T@0$^F3WKE_%GB*YM;3P]>Z)?VSVM]
MJ]M:RO&JRB6)WP=K9P.A&?Y5QGAS5+GPYJO@MO%\YMH)-!>"">Z;:L5P7!PQ
M/"L8@HR?<=S5WQ7'I,7AK11X::&"WF\46[Q3Y,D3RLY+.N3\R[L]"!P<<<T
M>FQZE8RWLEE'>V[W<8R\"RJ9%^JYR*LUQG@#54GAOM*U"-8/$MG+C4T9LM.Q
M'RS ]T88QV487@ 5V= !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%0W5Y;6,!GN[B*WA! ,DKA5!
M/ Y- #A;PK''&(8PD6/+4*,)C@8':H[BQL[ME:YM8)F7[IDC#$?3-0KK>E/I
M[Z@NIV9LHR0]P)U\M2.H+9P"*+?6M*N[^:PMM2LYKR$9EMXYU:1!ZE0<B@">
M2RM)I&DEM87D9/+9FC!)7KM)]/:HCI&F&,1G3K38I)"^0N 3U.,>PJN_B70H
MWB1]:TY6FD,40-T@+N."HYY(R.*EO-<TG3GD2]U.SMGCC\UUFG5"J9 W$$\#
M) SZD4 7MJ[=NT;<8QCC%4QI&F"-HQIUH$8@E?(7!(Z'&/<TRZUW2+$Q"[U2
MR@,P!C\V=5W@]",GD&I;[4[#3(UDO[VWM4;.&GE5 <=<9- !/I>GW5LEM<6-
MK-;H<I%)"K*I]@1@5)+96D\"036L,D*8VQO&"JXZ8!Z5G:G>"0:5)::[:64<
MUU&V6".+R,@_NT)/5LC!&3Q5FZUO2K&Y%M=ZG9P3MMQ'+.JMR<#@GN>GK0!+
M/IFGW4,4-Q8VTL41!C22)65#Z@$<4-IMB\1B:RMFC+F0H8E(+GJV,=3D\UF7
M7B[1[/Q1;^'YKV!+V6%IBK2!=@!4*#G^)MW Z\&K&E3/+?ZINUFWOHUG 2")
M5!M!M&48@DDDY/.#S0!:&EZ>)%D%C:[U "MY*Y '3!Q6-XB\.SW>G11:&-/M
M94N$FEAFM_W-TJY_=OMYQD@YYY'2M:TUG2]0N'M[/4K2XF1=S1PS*[ =,X!Z
M5#+XET* 9FUK3HQYWV?+W2#][@'9U^]@CCKR* ,;2?#$HU2UU'4-+T*QGM&9
MX_[,B)9B5*G=(54[<,?EQR<'/&#U,T$-S$8IXDEC/5'4,#^!J2LZ37]&AN/(
MEU:Q2;S5A\MKA WF-]U,9^\<<#K0 [^Q-)_Z!=E_X#I_A4SZ?92RI+)9V[R1
M@!':,$KCI@XXJEH\[.=2DDUJVU&-;M]OE*JBU7:#Y3$$Y(ZY.#S4T.N:5=OY
M-KJMC),0-JK.K'GIP#SG]: )X].L8KCSX[*W2;)/F+$H;)Z\XS1'I]E%>O>1
MV=NEU(,/.L2AV'H6QDUR7A+Q<)K6^C\0ZO9)=+K%S8VWF,D/F"-@H"J3R?S/
M-;,_B[1[?Q7%X=DO8%OG@,S*T@&WYE54Y_B;<2!UP/<4 ;<D:2QM'(BO&X*L
MK#(8'J"*=5%=9TM[X6*:C:-=EBH@$RER0"2-N<Y !SZ5=9@JEF(  R2>U %9
M-,L(@!'8VR 2>< L2C$G][I][WZTT:3IH#@:?:8?[X\E?F[\\<TVSUK2M1D>
M.RU*SN7C4.ZPSJY53T)P>GO40\1Z&9+>,:SIY>Y<QP+]I3,K X(7GD@\8'>@
M"V+"S"1(+2 )"V^)1&,(WJO'!]Q37TVPD:=GLK9FGQYQ,2DR8Z;N.<>],U+4
M[+3HO]+U"ULVD!\MKB0*,CO@D9 [UA_#S6;[7_!EMJ.HSI/=/-<(TB(%4A9G
M5< >P% %75/#NMR^(;N]BM]"U6RN%C$<.IHRO;!1@JA"L"I.6Z Y-;.B^';7
M3-.NK:2VLL7DIFG@@@"09*JN%3TPHSGJ<GC.!HWNHV.FQK)?7D%LC' ::0("
M>O&:R]=\7:/H.@KJ]Q>P/;2E5MRD@(F9C@!3W'OV&30!L6UK;V5NMO:P100I
M]V.) JCZ <4VZLK2^C$=W:PW"#HLT8<?D:Y*[\420>/=.@&J6?\ 8-QIL]TS
MC;M!1D&XR9QCD^E=5;ZG87>G#4+>]MIK(J6%Q'*K1X'4[@<8&* '_8[7[']C
M^S0_9=NSR?+&S;Z;>F*6WM+:TMA;6UO## HP(HT"J!]!Q5:WUS2;JVGN;?5+
M*6"W.)I$G4K&?]HYX_&G6>KZ;J$SPV6H6MS*B+(Z0S*[*K#*L0#P".0>] $M
MI8V>GQ&*RM8+:,MN*0QA 3ZX'>F1Z5IT)S%86J'S?.^6%1^\Y&_I][D\]>:=
M>:C9:<BM>WD%LKG"F:0(#],TR35=.BL$OI+^U6S?&R=I5"-GIALX- $D5A9V
M\S30VD$<K9W.D8#'/7) I(=.LK<2"&SMXQ(,.$B4;AZ' YI(M3L)].&H17UM
M)9%2WVE95,>/7=G&*@7Q!HSV<EXNK6)MHWV/-]H38C>A.< ^U $S:7I[I$C6
M%JR1#;&IA4A!Z#CBG3Z?975Q%<7%G;RSPG,4DD2LR?[I(R/PI#J5B+N*T-[;
MBYF7?'"95WNN,Y"YR1CTJ!?$&BO.D":O8--([1I&+A"S,HRR@9Y(!!([4 37
M&EZ?=SK-<V-M-*O*O)"K,/H2*F-O ;D7)AC,X0H)=HW!2<XSUQGM7,2>*K+P
MWX82_P!6U^UU,R7+0Q3PA(Q*QD(" *2/ES@G_9)-:;WR7.MZ6UIKUFMM)'*Q
MLUV.UWP,,K9R N"> <T :[HLB,CJ&1AAE89!'H:JQZ3IL5\;V/3[1+L]9UA4
M2'_@6,TV;6M*M[]+";4K..\D8*D#SJ'8GD +G.:+G6=+L[@6]UJ-I!,<8CEF
M56YZ<$]^U %EK>![A+AH8VF0%4D*@LH/4 ]147]FV'V[[=]BMOMF,?:/*7S,
M?[V,U:K'TN\5(=3N+K7K2^@CNW(D0(BVB8!$3$$@E<Y).#S0!H76GV5\T37=
MI;W!B;=&98P^P^HR.#1+86<TZSRVD$DRXVR/&"PQTYJ*'6=+N()YX=1M)(8.
M9G292L?^\<\?C47_  D.B_9Y+C^U[ 0Q,%DD-R@5">@)SP30!:@L;.VE:2WM
M((I&^\T<84GZD5+-#%<0O#-&DD3C#(Z@AAZ$'K4)U&R%['9F\MQ=2+O2#S5W
MLOJ%SDBHGUK2H]133WU*S6]<[5MVG42$XS@+G.<<T 07^E*OAV]TW2;6T@,T
M+QQQ@>5&"P(R=JGU]*I^#_#BZ!X?TZUN;2Q74+:UCMI+BW7)D"J%SN*@\XZ&
MK/B#6K72].N%.IV=G>F%GA^T.O7L=I(SSQ]:A\$ZG=:SX)T;4KZ0275U:)+*
MP4*"Q'/ X% &N]G:R2O*]M"TDB>6[L@)9?[I/<>U(EA9Q6[V\=I D$F=\:Q@
M*WU&,&J]YKVCZ?YPO=5L;8P!3+YUPB>6&Z;LGC/;/6I/[7TT?9?^)A:?Z7C[
M/^^7]]GILY^;\* '0Z;86UHUI!96T5LW6%(E5#_P$#%-.D:88U0Z=:%%)(7R
M%P">O;VI1JNG&2YC%_:E[49N%$RYA_W^?EZ'K4$7B'19O,\K5[!_+A6=]MPA
MVQM]USSPIR,'IS0!.-*TX7:W8L+47*])O)7>/^!8S4-OH]O!K5SJNR/[3.@C
MRD87Y1SR>K$X')[   <Y3_A(=%^S/<'5[ 01L$>0W*!58]B<\'VJT;^S%\+$
MW<'VLKO$'F#S"OKMSG% #KBTMKM ES;Q3*#D+(@8 _C0]G:R6AM'MH6MBNTP
ML@*$>FWIBJT>MZ5+?_88]3LWO,LOD+.I?*_>&W.<COZ5'<^(]#LA*;K6-/@$
M+B.0RW*+L<]%.3P3CI0!9_LVQ%DME]BMOLJ\"#REV#_@.,4Z*PLX+0VD-I!'
M;,"#"D8"'/7@<<UE:MXOT;1M6TS3;R^@CGORQ3?*%"(J,V]B> "0%'J3QT-;
M4LT4$#SS2)'$BEG=VPJ@<DD^E %?^R]/+QO]AMMT8 0^2N5 Z <<8IYL;-KK
M[4;6 W'_ #U,8W_GUK+\/>+-(\2:5)J-C>0F"-I ^9!E55V4.PZJ&"[AGM6A
M8ZMIVIF06%_:W1BP)!!*K[<],X/% $BZ?9)>O>I:6ZW;C:TXC =AZ%L9-/%O
M MPUP(8Q.RA6E"C<0.Q/7%4]=URP\.:-<ZKJ4ZQ6T"%B2>6/91ZD] *YG4O%
MDS:_X1>PU"U_LK4I)ENE7:^-D+/_ *S/&"!GITH ZZWT^RM)Y9[:SMX9ICF6
M2.)59S_M$#G\:9)I.FRW$D\FGVCS2@"21H5+. 00"<9/('Y4MAJNG:I:&ZT^
M_MKNW!*F6"570$=1D'%-L=9TS4Y98K#4;2ZDBP9%@F5RF>F0#Q0!=Z54&EZ>
MMY]L%C;"ZR3YPA7?SU^;&>YJAXNO[S2O"6JZG8R(ES96LMPGF)N5BBEL$9'!
MQ3O"MY>:EX6TO4;^5)+B\M8KA_+CV*I= V ,G@9]: -,6\ N3<B&,3E=AEVC
M<5],]<5%#IMA;W<EW!96T5S+_K)DB57?ZL!DU4>=AXG2/^VK98EM&9],*KYA
M.X?OMV=P4 XQC'-<M!XEO/%6JZO::!X@LK2?3[I(K:(B.9+I0BM(S#[Q7YB
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M6-U':W>I6=O<2$!(I9U5F)Z8!.>:Y[Q)XMMK+Q-I?A]=5M[%[M9GN;@R1[X
MB@J,/D L6'4'@''7( .JFMH+C9Y\,<NQ@Z;U#;6'0C/0^]1S:?97-S%<SV=O
M+<0_ZJ5XE9D^A(R/PKG-%O;W25U23Q)XKTZ^%I&C2)#"L7V9<M\SX).7 '&
M,@XK7\.^(;#Q-H\&I6$R/'*@8H'#-'GD!@.AQV- %VZL+.^,9N[2"X\IMT?G
M1A]A]1D<&I(8(;9"D$4<2$EMJ*%&3R3Q5:[U?3+!V2\U"TMW2,RLLTRH0@(!
M8Y/3)'/O7/>-?$<UK\.M1U_P[J-J[0P^9%<(%F1AG!QSC^?TH Z6[TZQO]OV
MRRM[G;T\Z)7Q^8I\EI;31QQRV\3I&0R*R A2.A [$56N-8T_3K:&34;^VM?,
M3<#/*J;L#)(R>U22:II\2VS27ULBW1 @+2J!+GD;>?F_"@!;G3;"]EBENK*V
MGDB.8WEB5BGT)'%275I;7UNT%W;Q7$+?>CE0.I^H/%066LZ7J5O+<6&HVEU#
M"Q662"975".H)!P*6SU;3M1=TLK^UN70 NL,JN5!Z$@'C- #Y-.L9H8X9+*W
M>*(8C1HE*H/88XIK:99%S*ME:B;;M60PJ2.,#WQCC'I5B::*VA>:>5(HD&YW
M=@JJ/4D]*K6NK:;?12RVFH6L\<)Q*T4RL$/7YB#QQZT ,T?2;?1K'[+;*JJ7
M:1MB!%W,<G"C@#L!Z 5+=Z987[*UY8VUP5Z&:)7Q^8J*TUS2;^X6WL]3L[B=
MH_-6.*=78IG&X 'IGC-6KBY@M('GN9HX84&6DD8*J_4F@ DMK>;R_-@B?RF#
M1[D!V$="/0U%/IMA=7,5S<65M-/%_JY9(E9D^A(R*KGQ!HXTNXU,:G:-96V?
M.G24,J8Z@D=_;K7):KXVDO=(\+:KH5[ MOJ.J6EO<Q861U27DJ3GY6QUXSSV
MH [B[LK6_@,%Y;0W$).3'-&'7/T--FTZRN$C2:SMY%C&$5XE(4>@R.*98:MI
MNJB4Z=J%K>"%]DOV>99-C>AP>#3+?6]*O+R2TMM3LYKF-2SPQSJSJ <$D YQ
MF@"9=/LDN/M"6ENL_P#ST$8#=,=<9Z59K/AU[1[FYBMH-5L99YBXCB2X1F<K
M][ !R<=_2M"@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "N/\ '>HV-C+X>2\BB\V74U^RW%Q(4AMY
M C8=\$;N,@*2,D]1BNPJ&YM;>\B\JZ@BGCR#LE0,,CH<&@#Q#4;BSN?"'Q0@
M^UP7DGVD7"$!?F_=Q_O% Z#/0_J:ZO6-'TY_$_@2XT2WMUNO,=Y'MU'SVAB.
M\L1U4DJ,GNWO72^-/#L^N^$]5TO3(K.*[U",1O+*2@P,<DJI)P!@"M73=.BL
M+3='86=O=N@\WR  '8>K;03]2* /);32M"NOA?XX%Q:VKSQZAJ"1D(#(D@<^
M2J]P=Q7 'K[UKZ?I<$WQ*T2TUNVM[B\_X1,+<I.JOOE$B*V0>I^]^M=)X.\)
MRZ-'>/JMIILEW)?SW<,\.9&19'+;<L@(QGM73FPLVN?M)M(#<9SYIC&[\^M
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MTL-K!%(XPSI&%)^I%)::?96 <6=G;VPD;<_DQA-Q]3@<F@#&\?,J?#OQ(68
M?V9<#)/<QL!5'PMXCT73_AWH<]UJMG%'#ID'F;IER,1KD8SG/;'6NKGMH+J/
MR[B".9,YVR(&&?H:KC1M+!!&FV8(Z$0+_A0!QX:)OC98R^6(IIO#DC.IP&SY
MZ<'W'/Y5CP-=S:1\4TTEBU]]LF$0B/SY^SH.,=^"![BO36L;1KG[2UK 9_\
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MM]%41WDGAR)HXX!AF<>8 0!_%C 'X5:T*X\)^)I_#=];:Y/>7UHA%M8H85>
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ML$#.<;F)P%'J2>@')JE_PDVB?V;/J+:I:QVENYCFEDD"")QU5LX(;V/-8?Q
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MM3AMS*43:9(QV;:P/&?48KG/ _CC3M0\/:#:ZIKEJ^O7EJLCPO(JR.QY^Z.
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MW-Q)N$:[O]85^\%/1B.X&<=ZR+#QKH^N6FM^1J4=DEC+);_:I"%V[57,GS<
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M<?0@XZU-_;VE_;5L_ML7GO*847G#2#.4!Z%A@Y .1@YKSJ2ZT^*Y^%1CGMD
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MWF *A'!#9^Z1Z'FH5\3Z(UO=S_VE L=GC[3O)4P@C(+@\J".<GB@#6IHC10
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M[6-/TQ@MY=)$VPR$')VH.K-CHON>*JW7BSP_9<76LV,)$'VDJ\R@B(XPQ'4
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M)MRL'< MD= H)/X8ZUHWGB'2=/MTGNKZ*.)X_-4G)^3^^0.B^YXH T@ H
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MC##:2I(R3SG/MB@#LFBC=U=HU9T^ZQ&2/I3BH)R0,TV21(8FDED5(T&YG<@
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M?[-:2&.YEW\0L!DA_P"Z1D=:CO/%?A_3]@N]9LH2\/VA0\P!,>,[\>G(Y[T
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M%N%D;[J%N@8Y& 3DY% &H1D<TFQ?[H_*LF]\5:!IT]Q!=ZO9Q36Z!YHVE&Y
M3@9'8GTZU976M,?2$U9;^W.GNH9;D2#8P)P,'Z\8]>* +NU0<X&?I2UQ.B>(
M)]1^)FKZ=%J37.GPZ?%,D#1A3#(SL&!^4-G !^;GFNVH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MQ^Y8/G_@1&??K7LE)@>@H \HU?5=/M/&'Q DD@CU!!HD!ELDDP9]HD#*<<\
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M2Z1X?BT+Q!I4=S)X:37);J^G8O(KM)$4%P >=@<GD#&1D=1G1\77.B:S\/\
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M&M?$4;3Z9;V;K%8C=+D'"Y+DD$G/)8X KH)H[BX\3?$C2K=9H[_5;.$V.8V
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M\3Q*PR"5< X.#@XYK@K:_BT[X$Z/*-/AO!##:Q3QR0F1;<AUW2.@Y.P_-CU
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ME"%.?J17G'A2^\.:W:Z%IMUIVJ-X@TQX=]E</<XM)8P 9,D[ H )'KD#'.*
M/0;#Q)I6IV][/9W+2QV+M'<GR7!C=1EE(*YR.X'-$OB+3(;2"Y,TKI/$9HTB
MMY))&C&,ML52VWD<XQR/6N0U'2[VQ^(%W86D#MI?BB /<NOW8)(L"4GTWQ$+
MG^]@U#XCU"U\.?$9K[7A?PZ-?:?%!!>6KS*D,L;N2C^4<\AP1G_&@#K7\9^'
M([:PN&UBU\G4,_97#9$F <_3&#G.,8JUHWB'2M?6X.F77G&VD\N9"C(T;8R
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M+.\D$4$H)(=B<8XYSG@^G?% &W163I7B;1];O+JTT^]6:XM@#+&492%/1AN
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M\ZVNI&C@,43LTC*6#!4 W$C8V>.-I-7-/U&UU2U-S9R,\0=HR61D(920P(8
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M5Y IRH^Z,$8QR3G%:AOXHO&/@G4G2X%K+I,]NC_9WYD/EX7&,@G!QGK7IE%
M'D.IV=WK3?%.PTEMUW="W\A5.#,%A4.J^N<%?J<5J:M=V_C&T\')HY_TZVU.
MWNIXE&'LXXU/F"0=4_NX/4D8S7I5% 'DJ36[:!\4QO0O<37'E#O*#;JJ[?[V
M6R!CO79>'-=L(=(\,:6\CF[O=/4Q!8V*_NXUWAF PI'H>_%=110 5YYX^N84
M\;>!]TBCR;^1Y3VC4QX!;^Z,GJ:]#HH X7XGR0_V7H0D*LO]MV<C#&?W:OEF
MQZ =33O$NKP6OC318)8_LL,]K,4U2*W\V0L2O[B,A6"EA\Q."3@ <G-=Q10!
MX7IEQ/8>$/#EZUM>/8Z/XAN)=1C,#EHU:24*Y&/FV[@3C.,BNOT[6=/OOC!<
M7]K*9+.3P_&!<B-O*)$[D_/C&,=\XX(ZBO1:* /$+:6$?!WP];OCS$UU&>)A
M\RJ+MG)*]0-I!^AKL6DMKCXQW2^9NAE\.+"6C/WF\YB5!'\6TYQUQ7?56U&S
M&HZ9=61GE@%Q"\1EA;:Z;@1E3V(SQ0!XSH.N>';C1O"ND:CKT-I#H]XES#YT
M$L4KE-PC1]RA$(W#<0Q!QQUS7M]<I9^&=<^P#2M3\007>E^5Y+1Q:>(I9(\8
MVLV\J 1P<*#Z8KJ^E 'G-O=6\7Q!\=O)*BHVGVJAB>&*I(& /<C< 1[U@0RP
MQ_#;X;QEE62WU6R:5.AC"[MY8=@,\D^OO7LM%  "",@Y%>16VK1Z3HGCW0-9
M\R+59Y[ZYA5HF;[5%(AV,A ^8 #!'8#GI7KM% 'C<&HQ:&WA#5]8BU*+1'\/
MQ6#W$(FC-M.NTG>$PVU@,9Y&5'I5O7H]$M]#T&32K.2VL;CQ1;7I,_F%IES\
M\Y5_F5<]S@=#WKUFB@#A?&L\*^*_!+;UPNHO(Q!X53"X#'T!) S[U#XCLM2T
MOQW;WND1R>7XAMSIUV\?_+&5 6CG/N(_,'_ 17H%% '":_?6ND^,-#TTVYL+
M;[#(D.H0VQEDX*@6\9VG;D#)X). !@\UQ=E(8OA9HVZ&Z4:;XE26ZWPOF)!=
MNQ)XYP""<9QFO;Z* ."N[R"X^+OA^=&(1M*N%RRE<%F0J"#T) ) /-5Y-*O;
M'Q_J&BP6[-HWB$+?S./NQ-&0LZG_ *Z#RP?]\UZ+10!YGK6I6GASXCZA/XB_
MM"'3-3M(%M+RW><1J\>\-$WE'.3NR,CN?6H[W2='M[70XM&OKGPE=00W$FFS
M2Y,?ELX+)*LG][Y7VL01]017J%% &#X+O;_4/"5A=:G:1VMY('\R.)2J'#L
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MW:W>7"^= \>^-FRKC(&01Z5RL>EZGJ_PI\2:?86MPM^VK3W<5O-"T1FC%P)
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M3)(O?,.WY?F&P;LC(KJM7BEO_B?;M;+<+'-H%Q;"Y$+[$D=U*@MC . 3CVH
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M)>7L+QR-R"(QOY8#!)/0'&,\X -[4M9L]*EM8;AW:XNW,=O!&A9Y6"EC@#L
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M+I]Y<VL4/VAENV9;>;R&\J4J"3AL8Z*<9QG'&16I/*(())F5W"*6*QJ68X[
M#DF@"2BN4\-^.++6?"8UZ[26R@+N,20L.#*R(JG'SL<*,+GYCBM:Q\0V%_J<
MNF*98+^*,3&VN(C&YC)P'7/WESQD9P>#B@#5HI&944LS!5 R23@ 5YSXL\31
MW=[X1DTRZU"**ZUJ!!(BO'#=0G=NYZ,"0I&>HY&1S0!Z/16'JOBS2='%P]V\
M_DVK*MS/% [QVY."-[ <<$$^@()P#5;4_'GA_2KV6SN+B=[B.V%V4AMI)"T1
M. RX7YAUY&< '/2@":R\.RVGC#4-?-\K_;88X&@\G 58\[<-NZ_,<\<^U;]<
MO9ZSH[>(M;G@O=2FN;>VA>ZM6CE*1)\Q4QQE>I&<[<YP*O6WBK2;OP_!KMO+
M-+I]PZI%(MO(6<LVQ<+C=RQ Z4 ;5%<_?>--%TY[K[1/+Y5G(D5W.D+-';N^
M-H=@./O+GTR,XJ&?Q='#X]A\-?9+D[K)KEYA [#.]%4# ^[RV6/ XYZT =-1
M7(V/B/0=/M?$.JKJ&I3V]K>-]M\Z.5_LSA%RJ)MRJ 8/ QR:W/[=L?L^G3AI
MFCU%@ML5@<EB5+#(QE?E!.3C@4 :5%8-YXPT>PD7[3-*EN;C[*;OR6,"RYV[
M2^,#GC/0'@G-377B73[6>:-OM#B"9()I(H&=(Y&V[5) Z_.OL,C)% &Q117(
MZ?X[M+K4-?CN+:\M[;29 C2-:R'("!F8X!QUX'7 S0!UU%<M;_$/PW<VSW*7
M4XMUMX[@2M;2!75R%4*=N&;<0-HR<\=0<7HO%FE.-2$CSPRZ8BR7<,D#[XT8
M$JVT [@0#R,]#0!MT5S-EX]T"_N=-A@N)\:DH-K,UM(L4C;=VP.1MW8SQG/&
M.O%7I/$NGQW)A_TAU%RMHTR0,T:S,0H0L!QRP!/0'C.>* -BBN?O/&>BV,MP
M)IY?)M;A+6YN%A9HH96QA68# /S+GL,C.*N:EX@L=+E>&7SI9XX3/)%;Q-(R
M1\_,P'0<''<X.,X- &I17(7OCZPCU+PY!8QSWEKK/F2+<PP.Z^6L;-\H R6W
M!<C' SG%7M.O]+G\7:RD%_>O>P0P_:K:8NL,*_-M9 P R><D9S@4 =#16#%X
MPT>6>R3SI4BOWV6=Q)"RQ7#=0%<C&3V_O=LU6N_'V@VD^I6[27<D^F[?M44-
MG*[1@@MNP%^Z ,ENG(YYH 0>%=1M=4O;K2_$MW:6][.;B:W>".8!R "49AE1
M@#@Y Q6_86,>GVHAC9Y"6+O)(06D<G)8XP,D^@ '0 #BJ9\1:<T-C);R/=?;
MH3<6RV\9=I(@%)?'8#<O7^\!UJYI]_;ZI817MJ7,$HRA="AZXY4X(Z=#0!9H
MJA?ZQ:Z?/%;R>9+=3*SQV\$9>1E7&6P.@&1R<#) ZD5GP^,M#NM-L;ZUNFG2
M_E:&VCCC8R22+G<NW&01M.<XQB@#?HKG)O'.@V^@7.M37,J6=K.UM<9MWW12
M@[2C*!E3D@<\<CGFK%AXKTG4M;DTB"287:Q>>@EMWC6:,'!>-F #KDCD4 ;=
M%5-30R:7=HLDD1,38>-MK+QU!'2N!\#>/]*C\*^&K/5;^Y:^O(4C^U3Q2-')
M,?X#,1M+^V: .LU[P[-JU[8ZA9:O<Z;?68=8Y(U61&5\;@R,"#]T<C!%6=,T
MF>UF^U7^HRZA>!#&LKQI&J*2"0JJ!C)52<Y/ YJ'5?%.F:,+EKEIVCM #=20
MP/(MN",Y<J#C@@XZ@$$\&M:":*YMXYX)%DAE4.CJ<AE(R"#Z8H DHK(U3Q)I
MVDO.D[32/;P_:)UMX6D,,?/S-@<#@X'4X. <&E;Q+I9M[&:"<W7V^/S;5+="
M[2I@$L .@ (R3@#('4B@#6HKG9O'&@6_A^YUN6[D%G:R&&X_<.7AD!P4=,94
MY(Z@=1ZTC>.="34VT]YKE+@Q&6$-:2XN%! /E?+^\ZC[N<]LT ='17,GQ[X?
M7P_=:W+<3Q6EI,;>Y$EM()(9 0-KIMRIY'7CD5+8>-="U/76T2"YE6]*&2)9
M8'C6=!U:-F #CW&?49% '0T5PW@C4S:V7BN;4K^>2"SUVYB22XD:0I&!&%49
MR>^ !W/J:W8/%>F3WUS8$74=[;PBX:VDMG$CQ$XWHN,L,\<9(/!H 37O#T^N
MO)!+JLT6EW%L;>ZL5B0B4$\D/C<I(X[C'8'FMM$6.-8T4*B@!0.@ K"T[QEH
MFKV^GSV%Q-/'J#R);E;:3DH</N&W*@'NV!6_0 453U35+/1M-FU#4)Q#:P@%
MW()ZD   <DDD  =2:HP^*M,EDU"%S<0SZ?&LMQ!);N'5&SA@ #N!P>F>E &U
M17,6?Q \/7TNF+!<3F/4B%M9VMI%B=R"0F\C:&(!^7.?QIWB;Q!9P:;JUHDU
MW]HMK8O-)9QNQMLJ2I9E'![XZXYQCF@#I:*YSP#<37?P^T"XN9I)IY;&)Y))
M&+,S%1DDGDFIM5\8:-HVIKIMY/,+UH3.D,=M([2*"!\NU3N.3T&3^5 &[16%
MIGC'0]7T235[2\+6L<OD2!HV61)<@>64(W;LD #&3D8ZTP>,]&7^T5GDN+>;
M3HA/<PRVSB1(ST<* 2R\'D9QWQ0!T%%<S9^/=!OTWV\UPRF*&6,FVD E\TX1
M4)&&;)P0.ASGH<:"^)--^Q7UW/)+;1V,@CN/M$3(48A2  1\V0RXVYR3@9H
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M_FM['97H%% 'C7C26^U71/&VGOI6HQ7:3YMK:SLW6.>(;,3O(HQ(Q /!)P%
M"Y&:ZB2XDC^*NF:H;&_^R7>B/:Q.+5SB3SE8*_'R?+S\V,=\5WM% '"^#+=;
MC4O&L%W:3""\U1V43P,BS1-$BD@D#()!'%-\ Z7JEF9-.U2-_(T!Y+&QE?\
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M2VZ6-ND#EY3&JJSA ,@,=W..0N>A%=-J\AG^)/@ZYB@N7@BMKP22BW?;&71
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M:30PSK#9.VSS/NL?]GIS[\9YJ+2=>T"VA\1:A;->HD&H;+S[0'R9R$ 5%8Y
M.5 & ,GTJ'PW%<1_$;QA<2V=U';W9M/L\TD#JDGEQ%7PQ&.#^?;-8UG9!['Q
MQ%J>A7]W9W^K+((/LTBM-"WE(73@$E<,W'/RT :_C353>^!_%$(@U"PN[+3V
MG^9_+;E7*E6C8@C*'(S[&M71M:C%OI.F+#<7%RUA#+(\8!6)2H&7)/!/.!U.
M#C.#7$3:9K=MX6\7Z3!-JVJZ3+IWE::;RV?[2)75P8AE0S*/E^8C SC/!J_X
M.75/"VI1:=-9ZA=:1J<*W27#6TC26<^T*\4IQG:<?*3T QTP: .^U+4K32-/
MFOKZ416\0!9L$GDX  ')))  '))JA;>)K6765TBYMKJROY(3/!#<JH\]!U*%
M6()'<9!'I69\1=(U'5_"P&E1^=>6=W!>I;YQY_EN&*9]3V]P*JW<#^*?&'A?
M5+:TO;>WTKSYYWNK9X&!>,(L8# $G)).,C"]>10!F:;GQOKWB.VU*'5+;[)?
M)%:3PR"-K,)&C8!#'#,Q)/!SD ]!CLM8\1VFAWNG6MU#<DZA.+>"2- 4,AZ*
M22,' )YZUA>"4GB\0>+&GL[R!+O4_/MWFMW19$\M%R"1ZJ:U?&VA2>(?"EY9
MV[;+Y +BSD'5)XSN0@]N1CZ$T 6-2UFTA.HVES#=F.VM//GDA0M\C;@-NT[M
MWRMT'&,^E4=(US1[+PKH36/VJ2"]B1-/@<[YYAMW <GJ%!)).!CDU'8)?/X*
MO=0U&TDCU34;=IYK:-&9D8IM2,*!G(4*"/7)KD=/TO5M.TOX>:S_ &?>.NBV
M[VNH6@A;SHQ)&$+A,9;:5YP"2#Q0!VCZ[9:YINMV$9NK6^LHF6XMW8Q3194E
M6#(>AZAE)%9/@WQ##8?#_P )1W)GN;_4+94@B3#23,$+,<L0. "22131ITUU
MXK\0>)DMKJ.TDTA;"%&@=9)W!9F81D;N,JHR.>>W-8^F/K.F>%/ ]B^E:FMI
M'$T.IFVMF^TPLJ (HXW*K$G++V'49H WM=^($-IX)O\ 7--L[B:6VN#9R12*
M%-O,'"'>,] 2.A.<CZB]?ZGI4OB?PW#?0:C!J4S3M9QG<J B,[_,VG8?E' R
M2,CI7!R:+J\GP[\:Z9%H>H1SR:RUW;Q2+EI8_-B<;3D[SM4],\]R:ZG6Y+G4
M?&?@G48M-U!;>"2Z><M;-F%7B*(7P#MR>W4=\4 7+CXCZ-!%J<JVNJ3+I<IC
MO/+LV_=  ,7.<84 ]^3@X! K9N/$5C#+I\$)>ZN-00RVL, &Z1  Q?+$ * 1
MR2.H%<,EK>?V1\28O[.OP^H2SFT4VLF9PUN(QMXY^88_7I4-[+-I9\#WL6F:
MJVH6FFO%*+>S,S*H2-61X<JV-V"&!X*]\T =YH'B:P\1K<FQ6Z4VLIAG6:!D
MV2 X9,D8)!ZX)[>M.O\ Q!;V-W/:I;75W/;P"YG2V528HR6"D@L,YV-@+D\=
M.F<;P#/IOV;48+6/48KV2Z>^O4U"T:WD:24D[@I_A^4@8)^[SS6;XTTI;[6I
M[RS&L:;K=K9J;/4K""21)^6/DR!058 @'#8^]UZT =7<>(8(A&MO:W5[<26X
MN?L]NJEUC/1CN8 9.0!G)P< X-5[7QCI&H:5I]_82270U$LMK!$N))&7.\8;
M 7;@Y)( ]>1GBKJ+5-(\26FLZ_X7DUF#4-*MH+H65JMP]I<Q[BP"?W#O/(]*
MGU*UO]$U/PYXFTWPQ)'I]L+F&YTNQ@7SH8YMI601KP6R@+ >N.<9H Z0^/M(
M739;UX[M$M[X:?<H8QOMYRP4*PSR"6'*Y'/6M)_$5G%XAET1X[@7B69O1B/<
M'B#!25VY).3C&,URWC#^TO$7@.ZN;31;N(I=V]S%:/'BYE2.5&9BF>"0#A>O
MR^^ 6UU=7?Q3@UH:-JD6FG0G@$TMLRD/YP?!7[PX4\8W>V""0"_:?$#1=<TY
MI8+75VL9;::1KA+.3: A*LNY>0W<8_0U2;Q;;Z-H/A"+1+"^N;'5)(H89)&#
M.L>TM@[FR7(7Z=>>@+?!%O=6/PC^PW=C>0WD,5RK6[V[AR6DD*X&.<AAT]:R
M4L-2MO!'P]D.EW[R:3>0&\MTMV,L8$3H3LZD D<B@#L;?4-)G\?2P!;Y-833
M%=UDWK$(?,XP"=I;<3R >A&:<WC33([C3EECNH[34I1!9WSH/)G<YVJ#G<-V
M#M) ![$UB7%E=ZA\3;N7[)>6]O<^'?L8N&@;8DQD9MNX<9 .>#CWK+\(1;;+
M3= U/P"R:OIYCB>]EL4-MB/ \Y9>[8&0!SN/89( .W3Q/:RSJ(K:[EMVNS9B
MZ15,?FABK _-N # C)&,CKR,GC%2?!>ME9)8G2QF=7BD:-E8(2""I!ZBN*&E
MWEMXFBU+PW%JNGW-QJI74]-F@<V<\7F$/."PVJQ4;P5/)(&,UW'BQ))?!^LP
MPQ2S2RV4T<<<2%V9F0@  >Y% &1H/B""P\*>$[21)[K4+_38FA@BP7D"0J78
MEB ,9'4]ZG?QYI"Z'::N([MK6YNOL?$0#13;]FUP2-OS#&>GOR*YR"?5K2P\
M%V4NE:I_9RZ:(;QK2W83QSK&BB-CPT:$@Y8$9('.,Y3PSX:N-4^'.O\ AO4-
M.NK!Y;NZ\HW"XP6D9XV4Y.=IVG/0]B: .TA\16LWB:?0!!<K>PP"X;<H"&,G
M 8'/()&/;OBHHO%-K/':>1:7<D]WYK06X"!W2,@._+!=H)7G/.1C(KA9-&\6
M747A_P 5"%X?$,P^P7L63^YMY$";B/\ 8<"7'JQ':N@\6Z#IMT=&T][;5+86
ML,GV/4M,20R63*$4+\@)PPSU&#LH ZS3=0CU2PCO(HY8T<L-DR[74ABI!'8Y
M!JW7(^'=4UNPT#18-=L;V\O[J=X'G@MP-B L4EF7/R94*3[GUXKKJ "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *Y_5O"P
MU'6$U>TU?4=,OUA%NTEJR,LD8)8!DD5E."3SC/-=!10!0TW2UTX.[W5Q>7,H
M EN;DJ7<#.!A0% &3P !R3U)J_110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MEW73@8+ 2?-@<#/?GTS0!7\.^)H-1^&5MKTMU._^AEYY/E\T2J"'4 #&[<"
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MP&\O._DC Q@]3SCBL+55M-=\>^%+_2I8I(]+6YFN[B,_+#$T>T(Q[$D_=/(
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MCR-WJ0K'UQ65IL6F7OAK4+:^O;FPW>*;F6UO;=MK6K$NT<O3&P@$9/!W=>]
M'JNGZI::I',]H[L(93%('B:-D< $@JP!Z$?G5;4/$>EZ6\ZW4\@^SH))S'!)
M((E/0N54A>F>>U8_@.[U:XM-2BU:6WO&M[ORXM3MXA&M\FQ?GP.,C[I(X^7
MZ5S?C -::UK6IZ%JQM=8BC1;G2KJ/S(-541@JJH>2Q!V?+SP <9S0!Z FN:=
M)JEUIJS.;VUB$TL/E/N"$X##CY@2#TS7(>+/%$4MAX6UK2=9DCTVXUJ*"=U/
MEI)'E]X;< 0 4P>@ZTQM232?BN;S5(I;<:AH<,<(6-I-TJRN6C!4'+#<.*Y7
M32P^&OA&66VN%CL/$HN+HO V(H_.F.\\?= 9>1QS0!ZCI7C#0-;%[]@U))&L
MO^/A'1HWC'8E6 ./?&*A\/ZII=OX1LKN+6KG4[-BR17MQEY9V+L, !06.<@
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M4FN&BDZV\3B4H&_NXW*.>AX[5TVD7-K%\2/'$TLL:1O;V8#L<!ML;A\'O@D
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M=)LY'8L[0(S,3DDE1S61#JFE)XGU=O[<F>:VMHS<V3-^YM@"V'''WCWY/04
M=%6!XR\.S>*_#-SHT5ZEF+@IOE: RD!7#<#<O=:CM?'GAF]FL(K?5%<W[;+9
MA$X1V.<+N*X#''"D@GTYJYJ?B?2-':87MTR>0H>=DA>00J>AD*@A ?\ :QQS
M0!J1"01*)65I /F9%V@GV&3C\Z?7/ZCXW\-Z3.T%YJL22K;?:RJ*SDQ<?,-H
M.>HZ<XYZ U+>>+M$L+;[3/=MY C25Y8X))%B1AE6<JI" CGYL<4 ;=%9%[XF
MTC3V59KHNS6_VK;;Q/,1#_ST(0'"^YX-2MK^F"UL[A+DSQWJ>9;?9XVE:5<
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M)9+6!NBR%5+!1AN7P>OI61X]U:_TJ/1/$FGZS,N@FZB34%@V,A@DP%E5BI(
M)&<'G=0!Z!17/^*)+N6+3K'3;^:TO+RZ15EA"DB)?GD)# C&P$ _WF6IK_Q/
MH^C--!>7C[K2)9+EEA>3R4/1I"BD+G!/..A/2@#:HK&OO%FA:=>06EUJ423W
M$1EB0 L74#.1@'/48'4Y&,YK+U;X@Z19>"[WQ)8M)>PV[-"$2%P1,.-K@@%.
M2,EL=?<9 .MK&U[2M5U1K5=/UZ72X5+"Y6*W21IT(Q@,WW".<$9ZTZ7Q+ID
MMQ))<"6X1WC@%I*9BJ\,WEA=P R.2,<CU%/7Q'I$FC6^KQWT;V-P56&5 3YC
M,<!54#)8GC:!G/:@"_;6T-G:0VMN@C@A18XT'15 P!^52UD6?B?1KZ_GL(+T
M"\M^9H)$:-XQC.6# $#'.>XI+7Q3H]WJ4.GQ73"YN(S);K)"\8G4=3&S* X
MY^4GCGI0!L45%<W,%G:RW5S*L4$*%Y)'. J@9)-9$_BS2[>UO9F^V%K.W^TR
MQ?8Y5DV<X(4J"<D'\CG&* -RBN>T;Q;9:CX6L-:N=]J+J.(^6\+@F1U!"(",
MR=>-N<]JT-/U[3=3:Z2VN?WEH0+B*5&B>+(R-RN 0".02,&@#1HK&M_$^CW]
M[#I\%ZRW-U$TEL6A=!,H'+1LR[7P"#QGCGI7.^"?$1M_"LESK>H7%Q(=6N;2
M.1T:1W(E944! >P[#% '=T4B,'17&<,,C((/Y'D5R7C?Q+:V/AG78[74+B"^
MM;1V\VVA9Q#)L)0.P4JA/R]2#@CID&@"[X>\.W.BZKK=[-?Q7*ZI<BY,:6YC
M,;;0N,[SD84=A70USVD:Y!;>%=$FOYYI;FXL(I-J1/-+(?+4LVU06/)&3CN/
M6K</B71[G2(=5@ODELYW\N)T!9G?.-@4#<6R#\N,\'B@#6HKB_%?B.&^\ >(
M[S0]3F@N]/@DWE$,<L,BKG:RNN5_(>QJV=0LC/X5AN];N;:^F0/%;1MQ>'RC
MD2<'(')ZCD4 =36)XBT.YUE;*2RU233[NRG\^*01"5&.TJ0Z'&X88]P1UJK=
M>/\ PQ9B\\W5%/V-_+N!'%(YC.,DG:IX (RW09ZUK7.M6%K!!*TS2"X7?"L$
M;3/(N,Y54!)&".0,<CUH J:?I&H"YANM9U.._G@R81#:^1&A(P6QN8EL$C[V
M,$\5M5D0>*-&NM-M[^VO!/!<2&*(11NSLXR2NP#=N 4DC&1@YJYI^I6NJVQN
M+1V>,.T9W1LA#*<,"& (((QTH MTR97>"1(Y#&[*0K@ [3C@X/7%/K)3Q)I<
MEW%;)/*SS2O#$PMY#'(Z!BRJ^W:2 C=#_": (O#VAWFEK)/JNK/JVI2JL;W3
M0+"-BY*JJ+P.68GN2?H!MUB'Q=H:Z1=ZJ;TBRLYF@N9/(D_=.OW@PVY&,\\5
M:O-<T^Q\H32NSRQF5(H87ED9!C+;$!.!D<XQR/6@#1HK@/$GB6)[[P;JNF:V
M1I%[?,DIC<"*5!&Y^;C/!7&,]NF:ZS1O$.E^($N&TVY,IMI/*F1XWC>-L9P5
M< CCVYH TZ*J:CJEGI-ND][,(D>18D 4LSNQPJJH!+$^@%5+?Q+I%S97EW'=
MXBLI#%<B2-D>)^/E*, V3D8&.<C&: -:BJ-AJ]GJ-Q/;V[2B:W"F6.6!XF4-
MG:<.!UVG\J=J.J66DPQRWLWEK+(L4:A2S2.>BJH!+'KP!V- #=9M+^^TF>WT
MS4CIMXX'EW0A67R\$$_(W!R,C\:;H^F?V59&*2Y>ZN9',MQ<R*%:60]6P. ,
M   =  .U+I>LV&LQ326,YD\B4PS*R,CQR#JK*P!!Y'4=Z9JWB#2="-L-4OHK
M4W,@CB\P_>;^@]SQ0!I45S]AXW\.ZI!?S6>H>:-/&;I!#('C']XH5W$>X&*L
MGQ/HXATN;[9^ZU4JME)Y;[9BPRH!Q@$CG!Q0!KT5SFC^+[76/$NK:1%;W2'3
MW2(O);2*&8J6.21@#&,9QGJ,@BNCH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KA/BE)%#IGAZ6<9
MA3Q!9,XV[OE#G/'?BN[KG_%7AVX\11Z8D-]':BQOX;[YX#)O:,Y"_>7 />@#
MD?$.E3>)_%NH7WAZ5&*^';BR>[B8;))I#^[C#C@D<DX^[D>HJI>2)XF^&N@:
M#8HT6NP364;6Q4K+9O"R^8[#JJ@*V">N1CJ*]87.T;B"<<D#%+0!Y3J[3:;K
ME_J7AK46>Y?446]\/7:;UNGW*OFPYY4X ;<,CY3G[M;>GR(WQ?U\*P^?2[>-
M3V9U9RR@]R 1D5W=% 'B)N%?]G$Z9Y4ZWMND4$D+PLK"07 )4 CD@ DXZ"NO
M>]&C_%2?5-1E5=)U/2XHK2]8_ND=&),9;HN[=N&>#]:[^B@#Q;5["2V\(Z_<
MLC+:ZIXFBN[2$H<M$)8]T@7K@[6;Z8/>NO\ M$+_ !KAE216C;P^T0D4Y4N9
MPP7/3.W)QZ<UW5% %74]/M]6TN[TZZ7=;W4+0R#U5A@_SKR/R?$2>&M+U^XM
MIVO_  A<?9%A4?->1JQBG8>H:/9CW1O6O9J* /-_'%HUCX#TVWN<-=RZG;7%
MP%&[+F822D?[(R?H *NBZMQ\:7G\Y/)/AX(9<_)N$Y;&[IG:<X].:[NB@#Q.
MPDNK3X=Z#J<%K/<PZ3X@EN[VVB0F00F6;Y]O4X#JP_/M74^(-9T;7O!'BG4-
M'M-PN-,DA:^-LT37#[&"1KN4,^,_09 &><>AT4 >8S3P?VM\,61UVPQR"0KT
MC!MM@W?W?F^7GOQ7IQ (P1D444 >.R^&M9FT76O#%HDL,?AV[:_TF<?\M&.)
M8(P>^W,BGZK6OX@L=7\1?";4]0MK.0:GJ@BO3:?Q&)60B+ZF-.G]YB.]>ET4
M >?:O<VWC#6_!]SHDGF26=Z;NX<#!MH?+(9)/[K,2J[3R>>P-<IJ5XEKX(^(
MFA217']IRZE=SI;K Q+12,I5\XQM([Y]NN*]LHH \\O[N*;XB>!95+*BV5V'
MWH4*%TC"A@0-I)4X!ZXKEAJ8L?A7XJ\+ZJDZ:_$;PO$T+,USYCLZRJ0/F4AA
MSVQS7ME% %#0Y1-H.GNJNH-NG$B%&'RCJ" 17'VUU!#\5?$TLDBI'_95NN]N
M%+*9"P![D9&1[UW]% 'BMH\<7PD\"0M\LT&KVC2QXPT864ERPZC .23Z^];=
MAKEEX?\ $7BG1/$MI/*NJWK7=FPM'G2]A>-5\L;002-NW!]:]/HH \]5X8_B
M[HX>WCM@F@/"(E *PR&1"(\C@':#@>E94E]I>C^*/$NC^+(-3$>J71GM'A^T
M-%=Q/&B&+;$<%AMVX(Z?A7J]% 'F-U<P66NKHHTV;28QH<:6WV>!I9K@?-_H
M_F -A4[@<Y.<@#G)T>*SOO _@Q#JUYH.K6EG*MKJ#1E8T9=@>.0. K*V1UX)
M0X/%>R44 >/W&J:G;P>%?$GB&QN%L83>VU_+IHD0*7<;+C:A#;7V$G_>SW K
MN_"":++'?:CH=G/';7DHD>YG,H:Z<#E\2?-CH,]^?0$]+10!P_Q$EC6]\(!F
M&8]>AE?_ &$"2 L?102.>G-4M/N+9/'?Q ED=%22VM KMP'VQ.& /?!(!QWK
MT6B@#DOAB?\ BVV@QMD216JQR*1@HPZ@CL:J^/+>[TV]T;Q9IEJ]S=Z=/]GG
M@C^]/;S$(5]R&V,/3FNWHH X+Q-)_P (YHWAZ&X@23=J"FYU$V_F_99&#LTR
MK@X8LS $C W=^E<_8SQQV'Q-@/VPF9'DB>YA=6E#6P53RHY8]%Z^@KUVB@#R
MF6ZBT^S^%^KW)9;"RB,-U,$+"%WM=@# #(^;CGH:H7XO=53XB?V79WDD[WEE
M=Q1&)XS/'&L3,H.!@D*>/O<]*]EHH X3PSJ'ACQ)K5KJ>DVFHSWUO$R23WAN
M ;16',9,A(+$]AGH3GIG;\=,H\ ^(%/WI-.N(T'=F:-@ !W)) Q7044 >7:[
M=0_\(=\/1O!,>HZ=)( ,E%1<.S#L%/!)Z5Z@CK(BNC!E89# Y!'K2T4 >:6E
MU'8:]\0[6Z66.2X83Q$Q-M9/LRKN#8Q]X8Z]>*REEBC\"_#&/(62WU&T:=<<
MQ!8G#EA_" 2 2?6O8** /(X+O2+'5/$/ASQ;::J\UYJ$\]K'%]H>*^AE;<JJ
M(SMR/ND' X'/!QZI80BWTZV@6'R%CB5!$&W;  !MSWQTS5BB@#RW1M0TFWG^
M(EI?M&7GU*4>05R]PIA0;$'5SG(P,GD>M5M(L)=$UOX9:?J1'VJRT^[2?/(A
M=T3:I/0'@J/7'%=UX;\.W.A7VLW$U_%<KJ=X;LJEN8_+8JJXSO.1A170T <%
M?-O^,D2QRB-CX?E@63LLAF4JN?7 )QUQ67X'UNP/AS2O">J:1,_B#3)%C:SF
MM&8(Z-Q.'*E0,?-NSGTR2,^HT4 >16UUI%EJ'B#PUXML]5DN+O4)Y[:*+[0\
M5]#*^Y H0[<C.T@X QUX./5K*(06%O"L0A$<2J(@V[9@ 8SWQTS4]% 'EVBW
M4>DZ'XN\/Z\K#4);N[ECB926OHY@2AC'\9.=N!DC&#4-U:SZ'HOPTTW4I,WE
ME>0M<#.?*41.OS'LH)"YZ5ZO10 BL&4,I!4C(([UYGH6MZ=I_P 5?&]S=7(C
MM[E;(03%6*2%(B&VL!@X)Q7IM% 'G?CS7+;7?AMXG6P622%8A;Q.8V!FE."5
M12,L "O(]_2G>*[VV;5_ <BS*R)?>:[+R$0PNNYCV&2!DUZ%10!Y7>:CIVB>
M-_$-KXHCU);+5FCFL;BW-PT4Z^4L;1$1'[P*]".0?IGM(_#^GW_@<Z";!K/3
MY[4PK;,2S0H0<=<X8<'KP?I7044 <!\-+?69K(3:_$4NM*C;2("?^6@1_GE'
M^]MC'_;//>L?Q?J N;OQQI9MI[2<Z;B%;6U8OJ/[EOF=PIRJD[< C&#DG.!Z
MO10!Y;9W<%QXH^'$HW!8M+N$<R1E=C&*-5SD<9*L!GKCC-9.I1O>>!_B;!:Q
MM+))JK3QI&I)=,0Y=1W'RMR/0U[110!Y]J7B.TN/&&D[8IK6TN=/D:'4X[)V
MFG.\?N$)4E0<;NF3QC'4\C82P6OPD\.37'VNVN=*UOS 7M9&5'$\IQ( ,E=C
M$97."17M]8?B'0KO5I=/NM/U:33[NQD:2-C$)8WW*5(="1G@G!!!&3ZT <$L
MVF^*K?QK)HNKPSZ[J^G"-+.-7CV)&A4 %U4L26(+8&,@>YT/#.J>'/$MWI)3
M3=4?6[ [I(;MKG%@VW#DESM]@!R<C@<X['3M)O4NH[S5]12^NHE9(O*MQ#'&
M&QDA=S')P.2WT YK8H R/%*64GA;4X]2AEFLGMV6=(<[RA&#MQSG'(KA]*_M
M<'6]%35%\1:8='D:TU#8#/&YRH@=EX<D<^O'/45Z?10!X_:W<J>'?AQK"17+
MZ=HH2#4E\EQY3-;^5O((R0C$Y(SC/UJUXFTB[\3ZYXDU'P]();>7PV;#S8F^
M2YG,A8*K=&(08)[;P/6O5J* .(\-^*]$\2#2VCTQQJ5C$?/^T6C1G3ODPXWL
MN!G&W .2/8''#>%K^X\.7,6O3E[O29=2N[6:#R\R61DF=DGC4#)5APW? !&1
MQ7N%% #(I8YXEEB=7C<95E.017D,.J+I?A+QWX=UA9H]8D?4)XU:%F^U1R(Q
M1T('(QP?0#G%>PT4 >/+J,6AWWAG5]8AU.+1)] ALFN(!/&;:X0[CO5,, P(
M&<'E:LZC]CT"3PWXETK2;R/P];ZA<S70V2/(1-%L%R4;+@9W>^#G^*O6** /
M//$VH:7JWP[\5WVDV6V*\M&477V<Q/>2["!@%0S8^4 ]^0.E0ZK<P/JOPWD6
M12D<C,[#H@-N5RWI\W'/?BO2:* /+89K??\ % EE_?Y\O/\ RU'V8)\O][YL
MCCOQ6;!?QZ&O@[6-52^_L1O#\=A-/:-*#:7 V,?,$9W '&WZK[5[)10!YC>:
M=X<GTBS>PDO] 2YU&2[LM4#.&\XQX,KB3D*XW+AL!L#^\*T-#\8/HOAK[5XJ
M=-S:D]G%?6ELWEW:]1.0!\H.&R>GRY%=]5:^L8M0@^SSES 2#)&#@2#^ZWMZ
MCOT/&10!9KRG2&FTS7M+/A[46O=+O;YA<Z)=INET\MO+RQM]Y4!SUX.[@G<*
M]6HH \4U*\2T\%_$70I8KC^TYM1N[B.W6%B6BD*E7SC&TCOGVZD5N?V]'X9\
M<QZKJ\5TFD:II%O!;W?V:1A#)&S$QLH&Y<[L].:]/HH \TUU[%+WP-]ET]-/
MLTU5YEM_)\KRXRD@#LF!LRQ!YQRW/.:T_#$L9^)WC8JPVR_8C&>S[8BK8/?!
MP#CI7<44 <CX_P!2&F6FD226J-"VI1J]XT'G?8N&_>A<'#?P@G@;N<]#QUI_
M9LTWCVTU0:JUE=7-HYG,,B2A2L:B4':,$-A@,=%Z8%>OT4 </X(N-636-3T^
M\U*'6[&"&%K;5T0!W!+_ +EV7AF7KD?WN>M6/'NIKIHT-I;9?(?4%5[]K?SO
ML7RMB11@X8_=#$8&>0>E=A10!Y_\/)57Q'XO@Q>$R7Z3H]S"ZET,2 ,20!DG
M/''TJ7XG2PP1^%)KC'DIXBM6<E<@#;)SBN[KGO%'AVY\02:0T-]%:C3K^.^
M>W,GF,@("_>7 ^8T <W=:?\ VWX^U75])VS6P\//8R3Q'*33NY*J&Z,0!R1T
MR!7-P:O;7'A#X<6L,=T\VG:G:1WB+;2$PND,BLI&.N<\#L,U[2,X&>M% '"^
M&9A:_$KQC:S1S)+=3VTT.8FVO&(%!;=C&,@CKUXKNJ** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MA:9+:-[5[F!&O?L_F_80$(\P+@X8'Y02,*3R.U<I<3*-&^*%L!>N]RBO UQ
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M<=[<@ AK2%4;S$D_N$DJNT]?H#6)YD+>"?B?&,&2YO[PPKCF4-$H4J/X@6!
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M20?*_>G!.<G R!@G/(SV] !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%4-4UBST>*![N1@UQ,L$$
M:*6:61LX50._!/H "30!-J%O+=Z=<6T,J122QE [H7"Y&,X!&?S%4/"NB2^'
M/#-AH\MTEU]CB$2RK%Y>Y1TR-QY_&JLOCC0X-&U#5)YIXH-.F,%VK6[EX7&#
MAE /J.>G(YIMGXZT&^UQ=(BGG6[DC:2#S;:1$N%498Q,1A\?[.<]LT =)17'
M3?%#PM! ;AKJZ^SI.8)IQ9R[(&#;?WAV_)SQSBKNJ>.="TB_>QN);E[I;4W8
MCAM9)"\60-RX&&Z]LX ).,4 =)16'<^+-,MEF8?:9Q;Q+-<>1;NY@1AN!< 9
M!QSM^]CG%1WGC;P_8_V:9;XLNI(7M'BA>19@%+?*5!!..B]22!CF@#H**YBU
M^('AZZTG4M1%Q<1QZ8<7L4EK(LT'&?FCV[@, \XQP?0UG:UXS\-:EX;U+[1>
MZM:V44<+R75M;S1MM<Y0HX7H2,9''.,\T =Q16/J/B33]+NS92>?-=);&Z>&
M"(R,D(.-YQVSD>IP< XK*U;QW9VA\.M8PS7EOK4RB.>*%F41[2V< 9+$#[N,
MCG/2@#IKV&>XL+B&UN3:W$D;+%.$#F)B.&VG@X/.#6?H.C7&E02/?ZB^I:C/
MM\^[>)8]^T84!%X51SQZDGO4>I^*M-TJ.>2<7+I:QB6Z:&W9_LZ$9R^!QQR1
MU YQBM6WN(+ZTBN;:59;>= \<B'AE(R"#]* )JR_$>E2:[X<U#28KE;8WMN\
M#2M'YFU64J2!D<X/K7)>%-2EA\1^-9-0O[Z:STR[5(4=Y)1%&4W'"C);KZ$\
M5LV?Q \/WTNF+!-<^7J9"VL[6LBPNY!(3>1MW$ \9SQCK0!MZ/92Z;HUG8S3
M),]M"D1D2/8&VC .,G'3UJ[6/-XEL(;EXL7$BI<I:/-'"S1I,Q4!21[LN3T&
M<$YJMI]]I<WC+6(H+V]:_@@A%S;S;UAB7+;60, ,GG)&0<"@#H:*\W\9^)HK
ML>&)=,N=0CBN-<M8TGB#I#<QE_F7(X8'&1G@@9&176ZKXKTS1UN7N3<-%:8^
MURPP-(MN" ?G(''!!(&2 03@$4 ;=%<UJ/CS0-,N_LLL]Q+.;3[:B06TDGF1
M9'S(0,-USQG !)QBM6]B?6-%V6=W-:_:51EG0%)$0D$XR.&VY'(X- &A17F[
M6MR/BU'X?&L:M_9QT,WA3[:^?-\[9G.<].W2MY_$.G>$5L]&U74+VZO91-)
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MP'M9!)#*"!L=<94Y(Z\<B@#IJ*Y[3_&NAZKKKZ+!/,EZ8S)$LT#Q"=!U:-F
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M:FN/^%D>-+62ZN);>$6+0QRRLZQ;HW+!03P">>* .SIDPE:%Q"Z)*1\K.I8
M^X!&?S%/HH P?!OAV7PIX7M-$DO4O!:AE258?+)!8MR-S<\UO444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M;7&NK>TU"RNWMEEMX2/W>(^F6X;YS\W./3/- 'M*.LB!T8,IY!!R#6)?^,=
MTO5%TR^U%8+YQN2!HWWN.>5&.1P>1Z&L_P"&<=XGP]T-KNZ2=7L86B"Q;#&N
MP?*3D[C[\?2N"\?3/!^T%X.ECMY;AUM,B*(J&;YI>!N('YD4 >M:3KFE:[;O
M/I6H6]Y&C;7,,@;8?1AU!]C6A7CNE:;JG@*[\;?$+6;5;:*Z#/!IJ2AF)+Y4
MN5RH.2!P3]YOQV_#/C'7=1U?0X;B&6ZL]7T_[1+<16,D<=E/MWA0Q&&0C@9)
MR>_.* /1ZS-/\0:3JNI7^G6-]%/=Z>X2ZB7.8B<\'\CT]*\V\&>+O'OC.WN7
MM&T>)+#51!<22QN#)",;@H!.& R<]\CICF+1_&QT;6/B3>76GV'_ !*'0B2V
MMQ%)<MEU7S&YR<@#/N30![#574=1M=*L9;Z^E\FVA7=)(5)"#U.!P/>O,[7X
MA:SI\G@BYU9[>XMO%&5DCCBV?978ILV')ROS@'.3QG/:J&J^+=8\8:-\0UM)
MK:VTG2+>:U6%H2[W'R.'8MD;?N\8'<9S0!ZWINI6>L:?#?Z?<)<6DP)CE3HP
M!QQ^(-6J\-TOQG=>#?A%X(F1'CL+J22*\O$A\QH$WL1A3QDGU[*>,UZSX5U*
M75O#\%])>VM\)7D,=S:KM22/>=AVDDJ=N 0>A!H V:*** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M OA*+P5X9CTF.?SCYKS.P!"AF.<*"20 ,#D]L]ZZ2B@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M( R<;B!T]Z9HNJ1ZWH5AJL,;1Q7ENEPB/U4,H(!QWYKAOMEUXJT'QE</J-U
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M82(T;-@G&>"HZ&J[?VSJ?B?QOIY\1:A!;Z?';R6WDB-60M$SXSM^[G\3QDT
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MEFZ@]:["B@#F+7P5;QZZVL7NJ7^H74EC]@E%P8PDL6XL055 ._;'XY-0Z!X
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M%(KJ&9"5.1N4E2/J""/PH Y-_AYI\GAC4M ?4M2:SU&X:YG;=%OW,V]L'R^
M3STJ36/ EMJFK6^KPZMJFG:I%"+>2[LI51IX\YVN-I4\^P_05U=% %6RL8M/
ML([.W:0(@(#NVYR3R6)/5B222>I-<X/AYI#^&K[0;FXO+FTN[EKHO(Z"2*5F
MW%T95&#NY[_EQ76TQYHXY(XWD57E)5%)Y8@$G'X T <_IO@^"ST^[M;[5-3U
M9KF!K9YKZ8,ZQ,,%5P !GN<9.!D\#%9O 5FWA_3-);5=4/\ 9D\<]I=&1/-B
M,:[5 ^3;@*<8V\]^:TM"\1PZ[=ZM;QVEQ;2:;=?9I1-MRS;0V1M)&,$=ZVJ
M.2U+P!9WFMKK%GJVK:7?-"L%Q+97 4W**,#S-P.6 _BZU<?PA9G6M)U.*[O(
M7TN)X;>)60H5< /NW*68G R<YSS70T4 4M8TFRU[2+G2]1A$UI<ILD0G&1Z@
M]B#@@^HK.L?"\=O<V%Q>:C>:E)IZLMH;K9^[R-I8[5&YMO&3G@GN2:WJ* ,/
M2O#,.DZYJFK1W]Y--J3H]PDICV91=JXP@(P,#KVI=8\,VVL:OIFJ-=WEM=:?
MYBQM;.%WI( '1L@\':.1@CL15ZVOII]4O;1["XABMA&8[E]OES[@2=F#GY<8
M.0.M9^M>*;71DTF0P374.IWD5G%- 5**TAP"V3G'7H#TH JKX(M5M]?A_M+4
M"NN%C=Y,61N78=GR<?*,=_SJM?\ P\L+RUTA8M2U.SOM)A$%KJ%M*J3>7@#8
MWR[6& .W\SGL*9-+'!#)-,ZI%&I9W8X"@<DF@"KI6F1:38K;1S3SMDM)/</O
MDE8]68]ST]@  , "N>N/A[IMU8:Y9SWVH21ZQ.+F<[T5HY5*E60A!C&Q>N1Q
M6I?>)(;'Q/I.AO:7#2:FLK0SC;Y8\M=S \YST[=^M;5 '-V/@V"S\1Q:\^JZ
MG=7Z6GV21II5VRH&+ L%4 8)Z+@>H)R:M1^%=*35=7U$V^^;5HEAN@W*LH7;
M@#MD8SZX'I6U5+2;Z;4M,AN[BPN+"63.ZVN,;TP2.<$CG&>O>@#/@\*V=IX2
MM_#MI/<VUM;I&L<T3 2@HP8-D@C<6&3QW-3V&@Q6>KSZM-<2W6H30);F:4*N
M(U)(4!0!U8DG^@Q6M69JFM1:;<V=FL33WUZSK;P*P4OL7<Q)/  '?W% ''B"
M6Z^,FI207MS:#^R885ECC4H[B1RRY92"0"#QR/SK;NO FG7&EZ?81W=[;QV5
MZ-0$D3(7EN Q;>Y93DEB2>@Y].*V-%U-]7TQ+N2PN["0LR/;W:;70J2#TX(X
MR".",&M"@#$UCPS;:M?:?J(N+BUU*P+>1=P;=VUAAE8$%64^A'TQ52^\$6&H
M:)JFFW%U=EM58->W2E!+-@  9V[0 %   &,>I)/352EOIH]8M[);"XDAEB=V
MNUV^7&5QA6YSDYXX[4 9LOA6&?6M(U634;YKC2HWCA'[L*P< -N&SG( Z8Z5
M53P'IO\ 96NZ;/=7MQ;:U.]Q=+(Z B1L E2JC'W5XYZ5?T#Q'#X@DU2..TN+
M9M.O&LY%GVY+!58D;21CYO6MJ@#$L_#:0WMI>7U_=:C<6:,EL]R$'E;A@L B
MJ"Q'&3VSC&3FG%X'T]-.U^QEN[V>#7)));H2,@(9U"DH548X ZYZ5T]% ',3
M^"H+FUT>&?5]3D;2KA;F&1GC+.ZJ5!;Y,8"DC  ]>O-3Q>$H(=4UO4(]1OA-
MK"(EP/W>%"*578-G& 2.<UT%% 'F.OZ-!X?M_#>C?:_$5MI>GI(T>J6*>:\3
M;=BQN$0\%6;YBO;'<XW_  ?'?BZFD76=6U/2FB&U]4MA$XDS_!\B,5QG.1CI
M@]:Z^D)PI(!..P[T 8LGAJ&3Q6/$0OKQ+L6ALQ&OE^6(RV[H5SG< <Y_2LH_
M#NP;PE-X;.IZE]AFN/M#-NBW[O,\WKY?3?ST_2M?PYXBA\1V]]+#:SVQL[V6
MRDCGV[M\> WW21C)]:V: .=OO"::@NI0S:K?FUU) EW;_N]KC8$)7Y,J64#.
M#],5*/"MHGB:VUR.YN8Y;>S^Q1VZE/*$60<8*[NH'.>U;M% '#2_"[3FT>^T
M2+5M5@T6ZD\W^SXY(_+A.\.=A*%@,CIG'/2KNK> K74M7AU>WU;5=-U)(1!+
M<V4RJUQ&.@D!4@GWQ_(8ZRB@#G9O!UG)J6BWT=[>POI D^SJKHP8R##ERREF
M+#.3GJ2>M;.HV$&J:9=Z?= FWNH7@E"G!*L"#@_0U9HH Y,> [;[)HL#ZSJK
M_P!D3+-;.SQ%BRKL7=^[Q@+Q@ >IR>:MWWA&UO?$@UQ+^_M;A[86L\=O*JI/
M&"2 V5)!!)Y4@^]=#3)9HX0IED5 S!%W'&6)P!]<T <<GPTTN'0=+TV#4-2C
METJ4RV-\)5\Z GJH^7:5(X((Y[U=L_!<-IJ&JWYU?4YKO4X$@N)7:/D*I 8*
M$"@X)[8YZ5=L?$<-]XHU+01:7$4]A%'*\DFW;(KEL%<$G^'OCZ5M4 <FG@&R
MCTK0M.34M1$&B3K/:',6[<H(7=\G( 8C\:BUS0&TN+Q)K]B=1O[_ %"S$+VD
M;(-P4%5V84," S'@Y/UQ78T4 >6:'!*#9Q>'_%/BJXEA,:FTU&PVPJ@(#*Y>
M%=H"YZ-GTS7::%I-[8:WK=S-?W]Q9W<JO##=RA_*8%M_E@?=CP4 !Y^4GZ[]
M% &''X9BB\37FO1W]XMU=6ZV[I^[**BDE<#9G())Y)K-@^'>EV_AVPTB.\OO
M^)=<&YLKLNGG6\A8L2"% ()8Y!!!!^E==10!EZ=H<5C?W&HRSRW>H7$:1/<3
M!01&N2$4*  N23TY)YSQ5?4/#%O>:]#KEM=W%CJ<<)MVF@VD2Q$YV.K @@'D
M'J*W*Q=<\1Q:%>:3;S6EQ*-2NUM(Y8]NQ'8$C=DYZ*>@/2@"M=^"]/N_#%[H
M/VB[B@OG>2[FC9/-G9SEV8E2,GV P, 8 I=6\(PZSI5AI]SJ=^J64T4Z21F(
M.SQG*%ODQP1V KHJ* ,2[\,PWGB+2];EO[S[3IR2)$B^6$8. 'W#9DYVCH1T
MXK+@^'FGVFK75U:ZCJ<%C=S&XN-+CG MI)#U)&,@'NH.#TZ<5U]% ')ZEX"L
M[WQ%+K=GJNJZ5=7*JEV+"<(MR%& 6!!Y XR,&KO_  B5HGB&PUB&ZNX7L;8V
MD-NA3RO*.,@Y4L?NCG.>*WZ* ,"TTF]A\:7VIB_OWL9[<(UK/*&A60;=IB7J
MN &W$]2WM6_7.:EXM6SGO8[/2[W4_P"SWC2\%FH9XRX! 5<Y<@$$@=CWYQT=
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MY&Q=^!;2_P! _LJYU34Y-TZ7$UTTJ--,Z$%=Q92  5'  ''UJZ_AF)_%$/B
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M22QQ@\8&,U6UC6]8TJ+QQHZZA<O_ &78+J.G79;][&&5OW;'^(!E.,Y..N:
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M*WA&#*,GDC P>Q&!@@UB_P!HS:[X^U;0&N;BVM-,LX9-L$AC>627<=VX<X4
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M5"*578-G& 2.<UT-8_BG7O\ A&?#=[K)LY+M;6,R-%&X4D#OD]OS/M0!F1^
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M1RVY4,& (P=P((()!&*OT4 <Q>>!-(U/3]5MM1\ZYDU21);BX)"2!T "%=H
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MQ)]@\6:-H9LI&&IK,R7.\!5\M-Q&.I/(].M;M !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7
M!_&?_DDNN?2#_P!'QUWE9'B3PY9^*M'DTK49)Q92D&6.%PN_!##)QG@@'C%
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M3/,1,X8AW.6(.!U)S4=[X9L+WQ!;ZXSW,5]!"8-T,Q17CW;@K#^(!N<?GD4
M>52)=V7P_P#%VNV>J7UM=Z?KMY+;K!,4CR)QG>H^^"#C#9'ICG/:75Y>Z_XQ
MU?1$8K%96=NZ(FH26C[I Q:0&-26QA1SP,=#FM%O 6E/H.HZ*]Q>M9:C.UQ<
MJ91EW8[FYVY&3@X'I]:76/ FEZU>6=_+<ZC;:C:Q>2M[9W)AF>/^ZQ7J/PH
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ME#Q>7G:!\^!@ C:.>M>J,H92K %2,$$<$5SEEX(TJQ@BLXI+IM,AG%Q#I[R
MP1N&W# QNP&Y"DE0>W% &#<:9!+\;X"TEV-VA23';=RK\PN$&.&X7_9Z'TK=
M^(4*S_#OQ"',@VZ?.X*2,ARJ$CD$9&1TZ'O5Q_#=K)XH3Q#]INA?) ;88==G
ME%MQ7;CN1G/7WK1O[*WU/3KFPNT\RVN8FAE3.-RL"",_0T >9ZG8B/3?AO!!
M<7,9EO8F,AE:1E)MFSM+DX]AT'I3;C7=0\*)\0((+^ZN(=,^QR6CWDS3- 9U
MPQW-DD _, <XKKU\#:<D&DQ"[U$C2I!+:L]QO(<+M!)(.<+QCI[9JR/"&F&_
MUB[G\ZX.L1K%>Q3,"DBJI51@ 8P"1Q_.@#-L-)UJT\46-\FH1QZ7+$\5S:RZ
MC+=>>VW<CQ[U 5A@YQP1GCBF?%C_ ));K_\ U[C_ -#6KWAWP1IGAJ17M;G4
M;A8U*6\=Y=M*ELIZB-3POIGKCC-:6OZ%:>)-&GTF^:46EP )1$VTL <XSCCD
M#I0!SVN,]UXA2RCO[R9AIA8:?:2M!Y3%L>?)*K# XVA>3P2 >:P+'6?$5Y\/
M_"6L_9[O5H_(9]2M[2<Q7,HQM5UP07P>J@\DBNQN/!NG7.L0ZK)/?"[2V%K*
MT=P8Q<1@Y"R!<9P2>F*CT[P/I^CV>GVVFWNHVPL!(L#BXWD*^-RD."I7Y1@8
MP,9Z\T <3J<FFZ[IW@6[L]0U"Z@DUXQ;Y;B5)4!$Q*/\V=ZX"[NN!P<&O6#"
M/LWD*\BC9L#[LL.,9R<Y/N:P+GP3H]SI=M8D7$?V>\-^D\4Q27[02Q:0L.Y+
M-GMSQCBM\0A+801NZ!4V*V=S#C .3G)^N: /&5N=63X1VOB;^W]5;4[6_P!J
M.URQ1E-X8RKIT<;3_%G& !@<5U,L]UX;^(OD1W^H7MK<:-<7<L%S.9 98W7#
M(#PA()&% 'M6O_P@&D_\(M_PCGGWW]F>=YWE^:-V[?YGWL9QO^;_ .M6B_AN
MVD\0VVN27-T][;P&W0EE"E#@L"H7G) /\L4 <!<ZGJ7_  J*#QS;ZI<_VPD:
MWK_OV,#@OAH3%G;MP2HP,Y .<Y)U$@O-:^(^K:;<:MJL%BVE6]P+>&Y,9C=F
M<$ K@KT'3DXY)'%;]MX'TFUA:SB>Y&EF?[1_9ID!MP^[=P,;MN[G;G;GM5Q?
M#=M'XANM<CNKI+VY@%NY#*5"+DJ "O&"2<_GF@#S RSZ]X%^'E[J5W=373:]
M';/,+AT9U#S+D[2/FPB_-UZ\\FNBDTE;_P"+6HV1O+VWA&@VZEK>X9)& ED
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M>6]N+;*W#8EC#;E#\_-AB3SUSSFKNLZ19Z]H]UI6H1E[6ZC,<BAL''L>Q[T
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M\!AR.QXP>/K0!Z'17C<VIZUI_AS5+*35[Z>31_$5O9V]Z9F$DD+O&2DA'WR
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M3RL9-O\ K0&<[1GC(^]["MGPC9:OIVDS66LZC'?3PW#B*19#(Z1'#(CL0"S
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M,@#'/)/)Y))H [:BO+=+?Q%XK\+Z?XDL-1BLKIIS</-)J,OE"-7(:)X-FP
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MII-Q;;#8R7\MTWG Y\Q&D4$#;P0..]=90 4444 %%%% !1110 4444 %%%%
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M;JRD\VUNK:3RY86/!VMZ$=0<@UM44 <G)\.M"N(]86Z:^N3JZ1K=M+=.2QC
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MP ?(O5V9@JK^+$#\:SX-3\4GQ ME<>'[8:?N!>_BOLJ%*DX"%0Q8, #VP0:
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M0FO#I\<J&\G:YGWSO)OD;JWS$X)P.GI3=2\.Z?JE_;:A,DL5];*4BN;>5HY
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MQ69ECSL4X!YP/0=<5V5]X9TG7-2M=8GBN4NXXO*#QS20,\9.?+D (W+GG:U
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MQB-G?&.<DXZXP0>-30O 7A[PW>FZTRTDC8%C&CW$CQP[NNQ6)"YR>0,X..E
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MM]\'D,.>O:N-N89U^%7B+6O[2U,ZCIFIW)M)S>R$Q[)\#^+#<<?-GBO2=#\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %5[R]MK" 374JQQF1(@3W9V"J/J20*L5P?Q3LX+K3= :96)77
M;-1ARN T@!Z'KCOU':@#<3Q%,?'S>&GLD6,:<;Y+D2Y+?O FTKCCN>I[5T%>
M=WFD6U[\7XM/D:X6U'ALADCG="X^T#@N#NQ^//?BL/2]<OH/"N@Z9)>OY$^O
MW.FO<7$K9,:-+Y<;.#NY*HO7D#'>@#V"BN6\-Z)>Z)KFIB74XWL[I4EAT]"S
M"V(X9E+$D*Q[=,CCO4'Q3:6+X:ZW/!<3P30P;TD@E:-@<CNI&1R>.E '845Y
MOJ>EBT^('A>"&_U)(]7MKM+\"\D_?!$1E[_)R3]S;@' Q6)<ZS>^&/#WC&SL
MKNY2VM-:AM899)6D:TAE$>\AF)(QN;'/!- 'L=%<'J\4GASQSX6_LAYEM]2D
MEM;RU,K.LBB,N),$G#+@Y;J0>:RM$O;BP\1:7IWB2UN8[N>>4VFL6LY>WU(,
MCX5\'Y6VMD ]-ORX% 'I-K>VUX9Q;RK)Y$IAD*]%< $C\,BK%<!\+-/MK6PU
MQX492NM7L('F,0%$O P3C\>M7/BLTL7PTUF>"XN+>:&)722"9HV!W =5(R,$
M\'B@#LZ*\ZUNV&@:OHFGVU[<^5KMZWVM[RZD97=8250'/RAVQPN <8Z<52UL
M:GX*TO4R=:5;*^OK-1%&S9TV&1]DK*S$D!L''3:<XH ]2HKA_$%I_P (E9ZW
MKNDWTZR#296CTYF+Q&2/GS\')R,@'UXSS4&G:)=2W>A:[::U%%:O'MGV2RO_
M &@DBC&XEOO \AAR/I0!W]5VO;==02P,J_:GB:98^^Q2 3^; ?\ ZJ\7N(9X
MOAAKVN#4M2;4=,U:?[)*U[(?+"W(4 C.&R.#NS78'3;63XYM*R/O.@I.2)6&
M7%Q@=^F ..GM0!T/A?Q%-X@;6%GLTM7T[49+':LOF!]JJ=V<#KNZ8K?KS/1-
M&;7]*\?:=%=36L\FNW'D7$,K1M')Y<>ULJ0<9ZCN*M^%=6/BQ=$@<2P7&D(S
M:G$LC I<+F(1MSR"1(^#G[J^M 'H-%,F=HX))%0NRJ2%'<@=*\\\,6\?B?P=
MH?B>76;BWU'SQ=7-S'(?G.\AH"I.-G\.W'8=^H!Z-17G>CK_ ,)C;^+I+^XN
M(;NTU.XLK9HYFC-HD:KL9,$8)/S$]\X.0,5BZ9J.H^(IOAI=ZA=WD,NHV]V+
MM89WC68+"=K;0< D<Y&#\W!'& #UZBO)K;1HIAX]TM[W4C9:7)YEE&+V4>0S
M6XD)#!LG#<@$D#TY-$<EWK5W\,_M.I7Z?VGILS7GDW3IYQ%NAR<'@G+?,,'G
M@CC !Z/XAU.71?#VH:I#;+<M9V[SF)I-FX*I8C.#V'I4NCWYU30]/U!HQ&UU
M;1SE <[=RAL9_&O,EAN='M/B7X=2ZN;C2K33//M!<2M*T!E@D+1[F))'RY )
M_G5VUOI[B;P9X?,D26MQH(N!',S*MQ*JQ +\I!.%+''3OV% 'HMY>VVGV_GW
M4JQ1;U3<W=F8*H^I) _&K%>0^)O#\VG>&;2RU'4_[0$7B2U:W4.^;6*21<1%
MBQ+8!X)Y -;TZOJ_C;5/#9>,6UC80-;V\TT@+!]^^0%3DD$*,GIVQDT >@5@
M:'XBFU;Q!K^E3V26[:5+%&'67?YH=-X/08X(XYKD;22_M]<\*^#M7UAM1C\B
MZEN+E24-V\386-CG)V@G<,\E1GO6AX(LXK#QWXZMH-_E+<VA4.Y8@& ' )[#
M. .PP* .YGFCMK>2>5ML<:EW8]@!DFN1B\3^)=0M-.O](\-P7=AJ,*S12-?"
M-H5)!'F KU*G/RYP1CWK;\4VT5UX5U2.4,5%K(WRN5.0I(Y!%>;W=L-/^!&A
MWEG/=6\YBTYV:.YD&[<\2L"-V,$$\=* /7Z*\V\;SWVGZIJ%]>6-QJ.@-:+$
M\UA.1<:6P#%I @(SD,K%@<X'/%6[*]M?%GC/5]+N;AY+*WTVUEL8T=D$BRJQ
M:; QDCY #_#VQDT =]7/^,_$4WA7PY-J\5DEV(I(T=&EV8#NJ C@YP6''%8$
MMM'%=>'M$?5[O6KF""X!MI&"K<[2$,L[]@ARO1B2<X)!-<O=W5U=? &_^US2
M2R0ZAY :20N0J7RA1N/)P !D]A0![/117%VTR>(O'_B+2M09VMM*AME@MA(R
MJWF(7:0@$9.<*#VQQ@DT =I17C-A=78\$^%+@WUXT_\ PE:V[3-<.7>(W,BE
M6.?F!  P<]*Z2ZO?L/Q \4K)J<UE9QZ#'<-)N+K Q:0&0(>,@ '@<XH ]"HK
MR_26N+/QIX3AA%U#::AIEP)6FN&,EWL6,K+(N2%?+$YW$_-SCI3/"GA^#6-+
MUJ\U"^U.X>SU34((E>^EV^6"4VL-WS<=SD\#MQ0!Z797MOJ-I'=VDJRP29V2
M+T8 XR/;BK%>.Z#='2_AWX#M8)?L\6KS)#<RR3.%/[MV5,@Y7<P4<8SR.]:'
MB31=1T'PKXPE&M.D,EE]JM;.UFE4VCJ""RMNR%8_P],YH ]2HK!\+Z)!IMI]
MM2YO)I[Z&%YS<7#2#<%ZJ"<+G/(&!TXXK,\:ZG-;ZQX7TD2/#9ZIJ!BN9$8J
M2JH66/<.1N; XZ@$=Z .QHKSFZ2XTOQUJ>AV<]RNE7FAO>F))W'V:97V[HV!
MR@8=@>HSZU<^&>DH?"^C:]->7UQ?76FQI*9KEW0CJ#L)P".F0,]<Y))(!V=Y
M=PV%C<7EPVV"WC:61O15&2?R%<O#XC\3WHTVYL?#=O/I^H0QW"S&^"M C%20
MZE>6VMGY<\@CW-[QU;17/@375E#$)83NNURO(C;'0\_3I7%:G;#3OA=X2GLY
M[J!WN-,+[+F0!]YC# C=@CVZ4 >K45YGXTN;S2]5U2]U*RN;WP_)$D?VW3YC
MY^E,%^8F,$'!R')';@Y&!5^VG@\7^+_$^E7=S)Y%I;VRV21R%-J2Q[S,N#RV
M2 &[;1C&3D [VL#Q=XBF\,Z5#?16272O=0V[AI=FSS'"!NASR>G%8$L$;ZKH
MNC-JESK=S!I\NZVD?8DN&5/M$SCN""HP&.22.A-<PUY=7WP*T>:]GDGG&IPQ
MF21R[$)>[5R3R<!0,GTH ]EHHKS_ %R[3P9X^M];O+F<:+JEN]O+OE9H[:Y4
M%U8*3@;U## '4>] 'H%%>;7<E[ILGA;2;B7R6UJXN)[M9YGV^9MWK!N!R%&[
M: ,9V =R"MYIL_A[2]5M+WQ'-';WE[:FTL[,,TL6]\&!&9LXD*D#D!?F[9H
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MFD*C)VJ"3CWXK-TC5=9O;Z,7>D10Z?/:+<1745SOVL<?NW4@'.#G(R.#6?\
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M)[U%"^:V1O Z!P#AQ[,#5W4= TS5+BWN;JW/VFVR(9XI7BD0'J Z$-@]QG%
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M)C:7TIFNHC/(1,YZLWS<D]_7 S0!IQ7 &EI<SOM A$DC^GRY)KRBQ"6]_P"
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M)ZCI7>6O@GPY9W0NH]+C>X$!MO-F=Y6,9ZJ2Y.>O?MQTJ.V\!>%K3['Y.C0
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M><^64=%(SC ],8H \HTV6#P]\,KZ\LTAL@^O/:W-RD>#%;&[VMG:0=H7C@C
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MT738[3S<;V#,S$#H,L20.>G2MN@ HHHH **** "BBB@ HHHH **** "BBB@
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M[1L))"JDJ^QL8!S@_3IUKK1R*\,-A96O[/\ XEDM[:&*5I[E"R( 2JW1 'T
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MYN&:V6X4>0C$]2"5 SSG'>NHTC02WQ#N-8M+.:ST=;!$6%@T"O=;CEA%QT3
M)(Y.,9QF@#I]7NM1M8[8:98Q7<\TPC833&)(UVLQ8L%8_P (&,=2*YFP\7>(
M]2UC7=+M="TPW.CM&LF[4G E+IO 4^3^'.*[>N!\&?\ )2OB#_U\V?\ Z)H
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M2S6>&]&+D7#-*TP P S.23@=.>.U4K+P-X;T^YL[F#2T\^R#+;R2R/(8@<<
ML3QQP.W.,9-:.I27[0PG2IK)76YC6<W.2/+S\X&T\/CIGC-79)HH0#+(B G
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M5<EIAYN#CN<@5:\,VWA?5-!\(ZS%<*+Z)5\N2&0"6:9TQ*LF.7.=Q;/H2>*
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MYW;-DORY'..!Q[5JR:9866H?$[3+6S@AL5TN"=+5(P(UD,$N6"] ?E4\=P*
M/3;'4[74-(MM3B<+;7$*3JTA"X5@",^G!JTCK(@=&#*1D,#D&O,+!='CT3X>
MV$5M&]_<0+<06X98X'D%L-\DP .X@,".Y..0,D9-N)F^&7C:UMK^VB,.N7"H
M$;RXFC$D9:-!D[5?)4#/5\=Z /9(IHIE+12)(H."48$9H\Z(S&'S$\T#.S<-
MV/7%<%!H;7OCE_$MII<5O!;Z3Y,<3^66>YW94@(2!M7Y<]\X&0*PO#=GIOB3
MPKX=U>;788-0M;B*622&!5NC=9VO&YSN.]B01CD8[4 >NTF]<GYAQUYI:\X\
M316?ACQ]!K+Z?'/::[:2:=<1",'S+E?GB!XY+@,GX"@#T;>N,[ACUS6:&U<7
MVI RV!MA'&;) K>8IP=QEYP1D<8QP#7G?@K3]BCP#J-K!(=#OC=3,(ODDAXD
MA//<NX_"(@UN>&8(H/B=X[6)%0,E@Y"C')C<D_C0!4'CK67^&.C>)UAL1<WE
MQ%'.A1MBJ\WE_*-V<@>I->C5XK!_R;YX=_Z_+7_TK%>U4 -DD2*,R2.J(.K,
M< 4"1"H8.NUAD'/!K@_$]\H^(^CZ;?W5O;V4]A,UL;J(/%)<;U!&"0-VSI]2
M!UK,O_ MI)X"U2RTFZ74;O3[Y[^PW1*4MYEVR&",#C8>5QG^(@]* /4-PSC(
MSZ4Q)XI6=8Y4=D.&"L"5/OZ5PEMJVE:_H&H>-9TDAL4TMHHI85Q-&FPM,4/]
MX,=GUC/K6-I2Q6/CKP.8$M;2"?2+A5BB<-(8@D93S7& Y/7@8!S@GK0!V7A+
M7[[69->CU%;9&T[5)+*,P@@,BHA!.2>?F-=+N&<9&?2O&M3ACG^'_P 4@\:R
M;-6N'7*YVD1Q<CW%='J36K?$OP"\9A,SV=X6*XW%?*3;GOC[V/QH [\3Q&8P
MB5/- R4W#=CZ54MM9L;S5[[3+>99+FR6-IPI!"%]V%^N%SCT(KR66:RET_PE
MJFEE$M)_%"F&XN'#7<^^602%F&-J]1MY.W;DCI6M%%%9^+/B3>Z=:VW]HP6E
MO+9,L:[A*ULY^7W8]<=: /4%FB:5HED0R+RR!AD?44^O+_#^GZ/J]GX4UZVU
MRW2>!D\O[+"JS3,RXDBD.2S=RV>>"QKU"@!DDT40)DE1 ,9+,!C/2G,ZHA=V
M"J!DDG %>8Z?X6T+7/B%X\L]3L8;BW4V;")_NH6@.7 [-U^;J,G'4UB>$[R]
M=/A[INL.TVF3"]$33<K.Z$B#=G@X3E<]>".@H ]AN]1L['3I=0N;F..SAC,C
MS%AM"COFBTOH+S38+]&V031+*"Y V@@'G\Z\JUVP%K-\2=/MH$.D#1Q=^3M!
MCANFC?)0=%)"ACCO@]ZLSW-G83>!; R65EIEW:.S,\*M"UUY413>,@;BI;&>
MY'M0!ZD)8S$)1(AC(R'W#&/K0)HB7 D0F/[_ ,P^7Z^E>0>*_#VFZ5X(UB*U
MOQ=J=7M9]D:A8[21YH]RQX/RY!R0#QN]ZZ"WTC3M.^,7V.SLH(;:\\/R/<PJ
M@VS,)U 9Q_$V&(R>3F@#IQK#ZYX8GU#PW<VAE;S%MYKK)A)1RA8[3G:=I((]
MC6LT\<$2M<2QIG +%MH)]LUXE'8:?_PS3>R"VMA<&&9V94 <E;API)Z\<@5V
MNK?V??>,19[(Y;V+12TQO6#6T$#/RP3JSDK@G*@*!D]J -CQAKU_H*:+)9);
MNEYJMM93>:I)"2. 2N".<9ZTD>O7_P#PLF7P_*EM]A&E"^1U!\S<9=F"<XQP
M3T[UY]:7#7'PD^'K/+YCC6-/4DMDC$Q 'Y 5U\D4<_QKEBE19(W\-!61QD,#
M<G(([B@#M]RXSN&/7-+UKR?3+"/3+O4?AF;5?LUQ=BZMF\O*FP<EY ?=64QY
M//SKZ5ZLB)'&L<:JJ* %51@ #L!0 DDL<6WS)$3<<#<P&3Z53NVU WVG&SEL
MQ9L[?:A,&+NNT[?+(.,YY.>U<GXPM-5.OKJ.D6UAK!M[$QW>C7?!>)V)WQ,0
M0&)4@@\$*/:L?SM-O]8^%NHZ=;O% ZS1PB4?O%C%LP"D]\8_SF@#U!IHDD2-
MY$5W^ZI8 M]!3F=5(#, 3T!/6O*=2T^?5&\>:28(]1O+V=5L[D2H! ?*79&Q
M8@KY9PW /WN.<BK&I^&]/MO''@/39K6!U^QWL4X5=JS;8T)R.X+%C@\<F@#T
M.^DN9=*N'TJ6V^U&)OL\DV6BWXX+;><9ZXK*UW7YM$T[25?R'OM1NX+)6 )B
M5WY9\9R5 #$#// SWKSYK&UA\!?$_3HX(TL[2[NFMX%7"0GR$;Y1V&[G K4\
M56-E<:/\/9)[6WE=]3LHF:2,,60Q.2ISVSVZ4 =9I)\6+K4D>KS:,^F@/Y3V
MRR+-+RI5BI)"@ L#R><5O^=$)A#YB>:1D)N&<>N*X2>T@L_C+IYL[>*-CH$Z
MA44*#MEC"CCL!Q67X130/$7@72=2U6?;J]O?">XE1PES]L$A&P_Q<YVA?[I
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M]9Z1;6M@+R.#5+>[N$9T"F*-LLN&(R2#C'2NOILDB0QM)*ZI&@RS,< #U)H
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M]/MUNKI=L\OEC=*O3#'N/K5R>XAM8C+<31PQCJ\C!0/Q-0?VIIX:)3?VNZ4
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M02RG$:2RJI<^P)YK _MO4$^)QT.26#^S3I#7J@1X=7$JIRQ)R,9[#K0!H_\
M"*>'_LEU:?V+8BWNI/-N(A NV5NN6&.>?6GS>&M#N;JTNI])LY9[-=EO(\09
MHUZ@ GL#T]*OVUY;7B%[6YAG4'!,3A@#^%,O-1L=/5&O;RWME<X4S2J@8^@R
M>: ,]?"7AY;&&Q71;$6L$OG10B%0J2?WP/[WOUJ>;1K&.\DU6WTZV?55A,<<
MS#:S #A"^"0N:MO>6L<L44ES"LDO^K1G +_0=ZAGU?3;:"ZGFO[9(K12UPQE
M'[H?[7ITH R_#]IJUQ=OK.OVEK:7[0"WCM[>7S1$@)9COP,ECC(Z *O/6NAK
M.T/6K/Q!H]MJ5C(KPSQK( &!*;@" V.AP>E37.J:?9B0W5]:P"/;YAEF5=F[
M[N<GC.#CUQ0!%>Z'IFHW0NKJSCDN!'Y0EY#[,YVY'.WGITI)M!TFXFLYI=.M
MFDLABU8QC]P.GR?W>/2K<UW;6UL;F>XBBMP,F5W"J!ZY/%,74;%[);Q;RW-J
MWW9Q*NP\XX;..M 'G=QX.GN]6OGUGP5HNL37%R\B:C]I$68R?D5U*%AM4 <;
MLXSU-==I/A+3+"UT_P ZT@FN[$,()F!9H S$[$9LD* =HYZ 9JQJ%ZUPEL=,
MUBPAV7R17!DQ('&<-"/F&'.0!W'I5Z[U*QT_9]MO;>V\PX3SI53<?;)YH I?
M\(QH7DW</]DVGEWAW7*>4,3'U<?Q?C3IO#>BW,-I#/I=K)'9D&V5XP1"1T*_
MW2/:M":XAMX&GGFCBA49:1V"J!ZDFN6\.>([K5_&?B/3VNK2YT^RCM7M'MEX
M(D#ELMN.X_*!D8Z=!0!O'1-,.IQZD;& WT2>6EP4S(J_W0W7'M5>/PMH$.N-
MK4>CV2:FV2;H0@.2>ISZGUZUI7-U;V<#3W4\4$*_>DE<*H^I-)'>6TMH+N.Y
MA>V*[A,K@ICUW=,4 9=QX1\.W5Q>3SZ)8237HQ<NT"DRCW./8?E5B/P]H\5X
M+R+3;:.Y6'R%E2,*PC[(".B^W2K5I?V=_"9K.[@N(E."\,@=0?3(-1KJNG/+
M!$FH6K23@F%!,I,@'7:,\XP>E %0>%M!&ES:9_8]E]@F??);^2-C-G.XCIG/
M.:U(88K>".&"-(XHU"HB+A5 X  '05%;W]G=M,MM=P3- VV41R!C&?1L'@_6
MHUU;3GE@B74+5I)\^2@F4F3'!VC/.,'IZ4 ,U?0]+U^S^R:M86][;AMP29 P
M!]1Z'Z4?V)I7]C_V/_9UK_9NS9]D\I?+V]<;>G7GZU/;W]G>231VUW!.\+;9
M5BD#&,^C =#]:;'J5A->O91WML]W&,O LJEU'NN<B@"&VT/3+2WF@@LHDCG
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MR%1N4'&0#V!VC/T%5M1T?3-8CC34].M+U(VW(MS L@4^HW XH \WOM/T[2=
M\ 6.E7EQ=V$/B.);>>X<,SKMFZ$  KD_*<=,8XQ6KX;:&_\ $WCNPUQ(WG-R
MH*3=#9&,"/&?X?OD^Y/>NTN=)TV\$(NM/M9Q#_JO-A5O+_W<CC\*;>:+I6HS
M1S7VFV=S+&-J/- KLH] 2.!0!XYI%@MS8_#!=;B28R3W<*M<#YI+?9)Y2L3U
M4KLX/!!]Z[+PMI4.E?$_Q1%I4*0:6UM;--#$-L:7)W9"@< [,$X_O"M#Q5X=
MO-:\1>'+F.SM+BPTZ:62XCG?[X>,H %VD'&<\XZ5U%I96MA!Y-G;0V\62VR)
M BY/4X'>@#D=>O[&/X@Z?:[H(-2339I1=7DA\F.$NH8*F0&<E?48 )YZ5Y]I
M\=C>_#'P-'(8)I(O$L4)Z;D1KJ4;?4 @#CT%>V76F6%]/!/=V-M<36[;H9)8
ME=HCZJ2,@_2H&\/Z,T2Q-I%@8UD,H0VR8#GJV,=3ZT ><ZNDNB^*O&R^'X$M
M[C_A&XIHX[9 O[P&4!@H_B Z?A4.J76AS>$_AM<V4UKL35K+RV##<HVGS,]\
M[L;O?K7J4>E:=#>F]BL+5+LC!G6%0Y'INQFJL?AG0(96EBT334D:03,RVJ E
MQG#$XZ\GGW- %G4].MM9TFZTZZ426UW"T3CU5ACBO'3?:DN@:5JCP9O/ LY@
MOW\OF9 WE.$/_7$;S_O+7MU0M9VSQ3Q-;Q&.XSYR%!B3(P=P[Y  Y[4 >=^,
M[2&Y^$7B/4[FW0S7\37O[Q!E1P(NO1A&$'USZU<UMA_PG/PYY')N\?\ @*:[
M>[L;2_MS;WEK!<0$@F.:,.O'L>*@;1=*=X';3+)FMQB!C I,0]%XX_"@#E_"
MQ!^)7CP ]);'_P!)Q5?QQ86=WXZ\#_:;:&0R7=Q&V]0=R>0QVGU&>W2NS@TO
M3[6ZENK>QMH;B7_62QPJKO\ 4@9-%SI>GWL\4]U8VT\T7^KDEA5F3Z$C(H \
MAUX7&F6/Q3@T6(Q)%-9.8;8;=L;11F8J!TRN[/XUU/B2*"?7O E_H/E^:]UY
M:M   UB8BT@X_@ "8[ D=Z[6#2M.M;B6XM["UAFFXEDCA56?_>(&3^-,L=&T
MO2W=]/TVSM&?AF@@5"W.><#UH \ZT*/3Y/#OQ#M)DMFD_M343Y+!2=H12#CT
M!Q^E5]36(_!KP2SJAQ+I0RP'3<F17IS:/ICO<N^G6C/= "X8P*3,!TW\?-^-
M,?0='EM8K:32;![>(YCB:V0HA]AC H Y3QS;IX>U#2O&MM  -,;[/J C3EK.
M0X8X'78V& ^M=#X9MG33'O[B(QW>I2F\F4C#+N "(?=4"+_P&JFJ:9K>HZB-
M,5--A\-,B>;MW>>V#EHPOW0K  $^A/X=+0!P/C0KX4\2:=XWCA9H O\ 9^J"
M),LT+D>6^.Y5PH]2&Q6?XABN-&L_"3:BJI:W6M+<:N?X!-)N9 Q_N*Y4 GCY
M%KJ[ZPU[5-=-M=?V<GAU)(IEV%S<2LF&V,#\H7> <CJ!CN<;UQ;07EO);W,,
M<\$@VO'*H96'H0>#0!P6H6<J_%.^-@G[BY\/N=011\K2;R(BP_O$;@/8&N7A
MU"P/PX^&2&[@,B:K8EEWC*[=P8GTP>#7L-CIUCID)AL+.WM8R<E((@@)]< 5
M5C\.:'#N\K1M/3?,)VVVR#,@SASQ][D\]>30!9U"QMM6TRYL+I!);74312+Z
MJPP?YUXTUSJ:>'-/NO(+WW@*<I>/LYFC5O+*H?0P9<_\!KV^H3:6S).AMXBE
MQDS*4&),J%.[UX '/84 >:^.46;X0>(=6==LFIM'<Y(P1'YD:Q ]P?+"Y'J3
M5Z_LH-+^+&CC2[:"WEFT>[4B-0OF$,A7=Z\\\UW-WI]E?VXM[RSM[F $$1S1
M*ZC'3@C%1C1]+6YBN1IMF)X0%CE$"[D Z '&10!Y7X:_L'Q%X1T :AXANH]5
ML+J.1K-#"ERMZ&PPQLWG<Q).3R#DG@U(NC:5+'\4C)86K>4TGEYC!$>;4,2O
M]TYYR.X]J]/31-*BU1M4CTRS34'&&NE@42D>[XS^M-&A:.!.!I5B/M'^N_T=
M/WO^]QS^- %3P;(TW@?P_([%V?3;=F8G)),:\UY;J6IZ=<:'I=W836]K9GQ7
M'*L,TF^Y9_M!$DCDGY!R?EP<*1D\XKVBVM;>RMUM[6"*"%/NQQ(%4?0#BJ;>
M']%8W!;2+ FY<23YMD_>L#D,W'S$'G)H 36TM[SPW?B18I[>2U<X8!E8;20?
M0^M>56=A96G@?X87T%O#'=R:G9*UPJ@2,&C<,"W4@X Q[ =J]CG@AN8'@GBC
MEA<8:.10RL/0@]:I'0-&,,4)TBP,4+;HT-LFU#Z@8X/TH XOPV;74Y?']AX@
M6,S_ -HRBX6;'%F8QY)Y_AVAB/?)KF]&L)+QOA5_;MNLUY+#>+(9URSQB$F,
M-GDC;MX->MW>B:5?W*7-YIEG<3QC:DLT"NRCK@$C(&:?<:7I]W<Q7-S8VTT\
M7^KEDA5F3Z$C(H X3PW%?6>L>.K3P[%8)-'J<+0PW!9(%+0H7.$&1GGH.M7-
M9L_$E]IFFK?:CI.G:]%J/FZ?Y >2WF(B?]W(& /(,G3I@$<UU]MI>GV4\L]I
M8VT$TO\ K)(H55G^I YIU[IUEJ42Q7UG;W4:MO59X@X#>H!'!]Z /)M9U$W_
M (.9M0TJ#3;ZS\3VT=\L;;H3)YD9:1&_NL""<]\YK8UW4=)N/$6O06<MI#/'
MHHCN+BYDW(\3%\)$F0#SG+9P#M&#7?'2=-;3VT]M/M39-]ZV,*F,\YY7&.O-
M(^CZ7)<P7+Z;9M/ GEPRF!2T:?W5.,@>PH \EL(=/U.Q^$YF2"Y;88)2<,2!
M:D[&]NGRGU]Z;K[S:/9_%*+1XS#'%-8LT=L-NQ'BC\YE Z$KN)/XUZPN@:,J
MVZKI%@%MO]0!;)B+G/R\?+SSQ4L.DZ=;3S3P:?:Q33C$LB0JK2#_ &B!S^-
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MA!$L88^^!S3+[1],U1HVU#3K2[:+/EF>%7*YZXR.* /'[-9+3PIX2:YD_P!
MM_%VRRED;@6N95CY/\/I[8]JW7N;.Z\;?$!(IH92^CP !6#;F5)<X]2./I7H
M]WIUC?V)L;RSM[BT( ,$T2NA Z?*1CBFVVE:?9R&2UL+6"0QB(M%"JG8.BY
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M4[^1NX'7D\^YJ]!96EK-/-;VT,4MPV^9XXPID;&,L1U..,F@">BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 445#=7=M90&>[N(K>$$ R2N$4$G &3ZD@4 34444 %%,EEC@B:6:1(
MXT&6=V "CU)-$,T5Q!'-#(DD4BAT=&!5E(R"".H(H ?114,EW;0W$-O+<1)/
M.2(HV<!I,#)VCJ< $\>E $U<7XKTC6+_ ,9>&-4T^Q6:WTF2=YM\ZH7\R/:
MOT]\5UT-W;7$DT<%Q%*\#;)51PQC;&<,!T."#@^M34 82W.NS:BC_P!DQVUL
MD3-(3<(TDS 82,8& ,DG.>WN:YR7P]K]KK6F>*+&$/K$[&/6+9IP(I(#T53Z
MI@;3CGG.,FO0** ."33/%7AWQ9JUWHVGVFHZ9K,B7#)<77DM:3!0K$_*VY3@
M'CGC\W:II'BG2?%%MXBT6.UU62:Q2SU&TEE^S[RK%ED1L$#EF&#V]>H[6XN[
M:T$9N;B*$2.(T\QPNYB<!1GJ2>@J:@#SCQ<^K1W_ ()FO(89;]M8+FWA?Y$'
MDO\ (K$#) [G&3Z#II77A>\UK4O$&K7$:VDU]I!TJTA=@Q5#O)=RN1DLPX!.
M OO@=%J?A_3=8N[.ZOH99)K-_,MV6XD3RVZ;@%8#."1FM.@##\(6VI6/A;3K
M+5+:&WN+6WCM]D4OF A$"[LX'4@G'/UKB/$7A+Q3J^G^*[)[.RNIKZ?S+&^E
MN<,D 9"L"KM^7&TYY ))/->IT4 <!XJ\-7GB>&>/4-!A>Z6%6TZ^M;E4DM)L
M<@N=K;0V#D YY^7I77IITLWAU=,O[AII7M/L\\XX+L4VLWX\FM"B@#RB7PSX
MQ;X>P^$6TZRE>QF@$-[]K"I-%'*K*=NTE3M7!SZ<9Z5U!TK5S\2#KGV1%M?[
M&^P[A*"1+YGF9P<97MGK[5U,=W;37,UM%<1//!M\V)7!:/<,C<.HR.1GK4U
M'G5AX+GE\1V>JC3!HLLMO+'K2V\ZF&]+(5&U5/4,=VXA3]:L>$-/\9:'86OA
MJ[MK$V%B1''JRW&6D@!^51%MX?'RY)P.O..>YGN(;6WDN+B:.&&-2SR2,%50
M.I)/ %.1TDC62-E=& *LIR"#W!H \[O?#OB.%O&UA96-M/:ZZLDL%T]SM*,T
M C*%,9SD<'..<D]JFN?"]SJ.@:9H^O\ AZWU"VM]/BB#6UPHEM[A1M+(S;2
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MQXF\':@+';!I4,Z7695R#)&J#:,\X(R>G'Y52\-Z7XS\-0GPU#;6,VDQR/\
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M1UQW]JI?#_PCXF\)1R:!=Z7I5UI\=R98-5:0;UC)R1Y>W);TR0 3U..?5**
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MN);R"Y\PW9 P-J;1L!."23VP!SQE:3X2O$\5:5KR:8FC7RH_]L&WF4PWI*$
M!%/)WG=DA<8[T :7C'6M9TW7/#-GIL5LT-_>F.4RS,C-MC9@O"G"\9)Y/&,=
MZNMXCO;N^U*ST?3H+R;3 JW/F71C4RLN[RT.PY(!&2<#D#UQ!XPT?4[^^\/:
MAI<,-Q)IE_Y\D,LOE[D,;(<-@\C<#TJIIVCZSX;\3ZW>6UFE_8ZPR7)2.94:
MWN NU@=V,HV <C)&.AH Z#PWK]IXHT"UU>R#K#.#E)!AHV!(96'J""*P1XYN
M(KG1C>Z.;2WU:]:SA268K<H06"N\1484[.S' 8=<UJ>#_#S>&?#$&FM*CW&Z
M2::1!\ID=B[8SV!.!["N(B\*>+GT[0Q=:?82ZEI^L)>75X]X2]Z!O&[.S*@!
MQP<XQ@ "@#;T*V@_X6MXSC\B/RY+2Q+KM&&)$N<COFI?A& OPPT@ 8 ,X _[
M;R59TS2]4L_'OB'6);+=:7MM;QPE)5W%H@V<@G@'=Q^N*E^'FCZAX?\ !=EI
M.IPK'<V[2;MD@=6#2,X((]F[T 8^D^+->"^,;V]L+:>'2;N1$BANB"JQQ(VT
M;DP<\DMD<GI5RS\9:S=:-!JG_"*S?9KN"V>T,=R)"[RD AP%RBKG);!XYP#P
M*B^'M=M%\:VD=G;S6^L22SVTPN,,6DA6/:5(XP1DG/3H#4EWHGB+_A6VBZ59
MQ(E]8BUCN[8W&Q;J*, /&)!T#8_+(/6@"Y%XVD)\3P/IT;WF@QI+(EO=!TE5
MD9AABHP1L8$$=N]06/CN\GE\-2W>A_9M/UY$$,XN@[QRM%Y@!3;]TX(!SGU
MZ5G1>&]?AU'Q9.FE6,-OK&FPP00P7 _=.D<B!<;0,?."3QC'&:D;P[K?]C>!
M+46*F30Y8&N_WRX(CA,9V<\YSD9Q0!MV?BR74[VYCT^S@N(K34#8W*BY(GBP
M^PR&/;]W/(YY'/TJ:OXYN-'BN+RXT<QZ?!J*V!::8QS2Y95,D:%<,N6X^;D
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M92Q7/JP(^G.*&\/ZWKGAW1= UFTB@%A/ ]W=),&2=83D>6!\V6(&=P& 3UH
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MD66,OO;(&2H$9/3/0>] ';45S7AOQ)>:KJNIZ;>V!C:SV-%=QQNL-RC#^'<
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M;6*[E<1I$\H#,Q&0OU(Z#J:Q[76IY_'.L:.--M(IK:QBFBN?,):8,6"A_E!
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M\D3B1F)CD^4$ JY!(!KTVB@#&T$>()%>X\0"RAE("QVUDS.B^K%F ))XXQ@
M=\U0\4:%-K\DEG>:3I^IZ1);@+'/*8Y(ILMEE.TX!!7D'(QP#7444 ><CP=X
MHT-]"U/1=0M+[4[/3ETZ^COF94N8P=P(8 D,K$X)ZC\C=UWPSXDU&'2-9M[V
MQ7Q'IER\Z1MN^S%'78\.<;L;0/FQUSP,\=S10!QFM^'M?\4^"-6T[4YK*VO[
MV-1## S-#"48,,L0"22.3C@8P#C)C71_%%[XQT?Q!>P:7 +2TG@EMX[AW(+E
M<$-L&?N],#'J:[>B@#E/!FB:OX>\/WEG>QV3W#W<]Q%Y,[%2)'+X8E 1C..
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MSW]SI5O+J=FEG?,O[Z!)1(J-[,.H[_C7%W>DZ?-\;;4R6<+EM#EF;*#EQ/&
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MM;6&XS<PPN)9"NT2.J9  Y^]TR*Y^ZN)+#XL:I<VWFS%?#'VE86D9E9Q,V,
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M<LB3VS0K'&P*:@K)NS+D$N0 6R3GDYK@1(1\"+*=I&^T1:KMCD+'>O\ IY7
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M0)&4(XM%(< $?,"!@GI^)S:EGFNX_A9?S3S/<7!C\XF1L.3:LQ)&<$YYSC-
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M144XWGHHSVR2.:;I\FO1:C<?VJ^FR:=Y*O#/ K1.K_Q*RLS CN&R/I0!6NO
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M2R2VDBO=4M[*8RY)"2-@E<$<X]: -.'0--@UJ36(X7%_)&(GF,SDL@Z*03C
M^E:5&1GK10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !7!?%&UAN+7PT9<@_\ "062;U8JRJS\X(Z?
M_6KO:Y#X@:->:[9Z/;6NG_;(X-5M[NX1G15,2-EE^8C)(.,4 <GJ^F/X0\::
MH_A&V^S^=X<N+F:UA'R><AQ%)M_O$Y'O@^]&IV]NOPR\+:]H2J-866R:"XC_
M -;/)(RK*CMU;=EMP/4CGI7IUAIEGI_F26UL(Y)L&1V)9VQT#,22<=N<#M5>
MT\-Z-870N+73;>&0.TB[5PJ.W5E7HI.3D@ G)H X#7C<:)J][JM]86NM>'IM
M3BEDN8N+O3I49% P1\R!E7@8.">W4\0&XT35M0U:]L+76O#TVHQ2RW$7%WIT
MJ,B@8(^9 RK@#!PQ['GT ^'-'-V]U]@B\V2432==KR#H[+T9A@8)&1@>E!\.
M:.UW)=&PB\V2432==LD@Z.R]&88&"1D8'I0!Y_\ 9K7Q9JOC+2-8O[*WN8KH
MQA;B -+#;>6OER1L6&T Y;('#9)ZTNMV=_;1KJ5I';>*=/CT>&"_L[SY+DQ@
M,1-&2,9<$DCJ2H[CCNM4\)>'M;OX;_4]&LKNZAP$EFB#, .@/J/8U->>'])O
M[I[JYLHWG>,12/R#)&,_(V#\R\GY3D<T >?ZR;BYBAU_2+"UUW2)-%@%UI-Y
M\EQ' 0SK)&2" Q4G([[!CH,66DL;OQW\.]1L4=8KK3;ID:08<Q^3&4#>X!_4
MUVUUX<TB\N#//81&4Q"!F7*[HQG"-C&5Y/RGCFI)="TN>_M;Z2QA:ZM%VV\N
MWYHATPOH,>E 'FNG16OB#X9^*;_5T0:S!<7K3SMQ+;2Q%C'M;JNQ0F,?U-.L
MK :SXT\(OKUJLMW=^&W>]CD'$CYBX=>AY)X/'Y5Z'-X;T:XOY+V738&N)2IE
M;;Q*5^Z7'1B.Q(.*FFT339]4CU.6SB:^C78EP1\ZKZ ]A[4 <M\,8TMM-U^Q
MA&RUL]>O(+>(?=BC# A5'8#)XJIH%O9^)M9\;VGB"WBGN(;\VRI,H)BM/+7R
MBN?N@_.V1WYKM=.T;3M(\_\ L^SBMO/D,LOEC&]SU8^I/KUJ*]\.Z1J-Y]KN
M]/AEN#'Y32$8+I_<;'WE]CD4 >3O')JOPM\"W>MPQW5XVL6D/GSQAGDA,Y"Y
M)Y(9 I/KWKU;5[&T7PO?62V\26HM9%$2*%4#:> !TJ74-"TK58H(K^P@N([=
M@T*2+E8V'0@= 1V-69K.WN+-K.:,26[KL9&)(9?0^M 'C4>C:>G@/X;ZC';K
M'?RW]C ]TA*RM&ZLK)O'S;2.,9P.U;4L.E>&?&?B^&)&T[2CX?CN;A+!0A5M
MTBET X#XZ'UKNCX5T)K.ULSI=N;:T<26\6WY8F'0J.Q';'2I6\.Z.][/>/IT
M#W,\1AFD==QDC(P4;/5?8\4 >=Z7!#9^._!Z1P6EK;7.C7">1&P9WB C*>:P
MP')R3TQG.":RK9[?0_AOK][:0P6S#7YH;F:*(;UM?M:AQQ@E0IQCL#VKU&T\
M'^'+%[1[71+&)[-F>W981F-CC)!]>!^0JS#X?T>WEOI8=+M$>_)-V1"O[_/7
M=ZY[^M '(Q>'=)_M>34H-3LY1>Z8\36=C J0W$0Y$C!6.<9 #>X%8&A>&M'/
MP/?5S91MJ,GAZ9'N&)+%0I8#KV*C'IBO1=,\(^'M&MKFWTW2+2UBNN)UB3;Y
M@]">N.O'3FIXO#VD0:.VD1:? FG."&M57$9!ZC;TP?2@#B+0V5TO@:P,?VC4
M5T;SHH9W MD3RXU:1UP2SCHH&."V2!S7-F0']GZ_B$J.L.HF--GW0@O@%"C)
MPOH/2O59_"?A^YBLHI]'LY8['BU5X@PA'HN>@X''3BAO"7AY[*>S.C6?V:XF
M,\T7E#;))G.YAW.?6@"7Q)!%<>&-4BF0.AM)<@_[I->6V6EV5AX9^%VKVMND
M>HS7EG!)=#_6/&\#[D+=2O XZ#M7KTUE;7%BUE-$)+9TV-&Q)#+Z'U%4#X6T
M)K:TMSIEOY%FP>VCV_+"PZ%!_"1[4 <9H=M9^)X?'$6OPQO>1:E/;LTH&^"W
M51Y)0G[HQE@1CG)K#TN"76[GX73Z[$9;NZM+Q9S(3F9!#\F_U!7!(/7<<]37
MJ5WX<T:_O6O+K3H)+AT$<CE?]8HZ*^/OCV;(J6YT33+R^MKZXLHI+JU!%O*1
M\T6>NT]L]\=: .&\*+>://XSL?#VG6THMM77[/9/-Y$2!HHRV"%.T<DX J#Q
MLNH:CI/AN37M/@L+K_A)+.-1:W9DQ&6Y._:I!)S], YKT"QT73=-N;BXLK.*
M":Y;=.Z#!E/JWJ?<US_Q T6\UVTT>VM=/^V1P:K;W=RA=%4Q(26'S$9)!Z4
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M\G[1SYFS^[NZX]JJ/X.\.2:>]@^C6;6CS>>T)C&WS/[^/[W/7K0!YE=0Q?\
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M6U]?:;:W%U;#$,LL89D'7&3[\U ?"/AYM&?2#HUE_9[R&5K<0@+O_O?7WZT
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **RM(\1:?K=[J=K8R-(VG3B"=\?*7V@X4]\9
MQ]:U: "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KG_%NI75AI\,
M5M9ZA.+F3RY9+"$R20QX)8@#H3]T'L3GM@]!10!YO\/-2@F\7^++6WTJ_LX3
M/ T:S6QC6)5MXU"-Z-W ].:](JE::596-]?7EM#LN+^19+AMQ.]E4(#@G ^4
M <8J[0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
6444 %%%% !1110 4444 %%%% '__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>18
<FILENAME>insidertradingpolicy005.jpg
<TEXT>
begin 644 insidertradingpolicy005.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#W^BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MT*[CN9+<@+\P MU)'&=V2/9?:J/A:^\*^(=,\,VLU]>2:SIDD.S3"VR2VFC
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M>,!MI/L#7 ZCK5[8:)XJLO%%G9:^EK8V[&^M,QK<Q-(P19@OW"I+,=O\))H
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M2*T229%L[<[DL@UNP6)F.6,F<+R1N(X6@#U";QEX9MT+S:_IJ()C 6-RN/,
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M@F?0!;F>W,LCR6V,):>41\V/X2Q4#/<G'>@#LW\0:1%J*:?)J5LMW(_EI$9
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M;- %J&"*WC$<$21(.BHH4?D*1;:W0DK!$I+^82$ ^;^]]?>JJZWIS:C<Z?\
M:D6ZMHA--&X*E(_[W(QMX//3BF66O:=J%T+:WF<S-%YZJ\+Q[H\@;AN R,D<
MCUH T-B;]^T;\8W8YQZ5SOC30;[Q%I=K9V3V\9BO(;IFG9@/W;A@H !ZXQGM
M[U=M_$^C7.HPV$5ZIN+A6: ,C*LX7J8V("OCK\I-:-W=V]A:2W5W/'!;Q*7D
MDD;:J@=R: %MH([>$+'!%#GYF6(8&>_89^M*MO"DSS+#&LKC#.% 9OJ>]9D/
MBC19M273OMZ17S@%+:=6BE8'H0K@$CKR/2A_%&BQ726[WRJ7F^SK(4;RC+G'
ME^9C9NSQMSG/% &HL,29VQ(N1@X4#-"Q1H"$C50>H QFJ6H:WI^F2>5=3L)?
M+,ICBB>5U0=6*H"0ON>*5M;TP:3'J@OH6L90ICF1MRR;CA0N/O$G@ <D\4 6
MX;>&V39!#'$F<[44*,_A3?LMOYC2?9XM[$%FV#)(Z$GVKC= UV;4?B;KEDFH
M7$UC!8P2);S1>7Y$C,VX;2JL. #\W.#Z5N>(KNS@DTJ&YUM],EEOXA$D9&ZZ
M;./*((.5;(SC\Q0!N=:A2UMXF=H[>)&D^^50 M]?6JD>O:;+<W]LEP6N+ *U
MS$(VWQALE3C&2" 2,4U?$.DOI$&JI>QO97! @D0%O-). % &6)/8#- %[[-!
MC'DQX]-HHEM;>=%26"*14.5#H" ?:N,\*Z]+J/CKQA"^I33V%FEHT*7">7]G
M++(7&TJI'('WAG@5NCQAX?\ .MXGU.&)KI=UL9@8Q./6,L ''(^[GJ/6@#8D
MBCFC:.5%=&&"K#(/X4"&)00(D&X '"CD#H*P+CQYX7MHKB636;?R[>4PS,F7
M", "<[0>!D9/09ZU9B\5Z%/K$6DQ:G ][,I:*-22),#)"M]TD#G .: -7R(3
M&T?E)Y;<,NT8/U%$<$,/^JB1. ORJ!P.@K,O_$^C:9.8KR]6';(L3R%&,<;M
MC"NX&U"<CAB.H]:BO?&'A[3[JYM;G58%N+90\T2Y9E!SCA023P>!SQF@#:>*
M.3&]%;'3<,T@AB5]XB0-ZA1FN:U?QUI.FZ?H]Y#(UW#JUS%#;R0HSJ58\L2!
MQ@9XZDC&.N.ECF22!9U.(V4."P*\8SR#T_&@!JV\"3/,D,:ROPSA0&;ZGO3]
MB>9OVKOQC=CG'I659^*-&O[N&VMKT-+<1M)!F-E6=%ZM&Q #@?[)-5?#?B^R
M\376IPVJ3+]BNGMP9(77>%5,GD8'S,1CK@9Q0!T! 92K $$8(/>F0P0V\8C@
MB2)!SM10H_(54U#6;#3)8HKJ9A-,&,<,<;22.%^\0B@D@9&3C R/6N6\<:^[
M^"+76M U9EBDN[95EMRI65'F5&!)!(ZGI@YH [1;>%)GF6&-97&&<* S?4]Z
MDKD+F^OXOBSI^GB^F-A/I4TQMB%V!U= &X&3P3U)K2\6^)[;PEH,NIW,<DF&
M6.-$0MEV( R0.!DCD_SP* -F*"& N8HDC+G<VQ0-Q]3ZFD%O +@W AC$Q&#)
MM&XCTSUK#N-4TZY\0Z(B:Y+;SR"9HM/ V_:QL.2ZLNX!<$CISZTD_CSPO;17
M$LFLV_EV\QAE9,N$8 $YP#P-PR>@SUH WC!"6+&)"3U.T<TU[2VDC,;V\3(>
MJL@(/X5FQ>*]"GUB+28M3@>]E4M'&I)#X&2%;[I(') .:6^\3Z-IDYBO+U8M
MLBQ/(48QQNV,*[@;4)R.&(ZCUH TS!"45#$A51A1M& /:A[>&4QF2&-S&<H6
M4':?4>E4+_Q#I>FR2I=7)3R5#2LL3NL0/3>R@A<]LXK3H 9Y,7D^3Y:>5C&S
M:-N/3%-6W@6)8EAC$:_=0*,#Z"I:* &F*,Q&,HIC(P5QP1]*2.*.&(111HD:
MC 15  _"GT4 116MO!M\F"*/;G&Q ,9Z]/7 J1E5T*.H92,$$9!%+10 Q8HT
M(*QJI"[00,8'I]*?110 C*KJ590P/8C-1Q6T$,1BB@CCC.<HJ  YZ\5+10!&
ML$2XVQ(-J[1A1P/3Z4J0Q1G*1HI]54"GT4 1Q6\,!<PPQQ[SN;8H&X^IQUIS
MQI( '16 _O#-.HH C$$(8,(D##H=HR*%@A4 +%&,-O&%'WO7ZU)10 Q(8HSE
M(T4GNJ@4T6\"SM.(8Q,PP9 HW$>F>M2T4 136\%P%$\,<H4Y4.H;!]1FG/%'
M)C?&K8Z;AFGT4 4;O2X;V]M+B;!%JV^-0H^]C&2>N!Z>O/.!5ZBB@ J-;>%0
M L48 8L,*.#Z_6I** (OL\&"/)CP>ORBB2VMY8A%)!$\8.0K(" ?7%2T4 -1
M$C!"*J@DDX&,D]30T<;NKLBLR<J2,E?I3J* (_(A*A3%'M!) VC&3UI?)B#!
MO*3<.AVC-/HH Y[QQH5WXG\(7^BV<D,4EX@0RS$X09!S@ YZ>U;-G;B"$%K>
M"&9^9?)Z%O7. 3^(JQ10!']GA\_S_)C\[&WS-HW8],]:588D;<L:*Q[A0#3Z
M* (H[6WBE:6."))&&&=4 )'N:#;P-<"<PQF91@2%1N ],]:EHH 888F?>8D+
M>I49IK6MNR%&@B*-U4H,&I:* &QQI#&L<2*B*,!5& /PIDMK;SLK3012%3E2
MZ X/MFI:* &20Q3;?-B1]C;EW*#M/J/>E6-%4JJ*%8DD <$GK^=.HH S-0MM
M0@LHDT 6%O(LRLZ3Q'8Z?Q ;<88\<\_2H_#NA1Z!I3V@<2R33RW,SXP&DD<N
MV!Z#.!["M>B@".&"&WC\N")(DSG:BA1^0HB@AA+F*)(RYW,44#<?4^M244 -
M5$0MM4+N.3@8R?6AD1RNY0VTY&1G!]:=10!%);P2RI+)#&\D?W'902OT/:I:
M** &-%&S%FC4DC!)'4>E-^S08QY,>!VVBI:* (_(BR3Y29/4[1S216T%N7,,
M,<9<Y;8H&X^IQUJ6B@!KQI( '16QTW#-*J*B[44*/0#%+10!$UO \ZSM#&TR
M#"R%06 ]C3FBC9P[1H6'0E1FGT4 ,6*-&+)&BD]2% J&2V,5K<+8K#!/(K%7
M\OY=Y'#,!C/-6:* ,/P_I6I6GFWNN7L%YJDR)&[V\1CC1%SA5!)/5F)/<GT
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MP!/D)YTV"P[##+^8KV#4+M?^$?N[R.U>[7[*\JV^TAIAM)V8(SD],$=ZOT4
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M,A3;G<.>@Z9_6L/PYJ\>GGX:W>IW"II']E201SNW[N.Z*J!N/0':"HSZGWH
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M?2WWKX>4CID$3D9^NT_D:XN-[-_ .G+(T#6,'C0>:&(,<<7VEOO=@N#WXP:
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M\62?\)+X1EL]5MUTC4/M/VQ5*,H\N OS)VP>O3I7,>(K21H?BE=V/S:9-8Q
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M[2VM=_V>WBAWG<WEH%W'U..M8L.L6-_KEI/9^)K-[1K-Y?L,9C;S1D8FW9W
M <>G-4K?QGI/B'0-5GL-<MM.\EI84NY60^5M^42E6P,;N@/7\: .L95="CJ&
M5A@@C((J**SM8;?[/%;0QP_\\T0!?RZ54_M.ST_2K6>^U*%D>-<7#D*)CMSN
M 'KR<"G#6]+;3X=034+9[28XBF20,LAYX4CJ>#P/0T 7(X8X5VQ1HBDYPJ@"
MB:&*XB:*>))8VX9'4,#]0:BLKZTU&V%S97,5Q Q*B2)PRD@X(R/0@C\*AO\
M6=-TK'V^^M[8E2P$L@4[1U;Z#N>E %N.&**$0QQHD0& BJ H'IBF?8[7Y/\
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M?K>DZM)J5S-H<T-S="53$!L.Q#M &_DX'4#KC(SZ?%;PPP""*&..$# C50%
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MA3DBC2,QI&BH?X0H _*@#C_#)\-ZEXFN=:T;5)M5NY+18;BY616C50P**VT
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MFM)".GJ5?:P'N:[4VMN5VF"(KN+8V#&3U/UK"N](UB_UP1SWEDOAU#%*MK'
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M,[R>>IDA(=T\F/YB H S@D<#(&1Q7KVB:A:ZGH]K=64HF@>-=L@! ;@=,]:
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MN6;,KD8*"3+$@]@.M96M:C:V_P 0_$TRP)J"CPN-UHC9^T%7D)CXZG:1[X-
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MKH_%-Y8:IX:N]=\-V$EU;)?V=W?3VD;(]ZD3@L%/!8H IW#CWR#7IU&,# H
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M]8ZKHYOKW4K:)U:2:6<_9%8?,K[SMR3@;>3U(X&:[^@ #H** "BBB@ HHHH
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MY=3VUM=?Z7YX=DM6"#Y(QMSMQSQGDFKUCXQT+4=5ATVVO&:YGB,L(:%U250
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M:(YH7A:,$$AB' .T@'!Z<5Y7IN8OAA\/;>6*19K;6[=YXFC;=$JR2%F88RH
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M %&;QUXNT^\OY+FWLFM/LRLJJ(P\99@, =^YYX%9MOJVI^)+3Q7JMG?S6O\
M9=S-::='&1L+0J"SN/XPS$C!Z <8/-6/"\R-\2_&C@G9.;+R7*D+)LA(;:>A
MP>#CI6;IZ2^%-+\8Z/+#*]U<WES=Z:B(2;I9U&U4]2&RI]."<#F@"&/QL)_$
M?A36I[^XM]-U'2)YY;-263S1L&%11EVR6 ZFNL;QIIU[X1O]=T/S=3%LKJ((
M87,AE'1"F-P.2,\=.:Y"QTD^#=:\"QZAE+:RTJXMI[K:3$DS>6<%NBY(;!.,
MXK4TBX@\/ZGXL\574-Q#I.HWD @"6[LQ"($:;8!D*S$\XY SW% "_#V^36+B
MXO$\8ZCJSPKY<]A=VZ0-;N3G)0*&'0@<D=>N*[^N.M;&#6/' \1Z4'AB&FR6
MLUUY13[0[.A3 8#=L"MSC'S 9."!J:'HVLZ==R2ZEXGN=5B9-JPRVL,05LCY
MLHH/J,>] &;X6O\ 49O&?B_3[V_DNH;*:V6W#*J^6KQ;R % [GOSP*O^+_%$
M7A32HKM[>:=YKB.WC$<3. 78+EB!QUZ=2>!6-X3F1OB)XU<$[)YK1H6*D"0+
M %8J>AP>#BIOB?'*_A&.6.&65;?4+2>01(78(LREC@<G YH OW_CSPYID[07
ME[+#.ML;HPM:R[Q&" 3MVY[],9P">@-27'C;P_;+)))>MY,)C6:98)&CA,@!
M0.P7"DAEZGC(SC-8*WD%U\8[&[1)1"^A21+))$R@.9E8*<CABH)P<'%<MXTN
MY=2T3QSIYL+NVNXY_P!U:6EFP%R@"8N)) OSD@'C. % P30!ZMJ.LV5C,MI+
M+,;F6-G6*WA:60*."VU02 "1R1C/%>?>']>M;GX<7-UK7B+4H(7U::.*^B=O
M.*K/\B@A20" %Q@<''%6K?6!HWQ+OM1U.*[33=8T^W6PN6MY"$,>[=$1C*DE
MBP! S]:YF9V?X0:W;"UNUF?76>.)K9U9U^V*^5!'.%!)QTQS0!ZE?>,-#T[5
M)=,N+M_MT</GFWC@DD<IG'RA5.XY[#)X/H:D@\4Z+<Z##K<5\K:?.P2*0*V7
M<MM"!<;BV[C;C.>U<X+F$_&?[5N'V?\ X1[RQ/CY-WG[]N[IG;SCTKD(O)B^
M&\4\WVJ&>Q\3&[A*VSOY9^T,59T W%"K'IUR,4 >IV7B?2;_ %672X+AQ?P_
MZVWDA='3(R"<@<$<@]ZUZX#PAJ^A:MXRU34H=4$NJWMO'&+7[-+"$BCST\Q0
M7.6))[#''<]_0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1169K'B'2M 6V;5+Q+9;F98(BP)#.QP
M!D#CZGB@#3HK!TGQ7HGB:>]T_3-0D^U6Z_O8S$\4B ]& =1D>X!'2L'P%XC6
M'X;:+?:W?S3W-U-+"KR;I99I/.D"J  23@=N@'8"@#O**P)?&N@0:->:M-?&
M.TLI3!<EX7#Q2#&59-NX'D=NXJ6Q\6:+J.LG2;:[9KSRC,BM"Z+*@."R,0%<
M#(^Z30!M45@^*=<?2+:RM[7;]OU*[2SMMPR%9N6<CN%4,V.^ .]3W.L:?HCP
M:?/<7$]TT32K&D;SRLBD;G(4$@9(]!DX'I0!KT55TW4K/6--M]0T^=;BTN$W
MQ2KT8?CT^E<8^M>+$\/74S>';Y[V'4=DL,<Z!IX/[T)[+]T>N,G.>0 =[17F
M7Q";7_#W@;7_ !%%KU]%=K,CVL"%/+@C:5$VXV\G!)Z]_:M#P9%K-_H'AGQ!
M-KE].);;S;^VDVLDH:-L%0%R"&V\ ^M '>T5QD/Q6\&W*VYAU4N;B[%DB_9Y
M WFG'!!4$#YAR>/R-6]0^(7AO3&E-S>OY$%U]CGN4A=HH9O[C.!@'U].^* .
MHHK$UGQ5I&BW5G8W4\KWE]G[/;6T3RRN ,E@J G '>O-/"7B_4M1T?XA27NO
MW,=M83O'97C0&1K:/]X ^U5R< *3D9XH [G3/"NM:1$+*U\53'3E9BB2V<;S
MJ&)8_O3P3DGDJ373VEI#8V<-I;KMAA0(@SG  QU[UQ6E>.-%T#P3H%UKGB%[
MP7J^7'J+6LBB=LGJ-OR^GS8SC-;>C^-="UV_U"QL[IUNM/ :XBN(7A95/1L.
M!\OO[CU% '045R'_  LWPL(+:X^UW)MKJ9H+6=+*9TN)%."J;5)//MSSC-;7
MB!W_ .$8U&>WFE@ECM9)8Y$.UE8(2#S_ "- &K17SQ;^-_%%M\((?&'_  DE
MPVI+J)M_)F2-HIT_N[=N<]\@C@&NP'BG7)?B_P"$K![B:VLM4T<7EUI[8*K*
M8Y21R,C!4=^U 'I.LV,FJ:->Z?%.L#7,+P^8T>_:&!!.,C/7UJ/P]I<FB>'[
M#2I+A;C[' D"RK'LW*JA02,GG ]:R+KXA^&K.1/.OF%NUV;+[6(7, G_ +AD
MQC/OT]ZGU7QQH&BZ[%HE_=RQZC-'YL4*VTKF1>?NE5()^4C YSQ0!T5%<;-K
MD'COP9=W'A75[N"9)?+$EO%ME612#L*N!C.1D^A^M64TG7'\2Q33ZQ=-9/IX
MCNH$ 2-9AC#QD<[B=Q/;'!Z@4 =316!X8UN34O[2T^\8'4-*NC:SL!CS!@,D
MF.VY2#CUSVJ#_A+(+CQI<^&%@O(WBM5D:<6SD;G8@8.T@*,'YCQGOP: .FHK
MS?P-XVLK7PQ91:YJMQ->37]Q;B>9)) &\]U17D *H2   2..G%==J7BS1M)F
MNH[NYD#6<:RW1B@>06Z-G!<J"%S@GGMSTH VJ*YG4?&5K8^*=*T58+F7[="\
M_GQ6\DB;% QM*@YR6&2,@#KC(JG\3[N[T_P<U[9WT]G)%=VP+0OLRK3(K GK
MC!/<4 =E16-I_BK1M4U&ZL+6[;[3;1B:1)87BS&3C>I8 ,F?XAD4VQ\7:+J-
MY:6MO=.9+U&DM&>!T2X5>6*,P ; YX/3GI0!MT5DQ^)-,ENX;9)9F:>9K>*0
M6\GEO(N[<H?;MXVMW[&L'XCW]QIEEH=W#J$UG'_;-I'.4DV*\3/\P<^F!ZX]
M: .THK#T;QAH6O7EU:6%Z6N;4;IH98GA=5_O8< E?<<4Z#Q9HUQJ-K8I<NLU
MVK-:F2!T2X &3Y;L K<<\'D<CB@#1O[5KVT>V$SPI(-LC1\,5/4 ]B?7J.V#
MR)+:WAL[6*VMHDB@A0)'&@P%4#  'IBLFX\6Z+:W44$]TZ"6?[,DY@?R3+G&
MSS<;,Y!'7J".O%5;OQ]X;LY+^.6^D:2P(%TD5M+(T>1G)"J3M Y+=!D<\T =
M+14$-Y;W%C'>PS+);21B5)5Y#(1D$>V*YD_$SP@%MG.KCRKB0Q)+Y$GEJP8K
MAFVX3D'[Q&>O3F@#JY(TEC:.1%='!5E89!!Z@BJNF:>NEV:V<4C-;Q?+ K\F
M-.RY[@=!GG&.O6LC5/'?AS1KRYM+[4"EQ;1K++&L$CE5)P#\JG/?ITQS5C4/
M%VBZ5O:\NG2*-UCEG$$C10LV,!W"E5ZCJ1C(SC- &Q,LCPLL4GEN1@/MSM]\
M5!IVG6^EV2VMLI" LS%CEG9B2S,>[$DDGU-6@00"#D&L*;QAH<%RT,EVP"W0
MLVF$+F)9SC$9D V@Y('7@\=: -VBN<U'QWX<TNZO+6ZU _:+,*9XHX))&4-G
M!PJG/W3G'3OBGR>./#4=EIUZVK0_9M1S]ED 8B3 )/;C&#UQT(ZT =!17.67
MCSPW?V.HWD&HD1:=S=K)!(CPC&<E&4-C /..U+:>.?#E]'/)!J.8X(([AW:)
MU79)PF"1\Q)XP,G/&,\4 =%161;>)=+NKJXM$DG6[MXO/>VEMI$E,?\ >5"H
M+#/'R@\\=:9:>+-&OO#[:[;7,DNF@D><MO)DD':<+MW'GC@4 ;5%8^I>*-*T
ME)7NY9@L,8EG,=M))Y*'H9-JG9QSSCCFI;G7]-A2UQ<M,UY&9+=;:-IFD3 .
M\!0?EY'/3D>HH TZH:UI<>MZ)>:7+--!'=1-$TD+;74'T-<S\--3GU73-;FF
MOKF\1-:N8H)+@G<(E*[5P0,8'; [\5F6OC"U\.^,O&,6N:M=O:V\MJ8$9'F\
MI6AW.0J*=JY/)QCID]* .DMO#VL21BVUCQ%]OL^ T2620F4#L[ G(]=H7/TJ
M7Q;X=F\3Z5%81WR6BI<17!=H/,),;AE'WACD<U(?%^A_:=+@6],CZJNZQ,<+
MNDPQDX8*5X')!/'>K\>IVLNJSZ8CN;N"-99%\I@JJV0IW8VG.#P#G@^E %I
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M+-@@E2&&%R,C*[<$^E '245DZAXDTO3)9X[B65GMXQ+<""WDF\E#G!?8IV\
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M 3N7\QZUZQ10!\P>*%O]8\'ZFEIX;U#31#KPE^P6]DXB5=C R,V,M(20,#@
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MWWDR!RBY"N=JKP?4X'2O2** .(\+WWA[Q!K$6J:5IVHO=PP-'+=WXG!MP?\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BJ6E:M8ZW8+?:=<+/;,[H)%Z$JQ4_J#5V@ HHHH ****
M"BLJ]\0V-AKVFZ+-Y_VO4?,\C$1V'8I9LMTZ#IUY%:M !1110 4444 %%%%
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MA1MRJLV.,$@5MW'A%Y-6T"_CU)@=':5P)8M[3O*I5V<@C&<D\  $^G%9U_\
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M9X)LI@J H)0?..IZKS6]XMU#4-+\.7%YIMM-<3QO&72! \@BWJ)&13PS!-Q
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MJ0A#$9VEQM)]QTK0U[5]8M?"OBC6["_"K:+*;(20JP B7#GL>7#@9SP ><T
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MZC!D< %O<X 'Y"O.O%?BC6M$M-8OX]1C::QO85AL[>$20BW9HUQ.Y7*.=S'
M8?PX!&: /2:**X>#4O$/B?3-5U#0=0AM9[6_DM;2VF13#((G"L93M+Y;#8VD
M8&WWH Z,>(;$^*/^$>'G?;_LIN^8B$\L,%X8\$Y;MGO6K7$2;O\ A==GNQN_
MX1V7..F?M"5FQ^*-:M=2\."XU%+I[_47L[V&"$&UCR'*B*7:"67: ?F;G.<4
M =Y;ZG'<ZK>Z>MO<H]H(RTLD)6.3>"1L;HV,<XZ5=KB(-;UN3Q%XVL#>0;=,
MMK:6R/V<8C+I(QR,Y;[H[]NE8<?B/Q4GASP9KIU:"1M7N+:TGM7M5$9\Y3\^
M1AL@C. 0.WN0#U.BN/T'4M7@\=ZMX>U+4!?PQV<-[!*8%B9-S,K)\O!&5R,\
M^YKL* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH *Q/%/AX>)=+BM1=O:307,5U!.J!]DD;!ERIZCVK
M;I&94&68*.F2<4 <Y#X8NHO%H\0-JHEF&G_8"CVXP5W[]Q(8<[O08QQ[UCGX
M:HWAN/3/[8FCN[:_?4+._@B"202LQ8\9(9?F(QZ5TZ>(;&3Q0_AY1/\ ;TM?
MM9W1%4\O<%X8]>3VST-:M &/H6D7VG1R2:IK$NJWT@"M.\*PJJC. J+P.I)/
M)/K@ "#Q)X=EU^;29$OA;?V;>I>H/)W[W4, #\P^7#'W]ZW^@R:165U#*05(
MR"#P10!RWB+P?/JNM6FN:5K,VCZO;Q&W-Q'"LJ2Q$YV.C<$9Y'/&?IB'5/ T
ME_!IES!KEU!KFGS/-'J;1J[.S@*X:/A2I  VC& !^/844 >9:#90:AXY\=Z+
M?ZE]LDN["T@FD!56;,<JOM4<#&X<=N,Y-:MMX!OE;P\UWXDFG;0W_P!'V6J(
M&39L (R><'DG/L!SGMPB@Y"@'UQ67KOB&Q\.V]O/?"?9<3I;IY41?YW8*,GH
M!D]S0!BR>"II!XI!U5<>(5VS?Z-_J1Y?E_+\_/R^O?GVJ;4?!46J^#;+0;J_
ME6:Q$36M] NR2*2(81P,GG'7UR>E=310!R1\(ZG=^']1T_5O$DNH75[:O:&Y
M:U2-8HF&&VQJ0-Q[DD]!Z8ITW@^XF_X1H_VF@.A$&/\ T;_7$(8_F^?CY3V[
M\^U=710!R%SX#@U"\\2OJ-WY]MK\<4<T*1;#%Y:X0JV3R.O(Z@=.E3:%X8UG
M3%7^T?%%QJIMT*V@FMD01G&-S[3F1L<9)'4]^:ZFB@#AXOA[)#X.TGPXFKCR
M=-NDN8YC;?,Y1]Z@C=CJ>?;TK0E\(2MK^K:I!J\UO_:EJD%Q$D2_?1&575CR
M,;LX]0.:T]/\0V.IZWJ>D6XG%UIHB-QYD10?O Q7;GK]T\].E:M '.VWAB0Z
M_8ZUJ=Y%=7ME;/;Q216WDEP^,ESN.X_+P!@#+<<\:>KV-S?V:Q6EZ;.=)4D6
M4)O'RL#M*Y&0>AYZ&K]% '&WGP\L=5@US^T)_P#2M7,+236D?D^4T7^K=1EC
MN!))))STJYI7AC48;6>+7?$5QK#O UO&Q@2 1HPP3A?O,>/F)^F,G/344 8W
MA;0IO#F@VVE2ZB]ZEM&L43O&J;8U&%&![=SUJ#7?#D^LZUHVHQWZV_\ 9<S3
M1QF#?O9E*G<=PXP3TKH** .:_P"$6GL_$5_K.CZDEG)J*(+R&6W\V-W08611
MN4JV.#R0>XJI)X#BB@\/P:??&WBT:X-RGF0^8TTC!MQ<Y'7>Q. .3^%=A10!
MS^I^&7O?%-AKUMJ,EI/;0/;2(L:N)8V96QS]TY4<UEGP%*WAWQ#H[:LICUNZ
MEN9I!;<QF3&X+\_3@8S^M;^L^(;'0I=/BO!/NO[I+2#RXBP\QS@9/0?B>U:M
M %>Q@>UL8+>202O%&$+A=H; QG&3C\ZP/^$4G77->U--20-J]NENT9M\B((K
M*I!W<G#'/]*Z>B@#C/\ A!)AH/AS25U90FA7,5Q#(;;F0Q@A0WS],,<X_2NL
MO)7@LII4#,ZH2H2,R'/^Z""?IFH;G4X[;5+*P:WNG>[$A66.$M''L )WMT7.
M>,]:NT <AX?OVT72_LD]KJ]W(99)6G_LUD9V=BQ+#)YR3TQVKDKF(>&?#7C&
M1GU(VNJQ7-P89=-:*.&5T(.UMQP#QD'/2O1[OQ#8V7B#3M$F$_VS4!(T&(CL
M(1=S9;IT[#GD5J$!A@@$>] 'EOAJ5=5\+^%S?C4+VRTZ*">*.WTU@&E1 %WO
MN(8*3G@+D@$^E9_AG6);_5?&D-A<7<<5WJ3EEAL#-)&IC52RD,-K=1R&' XZ
MY]A!16V J#C.T>E*$5?NJ!]!0!YEJ6AVQ;2+CP\NO:)?:5;_ &2">/33*KP<
M?(Z-PPR,_7)J>_L9+^STN.637'N++4(]1DN)=++&>9. " 0%7'&!V YZD]UJ
M^JVVB:3<ZG>>;]FMHS)(8HR[!0,DX%2V-Y%J&GVU[#N\JXB65-PP=K $9_ T
M <%<Z?;ZAK>L7U_::M-;:K9+8SVPTQUPB[L$-N//S'G'I6<NB7SV.BV5UJFO
M30:/>1W-J?[&Q(51655=B3N(!QG [Y!/(])M-3CO-0OK-;>ZC:S9%:26$JDF
MY=V48\,!T..AJ[0!P$"W%KX@US6+?^U4GU6**/!TAB(?+!"L/FY/S'.>"?RJ
MM+IR+J&B:C8Q:O:7NF1M%),NENWVM6Y99,MR"V6ZD[B3G->D52M=3CN]2OK%
M;>Z1[,H&DDA*QR;EW#8QX;'0XZ&@"@_B0&-A'I>K*^#M+6#D ]LCC/YUF:!?
MOHVGO;W%MJUY*\\D[S_V8\;,SL6.1D^N!TX ':MK5?$-CH]_IMG="?S=1G%O
M!LB)7?@GEN@X![Y]JU: .&\'Z;)I7B#5I8GOQ;ZK<-=R03:<T,<4A')5BQQG
MC.<YP.E;OB[P\?%7AVXT<W?V6.=D+R"/>V%8,,<CNHK<HH YV?PS-=>+++79
M[Z-C;VCVC0"W^617(+')8XY48_K69H7@*[T*1;.#Q+>2>'HY/,ATMX4RG.X)
MYOWBF?X>/0G&<]HK*Z!T8,K#((.012T <_H?AN32-3UJ\EO4N4U6?SY(O(VA
M&VA< [CD8 ZUDZ)X!NM"E%G;^);QO#R2&2+2VA3Y.=VSS?O;,_P\<<9Y.>VK
M)MO$5C=^(+[18A/]LLHDFE#1%5VL2!M)^]T/3B@#+'@F!M2U^2>]DET[6QFY
ML3&H&[RQ&2'ZXP <=CSFDL_!LRV>E:?J6JF_T_2I4EMD,&R1C'Q'YK[B&V\'
MA5R0,]\[^DZDFKZ7!?Q07,"3 D1741CD7DCYE/(Z5<H ;)(D4;22.J(HRS,<
M #W->5_#S1F\2_#"VTZ?4XGTJ6XF,]O'%^\*B=V\LONX5L GY<X)P>AKU8@$
M8(R*BEDCM8))2C;4!8B-"S'Z #)_"@#%MO#<MOXTN?$(OE(N+5+0VP@P%1"6
M4AMW7+'MCVJE'X-FL;G6!I.JFTL=7D::XMV@\PQRN,.\3;AM+=>0PSSCM6WH
M.MV?B/1+;5[ N;6Y!:,R+M) )'3\*T: ,#4O"6G7_@J3PM&IM[+[,L$)7DQ;
M<;&'J00#[D4_5?#D=_X.G\.07!MX);7[*92F]@A7:3U&6QW/>MRB@#D+SP3-
M)=:-J5CJYL]8TRW^R?:1;AXYX>Z/&6]L\-P<^V*Q^&\%S8:_::CJUS<KK%PM
MRS)&L1@E4+M=".<@J/\ /-=Q5:\OH++RA*29)G\N*)1EI&QG 'T!)/0 $G H
M YVQ\*ZNFFW4&J>*KK4+F2V>WM[C[.D7V<,,;]J_>?IR3V[9.;=GX:9/$D>O
MZA=0W%_%:&T1X+?R04+!B6^9MQRHQT R>.:Z"B@##\5>'?\ A)M)CM%O9+.>
M&YBNH)T0/LDC;<I*GAAGM66O@F[&J:MJ+:_+)-JEDEK.&MDVY4, P Q@ .<#
M/7&2:["B@#CCX'F_L;PUIPU50F@S130O]FYE,:E%#?/TPQSC]*ZRX@6YM9;=
MRP25"C%3@X(QP:EJ.29(E<L22JEBJ@LV/8#D_A0!PUI\.;JWM-!MV\2W+KHD
MV^U(M8UQ'M*[3URV#C=[=*W++PY<6?B[4M?_ +01S?Q1PO ;? 18\[<'=U^8
MY_I5[0-=LO$NBPZKI_F?99F=4\U-K?(Y0Y';E36G0!S6B^&+K1CK;)J<<K:K
M<O=MNML>5(RA>/GY7"C@_G6;'\/Y8?#GA[1H]8 CT2[CNX9#:Y,A0G:K#=T^
M8YQ[=*[8LJE06 +' !/4]:6@# U+P[+J'BG1M;^W+&=,655A\G(D\U0K9.[C
M@#'I[U2B\'3Q1>)4_M1#_;Q9I#]F_P!42@C.WY^?E'?O^5:VJ>(]/TFZTRWN
M#,S:E.MO;M'&60L02,MT' )ZYK6H XRU\"7-C>Z-=VFO2P3:=IHTMV6V5A-
M"".&)"O\HYYSZ5!#\./L_A2TT2/6[C=8Z@+^SG:!#Y3"1G *_P 7+'.3^72N
MZI&940N[!549))P * .>_P"$9G/BZRU]]3,CVUFUF8V@&9%8AF8D$8.5'08'
MI4L_A:RG\9VWB8LXN8+5K<QC[K\_*Q]U#2 ?[_M6[10!R6M>#+JZ\2#7]#UZ
M?1K^2%8+K; LT=PB_=RC<!AG@UTFGV8T^QBMA-),4R6EE.6D8DEF..,DDG@
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M$C8W1L8YQTH S;?P[+#XSN?$37RN;BT2T:W$. %5BP(;=URQ[5OT44 %%%%
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M@  84=.GO0!QMQXLN8_%T^C7^I3:/=F]C%C%/ GV:\M\IN"R%22Y&\8W#!P
M*M6VM:K+JGCBQ:^;;I2Q-9R>4FY-T/F$'Y<'GCD=/SJ[J?A";6;>>PU#4DGT
MV6\%VL;6W[V+#A]B2;N!D8SMS@D9'&&7G@R>77M7U"SUJ6T@U>%([RW$"N69
M$**RN3\OR\$8^A'8 SM%\4ZCK</A33C<B"\U+2CJ-W<I&N[ "#:@(*@EGSR#
M@*>.<BAXUAUV#P4D.L7-M<W":];"UFC&"\/GIL,@  #^NT8]*TG^'#1Z3H$=
MCKUS:ZKH<9BM=0$*-F,@ HT?1E( ZG/O5[4_!EQJFAQ6-QK4DES]KCO)[N2
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MBB:-K;(B$:LJD'?SPQSZ^U9-E\/)M.M_#HL]>DBN-$CE@CE^S*PEBDQD%22
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MGVZ5J:?X3O[3Q'>:[-KAGO+JT2V9/LJI$-I8@XSG'S=-WXGI0!RT'B[Q)<>
M/!NKQWMNMYJFIPVMT7MP0ZO(PXQC PH''/N#S6YIVLZWI_BGQ#H][<_VL+73
MX[^UQ"L3Y;>#%\O4948[\]Z;!\/9;?PQH.AIK \O1KU+R*4VOS2%&+*K#?C&
M6.<>W3O:U32;C1]3UOQ;]HFN9&TWR/L=K;_O"$W,NPY/S98]B/:@#!@\2^(+
MNP\&7EGJL<LNNOLNH#;(ZP?(78H!A@$(VG<Q_.O3:\=\/336T5N?#_CG3=5O
M0B@V(TJ/SINF5D=2'7W=AQU->ORB1H7$3JDA'RLR[@#ZXR,_G0!Y?X*O+RS^
M$GA(VU[#9PR2;+F5ANEV;I/EB7:VYRP48P>,\5:@U_Q-J/A+Q8UA=O\ VGHU
M[*EK)+;('FC5%<*Z8QN(8C@#G''45>M?AS+8Z'X?L;37'BN-"G>2UN?LP(97
M#!E="V#PQ&1C%;/ASPN_A_4-7N3JD]VNHW'VEHY8T7:Y55)R!SG:/0#TH Y[
M_A,I7\5>%6@U&1]%UBU4NIB3]W,ZDQ!FV_Q[)!@=U[#BI]4\0ZKIOA^VUEY+
MV;3KF^9IIK6W226VLR'\MU7;R"0A)()"L>_-3_\ "M-)'A*Y\/)-,D,UY]K2
M93AX2)-Z*ASP%'RC\3WKH=0TRZE^PG3;U;$VCY"&'S(Y$VE=C+D<<@\$<@4
M0>%=135M&^V0ZO%JMO)*QAN455)3LK  88=#P/H.E8FG7;ZE\8-:CE/[O2--
M@AA4] 9B7=OJ=J#\*WO#OAZ#P];WJQ,K27MV]Y.4CV)YC  [5R=HPH[GN<\U
MFSZ<='\?-X@4'[%J-FMI=L/^64B-F-V_V2"RD]B%]3@ R+K7/$VMPZS-X=2Y
M6>PO9+2VC"VY@E:(@,)2[;^3G[NW QUYSW=I)/+9027,(AN&C5I8@P;8Q'*Y
M'7!XS7)2>!;RV\07VH:)XEN]+M-1D\Z]LXX$D#R8PSHS?ZMB.IP?Y8VWLKG3
MKXW\5[</IMM8&)=+CA#;G4Y#AOO%MHVXH X5?%OB&\\+:-K5K>K%?W^K?89M
M.:W1UA!D9"H'#[T50QRV.IP!C'J$898U#L&< !F QD^N.U>+Z%=R?9TNM)\=
M6;ZJX:3^SI])CEN][$L8G(VR$Y."V!Z\"O4?L.J&YN[R75I(HYK)8TM(X%=;
M:4 YD4]6//0^E &S7!Z5'>R?%_Q"KZI=-##96C+"0FT*QD^3[N0 >>#GGDFN
MC\*P:I;>'K>'6+M[R[5G'GR1B-Y$W'864< [<<?GSFJ[>&98_%]QX@M-3>!K
MFV2">W,2NKE"Q0YZ@?,<@=?44 ><>'M2UO0?ACH^LV>H1K:1:FT,EEY"D31R
M7CHV7/(/S9&,=.<UU'C'7M9TI?$,]OJ:Q&QLUN+*VM85F)PI9VN,J=BDC PR
MY .,FIU^'DJ^"(?# U@>1%="Y$_V7YR?-\[&-^/O'\OSJ2_\ S7MSXA*Z[/!
M;:["$NH$@4X<1^7N5CDA<8^7]10!G7TU]J7Q"\'2KJ=S;17>FW%P8(@A1&"Q
MDX#*<YW$<YQVQSGJO&37$?@O6I;6[EM9XK*:1)H<;E*H3QD''3&>OI@\UG-X
M*F^T>'KI-;N%N](@DMS-Y*'SHW"@C'13\HP>??-='J5C%JFE7FGS%EBNH'@<
MKU"LI4X]^: /+[Z"ZC\(?#0+>-+-)J-DT;SHI$>;9\#"A<@>YR?6M1O%VJ^'
M)/&D.IW2ZF-&@M[FUD>)8B?-5L(VW P&4<]<$UI?\(-=G2_#UE)KIE_L2XCN
M(7>U'S^6A1%(##C:3GN3W'2K,W@B&]U;Q!<W]T)[;6[:.VGMQ%MV*@8*5;<>
M?F)SCKCI0!'92>+8O$U@'BN;C2)HW%ZUV+9# X&4:/RV)*DY!#9(XYJO\66N
M8_A]>R6UY-;%98%?RMO[Q6E12IR#QANV/RR#=\.>%-3T9X$U'Q/=ZK:V@Q:0
MRP)'LXV@NPYD(!(&>.<XSC&EXI\/Q^*/#EWH\MP]N)]A$R $HRL'4X/7E1Q0
M!SFM7?B2#QEH_A^QUM(XKVRN7:XEM$>173;AL# /WL8P!ZYJGXCUGQ#HFG:R
MTFMQO=:=IT<UNEI;*QF94)DDN%*GRU9@0 &' .,FNA;PM>2^)-)UJ?6/-FT^
M&6$JUL!YHDQOSAAC[HQ@<8YS5+4O ,E]>>(FBURXM[37H0ES;K"C%7$?EY5S
MR!C&5_(B@!8_$5WK/B/3M#MIS9%])75+J:)59\,0JHF\$#G<22#P .^:YC0-
M8O/#NG^)5W_:KZZ\6FQCEV*"6=8ANQD+G;DXR!G'05TK^!+B*[TC4K#79;?5
M]/M/L3W+VZNES!UV/&".AY!!R.^:B_X5M!/I&MV%]J]U.=3OOMZS(BQM;S_+
MAT('4;1[4 :&AR>)X_$MU!?PW$NB/;B2&XNS;B:.;=@QXA."I'(.,C&*9XXU
M34=!ATS5K:[,6G1WL46HIY:G$+MMW@D$C!*Y]B:N^']"U/36,VL:_/K%RJ>5
M$[P)"J+D$_*O5C@9))Z<8YSHZSI=OK>BWNEW0S!=PO"_J PQD>XZT <;!XLN
MK/QEXDTR_OIIK6WM!<Z?MB12V.)4!V_,RN54?7!!(J_=SZW:7&EV-YK(C+V3
MM*]I"CW4]SE?NQ["!$ 3SCCY<GUL-X$TYAX;+R2M)H;EUD)RTY(^;>?4N%<^
MZ^]3:CX6GNO%T/B"SU>:RF%G]BGC6)9!)'OWC:6^ZV3UP?I0!RMMXYU1_A_X
M<U^^2X2WN7==4N[&W$CP*N]0^PA@%+*,G!QVZUVOAB^&I:##=KJD6J1R/(8[
MN( !TWG:"   P7 / Y!K'T+P9?>'-)TZQL-?=ELFE"B>V#(\;MNVE0RG@\YS
MG/MQ6QX<\/V_ARPGMH&#&XN9+J4JFQ=[G)"K_"HX &3TZF@# EOO$%]\0=5T
M"#5X[2TCT^*YB>.U5GC+.R_Q9!/R]3Q[=QSJ^*_%/_"N;/Q;)JD&^VNEMY[5
M+5=ERHN?(8L3RI/7Y< >]=S'X<N(?&-YXA2_CWW-HMKY#6^0JJ2RG.[DY8Y]
M1Z=:QC\/)#X$;PI_; ^SM<>?Y_V7Y_\ 7>=C&['W_P!./>@!GB_6]8TTZ]+;
MZFL'V*P%S96]K$LSL55F=IPRG8F5 !RN1NY)JQ!XEO-:US1M%MYOL4ESI"ZM
M=S1JK,%8JJHFX$#+$DD@\#'?-+?> Y[R_P!>F779H(-=MEAO8(X%/S"/R]R,
MV2HQU7GZBFGP#/#)HE]8Z[+!J^EVOV/[4]NKI<0<?(\8(X!&1@Y'O0!S>B:O
M=^'(/%A\S[7?7'B=+**0HHRTBQ*&(R%R <XR 2.P-=AHLGBB/Q//#>PW$NAO
M;!XY[PVZS13AL%,0G!4CG)&0:H'X;P7.FZ]9:AJUU<#5KH7A=$6)H)@%PZ$#
MJ"H]JV/#^@ZGIK^;K'B&?6)T3RX6>!(5C4XR<+]YC@?,3VXQDY (O$NNSV.L
MZ!H=HXAN-8N)$\\J&\J.-"[E0>-QX R".<X.,5C7/B#6M+\0ZWX>DO%N)$TA
MM4L+R6%=RA259'5=JMS@@@#@\YKHO$GAJ+Q MC,MR]I?Z?<"XM+I%#&-NA!4
M_>4C@CC/K5=_"TEQ+J5[=7L<FJ7MG]A$Z6^V.&'DX5-Q/)8DDL><=AB@#EK'
MQ%XDBL/ VL7>J17$.M206US:"V51F2)G#AASNRO3@<]*[CQ,9U\+:J]M=2VL
MZ6LCI-%C<I"D\9!';TK"/@:?^QO#6FC5E":#/%-"_P!EYE,:E%#?/TPQSC]*
MZN]M8[ZPN+.4D1SQ-$Y7KAA@X_.@#R>XBNE^'/PV87C332ZEICQF=5(CS$<#
MY0"0/<Y/K6V_BO5?#5_XN@U2[&IQZ5817]LQA6)OG#@QG;QC<HP>N#WJ\O@*
MZ&A:#I;Z\TB:+=0W$#O:KR(1M1" PXP>3U/J*NS>#([S7=9O[ZZ6>WU:R6RG
MM1#MQ&N[&&W'GYCSC\J *UG/XN77]+?RKBXTN=&%_P#:1;((3MRKQ>6Q8C/&
M&W<8YJ/XMY_X5EJN,9WV^,_]=XZL^'/"&I:(T$-[XGO-3T^T&+2VEA1"F!A=
M[CF3 Z9P.^.!C7\3Z!#XG\.W>CW$TD$=P%_>18W*58.#SQU44 <V^I>)- \=
MZ/8ZEJ4&I:;K7G1JJVHA:UE1"XVD$EE(!'S$D>M4(O%&M6NI^'!<:BEV]_J#
MV=]%!"IM8\ARHBEV@EEV@'YFYSG%=5'X<ENM2MM0UF^2\N;6&2*W\B P)'O&
M'?&YB7(&,YP!G &:P+;X;7%OINB6/_"2W)BT:Z$]F1;1@J@##:WJV&QNZ>U
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M;*FT#;@CIT(/KS0!W=%>53ZAXDGT?QU=+XDNHGT.ZF-IY<$/S!(5<*^5Y7Z
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MF=J@\IEASV(I9]8U>U?P_I<DUT]WK+W%PW^J26*)%WB)20%! 90203\K>H(
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MU@1HYBCEB)"P).0,#!&/>@#V&BN!T7Q/=>+];M[!9I=/A&BV^H3"# =Y)AD
M$@X51Z=2>>!@X>H>*_$<7A36(AJ)34M&UN*P-T(4Q<Q/(@4N,8#;7YVXZ>]
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MSH%$PP#O3DY7G&?8T <]J?@07>NKK6GZ[J6EZB\*P74UL8S]I1>A=2I7<.Q
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M%XR<E'4@AESSCUIFJ> [/5-)L[9]0OX]0LY_M4.J+(/M FZ%B<8((P-N,8
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M(KV^.H(YD4/;3DYWHP&<Y'4Y_GD I&QFM/C-IZMJ%S<*^AW&PS;2R'S8\D$
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MQL5*;,,I8'GYCUR/8UOZ;H$=EK%YJ\TQN-0NXHX9) @10B9V@ =\L<DD]N@
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MOK2UD41S-C!89!*,>Y7!^E:,/A:&W\6+K\5Y,CK9+8+;!4\H0AMP'3.<]\T
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MV-/NHYU3(D924E0JHVX*G(Z8["L2]UGQ';:7XMT==9NGU^PND?376&$M-#*
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M5()"[2A=VU5VY;Y><J",<]*N:1K>GZ[!+-I\_F"&4PS(R,CQ2#JK*P!4^Q%
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MR-'-BUE+P%3AO,0+NC ]6 %7=0\8:!I=S%;7>I1I-+"9XT56<NG'(V@YSD8
MY.1B@#<HKAO$GBFTUOX8ZYK'AO5I%:V@E(FA!CDCD09VL&&Y3T[ UH-?V)N_
M"L%YK-W;W\R;X;:)CMNSY1W"3@Y Y;DCD4 =316'<^+]#M+B2&:\8"*X6UEE
M$+M%',V,(T@&U3\PZGC(S27OC+0=/U&?3Y[T_;8(A*\$<,DC[2<# 526/7@9
M/!]* -VBLJ'Q+H]QHEMK$-ZLEC<D""1%8F1B<!57&XMD$;<9X/%-M/$^CWEO
M?31W@06#;+I9D:-X3C(#*P!&>W'/;- &O165I_B+3-2U&?3H)I$O88Q*]O/
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M.4D'EJH7DY(YY/4\ XK1M=2_L?2?'>@:Q%<)J5S<7MU;_N'<744J?(RD @X
MP1VQ[''K=% 'D\<RBQ^%8>.:-K8()UDB9#%BV*98$<#=QD\'M5F":$7WQ.8D
M 3JOE$C_ %H%L$^7^]\W'&>3[UZ?10!Y U_;:/HOPVU::2>*XLK)H'S;R21@
M&!%D1PBEE?(7''9LUU7P]NM%N$UF33-56]N[N^:]NT$3Q>4S@!0$<!L83&>Y
M!^@U-9\/:A>ZU;ZOI>MOI]U% UN4DMUGA="P8_*2"#D#D$=!5_3-+FM)7NKZ
M]-[?2((VE\H1JJ@DA54=!DD\DD^O P <U\7#O^&6LVR!GGGC58HD!9W.]3@
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M!N<3%FR"!LX_APOL.1G6^%T<UOX.^SW-K<VTRWERYCN('B;#3.RG# 9!!!H
MZ35=9L]'6V%RS&6ZF$%O#&NYY7()P!] 3DX QUK+F\=:';Z#?ZQ/)<1V^GSM
M;W:FW<O#(,95@ <=1STY'-5O&U]>65QH?E6=Q)9/=D7=U:VIGFMEV-M** 2-
MQ.TL!D G')%<#>6E\/!/Q#TZ/1]7\Z\OS+:I);R2-*K+$%P>2Q^4D\G&.<4
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ME'^UE=+R*728EFO8GMV#1(P8@_[7"D_+GBK!\4Z6K:-F27;K(4V3^4VU\IO
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MB]L6@=)610RMM0@%F&[( ZUTDD0U?XA6'B*UCN%L-.TV:.69K=U,K2$;452
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M(43/\Q/EE=V%;H.N%%:GPZU>_P!5\'6*ZO97EKJ=M&(;A;JW>,N5X#C<!G<
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MEQP HVD\=:LZ%KV@^'O"^JWR:CK-_:V-Z\5]<WJ222I*JH'^4@$*..@ !)H
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M.EW%G!?3V,LJ[5N8,;XSZC((J/1M)31[$P"XGNIG<R3W,Y!DF<@#<V !T
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M<8RW'0UE-X?UB^^#&B6-K:2QZMI1MIS9SKY9D>%@2F3QSV/3.* .UB\56O\
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MF@#J-*U2/5H)IHH)HDCGD@S*%^<HQ5B,$\9!&?:LB34-''Q!-NT%Z=8BTMY
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MZ9=6^JHL%E([0GR%2-U_?"7&TC:N0 =V>,5Z==[DL)]D7G,L3;8SSO..GXT
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M[.XLT5PK.BJT<I+ )@J.2<8J\D5\OQ5M=0N;*?R5T$VTL\,+M$)S*KE0<<C
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MW<NK2N>5(W<CD\<9- '>3^*+:*>Y2*SN[F*UN$M9YX A6.1MO!!8,<;U)(!
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M6*SWMW;BRNX[R/[/LYD0Y7.Y6X![5M5FZQK=KHD=J;A9));NX6VMX8@"TDC
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M$!4@%FR1QD]LGC.,4 =I161>^(;>VNOLEM;W%_="#[2T-J%)6,D@,2S*.2"
M,Y.#@<&J]GXOTW4],T^]TQ+B].H1M+;P1*%D94.')WD!0I(!)/4@#.: -^BL
MK0/$-EXCLIKBS$J-;SO;7$$R[9(94/S(PR1D<="1S5>^\56MI)?K!9WE\NG
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MJ[T*(HQ@D_PGVK(\61:WJ=UXMTR;2-0N()-/*:4;8 0.3$VXR'(W.'. K9X
MP,\GTRB@#S6WM]5@UCP-J9T2_,=OIDMG/&%7?#(5C"[QGY0=IY/3OBNA^(UK
M<W_P^UFRL[:6XNKBW,4442%F9B?;I]:ZFDR,XR,]<4 >9:O;W.F^*[/7I_#%
MQK>E7FF16DT4=J))[66-F(/EO@[3O(/T^F;EXVIVMQH26WANYLM$N'G>YMM,
MC59XF('EB0H1MW<EBIZX!. <^A44 >2Z7HF[PU?:/KGAG4A:2>()Y5:)29(%
M8NR31["6.TA1D?WN_-.O-)\2GP8\,_V_5HK#7+>XLWFCQ=S6L;H264X)8'<!
MG!(&?2O6** *P9[O3BQA>%Y8SB.3&Y<C@'&>:\_T#P]>:O\ !L>&+ZPN;"]@
MM?)1IP%Q.C%D9<'H&"G/?M7I-)D @9&3T% 'ELWA_P 37DNA>(_*:#6=11K+
M58U)'D6TB#!'H8R@;']YS6WK&G7>C>/]&\06MG-<:6FGOIEQ%;1EVMU+!T<(
M.6&0 < D<5W%% ')^&-)G3Q9XF\121200ZH]ND$4JE7*Q1[=[*>5R2< \X'.
M,U6N$N=*^*-QJ\]C>2:?<Z3';)/;0-,!*LKL58("PX8<D8]Z[3<N[;N&[&<9
MYQ2T >47GAK5=/T*#4QIT\LS>*QKD]E;@/+'"21M !^9@-I('<GTJXR7USXL
M\3ZC/X8OKC3[W2((DAE11YP4ON0C/#$-T[<9Q7I0((R""/:EH \X\/Z7?:)>
MZE;:=+JT_ADZ<3%;7\,ADM[@G CBW#>5VYXY ..:S;'3=2A\+_#JUDTN^$VF
M7B/>)]G8F%5C=23QSRPZ9KUFFET4X9E!QG!/:@#RW7/#^JZUJGCV&TM)D:_@
ML39231%8YW@RS+D\8) 7G@Y]*U-(NEU*W>>/X>MIUW;6TIF^UV<:;F*$>5$P
MY;<>,X VY[FO0,C&>U(K*ZAE8,#T(.: /,-)T>[T6]E70+;5)?#\NG7#W&C:
ME&^R&7 V1Q%QD[CN! )7CKR*N^$M&NM&\2PQZ(^JQ^&Y;5VGL=2C<"SERNQ8
MBXS@_-D D#'7D5Z$"#T(/;BEH X;Q5!J6F^.M"\36]A<ZA80036=U%:IOEB#
ME2)%3JPRN#CG%8,[^)8+KQQJ.EZ%?J]Y/9R6[20IO>-419"BL>7 R0".O7D8
MKU>B@#SSP]:74/Q,N;]-&U2&PN]*BC6XNSD[UD<G>68D'D<=?8"G>&]!NM/\
M:ZCI8*'0=/G.HV: \QRSJ08\=@O[U@/^FBFNWU*R_M+3;FR^TW%MY\93SK:3
M9+'GNK=C[U7T72+;0[$VT4]Q.Y/F37%U+YDLK8 W.QZG"@>F !VH X.\T>\3
MQ&VK>';?5-,U9]3"WEJ8W-E>PB3#2L2-@)C&[((;/&,D&NM\=P3W?@37+2U@
MEGN+BREABBB0LS,RD <>YZUT(((R#D44 >>K;WC>+/ US]@O1!9:=/%<N;=P
M(G=(U4-QZJ:T/ UO<VVH^*FN;2Y@6ZU>2Y@:6)D$D91%##(]5/'6NRHH \S\
M5QZWJ=WXMTR;2-0N()=/*:4;8 0.3$VXR'(W.'. K9X P,\F#38]8T/Q%H.O
MSZ)J,MC-H,6F7$446^:UE1MP9D4D[3[<COCI7J61G&1GKBEH X#PEH\VH67C
M+3]8TJZMK35-4N)%\]5&^*1$7C!//RGGITYJ?P?I_B*Q\,W,NI1))K%K;M86
M@<_+*D.X(Y]-YP3Z@*:[BB@#R2RAUBXU;P3JUQH.LO=6CS+J+S(!LD:$KA$W
M86,-TP ,8ZFGR:=J,G@'Q]8C3+[[5J.I7<MI$;=LRI)MV,..AP>O3O7J^Y=^
MW<-V,XSSBEH \UBFU;PQXN;6!H>I:CI>K:=;0R"TAW36TT(( 9"00I#'GUI?
M$EOJL6NZ-XGN?#+:I:"VEM;S3HHTFFMU=PZ.JGAF&T!L'UP2.:](W+@G<,#J
M<]*6@#%\-)']@EGAT--'BGDWI;&%(Y", ;I%7@,3GCDXQGG@<YH27WA36O%%
MK>:?>W5MJ%^^HV4]O TJR>8H#1,1]P@J!\V!@]:[VB@#R@^&=1T'P5X&T;[)
M<75QI^KP7EW]GC,BPIND9^1U"E\<<G' KTV]C:[TNXCB!W2PLJAAMY*G&<]*
MLD@$ D G@>]+0!Y'#::JW@/P1I[Z)J4=QI>IV;7*M 252+.]^,_*.,>N> :O
M>(= U#7_ !)XNM[:WN(H]0T6*UMKB2)EC:5&=BI)' Y S[FO3J* ."\*W']I
M75F)O 1TC4+;FZNI[2-(T;&#Y+CEB3W P!G)Z O^)DWV=?"<WER2;/$5J2D:
MY8C;)T'<^U=U6)K_ (<A\1/ISRWUU -/NTO(A;[,&5,@;MRG(Y/% ',:OIMQ
MJOB35_$$%G=+;QZ!)IL(:W=9+B5V+<(1NVC@9('+'L,U4N]#U>\^%'A>.SLY
MAJ>B/97+V4H\MI6@ #1\\>I!Z' KTT< #.?>B@#BYK27Q+XY\.:U!:W=M:Z1
M#<O*UU T+,\J*@C"L 3CYB3TX')KC- MYO$GP)M?#5K97+75X6A$CP,(D7[0
M6,ADQMP "<9SD8Q7L<REH7596B)&!(N,K[C((_.LOPQX=@\*Z%!I%K<W$]M
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M-E- 5(+2 ;HGR1MP0,$\$'KVK-TCPCJ?AZ^\ 6BVDES!I$%V+VXC9=B/,HX
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MP#Y(V=2/E]AG]* .!\>:TFN>'=$OH--N#8RZO:&UO&*@$>:OS;<Y"L!P3[9
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MOK),1A:'<2KN#\VX _= Y(ZCK0!Z#J^K6FAZ5/J-\Y2WA SM&68D@!0.Y)(
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M6(0G<P4G!P.QQG!JY/XK@-]<V6G6TNH3VMHEY,(F4 (^2@!)Y9@I('3U(R*
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MD".5R<%EP#C//K7:44 <GIFDSWGCZ\\436\EK"=.CT^"*7 >0;S(SD G R5
M!YX/MFKX-\,7VA:IJ%M<;?[)LIY/[(4'I'-B1P1_LGY1]6KLVFB22.-Y$623
M(12P!; R<#OQ2R2)#&TDCJB*,LS'  ]2: /)-3TKQ3JFG(U_X?NKK5[/6XKE
MKCSXO+:W2;*K "_RC9C((7H22376:?9:D/BC?ZI-ITT5E/I<-NLY9"OF*[,P
MX.<?-UQ78*P=0RD%2,@@\$4M ''>)]*U&+QCH'B:PMGO(K))K:[MHR _E2 8
M= 2 2I R.I'2L/Q!X;U/5(/&6K0:?/\ :-5T^/3[.U)4.P4'+MDX7); R<X7
MWQ7IM% %'1_-&BV2S0/!*L"*\4F-RD  @X)'Y&N2CL-6T_QCXPG&DSSVFJPP
M/;W$4D>W*0E"I!8'=NQCC&.<BN[HH \LCT/6X_ W@73CH]R;O2M1M9KR,-'^
M[2,,&.=V#U&,58L;+6_#NN:O8-X336+2^OI;RSOE>)1'YK;F27=R I)Y .1T
M!KTNB@#-U.QGNO#%Y8)Y9N);-X5VC:I8H1P.PS7$P:)J>L^#/#7AFYTNXLFL
M&M/MTTY3:H@VDA"K'<6*@ C@ DG'0^D44 >9Z98ZYX=U;5-*?PG'JUM=7LMU
M8Z@'C"*LK%RLV[YAM)/(!)["DU@ZA9^-K^?3=)U*XSI\-K=7&D/!\S_,<.DI
M^5E4@KCLW.017IM<Y=>#-/GU:XU*WN]2L+BY(:Y%E>/&DS   LO3. !D8- '
M)W=J;_PIX<T_P_H&H01Z/K-JT]G.$62!(B'8L2V&)5@1@G.:VM.M=1MO'WBC
M4Y-+NOL=Y:VR6\@*?O&C5PPQNR/O#&<5UME8V^GVPM[9"J DDLY=F)ZEF))8
MGU)S5B@#R;1-!UVRT?X?6T^BW2R://(UZ-\9\L%'4'[W/WATS6I+I>K'4OB'
M*-)N2FJVT<=D=T?[YE@,9'WN/F/?'%>BT4 >;6VDZQ'<?#AFTBY T>V>.^.Z
M/]TQM_*'\7S?-Z9XJMJ>F7BV?Q":^T5Y(-5DB^QQS2JHN&\M(U (;(;>!@'!
M)Q7J59^M:)8^(-.:QU")GA+K(I21D='4Y5E92""#SD4 <3HM[)'XDL+O7-"\
M11W2PBPM[V]6!HHMQ'7RC]YB%&XCTZ9-;'C;1]1N[K0=:TN$W-QH][Y[VH8*
M9HF4HX4D@;@#D9([UH:=X?L--O8A)J5]?72J7A6^O6E*#H652<=\;L9YZ\UO
M4 <A!IMQ?^//^$IDL[BWM[;3#9PQ2 "69F?>QVYX   &<9)/8 D^&MCJ&E>$
M(]/U.PFL[F.XG<K(RMD/,[C!4D=&%=?4<4\4ZLT,J2*K%"48'# X(X[B@#D9
MK/4[+XI2ZM'IDUS876E1VWG1.@$;I*S$,"0>C#& <GCCDCECX?UX_""30_[%
MNO[2.H^<(=\?W/M?G9SNQ]WWZUZW10!YO+::SH7C+5;M/"QUS3-8:.XC:-HA
M+;2B-49'#D?*=H.0>/>N]LQ-;Z9'Y\,:S*F6AMQ\JGKM7IG'3/&?:K=% 'DD
M?A_7E^$%CH9T6Y_M*+4%F>'?'P@NS-G.['W3Z]:TC::SH'BW5Y5\*G6]-U>9
M;J"5&B$EO*45623>1A?E!R.GO7I-% '%>(/#]UXJT]/#]_:M:6D=N)VNK95V
MBX'W%BYR I.<X&< ="167JD/BGQ!\.[5-0T65=;LKVVFFA62/_21'*I+(=V
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MTBZTRYED2WNHS%+Y3 ,R$8(R0<9'XU-IUDFG:=;V4<LDD<$8C1I""VT# !(
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M&_%.F^!=?\%PZ0+R&47'V"^6YC5621BVUU8[@X+'M@^HZT >E:2<:)8G&?\
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M?:YI5!"27EY+<,@]%,C-M_#%;%% !1110 4444 %%%% !1110 4444 %%%%
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MG T>88HW4G><A2W!/&>N.<9JSX\TN^FN=$U?19EMM82X^Q*6'WX9AAP0.I3
MD'IL-=Q6-;>%].MO$-QK8-S+=S'($UP[QQ'&TE$)PI(XR.V1T- #I7FT2'2-
M/TS2I+FUWI;.R2*HMH@O#G/W@, 8%:]%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MN83*H=\<!\,0=I/U-<S96D=G^S=>7=I)<6UP(IV\R&=T/RW#@#@],'&.A[T
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MVOQ'U_3S"+2U^PVMPEFDQ=(V)<$C@!20!D#CCJ>M=[0 4444 %%%% !1110
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MN.3CC.*W*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MQ;,0VTDJ58=&5A@@CU!H \^U%$\-?$7Q!>:5#MDA\)O<QPY)4.LKX 7L"5'
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MD\ [2V,\9QFN,T;PO ;RTDTG1?$NBS02QL\EYJ1,2HK LFSS7WY (QC'/44
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M%Y;3VL-O)(GV-9)D1DR6.Y#\V%/ YXKTG1]#M=$6Y6UDNG^TS&:0W%P\IW$
M'&XG&<9Q6>W@;P_)X?;0WLY&L'D$LB&YEW2N""&=]VYB"J]3V'H*WXHQ%$L:
MEB%& 68L?Q)Y/XT 8?C&WU*Z\/20Z3+"MZ98F2*:0HMP%<,T18<C<H*_C7GU
M[XL%IX9U<6EG?:'J U"TMM1M97S]B24A2\3#C:R@X(QR2:]3U/2K36+06UXL
MC1K(LJF.5HV5U.5(92""#SUJK_PC.DO:7]M/:BY34 !=FX8R-, , $DYP!T
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M;+<RA'NIUMX5[N[=A^ )^@->=:+!_9OQ'\/QP6L-A!=:++NAC<%Y0ICV-*0
MI?D],]3R:TOB+I]E=ZSX,:YM+>8MK*Q$RQALH8I"5Y'0D X]A0!WU%>9)X9T
MC6?B?X@L+V!Y;)=/LI4@6=U0-N?!&TC&,# ' K&UUK:32Y-;TO,FWQ)&!J5P
MX^T,_GJC1QX&1$!E0">0#QCF@#V.4R"%S"J-+CY0[%03[D X_*L+P3K]QXH\
M(6.LW4,<$UQYFZ.(DJNV1E&,^RBL'3#:^)O'_BRQUF&*Y&GBWAM+>8;A'$\>
MXNH/=F/WASPHS7(>&;XP>#OA_I<L\$6G7L]ZDK749DB>17?RT<;ESDEL G!(
M% 'MM%<OX3T%?#U]J]M%J4<T4TJ7 L883'%9E@00@W-@-C..WXUSEKX;TS6_
MBAXMM]1BEG@BBT^=(S.X DQ(P88/4$<?4^M 'I=%>1Z?8#QEX8OM1N]8L]/U
M2TOYFGO!:DW5DT<S$*'\P878 ,8Q@],\UN:3]B\3>(_%L&NQ0W,FGSI;PP3J
M"(8/*5@ZJ?NEF+'=UX'/ H ] HKQ?0#GPQ\++IR3/)?,CRD_,P*RG!/?)Y^M
M7-6U&?1M0^*-SIC&.2""Q8>3_P L]R-O< =" 2V?49H ]<HK@;/0+.#6=,\0
M6.MV-K#-;21[-/M"B7JE"P9SO;<4QN#8SV)YK+\,QMIFOZ5H?B/1;8W4]M+%
M::M:8>'4DV OYP(SO*C<=V<DG'7D ]'TW4[35[/[792B6#S)(@Z]"4<HV/49
M4\TU&U/^V9ED2U&E^2IB=6;SC+D[@1C&W&,=ZX_X0V5G;>!+:6"V@BFDGN5=
MTC"LP6XD !(Y( X'I48C6'XJ^(PMT]NKZ#%(9BQ;RB7D!< GC& <#TH ]!HK
MS3PBTVC>*M/TC7=%@M=4-C+%:ZG8L#!J" HSE^-PD^4'YL]6]:T]?NUN_B;H
M.@7X4Z;+9SW*PO\ <N)U( 5@>&VKN;'J0>PH U?#OB"\U;7/$.GW=O!#_9=R
MD,9B<MO#1A\DD#GD=JZ.O&+J<>&+;XA'3?\ 1+>/5;)9&C!Q#"XB$A !! "L
MPX(P.F,5U<'A>TMM:_M&#5+2*"^L'B:RTVW,,=RH&X2G:YY&0-P[$#/- '>5
M2B;4_P"V+A94M1I@B0PLK-YQDR=P88QMQC&*\=TO3[>U\!_#K7(@XU-]4LX6
MN3(Q<QR.RNG7[I!Z=._6NDNYKC3/'?CBZL-[7,6@1W$*EB_[T"4C /N!Q0!Z
M76#XSUN[\.>$M1UBRMX9YK2(R[)G*J0.O0<_3CZUR.A:-:ZC:>%_$]KK5G Z
MF/=-;6Q$MX7 #13,9"7.<YR,@@GCFL"Z6T\2_!+Q%KNHPQRZRS7+32./WENZ
M2$+&#U50@4;>F"?4T >L7VH7-OX;FU&"&*2XCM3.(W<JI(7.,@$TSPQJLNN>
M%=*U:>-(Y;RTCG=$SM4LH) SVYJ.^_Y$JY_[!S?^BS7EHT&WT_X=>#?$FEB:
M/Q IL(XY5F8M.KE5:(@G!3:3QV ^M 'ME%>9ZC)'X#\<WLT5HLEKXBML6J;>
M!>IP(O99-P/U!KN=&T6VTG0+?20B21I%LER@Q*Q'S$CW.?SH Q/%'C(Z9X'U
M'Q#HJ6]Z+21HSYKD(2LGEMC'7#9[CIUKKAR*\,^PV5M^S[KTEO:V\,SW$Z,\
M<:JQ5;P@ D=@,8]*Z^>P@T'XK:6VF1,CW^EW1N1O)-PR%"I;)Y;)//7F@#T2
MBO)?#VG)XG\)Z)XD?6[2UU""=)KB\BM#]I,V[#PNWF9(8G;LQC&T =!79>.I
M;)='L[>]DN<76H6\,4$#!?M,A?(B<GC8V#N]@>O0@'445X_)"]O#\4[$K%:Q
M6]C%<1V]G(RQPR&V=B5QCDE03P,D=*6YT&#2;'P#XATDS)J]S=65M<2><S&Y
MADC^=6!., #([ #B@#U^BO'['PII6NZ=X\_M!IV:TU:Y-M*UP_\ HS+$A#KS
MU!QR>PQTIEE9OXBU7X??V[Y\KW^B7)NT:5E\X!(\;L'N&R<8SGF@#V.BO.M!
ML-/U'QEXD\/ZC9QS6>DV]I;:?:W&9%C@,9)9=V>2W!;KP!GBN6C6[O?#_A2"
M_N[N18?%+Z?#<>>P::V4RA<D'D_+C=U^7K0![=5;43>KIMR=-6![X1GR%N"1
M&7QQN(YQGTKR^;0X- \8>)-(TH2PZ/=>'7O9K=)6VQ7 <JK*<Y4L ?K@U"OA
MS38/@;+K21S#4IO#:>9<>>^6"Q;E&,XP#TXZ#% 'K<!E-O&;@()MH\P(25#8
MYQGMFH-0U.TTN*&2[E$8GGCMX@>KR.P50/7D_D">U<1)'9:CJWA[3FB%]>+H
MOG?8[HC[*D9V*96!!+/D;0!V+<CK7(VT$&H_#/P"]]'%=R)X@BMP\RASY?VB
M1=N3D[2%48] * /<*1MVP[<;L<9Z9KS>6VM_$'C;7_#=P=-2&TM+=+*UN;7S
M L+(=SQ .H4AN"0,C:O/%=CX5M&L/#-E9MJCZH;=3%]L=<&7:Q'/)SC&,Y.<
M9[T 9_A'Q->^([K6H[BQM[9-,OY+ F.8N9&3&6Y48&"*ZBO)M#C67PO\458L
M,:MJ# HY4@B)2.1[BHK/3;;38/AAJMJKI?70@MYYR[%I(VM22AR>5! P.@QQ
M0!Z]5*V;4SJ=\+I+46 \O[&T;,9&^7Y_,!&!STQVZUYQ,TVB>)$FUG38=0TR
M[UG=::W:$>=;R-+A89@>2H;]WD'  '&<5'?7]UH&I?%2^TTN;BVMK22+<Q?8
MQA8EAG/0DMCI0!VOB;Q!>:)J.@006\$D&I:@EG*[N=R;E9L@ 8_A/)/X5T=>
M5:QI>D0Q_#O4;"*(R2ZI;YNEY><-$[%G;JY)&<G)Y/J:;!IZ^-K;Q,E[J=G:
M7]GJ<\9N'MR;FR2-_P!TR/Y@V+M .0 #ENN30!ZO6=J]UJ=NEJNEV4-U---L
M?SY3&D:;68L2%8]0!C'5A7G[^'M/U_XG7%AJC37MK-X=@ED#2/&)7\YAOP""
MO0'';ZBO4%4(H4= ,"@#A]/\6^)=4U/7M/M=%TQKC1Y$C<-?N!*S)N&T^5QZ
M<UVEM*T]K#*\9C=T5BC=5)&<&N&\$?\ (_\ C_\ Z_;?_P!$U2D\.:9KOQ6\
M066I12SVITZTF,1G<#?O?YN"",8&,<4 >ETR4R")S$JM)CY0[;03[G!Q^5>.
M>(&MI-)NM:TO,AC\1Q@:E<./M&_SU1HX\#(B4949/(!XP<UU&FFU\2_$+Q78
M:Q#%<KIZV\5I;S ,J1/'N9U![LQY8<\*,T :/ASQ#K?B7P3IVLVMK81WMQ<,
M)HI'<1K$LS(VTC)+;5XSQG\JZVO$+&%!\%O"+JSYBUN)5(<\@WK YYY_&NID
MT/3]5^+NL6E_$UQ:R:/!(\$DC%&8RN.1GI@#CIWZT >C45X]I4E_-\*/"9$K
MW$$6KB*YMR^7N;=)Y$$8!^_@!3M[A#76^%] >U\8Z_JZ6LEKID_DK8P-N0!@
MO[UQ'T4,<=0"2">_(!K:]XF72M1T_2;2V^V:OJ!;[/;[]BJBC+22-@[5'T))
MX -,NM3UW39+/[386ES!<7,<$DMM*RF#>P&2K#YADXR".2.,5S&HYTWX^:7>
MWIVVM_HSV=K(WW?.63>4SZD?GFO0YIXH%0RN%#N$7/=B> * ):*\LTR"V\4^
M$O%E]JR@:M;WMY&)SQ+9&/\ U81NJ!0%/&,DD]S5:R2;7=?^'MQK(E:XOM&N
M6NT+LHEPD>,J#@9W$D=\D&@#URBO&8_#VF2>%/B';O 6@TJZNFT^(R-MM2(%
MD!C&<*0QSQ5]K.+7/%/@5=1DGF6^T*5[E#,P$Q"1'G![Y.<8SWR* .\\7:Q=
M>'_">I:O9P0SRV<#3;)G*J0!D]!S]./K4R7.JW,>CW%K%9_9YU#WOF,P95*9
M'E@<$[L=>U>7363:+X7^*6A6K2'1K&(&R1F+"(R0;Y(U)[ E>.V?>N@U:,#Q
M#\-I07#%W0C><$?9F/3I^- 'HU%>,^*VMI-"U[6=,S++;:Y$/[2N7'GQRK-$
MC10X&5C49')_O<$'-=#<:+8:K\8M0M+V-KBUDT**22!Y&*.QG=>1G!& ..G
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MB/[S-7*1^'-+\2?$OQG:ZM;FXMQ;V'[LR,JY*2<X!'(['MSBO254(H50 H&
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MXCT_6+&&)XVC5+&U*?V@KIG$A,C%BN"V3R"#FK7Q*L"-"@U^" 27>AW$=]M
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MU+$)'QEBV=QR ,+UZ5F6UK::KI'PI-VD=P[_ +F4L<EE^S,=C'N#QD'J#[T
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MGT^>S(5K.>WC9'R<[E=2Q'!Q@@\YKG]!\1>)->OM>MX5TF,:5?/9C?')^^(
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M0I].G2MK2[?PM>1^'-9TAXC>1VKI8I;R &4-'EED Y;&,G/1O<T =H;B$3B
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MI42% $5_(7<RJ2<'/4YZUN^(;/3XK;X?2VL%LCKK%JNZ)5&-T+L1QZ_*?RH
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M-/CB4Z/;"">UCQ\D-P\8:4)Z<E3@=-WO0![2LT3RM$LJ-(H!90P) /3(IY(
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M6VX/JV.] %V7Q!K6KZCK-KX<?3EETJ>.'R[Q6(N25#O\RGY  V <'D>E=C7
M>!=/L8?%OC-X;.V1X=358V2)044P)D# X'6N_H **** "BBB@ HHHH ****
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MHT"8+%F VYZ9^M+-/#;Q&6:5(XQU9V 'YF@!B6=K'9BSCMXDM@NP0H@"!?3
MXQ6=_P (IX>^Q0V7]B:?]EA?S(H/LZ[$?^\%Q@'WJAX\U^^\/>#+O6M+-M))
M!Y9'G*65E9U7C!'][/X5T] &?JFAZ5K=B++5-/MKRV4@K'/&&"D=",]#0VA:
M2VC?V.VFVATS;L^R>2OE8SG&W&.O/UJ^2%4LQ  Y)/:F0W$-S'YD$T<J9QN1
M@P_,4 4K/0-(T_27TJSTRTAT]PP>V2(!'#<'([Y[YIC>'-%;2X=,.E68L86#
M10"(!8V!R&4#H<YY'-7UN8'=46:-G==ZJ&!)7U'M[UG^(]3?2M"O;FVEMEO(
MK>26%+CHY52V, @GIVH E;0=)?37TY]-M7LG)9X&B!1R>I8'J?<T3:%I5Q8V
M]E+I]LUM;,'@B\L8B8 @%?[I )P1ZU'X:U&;5_"ND:E<A!/=V4,\@087<R!C
M@>F36F2 "20 .I- $-G96MA!Y-I D,98L0@QECU)]2?4U7?0]*DU1=3?3K5K
M]1M%R8AY@'INZX]JMI<0R2>6DT;.5#[0P)VGOCT]Z'N((YDA>:-97^ZA8!F^
M@[T 4)_#NC7-^U]/IEK)<OMWR-&,OM^[N_O8[9Z5+-HVF7&IQ:E-I]M)?1#$
M=RT0,B#T#=15QY8XR [JI() )QP.M$<D<T:R1.KHPR&4Y!_&@".ZM;>]MI+:
MZA2:"0;7CD7<K#T(/45#!I.G6VFG38+"VCL2I0VRQ 1[3U&WICVJS++'!&TD
MTB1QKU9V  _$T":)H1,)4,1&0X8;<>N: *&D>'M'T"&6'2-,M;*.4[I!!$%W
MGWQUIFE^&=#T2YGN=+TBRLYY_P#6200JA;OC('3VK22:*1W2.5&>,X=58$J?
M?TIOVF#>B>='O<D*N\98CKCUQ0!1'AW1AJ#7XTRU%T[B5I!&,LXZ.?5O]KK4
MC:)I;:B^HG3[8WKIY;7'ECS"G]TMUQ[5;FN(+<*9YHX@QVKO8+D^@S1/<0VR
M;YYHXDSC=(P49_&@#,7PKH"6T=O'H]E'#'(9HTCA"A'_ +RXZ-R>1S4DWA[1
MKBP6PGTNTEM%?S!#)$&7=G);!ZG/.>N:S/&NO7^@:597FGBV82WUO;R><I;Y
M)'"DK@CGGOFNAEN8(&19IXXV<X0.X&X^V>M %#4?#>B:LULVH:5:736W$+31
M!B@] 3V]NE">&M#CTZXT]-(L5L[DEIX! NR0DYRPQR<^M9FIZ]?V/CW1-'_T
M;^S[^WN978J?,4Q!3USC'S>G:K?BG6+C2_!VIZSI;VTLMK:R7"&0%XV"J3CY
M2/3UH E@\+:!;:0VDPZ-8IISMN>V$"^6Y]2,<GZU+=>'M&OM,BTRZTNTFL8B
M#';R0J40CI@=!BGZ=?B;0;*_NY(XS+;QRR,3M4%E!/7IR:O(ZN@=&#*PR"#D
M$4 9T/A[1K=KIH=*LHS=QB&XVP*/-0+M"MQRN.,=,5&/"^@"VM;8:-8>1:-O
MMX_(7;"W7*C'!]Q6M7,^/O$%[X4\'WNN64=O,UH%+0S*<.&=5X((QC=GO0!J
M7V@:1J5TMS>Z=;3SA/+\QXP6*?W2>Z^QXJ2ZT72[V:VFNM/M9I;7_4/)$"8O
M]T_P_A4UK)(+6#[7+"9W7G8-JDXS@ DGI[]JEBFBGC$D,B2(>C(P(/XB@#//
MAS16:]8Z59[KY"EVWDKF=<8PY_B_&KT-M!;VD=K#$D=O&@C2)1A54#  'ICB
MI:PO%VM3:'X9U*^LY;47MM:R7$45QDA]BEB, @GI0!I:?I6GZ3"T.G64%I&S
M%F2",("3U.!WJJOAG0DO)[Q=(LEN;@%9IA H>0'J&.,D?6I--U$3:!8ZA>2Q
M1&:WCDD8G:H9E!/7W-&IZYI^D_8Q=W"*U[.EO;KN&9&8]O8#DGT% $7_  B^
M@&S@L_[&L/LMN_F0P^0NR-O[RC& ?<50CL];U/7A_:MG96^E:?<F:T,4QD>X
M(4JA8$ +C<3WYQZ9/02W,$ 0RSQQASA2[@;CZ#UITDL<7^LD1."?F8#@<F@!
M]4;#1M,TN6>6PT^VM9)VW3-#$%,C>K8ZGW-66N8%3>T\879OR7&-OK]/>@W$
M ,0,T8,O^K&X?/\ 3UH SK;POH-EJ\FK6NCV4.H29WW*0J'.>ISCJ>_K2R^&
M="GUI-9ETBR?4DQMNFA4R CH<XZCUJ9CJ UZ,">T&FFV;,14^>9=PY!SC9@\
M\9R15HW, 95,\89F*J-XR6'4#WH J7^A:5JEQ'<7NGV\\\:E%D=!N"GJN>NT
M^G2BZT/2;U;9;K3;286I!MP\*D0D="O'RX]J5SJ UV$+-:#33;MNB93YYEW#
M!!SC;CKQU(JT;F ,JF>,,S%%!<9+#J![T 47\.:++/=32:39/+=KLN':%29E
M]'./F'L:?!H6E6T4T45A J3((Y 5SN0=%.?X1DX'09-7)KB&V4-/-'$I. 78
M*"?3FI* ,I_#6AOHQT=M(LCII.?LODKY8/7(7& :6P\-Z)I=Q]HL=)LK>;8(
M_,CA4-M],XSCDUIE@JDL0 .I-,-Q" "9H\'H=PYH S-.\+:!I%S<7&G:/8VD
MUP"LKPPJI8'J.!T]JGM-!TBQLY[.TTRT@M;C/G0QPJJ29X.Y0,'/>H?$>I3Z
M9X=U.]L6MS=VMK)<(DP+*=JEL$ @\XI?#NJG5- TJZN)(A>75C#<R1H<8+("
M2!G.,F@!MIX5\/V+VKVFBV$+6A9K=DMU!B+8W%3C@G Y]J>?#6A%;U?['L=M
M\V^['D+^_/J_'S=^OK6@]Q!',D+S1K*_W$+ ,WT'>J!UNSEUJXT6WN(SJ$,
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MXN([!1&V095+(!P'QT/K46E^59^/O!?E"SM89M'G1(87!?R@L9C$C\!R>O
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MTNT$MX-MR_DKNF'HY_B_&H9/"?AV6WM;>30]/:"T8O;QM;J5B)Z[1CC.!^5
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MM;>X-K;K%%<Q(VZ!H1O,9;TD+YQWQZ"I[.+2X]9T32;:\;4;JUT65DN]28-
M+4R!?,V<;V.W ((&SDGD9[;5O#6AZ]+#+JVDV5[)#_JVN(5<K[<]O;I4EYH&
MCZA=6MS>:79W$]I_Q[R2PJQB_P!TD<4 >26<PD^!?AE3*'9-4ME^]G"B\(4?
M3 P/I6UXP?3[V;QXD"Q&XMM)1+V6];>J?NG:-(4XP3NR6SC=C )KNSX5\/FR
M%D=$T_[*)3.(?LZ[/,/5\8QGWI\_AK0[J^^VW&D6,MUY7D^=) K/LQC;DCI@
MD?2@#SPV]IKFO?#>'4%2\BET>X,J2'<LA\F$X8?Q>N#5:73H]'T;XJV&FIY>
MB16I-O$O^KBF:W8S*GIR4R!TSBO2Y/#.ARV-K9-I-G]FM#FWC$( A/JF/NGZ
M5.^C:9)IATQ]/MFL6SNMC$/+.3DY7H<GF@#SR2_1/$7A*PU"[AM;&?0]UJUQ
M&KQO<?("/FXW;.A]R!UKIO"5GI/AG2KJTM]86:T;4'$9E94CCD?!\F+'& 3P
M!GDD=JUKSPUH>H:5%I=WI-G-8Q8\NW>$%(\=-H[?A4C:!I#Z?:V#:9:&SM'6
M2W@\I=D3*<J5'0$?UH T:X7XR<?";7O]R+_T:E=U5/4M)T[6+?[/J=C;WD&<
M^7<1AUS]#Q0!Q'BO3;*]^(/@07-O'()1>))D?ZQ!!G:WJOL>.3ZFK/@&WAL/
M$/C/3[2)(+.'4T:*",;4C+0H6V@<#)]*ZAO#VC--:S-I=H9+,8MG,*YA'^P?
MX?PJ6ST?3=.N9[FRL+:WGN#F:2*,*TA]6(Z_C0!=KQU)+37/AAX]NM4CADU:
M.:^%R)0"\+(#Y*C/("@+M]\]\U[%6->>$O#VH7TU[=Z+8SW4T9CEE>!2SJ1C
M!/?CB@#@[:^BE\3Z!INH7EO;VLOAV![+[3$KQR2$XD W<;MNSWQGUJMJ6@:3
MIFG>#[&VN5U*TC\3+$DLR*RJK+(3$IQ@H&XQZC':O1[WPMH&HZ=#I]YHUC-9
MP',,#0+LC_W1CC\*GN=!TB\TR+3+G2[.:PBV^7;/"IC3;TPN,#% 'GS?V?K?
MB_Q3H>IWUG;IY,*6D4T2,#:-".8BW& Y8G'0X]!5>7P_I,WB[P-8RM_:EJ^F
MWL33W(!-U&@CV;_[PP<C\#7H>I^%]!UI[=]3T>QNVMQB$S0*VP>@R.GMTJ>;
M1-*N+^"_FTZUDO+<8AG:(%XQZ*>H_"@#@['PSH:?%?4--&EVIL8]#ML6S1AH
M^)'4$J>"0 !DUR@TNQA^!PU1;:/^T++4-MM=,,R0JM]M548\J O&!QR?6O9_
M[#TK^T)=0_LZV^VRIY<EQY0\QE]"W4CVJO\ \(IX?_L\Z?\ V)I_V(OO-O\
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M(B\D2K"H81XQLR!G;[=* /(8;:V?X:>&8YHHY(K?Q2MO'YBAMD7VMQMY_AP
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ J*XN8+.!I[F>."%?O22N%4?4FI:Y'QS?6-K-X>BNHU:X
MEU-?LDDTI2&*548AWQ][ SA>YQR.M '1QZII\MBU]'?6SVBYW3K,IC&.N6SB
MEAU*PN;R6T@O;:6YB&9(4E5G0>I4'(KQ34Y+2Y\'?%"![FTNY!=_:$,87!/E
MQY=5R<<\9R?K74ZQH6G0^*O UUHEK;QW<DK^<T"C]]:F(F1G(^\,E>3GEO4T
M =\^M:5')'&^IV:O+(8HU:=07<=5 SR>>E/NM4T^Q9EN[ZVMRD?FL)9E3"9
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M1FCFO=.M+F6,81YH%=E'L2.*Y_Q3X=O=:\2>';N.ULI[#3I97N([F0YD#QE
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M.2,U9NK*UOX/(O+:&XBSGRYHPZY^AJ*'5M-N+F.VAU"TDGDC$R1),I9T(R&
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MC8QZA:O=C.8%F4R#'7Y<YXH 2^T?3-3DBDO].M+MX3F)IX%<H?521Q^%.O\
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M(*1(=*L2L/,0-NF$^G''X47.AZ3>W?VNZTNRGN=AC\Z6W1GVD8*[B,XP2,4
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M<VT$[(B!6D4-M'V0=,].1^@]*].N;*UO#$;JVAG,3B2/S8PVQAT89Z'WJO\
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M:YN/,0/ B1[E^]D LQ7!(Z X]1Q=C-#=? S6-'U,@Z[ ;F&XMF/[YKPRLT9
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MN =LAE*$,P)S@#VZ]*U=,U.*STB%]7U_3KJ5Y)%%TC)$CX<_*!N(RHP#SU%
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M!='4;06Q;8)O/786],YQF@"TT,3.SM$A9EVDE1DKZ?2D6WA2-HTAC5&^\H4
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M4*D[BL:!03Z\5+110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MB#*_T<>E>@VUI;65LMM:V\4$"YVQ1(%49ZX XI\44<,*0Q1K'$BA41!A5 X
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M.L[2Y= )OLZ 9/\ O  G\12R:'I,L]Q/)I=D\UP L\C6Z%I0"" QQSC Z^E
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M:O7_ .R-,\]Y_P"SK3SI 5>3R%W,#U!.,FGVNF:?8QO':6-M;H_WUBB5 WU
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MZ5VC4 R#[,&^8_Q<\\]Z]"L]1LM1^T?8KN&X^SS-!-Y3AO+D7JIQT(STJ/\
ML72MT+?V99[H!B(^0N8^_P O''X58M[2VM/-^S6\4/G2&63RT"[W/5CCJ3ZT
M 34444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !574=3LM)LVN]0NH
MK6V3[TLK;57ZGM5JN$^*DKW6AZ?X=@C>6;6K^*W:*,@,85/F2$9('W4QR>]
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MDN!M4@G/KGCT-:.F^.IM8T[PJEK###J.O0/,?,!:.!8URYP""W. !D=<YXY
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M<J"IXX/O7*Z9XI\0:7\$#XH>6RO[K:TVV>)E^],P;=AOFY.0!M  Q0!ZN""
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MFB,.U<$[PC9R<\;1VYKFKG0M-_L>$V^KVTFJKK+ZU,)[.4VTLKY#(5P2%VD
M'D\9[UZ_G]:* /.M>EM?$/A&YTN?5[>UN',3PK!9R&&)HW#@'(RP)7!Z<=!Z
MZD7B4W%C.+S4[6WN&@:.-;6"9E5R.'+,H/!Z  =^3VW[O7M.L=9T_29YF6]U
M#?\ 9D$;$/M4LWS8VC 'KZ5I4 >0V>F0PZ=X4MI=;M/^)+(K,B6DVSY8V4,N
M1RY9MQ)P,@<<'/4:+>Z/IVN:YJUSJ"RW.I3H5*V\@\N%$"HGW?7<3[M7;44
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MDD+.WRLL3+Y3N 1\RD%CSDDUU:7MF/'MUX@;5HC;O91VL,7V:7>H#,S G;@
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MZT[Q#H&JW_B/1=8TR\M4-@)5>"[1F0^8 -Z[2/G&#^!(R*Z61Q'&SMG:H).
M2?R'6L2/Q?HTWAF3Q%%/+)IJ,RF1('+9#[#A,;OO>U '*/\ #_6SX8U#1O[1
ML)!<ZO\ VBDAC==H\X2D$<Y)( XZ>]=%_86H-\0(?$;-:K;KIIL6A#L6R7#E
M@<8ZC&/Q]JZ8<C-% 'F\/@#7;7PAI^B1:K8M_9>H+=6P>%]DZ+([[9N?5ATZ
M%1U[2:AI^I>%E\8>)-0U:R6+4;6(9CM2?*F5/*7AFP5RPZ]>^!FO1*;)&DL;
M1R(KHPPRL,@CT(H \PT.+6?#\VELO_")7L'[NUC%E)-Y_EL0&\K<S# ^\0,
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MD)-'I=H(I4C .'RCL H]^.<#DB@!WQ7F>4>%M'<D6.J:W!!>#M)'G.P^Q/\
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M1FI]#N)[O1X)[FZMKJ23<1/:_P"KD7<=K+R>JX[FN$@@U^X^(GCE-!O+*TF
ML6,EU TNX^0<+@$8![MSCTH ],HKS-/'FLS>%] \22);6MB]Y]CUF,Q%C ?,
M,9D5MW"[@,YS@,/2NTL;V[O/$6I1K)&=.M%CA V?,9R-S_-G[H5H^W4GTH V
M"0.M9MCKVG:EJVH:7:S,UWI_E_:4:-EV;\E>2!G(4GC-<QXVEU-?%G@ZWL]0
M%O!/>R!XS%N#,L+D%N1D#TXYYYXQFQ)K!^(7CG^R;RUMITM+!FFF@,F2(Y,
M+N&,]SDX]#G( /2Z@N;&TO-OVJU@GV_=\V,-CZ9KB+#QS=ZMI/A@10F.]U>R
M>[F:&+S/+5-H;:I/=G&,YP >M;OA2^UV[@OHM=LO)DM[ADM[C8$^TQ?PN4R=
MK=B* .@5510JJ%51@ #  I:Y/Q+J^JV%_/'#<V]I:I8M-;L(_.FGG!.5\L<[
M% !) _BZC%8W_"9:_?6_@>6Q73XCX@B8SK+&["-Q"7R"&^[GG;U.,;AG- 'H
MM%>87/C'Q/HUOXMTV_?3Y]3T>R%_:W2V[+'/"0>&3?\ *P(QU_/O<E\2>*-'
MU/PW=ZG)I]QI.MS1VAB@A99+:61<H=Q;YP2#G@>U 'H=%>>Z1XB\2WCZW?7=
MYIL>FZ)JEQ!<JEJV^:".,-\OSG:1G/?.>V.4OO%^M:=X'L/&TIMY+&40SW-@
ML?,=O*0!L?.2ZAE)SP>>!0!Z'17!-JWBS5?%GB+1-+O=+MDL(K:6">6U=S^\
M5SM(W\YP/F[ ?=.>,RW\>^(-1T3PQ<P16-O=W^IMIE]%)&S!)%WY93N^[\F<
M=><9'6@#T.ZU6UL]2L=/F,@N+XN( L3,IV+N;+ 87CUQFKM<2=6\2:5XG\*Z
M/J5WI]T-1-V+F2"V:,GRT+IC+''!7(QU'7FJ.M^+M9T:5IYI;7>NKQVOV&./
MS0+9W"*[R+]R0@[@#CTP: /1,C..]%<#!>:C%\5-?-QJ(-C9Z;!,(3#PJ%I"
M0.>ORY)YS[8%):>)?$]_!H6KV.GO<VE^\;7-I]G"B&WD&0ZR%OF901GC#<X
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M)P<-@8W$8(XKL:* .+N/!VLV?B:^U3P[X@33[?4F5[VUGM1.OF !?,CY&&(
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M%&C2Z9J*N8G(97C;:\3@Y5U/9@: -*2*.:)XI45XW4JRL,@@\$&N4BU&>_\
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M*71VQ\Q(/(&2<].,5T<&C:A/J%M>:QJ4-U]E8O!#;6I@C#E2N]@7<L0&8#D
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M[MH[9H!!@*J$E2&W'G+'/% %CQ/=7MEH$\]A<6EM,K(#/=MM2-"P#-Z$A2<
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MWQ,FC.WV.7RDR (!( PQ@\G'3I6C9^#9ELM*T[4M5^WZ?I<J2VR&WV2.8_\
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M\\?D^9);*C2"3;NV"0A=N"<9YP>AFF^'<HTS05T_79K'5M$@^S6U_% &WQ8
M*21DX8<#OUJWJG@8ZOH45M=ZU=G5H;E;R+5$55=)@, A!\H7'&WT]^: .=\3
MS^+8?!?C%+^2ZM[.&V\VPO6, G=2OSQN(\J.>C  X/K7H.B0R0:-:)+<R7#>
M4IWR*H.,#CY0!6*WA"YU#PYJ>F:YKD^HW-_;FW:Z$"0B-<'&Q%X')R<Y)X[
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MN[6X\:BVN_$D6@BVLU$9U&SCFM[@NQ+%/,P 1M4$@Y.<8&.=!=%U/QAX-O\
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M%MGMPBP2C;C8W5P1O)[#('.#BUXFT*'Q/X;O]%GE>&.[B\LR(,E3G(.._(%
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M*GEA[YJ]9:EXB\4:%-K6A7\%O*+UX[:SG1?)>*.4HWF-M+[F"L?E(QD#'4D
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MZ_6=J>N66D2V\5R+EY;C=Y4=O;23L=N,G"*2 ,CD^M78(WB@2.29YG48,C@
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M9^E&I^!C?)I5U!K%Q!K>F2O+%J3QK(9"XQ('3@%6&!@8P  *ZP2(96B#J9%
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M$8S'M/7YMIQNYZ=,\U+:^ ;C3M3OO[.\0W5KHE].UQ<:8L*'YV^^$D/**W<
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M<)EE@$",4E*A<ASR5^4?+QTZUW%% ',/X4N9-;T#4Y-6\R31XI8@'MQ^^\P
M.201CA1C X[YJA;> +K3M2O!IOB2\M=$O9FGGTQ84;YF.7"2'YD4^@&>>".M
M=H)$,K1!U,BJ&9<\@'.#CWP?R-.H Y^SMM7C\:7TS:C+-H[VZA;5X BP2#;C
M8W5\C>3V&5'TZ"BB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M"?,9#L924\LJ!SZ\Y)!JPMI?W7CKQ_\ 8M6GT]XX+)_,@C0NS"!RN2P(V^H
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M48K#6)C<S6J%-J3'!+ E=V,J/ESBM9O"N_Q%IFM/JEU)/80/ JNJ$2!\;RV
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M-I7&!QGFO0;SQCI=AK7]DS1:B;G>B;H["9X\MC'SA2N.1DYX[T ;]%>9P?\
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MW<"",YZ]JX&PUGQ##HO@37;C7)K@ZM<V]K=6K0QK$RRHQW<+NW@@'.<>P'%
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MK$%@"<L0. <_A0!EOX6W^)-/UMM3NFN+*V>W575") ^"Q;CJ2 >, =A5#_A
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ML%TZ0QB/_2(%.5#94[3G^)<'Z5!!\.+2V\,:;HL6K:@HTV]6\L[C]V7B92Q
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M>7*7%HZ36U] 0DT4J\!Q@8SCJ,8JWH6B2:1%(UWJEWJ=Y* 'N;G:#M&<*%4
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M*1L\OS?*>3*HP(SG!/&>"< GH>E8.M>$+?6]<T[5Y-2U"VNM.W_93;M&!'O
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M=A4^4*P(V*IY)R!T!/.#P]QKVN_\*QU6Z75;N"\T_76LHY"59S$+E4"NV,G
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M+K#5[K1KQ;2]MM1FMK5S>NB0^4^W:\00JVX#)W9/S<8XKHCX'LC8:%9?VAJ
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M0!^9ST\2-'$J-(TC*,%WQEO<X 'Y"@#@;2P\SXS:T1>7B$:5;R+MF.%)>08
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M#C@]L&@#V4<@<8]J*Y&6^DUGQ]>>'I+F>WM;/3X[C9;RF)YGD9ANW*0<*%'
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M')(\J,QD9P<G "@#IUR#7,P^)=;ETC2!<7TWVVS\6KHMQ.AVB[B5R"64<<C
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M]H@=><=L#BEE\$6D^GZ1:2ZGJ;KI=PEU!(TJ,QD0;5+93& "1@ #UYYKIZ*
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ME*G!Y!P"/IQ5>\\#Z9=Z59Z<L]W;Q6UX+X/$Z[Y)PV_S'+*<G<2?_K<5TM%
M"*"J@%BQ QD]36%<>%;9]>GUJRO;S3KVYB6*Y:U*;9U7[I975AN'0,,''%;U
M% '-ZAX)TR_\-VV@))=6EA;NLBK;NNYF5MX+,P))W?,3W/6I]5\,0ZQ>:7=7
M&H7JRZ;+YT!C,8!?!&YALYX)&.E;M% &+_PC5O\ \)5_PD+75TUV;3[&8R4\
MLQ;MV,;<_>YSG].*S-'^'NEZ'>;[.]U/["LIGBTQ[G-K$^<Y5,9X/(!) /.,
MUUM% '(S?#O2WUVZU.WOM4LTO7\R\LK6Z,=O<MW+KC.3WP1FM2#PU;6_BB;7
MTNKK[3-;K;-$2GE>6I)4 ;<\$DYSWK:HH YYO"%K*?+N+Z]N+/[:;X6DK(4$
MOF&08.W=M#G(&[VZ<5LWUE!J6GW-C=)OM[F)H95SC*L""/R-6** .0M?AYI]
MM+HTIU36)I=(W+:O)=#*HR[=APH&,>F#ZDU*? =@=%UG26O]0-MJ]Q)<766C
MW%W^_@[. <#C\L5U5% ',7?@BSN-0L-2AU'4;/4K.#[,+RW= \T779("A5AG
MG[O6KOAWPS9^&8KV.SGNY1>74EU)]HEWX=SDX_SGWK:HH P==\)V>NZA8ZE]
MJN['4K'<(+RS=5<*WWD(8,K*?0@U2C\ Z<ECKEI]OU)EUHDWC/,I)RH5L?+@
M9 ]/IBNKHH YP^#K4WFAW1U"_P#-T6-H[7YH\$,H5MWR<Y4 ?_7YJ/7/ UAK
M6MQ:S'?:EIFI)'Y+W&G7'E-+'G.U\@@C]?R%=/10!R^K^ ]*U6#30D]]8W6F
MD_9;VTGVSIN^]EF!W;NISG)SZFI;SP9IU]H$>E2W%]\EPET+SSLW!F4@B0L0
M<G@#I@#@  "NCHH Y^?PE:OJMOJMM>WMIJ,4'V9[F)U9IX\YVR!U8-SR#C(^
MG%0WG@?3+S2+?31/=P10W8OB\3KOEGW;_,<LIR=W/8?AQ7344 9=YHK75_;W
ML>IWMM<0Q-#F$QE9%)!.Y60@G(&" ,<^M8FK>&(F\)IX/TN.2.UN?EN)S_!$
MS[Y6)Z%VRP '=LXP*Z^B@#G7T*=?&%CJ5I=WT-I;VI@DMO.'V9EP=H$?7?D@
M[O10._'1444 9>D^']/T6[U.YLHMDFI7/VF<YZO@#CVR"?JQ]:H0^"M+2'6X
M+E[B\M]:<R7D5P5VEB ,KM4$< =^P/6NCHH P;#PK;V<MA)<7][J!T]2+,7;
M(?)RNW/RJ"S;>,MDX)]35*X\ :7=VFNVMS=7TL6M2+-<@R*"LB[=K(0HP1M7
MU'%=710!S=EX,M+/7[?6VU'4[F_BM?LK23W&1*F[<-P  X/88'J":J#X=:4O
MA2Z\-+>ZD-,N&_U?G*3&F\OL3*\+N/U]ZZ^B@#!O?"MM>:E8ZHEY=VVJ6D1@
M6\A*!Y(SR4<%2K#//W>#R,5!?>!]-O\ 09](DGNTBN;D7=S*CKYD\H8-N8E2
M.JKP !@ =.*Z6B@#!N/"MM=:^FLRWUZ;I;-K+ ,84QL06R-G4D Y_IQ19>%K
M>VN].N;B^O+Z338V2T-T4)BW*%)RJ@L=HQDD_GS6]10!2U?2;+7=)N=+U& 3
MVERFR1#QD>Q[$'!!]15"Q\,PVMU9W-U?WNHS6*,EJUVR$Q!A@GY57+$#&YLG
M&?4YW** ,32?#4&D:OJ6I0WMY+-J,BR7"RE"I95VC "@C P.O:K.OZ'9^)-#
MN=(OO,%O< !C$VUE(8,"#Z@@&M*B@#GQX2M_[9TW57U+49+K3XGBB:21&#!\
M;]V5YS@=,8QQBJK> [!])UO3&O\ 4#;ZS.]Q=_-'DLP ;:=G ( 'X5U5% &&
M?#96>*:#5]1@D2U6T8H8B)$4D@L&0C<-QY %:&E:7::+I5KIEC'Y=K;1B.-<
MYP!ZGN:N44 8,?A6VC\72>)1?7IO9+<6S(63R_*#;@N-N>O?.?>K>O:#8^(]
M,-A?J^P.LL<D;;9(I%.5=&[,#6G10!D6>@1VU\VH3WEU>:@8/LZW4^S=''G)
M"A5"C)P2<<X'8 5DGX?::WA&Y\,M?:@=/N96ED^>/?EGWL VSH6YKK:* .8U
MKP19:U?V>I'4-2LM4M8O)%]93+'+)&3DH_R[2,\].M,U>[@T#3[?0+71M1U,
MWL,L:;8S+&S'KY\A/R[BQ)8^YKJJ* ,SP]HL'AWP]8:1;8\JTA6//]XCJWU)
MR?QJ#Q!X9M?$+V$TMS=VEU83&:VN+1PKH2-I'((((.""*VJ* ./E^'.DRV6M
M69O=3$&L.'NE^T;LG !QN!Z[1DG)]"!Q6G+X6@GUG2=5EO[UKG2XWC@YC"D.
M &W#9SD >G3C%;M% '$S?##29-.U'2XM0U2WTF_<R2:?#,HB1BP8E,J64$C[
MN<>U=E;PBWMXX0[N$4+ND;<Q]R:DHH Y*]^'NFWLFM W^I0VNL!C=6D,P6(R
M,NTR ;<[L <9P<<BK</@ZS@U32M02^O_ #=,MVMH%:16!1L;MV5R2=H[]N,5
MT5% ',1^"+./2];T\:AJ'DZS+)-=DM'N+2#:^T[. 0 /;MBBX\#V5Q;Z*@U'
M48I]&!6SNHI$614*!"A^7!! &<C/O73T4 8F@>%[+PY-J$EE/>.+ZX:YD2><
MN%=@ Q&>><#DY/O4^A^'].\/074.G0^6EU=274@/]]SDX]!V ]!6I10!RT'@
M/3+:TETZ.XO!HTD_GG3"R& '=N*CY=X0MSMW8]L$BM"/PW;Q^*Y?$0N[LW<M
MN+5HR4\ORP2P&-N>"2<YSS6S10!QEU\--(N[75+1K[5([/4;G[6]O'< )%,7
M#ET&WN1G!R/0"M.;PG =875K74=0L[W[,MK)+&Z/YT:DD;A(K#())R,'FN@H
MH YR_P#!6EWOAZ'1%DN;:TCF6X)A<;Y) ^_<S,"22WS$]S4.L^!+'6-8AU=-
M1U/3M2CB$$EU83B)IXQ_"_RD'\A^@KJ:* *]E9PZ?916ENK"*,8&YBS'U))Y
M))R23R2<UPFF64]W\4O%DT=WJ-C'-!:)%+%" DVU&#X+H5)4D<CU->AT4 <W
M>^"-*NM$TW2[=[FQ739EGM)[:0"6.09RV6!#$[FSD'.33+?P+I4-QK,TL]]<
MG6;=;>]6:X)$BA"F>,$'!/TSQ@8%=/10!S]AX3MK,Z>+B^O;^/3O^/..Z*%8
M3MV@_*J[B%) +9(R>_-+;^%+>UO]:O8K^]$VK[?M!)C(!5=JE?DXPO'?\ZWZ
M* .1G^'>D3^&=.T,W%\J::X>QNXY0EQ;D=-KA1^H/\JM2^#+*X\-WFBW%_J,
MZ7HVW5U+,'GE'3!8K@#'8  ?B:Z2B@#G[SPA9WMQH]Q)>7R7.E*\<,T4H1G1
MP RO@<@A1TP>."*S/]'\8^)[">31;ZWCT&YED^T7MN8M\N-BB/)^93]_/JB>
MM=G10 5B'PU ?%G_  D?VV\%Y]F^R>7E/+\K=OVXVYZ\YSGWK;HH YC_ (0;
M3D&HP075[!IVI2-+=V$;J(9&;[^,KN4-W"L!]*N/X8M3XFM==2YN8I[:V-K'
M#'L$0B)!*XVYZ@=^W%;=% #9'\N)WVLVT$[5&2?8#UKD-$2W\3^)X?%;:/>6
M/V6S:U@-]!Y4SEFRQVD\!0, ]][UV-% &'>^%[:XUX:W:W=UI^HF'R)9;8IB
M:/.0'5U8'!Z'&??%07O@G2KSP]%HZM<VZ0W NXKB&3$RSAB_F[B#EBQ).1WK
MHZ* .?TSPA9Z9X@EUM;V_N+Z:W6WE:>8$.%)()  &>3[#L!70444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%175S#96DUU<.$AA0R2,>R@9)H EHK%T'Q)%K
M[3B+3-5LQ" 2;^S: -G/W=W7IVZ5M4 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !6?K>CV^OZ1/IMU)<1PS8W-;R&-Q@@C##D<@5H50U?1[76[-
M;:[:=52194>WG>%U8="&4@T <_X335M(U[5/#M]J,^J6=O##<V=W<',RI(74
MQR-_$08R0>N#77U5L=.MM.B9+=7RYW/))(TCN<8RS,23P .3T%6J "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
+ "BBB@ HHHH _]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>19
<FILENAME>insidertradingpolicy006.jpg
<TEXT>
begin 644 insidertradingpolicy006.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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ME P;;^K8_&LC2;K0-1\/W?A?Q3?WJZQ#?2B;3 ^V2>4S&1&BP,MNRIR#]>*
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M76 +FQ18\[9-O#)C"9X.< XX%>@:)K^E^(]/^WZ/>QW=KO:/S$SPPZC!Y_\
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MI%20HH"C'ICZUW9(4$D@ <DFO"[N:Q/P4\92I);^8VL7#;U89)^T@J<_3D4
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M]P2L-FXR5E?!'"XX&0,D9(KAI=0L6@^*\3:E'=--9))'(VT>:/LN-R@ #;G
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M?9VV2^1*'V$],XK0KA-,GMA\:=:BBEBW/H]L656&2P=^WJ 1^&*[N@ HHHH
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M^)M&U?4+BQL-0BGNK=0\D:YSM)P&&1AESW&15Z]OK73K5[J\F2&%< LQ[DX
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M^;$AW!<]S@=^]>N44 >>>(]8A\*_$G3M;U0-'H5SICV:W:H62"<RA\M@' <
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MW(&'3C..OIUFK^-[^T\7Q>%([JSCNXM/:[NKTVSE6?HB)&&)&<@G)/' YYH
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MK&TO=="KB.(^3:Q @,53=DGGC)['-7H/B'J1M/&]C(EJ=6\-H\L4OE-Y=Q&
M2,INR#\N#@]P1Z4 >F45XU9_$[Q/Y?@?4+V+2S9^(;DVTL$,3AT_>! X8L?[
MV<8[=3GCV6@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M9;?2)S;VTIMMV9%4#8!N^9C(P7/8#H<T >GU4U#4[+2K=)[^YCMXGD6)7D.
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MF/S^6" 3CV)Q7#>(AJNJ:CX7T/4;B$2:E=B[O;*-04BB@Q+M#=3\P123PQ/
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MH@<"1,@;E/###'BH=$\*R:1XCU36'U>XNGU)8O.BDC11OC7:&R!Z=OYUT=%
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M!C&> "S8XR<X!.,9KIZ ./@U*Y\1>,_$&C)?7%E;Z1';H/L^T.\DJERY)!X
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MS[U[4ZAT9&&588(]JXM/AQ;1^&[/0AK6I&TL[B.>#=Y19/+;<B_<Z ]SR?7
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M5A(0L60&)7:OS+D9!R33IKGQ!>WOCJ!?$EW;II!1[0Q0Q!@3 ) K$J<KD],
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MQ2^+-6T/Q7>V_BFXAN-'U.[CM%%O%MD6( A9/EY&..,<DDYZ#O\ PWJDFO\
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M9P7* JLT:R 'J 1FIJHZ)_R =._Z]8O_ $$5>H **** "BBB@ HHHH ****
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M9(QZ $#;N/ S[USWB.V^TK\2-:L75]+N-'2'S4.4GG2-LLI'!VJ5!([G'8T
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M<1V=I$W1YI&VKGV'+'V!H V:*SY+R#1[2%;Z\>25SM4E"TDS]2%11D\9. .
M*9!XATBYTHZI%J$+62ML:7.,/G;L(/(;/&W&<\8H TZ*S+;Q%I-TMV4O40V8
M!N4F!B>$$9!97 (![$CFJ47CCPS-)9QQZS;$WIQ;G)"N>PSC )QP#@GM0!T%
M%8UCXKT'4FO%M=4MW-FH:XRVT(IZ-SC*G'4<5!'XY\,3/9)'K-LWVT[;<Y.U
MSS@9Q@$X. <9[4 =!67=:3<W-R\R:YJ5NK=(H?)VKQVW1D_F:32_$NC:U=W%
MKIVH17$]N 947((!Z,,]5/J,BD3Q/HTEY#:K?IOGD,4+%6$<KCJJ.1M9A@\
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M;">V3S)$)(^7.W*]FY('&>>.M2VWBC1+O19-8@U*!K"-BCS$D!6!QM(/(;)
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M':!QC'?@?32^),\VGMX;U61)'TJPU5)K_8I;RTVL%D('\*L<_E7=8 )..M%
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MCP9XBT#5]#\/:-+8&37=+6*)[*6V8/9R1KL:0DC"@#)!SSD#J:])HP,YQR:
M.-^*[HOPPUY68!I+?8@/5F)& /4UFWEY8S?%/PE()X' TNYVMN! +>7MY]2
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MSL+*"5VJ!MY !Z'(Y)JC=ZI97'P1\-1I.I>"73HI 01M='3>.>ZX.?2O9:*
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M"Q;G X&!CN<_3KY;CQ/X!U()?R1I;W,4V+&2*&V=HD B1-H"JI!&>>!RQQP
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M$$9D'0MC)Q[D5N:?J6D>)O$>IW5OK &NWNDMIUK;_99H%51N<MF11N;<<\=
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M\Q.T==N< <D]NM7+KQ%IUHRQNUP\S0B<PQ6LDDBQG^)D52R]^H!R".H-<_\
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MLQ?:,G& ><#IU)( ZUF_\+$\-?8+B[^V3E+:1H[B,6<QEA*\L7CV;E4 CYB
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MK+(8N,Y(52=H');H..:Y34)!XM\)>&-+L898M5M[VTDFA:-E>Q,7^L9P1\N
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M\OS#/3F@#TM@)X"%=D#KPZ]1GN,UYMX'^(&EV7A/38-?UF9[Z:YN(FN+A7<
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MB22W@OIO/FM[BT2?:^T*=C9! PHX.0,5NZ?8)I]L8ED>5W<R2RR8W2.>K'
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MIE8E=I)*G@ -T]:XGP3'K7B'0[Z[E\1ZB+JVU2:&++)L9(Y!A6&WH1P2.>:
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M#:00>F<YSQ0![7'S$OT%<#X6UB#18_&UYJM_.;*QUAP))Y'E*)Y<>%&<GJ<
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M TLEI.6*AO.0!T0$KR./E],=<U=^(]IJ+V.BZEI]I->C2M5AO;BUA&9)(E#
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MO]J$=HH<^2>C]0,'MSDX. <&@#7HKG[3QIHM])HJVLTDJ:RKM92K&=DFQ2S
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M._3I6A<?$;0;>+49 NH2KILIBN_+L9"8< $LPQPH!ZGK@XSB@#K:*R[K7[*
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M)C*]>_I6QI%[IVLC[9!X'N[6\M;:7SC?67E%"4(,4;$98L>.!C&<\X!]!HH
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M1CRC\H/4_(W'7MUKV.B@#SPW\NK_ !+\/ZI;:5JBV T^YB,TUF\85F9" P8
MKT/) SVS5'PM87FF:[H[:!_:D.CW>][_ $?4('":>=A.8W< K\YV[03G)(XZ
M>HT4 >-W-IJ*_";Q7H/]CZF;\WESL1;-V$N^<LI0@?,"ISD9 QR1QGT?6]'@
M\6>#[C37\R$74 \MW1D>*0<HV" 058 _A6[6/KVARZV+58]8U#3DB<F1;-PG
MG*1@JQ()'U'(_+ !E> 3J6H:.-=UJ-$U&]1(R$.0(XP5!!]&8R/]''I76U';
MP16MM%;P1K'#$@2-%Z*H& !^%24 %%%% !1110 4444 %%%% !1110 4444
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M!YJRPSQXZR,P]B"".E &NOB6VDTS2+Z*UN98]59%MT386^92X)^;&-H)."<
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M:6KR22DB,0>9P -VTG=GD#L>:<OC?3C-IA-M>+9:I/\ 9[.^*+Y4KG.W&&W
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M5&< 9SUQSB&&VUK1O#?C+PQ/HFH74MVU[-8W=O&'CG696(RV?E8$G(/)[9H
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MT%Q82V]O!<Q 7$TK*1]Q2=JC(&3UR>@'(!/X>\76@&@Z+-9W\,MW8J;6YEB
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MH^T#8&;<",':#DT >O45SNH>,+.P\1'0A8ZC<WYM#=HD$ (D4,%P"2!G)ZG
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MT[PW#IOB'5-:CO;N6?4O+\^.0IL_=J57: H(P#ZUM44 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %9VNZ/%K^B7>DW$\T,%W&8I6
MA*ABI&" 6! _*M&B@"MI]F-/T^WLUFDF6",1J\N-Q &!G  _2K-%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %<C\1+&]O-#L)+&TENWL]4M;N2&$ NT:2 MM!ZG':NNHH X
MB%+R7XL0ZH^FWD5F^B?93*\?RI*9@^TD9&=O<9&>,US/C&R\0Z[H_B_3KG1-
M1N;HS?\ $M,6!;?9P4*L!N&Z0X;.02,@# KUVB@#SY&U71?B)>:W+HVH7&FZ
MU90)^X0226LL>0%=0> 0Q.02 :Y^?2=:E^%'B#3#H=^E[<ZO)-!"44LZ&Y$F
M>"< *#R< ]LU[#10!Q;QW#?%BVU065W]@&B/;F?R&VB1I5<+TSG:#V]NM<K)
MI]S#X!U2"ZTG4/M;^(FNK1(U"S#=/O22,-PS!<G;['.!S7KU9.O>'K3Q#!;I
M<375O-:R^?;W%K*8Y(GP5R#TZ,1@@CF@#E_#>IVUQXNEOM0TO7;;5[VW%K%+
M?6/DQ%(]S^6A#,-Q^9CD\XXZ8KK]%U&;5=)@O9]/N=/DDW9MKH 2)AB.<$]<
M9^AJOIF@+82K/<:C?ZE.@(CDO9%.S/!VJJJH/;.,XR,\UKT %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M^83N(!)ZG- 'J=N\DEM$\T7E2L@+Q[@VQL<C(ZX]:Q?$OB-O#ITK_06N4O\
M4(;$N) HB,C8#'J3WXKG[;4Y-2\3Z!X?N[F9+5]"%\P25D:XERJX+ @D ;CC
M/.<GI6=XLTR?3= T'3I-:N+YT\3VH2>3!EA5GW*A)SN*AARV<\4 >GT5P_A]
M9M+^)>MZ-'>WD]BVGV]XL=U</,8Y"[JVTL20#@''2NXH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M8D")@$LP5B.64#@]_2K>CWMSJ&DV]U>:?+I]S(#YEK*P9HR"1C(X(XR#Z$4
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M"Y9U+!LG:3M&0I(XSFNEO?!.D:G9WT&H">YDOO+,UR\FV7]V<Q[2H 7:<D8
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MT]<T <CX;L%M/!7CN>TN;V":#4-26)TNY,ILY4C+$;L@?-U/<U<T_6+J]F\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MS=A(714D\J<?NPO&T;N5.[BO4+&"TTK1K:VM WV.U@2.((#(=BJ N,9)X H
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MX!P">30!LS>,]'@FM_,DF%M<77V.*\\L^2TV2-@;Z@C/W<C&:LZ9XDL-7O\
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MJ%)QQWKG_$6CWMUI?Q$U:ULKQX]9AM[>S@2V<R3-''M+[ -P!)P"0.%ST(H
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MW7YV &1P<'DCBK6FVMS)XH\8K!IVK&'4M)A%M/>1./,(24'+/]TY8#:<$9Z
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MO_#7V(O'_:,+++92;E B#L Q!&?E/W=HSVSZ#0 4444 %%%% !1110 4444
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MDT'Q%IOB6P^W:5+++;9P)'MY(@3T.-ZC.""#C."* (/^$5T[_GXU?_P;W?\
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M/+;ND=PJXW>6Q&&QD'CZC-:6I:I::5#')=.09I!##&BEGE<]%4#J>"?8 DX
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MRGKBJOB/1[RYTOXB:O;65X\>LPV]O9P);N9)FC3:7V8W $G ) X7/0BO6Z*
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M!H/L<FYG\_<=HQ\PP,[AQSUS77W;R2_%G2+U+2]-HNDS1-/]DDV*[.C*I.W
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M*WPT?^S=146?_'SNLY/W(^SF/+X'R_-QSCUZ4^%+@'XE$V%^!>9-MFSE_?\
M^CA/D^7YOF&.*],HH \?2.YT9?".L7^A:A?:8NA1:;=PQ6SF:TF7:=QCX;&0
M5/T^F;VKV<EHOA_Q'I'ANXM]-L]5>ZN;&*WQ<2))'Y9G:(<[@<G'WL8)QSCU
M*B@#@M&NFO\ XKW^HPV.H+8SZ1!''<36DD2,RR.2/F (X/?'\J[VBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M3!'+NV[6;_>^4GH#P2#FN5O]:;Q!XJ\$ZA:Z1JZ);7%P;M9;"5#;EH"N&)4
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MY+6_9%M]L1+-O^Z=O4 _IWQ532M2T9_$?B1H+R\^TVP@-^ET76* !&VE ^
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MR,X/%6;3Q1>77Q U#0/[+N%MK2WB?SMT>"7+?.?FSMPN  ">N0.* .JHHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH *H:UI-OKNC76EW3S)!<IL=H7V./<&K]% '/6?AN^
M4JFJ>([[4[9""()8H8PV#D;RB MR!QD ]P:Z&BB@ HHHH **** "BBB@ HHH
MH **** (+6SAM!+Y2G=*_F2.QRSM@#)/T 'L  *GHHH **** "BBB@ HHHH
M**** "BBB@#"C\.,GC.7Q)]M)DDM!9FW\H;1&&+CG.=V2>>GM6[110 4444
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M+J;3KK3W+NGD72@. K$ X!/!QD?6M"BB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MK_NU!/3)S*Q'HWO5G49UM?BG:17%C.;2'3WGL(X+<E);N20B1L@;0X7 RQ&
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M0_O1]G"?+Q\WS<<9YJG*X7P=\,(]DGF6MW9&X7RVS"$@97+C'R@,0#FO6:*
M/%?%E[+J7ASQ5:FPO+:[@U5&6QM;)U1XUGB/VAV5?WC,H)Z]A@<9KKO&ZW=E
M+H_C/1K5YKRU<6TMLP,;7%O.0H0@\@ARC 'IS7>5@R>'[NY\1MJ%WK4\^G(R
M2P:9Y2+''(JXW%@-S<Y8 ]#@]A0!?T;3O[*TBVLV?S)$7,LG_/21B6=_Q8L?
MQKE_&C >,?!;;7*PWTKRLJDB-3"R@L1T!) YKMZ* /,()$%S\36*N!< >23&
M?WP^S!/EX^;YN.,\UU_@4G_A O#Z,&5X]/@CD5@0598U!!!Z$$5T%% '$7+
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M)%$^<;792 ?P)%>83H^O?!ZP\)16TL'B");6S:U:,J]N\4B;I3Z)M4MNZ'.
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MB:S:6*^624R+)OVE ,MR6(QCVK32]71/BMK3WL%SC4K"U%H8H'<2LA<,H(&
M1N'4C@Y/% &ZWCGPVFGZ;?G4A]EU)MEI)Y3XD//^SQT/7'2JD?B30=;UCP_+
M;:S?133O<?9;54DB2Y*JP<2JR_P[21G'->?Z0Q3P!\-H9K:Y22UUB.6=)+=P
M8T E^<Y'W<LOS=.>M=KXJ=1\1O \F&*0RW;2NJDK&'@*J6(X&6X&>M %S2_&
MUEJ]UKT#Q7EK#ILQA,KVLJG 12S$[<*<MP#S@ XYJWHFK:5:^$],N(-3N[^T
MF0);7%P'EGN3R>FW<S8!/3H">@KG_#UP-.USQQ:W<-Q$\MZUTC- VQHC"@#!
M\;3D@C .<]JY:R%SIO@?P#JTUE?S6.EK+#J4%KYBSP[UVA]JD-\I'/LWO0!Z
MA;>+-&NK*XNH[I@+:<6TT3PNLJ2D@!#&1NW$D8&.<\5=T_5;74VN%MS*'MI!
M',DL+QLC%0V,,!G@@Y''-<%<VWA;5=#OKN"PU.WL;^YMPVIJ)DN#*A.R4;P7
MPAV_,1CD]A6SX$FUCS-7M-2O8]4MK:6-;355B"-=*5R0V.&*<#<.OU!H JZM
MK+Z1\5K1+G4+O^SY-'FE^R(&=3()4 *QJ"6;&>Q/6NDLO$^CZAH:ZQ;7F^R9
M_+#>6P;?NV[-A&[=NXVXSFN=O9$3XS:?*V1$FC31-(5.Q7,J,%+= 2 3BN-$
M=ZOAN[O[:RO+F/3_ !=<7\]M '262V8N-Z8P3P^X8ZX/I0!Z+>^(;+5M%UVW
MTZ\N+>_L;=C*AC:&:$["RMM< X..#C%1>%M=CM_A[X<O=4NY)+BZLX &8-++
M/*R X &69CR3]"3TK)MKG0-2TO7-9T>PO/GTYX9;Z[28/(<';$HD^9L'TXR0
M!G)QS]G-<:18?#;6[BWN'TO3[%[2^V1,S6LCQ*H9D R """<<9]Z .H\':M-
MJ7CSQC#]LO)K6W-H(8;D,GD%D<N A V\^W/'7BD\6:P^B?$#PK)-J-Q#I\\5
MY]H@4DHY2-=GR*,LV6X'/.,4SPE=I=_$GQ?<Q0W/V>ZCLC#,]M(B2;8V!PQ
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MGM[^)2AM)/,;Y9 1@*RMT; . ,\T >MZ=J-MJMDMW:,[0L[I\\;(P9&*,"K
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M/.%]#;"Z?=$5386V@ACUY],C@T :M%4M,U./5()9H[>Z@$<SPE;F$QL2IP2
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M9(-S))'/%]^)U8,K*>Q!%0>)O"\7B#PC/X<BG%E:RQI#N2/<412,!1D8Z 4
M5;C6;K4?'$GAJTNGLTMK 7D\\2(TC,[[55=X*@  D\'J.G.>,\2Z]?:G\,/'
M6EZH4>^TB0VS3HNT3H2K(^.S$'D#C-=Q>^%II=?L_$%GJ"6VKPVQM)W-OOBN
M(B=VUDW C#<@AN/>JNH>!8K_ ,+:OH_VYDFUB8S7MWY0+.QQ]U<X4 *J@<X
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MVU?[1BOS S>2FV1/M?DX(Q_=],<UV5MX>GDU>RU36+Z.^N[")X[8Q6_DJI<
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ML]>EAGTNP_LXN+96$T'RXX8D*_RCYN?I7:U2TW4&U%+EFL;NT\FX> "Y0*9
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M*DN/ UO?IX@>^N5-UK=HMI/);0^4JJH8 A26RWS'DD] .,5UE8OB3Q/9>&=
MN=8N(Y[FVMVVR"V 9E.[;SD@=2 : +>C6%QIFE06ES?->RQ*%,S1A,@  84=
M.GO6,OA.X35_$6H+J:;M:ACB=#;9$(1"BD?-SPQSGOZ=*ZBB@#C&\"S'P_X=
MTA=64)H=Q#<12&VR9#$"$##?TP3G'7VJY+X4N9/$>IZPNIQK)?6(LC&;;(10
M20P._DY8UTKND<;22,JHH)9F.  .YK"M?%4.H0&[T[3-1O;'G;=PQH$<#J4#
M,'<>ZJ0>V: ,K_A YAX;\/Z,NK*$T6YAN8I3;9,AB^X&&_ISSCK[5=G\'K>^
M)-1U2]NDG@U#3_[.GM/)V@Q98\-NSGYC_GFMK2=5M=;TR+4+)G:WE+!2Z%&^
M5BIRIY'(/!YJ[0!R'ASP9J&B&"VNO$]YJ.EVG_'I9RPHI0#[H=Q\SA>PX' ]
M!69+\,91X<U+PU:>()H-!NV+16IME=[?+;BJN3RN<\8SSU]?0J* .<?PQ/)X
MJTS7'U,N]C;/;>6\ S('P6)((P<J,8&![UA0_#.>#2-.TM/$EU]ETS4%O;(?
M9XR4PS-M8G[Y^8\\?0UZ!10!S(\'1_\ "0ZOJ+W\LEIJ\"17EDT:XD*QF,'=
MU *GD#OW[54\.^"K_0C!:3>)[V^T>T(-I8RPHI3'W0T@^9PO8<#@=ABMFU\1
M6UWXHO= 6"X2ZM($G=W4!&5B0-ISD]#V%6]5U:QT33Y+[4;A8+>/ +$$DDG
M  Y))X ')H YZ"WL_ 46NZYJ^K+]BOKL74S?9F'E.VU !M+$CA>WOFE\%Z/9
MV]QK6NVD,D4>L79GB20%<1@8W!3RN]M[_1Q5R[\6P:?8-?:CI.J6EF!GSI(5
M8'/3*HS,N?\ :  [XKH: ,7Q7H!\4>&KS13=?9H[M0DDHCWD+G/ R.>*J>(O
M"7_"1Z/902ZC+:ZE8RK/:ZA;)M:.0#&=I)R"#@KGFNEHH \P^(.G7.D_"CQ
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M<#\1^8H Y;P[X1U+14@@N_$MSJ5I9KMLH)H$3R^-JEV7F0@' R0.^,X(I/\
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MG@N5R?EPN"A'KG!Z8K3N/!%GJ7ARZTG6+Z]U"2ZVM+>RLJRAE.4*;0%3:>0
M,<G.<G*6/@Z>#3;JWO?$.I:C//;M;)<7.S=#&W4* N"3@99LG@4 0^ TUB\T
M/3-;U/7)KS[=IL#M:M"BHCE02X(&<D'G/?/08 ZR:,RP/&LKQ%E($B8W+[C(
M(S^%<S<>&Y['P$GA^PU34D>WBCAM[BVV+/M4C:N< #(&">.*Z&PCN(M.MH[R
M42W21*LTBC =P!N(^IS0!XNL=Q_PSM+<2WUQ</-=*<3E6"G[?R<@!B2>3DG\
M*[4ZIJ>@>/Y;*[U2?4+&?1YK\Q2QHOE21NHPFU00I!Z')XZFI6^&]L?"MQX<
M76=1&G23^:B?NR81YOF[5.WD;^<G)[<5KR>&%G\4VVO37TSS0VC6?D[$\MT8
M@MD8SDD#O0!S6FWGBW5K'P]KMC(Y6Z,4][#/+%]G:W=<L$ &X,N1@DY.#NS2
M_&R:>+X:W0C9E@DN(([EE[1%QG\,X'XUHZ)\/8="N5BMM;U1M'CE\Z'2GD4Q
M1MG<!G&XJ#R%SCUS74ZAI]IJNG7%A?0)/:W"&.6-^C*: )H4CC@C2$*(E4!
MO0#'&/:N!\4V17X@>![2PF^QC&H!7C0,8P8E)V@Y&>N,@@>AZ5N:9X7OM)M4
ML+?Q)?MI\8VQ1RQQO+&G91(5R0.G()QWJ6[\*07&NZ-JD=W/ =)658(5"E6\
MQ=K[B0220.N>O- ')QZUKEMX0\=Q'6)I+S09I_LMY)'&9"BPB10PV[2<DC.*
MT!K^HWU[H6C1-<&2XT8:A<20.B22'Y% !;@#)8G'/3H,YT#X&B:R\1VIU2Z*
M:\S-='8F4W)L.SY>/E&.<TS4_ ,%_::.8=5OK+4](C\JVU"W*B39@ JXQM8$
M <8_F: .5\:6_B(?!SQ!'K]VWGV\A$+1F,M/ 739YN%P&&3G;CH*]2M+=[:W
M$4EU-=,"3YLP7<?^^5 _2N=U+P3%JOA*YT"YU6^=;Q@UW=L4,TQR#_=VC[JC
M ' &*Z2".2.W6.68RR 8,A4 GWP.* /,M!_MS_A,OB%_8@L?-^UQ8^U%OO\
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MNQ>:>A>T,**BN3G>"!G..".G/;@"YIGA">RLYXKSQ%J>I3/"UO#-=%"8$/7
M P6.!\S9/'URG_",/I?@'_A'K'5-23R8EB@N;?8+A0",*#@#VR<<'D]Z .GD
M0R1.BNT992 ZXRON,@C/UKQ%X9Q^S[KT\U]<W!>XG&V8JV"+PY;.-Q)ZG)/X
M5[+I<5W!I%E#?S":\2!%GE'1Y H#'\3DURLOPXM9/#6I>'QK&H+IU[.THC'E
M_N0TGF,JG;SEN[9..!CG(!&U_JNB?$.TLKK5I[ZRO].GN'ADB11#)$5_U>T
M@88C!)/N:HZ;J/BW7=(T3Q!ICN#<R)/<P32Q?9C;M]Y% &X,HQ@YSD'/I743
M>&/M'B73M<EU&=I[&!X%C"($=7QNW<9R=HZ$5EZ3\/(-%NV2TUK4UT7S3,ND
M%U,*L3NP#C=LSSMS@]\\T 5/C1<7=O\ "O5VM"XW>6DS)U$;2*&_,'!]B:[&
MW")HL TL0^4L"_9@?N;=HV].V,5/=VEO?V<UI=PI-;S(8Y(W&592,$$5@:=X
M6NM%L!IVEZ[=16"#;#%/$DS0+_=1SS@=MV[% '+Z3XYOM6\+>';JVL8[&37M
M0FB5+=P6C"F5G(9QMW,R=Q_$>]/UJX\8:'X9\5W;WTD-O;VXN=,FE,4DZ$+\
MZ-A=I7/0]1ZUM2?#?1CX+LO#,4UY##82^?:7:2@3PR[F;>&QC.6;MCFI)/!!
MN_#E_I6HZ[J%[-?Q>3->2[-XC_NHH7:HY/.,GN>F #-BOM9TWQGX6AGUB:\M
M]:MI_/MY(D5(VCC5U:/ W#J0<DYS5.TU7Q9XDT"T\0:&\B327!D6&66(6S0"
M0J8V&"P.T?>Z[L]!P.GE\)B;5=!U!]3N#+HR.D(")B0.H1M_'H!TQ6?:?#NW
MT_4KAK+6M3@TBYF,\VDHZ^0S$Y8 XW*I/501GITXH I6I\0:OX\\2Z8GB2XM
M;339+*6%4MXB<.I9D)*_=."/7ISP0:%[XAUBQN-*N4U5[N2?7ULKEK=%^QB%
MY&41*6 )=1C++G# @GM79Z;X;73?$VJZVM]/))J8B$T+JNQ?+4JFW R.">YS
M6"GPRMH],M]-CUW5$M+.^6^LHQY7^CN'+X!*?,,D_>S0!+8?\EFUG_L#6W_H
MR2L[X@.S_$+X?6T__(/>^FD<'[IF5!Y6??).*ZFU\,I:^++CQ +ZX>6>V2U:
M%PI38A)7G&<Y)YSWJ?Q#X=T_Q-IHLM060!)%EAFB?9)#(OW71NS"@#1N((;J
MVEM[A%DAE0I(C=&4C!!_"N2M-1O/$_B;Q'IT.HW%A!I+16\7V<+N:1DWF1MP
M.0,@ =.#G.>-6VT*_P#*$&HZ]<WUN."C0QQF4>CE1R/7&,]\C(J.;PJJ>(KG
M7-,OYK"ZO(EBNU1%=)MO"L0PX<#@'ICJ#0!QMAXQUR_T_P *7$MUY-S+K;Z5
MJ"1QKY<X02989!(SL!X([UI7.L:PFL>/K2/5)533;""YLB8HR87:.1CCY>02
MH^]FMB]\"V$V@:=IEE<W%B^G70O+:ZCVM()@6)=MP(;=O;.1WJ)/ B+<ZW<M
MK6H/-K%JEM<LXC.0JE=P&W@X9NF ,]* ,"RU77K5/ 6J7&MSW2ZT(H+NU>*,
M1'? 7#+A=P;(R3GG/0#BK"^)KJ+Q:=(UJ]O=)OGU$BR\R-3:7MOO^5$?:<.5
MZ\@[N,X.*VF\$1M9>';7^U+H)H+H]L=B9<HA1=_'/RDCC%33>$%NPL%[J,]S
M8I?_ -H)!(B[ED\PR!0X&=@8].N.,XXH YY]3\3^);#4[S0)9H;JVOY;>U4O
M$(,12;")%(+'< 2?3(QC'-Q&D?XS6+S*JRMX:D+JIR ?M$>0#W%67^'\4>NW
ME_IVN:IIUMJ$GG7MC;2*(YG/WF!()0MW*D'W%:?_  C$2^+H?$$=W-')#9&Q
M2V55\ORBP;'3.<@=^U %;Q;KEQIU[H.E6DI@FU>]^SFX"@F.-5+-MSD;C@ 9
M!ZY[5ERZGJVE^-+KPX=1FFM;O2GOK2XD1&EMI$;:RYVX93D$;@2#Q71^(O#E
MIXDLH(;B26":VG2YM;F$@202KT89!![@@C!!J*/PWFZNK^YOI)]2GM?L@N?+
M5?*BSDA%Q@9)R2<Y('8 4 8WP[.MZIH&E>(-4UV:Z%W8C?:&%%0/NR'! SG
M((Z<]L 57O;>XE^-ED!J5Y''_8DLHC4H5&)HP5 *GAL#)Z\#D8KJ/#6A1^&=
M M='AN9KB"U79$\P7=M[ [0 ?RJ#4?#,5]XELM=COKJUNK:![9EAV[9HF8,5
M;()'*CD8/O0!YNLFK:?X7\>ZSINKS64FGZ[>3QQ1Q(RRLNPD2;@201Q@8_'M
MUUQK>H:SXCFT>T^U0QP:=!<N;22-'+REN<OGA0HZ=2>:G/@&%M!UW2&U6[,&
MM7,ES<OLCW*TF-P7Y< <#KG%+JG@)+V\T_4K/6K_ $[5K.W%J;RVV9FB'.UU
M(*GGGIU_"@#6\*_VX/#]O'XC,#:I&665X2,. ?E8@< D8R!QFN)USQ#K&FA[
MV'57N98]<CMV6V13:QP-*$$+%@,R8/)4DANX%>B:;I\>F6*6J2RS%<EY9FW/
M(Q.2S'U)_#L,#BN1E^&=M)IUUIRZYJ<=E)>_;H(5,>+>7S/,."4RPSGAB1ST
MSS0!!(?$&L^//$6AP^([BQL[>UMIH3#;Q%XV??P"5Z9'.>>!@CG.%:^*O%%[
MHWAM7U-8+]]<DTB]D6!"DVP/\^".#\HX! SGZ5JZ;%++\6?$*VFJM"PL+2$,
MR+)YI4/NZ]77CITR<@U#XPTFST2/P7I5C=/;B'6EG>8D,XRLA:5\C'+MR2,<
MXXH 5]2\1Z'KWB+P_/KD]XJZ*VK6-[+#%YL)4E2C +M89&>G2HUUO7M*\%:)
MKMQKLES<ZW%86J1R0(([:27&Z48&2=I)P>-WM@#L)/"L=R-4GN;V62_U*V%I
M)<JBCRH>?DC7D ?,QYSDGV #'\%V%QX)A\+7L\]Q:011Q13$A98_+QL8$#&Y
M<#G'US0!FWU]J>@>.=$TK^T+B[T_6XYXOWRH7MYHTWAU(49!&00<@$<8Z5R:
M:KXPD^&<GB^/Q([76GRW#FV:VC$5Q''.ZL'PN<[1QM( P.,\UZ);Z"MO?V^J
MZMJ3WMQ8PO'!+,B1K$&QO? &-Q"@$],= ,G/%_#_ $-==\ '3[O4)3827EPU
MQ9!%#%?/9@A;&0C#!(ZG)P0#0!<DN]?U[QQ<:59^(+G3;.;18+^()!$S0N\A
M&!E>1A><\^F*N66K:P/$WCFQ?58F33[6VDLGNU5(H&>*1B7*@?+D DGG K=B
M\-)%XPD\1K?3^;):+9FWVIY8C5BPQQG.2><U2N? UI>WGB*:YOKITUZ!+>YB
M 50BHI52A R" QZYS0!B:1K6I_\ "8Z-IIU&]N;34=+EDDFGB15>9-G[V(%0
MP'S'@@*1@@&LCP[JM[X?\"WUZE]<W%Q<:[+8Q^>48(SW6PR9(&6P2>3C..,5
MU]IX&\C5='U.?7M3N;K3(G@5G\L"2-MORD!!_='(Y/<TT?#O3'TC5](N;N\G
MT[49WG%NS*!;N[[R4(7.0V"-Q.,?7(!)I$/B6V\4/]IDD?0Y;;[MW+&TT=P#
MU4H!E2O4'H1Q@5U=<]X>\,3:,_F7NNZCJ\R)Y<+WC+^Z3C. H&6.!ECD\=N<
M]#0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !63XC\0VGA?1Y=5OXYVLX<>:\*AB@) !(R#U(Z9K6K
MA_C#_P DHU__ *Y)_P"C$H [*TN/M=I%<>3)$)%#!),;@#ZX)J:N&\07NK0^
M*/!VGV&J26EMJ(GCG01(X.R L&&1G/XD9 R#C!H6NJ^)8-/\8Z;:7%QJU[I-
MY$MK(ZQB=XG5'91A0I8*7V\=<<=J /0KNX-K93W AEG,4;.(H1EY,#.U1W)Z
M"DLKDWEC;W+036YFC60PS+AX\C.UAV(Z&N"M/$HU/POXFOM'UR]6>SM"XMKR
M%1<6,JH[%75EY!P.N>A /'$ECXBO]1;P9HOVN2*?4M*%_>W*@;W"QI\JY& 6
M9LDXX XQG( .HTGQ%;:OJ^K:;%!<13:7)''-YR@!BZ[@5P3QC'7'6MBO)(M4
MN?">I?$2[%PUU<1W=A%'+.%R/,1$4MC .W>/KMYKJK6U\51>(1_I5PND3VS+
M*;J2%Y8IQRKQ[5Q@CJIX]!0!V-8^H^(H=.OWL_L%_<R) )Y&MX=RHA+ 9)(&
M?E;CVKF_AM)KFM>'M*\0ZIKTUS]HMG62T\F-4+>8</D#.< CTYZ#'/9WRJ+&
MZ8*-QA8$XY(P?\30!@Z5XZT_6+>PNK6QU,6=^^R"Y>WQ&3R!DYXY&.>]=/7#
M_":,2_"704)QF!L' .#YC8//&0>:S?#$_B34]$O=9G\4;6LKB_@6.XAC6!]A
M94:4A00%(!.,# Z=20#TJL?Q/XBMO"N@W&L7D%Q-;P8WK;J"PR0 >2.,D5R.
MDZ_J,'B_1+.2_N[NQOM,FFGEN(U5)98]A\R(8#!3N/! !!! [U@^*+V^\4?!
M#4/$LNH3Q_:_WJ6B!?*2+SPJQD8R3@ ELYW>W% 'J\FH-'K,&GBQNV66%I3=
M*@\E"I VLV<ACG(&.QJ[7(WFH:C%\4M/TM;^0:?<Z7/,8-B86170!@<9Z$\$
MD5QESKGB:'P#KWB+_A(K@W.CZG/'%$((@DR1S!-LGR\_+_=VX]Z /8:*X[5M
M8N%\=PZ/=WK:;I;Z8UQ%<*RIYLX?!7>PQ\BX;;WSDY J?X>7FLZEX2M]0UNY
MDGNIV<J7B2,; Y"L H'#* W/K0!JZIX@LM*NK>S?S9[^YR8+2W7?+(!U..BJ
M/[S$#WJ.+Q) =5M=,NK*]L[VZ#F&.>,$,%&2=Z%D_#.>>F*Y+PT[3_&[QHUY
M_KH+6TBM W:$KN;;[;L$^YKO;[[/%#]LGC#_ &0-,AQRI"L#CWVDC\: +-%>
M83^(=<;X7Q^.[?47^UJGVQK(JIMVBWX,6,9X7^+.<CTXK16\U?6/B!=:5%K=
MW::=+HT-[&D440DB9Y&4A6*GLHZ@]\8H [ZBO'SK_B5/ABOBF37YFO-.N_(,
M*P1K%<JMSY1\P;222O=2H'IGFNBNWU[4_B+JF@P>(;BQL5TV*Y0PP1%XV9V4
MA25/'RCKD^F.M '3>(_$5MX9L(KR[@N)8I)XX/W*@[6=@H)R1@9(JV^H,FLQ
M:=]ANV62!I3=*@\E""!L+9SN.<@8Z"O*=0UG4]6^&%U#K,BSW^F>(8=/EN%0
M*)S'<QX? X&01^5=M/J.HQ?%:RTP7KG3I]*FN#;%%P)%D10<XW=">IH ZVBO
M,&\0ZQ:77AR?^U7OFO=9-C>20HOV)D;S,)'D!B5"K\RY&0P)/2I);GQ!?:IX
MZM4\1W=O'I/EO:&*&+<"8/,VDE""N3Z9/K0!Z717 :1XGOO$-QX7TU[@VKW^
MB#5+N6$ -(WR+L7(.T99F..>!CO4MYJ&O:#%I>C7FH"]N]1U.2"*ZB5$D6W"
M-(H.X;?,^4+G'?/6@#NJSM6UNQT6*%KN1O,N)!%!#&I>29S_  JHY)_0#DX%
M9?AN+Q%;:KJ<6JR&33&*/8&>1&G3CYU8J,$9Y!Z^M<]J+._[0.CQW.?L\>B2
MO: ]/-+D.1[[ /PH ZM/$UM'J%M8ZC:7>FSW3;;;[4$VS-C.T.C,H;_9)!/8
M&K&J:U%IMQ;6BP2W5]=!V@MH2H9P@!8Y8@ #(')ZD5R'QK&/AE>2QDBZBN+=
M[4K]X2^:H!7WP33-4LKJ;XM>'B^HW4,DFEW+$1^7B,@Q95<J>">N<GT(H VU
M\<V\UCYUKI&JSW26QNIK$0JEQ"@9E^9689)*-@ G...V=?0M9_MVP:[&GWUD
MGF%$2]A\MW48(<+G.TYXS@^U<AI-C,?C!XB/]IWGRV-H^,1X8%I,*?D^Z.V.
M?4FJ=IXNU:T\.ZD;B^,]VWB=M'M[F6-1Y,9E5 Q4  D+D],9ZT >FL<*3@G
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 5B>*_#D7BSP_<:-<W<]M;7  E, 7<0&#
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MC!QD$$$<%2""*UZ* ,"3PS_:%]:76LW\E^+.036]OY:QQ+(.DA4<LP[9.!U
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MBBB@ KE/B/K.H>'/ VHZUIDRQW5H$95>,.KY=5((//0GH:ZNN#^,TB1_"?7
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M^"_[5A-J]MYQN/LB[\["V,9QC(KM+76CH5A''XMU:QANI+B2.&9L0K.N[Y,
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MO=B7)8+U&"NX,.P&1C!H ]XHHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ J.6"*8 2Q))CIO4'%244
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !116-J'BK1=+NIK:\O"DL$8EE"Q._EH<D%BH( X/
M7TH V:*P;7QIH%Z\"V]\7-PA>#$$@\U0NXE<K\W )XJ_HVLV/B#28-4TV8S6
M<^[RY-I7=ABIX(!Z@T 7Z*I+JMHVMOI 9_MB6XN2OEMMV%BH.[&,Y'3.:NT
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M9OM[1^:(O*?E/[V<8QGC.>O'6@#0HHHH **** "BBB@ HHHH **** "BBB@
MHHJE9:K:7]Y?6MNSF6QD$4X:-E 8J&&"1AN".E %VBJ6HZM::4MJUT[@75PE
MM%LC9\R/]T':#@<=3Q5V@ HHHH **** "BBB@ HHHH ***I:AJMKIBQ?:&<R
M2DK%%%&TDDA ).U5!)P!F@"[15#1]9L->TR+4=-G\ZVESM;:5(()!!! ((((
MP?2K] !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5A>+(8X_!OB-
MT0*\NGSLY'5B(B/Y 5NUFZ_I\^KZ!?:;;SQP/=P/ 99$+A0RE2< C)Y]: ,G
MP##'+\//"SN@9HM/@="?X6\K;D?@Q'XUP7A+6=;\/_#;POJ,$UF=-:^%K+:M
M"QD=)+AU+A]P ()X&T].O8>F>'-(N]!\*V6D-=0SRV=NL$<PB*JP50 2NX^G
M/-<Q'\/;^+P)IOAD:O;'[#=K<BX-HWS[9?-"[=_')QG/2@#5&O:HGQ#O]#98
M);2+25OH$C0K(7,C)M+$D'[OH.M4_!OBV7Q+<0%=2MFE2!O[1TYX#%<6DWRX
M !.=@.X9(/;GM5^3PS?R>,KK7_[1A03Z8-/$20L&3#,X<-NZ[F/&.E,MO"=Q
M)XCTO7-4N+22^TZ"2'S[: QM<[E"YDR3@ 9(7GDYR.E '5UXAH-AJ?B#X.7_
M (?T[2&N)+V^N(Q<RRQK#%^_)W'YM_&.R]:]LE$AB;RBHDQ\I<9&?<5SG@?P
MQ=>$M$?3+B^AO%,\DRR) 8R"[%B""S=S0!3TZ^OFU?\ X1&QO41]'TVW-U>2
M1>8\DC#"@ G&,(6)YZ@<=:Y?Q1XBN=?^$WB2*_ACBU'3-0CL;KRL^6[)/%AU
M!R0""#@GBNTO/#-S%XN/B32+N*&YFMA:WD$\9:.95.48$$%67IW!'''6L_4_
M #WG@_4M%@U".*ZU2\^VWEV\!8-)YBN=J!A@?(J@9. .YYH OZAK>HVGQ"T7
M1E-N=/OK:XE8>6?,#1A?XLXQ\WIVJC8ZYXC\0:'!K^ABS>"6[*QV4RXWVZR%
M&8R9X?"EA@8'3!ZUHWGAV^O/&&C:\U];JNGP2PM (&_>>9MW$-NXQM&.#65I
M/@C5]#GN-/L/$"Q^&YIWF%H;;,T0<Y:-)-W"DD\XR,\8/- %NW\0ZA8^.M1T
M;6I[5+(V?VW3Y5B*%D4D2AR6(+)QT X.:VO#T^H7>AVUUJ107$Z^;L2,IL1N
M54@D_,!C/OFN5\3QZ%XTUW3-(MKU9M0TZ]9KI8'^:&'81*DGHKY5".Y/L:[Z
M@#GM0UFYE\66_ANQD2"9K)[Z>=TWE8PX1549QDL3R> %Z<\9<OB+7M-ATC2]
M3BLDUK4[^2UBECRT7DH"QE*YZE0/ESU/X5:\2^%+[4=<L/$&AZHFG:O9QM 6
MEA\V*>%CDHZY!X/((/\ ]9FI^#;G4]/L)9=6)URQNQ>PWQA^3S,8*>7GB,K\
MN,Y[Y)SD KR>(]7T[Q+J/AVYDMII_P"S6U'3[MH2 0IVLDBAAD@X(((X-95C
MXO\ $O\ 9/@[6[R73WM-:N(+2>UC@8,IE5B) Y;L1]W;T/4]:Z4^&KJYU&\U
M>\N;<ZG-8&P@\N)O*@C)+,<$Y8DX/4< #U)RQX$U!?#/AC1UU6V_XD=W#<B4
MVK?OO*! 7&_Y<YY.30 SPY)K-QX_\912:G$Z6TEO'&KVY(56A+J!AA@ N<]S
MZBL^/QQXAF^'GA[7D%A]LO\ 4UM+B-HF"%6N&C&T[OEX Y(:NHL_#=]I_BW6
M=9MM1A^SZF(GDMGMR662./8,/N^[C!(QG/<=\2'X>ZA#X,TCP^-8MB=.U!;T
M3FT;]YME,H7;OXY.,YZ4 6K;6]?M_%.L:#?75E-)'IJZC:W$-L4"9=E*,I<[
MAE>N15./QGK$GA#P9K/^B"76+ZUMKN/RCMVRD@E/FX(QWS6Z/#5T_C>?7YKR
M!H9M.%@ULL)!VAR^[=NZY8\8Z5S\'P\UJ/0M%T=]?M?LVBW\5S:,+([F6,DJ
M)/GY/('R[>_7L 6M0\3ZY?C6SX>A+2Z9<-;0PFU,BW,B*"P9MPV@D[1CIC))
MS@1ZIXVNK/4[:QOYHO#\UUI\<]JU[%OADN6W;XGDR -N%XR"<YST!LOX.URP
M\1WVH>'_ !#'8VFIR":\M9K03!9< &2/YA@D <'(SZ]*N:MX7O=1M+S36N[6
MYTNYM4MQ#>PF5HG (\T-N^8G(.,#D9S0!TUN9#;1&7'FE!OQTSCFN'%SJ8^+
M]]%)J2"QM](CG$30Y"(TK!@#NZG8"6Y^G%=CI=@FE:19:=$[R1VL"0*[G+,%
M4*"??BL:X\,W+^.!X@M[^-(9;);*ZMI(-Y=5<N"K;AMSN(.0>/?D &!-XPUI
M_ 7_  G%J+9K1<W!TYH^6M@^/]9GB3;\V<8[8[UWUK<1WEI#<PDF*:-9$)'8
MC(_G7%VO@*ZM?#5QX374XV\/RNP0&(_:(X6;<T0;=@]2 V,@'IWKMXXTAB2*
M-0J(H55'0 =!0!P?C#Q3K6@Q:Y=1RVD*V$*365OY9F:Y7&7:0*<QKG*@\#(S
MDYQ4U_X@\0W'C&PT72Y-/@@OM*>\66>%G:%@R#D!@'^]P/EZ]>,&/5/ 6I7S
M^*((=<BBL=>7+J]KOEB<($ #[L;.!QC/8$=:HRVVHV?Q1\/6J7EM+>0Z#,LC
MR1%5E D08 !)7VZ]/QH JS^/?$MEX;U@7$>GG6=&U.&RG81MY<\<K*$=1N^4
MD-GG/TK=@UWQ'I/C[3]$UQ["YL]8AF>TEM86C,,D8W,C98[AM/7C)[#I6+X]
MT+^Q_ .K7$ETCZCJ6J6MQ/<;,*&\Z-5"KG[JJH')YP3WKL5T&ZN_$-IK6ISV
M[SV$$D5I%#&0BM)@/(23DDA0 .PSR<\ '$Z->ZUIGP\\1ZCH(@>[M-9OYC#-
M$7$B"4E@,,,-C)'KC'>NTM=;EU;4M(72[F&6RGLOMMRYCR2C8$>.?E+'?Z_<
M:J&D0VGP]T:Z_M_6K);>\U"69)G3R5#RL7*<L<]_P%/^'N@6^B:)/+;+*L5[
M<R36Z2YS%;EV,2 'HH!W =MYH Z>]$S64XMIA#,4.R0IO"G'7'>O-/"OB;4K
M#X=^&))KF*ZU#7+E+>!I8S^[9V=G=\-\_ )P-N3@5ZBRAE*GH1BN MOAQ<Q^
M#]/T2764,^DW*7&EW<=KM,+(Q*[UW'?D,0>0,8[\D U+?7=0T[QW%X;U-XKF
M&]M&N;.Z2/8P9#AXW&<'@@@C'I[UT6HK>OIUP-.DACO=A\EID+(&[;@"#C\:
MRK30;B3Q#%KNJS02WD%L;:".W0JD88@NW))). .V ,<YS6M?W]II=A-?7TZ6
M]K"N^25SA5'J: .0T;Q5J6M>%]'DBD@BUNZO/LMW$T)*P/&6,X*[LC"J<'/4
MKZU+#KVLZ_;Z]=:)-;0KI=U+:6\4T)?[1)$!OWG(P"Q*C'(QGG.*;X3TS3;K
MQ5K?BC3)3+97C*D#*V8G?:OG2)VPQ6-2>YC-6+;PGJ&D7^M-HNHP0V>KRM<R
M13P%S;SL,.Z$,,@\':>A'7M0!G:7XZNM9U+P;+:I$EAKUM<R31.A+Q/$@.%;
M/(W$CIVJKJ/C/7K3PWXUNXGL3<Z%=F*!G@;:Z;$;D!_O?-UZ<=*U;GP*]G%X
M9/AZ\AM)= 62*$74)E26.1 K[@K*=W&<@]:I7'P]U&XT?Q3I[ZY"PUZ;S6D:
MT.8CM53C#C/W>!V]30!U.A#7&$\VKW%E)'-L>VCMHF4Q K\RL23NY[\=^!T'
M/?$&;4XM0\*165^MO%<:O'%(ABW!SM=@3R,@%1QQSWXKL;**:"Q@BN)$DF1
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M7 .>F23TZ5?N/!^H:_X;O],\4:PMW+=Q"-7M(/)2#!#!E7)RVX*22>P  YR
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M7*L=PVK\X7CGJ<]J6Y\&ZM=Z!X?T^;6+4RZ1>6]UY@LR%D$(PJXW\9[G)YZ
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MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *X?XP_\
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M![8EHY=@0Y;=RO&<8!SW]0#&TGQQ?ZCX>\'JP@75O$)?+[#Y<2HK.[!<\G
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M;5(S;MN@;=L=A\WRJLA53G/WA4WQ$NKN\^'WC-WDC:QA3R+<+'AB5*[R6SR
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MEJYC(GC0AT5P2 1@]#P<9[XK@I?%_B1?AC<ZVM[;_P!H0:JUJS&W&UD^TB(
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MMZ6OVLAHF5/+W!<ACP>3VST-:M>?V5M=6OQN9+B^DO%/ATF-Y4174?:!D'8
M#SST[ULZAK5S<^.8/"UI<-:8TYM0GN$56?;Y@C15W J.=Q)(/0>N: .F=UC1
MG=@JJ,EB< #UK#L/%FGZCJ5M9117:F[MS<VDSPD17$8QEE;\0<-@X(-<I<:U
MJ>H^'O'6A7UT5OM$A<?:H8U'VB%X6=-P((#8X.,>V*Z7P+!-%X$T027<DV_3
M[=DW*H\L>4N%& ,@>^30!I:SK=EH.D76IWK2?9K52TOE1F1E &>@Z<>O%7+6
MX2[M(;F+/ES(LBY'.",BO(XEO7^&_P 1Y;O4[B[*76HP8E5.=BA0V0H.< #
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MU'B?PW)K_P#9DUMJ#V-WIUV+J"41"12=I4AE)&00Q[\5OT4 <--\/9I;?Q+
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MQ/;AEN,H4V&-2H50,8 /50>23GH:* ,;P[X=@\/0WPB96DOKM[R<QQ^6F]@
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M>;'-"QR4=<J2 >001@^M=!10!S3>$LZ1KEN+T?;M;W?;+LPYZIY8"INX"J
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M&[<QEN^ ?Y86]\ M<7VO/:ZU-:V6M6JV]S;+ KE=L?E@JYZ#;U&/H10!2O\
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MD5@Z]JVJZI\)_&:W=]=I)INIR6B,=BR/"&CPDA48/#D'&,X&>^0#V6BN,O\
M4=07Q-;^&;>YOIRNGM>RSQM"DSYDV*,D!0!SG S]WWSB:E?^--*T30X[[44@
MOIM?BL3($C?S[=S\ID & V."%QT]Z /0;W4#9WEC;BRNYQ=2&,RPQAD@PI.Z
M0YX'&,\\FKM<%?R:[X?U[PG82>(+B^BO;^:.X,L$2F1/+=U!*J.F .,9Q6=X
MK\1:SI-EK.HV^JM-/8ZC"L<5K&K6\,#/&OES%EYD.YB0I)&5Z"@#MF\16J^+
M(_#A@N!=R6K7:R%!Y916"D9SG.6':MBN*O/^2TZ5_P!@.X_]'1UVM !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !6=JFFS7\EG-;7\MG-:RF12BAEDRI4JX/5><\8
M.0.:T:* .2NO -E<Z)=V0NYH;JYU :FUW$JADN05(95QC V@8.?<Y.:?;^"(
MAKL^K7^J7E_+=:?]@N8YEC$<R98G("\?>QA<=.<DDUU5% ')>'O QT Q0#7M
M2O-.M3FSLK@H4A],D ,^WL"<#CC(!$3?#^%_#FMZ(^JW1M]8NI+FX?8F]6D.
M6"\8 R!U!Q7944 00020620&8O(B!/-*CD@8R1TKDC\.X6\'3^&3JUW]DFN3
M<-)L3S-QE\T@'&,;N>E=I10!SLWA7;X@;7;#4)+/4)H%M[LK&K1W"K]UF4]&
M'8@]..:K77@2SETW3+&"\N+=+"_&I>8 K//<!BQ9R1SEF).,>V *ZNB@##M?
M#@MO%MUXA-]*\US;I;/"44($0DKCC.<D]^]8OQ;9?^%8:U%G]Y+&JQH/O.=Z
M\ =S7;44 8%GHD=W?:?JUWJ)U$V<;"S8*JJN\8:0X^\Y'&>!@G &:Q+SX:07
M>F:OI7]MZA'I>HW#7/V5!&!$[.';#;=Q&0< G ST-=U10!SMQX6=M?BURTU:
MXAOQ9BRE=XT=9HPQ8$K@8;))R,#VJOJ/@6ROO"TF@I=W$$4]P+JXN%VM+-+Y
M@D+,2,9+ '@=.!@5U5% &#/X:-SXIT_7Y+^7S[*!X%B"*$=7QN)[Y.T=#Q67
MI_P^ATN_G%GK.HQ:-/,;A])!3R=Y.2 V-P0GJH(![\<5V5% $-U"UQ:RPI*8
MFD4J' !*Y[X-<G'\/X8="T'2$U6Z$&B7275LQ1-S,F=H;C!'S'IBNRHH P+?
MPTUMXFU'78]1E^T7T"0/&8UV(J9VD=\_,>IYK/M?A]I\7@N7PK=7=S=V#,TB
M2-M66)RYDW*R@<ACD<?F*Z^B@#!MO#DGV^UU#4=1DO[RRB>*UD>)4$>\ ,Y
MZN0 ,],9P!DU#H_A(:-H%_I$.I7$D=W)+)YLB)NC:0DOC  ZDXR.*Z2B@#D#
MX#C_ + T+2!JMR(=%N(KBW?RTW,T?W W&".3TQFI=0\#VVJZKJM[=WUPRZGI
M_P#9\T**JJ(^2"IQD,"Q.3GZ5U5% '(6G@4P:GHNH3Z_J5S<Z5$\*%Q&HDC8
M*-I 7_9'/4^O3#X_ L4&EZ[IL6JWJV>KO.S1$(1!YW,FSY<G.3C=G'YUUE%
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH ***P/%VNPZ+I(C^VP6M[?2+:VCRL %=R%WX/4+G<?ICO0!SFB
M?$9=3^*^K>%I%V6T<*_87*X\UTSYA'J#DX[8C/K78ZQKVEZ!;1SZI>);I+((
MHP06:1ST55 )8^P%>*_%/1K[PE+X8\6VEY8R3Z6\=M'%;P-$TD0R1G,C;AU!
MQ_?K2\=ZQ;WGBSX>>+5F#>'1,2\Y^Y [%?O_ -T_7IM/I0!O>"_&.HZW\3O$
MNCOJ(N])LXD>US$JLI.W()"@Y!)&#R,<\U0^)WQ-33O#/VSPGKD9O(KP0/MA
M#QR#!W ,RD,00/NGC/-8>C3'5OB=\2!I$N9;W2V2RD7Y1(YC7!4]^>0>XYZ5
MR&J:E92?L]:9H2'_ (FUIJ;+<6FP^9&=\IRPZC(8#GKR.QH ]PU'6;Y/B1H>
MGQ>(+*VM)+9VN-,EA/G7#;6(9&VXP,=F&-IZ]*9HOQ+TK7?$FM:7;.RQ6 1(
MY3"[&63#F3@#H-HQT)Y]JY/Q#>VLGQ^\$3)<1-&+!@6## +)+M!],Y&/J*7X
M=W4.E?$/XCVM^_V>:>^,\:R C,>9FW^RX(Y/'(]10!UG@CQ$_P#PA-QJWB'Q
M/INI)!<2;[^W7RXD3C"G*KSSZ=P.:Z+3_$>E:H]Q'9W1>:W0/+ T3I*JD9!\
MM@&P1T..>U?-MA97M_\ L^.EDKR"SUW[1>PQ\L(=@&2.N,D'\,]J].M'.J?'
M^36=,GCETFTT<)=W4;@Q9.2%+#C/*MCT% '7?\+,\&>3'-_PD-IY<DODAOFP
M']&X^7KU.!U]*VM2U[3=(9$O+G;(Z-(L4<;2R,J_>8(@+;1W.,"OF*&2'_A0
M6M1;D^T/X@#!,C<5V+@XZXX;\C7IGB/6=.B\=^%(H[:2._N-*.S5HT>8B,JW
M[N.-<JS$YY(.-W0]@#H?'_C-[;X7W'BCPKJL;;'C\J:-5D5@9 C A@<=3Z$$
M5V.AW,U_X=TV[G?,\]I%)(P &69 2<=.IKYRT^>-?V9M9LW;;<KJ:KY3 @Y\
MR,X&>IP"<>U?0GA.6.3P;HLB2*R?8(?F!R.$&: .$\*>*-?U+XQ>(/#EYJKR
M:;IL;21)Y$09OF0 ,P7.,,>F.U=5/\2?!]LEPTVNVZ?9I/*F4J^Z-LXP5QD<
MC!XX[UYSX%O;4_M#>+I!<1>7/ R1/O&)&WQ<*>YX/3TKF1<6S:#\82)8BT]^
MIB.X9D4W#X*^HZ=* /4?BAX^D\,Z%ICZ/<1^?J5Q&JSA-X6%@277@J3P,9SU
MSBMC2]9.A6BQ^(-?74)KZ:2;3Q%:,)FM\!@#&BY;:.2VT8[UY3XWNH'^$'PZ
M03QLZ36A90PR L1#$_0\'TKJ]1)TWX_6.M:E<)'I-SI+1VEU(X$08 DKN/&>
MK>X- '?7'BW0;708M<EU2 :7*0%NE):/)..2 <<\<]^.M0+XY\,R37D4>L6\
MCV5N+FY$>YO*B./F.!T&1GTSSBO"1:7EG^SKKKWBM%%?ZJLUC%)P6CWQ\J#V
M.UC]!FO4[VSTFT^"E[=VL%I&[^'6A^T(JAG_ ') 4MU/S'IZGUH W8OB+X0F
MGM(4U^T+7F1 <D*Q';=C /L2#R/45>T?Q7H7B"ZNK72]2BN9[3'G1J""H/0\
M@9'N.*^?;N6U_P"%9_#*,O#F/4W:921\H\T[BP[#D9S7::3>6H_:"\:RDB>!
MM) V1')E*QP[E7U;AACZT >DQ^,_#TM_:V2:G'YMVS);,481SLIP0DA&QR#Q
M@$\UDW'Q'TN'X@IX65B62!GN)C&Q"R94(@P.>I)/0<#UQX>=4M+NP\#W5E!)
M8Z=::\<6:QR,EHOFJWS2L"7<X).#@#L._HPG33OVE)[B[W117FDJENS(?WK?
M)PO')X/Y4 =5X2UN[OO$'BG[9XBL;ZRM9U\FWCB,;V*?/E9<J.?E[D_=)XZ5
MM:;XMT+5KJ*VLM02269&D@!1D$Z@X+1E@ X'JN:\1L8+G5Y?C'9Z2_F7=U*K
MP)&V6F19)2X7'WLJ<<?WAZU<A#ZU>_"&VT5Q+<Z=#YE\(CDVZ+Y0</C[N=CK
M@]3Q0!ZK=?$/PG8O>1W.MP1R6;;;B-E;?&<XY7&?TKH+.\M]0LX;RTF2:VG0
M21RH<JRD9!%?/[7%M_;?QA<RQ9DM&6(EA\WW@0/7DJ/KBO4OA)(LGPLT$*X8
MI 5;!Z$,W!H [6N<\>7][I/@G5M3TZZ:WNK2W::-@BL"0.A# \51CT+QNOB/
M[6_C*%M*^TF3[#_9D8/D[L^7YG7IQNZ]Z?\ %">*'X:Z^)940R6;H@9@-S$<
M >IH XW3_$_C&3X0V_CB'5DNKN-9)KFRN+:,1/&DK*=I0*RD*N>IZ&M'5?'T
MNM^ =$US1M<L] EO+I5E:]B,B_+D/$"%(SD9'0D#M7+:!KUI%^SI'HEJXN]9
MNK>XM(]/M_WD^Z25QDH.0 K9R?ZUD>,?#D_A#X)^&=)OV5=0;5EN9H@P)3*R
M$C_@(*@GIF@#W2_\7^']+U-].O\ 5(+6[2$SF.;*_NP"2V2,$<'\L41>+]!G
MTJRU*'44EM;YBEJ8T9GF8$@A4 W$C!S@<8KS77FL+[]I/PZ97@F@&EXY8,I<
M^<5'IGE2/J*;\00GA7XF>$-48R:9X=@@EMA-9PILMI'W9.TJ5&=RYXY ..E
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M[87Y@3VS6[IF^Z^,OC+7;69&T2/2U@ENE8&)Y?+C( ;H2 &SZ?C0!WEMX_\
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M4-C93WEP^R""-I9&/\*J,D_D*\]\!^(];^(L.HZU]OETG2DN#;6=M;11-(V
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MA@>H(S2T4 & 1C'%(JA5"J  .@%+10 8XQVI%544*JA0.@ Q2T4 %(%4$D*
M3QD"EHH **** "D95888 CT(I:*   #H**** "BBB@!" P(8 @]0:    !@#
ML*6B@!%547:JA1Z 8H55484 #KP*6B@ HHHH , 9XZ]:0JI8,5&X=#CD4M%
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M4RZM9OK4FD"1_MJ0"Y9/+;'EEBH.[&,Y!XSF@"[1110 4444 %%%% !1110
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M,9]J -.BJ%KK5A>ZE=:=;SE[NUQY\?EL/+STR2,<]1ZCD5?H **** "BBB@
MHHHH **** "BBB@ HHHH **** "BL[3M=T[5;V_L[*<R3V#K'<J8V78S#('(
M&>.>*T: "BBB@ HHHH **** "BBB@ HK.TK7=.UJ2]33YS*UE,;>?,;+LDP#
MCD#/!'2M&@ HHHH ***I6VK6=YJ=]IT,CFYL?+\]3&P"[UW+@D8;CT)Q0!=H
MK-U/7M.T>:QAOK@Q/?3K;6X",V^1N@R!@?CCI6E0 4451U?5['0M,GU'49O)
MM(%W22!&;:/HH)H O45'!-'<V\4\1S'*@=3C&01D5)0 4444 %%%% !1110
M4452U35K/1[1;J]D9(FE2$%(V?YG8*HPH)ZGK0!=HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M?-U.0<]L<WH?"VHW<.C6VN7]O=P:1,D\;10E'N)$4B-GR2!C.2!G) Z#@V-
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M;N>6/&*R[7P \GA?7=!U2_CFAU6[FN_-MXC&T+NX<8RQSM8 B@"UINJ^(O\
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MP,D'CN <=U0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MC6/]HVMP8F\NXAVDX9 W# J5R#@]<=JDM/$GB&'6?"?V^2PDLM>B8-##"RO
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M*J:7+=3:7;2WFS[1)&'<1QE ,\XVDDC'UKD+J;5W^,D%I%J,:VBZ*\Z0O 6
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M),^HP66@BPO5MEFUNSAE!BW;P901DY' (!('7ID=Z%W%JK_%\16=U:QWA\-
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MJ>WGR/E=220OWL<=CR:ZZ@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M8EBZMN.&R3VQC\ZI6G@+4(+CPY/-XD>630D>*';9HBO$R!,$9.&P!SD]. *
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M7C)SR*2_^&UQ>:=KVF)XAEBL-5O#?"/[*K-%*75SEB<LN5&!P1ZUK:IX5O\
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M0VMPL0F!C'\+*2,]^_\ $<YS5CQ3\.T\7>&X+#4=7N#J4$WVB+450 I)C'"
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ML+5)DD<#&]-Q^1L#K@T 9^L>,+_3+VR@UZ:3P\EU81O'=")9K=;PEM\4CX8
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 P11A]XC0-_>"C-/HHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ IBQ1HVY(T4^H4"GT4 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%-EECAB>65U2-%+,[' 4#J2>PH =16?I>KPZO$+BTAG-HPS%<.H591ZJ"=V/
M0D $<C-:% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
' **** /_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>20
<FILENAME>insidertradingpolicy007.jpg
<TEXT>
begin 644 insidertradingpolicy007.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M*DQ@-C[K'CGD8//IS2ZAH8U/Q;X=\7ZG<64MU?R2+ S;5N[=PHCV?*2QP N
M<\#%=GXA\+Q^(/AV^AQ)+#)]D3[+YK9DBE0 QY;U! !/UH N>()]0.H:18:9
M>FVGN9V:;]TK_N$7+MR.#DHH/JXR#5NZ\0:/87)MKK4[:*96565Y -I;[H8]
M%)[9QGM7._#V]OO$>GKXDU2V>"Z>!+-(W&"/+_UK8[;I-W'HBUPWC?5]/NO#
MOCZTMY(=/GBN@);,?-<7;J(_WS!L[8\ 8V@?=R3SB@#UN\\1Z)I]Q-;WFK64
M$T,7G2QR3J&1,@;B,\#+ >^:SM8\<:'I.@6VL"]AN+:[E2*V:)P5D+,%SD=
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M9"P& /0=<GCK0!U](54D$@$CH<=*RK;Q-H]WJ,5A#>J;B=#) K(RB=1U,;$
M.!URI/%<M\3/%<>G>"]7;2M6FMM0MB$$L$191)D9C+E2H;!Z9#=* .^"J"2
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M_:$2;59)I5B1@ZP.D2B4''KDCUQWK8\%7>JIXBO=+N=4MM?L8[2.2#5XE D
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M]LS.B;,X*%70KU)(.1DDUK:7IK6 GEGF%Q>7+B2>81A Q "@!1G  '<D^YH
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M)))80&M[8!F(^8" JP![X. ??BI?"%CK>H_#OPS_ &/XB33!#8I'.C62SDN
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MRZG--I]DMH8EN%$?V?<DA<$%5(Y'\0SP,UP_A[4#I&A_#75[TL-'LH[FWO)
M"1:S.-J,X[=QD],^]6]3D?7-1^)2:&'NI;JSL'@\I6Q<*B$NJL!@Y7@8ZY&*
M /3[?Q1HUS=O:I?*DZ0^?LF1HMT7]]=X&Y?<9%0Z;XS\.ZQ>6]II^K07$]Q&
M\D2)GYU1MK$'&."/Z]*YGP_J_@[Q)J^GZK8)?3:C8QR%Y+J:X_T!64APY<[<
MDX&.?4<#-6/A$;<_#VS6/9YJ3W/F ##*3,Y&>_(VGZ8H WO%OB>V\)Z#)J5Q
M')(=RQQHB%LNQ &2!P,GJ?YX%8&J>)&LOB#HSOJDT6CW.GW,KP2)L7>C( <;
M0Y)W'@Y]A5CXKH[?#K4&1&?RY;:1@JDD*L\;,<#T )_"J-[J5A??%?PQ=13Q
MM%_9UWM=N.6*;>OJ <>HZ<4 ==9>(M(U#1CJ]K?Q26 )4S<@ @X*D'D'/&",
MTVV\2Z/=B]V7JHUBN^Z2=&A>%<9#,K@$# ZXQ7E+32?V!K]Y:1S74%CXR>^N
M8+5R)'M@5RR;2">?F!']T^E;[2^!]?L-7U:S2_N[>73S:WNH"6X+)&6!"+YA
MY8<MP"1CGK@@'>6FN:?>33PQ3.LL$8EE2:%XBJ'.&(<#CY3S[&H[/Q+I%_J"
MV$%V#=/'YL<;QLAE3^\FX .ONN17FERGB*\T?Q+H%MJ4'B*(Z3YEIJ<( E/S
M?\>\A7AF*[L=SWZUN>'-4\)>*M8TJ]L+?4)]7L@Y*W$MP38;DPX?>=N3PN.<
M]1P"0 =W?ZA::792WM_<Q6]M$NYY96VJH^M9-GXW\-7^JP:9:ZQ;R7D\8DBB
M!(W@C/!(P3CG'4>E/\:?\B)XA_[!ES_Z*:N"DCLM?\*?#ZRTEX9=0M;FRN"(
M<;K:-$!E9@/NCC'.,D@4 =T/&_AEKY+)=9MFN'NA9JBDMF; .W(&.X]NU6'\
M4:+'=);O?*IDF^SI(4;RFESCRQ)C9NR"-N<Y&*Y/P<T5UKGCQ+2:$74NH;HG
M&"<>2JJP]0&SSZYKG(WCO_@B_A)X]OB.)!9G3V/[X3B7(?'7'1]_3&3G@T >
MJPZ[IL^M3:/'<YU"%/,D@\M@57LQXQ@^O>LO6M<TF?3H\Z_+I@^W) )47:\D
MBN 8@&7G)^4X%8OBZWU#0-5T#Q/80->W<2C2[V-.#.DN A/TEVG_ ($:B^(%
MM%I/@72[-Y@TB:E:.[G@R,)E:1\>YW,?K0!V&H>(=+TMI5O+ED\E!),5B=Q$
MIS@N5!"YP>N*KM>6;^-8[5=;<7B63LVEJ05*[E_>L,9!&0!ST-<1XOE^R:OK
M6JZ!K446HI#&+O2+Q1)!J:>6"H0==Q#;?EZD <9R=*:Z\[XO:6SE;>Y?P_*C
M(S ^7(TB,$/OP3CVH ZJ;Q1HMO<B"6^5"9OL_F%&\H2]-ADQL#9XVYSGBF7O
MBW0-.O9K*ZU.!+J"/S9(1EG"YP. "2?8<^U>:6DD<WP4O?"-ZG_%1Q)+:M8-
M_KI)S(61U'5@20V\<=3G@UOZ<T=I\7(H[RYB>>#PQ%#+,S#F1926Y/?'S8].
M: .RB\1:3<:5:ZG;WBSVEV=MN\*LYE//"J 6)^5LC&1@YZ&K6GZC::I;M/9R
MF2-7:-LH5*LIP000""#7D>AIIMYX%TV"769=(NXM9NWLKZ(C%O(7E*[P>-C(
MQ&#@'(]:Z?0O&:Z/X;DO/%DUO$?[3:RCOK2%O*O#@$3  ' .&!/3*F@#OZQW
M\4Z+'>"U>^4.;C[*'V-Y?G?\\_,QMW_[.<UL5X?K>LVU[H5P0K6$EKXCC>?3
M8+<@0@7(S+*VTDLWWLY YP 2,T >IWOC/P[I]Q=V]SJL"SV@4SQKEV3.<<*"
M2>"<#D8JX==TO^R8-4%[$UE<!?)E3+>;N^Z% Y8GT S7(:3?6)^+7B*Y>:)$
M;2[4!I/EQ@N6'/0@%<CMQFN+\/WQTGPU\.-7NM_]CZ?->1W[!21;2/N6)W'8
M#)Y/0-[B@#O?"VN3ZG\0O%-J-0N+BRMH;0PPS1^68&82;EVE5(Z#J,]*Z^\O
M;?3[<SW4GEQ[@HX)+,3@  <DDD  <FN&\+:E9WWQ4\4SVDGG0W%G9&.9$)23
M:),D-C!ZCFMKQU!I]SH<$.HWT^GJUW'Y-] VTVTHRR.2>,9&#GCGMUH U8=>
MTR:SN[L70CALW*7#3*T7E-M#88, 1PRG\12V.O:;J-Y+9V]P1=Q()'@EB>*0
M(> VUP"5]P,5Y9J5QXCNO#=W]I\G5H]'UNSN9[ZPBP-1MTVLWRC(++A<XX^7
M':NGNGM_$7Q'\+:IH=S%<P6-O=->W$#!E$;HHC1B.Y;D+U&TF@#LM3$ITN[\
MF=X)1$Q65 I92!U&X$?F*YWP9KV[X<Z'JFL7I:>XMTWR/R\LC=  .68]@!FN
MBU66.'2;R25U1%A<EF. .#7D>CS26/AKX9:Q)EM*TWS(M0P,BW=XRB.X[!23
MDGINH ]1B\3:-+9WEW_:$4<5D<77G QM <9^=6 9>.F1S4%GXR\/7]_:65KJ
MD,EQ>1^;;J P\Q=N[@D8SM.=O7':N-U5(KOQ/XJU^QGC;23X;-I+.C QS7&7
M(P1PQ5<#C^\!5'[3:1^&/A6!+$K0W-MY@! *8MV5MWI\Q .>] 'H]_XFT?3'
MG6\OEC%MM^T/M8I!N^[YC 83/'WB.HJ_9WMKJ-I'=V5Q'<6\F=DL3!E;!P<$
M>X->0ZQJND:?J'C?P]=:Q;V4.K3_ +Q[V*0/"SQ*'9 %*NN,;<LN"#VP3ZOH
MKV4FAV)TZZ6ZLQ BPSJX8.H& <CKTH KZCXFT?299H[V\V-!&)9]L;N(4.<-
M(5!" X/+8Z'TJ>ZUK3[/RA+.6,L9E188VE)08R^$!.WD<].:\W\7ZI!-?^.-
M*\MK&Y_LP;%@MRTNI?N6PQ;!^1<[>,8YR<<4UGM[O3_#U[I?B/\ L/6[?1HO
M*ENE M[J/'S1NKXSAEZCGG(SC@ ]3M+N"_LX+RUD$MO/&LL3CHRL,@_D:IZE
MK^F:06%[<%&2,S.J1O(4C'5V"@E5X/S' X-0>$KRYU#PEI5U>6*V-Q);(7ME
M4@1\8P >0,<@'IFN.?7K+PO\1?$D'B4/%9ZPEN]C.\+21S*L>QXN >0<G;WW
M'UY .YFUS38;2WNOM(EBN4WP?9U:9I5QG<JH"6&"#D#O51O&/AQ;&SO6UBT%
MM>R"*W<O]]\XQCJ"#UST[XKB-7O;#PWXIT;4=2LKS3/#<VEFSA:W,D8LY/,W
M .(R"NY=O'8CV)JOKT?A^UT3P\^E6[6^GW/BBWO,W#.3,/XYL2$L%SW.!W[T
M =4WQ(T&75-)L[&:2[6_>8&6."0J@C4[OX>6W;1CT.3VSLW/BG1;.Y>WGOE1
MHYE@D?8QCCD;&U&<#:K'(X)!Y'K7-^+KB#3_ (@>"M0FRMHOVY&E1"PWO&NT
M< \L0<>M<9XNU>WO?#?B^V1'L9[?55+Z?!;G,H66+-Q*VTD[@,@@@< <F@#U
M*:^L1XQBMSKK)=163N^FAAL*;E_>MQD$=.HX/UJ'_A/?"V(F&M6Q66;R%<9*
M[]VW!., 9X!. >QK#N-0M)?C%I,ZS*$;1)AE_EP6D1E!ST) )P>U<;<S6S?!
M3Q;&CQF635IV5%QN?-R&4@=3E1D>PH ]QK*U#Q)I&ER2I>780P -.RQLZP@]
M#(R@A ?5B*TH98YX4EB=9(W *LIR"/4&O.?#]_:Z+=^,])\22)%/<ZC/=Q";
M_E[MI$4((\_?("[=HR1P* .EUCQEI^D:WHVF,)96U(NRR11,ZB-8V;<"H.22
M%&!V.:PK#Q=#HOBSQ?#K^M.;.TFMA;"5<F-6A#MA47H"W)QZ9-<_IUK=^&(/
MA<=<$L9M%NXYV92WE-)$?+C. >>B@>HQ6E:W5F?$7Q.D:6$"2& *S$#<!;;2
M!ZX;CZ\4 >@SZQ86]K!<M<!X[@ P>2IE:4$9RBJ"6XYX'2J)\9>'5TZWOVU>
MV6VN9OL\3LV"TF<;,=00>H(X[XKS*QU*#1=/\"ZOJS78T0:)]@FN+:21?LDY
M\L_/Y9# '9M^H]JM^)$\/1>$[>XTBW>*QOO$-M=/)</(WVH[U,DH$A+;<#D]
M#C/0@D ].TC6]-UZUDNM+NTN88Y6A=T!&'7J.?J*-1UO3]*(6[G97V&3RXXV
MD<(.K%4!(4>N,5>C*,@>,J5;Y@5Z'/>O.KO7K;PG\3M8E\0EX=/U:SMELKIH
MF>/,>\/$2 <$ERV/?WH ZN?QCX<MDLWEUBT"WL;2VQ#[O,0*6+#'; /\NM5+
M;Q!HNL:[I=Q8>(V?S;266.QB/R3IQ^\88R"N..G6N9U5],M_$_P]2"SBT^SC
MN+IX[9D$?E(T3!&*X&S<<'!P03CK6EJ\T$?Q@\-H'C4KI]VA&0,%BFT?4X.!
M[4 :WA_QIIVOIJDR&2W@L;B2)GGC:,;8P-S,6 "\D\'G Y J[!XIT6>XN+<7
MRQ36\7GR1W"-"PC_ +X#@97_ &AQ7F3&ZE\'>-],LH)YM2@U^:]>T165Y(1<
M))@$?WD!QCD\XKI-#U7P;KVIQ:WI?VN>[M;9UENKJ:?%HA'*/YAVY)[<]">U
M &Q)XX\+ZA:7$%OXB@A9K-Y_/0X,<?W?,!(QD$@@'VXP:NVFLZ;8Z'I)DU.6
M\%U GV:8QL\UV @;>$5<DX^8X'&:XOP>]K%\  "8D:/3+F.0' *N=_RD>I)'
M'?(J"RUJUL]+^'L$WEVP?3/+&J>5YCP.(D#0IP0KL1@Y!^[C&3P >F:;J=EK
M%BE[I]PEQ;N2 Z^H.""#R""""#R*;?ZM9:8T"74Q66<E88D1I))"!D[44%C@
M<G XKC_A3,AT/5;8>=YD.KW9831LK -*2,Y YQR1VSSBI_%^KV^G^+?#T%RJ
MV@E2X":H8?,>(X7]U'P0&?CD@\+@ D\ &X_B[P_'I5OJ;ZK;K9W$GE12%L;G
MW;=N.N0>",<=Z+7Q;H5]9O=6FH)<1)<-;'R49V:51DJJ@;F..> >.>E>1-=6
MO_"L+ZRE,F^/Q-EX[B,JQ7[6&.00,G;DD=N^*[3QQ?0:1XF\/:[?"Y.@"*X@
MN+FS=QY#R>64D8QG)4[",_\ UJ .VTO5[#6K0W6G7*3Q*[1L0""CCJK \JP]
M" :BU'Q!I&D75M;:AJ$%O/<Y\I)&P6P"2?8  \GBLSP?%H;0WU_H%O.MK>S^
M:]S*\I^TR8Y<>8<XZ#/<@^F:R?'4UNGBSP2)7C&S4G=MQ'RCRG )]!N(&?6@
M#8_X3WPQ]CGNO[6C\NWD,<J^6^]& R<IC=C'.<8K4?6M.33[>^%TLEO<@&W:
M(&0S9&1L502W&3P#P#7%:3=6,?Q%\?2R30*K6]G\[, &"Q.'Y[X. ?3BN2TB
M_CTCPQX U?41=G1K:TN+.]EMGD5K21RNUGV$,!\I'MGW% 'HVL>/]&T[PT^L
MVTK7<?GBU58XV)64L%VN,93!/(;![=2*Z:WN([JW2>+=L<9&Y"I_(@$5Y5XE
MAT1_A[K&J>'K6Y-G<:A:74]T[2O]H*S(7D ?)V@#[PZX/IFN^3Q=HDFMV.D+
M=M]LOX&N+9#$X$B#/(8C'\+$>H&?2@#8GFBM[>2:>58HD4LTC$ */7)KF]*\
M1:'IGAO2I+CQ(+V&Z?R;>]NF >Y8N1V Z'C.,8'XUTLLL<$3RS.L<:#+,QP
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M>99MY,G[U=I;CY>#@=#R<@8R:GTSQ5H^K65[=V]TT<5B[)=BYB:!H"!N.]7
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M,D  #J20!QSR*X#0M6M<?$*;4IM533H;@(ZNTKS0)Y WA<$LN#N((X'4''-
M'I]%<J/%^AZ+8Z!:DW[KJ%LILAY$DKR*L>X MSER .,DDD5;3Q=9SV45Q;V6
MHS2/!]I:U6W(FBCR1EU8C&2K8'4X. <4 ;]%8<'BW2;S3=.O;"9KQ=1!-I'
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M521R P&>V: .@HKF-#\5R:QXIUO2CI]S#'ITD<0=T')*;BQYX!!&!_CBNGH
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MD N%^7#$=SZ<17)ETKXK3ZI<VEX;"XT>.WCG@MGF7S%E=BIV D'!'4<UV]%
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M;QR#;OW+N4'TSD"K=Q EU;O#(7".,-L8J2/3(YI\<:0Q)%&BI&@"JJC 4#H
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M10BV;['+B;;;[&V?+\WS<<?7I0!US^)-.^RZ=/ [W1U) ]E%"N7F7;NR <
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M<30VLCI%OBVKDJ".3Q18+-%\5]<O'L[Q;5]-@C2<VLFQV1G+ -C!.&'3KVH
M@^'>K+:?#FSN=0N9YY'O+F%"[-++*WVB0*HSDL>/R&3P*W[7Q?I4[:I'</)8
MSZ6HDO(;M0C1(1D/D$@J0#R":\WM-*U:/X<:).FAW=S/I&LS7ESILUNR230N
M\P^56 W-MD! _K6GKNECQ7X*UI_#?A>33+F6*+#7=H+::Z*2*YCQUVX4CG@D
MC'>@"]JVLO>?$CP2(H]3M([AKIBDQ9(YT$#%3L#$9!/1@&&>E=AX@\06?AK3
M#J.H+-]E5U1WBCW;"QP"?09(&?>N+O=7G\0>+?!6HVVB:Q'':S7!NUGL9(_(
M+PE0"6 !Y/49'O7=:WI,&NZ%?:5=#]S=P-"QQTR,9'N.OX4 5QXCM/\ A)E\
M/M%<K?-;FZ 9!L,8(!.[.#@D#'7\.:R-=U_1;G3+5]0_M."$ZHEM$T*NA:=)
M=H!9>-FX$<G!P<9KD?[)\7-I&A>)VMF/B/3IDL?LS$D/ <PNS#_:<^9G^Z!Z
M5O\ CG3)+7PGHFG6-K=W9MM1LW;R8'E;9'(&=VV@^A)]2: -0>*7N?'=UX9_
ML^Z6&&S65IU&-Q=B 00<A1@\]<_0$\QX)\8V>C>%HTU234)@=3N+=[QT>5(B
M9V5!)(>F>!U/49ZBMG_2;'XLW%\^GWLEG>:1#%'/% S(K)(Y8,?X2 P.#R>@
MR>*Y&6RU!O@OJ6FC2M2^W2:FTB6_V*7>RF[$@(&WILY_^O0!Z%)?Z3_PGRVS
M27_]K1::\GE@2>28=ZY('W6;) XR>HJDOQ+T![..]47YLS<FVDN3:.(X'W[!
MYA(^7+?CR,@9%03&5OB[9Z@+.]-F-#DA,_V238)&E1PI.WKM!X_#K7)3V.H/
M\&=;TU=*U(WTVI221V_V*7>RM="0$#;TV\YH ]>N[C[+:2S^5)-Y:EO+B&6;
M'8#UKCM'^(MO<^$]-US4K&[@COYA%&4BW(&=R$&<].@W' SZ5V883VVY P#K
MD!E*GD=P>1^-><^%M!FUGX-#PM?V-W8W<5JUN3<Q&/;,&)5ESU 8*V1QZ'K@
M [.'Q%:3>))] $5PM]! +A@R84QDX# YY!(QQ^.*C7Q38O9VLZQW!DO)7BM;
M?8/,F9<[BHSC:,$[B0,<YY&>"DTOQ7=)X?\ %BV\D.OW _L^[@.<06\B!0Q'
M^S(/-Q_M$=JW?$&F7&C>*O"FL6=I//I.FPS64\4"&1X$=5"R!1DL 5 . 3B@
M#I](U^RUJ2[@MS)'=V4@CNK:9=LD+$9&1W!'(()![&N3\1ZF-'^*6BS/)?20
MRZ;<DVL'F2^8X9 NV(9&[!/('N>E:&@Z;+<>/M<\2+%+#9W-M!:PB6-HVF9,
MEGVL 0!D*"1S@]L9B\0)-9_$;0-8>TNI-/BL[FWEF@@:7RW<H5W! 2 =IYQB
M@"U'\1-"D\/7&M@W2VUK.+>[1X"LMM(6"[70\CEATSUK8DUZSB\11:'()4O)
MH&N(R4^1D4@,<^Q(X->=>(/#6I:AX<\=ZG:V,^_5YK:6UM-A$KI!LRVWJ&;:
MQ"GGID9.*U3?7&J_$O1-5M]'U1; :9<0F6>T:,*S,A 8-@KT/4#/;(YH ZFR
M\3V=_)9^3;W?D7JL]K<F,&.90-V0021D<@$ GL*Q++Q7X<T7P]K>M1RZDUE!
MJ4RW1FCE=TFRNY0K<HH)  . *Q/"^GW>EZ]I#Z -5M]&NED?4-(U"WDV6!V$
M@Q,X!7YSMV@G.2>G3,O;+4)OAMX\LX]*U(W5]K-Q+;0_8I0TJ/(A5E&WI@'Z
M=Z /1;+Q=IM]KW]CHEW%<O"9X6GMVC2= 0"8R?O8R/SR,BF3^,]*MI;4S"X2
MSNKC[+#?&/\ <-+D@+NSD D$!B-I[&L755FN_B/X8NH;2^^S1V-W'+.+20+$
MT@38&)7@_*>O3O6!X3MDM=,M/"VL>!I9M7L6$0NY+)6M) I^6;S3QTYQ][/3
MF@#T!_$UFMPT:074L*7:V3W$: QK,6"[3SG@L 3C /&<T2>)K-+AHT@NI8DN
MTLGN(D#1I,S*NT\YX+ $XP/7-<1?:=>6_B&75?#*ZK8ZG)J82\TZ6!VL[U/,
M"F;)&U3L&[>#VQU/)J&G7D'B"?5?#*ZK8ZH^I*EWITD#M9WR>8%,V2-JG8-V
M\'MCJ>0#TN[N[>PLYKR[F2&W@0R22.<!5 R2:X#6-9:\^(G@@11ZG:1W$ERV
MR8LD<Z"!B#L#8R">C ,,]*W/B/I%_KO@#5=/TM=]XZ(\<><>9L=7*_B%(_&N
M?OM7G\0>*/!6H6^AZS&EK<3F[6:QDC^SEH2N"6 !Y/49'O0!TQ\;Z0)XA_I!
MM9;[^SDO!&#$;C.W9UW?>&-V-N>]6['Q'9W^OW^BQ1W"WEBJO,)(]J[6SM*G
M/S X/(].<5YEJ;:QJ>EV\MYH>L#4;/Q!%/-;P6K+!%"L^0T8&!+E<$L-QR3D
M@8KJ/&MEJ=OK&C>(="41ZE/G2YXY"!F.4$JQQG)C<;\#MNH Z&+Q39W$5N8+
M>ZDFN9)8X( JAY/*.'898#:#QG//&,Y%:.FZA%JEBEW"DJ(S.NV5-C*58J01
MVY!KDO%/A_3'@T/2VBU6V6TB<6>IZ<LADLW4(H!* \,"<Y&#MK8\%-K+>&(!
MKIWWJR2*)6B\II8PY".R?PLRX)'OSS0 RZ\;Z1:/<,_VAK6VO%L;B[2,&*&<
ME1L;G=U902 0">36/XIUJ0^.=#T&2TO9;":*YEN(X5(\\JJ;<$$$J-Y)'KCT
MKEO%/]L:OH7B.VGT35S?0ZHCV\%M;,(&MUFC(D&W E9E!)^\P/8 5U6JR3S?
M$SPQ>KI^H?9H;.Z6:3[([+$T@3:&8 C/RGOQWH /!NN1VUWK.ANNHBQT638+
MK4'#L%*F0EWSPH# +GG:!FMN/QAIQU.TL)HKNVDOHVDLVFA(6Y"C)"XR<XYV
ML ?:N0N='U*]U#XB:,EE=1R:PBM:7)C(@8?9PG,G3[PVD=>>F,U:\,7=IJ<M
M@L_@6XL-5LANN)[FP"QP,!AC$_\ &3T&WUR>E &]I/CO2-;OH;6PBU"3S998
M3*;-UCC>/.Y78CY3QP#S],BNFKB_AK%/;Z+J4-S:75M(=4NIE6XMWB+(\A96
M&X#((-=I0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !117,>-O$EWX;L=/DM+&2Y>[U""U+*R ('<
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MF;:Q))!R  >,=#FM/3?%UKJ&JVNG/97EI/>6GVRV,X3$L8(S@JQP1N'!QUH
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M09H V**X;X22>;X%5_WN#?7>!*27 \Y\ YYS74ZKK%MI"6_G"22:ZF$%O!$
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MYC@=/<C*L+#5?#GBZ'78+">XM_$"[M7MH(/^/20<HXX!. 2K#J2"V.U>DT4
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MQ9M> :@++'GB':?N'((&[&2#G'3% #9_'^F6NAZOJEQ:7T8TB<P7EOY:M(C
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M2/B%HZBVN9;&R\.C3#=B,[#*'0C\PO7I0!OS>+8%^U_9=-U"\:RC5[M8$3=
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M?^!>F?7I0!K_ /"=Z;YD#_9;PV4^H?V:EYM3RS/N*XQNW8W KG;C/MS3-/\
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M"ORA#\V% )SC!)&,\T <_H8_X2C^VM1U/1=1EO+#6IFM9XIHDDB$3*JPJWF
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MC=$6!*G'3(./UJQ10!Y7+X6UZ\^'7C'2O[,>&]O]4GO+6*26/]ZC3+(HRK$
MX&.<<UL>(](_X2EK<ZMX:OXBEOYEK>6D\8NK.;<<KN#]P%/&5SU-=Y10!D^&
M8-5M?"^G0ZW,)]3C@47#@@[F^O<^I[FN;\-:#J+Z9XPT[4K*:Q35M0NYH9&>
M-LQ2H%!^5C@C!X-=U10!P'A'_A)[:VL=$U/PQ!;R6(2*351-&T4L:8 9%'S;
MF QR!@G/M55],\66T?CN?2;"2VOM0GCFT^1Y8OG"HB-C#':V%;&X#J*])HH
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MRCD]<_CW]% $-I++-9P2SP&WF>-6DA+!C&Q&2N1P<'C(J:BB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *Y_5O%+:7
M)J&-$U*ZM["'S;BXA,(11MW$#?(I)"\G [BN@K%\7C_BBM?_ .P=<?\ HMJ
M*FC^,/[8&E2KH>IV]IJB;[>ZE\DICRS(-P60LN0#U'6NEKC_  I>_P!F?"#2
M-0\LR&UT6.<(.K;8<X_'%<YJ.JZI8_"W3O'-OJ5S+J8CM[NXB,I,$ZR,H>+R
M\[5 #X! #?*.<YH ]3KGM5\3R6MW?6>F:;+J=W80)<7,,4@5@KEMH7/WG(1C
MMXX'7D"N@!R <$9[&O/- L(H?BCXTE^UW*>1#8N&DN7*\QRD[P3\P'H>![4
M>@02^?;Q3>6\>] VR089<C.".QJ2O+=.U748-<\%M'J-]>0ZD\\5W=RN1#>_
MNF<-'$2=@!'! 7(]0:T=+;4?&?A^^U6VUR?3=034)8X&5B8K9(I=H1XLA7RJ
MY);GY^P % '9M>W0UEK,:;,UJ+;SA>!UVE]V/*VYSG'.>E9&F>+)-8\/:EJ=
MEH]R\]G<36PLC(@DD>,X(SG:.?<U3AO;P?%^2Q^WSR6#Z$+E;<L/+5S/MW
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M[1:Q3F.2+S$#^7*,,F1G##L1WK@] TV-?BYXJ;S[LF*WLG -RY!)$G!&>1Z
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M^-I4X!7@CGU%<Q%=:TGA#P)KJ^(-1-[J%W:6EP'D#1LDH(;*$8+#J&.3GVX
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MV1!)&R$L P()5BIY]".17FFGZEJ-G;Z[X0N]1NY=<%XL5E=23'S'@FY25?\
MKFH<L!Q^[YZT >FT5Q-E<OKOC77]!FN[R&TT:WM4B6&Y>-Y'E5F,C."&; "@
M9..I(.:YF'Q%K<ND:2+B_G^V67BY=&FN$;:+N%7()91P<C /'4'U- 'KE%<A
MIUY=#XIZUIYNIGLUTZWG2%W+*CL[AB >F0HXKKZ "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MJ*2QN)AJ-[%9+*A4)&SG@MDYZ G@'IVK0U75;+1--FU#4)Q#;1#+,0222<
M#DDG  '))H YV\^'6D7FD:38_:M1@ETA=EC>V\XCN(4P!M# 8(P .0>E6;SP
M3I]]X=_L2:[OV@:99YIFF#332*0P9W8'/*KTQP .@Q6OIMW=WL/GW%@UFC@&
M..60&7'^VH&%/L&-7J .,\2A/$LLG@V?1]0GB+0/<7T\ 6W,88.Q5QC+_+MP
M!U/3 -=D %4*H  & !VI:* ,;5?#EOJ^KZ9J4MU=13Z:[/;B%E"AF&UB05.<
M@XJGK_@C3M?U6WU;[7J&G:E!'Y0N]/N/*D>/.=C<$$9]JZ6B@#SKQ-I(M_%/
M@BTLEU&.WLYKEY;J"-Y6BW1$!G<JP)9SR6SG)S74CPII<EIJ=O>H]\=4 6]D
MN"-TH VJ/E "A1TP!@\]236X2 ,DX K,N=3GETJUOM%M$U);AHBH$PB'E,1F
M0$CG"G..] %2P\*VUG+8R37U]?&P4K9_:W1O(R-N1M4;FV\9;)QGU.9M"\.6
M_A][]K:ZNI?MUR]W,)V4CS6QN8848S@<=.*V** .1'PZTE?"MSX;6ZU$:9.V
M3'YX.Q=Q?8N1PNXY]?>M)O#$#^(;76WOKUKRVMC;(<Q[2A(+9&SJ2 <^U;E%
M 'GOB/PRFB^&[FULXM9OK?4=56\OGM6!G@)?>TL80 D[E7@9QG('&*D\,VEQ
M_;-M<:;K/BJZLP6%TFM1%(RNTX"B2-7W;MIR,C .>V>^HH @O;*VU*QGLKR%
M9K:XC,<L;=&4C!%8VG^$;2Q&GI)>7M[#IQS90W3JRP':5!!"@L0I(!8MC-=!
M10!BV7AJWL?$=]KD=Y=M=7RHDZ.R%"J A !MR,9/?OSFM2ZMHKVSFM9UWPS1
MM'(N<94C!'Y&H+"YOKB6]6]L!:I%.4MV$PD\^/ P^ /ER21M/I5V@#DU\ :>
MNEZ3IXU'5##I4\=Q:EIE9E9!M3JO102,=/7-7M0\)V6H>(+?6S=7UO>Q6_V5
MVMI_+$T6[=M? ]<G(P>>M;U% '(0?#G2K72M-TV"\U)+;3KP7MLIF5ML@+$=
M5/ W-Q[\YJ[<>#;*YU+5+^2]OO.U*U%K/M=5 09V[<+D$9.#GO7144 <Y<^"
M].U%;G^U)[K4)+BR:Q,D[(&6%CE@-BKR2 <G)X%0VG@33[74=+U!M0U6XNM-
MC:**2:Z)WH<?*P  (&T=,9[YKJ:A6[MWO9;-95-Q%&LCQCJJL6"D_4JWY4 <
MSIOP\TC2=2>XL[G4DM&G^T#3/M1^R+)G.X1X]><9QG'' K0B\+6EOK^H:S;7
M-Y#<WX7SD24>7O5=@?:01NV\<Y'?&:W** .5B\ :/%X6M?#_ )EVUM9S">TF
M,@$UO(&+!D8 <@D]<]<=*T(O#<"O=SS7EW<7US +9[R79YBQ#)VJ%4*!DD_=
MY/7H,;5% '+#P'IXT72-)6]OQ:Z3<)<6F'3<KI]S)V<@9/'OSFK$_A"TNDN(
M+F^OIK&XN1=2V;LAC9PX?^[N"[@#@,!^9ST-% ",P52QZ 9.!FO-?!?A[^U-
M*\06NH2:I;VMWJ]U))9R1&))XGDR#EDW;6'7:PS^)KTNB@# U/PE9:EJ]EJB
M7-Y8W5I"UN&LI1'OA)!,;<'Y<@'C!'8UG?\ "N-(&BRZ3'=ZBEK+>_;F G!/
MF;]XQE3@!N>.N.<UV%% &7>Z*;R\L[Q=2O;:XM8WB#PE/WBOM+;E92IY0'H,
M<UF7/@32I])L+&&6[M&L;EKN"ZMY LRRL6+MD@@[MS9&,<]!70F[MQ>BR\U?
MM)C,HC[[ 0,_F?\ .*FH Y&;X<:)<1ZTEQ+?RC6%B6Z+W))S& %8?[60#DYY
M]N*L6W@FSMM9AUC^TM5EU"*U-H9Y;G<70G<-PQC@C., >H-=-10!R2_#[3$\
M,6GAY;W4!86LXN(AO3<&#[QEMG(#<_\ UJTU\,6:^)FUY9[M;N2%(9D67;',
M$SM+J!R1D^@]JVJ* (+VTAU"QN+*Y7?!<1-%(N<95A@C\C7/#P'I?]B6&FFY
MOV;3I%DL[MI\SP,HVKM.,8VC&W&".H-;<MS?+K$%M'8![!XG:6[\X QN"-J[
M,9.03SVQ6?XP\0OX5\+WNM)9&\%JH9HA*(\C.,YP?7TH MZ=HL&GW=S>F6:Z
MOKD*LMS/MWLJYVKA0% &3P .23UIVM:/;:[IK6%VTR1&2.3=#(4<,CAU(8<C
ME1TJ\C;D5L8R,TZ@#"'A>*6_L[O4-1OM1-D_FVT5R8PD<F" ^$1=S $@%LXS
MZ\UGW'P[TF;7;G58;O4[/[8V^\M+2[,<%TW<NHYY[X(SSZFNMHH Y?5O FFZ
MIK::Q#=ZCIE\(A#+)IUQY/G1CHK\'('8C!]^!5F_\(:9?2Z1*&NK5]*WK;-;
M3%#L=0K*3R2" ,GKWS6_10!A0>%+&+5]7U%Y9YVU:-8KN&8J8W15*J,;>  2
M.O.><U#I_@RPL(K&V-W>W-EI\@DL[2XD5D@89"X(4,VW)QN8XX]!CHZ* .=3
MP?:)+KDJWU]NUH8N_F3LNP;?DX^7C_Z_-:FC:5#HFCVFEV\LLEO:Q+#$92"P
M11@#( S@#%7JBN;B&SM9;FXD6."%#)([' 50,DG\* ,O4?#=OJ6O:=K$EW=Q
MW.G>9]G6,H$7>NU\@J<Y [GCMBI=3T*VU*]L[\R36U]9[O)N8" X5AAE.X$%
M3@<$'H",&M)'61%=3E6 (/M3J *.F:5;:3#,D&]GGE:>>60Y>60]68_0 <8
M    %5==\.6_B"33WN;JZA-A<K=PB!E'[U<@$Y4YQD\=.:V** .=\1^#-/\
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M%ODFD+)* NT<=!@<<8JOH7@;2/#R2+8O?$F,Q1M/=O*8(S_#'N)"#@=/0>E
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M+AY%O(YA@DJ21NS@@@#'3IQ4^E:9 /C'K[^9=Y2PM)1_I<N"2TF01NP5]%/
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M5(]/U"*^F(NFO)0+81RD>6T0&S;L !!ZYW'F@#U.BD4DHI.,D=NE+0 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !7$_$JRFU&QT.VAM;R<)K-K/-]EC<LD2,2[97D8'ISZ5VU% &1!
MX?LU>YN6DN9;JZA$+W,K_O1&,D(.!M')/ ')R>:;9>%=(L?#)\.K;M+I1C,7
MV>=S(-A_AR><?RK3O+N"PLI[RZE6*W@0R22,<!5 R2:?%(LT*2I]UU##/H:
M,G3O#%AITUM*'NKE[2,Q6INIC)Y"D8(7/?  R<G'&:M3Z-87.M6FKRVZM?6D
M4D4,O=5?&[_T']3ZU?K,.KK!KJ:5=H(WN$:2TD!^68+C<OLPR#CN.1T(  VZ
M\/6-YK]GK4IG^VV:,D#+*0JJV-PV]#G Z^E9%S\.?#]S_:2;;R&VU(E[JU@N
MW2%W/5]@.,FNLHH YC5? .A:O]@>5+N&XL$\JWNK>[D294_NF3.XCZDU=/A>
MP06!M'N;-[&-XX'@F(.UR"^[.0^2H)+9.>>M;5% '*:AX+LY!HD5@)[;^SKS
M[4LJ7# 9+AI-XS^\9^1S_>8^QZIAN4C)&1C(ZBEHH YFT\"Z583WD]I<:I!)
M>S&>X,=_*OF2'JQ ;&:EG\%:1<Z-%I4OVM[9+C[5EKIS(\N[<&9R=S$'U/8>
ME=#7/:KXAN=.\8Z!HHM(GM]4\_,YE.Y#''OQMQCGCG/KQ0!9N?#5C=ZY9ZS+
M)<F^LXVC@<3$!58 ,-O0YP,Y%9U]\/O#]_KLNKO#<Q7$^/M*6]R\4=SCIYB*
M0&_'KWS6Y8RZC)<7HOK:"*%)L6K12%C)'@?,PP,'.>*NT )M7;MVC;C&,<8J
MEH^CV.@:5#IFFP""TAW;(QVR2Q_4FKU% '*7?PZ\.WPU1)H;KR=3E\^X@6[D
M6,RD@F0(#@,2 <XK0A\+:=!K0U>)[H7HM?L8D-PS?NLYP02<G=SD\Y[UMT4
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M-].]Q<1?WY&?>3^8'Y"K&NZ!8^(]+;3=165K1F5F2.0IDJ0R\CG@@'\*U**
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M?:Q':)="SB,SQ-+Y9*CDX.T\T 1:=X2TS3#9B,W,T=CG['%<3M(MOD;?E!]
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MY9+34GD>ZBFF9P[2??/)R,Y[53M/A_H5I/I<ZB]DFTS<+9Y;V5RJD ;.6Y3
M'R]/;DUU%% ')7'PW\/7":C#LO(K346,ES9PW;I SGJVP' )Q]/TJ;5_ 6A:
MQ)8SS+=PW5E'Y4-U;W<D<PC_ +I<'<P^I]?6NGHH KV-E;Z;916=I&(X(EVH
MN2?Q)/))/))Y)YK*U3PEI>JZS!J[_:;;4(8_*^T6EPT+O'G.QBIY7/Y=JW:*
M .4'PZ\/+IT=G'%>1K%>&^BD2\E$D<Q)RRMN^7.3D#K]>:L0^!M A&K*+:9D
MU:/R[Q)+B1A(-H4GD_>( RW4GO71T4 <Q?> -!U+1K/3;F.Z<63;[:Y^U/\
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MQ2':?49 .*]$TOPAH>BZ;<6%A:/%!<+LE)GD:1EQ@#>6+8&3@9XR?6F2^"]
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M+MMP2<*C $'D #/TI\2W$+_$O3R#90VUE#<0V]G<.$@=H')*$;<9*J2  ,T
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M*W;3+P6P\N4OO!16W9('][IBNAKRL7-O:6WQ+ENM0N=/A_M!$-S:C,J%H8U
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M*4&1+Y3$8!SAL^G3K755X8EC;6W[.=_+!$L<DEPRLR^BWV!^0KKYK<>'OBC
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M+-[\FH+_ ,(Z'J2Z>)[';_9R[+0P2O"8E( *@H0=I  QTXK:+ $ D GI[TM
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M]IE.XM]X@ELC.><$9J$^#-";3K#3S:2_9=/D66TC%U*!$Z_=(^;/';TK>HH
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MTEC9K1\2_/'$ JEN!EFQSQS6CI-HMO\ %:\T^2UL[."Y\/H\MG9G"9$Q4;B
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M+1K.ZO(L;99(\DXZ _WL>^:VI&,<;,L;2$#(1<9/L,D#]: /!X?#MA)\#O\
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M ">H#;QGVKU>X\,:+=303/I\236\7DQ20DQ.L?\ <W(0=O\ L]*?>>'M(O\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M_8-_:266H-!]H@#,'2>,'!VL.X/4$ ]^1S0!O4UI$1E5G4,WW03R?I2L2%)
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M8R(WP?D<CH.0<$9S0!T=%<5-\0PMGK5U!X>U.9-&G>*\&8E**BAF89?#<'(
MR>.<9%6XO&\,FJZ3;/I=[%9:N"+*^DV!)&V;P"N[<N0#@D#/ZT =52%E! )
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MAB#G''-</!X=\01?"?0]$;1+C^T;748YI81+#PBW!D)W;\'Y3Z]:]:I"0.I
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MB[QO"(Q&B#:.F  <C.<8Y-=+:^-K:]\26OA^\MK1O[0A=X'MKM;E#M&6CD
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M7Q!_PJ=O#O\ 99_M$W_G[?/CV;/M7G?>W?W>/K[<T =)!KVLS?$Z]T4VUO\
MV?;6,<P(G.XAW8%R-O)^7&W]>< MO'#O=:&+K29+6VUJ:2&V,DN)D*AB/,B*
MC:"%/0G&1FFOI>M0_$2XUBUM(S:7VEQVQEDE -O(CLWS*,[N&[<9'7O7-6WA
MKQ6\7AJYNM%MVU/3M1\Z^NI+U6>Z^5UW[L$[?F''4= N!0!U6H>-Q;6^O7=G
MIQN[30GV7C>=L<D*'<(N"&VJ1U*Y.<4^7QK (=/18K>"\O;8W:17MXD*)%D
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M.&PI&3R>OK6H.!110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M6>,0RE!O4Y4G'7!YP>* /"M?:;X?_$30/&'D7D<%V/(U>2:$H))&R9&'U!W
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MW8/0Y9NGK0!YS'KNI:3\6_B (KJZGM].T5KNWM)9G>,2".)^%)P,DGIZFG>
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MI&01WH 6BN8C\=:7))9LL%W]BO+YM/@O=B^4\X++MQNW %E8 E<9'TKE[+Q
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MQ3<3G. ><8..": .]HKG-6\::?I%O<WDUM>2Z?:3>3=7L**T<+9 .1N#$ D
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MC&TG')W#V'<BLS6/B&D?@B37=*L+J2070LI(IE5'MI?,$9#@MU!/09Y(Z#)
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M[?7I7I=% 'E.E64^BW>HZ!J?@9M6DDO)IK+45MHY(98Y'+CSG;[A4L<]3@<
M\9]3B3RX43"C:H&$&%_ =A3Z* /';J'Q#J=AHUSJ'A_5I-6L=?BN+L*H$*1+
M*W^I7< 1M*_,!SSN:NHT]KO0_'7BN\NM*OWBU+[++:-;P&42%(0C*67(0[N/
MF('?.*[JB@#RC3/">K>$)/"&I&V>[CLDNH=0M[4&1H!<.9 R*.6"MA3CG R
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ML'V?2((_[/@T\8+"TA50L0))"X7C.#SCC.<5S1BN(_B]-J36=U]A&AK;?:!
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M2XVL-J9 !SDXQ6[IL=Q:_$;Q3?2V5X+2XM+5(9A;N1(T8?<!@<_>'U[5V]%
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M%C<2M+$KS22*D"X1"B$D#>1O&!_&!5/QQX:U6Z\2Z-K.@L8[F57TR_=>HM9
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M.^-)!M<D@@[BHQUYK"L8-8N=:\$:M/H.LM<VK3)J,DZJNR1X"ORKNPL8;I@
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MT31N3&PRKJVX!EQ^(]*V]#UR76FN"VDWME"@C:&6Y"A9U89RN"3QW!P>1QV
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M/&R%'52> V#QFNPHH X+Q'8:]XX\&7T*:<VDSAHIK*WNW4N\D;ASOVDA0<
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MIU/3[634/#UU=:Q9:Y%=2W!GBV/ LV5$ +_*-FW((7IDDFO7:0L%!+$ #N:
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MPQPZR'Y7567&.S9.<C'IM<Y<>"]/DU6XU&VN]3L)KI@]RMG>/&DS8 W,O3.
M!D8- $W@^:Q;PY;VEAI]UIT-D/LIM+I=LD14#AN2#D$'.3G-;M5[.R@L+9;>
MV0K&N3\S%F8GDDL<DDGJ2<FK% 'F=QX4U;48_'FAO9O##K,QN+6_,B^4<QH
MI .[.Y,'C&,\],W+O3]6\5Z3X=TZ^TJ>QGL;VWNKZ20KL7R021&03NW'&,=
M3G!X/H%% !7-?$+2;S7? .LZ9I\8ENYX,11E@-Q!!QD\=JZ6F[UQG<,9QG/?
M.* .'OX=6U+QEX.U7^Q+N&WLUNOM.]XRT/F1A5R W)R#TS@?E6)>>%]>U&T\
M7?9[ P74VKPZGIXN2GEW'E"/Y6P3C)0CG'45ZK10!RWAFZO]0G$USX4&A+&A
M$GFF-GD<XX39_".>3C/&!UKJ:** "BBB@ HHHH **** "BBB@ HHHH ****
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M.FW-_8:I=?;[6:W*DB1E >-PQ&WE1@],=Q7-)HMQX.F^&^GR1-<W$-U>/-'
M0<,\3LP7.,A=Q^N/4XH ZJ'XC6ATW79KK2-1M;W1%\R]L'$9E5"I8.IW;67
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M$>#>< 88\;MW4#I7-^)?#U[J6K76J:1IM]I?B2.9%M-0MW"Q747R_P"O&[!
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ME1D'=@K\RG(YYZ5SFDZ=XHTCP3X0TUM)O&@M7>/5K.VFC69EPVS:V\ IN()
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M,&196<C&[/0]<=: (/A7&L7A:\C081-6O54>@$S 5T.H:Y'#JJ:/;6SWE_)
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MUC(7(9F(PH;=C)S@5M2Z?J>F^.[+Q/%87%Q9W.EBPNX$VF6W97WJ^,_,.2"
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M1(UP/*D-V_EELL#P<=,UT-I!K?A_Q]K&IG1;F^T_78[>0&VDC+VLT:;"CAF
MP1SN!P*P8?#_ (A7X5:?H[:'<?;X=6%PT0EB_P!6+HR[L[O[IQ@\Y[4 =M>>
M,?L_B2YT"VT74+N_AM5NE6/RU61"Q489F '(/WL=. :;;^.M,N?#&FZU'%<
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MM93R1HZQH^S(.X@Y/3!QZD<9W=/N_P"T--M;P0R0_:(4E\J489-P!PWN,X-
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M)8^,G/S %2.00?I6E<^+K;2[_1M(ATB^E?4+5I;180A4A%!*9+#!&Y>3@>]
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
' "BBB@#_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>21
<FILENAME>insidertradingpolicy008.jpg
<TEXT>
begin 644 insidertradingpolicy008.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MJB[AC)(!/Z5P<OP]\6?\(OX0TB"^TL1Z1*6O;:5Y&@N@&!0G"@MCGY3@<]:
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !17(OXU
M6/XD1>&&@Q;36[B.Z/1KE0KM$/I&RGZG%==0 45Q4^O>(9?B1/X8M9]+B@73
M1J"32V<DC<R;-AQ*H]\_I5GPAXODUQ-9M]4A@M+S1[MK6Y>-_P!R^.CJ3R ?
M0]* .LHJL=0L@L+&\MPLQQ$?-&)#_L\\_A6!:ZUJ+_$J^T*9X&L8M-CNX@D9
M5PS2,I#$DY^[VQUZ4 =1159-1L9+U[*.\MVND&6@652ZCW7.15AMP1B@!;'
M)P"?K0 M%<UX-U^^UZ#6&U"&WBEL=4GL56 DJ5CV\Y/4G)]/I6,?'-])X7NO
M&%O%;MH=O<,JP>6QEEMTD\MY0^[ .0S!=O08SDY !WU%<A#XHGC\?7NG7EY9
MIHZ:5%?12E?+QOD*_,Q;!^[[=:U_$/B&TT+PW/J[SV_EA0(7>0"-W8@)EO[I
M)&3V&30!L45S?A2[\1W\3W6L77A^YLY%!MI-(,C!N3DEF)&/I71MG:=H!..
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M/#:W=O)/"=LBHX<QM_M '(^G%<UX/\33ZCI%]<:W=V<<L&IW-FK+B)"(WVC
M)/IGJ: .MHJ!KRU5H5:YA#3#,0,@R_\ N^OX5/0 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !5+5]3
MAT;2+K49^8[>,OM!Y<]E'N3@#W-7:K7NGV6I0B&_L[>ZB!W!)XE=0?7!'6@#
MS/Q7X9\0VO@F/41-8/J6CW!U@-'&X=Y02\@SNP006&,= !7HVBZM;:[HEEJM
MFVZWNX5E3GID=#[@\'W%6);*TGLS9S6L,EJ5"F%XP4(]-IXQ3;'3K'3(##86
M=O:1$[BD$2QKGUP!0!YQK&GW&J_&>_M+/4Y]/NF\+@1W$!&4;SSC((Y'(]/K
M6I\-+BR31;S0I+&*RUNQE9=4M]Q9I9#_ ,MMS$EPXP<G/I77#1=*%^;\:99"
M\)S]H$"^9G_>QFGOI>GR:@NH/86K7JC:MPT*F0#T#8S0!XQ9WMFGP;\#PO<0
MB:/5[7*%QN7;<'=D=L=_K77WLEQ_PM#7GT\[KO\ X1=&M]O.7\V7;C\<5UZ^
M&M"5IF71=.#3RB:4BV3]XXY#-QR02>3ZU972M.2_-^EA:K>$8-P(5$A'INQF
M@#S+PTGAOQ!H7A*[/B&X_M"QEB:*UB:%9A<8Q(C )O*D[BV3R,L3WKUBJ%OH
M>D6NI2ZC;Z790WTN?,N8X%61\]<L!DU>90RE6 *D8((X(H XCX>J)8?%R!L;
MO$5ZN1V^[7)V:267[.U[HLD9_M&#S],:W'WC.TY55 [D[U(]CFO6;+2M.TUI
M&L;"UM3(<N8(53<?? YH.EZ>U^+]K&V-X.EP8E\SIC[V,].* //;+0K"7XH1
MZ9JMK;7@MO#%L@CG0.I9974G:>#]??WJ?P%;:79^'M1L+]K0Z/-K=S%I,5VR
ME)(L_*L8;[PW"3&.HYKN+_1M+U1XWU#3K2[:/.QIX5<KGKC(XI;W1],U*R6R
MO].M+JU0@K!/"KHN.!A2,#% ''Z!H9T'Q1XDA\+K FGR6L<BVSL1;Q7IWY48
MSM&T(6 Z9'L*Z30F\2LT_P#PD$6DHN%\G^SY)&)ZYW;U'MC'O6I;6MO96Z6]
MK!%!!&,)%$@55'L!P*D(!!!&0>H- '%?#\@ZAXSP?^9@F_\ 145=M5.STG3=
M.DDDLM/M+9Y3F1H(50O]2!S5R@#%\7QK)X+UQ60-_H$Y (SSY;8KSB^MM*O?
M"'PRQ':RM]NL(I2NTG#6[%E8CUP,CO7L#*&4JP!!&"#WK-_X1O0O(A@_L73O
M)A8M%']E3;&3R2HQP?I0!R5W%H6D^.(-*TZVL=.N(M*EE:2;"V\<#R_,%B!
M9RRG)R, =^E<;X<U:*+PU\,H+RXC.D&ZN$NRS#8LR[_LZOZ?-R >Z@]J]GN-
M*TZ\NK>ZN;"UFN+8Y@EDA5FB_P!TD97\*B;0M(;37TTZ79&QD8L]M]G3RV).
M22N,9SS0!Q.GQ:;+\5/&5N5M76XTZU,L9VD2-B3.1W.,9_"N7M;2UN?A?\,C
M/#&['5[6/<1SM)DRN>N#CD5Z[;^']%M$9+?2+"%7C$3".V104'\)P.GM2?\
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M*%P'E=BS$#L,G@=@ .U:% !1110 4444 %%%% !1110 4444 %%%% !1110
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M81QX('8YK9\36^F>&[#PS?111:?IUS>P?VG=PQ+EL0N(GD)!# .0<MGG!ZT
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M"2XN5V3RO;(6E7CACC+#@<'TJ5M'TM[F&X?3;-IX1MBE,"EHQZ*<9'X5=HH
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M2\@1@RQW$*R*I'0@$$"KM% ')>&- O-/U7Q*]_:6PLM3N1+#&KAQL$:Q[67
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M=ISR3G@''?.*GMM"\1Z%>>)[&RL(+[3=:GFO89FN1&T$LJX='!!R,@8(S^O
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MK:GIT<+W-I:R3*)F(4;5))X!R1CIQGU%<3K<UW)-\.]1NK*.74#= #RI=[2
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M #R!MY^O&:W](GU.XMIFU6RAM)EG=8TBE\P-&#\K$X&"1VH T**** "BBB@
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M45@:IXBETWQ;H6B?8@\6J^>!<>;CRS'&7(VXYSQW]: -^BBB@ HHHH ****
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MN!W$@@[5.",#'&*?<>#=$N=-L[!K:5(K.X-U \5P\<BRDDL^]2&R=S9.><T
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M=S(9)Y[""65SU9FC4D_F:XKPEI=O%#X^:&2ZB=-5N41X[J0%?W4;9^]][/\
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M^68DC)[#/ K0K/T;1K/0K V=B)1"9'E_>2M(=S,6/+$GJ:T* "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **9%-%/&)(9$D0D@
M,C @X.#R/<4^@ HHHH **** "BBB@ HHHH **** "BBF2S10*&ED2-2P4%V
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M-?4-/U:87L9@FC5H)BH#H^\KE3@$$9^E<U+H=QX0F^'>GK']LNH[^ZEE2%@
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MY7N!)T9RV$VXZX4GKT(]:T2< G!/L*Y_P5:7UOX9MKG5F#ZK?*+F\;&/G*@
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MANM6M-;CO)+Y[Q,W$*S;E6,'[BA<#:<=,@$DUT)\/:K)XP\1M-:)_9NNZ?#
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M)N()WAECSU ="#@^F<59TS1K+2$=;5)2[XWRSS/-(^.@+N2Q R<#.!DU?HH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MR.?>@#1HI 00"#D'H16597#-K6K;]:MKF",1;;-%4-9_*=V]@<G<03R!C!H
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M=112WMPD$2.X7J>6.>BJ,DGZ#O4\_B/0[4,9]9T^(*JLQ>Y08#?=)R>A[>M
M&G15"36]*AOEL9-3LTNV8((&G4.6(R!MSG)':EU+5++3HL76HVED\BGRVN)%
M4<=\$C('% %ZBN"\-:_J.M?#S3-2O=?M+"^GO'5KF2)-DJK<,OEJI(&650H/
M7ZFNNN]<TFP:9;S5+*W:!!)*)9U4QJ3@%LG@9XYH OT56_M&Q_L];_[9;_8V
M4.+CS1Y94]#NSC%,M=6TV^<QVE_:SN"05BF5B".O - %RBN5\<:OJ6C0Z++I
M]Q'$MQJ]K:SAH@Q:.1P" 3TX]ORK;L]7T[5X[A=*U.SNI(24<P2K*(V[;@I_
M3B@"_17(^!_$4^H>!8-8UV]@64S3I).VV)/EF=%]AP *Z6SU&RU&!I[*\@N8
M58JSPR!U##J"1T(H LT5G0ZO8:FL\&EZI9S7*)D^7(LNS/0E0>E8/@GQ1_:'
M@/1]5U[4+6*[O0P+R,L0=M[ !1QV X% '7T51O=9TO32@OM1M+4N-R^?,J9'
MKR>E2R:C8Q7,%M)>VZ7$XS#$TJAI!_LC.3^% %FBLJ^\2Z+I]A?7MQJ=J(;$
M9N2LJL8SV! .<G' ZFI=$UBUU[2+;4;.6-XYHU8A) _EL5!*DCN,T :%%91G
M;_A*-G]M6PA6S);3-J^8&WC]]NSN"X(7&,<]:</$>AM);1C6=/+W3E(%%RF9
M6!P0O/S$$8X[T :=%%46UK2DU%=.;4K,7K'"VYG7S"<9P%SG..: +U%<3JGB
ME;[QA+X8L-=MM.ECLO-%PK1.QN&D*+%M?(.,$E?O'(Y'?.T_Q)JWB2ZU#2K#
MQ+IEOJFG"".)HE22&]D\L/*VTY;9S@;2",$Y/0 'H]%4+;6M+NKUK&#4K.:\
M0$O!',I<8X)V@YZTLFLZ7%?K82:C:)>.P58&F4.21D +G.<<XH O45A6'B[1
M]2\1W^B6U[ ]U9A X$@RSL&)51W*A03CIGV-:=[J5AIJHU_>VUJLC;4,\JH&
M/H,GDT 6J*J)JNG27[6"7]JUXHR;=9E,@'KMSFL[4=3@NH;)]/\ $5C:*;Z.
M-WRDHGP<- ,GAFR!QR/2@#<HK 3Q9I5WXDO/#UM?VZZA;Q*3N<'#MN^0+D;F
M 7) Z9%97@3Q>FI^%]*?7-5LQJ][).J1,Z1M+MF=!M3.3PH''I0!VE%(2 "2
M0 .I-4(->T>ZN8K:WU6RFGFW&.*.X1F?:<-@ Y."#GTQ0!H451M=:TJ]O'M+
M34K.>YC&YX8IU9U&<9(!SC/%$>M:7-=_9(M2M'N<L/)692^5^]QG/&#GTH O
M45EGQ)H0E@B.M:<)+ARD*_:DS(P."%&>2#QQWJQJ&KZ;I**^HZA:VBMG:;B9
M4!QUZGWH N456N-1LK2U6ZN+R"&W;&V620*K9Z8)X.:R-8\9Z'H^FV5]+J%M
M)#>W$<%NT<RE9"SA20>F%R23VQ0!T%%1Q3PSP+/#*DD+KN61&!5AZ@CC%8^@
M^+='\1SW\6G7D$IM)VA.V0$N%"Y<#KMRVW/0XH W**HV>LZ7J$[P66HVES,B
M[FCAF5V Z9P#T]Z?J>IV6C:;/J&H7"6]K A>21SP!_4^W>@"W17!ZGXRFN;;
MPAJ6CWMNMGJFHP6]U$ LC*'C:0J6S\I& ",9YKL-/U;3M6BDETV_M;R.-RCM
M;S+(%;T)!.#0!<HJC::UI>H74EM9ZE:7%Q&-SQ0SJ[*.F2 <XJ]0 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !7A?QO^'GBCQ1XBL=4T6W
M-];+;"!H%D53$P9CG#$#!R.1Z<]J]THH YCX=Z%?^&O >E:1J<HDO+>-O,PV
MX)EBP4'OM! _"NGHHH *X/1[NVM?B[XLAGGCBEN+6P,*.P#2867.T=\=\=*[
MRH9+.UFE,LMM"\A0QEV0$E3_  Y]/:@#Q*QALXO@GX8O$2%9QK,#^< -VX79
M&<^NWCZ5O3:CI?\ PE?C'1/%&N-I8NW5HUF:)([BU:%5 5G0]"'X!ZDD#.:]
M)_LG33&(_P"S[38#D+Y*X!]<8IT^FV%TT+7%E;2M <Q&2)6,?^[D<?A0!YLF
MDZ.OQ \(6/V?SK8:'<)&EZH:1T&P)O!')VYX(_E49N]'M?%'BSP_XAU<:-!<
M",6\3^3%#-9^2J!4+H>%(<8!&"3@9S7I[V%G)<BX>T@:<$$2M&"PQTYZTESI
M]E>R1275G;SO$=T;2Q*Q0^H)'% %7P[:VUEX<T^ULS<&UB@5(3<_ZPH!\N[\
M,=>:X(0Z:_B7XHVUW/\ 9;*2TM%N)(< QJUNX9OPSFO4*K#3K$/(XLK<-("'
M81+E@>N>.: .,\+7>M6WBYM&UT6>H3+IWG6NL6@V&6'>!ME3H&R<@CCKCO2_
M%2*VET?1/M"1L/[<LE^<#H9!D?EUKL[33[*P#BSM(+<.<L(8PFX^^!S2W%G:
MW847-M#-M^[YB!L?3- 'FVLPSV_Q \2V^A(L5\_A0-"D("DRB20(0!W' 'X5
M4U![?5OA'X4.BL@U2*>R2R5/OQSJRK(#W! \S=[ DUZFFGV4<XG2T@68=)%C
M ;TZXS38M-L8+N2[ALK>.YD^_,D2AV^K 9- $6MM=IH&HMIX)O1:RFW Z^9M
M.W]<5Y+=:WH>H?"KPI:V=W;R7D5[I_G0;@98Y1*HD++U!W%LD]=WO7M-<EXP
M\*RZOI\46CVNGP7#7T%W/+)F,R>6X?DJA+$XQD]* ,FUU"RTSXH>,!?7,-N;
MBQLFA61@#* LBG:/XN2!@=S7->%-:TN#PM\.X6DM4O?+N1#>W$I$5J54APRA
M@&<A@ "1C)/L?7VLK:>>&ZN+2W:ZC7"R% S)GJ%8C./RH;3K%H(8&LK<PPD&
M*,Q+M0CH5&,#\* /#[N>PF^%7B^%KF&=X?$;,&)4,%:ZCPV!]W(R>,=Z[?QQ
M:Z9HUWX1GA@M+*V.OQ/-(B+&A/DR %B,#H ,GVKN'TVPD#"2RMG#OYC!HE.Y
MO[QXZ^]2/9VLMNMO);0O N,1L@*C'3CIQ0!YA)JVDOXO\5Z9XBUTZ;#?I%);
M&5HDBN;1H0N%:1#T;?P".6) ZTHTG1H_'/@:Q2$S6@TJ[2);U0SR(!'LW CG
MY<X!' [ BO2[G3[*]>)[NSMYVB.Z-I8E8H?49'%+)8V<MP+B2T@>9<$2-&"P
MQTYZT <9#';VWQJBM8$BBCC\,A$BC 4*HN.  .@QVK*L[&?2_$5]X!2W;^RK
MZX&I6[A?DCM"Q:>(^WF )CTEKT6>QA+27,%M;"]VGRYGB!(;&!DCG'XUF>']
M-UB.234?$,]E-J<D:P@62,L,2 DX7<226)R3QT48XY +\>M:9+K,VCQWL#:E
M#$)9+8-\ZH>A(].1^8]:R/&UHM[IEE NK?V7>&^C:RN2H9!.H9E5@>"#@C'J
M16J-'MSKW]KLD?VA83"A6, [203N;JQ^48]!GUJY<VMO>1>5=013QGG9*@8?
MD: /'/$U]<7G@37X=>T^RM]1L-8LUNKJU),,S%H?WBD\J=FT$=JWM<T=(/B1
MHD_AFW@@NETN\^U?9E"J8]@$&[''^L/'T/I6_P",O#-QK'A8:-HL%C;K]HAE
MQ(3$BA)%? "J>NW';K70V-C;6,)%O9VUJ7PTBVZ  M]0!GZXH \K\+W'AOQ!
MX=\,6UYKEVVK:;/"5TP-$D\=TGRME0@<KG<6).",DFI]#U3PY>:'XA\.^+I(
MO[0_M6=KJSED*37),FZ(Q@$,W 0+M_N@=*].33[**\>\CL[=+J08>=8E#L/0
MMC)I7T^RDO4O7M(&ND&U9S&"ZCT#8R* .(ED@M?C1/,8\-_PC!DD1 -[8GSV
MZG%<C::QI3GX=W5K>65K8QWC^59QR[VM4:*08ED8DEB>#T&<C!QFO9OL-I]I
M^T_98/M'_/7RQN_/K3$TVPC $=E;*!)YP"Q*,/\ WNGWO?K0!R7A9U;XF^/%
M# D/8Y /_3"F_$*YDLM2\)W5P<:/%JJF]8_=1BI$3/Z*'(.3P#CVKLHK&T@G
M:>*U@CE;.Z1(P&.?4U)+%'/$T4T:R1N,,CC(8>A!H \]U*T67XF:K<6PC:R;
MP\1J/0HTF\^5N[;MH;KV'TJ_\+-/T^/X?:!>P6MN+IK%4>X5!O(SDJ6ZXR.G
MM760Z;8V]H;2&RMH[8]84B4(?^ @8J6WMH+6/R[>".%,YVQH%&?7 H XOQ/=
M/9?$KPC+>';I3K<Q([?<6Z91LW'H"5W!?J:YW7;61;CXHRV0_P")=)I(\P)]
MPW7DMOQVW;=N[ZC->K7%M!>0-!<P1SPO]Z.5 RGZ@T0VMO;6XMX((HH%&!&B
M!5 ],#B@#S+5+G3M4_X5LBRV]U ;I58!@ZDBV/!['DBL[6_.@G^*<6EQDLGV
M"5X8 ,E#&IEP.F2@;/K7K']E:<5C4V%KMB&(QY*X0=>..*DBL;2"9IH;6".5
MOO.D8#'ZD4 </I$GA3Q%XATS6++7I=6O4M9$6-6BQ' PY$R(BD#.,!OXL>]-
M^#^GZ=_PKS1[Z*UMC= 3K]H"*7 ,K9&[KC 7CV%=M!I>GVR3);V-K$LYS*L<
M*J)#_M8'/XU+;VEM:*5MK>*%2<D1H%!/X4 <;\2)HK=_",\\B1PQ^(;<O(YP
MJCRY1DD]!5&UL='U7XOZN)K6SNXI=%MI LD:NKYD<[L'@\;>?I7H4]O!=1&*
MXACFC)!*2*&&1TX-1K86:7/VE;2 3]?-$8W?GUH \8\2ZOIEQX8ULV<]M8)%
MXB1I+1GW3O*MQ&'E<L?D7C(  P .><5U>CZY91_$_P 4)JUW!'Y]K:OITD[@
M)):["6V$\$;R2<?TKNFTVP=IF>RMF,^/.)B4^9CINXYQ[TZXT^RNY(I+FT@F
M>$[HFDC#%#ZJ2./PH \2LY+%_@EH(C> FWUU%&",QYO6./;Y>?I7;16EC-\;
M[_S+>W=AH4+X9 ?F,S@GZX(&?0UVK:98- D+6-L8DR40Q+M7/7 QQ1_9EAYA
MD^PVV\C:6\I<D8QC./3B@#QW3YK>W^$OAFZ-];VZ6/B R1QS2!(I0MS+B,MT
M4;?F!/ VBNT\)PZ=J'C+7O$5M?:;.]ZD")!;7$<SQK&I4NY4D MG& >BCGL-
M#Q%X=O+E+$Z(NF1I;S&6:RNH/W%SE2HW%>05SD<$9QQP*-#\-/;:G'JEYIVC
MV-S'&T:)ID6,AL9+.54MTX& !UYXP 9OQ36%M$T;[2$^S?VY9>=YF-H3S.=V
M>,8]:9'I=K%\8+:ZT:"*&./2I%U(P*%0Y=?)#8XW<,1WP/3%=U+%'/$T4T:2
M1N,,CJ""/0@U%;V%G:6IM;:T@AMSG,4<85#GKP!B@#R'0]3TZS^&OAC[7'"[
MR:]*+:>:4K#;RB>9ED<@C( SA2>21TZU3O[]SIWQ*2QO%OIC<VEQ(MO@&: )
M%YQ51_#MW#//'<]:]G_LK3C;M;FPM?(<@M'Y*[21T)&,5,EM!%(\D<$:22 !
MV5 "P P,GO@4 <QINI^$=>UNTU72I[:\U!;)HUEMY,^1;G!Q(H.%YP &&<YQ
MT->??#353I-EX9;73$^EWL#0Z3==$MKC>^^-^V]QT;TRH[U['!IFGVT,L,%C
M;112G,B1PJJN?4@#FF_V3IQB$7]GVOE@[@ODK@'UQB@#C/#ES%_PF?C>QUPQ
MB:26.51/@+)9>7M7&>"H^;/8%CGK7)Z2)M+\/?#>?5)3%;1:K.L4MPV-D+)+
MY(8GIE=N/;%>P7&EZ?=^5]IL;:;R?]5YD*ML_P!W(X_"I;JTMKV P7=O%<0G
M!,<J!U..G!XH \HN+^SO;[XM"UN(IC+ID31A&!W@6C E?49[BO0/!EY;7O@[
M2&M;B*94LX48QL& 81KD''?FMB.UMX6D:*")&DP'*H 6P,#/K@#%+!!#:PK#
M;Q1Q1+]U(U"J/H!0!Q#1V_\ PO+;LCW2>&VWC ^;_2%Z^O%<-]GL(O@1=W<4
M5NDR:ON650 RD7X P?93^1KVM]/LI)S.]G;M*PP9&B4L>,=<>E,_LG3?+\O^
MS[39G.WR5QGUQB@"V<E3MQG'%>->';C0M<\)66DZ]KEW'K-E>9ETP-$EQ]L6
M0G*#9O)+'.<]SD]:]D1%C1410J*,*JC  ]!4 T^R%\;X6=O]K(V^?Y2^9CTW
M8SB@#D+>2,_&^_0.I<:!#\N>?]>_^(_.LFU:ZENOBHFE.6U#<! (S\PD^R@+
MCWW#'U%>B_V=9"X^T?8[?S\[O,\I=V?7.,T0Z=96TOFP6=O%)_?2)5/Y@4 >
M;^';GPMXCC\+7,.N7%QJ-CM^S6$;1+);MLVR*Z*@8( "#G@@<9)&8/"&J>'=
M1\%V^B^(VBDURTU!VN+!Y"MQ)>"9F5E4$,Q)(.>F,YX!KT^'3[*VN9;F"SMX
MIYO]9+'$JL_U(&3^-*+"S%\;X6D'VLKM,_ECS,>F[&<4 <9X=NK>#XK>-+:6
M:-)YS8F*-F :0" Y*CN!@YK<\:Z$WB+PC?V$)VW>SS;5^Z3(=R$>GS ?@36W
M]G@^T_:?)C\_;L\W:-VWKC/7'M4E 'CS>(=0?4-#^(=O8R>3>PC2)K0)AG9A
MN5O7 N,Q_3GO6WXUTZ#2]'\&P2&-IHO$%ENF8 %W+DNW_ F))^M>A>1#Y2Q>
M5'Y:D%5VC (.00/KS3+BRM;O;]IMH9MOW?,C#8^F: .+TV[MK7XQ>(HKB>.*
M6XL++R4=@&DP9,[1WQWQ7#VT5G'\#-*O42%9QK*2"8 ;MPOB,Y]=OZ5[8]G:
MRR"22VA=PACW-&"=AZKGT]JB_LG3?+\O^S[39G.WR5QGUQB@"VRJZ%6 92,$
M$9!%>/Z!ID<OPC\07.D6<#ZM'+J2V\L48,J$NXPAZ@E>!CVKU_RH_*\K8OE[
M=NS'&/3'I45O9VMH&%M;0PAOO>4@7/UQ0!Y]H5UX4\27_AO4K/79[S4+1&^R
MVD;0J]NK)AUD1$4A0!CGC.,=1FGX;DO-)O\ PUI[2VNO>'+[S!I=X%VW-J/*
M8E9 .'7;E2?7KV%>EV^GV5I-+-;6=O#+,<RO'$JLY_VB!S^-,ATRRLGDGLM/
MM(KAEQN2-4+>Q8#./SH \;M=*T6[^"OB'=:VSWBWEVD)1 95G$S>2J]P<E0
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M!UKJ?%REO!>NJH))TZX  [_NVK0M=.L;%Y'M+*WMWD.9&BB5"Y]\#FK/48-
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M 44V21(HVDD=41069F.  .I)JKIFJ6.LV*WNFW4=U:NS*LL1RK%25.#WY!H
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M\CI77URGARP\90M!#XBU+3)K>U&%DLT<2W)Q@&3=POJ0N<G'('!ZN@ HHHH
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MM!QM'#=>* .NMM8TZ\U.ZTZVO89KRU"M/"C9,6<XW>AX/%7JXG2/^2O^)O\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MO%F7*N(I(PK+@GKNPV<XQV]ZV7\,7UUXWN-7O#:26-QI TR6-68.WSLQ;&,
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M#-:U% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M/I$GQ7DT3$4X6Q8BW(#*&3$K#'0@%R3V/-=!K8T1?%WPYNM-^R+ 9)UMWBP
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M7_\ 1H"RZ;:N/D'#%Y,GZ^]1^"=.T^76/&\;V=LZ#5VCVF)2 AACRO3IUXH
M[#2);I-$ADU6]L[BX529KBV&R(X)Y&2<8'!Y[&KEO=6]W")K:>*:(]'C<,I_
M$5XOH&I1Z=X$^&C:@X31'NI%NV?_ %8?$GD[STQOYYXRH/:M_P 8-I&DZ)KE
M_HTK&.XOK.76&MV\Q%BWJ'PO(!*#YAW##/!H ]'M[VTO%=K6ZAG5#AC%(&"G
MT..E(M_9OG9=P-M3S#B0'"?WOI[UP;:1X>O-2O=4MM8349KK2)(I+>$1&&2$
M<J[JJ]02 "?IVK+T'PQIEQ\(]'NK9[;3M5NK2UC746B#EG\U&1'_ +REU5<'
MMQT&* /4K>[MKQ-]M<13I_>B<,/TITT\5O"TT\J11*,L[L% ^I-<AX+U"\GU
MG6['6-)M['6K<0-=2VC;H+I6#!)%SR#A2"#SP*B\1W3)\3_"EK>@?V;+%<F+
M=]QKH ;<]LA=VWZG% '7O?VB6+7OVB(VP7=YJN"I'L>E<OX8UK6_$D6E:U!<
M:>=+NXV>YLRI\VW!R8]K G)Z!L@=R/2LO3;(0>+_ !W:11(=&,$$S0E08TN6
MC)? Z D!6/N0:U?A;!#%\-= >**-&DLT+LJ@%C[^M &W<^(=-M=>M]%DNHUO
MIX7F6,L/E52!D_4MQZX/I61X4\2W.H'7$UFXLXWL]8ET^ H/*5U54*\,QRQW
M'O6;JT5DGQETB6Y2W4-H]PQ:0 9821X.3W KE;O2]/O/!?Q0N[BTAFN(=3O3
M%)(H9HRL4; J3]TYQT]!Z4 >Q7-W;647FW5Q%!'G&^5PHS]34JLKH'1@RL,@
M@Y!%>8G4XY/'%A::QJ2VD5SH,+V3SJC)*Y9O. +@C<1LR.X%=;X)TS3]'\.)
M8:5?S7MC%+((II65AC=DJA4 %0<@?0T 17_B2YG\5CPSHJ0->Q0"YO+FX!:.
MV0G"C:""SMZ9&!SGM5D7'B"TUG3[:Y6RN[*Y9UEN(8FB:(A"R@J68$''WL^V
M.<URFCD:#\;/$<>H,(UUZWMYK"5S@2&)=KQ@_P!X9SCK@5WM]>>2IMX"'O9(
MW:&+KD@$Y/HN<#/J0.] $OVVT^U_9/M4/VG&?)\P;\>NWK2S7=M;[_.N(H]B
M[VWN!M7IDY[>]>08AU'X "_7=_;4#>=YP&)UOQ-@\]0Y8X^AQTK=M-)L[OXO
M7B:C8VLLDF@6\L\;1AD:7S7!8CH3QC)H ] -]: P W4 ,_\ J1Y@_>?[OK^%
M.GO+:V#&>XAB"+N8R.%VC.,G/;->'MIEA#\"[O4$M8A>6FH,+>X*YDA"WV%"
M,>5 !/ XY/J:ZYM#T?4OC-JUO?:?:W$;Z-!*T,L897;S'4N5/!.,#)Y% 'H;
MW5O';?:9)XE@QN\UG 7'KGIBFI>6KVOVI+F%K;&[S@X*8]<]*\@\/_9=/TW3
M-*D5YHQXFNTT+S9BL BCW89SSN4'?M'=L8(ZU1U#[+/\._B7!++:7#1ZG)-'
MY2@*&VQ9=%R<<D]^IH ]N6\M6EDB6YA,D2[I$#C*#U(["D6]M7B>5+F%HT^\
MXD!"_4UP5SIMCI?Q.\'FQM8;=KNQODN&C4 S +&PWGJQR2<G-9Z6;:%KNK>
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MG# 'TXJ:N#TW2K;6?B.OB86MI%%!I@MUC9X99#+OR'&PL%VK\N<Y.['2N\H
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@"NEA9QM<LEK K71S.1& 93C'S?WN..
M>U+9V5KIUG%:65O%;VT2[8XHD"JH] !TJ>B@ JC?Z+I>JM&VHZ;9WAC.4-Q
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M&><>U '*C2XM&G^*%IID2P:.--#B",8CBN&MW+A1T'&TD#U%7K&ZLC_P@5J
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M)]Z6_P##FB:K#!#J&D6-U%;_ .I2:W5Q'_N@CB@"KX-L+/2_"=A8Z??3WUG
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MX5C!/OM HO=*T[4S$;_3[6[,+;HS/"LFQO49'!^E '"6::?!\2?'!N&BMO\
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M_#USK'C?P]?MI\-QINGI<+.)77),@4*54_W2N>WM73QZ9816#V"65NMFX8/
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M:B^H1Z?:)?.,/<K"HD8>A;&34<&@Z1:WS7L&F6<5TS%S,D*ABQX+9QU/<]Z
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M3V<H^&O@[QC;0^?J>A65O<L<9>:W,069,^NTDCW'O7:^%O+U!+OQ$$P=4</
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MJP&:OT %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MO\A. O0'J=QZ=^^H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M6FEZ?8"06=A:V_F_ZSR853?]<#FEN-3L+25(KB]MH9)%9T6255+*HR2 3R
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MFML$$ @@@]"* *T&FV-M=2W4%E;17,W^MFCB57?ZD#)_&E_LZQ^W_;_L=O\
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M/-7YF(8LH'<J%R<=,^QH LV&DB'5;O5KDK)?W*+%E?NQ1*25C7VR22>Y/8
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M>0\EDSF3S8R_S8D'3&.*O>"O&J>(O")UC5!;V#PSR6]PQEQ#O0X+*S?PGWH
MZ,:5IPDCD%A:AXP C>2N5QTP<<5C^(?#DMWI7DZ&NGV<_GQRR)+;_NKE5.3'
M)MP=I./7IC!!-;)U/3Q-;PF^MO-N5W0)YJ[I1C.5&?F&/2N?\-ZOJ5[XO\5:
M;?3QRP:=-;K;A(@FU7BWG/))//KV[4 1:7X6E.IVE_J.D:!82VCF2,Z9&6=V
M*E>7**0N&.1@YXY]>OJC::SI=_<R6UGJ5I<3QC<\4,ZNRCID@'(%7J "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "O/\ QG:V$WQ+\"B]A@99'O4/FJ,.
M1$"H.>O.,#UKT"N3\1^'+W6?%OA_4!!836&G?://BN)#ND$J!>%V$<8SR>?:
M@#DY-.BT^Z^*+Z>B0Z4^G %(QB,7/D.9-H' ."N?<U8M-5T^V'@*"1[:VOCH
MOF0W]U(1%$GEQAU5<@,YXZG@ GGI7HXT^R6S%F+.W%J.D(B79US]W&.M-_LO
M3RD*?8;;; V^)?)7$;>J\<'W% 'B43V%S\+;6!I8)F@\3JI#;<HK79[?PY&3
MCCBN]M8;:S^-LT%M'%"K^'49HXU"@D7! .!Z#CZ5V#Z5ITBE7L+5E+F0AH5(
M+'JW3J?6E33;&.X%PEE;K.!@2+$H8<8ZXSTH H^+8XI/!VM+,J-']AF)#C(X
M0UYR+>SN=,^$8GBADWI&AW@'<!:GCW&<<5ZU-!#<Q-%/$DL;=4=0P/X&JW]C
MZ80@_LZTQ']S]POR]^..* .3\(K##\1O'<$ 1(Q+9/Y:8 !,')P/7%6/B>J?
M\(3-(]Y%;"*YMY 9FVQR,)5(1SV4G )/ ZG@5U,-A9V\[3P6D$4S_>D2,*Q^
MI K)\5Z5J6K:=;QZ9/:I)#<)-)!>1EH;E5S^[?'(&<-D9Y4<&@#E;=8-=\5:
MOXDTF]TQ[_\ L;[+:6T%U%/)YH+-YK;20.6"CGIG..E8ERT.J? /3(]/.-9@
M:VCMU!Q,E^LJAN.H?.\GO@DUVVD>%Y%U2UU*_P!)T+3Y[5F:/^S(R6<LA0[I
M"JG;AC\N.N#GBNC33+".^:^2QMENV^].L2B0_5L9H XOP]< ?$#QG9:T8Q/(
ML#PB;&V2T\O'RYZJ&W9]V.:X[0[FXT6W\ _VO(T?A\7]]Y,DY^1 =PM2Q/;!
M8KGU![5[+=Z;8:@8S>V5M<F,Y0S1*^T^V1Q4ES:6UY;M;W5O%/ PPT<J!E/U
M!XH X7PO=Z>_Q:\9"VN+=FF@L6Q&X.\JKACQUQQFN@\=,J_#[Q(6( _LNYY/
MKY35L6UC9V9)M;6" E0I\J,+D#@#CL*?<6T%W%Y5S!'-'G.R1 P_(T >=3ZG
MI]IIOP\CE%NEU- 'M+RYD*P6Y%L S, 0&8AL*"1R<YXYYM9[*X^&/Q)A-U!=
M.FI7DRGY>ZIM< = 3G!'X5[&=*TYK=;=K"U,*OO6,PKM#>H&,9]Z5]-L9%E6
M2RMV65]\@:)2';ID\<GWH X+4KNVM/&_@"YN9XHH#I]V!)(P"D^7%@9/>LUK
M6RN8?BO+-#!(ZF0;G4$J/LH/7MR/S'M7J/V"SV0I]D@V0-NB7RQB,^J^A^E1
M#2-, D TZT_>??\ W"_-SGGCF@"EX.D,O@C09"VXMIUN2V<Y/EK7"^+=3TY]
M0\=644EO972:4D=T]P^Z2[S"[(D2$X &[!(!)+=!C->H06\-M$(K>*.*->B1
MJ% _ 5')8V<MS]IDM8'GV&/S6C!;:>JYZX]J /++4:=J6M_"MV%M<[M.G5R<
M-N9;>/@^I!S]"*S-7F>QT'QZEHA^Q1^(86O(X1TMR(O-X'8X(/MFO8_[*T[=
M$WV"US$ L9\E?D Z <<4Z'3K&W,A@LK>(R##E(E7</0X'- ' ZKJFC7/Q5\$
MW%G>V4@DM+U0\4JG*E4V#CU^; ^M=UJZ12:->I,J-&8'W!P",8/7-+;:1IMD
M4-KI]I 8]VPQ0JNW=C=C XS@9]<"K,L,<\3131I)&PPR.H(/U!H \9L[>SM_
MAQ\,[F**&.9M7L<RJ &).X-D]3QP?I73>&9[:75/'NG^(3&)FOGDE$Y #6)C
M41GG^ *&]@<^M=L='TLQK&=-LRBDE5\A< GJ0,4ZXTO3[R6*6YL;:>2+_5O+
M"K%/H2.* /(]&>XTS3_A5+KLWDM&]V&DN6V[4,+^4&)Z';M'->S*P90PY!&1
M4<]M!<JBW$$<H1@ZB1 VUAT(ST/O4M 'A]SK6E7.B>&;JSN;6QLE\41RBR:3
M=-%^_??),S'*Y))Q@ !@,FMS6KF\T:[U76M-GM=9T*748FU'3)AB>";,:JT3
M#J>(V"GVQ7I/]EZ?^\_T"U_>R"63]ROSN.0QXY/O0=+TXW@O#86IN@<B8PKO
M!]=V,T 6B P((!!X(->-V.DZ!=>!OB(+RUM"T6J:@H8H-\9!S&%[CYCP!W->
MR-G:=H!.. 3BN1\)>$Y=*FU2?5K/39;BYU.>^MYHOWC1K(V0N60$$>U '+6U
M[';75KINI20V6MQ>&(([VZO'):53G]U&A.TMNSEN><#![9.F'3K_ ,+?"L2&
MWG*WBP29(8C$+_(?QV\>XKV>2SM9KF.YDMH7GB!$<K("R9ZX/45"='TQDC0Z
M;9E(QA%,"X49SQQQS0!Q5\FFZ'\5] C5+6PM#I5TD2*JQH7,L9PH&!DY)P/6
MNWU3[5_9-Y]A_P"/SR'\C/\ STVG;^N*FEMH)Y(I)8(Y'B.Z-G0$H?4'M4M
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MQJK/CY59MH)]S@X_*N3\"^$G\.Z%;VVIVFG/J$$DK+=0#>Q#R,^-S*",;L4
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M(%B7=G'<8Z=:Z6TNH+ZS@O+:026\\:RQ..C*PR#^(- $U%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !2,H888 CW%+10 @4*,* ![4B1I'NV(J[CEL#&3ZFG44 ,\F(S"
M;RT\T# ?:-V/3-#11O(LC1HSI]UBH)'T-/HH *0J&&& (]#2T4 -\M-A38NT
M\%<<&E      '0"EHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M;5/"EZ;FU']AI(KKAOWV^/RSC^[QSW]*Q6^'VM6WAO6O"^GZK9#1+[S6MQ/
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M\0(<%P0 ?X2>P!Z;P;<:E%>7.FW/]A3P*AF,^CAU59">1(&)RS9)SG/!SU%
M'8UQNK:[XB_X3L>'-+734CETQKQ)[A'8QL)%3D C<.>@QUZ\8/95P&I&\'QK
MLC8_9VD&@2%DF)4,OGKP" <'.#G!Z$>X .?\2^(]0UWX1>,;36+>"'5=*F%I
M<_9\^7)AT*NN>0"#T-=QXBU?5K#43% ]G:6?V1I([B=?->>XR<1+&K!B !DD
M ]>V*S-4\!7%_P"#]<TI+V%=0UNY^T75RT9V*<KA57.<!451D^I]JN7?AG69
MO%C:U!J5I$ESIXLKB*2!I#%AB=T1W#&<\@^@//2@#*_X3C6KO1_!=_9VMBIU
MZ18IHY=_R,49LJ0>!E>X)_G6UX7UO5;O7]?T35S:2W&EO R7%K$T:R)*A8 J
MS-@C!'6L:P\!ZO9Z1X4L7U*RE.@W'G;A"R^: K*%ZG'#$Y]>U;^D:!>:?XPU
MW6I9X'AU18 (D!W1^4I4<]\YSVQ[T ='7):QKFMP>.M/T&Q%@L%[933B69'9
MD9"HR0&&1\W3C/J*ZVN<OM O;GQSINOQSP""SMI;<PL#N?S"I)ST&-HXH Y;
M_A+O%K>%_$.H*='6X\.W-Q#<$P2%;L1*'^4;QY>5([MSZ5T%_K^INUC);&TL
M;&ZL/M"7$Z^<[SG!6%8U8,>"22 <]!BJ2>#-3'A_Q9IC7EINU^XGF$@5OW'F
MH$(Q_%@#KQ3[?PCK5IKFG:C;ZI9KY6E)ILZ20,^T*V?,B^88+<9!R.!UQ0!G
MMX[UA_ _ASQ6L-C#8W4D2:H'B=S C/L,B$./E!QP<\'VKK[:_O+KQ+>VL;0'
M3K2&,.?+.\SMEMN[=C 38>G\8YKE[.QTKP;\/XO"OBK5[*6.2WF@BC \MIX^
M<JBDDL_S#IW(P/7H/!6BRZ!X2L+*YD>6\\L/<R2'+-(0,Y/?'"_110!OUR.N
M:[KEKXVTG0]/6P$.H6T\HEG1V:-H]O) (R/FZ<9QU%==7.:CH%[>>-M(UV.>
M!8-/@FA,+ [G\S;DYZ#&T?6@# MO'E_;^'[XZC#:RZM;ZW_8D)B#)%-*S*$<
M@DE1ALD9/W3SS6I/KVJZ3XOT[0M0DM)H]7AF^QW44#)Y<T:[F5UWG*D'(((/
M&/>LZ3X=W%[I6N6EU?Q1S7VJ_P!K6EQ A)M9AMV\'[P&WVSD]*W(M!O;_7M,
MUC6Y+4SZ9%(MO%:AMIDD 5I"6Y^Z,!>V3R>, &9\,+G5+[PQ)=ZE>QW+27MT
M,B$JVX3N"2=Q&..  ,#CFNVKF_!_AV]\,V=S8S7L-Q9_:9IK8)"5<"1RYWDD
M@D%L< ?X=)0!YY<IJ<GQ@U--)EM8;AM"@_?7,;2*G[Z3^ %<_F,>_2K.E>+M
M7U?P9HNKK#8VK7,[Q:A<ROB*V5&="RJ6!.YD  SQN[XK5CT"_B\=WGB)9K9H
MI[!+-8"&##:S,&+>Y;&,5S]EX UG3M(\/V]MJMD;G1KV>Y42PLT,PE+D[ER"
M&7>=IS0!);>+O$.H>$/$E[IT5E-J6C7LT""2WD5+E$57SLW!E8JWJ>1[\;ME
MX@FU5=#FL)[5[:[M3>73M$W$6!C;AOE)9L8.?NMZ4WPKX;O] O=;ENM0@NHM
M1O6O J0%"KLJAL_,>/EX'YDT[PEX1A\+6U];QS&:*>X=H58<0P%F98A[*7<_
M\"- &%%XSUV_LM+UC2]/>[L[N9=]D+&4.ENQXD$Q.TL!@D8QR0.F3Z#7":!X
M.\1>'\:/;Z_ WAJ.0M"C6Y^U1QDY\H2;L8YQNP3CICC'=T 8_B;7!X?T?[7Y
M?F2R3Q6T*8)S)(X1<@<D#.2!R<<<UA1Z_P")(]3O[8V:W%FMBUS;WSV,MLB2
MJ>8G5CD@CD$8]/>MOQ7X=C\4^'I]+:XDM9&9)(;B,9:&5&#(P^A K/T_2/%4
MEA<)KFKV-S/Y#00+;0-%&2PP9).3N;V& ,GU& #!L?&?B-M,\(:S>)IIL=;G
MAM9;>*-Q(C2JQ#ARV,9'W<'CN>S[#6]1TWQ3X\OM3OHI[#2$A<Q+;D-Y8@,H
M5#OP.6.<@Y/IVLCP1J:^&/"VD+>VF[0KN"Y,I1L3"($!<?PYSUYZ5=;P9--K
MWB2:>\A;2M?A1+FW$1\U2L/E85\X QSTSF@""V\1>(Y-5TG;8_:K&^4BYV6,
MT/V,E<JV]SAUSP> >_M5'2O%WB.XL=3UF^&E1Z5H]W>Q7B1I)YLB0@X,?S8!
MR!UZY/2M/PWX>\5:4EO8:GK]M>:99 "#R[=HYY@OW%E?<1@<=!DXY/4&30O"
M$MGH>NZ1JLT-Q;ZM<W,[^2"I59\[EYSTSP?TH K6GB/Q#)JFC,+$W5A?<72Q
MV,L1L\KE6$CG#KG@\#U&.E<YXRUO4O%'P@UW6[22UCTN59%AA>)C))"LFS>7
MW8#$J6 P1C [Y'3^&O#GBC25MM/U/Q!;7FDV6! 8[<I<2JOW%D;=C XZ#)QR
M<9SCO\.M;@\):KX1L=6LAH=R7-J9H&,T"NVXQY#8(!)P>OMZ 'HMM_QZP_[@
M_E3Y-_E-Y1428.W=TSVS4=G'-#9PQ7$B2RH@5W1"BL1W )./S-2/OV-Y84OC
MY0QP,^] 'FR^.]>;X=Z9X@2WT\WEQJ7V2:,JX3:;@Q#;SD' ')S].U;-IK6O
MCQ?J'AR^FT\R-IHO[2X@MW BRY0JZE_GP<'(*Y]!6='X U2/P/9>'?[0LR]M
MJ(O?/\ML,!,9MNW/')QG/2MY?#]\WCW_ (2)YK<0MIOV P*&W#Y]^[=TZ\8Q
M^- '*>%?%.IV7PZ\.W%U<07>H:U=K;VQ>(KM>21R[R'=\P !. %[#OD=-!X@
MU"P\<0^'-5^SS)>VK7%E=01F,Y0_/&RECV(((/MBL:V^'-]'X-L-$EU>'[3I
M%TESI=U';D;&1F8&0%OFR&((&!716NA75SXDM]>U=K?[5:VS6]O#;[BB;R"[
MEFP23M  QP,]<T =#7/ZWKTUKX@TC0;+RA>ZB)9#+*I98HHU!8[01DDD <CN
M>V#T%<WXC\-3:GJ^D:WIUS';ZII;OY?FJ3'-&XP\;8Y&1C!YP>QH Q+SQGK&
MFIXKTZ>*R?5-%LO[0@FV,L5Q#M)Y7=D,"I4\X/6M[PM=>(-0M4O]6.GBUNK6
M&:WCME<2(S+E@Y)P>HQCW'N<^^\'W6HVWB*XFGMUU/6K/[#N 8QV\.U@ .['
M+,Q/&>.!BNBT2SGT[0[&QN7CDEMH$A+Q@A6VJ!G!Z9QTH OUP?B_Q9K7A^'6
MKM18PQ6,:2V<$BF62\7 ,C':V44$E02.",G(.*[RN U;P)J]^?%5O#J]JMGK
MR@DRV[/-$P0*$#;L;./3C)QZT 2ZY,+CXD> 9P-OF0W[@'MF%#6;HOB/4](L
MO&VL:I=Q7D5CJLL2Q+ 49F"1*@4[B%7D#&">IR:WI/#&JRZYX7U*6]M'.C0S
M1RJ(F7SC(@4XY.T *,=<^U5F\ RW$/BG3;N_C;2=<G>Y"I$1-%*RJ,[LX(4H
M"!C\?4 FM=:\1GQ';61M!=6%U!(6NOL$UN+251D!MY^96Z#'(/UK&TCQMXBD
M\'#Q=J<6EC38XK@26\*R"5Y5E,<>TDD $@ Y!/?O@=!H&D^+;01KKFN6=\EJ
MI$'D0-$T[8(#3')SP>@'7GG%5=)\"M%\.KCPAJMS'-#*)E$\"E2-[M(#@YY5
MFX^E "P^(M<M=?MX[RV-SI$MO+)<726$MM]C=%W<[R=RL 0,<@US/C#5-6U_
MX9VNMLUK%87MY:2K:^43(D1G38=^[!;[I(QCDCMD]7HN@>)1 +/Q+K=K?V44
M;1*+>W:.2X!4KF4EB#P3P!UP<\5AO\/O$7_"'?\ "*+K=BVG6\T3VD\ELQF$
M:2JX5\, <8QD=>.E 'I55-5GO+72;N?3[475Y'"S00%P@D<#A2QX&3WJS&'$
M:B1E9\#<57 )]ADX_.LKQ1HTGB'POJ.D17;6CW<#1"91DKGV[CL?8F@#!T7Q
M7>W/C.'0[BXLKR*;36N_/M8F0)*KJK(#N977YNH/!&#7:UQECX5UQ/%.E:Y=
MZEI^ZUL7LI8+>T94*%E8;,MP<KU/ '0=Z[.@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHK U/6K@>)K+P]8&*.ZGMI+R6:5"XCB1E7A01EBS#O@ 'K
M0!OT5QDWB77=+L[&RU6TM(]8O]3-C:NA)B>/EO/*ALCY0?DW9SCD9X?_ ,)%
MJUCXLF\-WGV26:>Q:\L+I8V16VG#)(NX\C@Y!&1[T =A17F%MXP\8S_#Q_&!
M315MQICW(M_+E+^8I]=V-I /'4<<FM=_$NOZ=;V4NI?V>QU>6&*P2V@E=H28
MV>0R*#E\!>-N,D]AS0!W%%<%+XL\0Z;9>();K2I+F&QCCEL[Q+.2(2JQ <-$
MQW$IDG@C<!VI+KQC?#P=K?B'2=1TG5;6TM5GMI41E^8!BZ2*')!&%Q]WK0!W
MU%< _BGQ+I6L^'I-7@TU]'UN5+51;*XEMIG7<FYB<,#@YP!C\.9#XMUC4/"F
MH^*=(6S:RM))S#:2QL7N(H6*N=X;Y6.UB/E..,YSP =W17"#Q=J^J^(](LM&
M%@ECJND'4(9;F-V>,Y3&X!@&^]TX^O%0V?CR_'AT_;(;5]:_MMM#C\L,L,DP
M?;YF,DA0H+$9[8R,T =B-<TTZ]_88NE.I" W)@"G(C! W9QCJPXSFGZ9JUEK
M-M)<6$WFQ1S/ S;&7#H=K#! Z$=>E<5%'J47QJ@6[N+:=O\ A'IC$\<)C_Y;
MQY##<>_<'H?;)K3>.M>C^'=[KZPZ>;RUU-K-DV/L*B<1 CYLYYSDG\* /2Z*
MY*QUS6X/'W]@:K]AE@N=/:]@:VC96B*N%*,68[_O [L+]!6&WCO6Y_"FE>([
M..R\O4=2%D+.2)BT2M*T:G<&Y<$9(QW([9(!Z3138]_EKYFTR8&[;TSWQ7%#
MQ/K.JZ'K.MZ*++[/I\\T<-O-$S-<B'AR7##;N(8+P<<$YS@ ';T5Y[)XTUG5
MM2\.PZ"E@EOKFG2W4;7:.S0NBJ<-M(R,MC ].M=U8B[%A;B_,)O/+7SS "(R
M^/FVYYQG.,T 5]+US3=::[73KI9S9S&"?:I&QP <<CG@CI6A7DUO?ZYI(^(>
MIZ.U@HL=2DN9%NHV<RA($8H-K+MX'WN>O3O743>+Y;R\L;&Q!@FN--349)/L
MDESL5SA%"ICN&R2>W3G@ ZRYM;>]@:"Z@BGA;[T<J!E/U!XK.TO4=$^WW6AZ
M6T$<]@JM-;0Q;%B#9QT '.#TKFK3QCK4EKHVG7VFI9:]J5W-;KYL;"+RXE+M
M,%)W8*XPI(.3R>*HZ==WFD?$+QM>WYCNWM-*MIE^SQE#(BB5@,$GYN".OY=*
M /2:I6VK65WJE[IL$VZ[L1&;B/8PV;P2O)&#D ]":XM?%NOL/"$T9TZ6/Q"N
M601/_HY,?F#!#?, ,@DCKS[5=C\3:PVL>,['R['.C002VAV-A]\;N=_//W0.
M,4 =H0",$9!JE::-I=A.\]GIMG;3/]Z2&!49OJ0.:X:Q\8>(_L?@[5;Y=--C
MKLD-O+!#&XDC>2,N'#EL8ROW<<#N>M6]2\7ZIY7BZXL!:1+X='$-Q&S&?$8D
M8DAAM!!POTSSTH [NBL[0;RZU#0;&]O$C2>YA68I&I 4,,@8)SD C/O7+&XU
MJ3XP3V2:A!]DBT=9XX7MR0H:8AAD./F.P?-Z<8]0#NJ*X#P[XA\8ZW9W&HK;
MZ3)!:7%Y;O;('22=H]PCV,6VKE@ =WN:ETOQ;J<GBG2]'NI;"Y-_8RS2&WC8
M+;SQ[=R!]S*X^8@XY!'O0!W5%>6S>.?%47@_4O$C)I(ATO4)+>> 12%IXTE$
M9VG=\AQSSNR?2MS7_&$]AXEN-$2\LM.N3:K+I[7\3&.\D.[*A]R@8(48Z_-G
MGI0!VU%<?XEU[6=+EO#&UE:00V/GV[S(9GNIQN+($5@P50!DX/WLYXI+'Q=<
MZU_PCUI9)#;WFJZ9_:4SR*76"/"< 9&XEG '/ !//2@#L:I3:M96^KVNE2S;
M;VZC>6&/8QW*F-QSC QD=37!>+;_ ,60^%[47KVEC<_VY!:EX4WK<P&90CXW
MY0'NN23C&1FN@GUO5;/QWHVA3FSEMKVSGFDE2)E??'MZ L0 =W3GIUH ZJBN
M!/C#6+[P9>>,-*2S>PMVFDCLY(VWS01.RLWF!OE8A&8?*0. <]:D'BO6=5\5
M6&G:.;!+'4=%_M*">XB=GCRR ;E# -PW3(Z]>,$ [*\L+/48?)OK2"ZBSG9/
M&'7/T(IUM:V]E L%K!%!"OW8XD"J/H!Q6%X)UV\U_1)I=12%;VTO)[*<P A'
M:-RNY022 1CC-.UG7IK?Q%I7A^Q\I;R_669I95++%%&!D[01DDD <^I[8(!T
M-5#I6G-?B_-A:F\'2X,*^8/^!8S7$WOC36--@\66$T5D^JZ':?;H9?+817$)
M4L"5W9# J5/..XKHO#%SK]];B]U=M/%M<V\,MM';*X="RY<.2<'J,8]Z -^B
MN3\4Z_K.E^(?#^FZ9%9.FJ2RQ,;C=E"L;.#P>G'/KC'&<UAM\0=3\.CQ+:>)
M[>UFO-)@BN;>2R#1I=)(=J##$E3O(!Y/7VY /2**Y#4-?UCPYK&A1:LUG<V6
MK7 LF>WA:-H+A@2F,L=RG!'8CK[56T7QA<:UKDE@EW907EO>RQ76ESQ,DZ0J
M6"NC%OGR C9 (PWMR =79ZM97][?6=M-OGL9%CN$V,-C,H8#)&#P1TS1J6K6
M6D);/?3>4MS<);1'8S;I'.%7@'&?4\5Q5[XFUV?2_'L236MK<:(A^S311%N/
M(\S)RWWN<9Z#T-(NN:UH7@[P;*)+*X%_<V-I*6A=2L4H4<?.<L.>>G/2@#T.
MBN636]2UK7-:TW1IK2W&E>7$TMQ"TOFS,N[& RX4 @'J22>F.<!?B%JU]H_A
MN]L;*SBFO]4.F7D$Y8^5*N_=M8=OD]#P: /09K.UN9H9I[:&66 EHG>,,T9/
M4J3T_"IZY7PUK>K7/B77M"UAK26;3A!+%/:Q-&KI*K'!5F;!!4C.>:L>-]5U
M70O"UWJVDQV\LMF!++'-&S[H@?G(PRX(7)_"@#HJI:GJUEH\$,U_-Y4<TZ6Z
M'8S9D<X4< ]3WZ5S7_"6W"_$'3=&-Q9/I>HV!N;>5(6#E^H4MNVX*AF'&>"/
M>J^J>*-<L/#^E:HHL)$O]4A@ ,+KBVEEVHP^<_,5P?3GIQ0!W#NL4;2.P55!
M))[ 53TC6=/U[3UO],N!<6K.R"0*5!*L5;J >H-<K:W&L2_%[4K1M0A-E!IL
M,B0FW/RJSMD [_O':,L0>W Q7*:!KFM^&_AXNL6OV%M.M]6FCG@DC9I94>[*
M$JP8!"-W3#9Q^% 'L=%%<)IWB#Q1J6NZQ;J=(ALM(U%8IV:.0M)!L#MM^;AP
M#U/!]!CD [NBO/[?QCKU_:Z/JVG:>UU9WTJ&6S6QE5XK=^D@F)VL5&"1C!SQ
MTR;%IXPN-0\2W>D1W=E:WUK?^4VFW,3+++;!@#+&Q8!B5RPP#QQCN0#N**\\
M_P"$A\:ZE/XE@TJ+1EET>Z,<8FCD;SQY:N$X88)S][ITX[U-IWQ ;7[31Q81
MM;3WVGF^F;[+)<^4 _E[0J8)^;=\QXPO3G@ [VBN%LO%^MO;Z;I^H:<EIK-]
MJ$MI$\D3+$\4:%S.$)W8*C 4G.3UJIXUO_%ECX$\5M<26MO]F0?9+Z!.9XF'
MS#9N.Q@3C=^('>@#T6BJFF+<IIT(NYHI9MHR\41C7';@LW\ZY%KK5S\8GM/[
M0A%A%HPN%A:W)VJTV&&0X^8[!\QX'IZ@'<T5Y_)XSUB?P/)XUL([1].C+S"Q
M>-O,>V1RI;S-V ^ 6^Z0.G/6NYLKN*_L;>\@),-Q$LJ$C&589'Z&@!;JZ@LK
M66YN9!'#$I9W/85%IFI6FL:;;ZC83>=:7"!XI-I&Y3WP0#7$:1<:Q<>+O',5
MW?PS6UIY42Q_9R"$,!=0IW\8+G.0<^U8_A/7-;T+P9X$D/V%]*OY(-/:#RV\
MY3(&VR;]V.H^[MZ=_0 ]:HKA-1\6ZQ<QZQ)H$ EDTZY:WCMFL99?M+IC>/,4
MA4R25'7&,GK@=I8SR75A;7$MN]O)+$KO#)]Z,D E3[CI0!/17#KXPN+GQ5>:
M)'=V5G?6]Y'&EA=Q,KW%N2NZ2-RP#$@N0 #C;@CO3=2\6ZO<IK#Z! )9=-N&
MMX[=K&67[2Z %QYBD*F22HZXQD\'  .ZHKDX/$.IZWJ=QING1Q:?<VEC!<W/
MVN(R,DLP)6+:&7IM.X^X ]:KCQ'XAM=7\(6.J65G;2ZMY\=[ N7,3QQLX*.&
MQ@X'!!QGK0!VE4M6U:RT/3)M1U&;R;2';ODV,V,D*.%!/4CM7&7WC'6K6R\<
M.B6#S>'RK0$Q.%D4PB0[ANZ\XX(IFM>)/%VB^";[Q',-'=?*MI;:%8Y"4#D*
MX?YL$C<""/0T >AU2LM6LM1NKVVM9O,FL91#<+L8;'*AL9(YX(Z9KE+VXUAO
MC#8V46H0I9#2)9Q"]N6 _>QJV2'&6..#T [')-,C\<7EG:>+;C4H+=_['O4M
M;=8%8>87";-V<G.YP"0/PH [NBN-M]>\0Q:\+>33WU#3Y+623SX[&6U,4RC(
M0[R=P;H".0>M)X.\63>*)()HM0L)X_L[&]M%A:*XM)\KA"K,3M^^,XZJ.>:
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MF7< >Q(R,CVR*\P\+^*=4TSX=VFHWUS#>WFI:H]G:JT13]])<R+EVW$%1R<
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M=@Y!_P ,)O &J-\/;CPN;^SWRWAN?M/EM@ S^=C;GU&.O2O0Z* &IO\ +7S
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MGR#E69V7Y_F^;[O8KUK(_P"%=ZP?#]EH+>)HWT_3KJ&>S9K',RK&VY4=M^&
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M>K,22>3Z8 K2\.Z9=Z/H=KI]Y?+>R6\:Q+*L(B&U5"CY<GL.>3R3T'  //\
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M?@E0Y5Q]#_,]*SH?#.NSZ+?VNL>)%O;NYM7M(YELA''$KC#-L5OF8\<DX&.
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MFP9,@ ,AW=P"0OU#>V.=\4>+9-(\1MIEWJ']C0RVJMI]Y- &MYYR6W)(Y&%
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MJ^I>&M3T_5=?2YO;^V:U-PMF$CAC8$';&&^\<\DMV'&!BED\(7DE[X7N3JL
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MBCS!C"M\QSMZX]"<@'IA (P1D&H8;2VMR3!;Q1$\$H@7/Y4MO'+%;HD\WG2
M?-)M"[OP%2T %%%% !1110 4444 %%%% !1110 4444 %%%% !4;V\,LBR20
MQNZ?=9E!*_0U)10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !33&AD60HI=00K$<C/7!IU% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 (RAE*L 5(P01P:;%#% FR&)(TZ[44 ?I3Z* (9K2VN&#36\4C 8
M!= 2!^-3444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M1NK*%CSPH*],Y.2<\UUE% &3%8:PNI6,\NLK);10NMS;BU51/(2"&#9R@'(
MY]R>M:U%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M 9[:[B2>)F&Z,_;<E6'8[03CTYZ4 >P1^*-!F@>:'5[.6-)S;$QRAOWH&2@
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M6"ISZXZ>U=+?ZUINF?$36X?$.JRZ?9:E:6[6%QO AFC5"'3<01D,Q.,_Q>]
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M!&(X8TCC7HJ* !^ I]% #418UVHH5?0# ILMO!.R-+#'(4.4+J#M/J/2I**
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M@#)X%4-*UK3M;CN9--NDN$MIVMY64'"R* 2O(YQD=* +]%%% !1110 4444
M%%8\/BG1KC5H=,CO0;J<.8%,;A9MGWMCD;7QCG:3BM6::*WA>::1(XHU+.[G
M 4#J2: 'T5GMK6GIJ-GI[SE;N]B>6")HV!=4QN/3C&1P<&K5K=P7L FMY!(F
M2N1U!!P01U!!X(/(H FHIKNL:,[L%11EF8X 'J:H6.O:7J5P;>TO(Y)O+\T)
MR"R=-ZY^\O\ M#(]Z -&BLZ?7=+M;[['/>Q)/E592>$+?=#'HI;L#C/:M&@
MHHHH **S]2UO3=(DLX[^[2![R=;>W4@DR2,<!1CW_"M"@ HHHH **SSK>FC7
M%T7[6G]I-"9Q  2=@(!)[#J*T* "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "O(?BS\7=1\#:W:Z1I-C;2S/ +B66Z#%=I8@*H!'/
MRG)S7KU<WXH\!^&_&30/KFG"XE@XCD61HV _NY4C(]C0!)X(\3#QAX/T_7/L
M_P!G:Y5M\6<A65BIP?3*G%=!5;3]/M-*T^"PL+=+>U@0)%$@P% JS0 5Y_<+
MJC?&VW2.\M50:%(ZJULS80W$>1_K!\QP/FZ<?=->@5S,F@Z@?B%'XC66U^S)
MIYL/();>09 Y?.,9XQC]: ,F/Q/JEUX4U+Q!H,%@-.L))A!9O$P:XCA8AR'#
M (3M;:-I[9Z\,F\8ZWJFLZ/:>'XM.%OJ^DO?V\MX')C8;,!PIZ?-C _/C%6+
M3P;J>E:;K&AZ=>6PTC49)7C:56\VS$OWU4#AQR2N2,9YS5F+PC/8^*=$OK![
M>/3M*T]M/2!RQ=D.WG.,9&P?7VH ZBT^T_8X/MGE?:O+7SO)SLWX^;;GG&<X
MS7G7B;6]1\2_#GQ9J&GO:1:9%#=6T:21,SS)&"KON# +DAMHP>@SUX]+KSMO
M >N6>C>(?#^F:E8_V-J@G>$7$3F6V:4'<@P<%<G@]1GH: +MMKU_I^I>!](C
MBMFLM3LW$CL&,BF. ,,<X )QZ]*BTOQ+XGU'4=7WII$-AH^I-!=,1(7>!8U8
M[.>&&>_!SVQS;/A35/[4\)7;7=I(-"BDCDPC)Y^^,1\#)VX SU.?:K/A[PW=
MZ;<^(3?O;36^KW;W)2/=E-R*A0YZC"]>/I0!E6WC#7KQ-#U*STUKJQU&2/S[
M9+"97MH9!D2><3L?;QG YSQZU:'B'Q#K&EWNJ^'+:RN([>\>WALY@0]RL<FR
M1O,W )T8C(/09ZX$7AOPKXGT%(-'?7[:?P_:L/(/D,+ORP<K$7SM"CH3C)''
M'9MAX0\0Z)J>H6^CZU:1:%?W+W+1RP,UQ;,YRXB8$+@GH6!QZ'N )#?ZJOQ5
MU>*XU" :=::9#.(FMS\B,S[L$/\ >^7EL'H.!BHKCQKK$7@B+QK'!:OI9(F>
MQ\MO.%N7V[A)NQO PQ&W'49XR=>3PO=#QK-K$-U!]AN[!+.ZMY8V9R$9B-K9
MQR&(.<UEVW@74(?"4G@Z6^@ET,OL2<AA<"W+[O*(^[G^'?GI_#0 ^Z\1^)[W
MQ=>Z)H::0$33X;ZWGNA(00[D8;:>X7MT]Z?9>,+G4O$5WI,5U86]]:7_ ),F
MFW$3+,]N& ,J,6 ;*Y<8!XX]SHVGAZ\MO'EQKHDMA9RV$=DL"[MZA&+!L]/X
MB,?K5'5/!][KMS;?VDUBQM-2^V6VH1AA<Q1"4NL0XQTPI.[&/X<C- ':5P"^
M,]8M=5T*#4([%9-1O6M+FPB!:2SR&9,RABI;"C((&<\8Q7>R(7B= Q4L"-R]
M1[BO.+7P!XA@TKP_8MK&G'^Q;\7,4@M7S,N'!9_FY<[^W?.2: )I_%/BJ5_%
MR6::1$="?<AECD?S5\H2;<!A@G.-W;T/6M.W\73ZQ<Z!8::D,-WJ>FC5)FF4
MNL$)"X  (W,6? Y&,$\]*9%X4U.-_%S&>T)U[[G+?N3Y0BYX^;@9[<\>]4X_
M ^KZ>_AS4=,O[--5TBP739A,K&&Z@ '7'*G(W#KS0 _X>BZ77?&@O6B:X&K
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M<X9<C)!XZCI0!H45Y/I'BGQ'I?PGT36_,LKZ>\N(D831LK?O9B&R0Q!)+=<
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M;ZE86]]:2>9;7$:RQ/@C<K#(.#ST-6*X&3Q?KAM/!$EM;Z>S:_$IG\S> CF
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %<;'X5UC2O%&K:AHM_9K8ZN1)<V]U$S&*4+M+H5(SD=0<?6NRHH \YT
MOP#KND6'A1(-7L))]$6:-DEMW,3K(,;@ V=Z\X/&03T[Z6B6,/@:RU,>(M<T
MX6FHZE-/$TP$(+2DL58LV">#P.P/7MUUU=065K)<W,JQ0QC<[N< "LNVU'0?
M%#W-F$BNY+"53-;W5LRO"Y&58I(H(R,X./I0!C> _#JZ3X3N%M9IA]L>5[1Y
ML[HK?+>0OJ %(..Q8U):>$[F7Q1I>OZB+&._L8)(I9[,,&O2RA?G! P!R0,M
MR>HQSOZQK>FZ!9B[U2[2V@+! S G+$X   )ZFM"@#FO$N@:EJ>M:'JNF7MM%
M)IDDI:"ZC9XY!(H7=@$'<HSCZFLBW\%:O;^&_%.DG4K.7^V[BYE20PLGE><,
M,3R<X[ 8^IKO*J:CJ=EI%F]YJ%PEO;)]^5_NK]3V_&@#F-1\)ZG>^'O#MK'=
MVD5_HEU!.CLC/%+Y:%#D<$9#$]>U17/A7Q)8>)KG6?#NL6,?]HI&-0M[VV9X
MS(BA1*@5@0<#[N<>Y[;J>+M D>W5=5M\W#K'#DD"1F.% /?.>*VJ .3G\,ZD
M_BK0=6%[%-'ID$T4OG9\R<R[=S<<+@KD#IVXK6\3Z/)K_AC4=)ANVM)+N!HE
MG49*$_T['V-:U% '#V_@_69/$&EZG?WVFE+?3Y+">VM[9E0QL5/R9;@G;] .
M@[UER?#WQ$/!,_@^+6+!M,26,VEQ+ YF6-9ED". 0#C&,CKTXZCTRB@#DU\-
M:EIGBR\U_2[BTD?4H(X[^VG#(C21C"R(1N(X."ISGUKF?%&@MX>TKPK:VL\<
ME[/XIBNIII$PLD\GFLQV@\#)P!G@ =:]&M=6TZ^O;JSM+V">XM-OVB.)PQB+
M9P&QT/RGCVK/UJX\-?:HHM:6PDFB D7[1$LGD@G <D@[!GC<<#- %9?#4U]K
M5[K&IO$ES/8'3X8H"66&(DLQW$#<Q..PP% ]36))X'UN7X?6'AF34;!GLY+?
M9,L3J-D+!ER,DECM&3P!Z5WX   &,=L56O\ 4K+2[<3WUU%;QE@BF1L;F/10
M.I)]!S0!S[^'-0L?%]QXCTF6V\R_MXX;^TG9@CLGW)%< D$ D8(Y'I6==^ K
MG^R+.UM+NW-R-:76KR:12!+*'WE549P.@')P%'6NKL-=TS4YY+>TNU:XC4,\
M#@I(JGH2C -CWQBM"@#F[;0;^/Q]<^(9);;[/-8)9^2I8LNUV?=G&#RQ&*37
M?#=S=^(]+\1:7/%%J-BKPM',#Y=Q"_5&(Y4@\@@'GL:Z6B@#EXO#-R@\07[2
M6YU;646-CSY4**A1%'=L98D\9)[5>\)Z3=:#X7T_2+J2&5[*!8!+%D!PHP#@
M]#^=6=4U[2M%,(U*]BM?.8)$9<@.QZ*#W/MUIEIXCT>^OELK:_A>Z=2ZPY(8
MJ.I /ID4 9$7AO4[/Q9KVK6EY:FVU:.(M#+&V]9(XS&,,#C;T)XSQCWK)B\"
MZK%X.\-:$MW9E]%OH+HS$-B41,6"XQQG.,Y.,>_'H-% '#GPKXDTKQ'J%[X=
MUBQ@L-4E$]U;7ENTODRX 9XB&&2<#@\<5V4-OY-G';F2239&$,DARS8&,D^I
MJ:B@#SE/ &MQ^!+'PS_:=@ZV-S%+#-Y+K\D<F\;ADY)X!Z 8[UO:YH&K7_B+
M1=:L+RTBEL4ECDM[F-I(_P!X "ZX*G<,8[9![5T[NL:,[L%51DL3@ 55T[5+
M'5[4W.G7<-U;AV3S87#*6!P0".#S0!P7_"MM2_L*2U_MF!;ZVUAM6TZX6W.$
MD+LV)!GY@=Q! QCWK8L_#WB ^-(O$E_>:;O7339-;01/@DR;\AB>.0.<'KC'
M>M]=>TM]0^P+>Q&X\PQ;<\&0#)3=TW <[<YQVK1H \[_ .$!U;_A!F\._;;+
MS&U'[;Y^U\8\[SMNWZ\9STK8O-+N[3QB?%US+;I9VNDO;2PKN9\;A(S@XYQM
MQC'/Z5LVGB'2;[4YM-MKV.6]@_UL"@[X^,C<,?+^-.L-=TS5+JXMK*\CGFMV
M*SHF<QMZ-Z'V- 'EFBOJUEI-OK-I?^#M04EKN,2+(L[R/DD *[*LIW;?E7J<
M<UZ!XZ8M\-O$3.NQCI5P2I/0^4W%:!TO0=(>;5?[/TZS=%+RW0@1& [DMC-0
MP:IH7B62\TLB.ZDMMOVBTN[9E*AN5)211D'L<8H PM*T*]US1?"IU-[46>G+
M!>(("Q:>18\1D@C" 9S@%LD#D#K%>^!M3OX_&,9U&&W'B#RS&\08M"40)@_W
M@P7GIU/6NWMK6WL[=+>U@B@A086.) JJ/8#@5+0!Q=IX8U^/Q58:_<7VF>9!
MISV,EM!;NB8+*PV$L<<KUQP.@[UGKX!U9?AW#X7^VV7F1W@N?M.UL$"?SL;?
MKQUZ5WMY>6^GV<MW=RK%;Q*7DD;HHING:A:ZKIUOJ%E*);6XC$D4@!&Y3R#@
M\T 8]K/KI\:3PS36DNCFT#".*,[[>8;>&?HV[+D#'0#IWC\0>&[B^U[2?$&F
M7$4.I:=OCV3 ^7/"XPR,1R/4$9P>QKI:* .*U+P7=:EI_B61Y[9-4UV!;9V
M8QV\2J5"KW8\L2>,D]!BNITJWGM-)M+:Y,;30Q+&S1YVG QD9]<5F:KXU\/:
M([+J.HB!59HS(89&CWJ-Q3>%*[\?PYS[5LVMU#>V<%W;OO@GC62-\$;E89!P
M>>AH Y?1M/.@>.]=5^+76FCN[9^WFJNV5,_WN%8#N"W]TU':^%=4MX/%B-/9
MEM<D>2/&[$):,1X/'S8 SVKL'1)  ZJP!# ,,\@Y!_.G4 <-JFE7MA\+HO"D
M;Q3:E/9+I<)CSA@5"-(0>@"Y8^F/<5U^FV,6EZ7::?#GRK6!($S_ '54*/T%
M)J%Y9:5:3:E?21P0PQDR3,/NJ.?K4EG>0:A8V][:R>9;W$2RQ/@C<C#(.#R.
M".M '-^$_"=QHGA%O#>IW-O>V2I)!&(XBA:)BQ._).20V....]97_"LU?PKH
M^ES:C))>6-RDLEYC#2Q[?*>/V!APG_ 0:] HH YOQ)X9FU/4]'UG3;B.WU/2
M9',/FJ3'+&Z[7C;'(R,8(S@CI4^E:%)#K]]K]^T37]W#';A(<E(8DR0H)P6)
M9B2<#L,<<[M% '-:KH%^_B^Q\1Z=-;-+;VDEG);7&Y5='96W!US@@J.QS[5G
M:EX"?4/#.M6AO475=5N4O);GRSL61&0QJ%SG8 BKUSU/?%=M10!QD?AGQ!-X
MM@\07NI6"S+ILED\-O ^T;F#94EL]0.3^7>G6OA*[E\2:5KVH"P74=/@DCDN
M+0,K7I9-H\P$<*.3C+<]"._8T4 >=S^ =6G\$ZUX?-[9+)J6HO>B?:V(PTHE
M*[>^"N,Y[^W.Y>>';Z^\9V&MS-:"W@LI;26WRQ+B0J6(..VW&._M6WIFK6.L
MV\D]A/YT4<SP.VTKAT.UAR!T(J[0!PWASPGXFT!(M&_M^VE\.V[Y@S PNQ&#
MD1%\[0.V<9QTQQB74_!][KEU:G4VL6:SU+[9;7\887$<0E+K$./3"D[L8_AS
MS7:44 <7JG@^]UVXMO[2:Q8VFI?;+:_C#"YBC$I<1#C'3"DYQC^'(S6KXQ\-
M#Q7X??3UNFM+A)4N+:X5=WE2H<JV.X[?C5^77--AUJWT>2[0:A<(TD4&"254
M9)Z8'XU-J.HVNDZ;<:A?2^5:V\9DEDVEMJCJ< $G\* .47PUXDOO$VC:UJ>H
MZ;&]A;SP2):P.=_F!02I9N#\N?;WK+M?A_XA@TC0;!M9TX_V+J NHI/LKDS#
MY\M)\_+G?V[YR:]&AE2>".:)MT<BAE/J",BJ6I:YIND36<-_=I#)>SK;VZD$
MF21C@ 8'Z]* .2UVUT7Q?XMT2.PU&*>\TZ>47XMI5;$ 'S12XZ9D$8P?]KT-
M=#K6F7VH7#((M/O=,E@,4]C>@[6;.0P(#=N,8YXY&*U+>QM+-YGMK6"!YW\R
M5HHPID;^\V.I]S5B@#'\+:&/#7AFPT83M.+6/9YC<9Y)P,DX S@#/0"L:Q\'
MW+3^*8]5>VELM?<LZ0E@T0\L1XR1SP <\<UT.GZYINJW5[;6-VD\MDXCN%4'
MY&(R!G&#QZ5H4 <3!X/U.YT'3/#VL7EK<:=I\L3>=&K"6Y2(@QHRGA>BY()S
MCMG-:%GH.H6?C76->\RU>*_MXH4ARP9/+W8)..^XY]/>NFHH \\M?AW>P^#=
M)TMM0@34]'O3>V5VB$H7,C.5=3SM(<J<'T/M71V>A7,WB9/$&JFW%W#:&U@A
MMR62,,P9VW$ DG '08 [YK0OM;TW3+VRL[R[2*YO9/*MXR"3(WIP..G4UH4
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %<K'KFJ:WJFMV>AR6
M<(TIUM]]U$TGG3%=Q'#+M49 SR<Y].>JKE(?#>HZ-XFU75-%GM6M]6VR7%M=
M;@(IE&WS$*YR".JG'(ZB@#DO$WB.Z\5_#32=5MC%9>=J=M#=6TD9D*RK<*N
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MA^"Y$P&"9GB63S%@;M@-@;LY*C& >:ZUM,L'N?M+V-LUQD-YIB4MD=#G&<T
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MDEU9O+??:=MPH8!//+$Y7OC<>_/M5U- U6/2=/TV5=,OK*&P6TN;2Y#;)64
M*X.TXX!R"#UZ\9H 5=?U*6_TG0U-FNJW5F]Y<3JI>&.-2JY10P+;F88^;@ D
MYZ4Q]5\56NC![ZQT^"Y74#!+=-*! EJ"?](*E\C(P-F[.3^%9"_#K4-(LO#\
M_A_5HHM6T>.2'==1L\,\4C;C&P!W!0?N\Y&/QK2U;PMKNI66F3MJ]J^J6E^M
M](LD+?97PI78$W9 '4$DG.3WX ,__A)+G7?"7CFTNO)=M-AGA2>&-HUE1H-Z
MG:Q)!Y]<'J*Z;P7_ ,B+X>_[!EM_Z*6L*+P;K$:^+0^I6<O]O)@8@9/+<Q",
MG[Q^4 <#J>YKIO#VGSZ3X<T[3;AXWDL[:.W+QYP^Q0N<'IG'2@#D=1\9:S)X
M%U'QAI)L%L8/-:VM[B%W:9$<IN9@XVY() P>,9//&O;^(=1D\=PZ$XM?LL^C
M'4%<1L'602(F"=V"OS$] :XKQ+X7UKPK\-/$NF1:G:2^'DAEEMHV@;[1&&;=
MY>[.W:"3S@GZ=NON?#VJ2^(-(\1:/=V<<L>G&QGCNHV=3&Q5PR[2/F!7H>OJ
M* *VG>*]<U#PW<7BV]A]H@U>2QFG8^7#! DA5IF#/DX SM#=ZK+XXU3^R/&4
MD0LKBXT!?-AF\IXXYXS#YHRI).>HR#@\$<5&GP^UJ#1Q;Q:Q://%KK:O&);=
MO+D!9CLDP>>H/ &"/Q%B;P3K4S>+R^J6+_\ "16RQ-BW9/*;R?*)^\> .@ZG
MU]0#*\4:MXQ?P*-3FN],M;:[-CY:6\+M+B5U#JQ+8Q\PZ=LCWKI[WQ#?1ZP^
MAPSQ"]M[1+B>Y33IITR[,$41HQ*_<))+>F.O":OX4O=6^'T&@&Z@AO8$M]DX
M4M&6A96!(X.#L_#/>JVJ>%O$7]O6OB+1=6L8=6-L+6]BN+=C;7"!BR\!MP*D
MG!SR.XYR 49/&7BE+'PR9='M;*]U.^:RN(;E7&U@K$.G.0I"@\Y/./>NUTH:
MLNDQC5VLGU(!M[6H98CR=N V2.,9]\USVI^%]8OY- G;4+>:XTV]^VSR2(RB
M5MK+L11G8H#<<GH,Y.2>O;=M.T MC@$X&: /-IO'>NQ?#R_U];;3S>6FIO9M
M'M?85$XBR.<YYSU_"MVQUW6H?'O]@:JM@\%S8->V[VJ.K1%752C%B=_W@=P"
M_2LB3P#JTG@?4?#QO;(27FHF]\_:V%!F$NW;WY&,YZ&M^30=0F\=V7B%I+58
M8+%[-X 6+'>RL6!QV*XQB@!OB_7=1\/-I-W!]E_LV:]BMKYI8V9HED.T."&
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M(O*YX^;CGMSQ[U0;P+K=G9^';K1M5M;;6M&LAI[-+&SP7< "C:X&".5!X[T
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MT!)('7''7%=1)X4DU*[UK4-2FB2\U+3_ .S8Q#EEMX<,>"<%B6<DG Z =LD
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M&-#6:2><#^.5-JQ9]<$N1V&W^]7.^$P+_P $>.Y[WYI+G4M16?=V 78%^@4
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M[CN5G-D?WGEOO52OF<<]3G\J;XC70_&NMZ;HT%V+C4=,O2]YY&088@A$J/\
M[+Y"8SSGV-=]3%BC1W=(U5G.7(&"Q]_6@!]<5+X,U>S\27^H^'_$9TZTU*02
MWEI):+,/,P 9(R2-K$ 9R",^O KM:* .>\2>%(/$'AN'2?M,UN]O)#+;W2MF
M2)XR"&!_O8R,^YIOB;PE#K^A6MA:W3Z;/82QSV%S"H)MY$&%.T]1@D$>E='1
M0!R$_A36]3\,ZGIVK^(8[F\OK9K7STL]D<,;##8C#<L?4GL, =WR^$;V6_\
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MV2V$DYM=\5S".BM&6XP><Y]?P[FB@"EI5E/8V0CNKQ[RZ8EYIV4)O8^BCA0
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !4$=E:0S&:*UA24
MYRZQ@,<^]3T4 %%%% !28!(.!D=*6B@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MY$EC62-U=' 964Y!!Z$4ZL#6]=?3M7T;0K%(A>ZFT@C:124BCB3<[%003_"
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MV\8VY]_:N>OOA]KT_AO7O#D&IZ?'IU_=O=02-$YE7?*)"K<XP#GD=?:O2J*
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MQ))YA&,<D8QU[^W/HE% '&R^&=;L_%[^(](N;%)+ZVC@U&UN0Y1BGW9$8<Y
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M <;:>$;N7Q+I&NZDMA'J&GQ/'-=6>X->[DV_."!@#[V,MSC&*[*BB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ KC/$=Z]U\0?#'A_/^C,)M0N%_OF(
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MPQPW$V])4C)*AT=D;&><$J2/K6U<B9K:5;>1(YBIV.Z%U4]B5!&?ID5A>"-
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M8CS?,+[=P #;=O?&21FI/#6A^*;&&VL=;UBQNK"R79$;>!DFN !A?-)..!V
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MZEE8+DD'@@KNZ]Z /0Z*XNW\2:[!XJT&PU*+3S9ZU;RO$+=7\R!XT5_F8G#
M@GH!CW[]?=7,5G:374[;884:1V]% R3^0H EJEJ.JV>E1J]W*R[L[4CC:1VP
M,G"*"QP.N!Q7&W?C75[/P9:>-'M[1M)D\N::S6-O.CMW8 ,)-V&8 @D;0.HS
MQDMU$ZE-\8M)$%[:B(Z3<21![9FVJ9(MP/[P9)P.>,>AH [?3=2LM8TZ#4-.
MN8[FTG7='+&<AAT_GD5:J...&UAV1HD429.U0% [GBN$E\:ZO)X)?QI906DF
MEH6F^Q,C"9[=7*EO,W8#8!;&TCMGO0!W]%<0_B?6]0\8C1M(735M9](34K>Y
MN%=B S[1N4$9^@(Z]>,&'3?'US=^&M)FN+>*/5K^]FL2(8I)8T:(OO<(OS,,
M1\#/5ASC)H [VBN:\-:SK%_J>J66J6++#;,C6M\MK);I<*PY&R0DAE/!YP>M
M3>,/$)\,Z/'?D!86N8XIKAXVD2W1CS(RJ02!TZCJ* -/5-4LM%TR?4=1G$%I
M NZ60@G:,XZ $]ZMJP=0RG((R#7#:YXKU73?A_J_B&TETC41;MOM9HMWDS0X
M3D@,?F#%AC=VJWJOB#7(O&FGZ%80Z?Y5[8RW"S3[R49"HR0",CYNG?U% '7T
MC,J*68A5 R23P!7G\?CZ_M?!6K:E?VML^HZ;J;:6YAW+"S^8J"3!)*K\X)&>
MW7FM2#7=:C^((\-W L9H#8"_-Q'&\;!=^PKC<PSGD'/3/I0!K>';G0KNPED\
M/K:BT$[HYMHA&ID!^;H!DY[UKUYAX7UU= \+:E*$WS7/B:ZM(%V,PWO,>2%Y
M( !.!R<8[UT.F>)M1BUJ_M]:B2/28;=;B+5GM9+.('.&C<2DX(R"#G!% '74
M5Y_\0?$T5S\.=7O/#6NV,S0B..9[:19R%=PI&5;Y203SSWQZBWK6N^)M/\3:
M-H5H-*FEU&WN7^T21R(JM& 02H8G'S#C))QU'8 [6BN"UOQ-XET33K^>]72;
M::RL%G0;6E%]*$+2B,!PR(N ,D'KD\"M)/%4^IZGI&E::L,-W>Z:-3G>=3(L
M,)V@ *"NYBS8ZC 4GGI0!N:9K>FZR;H:==QW/V68P3%,X5P 2,]^".E7Z\K\
M.:Y/X>B\7W%XL4U[+XC6U00HVQY)%B53M&6QSN(&3P0,UU>BZWK<_B>?3;VR
M:;3S;":'4$L9;95?=@Q,LA.3CD$'IQ0!U-%8/C/6;SP]X0U+5[&*"6>TA,H2
M<G:0/IR?TK!?Q7XCTO7]"76+33CI&M2"WB:V+^;;S%=RAR3A@<'H!CWQR =;
MINMZ;K#W::?=QW!M)?)GV9PCX!QGH>".E7Z\ZT*ZO[&?XA7.EV2WM]'JF8;=
MI @=O)CZD\ =_P *TM*\57UYXMO-!6?3[[;IRWMO=P1O''NWE"I^9MPR <J?
M4=10!V=%>8V'CSQ)/X8\.>)+FVTM;'4;R.UN+>-9/, DD*!U8M@8./E(.>N1
MG ].H K:AJ%II5A-?7UPEO;0J6DD<X"BGVEU!?64%Y;/YEO/&LL3X(W*PR#@
M\]#7!:]KFH^(O!OB^XTQK./3[.*ZLP)HF=Y_+0B1@P8!1G(7@],GKBIO#^NW
MME+X(T4+;M9ZCHWF%BC>8C111]\X(.[T[4 =[5+4]6L=&M5NM0N!!"TJ1!BI
M.7=@JC@=R17"ZAX[UNS\)>+-3CM["2YT/46M4RKJDB 1\D;B<_/Z@<5>U[7_
M !5H&E&_NX-'>.74+>&%(_,)2*1E4[LG!8$]1@=\=J .YHKC;O7O$,OCN[\-
MZ?'ID:+IJ7L5Q.KN5W2%/F4$;ONG@$=<YXP:5IX^O)_!>AZE):01ZAJ>I+I;
M8W&&*3S70OC.2OR$@9ZD#/>@#OZ*Y31]=UBY\;:MH-VED\&GQ12_:(D=&<2
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MA9 SLQ9'4]5(<@_Y!]&HH Q]!M=<C1Y_$%[:37;@*L5E&R0Q@=QN))8]R?0
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M>5);+;!2\V[/F!LD@8XVT :M%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!#<6EM=
MH$N;>*90<@2(& /XU)'%'#&L<2*B*,*JC  ]A3J* "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
F**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH _]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>22
<FILENAME>insidertradingpolicy009.jpg
<TEXT>
begin 644 insidertradingpolicy009.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#W^BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M @)V_,O/3YAZB@#2HJO87UMJ=C#>VDGF6\R[D<J5R/H0"*G9E1"[L%51DDG
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MG/&*R?%U^VH>'?%]I]CNK2Z@U-6%C:V;!9466+_2)&"_.6 )ZXX'!(S7M=%
M'FO_  D$'AOXA:S=:U;W:Z7KEM;/8W(M))!E$*M$RA2P))+ $=SZU)K31:?X
MB\!:@NERV.G0/=IY,-L3Y(>+$:E$'RD^F.#Q7HU% 'E]Y;7&J^+/B#96#E+J
M]TB""V8\!I!'("H;ID%@#Z9J&]D7Q1\/?#VAV,;Q:W!/9K);LA62R:$KYCL.
MJ@!6P3UR,=:]6HH \VLYX%\4_$B1V4)-#;B-B.)-MN5.T_Q8;CCN<5DV%K:W
M/A+P<%UJXT'6K32RMO?8'EJ0$#PS*WRG)"G:<'Y>.E>OT4 8/@R[U&^\)6%S
MJMK';7KJWF)&A16^<@.%/(W##8_VJC\>V%_J?@+6[+3 QO)K1UC53R_'*CW(
MR/QKHJ* /)]3\26&M1>!'LH+KS+75(?M-N+23=;$0NI5@%X(/Z#/2F7=ZFFK
M\2]+N(K@7MZ);BVC6!V\V-K8#<"!C ((//&*];HH \JM)XCK_P ,6=)$^SZ;
M.DOFQ,AB8P1JH;(^7)! SU[5MW4T4?QILY'8+&FARQ,Y^ZKF9&"D] =H)QZ5
MW5% 'B5PRM\$?$%LB,;B35972$(=[ W8=2%ZGY1G/H*Z+Q!KUAX=^(PU4710
M7>D)&[26TLL+CS&*%&C5L$?-D' ((P>M>EUS-WX<U==?N]5TGQ";47@C$UO<
MV@N$&P8&P[E*]SC)&23WH C^'2:/;^"[.RT34AJ%M:EXWFVE#YA8NP*GE>6X
M!Z BNJJCING?8(Y2\[W%S._F3SNH4NVT*.!P  H 'MW.2;U 'AYFQ\!9=&>"
MX6_MKP1RP/ X.[[;O(&1\WR_,<9P.M=;J["\^*=L+.=09O#]Q DZGY5D=T*#
M<.,X&0*]#HH \D\)7.B:AIFB^']4TC56\0Z6\*M97#7!CADBPOGAB?+50,D?
M7 !R,^MT44 </XVD^Q^+O!>I2QS&TM[NX662.)I-A>!E7(4$\GBN=6\TS3/$
M'B/1?%EGJQ74KQ[BT\D7#Q7D4B*/+VQG&X8VD$>E>M44 >=626]I\5M'A6V%
MK%#X<-LD6=XA?S$(BW=-P4'OR*FTBYMX?B-XZFE=4B>"S"NW"OLC<. >^"0#
MCH37?T4 >+6[+%\'O!4#*RSP:G:-+%M.^/9-N<E>HP#DGW'K7M"L&4,I!!&0
M1WI:* .(\>+=6NL>%=;6*6;3M-OG:]2-2Q17C*"4@<D+DY],TVSCCOOBC<>)
M+.9#I4.C"UFN5/[N64REP W1MJCDCIN ]:[FB@#A_A1*I\%) <K,EW=,T;@J
MP#3NRD@\X((-=Q110!Y1'.+3P_\ $[3)XITNY[J^GB4PMATD@14(;&"6(P #
MD^E2R31#_A5Y5A_H^/-P/]4/LQ3YO[OS?+SWXKU*B@#Q[39=*A@U/PEXJTS5
MKC46O9VBME-PT-^CRM(C+M.P#)&2V ,9/?'KT2[(D3 7:H& <X_&GT4 <7\3
M5<>'].N1'(\5KJ]G<3&-"Y2-906; YP*JQWEO<_&>VN5#")_#[1([QE<.9PP
M4Y'#%><'G':N^HH \6\:WS:CH7CG3_L=S:74=P/+L[6T8"Y0>7_I$CA?FR <
M<@ *!@FNABUE-&^)MUJ6J+<1Z9J^G6Z6%T\#[59"VZ(\94DMN (&:](HH \0
MN9/,^#GBBW6WN5EDUJ5HHWMW5G!NU8;01SP"3CICG%=G-=6[_&6RN1(AA_L&
M1!-_ &,R,!NZ9*@G'I7>44 >+XMS\.];DD>>)[?Q.]U T<#2;";D&-V0<M&<
MYXZCIDUTWA;6]!UOQW=:K'J\3ZK<626L5FL$L0$:,78YD52[9;L. ._6NI\1
M:'/K<%H;74YM/NK2X%Q#*B+(I8 KAT/###'TYP<\4EAH^H"XAN=9U5+^6W):
M%8K40(C%2I;&YB3M9AUQR>* -JO/FU"QT[XU:@][/%;AM#@"R2G:O^N?(W'@
M$^G?'M7H-<]!X<N8?'-UXC:_B9)[1+3[,+<@JJL6!W[^N6/:@#SB]TV33?AK
MJ),$D46H>)!?6=L8R'6W-PA'R=0-JEL=@:V?$VI+=:UXGT[[/-;F725^S/9V
MI=]3S&YYD53\B$XP".IR<<5Z?10!Y+IMU%+>_"EBLBBVLI4F,D3+Y;?9509R
M.,L" 3U(XS71>"9$;Q;XTVGY9=0CDC.,!U\E%++ZC((R*[BB@ KS[P!9W,>A
M>+-+WF*]CUB]7<>""X#(_P!"&!KT&J TN*/6&U*!C%+,@CN% RLP7.TGT89(
M!]#@YXP >9>$KG1-0TO1O#^J:1JK>(-+>%6LIVN#'#)%A1.&)\M5 !8?7 !R
M,V/%##^WQXYTRV6>#2IDM;RW4'??(#RP7H3&6!3(YP3T"Y]4HH \XU7Q!#HG
MQ!L?$MTL\GA_4-)%HEW%"\@@E$A?#*H)7<"!TSD8[<5_$LT=G_PCOB&VT:\@
MT"VNK@W,5G&\,RI*N!.43:P^;<3WPW/)Q7I]% 'D'B\Z'<_#3Q/JVBV5R(+M
M[0RWEP)=UVRS(.!+\Q"@@9[Y([5TFHQ6_B#XA>%+[2629-,6YDNKB(?+&CQ[
M%C)_O%C]WJ "<5N^,?#LOBKPW/H\=ZEFL[(7E,/FD;75Q@;E[J*W(Q((E$K*
MTF/F95V@GV&3C\Z .(^&$ODZ'>Z9+%/'=6VHW9E62%E"[IF9>2,'((/&:[FB
MB@#S>PW7_C'XB6UG.(KB]M[>.TE.0&<6[*2I[[6ZXZ5D3@Z[\'+'PG!"\/B&
M);6S-HRD2V\D4B!I2.R *6W]"#UR:]?HH X70Y(O^%N>*"2"9+.T2-R.'*!]
MX!Z$C(R!7=444 </XRE^Q>.?!>I2Q3&T@ENXY)(H6DVL\.$&%!/)X%95K<0?
MV]\2Y&(59XH?++#_ %F+;80O][#?+QGGBO3:* /&+2[_ +$L/!&L:G#J#:/'
MHG]GW4EHTJO9S?NSEQ&0V#LVD>P]J]&\(PZ4+&ZN]&L9K:TO+EI_,G\P/<L0
M-TI$GS#)XYZXSW%=#10!7OHI9]/N8;>3RYI(F6-_[K$$ _@:\E"G4O@J/!S6
M[Q^(HT2R-@RD2+*L@Q)_N8&_?TQWKV*B@#@;:7^R?BU>&]$VVYT:W2.?RF*.
M4=]Y+ 8&,@G)[UQ[,O\ PHVYM@K?:CJI<0A#YA'VT/G;U^YS]*]NHH \LOM1
ML-%\>:W_ ,)$FI?V9K"P2V%W:-<-%(!$$:(B$]<C(X.0?>II(+&P\:^ (+6Q
M-C:6T%\%@?)^SB14\L.3G:6P>">N17IM% !1110!1UJ>*WT6]DE<(@@<9/KM
M/'UK@_ASXFTK1OAKH]KJ$\L%S;0$2PM;R%U.YN-H7)KTJB@#S[5KW[7\0? =
MW)$T.8+QY$8<P^9$NQ7/0$]/J"!6/#+$?"/Q03/SW-W>F!<<RAH%52O]X%@0
M,=37K-% 'E]U/#_Q;(JPQ ZF7 _U0^SE/F_N_-QSWI8E:\U#XI0VZ-))=0J(
M%53^](M=AV_WOFXX[UZ?10!X_/J'D>'_  'KC6NI2Z3IML;34?LZ2QR0LT,:
MA\+ABJLI!(XY/6I=?@L[GPZ=>\+Z5?36::M9WU](RRF6^CB8EL))\S!?EY[X
M/I7K=% 'G*ZU8ZQ\5]!O]/,]Q:MI=Q'YZ6TFT,70@$[>.AZ].]>C444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M8W M9#$)#,K!=^W&< GK7-:-%!8P7GA37_"=]J%^+J8P2?9VDMKQ'D+H[/\
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M&ESQ-/\ 99 BLSH55FVX!P#UKN* "BBB@ HHHH **** "BBB@ HHHH ****
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M )QZ=>O(N44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% '.ZKX9N+O7!K&FZY>:;=M MO*$1)8Y$4EAE'!P0
M6/((ZUIZ;IGV#S)9KN:\NY0HEN)@H9@N<* H  &3@ =SU)S5^B@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH *XKQDL]OXP\&ZJ+.ZN+6TN;E9S;
M0-*4\R!D4D*"<$\9Z"NUHH \ZLS,OB?XASR65\L5U#;^0QM),2E;<HP4[?F(
M;CC-<_:0WFBZ5X)UB]T34;RPM=*;3K^WCMW\ZU<["'\OAB,I@^WX5[+10!@^
M%8[(V=Q=Z?HSZ9!=3>8%EB\J68X&9'4\@D\<\X&>]8N9M.^+EY=365X]M=Z3
M#'%/%;L\>Y)'+!F PI (.#U[9) KN** /,_##ZE8?"?6%M]&FFU&.2]=+*[M
M77SM\CLORL!N!4C@=>E5++[1=>-]!OK>VUMDGTFXMGN[FT>,1S,4_@( C P>
M@ ..-QKU>B@#Q&::^3X+3>$I]&U0:Y8M%"\$=G(ZR!;A6WHX&U@1SUSG-=K-
M([_%VQOA:7HM!H<L1F-K)L5VE1@I.W . 3BNYHH \8N+6]D^#&OV"Z9J)O)M
M3E>.W^Q2^8ZM=!P0NW.-O.:W?$&JIHWQ#&J6L6HJT^DI'-(FF2W4;#S&*95"
M&1AANO!!QC(S7I5<U>>%KLZ[=:MI?B"]T^2\""YA$<<T;[%VJ5#J2IQZ''M0
M!'\/O['A\)6]AHL]Q+!9LT<GVF%HI1(3O;<C $9+YZ8P16-I^IVVG?%GQ=]I
M$P#V=B0T<+R#A9./E!Y.>!WP<5VVG:>NGPNOG2W$TK;YIYL;Y&P!DX  X &
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M >C45R?A#5=4GUCQ'HVJW:WDFE74:QW(B$9=)(E< J.,C)&:M:[K,\/B'1=
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M/<2#.9755+<^B@#]*Y*SU75O%#^(FTF_%C_9=Y)86R>4CB66-5+&3<"=I9L
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MY0 J,CGCJ<\B;2O%-['XMLM/N-1:^L;G2I+N29K<(JRQE<F)@J[XR&/KVP:
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M2(^0@8@NP49R0 ,D4 5Y/!^EGP._A.-"FGFU-LN>6''W_=MWS?6DN_"%A?\
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M>X5EP3N'&&/^-=!10!CZSH*ZK<Z=?13"WU'3I6DMI]F\#<NUU9<C*L#R,@\
MYXK/E\$VMWI&O6MY=/)=:Z#]LNHT"'A0JA%.<*H' )/?GFNHHH YRV\,W$MQ
MI<VLZA%>C2_FM4BMO)7S-NT2."[;F"DXQ@#)..F$7P[JMTMQ::QKPO\ 399"
MWD"S6)RA.?+=P<,O8X4$CJ:Z2B@ K \3>'9O$+Z48[Y+9=/OH[Y08/,WNF<
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MLULL.THJ!@I5MQY^8GIUQTKK** .4\.>%=6T=X(]2\47.JVEH,6L+VZ1E>,
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M0/+#H2)G)3&1R 0< C'TK:OO =I>>%I-"6]N(DGNA>7-R%4RS2^8)"QR,#+
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M %%%% !1110 4444 %%%% !1110 5XW\7OA/K'C77K35]'N;;>L MY8;ARN
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MTKQ$D,%]*)I;>[LA/L8*%^1@ZD#"C@Y K<TW3UT^!U\UIII7,LTS@ R.0!G
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M.PSR>YXR>!@ LUXMXVO_ .T-#\>:>+6>SNHY?DL[:T;-TH"?Z1(X7D$ XY
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M1Z8NILELQ^QNNY9?4$=QW(]!7#Z??VTOQ'TN^2>\O[:?0IH1,;1XXV;S$.Q
M% 50 ?IW)->K44 >6^$&N--UW1;'1M4.K>';B*1A:W2 W&D@)E06ZA<D)M;D
M=J]2HHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "N;N_'6B6=[J-D6O);O3U5KB"&RE=P&!(( 7E<#)8<<CGD5TE<'ILA@
M^(_C.YEM[I8);2T6.4VS[9"BR!PIQAB-PZ4 =.OB/3)=,L;^WG:XAOU#6JPH
M6>;(W<+UZ=<XQWQ4%KXNT6[TRXOUNF2.VG^S3QR1LLL<V0/+*8W;B2   <Y&
M,UY=ID%[I'A7P+JMWH^HW-EIUO<6FHVL4,BSP>85*OLX8@%.?8ULZW:^;HEM
MXA\->';I(K35[?4)H&A9+B^1 RNP1OF)&X8SR=I.,8R =U:^*M)N9]0MWG:U
MGTZ,2W45RAC:.,C(?G@K@'D?C26_BK3)]673':>VNY(3/$EU T7FQCJREASC
MN.H[BN9U^>7QOX.UK^P-+N(YI+90DUW;FW>=U<,(@& 8C 8$GC+<$\X;HFH:
M/KLT-Y!X3U"._LX9#,;^WD3[/E"&C5G^\6.!A>V2<<"@#J[+Q+I]]/;QQ"X5
M;F%KB"62%ECEC&,L&/'\0.#@X.<8HLO$MA?SVT<(N MU$T]O*\++'+&,$L&/
M&.0><$@YQBN%\.6MUI&K65OHLU_>^')K69Y]-U&!O,TTA,JBNPW#)^78<\9/
M/6CPY;W^C:M81>'9;^]T*:VFDDTO48F#Z<X3*(KL 5RQ";#VR>>H .SLO&>C
M7]U80PS2[=0WBRF:%A'<% 2VUL>@)&<9 XS58?$#0&O9+.)[V6>.Z^R2)'8S
M$I)C(#?+QGL3UYQG!K@K6YN;N;P/J,FEZL)K:]<7ENFGR10VC&)U$:1X V@G
M&[GC[S"NN\#;U\0^,"]O<1"?5/.B:6!T$B>6BY4L ",@]* -JS\7Z/?>&YO$
M%O-,VG0[]\AMW#?*<-\A&XX((Z=JLZWK<6B>'+O69+>XECMX#.8HXSO( S@C
MM[YZ5QT>BWMG\0+O1($!T'494UJ3G_52(</'CT>01/Z8#BNL\76LU[X,URUM
MHVEGFT^>..-1DLQC8 #W)H KZ;XJM9_#NF:A=K+%/>I&J0"!P\LK(&(C4C+#
M&3GI@$DX!J_I6O6&L2W4-M(ZW-FXCN;>5"DD1(R,J>Q'((X/8UYZKWB#P!XA
M2QOS8:7 ]I?1-:NLD1>%4\SRR-Q56!!('3)&1S71:-8O>?$C5O$<"2)I[Z?#
M9JSH4^T2!F8L <$@ JN>^3CI0!O:AX@LM.GFAD$\LD$(N)U@A:0Q1G(#,!Z[
M6P!DG!XJ"\\5Z99R"(F>:;[)]M:*"$NR0?WR!T'7CJ<' .*Y7QI9"37KF_TR
M]U+2->M;)?)N(86E@OERQ$+KM*N0<\?>^<'FH+F_U2XU:.RU72+NT>?1(BO]
MG6K$SSD'?"TRCY%0GA=RCDDG!H W]6\=6=G)X=^Q0SWD&M2#RYX8691'L+Y&
M!DL<#C&1R3TJU;:EI,GC.]5;Z^6_AL$:>VFWI!'%N)#@, -Q.02.PK@=.6ZM
M_"7PWNI=-U%4TRZ$=THLY#)'^Y=<[ -VW<0,XKH'=S\3]8NWTZZDMV\/I%AH
M'"2.KNS1[L;<X(Z$]: .IM/$MC>S11Q1W8\^W:Z@9K=P)8EVY93C_:7CKSTK
MA+778-;BUW5M3O=<L1I.K2>5+:1S!8H(M@V,@!4Y^8L"">3V Q8\)VMWHWB&
MPMM'O+^[\-RVTCR6NHP-YNF$ %4#L PR?EV'D!<\]:TOAZN^+Q/!<VMQ&MSK
M=W,J7%NZ"6%RN&&X#(- '2?\)%I_]G:=?AIFM]19%MBL+$N7&5XQD CG)[52
M\9>)QX5TB*[%K-<237$5N@2,LJEW"Y;'UX'4G KGO!&DZA9ZQ<Z-=C?IGAR9
MTT^0MN,@E4,@/O'&S)]'K2^)MO<3^$5>WMYK@V]]:SND,9=]B3*6(4<G YXH
M U;OQ9IMG)Y3K=/.ML;N2!+=C)'"#C>RXR.0>.IP< TRZ\9Z'9VVE74ES(;;
M56C2SG2!V21G^Z"P&%)]\5S.L:G/?>)[JV?3-3AM+C2P;26VLG62[<EODDD
MW1A>"%)7[QW>E4]'M5UKX5Z#X3N]/O(IKNV6"5Y[211;;!DR9(X8$87.,M@\
M@4 >B6&JVNIR726WFG[+,T$C-$RJ7'!"DC#8/&1FJQ\1Z>->FT3,YU"&W^U-
M$('YBSC<IQAN>.#UK$^'U_>#2I-"U.TFBO=*=K<SFW=(KM ?EE1B,$MWYSG)
M[TSQM9:E;:OH?B+1+;[1?VTK64L79X9AM!;_ &5D"-[#- &M:>,-(OM!&MVT
MEQ)8F;R PMI-Q??LP$QN^]\O3K5>+5=*3Q1K+17.IS7]M:1-<66R0HBY;:8T
M(P6//(STK \-^&]0T;Q=>:*PEFT*.1-6BN)#DO,RE&0_\#4R^QQZU=L%D;XL
M>()/L]PL,NFV\4<S0N(W=2Y8!R,$C<.] &%KGBZ77OASI?B""2\TUFU&V+;6
M>)3&TX&TMP'&WKVKM[/Q'IFO7=]I%O)>0W<,0=TEADMW,;9 ="P!(R",BO-(
M1=?\*;T'2FTS4UO;*^M5GA-E+D%)]SX&WD #.1QSUSD5USS;/B^]\8+K[)_P
MC_E>>+:0IO\ .W[<[<;MO.* */P]\;6<?@SPW;ZK>7DMY>DP_:I8I'1IF=MJ
M-+C;O/H3FNRU#Q+I^GS7,+_:)Y+6,2W*VT#2^2AR06VCT!.!SCG%>7VD%U%\
M(?!]F]A?"[MM5MGF@^R2;XU2<LS%=N0 ISFNHT.XD\->+O%$>JPW)M]2N%OK
M*Y2!Y%E4H%,?R@X9=H 4\D=* )/&6J"YM_!^I:5J4IMKO6[1-]O,0D\3[B0P
M'4<#@UT&KZY80?:[!GNWFB@\R?['&S- ASAB5Z'@X Y."0*\Z70[[0O _@FP
MGM+DS1>((KV6&*%I/LT1DD?#;0<!0ZY]\UMZ3?3>'/&WBBVU6SOG359TN[&Z
MAMI)4F7RPOEY4':5QC!QZT 5_#&KVLWPY\%RZ[JFII=7=U%Y4T3R%IYC(P5)
M' .5/<,>0/:NJN_'&BV>H7^GLUY+>V**\UO!9RN^ULX( 7D8'WAQTYYKSJPB
MND^%_@"V?3M06>TUBUEGB-G)NC1)&+.1M^[@@YZ<UUVF2^3\4?$]W+!=+;26
M-JJ3&VDV.4W[@IQ@D;AP* .B'BC2'TBPU.*Z\VVU!D6TV*2TS,,A57KG@YST
MP<XP:-+\3:9J^HW6GVSSB]M#BXADMW7RCQP6(VY(((P>1R.*\ML4?3?AGX'F
MN+348-1TZ_. +*21HCB0L'BX9E*<<=,@YP#78^"-0T>]U_6[J"[N'U?43'//
M%/92VH6.-1&NQ7'(&>3D\MVX% '47^M6EA=1VC"6:[DC:5;>",N^P$ L0.@R
M0,G&3P.:XWQOXBMK[P;8ZSI&J310IJEM'(\<C0D#SE61)%X(QSD-5FY^T:%\
M59M6O8IGTK4=-2WCN4C9U@EC<G8V =H8,2">,\5S6HZ!J">'-=U&*RNC%>^)
M(=1CMDA8R"!)$W2>7C=D[6;&,XQQ0!W^E>,-&U[4[G2+::YBOHH_,,-Q;R0.
MT9XWIO )7W%<?HNJVL7PJU.?Q#JVJ);+?W43WD,DCSHHG8+AP"1T ST[5M2P
MKKWQ!T;7+*.06.EV=P)KEHF02M)M"QKD MC#,>PX'4UR$EO=/\#_ !'8K87W
MVR:\N?+M_LDGF.'G+*0NW)!7G- 'J=WK-G87%M9$R37=PC/%!&NZ1D7&YCZ
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M;E!V-C([<XH ZJBN/T?Q?<7FO^)8-0L9+.PTF14,SO&5C41[RSD-GD'/ (
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MB+E3F3 *CD9YYZ#')%8LG@[6='TW2=9ATB+4;F#4KR]N])+*?W5R?NJ3\I9
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M^$*?16B@<2>9'%YDDA&-D6PY*^K'';CDD8\'AC6KSX(V.B16S6NMV*1.D,Y
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M,_,64L> ,'ID#FM&QT_5+7QYXGU1]+F-G>VMO%;NLL69&C#@\;\C.X8SC\*
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MP,C-MR, Y! /'0U#;^.;B;3HK]_#>H1V]RMM]C?<C"=YB !@'* $Y)(Z<XZ
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M8Y#K-EYZ-;2N5^7RT5B-V_G( X'J<'T6@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH ***XNY\9ZN^MZYI&E>&6O+K2Q"YWW
MBQ+(KJ6'.#@\# YSSG&.0#M**X-/B4MWI?AV^T_1YIUUFX:UV-,$:"50V5(Q
MSRAYXXY]JT[7Q/J5S=V^DOH\4&N-;-=7-M)> QV\8<HI,BJ=Q;&0 .F<XQR
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MQ#;WZW5B+*]T^\>SN(5E\U=R@'*M@9!# ]!6_0 4444 %%%% !1110 4444
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MM;1B.),X ).23DDD\DD\DGDFIZ* "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "O/=*NKR
MV^*?C4VNGO>!H;#A)50JWE-C.XC@\\C)&.AKT*LRS\/Z;8:Q>:K;12K>W@47
M$AN)&\S:,+E2Q' Z<<4 <3'X+U32[+PI;VT,=U)I^I2:C?.L@12TF_<J ]<%
M^,XX'O6U?Z+J5AX_C\4:; +R"XLOL5Y:B14D&UMR2(6(4]2""1Z\UU]% 'FF
ML^"M5N_#/B 06\3:IKFHPW;1^: D,<;QE5+=SM0YP.K>@S6]-IFIR?$BRUT6
M)%C%I<EH^94WAV=7X&>@VXZ]?:NMHH \R_X0W7;CX?ZQH[0017T^K-J$(>8%
M'4W"RA2P!P<#'3&<5TATN^UKQ1I.MW]D;*+28IO)MVD5Y))9%"DDJ2H4*#CG
M)+<XQSU-% 'F4G@W7+KX=^)M%:WABO;[4I;VV#3 JRM,LH4D=#\N/3D5MZKI
MNMZGXD\)ZHVGQQKI\L\MTB7 ;8)(R@"DXW$9R> /3-=E10!P>EZ%KGAN/Q!I
M=G9QWMGJ%S-=64YF51 TH^9)0>< \@J&)!Z4RS\'WNBZSX,CLX?/L-#LY[>>
M8NJL[2*HW!2>F5)/UXS7?T4 </I&G^(M$B\67=MI<,UW?:@;RRAEN%574JBX
M8C.TX4GT]Z[9"Q12X"N0-P!R ?K3J* "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBOGW]H&V\53:]IILH[Z31Q  @M0Q43[
MCG<%_BQMQG\.] 'T%17+?#A-;C^'^D)XA\W^TQ$?,\[_ %@7<=F[/.[;MSGG
MUYKJ: "J.M:I%HNBWFI3*SI;Q%]B\LY[*/<G 'N:O5S&OR7E_K^GZ;8VT5RM
MF1?W:2S&->I$()"M_&&?I_RS% &EX;URW\2^&]/UFVXBNX1)MSG8W1E^H((_
M"M6O./ ,EQX=\6Z[X1O88[=)6.JZ=$DF]1%(V)$4X'"OVQW-=-XSM+^^T#[/
MIDULEX9XV2&Y)$=SM;<8F([,%(]^G2@#H:*\@N/$L=IX?U")-/E\/70U>SAU
M:WD.Z*VCDV@NC(0/+95Y((ZGIG-;EWX8&ER:U=Q:M##!>:1+_P 2VPA:W0NG
M/GJ1(<'D*<8SD9H [G46O4TVY;3HH9;T1DP).Q5&?' 8CD"IH#*;>,SJBS%1
MYBH<J&QR >XS7DHT"R@^"$NN(]V-2F\.1F2?[7("=L>Y> V.#QTZ5K27+:AX
MFT#0+J6T%K+H8N(H;R$RQSRY4,-NY0S*HR,YQDG'>@#TBBO,YO#VL:7HEOI^
MFZC:Z])8ZC+,=-N\Q)+"4_U +,V=F\,NXD#C/W:Z3P'J%CJ'A^4V5G<V)ANY
MHKBSN/O6\N[<R>FT;N,=B.G2@#J*R/$>N)H&G17!C\V6XN8;2!"<!I)'"KD]
M@,Y/L*Y31(+?Q?JWC&WUN/S)[34#:0*QPUM (UV/'_<+$LVX<GCT%<Q,\VO_
M  O\$ZAK<:W%\^L6L#32#+21^>5!/^\H!/KG- 'JND3:T\][#J]I;1K%(!;7
M%NYVSH1G)0Y*$'@Y)SVK4JJ\$5GIDD-NRVL4<3!64<1C'7'MUKS/1+R\\/ZE
M;Z?J^BK%K::?<"RU&S??!JFU Q+_ ,7F?*#\V3RW/- 'JU%>6Z!I/]NZ#X8\
M3Q:_:V]RKPRW%U#;-YURS862"5O,^;+';C'! P!TJC9>&+'7-(\=->W-[YEE
MK%W]DE-Y)_HS+%&P<?-R1QUSP,>M 'L%%>6Z-.?$B>'X]31M1U630%FGM+M@
MMO&KL!Y[<$F1L8&!TSRN<UCVK3ZG\//AK-<WMVTTVJQ6\DBW#@NG[T8//7Y1
MSU&."* /:JJWVHVNG) UU*(_/G2WB!ZN[G  _G] 37#S:%HUGXEM/#UA;O=^
M3I\LPTZ[F+6T*22\S,6W,7SE5 S@9^[UKD[>*/5OAY\-+G45%W.=:B@,LWS,
M8\S#;D]L*OY"@#VZBO-GM$\3^+?$WAZ::RC2QB@BLX)[=I#%$T0/F18==IW$
MC<!D849Z5V?AR"6S\-6=O+J1U66"/RS>%=IF*DC)Y//&,Y.>O>@#6HKS+PK;
M:?XJ\$:9XBO[Z6WU:*[-Q<WL+ 3+(LA!A)()"8(79Z8XJSHEO;^,+OQE%K2[
MKJUU.2S@R<-:P*B^6\9_@).YMPP2?H* /1*AO+NWL+.>\NI5BMX$,DDC' 50
M,DFO']*GOO$"?#"YU>XNC<7?VR.=EG=/.189-K$ ]64 Y')SUI-4L+:V\*_%
M#1TCSI]BZRVL#DL(6:!7.W/3YN?:@#V."9+BWCGCSLD0.N?0C-25Y?K.D6?]
ML?#ZTA$D%O</*LT4$K(KC[,Q.0#C)]>N#UI^IZ-I,%[J.BZ=$]V-.T?:;>[F
M+0V2L78.I.6,K>W0*/F'% 'IM5=1U&UTJS:[O)1%"&5<GNS$*H'N20*\ST35
MWU$_#[2]8F,MG?Z0\SB8Y%U<*B;5?/WL*6;!ZG!Z@4>-O#VEZ;X1>TAF>[CC
MUZVE6*<AA:>9*F8H^/E7:>!V#>] 'JU%>;^+[6YTO4I;R#1H-9T*&Q6&XL87
M"W%C@N3+"#QR#SC#?(,'BNVTI[+5/#=E) 3/8W-I&4,B\O&R#&1[@T :5-?>
M(V,8!?!VAC@$]LUXE>6US'X;U/PG:Q>?K>@:A)>6[.26DM1^^4L?XMP(BP>I
MQZ5WFDR6/BNTOO$=NK"UN+);>U=&*-M"[G(*X(.YMA]/+/K0!O0ZI+8Z382:
M]]FMKZXDC@:*!RR&5S@*I."?7Z ^E4K3Q#=S^/-0\/36L,<-M91W4<R2%F?>
MS+R, #[IXY^M>;QVEO?_  ]^&$UY"D\C:I;1L\@W$JRR%AD^I S]*Z1]$T_5
M/BQJ=A=0E[)="ME\A7*H1YL@ .TC('8=/R% 'HU4]6NYK#1[R\MX8YI8(6D6
M.1RBM@9P2 <=/2N:^%=Q-<_#C2FN)GE=#-$'D;<Q5)G5<GV  _"L.T^S^*K3
MQY-JT8EN[*[N+.!&/-M#'&-C)_=+'<VX<D_04 =7H^LZMK7AWP]JMK:6@%\D
M<UXKR,/*C9,G9P<G..M&J:[>?V\V@Z1%;MJ*V)OBUR6\O;OV*O'.6.[GMCH<
MUPELI7PQ\)Y4DE4M/;1LJR,%9?(8\KG!Y YQ6XFDZ>WQPN&:SA+#1([@';_R
MT^T-\WUXH NQ^*/$&HB_M]-T>U&IZ8D'VRSGN/ORR+O:-)!P,*1\QR"3C QF
MNS4DJ"PP2.1Z5Y786L&CZS\2M1TVRA%YIZI):;4SL;[(#@?4U=T;0X[^#PUX
MEM==M8 0GFRV]NPDOA( &CE;S#N;/<@E2">,4 >D45Y)H.EQ1:/XMUY/M5QJ
M6C:KJ;:?ON9&"%5(5<9PW;KG.!Z5HZ+HB:C:>&?$UKKUK ?W9EF@MV\R^#@!
MHY6\P[CD]2,J1VQ0!Z555]1M8]4ATUI1]KFB>9(^Y12H)^F6%>-76E0/X \>
M:@\MTUWINL7C64K7,A,!1EVE>>O;)YQQ74O86=Y\8=)N;BUA>630'F=V49+K
M+'@_49- '2>-/$-WX8T#^TK6UAN,3Q1.)9"NT/(J9  .>6Z9%=%7$_%E=WP^
MN5R5S=V@R.H_TB.LZXT*'P]\3M"CT=[J.#5X+M=3A-S(X<(@*RDEB0VY@-V<
M\T >CT5XKI%J=+^$5YXLM#=2ZW91WR6\SW#MY:F=U)VDX. -W(//-;^N6T6C
MVG@[6?#Q*W-Q?VMO*Z,2;V&5?G\P_P 9Q\VXY(P30!U/AKQ#=:UJ>O6=U:PV
MYTR\%LOE2%]X**V22!_>]*Z*O&&U);7QCXCLM3C:/P]>ZVD5Y>(W,;^3&8T8
M_P ",>"X]AQG-=3J_ES_ ! LO##?88=/.EM/;VUS;^9#-)YF& 4,H+*H!'7&
M6/O0!WU%>2:UH4FCZ/X<TQM=N;WR_%$$ >-WB\F)\MY/WSG;Q@DY' XQ77O'
MJ'A&&+3?#/A:74+$[I2YU)4V.S$E?WA)]_3F@#JI"XC8QJK. =H9L GMDX./
MR-8/@OQ!/XG\-1:I<V\=O*\TT;11L65=DK)U.,_=]!6%I\T?B3XB>(M-UJW1
MTTZUM1:V<I#*HD0M)(!T+;B%W=L<8R:Y'P[>M8^#_".EFXC@L+S6+V">2X!=
M'*O,8XW^8$AFQQGDCG(R" >UTR8RB%S"B/*!\JNQ52?<@''Y&O-M2T>W\,Z9
MK\%UKTR6FH2VIBT_3H?*,#,^W9'N<A1*001D ?-5SPJLUE\3-?L?L\%E;M86
ML_V.V?,2.6<$@8 #$ 9P!^/6@#H?!7B";Q3X1L=:GMTMY;D.3$C$A=KLH&3U
MX6M^O%_#^HR6OPZ\!63W$5O8W]]-#<23*6C;F8I&P#+D,X7C/.,'(R#H^*_#
MKZ#X/\:&/5P8YK5;J+3[2-X([1@"I9<.<!R#E>F0>* /5Z*\[U3PM+9:59W7
MA^.*YO[B>*XNK*_N7*:B$B8%/F)"GYMPXQE1D<"MKP%J%EJ&D7AM+"XTZ6&]
MDCNK&?&;>7"EE4C@KR",<8/;I0!NG4HI+V[T^U:.6_MH4E>)GV@!]P7<0#C.
MP]C6;X*\03>*?"-CK,]NEO+<[R8D8D+M=EZGK]VN>\/:98+\7?%\PM81*D5E
M(K[1D,R2;C]37%:580VGPK\):["TRZC%JL2),)6^5&NF5D SC:03D8Y[T >Z
MU5EU&UAU&VT]Y0+JX5WCC[E5QN/T&1^=>7^.#!=6/C>\LB]U<V,2!KJ>3;]A
MD2,,$M\#=GG<QRHRW4\BM&XL;.]^*GAJYNK:&66;19I)'=02S*T>"?ID_G0!
MZ317)?$759=)\.6\B3BV@FO[:"YN#G$4+2 .3@@@8X.".#U%1:9X4BL/$UQ,
M=0M#9ZA9;7TFVM3'#(58?O@-[ '#!3@#.10 0>+=2O;*/7;*RMI=!6>>.X+2
M%9HXHF93,,\,,H?EZX(YZXO:'K&N:J^FWSZ?:C1]0LQ<K(DI$MN6 94<'[^0
M>HQ@@_4\1X5T?3G^!VHS-90F1H+\EBO)*R3;?RJ2&2'3?#7P]T^(VUG9:K''
M]K>6,M'+)]F!1' 9<AF[9Y(&<C(H ]7I&944LQ"J!DDG  KRK7K:?P/I6JF/
M6@MC>W]D9[>VB:%=.@D?9*R'>VT. >F,'.*Z/4O#.BVK:I-;ML2]TJ1'TU,?
M9Y G/F[ /O?,!GN"* -V74KK4-"@U#P\EM=&<QO&;ARB-$6&YL@$_=R16M7C
M4]G;VOP*\/7%LI@F8Z>[F)RF\M)&IW 'YN">M=+XH:W\)^.](\4S833KM7T^
M^8_=B=ANCEQV)*E"?0B@#T"LOQ)J=QHOAK4M4MK>.XDL[:2X\N20H&"*6/(!
M[#_]5<5K+R:1;>'+><PV,>MZF[WYF0E SH[QPN RY&[:N,@';SD$@NU'P^WA
M_P .>.575(I(+K2I9UTZ"W,<=J?*=2R@NV Y!..!D'% '<Z-?/J>A:??R(J/
M=6T<S*O0%E!('YU>KR_5[,V'@SPEXO@B,DFBVUM+=1+SYML8P'XZ$IG>">F#
M76^&A!J5WJ'B.(*R7T@CMG'\4$?RAO\ @3!FSW79Z4 6M<UPZ9=:780HK7NI
MW!@@WYVIM1G9FQR0 O3N2.G6I]$GU:>R?^VK."VNDF9!Y$N])4'W7'=<^AY%
M<CXVTRQNO'W@HW%K%(9KJX20LN=RB!R ?H:-)@@3QYXZLBB"S%I9,(3]P9CD
MR0.@Z<T >@45XMIZ/>^$/A>\MU=;Y[L12LEPZEU,<A.<'KP.>H[&K&H7=QX1
MC^)4.B-+!#9Q64T$:L6\AI5(E=<YP<#=]10![#65)JDVHZ#<7OA[[-=W ,D<
M'G.5B=T<H<L,\94\CK63;^'= &I:?J5E<%(KJU:W\B)@8KY&7=NDXRY !.XG
M//)YKSRSL+6W_9PU"YMT\B<Q7#&2%C&S;;AP 2I&0!Q@\4 >V)O,:[P ^!N"
MG(!]J=7 O<#4_B59:#J2++IR:$+N&WE&8YI3(%8D'ABJ@8!Z9)KD/$'VNV\'
M>/-+6XN?L.E:E;K82"9LQB1HF>+.>57?@ YQGZ4 >VT5P$5A#HGQ>L8K$RHE
M_I4[W0:5G\UTD3:[;B?F^8C/H:[^@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M0<D\@\5I7!U(:O9>0UF-.*R?:1)N\XM@;-F.,=<Y]L5<,B X+J.=O)[^GUH
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M+&TB^#?CZWBB00VVM78A5>B8D0#'X<5UVLZ387_Q;T2.[MDFCFT>X\V-^5D
M>/ 8=&'/0\5U(\'^'%L;FR71;);6YD\V>)8@%E;.<L._/8]*L_\ "/Z5]N@O
MOL4?VN"/RHIN=Z)_=!SD#VH \MB@F@^&OBVPT^9+>"S\0S0PP%]BF$3(3 I[
M;LE0.^['>NLTOP^+GXBR>(8M.6ST]-.2%8W"JSW&X_.%4G&$^7)ZYXR!FI_$
MGA-?[#DM="T?3YDN+Q+B_LYSL6[4'+#=@@.2%.XCG%4O#G@RUM-9M=3MO"UO
MX>>W+%_)NM[S J5V%5^7;D@Y)/*CCN !WQ2MH9[#PZ9-RG^WK--ZN5*AGP<$
M=*K:?H5KX<^+\,&A0"ULKW29);ZVBSY>Y9 $DQV8Y(]\'WK6^(.C7NO6&E6M
MII_VQ(=3M[JX0NBJ8D;+#YB,DCC%=!9Z18VB3&"VV/<*!*[,6D8 < N22<9.
M.>.U 'EOAV6Q/PR\*6EVLLLUQK,PMK=9 D<TBW$S!920?W8QDC!)(&!5>ZAC
M'A?XIV4GV<I!(98XH!MC1_(4L57/'S=??TZ5Z<W@_P .OI2Z6VCVAL%E\Y;?
MR_D5_P"\!V/)Y'J:4^$/#I%T/[%L@+M%CG"P@"15 "J<=0 !QTX% '%KI=EI
M7C;P!<V-ND%Q>VUS'=2K]^X46X8;VZM@@$9Z5TWCZ>PC\-"'43<&.YNX($B@
M<(9I&D&U&8@@(2,-G^'-:A\.:.9K*8V$1DL1MM7.<P#T0]N...W%6=3TNPUF
MPDL=2M(KJUDQNBE7<IP<C]: /-+:W5?$GQ!L)TM$C?3+>1K:VXC63RY>@[MA
M1DX&<#@5GBQL- ^$N@Z_;PK!/=6^GP:E>G<Q^S%D+AAGE>BX_N\=*],3PCX>
MC=WCT:S1G@^S,R1 $QYSMR.QR<^O>KEOHNF6NE'2H;&!=/*E#;; 8]IZKM/&
M/:@#F]$T.QLO%_\ :MGJEJ7O+'8UG80B.&558$3$!C\PW!0WH<53^(%C;77B
M7P7YR9+ZFT3$,5)0PN2,CMQ74Z)X9T3PW'+'HVF6UDLQW2>2F"Y[9/7BIK[1
M=-U.XM[B]M(YYK9M\#N.8V]5]#[T >4:J\_ABW^*$'AR'[(EM%92PPVR[5A\
MR/$KH!PIV@G(],UO^(+*TT^]\$:GX:BBBEGU"&V)MP!Y]H\;,^['W@%4-DYP
M>:[>#0]+MKZZO8;*);F[&+B7',P' #>N!QS4>G>'='TF19+&PA@9 5CVCB,'
MJ$!X0'T7 H Y/X=6&GVVK>+I(K2VBF379XHV2-594\N,[1WQU.*L:_?0?\+.
MT+2]6*?V;/8SO;I-CRY+H,H&0>"0F[&?[WK74V^BZ9::I<ZG;V%O%?7( FN$
MC =P/4_@/R%-UG0=)\0V8M-7T^"]@#;E29,[3Z@]0?I0!Y_K<.G:!'HNDZ=-
M(VAW7B+9?JS[HT+@N(1V$>\K\O3J#W%7;K3H[/XG36-C B:;?Z))+J%L@VQ[
MU<*DF!P&()7W ]J[,Z#I)T4:,=-M?[,"[!:^4/+ SG[O3KS]>:6WT/3;2WG@
MAM%5)U"RDDLT@ P S$Y( XQF@#Q_3-,LK7X??#K688%74FU2RB-W_P M"CNR
MLF[KM(/W>GM6YKYGT35[_5KZPM=:\/3:C%+)<Q8%WITJ,B@8(^9 RC@8.&/8
M\]W_ ,(GH/V&VL?[+M_LEK)YL$.WY(G[,HZ ^XJ3_A&]'^U/<_8(_,DD$TG)
MVR2#&'9<X9A@8)&1@>E '$W<DNE?$#QI>:=$#=Q^'X[B-0,[I1YI''?D"L:_
MM=)N?AQX'U:%(9;N34]/DDN^#(\K./-W-U)+;L@]Q[5ZK'HNFPZK+JD=G&M_
M*NR2X ^=E]">X]JS1X$\*!Y&_L"P/F2B9E,(*[\YSMZ#G\Z ..-O;>+-9\9:
M/J][8PW,5QY:K<P!I8;;RDV/&Q8;1G<V0.&.3UIC:!IFJ?$'0K*^9M3MIO#<
M@EEFR#= /&%9QW)'/UP>U=UJ?@_PYK-Y!=ZEHME=7%N L<DD0) '0>X'H>*M
MR:'IDNK1ZJ]E$U_$NQ+@CYU7T![#VH \Y@T^QU_5/%GAV_N;&V:U=;>"*X@W
MR06GDIY;1,7&T [FR!PW)[5;T>6&\^(%EHFI71U&UM=!BEL'NE!^TL6*O-@\
M%MH SUQGU-=EJWA'P]KM[#>ZKH]G>7,. DDT08@#G!]1['BIM5\.Z/KAMVU+
M3K>Y:V.86=?FC]<$<@>U '+_  M@@M=/\1VULBI!#X@O$C1>BJ&7 'X4EJT6
MK_%7Q#IFLP13Q6UA;'3X)T#*8FW><X4\9+;5)]@*ZW3-#TK11,-,T^VM//<R
M2^3&%WL>YQUI-0T/3-4GAGO+1))X 1%,,JZ ]0&&#@]QG!H \NM_#EUKGPZU
MRS1!<3:+K%R="DE&\^7"X*H">JDAD_\ U5NC5AXA\,ZIXUTFV7[1#I#QZ<VP
M%UD\LO)@XYPVU,>L;>M=_;6T%G;1VUM#'#!&-J1QJ%51Z "FVEG;6%JEM:0)
M# F=L:# &22>/J30!YWHFDZ1JD?ACQ!:ZQ:1L@"I]C@VR76]?GBE.XENY.>0
M02>]+\.?#FD2RZKJ,EFCW=AX@OTM9"3F%=Y7"\XQ@_YP*Z_3O"'AW2-1GU#3
MM&L[6[G!#S11!6P>N,=,^V*M6&A:7I<5Q'864=LERQ>8197>QZL?<^O6@#R_
MP]+8GX9>%+2[666:XUF86UNL@2.:1;B9@LI(/[L8R1@DD# JGJ,2+X4^*5G(
M;?;!.)8XK<;8T<PH6*KGCGK[^G2O4F\'^'7TI=+;1[0V"R^<EOY?R*_]X#L>
M3R/4UC^+O"%K+X4URWT#1;9=2U*V%MNA5(\@ !<DX^4 #I[<4 <_J?AVRTCQ
M#X(U318C%J-[="WO&1R6NH&B+2&3GYL;0<GID>U8UOX6T34/ 7C:[NH0+BPU
M+46M;C>0UJ8SN79S\O(&<=>!Z5ZEHFB6>GV=M<+IOD7<=N(]C,&:,8&43DA0
M2!PI Z5SW@_PB(!K#ZWI 22ZU:>]C#R*ZR([[DW*K$%E]P<=C0!F6Z3R^,_A
MU=:@A&HW&CW/VLMPS.(HLY]\LWYFN=N-"TR3P!\1+I[2-I[+5KUK20\FW*A"
M#'_=.>XP3@#H*]AN-%TV[U.#4I[..2]MP1#.?O1@]0I[9[^M5AX5T(6EU:#3
M+?[/=N9+F+'RS,>K,/XB>Y- '+WTDC^-?#US>*+^TDT>7-I\K-'(2F9BAZ@@
M[,]>3VS6G\//#DOAWP_)'<PI#//<22B,,&,<1<F-"02"54XXX'3M65XD\*27
M6MPM+X4T_7='AM5@M83,L4MJV26^\,,#\N.>-O Y.=[PCX<B\/P7/D646G17
M+*PL89FD2(@')R?XCGG QP.O4@'-W6@:5J_QDU&TU"U2XMY-#AE>!R=CMYSC
M)'?  _0]0*YB2"6R^$VN:?YDDEA9>)%MM/9V+?N%NH@ ">H#;A^%=S-X<N+[
MXH3ZO=Z;(=/.F):1W"S*K!UD9B?E8,%(;'\Q727/A[1[S3(M-N-.MY+&+!CM
MR@\M<=/EZ<4 <-XL73]1U;Q7%'''/=6FCJMT]\0T5LK+(RB),9W-U)R ,+U/
M%9D=M;ZM=?"=[P>?)/8R+.Q<YD'V/=ACGD'/(/7)SUKT>X\+Z%=WZ7]SI-I-
M=I%Y(FEC#-L]"3U_&FP^$] M_L/DZ3;1_8,_9=B8\G/7;CH3W/?O0!P%GI*B
M'Q]H&EW%OI<"ZG;"T1D_<([K$=A4?PNV%('9C6]X.U-8M5URVU?1K?1-6MHH
M9+PP2 VTT?SA95/&.C YYX'H:Z)O"NA.MX'TNW87K*USN7/G%2"I;U((!![8
MJ4^'=):QN[.2RCD@O%V7 E)<RC& &8DDX'3GCM0!I*RNH92&4C((.012U'!#
M%;01P0QK'%&H1$48"J!@ ?A4E !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M0D#J6/8&@#T*BN8MO%-Z_BMM!O-&^R2S6C7=G(UR'$JJP4JX ^1OF'3</>J
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %<3/XM\0W&OZ]HVD:!:3W.E
MK"X>:]*)(LBLP_@R&.  .G7+=,]M7GNE3:A#\4_&ILK.*Y!AL 0\WEE6\IMO
M8_+UR>HXX/8 MZ?\1K75=%T>YMX%@O-2$N8;ECBW,1VR;B!DX8@ 8&<CIS5.
MY^(U_:>&M1U)]##3Z?>QVL@\UECF5W55EB)3Y@=W0XQCK43> M9T33]!O= N
MK236M,DN'G2XW+#="=MTJY&2N"!M^@S5[Q)H?BGQ)X-GLYTTZ/4+B>"00+.W
MDP)'(KXW["68[3DX Y'ID@#]7\0ZOIZ:8=9\.Z>5NM;@LX<77F^6KD;90"GW
MA\P[8(XK4?Q!>W^K:KIVB6UM-)I803O<2E%>5EW"-< XXQECTR!@\X@\8:-J
MNNVVABRAMA)9ZI;W\RRSE1MC.2JD*<D_A4-KH6KZ#XNUC5--AM[NRU@1RRP2
M3F-H)U7;D':0488SW!' - #;'X@6^KZ9HKZ=:G^T=6FD@2UG?;Y#1 F8N0.B
MX[#G*],Y%+PC]J_X6CXT%Y#!',(+#)A8E7&V3#<C(^GMU-56^'^IZ/;^']1T
M::VGUC2KFYN)XYF,<5R+@YE4'!*XX"G';FMKP_H^N6_C;6];U"WLH;?48+=!
M'%<-(\;1AAW0 YW=>.G?K0!5^+$]]#X+<6@B\N2ZMHYB\A4X,\8   .0>0>G
M'K5[^T##XI&G6FG6"^(+JS^TWLX8[%A1MD>6VAG))( XQ@\\#+_'NBZGX@\.
M#3M+2V,K7,,K-<2E% CD5^RG).W%07^A:I%XUL_%>G1PR2M9&QOK.27;NCW;
MU9&QC<#V.,@]10!G7_Q'N++PQK=\=)C.I:)=+;7MH;@A?F90LB-M^92&! (!
MZ_CUND7.KW'VHZKI\%F%EQ;^5<>:7CP#EN!AL\$<_P!3QFN>!M5U'PYXF6 6
M@U;7[J&:0/,PBA2(IL7=M)8X0Y.!RWM7H<+2-"C2HJ2$?,JMN /UP,T <GXE
M\6W^A1ZQ<KIT*6>F0)*)+N4QB]8J69(CC&0!CODG&.]=18W27^GVUY&"J3Q+
M*H/4!@"/YUPFN>%?$>H:CXJ6/^SI[;5K'[/9W%Q*PDM 8BK1A I&&8YR".N2
M#C%=AX?MKRR\/:?:WZPK=00)&XA8L@*@#@D GIZ"@#D;CQUKOV/Q+<6V@V9&
M@3NL_F7I D1(PYV83)8@G@@ <<GMK7/C*%Y;&VLO)6XN[%;_ '73,%CC;A00
MH)))S]-IYZ Y:>%]=&F>-[8PV6_77E:V/VAL)OB$?S_)QC&>,U"_ACQ3I5QH
M6LZ-_9\FH6FF1Z9?64\S"*:-.59'"Y!#9/(Z&@"9/B#?'1M+U*;1!;Q3ZD-.
MO?.E9?L[%MHD7*?/&<CGCJ*T[7Q<[>+-=T2]AM+8:9:I=+,)RWF1L"2Q&T;=
MO&>3U%3ZCH-[XA\&:AI6M20?:[Z)LB#)C@; V;2>3M(!R>IR<#H,27P%>7,G
MAV\GO5.H0LZZQ*/^7J.0!G3W&Y$4#LM '9:3<W=YI-K<WULMK<RQAW@5RWED
MC.W) Y'?CK7&:3XB\0G4_&<UQ;V=Q%I<VV*$7#( JQ!PH.P]<DD^O;%>@5Q"
M>'-<M-3\7&WCL9;36?WL+O.RNKF$1[67:0!D9W9/'&.> !-.\7^([[P]!K2^
M&4DMKJT@EMHX+DM(TDC*"&7;\J -NR,_*/4D"Q9^.84O_$5KJ9M@FB6Z7,ES
M:R;T=&#$C'4,"A&,G/%4I?#'B'_A5VFZ! ]I'J-DEO'*GG-Y5S'&1N0N%! <
M#!X]NAJM-X'U?5=3U_[<FG6>GZQI45GMMI&=K9D#A0 54,!N!SQTQCO0!7\5
M7FIZA+X%O;NPMH+>XURVE0+(6EBRCE5;C!R#DXZ$8YZUOP>(IO\ A(O%=K'H
MUHMSI=O!*)1-@W0978!FV97 7&.>IK&FT#QGJ&F>&;.\M=)$NBZC!<23K=OB
MX2-&7('E_*2"/7GT%:D>@:U%XG\5ZD(;-H=5M88;<?:&#!HT9<M\G ._MGI0
M!4L?'VJ36GAC4[K1K>'3-<ECMPRW1:6.2125.W;C;E<?>SWP.E7[_P 8W*-X
MD?3K**:/P^@:X660JT[>7YC*N =N%Z$YR>, <UE#PAKR>$O!VE"*Q,^B7MO<
M7#?:6VNL08?+\G4[N^.E4KNRU76?$?B*[TK2]+U.PGE6RG']I2VID\M '215
M4A\,67)[<=.H!Z#H&I2ZSH-EJ<MNEO\ :X5G2-)#( C#*\E5YP1VKE9?&/B2
MYO\ 7[+2?#EK<3Z/*JOYEZ5$JE X"_)G<0>AP!ZUT_AV_?4=#@GDL5L74O$U
MNCAT0HQ3Y6  *_+P<#BN.T";5(O'7CP:?9P7!:ZMPK23; C_ &=<;N#\OTY]
MJ *^JZ[:^*8/AWKMK&4CN]65@K<LA\J4,N?9@1^%:_B3QQ>^'K74]0FTV*.Q
ML+A(52XE,<MXIV[GBXP0-W'7.T]*J'P-?Z;I7@[3=,-O/%HEX+JXDFD,9D)#
M[MH"GJTA/)]JI:[X+\4:I8^+; ?V;-_:LWF6M]/,_F)$"I6#;M^51M/(..<X
M))H Z*_\3ZM'XT;PW8:5;2R-IQO8KB6Z*+_K F' 0D#KTW9XZ<D7_"'B%_$N
M@B]GM1:W,<\MM/"K[U62-RK8.!D<9Z=ZS8M&US_A8,/B">"R\A=(-DZ1W#%A
M(9!)D93E1C&>">N!TJQX'T74=!TJ]M=22W$DU_/=(8)2XVR.6P<J.1G% #KW
M63!\0=+T>33+=OM-I/+%>E\R(%V[D V\ Y'?G'2N>\/Q7FL>.?&MEJUE87%F
MTEK#<1/(S@)Y *JH*889.3G&"3UK>U'1=3N?B%H^M0QVYL;*VG@DW2D2$R;>
M0NW'&WU[TSP]HVK:?XN\2:G>0VJVNJ30R1>5.6=!'&$^8%0.< \'O0!%\0M4
MU/1="L3I'D1^;J%M;2%F*D(TBC:N!QGH3V&<#TRKY]2B^+UH]K9VLFH/X>D!
M5IBL2GSUY+;=Q'T7//;J.A\<:'>Z_H$=OIQ@^UV]Y!=1K.Q5'\N0-M) )&0.
MN#51='UQOB#;>()H+(6Z:4UG(D=PQ8.T@?C*<@8QGC/7 Z4 0V/C]9_#=M>W
M5I'!J$NH2::;?S28Q,A8,=^,[=J,W3/:K_AWQ/<ZMK.I:7=V01K0))%=P;C#
M<(WH6 PP/!'-<PO@7Q"OA]Q!/96NL6NN2ZO8OYC21-O9LQR?*" 5<@XS79Z"
M?$,X>XU^.RM7VA8[6SD:11ZLS$#D\8 ' SR<\ '/_$^>_BTK2([583#-J]FD
MF^0J6/G*0N #\I(&?Y&K\>H%/$]SIFFZ=IZ:U):I=ZC/N.P<E(U)"AG)P>N,
M >^*=XXT75-<LM-@TR.V9K;4;>\D,\Q0;8WW8&%/)J&XT+5+'QQ_PD^FQ0S+
M>6:VM]9O+L(*G*2(V,'&2"#CCF@#FO&GB*/Q+\(_$WG6GV:^T^<6EW;EMXCE
M25.5; RI!!!P*W?$"J/BOX+8*-QM[\$XY/R1U2U?P+J=UX*\16-L;0ZMKMY]
MJE+RL(HOF7"AMI)PJ 9P,DGI6QJ>C:O?>-O#>LI!:K;:=%<)<*9SOS*JCY1M
MP<;>Y&<T 0S>,[V70M1\0:7IT-UI=A+*K S%99TB)$CIQ@8(; /WL=LU-%XQ
M>X\1Z-906T)TW6;%[JQO&E(+LJAO+*;>#AL]>@-9FG^%=<T70M:\-62VDVG7
MCSFSNI)2K6Z39W*Z;?F*DDC!^;OMJ]K?@MY?"NBZ;HMR+6\T:6W:SN7&2H3"
M/GURA;CN<4 1Z3XWN]4T/5+I;&T74+'43IPM5N2RO)O5!\^W@'<#G!X^AJY'
MK4Q^(%SHS:5:"Z325NDNQ+\TBF0J(R=F57<&/?UJO9>"%T[QNNJVDHCTS[)&
MKVW4M<1J8T<_]LV(^H![5.=&U5?B3-X@6&V:Q.E"Q5?/(D+B1I,D;< '..M
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M("C/ R?F8* ,=#R,<X]_\1+G3] \23OI41U;P^ZK=6IN"$9'&4D1MN2".<$
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M36<L\*R/;3J5>)B.58'N#Q7#3^-?$S:;XIO+;3M*5= N)5D$DLC>;''&KD#
M'S8)Y.!T&#UH ]%HKDKCQ>UQ=6=EIR&.>XT]-09WM);D1HYPB[(\')(;DD8V
M]\UF'QOKL.BZ3J=]I"V"2ZDMAJ"W,4BF(,VU9DW8.PDCJ.-W?% 'H%%<=;>+
MYE\6^(M&U"2SBCTNT6[BD1&)>,C+%AN_AX! Z[@>*Z72I+Z;2K674HXH[QXP
MTT<0.U&(SM&2>G3/M0!<HKSW2=7\0_V]XVEDFL[E=-D18H65HP%$(=0#DX^\
M<\')].TVE>)_%VH^&(->31M.EANK*&2W@BF82"5V4$MGC8%);@YP,=^ #O*H
MWVL:=ID]K!>WL,$UW*(;>-V^:5R< *.IKE[+QVD6H^(;?49[2XM=(LTO?MED
MI"R(0VY=I9OF!3'#'.>U8WBFZUB_A\#W]ZEG';W6NV<H@C5O,@+!BH+$X?@G
M. O/K0!Z)#JEC<:G<Z;%<H][:HCS0@_,BOG:3]<&K=<C#XCU!_$_BC35L+,-
MIEK!- WF,#-O#GYVQQC;T /4\UD6/CK7I=,\*ZS=V&GIIVM7$5J\<;N94>0'
M:XSQMR.G)QW[  ]%HKC+_P 6WYN/%"Z;#:@>'HE>1+@,3<,8_,(!!&P;> 2#
MDY[#G?\ #FIW&M>';#5+F".![R!)UCC<L%5@&&20.<'GB@#4JC?:QIVFSVL%
M[>PP37<HBMXW;YI7/0*.IKDY/$OBR^U[Q%I&CZ;I7G:282CW,[E9 Z%P. /F
M/'H!ZFL?5/$:>+/#G@+65MS;O-XBMQ)"QR8W42JPS]0?PH ]2HKAO%?C'5?#
MMOJ]Z;>RAM[#8;>&X),E^N 7*$-\H&<<JW(YQ5J_\2ZR/&=KH6G6=B8[O3GO
M(YYY&RI#*/F '3YN@SGCD4 =?17.^#=?NO$&DW,E_!##>V5[/8W @),;/&V"
MRYYP>.M5M8\0ZO:^--/T"RM+-DO;2:9)II&RK)MZ@#I\W09S[=: .KK!NO!7
MAJ]U&34+C1;1[J0YDDV8\P_[0'#?CFN6_P"$U\4-X;U^_6PTD3^'[B>*\R\F
MRX$2ASY8ZKE3U8GGM6]>^(M0?[%+:1VME8W%B+K[;>_,GF-C9"%#*=Q!)SST
MX!H Z>.-(8UCB14C0!551@*!T %4+#0M.TR^NKVT@,=Q=D-<2>:[&4C@%LDY
M('&?2N.;Q]J+^#/#WBA+2UBL+Z6./4/,W,;4,^SS 01E0WKZBNM@U"ZN/$MW
M91B$V5K!&9'VG?YKY.S.<<* QX_B6@#5HKF?&'B+4/#QT;[#9V]R+_4HK)_-
MD*E=^>1@>W7MZ&L^'QK=Z7?>)+;Q'#:J-(M$OEDLBQ$D3!OEPW\0*X]#GM0!
MVU%<7>>*]5T6WT34]5M[0Z;J<T4$J0!A)9M*/D)8DB1<\$X7U&>E-\*WVM7G
MC;Q7#>W=O);6=S%"B+$P*J8@RA?FX^]SG.3Z=  =1?ZQIVERVL5]>PP27<RP
M6Z.V&E=C@*HZGDU>KAOB<9%LO#30QB25?$5D41FVAFW' SV^M(GC74]$UW4-
M-\5VEG&L6GR:E;W-@S,KQ1_?0AN=X_(T =U17%6OBO6WU;1U?2I)[#4>)C#8
MW"-9$C*EG<;77L2 OK5+4/'^HP^&-5\26=I:O9Z?J#69M9=PE=5D$9;<#A3N
M.=NT\=\F@#MY=4L8-4M],EN46]N4>2&$GYG5<;B/ID5;KE9]>U&W\;Z/HMQ8
MV0%Y933&5)&9E=-N5!*C"Y8<]\=!7/3^/?$L?AS7-;73=,$.BZA-;SQF5RTJ
M1L%.PX&#R3D_3'<@'I=%,1_-A5T.-ZY7(]:X5_&VIIX-\4:O]GM#<Z'?7%L$
MVMLF6+'/7*DY]3B@#O:*XV[\3ZV?%>GZ)8V5B5O=-:\2::5_D8%0<@#H-W09
M)XY%<]KGB[7;WX;ZC=QFULM1LM5_LR\,2LROB=8R8R3E00PZY.,_4 'I%QJE
MC:ZC9Z?/<QQW=[O^SQ$_-)L&6Q]!S3+'6-.U.XNX+&]AN)+1Q'.(FW>6Q&<$
M^M8=[KFHZ?XP\-Z/<V]E*FHK<E[E P9#&F["J<X!R.Y[]*I^$1CQ[X[_ .OR
MU_\ 2=: .VHK&U[4;^P:R6SAA6&:5A<WMP1Y5H@4G<PW*3D@*.1UKE9O$^H>
M(/AOXKN(6M8KK3C>VCS1JQ258XR=Z#.5)!&,DX]Z .OL_$>CW^HG3[6_BDNO
M+\Y8QD%X\XWH3PRY[KD57U#P=X=U74#?WND6TMV0 TVW:S@= Q&-WXYK@[N3
M6;/PQ\/Y(9M.1Y[FRM5D%LV\1M&'"[MV0,QC<!C/'3OTVI>*M1%WJ5AID<<E
MYID2>:38SS)-,R;]B^7]P8*\DG[W3CD ZVWMX+2WCM[:&.&&,;4CC4*JCT '
M2I:X&;QGXAFO?#=G::)!:W&LVL\ABOW='MY(E!(<;0=N6]R1V&<UVNGF];3K
M8ZBD"7IC7SU@8F,/CG:3SC/K0!9K.BU[29KJ^MH]1MFFL K7:B0?N <XW'H/
MNG\JY0^-=4M-2T2+4;:SA;4[XVDFG@DW%J#O,;LP8@Y"@XVC[W&<5-H _P"+
ML>,_^O;3_P#T&2@#K--U*RUC3XK_ $^Y2YM)<^7+&<JV"0<?B#5JN)^$?_)+
MM%_W9?\ T<])<7^MM\7HM-BNK86*:.UPL+1MSF9%;)#?>^7@XP 3P: .WHKA
M="\4>*=:>]G32M-^R6%_=6EQ&L[^;)Y0.WR\C'+8&6QUZ#&2_3O&.H'Q-HFD
M:@EB9=3MI9)8;?/F6,J*KF-SN(;AB.B\CIS0!U>J:MI^BV$E]J=Y#:6L?WI9
M6VCZ>Y]JM(ZR(KJ<JPR#ZBO+?&FNZAXE^%'B#5;!;1=)9)8HDD5C)+&C[#(&
MSA>02%VG@#D9XZ6X\2W"WAT?30JW%K90SRRR6<UPN7W;$VQ<C[A))/I@'G !
MU]%<"/B!<)8: VK6J^'KC4_.65]2B?RX9(R $Y*XWY+*21P.YKLM*FO)]-BD
MOTA2Y.[>(3E#R0"I]",'\: +E%<Q9:_J%WXG\2:*4ME.F0P2P3;&^;S5<X89
M[;<<&L*'Q]J]SH'A#48-,LV;79Q!(C3,HC8AR,<'CY.O/T- 'HE4;O6-.L;^
MTL;F]ABN[MBMO"S?/(0"3@=>QYKE(O'5SI:^*D\106P?04BF+V>[;,DJDHH#
M<ALC;Z<BL_Q$VLOXJ\!RZD+())J#,8X%8-"_DO\ *6).\8)YPO3ISP >DT5P
M-_XXU1[&YU+1-,>_@MKIH!:)8SO)<JDGENR2J-BG(8@8/ Y()P)KCQ-XGNO%
M6HZ'I&G::'M[2"ZBDO)9%RKL00P R&P#QCCN>U '<51O]8T[2YK6&^O88);N
M58;>-V^:5R< *.IJ/Q#<7=IX=U&YL)(H[J&W>2-I4+J"JD\C(STKS2^N-2G^
M'_P[N[MXKJYEU739(R,H6)C)^=B3R3U('X4 >NT5Q$7C6\TN\\2VWB&"U']C
MVB7RR61;$D3!OEPW\0*XST.>U36OB;6_^$@TRUGTN2>QOE82RPV-Q%]B<#(#
MLXPZGIN 7GM0!UHMX5N&N%C43,H5G P6 Z ^N.?S/K08(FN%G,:F55*JY&2H
M/4#TS_05F^(]<C\/Z.U\\9E<RQP11C/SR2.$4< G&6YP"< X!Z5C6&OZ]<>(
M)]*DL=\+VOG6^H_V?/!$D@.#%(KGKCD$-^% '7U4BU2QGU2XTR*Y1KVV1))H
M0?F16SM)^N#7)^&?%NLZ]>G39K.VM=1L)Y$U:)D<K"N?W?EG/S;QR#TQD]AN
MLIXHO(_$WB>RDTZ%UTJQBNHO():6X#!R%/'7Y< <]>IH ZZJFIZI8Z-I\E_J
M-REM:QE0\LAX&XA1^I KF=#\37WB'3C>:9?Z3=6[V;2>;#&V;:?Y<1R(7R>"
MW]T_+VKG=/\ %.N:;\&+3Q'<I9:A-((W83!E/[R4*2>NXY8'C:.* /4Z*Y'4
M?$.MKX['ANPL[ K)IK7D=Q/(_!$BI\P Z<G@=>.15"#Q_=#P:NI75E"NI?VI
M_9+(C'R1-YOE[\GG9W]>WO0!WM<^_@?PO)?R7K:'9>?(V^0B/"NWJR_=)]R*
MJV/B#5F\>7/ANZM[*2*&T2\^U1%T)1B5 V'<,AE_O=.?:H/B;?ZGIO@YY],N
M(X':Y@AD9D+$H\JH0I!&/O=?3/3J #L      !T I:XK5?$/B:T\46?AZRM-
M+FN+JPFN$GE>1$#H5'S*,D+\W8DGVJOX@\7Z]H&FZC>7=KIML;"WCD2*1RWV
M]]@:41$,"JJ20"5/3)Q0!WI( ))P!U-9 \4Z&VE7NJ+JEN]A92-'<7"MN2-A
MC(R.OWAT]:HR>(Y[[7K;1=*$*7#V(OYYKA"ZQ1L=J+M!&YB<]Q@+WR*XC2-:
MU'P]X$\=:M]CL[B[MM=NWEA=F$1^X#CC)'L<?6@#UI'61%=&#*PR".A%.KD-
M3\2ZS!XKTK1+&RL674+*6=9II&&QDVYR .GS=!DGVZU0C\?W=KX,UG5-1LH#
M?Z5J+:;(D#$122;T57!.2J_O%)SD\&@#OJ*Y.+Q!K$7CV/PU<06,\;V/V[[5
M'OB*J'V%=AW9.2#G(&#[5UE !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MHS&PQ&Q*@YQCJ#QG- &->Z/J]U;6UO>+INK6TD4HO[>[W1H[L5*E!M? 7#
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M:W73M7TU+ B*1C+'MW8;!4#^+IGMWJQX:TSQE:?9[37M3TV>RM  DMJCB>Y
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MR?;+4_V\ %^1OW&(O+YY^;CGMS0 6OB^?6;O0-.L%BM[K4]+&J3/(I<0Q$*
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M+?3Y+/R.=LA8!_,SG<",XP!VYZGHK[Q!XBU9=;?P[#-YVFW3VMO&(XFCGD0
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M%W)8:C%_PD+"YNM735XY1:#;',I7 *;OF7Y1QD5Z!37=(P"[*H) !)QR> *
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MQ!I.M6&JBRN;!98RLEOYR2))C=QN&UOE&#^AKHZ;(XCC9R&(4$X522?H!UH
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MG.-Q[9P<#K^'- '&6WAK7O#'AG1-'T?70SVEWE\6 (N8F<LRN2QV ;B=P/8
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MV(WARI8[M_'*C'!_&NBHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M!F,L@0[.?[H[YYJO>_#]I8M&GL-<NM.U?2K86D5]!$I\V$ #9(C95AP#]>:
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M1(8[V1 C,),E2""!D9P#CU!P,;GPUU"ZU7X<Z%>WLSSW,EL \KG+-@D9)[G
MZUH0>%M-M=3O-1@^TQW5Y$L,SK</RBC"@#.!@$XQZU!:^"]&LK#2K&WCN$MM
M+N/M%H@N7.QN>#SR.3P: .AHHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MJLJLP!8X4$]?I0!Y]+!JFF>,O%Y31KRZBUFV@:UGA"F,%(2C!V)^4YYZ$D=
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MMA*G<V2?O$ 8&.]:?C:768?#C/H<$LUQY\7FK %,OD[QYACW<;]N<?XUT5%
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M"QM]0GU:S>TBLHHY3(L@D28.6 "'C)R,8(')';FJMAXSMKGQ/'H%S;_9[N>
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MI#97<R>=-9RG"AG^Z9%55/7\3CD Z6Q^(.F75G?M)#+'>6-VEE):*RR-)*Y
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M3PC;O'&9'75+,J@(&X^<N!D\5:DTVZUCQQIFNR6,UK;:3:3H@E*^9-++M!
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M R.<\5UE>=6>GZ]X=U3Q58)H\VH6.L7$M[:W4$L8$;R( R2!F! ! P0#Q^5
M$_@G6XM/\!>#]/CB:XU"]L5\B!6"_*B L[$]%&1SR<D8!K8@\;Z=Y&L?;XY;
M*ZTAE6[MGPS#?_JRA!PP?( /'/7%<EHWAOQ!H\'@O5SIDCW&E63Z??V*RH9/
M+8##H=VTD$ D9R15G6O!6I^(?^$HU.)!97E_':I8Q3D$YMV$@,F"0-S#&,G
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MEV7<<8P#P,BM?1M,U*U^(7B+4Y[-EL=0AMHX9?,0G,0<'*@Y .[CZ<XKK**
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M)$4!I UH2=QZG)P>:],?3K&2Q^Q/96[6F,>08E,>/]W&*A_L/2/W'_$KL?\
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M/O4[:/I;7,ERVFV9GE4K)*8%W.#U!.,D4 >,Z;8V4'PC\$:A%;PI=C5[0_:
MHW_\?!4_-UQCC'I72ZK<06WC/QC:3W%G=_VEI]O$D4UU'$;<^6Z^6P<CY#NW
MY7.,GCI7>GP_HIMTMSI%AY"-O2/[,FU6]0,8!KD[[POJDNN7T]SH/AK7;6XD
M#027Y,<EM&% $>/*<%1@D8QR3ZT =#X.T:'0/".EZ;%);RF&W19)K=0$E<*
M6&.N<=>IK<K*\/:+%H.E"SAC@B4R/*8K=-D498Y*HO91_B>,UJT %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%5+G5=.LQ(;J_M8!%M\SS9E79NSMSD\9P<>N*MUYKIFAZ'J'Q/\ '$&H:?9S
M1^39/Y<L:E1NB;>V#QG_ &NO/7F@#H/&&N:AI!\/2:=-;^1?:M;6<^Z/<6CD
M)R5;.!P/0]>U;]SJFGV<\<%U?VL$TF-D<LRJS9X& 3DUX_813VWPY\"Q3N[1
M#Q1 +4R'DP>=)Y?X;<$>V*M>-K_3[G3?B'':O;VTB1I'>&Y?=)<2+$"@C4D;
M% Q@\Y.[ '6@#UJ>]M+9]D]U#$VPR;9) IVCJW/8>M.MKJWO;=+BUGBG@<92
M2)PRM]".#7FQMM-U3XD^%9GBMKH3:).SL0'$C*T8&[^]@YZ]"/:M;X9I'#;>
M)[:%52"#Q#>1QQKPJ+E3@#L.3Q0!TTSW0\06JIJ-K':F"3?9L@\V5LC#*<]!
MSGCO4Z:II\EX;-+ZV:Z!(, F4N"!DC;G-<AJ,4,?QIT.58T6632;H.P #-AH
M\9/?O6/HLM]H>J>'H)_LNM:!>7<G]EZA'\MS;22)(2LB]&&"X)'/!)Z8H ]-
MN+B"TA::YFCAB7[SR,%4?4FF0W]G<7,UM!=P2SP<2Q)(&:/_ '@.1^-<;\8(
M89?AEJC2QHQC:!D9ARI\Y!D'L<$U5O[*'2_BMIBZ1;06\\NAW:A8U"B1@Z%=
MV.O/K0!W7]IV OOL/VZV^V'_ )=_-7S/7[N<U0'BC26\3/H"WD)OHX1*Z>8/
MER<*O^\>3CKCZBO,\Q:E^SZ)%W?VQ V[=TG34!-^8D+GZX:NDL'BM_C#="_:
M".YDT*UZX&Z3S7!V^IS0!WL\\-M"\UQ*D42#+/(P55'N3TJNNKZ:]G]L34+1
MK;=M\X3*4W>F[.,USWCV]L+2TT9+V(223:M MJ7E,<23#+*TA'51@G'<X'N.
M<\.VEEKWB#XB:)=WEK<I>O K>0 JMNMU#,JY/0XYR>1US0!Z+_:FG^;%%]OM
M?,E ,:><N7!Z8&><TXZC8A9V-Y;@6_\ KB95_=?[W/'XUXY_:FH_V-HGB*:
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M.;J3P.H_.O14=9$5T8,K#(8'((H 6BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"N,L?"<DOCGQ!JVKZ;I]Q9:@MNMOYA$KIY:%3D%<#.1T/:NSHH J7>EZ??K$
MMY86MP(CF,30J^SZ9'%,DT72IKB6XETRSDGEB\F21H%+/'C&PG&2N.,=*O44
M 41HNE+-%,-,LA+"H2)Q;KN11P #C@>PJ2STRPT\R&RL;:V,AR_DQ*FX^IP.
M:M44 5'TS3Y;Y+Z2QMGNT^[.T*F1?HV,BF6NBZ58S^?::99V\W/[R*!4;GKR
M!WJ]10!7O+"SU&'R;ZT@NHLYV3QAUSZX(J(:/IBW4=R--LQ<1 +'*(%WH!T
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MF([#D=:=I^J6.JI.]C<QSK!,]O*4/W)%.&4^XKAY1J:?&31Q?-:2G^Q[DQO
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M UI@_E9VG]U'R,\C/7'.,]30!WE%<S?:]J%EXYT_19$MDL=1MI7MIRC%_.C
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M3;:ZR3YT-JB.,]<$#(K1N[2WO[62UNX4G@D&UXY%RK#T([B@#S_P[H>H>(O
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MX>T0H;T2*%/F9Z  '"Y;D]>* *-[XRUG3O!ECXTFCM'TR;RIKBR6-O,BMY2
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M2:3+:RM,T;$2^1C: ,\9P,\G%)XZETW6].'AS^T88_$1F@EM(H)09H)=X(E
MZX4;B3C[N?6@"+Q%XKUS3/!6N>(;3[!)';7)2S62%_FB#B,LV'Y.[<01@8 /
M?B]JNMZ\GCVW\/:>=/2"YTZ2Z6:>-V:-E=5R0&&X?-TXZ]>.9_%'A-M8\"2>
M&-.FBM(FBCA6212VQ$*D<#&3\H'7O3I= U*7QO9^(C/:A8+![-H &RQ9E8L&
M[<J.,4 847CW4K?P1>:A>6]L^I6FJMI+NBLL&\3"/S2,Y"X(.,^V1GC6M-:U
MI?B%)X<G:SFM$L%OC.L+*^&8IL/S$ [AD>WTS7-ZUI4WAKPGJ.G7VJV$)UW6
MC*D\L),">:^]XY=Q^[M1AG(SG''6M+PQ-JMAKT-J\_AB]ANL^>VE(ZS1JJ$J
M[Y9LKD!>2,;ACTH M?$BYU.VLM"&GWJ6ZSZU:0RAHM^\&0$#.X<9'([],CG.
M?=QZLWQ?\JRN+-+T^&E#W$L+&-?](.2(PV3SVW<9ZG&#TOB_P_/XBTRUBM+J
M.WNK2]AO87E0NA:-L@, 0<'V-5HO#VJ)XW'B*2[M)?\ B6"P,0C9,G?YF_.3
M@9XQSQW- &3IGCV\NO#>CO<0Q+JU_?3V+>3"\D:M"9-[A =Q&(^!GJW7 K:\
M-:KK=YJ>J6>JV3"V@*-9WPMV@$ZL.5*,20RGC/0^U8"_#G4%\,P64>KQV^JV
M6I2:C8WL41(1W9B492>5(8CKZ?0]9H-EK4"//KVH6]U=N H2TB,<,:CT!))8
M]R?0  =P#'US7=?@\;6.@:6NG".\LIIUFN$=C&R%1D@$9'S=./J*Y?6O$6IZ
MM\.?'>DZY#;IJND1M#,]L"(Y49=R. 22,CM6UKYN_P#A;WATV1@,HTR[)28D
M!UW1\9'(/?.#TZ59U#P1<7WAWQ':_:X!J>OOFYN"AV1J%"*JC.2%50.>I)/'
M2@"S=ZGJ=I_9EO#):V=C)8[OM<R^:[S_ "A8DB#!B<98X!Z8XK#3QYK=WX2\
M(:Q;6M@LNL7\=G<12;\ DN"5.>!\G<'K[5L/X7UE?$NG:S;:G:1M%IW]GSQ2
MP-(H&[=YD?S##' !SQP.N*RK/X?:M9^'/#ND?VI:2C1M26^1S R^8JLY"'D\
MG><GV''<@&UX=UO5YO%6MZ!K#V<TEE'!<0SVL31!DDW?*59FY!7KGFNKKEX?
M#VIP>+=9UR*[M5-_:1V\2&-B8FCW;6//S<MR./K6[ID=]#I=M'J4\5Q>K&!/
M+$FQ7?') [4 6Z*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M-TXS'/'Y84HK="RX V]3G(% '82Z]I<6G6U_]L22VNRHMFA!D,Q89 0+DL<
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MY863B7>H9$!V[EVC '48[4[6V\K4/"OB2QTJ2WT*TU"=[F-+<HVV:,H+AHP
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M5&1D>)QU5E8!E/L17G_B.>/3KGPWX@BT:]MO#T$ETEQ%9QO#+$LNTK.T:88
MLK$CKAN1DXKJ_"*Z-.+[4M$LKB*WO'5GNKCS0]TP!!;$GS8' R>O/ID@&G<:
M_IMKK=OH\TSK?W*-)#%Y+D.J_>(8#;QWY[CUJO;>*]&N[#4;Z&YD:WTYW2[<
MVTJ^4RC+ @KDD#KC.*R/B#:W$-CIWB*P@DGO=$NUN!%$,O+"WR3(/JK9_P"
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M]R+6:5VN3$TWDPQ/*XC!P6*J"0,\9[G@4NCZYINOV?VO2KM+JWSCS$!P?S%
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M$T$D:SHHR3&S* ^!SP3QSTJB?B)X6%M'<_VGFW>8P><()"B/NVX=MN$YX!;
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M53T)^8 ^A-5]0\0V6KZ+X%2UMKP7%EJ]I]JMA9R;[8I&ZLK +Q@_F!FO7:*
M$+*J%V(50,DGC KRS0;&YU7X6^+M,L%*7US=:AY:$%"^]F*'GLPX!Z5ZI10!
MYMX;U3P]XANM+D_LK5/[9L/GF2^-P%T]MN'):0[>V !R>.  <<[/\_P0\36J
MQN;B74;@I#Y9WONN=RD+C)RO/T'M7M=% ' ZU=1/\3?"=Q;_ +V-+*\!9/NY
M=8]BD] 6P<9KD8]3%[9^#;TVEY ]MK(^T6%O82)#8Y64; H7DY(YY/)/ .*]
MLHH \R\^-?$WQ*=LA9K&W6(E3B0K ZL%_O$$@8'<XJB9$3PE\+TP1);7=H9U
MVG,(6!E8N/X0&(!S7K=%  2 "2< =Z\3U$^;\+_'\"([37&N3O#$$):56E0J
MRC&6! )R/0^E>V44 <)J-Q#+\5_#,T+AH1I]TAD094%C&4!/0$X.!7=T44 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !61J
MGB;2M&\XWL\@6!0\[16\DJPJ>A<HI"COSCCGI6O7E,UY8:+XM\2:9XIM=5-O
MJMQ]HLY;;[0\5U&T2(8BL1QN&W&".1[8H W_ !5XJCAUGPWID$EV;34YG>>:
MTAE8O$(F=1&\8R<G:3L.0!V!K(BNY(_%Z^$)]6U^>Q-E+=)-Y4Z7"N\JJB^8
MJ[BB#=\Q.,GYB<8J;5Q;:=XE^'L,=J;*WM&GWP9+"U0VY50[<@<D#DU>:YB'
MQL5RW[O^P3!YF#L\PSA@F[INQSCK0!JVOB'3-#M+/3]1UB>ZE206C7\UNPCD
MFSC:T@78&SQUZC!YJ[JGBG1]',XO;EU%LJM<-' \BP ]"Y52$]><<<]*\TT)
M]+&E2^#_ !+I6K7.M0W$BK:,UP8+S,A=)5(/EJO())QC!-:NGZS;^'/$/BC0
MO$=A=3+J=^]W9E;-[A+R*1%7RQM!!(V[2#@4 =0WC.T_X32W\/QPW,@ELC=_
M:([>1T.714VE005^9B6^Z..>M:VKZUI^A6BW6I3M!;EUC\SRV8!F( SM!QDD
M#GUKD'=M.^*^DW$]C+;PW&@&TC2&(NB2^<K>7E1@8'?@8%7OBE;SW'P]U 6\
M,DSQR6\S)&I9MJ3(S$ =< $_A0!OR:]IL.L/I,EP4O5MS=&-HG&8@0"P;&#R
M0.#65!\0O"]T+)H=3WQWLODP2B"389-Q4*S;<*20<!B,]1P:P(]:M-0^+&G:
MG;+<MIYT2:,71MY%CR94;DD<# /)P.V:YB$A?@;IEL8W%TFJ([0^6?,4"\+D
ME<9^YS]* /2+?QC:S^,=1T#[/=)]BAC=YFMI-I9MV><8"@*/F. 23C.*YCQ+
MJB)\(M:U/P]XBU*<Q32,EX\A$@;S0&0$J"%&2!CL.M:-A<I9?%K6WF2417^G
M6C6\JQ,T;A/,W'>!M &1U(KD)B7^!WB:V2.0W$NH7'EPA#O?=<;EPN,G*\_2
M@#V<R". R-N(5=QVJ6/3L!R3["O+_$GC:;7?A;KFKZ5+J&FSVLK+&ZQ/$2JS
M"/EBN,D9R%.1WKT^WECGMXY8G#QNH*L.A%>+7<C)\&?$VBM;W(U"._G!A-NX
M)+76Y0O'S97GC/'- 'JEAXIT;4M7DTFUNR]['%YVQHG4.F<;D8@!USQE212-
MXLT5+ZVM7NV5KF4P02M"XAED&?D63;L+<'C/.#7,:S*EU\3= :TF 5M+NXA,
M@RJ,^S8"1P"<' ]JPO"<VD76CZ5X9UG1]6?Q!IKQQFRF:X,*O&<"<-GRPF/F
MS^ !R,@'J.K:O8Z%ILVHZE<""TA&7D*DX'T )K*'CKPY]M2T;4=DLD1FBWPR
M*LJC&=C%=KD9'"DGMBH?B/\ -\.M?C4%I);*2.-%&2[$8  '4US^HSP/XC^'
M$BD&.%9C(P'$8-OM&[^[EN.>] '8:=XIT75-/O+ZVO0L%DS)=&>-H6@*C)WJ
MX!7CGD4ZT\2Z7>ZBFGQS21W<D9EBBN+>2$RH.I3>HW8[XSBO,->LK[5G^(\&
ME1/-/)<V-Q%$H(^TI$B>8J_WOND<=^.]=+JLT'C#Q!X0NM&=G:RNFN[B780;
M>+RR"C_W68E1M//!["@!/B7XJAM?!&MG3-2O+>\M1Y8N+6)]J2Y'R&4*54\X
MZ@@X'7BN@:]T]O%VG6KZO=IJ(LW86",?*E4[<NXQ@L.,<]S7ESW[VWP5UKPE
MJ%O=+XAM1,DL/V=V,Q:8N)5(&"IW=<]?PKLI[F.?XI>&)U$BQ_V5<(Q>)DV,
MQC*JV0-I.#@'F@"L-8;Q7KGB.S.IZQI8T^6)+*>W@FB$6(P[M("H4DDD;9.H
M P.<GI?#VJZ3;^$+*[@UF[U*S=F2&\N=TDUPV]AC 4,QR"  .@K&\(7MNGB_
MQM*\H2.2]BDC=QM5U6%5+*3U *GD5QNE_:;#X=>#-3:SOIK32KVX.H6UMO2>
M))#*H?"D-\H<'Z-Z4 >L6GBC1KRUOKA+U8TT\D7@N$:%H.,_.K@$#'(..>U<
MQ<^(&NOBGX<M+.]OTMI[2ZDGM)H7A1L*NQL,H+=6]>G:L'Q#;V6K^%M2UGPG
MI=]<@W%I/=S2B;S+](7W%%67YFV@#GH>@SBM.YUZQUSXD^#K_3A<SVPMKU7E
M6UDPA98\!CMX]_3OC- '<:QKVF:!!%-JEVEM'-*L2,P)W.QP!P/?K5+2O%VA
M>(;V[TW3-2+7D";G3RVC<*> Z[U&X=.1D=/6L3XL.D?A*U>52T:ZI9E@%W$C
MSESP.OTI)XH-8^)VD:UITB/:Z;I]PMY=H?W;;]NR/=T)'SL1V[XR* $\"^(1
M;^ X+[7-1FFD>_N+999<R22MY[JB  $DX   ':MYO&.A)IM_J$MZ8H-/<QW?
MFPNKPMC.&0KNZ$'IS7G&D:F=,^'ND[[(D?V]+YUP]J97L5::5EF"$'!P0 V,
M#=GGH8KJ0#3_ (GVZQZ@[7D$;6[7$$@:;-N%&,J.2W1>OL . #TVQ\8:%J.K
M1:9:WI>ZFB,L(,+JLJC&=CD!6(SR 216K>7MMI]I)=7<RPP1C+.W0<X ]R3@
M =R:\]NYX6\4?#>1#F.&&X$C*#B/=;[0&_NY;CGN,5K_ !)BOQH%C?V%K+=_
MV;J=O?3VT0R\L4;98 =R.#^% &Y9^)=)OKF[MH[DQW%F@DGBN(GA:-",AR'
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MWE67S;V0XRX1_G]LGDX)Z8)O^.+V"?0_"CPOYH76;&9MBEBJ(V68@= .^>E
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!@>+?#LWB;3K>S
MBODM!%=17)9H#+N,;!E'WEP,CFMY P10Y!;') P"?I2T4 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 445\_?M :QXIT[7M-CL;J^M-(: ,CVKL@>;<=P8KU(&W /K
MQWH ^@:*Y;X<7.M7?P_TB?Q )!J3Q'S#*,.R[CL+>Y7:374T %<;XA\;WGAW
M2-1U>?0)7TZRE\LR_:55I/G";E7'3<>_IFNRK@_C/_R2;7/I#_Z.2@#1U+Q5
MJNE6-_<W7AU@+6QEO5*W:E9!'C<N0,@X.>G-;^DWQU/1K&_,?EFZMXYMF<[=
MR@XSWZUE^-?^2>^(?^P7<?\ HIJXRQ@DTC4_AU<VU[>EM1@,%TDEP[1R)]FW
M*-F=J[2!C:![YH ]3HKRRTBU?QEX>O-4M=4CT_48;^8"Z-S(#:>5,0(VC'R[
M?+ R#UW9/->HQDM$A)!) )(Z&@!U%<-XM2:3X@^#K9+Z]@@NS>)/'!<,BN%A
M)' . >3R.1G@CC&#;:3YW_"=Z4^I:K]CTJ3S+%!?RAH6:W$F=V[<P#= Q(]J
M /5Z*\QT?7;S7+_P3I6HW$OD7NA_;[AE<H;J8*@VDC!( +,1WR,]*SM8\1ZK
MX4'C/3+:[F:TM);+['<S.9&M!<G#C<V<A>2N<XR.U 'H&I>(I-/\7Z)H9L@\
M>J+.1<^;C88DW$;<<YR._K6A9W=Z[7YU"R2TA@F*P2"8/YT0 .\@#Y><C!]*
MXK5=(M=,^*7@AK9Y\/'?*PDG>0,1"/F^8GYCGD]3QGI1X>C>\L/'EI=75Y/%
M#JDR1%[F0LBB&,A0V<@ ]LT :*>+?$&H6-CJ.B>&$O["_C,D$AOA$R#/!D#+
MQE<D8+<\'KFNSKQJ2!M._9WLKZRN[VWN?LUH^^.[D'61%( W8 (8C XKJK^X
MN==\>:IH#LGDVEC!)%"US)"7WE]\@V<DC"#/\/;K0!W=8&B^(I-5\1:]I,MD
M+=M)DA3?YN_S1(F\'&!CC''-<E:S:G;:SX5\':OK)O@\5U+<W4;LC71B.$C9
MLY. <MSSM&>^;_@JSCL/B!X[MX6D,:SV97S'+D P9QD\X&< =A@4 =[4%K>6
M]ZCO;2K(B2/$Q7H'4E6'X$$?A4LD:RQ/&V[:ZE3M8J<'T(Y'U%>(1VW]G? 3
M6;VQN;VUN8[FX"/#=R+M NF7 &['0D'U[T >XT5PNKZ3;:1>:?;KJ^K3S:C?
MF5K$SEVO"L1RH)8"-!]]NW&,=!7,+XCU32/"?B" W,D++XF&FQRF8R_8X9#&
M6VNPSA0S8)Z9'I0!Z%>>(I+3QIIF@&R!COH)IEN?-Z>7MR-N/]H<YK2TZXO[
MC[7]OL5M/+N'C@VS"3SHAC;(< ;2>?E[8KB;W2;;3OBYX7^S&<++87H97G=Q
MD"/YAN)Y.>3WP,USU_<WJ?#'X@R+J>H":RUFY2WF^U2>8BJ8P%W9SMP2,4 >
MR45P!@ET7XF^'H[>^OI$U2RNOMB3W+R+(T8C96"D[5/S'[H QVK"N!KFI>']
M0AC?4AXJ36C''+ \BQ^5YP& Z_*(A%G(SPPY^:@#URBHX(A!;QPJSL(U"AI'
M+,<#J2>2?<UQ/CM;A_$?A&"#4+VT2ZOW@F%O.4#IY3GD=,\<'J.U '8:E=26
M.F7-W%!Y[PQ-((M^W=@9QGM53PUK!\0>&=-U@P>1]MMTF\K=NV;AG&<#/Y5Q
M&GP76@>+?$_AZ*]O+K26T@7\2W4[3-;NQ="H9B3@[2<$]JBT&2-O!?P_LVNK
MAGFM=RZ;!\OVP+%_&^1M1,ACUSP,$XH ]1HKQ>\O=3'PK\2EM0O(;C3M>>V@
M:*[<M'']HC79O."Z@,P&[MVKK;:"31OBS;V=O>WLEO?Z3+/<1W%R\JM*DB .
M QPIPQ&%P,=J .[HHKS./33JOBGQ]8W6HZF;:V%LT$:7LB>4S0%L@@YQN).W
M.WVX% 'IE%>/V\UZOA3P!XD;4]0DU.[O[*VN'>Z<I)%)E64QYV=.<XSGDG-;
MMG).VO?$:S:[NS;VR6[0*;A_W):VWG8<Y7YN>,4 >AU!<7EO:R6\<\JH]Q)Y
M40/5WP6P/P4G\*\RM[O77\&>#]4CM;C7+9=-WZA9I=%;F0LJ8F7G,A7#<$]6
M]>1!<#2M=OOAU>6=S?7%M+=7,:R33R), (Y,JQW9#!A@G.3CJ10!ZW6!?>(Y
M++QGI.@&R#1ZA#-*MSYOW?+ )&W'^T.<UO*H50HS@#')S7!^++1;[XG>#[=Y
M9HT>UU ,89"C$;8N PY'U!!]Z .]HKRK3[MK7PUXDTR;6K^W@M?$/V&T=7::
M=D)B80(Q;=EMS*#G@'.>*T= AN;OQ=XNT*X>ZL[,VMI)%!'>.S6[.K@E&!^4
MG:"0IQD=30!Z)17FOA*\N=5TFP\,WMS<G5-+O9(]2D%PX=EA.0V[.2)-\77@
M@OZ5'%#JOC6UU]K;4%L[ZTU.:V@G%U*K6GE/A?D7Y2"HR<_>W'/; !Z=14%D
M[O86[R2I,[1*6DC&%<X&2/8]:YSQ0\<NO:)9?:KB223SG&F0G:+D!0-\CY&U
M$SGODD8!(% '545QOPTNKNY\-W<=Y-)*]KJ=U;(9)3(51)"%7>W+ = 3VKH/
M$*LWAS4MDLL3BVD99(9"CJ0I(((Y'(H TJ0YP<#)KQ](;J'PK\.]8CU;5%O[
MZYL[6XE-V[!XI8VW#824SP#G&<\DD\UTFA6ILOB%XBT&*\OCI[V%O<JDMW)(
MT<C%U8J[,6&<#OUH [#2;B^NM+@FU.Q6QO'!\VW682A#DX^8  \8/XU=/2O&
M;2[U"Z^%O@*[;5;]+JXUBWBFG6X;=(K3/G=G(;H/O ]*ZG1+4V'Q&U[0XKR^
M;3Y=.@NMDMW)(R2,SJQ5F8LN0!T- '8:3<7]UID,VIV*V-XV?,MUF$H3D@?,
M  <C!_&KM>,VMYJ$_P )O!=XVJ7ZW<NLP12SK<-ND5KE@0^3AN@^]GI6_%HR
M#XG7^@_VAJATNXTB.]E@-_*=TOFLF0^[>H(QD*0#CGCB@#T>BO'+;4-0'@;P
M[(=1O6FM_%"6/G&X?=)"+EDVN<_.-H YSTKJ6,S_ !0UK3_MEVMJ^AQ3>6MP
MX"2&5P649^4X Y&* .ZHKQ6U%X/ASX*U]=7U0:I-?6L$DYNW8-')(592A)0\
M'J03[UV&D0MH_P 5[W2+:ZO'L9]&CO6BN;EYL3><R%@7)(R.H'% '=5F>(=5
MDT/P]J&JQVOVDV<#SF+S-FX*I8\X/8>E:=>3SRCQ9\/?&VKWL]Q]IA:^@BC2
M9D%ND2D*FT''(&6R/FW$'C  !Z9I-\=3T:QOS'Y9NK>.;9G.W<H.,]^M7*\U
MTF::'Q/X#ACN)U@N=!D,T(F;RW*QQ;25SC(R><=ZP]7N[Y/AUX_DCU*_26QU
MR2.VD%U)NC3,(V YSMPS<=.: /9J@O+RWT^RGO+N58K>!#))(W15 R37&:MI
M-MI%[IULNK:M/+J-\9FL#.SM>%8CE0Q8>7&.';MQC'05Q>LFXO/A-XZMK]Y6
M&G:Q)%;H;EY!$H,1"!C@LH+MC/\ 04 >PWEQ?Q7EC':6*W%O+(PN9C,$,"[2
M0P7'S9.!@>M7:X3Q#$^F>+?!$-I=7B02WDT<D374CK(/)=AN#,=V#TS5;23)
MXQLO%D]W>75O>6FI7%G:F&=XS:+$ $*@$#)/S$GKG!X&* /1**\BT[4M2\27
M7PXN;Z]OK=]4M+O[8D$[1K-LC&&P#@$\G(P1NX(XQU'@!I;>]\4:4;BXFM;#
M5#';"XE:5HT:-&V[F)) ).,GO0!VM%4M8O)-.T2_OHHO-DMK:29(_P"\54D#
M\<5YEJ-W>6WPDTWQK8W]U)K:1V]W(_G,5N&D=1)$R9V[?F(  XP,8H [_5==
MEMM7@T;3[:*YU.:VDNE2:4QHL:%5R6"L<EF ''KZ<WM)N[J^TJWN;VP>PN9%
MS):NX<QMZ;AP?K7%76F6TWQMM"YN06T.68A;F1?F$\8[-P/]GH?2O0J "BN(
MM[C_ (2+XB>(M&U!YA:Z9;6PMX$E:,.959GD^4@D@[5![8XP37(/J.L7'ANQ
MMY]4OEFT_P 8)I*7:3%7N(%E !?LY[<@_=Y[T >S45Y?=WMUX0\1^+XM.N+N
M>&#0%U*.&ZN'G"S@R#<"Y) .T$CVK1TO2M1EN?#^OVNL116S(OVDFZEF%^DB
MC&0WRALG((Z=.G% '?T45Y_JU\/!?C\:E?W=VVBZM:NH$D[NEO<Q@OA5)P-Z
M@X [KQUH ] HKSBYDU#3;KPKH5Q,PDU8W5S=+/=R &4!6$(?)(4;R !C.P>X
M)<V%YH&EWMEJ'B.9(;K4K=K2UMF>6<*[\VRNS!L.5(!R-HW=A0!Z/17ED,U]
M'+\1K RW-G%9V4-S:PQW;L;9V@=CM?@KDJ"0.,YZUTO@+21#X?TO6)+^_N;J
M]TRV\X7%RSIG8#D*> ><9'7'J22 ==15+5YTM=%OIY+P621V\CM=%=WD@*?G
MQWQUQ[5YYI4MU:>,?"$,,EZMIJ.G7(FDN+AB]X41&$KIDA&))(YW?-@XQB@#
MU"D8D*2HW$#@9QFO%+N.[7X=^+=8_M?53?:3J]U]BD-[)^["2@ $9^?CCYL\
M=,5VD5Z?$'Q%U'1KUY%M-/T^"6.W21D$KRY+2'!!.T!0/0DGK0!M^$_$3^)=
M,N;N2S%H\%Y-:M'YF_F-MI.<#KBMVN&^%4(M_#6HP!W<1ZQ>IND8LS8E(R2>
MI]ZZ/Q1<QV?A;5+B74CIB);/F]";S!Q@,%[D=AW- &M17G.AR7EE\2;"R5+N
MWL[G1'E:"XN3(TCI(@$CKDA7PQS@DG/->C4 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 48S110 4444 %97B'P[I_BC2WTS5$EDLY"#)$
MDK1A\$$9*D'@@&M6B@#/O-&M=0T272+IIY+2:(PR9E8.Z$8(+=>1Q5%O!^E,
M=()^U$Z1_P >7^D/^[XV^OS?+QSGBMZB@#EI?A[X=EUZ;6/LLR3SN)+B*.X=
M(9W'\4D8.UOQ&#WS74T53U1]0CTRX?2X8)KX+F&.=RB,WN0"10!6O_#UAJ6L
M:?JMQY_VO3RQMF29E";AAN <'(XYJO'X2TN*75I$-T'U88O#]H?]YQMXY^7Y
M>.,<5MIN**7 #X^8 Y -.H YX^"]&_LW3+)(YXQI9S8S).PEM^,85\YQC@@Y
M!'6K)\,:1)I=]I]Q:BY@OR3=F=B[3G &6;KD #&,8P,8Q6Q10!S%IX"T6TN]
M-NM^H33Z;N%H\]]*YB#  @?-TP,8Z8ZYJW:^$],LHM4C@-THU21I;L_:')=R
M,$@Y^4D #C%;E% '.2>"-%E\+IX;=+DZ2FT+!]I?@*0RC=G=@$ ]>U&N>"-%
M\0W%I=7J7*WMHNR*[M[AXIMO=2ZD$C_$^M;.HZA:Z5837U[*(K>(99C^0 ]R
M< #U-6J .?U#P7H>HZ?86;VTD(T]]]I-;S-'+"W<JX.<GODG/4\U-I'A;3-$
MU*]U&T%R;N]V?:))KF23?M4*"0Q(SCOUY-;5% !7+R_#[P]+IE_IK07(LKZ4
MRS0"ZD"Y+;B%&[Y06Y(7&3]*ZBB@#%U7PKIFLQ6"WGVDRV#^9;7$=R\<R'&#
M\ZD'D<'GFJB> O#BVFJVAL#);:HV^ZBDF=E9N/F )^5OE!R.<@'/ KI:J:KJ
M,&CZ1>:G<[O(M('GDVC)VJI)Q[\4 8MIX&T>TO["_P#,U">ZL$:.WEGOI7**
MV 1RW(P,8Z4/X$T.32M3TQTNFM-3G-Q=H;I_WLA(+'.<C.!D# XJ;1M2UV]O
M()+O3[5=,NK-;B.>&8[HG.#Y3*?O<'.X8'!XK5NM0M;*:TAGE5)+N7R8%[NV
MTM@?@I/X4 9\OAFPDU.PU1C<R7NG1M';,UPV & # CH<X&20>E>>:9X>,BLE
MSHGB[3]7DEDEF6QU!H[7S&8L2C>9M"Y/IGV)Z^NT4 5M.AN+?3+2&[G\^YCA
M1)I?^>C@ ,WXG)KC_'=A-J.O>%!';7LD-K?M/<2VJ/\ NE\ME#;E_P!HCC\Q
MBNYHH R8O#MC'!?H3,\M^-MU<-*?-D & -PZ #( & ,GU-9[> M"-GI5LL=W
M&NDEOL4D5W(DD2L &4.&#;2 !C-=-10!RS_#SPX^GW]A]FG6UOKC[3/$MU(
MSY#9'/R\@'C&2!GH*TCX;L&UZWUIS<-?V\)@CD,[8V'!(*YP<D GBM>B@ K$
MC\*Z;#?:K>1FZ6XU0*MVXN'^<*-JXY^7 XXQ6W10!S9\#:+_ &1INE;+H6>F
MS)/:(+EQY;J<J<YR<=LT^]\%Z/?ZM<:E,ER)KJ$0W*QW+I'<!00OF(#AB 3C
M(K<N;B&SM9;FXD6*"%#))(QP%4#))]L56TF^DU*PCO6A,,4X#PHWW]AY!;T)
M'..U &;:^#=+L(+"*P>]M?L$+06[1W3DJC8RIW$@CY1P1QCC%+<>#-$N+#3[
M,V\L<>GS&>V:&X>.1'.=QWJ0Q+;FSSSFM^B@!$54144 *HP .PK+O/#UA?:[
M9:S-Y_VVR5E@99F"H&QN&T'!S@9SZ5J'.T[0">P)Q7/^$O$-SXAMM3DNK6*V
MDLM2GL=D4A<'RR!G) SG)["@"&;P!H$]G?VLL5RR7UT+R8FY?<)QC$BG.5;@
M=,=*MZ=X2TC2]9DU:VCG^VRQ+%)+)<R2&0+G!;<3N;DC)YQQ6Y10!1MM'L+/
M5;[4X+=4O+X1BXD'5]@(7\@:Q;[X?>'=0UV36);:9+F?'VE8;AXX[G'3S$4@
M-^/7OFMYM0M5U1--,J_:WA:<1CKL5E4D^G+#Z\^E6J      8 Z 5CZQX8TS
M7+ZRO;M9UNK(MY,UO</"X#8W+E""0<#BMBL\:D+VSU Z2T5Q<VK/"%=L(9E4
M':6&<#) )[<^E $.A^&]+\.+=+ID#PI=3-/(IE9E#,<G:"<*,GH*OWMG%J%C
M/9SEQ%,AC?8Q4[3P0".119-<O8V[7L<<=T8U,R1,657Q\P!/49SS4] '.MX)
MT9M-TO3RMT+72Y4FLT%RX\IDX4YSDXYQG-6E\,V":U=:PC72WUU"()9!<-R@
MS@ 9P,9."/6MBB@#F4\!:%'H^GZ2D=TMEIUP+FUC%T_[N0$D'.<G!)(!XYJ\
MOAJP36[C65:Y%_<0"WDD$[<QC)  S@8))R!6;>>(]6N;_5K7P]I]O>3:3)%'
M-%/*8S.SJ'*HW1<*1R<Y)QQC)ZH<@9&/:@#F4\!:%'HECHZ1W2V-C<"YMXQ=
M2?)(&W YSDX))P3CFKX\-V U]M<#7/\ :#6_V4R>>V/+SG;MSCJ<].M:]% '
M-?\ "":%_8$VB^5<?8Y9_M.#<N727=NWJV<J=W/!I]MX*T>UU&348_MGVV2U
M%K)<->2,[IDGYB6^8\]3G&!C&*Z*B@#FO^$%T0:'8Z,$NA86,RSVT8N7&QU.
M5.<Y.#R 35]/#M@GB+^W@9SJ'V<6QD:9BIB!SMVYQUYZ=:S?$WBX:5X1U;6]
M*B@OCIS,DBO*47<I 8 @')!.,<=#S7202&6WCD(P74-CZB@"2N8N_ &A7=WJ
M4^R[@&IHRWL-O=21Q3DC!9D!P6P>O?OFNGHH YVY\$Z+<6VE0A;N'^R@4M)8
M;R5)8T( *[PVXJ0 ,9[5 _P]\.OIFHZ=]GN%M-1G\^ZB6ZD D?(/0'CH.G7
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MKW4TC>!S&RJA)4 J0<# XKT>Q\/:9INJ7>I6D#QW=YM^T/YSL)-HPN06(X'
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M#&G"$<%" ",<<GC%5/A!,[?#33%E;*I)/%"6/5%E<+^@Q^% '=4444 %%%%
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MQ<R[0V[=G[W][GZ\U<_X1[33K,.KF&4W\,7DI,;B0D)W7&[!!QDY')YK4HH
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ML,V%K(LMO%YTF8G7H5;=N7&3T/<U-#X9TFWU*748+>2*ZEA$#2)<2+^['10
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "HKF%I[>2)9I(&<8$D6-R^XR"/TJ6F32K!"TKAR
MJC)"(7;\  2?PH Y3X7WMUJ/PWT:[OKF6YN98W:2:5BS,?,;J347AVXO/^%E
M>+;.>_N;FWA@LGACE8%8MRR%@H  &<#MGBG?"RWN;+X=:397EK<6MU;HZRQ7
M$+1LI+L>X&>".E1Z"DZ?$_Q3<O:7<=O=06:03O;.L<AC63> Q&.-P^O:@#M:
MAN[N&PLI[RY<1P01M+(Y_A51DG\A56SU3[9JNH6/V&]A^Q&,>?-%MBGW+G]V
MV?FQT/H:R?%1;4)]/T$P7OV:\F#7<\$#E4C3Y@I<# +,%'7INSVH QO VO:P
MWB;6M#\0DK>2A-4LT)^[;R  QC_KFPVGW)KO9)!%$TC!BJ@DA5+'\ .3^%>;
M^,M&N="UWP]XETB+5M1O+6Y\BXA427#/:N"']<8X(SWKT>*59HDE4.%89 ="
MI_$'!'XT <:/BIX;-I:WN;\6%Q*83>-9N(87WE0)&QA22.G8$9QFMS5/$EKI
M9N1]GNKMK6(37(M8PYA0Y()R1G@$X&3CG%>8Z(KZ[\#Y/#EK9W,M[=RW$$>;
M=_*!-RYWF3&T*O4\]5QUQ6K/;'PSXRU0:MX9O=;TW4D@:VNK6T^T-&Z1+&T;
MC^$':"#TY^N #JKGX@:#;MIRQO=71U&W>YM/LUJ[^<JKDA>.6Y' Y'?%2GQG
M8&RENX[34)(H+=+BY"P8>W5UW .I(;..2 #@=:Y^:SEM_&W@EX-$EL[2TM[U
M98[:U8Q6OFA-BDJ-H/!SCC.>U5O%^F32:SJFIZ&-7T[Q% B+"\%N\EMJ:A 5
M208*'!)7)(QU/'0 [>]U^WM+V2QB@N;V[BB$\L%J@9HT)(!.2!S@X&<G!P#B
ML^?Q[X?ATK3-3%S+)::E<+;021P.0)"<8;CY2"#D'G@\5C:<-0\._$#6K_5+
M.YDL]:MK61)[6!YUAEB38\1" D9SD$C!]<US\F@:AIVAZ6QL+QGN?%XU=K>*
M!I#;6YD)^;:#C"X)'J<4 >B:-XHL=;U"^L(8KNWN[/8TD-W 8F*-G:X!Z@X/
M]<4[6O$^FZ!=6%O?&<27TODP>7 S@M@G&0,9X/'4]@:P]/CG_P"%MZK=FTNU
MM9=+@A2=K=UC9U=RPW$8Z,*7QS%/+K'A)H+2ZG6VU99YFAMWD$<?ENNXE0<<
ML* +,?C_ $R5K^%+'56OK$CSK(6;&8*1D/MZ;2.^?;KBK:>,-)GL-(NK1Y+K
M^U\_88HE^>7"EF^\0!@ YR1CI6/I7G6_Q*\5WLMG>K:S6MHL4WV60K(8P^\*
M=O.-PZ=>V:YCP\^L:3X1\%V%QI&J16J-<1ZBT%FYN8&R2BCC<JMNY=?3&10!
MVT_CW1K?P_+K<BW8M(+EK6Y A)>WE#;2KCMS@9Y'(YK9GU6*#4+&Q>&8SWBL
MR!5!"A0-Q8YXQD?F*XOP5HINM$\5Z)JVE7MM;7FJ7;8NE^_%)C!#$G<<?Q G
MGO5OX=VFJM:27&MNLMS8;M)MY5.1)'"Y#2_5R%!_ZYB@#K-3U2TTBU6>[<J'
MD6*-%4LTDC'"JH'4D_YQ6?;^*K"6[O;*:.ZMKZSA$\MI+%ND,1Z.@3<'&>/E
M)P>#BLGQ_I^H3#0=6L+>6[&DZDEU/:Q#+R18*L5'\3 -D#OS4$MLVJ^/(?$D
M%O=QV-CI4L#.]M(CS.[ A%1E#$  GIU('K@ N6?Q&T*]72I8EOA:ZG((;>Z>
MV81>8<[4+=,G'OZ'!JE:W,EG\5/$67O)X(]*MYQ;B1I,$N^=BD\9P.!7,VUC
MJ$7PM\%6+Z7J(N[+5+62XA^QR%XECE+,Q&WH ?Q[5UFG1S_\+:U>[-I=K:S:
M9;PQSM;NL;.K.6 8C'1A0!JVOB_3;WPO%XAMTN)+"5@L>(_G8E]@PN<_>XQU
MK6O;Z'3].FOKD2"&&,R.$C+L .ORKDG\*X72-#O+'Q]?Z,@0^'XYEUJ-0>4E
MDW+Y6/[N]6D'H5%=IKA(T'4-L<DC&WD54C0NS$J0  .30!@Q_$;0GCTN9EOH
M[34P!;W3VK"(N5W!-W]X@'@9YXZUH:7XLTW5+K4+7;<V=Q8*LD\=["82(V!(
M<9_AX//;'.*X4VE\O@'X>VATW4/M%AJ%E)=1"SD+0K&I#EAMX R/KVJUKNC7
MVN>+?%EK;074*:AH"6<%R\#K$TH+DKO(QT8?F: .MC\8Z8\^GK*EU;P:DP2Q
MNIHML5PQ&5 .<J2.0&"Y[9JIXJ\06PT;7+2W6^FDM+9OM$UD2OV9BFY<L&!S
MC!(7) (R,&N>O(+SQ7X/\/Z'_9M]9ZE;W-JUWYULZ+;>2078.1M;.W"[2<[A
M[XCLGU#0/^$TT2^TK4IY-1NKJ]L;FWM7ECG65,!"RC"LN,?,10!=T74=-_X1
MCX?1ZK/?F]N(8&M6C,FV27R>?,8<'C)P3GVI=5U!M:^(EQX=O+/4'T^/2MXC
MA.P^8\I7S<AAP HVGMS67#;7Z^'_ (:0OI6HK+I\T)NU^RN3"%@9"6P#CYB.
MO-=!")Q\8KN[-G>"T;1X[9;@VTGEF43,Q7=C'1@<]* +WA_Q'IK>%+BYAEU"
M>VT@/;W$MZ!YY:(?/NSC+#OP,UT=O<">UCN-CQ*Z!]LHVLH//([&N!U#0[R#
MXBO96@0Z/K\:WFH)GF-[=E#$#TD#1JWKS7?W#2I;2M @DF"$HA. S8X&?K0!
M@67C;2;^YTV.);E8=3+K8W+Q@1W!0$D#G(X!(W 9QQ5OQ5KA\->&-0U@6LER
M;6%I!$F.<#N3T'J?3UKS6W.JWDG@S4;C0];-Y:7S?;HS:M'' 3&ZA8X^%" D
M8<#&,;FS7H?CFQN=2\":[96<337,UC*D4:]78J< >YH IGQS86-KHXU*"^BN
MM23$2+:LV]@FX@8R.>PSDY'%2+XYTZ6%6BL]1>?[(;V6V-OLEAA#%=SJQ&.5
M. ,DXX%<Y>37-[>^ +E-)U1([.9C<;[*3,0\@IE@!\OS''//&>G-7?$4VI3^
M++W3YM,U%["330+22QB($\I+;EEE&-H'&%)"G)SG(H Z4^)],;3M-O;>1[E=
M3"FRBA7+SY7=P#C&%Y). .^*XS0=5A_X2#XAR7S:G'8P"W#PR&1Y8 86WA0"
MQ'.2"IQW'%8^CPZOH]GX!UN;1=3>UTVREL+VW6V8S0EU4"01#YBN5P>,X'3I
M6O:-=S:U\0[O^RM32WO[6#[*SVCJ9B+<J0%QG.2.,9'?&#0!O6OBW0-&T3PY
M$KWYM]1@1;$O$\KLNS< S<Y; Z9))Z"M#3?%^E:C;ZI*QGLSI1_TV.\B,3PC
M;N#$'L5Y!KB8;:]31OAG$VFZ@'T]X_MB_8Y,P;8&0[OEX^8@?KTJQ<VH?5_B
M5)?Z;>O87EE#Y9\IHA.$@97".PV@YP,_SH ZE?&NF"]TZTF@OX9=33S++=:L
M_GKP21LR5P""=V" >:T/$&OV/AG1I]5U$S"U@&7,432$=N@''U.!7GFA:I:R
M:IX:DUZ'7(I]+B^S6DESHTMO%YDBK'F1\L"2,*/NC))],='\6?\ DEGB#_KW
M'_H2T 7K+QSH]]XACT0"\@N9T:2U>XMFCCNE7DF)C][ Y^G(R*PO"FLV^AV/
MC2]U2]G-G9:[,@>:1Y65=D051DDGD@ >]6=2MF\3^)/"D]K:W44>F3/=W$T]
MN\6P>65$8W ;BS$9 SPN?3.'$^M:=X?\;2V&CWDES/KC7$*263%G@;RE,D:N
M,.P"L0/4#B@#N8/%5C)=7]G-!=VUW8PK<36\D.YS&V<,H0MN'!''(QS6?9_$
M30[[^RGB6^%MJCB*VNGMF6$R'.U"W3<<'UYX.#7/::L\'Q U'4$TK6S8W6B(
MB7-S!(S,ZNY.0>5/(PF ?10.:SH+*_B^&G@2R;2]1^U6.J6DES"+.0M$D;DN
MQ&WH ?Q[4 >M7%Q#:VTMQ<2+%#$A>21S@*H&22?0"L2'Q?ISWEA;S175JNH_
M\>,UQ%M2X.,@ YRI(Y 8*3V%'C;1[GQ#X(U?2K)]ES=6S)%N.W+=0I],XQ^-
M<QJ"77C#1_"]BNG7MG>VE_;75X+BV>-;;R02^'("L2?E7:3G=GIF@#9N?B+H
MMNFILL&I3#3)"EWY5DY,0"ABS9 PH!ZGK@XSBMB?Q!91_8UM_,O)[R(SV\-N
M 6DC !+\D +\R\DCD@=37#QP7?V+XDJ=.OPU^TAM ;23]_FW$8V_+S\PQ^O2
MJUH^J>&=1\,:\^C:E=V#:!%I=W#;VS-/:RJ0VXQXW$$Y!QZ?3(!W%EXOTG4=
M)@U"T>643S-;1P",B4S+G='M/0C:2<\  G..:L:+XBLM<EO;> 30W=C((KJV
MG3;)$Q&1D D$$<@@D&N.\5IJ-U%H7B./PY-<VEE=RO/I7E SM#(FWS-G0N#\
MVWK@C.#G'1^%/L-P;O4+#PZ^D13A 6GM1!/.5SRR]=H! &>>O;!( [4KW25\
M:Z):7#WJZF8YVM53>L++M&_=_"Q  P.2":HS?$K0HK6^NA%J4D%A<M;7;I9/
M^X*XRSY&0HW?7@\<5'X@BG?XF>$KB.TNI+>VCO!/-';NR1F1%"98# R0?ZUS
MGV2];P1\1K4:9J'GZAJ%W):1FSDW3*\:*A4;>02I^G>@#U5'62-9$8,C %6'
M0@USL'C?2;B:QV"X^RW]R]I:7AC'E32J6!4'.1RK8) !QP:U-$+?\(_89CD1
MQ;("DJ%&!"@$$$9'->5.VL:C8^&;R\T'6AJ5GKL<M[ EJR0VZ R#$2#"LO(.
M\ _[3<T >P75U!96DUU<RI%!"ADDD<X"J!DDGTQ6-#XMT][^QM)XKJT;4%+6
M3W,6U;C S@')VMCG:VT^U0^/-%N_$?@/5]*L3LN[FWQ&"<98$-M)]\8_&L'4
MQ<^,[?PK#'I][9W-GJ4%]>?:+9XA;B)6W*&8 ,2Q"C:3D'/2@#3G^(^AP0:C
M,(=2ECTV<PW9CLG_ '. "68$#"C/?DX. <5MW6NVL/D);QS7LT\)GBAM0&9H
M^/GY( '(ZD9[9K@5MKP^'OB5#_9NH>9J%Q<M:(;.3,X:!44K\O.6!'ZU!-#<
MZ/J>@ZU?>'+W5-+ET2&PN(HK0R3VDR$G<8R,X.X@X]/ID ](T/7+#Q%I<>HZ
M=*7@<LA#*59&4X964\@@]JANO$=G9^([+0IH[@7EZC/ ?+_=N%&6^;.,@=1U
MK'M_#B:KI$)LCJ7A:$RO*MOI_EP.X8#YI5VL-QQG'4 \\](/&NB3V_@R&]M+
MN:?4] (OK:YNG!>0Q@[U<@#.]-RGIU% '02>(K&&74$F$T8L72*5RF0SN%*(
MN,EF.Y> ,_,/6JL?C'2UN]0M+WS]/N;"V^V3Q72 'R.?WBE20R\$<'(/&*YW
MQ%H&K2^ 8)H+);O5H[Z+5KJR)_U[!][Q9[X7Y1[(*8EX+W1M4U7P]X'DM-0B
MT^2-?[1L!#)*YP1$J]77J3V)  SDX .GL?%MA?7\5D8;NWGGM/ML"S1?ZZ'C
M++M)YY'RG#<]*KZ/XZTG7KR"WT^'4)!,\L?G&S=8XVCSN5V(PIXX!YZ=,BN3
MTW[4WCKPYJPTK7G@.FSPW%Q=V[*5D)C)!0X$8&#P  ?X0:W_ (9PW%MX<NH+
MJTNK:4:C=2[+B!XR5>5F4C<!G((H V-;\5:7X>O+&UOVN!+>LRP".W=PQ"DX
MR!C/'"CDDC JOI/CC1=6@U-]\]G)IG-Y!>PF*2$8R&*GL0.*Q_'EPMIXK\$3
MNDKJNHRY$49=L&!QD*.3CKQ6/XB\,:CXFO?%>J:9;O%]HTZWM;59XS&;J2.3
MS6.UL$#A4!.,\]N: .UB\6V!U8:7<V][:7<D#7$$<\!S/&OWB@7))'=3AO:L
MVU^(&A:U8-);Q:JUG+;32&X2REVA4)5AN49#=\#GZ&J?AN^L-4O+:\3P1=:7
M=VB,9Y[NPV-"2I!6)L;G)/\ =&-N<\X!C\#0W-E\(_L=U8WL%W%%=*UO);.)
M"6DD9<+C)R&'3/6@#;TC6]'LO"FB/9/=2V]Y$D=A%(2\\_RY Y/7:"22< #D
MBKECXHTR\_M%'D:TGTWF]AN@$:!<;@QY(*D<A@2/>O/M.T[5=.TGX=:R=/O7
MCT:"2UU"T%N_G1B2,)O"8W-M(YP"<'BI?%'A;4O%=SXJU+2XIH%NM'BL+=9D
M:)KF19#(QVL 0,80$@9R>U %[Q#KGV[Q9X)>VCU.VBN;YBID+)%<1>4QR5#=
M<[3AP&Y^M>CUYCJ&K7>OWG@NYBT#68I+/4 ][%)8N@@/E.IY8 $9/49'N.!7
M?:?JG]H7>H0?8;VV^QS>3YEQ%L6;@'=&<_,O.,T :%%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M9RP.X  Y&W '/K0!=HHHH **C-Q"MREL9%$SHTBIGDJI )^@++^=24 %%%%
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MI*E23N4DY!(Y/?/7F@#,\&3WD'B?Q9H<]_=7EMI]Q;M;O=2>9(HEA#LNX\D
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M$;MO'.1WQGF@#SO0FO\ 1_!OP[U.VU6]S=7=K92VI<>089 P(V8ZC .X\Y_
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M@'!QP*W];<)H5^=KM_H[@*B%F)*D  #DT >5-<^(-/\ A]X;\:IXAU&XN_\
M1?M-I*X,,\<C*A7;C[WS [LD]?8#I893!\2_&4PN8[4II%JPGE&4BP)3N;V'
M4_2CP'X;2X\#^'4U.74&^Q1QR?8+I BQ3*.,@H'.T\@$D9QZ#&]-X.T^YU35
MKZXFNI3JMK]DNH69=C1 $ #"Y&-QYSGF@#D]*U+4+?Q9X1MX[W49;;4[&Y^T
MSW4A*W;HB,)DC8DQC)) PO!QC K'NKK6QX$\6ZU_PD>J?:]&U:Z6TQ( NV.0
M !P!\P(XQT]J[BU^'VFVT^D7!U'5II])5TMI);O)",H780 !C '8$XY)IS>
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MH ].EEC@A>65U2-%+,S' 4#DDU3O+^XA>P^R6$EY%<S!))(W51 A4GS#GJ.
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M-,.SHF"=I[%BI/4#&* *%]X%TW4=/O+2XN;PF^N4NKJ=6023.FW9G"X &Q<
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MC=/-2/:%V'*E64@ 893T]:GF\(:7<Z-JFFW0FG75,F\G=AYLK8 !R  ,
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M$=WKJ7MXEY<VXMFP4VJ@)*X!7J"2<^];=% ')I\/],C\-V&@)>Z@MC83K<0
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M[*#DJ5((8$$8)X(K0HH YB]\!:)J.BW.FW:SR?:;O[:]T'"3"XX D5E "L
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MW%TDS+_K./F4JH*D;5Q]*ZBB@#!\/>%+;P]EEU'4]0EV>6DNHW)F:-.#M7@
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M9?+V-C<"-N3G []JV** .8'@73$2^MHKB\BTR^E,USIR.OD.S?>_AW*&[JK
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M_>?EMH3D?,3SD#J<5!+X]TF#1-5U*:&]1M)?9>VAB!FA.,C(!VX(Y# X([T
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MM))$> Z;&8,,\<'@]<5G67Q&TJ]31YUL=3CL]6D6&WNY( (A*V=J,=V<G'4
MC/&>M '8445S%QXZTRVL?[3>WNSHXF\AM255,*G=LW'YM^S=QNVX[].: .GH
MKEM4\=V.F:Q<:2NFZK>WL-J+ORK.V\PR1EMN5Y&><^W'K@'I6E86QE2*1VV;
MA&,!FXZ<D 'ZD4 245QOA;QL^J^%VUG4[">U5KF2&( HWF'SFC2-0K$EN%!R
M ,\].:N'QO80W6I6=Y9W]I>Z?:_;)+:2-7>2#IO38S C(P>>#0!TU%<3)\3M
M+AT.36I-*UI=.2UBNEN#:?(ZR$ *#NQN!.#G ]"1S5Z3QQ9PZV-)ETS54N98
M6FM,VXQ=A2 1'\V01D??"X')XH ZBBN-O?%NB:OX(UN[O[+44L[0RVNH6A3;
M/&5'S#Y&P."#D-C!ZU:F\7Z9I,VBZ8MGJ#OJ%L7LTCA+Y5$!VDD\M@KZ]<D@
M9- '445R\'CS2I-!O]5FAO+46%S]DN+6:,"9)LJ F 2#DNN#G'/7K4H\71,V
ML6ZZ9>KJ&EP+/)9R&,-(C E2K!RN/E/?C'2@#HZ*\\?Q19:M\.--U7Q/I=\(
M+M[9\0$ ,[.I1@4?(7=M'S8)]*ZV]U^&VU%].MK2YO[V.$3R06VS,:$D*6+L
MH&2#@9R<'M0!K45RDWQ"T.+1+#5E%W+;7EVMF!' 2\4I;:5D'\)!ZCKZ9J]H
M_BFUU?6+W239WME>VL:3&*[C"F2-B0'7!/&01S@CN* -VBJ>JZI::-ITM_?2
M>7!%C) )))("J .222 !ZFL^#Q/;OK<>C7=G=V-_-"TUO'<A,3JOWMC(S#(X
MR"0>_3F@#<HKS/2HAXWU[Q)!K&FW\?V74$CM;A9HT>R"1HP565R58DDDKD'=
MR?3I_'?B*Y\+>%+K4[2S>YE4I&I#*!&78*&;)&0"PX&><=!D@ Z6BO.M<OGM
M?B;X9O7L[]9)K&\#6882.678% 56* \GG..>2*Z33O&6FZCHLVI".Z@,%T;*
M6UFC F6X#!1'@$@L2RXP<<]: .AHK$TWQ/:W^NW6B2VUU9:G;PK<&WN0F7B)
MP'4HS C/!YR#57QUXCNO"_AQK^TLGN96FCA!5E CWN%#'<1GKP!GG&<#)H Z
M6BN6U'QS:Z9J,6FSZ3JS:A+:O<I;0P+(S!2,J"K$%N<\$CWSQ3;KQ_IUI;WU
MPUAJ3Q:?#%-?D1*IM1(H<!U9@2P4@D*#CZT =7163>:_:P75M9013WMW=0F>
M."VV[O*& 7)9E"C) &3DD\=Z\YT34M+@\ ^-;C6[;4I-,&MW230!F,ZIA/E)
M#9&.F=V/>@#URBN<O?%UAI>K66C?8]0FNKFV::W2&'<'50/ER3UY'L.Y%-MO
M'.D3^&[S6Y5N;6&RG:VN()XP)8Y@P7R]H)!8EEQ@GJ* .EHK A\66S^)%T":
MPO[?4&A%P$>-67RLXW[D9@ #P??ZBM^@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *9
M-*L$+2LKL%&2$0LQ^@')I]% '$_#N.\T/X86-O>:;>+>V,,GF6GEXD8[F8*N
M2 201CG'-%Y:#Q?K/AW4H=+O+&33;HW,L]Y!Y,BIL8>2 >6W,5)QE<*><X![
M:B@#/L]1FNM5U"S?3KJWCM#&$N90/+N-RY.S!SQT-<I\2[>]NQX:%CI]W>-9
M:W;7TX@B+;8DW;CGIGD<9S7=T4 8*^(+FZOK6TM-&U)!+)^]N+F#RXXD ).<
MG))QM&.Y]JY[P_#=VD/C=Y]/O4^V:A-/; V[9F1HE12HQW*G@_4UW]% 'DS:
M)J__  K7PBT.C/=7V@R1R76EW,>TS*$:-U7=P3ALCK^?%=IX6>*[>:]M_"[:
M'"R!,7%M'#/*W?*H3A1[]2>@QSTM% 'GVJ^$M0;XE)>60 T;5X$.KKVWP,&C
M_P"^QA"/3=6UXWGU>#3[!M+M;FXA-]&+X6@!G6WYW&/WSM&1R 3C'4=/10!Y
M(^E:G';?$:WBT#4(H]5M4^Q;@',C&WV8)#$EBV23SCG)K7N+:\?5/A[,NGWA
M33U?[6?(;]SFW,8W<?WN.,^O3FO1** /,(XO$^CZ3XYMM,T>=M0GU*:]LY65
M#')')Y8^3)^9]H<X(QD#/H9]'M+I/B3;ZJFB:K%I]QHK6[W%ZP+^9YH8F0EB
M1P,8_( 5Z14-U:PWMG/:7";X)XVCD7)&Y6&",CV- 'CFCW,%OH6E6>IZ!XE7
M1].NS?P)%9+-%& [.F958EXUW9!"@G ZCBMJ6WFT7QAK$UWX1E\0:9K$B75I
M=6UO',T;&-4:-]Y&U?E!!SCGZXZBQ\$PV,*VIUO6KG3T78ME<7*M'MZ!20H<
MKCC!8C'!R*Z<  8 P* *NF0M;Z;;Q/;06S*@S! ,)'_LCV'3/>N1TJ.YM?'O
MC*^FL;Q;6ZAM!;RB!B)3&CAPN!V+#Z]LUW%% 'D4.E:I%\*?"6F-I=]]NLM0
MMI+B 0,6C6.7<Q],8QTZ]N];A34=,\=>*)ET>^NH=9M+8VLT*#RPT<;*RN21
ML/(/KCH">*]!HH \GT_P^MUX&\*:7KVBZO:3VEK)MOK0-]HLI5V!2/+R0&!;
MJ/X1D#K5F:Q\3#1_!U[J=K=:E=:=JKO.8T43- 1(D;LN0-V"A/IGGO7I]% #
M8V9HU9D*,0"5)S@^G%>9V-CJ=MX3\4^&WTF[.H:A>7OV<M$3 R3LVUS*/E
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M>+26//R[.HC.XX(_2O1** .,^'5M?VEAK2W^FW-DTVL75Q&)]OSH[D@C!/\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M?J"76JA(XQ'$K!Y#'NR-K$ 'G Z^PK9\5V4^I>#];L;5-]Q<V$\429QN9D(
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M$DA?EXS@\XXSG%>?>'[UDB\?V4>GW=U-/K%TL*1PEDD9HD7:6Z+VR6(&#]:
M-+6[JWOO'WP_U"RN&DM[O[4Z,LC;'0VQ93MZ=^N,UK7'CO3+=Y7-O>-90Z@-
M.EO%5?+2?<%P1NW8#$*2%QFN=A\/7NAZA\.;,6\]S'H\4R7D\499$+P;!SZ%
MB?H.N*R?$-KXBUC1]4CO-!U*?4;?5XY8?+V^0+=9U*F(;OF8J#DXW=<D# H
M[N[\:VEOKE[HT.FZI=W]K LYB@@!WJQ(^4L0.QY.!Z9/%:F@ZW9^(]#M-7L"
MYMKE-R;UVL,$@@CL000?I7-6"W:?$[4]4FT^\BM)=*@A60PEAYBL[,ORYR0&
M'3@GH35;P-+J/AWP%HMC<Z'J#W37LD$T2Q@&!9)I&$C9.-@!&2,]: ._HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
*HHHH **** /_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>23
<FILENAME>insidertradingpolicy010.jpg
<TEXT>
begin 644 insidertradingpolicy010.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M'*[=V.=N<^U= Q"J6.< 9X&: %HKF/#WC6QUV'5KADGM+>PN)8FDN8'B4)&
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M,V @9U7J=S!B/4#/2O1)_#ES+XYMO$8OXE2"S>T^S&W))5F#$[]_7*CM70T
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M9=VNFZJ^K60<R"^-Q_Q+RRX<%I#M)/"X&2>O;CT*BB@ HHHH **** "BBB@
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M>0>0[98HR@C<5& !\W.1ZUE>'[R/P_>^,-*\0*RR76HSWMN60D7D$J@*L?\
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M?V<H:[CGADCDB4C(8HRAL$="!BI-'\5:-K]S+;Z9>>?)%%',X\MU&Q\[2"0
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M:G>->%5MS'Y;%57 .\Y&%%=!110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M">Y"A\$Y .T <=.E8UYX(MKVQTVWDU34@]C>I?B?>C233KT9RR'/I@ #&!T
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MGQ1HEQJVA7'V>\2^E2V62=1 J1S%"DB;23E5))ZY/! XKT9"SQ*3@,5!.TY
M/L:Y'_A7=E%K-Y>6>K:K9V=]*9KS3H)@L$SG[QQC*[N^",UV'RHO95 ^@ H
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MLS*8BC2+(4<\8SN7!!]QBO&;>U$?P#T&5)9O,GO+,DR2LX4_:1RJL<#Z#&:
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MDX'/%<=\.?#'VGX?:79ZO_:<:0RM++IMU%Y:;Q*S+D,@8KG:V,[<]NU>E44
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBN.\9_$WP[X%N+>VU5[B2YG7>L-M
M&'94SC<<D #(/?/!H [&BJ.C:Q8Z_I%MJNFSB:SN4WQN!C/8@CL0001ZBKU
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MZI#JD.I:CINH11& 3V<JC='G.UE=64C//3-7M,TE--#NUS<W=S( )+FY<,[
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M:="RI)--+(=TL\[[GD.,9)Z=.P  ["@#C+^]2Q^-D$DD-Q(C>'F4F"%I2O\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M'+$*#\N2<_*17344 16]O#:6\=O!&L<48VJJ] *EHHH **** "BBB@ HHHH
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MPP&;D\@=R 30!UWCKQ#>>&?#4VI6$=K+-%)$K).3]UY%3( QG[WK72EE7[S
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M4)(1_>))&>_/O7-6=C#H_P !X/$^GP.NLFP6WDO4=O,6!IP),<\87.#VZ^M
M'N*NK$A6!(.#@]*0N@ZL!SCKW]*\^U^PMM+\2^#+WP[#% ]U=_99EM@%6>U,
M;,Q;'W@NT,">A/O7*R:#ID_@#XBSRVD;RV6JW[VKMDF!E52I3^Z<@<CK@#I0
M![9N7<5W#<!G&>:0NH(!8 DXY/?TKS*73K2Q\8^ +ZVA$=YJ"7"7DX)\RY!M
MBW[QNK?, 1GIVK%M?"NB:IX0\=W%Y%^]L=5U$VLYD.;4H RE.?EY SZ@ '@"
M@#UR75K.'6+?26E'VVXB>9(@>=BD L?098#_ /55VO)])M4O?&_@^[UJT@>^
ME\---<O/$I8R@Q?,V1]X<_3FO6* "FAU) # DC(&>HJAK\,=QX=U**5=R-;2
M9'_ 37D]CI=E8^%/ACK%M L>I2WUG!)= DR-&\3AD+==O XZ"@#V@NJD!F +
M< $]:IW>K6=EJ%A832@7-^[I!'W;:C.QQZ +U]2/6N$T*ULO%3^-X=?ACDNX
M=3FM@90-UO;JB^24)^Z,98$8YR:Y_28VUJ7X67?B"UAN;NX@O%F>XB#&5%A8
MQELCGC#<]SF@#UJ$ZG_;%T)S9_V=Y:?9@F[SMW._?GC'3&/?-70ZEBH8%AU&
M>17EUW+/I?BOXC7>DKB[31;>>';S^\V2D$#Z@'%:_A_3O#5[I_A37[2?9=+%
MMAD@<![IW3]XLO=R""QST()/>@#N=Z[]FX;B,[<\XIU>/:)9V_BSP?!JM[K-
MK9:I:7C37-Q';?Z7!<+(?D+%\\\*%QR" !TKV&@ JEI6K6>M6/VVPE$MN9)(
MED'1BCE"0>XRIP>]6I8HYXGBE19(W4JR.,A@>H([BO$=/EAT?X0Z7-;Q16\5
MWK7V?4YHE"-]E^UN&W,.<8POT;% 'N"NK@E6# ''!S2UP5_8KHWQ2\,_V+"E
MM%?V]U'J$,"A4>.-5,;E1QD,P /7G%=[0 4444 %%%% !1110 4444 %%%%
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M_P#PB>@_8+FQ_LR'[)=2>;<0\[)7/5F&>2>^>N!Z5JP01VT"00KMCC&U5SG
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "N!<_\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M2VNY(U$,KI"&91\VX' ."5 ..": .ZHK/UO6+3P_H]SJE\7%O  6V+N8DD*
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MH\IBQ^9@!R>F<GL.M3>*M7L/$6D^"=;TR=WM[C7[0(=Q7C<P967ID%<'/<4
M>D45@:MXKM]+2_=+&\O8].7?>-;!/W(V[R/F8%B%(; R<$>HK6L+ZVU73;>_
MLY1+:W,2RQ..-RL,@^U %FBO-_">K6?AO2O&M_>-,;6V\0SJ "9'.1$JJ,GD
MDD 9/>NGB\61/>:G8OIE^E_I\"7+VN(V>6-LX*$/M/*D8)!R* .AHKE!X^T]
M]+T+4DL;][76I5AMG B^5VSM5_GX)P?7TZ\5NV^IK<:M=Z>MM.#:JA><[?+)
M89"C#9SCD@@=1ZB@"]1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MZ:VD7;MJ,]S/:S(%*2B6%411SG=N'/&!W-.>PU VWPZ4:;>%M,*&]'E']SB
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M% ,(A_NK[#I5FB@#RZ"'Q+IWA_Q>^F:;=I>76N/=P+Y8#R6S&,,T>[C?M5L
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M70O*G^ARG=%(4884G@@@CI7G2"^T[X>_#PZ;JU]:F]NM/AFQ+O!5X^1ALX'
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M0MOD)4@G;A .PR3UK3/@71CH^I:4?M1L]2G:XNT-PV9'8Y8YZC)QD#'2C5?
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M"X>T^VQ)+"<RPY W+MSD\CY?O<CBLC_A:?AG[+;7GF7HL9I3";LV<@AA8.4
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M+5;72H8I+EFW32B&&-%W/+(>BJ.YX)]  2< &@"[16-9^)K*]FOK5([E+^Q
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M;_*&(.7!8A2&(7. :XFU\+:KX;T?P-_Q+YKI].OIY[R"TVLT7G+)@#) (4N
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M:* //_%TOB+Q5X+FT.Q\/7-IJ-^BPW#W4D8AME)&\[@QWCJ!M!/.>.E6-/\
M#DOA'0?#&BZ;8W%_'87/F7$T;1K]Y) SX9A_$^<#/'TKN** /-OBC\-U\61V
MVLZ8@CUNS*]#M^T19Y0GU'.#]1WXZ/4YM5C\2S0RZ,^H^'I[&-9-I1BDN^3=
M^[8C<"I7./0<'G'344 >=^!/! T#QCK^MVEB^EZ7>I'';6+,,Y'+.5!(49SM
M&<X)X' KT2BB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MB-/' 5-QY1!=MH/W3D9-1V_B]X?%EMX;UG3OL-[>0M+:213^=#,%Y90VU2&
M&<%?QH 3_A7^B"WTN)6OT?3"WV6=;V02HI4*4WYSM*JHQZ"LCQ'X0M-*\.W=
MOI.DWUY;ZAJ$=Q?PV]TWFHNX.SP@L/FW*O .3[X%>@5SW_"0W ^( \-O9QK
MVFM?)<"4EFQ(J;2N!CJ>Y[4 8'AK2)5UBUN].G\5Q6R%OM,>LW+-&ZE2 H1R
M6W;BIR,  'GL=;3/AYX?T?5&O;*.ZC3S3,MG]J<VR2==XBSMSGIZ=L8%;NFR
MZC*MS_:-K#;E;AU@$4I??"/NL>!ACW':KM %35--M-9TNYTV_B$MK<QF*5"<
M94^XZ?6L2V\":1;7VG7QEU":\T]'2"XFO)&<!@!@G/( ' Z<GCFNFHH YAO
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M26TTVUGMTED:01MY<I) 8G SS@<<5W=[X;TK4+C3Y[BV;?IQW6GE3/&(CC'
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MF9Y6:,$D+N8D@ DG@CGGK0!Q=K/>:)X^N8[:Q^R1'PS)=K9+-O\ ,ECD 5G
MX\S!(."?J:O>&K"RUKPQX7\2G5;B*_/E3W-U')S<R/\ *\+^J[S@+_#@ 8KH
MK+P5H%AJ-KJ$%BWVRVB,,<\D\DC;"0<,68[L8&-V<8&,5'IG@3PUH^K/J=AI
MJPW#.9 !(YC1SU98R=JGW % '*^$M(LD/CTQ1O$Z:I<1J\4KHRCRHVX(.0<\
MYZU0T75;B71/AEI-U-(;+5(I&NW+G,S)%N2-F[AF.2.^W'3->ACPIHRWVH7J
M6C)<:@,7+)/(H<XVD@!L*Q P2,$^M1_\(=H7]A6^B_8C]AM762W3SI-T#+RK
M(^[<I';!H XO4TN-+\1^+-#LYKB/27\/G4D2*9E^RSY=,1D'*AMN[:...G6J
MMG:_V=:_#/5H+F[-[?&"WN7>X=A+&]L6*E2=N 0"./?KS7HH\-Z7]BO;5H97
M2^79=2//(9)5QC!?=NQC(QG')]:@/@[0VM],@-M-Y6EL&LE^US?N2!@8^;G
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M5OI7B/6=7@C\DZD4,B"5GWLN[,A!X4G(&!T ]\  Q?'\+:1=:3XPC\QHM+N
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M%\307=UX:U"VL+Q+.\FA,<,[L5"NW R1R,DXR.1GB@#5HKR*?Q+/H^C^)_\
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M5RTU72-5T?1;6U&I0R/JTZ'1I\!I)5#N\,I)P(TW!N_ 48)P* /3Z0D*"20
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M;%SL(VD D D8 Z\5+>:4^B?\(-K^FWE\;^^N[6SO1)<NZW$,L?S94G V@9&
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M=@ *XP0<G)R:E\>(^A:[%K-G<3?9KFV,.LQ1JSBW@=@/M2KG",#D>_)P=K4
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M&<[\DXXYSQQTXK?R,XR,CM1D>H]* ,F/POH\5YJ5U]D+RZFH2]\V5Y%F4#:
MRL2.!QTZ56\/^"?#_A>5Y=(L/(=U*@M,\FQ2<E5W$[1G' QG ]*Z#(SC/-)D
M#N* ,_6="T[Q!:1VVIVYFCBF6>/;(T;)(O1E92"",GH>]16OAG2;+63JUO;O
M'>F$0%Q/)CRQT7;NVX'88JU+JEI%JUOI;2C[9/$\R1#KL4@%CZ#+ 5<H YBX
M^'OA:Z%\LVE[DOIO/G03R!?,R&WJH;",2!DK@FK\/AC2;?5'U*&WECNW@%LT
MBW,H_=CHH&[  [8'!YK*T+Q!K7B"+3-8L;>R;1+QY0Z.66>%%+!'W9(;.WE<
M#&>IQFNMR/6@#G[;P5H5G:6MM:6]Q!':2/+;^7>3 QL^=Q!W9YR<CIR:6Z\%
MZ!>6MO;S63$6]PUU'*D\B2B5OO/YBL&).><GG\!6^"",@Y%)D'N/6@#!A\%>
M'+>'4H8]*A\K4O\ CZC8LRR< ="<+T'3'(!ZBI-"\(Z'X<@EATRR*+*NQS+*
M\K%!T7+DD+ST'%;8(/0U3U#5+32UMS=RA#<W$=M"O=Y'.  ._K] 30!D#P'X
M;715T<6#BP619!"+J7@J<KSNS@'D#.!V%7;WPWIE_?6]]+%,EY;QF)+F&XDB
MEV'JI96!8=\'///6J-KX@O9?B!?^'YH+=+6"PCNXY58EVW.R_-G 'W3Q^M:^
MJ'4Q:(=)%H;CS4W?:BP3R]PWXV\[L9QVS0!2NO">B7FGVEA+9D6MG*)X(XYI
M(]L@.0Y*L"6R2<G)R2>M3Q>']-AUUM:2*7^T&A$#3&XD.8P<A=I;;C//3K6D
M2!U(H.=IVXSCC- &5K_AK2/$]DEIJ]FMQ'&XDC(9D>-A_$K*00?H:8OA30QH
M#Z&=/C?3I.7B=F8N<YW%B=Q;(!W9SP.>*YJW\;>(+H>(WM]$L9ET*X>&1!>,
MCSA5W$K\A ..Q/7O75>'=>M/$WAVRUJRWBVNH]ZAQ@J02"#[@@C\* %L] L+
M%Y)(EN'GDB$)GFN9))0@_A#LQ8#OP1SSUJB/ _AX:#'H8LI1IL<GFI;B[FP&
MW;LYWY^]SUZ\U<\2:E<Z1X9U+4[2**::TMI+A4E8A6V*6[#VJ"RO]7U+1= O
M[6.R'VM(9KX2EAMC:/<?+QGYMQ&,\8H EET'3(M6373;W$FH00>2DBSRLWE]
M=NW=@Y(!Y')YKE?AUX22U\%Z9;:S8745Y;2M*]K/,QC$GF,RL$#%#U!^O/7F
MO0"0,9/6EH S#X?TTZ\VM^3+_:+0?9S,+B0?N\YV[=VW&>>G7FJT7@[08=(O
M=)%@)+"^=I+B":5Y [L<EOF8X)/.1CGFMRB@#G-.\">'-+TJZTVUL"+:[01S
M!YY'9D'1=Y8L .P!%:5CHECI]TUU$LKW+1B'SIYWE<(#D*"Y) SS[]\UHTA(
M'4XH K:EIUIJ^FW&GW\"SVMPA26-NC TV32[&74;74'MD-U:1O%!)CF-7V[@
M/KM%7** ,R;0--N-=@UJ2&0ZA!&8XY1/( JGJ-H;;@\9XJC)X'\.RQZE&U@?
M+U-VDNT6XD59&8Y;@-\NX@$XQG SG%=#TI,CGD<=: ,AO"^DO>Z;>-!,UQIJ
ME;1S=2DQ C!_BYR.#G.14VMZ#IOB*R2TU2V\Z))5FCQ(R,CKT964@J1SR#6E
MD8SGB@$$9!R* .(\2>#=-M/#7B.71=*=M5U+3WM?W;LS2L4*J3N.,\\L>3W)
MK1\,^'K.TTG2+B:UN5N[2U5$CN97?[.VP*P122 >HR.W XKIJ* //?"GA=;B
MX\4?VQI][#'?ZM-<)&\SI'<0,%V[E5L'.&R",D<'CBNNN_#VF7VIV&HSP.;J
MPW"U=)G01;A@X56 Y'!XZ5IY![T9&<9&?2@#*M_#6D6MYJ5U':EI=2 %YYLK
MR+, -H!5B1TXZ=.*J:)X'\.^'7E;3=.$?F*R8DE>4*AZJH<D*#W QFN@) QD
M@9H8[5)&,]LG H YB#X=>%;>*UBCTL[+2;SK<-<2MY3<\+EN%Y/R?=/I5R7P
MAHDUW=W#6TBF];==11W$B17!QC+QAMK9'!R.1P<U!X/U^\\06NJ/>P00RV6I
MW%B%A)*D1D#.3USSZ?2M>;5+2#5;;3'E'VRY1Y(XAUV+C+'VY _&@"O?>'M,
MU&^L+VY@<W%@2;5DF=!$2,' 5@.G'3IQ6??> ?#&HZZ=9NM+5KU\>8RR.JRX
MZ;T!"O\ B#71Y&0,\FEH :Z"2-D)8!A@[6*G\".17.GP%X;_ +'MM*%A(MG:
MS_:+=5NI0T,F2=R/NW+R3T/>NCR 0,\F@D#J<4 9.E^&-&T6_N[[3K)8+B[V
M^<X=CNP ,X)P"<#)'7J<TY_#6CR:7?:8UA$;.^E>:YBYQ([MN9C[Y_E6K29&
M"<C ZT 4-7T73]=LEL]1@,T"RI,%#LF&0Y4Y4@]15V6)9HFC8N%88)1RI_ @
M@BGU%</*MM(UNL;RA3L#L0I/N0#0!0T+P[I?AJS-GI-N]O;EB_EF=Y ">21N
M8XR?2C4?#NFZG?P7\\4B7L"&..X@F>&0(>JED()7V/'>JG@K7I_$_@[3=9N8
MHXIKN,NT<6=J_,1@9Y[5OT 8EWX2T2]TRWTV>S;[);RB:.-)Y$Q)G=O)5@6;
M=SDDG//6MI5"(JC. ,#))/YGK2T4 <U-X!\,3Z^VMOI:?;G<22,LCJDC#HS1
M@[6/?)%:;:!IS_VEOAD;^TEVW6Z>0[QC;@?-\HP2/EQ4M^=3$]E_9ZVAA,^+
MO[06#"+!^YC^+..O&,U#+K$4LNIV=@T4U]81*\B,V%4L&*JQ&2#A<XQT(]:
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M/. *I6WB_3;GQ#9Z/'>6[2W5DEY V2/M"MN(,8[@!"3ST(]\;TC/Y3^2$:4
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M)=1>8VV9CU9AGDGOGKWH XJ73[:P\:> K^V0I>:E'<)>S[SON1]F+_.<Y;#
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M@D0D8R",BLZX\,Z1=7$T\UH7>X54G_>N!.JC $@SAQCC# UJE1LV]!C''&*
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M]'GU.;4I-/B-]/%Y4DXR'9<8QD>Q(SUQQTH \CTK3;2S\ _#G6H(MFI-J=G
M;G<=_E.S*T>?[I'\/2O:KNWANK.:"XB2:&1"KQR*&5AZ$'K65_PB.@_V?:V'
M]GH+2TD$MO"';;$XY#*,\$=L=,GUK; P /3UH \.MK.TC^ >@-##%%+/=V9F
M>)0KO_I( )(Y)Z\UT=S;CPU\0];70;<0M)X8DO#"F2);A)6"N0>K<XSU-=>O
M@GPVEB;)-(MTM3-YYB3*KOSD' /8Y(],\5>30M-35UU46_\ IZQ>2+@R,6\O
MKMR3TSSCUYZT <!X?TBSU;3?"WB:#6[.&6-HBTUM:D373. 'AE<R$L22<Y'!
M&>*]-EBCGB>*:-9(W&UD<9##T(/6L33_  7X:TG6)-6L-&M+>_DR3,B8()ZX
M'1<^P%;U %*\M;5+5YML5N\,#HEP(QNA7'.WT QT]J\_\)^?HGB?2M(UW1[>
M._:TEBLM7L"#%?H K-Y@^\'PH;)SDDXZUZ5+$D\+Q2*&C=2K*>X/!%9MIX;T
MFPV?9K4IY<1ABS*[>2AQE8\GY <#[N.@]* /'K'3;2W^$OA_78X\:I;ZNGE7
M.X[D4WK*5'HI!.0.#GFNWTN.V\2>.O&&GZ[;17/V,V\-M!.NX1P-'G<@/0LV
M26'/ '85T8\'Z -*CTL:;&+".3S4M@[;%?.<@9QG//UYJQ>>'-*O[N.[N+7-
MU''Y(G21TD,?]UF4@LOL<B@#R6&.YU'PSX*74IYYRGB5K**X:5@TUNOG!<G/
M.=H&>O YKH+KPMX?TCXF>%K*UTNTCM197SE'3>,AD89+9/!9B/3/&*[J[\.:
M/>QV4<]C&8[%E:U1246$CH5 ( ([$=*?J&A:7JUQ:7%_8PW,UFQ:W>1<F,GK
MCZX&1[4 4+/4_$LVM_9KOPW!;Z=O<?;%U%7;:,[3Y>P'G XSQGVKH*** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH ***Y[QI97>H^'C:V%U;07;SQ-$MT"89F5PWE/CG:VT@_6@#H
M00>AS17E<.F0>+O#7BK09-"&BZ[$4DDMU*M$L^S]U)$P&-K;.?QSU-9G_"26
MTFJ>'/'WV.*&PBC33=481\QRR+UQV\M@BYZX<CM0!ZUJIU,68.DBT-SYB9^U
ME@FS<-_W><[<X]ZNY ZFO+_&.D1V/P]MIY+<07L^JVUU,J?+MDDN%+*<==H.
MWGL*MW6BZ?J?QEO+:]M_M%M+H$<DD$C$H[>>P^9<X(P!QTX'I0!Z+5749;N+
M3+F73X8[B[6)FABD?8KOC@%NPSWKR;3?MC?"C1(H9&E@MM=\F6U9_FN;=;EU
M\E<GYN-ORGJ%QTKK?#_AO9XUUS5Q8FVTNXBBCMH'&P,^TB5Q'T4'*CD9)!/N
M0"6U\4:[.OAN9]%@$&HLT5WMN<M$XSAHQCYT(4MG^[^O8TWRTWJ^Q=R@J#CD
M ]1^@_*G4 4[O5+2ROK"RGE"W%](T<$?=BJ,[''H IY]QZU<R/6N \9:;87G
MQ)\#F[LK:?S7O$D\V)6WJ("0#D<@'D#UJEHWAO2-5^(_C$7MN9X[2ZL+BW4R
MMB.3R0^X8/7/\SZF@#TO(SC//I575+F:STNZN+9(WGBB9T25BJL0,\D FO(W
M:U:V\(ZQI0_<7/B1534+A@;NZ5WD#[B ,)V"G)P%R!C%;>G"S\42^/#K$,5Q
M=V=U+:PI* 3!;K$#&R?W=QW-D=3]!0!TVAZSK.O>%O#VKVT5@CWHCEO5D+@+
M$RDMY>,_-G&,\=:Z;('4UX[;1)_PA7PHG&?,%_:1Y#'&TQ2$C'3J!^5:">'M
M+U7QI\0K>_MOM$"PVCK%([%0QA<[L9ZYY![9.,9H ]2Z=:.M>3Z?/>7GA+X;
M7%P[7MJ<"[M"=SW'[EMK;3]\(1N(YZ \D5TW@OP]+I>JZ_J#VS6UM>79-C Q
MP8XL+N^7.%#."0.H]LXH [*C(]:*\TL?#6E:S\4/%\.H6[3Q0C3YTC:5P%DV
MNVX8/7(_4^IH ]*R,XSSZ4N1G&:\@TVP3QAX5NM1O=7L[#4[._EDN+M;4F[L
MY(Y6PN_S.!M 4#;C:<8S5KQ09M&U75-7U+3;?6?#\MS$TMU#@7>F,H08 (Y0
M$!L#'WFSUY /28M4M)]6N=,BE#W=M%'+,@YV!RP7/N=I./3'K5B8R^1)Y&PS
M;3Y8<G;N[9QSC-<!H^DZ7+\6?%QDL;;=]FLF5O+ 8,ZR!B#U!;N1R:R/ GAK
M2I_A;#K$UN[ZA]BO(1<&9]P0RR?+UQC*@_7/J: /4-.-\=-MCJ8MQ?>6//%L
M28P^.=N[G'UIFJ:K9Z-IDVH7LRQV\0!+9ZDG  ]220 />O+]'OXUTOX8:7J+
M+_95]8OYBR?ZN698D\I7SP?O,0#U('I4_CWP_HFE^ M>@LOWRC4K:Y,,@5DM
M'DFC!6,8P@*DDKZ-Z&@#TFZ.IC4K 6BVAL"7^V&4MYH^7Y/+QQUZY[=*NY&<
M9K@-<L;2R^)7@-;.&.",&_01Q#:@ @)P%' Y)_,UE:7;VOB?PAXMO=81?[6@
MO;Q#.W$MF8_]4$;J@4!2,>Y[F@#U2C(QG/%>16-O)KOB'P!-KD;R7%[HEPUV
MC,0)<+'C<,]\DD=\G-/TC3+B7PUXDT72+BVMOLOB:1+&VNLF!U7RY/(('1&^
M;CWH ]:!!Z&BN-\!7T,\NM6DFB'1=4M[A&OK-65HMS1@*\97@JP7/US794 %
M%>2B*VB\-?%6%DB2**XN&C0@ (?LRE2!V.[D>]/.GVU_XA^&J7"M(ESH]P)E
M\Q@) L$6 >>GS'([Y.<T >K@Y&17-WOB"\M?'FDZ$L%N;.^MIY3+N)D#1[>,
M= /F]_PKSB:];PYX6\46-D[6FF1^)TM&,;%1:VTGE&3:?X1R1QTW<5TVH:7I
M^E_%CPU)IEE;P-)IMZ-D*A%?:(]O X[GG_"@#T7(SC//I1D>M>1>'M/B\4^$
M='\03:U9VFHVUPLUQ=Q6A^U"<-AHG;S,D,3MV8Y&T =*TO#_ (:TK4_'_BYK
MVW:;[#J5K/;!I7Q%((5;<.>N3WH ]+KG]<\0RV.MZ5H=DD#7^I"5T>X8B-$C
M +' Y8\C"C'<Y&*Z"N5\8>'M$\62V>D:C)+!J"I)=6-S;OLEA*% S(?^!+Q_
M@* -#2=1U6;5[_3M3L8(?LT4,D5Q!*66<.7!X(!4C9TYZ]:VLC)&>17E$>M^
M+_#D/BCPYJ-VFJ7=AHKZAI^I)'B0K\R@2#^\""1ZX/7-:&C:+8W3^&_$MCK%
ME$0NU#9VI1[[>O,<K&1BY&"22,@@D]Z /1\C.,\U3M]4M+O4KS3X)0]Q9B,S
MA>=A?) /O@9QZ$>M>=>%+;1_%'@?3M=U2Y>+5X+TSW5W$P6X6X60CRB<$X.0
MH3N" .U7O#&DZ9_PLGQQFQM5=9K4(RQA67?;Y?:1R-V23CKS0!VVDG4SIL9U
MA;1;[+>8+0L8\;CMQNY^[C/OFKH((R#FO%-%O9+7X<^!K.1F&FWNMR6]ZQ)P
MR^=,51C_ '68#.>N,'K73SZ<FG?$UM.TZ$0Z7J&C2RWUK#\D:NCA5D &,,<[
M>.N/:@#T3(]:*\.TO3;6U^'OP]UR*,C5#JEI$;HL2_EO(RLF?[I!^[TKW&@!
MDS2)"[11B20#Y5+;03]>U8?@SQ#+XI\+V^KS6JVLDLDR&%7WA=DK)UP,_=]*
MWZ\[\!_:C\')A8Y^UXU#R-O7?YTVW'XXH Z33_$$VOWURNCQ1'3K64PR7TQ)
M6613\RQ*,;@.A8D#/0'FN@KQ:VLGT;X.^&]>\/WEXFI6YM<0K<N8YVDE5)(C
M&3MY9FZ#.17M- !0"#T.:XOXC7\MG:Z# 6*6%[K%O;7S@X'E')VL>RL0H/MD
M=ZJRZ?'I?Q5L++3+:./3M3TR<ZC:1H!$=A4)(4Z9.[;GN* -&#Q!K6L7-U-H
MEO926ECJC6$\-QN61U0@22*X.!@DX4J<A>O.*ZVN ^&&FV%NGB.>"RMHIDUV
M^@62.)581B080$#.T8''2N_H H?VK!/J%[IEI)')?VD,<LD;-A5W[M@8C.,[
M">G3'K6;X(U^X\3^#[#6+N**&>Y\S='%G:-LC*,9YZ**P- TW3D^+OBZ;[%:
MK+'#8R1OY2AE=UDW,#C@GN>]<3INF6EO\*?">NQ18U.'5H5CN=QWHK7;*R ]
ME()RHX.: /=B0.IZT5YC):)XO\2>+]&U&YL$N+>18X4N;8R2P6YB4K)$=Z[?
MF+-D#KC)Z =YH$?E>']/B^WOJ 2!5%VXP9P!@.?KUSWZT 6KZ2>&QFEMQ&TJ
M(642$A3CG!Q7*>&_$OB+Q/X3M-=M-.TR,74;/'!)<OG()&"0GM767G_'C<?]
M<V_E7F?PWT*YU+X3Z'Y>M7T"E=_DKY?ED+,25/R;L'&#SWH ].M97FM(998C
M%(\:LT9ZH2.1^%2UYWX]LQ>)I/B/PTB3^(;9VFLE1-PNH@/G##C*[3\K>I4#
M[PJCJ6JZ18?#CP_=:/(8]%OM2MDU"?[C^6S'S?,(Z$L-K>Q('% 'H&OW]QIG
MA[4=0M(XI9K6WDF5)6(4[5)P2![4>'=1DU?PUI6I3JB37EG#<.J9VAG0,0,\
MXR:YG6=$T;2K+Q-<Z<Y@FO-&E,EG"0(-JHP$FP#ACG&>X'L:YFRTRTTR'X7:
MI:1>7?72PP3S[B6EC:U)*,>Z@@8'08XQ0!Z[D9QGGTI20.IKQCQ$UK+HU]K.
MF#<8_$<>-0N7!N#()T1DCP 5C4949)) /&#FN@.AZ9JWQ<UNVOK<7-K)I%O(
M\,CED=C)(,E<X/08].M 'H] ((R#D5X[I+WL_P *?!Q$C7$$>K"*XM6?+W,*
MS2J(P#]_ "G;W"'TK0O]+O\ 0K;QWXETVUDM(FM =-CP5,;+&?-D$?1<G!Y&
M25)QSR >I9!)&>E%>?:1H>GRZGX>\1V&KV,*,C1HMC:E#?*R9VR$R,6*X+9/
M(()->@T (2 "20 .I-<UX-\8VWC"WU"2")H6L[MH=C<%HS\T<F/1E((_&I?%
M\MQ+ID>CV(5KS4W^SJ&D* 18S*Q8 E?D! .#AF6N1F:^\*?%'3M4O+.SLM.U
M^)=,F6VN&D03H,PL<HF"1E!UH ]/) ZG%4[K5+2SU"QL9I0+F^=T@C[MM0NQ
MQZ #KZD>M<8@L?$/Q$\3Z'KD<<P@M+<64$P! A="9'0'^+<<%ASPM9E_HNC#
MQ?\ #VV54U*V6&]@^T7BK*\R1Q?+N8CY@#D@].XH ]2HJ..>&5W2*6-VC(#J
MK E21D9].*DH I ZG_;;!EM/[*^S@J06\_SMW.1]W9MQ[YKGT\0:UJ]S?OH-
MO926^G:E]@GAN=RO*%"F1U<'"XW< J<[3SSBJ,5M$/C9?QE-R3>'HVD1SN#$
MSL#P?8 ?A47PTTS3[>?Q3/!8VT4L>OW<*2)$JLL8V80$#A?;I0!Z!1D#&3UH
MKR3QNEE?VGCNYM4%Q<6=L@FN;M@?LLBQ[E2W &0>0Q.1\QXSR* /6Z,C&>U>
M7W6G6FM_$+PU'J&^>*ZT&5IXS*VV4@Q\,,].>1W[US&KZ=_97A+QKI-M),-)
MTW6;,6'[QB(?,>(R(IST7?C!SC)H ]V).UMN"PZ G'-<GH'B#6_$'AW6)X+>
MPCU2TOKFS@1V?R2T;;06/WL'VQ6)-H%MX;^*_AR70T>!=3ANUU.,2,PE5$#+
M(V2?FWL!N/)S6)+$DOPB\?[L_)JFI.N&(P1(<=* /8(B_D(9M@DVC?M/RY[X
MSVI^0!GM7G@NK>[\?Z-HFK+')8MH0GM()P#'+/OP_!X9@@&/0%O6F76GZ'IB
M:!X>M)[O4"-1G-K9S3+Y#LJ,S)(Q4CRX]W  )# #D@X .B\=>(+WPQX3N=8L
M(+>>2!HP5F8@89U3.!U^]ZBNC)X.W!([9KQ"]W1_"GQ[9EXPEOK[1Q1P\)&O
MF6Y*H.R@L>/>NJO= M?#OQ-\,W&A1O!+J/VE-119&83Q+'N$CY)R0Q7YNI+"
M@#H_!^OWFOP:NU]!!#)8ZI/8A822"L>!G)ZDY/I71@@]#FO'#J<NE>$?%-PD
MODV[>,)([N8@D1P--&')P0<8X.".">178Z+X?MM*\6_VI;ZG9QK>6.UK&PMO
M*AE"L")B-[#(W!=WH0* .RIDOF>4_D[/,Q\N_.,^^*6.1)HUDB=7C895E.01
MZ@TZ@#DO!_BR]U_4=9TW5;&#3]1TN<126R2ERR$960$@?*W./_KUHZ!JFHZM
M)>33V]M'81S/%:S1R,S7 4X+X( "YR!R<XSTQGD/B1IXM?$OAC5[&XEL[S4+
MY-&NI(3@RV\H)(/N,9![$Y["M_Q_=77A_P"&FK3:(AAEM;0)"(ACRDR%)7TV
MKDCTQ0!UF0>_2BO-]?L;32KGP7JGAJ*.*6YU&"U<PC'VJUD1F??C[^ N[)S@
MY-8[16\7@#XHQ,D2)#J-X8E( $9\F,KM';GICO0![!16?H)W>'=,.<YM(CG_
M ( *I>,[NSL?!FKW&H75U:VJVS"2:T.)5!X^3_:R0!]: -P$'H<TN1ZUYEI%
MF+'XI6UG]DM;&"Y\/,9+6V?@[94"ER  SX)&0.Y )K T738--^#UWXHLH9#K
M5G'?)!<B1B\49G<-@9QP 6^N30![9D'.#THK@M*T*P_MW0O$.GZO811RQ/$D
M>GVIC6_1DR!(=[;BN"V3R#G-=[0 4444 %%%% !1110 4444 %%%% !1110
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M% !C(.2<^@Z]D;JW6Y%L;B(3D9$1<;B/7'6G27$$.?-FC3:I<[F PHZGZ>]
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MFD'18)8MALA=&;>V<[V&2JD=!M)ZG)Z5U4MU;P9\Z>*/ W'>X&!G&>??BI:
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MGEM<F!?,*_W2V,X]J /+_#MC>W7@+1X-(OK6WO['6;MK&WO%+0SA'F'E-CD
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MS_9=#TZ'[-(98/+MD7RW/5EP.#P.?84 <3IY']E?%'G_ )>[G_TF2NO\#_\
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MSP*Z2+PUH<&D'28M(L5TXMN-J(%\LMG.2N,$Y .?:GG0=)-A<6+:=;-:W/\
MKXFC!$O^]GKT'7T% &@K*ZAE8,K#((.012TV.-(HUCC541 %55&  .@ IU !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 &1
MG&>:*\7UWQCJ6B_&/1=6NFV>&M023383GY>'PTA[#Y]I![IBO:* #IUI-Z_W
MA^=4M9TJ#7-'N=,NL_9[E=D@'4KGD?B.*\5\7Z)I-I\?/!^G6^F6<5E):KOM
MT@41O\TO5<8/0=?2@#W<$'H<TM<%XBU#3_A+X;O=5T_2EEL[F^$CVL4@B$;.
MBK\HVD8RF<<=33Y/B)<6FFZMJVH>&=0M=*LK:.XM[@LK&Z#D  */N]1U.0.H
M'2@#NJ*XG2/B ;[QG%X:O-.2WGN;%;ZVFAG,BNA&<,&12K8SV-84_P 8+E++
MQ'<P^&&E70+D07;?;E"GYRF5.S).1TQT[CH0#U.BN&U'XE6-K)X;B@BA$FO6
M_P!I@>]N/(CC4J& 9@K?,20 ,=>_3-N^\;26!T&TFTF2+4]9EDBCMY7(CA9.
MN]U4^V, YSGIS0!UU%<)HWQ0TZ_\+ZYK6H6KV7]BS/!=Q*_F@L#@;&P,[CP,
M@<U+IOCC4KW58]/F\.20O<Z8-1M)5G+Q,#_RSD;8 C=,XW=?ID [4D*"20 .
M230K*ZAE(92,@@Y!%>+^'O&&J>*/A7XIUC7=/2YT^0W!D$5X8V5 J#RD&TX
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M%#1MY9X.T'>N3SW&/7T2>^>RT66_O(1&\%NTTT2/O"[5R0#@9Z=<"@"U+-%
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M1+.SM;$P31M=H[JQ$@/3K@OGCMCG.0*>D^#?$=I'\2_.TL@^(A*;$">,_?\
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M;]I"6>UL'NY!HXS LBHY''0L0N>G4@=>?7V6L+_A#]&'BH^)A!-_:Q3RS/\
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M\NY5B@C&68^YP!]22 ![T 9MUX8L+K7K'6F>XCOK*(PQ/%)L!0]58 88'T/
M[8J@OP^T*/7)]3B%Y%]IE\^XM([IUMII.N]X@<,<\\\>U;ES-J*:I8Q6]I#)
M8R"3[5,TNUHL ;-JX^;)R#R,5=H Q8_#%I#K&HZK%<7:7>HQK'<,)!@JH(4
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MJRES*)-W48&W&WIS]:Z"@#!B\)6$;PAYKN:W@NC>16TTNY$FR6##C=P22!G
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M3P%HVJ:A;:@7O[6]@B$'VFSO)(I98_[KL#EA[DY]ZZ>B@##O_".D7XTL-%-
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MFU0.&/N, 4 5H[*;2O"OB2XU+4=7T^UN]2\K3@)I&E6W+H$C2-FPA9MRCA2
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MF,<9P2JER<9P,]S@9Z4:'X=TOPW:-:Z5;&"!FSL,KN%Y)P-Q.U<D\#@9/'-
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MH7=_902K=W803RR7$DC2;1@9W,<G'?KR: ,#XCP26-E8>)[<S$Z/<I-=0H[
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MT?EW8@N9(DN!C'SHK!6.#U(H XW1KN6^;P=X>DDMUM9/#45RD-P&*3R812,
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M_P C[-YW\7E[MVWZ9YH X_2-1B\7Z;)K^GSBR2'2O(AE+$+!.Z;G+#H?+^0
M]LO5;P?>O:^)X=(UK2)M*UM+%U!CE,EM?J&3=*K?WP1SD;L-R379PZ#IEOH]
MQI,-HJ6-QYOFPJ2 WFEB_/49+'Z=J;8^']/L+J.YB6:2>*(PQ/<3O*8XR02J
MER<9VC)ZG STH YKXOVT4_PPUN2126BA#(=Q&#N4=NOXTS4&CB\>>'_#!5H]
M*FL[BZ,1=B+B5< (V3\P +-MZ=/2NKUO0]/\1:9)INJ0O-9RX\R)97C#8.<$
MJ02,CI4-]X:TO4;:TAN8I6-F_F6TWVB031-TRLF=W3@\\]Z /-M=>]T^P^(V
MC075VNGZ?:17EDR3NK6[NC%HPP.=N1D+T .,5Z%X7T.VTRT^V1374MQ?0PO.
MT]P\@+!>H!.%SGH,#IQQ4LWA71[G2;O3)[>22VO6W769Y-\YP!\[AMQX &,X
MP .@K2L[2&PLX;2W#B&%0B!Y&<@#H-S$D_B: .%ETNSF^.3.\3;VT 3%A(P.
M\7& >#Z"LOPMIMJVE:]K>H:MJ,3Z5J>I)#<O=R.((QN7)4DA\#GYLG@?2O0+
MWPWI6H:Q;:M<VS-?6\9BCE65T^0G=M(4@,,C(!S@\U'8^%=&TZPO[&WM7-KJ
M#2/=12SR2K*S_?)WL>N><=: .%TKSK/QCX,2W6>"UU#3KE97DG/FWH6.-EEE
M4<!\G(.2?F.<=*P[NS8?#KQCJOV_43?:7K%W]BE-Y(3#LE4+_%\W'&6SQ7I-
MMX \-6DFGR16,ADT_<+5WNI7:,$8VY+$E<#A3P.PJ0^!_#YTF^TLVDYLK^9I
M[F(WDQ\UV.6)._/)Z^M ',^,9M0M-0N-3N=-?5]":Q2.=;.;;<Z<WS%I47(S
MD,.00?E'84FIS66N7-Q]AN)M3"Z%'*D4CF*&V5PS+-GEO-8 8P,@+U&:ZZ7P
MGI4TDCD78,L"V\NV\E'FQKG"M\W/4\]>3S4=QX+\/W6HI?2:>!,MN+4B.5T1
MXAT1D4A6 [ @T <7HFMSZH/A_I>JW+O;ZAI+W$I=S_I<R(F%8_Q8!9B#U.,]
M*;XX\/V>G>#Y;07L]XD>N6TL4<TA/V022I^Z7_9 )P#R U==-\/O#$^@6NBO
MIO\ H=H_F6^)I!)$WJLF[<.PZ] !VJY)X0T.7PZ^@O8[M/=@[(97WLP(8,7S
MN+9 .[.>* ,#5(18?%#PA;VTMPEO);7H:'SW*':B;3M)QD;CSUK$L7;Q+\-]
M>\07-Q-!K<,MY(DZ2E7LVA9MB+S\J@*N1WR<YS7>'PKI!U'3[\P3?:M/5DMI
M/M,OR!OO9&[#%NY.2>^:CE\'Z)+=7DYM9%%ZV^[A2=UAG;U>,':Q/?CGOF@#
MB+,W'B'QAX6?4YKR/^T?#C7%W;1W,D:,^8L_*#\O7G&,]#GFF:3%K$W@_4].
MTJ9;F33O$=Q!;VEY<$?:;>-MWD;SSTSU[#!XS7H<WAW3)]<AUEX9?M\,1ACD
M6XD4*AZKM#;<' [=JIQ>"M"@@DBA@N8Q)>&^9EO9MWGG.9 V_()R<XX/>@"E
MX#U.SU"VU1(+*\TZZAN\7>GW1R;9S&@VH>FP@;ACCD\"LK6M.35/BW;:=<7=
M\+&?1)9)K>*[D1'(F0=B-OOMQG'/&0>UT_2K33//-LC>9<2>9-+(Y=Y&P "S
M$Y.  !V '%<EJFD3W_Q7L;Y[6^6QATN2W^U0LR!9FD5@,@@D;0?44 <7=&^T
MOPMXATY;VZE@T?Q!;06-R\S&1(W>(M'OSD@!\<^M=O*"WQE^R"698)_#TDDD
M:2LH+>>BAN#PV.,CFM^;PMHUQH%QHDUD'L+@EID9V+.Q;<7+YW%MW.[.<U7M
M?!6AV=_'?Q6]P;V. VXN7NY6D*$Y.6+9)Z<GD8&,8H X3PAH,^I?#*'5H-6N
MX]<DANK:"YN;R38"T[J 1GN1][KEL]AA_P#:,<NC>+K*[T>ZT/7(-&:9K19=
MT)"+)MGA93C[QY(P>!UP:[RT\(Z)9>'Y-"M[65=-D))@-S*V,MN.&+;EYYX(
MYJQ!X>TZ%[B1HGN)+B'[/+)<RM*S1<_)EB?EY/'?/.: .(EN)M_PPG%Q+YEP
M%69A(?WJ_92WS<_-SSSWK+U^Y9=.N-9TRXGN7C\0QK_:<LNQAF=4:"-1G=$H
MRIS@'DX/6NWMOA[X:M!8^79S-]@D\RU,EW*YAXP I+'"@'[O3VHF^'?A>X2\
M233F,=W/]IDC%S*%$NX-O10V$8D<E<9Z=* ,,Z3#J_Q4U[3[VXOI+%M,MY3;
MB[D5-S.X.,-D#CH,#OCI7+PI_;'@+X<7.HO)<W']N);&620EB@:9<$YZX1>>
MO%>J0>%])MM4FU*"&:.[FA6W>1;J49C7[J@;L#'; XJJ/ WAY="@T5;*06%O
M.+F!!=2[HI 2=RONW*<D]#W- &Z;:(VGV7:?)V>7MW'[N,8SUZ5XQHUS_8'P
MDTF2R+VPO]:^Q75Q&[ Q0&[D#$'/R_*-N1C&?6O:88HX(4AB4+&BA54=@.@K
M#A\%>'H-/O\ 3UTU&L[YF:>"21W0ECN.T$G9\W.%QSS0!AWD4GA[XF>'+?2M
M\=CJT-S'>6H8F,>4@990.@;)P3WR,UW=9FGZ!8:;.+B)9Y;A8O)6:YG>9U3.
M=H+DD#@9QUP,YQ6G0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M#@DJ6;&ST Q@"L^VT]?&NF^(&O=5LK+4+/4YUDN6MR;FQ$<A\LK)Y@VKL Z
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
.444 %%%% !1110!__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>24
<FILENAME>insidertradingpolicy011.jpg
<TEXT>
begin 644 insidertradingpolicy011.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MH$N##&DUJ80"H:13T;S,@'J3[UWWAJUM;'PUI]K8R7,EI%"J0/<G,C1C[I/
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M[5M;UZ+XC6'AZRNK**UN[*2ZWRVK2.I1L8X=00<TWX1L#\,]+"G*H]PBX.<
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M6/#U_IC(0G]EHY829'!8L1P,Y&,].E9'A1-*T+5?&$DDEI:>&YM2BCM1*RI
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M/E>?;Q2^4P>/S$#;&'0C/0^]8V@^+])U[P^-:BNH8K7EG,D@'EKN(4MG[I(
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M':M;J%51"7$F\$@ YRHZ\C%='9:_I.I7;VEGJ-M/<*GF&-) 6*=-P'=?<<4
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M\GEWVR17(."(WX.?0E?QQ7;^%I[<_%+QU%%+&6/V%BJL.3Y3 G'Y9KMOL\.
M/)CP.@VCBE6*-6+*BACW YH XWQIJUAIOB3PREW]FM9I9+@PZG=,1':XCPP'
M(4NX; W' Y//0\=8ZA9K\,/B1 ;T/(+W4N9<*QWCY21@ %CT&!GG KV1XTD
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MVE7*-J$L42VPCD&XR?9=HQ[AACV(KTQ((4E>5(D61_ON% +?4]Z588D;<L:
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MMYHE*QM*,,^P,?K@\$XZ9S]#2V5G#I]C;V=LFR"WC6*-<YPJC 'Z4 >8Z0-
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MN#0!X?X9URVT?0OAOJM[,/[%@ANK:XG'*6UPV A?'3C<,GIN/K70>,YM#F\
MZKJ6B1Q_8Y=4M;FXO(O]7,_G1[W![@ #+#C.?0UZ>T$+0>0T2&'&WRRHVX],
M4OE1^5Y6Q?+QMV8XQZ8H X'6-1L+KXI>")K>[@D22VO]CJX(<%4VD'N#@X/?
MM6%IES;M\)_%&AZVR?VU%)>I<P2?ZV6:1F:)E7JVXLFTCK@8KULQ1E@QC0D=
M#M'%(UO TZSM#&9E&%D*C<![&@#S+1X_LWQ*\-6^K2POJ=OX5V3&1@6$P>//
M/K][\,UF:.MC?>&KBWBUU=*ND\679TZZCVLD<O[PJ&4G!5EWC'?(KV$Q1LVX
MQH6]2HS36MH&0HT$91NJE!@T <SX$U+4+^TU2/5;:T2^M;YH)KFSSY-TP1/W
MBYZ'& 1V*GZ#.EO#IGQD9]4D6*TO-(6*PFD.$WK(6DC!/&X\-[@#TKNHXTBC
M6.-%1%& JC  ^E-F@AN(_+GB25,YVNH8?D: /$=;@AMO!OB>:1XETB\\30RV
M0<C8Z^;'YC)_LDANG'!->V6\-M$A:VCB1)#O)B4 .2.O'7@#FGM%&RA6C4@=
M 1TIP 4    = * /'/&NKZ?/:_$&QBDAT^Z2 ":'[UQ?,(1A\-G$87CY1V))
M%:6G>(+.S^(>GWFIWL46G7F@1QZ==RN%A+A\RJ&/&XX4^X ]J]/,,3.SM&A9
MEVDE1DCT^E));PS(J2PQNBD%5900".F* /#DOHUT._N[1TETZR\<M=Z@D7.+
M7>"'('\(;:WX>U=Q>I'J?Q4T>_TJ:*>*+2[A=0EA8,IC8KY*L1QRVY@/0$UW
M:QHJE510"22 .I/6H&MQ;V<D=C! C$':GW%)/K@'^5 'B=I9Z?JO[/VE65@M
MN^LR31+:"+'FBY\_KQR"%R2>RC/2NXT6\M[3XO>*;6XG1+BZMK$P1L<-*%23
M<5'<#OZ5L>"/#<GACPQ8Z9=BUENK2,Q?:(0<NNXD=0".O3GI71[%W[]HWXQN
MQSCTH Y/XA:E9Z7I.FS7MO"ZMJENL<]P6$5K)N)69\$9"XZ9 )(R16/X&O[:
M7XC>,HTU%;QYQ92QR8 \U1"064* "H.!GZ<G//HDD:2H4D170]589!H"(K%@
MJAB "0.3CI0!RGQ%T^>X\+'4;)-VH:/,FI6P_O&,Y9?^!)N&/>N4>;58O%4.
MKV<4R6_C.W^S*H7#6K(/W4K>_D[V(/<8[5ZP0""",@]J38OR_*/E^[QT[<4
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MI-!,@>.1#E74C((/<$5YD^F6]@NCIX1UK^R+^SL)#:6^J?-%=VK2$X;<=PY
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MH+9T<^7&^R,@_P#+LNXX'N#GZ4 >CQ^+]!-K:RSZO80M<1&14:X7.%4LW?H
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M@<8(_ISTK6H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M&J+/I=M80S(A55$#EG#!C@'HH^]71VGB+1KZ1X[;4K:1TB\\@.,^5_?'JO\
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MV]S;V%M!XDC=M,0Y-F"\N3,S98,22?X1\Q !QFO<ZC$$0SB).6WGY1RWK]:
M/,;2;39/$7Q0D9[8Y@A!+$9V_9<$'/;/!]ZS/#^LPZ;>_#R]U2Y1-';0#;0W
M#L/*BNR$R&;HI*+M&?<>M>Q>3%S^Z3GK\HYI'MX)(C$\,;1GDHR@C\J .#\
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MR3CJ,<XR*XJZOK2/X ^&2]S"O[RP'+CJLR%A^ !SZ5['';PQ1>5'#&D?]Q5
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M_:X!V_[72O)[ W$_P4T:2Q1[@Z;JRWE]:1C,C0)=.Y!7KTVMCT%=;?3VFO\
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MQ7F]K=VZ^ OA@CS('@U2V,JEN8PJ2!BWH 2 <^HK?L;JR7QK\1I))H0KV]J
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M3@*JC))/H!0!8J*Y262UE2"40S,A$<I7=L;'!QWP><5EOXKT6*W-Q+>&.(7
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MNHV,>H7,EA%I,<WV:>(Q>3*92#\I56^Z%/.>O7%=##XIT6XOH[..]'GS1M)
M&C=1.J\DQL1B0 <_*3Q0!L45S7A[QKINOV>H7BF2VM[2>6,O<1-&-J'!8E@
M.<\=1W%7(O%>B2/=HU^L,EG&)ITN4:%DC/1]K@$K[CB@#9HKES\1?" B>0Z[
M:A$MUN6)W#]VQP"..>HX'//2K7_":>'!?361U6!;B*,RLK C*YQE21AN3C"Y
M.>* &:YH>J7FKVFJZ1K"6=Q;PO"8;BV\^%U8J2=H92&^4<@].*N:9I=S!<M?
M:G=Q7=^T?E;X8/)C1,YPJEF/)QG+'H.E4+KQ+H>J>$]0OX->%I9J'@DO4^1[
M=P.>&&0PR#@C-3GQ/H>F1V%I=ZS&9I[<21&4_/*@4'>0!P3]!DG ]* -VBN:
MO/$NAZIX1O[^#7A9V0#P/>Q_(]NXX/##(8>A&:L/XHT/3!96EWK$7GS6XEC\
MT_/*@4'<0!U/T&2<"@#=HK)LO$VBZAH\VKVVHPM80%EFF?*"(K]X,&P5(]#2
M0^*=%FU)-.^W+%?. R6TZ-%(X/0A7 )'7D4 :]%<]K_BZST#6=(TR:.=Y=1E
M904A=PBJC,3\H.3D 8'/.>@KGK+Q;%HWC'Q?'KFLR&PM3:-;+*F3&KQ%WPJ+
MG )Y..!C)H ]"HJA-K6GPV=O=FY$D-R T'DJTK3 C=E%4$MQSP.E.TO5K#6K
M(7FG7*7$!8H67(*L#@J0>01W!YH NT5CR>*M%BO!:O?*'-P+3?Y;>7YQ_P"6
M?F8VA_\ 9SG/%1W?C'P_8W-Y;3ZI$)[,*T\2!G9,YQPH))X/ Y&* -RH+RU%
M[:R6S221I(-KF,X)4]1GMGU'/H16,OC?PT\EBB:O;M]N*BW9<E6+?=!8#"D]
M@2#5[4-?TW2Y'CNKA@Z1^;(L<3RF-.?G8(#M7@\G X/I0!+J%BUQHMQ86C1P
M&2 PH63*H",= 1T';-5?"^CS>'_#.GZ1-<)<-90K )4C*;E48!P2>?QJ1O$.
MDK)IZ?;HS_:/_'FZY9)N,X5@,'@9ZU')XHT2'^TO.U"*'^S IO/-!3R=P)7.
M1W )&.M &O16'9^,/#^H:C!I]KJ<4EU<1>;"@##S% R<$C!(!R1G([BH?#GB
M^S\27NJV]M'.GV&[:V!D@==^U$)/(P/F8C!YP,XYH Z*BHY[B&UMY)[B5(H8
MU+.[G 4>I-<_#\0/"EQ>6=K%K=LTU[@6XYPY/09Q@$]@3DY&.M '245S]WXX
M\,V-Y/:7&L6Z3P2QQ2H,L4=R0H.![?AWQFET;4M-DDUNZAU\WT$-R3/YKKY=
MGA!E%; &T#GJ>M &_1678^(M*U&_:QM[H_:UB$_DRQ/&S1DXWJ& W+GN,BF0
M>*-&N=1@L([T?:+@,UN&C95G"]?+<@*^.ORDT :]%4]0U6RTL0_:YMC3OY<4
M:HSO(V"<*J@EC@$\#H*H/XO\/Q:1_:LFJ0I9B4P%WRI$@."A4C<&!XQC- &W
M163IWB;1M6U*?3K'4(IKN!/,>-01\F<;E)&&7/&1D5RGQ \61V^B1G2-6GAN
M!J$$&^&(^7*?-57C\PJ5) W9"MG@^AH ]!HJ.>>&UMY+BXE2*&)2\DCL%55'
M)))Z"N&N_$C77Q-\,V5AJ-U]DN;>ZDGM9(3$K;44QN-RAF!RW.2..* .]HK'
MB\5:+/>0VL=\I>>5X87\MA'*ZYW*DF-K$8/ )Z'TJII/C"QU?Q#JVE1),AT]
MEC9Y(74,Q4LW)&  ,8SC/49&* .CHK)M?$VCWNHQ6$-X/M,T9DA5XW03(.K1
MLP <=\J3QS5R^U&TTV-'NIMGF/LC4*6:1NNU5 )8X!. #P#0!:HK)C\2:7/I
MMU?6]P9H[5BDR+$_F1N/X63&Y3R."/?I7,^"+N]\46.D^(SK%Y'*T;/?61B/
MD2A\[%7< %V\?,N<XYSG- '>45P]UXSBUC3?%=MIDMW:7.EQRK'/]G()=8MY
M/SJ0!DXYY/4=0:L>$/&&F7NC^']/NM4676+K3H9&5\DROY2L_P V,%NI(SGV
MH ["BLB^\4:-IDYBO+T18D6)Y#&QCC=L85Y -JDY'#$=1ZT>)_$%OX6\.WFL
M74<DD=O&6"1H6+-V''09[G@4 :]%<^WC70;>*S^VZC';374;2)%*C(Q"KN8[
M2,XP#]>V:7_A-O#ILDO$U$26[6XNB\43OLB)(WOM4[%X/+8Z'T- &_16/=^*
MM!L9[6&YU6VCDNXS+ N_/F(%W;ACMCIZ]J6R\4:+J&E2ZG:WZ26D4ODR-M8,
MLF0-A4C=NR0 ,9.1CK0!KT5E#Q)I(M;RYDN_)BLRHN//C>(QEL;00P!R<C Q
MSD>M26&N:=J<UU#;7!\ZTV^?%+&T3QAAD%E< @$ X.,'% &C16/!XJT6YNX[
M6*]S++$TT(,3@3HO):,D8D '/RYK!A\;:3X@\(ZI>OJ%QHULC30B[:-HWC"L
M5# LN-W&=O4>F: .VHK-;5K&PLK/SKMY3.@\G$;22SX7)8(HR>.3@<9[57E\
M7>'X=%.L2ZK;I8*YC:5B1AP<%"O4-G^'&: -JBLFP\3Z+JFJS:99:A%->0IY
MCQ*",IG&Y21AAGC(S4.NWEE%J.CV]QK<FGSR7:F*"(C-V<$>6PP3MYSVZ=:
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MZ\SR+>,R/Y<9=L#T Y->2:1/H,FE7?@_Q5::G-K27<N;#S;D)>DRM(DB;3L
M)()/ &"3ZUZIKT4DWAK4X8D9Y'LY555Y))0@ 4 <\?%.FZUX6T74)]6GT9KV
M6V= BE6D=MK>4-R_,IR 2./>MB\\7Z!8W=U:3ZG$+FU0/-"@9W4'..%!)/!X
M'/%><7>I6EQ\(O!L:2'?;W6FQRAD*[6C*>9U'\.#D]!72V5U:#XR:O,9X0O]
MC0*)"PQD.[,,^P()]J -P>.?#+"Q*ZQ;LM\5%NZ[BK%CA06 PI)XPV*O:IXA
MTO1M_P!NN&3RT\V39$\GEIS\S[0=J\'DX'!]*\A$MNO[/[0*R"?^TL^6/O\
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M\DJI"CD@<;CCIDXKEKYO[-\:?#JUO[I&N;2SN8[J0MP',"*"Q[;B#C/6NO\
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M6]Z_EV[[_OMT(QU&,'.<8QSBJ4?B30M<U;0Y+#Q(RM+).(;2+@7956#!U*Y
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MZ5+;Q7NJV\4EQ&TL*[MQ= NXL,9XQT]>U58O'OA>= T.L02YMQ<A8U9F,9.
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MS\AXH VJ*YG2O&]CK$6G7%O8:DMIJ#;;>Y> ",G!(R0Q*YP1R.M=-0 4444
M%%%% !113))8X4WR.J+D+EC@9)P!^)(% #Z*I2:@\>LP:>+&Z=)86E-TJCRD
M*D#:QSG<<\<=JNT %%%% !1110 4444 %%%8^B^(K?7+W5;6&WN(9--N!;S"
M=0,L5#9&">,$4 ;%%%% !1110 4444 %%%% !1137=8XVD=@J*"69C@ #N:
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MWL6<[&5@0<'D<?TI]]X,LKNWTPQ7-U!?:9*TUM?!PTH=OO[MP(8/D[ACZ8H
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M3:66)EC5 %!SSCJ<YJ[X:T*._P!#\.75[J$M[%801RV\+*H"2B/;E\#+,N6
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M?#>GKXK/B-4(OC:"T./N[ V[./7MGTXH PX;O49/B;J6B/J=P;'^QH[B)0J
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M_$NG2WMM!/ D=Q);LDX 8,C;3T)'4>M $6E>&DTK7M6U=;^YFFU1HVGCD";
M478NW"@C@>IJ"]\'VMU+J8BN[FVM=5P;^WAVA9CMVD@D94LH"L1U ['FNCHH
M P-1\*P76H:7J%E=2Z?=:9&\-N855D\M@ 4*L#Q\HQC!&*1O"J)IE[!::G?6
MM]>3BXGU&(KYSR#&,Y7;MPH7;C&.*Z"B@#,T[1_L<YN[J\GO[XQ^5]HG"*53
M.2JJ@ 4$X)XR<#).!C3HHH P].\-)IWB75-;6_N99M2$2SQ.$V 1@A-N%!'!
M/?FF:/INH6GB36;N74;VXL+DH88;E@5B<9W",#D)C;UZG/U._10!S?B?1I;J
M_P!&URSC,E[H]PT@C'66&12DJCWP01ZE0.]37>@0:MXATGQ"+ZY1[!)!!$JJ
M$82 !MP9=V< =QC%;U% '/:?H<'AN]UG5OM=Y<MJ,HFEB**WSA0H"!5!Z #!
MS2^$-#ET73;J2Z"B_P!1O);^Z"G(5Y#D(#W"J%7WQGO6G:Z@]SJ-]:-8W4*V
MI0+/*H$<^Y<Y0YR<=#D#FKM ',:]X+AU?7+?6[/5+[2=4AB,#7-F5_>Q9SL=
M6!!P>1Q_2GWW@RRNX-,,5S=07VF2M-;7P<-*';[^[<"&#Y.X8Y[8KH8Y8Y0Q
MC=7"L5)4YP0<$?4&GT <Y/X0M[JPUF*XO;AKK6(?(N[L! _E[2H11C"@!F[$
MY).34<O@N*6/P^IU2\']AD-;D+'\Y"%!O^7GY3CC%7/$7BBT\,BS:]MKJ1+R
MX2UA:!%;,KYVJ<L",XZ]/>ME&+(K%&0D9*MC(]CCB@#@_%OAZ'3-#\:ZPM]<
M2W&KZ<T30.$VEEB98U0!<YY(ZG-7O#>@QW^B>'+J]U"6]BL((Y;>%E4!)1'M
MRV!EF4%@,XQW!/-=A5+5K]]+TR6\CL;J^:/;BWM5#2/E@. 2!QG)YZ T 9-M
MX22UOM>NX]3NS)K.TSY6/$9"; 4^7^[QSFJ$_P .=/F\,:5HZZA?Q2Z0P:PO
MXW59X2!CJ  1C@C'-=BQVJ3@G S@=363X=\0V_B2SN;FV@G@6WNI;5TG #;X
MSANA(Z^] %.+PH\5C&AUS49+]9UG:_D*&1BH("XV[0F&(V@=SW)-7M)T*'2[
MS4+[S&FO=0D1[F4J%#;5"J !T  ]SR>:U:* ,GQ'X>LO$^CMIE^'\EI(Y,H<
M,I1@PP>W3'T)II\-:=_PE,'B 1;;R&T-FH'"[-V0<>H^8#V8U1U?QM9:-'J,
M]SI^IM::>=MQ<QP Q@X!X)8$XW#H.M6]-\2Q:C?0VG]G:C;-/ 9XI+B(!'4;
M<X8,>?F!Q0 ?\(W'_P )C_PDOVVY^T?8_L7D83R_+W;_ .[NSN[YK%D^&]F_
MAF^\/#5]273KJ<RB,&/]R#)YA53LZ;N<G)[9ZUVM% &#)X96;Q/8Z_)J-TUS
M:6[6ZQ[4".K8+9^7.20.A%6?$>@VWB;0+K1[N26.&X"Y>(@,I5@RD9!'! IF
MM^(K?0KS2K>XMKB0ZE=K:121A=B.P)&[)!Z*>@/2K=OJ#SZK>V1L;J)+98RM
MS(H$4VX$D(<Y.W&#D#K0!DGPD'UW2]8FU>^FNM.BDB0N(\2"3&\MA!UP.F ,
M<53?X=Z9<:3K6FWEW>7$.K79O9&8HK0S''S1E5&,;5QG/3W-=?10!@^'_#<F
MBDRW>LZAJUSL\M)KUU)C3@X 4 <X&2<DX'-.\0>&X_$$^F2R7US;'3KI;N(0
MA,-(H(&[<IXPQXXZUN5C7/B6UCU672[.WN=1OH5#SPV@7]R#TWL[*JD]AG)'
M.* *7B/P9!KVHV>JP:E>Z7JMHACCO+-@&:,\E&!!#+GG![U%J?@.SU'3K",:
MC?PZC8SFX@U-9 ;CS",,6)&"", KC&  , 8K6TW7[;4M2NM.$%U;WEK'')-#
M<1[=H<L%P02K?</*DCWSFM6@#S?P_8PM\0_%FG7=W->I<Z?:P/-.1NF($@D
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M-=Q110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M6ZMHTB\NV80P1[L!]^-HV;=P&>H ZFNOM;6&RLX;2W01P01K'&@Z*H& /R%
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M #N2"/F<\D]2374S^$(+NUUA;F]N'N]7@^S7-TJJ&6+:5"(,$*/F8]SEB<T
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M8^$T@;31?:E=:C'I9W6:W 0;6VE0[%0-[!20"?4G&>: .,>]\0W/AWQS>?\
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MZD8R1&P#JY(?!3DG'/;D\"NUTSPP-+US5]5CU*ZDFU1D:9)%CVJ438NW"@C
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M/:HX/0CIW KK:YKP[X1;0G1KC7-4U40KLMEO9%80KTXP!EL<;CDXR!C)STM
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MOB/7;OPZEU!J<]OXF.LFTDTV,(2D?FE=@C93TCP^\CWSCB@#UFJ5[?O:7EC
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M\GO;5I92 "Q^U@=!QVKJ+_4M4UKQ+KNC6$ES"--BA56MIDC822(7#MN!R!P
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M'$KA7^3!7M@ =23GC%WQ3Y^JW_P^O6O+B!KJ[1BD6W:C&W=BRY4\\XYR,=J
M.YT75VUBWG>33[RPE@G:"2&[0*=PQRI!(93D88'%:5<78WMWXB\3>(=)74KJ
MT@T<06\;0E1(\CIN,K$CGL .G!R#GCF5\5^(M1T#PY)_:)M;YO$']CWKQ0H4
MG"EP7 (R#\HX! SGC% 'K5%>>746O:7XP\-:%_PE%]<07T-ZTTDD,._Y-I4@
MA.H#XYR.!Q6:EQXAET'QG&?$U\K^'[B?[),L<7F2!8A(HE)7# 9QP%[YSQ@
M]5IDDL<*AI75%+*H+'')( 'U)('XUQ/]K7VJ+X>DDU"1%OM*%R]C8#%Q),P0
M[\GA8UR>20,D YZ5RL^I:EXA\!^ M1OM1N%NI]=A@F:+:@DQ+(H8@#!(V ^F
M>U 'JS7[KK4>G_8;HQO 9C=A1Y*D,!L)SG<<YQCH*NUQDFHZA8_$^#39-0GF
MT[^PY+EH'5/]8DB+NR%!)(S^).,5A-K^M7GPM/CJUU*1+U4>\%IA3;^4KD&$
MKC/W1][.[=WQQ0!ZA17GJ7NK:WX^;38M:O;+3KG0HK]8XHXO,B9Y",*Q4XX
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MY9$51'&2"0JJ  6(!)]AT'%;%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %<+\6X!-X(+&29"E[
M:X\N5D!S.@.<'G@]^_/45W59GB#0K/Q)HL^EWQE$$I5MT3[75E8,K*>Q! -
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M%DGDA@<* PD094XR#SUY(YP16C?_  [T?4'UD27.HQV^K_-=6T5SMB,F /,
MQ][@=21QTJ[!X1M+?6K/54OK\W-I:FTC+R*X,9()SE2220#G/;C XH XG3_$
MNIVF@0:9-J,\C2>*I=$%]*V91"KL1EC_ !D+MS[YZBMOQ'+J'@G1]?U:#6))
MK9XHC:6MTQD:V<LL;R!W+,5^=6P<@8]ZOO\ #W1IM$U'2;E[NXM[Z[:^=GD
M>.=CN,B,H&TYY]/P)JW9>#M.M]*N["]GO=66\B\F>749S*[Q\X7/&!R3P!SS
MUH HV&E^(;/Q39W8OHETF6%X[JVFU"6Y:23&4>/>@VG@Y (&.W%=<ZED90Q4
MD8##&1[\US?ASP59>&Y$:'4-4O5B4I;QWUT94MUZ81< #CC/)QQG!-=&[A$9
MVSA1DX&: /'$'B&[^'.K^(T\5:HFH:3<WDD"[U\MUAD;Y9%Q\^0N.P'&!USL
M;]5\2^-H+%M<U/3K2]\-QWS16LBH8I6D ^4XX_')[9P32^!?#@U/PSJ%GJ3Z
MG#;3:E<236$T7E)*C2EE^\@?:PQD!@#WZG/9CPW;#Q4/$*W-T+L6OV01@KY?
ME;MVW&W/WN<YS^% '-:+)=>+CXF5]3OK673K^33K,PS&,Q>6B_O6"X#EF)/S
M C   ZUF^%_%]_XN;PM8ZA(]J;W3;B[N3 YB:XDCD$0567!4'YG.TCMVSGL)
M?"-I_:U[J-G>7MA+?J%O$M74+.0,!B&4[6QQN7!J'5O >C:I8Z9;QBXTY]*&
M+&XL)?*E@&,$*W/! &<YS0!C:C/JWAV+2]$;6#?/J6KO DTTAB>& HTBPF0;
MFW':%WXR0>QP:HZW?>)? ^C:_?S7T#6LQA73HI+I[F2U=W6-V+.H+("P8 DX
M(QWKJ;[P/H^I>'#HMY]JGC,HG^U/.3<><.DOF==PZ>@'&,<4D'@?2QH=[I6H
M37VJQWJ".>;4+@RRLHY4!N-H!Y& .>>M '/:SI*V'Q-\#;;R]F#B^5Q<7#29
M(@^\,GY2<\[<#IP*S+G6-43X7^-+Q=2O!=:;JEY%:S^<V^-(Y JKGN /7-==
M;> K*&]TF[GU;6+R;2M_V5KBY'RAEVD':HSQQD\G/)-17GPXTB]CUB![S4DL
M]5D::XM([@"(2MC<ZC&<G&<$D9YQG& #,U2/4M4^(MKHZ:]J5G976A23NMM(
MJ%7$B*&4XX//4Y[CC-1+_;OB7_A(;+3[]X[G3+C[#:3MJ#PO&RQ(1)(B(1)N
M8DG=P1P .IZJ+PI:0Z_::RMY?&YM;7[(BM(K*8B02#E<G) .<YJGJ7@#3-0\
M02:U%>ZIIUW.JI=?V?=F%;D+P-X'MQD8- '/:_J^L:.UM<Z^M[/I1TV-)[_1
M)FQ:7/S>9*R+@LA^4@D$#:>.37H&E31W&D64T5R+J.2!&6X'24%1AOQZUFW'
MA>WEFD:WOKVSBEM4M'@@9/+,:[L !E.#AB,C!_*M6QLK?3;"WL;2(16UO&L4
M2#^%5& /R% ',:KJDUY\1=/\,&::"T;3I;Z4PR&-IF#A%3<I! &68X(SQVSG
MD-=UK6].T/X@:3'JMX&T-8)[*\# R[)5W>6S$9.W!Y^]@CFO1M8\-V>L7EC?
MM+/:ZA8LQM[NV8!T###+\P*LI'4$&JEYX+TZ_P!$U'3)YKHKJ;[[VX#+YLYP
M!R=N ,*  H& .* +FA:5-IZSSSZK?7SW>R0K<N"D1"\B, #:#UQS7/\ Q7#'
MP.0K;6-_9X;&<'STYKL;6 VUK% 99)?+4+ODQN;'K@ ?I5/7=#LO$6DR:;?B
M3R797S&Y5E96#*P([@@&@#DE35/#7Q)T:Q76;_4=/UJ&Y\Z&]<.89(E#!T(
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M=W/FK:J1C$:D8''&2"<<=": .#^'6IB_M[#PW+/<Z>J37=Y&Z.4-]BYE#(C
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MV2U:1Y&*DAD4MA=O3('S<YXQT7A*VUFRT,6>O7T%[?02,GG1.6)3J@<E5^8
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M_P!JWUW;ZG8W3W$$[[D#Q!&5D7&%^\1@?SYIGAW^T/%/A31_$\>O36=W+/\
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MCK70"\NCK;61T^06@MQ*+W>NPONQY>W[V<<YZ5=H PF\+6[ZWIVK/?7K75A
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MP^W7Y@UJ5Y;S+IEF<!6P=G&0 /PXKIZCGGBM;>6XGD6.&)"\CL<!5 R2?PH
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M:D/]-AMG4).<8W'*DJQ'!*%2?KS0 [P/K=QXD\$:3J]X@2YNK<-*%& 6!()
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MTA>21CR69CR23WK+N?"-I>+=0W%Y>RV-U<"YFLF=#$S!@V/N[@N0#@,!^9R
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MD4,@BU&,SY0O+''Y8W.BY 8J.<'T_"O7;"Q73M-M[&.65T@C$2/)@M@# S@
M=/:LS1O"MKHFIZE?V]W=RRZE)YMRLS(59\8! "C''''% ')7-E8>&?@7.WAC
M4;@P6]BUU;7D<I5W8Y;<<8[D\'IT[5IWU]>0^-_!$4=W.(K^WNOM,7F'9*4A
M5E)7ID$DYK1L_ NDV.EZEI,+W7]E:@)!)8M(#%'YGWO+XR@Y/ .*CM? .GV]
M[I%Y+J.JW5SI0=;>2>ZR=K*%VG '&!CC&<\YH Y)=;G\/:=\0M1MF5)EUR.)
M9&Z1^8L*;SP>@;/0].AKJM.TK7[#Q5#=&]B32)H&CFM)M0EN6:4<J\9=!M.
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MW.CWWV19K.#?+<QLB.C%0?O 2#=].];MWX7@F?3S9:AJ.EI8Q^3%#8S!(RG
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MR1N=6(P?E;@9)QG&*T9/$FFK9:=<PR/<_P!I*&LHX5R\X*[L@'& %Y). .]
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M7KU% '$::98/BEXCO)+.]6UDL;9(YOLDFQV3?N"G;@D;ATZ]JY#3+2_A\!^
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M/XC^$AU]%O-.D%Y$599&C4QFZ"8)!PWR<'/&:[[3?%6G:IK<^D1I=PWD4(N
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M69]8U9KR2/S+C??RLDP(92"I; ZY!&,$"NRUU]F@W^(Y9&-O(JI%&TC,2I
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MLH;=Y?-:) F_;MW8XSBIZ\YT/44T#6?B!>/#>75O:7D4C1Q'S) OD*S$;FY
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M<D$'H AY. >,9S777T5Q-\4=%U&.SNVLHM.GADG\A@J.[(5!XST4_3O7:44
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MDG<4^V"7.>GW.>OM6IXHCUS5[GQ3I\NCZA<VL^G;=(,.$A):([C)D@EPYX#
MXP, ')/IE% 'FJVFKPWOP_U+^Q+YEL;*:UN85">9$[11JI8;L $H><\=\=*]
M*HJ"]M1?6%Q:-+-")XVC,D#[)$R,95NQ'8T <-I.@75E\0M1T^-D.@I(NLI&
M#S'<R!T*8_NY5I,=CBIM'BOO"OBKQ*+JQO+JQU2Y%]:7%M$9<N5"M$P'W2-H
MP3A<=Q73Z%H5OH%B;>&>ZN7=MTMS>3&6:5L  LQZX  ].*TZ /)X?"^J>%]
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M8JL+2%6W^<=PR02N <C'09H Z9_%%@;72IK59;N358Q+9PP@!Y$VARWS$!0
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MD=P#V:N7AU+1QXYU6.*RO?[7@L(VF?:Q62+<VT(N<$YW<@?C731L7C5F1D)
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M3/E<\D*PQG&><9KJ;&6^O/BC_;?]B:E!IS:&+?S9X@I#B8O@KG=T[8S[8(-
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MUC+%NN(C$\LDA7Y=K8.% ))QC)&,\X[&@ HHHH **** "BBB@ HHHH ****
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MT]Q6%XKURU\1?##Q5-;I=6\UA'<031.VQXIHUS@E&((Y!X)!S0!WU%4=%_Y
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M6D:O<_"EO ESIDZ:HB"R$WEDVYC#C$PD^[C;SM^]D8Q6_P"+]!U19]!U;P\
MVIZ?)]D8OT:WE 1BWKM.U_\ @)KMJ* .-\21:EI4?AVRTNSO;C1XY#%?"R/^
MD!!'B/!R" 6^\00??FN7BTC58?!?C_2QH-Y!)J%U<26<8"MY@DC15 VD\\')
MZ#U->M44 <M;Z_+IG_".:;+I%^4O(5B>YV82WD"@!7!YR2#_ #Y%=--%'/#)
M#*BO'(I5T89# \$&F/:PR7,5PZ;I(L^6220I/!('0'!(SUP2*J:WI*ZWI;V+
M7M]9!V5O/L9S%*N#GAA].: .3\ :+?6%U>VUY*)K/19)-.TM\Y)B8AR2?4#R
MX_;RV%96EZ5JVF?#?5O T^F7,U]LN;6SN!&3#.DQ8K(9.BXWG(.#\O ->D:=
MI]OI=A%9VH811YY=BS,2269F/)8DDDGJ2:M4 >=KI=]X6\9Z%<QZ?>ZE91:"
M-),EJ@9ED1U8%LD8! /)XS6G\.+/4+'1=0@U'3YK.5M3NIE$A!#J\A8%<'./
MJ!78T4 >>^)8];O]<UW3I])OKNPETX+IAMF586D*MO,QW#)#$8!R,#(&:S].
ML]423X:M-H]_$-*MGBO-T6?*S;B,$X)ZMGCJ!R0*]2HH \WUNSNM%\?7NJW'
MA:3Q!I6J00KFW@CFEM98P5QM<CY6!!SGJ*[G186@TF%6L(; G<WV6$ +$"20
MIV\;L$9QQG.*OT4 >97=KJUA>^/K%-%OKG^V(VFM)X5!B8&W"$%L\,".F,GM
M2_8=36S^'"R:3>H^F%#>+Y8;R0+<QY.TG^(]!SCL*],HH XK1(;[2O'GBR6X
MTVZ-I?207$-TBAD*K"%(X.2VX8P![URMGI&K0_"_PIICZ3>B^LM7AGN(!"28
MXTG9RWH?E(Z'^1KU^B@#BUBN1\6I=4-E=_8#HBVPG\AMIE$S.5Z9^Z?3VZUS
M6F1^(M*\+V=O'I6HK"VN7$E_' FVX^SN[LI0Y'!RN2IW 9Z5ZS10!Y+_ ,(_
MJ\VB?$/3H-"NK8ZCF6S$C)B3,*@+G<<L2#GJ,]35O6+?4OMOA[Q+_P (M<:C
M:06;V5YILL:-/&K;&$B(203N4C&<X^O'I]% 'FWBFQNM3^&VHPZ;X9DL9;RX
M@>"QB@592JR(Q:0(=JG"MQGH!W.!J^/[2YDTG3_$.DJ!JVE7*2VJ2@IYHD(C
M>$YY&\,!CU KM*Q)?#%K/XC&M3WFH2LH799O<L;9'7HXCZ;N>OKSUYH NZ-I
MW]E:1;69?S)$7,LG_/21CN=_JS%C^-<V+>Z'Q@.H?8KG["=%%I]I\H[/-\XO
MMS_N]^G;-=E10!Y=!976@>)-:LK_ ,%/KD&H7TEY97T,,3@"3DQRER-@4YYY
MX[5-XGT![NXEN+2RU#3/$%E9HEA?Z3&PBG(7/DL!\NP-Q\^!@CG@UZ710!YO
M%>W%C\7+9]2@EDN&\+Q"X-K$T@63SSGY5!.,YZ#TK.F\(ZS;VZ^(+:R=KE?$
MKZRVG @.8&&PCKCS-OS8SW(ZUWX\-P#Q<?$GVV[-V;7['Y64\KRMV_&-N?O'
M.<YK:H XF2SEU7QQ!XE6TNX;.PTR6!?,@9))I)&!VA"-V% ZD<EAC.#7,VVD
MZK#\,/!NFOI5[]ML-3M9KF$0DF-(Y2S-Z'@CIU_.O7** /,=>T:[GUJ[UCP_
M:ZGI?B,7*(KQHWV74(@5&90?EP%SUPWR\9XK:M[2[/Q4U6]-G<+:3:5%;1W!
MC(1I%=V(S]&'/2NTHH \GLM"U+4?A-9>!I],N[:__=P74DT>(H464.SA_NOP
M. I)R1G R1MWFDW>H?$/6_\ 1[F*SO=!%@EV8SL$NYR>?8,#GI7>T4 >:>#X
MKN.#3M&U#P(MMJE@8TFU)[>(VY5,#S$<'<7('  X)Y.!7?ZNQ71[PK')*QA<
M*D:EF8D8  %7** /*8M"UK_A7G@UX-/N/[1\/7,$]Q8.NQY54%7"D\%L'(Y_
M6NB:TDU7QW9>)5M;N&RTW3Y8OWL#))-)(1\H0C=A0#SC&2,9YKM** .0^&%G
M=Z;\/-)TZ_M)K6[M8VCEBE7!!W$\=B,$=*J^*8M6T?QMI7BFPTRXU2S2TEL+
MRVM0#,BLRNKHI(W<J :[FB@#@/$MKKFL6VA^(+?2YDDTS4ENAIKLOG/;E=K9
MP2OF<DA<]..O%67LI=4\;IXF6UNHK.RTN2V420,DD\CL#@(1NPH'<<EN.AKM
MJ* /(X=)U6+X4^$]+;2KW[=9:A:R7$ A),:QR[F/H1CTZ_G71W,%TWQ/NM2%
MG<BQ;0#:BX,1">;YI?;S_LGKT[=:[FH;N W5I+ )I(?,4KYD>-RY],@C]* /
M)-&LYO%7P3T/PW;V5RLUPMN))GB(CBC24.T@?[I^5<  YR>0.<==:07,/Q5U
M;49+.Z%E)ID,"3^2Q5G1G9@,>S#Z]JW_  [H4'AK0[;2+6>XFMK9=D1G*E@O
MIE0,_E6I0!Y1I<7B/2/ -C;0:7J"N-9D:_BBCQ<"U>61\QY[G*Y(.0"<8/(8
MVDZG'!\1((?#]_%'JUH@LL[7,C&WV8)#$EBQR3SCG)]?6J* /.Y[2]?4/A[*
MNGWA33E?[8?(;]SFW,8S_P "],^O2H_"DWB'PO!<>%9/#]Y<O'=3-8ZBFTVS
MQ2.7#2,6!4@L<@ DXXKTBB@#S&:SNM \9:T;WP?+K]AJLZW-K=6T$4KQ/L5&
MCDWD;5^4$'..?KCT33H6@TVWB>""W=4&88!B.,_W5]AT_P *M44 <!?>$;J[
M\::I:-%GPWK4"7-\,X_?Q@IL'IN'EL3W\LCO5[P#I>JZ7H;-KV6O+=?L4;*"
M2UO 65&QU););W!6NQHH \CCT/6&^$;V(TJ[^WP:M]K-J4P[Q_:_-^7/!.WG
M&?:ND<7EQ\3]+U9M,O8K1-)F@D=HL['>1653C/.%[9 Z=:[BB@#COA]:W=G;
M:\MW:7%LT^LW5U$)HRN^*1LJP^OIU'>J?BBTN;KXF>$[Q=.N;BPL8[Q+N58"
MR+YL851_M<CG&<5WM% '">'K'4?!.NW&AQV=S=>&;@F>PFB7?]B8GYH6'79G
ME3SC/Y<UJ6FZW'X1\<^'8M!OYKJ^U"ZNK>9%'DR1RN&7#9Y;MM Z]<#)'L%%
M '"WD%]/X]\(WW]FWB06MG<QW+&/<(6D5 H)4D=5/3..]86@:=>:*L_AK4/
MZZA<I<2?9-5-O$]O+&SEE>5R<J1GD $G'%>KT4  & !7&Z1!=)\4=?O9+.Y2
MTN;2VBAG:(A':/?N&>WWAR>#VKLJ* .'L[*^\*:UXG:WL+B[AU647UEY";LS
ME-KQN>B?, 0QP,'KQ6/:^$[[PG:^ 0MM->0Z,UP;]K5=[*TT;98+]YAO8] 3
MCM7J%% '$VUO>6>O^(?& TN[F6:W@M[:RC4+/,L>2S[6(P26X!P<+TY JXEL
MWB/Q'HVM'3KJRCTU)F5KN,1R.TB[-@7.< 9))QR%QGG'544 <_I?A.+2]4-^
MNLZY<L=W[F[U!Y8N?]@\<=O2N@HHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ IDJ>;$R;F7<,94X
M(^AI]-=Q'&SL&(49.U2Q_ #DT <=\+Y9Y?"$AN+F>XD74+M/-GD+N0LS 9)Y
M/ KH-9URVT5;031RRS7EPMM;PQ ;I)""<<D #"DY)'2L+X;VMW8>&Y[6]LY[
M6?[=<R[)D*Y1Y692#T/!_"I_&DVL0C2?[/M+NXL6N\:@++'GB+:<;#D$#=C)
M!!QT(H 2;Q]IMMH.KZK/:7R#29V@O+<1JTB, #V8J00P.<XYJQ9^,;.ZU^VT
MA[&_M9+N!I[2:XB"QW"KC<%YW @$'Y@.*X"YT75U\,?$#38O#][$VI3^99IA
M6W[HT &0QYX))Z>Y-=-J%O=W/C7P7>16-Y]FL[>Z2YE\E@(3)&BJ#GW4].G?
MB@#,^)_B"'4OAMKS65K?2VL1,(OH6"Q^8KA6Z,&90<J3M(S[#(])+M':[UC:
M5E3(1",L<=!D@9^I%>.MIWB"S^$6J>!I= U"?4;=7B@N(4#0W"-+O#AL]<'D
M=?UQ[#:N\EI$\D+PN4!,;D%E/H<$C\C0!Y+XD\1W?BGX+:MJMU97%FZ7!\MA
M*H7 NM@7Y6R<*,'< ">F:] LO%MK=^(7T62QO[6Y^SFZ@:XB"K<1@@$I@DY!
M(X8 \]*\^FTC6Q\'=4\-'1+[^T$NW" *"LV;KS<H0>FWG)QZ#)KK;V*YG^)^
MBZG'979LHM.GBDF\A@$=V0J#QGHI^E #M#\0Z!9Z-J-[I]K>01MJ\EM)#,?W
MDMV[A2%W,0 6(ZD <]*Z/3=3.H2743V5S:2VT@1TG"_-E0P*E6((P?SS7G^F
MZ4S^&-?L=8\/7EU:WVO3SM;F,AS!(^Y95P0<C .!\PQTSBN@\#:?JFF/JMK/
M>7UWHZ2I_9DFH B<+M^=3N 8J#@#< >#VQ0!D>.%A7XC^"H9[F6"TO&O%NE6
MY>))-D0*;MK#H>E0>%=?.G>)O&"-JDMSX2TQ8Y(KNXE:80R;<R1K(<E@.>,G
M& ._.CXMM+FZ^(O@^\CTZYN++3VNS=RI"65!)$%7_>Y],XK5\=^'9O$7@/4]
M%TXI#/-&#"/NJ65@X7V!*X_&@"Q'XLMEU2PT^^L;W3Y-0!-H]RJ;96 R4RK'
M:V.<-C/UXKFM D@L=8^(9N%N)K2*ZC+QJS.Y4VZE@.<]SWJSJ,%[XSE\+A]-
MN["33]0CU"]-Q$4$1C1OW:D\/N9ARN1@$D]!46FVM[#J7CV:33[Q4OG#VA,+
M?O@(!'\O_ AWQZ]* -C1M=T>S\+: -+MKGR;Z!5TZRR&F9 F[DLV!A>22V/?
M)&8+GXB:;9Z-?:E-I^I!-/N_LE[$(TWP/Q@GY\%3N'S D<]JY6WTW7M&T3P)
MK-OI%U=2Z+:O9ZAIZJ!-M=%4L@/#$%!T/.?KCO;??XGT6\BU32Y;.RO(S"+:
MYP)BA&"7 )"DYX&<C&3UP "W-JZ0ZG86'V6X>6\1Y%*;"L:IMW%OF]64<9Y-
M:-<1\.=/U*+3Y9]7F6XGM"VEVLRG.^"%V4/_ +S'KZ[%KI]&U&?5--6ZN-.N
M=/D+NOV>YQO #$ \$\'&?QH T**** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "LO7=$37K.*V?4-1LA',LHDL+@PNV 1M)'53GD?2M2B@""SM(+"SAM
M+6,1P0H$C0<X _G4]%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M\1IX<33WDLYKA;V]BLPT;*!&TC!06R<X^@/X4 ;=%%% !1110 4444 %%%%
M!1110 4444 %%%<[JGBE[2ZU"VTW2Y]4GTU(Y+N*!@'4/D@(#]]L G''&.<G
M% '144V-_,C5]K+N .UA@CV-.H ***Q?%GB)/"GARZUF6SFNX[< LD+*" 2!
MD[B.,D=,GVH VJ*0'*@^HI: "BBL2U\1I<^+[WP\;.:*6UM4N?.=EVR*S%1M
M )/8]<?2@#;HHHH **C:>);E+<R*)G1G5,\E5(!/T!9?S%24 %%9VO:L-"T*
M]U5[:6Y2TA:9XXBH8JH)/WB!T%3Z9>KJ6E6=^J%%N8$F"$Y*AE!Q^M %JBHX
M)XKJ%9H)%DB;[KJ<@]JDH ***YRU\5O>W/B*UMM)NFN]&VKY!= UPS)O4*02
M!D8ZGO0!T=%16TCS6L,LL+0R.@9HF()0D<J2.,CIQ4M !1110 4444 %%%%
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MW'! Z >] '(>-=2OK>W\67=EJMY-<:? DENMHYCCL"J!B)/F"R,QR=N&(!'
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M+',% < ?,".,=/0=<]A'=3^*?$_B72&O[FR73(H([<6TK1LKRQE_-;:06P2
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M?+*2OTWE75@&]2,9[YJQIOA^TTFWNEM'F6YNW\RXO'8/-*^,;B2".!P!C '
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MD:7U_<V^IP7"W5Q<.?+O&6(.)(XV),8SR,!<@]"*VOAY_P ?7C+_ +&.X_\
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MH+:2987F9%+".,C<WL,D#\S7EDOCB*UT;5YK*?4[#4%>SM9K#52SO8%Y"C3
MN3N4AL@Y(RHSUQ7<6^C76FZZ]S'K-P^G36AC-C<R-*3,#GS%=F)'RY!4<=Z
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MZIY.EZR!#$CJJNGEHQ1QMY7GH,>O6O0Z "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *XCXJ0R7?A&.
MUAANI9)+ZV;;;1.[A5E4LWR@XP 3FNWJO?7MMIMC/>WDRPVT"&221NBJ.IH
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M#10 C LI 8J2,9'45R7_  KS3?[&.E?;]1^S&^^W_?CW>=OWYSLZ;N<5UU%
M&(?#,/\ PDIU\7]X+XVGV/.8]OE[MW39UW<Y_IQ5&W\!:1%X9NO#TTEU=:?<
M2-*5G==R.S;RRLJ@@[N?8UU-% &):^&XX;J.\N-0O;V]A@:""YN3&6A5L;MH
M5 N3M7)().*IV_@;3[;P;-X52\OCILJNAW.A<*Y)90VWH23[\UT]0W4DT5G/
M);0>?.D;-'#O">8P'"[CTR>,T 8LOA*VFN]%N7O[[S='!%J08^Z["6^3G*\?
M_7YJE??#W2]1?5GN;O4"^IRPSRNLBJ8Y(L>6Z$+\I  '?WS736,MQ/86\MW;
M?9KEXU:6 .'\MR.5W#@X/&>]3T <S#X&TV/5+G49;K4+F>ZL_L=QYUR2LR?-
MRP&.<,1Q@#L >:A'@#3QI&E:;_:.IF'2[B.XMBTRLRM&,1CE<;5' &,>N:ZL
MD@$@9/IZUA^%_$3>([?49'LC:/9:A-8LADWY,> 6R .I/2@!DOA*U_M>\U.R
MOKZPGOD5;P6KH%G*C 8AE.&QQN7!I/\ A#=-2_T6ZMGN+4:-&\5G#"5\M590
MK @J2<@#DGWZT_Q?XC?PKX?DU5;$W:QR1HR"4)C>X0'.#W8=JWJ ,?1_#MOH
MM]J5W!=74LFHS>?.)BI&_ &1A1C@ ?A5K6=*BUO1[O2[B66."ZB:&4Q$!BC#
M##)!QD&KU% '.ZCX+TO5O"]OH%\]S-;VP3[//Y@6:)D&$964## <9Q]<UB>(
M/#?]D>#+RUA_MO6I+N2**ZN&N#+=K"&R2F,9VC)"@<D\@\YUM1\67%EXNM_#
ML6D/<7-Q;-<Q2+<*J[%.#G(X/MSUZU9\.^*[3Q#<ZC9"WGL]1TV417=I< ;D
M)&5(*DAE(!P0: .6T73GO;Z$:?K/BV\M')2\AUJ%DA,14AE_>1HQ;IC:3COQ
M6K;_  VTJWATJ(:CJ[C2I=]F6N^8EVE=@P!\N#C^]VSBNRHH PM*\)V.E0:K
M;^=<74&J323W45R596>08?HHP".,=*R(_AIID=E8V)U767LK"Z2ZL[=KH;8&
M3.U5(7<5&>,DD8X(KM*P?%/B-_#5K97 L3=+<WL-HQ$H3R_,8*&Z'/7I0!!+
MX*LIKC79C?7X;6X5@O '3!15* +E./E)&??UYI6\&6;)H2F^OL:)C[)\T?9=
M@W?)S\O'_P!?FNDJ%KNW2]CLVE47,D;2I'W**5#'\"Z_G0!Y18VGG7-V;BZ\
M=:/JEQ=2S/8V<;O &9R1L<HT>",<E@/H.*]1TE+V+2+--1E$MZL*B=\ ;GQR
M>..OIQ2:=<WUP;O[=8"S$5P\<&)A)YT0QMDX^[GGY3R,5=H QM8\,V>M:EIV
MH3374%UIYD\J2VEV$JX =3[$ =,'C@BJ]EX.T^SMM:MFGNKFWUEY)+R.9EPS
M2+M8C:H(RH _"NAHH Y*T^'NFVL^CSG4=6GETC<MJ\MWG",H78< #;@#I@GN
M35:;X8:/)IM_I4=]JD&DWLGFMI\4ZB&-MP8[/EW $CIG'/3I6Q<^(96UV?1M
M*L1>7=K"DUT9)Q$D0?.Q<X)+':3C&,#DC-6M#UAM9M[B22QN+*2WN&MWAG*[
M@R@9/RDC!SP0>1@]Z *H\*VZ^(5UM+^_6\6S^Q ET8>5NW?Q*<G=SD_RXJ@O
MP^TU/#%GX>6^U 6%I.+B(;TWA@^\9.SD!N?_ *U6_%'BAO#4NE*=/:Z74KV.
MQB9)0NV5\XW C[O!Y'Y5+>:]<PZ[:Z1::;]LGDB\V=TG 6U'0%R1T)SMQR<'
MCB@#A[VW63Q5J\M_<>,])N99U2(Z7%)+#<QH@59,I&ZAC@DCY<>G4GO_  W!
M?V^B11:C<3SS!GVO<[?-,>X[-^WY=VW&<5K5SFO>*9-$U[1]+_LXW#:K*T4$
MBS!0K*-QW C@8],]* ,?XBP27>H>%(XEO1Y6KI/)-:PLYA0(XWDA2 ,D=>/P
MK?'ABU9-2>6ZNI;O481!-=N4\P1 $!%PH50-S=!U)/6M6.[@DNY;195-Q"B/
M)&#DJ&SMS]=K?E4] ')Q_#_38#I#07VIPRZ5 ;6"6*<*S0''[MR%Y' YX/O4
M<7PXTF"T@M8;W4TAM]1_M*)?/#;)@Q88W*> 6/'?/.>*["B@#F[OP99WFJ7^
MHR7^H+/?6Z6TICD1<(AW+MPN0023G/>KUCH,-IJKZI-<W%Y?M;BV$\^P%8PV
M[: BJ.3R3C-:U<_XA\6VGAZ_TBQDB>>YU*[CMD5#_JPYQO8]AZ#OSCH< &\Z
M+(C(PRK#!'J*Y&'X=:9!IFG:='J&J"WTZZ2ZM5:=6\MD)*#E3\HW'COGG.!C
M4O/$++K4FCZ;9_;;V"W%S<+YHC6-"2%&<'YVP<#IQDD<9KIXSL+O3M'N-.1K
MF76)&CM(6/EX959GWGG;MVL#U.1@ T 1:GX"TO5[O5;B^N+R7^T[9;6X3>H7
M8IRFW"Y!!.0<_7-/L_!-C::U9ZN^H:I<WUM;FV\R>ZW>:A(.'  '! .!@'OF
MK-OXBDGEU.T_L]CJ&FE#/;QR!MZ.NY6C8@;B0#P0O((XX-:MA?6VIV$%]9RK
M+;3H'C<=P?Y?2@#.\-^&K/PMIYL+":Z>V#$QI/+O$2DD[5]!DGW]2<"IM=UE
M="L%NWL+^]!E6/RK& S2#/?:.P[FM.B@#GO">B1:7IMW,;);6?4[N6]N(.#M
M+GA3U&0N,XXSG%0VG@73+.T73X[B\;2$G$Z:8[J8$8-O 'R[]H;G:6Q[8XKI
MZP?&/B-_"?ABZUE;$W@M]NZ,2A."P7.<'N1VH BO?!EC>:Y=ZJ+R_MWO85AN
MX;>8+'<!00I88SD XX(XX.>:T= T.U\.:):Z39/.]O;)L0SR;VQ]?\.*TJ*
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M.MRZNB%0I0L""5*@ Y]* .0MDUKQEH5_J%GJ*6&HPZA.D=S]ME'V412D!&A
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M[XB7EYJVC^#9X[2?2KN3Q);+''>HK-$V) K,JL01T.,]*T/ .MFTN[CPMKT
MM/$T;&:61F)&H@_\MT8]>!C;_"!@  8'3Z[X8T_Q%+9/?M<'[%.MS;B*8H$E
M7.'XZD9[U7U_P9I/B6XL+C4OM+3V!+6TL,[1.C'&6RN#G@4 =#7 ^./^1_\
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M@$T :=Q*8+:681/*8T+".,99\#.![FO%_$6OSLF@7-YX<UZ/4)-?M;FX>6S
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M"*>Z>6.W!Z^6K'"YZ9ZXXSR:Z:@ HHHH **** "BBB@ HHHH **** "BBB@
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MDJ(6&""I/<K@]>Q(H ](NKNWLH1-<RK'&72,,W=F8*H_$D#\:@-S?#6UM18
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MM@8<J6( R.<9Q0!UU%>;:P]YHWC"^T>RO+P:=?:'/>;/M#EK6:,X#HQ)*@Y
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MQ'IDD<?GMTFWKNW*/[OH>_4<5T%>9> M86Y^(GBV&/1M2LXYFM2JS6X18 D
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M9'3BN#T'3+=?B[XI</=9BMK*1<W4I!)$N<C=\P] <@=@*]!H **** "BBB@
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M;6*W5W=8U"AI&W,0/4]ZI:UH=CK]I';WR2$0S+<0O%(R/%(OW75@<@C-:5%
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MXUR-[C[=<1B*5FE)5D7.U=O0 9/2F7_A?3=1N;F>59HS>1K%=K#*46Y09P'
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M4RT\#:+::C9:@/MLUW:0M DL]Y)(60X^5LGY@,# /'M7244 <QHW@'0=!O\
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M<I)#(O1E8<@U5E\*:;<6.H6MP;B8ZC'Y5Y.\I\R5,$;"PZ+@GA<#D]R:W**
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MN9K<%0&"J1G=@8R<MCC//(!YI'9ZE<_"S4?$B^(]835-+GNY;:0WC%,13/\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M,C@'!P5([B@#VBBLNUUL7FMW>FQ6%WMM,"2[(3R=Q&=H.[<6QU&.,C/45J4
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MC002S!1G 7KSUQZ9]*Z_7KR]AUJTMI-'EU'0[BVE6]V1+((VW)M)0\N"-P(
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M HHHH **** "BBB@ HHK%\4WMW::+(EA;74UU<$0JUM&7,(8@-)_P$$L!W(
MH \_C\?7UO\ &V&PO-T>A:I;?9K D_*[H[ 2?\"<.H]04-=IXO\ &^G>"EL7
MU*VO98[V;R(WMD5\/Z$%@?R!KA/BAX NKSPKI<^A3:G=ZEILB?883&N4CX!
MVHNTC"GYC_#ZUG_%34KW4?"?@J\OM/GM=0_M.+S[61=K"0+R!GC!/0Y[_6@#
MT?2O'5GJ?B.]\/R:??6.K6T/GK;7(0&:/C!0JQ7N."1U]CC"B^,NC7&@3:Y%
MH^M-IEM<BWNIS#'B G&"?GY&6'W<X[XR,UM/T?4M;^-S>*3IUW9:99:>+96N
MH_+::0@Y 7J0-QYZ<5YSX174-2^"WB/0=-TB]O+N_P!5*0O%&#&#^Y)W-GY<
M!<Y.!R,=\ 'M&N_$71?#]YHL%TEU+%K*[K2Y@17C8?+U^;=_$O0'.>*9#\1M
M.?24O9].U2TFFU#^SK:RN8!'//-QC:I.,<]20!@UQ?B#PGJMKJGPQMH;&XO(
MM!"?;IX8RRICRN??[C' YP!6S\7O#VKZFOA[6=(LI+^31[WSI;.-BKRH2I.,
M<Y^3''/S4 =#_P +!T2+1]8U"]>6S_L>8P7L$H!='_A VDAMV1@@\^W-4KCQ
MW8W\?B#1Y[/5;"_LM.-U+&OEB7R63.^-@Q7<NX<$CGUKF?%G@U_%7P^U1M \
M.7&E7MQ+#<F*[(6>Z9-V0PW'& QQDY)'0#!._!JVK>(/ VI+=^%]0L=1;2Y+
M>4S1*&EF*%0L8!+,I))R0 ,]^< %;PCXOT/0_AMH$_V[4KR*^N&M+0WNWSYI
M#(PP?FVJ 0>2V ,5LV'Q!LM0M/$)AT^\%_H)87=D^P.<9P5;=M(.T\Y[=.F?
M/+'3O%ND?"3PUI-IX?N'O(=0?[:ODH9X$,K.&BW\!B&X<?=]NVAX-\+ZW9>(
M_'T=QH]U:0:M#_HDLTJNO(? 9]Q);YQD\\@Y/J $7C>X\2_!K5-7UJWU:RMY
M6?-YIYBRB&;:JIEPQQPIR!D9KKK/QAIFDZ%X5LHFOM0N]5MHA912%3/*HC!+
MR$D*..2<]>F:X&PT'7X_V?K_ ,+RZ#?IJ:L46,H#YA,^_P"7!/ 7J3@>F:O0
M^%]5L]8^'7B1K&Z>'2M.6QO[=8BTL#"-EW;!RPRQS@'H#S0!VH^(VCGPUJNM
M""[(TF9H+^T"IYT#J<$$;MI^H)S56P^*>D7^K:)9?V?J=LFM1E[*XN(E5'(Z
MKPQ/MG&.1C(YKB8?!VMIX1^(M\UA<?:/$5TS65EL_>;!(Q5F'\)._H>F*9_P
MCVM_;/A<_P#8]]MT>,+?GR3^Y.5'/K]TGC/% 'LNKQ+-H]XC[@/)8Y5BI!P>
M01R*\!\&ZM#<_!G7M3U?Q'?1:Q!-,+.8ZG*LNX1H8U4;_F!8D8QW->_ZJYCT
MF[(CDD8Q,%2)"S,2,  "O!O#'PLOM6^%E]I&HZ=/IWB&VOGO+"66,KG*(-N\
M<8)4C&>#@]J .DDUK4I_V?TOO%TVK6LLFU9+JR55N GF@(Q#%?O?*#W(.>]=
M?!XTTVP/AW0[9;[4=2U&Q2>"-BOF&()GS)68@ D*>YR0:XO6I/%GBGX)WFC:
MIH.H+XA#0Q;?*R+@+(K>9D< X4YSW^M4_$.IZ=X3USP/JNH6]_I^HV^C^2US
M]F,JG:FPPM'E22"S'<",<=0<@ V?%_CF#Q1\)O$6I:-'J5B]@\<8F=A$ZRB1
M0R@HY.0#SG'##K6EX-^(5HT7A;P]J%MJ27U_ID4D-W<*-EPRQC=SNW=0>2.?
MQ!/)0)H&M_!KQ'HW@EK[4[^:=)+E)82LSRO(K%B,8"X0XQQ\OKULIH.L_P#"
M4_#2Z_LF]$&E:<D%ZYA.(7V;2#Z\CMVH Z;1OB!?ZK\2M;T9M*N8[#38UC8A
MHOW;$DM+)EONXQ@+N..W-;?A_P =67B06<MC8WGV.]>1(+IO+*$H"2& 8LI(
M4D @$BN8\/:-K&C?%[Q9>3Z3/)9:HB-;W*[3%@#D,<Y![8QG\.:RO!OA*_T3
MXA6&H:!::EIFD7D$DFKZ==H5BMWV_*J,>'^8\8R0 <GG% 'LU%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7->+O!-AXR%@+^[O(5
ML9A/$+9D'SCH3N4YKI:* &%&,!C\UP^W;YF!NSCKTQG\,>U<[X-\%6'@?3[B
MQTVZO)H)YC.RW+(Q#D $@JH[**Z6B@ HHHH **** "BBB@ HHHH **** "BB
MB@ K%OO#<%UKJ:W!>7=GJ"V_V4R0%"'BW;MI5U8=><@ UM44 9FEZ%:Z7=7E
MXC23WMZ5-Q<S;=\FT84?*   ,\ #J:TZ** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***P]4UZ\L
M;VX@M]&N+N*WMA<2SK*B*,EOE&XY)PF?Q% &Y17(:/XVN=9TW3=3@\.W8L=0
MXCE,\9VY!QN&<C)&/Q%:GA'Q#_PE7AJVU@6IM?/>5?)9]Y79(R=<#KMS^- &
MW1110 45#;W4%VLC6\JR+'(T3%>S*<,/P/%34 %%%84?B-G\<2^&FL6398?;
MEN3("''F;,!1TYSU/;I0!NT52TFYOKS3(I]1T_\ L^[;=OMO.679AB!\R\'(
M /XU=H **** "BBB@ HJ&ZNH+&UENKF58H(EW.[= *FH **I0W-\^KW-M)I_
MEV4<:-#=^<I\UCG<NSJN,#D]<U=H **S;S4Y3I%U=Z/:KJ=S"S(ENLPC\R16
MVLN]N!@@_E6BI)12R[6(Y&<XH 6BBB@ HHHH **** "BL+QAXB;PIX8O-:%D
MUX+90S1+($X) SD_7T-;@.5!]10 M%%% !17.:WXMBTN+1I[:V^VVVIZA%8K
M,D@54+MMW>K#@].OK70N66-BJ[F )"YQD^E #J*J:7<7EWIEO/J%C]ANW3,M
MMYHE\H^FX<'\*MT %%<F_C*Y_P"$GU#0;?0;FYNK&!)W,4\8#(WW=NXCGV.*
MU/#7B73_ !7HZZEIQD$>]HI(Y5VR12+]Y&'8C^M &Q15:_N7LM/N+I(&G:*,
MN(U8 M@9QD\"L;2_$=[K/AK1-8L-(,HU%HFFB^T*OV:)L[GR1\^WC@<G- '1
M4444 %%%1W$CQ6\DD41F=5)6,$ L?3)X% $E%8WA37U\4>%[#6UMS;K=H7$1
M?<5&XCK@>E;- !1110 445#:W4%[!YUM*LL6YDW+TRK%3^1!% $U%%% !113
M9&98V9$+L 2%! R?3F@!U%8GA+Q#_P )3X<AU;[(;7S9)4\EGWE=DC)UP.NW
M/XUMT %%0W%U!:^5Y\JIYL@BCS_$QZ 5-0 445D:UKT6E:1JM[#%]LETR$RS
M0(X4C";\$GH=O/XB@#7HJGI%_P#VKHMAJ/E^5]KMXY_+W9V[E#8SWQFKE !1
M110 4444 %%%0FZ@6\2S,J_:'C:58^Y52 3^;#\Z )J*** "BBB@ HHHH **
M** "BFNS+&S*A=@"0H(&3Z<UC>$_$/\ PE&@)JGV0VA::6(PLX<C9(R=0!UV
MYH VZ**S-<UJ#0K&.XF4N\T\5M!&#C?+(P51GL,GD]@#UH TZ*R](U#4KR6]
MAU+238O;R!8W2<2QSJ1D,C84^Q! P?6M2@ HJ&VNH+V'SK:598][)N7IN5BK
M#\""/PJ:@ HI')5&*J6(&0H[^U8GA3Q%_P )/H[Z@;,VA6YFMS$T@<@QN5)R
M .N* -RBBB@ HHJ&:Z@MYK>*654DN',<2GJ[!2Q _!2?PH FHJE;7-]+JE];
MSZ?Y-I#Y?V>Z\Y6^T9&6^4<KM/'/6KM !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %4]7_ .0+?_\ 7O)_Z":N57OK1;^RFM)))(XY5*.8
MVPV",$ ]J .6^%/_ "2WP]_UZ_\ LQK@-+CN--^%.BZ]:ZC?175OJVQ(TN&6
M$HUZR,C1CY6!!/+ GWQQ7K>B:!:>']%CTC3Y)TM(E*Q!WW-&#D\$CU/?-9@\
M Z./#D>@![P:;'-YZ1>><A]^_.[K][GKUH PI#JGB^_\565O<FWN+&Z^R6K)
M?RP-;?NE99-B##98L<L>0,=!SVVEQW$F@VL5_=1W-R8%2>XMR561L89E(P1D
MY/'2L74_ &BZKK0U>1[ZWOFC6*>6SNW@-RHZ"381G]/Y5TT,,=O!'!#&L<4:
MA$11@*H&  /2@#Q&&"73/@GJ=_IU_?VEU'J4B*\=W)@#[9LZ%L="<XP3WS7;
M:CI::5K&G6BZYK%XU[<37#:<UP6>X(C X?<OEQH?F(Z$D #H*T)OAYH4VFWV
MG'[:ME>SF>6!;I]H8OO.T9^4;@&XQS5_5/"FGZQ<Z==W4MXMWI^X0W,%PT4F
MU@ RDKC(.!F@#SW3_$>J1Z%8:3/>SJUWXHFTIK@SL\D<"NQV"0_,2<! W7![
M'%;=KI<5I\9[J"&>Z$<WAT'YYV<I_I&#M+$D=,_4DUL-\.?#C:7>Z<;:<V]W
M=&\.;A\Q39SOC.?D.2>GXYJQ9^"]/L]7&K"[U*741:_9/M,UV[MLR3R.AY]1
MCC.,\T >>V5_JMQ\./ MT=9U!;JYUU+>><3DM*C32@ALYW?='!R..E;]J=4T
MKQ3XOTC2;RZN672HKRRCO;AIMEPPD'#.3@$JIQG'TK=B\ :/#I.FZ7')>+::
M;="[M4\_F.4$L&SC)P68X.1S4?B'PV8K?7-8TVWGOM7O+$VK0//M25.0%QP!
MC<Q&""?7F@#F],%_JUSX,ETZ]U?$ENSZT6FE XC!!?=P&,G0#J"<?*..G^)$
MMQ;_  [UNYM+JXM;B"V:2.6"0HP(]QS7,:-HA,MHNBR>-[*:%H_DU*X86Z*"
M,AE<D,,9&%SVZ=1Z#K>CVNOZ1<:7>F3[+<+LE6-MI9?3/7'TH X>\2YT6^T"
MUCU2^N#X@F'VDW=\Z(#'"S!(V )CWL1D+UVXXS3[K2?%>EV6KQ65]%=B6XM[
MBTTPW[F58P<RQ+,^& ?:=OI@BNHU;PCI6N>'X=&U))9[> JT,AD(EC9?NLKC
M!##U_/-16_@O3;;31:+<:B\@F2<W<MV[W!=/NY<Y.!D_+TY/')R ><^)+_3]
M<^'FMF(ZM;75KJ5IY^GWTT@DLV:2)=O+'*$98=LDD8KHM5TN:Y^)-KH2:SK%
MOI\^B32.D5])NW"5 &#$D@\]>O&.A(KIKKP;I-_IVI6=\LUP=29&NIV?;(Y3
M&P@J %V[1@  ?F:=!X3L(-:M=76>]:\MH#;H\EP7S&3N8-G[V3R2>?TH XR]
MU?4?#.M>-W@O;N\73=%MY[:.ZE,@5\29;'3L"?7%='8Z()3HFK0^(+WR9;<K
M<HUP[K?^8@VD?-A&!^8% /08%:B^%].&M7^JOYLL^H0BWN4D;=')& 0%VXQ@
M9/YG-5- \"Z/X;N%DL6O62/=]G@N+MY8K8'KY:$X7@D9ZX)&>30!YQ9P/IOP
M#UB_L+V_M;J.6Z*217<@V[;EP,#=@<=2,$]Z[5+Z36OB'<:!=33QV=GI45PL
M44S1&9W8@N2I!(4  #.,DGKC%YOA_H;:1J&D@7:V-_(TDT(N6VC<VYE0$_("
MW)QC/TJ[=^%K&ZO+*^$UU#J-G$88KR&0"0QGJC<$,.^"#SSUH \VO=4UI=&N
M]/.K7ZMI?BF"PANUE.^6!W0A9#_&0&P<]>,YK>,>I:9XXU_1=,U:ZQ<>'_ML
M+7URTJPW.]T#@MG:O ) XXZ5TUWX,TB[TR'3W$Z0Q70O24E(>2<-N\QVZL<\
M_P#ZA3KSP?IU_J5WJ%S+=/<7=BVGS$2[08#G*@ <<DG(YS0!S_@W5Q-XA.FZ
MC:ZII6M0V9\ZQN[AYX9QN7]]$Y8@\\$]>?:KOBVXN+7QAX.^SW5Q$EQ?20S1
MI,P21/)=@&4'!Y /(K=LM MK34$OY)[F[NXX3;Q2W+AFCC)!*C &<D#).2<#
MFDU_P[8^(H+:.[:>*2UG%Q;SVTICDB< C(8>Q(_&@#S[7+W4(5^*$<.J7\2V
M%O;S6NVY?,+& N=I)RH)YP*OI]JTCQAX+ECU/49QJUK<+>QS7#.DFR 2*0A^
M52"/X0,YYSS6^WP^T-EU8?Z;_P 3:-(KP_:G/FJJ[><GJ1G)Z\GGFKC^%+&2
M\TB[>>[:;2%9;1O-^Z&7:<\?-E>.?YT >9:W,WBCX#ZCXGN[NZ-[=!YMJ7#B
M.-1/M$00';M"@#D9)YZUU5Q-?>)/%/B+18Y2@T^&!(0E_+;,ADCW^:/+'S')
MQR<#;TY.="?X:>'Y[?4+0&^BL+]S)-90W;K!O)!+!!TR1TZ>W J?5? &B:K?
MVU^SW]K>V\0@%S:7LD<LD?\ ==P<L/J<^] '+366LR^)O"FBZEXCNY7N-/O(
MKV6QN&C65H]JAACHW)R>N<]*[ZXTV.+PO)IKSW,T<=H8C+),WFN N,LXP<G'
M)JL?"6F#5=-U"/SXI=-B:&U6.3"(C !@1WS@9)R:W&574JP!5A@@]Q0!XK;6
M:I\*_AZ8IKA'GU?3R7,K/L.YN5#$A?H!CVKJM.BGL?&_B;0XM2U![-M-ANX_
M.NGE>&1BZL49B2,[0<?EBM:+X>:)!IMEI\3WRVUC<I=6R&Z9O+="2F,YX7)P
M.G/.:T#X7LSK-WJPN+L7EW;BVE<2#!C&< #&!C)Y'/- '!Z9J'B"7X>>$-4B
MAN]9C$#R:C:Q73)<S@\!U.07VDG*YYR/05W'@O4;+5/#%O<Z?=W5S TDH#79
M;SD/F-F-]Q)RN=O)[4RS\&V&FV>FVUA=7ULNFI)':LDV2B/@LIW AA\H^\#C
M\JU=+TNTT>R^RV:%4+O*[,<L[NQ9F8]R22: .#MTU!_C/XD&G36T4O\ 9=MS
M<1,XZMC@,*A32F\%7'AKPO%?SNNNZE<7.HWJ_NFE<1[MJ[3\@8A1P<X4\\UV
MEMX7L;3Q)<Z_'-=&_N8UBF9I<JR+T7;C Q[<U9UO0;#Q!:1V]]&Q\F59X)8W
M*20R+]UT8<@B@#D1/>:5X[UCP]'<7$^E7&B'4(UGE:0V\@<QE59B3M;K@G@@
MXQ6#93W5K\.?AI);7EQ!YFH6,$J12%5DC;<2K =1P*]'B\.VD27C--<2W5Y&
M(I[N1P9609PH(&% R> !R2>IS5'_ (0;2?[)TK2Q)>"UTJ=+BS43<QNGW3G&
M3C)X.>M &+9+/XUE\5POJEW8W=E?O96AMYG3[,J(I63:I 8LQ8\]1QTINHW4
MOACQ?H>LW>KW-QHNHP?8KAWN&$$=P5#1S!,[0' (XX!(/>MG4/ .B:CKDFKL
M;VWNIU5+H6MV\*72C@"4*1NXXJOK\9\0W3^$G\/W7]GJ\$DM[+&HMC$I5RJ'
M.2WRA,8XR3T'(!J^%HICI)OKB2Y:2_D:Z$<\K/Y2,<H@#$[<+MR!WS6#IL[>
M*_$OBJWNKJZABTR9+.VBM[AXC'E-QE.TC+$G@G. O'4Y[GI7/W?@W2[K7Y-:
M1[RUO)HQ'<FTN6B%PHZ!P.N.@/!]Z /._ VIS2:/\/O#AEEAL[RRN;B8QN4:
M8QD[4##! Y+'!YP.V0>P\,W-[9>//$/AUKB>YTZWA@N[5IY#(T'F;@T>YLDC
M*DC)X'%7(/A_H5KHNG:9;I=1KILAELYQ<,98'/4JQS@')RN-I]*V=-TBVTQ[
MB6+S)+FY8/<7$K;GE(&!D]  .   !Z4 <IXE2YF^)7ANQ34[^WM+RTO#/#!.
M45M@3'3H?F/(Y]"*YJ/7]1TC2+W25O[MH3XN31TNII2\L%L^UC\[9.0"5#'D
M;AZ"O2;SP]:7NOV6M2R7 O+)'2 J^%57QN&W&#G Z^G%4?\ A!M%>QU6SGCF
MN+?5)S<W*RRDYEX^=2,%3\HQC&,"@#&OXY](^(6D:1;W%Y+I6N6ERES;R7,C
M^4\2AA(C%MR$[MIP0.AZ\T[X/VL</PTTB96F+31L6#S.ZC$C_=4DA?P S736
M&@6UC>"]>:YO+Q8O(2>Z?>R1Y!*C  &2!DXR<#).!3?#_AO3O#-F]IIHG6W+
M%ECDF:01@DG:H)^49)X'K0!QOC&XF=O%KVFHWMQ<6.FB2..WF:WCTUEC=]Q9
M6^=VX;&T\  X!J'?J&M^+/#%M-K&HPV^H: UQ<QV\YC#./+Y&/ND[CR.?0BN
MKOO VBZCJ6HWTRW2MJ4(AO(HKETCG 7:"R@X)"\5S4_AP67Q"\.VUBFK16-A
MIDUNMXBR2;'9DVAG8%3\H/!R!QTP* .<OKO7-+TO7=&77-1==*UVSAM;MIB9
M&BF*$QNW5]H;OZ^G%=5%;7WAGXHZ396^JZC>Z?K-K<-/!>3F;RI(@I$BY^[G
M<!@8'Z83Q[X>C@\'#3M-L[VYEN=3@N;AH4>260B56DD9E&0=H]L8 '0"NML]
M$MX[IM1:>ZN+V2#R4N+C&^.,\[5&T!><$\9) SG H \TTFQU&;X,V^H:3<WD
M=[IUY<W0AM[AXA<HES(7B8*1G<H..^<8ZUW&A:E#XHUG^VK"ZG;3(+2..-5F
M8))+(!(Q9,X)52@Y'5F'44Q8HO 6E6NG:/HVK:I!-,^V. K)Y+,2Q+,Q&%+$
M\G@9-:GA?0XO#OAVTTV..*-D!>41#">8Q+/CVW$X]L4 <S\0K&&Z\1>"VD:<
M%M5\O]W.\> 8G/&TC!X'(Y]Z71RWBS5/%-K=7E];C3KL6%JD%U)&T*K&")>"
M-S,Q)RV> !ZYZC7/#UAXABM4O?.5K2=;B"2"9HG1P",AE.>A(_&JTOA+3CJ<
MNH6LMW97%Q$L-RUK,5\]%&%W9SR!P&&&]Z *GPYUF_U[P+IU_J9#7A\R*20#
M D*2,F_'OMS7&6NG00:9\5)$>YW1O<J US(RD&U4G(+8)YZG)KU6RLK;3;&"
MRLX4AMH$$<<:#A5'05B7'@G2+BYU:<F[C.K)MNTCN&"/E=A(7H&*\$CGZ4 <
M;IT=QH]S\.;JWU&^;^T85M[J&2X8PNGV;<H$?W5VD#! !]2:=8G7?%WAC^W+
M'4H["_2[ED%R]]*$@6.4@QO %V;=@P<]?O'FNR;P=IS+HRF:[QHV/L7[W[F%
MV\\?-\O'.>*J#X>: NNSZI$MW$;B7SKBTBNG6WGD_O/&#ACGL>#W% &_JK7J
MZ->MIP0WXMW-N&^Z9-IVYSVSBO.-,_M#5_\ A"Y+"]U?S9(BVMDS2@8\O)+Y
MX!\S[N.H/'R].^\2B\;PQJ::?9K>7;V[I';L^P2$C&,Y'KZCZCK7 Z/H1S:Q
MZ+)XXL;B H NHW#"WC4$9#*Y*L,#&U<^V.H )_#]E/?:EXGN[WQ%JL4>D:S(
M8";H^6B+"A(<'ADYSM/'';)S7TR[O8/$G@@07NH2VNI0W*7%U<SM_I^(=ZRB
M(E@@SRO0@'&,5W%CX4TVP&JJIGFCU5F>\CFDW+(S#:QQVR..,"L^V^'>AVO]
MF%7U%VTQB;1I+V1C&I7;L'/W<<8[XP<B@#@KK^T1X!\8:Q_;NK_;-(U>[%DW
MVQP$$<@ # 'YQCC#9&.@'.>FAL89_C9Y[-<!VT".X(6YD4;O/(Q@-C;P/E^[
M[5NGP)I#:+J6D-)>&SU.=[B[0S<R.YRQSC(R<$@>GUJTWA337UBRU9FNC>VE
MN+99!.R^9&&W!7 P& ///XYH SO'NL7&EV>C6]O*\ U/5K>QFG0X:.-R2V#V
M)"[<]LY'-9UZ+K1OB'IVDVEW>'3=9L;@RQ-</(8)(@I$B,Q)7.[:0#C//6NO
MUG1K#7]+ET[4H!-;28)&2I4@Y#*1R"#R"*K6WAVV@E>X>YN[B\:#[.+J:0-(
MD><[5X &3@DXR<#).!0!R_PML;B\\+:-XAOM8U2[O)[1HY(YKDM$<R$AMA_B
M&/O=>3[8T=>_TOQ9!8+>7<[?8'?^S+>5H N7 $\DJL" ,%0,$YR0.#6YH&A6
M?AO1X=*T\R_9(,B))7WE 3G )YQDGK5;4/"FF:EKL.LRFYCO8X/L[-!</$)8
ML[MCA2,C))H \\M=5U3_ (5GX2\7W.I7TC6,Z?VD%N' GMS(T;,Z@@,5^5LG
MK@YJY!KL^G>+O$%H;B\FMM5M]VB&:\D93*K^2Z)EOE!D96!'\/(..G:Z=X/T
M?3/#$_AVWBE.FS))&T<LK/A7SE03T')P!_.K!\-Z49-'?[(H.C@BRQ_RR!39
MC\L?D* .4U:V:*_ETN#5=2OI;31P/LZW3QF%B6_TB6;=DLV, 88C:2!@UBVU
M[J>LP?#-IM8OXFU.WE6\,,Y3SL6Y.3C^+KSU&<C! -=[?>#])U#7'U>47*7,
ML MYUAN'C2>,9P'52-V,G^1XJI:> -&L5TA;>2^7^R"S6>;EFV%AM/7J-O&.
MF.@H R-"B^W>+=9\-7&H:C+9Z%:VT4(>[=99FE5G:5W4@L1\JCTP>YJQ\)(S
M%X AC+LY2\NUW,<EL7$G)]ZVM1\(:9J.NQZUON[34%C\EYK.X:(RQYSL?'4?
MJ/6K'A_P[I_AG3VL=-$PA:1I2)9FD^9B2<9/')[8H YO2Y'\7:_XKM;R[O+=
M=.N5L[:.VN7A,2^6#YGRD98L203G@ >N>1NKN[\2> /!]_J\L[7H\06]I)+%
M,\:RA;ADW[5(&X[?O=0<X(KTVY\+6,^L3:M!+=65Y<1B*YDM9=GGJ/N[A@C(
M' 888>M1W_@_2;_3M.T\I-!9Z=+'-;16\FP(Z?=;/4D>_P"- &P(1:V)BAD9
M1&A"O-(TA''5F8DG\37G'AN^E;6K+0?$L6JV&M/;2H6^V2/;:D-HW21N&PK
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M8* 6;8./P&*AN-/\6:-I!@CN!K"P:D;@Z?'?.+@VA1L0B5L,Q5B&&>2!CVH
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MFWO(U^T2;9&V2G!7=@C@8!X'8"K>DV6M7]OX;\0VVJQPQN(I+R1[^69;Q)
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M+/<-N8D+@,Y[GC)->>>&KV1]:M- \2PZKI^M-:2QMF[D>VU+@;I(W#<,,$X
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M(C/(#&HC5U!8* 7;8..<]!B@#T.JNI3W5MIMS/8V?VRZCC+16WF"/S6[+N/
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M7C0ZO)YEZOG?ZUL >GR\ #C'2K,_A>TDO]-U$RW4EWI4;I:9FP &&&!XP<@
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M^BG6X2.\D.\"VW=221WQCIVP0*[5O"NG3K??;O.O9+VU^QS2W#C<8.?D&T
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MK<RE"8?O !E&1Z&I-/TR+PQKGACP!;7-PNFBSN+J602&-[J4,/E+*00,LS$
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MLM-TFUTO[0\.]Y[E_,N)Y6W/*P  )/L   , =A56^\,Z??Z[;ZS)]HCOH(3
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M+66UN8DE@F0QR1N,JRD8((],5C:=X1T[3?L2K)=3PV!)LH;B8R);\%?ESR<
MD L20#@8H YSPQIEO'\5/&3B2[)A%BR[KN4@EHGSN!;##T#9QVQ7H-8]CX;L
M].UV^UB":Y-W?[/M)>3*R; 0GRXP, ]L5L4 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 445SGC6WU
M2YT:!-(^SRW*W22&SGD\M;Q%!9H=W;(&>>/EYXS0!M7U_;:;:M<W<JQ1!E7<
M>[,0JCZDD#\:LUXMK=QIFL^$) -.N["[MO$-HMQI]TQS:.S1*0F#C85&01_>
M.,5UEF(-5^(FM>'[Z,FPTVQMS9VK,=K>9N+R8SR0=J@]L<8R: .]KG_&OB&X
M\*^%KO6;>SCNC;E-T;RE.&8+D8!S@L../K7GNE:[J"7>G>'-3O)WTL>([S3A
M<R2'?/%$FZ*-GZG+G:?7;@]ZT?B!HUMHOP_\6Q6M[,\<YMYULG;*6H,JC"#L
MK%2<=..* /4:*XOPC>0Z[K&J7>HQO!KUG-]GFL7;Y;9 28RHZ-N!SYF,GH,
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M:_C#7+,)<(@&U^<Y5MP//)SUH ]<JEI<NHS6TC:G:PVTPF=42*7S 8P?E8G
MY(YQ7!>&=!M]6\4>)VO+O4I!I^LJUJOVZ4!#Y2'^]DCG&#G Z8YSC:;K%Q8^
M%].M9KVX6UO?%<UC<W$DS%_*\R3"%R<C)55)STS0!Z]=74%E:375S*L4$*&2
M21C@*H&23^%.AE6>".9#E)%#+]",UYMX\\.:?IW@_P 7M%=2F*XL1<)IV[]U
M R#&]%[;CCCH2,]N)),'Q+H?AE&MXK*;26NDAN=[)<2[E!&-PW%5R0.G)..
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MK6TO9KE6UFTN$MI7RML&F3$:GLN02!VS6_X(O+?79+[5;M'CUV.8P7MI(?\
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MTP8RR;BSG+#!;=@GKGBN;U:"WU7X.Z3XAGE:XU*YN;2>>YWG+.TZ!D/^RI.
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M4R6VI %"TF[KY@VY^89PQR>16S\4MZ_#77)8IIX98K<NCPRM&00?52,CV/%
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MTFBN UVU_P"$?\7>%GT8R1Q:C.]E>6Z2-MGC\LL)#S]]=I._KSR:Y>P232_
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MBVBBM86T]HG,TYEPZ.,;0%QR#SSG_P"OA^*O& T3PGJ6MZ;!#?BPE\F5&E*
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MU<_:YHVNYCNFSG?G?D'//!K7BEU$ZQ/%):PKIRQ(89Q+EWD).Y2N. !CG/\
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MNUEEA$T(#>83,I D#-L*;6/48P,U?TS1HK_QIXQ-Q/J,XTR]M;BTA^VRX5Q
MKX^]R"3C!R #QBJ6E^#83:0VUCX;\1Z+J<<847;:IB"%P/O@+,0PSSM"8/3
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M99H(U,<D>UUQEMS9[XP3@ " :,-8\?VFE:CJ][>V\WA@23207,D23N)E7S
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M9G,:<(>A0@;ACCD\"@#KJ*XB>Y&K_%2?0=17?8VVDK<PVSGY)7:0JSD?Q;0
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M2/')_;MG&71BI*-)AE..H/<5G:D&/Q"\2VJ3SQPMX=2?;%,R;9/,D^8;2,'
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ML'!#9))).>3R<UT!8!2Q(P.IKD==\9/;:/H^J:.EO=6=_J4-FTLC'[CR["R
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M;1F21R>@'IZGL!W- %RLZ^T.RU"^AO9?/2ZA1HTE@N'B(5B"0=I () Z^E:
M.Y01T(S2Y&>M '.ZEX%\-ZMI5GIMWIJFWLVW6Q21D>(GDD.I#9)Y//)Y-2R^
M#=!FTBUTI[)A9VLHFBC2>1") <ARP8%FSSDD\UNY&<9YKG- \07NJ>)?$>E7
M=O!$NERPI$T3%BXDCWY)..>1V_.@"^GA[38]>_MM8I?[1\@6YF-Q(<Q@YV[2
MVW&>>G7FM2C(/0T4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M,:6)6W;1&5SD<XR<>F37,:RUK)IL>MZ7\R_\)-'MU&Y<&YD?SPC(F -L0&5
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MIXT]19VD@EMX!(^V)P<AE&>"#R/3)]:LPZ!ID&HW.H1VH^UW2!)Y6=F,J@8
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M2%  )!*V&"CC/ ^N* /6,@DC/(KG/'/B"\\,>%KC5;&"WFDA>,,DS$##.J9
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MS+:8%HW[,N<9'L<5;!!&0<B@#%T/0[*RM[2X^PO!=1P"(+-*9#".,JGS,%'
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MHPR&!Z@CN*S=-\-Z1I+QO968C,2E(@79Q"IZJ@8D(#@<+@<5JY ZFB@#-LM
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M-,L]5GU2WMBE]<8\Z82-F3 P W/(';/3M6E110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7"_%N!
M9? KN2ZNEY:[65B",SHI_0FNZJAJVC:?KEH+34[9;FWW!O+<G:2.02 ><&@#
M@]5T[3=#\:Z/H=NEI9Z=J:W-RR7:-/%<7?[L#<"X^;;N(YQD],X-1S^%[W3=
M/.GZ)JEC?S0:JUVFE7492V(,;%K9>6P &#J#PIP<=Z[O5_#FD:_IJZ?JUA%>
M6J$%5FRQ4CC(;.0??.:B3PIH<6G6EA#IT<-M9N9+=82T9B<@@L&4@ACD\YSR
M: /,=0.DZQHN@'^P5L)X/%L-M=V5PB.()&YD13C!0Y4\<&M@>%M%U?XHZWIU
MW:"2P&E6CK;K(RH&#N 0%(QC:,8X%=S/X8T6ZTLZ;<:?%+:M+Y[))EBTF<[R
MQ.2V>^<TZU\.Z39:F=1MK)(KLQB$R(S#]V.B8SC:.PZ"@#R_5+V?0;/XE3V+
MS1B/4+17=&)>.-UB$C*>H.UF.>W6NRN/#GAD7/V^S$0%YILD(M(-I@NHL;A(
MZ ?,1QAC_> [BM^#P[I-M+?2QV4>Z_&+O>2PGXQ\X)(/''/;BH=#\):!X:\[
M^Q]+M[0S?ZPH,EAZ9.>/;I0!Y=HT]MIO@KX>VW^A6EEJ;8OI9808Y9!$WE+*
M 5W MZGJH]*O>([3_A#;.^CM]65;/5-3L5O;:UB,,5C"[%9&3YCLWA>>>^1U
MKOQX,\-KHTVCC1K3^SYFWO;^7\I.<Y]L=L=.U26?A/0+#0I=$MM)M4TV;/FV
M^S*R9[MGDG@<GT'I0!RTNE:=IGQDT,V%I!;"72;D,L*!%;#1X.!QG!Z^P]*M
M?$1$6[\'S[5$@\0VT?F8YVD/D9]"0./I6U8^"_#FFW5M=6NDP+<6JE()6R[1
M@]@6)/;CT[5H:MH^GZ[8-8ZG:1W-LS!MCYX(.001R"/44 ><ZK#;OXI^(L*8
M"_V%%(RQMM_>;)3DX[]#^55;/3+338?A?JMI&8[^Z$,$\^XEI8VM22C$]5R!
M@=!CBO05\&>'4,Q32+=6F@^SR, 06CYRI.<X.3GUR<YJ4^%=%:*PB-D-FGD&
MT7S'Q 1P-G/&!Q].* /-=4LK8Z1\6H7A62.+$B"3Y]K?9@P(SGD$Y'I6M?:5
M=0V.@W.@:9I6HI;6!:YT68+&)@X3]ZAQM\P;<9(Z,?7GMXO#>D0OJ#)8H3J(
M*WFXEA.",?."<'CCZ<5#%X0T*WCMDMK 6_V9#'"UO*\3*IQD;E(.#@=^P]*
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MQY4[G(YP2/KUQ)?_ !#6W\30>'[>PB?49+!;SRKFZ\@N3TBCRIW/UX.T?K@
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M]0+A-V,C#'^=<;\.M170M=^)4MO;I+(FK^5:V@?R_-?S)@L:<'!/;C'K@9(
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M4,?E*Q2)0HR5!)P.] &A17COCDVUSH?C;4M/W3SV4Z*]]<N ]K,@C_=V^!D
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M-FV'J!@D=.*[/PWX>70/$.IM%J4)CO8TF.FVUN8H8"/E\Q1N;;NYSTR03VH
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MFEN-/\1W8M&>=SY7RJ.!GG@]\]!Z"O2J "BBB@ HHHH **** "BBB@ HHHH
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M(H5$+@#<1R2?5B!P!6CIET][I5G=R*JO/ DC!>@+*#Q^=6J &NB2QM'(JNC
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M-FWOG.:NT <W/9S>$],CB\*^'EO1+<9EM_MODK&&R6DR^>^,@<G.:T= TO\
MLC24MW\LW$CO/<-&,*TTC%W(]MS''MBM.B@"IJ6F66L:=-I^HVR7-I.NV2)Q
MPPSG^8!JG/X7T:XM[.%[)5%D2;9XG:.2$GKM=2&&>_//?-:S,J*69@JJ,DDX
M %<GKOC%[32-$U328H+JSU+4+>U,DC$821]NY0!S^)';K0!TME86NG6PM[2%
M8H]Q8@<EF)R6)/))/))Y-5M3T'2M9GM)]1L8KB6T8O SCE"1@_@>X/!K1HH
MQAX5T95U!1:-MU'/VP>=)^_R,'=\W/''TXZ5%J'@KPYJND6NE7VEQ3V=IC[.
MCLV8@. %;.X#  P#V%;U5+;4[2[O[RR@E#S6>P3A?X"PR ??'/XB@!VGZ=9Z
M3816-A;1V]K",)%&, =_Y\YK,UWP=X>\3303:QI<-U+!Q'(V591Z94@D>QXK
M<HH HQZ-I\5Y;745LL<MK";>#8Q58XSC*A0<8X';L/056MO"^BVB7Z0V$?EZ
M@S-=H[,ZSLWWBRL2"3W-4_%7B"\T&;0Q;VT$L6H:G#8RM(Y#(')Y4 <\ ]3^
M!K6A;4SJ]TL\=J--")]F9&8RE^=^\$8 Z8Q0!FZ1X)\.:#;74&EZ7':I=+MF
M,;MN9?3=G(')X!Q5VTT#2K'1CH\%E&--*E#;.2Z;3U7#$\>W2M*B@#$T3PAH
M/AR&>+2-.CM!.,2-&S;B/0,3D#DX /%)%X0T*#3[>PAL3%;6TQN($CFD7RI#
MG+*0V5/S-T/<UN44 94OAK1KC2;C2Y]/BFL[EB\\<V7,C'^)F))+<#DG/ ]*
M70O#FC^&;-K31[".TA9MS!,DL>G+$DG\36I10!1U31]/UJW2#4+99DCD$L9R
M5:-QT96!!4CU!!I(=%L+>SGM8H65+@YF;S7,DAQC+.3N)P ,D]!BI-1U.TTJ
MW2>\E$:231P)GJSNP50/4DD5;H HZ3H]AH=BEEIL'V>U3[D0=BJ<YX!)QR3T
MJ*]\/Z;J%Z;R>&3[2T(@:2*>2,M'DG:=K#(RQX/K4T+:F=7N5FCM1IHC3R'1
MF\TOSOW#&,=,8J[0!E77AK1;U]/>XTVW<Z>,6GRX$0P!M '&, <=.!3+GPKH
MMU?7%Y+8@RW( N LCJEP!T\Q 0K\<?,#Q4\>J+J-IJ/]D20S7-J[VXWD^7YR
MJ#M)'. 2 <=.?2K5D;HV%N;Y85O#&OGK"24#X^;:3SC.<9H SM=\+:'XEB@C
MUC3HKH0-NA)RK1GV92".@XSVHF\+:+<6UA;/8(L%@X>TCC9D6%AT90I&&&3S
MUY-;%% &9:^']+LM7N=5MK;R[ZZQY\JR-^]P,#<,X.!T]*GU/2K'6;)K/4;:
M.XMV(;8_9@<@@]01V(Y%7** ,#4=%AL_#NK0Z99R37=W;/&29=\LK;"JAGD;
M) SW/%4/!7A>'3?#.AK?:?)#J%C;(ACFG,BQ2A-K,BAF12?FY&#R?4UUU% &
M6?#ND?VM<:J+)%O[A!'+<(2KL ,#D'@XXR.<<9J*/PGH4>@G0UTZ+^S,[A;,
M2RJ<YRN3\ISSQCGFMFN<UCQ!>:;XP\.:1';0-:ZJ\ZR3,YWH8XF? &,<X'.3
MWXH T8- TVW@N(4A<_:5"32/,[R2*. #(Q+$#)P,]SZU5_X1#0OL%E8_8?\
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M[HP;UE*CG 4@G(Z'/->P6?AK2; QFWMW7RHC##F>1O)0XR(\L=@X'W<=!Z5
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M$%M,T4OSC( _A4DX&<=*KZ1H$NL+X)N(-.N+5K:#?JT[$Q^</+&,N"#*6?#
MY/<G&<'J]4\(6=MIFI3^'M*L(]8GLS;1R3+\K#!&&SG)P3R0<YYR*YC2O UH
MTUN;7P7<>'[J%T87G]J;A'@@G8$D.\]L,H!SSZ4 06^GCQM9^(_MFJ65G?V>
MISQM</;DW-BL;_NRDGF#8NP \  Y;KDUZ?9HK6UO,S":7R5!G,>UG& 2<=1D
M\XK(OO!'AG4];36;S1K:;4%P?.8'YL=-PSAL8'4'H*Z"@#RN^>;1/$+7>LZ;
M#J.D76L*]OK5J1Y]G)YH58I0>2@8;,@XQVS7JE9">&-(2Y:=;0[FN#=,AE<Q
MF;.[?Y9.W=GG..N#VK7H \UN+8>+?&/BO0[Z>Q#VRPI;175L97CA:('S(CO7
M:=Y;+ 9R%R>!1IC1W/C'2?#&JZ@-7L;?0_/A>X7Y;R42E"[*20Y55&,Y^\6]
MZZW7/!GASQ)=PW>KZ3!=7$(VI(V0V/0D$9'7@Y')J35_"FA:[':)J.F0S"S.
M;?&4,7LI4@@<#CIQ0!Y/J4$%O\.OB$MNJJEIX@Q;[3_J0#;C"G^$ 9&!T'%=
MSJ(C7XR:,J$*TNDW)E"G!;#(%)Q^.#3?"7AIXH/%.FZOHGD:;J.HR30PR&-D
M>!D10,(QV_</'&.*W;/P9X=L+BUN+;2X5GM59896+,Z XSR223P.3R,#% 'E
MFJVD#?"+X@))&)1;Z[=&$R_.4Q(@!!.3D#C-==XTTJS\/'2/%FG64,<>C3_Z
M9!#& K6S\.VT<;D+;Q^-=5%X5T2'3[^P6P0VFH,SW43LS+*S?>8Y)Y/<]>!6
M5JMAJ,<*>%]&T.%-%N;9HIK\W*@6X8D./+(+.VTD@YP2>: +GA>*&\:^\0(B
M9U.7="X'6!1MC/T;!?\ X&/2M?4H4N-,NHI-VQXF!VL5/3U'-300QVT$<$*!
M(HU"(BCA5 P *)X([FWD@E!,<BE6 8J2#[CF@#QFW@%S\-OAD[RS!Y-5MHV9
M)64E6$A/0]<@<]>*NZ@\OA'4/B''X?0VZPZ3;W<429*QRD2!I #WP,GUQS7H
M(\'Z"ME962V&+:QE$UK$)G A<=&7YN",G'ID^M6HM TR'5+C4EMO],N4\N:1
MI&;S$'12"<$#L.U '/6&D:"C:'XATF=DG:U=(! XQ?[H]W[W@ER-I;).0<YK
ME_#VFKXG\*:'XE;6[.UU""=)KB\BM#]I,V[#PNWF<AB=NW&,;0!T%=]HG@WP
M[X<NI;K2-)M[2:7(9TR< G)"Y/RC..!@<"F0>"/#-MK[:Y!HULFI,Q<S '[Q
MZMMSM#<GG&>: . ET'3]0;XF"[CDG%K(9(!)*Y$;_9@P89/W@>0>W;O4RVMK
MJVN?"V[U&V@NI[O2IFN))HPQE(MHV&XGK@DGGU->@CPMHZ_VABT8?VC_ ,?G
M[Y_W_&/F^;GCCZ<=*;+X2T&>TL+6;38I(-/.;1'+-Y7&,#)^[CC;TQVH YK1
MM/MKOXC^.[&X0S6T]M8;T=BP^9)<XR>/7CI6=X2C%S:1^!;Z)9+C1;]S=,Z_
MZR!"'AD^K[XQ[A7KT"VT/3K/5KK5(+<I>W0 GE\QB9 .@()QQV].U3Q6%I#?
MW%]% B75PJ)-*!RX3.T'Z;C^= 'FD>GCQN_BNUO-0LK:]L]1EA662V+7%G&F
M/*>-_,&P8&[(&"2V<\UZ5IA)TJS+7)NF\A,SE=IE^4?-CMGKCWK*U/P1X9UG
M5X]6U#1K:XODP/-8'YL=-P!PW_ @:WZ //?%FFV^H?%#PM:W+3&"YM+T31+,
MRK(%6/ (!Z<G.,9Z'(KGGL3HF@?%/0K1I/[%L[7?9QLQ80M);EY$4GL"5..V
M?>NM\2:'>:K\0O#EY_9MQ+I]C#<K-<Q3K&8VD";2N'#\;3G'KWKHF\.Z4^DS
MZ6UH#9W!9IXR[9F+?>+MG+$]\DYH Y!DLM1U'PUIS1?;KQ=&\[[%<D?94C(1
M3*X()+9^50!W/3K7*6RM>_##P.9KF=I%\116X=)F!V?:I% Z]@HQZ8&*]3G\
M'Z!=-8M<:9%*UBACMV=F8HG]S)/S+_LG(J-?!'AN.UCMH]*BCACN?M2)&S*%
MFSD.,'J"3CTSQB@#D8]-@TKQMXNTK3+G^R[6XT*.X:16.V&8F53-UZ@ $GOB
MK'@^9[#Q4ND:SH,.EZRE@VRXL2#;7L2LFYQP"&!QP>>?I773>&-'N+RZNYK/
MS)[NW-K.[RN?,B((*'GIR>*DM?#VEVA8QV[,S0F#=-*\I$9ZH"Y.U>G P.!Z
M4 :*.DJ*\;JZ,,AE.017(_%7_DEWB'_KU/\ ,5TNEZ99:-IL&G:=;K;VD"[8
MHE)(4=>_-,U72+'7+%['4H/M%J_WXB[!7^H!&?QH CTZXAM/#-I<SR".&*S1
MW<]  @)-<Q8H(_C5J6TOB30X9"K,3AC,X. >G ' ]*VAX)\/!(D.G[HX65HX
MWFD9%*G*_*6QQ@5</A_3#JTNJ^0XOI8O)>=9G#%/[O!Z=\=CS0!Y/\.+N"ZM
M/#NC^(+55LBD\VDLV#'<S":3S ^1]]0?E7H1D\G&-Y[)?&'B+Q=HM[<6,<]K
M(D5O'<6IDDMX#"I62([UVG<6.0,YQD] .N_X0KP[_9EMIO\ 9J?8K6;SX(?,
M?;%)R=R\\'))X[DTFK^"/#6O7D%WJND075S H1)9"VXJ.S'/S#V;/4T <AJD
M-OX:O/"?B>YOEO[18_[,U&^D3 F1UQ'.PY_B4 MSD/UQ5'P]$T5YJO@J\LEA
M;4KJ/48$*\K9R9=T)]4V-'GL77%>IW>G6=_9?8KJVCEM<H?*9?E^4AEX]B!^
M5.-A:G45U P)]L6(P";'S!"0Q7Z9 - '%"&.U^,URL3M#&?#8;@DJA\\C(!X
M' ' ]*Q=!FN] U;3M.U?1H6U0VDXT[6+%MT>I;8]Q\T?>#D*&R<Y.<=>?17T
M#3'UA]6:VS?O#Y#3>8V3'UV8SC;GG'3//6F:?X;TG2Y('M+4J;=#' 'E>00J
M>H0,2$' 'RXXH \]\.Z7'XB\->&_$PURSM[V*6*6>\AM#]HFE/RR02/YGS!F
M.-N/3  P*]426.0N$D5BAVL%.=I]#Z&L*U\$>&;'77UNUT:VBU%V+F90>&/5
M@N< G)Y SR:?HOAJUT;6=8U*WAC@?4I%>5(V8AF!8[SG^)MYSC@8'7K0!>UN
MWANM"OX+B&.:)[=PT<BAE;@]0:\E6RM8_@_X($,4<+W&HZ:TKP@(S$OC<2.<
M^]>T$!@00"#P0>]8">"/#<5C%91Z5'';13">.-'90L@.0PP>H[>G;% '%WBM
MX4\6^+TT"(P_\4V-06%26#7"M* ^#G+<#/K5S1-$M;S_ (1GQ-9ZU9P\*"]K
M:D27V]<&.5C(2YSDDD$@@GC!KMH]!TV+6&U9;<_;WB\EIFE<EH_[IR<$9YQZ
M\U2TGP1X:T+5)=2TS1K:UNY,YD0'Y<]=HSA<^P% &_7E^DZ1IO\ ;_Q&VV<$
M;I*@C>-0C+NM@S;2,$9.2<=>:]0K(F\,:+/J-WJ#V$?VR[C$4\RDJSJ!CD@]
M<<9ZXXZ4 >;:7I&A6/PGTS6;M[Z.]O["UM))K><^;,&D4K$-QV@$_*3QA2>:
MEDO;[PUKWCA[&VMK62#0XKR.TM.8DE D&[& "< $\#.*]#;PKH;^'CH+Z?&^
ME8 %L[,RK@Y&,G(P1D8Z4EGX3T"POUOK72K>.Z$/D>;MRQ3G@YZGD\GDYZT
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M'&RLO/!SWZX&*Z#Q"NJ-)::RFFVOB&S728A>Z;(P6>+=N8S19XRW((X)V#%
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MNK9HOLNGVOEQWBXW!V^=@2O]['?&>:[:@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "J.JZ18:Y8O8
MZE!]HM7^_$78*_U (S^-7J.E $%G9P6%I':VRLL,2A44N6V@= "23BLZ?PKH
MMS>SW<MBOFW./M 5V5)\=/,0':__  (&M2&>&X0O#*DJ@XRC!AG\*%GA=PBR
MHS$$A0P)P#@_KQ0!2N]"TV^U*TU&YMR]W9Y^SRB1@8L\';@X&1P?4<&FVWA_
M2[2[OKJ&T FOQBZ9G9A-QCY@20>./IQ6A--%;QF2:5(T'5G8 ?F:/-C$8D,B
M[#C#9X.>G- &%I7A'0O"XNKG0=&MX;J1&P%8C=WV G.T$XX''MQ4>@6VIW^H
M-KVN:7%IMZ;<6L-JLZS-&F[<Y+J #N.W@= H[DUT*31R,ZQR([(<,%8':?0^
ME.9E12S$!0,DD\"@ 90RE6 ((P0>]<U'\/?"<055T2W\M)Q<)&2Q1'YY52<+
MUZ  ?E5OQ-J\^G>$-3UC2WMII;2UDN$,F7C;8I;'RD>F.M6]*U#[3X>L-1NW
MCC,UM'+(Q.U064$]>@R: (+OPQH]]>O>368%Q)&(97BD>/S4'17"D!U]FR*U
M8XTAB2*)%2-%"JBC 4#H .PH$B-&) ZE",A@>,>N:I:AK6G:9HUQJUS=Q+96
MZ%WE# C [#U/8#UH J#PEHBVU_;"R/DZ@Q>[3SI,3L>I;YN2>A]:?/X8T>XM
M[*&2T.+'_CUD65UD@&,860$,!CC /2I+FXO;A=-GTV>S2"293<BX!+-$5/RI
M@X#YQUXZU?DN(861998T9SA S %CZ#UH HR>'])FT:;2);&)[";/FPL,AR3D
MECU+$\YSG/.:MV=G;Z?:1VEI$L4$8PJ+V_Q^M2LZJ5#, 6.%!/4^U)%+'.F^
M*1)$SC<C B@#GE\ >%%B\L:':>6)Q<!<'"N"3D#/ Y/ X]JQ=&\+23^,/%=Y
MJNDW,%IJ$L)@<7(598UB5"K+')DC(/##&#[FNNO=;L+#5+#39YU6[OF<0QY&
M2%4LS'VXQGU(JY)<0Q.B22QHSG"*S %C[>M '%^)] N=0\8>$Y+?299-+TTW
M'G/!*D0B#1A4V_.K#! ^[TKI1X?TO^S;G3_LN;:[)-P#(Q:8D8.]L[FR..3T
MXZ5IURWAGQ%=ZCJ'B"VU1K2,:=J/V2%HP4#*45AG<3EOFH -4MM5L;:V\/\
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M$6JV[?93IMFR1)(B,)&D*ABIYQ\H9>>Y/;%:T5Q!.7$,T<A0X8(P.T^AQTH
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MTS1KNXMY;9;N.!Y(4G/RN5&<8!!/3M3/"VISZUX2T?5+D(+B\LXIY!&,*&9
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MCCZ=3["KDMQ! BO+-'&K' 9V !- &;=>&-#O8[".XTRV>/3_ /CT79@0C&,
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M8(^F@ +;R,S*@'3;D_+CMC&.U20:#IUO!<11PR'[2H2:1YW>1U'0&0L6P,G
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MLGLH3;7[.]U'CB5G&&)]S@5=:6./AY$4[2W)QP.I^E*DB2HKQNKHPR&4Y!%
M%/5-'L-:TY]/U&W$]F^-\)8A6QT! (R/;VJ&Z\.:1>SV,]U8QSS6.1;22$LR
M XR,DY(X'7/2M":>&W3?-*D2DXW.P49_&G221Q1F21U1%&2S'  ^M &,/".A
MK:WUJ+(^1?N7NT\Z3$['J6^;DGOZUJ6MG!9V4=G;JR01IL1=Y)5>P!)S4BRQ
MM%YJR(8R-V\'C'KFD6>)Y#&LJ,X 8J&!(!Z'% &$G@?P['///'IY2:X<R3.L
M\@:1O5B&Y/UJ9_"&@R:0NE-IR?85E,PA#L 7SNW'G).><FM9KB!2 TT8);8
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MD T>Q\JS.ZV3R%Q">N5XX/N*DO?#^D:E=BZO-.MI[C9Y9D>,$LG]UO5?8\4
M>2Z1;2ZM:?"V77(_/N9GNXGDESNEA$4FS<>I!4*<'KGGJ:['P-;0:=XQ\;:=
M90QV]E#>6[QV\2A40O I;"C@9-=9=:)I=[<VUS=:?;33VO\ J)'C!:+_ '3V
M_"EM-&TVPO+B\M+"W@N;CF:6.,*TG^\1U_&@#CO%]G83?$WP4UW;6SJZWPD,
MJ*0P6)2,YZXY/M57P_!9>(U\=6^OQ127*:E- _F@;HK4(/)*D_=7&6!'?)ZU
MWFH:1INK>1_:-A;7?V=_,B\^(/L;U&>AJ*\\/:/J%X;N[TVVFN"GEM(\8)=?
M[K?WA['(H R?AQ<:C=_#O0I]59VO'M06:3[S+D["?<KM/XUPUUH^G:CIOQ3G
MO+.&XE@GG:%I5W>4PM5(9<_=.0.1SP/2O8    !@#H!66/#.AJEV@TBR"7G-
MRODKB;_?_O?C0!Q5I<VFHZIX>AEV3ZI_PCBSRO?-NMXX7V!GV=7<E<=1\N<G
MIG$TO2#KGP)T>[MDBN-6T<F]L]P#',4SD)]&52N/IZ5Z>_A;0)&LF?1K%C8C
M%J3 I\D>B\<#VJWIVEZ?I%LUOIUE;VD+.9#'!&$!8]3@=Z .#U#4WUGP5K_C
M31XF6>33#'I\@3]XJ*I9V'<'<6'_ &S4T_1M.T*_U+PWKVG:W!O2-H[>&SB1
M#.C)EDD R2%QGGH0>]=];6EO96D=K;0I#;Q+L2-%PJCT K/TSPOH.BWDUWIF
MD65G<3\2200JC,.N,CMGM0!E_$K_ ))IXC_Z\)?Y5?T2[M[+P3IEW<S)%;Q:
M?"[R,> HC'-:.H:;8ZM:M:ZA:0W5NWWHID#J?J#P:S%\$^%DV;?#NECRR&3%
MJGRD=".* ,"&"#_A=L[+ J?:/#:M*I498FX(^8=SC _"N9MHAI?@[XD7VDVD
M45[;:K=I%)!&!)''LCW!2.1@;CQ7JAT73#JAU,V%O]O*>6;GRQYA7^[NZX]J
M;8Z%I6EO,]AIUK;-.2TQAB"^83U+8ZGW- '(:1IFAW>N^']>T[6[<N(9(H(;
M&)(Q<1LF2L@&3A<9YQ@^YJKXTG;P7XXTSQA%!)+:7T1TS4(HADLV"T# >NX;
M<^F!79Z5X8T+0[F>XTK2+*RFG_UCP0JA8=<<=O:M"XM8+N-8[F%)45UD577(
M#*P93]00"/I0!S&HQ6_A_P"&NHG6)9P/LDLM]+:'$ADDR9"A['<Q STX["N:
MTR**V^)FB0,EA!#/X?DC-M 0P\O?&$5VX#GDX.T=3C->G7%O#=V\EO<1)-!*
MI22.10RNIX((/45EVWA/P]9FV-MHEA$;8,("ENH,>X8;!QQG% 'C_P#9&G0?
M!BZU6*TB6_L]68VUSCYX<7P "-U48)X&!S7;BWTZ'XU:A//;VRE=$@F#M&N0
M_GN-P_VN@SUZ5U/_  BGA[^SVT_^Q;#[$S^8UOY"^66ZY*XQGWJR^B:5)?VU
M])IUJ]W:IY<$[1 O&OHK=0* /)89K)8? .H:<8H+*;6',#S2![N5'64N\KC
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MO(-/MH[FZ&)Y5C :7_>/?\:JKX1\.):PVR:'IZP02^=%&+=0J2?W@,<-[]:
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MQ766.BZ7IEQ/<6.GVUM-<',TD485I#ZL1U/UJ:^L+34[*6RO[:*YM91B2&9
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M8^)\*K9^^<' .T<'I6MX?\$Z?;/=2R^'M/TRVNH#!-I\#^:DP)!W2# 7(Q@
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MC!/N:-1\+:#J]K;VNHZ/974%M_J4EA#"/V7T'M0!Y]:?V?H&M^#=#N-3>^T
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MC#;R?"'PUK>B!?[9B>R>VG3_ %LD[NJ2JS=6W%GW ]<'- 'K4EQ!"&,LT:!
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M4?/,IM2<.W5N0,9Z8XJO?Z9/K.F^-M""07M]>:J3;WIFC"P\1[58D[@8@,8
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M*TU&'P]JNI7MY?/86\<MI!*4$43E!\^$5=Q'8L3B@#K'N(8Y4B>:-9'^XC,
M6^@[USNLZ[J&G^-O#6E1+;FQU,W F+*?,4QQ%Q@YQ@G';M7'Z5%::_X%\92:
MW''_ &G%>7@N9)!^\@,>3$5/50JA2N/3ZU+;3W]QJ_PJFU7=]ODMKEIB_P!X
ML;4<GW]?>@#T*T.H?VGJ NIK1[3,9M$B4B1%V_-YF3@Y;.,=JM+<P.\B)-&S
M1_? <$I]?2O)=2DN=(;XL3:,AAN(TMG3R1@KF %V&.AP6.?7FNNT^Q\'W]YH
M6IZ:T!=K5X+:.W8;9867+"11]X#'?HQ]30!UPFB*%Q(A4=3N&!3@0P!!!!Y!
M%>4Z?8II5_J7PU^RC[)>70N[5@GR_87)>53_ +I5HP3S^\7TKU5$6-%1%"HH
M 55& !Z"@#GO&^OW'A[PIJ.H6$EH;ZV@:9(KC)# => 0:V8;Q!IT%U<RQQ!X
MU9F9@JY(]Z\=DDM-<^!_BC4-2CADUGS;IKTR ;XIED(1>>1M78 /2NHTV=;W
MXF1Z?J2));IH,4NGQR ,C9;$K 'C=]T>N![T >A@A@"""#R"*9-/#;1^9/+'
M$F<;G8*/S-<9\.8IK0^)+!"?[+M-7FBL%)XC3 +(O^RK$@>G([5)K\EE<>/-
M-L@B2:E'I\\R_:F_T:*$LJLY3^-^,  CC=DT =B9$"ABZ[6Q@YX.>E)'-%,&
M,4B/M8JVU@<'T/O7AEG#:WGPT\"K,R.R>)$A#HVUEC-Q,H"D'*C &,'L/2N@
MOO#MAI'CW5K/2;**#3+OPY++?6D2@1>8'Q&^WH&.&_(GUH ]16X@:18UFC+L
MNY5##)'J!Z5SNEZ_?7'CG7]&N_LRVEA!;RP.BE6/F;\[B20?NCIBO-V\/V,/
MPO\ !NO:7;K'XA66P$%RA_>RLQ56C)ZE=N?EZ +Z5V>GVMO??%'QC:74*36\
MVG6221N,AE(ER"* .Y\Z+9O\Q-O3=N&*<2 ,DC'7->5^&[7#CX<7=N'32;W[
M0SO'\LMDI\R$D]"Q<HI'<*U>IO''+$T4B*\;+M9&&01Z$>E %'1M;L=>LC>:
M?.LT EDB#J00Q1RA(]LJ<'N*N0W$-P"89HY IP2C X/IQ7B-I-%I?P@LY88X
MHHIM:,6IO&H5OLGVQPX8CG;C:OT;'>NVU2S&G_%/PM+H\20B\M[J._2$!5D@
M1%,;,!QP[  _[6* .VNKJ"QLYKNYD6*W@C:221NBJ!DD_@*QA?:QJ7A=]1L#
M9V=S<(LMHMZK%(XR0<RX.<E><#&"<<XR<CXO&<?"K7_L^=_DINQ_<\Q=_P#X
M[FJ_Q9@MI?A+J;>6C+%'"\)(^[^\0 CTX_G0!T^H:PVDZK8Q7@3[%?RBWBF'
M!CF()56]0V" >,' YSQKUPGQ>WCP!*T&?M2WMH;?'7S//3&/?K7=.BR(R.H9
M&&&4C((]* .-\2>-?)\"ZSKWAV:UN'T]G3,P+HY1MK8VD9YZ'VKK;>XCF4+Y
MB&4(K.@/*Y'<=J\7-O90?!/QB8H;>.<W5\A*J VU;C@>N!D?3(KJ)M-L](^)
MWA*33K6*WEO+"]6Y9!AI]JQL-YZL<G.3DT >A?:(1.(/.C\XC=Y>X;L>N.M2
M5X[H%OIOBCP=87NHZY':ZK:7GG7!CB1;N.[#D%<GYB6/ &.00!7KMR56UF+R
M-&H1B77JHQU%  ES!)(T:31LZ'#*K D'T(H2Y@DF>%)HVE3[R!@67ZCM7F&@
M37'AK5M'T[7K*TN(193+IFNZ?P9HEC#L)5ZABJAL@D$_C6=8O:0WOPYO+(PV
M]E+/.8#)('N7B:)RS2N,#)."1@X/<T =_P"']=U#4/%GB;2;Q;?RM+DMU@:%
M2"RR1[_FR3D\@<8Z5T4=Q#+(\<<T;O&<.JL"5/N.U>5:K=7ME>?%BYTXN+J.
M&T96C^\H^S#<1[@9/X5LZ1IN@WFM^'M>TW6H"XA>*WALHDC$\;)DK(!DD+C/
M/0^YH ] J..XAF9UBFC=D.'"L"5/H?2N4^*%Y?:?\.=7N=/,BRJB!VBR&6(N
MHD(QT(0MSVZUF>(;.VL_$?@B_P##L<,4DUW]G/V90JRV9B+-G'50%4C/0GWH
M T[OQ!JVIZSK6E>'9=/CNM*2 _Z8K,MP\BE]N58;0% YP>3[<];&7,2&0*),
M#<%.0#WP:X+PIIUA'\3O&K1V5LKP261B*Q*#'N@YV\<9YSCK7?T %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 53U/2M/UFS-GJ=E!>6Q(8Q3QAUR.AP>]7** ,C_A%O#_[_P#XDNGC
MSXE@EQ;J-\:\!#QRHP..G%//AS1#]CSI5F?L7%K^Y7]Q_N?W?PK4HH *S+3P
M[HUA=?:;33+6&;<SADC VLWWB!T!/<CK6G10!PVD^%#-XQ\3ZCK&D1M;:C)"
MUNSLC$HD01E< ]"1G'(]:ZN_T;2]5AAAU#3[6ZB@</$DT2NJ,.A (XJ]10!2
MBT?38-3DU**PMTOI1MDN%C D8>A;J14-MX=T:SO#=VVF6L4Y<R;TC PYZL!T
M!/<CDUIT4 9O_"/Z.+BZN!IEJ)[L;;F01#=,/1C_ !?C5FPTZRTNT6TT^UAM
M;9/NQ0H%5?H!P*LT4 96K^&M#U]X7U?2;.^:$_NVN(0Y7V&>WM5L:98B^CO1
M9P"ZBB\F.8(-RI_=![#VJU10!G6WA_1[-;M;;2[.);S)N0D*@39Z[^/FSD]:
MAL/"N@:59W-I8:/96UO<_P"OCCA4"3V;U'M6O10!2M=(TVRTXZ=;6%M#8D%3
M;)$!&0>HV],&H-,\-:)HMM/;:9I5I:0SG,J0Q!0_UQUK4HH R5\+Z"EE%9QZ
M19QVT,GFQ1)"%6-^?F7'W6Y/(YYJ=M$TM]+DTQ]/MGL9<F2!XPR.2<DD'J2>
M<GG/-7Z* ,JV\,:'::--H]OI-G%ITP(EMDB 1\]<CN??VK2BBC@A2&%%CBC4
M*B*,!0.  /2GT4 9RZ!I":H=473+4:@PP;H1#S"/3=UQ0= T@ZJ-4.F6IU <
M"Z\H>9CTW=<5HT4 9DOAW1IM0>_DTRU:Z<JSR&,9<K]TMZD=B>15ZXM8+N(1
M7,*2QAU<*ZY&Y6#*?J" ?PJ6B@"+[+!]K-WY*?:#'Y?FX^;;G.W/IGFL[4_#
M&A:U=PW>IZ197EQ!_JY)X5=E'7&2.GM6M10!#<VMO>VLEK<PI-!(NUXW7*L/
M0BBZM;>^M9+6[@CGMY5VR12J&5AZ$'@U-10!D6GA70+#2YM,M='LH;&<YF@2
M%0DG^\._XU%JOA;3-1\.'0UL+-+(X"1-""D6.A5>F1V[?R.Y10 R&%+>".&/
M.R-0BY.> ,"L^7PYHD]S=W,NDV3SWB".YD:!2TR_W6..1P.#Z"M.B@#*/AK0
MREHATFR*69S;+Y*XA/\ L?W?PI+GPOH-[K$6KW.CV4VHQ8*7+PJ7!'0YQU';
MTK6HH *RI/#.A327DDFCV+O>X^U,8%)GQ_?X^;\:U:* ,VY\/:-=Z2FE7.EV
MDNGQD%+9X@8TQTP.@Q2V^@:/:33S6VE64,D\2PRLD"@O&!@*>.5 P,=*T:*
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M'&%>3_>(Y/XUH444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
' %%%% '_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>25
<FILENAME>insidertradingpolicy012.jpg
<TEXT>
begin 644 insidertradingpolicy012.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M#:7D,TJ*':-6^8*>C8ZX/8]#7 3'P5KD.LZM#JUW?++I#VU]?12Y$,!((!X
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M!"66619!B,KU#?W2.^:\7T;5HM/\#>#-2FN)H]*LM3O%U"2WY:V9WF$;L,'
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M=,2X,82S&U?W19>N.N3SS7-^%=?\)^(K#PTEND4^K6$06*U (ELF";)-P_A
M (R>#QCDBL6Q.DW>B^/K>[U/[%;OXB'^E0.N8'+0".3TP) ,]N#0!Z;:ZQIU
MZ+@V]["_V< SC=@Q9&1N!^[P,\]J;8:YI6IW$MO8W]O//$H9XT<%@IZ-CT/8
M]*\NU>^\1OX>\4:?>QV^I7E@EE,^H:<FTW=N)=S(R\@.$#D@<8;TQGIO#UWX
M5\0^);/6=)U2XU348[5HS)YG$$3<[9   "6Q@'G.2.AH [:YNK>RMWN+J:.&
M%!EI)&"JOU)JK;:YI=Y#<RV]_ ZVO_'QAP##QGYP>5XYYKEOB/--9/X:U"0'
M^RK35XI+\CI&N"%=O]E6()].#351+KXO1:GITT;6L6C-'?RQL"A)D!B5B.-V
M-Q]<>QH BT#7;WQA<RW>F^(8[9K74Y$-BL<<B2VJ/LYXW MU# X&>E=I?:I8
MZ:(_MEU'"921&K'YG(&3@=3@<\5R'PKNK>XT#5/)GCD_XG%ZWR,#P920?Q!!
MI_BC6-/L?'.B6UR]O87+VD[1ZG<MPBY0-%&"=I=N#ELX Z'- '86=[:ZC9Q7
M=E<17%M*-T<L3AE8>Q%5K_7-+TMF6^OX+<JGF/YC@;%_O-Z#@\GTKDOA%<PR
M^"WMXYM\EO?72R*1ADS,Y 88&#CG&!UZ5G^,6GLM7UW5-%U:T:X@M$&J:+J
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M][>)9F.6\C/$,)8,$<]%)/.T\\&@"[HNI6UOX;M[JZ\00ZI&SNJZ@ BB8[V
M50G!(QMXZ[:OQ:SIDUC)?1W]NUK&Q1YA(-JL#@J3V.3C'KQ7E/AF.TOOA7X6
MBAUT:5?IJ4YL+I=KHL^^?"NIX(9"PQWR*6_UW4ET:RU+6;=8(=+\0F/5+K3
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M\4 7(K6W@V^3!%'MSC8@&,]>GK@5(0&!! (/!!JA)KFF1V=M=B[26&Z&;<P
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M+]"GU[P??Z'8&W@:ZB\D-)D+&OJ  <_3BM33;3[)9QJ\$$5P5 E,/1F QG.
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MUXZBO5:* /,8;RU7Q+\3B9X@CVUN5.X88BV*MCUP< ^^!5*UCL[KP7X&\OQ
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MMWN989(9WMT&6FC257=0.^0#QWZ5UU% ' SZSI'CG2M2G\+1BXU9]+GMTO3
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MS8E:'5+%I%R 4VAMY/IC/)/3/-5?&>K07WASQQ9QHUC<0WP)L;>W):X :/\
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MJW"[>#WKG)6M-1\#^);OP]J,6KWLVJ1:I>6=BS J@DC)C7HW*QGYL#)SCTH
M])A\4Z+--<P_;EBEMHA--'<(T++&?X\. 2ON.*KVWC?PU>7-E;V^KP227O\
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MAL;L6EV\96&X,8D$;8X;:>#CTJU10!E:%I,^F6\KWU\;_4;A@]Q=&(1AR %
M51]U0!T]23WK5HHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MVY!/ R20,]ZMOXP\0Q>)_#7@VZ%C#K=[;/<ZA<Q(7CB4!RH121DG9R3P/0T
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M<'IG'3FN"U'X9:K+K_BNZT_5[2&S\16WE3+- SR1MMQ\N"!@Y//H>G>O3Z*
M/+=5^%FHZE\+](\'C4[6-["?S6N?+8AP-^ %[??]>WOQUOC+PE'XU\'S:+>2
MBWED"NDT8W".1>0<'&1U';@UTM% '&Z-H'BJ#PO-I6LZQ873BS:T@:&!ESE=
MH>1B220.P [YSVY)_A!JC>!M%\-C5K,'3+]KWSS$W[S))"XSQ]X\Y]*]?HH
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MRH-,.@+'>2*PV-=#?MR>A81XSZ!AZUD?:+4>!OA2QFAW#4+(9W#(Q"X/ZX%
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M5H5P:/:Q?'"..%H4W>'"-J$#.+@8&![9Q[5WE !1110 4444 %%%% !1110
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MNMFRZK9%;X@6I$Z_OR>R<_-^%*^O:/&UXKZK9*UE@W0:X4>1GIOY^7.#U]*
M+1M+9A@V\1&2V"@ZGJ:/LEL6W?9XLGC.P51M_$NAW7G^1J]C)]GB6:;;.O[M
M&&59N> 1ZUB>+?$H'@;7=1\/:K!]LT^!G+1A9#&P&0&4],CU% '3O86<D1B>
MT@:,]4:,$'\/PJ9$6-%1%"HHP%48 %9&C^(M,U!XM/35+2;4TMTDGMTE4R+P
M,DJ.G)_6K$>OZ1-?K8QZG:M=,S(L0E&69?O*/4CN!R* +:VMNCAT@B5Q_$$
M-221I-&T<B*Z,,,K#((]Q5&37-*BO19R:A;+<&01",R $N>B?[W?'7%)<Z]I
M%E>)9W6I6L-P[A%CDE .X]%^I[#O0!<2UMX[<6Z01+".D:H OY=*:;.U( -M
M#@=!L'%2R2)#&TDKJD:C+,QP /4FLA/%OAR6ZM;6/7=.>>[_ ./>-;E"9>2/
MEYYY!'OB@#4>VMY)HYG@C:6/[CL@++]#VK#GTK6K_P 0EKZ^LSH44D<\%K'"
MPF9U&0'<G&T/\W SD+Z'-2RU743\3M5TF>[#Z?%IL-S%%Y:KY;,[*>>IX7N:
MVK3Q#H]].8+74[2:41F7:DH)*#@L/5?<<4 :50RVEM-*)9;>*20*5#L@) /4
M9]*S/^$N\.;[=/[=TXM<R&* "Y3]XX."%YYYX^O%;- $4MK;SP>1-!%)#P/+
M= 5XZ<'BGHBQHJ(H5%& JC  J@^O:1'?+9/J5JMRTGE",R@$OUV?[WMUJ*]\
M4:!ITLT5[K5A;R0E1*LEPJE"QPNX9XSS^5 &B;6W9RY@B+GJQ09- M;<1/$(
M(A&_#)L&&^H[U!JNJV>BZ7<:E?S+#:VZ%Y'/H/3U/M5'2_%&EZEX=M=9^V6\
M4$R1ELS*?+=E!\LG^]R!CK0!K0P0V\0B@B2*->B(H4#\!3HXTB0)&BH@Z*HP
M!5>PU*RU2 SV%W#<Q*Q1FB<-M8=5..A'H:9>:OINGS1PWNH6MM+*&9$FF5"P
M4$L0">@ ))[8H L&UMR9"8(B9""_R#YB.F?6N9T[PQ<Q>,]=UB_AL)K74?L_
ME)DN\1B4J#RN.<YXZ>]:</BOP]<:6^IQ:WI[6$;['N1<IY:MZ%LX!JX^K:;'
M>16<E_:I=3(9(X6E4.Z@9+ 9R0!SF@##\0^'KW5_%'A_48ELVM=,>=I8IW;,
MHDC,9&-I' .>>OM71K:VZ0+ L$0A7I&$&T?ATK/M_$^@WEW!:6VLV$UQ.7$4
M<=PK-)L^]M /.,'/T/I3H=<TO49WLK'5;5[LQEE6.16;'3<!_$ ?PH H:QHV
MKZC>I9V]Y96_A^6'9=P" F=_F.X*P(4!E^4\9&3W((Z(  8 P*X;P)XS@OO#
M&DC7M:M#K-[+.J)(Z1O+MGD1=J#'90!QSCN:ZB\U_2-.N#!>:G:P2C;N624+
MMW'"[O3)Z9ZT 7S&C2+(44NN0K$<C/7!J/[);"Y^T_9XOM!&/-V#=CTSUJO?
M:UIFF-MOK^WMCLWGS9 NU?[QST'N>*2_UO2]+A26^U"WMT==ZF20#*]V^@R.
M>@S0!?J&.TMH7E>*WB1I3F1E0 N??UJO<:UIEK##-/?VR1S)YD;F08=."6!_
MN\CGIR*M6]Q#=VT5S;RI+!*@DCD0Y5U(R"#W!% ");P1JRI#&H888*H&?K2P
M6\%K$(K>&.&,<A(U"C\A5*\U[2-.G\B\U*UMY?ERLDH7;N^[G/3/;/6L/Q?X
ML@T6^T?3%U""UFU"Z$<LK.@:"$*S%P&R!DJ%!(QR: .H@MH+966W@CB#'<PC
M0+D^IQWI#:6Q7:;>(J"3@H,9/4U1T&WU"VL9%O\ 5EU,-*SV]QY2HWDG!4-M
M^5B.?F &>.*DM=<TJ^NA;6NH6TTY0R+&D@)900"P'=<D#(XYH M36=K<*BSV
MT,JQG*!T#!3[9Z4Z2W@F(,L,;D< LH.*I0Z_I%QJ(T^'4K62[(8B%906;;][
M [X[XZ=Z637M)BOUL9-2M4NG?RUB:4!B^,A?]['..M %K[);$L?L\66ZG8.:
M6WMH+2/R[>".%,YVQH%&?7 JF-?T=K>ZN!JMD8+1MMS()UVPGT<Y^4_6H[CQ
M-H5HL;7&LV$:R0_:$+7"C=%C.\<_=QCGIS0!J,JN,,H89!P1GD<BC:N_?M&[
M&,XYQ7/PZW83:S+>1>)[2:Q73UE-E&8VV#=GSRP.[!! QTK/7QAIGB/PC_:&
MG^(K;1_,E 2>0QNR 2$ %&[NJG@\C=[4 =:+>%93*(8Q(?XPHS^=--G;$ &W
MA(!) *#J>M5]1UK3-(4-J-_;VH(+?O9 ORCJ?H/7I1<ZUIEG%%)<7]M'',GF
M1L9!ADXRP/\ =Y'/3D4 65MH$D\Q88U?^\% /YTKV\$CAWAC9QT9E!-$$\-S
M;QW$$J20RH'21#E64C((/<$51'B#139W%X-6L3:VSF.>;[0NR)AU5CG"GD<&
M@"[-:V]R4,\$4IC.Y-Z!MI]1GH:;/9VMRRM<6T,I4@J9$#8^F:IS^(]$M6VS
MZO8QMY/VC#W"C]UQ\_7[O(YZ<U+;ZUI=WI/]JV^H6LFG[2WVI95,8 ZDMG Q
M0!AW?ANZN_B!'KDT5C+IZZ<UBT,C%F.9 ^_!7'&,8S[YKI_*C\KRMB^7C;LQ
MQCTQZ5QNG^)9M0^*<NE6VIQW.F+I!N?(15S'-YJKR?O?=P<'^]GTKHX?$.C7
M%Z;.'5+1[D*S^6LRY*K]XCU [XZ4 7H;>&VA$,$4<40Z(BA0/P%)!;06L92W
MACA0G)6- HSZ\5GVWB?0KV[@M+76+&>XGW^3%'<*S2;,[MH!YQ@_D?2H/$?B
MK3/# L1?SHCWMU';Q*S;?O, S$]@HR23Z8[T ;4<:1)LC144?PJ,"@1H)#($
M42$8+8Y(],UP\/BY;+QQK4>J:W:IHD5C;7%L\A1$4R%^C?Q9"C'-=<^K:?'I
M\=^U[;BTE ,<WF HX/3:>^>V.M $T5I;02R2PV\4<DAR[H@!8^Y'6L+QUH-[
MXF\*7.CV+V\<EPT9,D[, H217Z '.=N.W6MFPU*RU6U%UI]W#=0$E?,A<,,C
MJ..X]*KWOB'1=-EEBOM5LK:2&+SI$EG561,@;B">!E@/J10!:M+:.WB)2V@@
MD?YI%A P6^N!GZXIRVMN@ 6WB #%P @X;U^OO7(>./$DL/P^FU_PWJL)59(0
MD\(2575I5C8 G(_B/XBNEU#7=*TI]E_J-M;-L\PB60*0F<;CZ+GC)XH N1V\
M,))BAC0GJ54#---I;%=IMXBN2V"@QD]3]:JW.O:/92I%=:I90R/&9E62=5)0
M#);D_=QWZ5+INJV&LV2WFFWD%W;,2!+ X=<CJ,CO0!+):6TWE^;;Q/Y1S'N0
M'8?;TI9+>*1O,:&-Y /E+*/PYJ0C*D D$CJ.U<;X-U?5=5USQ-;7][YL.F7Y
MM8%6)5)7:#EB!R>>V![4 6?"?ABXT>;59=2BL99;O4Y[^&2++-$)"#LRRCIC
MJ.OH*Z=H8FE65HD,B@A7*C(!ZX-<?X4U?5=1\8>*-.O;[S;72IXHH%$2*6#I
MN)8@<D<=,5T5OK^D7=X+.WU*UEN&!*QI*"6 ZE?7'?'2@"Z+> 1I&(8]D9!1
M=HPI'3 [4);PI(9$AC5SU8* 3^-9P\3Z ;2XNQK>G?9K=_+GF^TILB?^ZQS@
M'V-6?[6TXM:+]OMLWG_'L/-7]]QGY.?FXYXH FBM+:"222&WBC>0Y=D0 L?<
MCK2?8[4 @6T.#U'EBJJ^(-'?4!8+J=H;L[L0^:-S%?O >I'<#I2VFNZ1?V]Q
M<6>J65Q!;$B>2*=66(CJ&(/'XT 7ECC2/RU10G3:!Q^51?8K3&/LT./3RQ52
MY\0Z/:6<5W/J=HEO*GF1RF4;74=6![CD<]*2X\1Z':"(W&KV$8FB,T>ZX4;X
MP-Q<<\K@9STH O"UMU<.L$0<=&"#(J6H+.\MM0LXKNSGCGMIE#QRQL&5P>X(
MJ>@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "N/^*DL<7PP\0>8ZINM&5=QQDDC %=A3)(8Y@!+&C@
M= R@T <MIWC#P]8^%+":36+%RMI$!%'<(TCMM "JH.2Q/&*S],G@7XS:X-\2
M2'2+8NH8<$.^<_0$?I7;"SME((MH01R"$%*;: N7,$99LY.P9.: /&;6]9?A
M-<W=F[SP6GB![B\6V(9_(6[WL0.<\8;GC'M7:^')O#&L^*1K>CZK-JM_]A\F
M6=9 4CBW!E5P  &)R0#SP?2NRCMX8L^7%&F>NU0,TD%M!:H4MX(X4)W%8T"@
MGUXH \TU^SU'0?B+)'I4<GV;Q=;_ &>1X_\ EWN(^LOM^Z+'W*UO>.KK3="\
M/:1'/:0?9UU&UAMWF9EAM&!RDKX(^5=O3(!. 2.M=B55BI*@E3D$CH>E-EBC
MFC,<L:R(W57&0?PH \5OM0L7'Q51M3ANWGTV&2.0[0)<6[#<H'!4' !Y[<DG
MG=E>Q@\0?"TPM;Q@Q3@;"!D-:_U;'XUZ6UM Q):&,Y !R@Y Z?E2?9+;Y?\
M1XOEZ?(.* /'XM;TG3O"'BFUU"*&ZD7Q+,9+>20J(=URNR63;R$!PWOC'K5R
MVO+&\\;>+X)==247N@QC[7;J,8 E#-&%^\%!]2<\9S7JS6\+"0-#&1+_ *P%
M1\_;GUJAK6DOJ6B7EE97/]GW,\!ACNHXP6C'MTX_$=>,4 >:>'+[2/$#>!X9
M=;T-)=&BP(HKQ6EN&,0C5 AQMSU8<\C SUJ&QO-!OM*UKPOXMU.[AU :C.9M
M/R%>ZW3&2-HOEW-D%<8.>!VQ790>%]3OECM]:M_#RP(5)>QM&$C[2"-I8_N^
MG49/I@\CK6MK=[A;AH(FG0860H"P'H#UH =$I6%%.[(4#YCD_B>]>7:)<W6C
MZIH,=C>VVN>'+^]D%HCC%WI\C+(6Y!PRJ"X.>1FO5*ACL[6&9IHK:%)6&&=4
M 8CT)H Y?XF-=1^!KN:UCED$$L$T\<(R[0I*K2 #_=!S[9K$6Z\):[/<ZYI^
MKR:I>)I4T4DID79# 03MD   );H#SU]#7I-01V=K#&\<5M"D;G<RJ@ 8^I'>
M@#QUAIQ^&/PT5Q:[6U2PW@[<'(8/G^OZUJZ\]L?&OC>%6B)?PL"R CEAYO4>
MH!'X8KT[[);$ ?9X<#H-@K/U[2CJ&A:C9V<5LMS=6\D"R2?*%WJ5R2 3QGIW
MH \UEL-/U#P-\.QI"VYU5;FRDB>#&]0J@SDXYP #NSWQGFH-?-W>0_%>#2&\
MZ[+VA,<399HQ$GF  <_=#C]*].\,:,=%T&PM)X;47=O:QV\DT _UFQ0H.2 >
M<9QVK52"&-RZ11JQZLJ@$T >?^(+BT\0ZEX$O/#T\4LZWZSJT)&4L_+;S<XZ
M+]U2#W('6J]Y8W>D>,-0\,VL,G]E^*3]J21!A;=A@70SVW)@@_WFKT:&UM[=
MI&@@BB:0Y<H@!8^IQUK%T'2M9CNVU#Q%?6EW>I&T$ M(6CCCC+ L?F))9L+G
ML-H]R0#D;_5M/T7XCZS9^(-3DTJSO;.W^P2ML6&2-%8/'N92 0S$XX^]]*SH
M[G2?"/B#0%:]OM,\-2Z7+;V%W,00LAF+D,SJ=H==I&<< >G'K4]M;W(47$$<
MH4[E$B!L'U&:6>WAN8C%<0QRQGJDBA@?P- &!X+L]'M-'N#H3S2V$]U).LTC
M;EE9L;F3_9SGIQD''%<CXMENM,U/Q'JVC:A:7:1)&NL:'>CB9?*7#1,/F5BA
M  Q@D'OQ7J"J%4*H 4#  [5$]G:RSK/);0O,ARLC("RGV- 'F\U[(OC[Q9#;
MRBUU6_T.W^P12,%=Y-LN-H[X)&<=*R[N6WUGX(:+8:8RKKD+V<%O"#B:&\CD
M4/QU!&)"2>V37L!C0R"0HOF 8#8Y ],U&MK;I<-<+;Q+.XPTH0!B/<]: /,]
M.UO0[35?&?A_QA-%%-=W[2K'<Y'VJV=%6,)W; 7&%YSTYK-\3B^/C[R]"1$D
MM_#4#RZ:S[7FA6<E[<,#E6*]_;'>O7Y+:"6:.:2&-Y8_N.R LOT/:@VT!<N8
M8RYZMM&: ,WPSKFE>(= M+_1I(VLWC 1$ 'E8&-A4?=(Z8KE-FF_\+NOUO%M
MM[:'"R"8+S^]D#$9[XZ^U=_'#%#GRHD3/7:H&:Y@>&;F;Q]=ZY=Q6,UA/91V
M@A<EG!1V8/@KC^+&,\>M 'G-O;1Z-X?T:[9E@T1/&S7%I(YVQQ6A$BHV3T0M
MR#TPP/>M'4M6TR[UWXD-'>6\D<V@1&)MXVR;8I@2I_B&2.17K<L$4\)AEB22
M)A@HZ@J1]*3[-;X8>1%AL C8.<=/RH \IU%[32OA[X'UJ&VC;3[::QDU*2",
M$^4(S\S8Y(61@V/7FKWC#4/#6I>#/&&J:-);W$UQIOEW-] ^4<@$1INS@M@G
M@<CC/45Z4(8EB,:QH(SP5"C!_"F):6T<"P);Q+"O2,( H_"@#SJ[ELK;QE\-
MS;M BFTNU C(&5,"D 8]3^M<P->TFYTGP5=6MW:V-G%KZM_9R/DV:GSL^<[$
MMO))/\(Y. <9KVS[+;@J1;Q97H=@XI1:VXSB"(9?S#A!RW][Z^] 'E[W-UH^
MK&ZTN]M]8T*[UWRKC3)QBYL[DSX9HB.2 XW;6'W?;)JA8WF@WVF:YX7\6ZG=
M0WXU&<S:?D*]UNF,D31?+N;(*XP<\#MBO7A9VJW/VE;:$3X(\T(-W/OUI6MK
M=[A+AH(VG0860H"RCT!ZT +&@^S(CJ2-@!#G<>G?UKPRSL--U+]GJTMK..W?
M5Y)@EJ(L>=]I\_Y<8Y!V_DOM7NDID$3&%4:3'RJ[%03[D X_*N:\"^&)/#'A
MJRTZ]2SEO+563[3",EU+ENI (ZXQSTH YK4;ZUM/B%XJDND^V+#X90S6\;8:
M4*TA91CD$@_AFLK3]8TZ7Q=\/ITU.R:W-C<PI!;D&*W!BCV0[CEF?H"&.>!\
MHS7KPMX1+Y@BC$G][:,_G35M+9%55MXE5,[0$ "YZX^M 'B-P;!?@=XIEC-N
M'_M>8AU(SD78*\_3I[5[?(S2VKM;.I9D)C;.1G'!^E)]CMMN/L\..N-@J555
M%"JH51P !@"@#QJ"6"^^ MUH]Q_R'(2\$EJQ_?\ VWSBR\==Q8AL^^:W-(M;
M2X^+&I6NI+:7-V-"M%E5PK;G#-OX/X'\J]$^RV_VG[3]GB^T8V^;L&['IGK3
MA;PB7S1#&).NX*,_G0!E>+D9_!>NHBEF;3K@  <D^6U>=V.L6ZR_#._-U%)H
MT%F;6>96!C@NFMT5 YZ _>7V)([UZ[41MH#;FW,,9A(P8R@VD?3I0!QN@6[-
M\4O$M]8L#ILEK;),R'*/=#.<=LA-N?J*K^/%LO\ A-? K7PA\DWTZDS ;<F%
MMH.?]K'XXKO(H8X(EBAC2.-1A410 /H!7->)/#][K'B+0+^$6C6VF2RR2QSN
MV90\90@ *1P#GGKTH X+Q/I0,WQ)NM)B'V"328DG$(^1[E0S-C'&0F,_[U:M
MWK^CWWCOX?RVVHVLT0M[Q&D20% S0IA2W3=[=>1ZBO3(H(H(1##$D<2C 1%
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M/!4BR6TI_P"$=<JVY6PP\O'X\-^1K -^EEIEQ<AE;1[3QU+)?^7\RQP[LJS
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M]FI;?L;X.V8L,@*<8R1SBN-T'QQ9:1=>(H?$WB!08=:DMK9KG:"(PD>!A0
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MFX[<T =K-XPL(/&<?AMO,\_[*;AY#&VT'>JJ,XP<Y8D]!BG:)J>G&SU6]3Q
M-1M8[V0O-(R[+8X7]TI  *KD>O7K6#<W]K:_&6QNI90(+S03#;R*"RROYX;:
MI'4XY^G-<D9Y&\-^)KNR62[BL_&#7US!:L?,DMU="67!SVW C^[[4 >JV_B7
M1[K[8$OD1K)=]RDRM$\2XR&97 (&.^,58L=8L=1N)K>WE?SX55Y(I(GC95;.
MTX8 X.TX/M7GDLW@7Q%9:GJUK)?W43Z?]DO-166<F&)I%(4;^-P)+8 )&WGJ
M =7P5>:JGB*]TN\U*UUVTBM(Y8-8A4!\%F AE*Y4MU8$=N3UH ZS4-;T_2Y4
MBN[@K*Z-(L4<;2.47&YMJ@G:,C)QCF@ZYIG]FV^HK>Q26ESCR)(SO\TGD! ,
MECUX SP:Y77M8M;7XC6MC/C3Y9=,)34%AWS7&9/^/>/@C/&XC!)R,8ZUP?AC
M6$T/0/ &LWBS?V18+>6E[((F(M97;Y&88Z<%<]LGUH ]CM_$.D76FSZA%?P_
M9;=S',[G9Y3@X*L#@JV2.",\BH(O%FBRW$]NMX1<00F>6!X9%D2,$#>4*@[>
M1SC^1KAO$^I::MGIGB/2;%CH46N17>HW,,!'GC8P\[&,LJL4^;N1QTS5B'4K
M/Q!\4Y[C2IA<PR^%W2.55(5SY_\ "3U'/4>] ';?\))H_P!GTZX^WQ^1J+K'
M:2X.V9F^Z <8R>PJC#K.E6^LZ[<2^)$DCM4A^TVSNHBL>&YSC@M@Y!)Z5YC:
MZWI\GP_^']DDQ:YL-8LDO(U1B;=D+A@_'RGKP>2 3T%;\]]9KXJ^)9:XB4/I
M=NHW,!N(AD!'N02 1ZD"@#M;3QEX<OS*+75[:0Q0)<OAL8C?&T\^N0,=<D"K
M=CX@TO46NDM[M?,M,?:(Y5:)X01D%E< @$<Y(Q7F]RWE?!_P?J-G!)/;Z<;&
M;4([,D2>6B8D^[SN5B&(]034'B1=&\2>%/$&J^#$O-1OY+%(I[KS)FWQ"5&:
M$!SRQ4/P!D#C^(4 ='JGBG[1X^\(6FF:I-]DO'N//M_*VI,@A9E=2R@L,]U)
M7I71>+/$]KX3T1M0N4=R76*-$0G<[$ 9(' R>O\ 7 KB]2\4:'KOC'P#>Z7=
M)/$EQ<[Q&I)AW6Y 5@!\IR0,&MOXK@_\*^O'"L5BN+65]H)PJSQECQV !- $
M%UXG^Q?$BW\_5I$T671I+GR9$"J)!,B @;0Q)&>#GKQ74VWB'2;S1H]7M[^*
M6PD.$F4Y#'.W:!UW9XQC.>,5QYU/3KSXR:;=1W,+Q'0I@CL<?,9E(QGU4$CU
M'(XKD+>]6ST9-5 GGTO3O%=Y->K:,V^.&3S%24;3G:-^>.QH ]5?QEX=BT^Z
MOIM5@A@M'\NX\[,;1/V5D8!@3V&.:D@\5Z%<BZ^SZE#,;6402K'EF$A&0H &
M6)YP!GH:\V\62^&+[P#XMU?0#-.U]:Q12WTDLK"X=6&U%\P_,RCK@<9 ]<;G
MC2\M=-G\*Z\5E;P_;O(MW-8LP\H/&%CD^3G:,$''9L>U &_K'C73;3PCJNMV
M%PERUE'*OE[&RLRJ2$=<90\<Y K(T?7K*TGT[4M0\7.%OK,"2PNU #S!0[2)
MD J -PP!M/U%9FJR>&G\ >,]5T+S6BU&R='O999"+J7RV4!/,/)&0,CJ3CD@
MX35;_3Y9OAHS7-NZ).K,2X(7_1R 3Z?-@?7% '<1>+-#N+"VO;>_6X@N4:2'
MR(WD9T4X9MJ@M@'@G'!I\GBG08;.QNWU:T%O?R+':R"0$3,3@!?7GKZ=\5R\
M=VGA_P"+&J2ZO)':V.HZ? MA<2D)$#&6WQ;CP&);=CO7(75JMAHD,LY6.PO?
M&\=Y9QR<#[-Y@RX!Z(<,WI@@]Z /3E\<>&G2[9=7MS]E(651G<,Y(PN,MD X
M(SG%:VG:E9ZOI\-_I]S'<VDZ[HY8SD,.G\^*XN*ZLO\ A=UW+Y\''A^-=^X?
M>$SL1GUVX)]L54^'?B#2])\%VZW=TJ?:-9N+2%54MF22=R@PH. 1SD\4 >DT
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110   # Z4444 %%%% "8&<X%+110
M 5R</A_Q)I^H7S6&O63V=Y<O<%+ZP:66(MCY599%!   &1P !VKK** *>F:=
M%I=BMK$2PW/([D %G=BS' X&6).!5RBB@ P/3K1@ YQ110 4444 &!G..:**
M* "@  8 Q110 48&<XYHHH *0 #H!2T4 &!G..?6BBB@!K[O+;R]N_'R[NF:
MP/!GAZY\,:%_9MS<PW)6>6598XRG^L=G(()/0M70T4 <Y8^'KNU\;ZIKTES
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MT5C?\)=X:_Z&+2?_  -C_P#BJN6&L:9JAD&GZC:79CQO%O.LFW/3."<=#^5
M%VBBB@ HHHH **** "BBB@ HJK8:E8ZK;?:=.O+>[@W%/,@D#KN'49'>K5 !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 5R'Q3&?A?XAS_SZ-_,5U]<]XWT:^\1>$-1T?3S;K->1>5ON)&54!(YX4DT
M>=?#6XM]=\#Z'X0OM+F:RNM,NY99Y8AY;D3!1Y;<_,-Y/;!Q7LJKM4*.PQ7G
MWAKP[XN\,>"K+1;6WT&6^LXY(X;R6[EVC>Y;.SRO<<;N<5J6.D^+K7Q/I;OK
M%M)H%OIZPW-N4S++.%P7SMSR<'.?48[T ==7G?Q9T[Q%-I^CZMX=@%Y/I%Z+
MM[(KN\T <';_ !$<\#GGCD5Z)6#KECK<NLZ7?Z/-:A;99EN(+EF43*^S"@@'
M:<KG.#C'0YH XOP/X]T3QOXC-R+ Z9XKM[*6W:WFZ2H61B-V,G:R#@C(R>O-
M9OP\\:ZL=!\6^*->F@FM+:]E:545@X98T"I&,X"] ,\Y/)KL(?!\M[\1+?Q?
M?VUI9RVEJT$<5O(9&F9L@O(VU>BD@#GKUXQ6)X=^&-_IWA_Q-X;U"[M)-+U6
M:66*:+<9E+ !<J0 ,;0>IS[4 /L_B7?PGPE=:O:6BV7B9F2$0;@]JV0$#$DA
MP=PR0%Q[U)=?$#6[^37Y?#&D0ZA#HEXEI);D,9KILXD*$'"A>W#9Y/%5;7X;
M:K=GP;::O+9)9>&2SA[>1F:Z8%2GRE1L'RC/)[CWJ;2O!'BCPIXVUF_\/7>E
MR:/K$OGS17OF;X'))RH48;!9N,C(P.,9H Q==U*UTW]HC3=1OY4M+>+0FDE>
M4\1C$O7^7%>G^';O4]0TQ;W4A:*)_G@6WS_JSRI8DD9(P<#@>IKBO$'PTN?$
MGQ'AUO45L+G2!IYL98G=A*V0_P"\ V8!!?CGMUK8^''AWQ%X3T1]%UF[L[NT
M@8_8I8I',B(3]Q@5 P.QSWQTQ0!S7Q)E\3^&/&VF^--)T[^U=-MK)K2XM@"3
M%EBS.,<KD;?F .-O/%3Z'X[T/4?"_B?Q=X;@6'48K=;B^L;A<?.BL=QVGG<.
M-P_N\C.:["XM/$-OXKN-2L39W&FS6L436DTC1N)%9R75@I'1@,$<XZC'/&:S
MX-_L;P]\0?$,\5M;W.JZ?(!:VI)CB58SDY(&68_,>!^/6@"$_%;6['P_X;\3
M:GIFGIHNJS_9Y5AD<S1$EL/D\8PK''MUYX2U#G]IC5!&55SHHVEAD _N\9'&
M:Q_#W@W6/''PT\&Z;.UC#HEK-]KEF61C-( SC8$VX!^9AG=Z'':NVB\'ZS!\
M7+SQ@K6#6<UE]E2$S.). N"?DP.5]>_>@#S_ $SQ9/8? O7]8\-Z79:+)%J)
MAD6%G?[_ ):EUW$X;YQCL .!743^.[WP=X4\'1:DUG$FI1HGVXQ221V\2Q(0
M74$$L2>Q P">U5M*^$^LV_PIUWPA=WM@+B^NA=0SQ.[("#&=K J".8^HSUZ<
M<]'-X6UB]\*:5HNJV6C:A:P6OV>ZM6E=%.U45'2382&&USG ^]CMF@#JM O;
MK4=&AN[P6WFR,^&M7WQ.@=@CJ>X90K?C3/$UA=ZKX6U73[&?R+NYM9(H9,XV
MLRD#GM]:\X'AKQAX%\&^'M/T+6K3S(+QC<VSKO\ M'F."L49*YP 6R?E[MQB
MO2/$=C>:EX>O;/3YUM[R6/$,S=(WSPWX=: /%=%\=P6-C8^ _B'H;Z9):>5'
M;7OE_(K1D;'([<@?.I(//09KJ-7USQ%-\==/T.VGM%M(+%[B&)PVT[@06?'5
ML X[#/UK:\5^$]6\<:#!HNL6NF1 2H\M_#*SLH4@L8D*#:S 8Y; !/+4W4?!
M.J#XHZ?XKTNXLOL\5C]CEAN"^Y!SAEP/FX(X)'3KSP 4+OXF7TQ\6W>DVEH]
MAX:94E$^[?=-DA]K X0#:<$AL^U:#_$5-3O_  QINAI%]KUZW:[$ER"RV\:J
M2=R@@LV59< CH>:R;OX:ZK:IXQL=(ELFL?$KK)OGD97M6))D^4*=X^8XY'I[
MTFL?"W4+*7PKJ7A.^MTU+0(1;XO=P2X3G.2H)&2SY'HW48H YSXL:MK&L_!B
MWN==TAM+U!=56.2 GAMJO\ZYYP:]5TO6[G6-=NHM.GL)M(L\0S3+EI// ^:,
M8., $$GU.,'!(YSQ_P"#?$GCCP5!I4EQI<5\;M;B0AI!%&JJ0%4[26Y.<G'T
MI-$\"ZQX8\?W&KZ(VG6^B:A&GV[3O-<;9<<M'A,<'IG&<D<<8 -/XM#/PK\0
M9_Y]Q_Z&M< VD6FH_LQ6ES+&HNK&U-S;S@8>-UE)X/49&1^->G^.]$OO$O@[
M4-%T\VRS7B"/S+B1E5!D'/"DGI7)1> /$T_PWL_!%Q=Z;:6B#9<WD$CRR2)O
M+[50HH7/ R6/TYH Y*Y\6MJ7PR\#ZEKNEVNK2RZA]G+7+.K!T9E63*D9X7D'
M()KT*7QMJ-C\5H?"6HVUI#97<#3V=T-VZ7 /R')P""&^N!QS6?XN^&=Q?^'?
M#>A^'3:06FCW*SYNI6!?'^ZIY)))/'/:M?QWX$3QF^ASF46USI]XLKR(Q!,)
MQYB*1SDX&#[4 <K\0M=;_A&O#U_K6CZ;J45UJH%O&WF)L4Y\N3(;J5&2IX^8
M#G'/27'C34=0^(=YX3T.VLR=.M!<7<]V6PS';B-=O3AA\QSCGCCEOQ+\%ZGX
MPT_2+32GLH5L;Q;EC<.R@A00% 53Z_I4#^#-<TWXF7?BO19-/>/5+007D%U(
MX\EP%&],+\X^0<';GGD9R #A?ACXM@\$_!'4]9FA,S)JCQPPAMN^1DC &>PZ
MD^PKO+3Q_=/J6LZ2[:==75EIG]H075IDP28'S1M\QY!QR#R#G Z5SNF_![4Q
M\*K_ ,)ZC>V8NY+S[;;3PEF17P!M;*@XP",C^][<]G8:?XPNO"UU8:Y+I1NV
MLGMH_L[N5E8KM\QV*Y7Z 'J?8  XN#XOZZ= \.:_<:1IR:?J=^;*5$E<RCYB
M-R]AT/!SG';-=9=^,]1N_B/+X0T.WLS+9VGVN\GN]Q'.W$:A>A.]?F.<9Z''
M/'M\)O$9\!^'O#XN=*\[2M1:\>4S2;9%+$@#]WG/S'\AZ\=/<^#-;L/B?+XP
MT1[!Q?V@M;VWNI'780% ="JG=]Q>#C.#R,Y !Y_\.?%,G@WX/:_K*6@FDCUI
MD"')5"RQ#<V.PS[9X'&:]@\):]-X@LYKL7%C=V9*_9KNS#*L@(^8,C$E&!X*
MD^GK7(>#? /B'PMX/O\ 2)GTB\DNK_[2\<A<Q2QL%5XWRG&0O! /)]N=CX>^
M!F\&W&N3*([>WU&X62&QAF:5+=5!'WF )))/;@ #)H M^)?$^I:9KD.F6EFL
M-N]G)<R:K=1,UM&RYQ&Q#+@G'4GN.#GCF8_BK>W/P>F\:PZ?;K=6TPBFMG9B
MC'>J94]1]\'G/<>]:_BCPEXBUGQWI6K6>HV(TNT@9#:W:.X24[AYJH,!FP1@
MDC&*YNT^%GB&V^$.H^"VN],:XN;L2QS!Y JH'5B3\N<_)C&._6@#5TOXB:S+
MXV\.Z+J>G6,=MKNG"\A:WD9GB.QFPQ/!^[T XSU.*RO$/C/4O%OAOQY#IMM9
MKI&E02VKO*6\V=MK!F4CA0,9 (.?4=M./P!KH\9^#]::33A#H>GI9SH)G+2'
M8R%E^3&/FR,_I5+_ (5MXBTR+QCI>D3Z:^E^(-\D;W$CK);LP;*[0I!'S8SG
MC&<'I0!T_P )?^25^'_^O<_^AM7#>(=>\1?#+XA:UKEWI#ZIX>U<Q%KA/O0A
M5VA<]!C)X/!XP1S7I7@70KSPSX-T[1;Z2"2>T0H7@)*L,DYY />H+6R\1V$^
MJ1R0Z=J.GW5S)+!#),T;1*W5&^1@P)R?;)Z]@#S[Q3KGAC_A30U+1]-M=2T6
M34"S6-P&B\J1W+%?D(*E6)X'&#Z=>FUKQQJFD>+_  WX=T[3K&6/5K;>AD=D
M\DA3QD9R!CT]JQM1^$5\WPUG\-:;/8QW5YJ)OYV=G6&(GHD8"DD !1SCIGVK
M9U/P3K=_X[\*^(%?3TAT>#RIHC.^YR00=OR8P,\9QGVH PX_BCXGET3Q5,NE
MZ4+SPW<M'<N7D\N50Q7"+US\K')/IQSPOC#Q3::EIGP_U:[T.TNTU.ZB>..9
MW#6TC;<E2I 8<]",' J2#X:>(8].\=V[3:7O\2SF:$B>3$.7=B&_=\\/V]*?
MJ?PV\07OAOP7IL<VF"70)4EF9IY-LNTC 7]WW []/>@"+2W\K]I;Q)($9RNB
MJVU!RV!!P/>IS\5-4MK_ ,,_VAID-LFM7;6TFGRHT=U:#>$1VR?F!SG[J].*
MTX?!6NQ?%+6?%:7%C#!?:>;.(+([21-M3:Y!0 \ITSWKEXOA/XM-EH)N=2T>
M:]TS53?R2'S2UQEE8L\A&6;Y0 -HX[T =+JWCW7K;XC7/A'3-)M+R8V1N;9W
MD:,;L9PYYXZ].IP..H[72'U&[T&V;6K:*UU"6+_2887W*C'J >?YG\:Y1/!V
MKK\7V\7F2Q-B;/[)Y8D<2]!\V-N.O;/XUWE 'AGQNTZTTFQ\$6%E"L5M;W9C
MC11C &P5Z;XH>/PQI.M>*K"VA-_'9@R!QA95C+$ XP<_,PS6!\3_  -K7C:?
M1O[.EL(8].G,Q-S*X+D[>,*AQTZYKI_%FDWWB#P7J6DVXMHKN\MVAS)(WEH6
MX)R%R?RH YSPQXR\5:_8V&LMX>MUT6:QDFD:*;=.TJYPJ(>S$8'7/7(Z5FP?
M%#4XM<\+6NHZ?;PKKSO&]D5:.YL6W!5WY/S Y!'RKD<UU/AOP]JNB_#B'P^;
MJWAU*"T>"*YA8NBN0=K\@'@D'&.U<#:?"GQ7&/"D]QJ&CR7.C7TES,V)2T^]
MU8N[D9=_E Z#@#F@#=U#X@>($\=>(?#.GV&FR'3+ WJ7$[NH(VHV"HSD_/C@
MCUXZ55;XNR)\--%\3RV4<$E_>BSG<JTD5MAF#2;00S#"Y"Y!YZ\<W9/ NN'X
MB^)/$B2:>;?5-,:QBB:9PZG:@#-\F,93D#.,]Z;X<\":UH?P^LO#5U#I&HHE
MS(UW!+(_E3PL&. 2F58,5(..W6@#3N?&.JVWA(ZM;:='K#RWB06SZ8&DC>)@
M/WQ )( .X%<\$8SWJKX?^(K7?BCQ+HNIFSDCT:#[3]NLLB.2, %LJ6;!&>Q/
M0U@_\*JU^S^'=YX?T?58+.2[U1KMH&F=HEMR,"#>!N/123@9QBM+1_AQJEOX
MTUW4]1N--?3M8TX6<T-HCQF/Y%3:BG(  7KG\!V +6A>-_$>N#0-4MM#BFT7
M5YID?RMWFV2JQ57D;."#@D@ 8QC)-9'@36_$NN>//&ZW4]BR64T=H49'*HJ&
M8*$&1QG).>3FM7X?>%/%_@ZV_L*>^TJXT2&9I()P',^PG)3;@*,G/.3C)Z\8
ME\->#-:\,^,/%6I0S6$]CK4WVE0[.LBM\YV$!2 ,R?>R>!TYX .0\*_$33?#
M/P>GURRT"WLVDU)[:WLH)7*22LH.XLQ)Z _@H Q7=6'C&]C\>R^#=66U^W/9
M"[M;JW1EC;KE60L3D8)SNY [5QUC\&]2_P"%73>%[Z]LEOHM0^WV=Q"SLF_:
M%VN"H(&,CC/7/;!ZRQ\'ZC<?$67QGJHM8[B*Q%K:6D$S.H.#N9G*C'4@  \'
M/M0!QJ_&3Q$_@FX\3C1],%M9ZD+*:,ROND& ?E]#SU.>O3CGJ?$7Q(&D^+M/
MT-7L[%+RQ%W'=7ZMY<CLV%BRI 3H<N<@<<5RT?PA\1K\--1\+&ZTKS[O4Q>B
M832;57: 5QY><Y4?G[5U'B[P1J7BC1QIMS8Z5<QK81QV\DD[I):7(W!G5A&2
MR$;,@XSMH [S3Y;B?3;66[B$5R\*-+&IR$<@$@?0YJQ6=X?TMM$\.Z;I;W#7
M#6=M' 96ZN54#/Z5HT %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MZ9)P!WY]*O3:G86UU':SWUM%<28V1/*JNV?0$Y- %JBBH;J[MK*$S7=Q%;Q
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M<Q;I_#LHE^4?O/WZ#YO7CCFN$DT[3X?@EK-]':VZW,&K.8IP@W1[;T!=K=5
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M5M5N+K2S)<D-$\*.J'RV^10!)C//7 ^E=UX5TC3=/T6TN;&RMX9KFTA,TT:
M-+A>"S=6/)Y/K5V+0='@TXZ=%I-C'8EMQMDMT$>?7;C&:MV]M!9VZ06T$<$*
M#"QQ(%5?H!P* .4^*4M]#\-]9DT\2&41KYGE?>\K>OF8_P" ;OPS6?XDC@G\
M0> [_03'YKW6Q6@P UB8B7Z?P#"8[ D=Z] (!!!&0>U4K'1M+TQW?3]-L[1G
M^^UO L9;G/. ,\T <EX5B@'Q-\<[4CW))8XP!E<P?I7=52@TC3+6Z:ZM].M(
M;A^6EC@57;ZD#-7: "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MMQN$6?\ IFLN2#T^4>U=-XP7P^_A'QS?Z/)'-<W=@&O9H)M\98(50<':&QU
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M0"O2* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M %U]'TN2PCL'TVS:SC_U=NT"F-?HN,"FWFB:3J$,$-[I=E<Q0',*36ZN(_\
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M+&10C<\8#;2<]LUR,5]JGV+Q?I7B-+"ZNK;20_\ :EJNU+B(K+L$BGA7!W'
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M>$_$FMVFIZ/+;WVH+:,@F@;)MX3@[9 #A26QA2,]<< UU"PQ([ND:*[XW,%
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MU!J6"RM+5Y'M[6&%Y.7:.,*6^N.M210Q01B.&-(T&2%10 ,G)X'O0 ^BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MA'J?:OG;P1JNDZ!K/Q%NK_2_M@CO-L$8LS,BGS)@ Q *HN<<DC@<9Q7:>/\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MD8Z&I_&'A#7=9\1>"[^UMK1H]%N3<72HX13EXSMC!ZX"'DXSD>^/2:* //\
MXM>%-7\8Z#IUAI$4+207R73M-+L4*JL,=^3N_2F:IX4UQOBUIGBZPAMI+86!
MM9HIIMC1,=W/ .X?,.!Z'IUKT.B@#QGQ1\/_ !KXCD\6QW+Z=<QWKQ_V9+-.
MVZ")) XC1<83( W'N5[YR-'7/!7B+47^'DB6MJ&\/-&]X!<9#;3%PA(&3B,]
M<#GJ>M>JT4 >6:;\/M4F\0>/'U)(X;#Q%&T<$D<@9X_O %E_X$#^%:/PZTGQ
MEX?TB#PYK%GIQL;,LJ7R7)9I(R20HCQUYZDC [&O0J* /*? O@SQ+X-EO-".
MG:7>Z2]R9K;4I9/WD2'&08]N6. .,@ YY(KU:BB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *P=7O=
M>M[FZ:PM['[%;VHE,EP7W._S94 <8 5>?]JMZJ6K_P#(%O\ _KWD_P#030!R
M_AKQ'XE\0:%I&M+9::+6^&7C5Y-\0.0#Z'Y@,].#6AX(\0W/B+PU#?ZB+>*Z
MDN)XMD.0I\N5D& 22>%JG\*/^26^'O\ KU_]F->=#3+*/X/?VVMNG]IVNLEH
M+H\R1?Z?MPI_A&">!P<YH ]S>6.+;YCJFXX&XXR?2GUYE<);^(O&OBS0]6N[
M*)UCB2WBNX [?9FB!+1DL,?.6)(Z'&>@KM_#-NEKX:T^WBOY=0BBB")=R_>F
M4<!L]^,<]QSWH O7U[;:;8SWMY,D-M ADDD<X"J.IHM+R*\L;>[C.V.XC61
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M'3=8LM7:\%E,)1:7!MI&4Y&\*I(!]MV/J#5Q)8Y"P1U8J<, <X/O7BDA71/
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M6CSC.">G0?2JO@_Q#=ZW;:H=2%K'-::K<6""'*JPC( /)))/)KI=PSC(SZ4
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M5<WMI>3Z?;2W5F-MO-)&&>(>Q/- 'E!NCHGA'QL]M^XM$\5[+DHI.RW)@$G
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M2N))&"8$CCD,PZ,P]2,UGZU;:WK&I/H[6%HN@2JC3W;3YD< Y>(1X_BP!G/
M)/7B@"?PI8K%I\VIO;+#=ZK*;R8; K -]Q6]U0*#[Y/>N>\<P6F@^)-"\9RP
MQ"&"4V&HR% ?W$PVJY/^R^/P8BN_J&ZM+>^MVM[J%)H6()1QD$@@CCZ@&@#R
M70+,VNIZMX*N]-BACUJXCU2*(1#"6LF6EC;_ '2FSV,@Q@5TMO:P6OQOE$$2
M1!O#BDA!@'%P0./H /P%=J;2W:]6\,*&Y2,Q++CY@A()7/IE0?PJL=$TPZJV
MJ&RB^WM'Y1N<?O-G]W/7'M0!Y-<_\D,\9_\ 80O?_2BO98?]1'_NC^590\*:
M -.FT\:3:?8IW\R6W\L;)&ZY*]":U((8[:!(84"1H-JJ.@'I0!YIHUO9^)-"
M\;'78HVOXM0NHI'E WV\:#]SM)Y4*,,".^3U)K)L+$Z_JWPZ;Q#;B>YO=(N_
MM8EZSJ$CV[_7@Y^IKU&Z\.:->WKWESIMO)<2*$D<K_K5'0..C@=@V:EN-$TR
MZU&#49[&&2\MQB&=E^>,=]I[?A0!-::?:6.FPZ=;0(EG#$(8X>JA , <]1BO
M&'L[&W^"WC1X;>WBG-Y>Q[D15;8MQPO'.!QQVXKW"L:3PGX>F%Z)-&LF%\_F
M70\D?OFZY;UYYY[\T <C<Z;::+\3_#$FEVL<,U[I]ZMRR<-<%1&RESU8Y/4Y
M-8WAVTL?$_A#2-6N];@MM3M;I9IY8K<"[6Z#$-&S%LG<3C;CD$ #&*]._L#2
M3>6MX;"$W-HNVWE*Y:(>BGL*@C\)^'XM=;6X]&LEU-B2;H0C?D]3GU]^M &S
M7CWAV6Q/PY\)V=TDDT]QK,WV6W$@2*619IB!*2#\@ZXP22%Q7K[HLD;(XRK#
M!'M6,W@_PZ^EKIC:+9&Q63SEM_*&Q7_O =CR>1ZF@#@M(\/V_B.S^(/ANX-J
MRR7Y,*Q)B.&4PH=Z+DXP^,^^?7%98UM)3X9\<26$,*:-LTW67,.&5G_=O]!&
MP0\=I,#H:]<L=#TG3+N>ZL=-M;:>=5662&(*6"C"@X[  <5(VDZ>UG-9M9PF
MVG=I)8B@VNS-N8D=R3S0!Q.HZ#>OHFG7&FBPMM:N+]M2:TO(_P!U=.4<^2^.
MZHPP?5,^]:_@&_@O=)OE32&TBYM[Z2*\LMP9(YL*S;"."IW _B:W]0TJQU18
MEOK9)O)?S(BW6-\$;E(Y!P3R/6I+.QMM/@\BTA2*/<6(4?>8\EB>I)/4GDT
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M6LKL78QGS2=KG)*DC(YP1C'&*FTOP_H.I?$GQY;ZCIUG-$%LV\N5 57="=S
M=B?[W7WH [K5)+K%@UGJ%I:JUU'YIG7=YT9SE$Y&&/&#S]*LW6HV-B\:7=Y;
MV[2G$:RRJA<^@R>:\;L+1XO /P[>Z&^2/Q'$EK+*/G^SF279SUP5"D>V*V6F
MTO4_$/C30_$FLC3Y)I0!',85#VAB4(4:13T.\\'@G/4T >G37EK;MMGN88FV
M&3#N%.T=6Y[#UK-UCQ1I&BZ'_:]S>PFU8A8F20$2L3@*I[Y/]3VKAK?1M*;X
MC^&;<Q&\A_X1^0"2\0&295>,(TG W''/(_45@7L4$/PO\5PJD:6]IXJ9(EP
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M7:<<>H [8KK+'0])_P"%O:S:_P!G6GV<Z3;2F#RE\O?OD7=MQC.WC.,X)]:
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M?.8UY&&/&#S]*Q-8\2EO%D/AFRU&VLYWLI+I[E]K[&#JB(%)QDEB3GG XZY
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MD*'<+NP,G&>O )H 6:"*XB,4\22QMC*.H(/?H:#!$;A9S$AF52BR%1N"D@D
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M<D'G)JQ#J5A<7#V\-[;2SH2&B25692.N0#FI;BY@M(&FN9XX8EZO(X51^)H
M@BTG38+Y[Z'3[2.[D^_.D*B1OJP&33)-#TB75$U232[)]03A;IH%,J_1\9J=
M-0LI(4F2[@:)V"*ZR JS'@ '/)/I1:WUI>^9]DNH)_+;8_E2!MC>AQT- #[J
MUM[VVDMKN"*>"0;7BE0,K#T(/!JO;:/I=G+%+:Z;9P20Q>3&\4"J4CSG8"!P
MN><=*DAU&QN+N2TAO;>2YB_UD*2J73ZJ#D4-J-BEZMD]Y;K=L,K 95#D>RYS
M0!*MO"LDLBQ('EQYC!1E\# SZ\5&]A9R6'V"2T@>S\L1?9VC!CV 8"[>F,=J
MJ)-<1ZW>F?4;0V*6Z,MMM DB/.YV;/W3QV[5REOXAUKQ/%>W7A[5M+M?LM]-
M;>1=)O4PH=IE)!SG/S#HN, ^M '6QZ!HT001Z38((XC FVV0;8R<E!QPN>W2
MK%GIUCI]N;>RLK>V@)),<,2HISUX Q4-K=K;:);7.HZA:OB%#+=J0D3D@989
M. ">1SWJS%=VT]J+J*XBDMRNX2HX*$>N>F* *VG:)I.CF4Z9IEG9&8[I/LT"
MQ[SZG:!FK]<A9>)I[[XDMH]O>V5UI1TDW:-;C+"02A""P8@\9Z =:Z^@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "N(^)UU)::1HTC_\ (,_MFU&I$_=%ON.=W^SNV9KMZ9-#%<0O
M#/&DL3J5='4,K ]00>HH XG4+5D^+^C3:>HVW&F7 U,)]UHE*^46'<[F(!]
M:3X:Q0#_ (2IXXXPR^(KQ 5 R!E>/I7766DZ;IL+PV.GVMK&_#I#"J!NW( Y
MHLM)TW3F=K'3[2U9^7,$*H6^N!S0!QOBNPLKGXI>"O/MH9#+'?J^Y =X$2D
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MVBMFT;3S!#)YL<1M4VH_]X#& ?>@#QV6:UD^$_B9!<6\P@\2,P*8VJANX_F
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M/S+6YC,<B],@^A['T-5(-&BN+6WCUFVL[^XM?EBN)859F QAL$?*Q[XXS^0
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M>"60*KO%$JLP4 *"0.0  !Z 4ESI>GWMU!=75C;3W%N<PRRPJS1'U4D9'X4
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MG*D Y52 023RI!./2@"OX6TJTN/&WB#Q.BV6;Q8(X4C>.65-BD,S,A(7=D#
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M'X8KOZSK'0-'TQT>PTFQM7C38C06Z(57.< @<#))K1H **** "BBB@ HHHH
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MUH2WYGAG8*[DH?)*@\D;0@7'H,4 >DZ?K=O#X7TO4-7OH(&N+6*1Y)G5 S%
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M6GTN*]2)K<RF)(KBV,(4J&=3T;?P".6..]26UWHFD>(=(TFTD_L]H]$(AO\
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MKQ65_;7$B*&9(I0Q4'H2!V/8U0\0>*]*\-S6$%_=11S7TZPQ*[A< _><D]%
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MFV@@;L ],D#/3FKU !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M<>QXIIL;0JZFU@*O@./+'S8Z9]<=J /+]2L=+C_9Z-U%;6BROH$(:947<S;
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M5538VQ"]!Y2\?I7(CPSK\=_>":/P]JEO<7#S+<W]NWGHK'A2 "&"C"CE> *
M.JT6VM[31+&WM9DG@C@14F3&) !][CCGK^->.^(-:TRY\.:@]I<6UA'%XD22
M2R+[IS(+E=\TA8DH#U   '')SBO8=&TN'1=*AL( H2,LV$0(N68L=JCA1EC@
M=A@5.UA9L92UI 3,0928Q\Y'3=ZX]Z )%E2>W$L3!XW3<K+R""."*\/M=-TZ
M_P#@%IMM9P6S:Z\J+:&(+YXNA-ZCD$*#GT4'/ KW2J\=A9Q73W4=I EP_#RK
M& [?4]30!PUQ=0VWQ>U.27,OE>%T9XXS\S8FD) 'KC^8KEM/UC2WU'X;W-O?
M64%FCS+'9PR;A:(UNP5'<DL7S@<XR1P.]>R"SM1<?:!;0^=_STV#=^?6FI86
M<041VD"!7,BA8P,,?XA[^] 'E^@:MX=N= UOPWXL:)M3&J3M<V4K%9KIC+OB
M:, AFR-@&W^Z.U5/%,]_'\1-?N;)%N;>UT^SEU&P5L27%N#)O12#U ()'\0&
M.AP?7&LK5KM;MK:$W*C:LQC&\#T#=<4AL+,R-(;2#>^=S>6,MGKDX[T >?Z]
MKME=:SX!UJTGC?PRUQ*))5XCCE>+;!N'\."6'/0U!J]G+/XO\:S::-]G-X<\
MJZ$?(>[P^P>["/'X,/6O1Q86:P/ +2 0R??C$8VM]1T-/M[:"TA6&V@CAB7H
MD:!5'X"@#R/^W-*FTOX6B/4+9S!+ )ML@/E'[,RX8_PG=Q@\\'TKIO!=W;Q>
M,_&EB\\:W;ZHLBPEOG*>1'\V.N/?I791:=90;?)L[>/:YD79$HPQX+<#J?6I
M1!$LS3+$@E8 ,X4;B!T!- '"?$6*R?7_  4UZD)B;5MC&4#!!B?"G/8G'%<Y
MXGTJXAUWQS/X:@(A;1(5NX[88#W&\EE '&[R0<CK\P]:[GQ7X?O]<U709[=+
M)[?3KHW$R7$C R HR%0 I'1L\UTEO;06D(AMH(X8AT2- JC\!0!P.BW7A/Q-
MKFBZM9:W/J=]!#((H0T8,$3)AA,B*,+T&&[XQ57X;V.DR?"\71M;-I4:^#2E
M%)4&:3C/8;0OX 5Z)%I]E!YWDV=O'YYS+LB4>9_O8'/XTJ6-I'$\26L"QO\
M>01@!OJ.] 'D&C7C6?AWX57MPX&C1%TNG)^2.9HRD);L,,6&3T)JWXN@U/\
MX2+QK>>'"Y5O#R)<F _>NM[8QC^,0YZ<\KZBO5196HMGMA;0B!_O1>6-K?4=
M*=;VT%I"L-M!'#$O1(T"J/P% 'E>L:[X=O+?X<W&GWMD(8]1A" 2*#"GDN"I
M'\/(4$'N*])T_7-,U6[OK2QO8;BXL9/*NHT;)B;G@_D?R/I4T6FV$+[XK*VC
M<OYFY(E!WXQNZ=<$\^]0V>DP6>I7NH*J?:+O:KE$"C:I8J..I^8Y)Y.?0
MY3QG=6]AX^\#7=W/'!;)/>!Y96"JI-N0 2>.369;I8W/BSXFR2I!(1;6ZY<
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M+:6XG;;%$I9VP3@#V')KE_#OBG1H=-\,:1+J$?\ :%]IT;V\8!/F;4&[Y@,
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M8VT[>9&H+12QH6VLK@X/3((SS7%/XFFCTJQ;Q!:Z:L\?B VXUE%/V566/BY
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M2+RV^PMAAGH?F;!.&STZ5A^"/&$3^ M O?$.J+]OU#>BO(,&:3S& 50!C/3
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M#*PR"#D$5D>*+NVL_#MW)<ZTNC(5VB^)7,9]@W!/M0!KLJNI5E#*>H(R#0
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MU0%  R>YZDUHS1F6"2-9&C9U*ATZKD=1GN*Q]*U*SM/#&GW,VL?;XGC54O6
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MJ;*^3;B&<(Y7<&X*D;EP>N0*ZH #. !GK00&!# $'L: /'+_ %C5QHL&HZQ
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MU'Q/X:\8S7L-Q=:C-+%;[Y=M[!(08]@3[QQA<#G@?AZ]TI"BE@Q4%EZ$CD4
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MM95(S!<I*S(?;G'X$UZO6/KUCK=]]E71]7BTY S"Y+VPE9T(XVY(VD?C^F"
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M*DAD:T\56XEU$=1;/$P+(?9HF$7N1FMG5I4'Q@\/'/":==(S=E9BA4$]B<'
MH Z.#Q'I=Q>06L4TC/<.\<+^1((Y&4$L%?;M. K=#VJ.?Q7HMM>16TUV4,T_
MV:.4POY+2YQL\W&S=D$8SU!'6N"\/&?3=;T9?#^HO?:->W#F;2+M-TVEDJY+
MJW55!RN&X.X8SNS5+PS+I$FB0>$?$>F:K/X@LY=ALG:X,4[*Y*S*P.P)T;<<
M8YZ\9 /8ZP_^$OT3R=3F^UR;-+;;>G[-+^Y.,\C;Z<\=N>E;E>?:[I=];>/7
M2Q@=K+Q-9?9;UU'$+Q=9#Z$Q,ZCW"T =>FOZ=)!ITZ2R&/4F"VA$$G[PE2P_
MAX^4$Y.. 3TJO<>+-$M92DUZ403_ &=IS$_DK+G&PRXV YXY/7CK7,^ =.U.
MW,^EZ@CK%X>:6PLIGY\Y6(97Q_LQ>6H^K"N>L"1\&]1\&W\#GQ%%'/:?8V4E
MYI6D9DD3^\I+*V_H,$D\4 >H+KFG/JUQI2S.;ZWA^T20^2^[R\X##CYAD$<9
MKDO&GB(7G@:#6?#^JSI%]O@B\R$%-X,ZQNIW#<.X[54BE_X1GXE6+:L\S";P
MY#9QSK$\@FGCE)91M!RQ!!Q[US2RG_A2Z6[PSQSC6]WEO$P)'VW>2./F 7DD
M9 H ]<U+6;&QD^R33S"YDB:0);0M-(J#C?M56P,]R,9XYK ^%^I7.K>!X+RZ
MO9;V1[FY GE;+.HF<+^@%9EOJT?A_P"*6NS:N9%L]8MK5M-NA&SQL(U8-&"H
M/S;F+ =\^XJY\)W_ .**$9BFB9+VZ.V6%DX:9V&,@9X(Z4 2?$'4KC2)/#5U
M'J4MI;OK,$-T X5'B(=FW'&<?*.^*VM&\7:%K[7::=J"R26?_'Q'(C1-&.Q*
MN <>_2L3XCJ5@\-W;1NUO::[;7%PZH6$48#@NV!P 2.?>L'Q-H]SXJUO7=2\
M/XDC;PY+8"XC.%N9G?<$5NC84$$] 6 SUP =W:^*='O-2AT^*Z9;F>,RP++"
M\8G0=3&S* X Y^4GCGI6Q7G'AK5/#GB:^TJ2/3-4;6K'+217AN<:>VW#Y9SM
MYZ #).1P,''H] !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%9^KZ[IF@V\<^J7:6T<DBQ(6!.YB<
M <?6@#0HK TWQMX=U:[N[2RU..2>T3S)49&0[/[R[@-R^ZY'(]:CT_QYX9U2
M5([/5HY-\#W(8HZIY:'#,6( &/0G.,'H<T ='161:^)M)O;Z*QBN9$N9XS+
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M2Z4^B0:REP[6%PR+%*L$AWEV"KA0N>20!QW% &M1110 4444 %%%% !1110
M4444 %%%% !1110 4444 <WJ/AW5G\02ZOI&O_8WGA2&:"XM1<1D(6*E?F4J
M?F;/.#FM33--:R\V:XN3=7D^WSIR@3(7HH4=%&3@<GD\FM"B@ HHHH ****
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M='FMIY!R!)LB49/^T5;&>M8SQ7\OA+QGIEG9W<FHP>()=0-LL;H981<)( K
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M HHHH **** "BBB@ HHKS;XY:[?:%\.9382/%)>7"6KR(<%48,S8/;.W'XT
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K
M UH:^D]W<V5]:VUC!:!T5[;S7DD&XMD[A@8"=NYK?JCK3JFA:@SL%46TA))P
M!\IH Y3P?JGB?7?#FB:_/?V+0W0\RZMEM=FU.1E7W]C@\CIFNHA\0:-<W$<$
M&K6,LTH=HXTN$9G"$AB #S@@Y],&N<^%)CE^%6@#Y77[*58=1]Y@0:Y;PS#H
M-I\)=:U2[TN&\6WEU$2"$ 2%"[J55QR@*X&1VYH ].L];TK49'CLM3L[ET3>
MRPSJY"_WC@]/>HO^$ET(R6\?]M:?ON7,<"_:4S*X."J\\D'C [UYWINHV4GQ
M(\,L=2T^:.71IH$CMF!B0$Q[8@226./4\]<#-84L%A%\#-;NHX[=94U=RLJ@
M @B]&W!]@>/8T >SWNLZ7IK[+[4;2U;;NQ-,J''3/)Z47VM:7I;A+_4K2U9E
MW 3S*AQG&>3TSWK@/%_VVQO_ !%K&CWEG?6\=JBZSHM[QYD0CR&C<<J2C$>A
M(/>JOB'6].O+KQ="GE:9=OHL7VDW39FN@T3LD<:$X 7<0Q ));&!C- 'I]U?
MV=C;BXN[J""$D 22R!5)/3!-8^L>--"T?3K&]EU&VDAOKB."W9)E*R%G"E@>
MFU022>@Q7 Z-XBLM-U7P+>ZG>1+I$OAX6T-T[CRHKO$9<,W16VKMR?<>M7/$
M_P#8-KX;TNZT41Q:9_PE%K<27"N3$[&0%Y%8DC;G(R.,@XH [H7BW/B"S-MK
MUH;9[5W^P($9I\D8E5LYV@<<#!S5J36M*AOEL9=2LTNV8(L#3J'+$9 VYSG'
M:N/NYK6;XQ:'/;/"QFT:Y*R*1^\&]-ISW'!Q[5S5C)#>_ C6;#4N=:@-REU$
MW^M^VF5FCXZEBQ3'U&* /5;K6]*L9)8[O4[.W>*/SI%EG52B9 W$$\#) S[B
MG#5M-.G)J(O[4V4@!2X$J^6V3@8;.#S7 :;9J?BSIJ:I'!+J">%D:<LH),PF
M 9OK][FLG0+5+SP;:6UCK":7?0>([O\ LR0J'B\P--B-E_NE"_ ]1B@#UFSO
MK34(3-974-S$&*EX9 ZY'49'>LA_%VDGQ0_AQ+ZW74%@\PAW'RL2 J8R-S'D
MX'. /6JG@74KS4++4TU+3[>TU&UOW@NFM6)AGD"J3(F>0"",CU!SSFL[[7;V
MGQMN5N)XXFGT*!(@[ &1O/?A?4\T 2^"_%ZW>D*-?U>R749=0N;:!79(3*$E
M**%7//0>M=1?:UI>EN$O]2M+5BNX">94.,XSR>F>,UXU<168^"/B*\5(//&L
MR.)@!N!%X,'/T/ZUT'BK5--?5/&ME%+;V-TNDHEQ),^Z2\!BD*)$I. !N()
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M/S#_ $9L Y[@%0?>M/6!>>&OB!+_ &=&XC\56XA5D7(AO(^!(?0>62Q]?+-
M'</K>E1V"7[ZG9BS<X2?SUV,?0-G!Z'\JL6MW;7UK'=6EQ%<6\@W)+$X96'J
M".#7GNO7EIX8\>Z'!>W\FDZ,=*>TL[D;/+CF#J2K,ZL%RBKSQTKI/!5CH]CI
M5T-#N9KFRFO))A.[JR.[8+&,J -F<]!C(.* -.[U_1K$W N]6L;<VX5IA+<(
MOE@\#=D\9[9H/B#11<6D!U>P\Z\4-;1_:$W3@]"@S\P/M7(Z;:V,GQC\1AX;
M=F&F6I(90>29-Q_+&?K7%6\-E#\ =,NHT@25=3C990!N!6]P#GV7CZ4 >S7^
MLZ7I6W^T=1M+3?\ =\^94SV[FB[UK2K!@MYJ5G;L8S*!+.JG8.K<GH/6O.[G
M4]-B\;>+-(\2ZVVEQWJ1-!YQB2*XMC"%*JTBGHV_@$<L<=Z;_96C1>-_ =C%
M"9;0:;>)$MZ SN@$>S<#UXS@$<#L,4 >AW'B#1K2W@N+G5K&&"=0\4DEPBK(
MIQAE)/(Y'/O6+KVL:A9^-?"=G:W48T_4I;A)XQ&"7V0LZD-V&0.GIUKEGO-(
MT[QGXGT+7=5&BVEQ! +-&$,4$MH(0A12Z$ *V_Y01]XX'6IY[>QT[7?AG:63
MS_8XI+I;<W+?O#']G8*3GV(Q[$4 >@6NL:9?>=]CU*SN/(_UWDSJ_E_[V#Q^
M-3VMW;7ULES9W$5Q _W987#JWT(X->>ZVE]X7\:W"Z7$_D>*XQ$C(N1;WRC'
MF'V,9+'U,9KT&RLX-/L+>RMDV06\:Q1KZ*HP!^0H KG6]*6_%@VIV8O"^P0&
M==Y;&=NW.<XYQ5^O#]5UK2[G0;:>SN+:PMX_%$<K632;IU87/[R64L25SR<
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MU4G4)L G&?W#C^9'YU%H%TB?$'QI9:R8UFE\B6 3X"R6@C(^7/50V[/NQ]:
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M%FP#+<&5?+(/0ALXYKS"#Q':0>*=&NM2NY_#^FZAX?@^P-(8_+C<,2\1>12
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M+[>:>..:XAL##&S -)B.3.T=3COCI7=T %%%% !1110 4444 %%%% !1110
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M.>E2P^)M%N))8XM2@9XH?/9<X)B_YZ#/WE_VAD4 6O[)TXH$_L^UV DA?)7
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M)J;:G/(UC+&6>^#R;XV0?Q9^4#TVCH*]6$:"0R!%#D8+8Y(^M!C0R"0HI<#
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M-CA1DX')_2N?UC5]'U'QG\.IX[RUF@WW15RX*D^1A2"?]K !]1CJ*]-I-J@
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MQ9H/C"\NK,W]TTL*EW6.[MGC5 %VCDC;MP.>F.E>M4UHT=E9D5F4Y4D9(^E
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MQ*(Q((WN068#V  Y[YKB+V[GTC6+J^T+4X-2L)]95+[0;H S1S^:H+PD<YR
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%075[:6,0EO+J&WC)P&FD"#/U- $]%4!K>DFW-P-4LC #M,GVA-H/IG.*G
MM+^SOT9[.[@N54X8PR!P/K@T 6***.E !16?#KVCW%R+:#5K&6X)($27",Q/
MI@'-:% !15:74;*"ZCM9KRWCN),;(GE4.V>!@$Y-6: "BBB@ HJ*XN(+2%IK
MB:.&)>KR,%4?B:H_\))H7_0:T[_P*3_&@#3HID4L<\22PR+)&X#*Z'(8'H01
MU%/H **** "BBB@ HJO-?6EO<P6T]U!%<7!(AB>0*TF.3M!Y./:K% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MC'TP>M,TGXFWDEGXS_M32XA>>&22R6DA*3#Y\8)&1RAR<=#TJ#5_AOJ7]H>
MUTE[1K+PT096N)61YN4)P I&?D)Z]ZET#P9XDT77?&VIJ=,+:V_FVBF5G"L&
M<A9 4'!#\XS0!M^"/%\_BVWCNU:PGM'MP[26K,&AFR,Q.C<@C/!_BZ@#OV%>
M>>#/A^_ASQOJ>NP6L&F65W:K#_9]O.94,NX,SC*C"\8 ]STZ5Z'0 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% &3IOAC1M'U"YO]/LE@NKH[KB578F4Y)RV3\QR
M3R?6M:BB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M4<=Z ):*@@O;2ZDDCM[J&9XCB18Y Q0^A Z41WEK+(L<=S"\C E560$D X)
M]CP?>@">BHY[B&UA::XFCAB7[SR,%4?4FHVO[-8HY6NX!'(,HYD&&'L>] %B
MBHDN8))3$DT;2 9**X) ]<?B*:E[:RW3VL=S"]Q&,O$L@+J/<=10!/14#7MH
MMVMHUU"+EAE83(-Y'J%ZTD]]:6P<W%U!$$P&,D@7;GIG/K0!8HK+U3Q#IND7
M>GVMW<QI/?RF.!"P!.%+%OH .OJ1ZU)$UZ=>F#7EHU@;=3';JO[X/DY8G/*D
M8 XH T**@6]M'NVM%NH3<J,M") 7 ]2O6B:]M+82&>ZAB$8!??(%V@]"<],X
MH GHI 0RAE(((R".]<EJ?B*ZN_$]QX<T>^L[6ZAL1<^?.OF!I6<JL>,C^Z<]
M^1B@#KJ*H:?>E[6UBOKBS_M%DQ+';R94R*!O"9Y(!_'UJQ'>VDMS);1W4+W$
M?+Q+("R_4=10!/15>:^L[82&>Z@B$>-Y>0+MSTSGIFG&[MA<I;&XB$[KN6+>
M-S#U ZD4 345!>WMMIUE->7DZ06T*%Y)9#A54=R:Y+5O%]Q]G\)W^D26[66L
M7\%O,DB;I%61"_!#84X&""#UH [2BH([F&ZAD:TN(9"I*;E8.%8=C@]O2J>G
M74EMH-O/K&H64DP0>==1'9"S9QD9/'YT :=%,BFBGC$D,B21GHR,"#^(KC;C
M7_$,GQ$N/#-F^EI$FFC4$EFMY&)S)LV'$@^N[]* .UHKE_!?BUO$]CJ(N[5;
M._TR\DLKR-7W)O3JRMQ\I]ZZ"&[@OH'>QNH)@,J'1A(H;WP?TS0!8HKBO#^N
MZWKW@.[OS=Z?:ZFEQ<0K/)$1 @CE*Y*[LXP/6NOGNH+. 2W=Q#"@P"\CA%S]
M2: )J*@:]M$*![J%=X!3,@&X'H1ZT_SX3.8!+'YH&3'N&['TH DHICS11NBR
M2(K.2$#, 6(&3CUX!-0?VG8?9?M7VZV^SEMOF^:NS/IG.,T 6J*B-Q )Q"9H
M_-89";AN(^E"75O*CO'/$Z)]]E<$+]?2@"6BLR\\0Z18Z1<ZK-J%M]BMD,DD
MJ2!@!^!ZG& .YJW8WL.HV,-W ZM'*@888'&1G!QWH L45R?ACQ+<7EUKT.LW
M-E&;'56LH&0>4'4(C 89CEOF/>NGN+JWLX3-<SQ01#J\KA5'XF@"6BFQR)+&
MLD;JZ,,JRG((]0:AFOK.WN([>:[@CFD_U<;R ,_T!Y- %BBHI;FWM\^=/''A
M2YWN!A1U//89'/O0+JW:W6X6>(P-@K('&TYZ8/2@"6BH8;JWN'E2"XBE>)ML
MBHX8H?0XZ&DCO+6:18X[F%Y&4L%60$D X)QZ \?6@">BH(;VTN99(H+J&62(
MXD1) Q0^X'2B.]M)5=H[J%U09<K("%'J?2@">BJ\M_9PVHN9;N".W)P)6D 3
M\\XJ1IX4@,[2H(0N[S"PVX]<],4 245RF@>(KO5/&NOZ8T]I/86<-M+:R6Z]
M1)OSN.XAC\H&1CZ4_6]<U#3?&_AK38WMAI^I&Y$^Z,[U,<1<$-NQC..W;K0!
MU%%5UU"R>V6Y6[MV@8X$HD!4GZYQ3C=VP6-C<1!9.$)<8;Z>M $U%9NO:Y8^
M'-%N=5U&98K>!"QR<%CV4>I)X K&U+Q%=VOCGP]IT$]H^EZC#=/(P7+J8E4_
M?W8Q\WIVZT =7144%Q!<P+/;S1RQ-TDC8,I_$4VVO;6]5FM;F&=5.UC%(& /
MH<4 3T5%<75O9PF:YGB@B'5Y7"J/Q- N;<VZW GC,+8*R;QM.>G/2@"6BH8;
MJWN'E2"XBE>)MLBHX8H?0XZ&FB_LS+'$+N R2Y\M!(,OCK@=\8H L45!+>6L
M#%9KF&-AMR'D (R<#KZG@42WMI#<1V\MU#'/)]R-Y &;Z#J: )Z*CEN((/\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %<YXM:6]M[;0+1H_M&I,1()"<"W3!E)QS
M@C$?_;05T=4Y-)TZ74$U"33[5[V,82Y:%3(H] V,B@#SZ]-]X3^*.F:U?FT2
MQU]!IER8-P43*,PL<]R,I]*LC1M+O?C1JB7-A;3(^BP2O')&&5G\UQN*G@G
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M,XQ*@C&)!C&&]>..>U265C::;:):6-K#:VT?"0P1A$7Z <"@#S#3]!\/ZO\
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MM&T73FMI)#*\36J%&<G.XC&"<]Z .1U#2=.O/C9;K<V5O,)-!D>170$2$3H
M6'1L=LYZ#TKFH8O*^&.I6\%Q#!;V?B:1([:1PD<L:W0(@ST ;/?CUP,FO6/[
M#TC[8MW_ &79?:43RUF^SIO5/[H;&<>U8'B/PJ7TJ*WT#2=&$/VI9[RPFA$4
M5XH!^5BJG!W;3D@YQ@\9H J:+I%OJ/Q&OO%0M[1%-E%;Q*6BEF\P%MTF4+!?
ME(3KD@'MBNYKBO#_ (1AMM8M]5_X1K2-!EM]V%T^3>\VY2NUR$0!><XYR0#Q
MCGM: "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH *P_%OB:W\)^'YM3FB:=]RQ06Z'#32L<*@/;)[^@-
M;E<#\6],O+WPO97UE ]P^D:E!J$D$8RTD:9W #N0&S^!H WDM?%/V#[0^I6/
M]H%-WV7[,?LX;'W=V[?[;L^^WM5NUU9+;0;"\UN>"QGE@C,PF<1@2%067D]C
MGCVIUIXBT>^TE-4MM2MI+)U#"42#'/;V/;'7/%<L+]U^,=K]O5X;:ZT3&G><
M,?O/,W2J/1]NTD>@% '8/JNG1V"7[W]JMFX!6X,RB-L],-G!J,:]HYDNXQJM
MB7LQFY7[0F8!ZOS\OXUX]K]DD/@CQVRJG]D_VY"UCG&U6,L7G%/0;MPX[AO>
MNPU+3M.3XP^'XUM+90=*N?D$:@':Z%>/;DB@#LTUG2Y-.344U*S:Q<X6Y$ZF
M-CG'#9QUXI;;5M.O[BYM;'4;2>YMSMECBE5VB/\ M*#D?CBO&=6BM%^'7CE2
ML2Q6WBKY,8 B!F@SC^[U/3WKL;_1K*U^*WA2?0[:"!EM+K[<+9 JFWV 1[L=
MMY&/H?2@"SH.N:IJGA+7YKW6;6RN[74+JTBOI(5$<(C;:K%2<'\3753:I8Z;
M:02:CJ5I$'3B6618UDP,DC)_&O*7$$WP@^(!<1N%U3464G!PWF<$>_-=%/JN
MG0^+='MC+;6=]_86\W]U)\GD,ZYCC0D*SDKG)Z #@YX .Y?4[!(K>1[ZV6.Y
M(6!C*H$I/0*<_-GVI+#5=.U19&T^_M;M8GV2&WF60(WH<'@UXII?]GWOPT^'
MD4A@G:/Q!%!(K8)4%YOD/ID8X],5MZ]%<V_B'XAP:&GE7;Z%;NL=N,,6 D!(
M _BV\#OTH ].MM8TR\NWM+74;2>Y0$O#%,K.H!P20#GKQ1_;.E_VB-._M&T^
MW'.+;SU\PX&3\N<]*Y+1]4\(^(4\/7FDO;3ZG:VKK8Q0R?/:JT>'#H#PHP%^
M8=<8Y-<MX:G\/Z_X2T:PU?7;M=8L+I&;30T27*WB,<D#9O.6)).>A.3P: /6
MM0OK?2].N;^[D\NVMHFFE?T51DG\A7-Z%>Z_XHT.'6TNX=+BNU\VTMC;B4B,
M_<,I)&21@X7;C.,GK6EXPTB;7O!VL:5;D">ZM)(XLG W$< ^V<5F_#_5K>7P
M#IJ3NMM/IMJEI>Q3'8UO)$H5@X/W>F>>Q% #-'\=V\^C:Q-JPAL[_19GM[V+
MS $+J"5*$]G XSSVKG)_'=_9^$(?%ZZ[IMQ%+8>9+I3[,QW#J"B(5PWREOF#
M$G /3LF@6;RV7Q$\4LICL=7#_9"XQYD443J)1G^%LDCV&:BUUXQ^S1;-N7']
MD68SGO\ NQ0!T]O+JK:U93Q^-=.GTB>1=L30Q-+.X#!HT92!C.#T+#&/KTMY
MK&F:?,D-[J-I;2OC8DTRH6R<# )]>*Y'QNMO_P )+X&FQ'YAU;:K\9*F%^,^
MF<5D:9JOA^2X\;:#XPN+>&>;4I&>*ZDV-/:LJB'8<@MA0  O(/UH [Z:67_A
M);6-=7MXXOL\A?3BBF24Y&) <Y 7D<#'-3+K6EO?_8%U*S:\R5^SB=3)D<D;
M<YR*XV:.VB^+?ALQ0>0S:+<#8P^< &/ ;N2!D=^AKCY-:TJXT7PA=65S:65@
MOB5)$LFEW30@R2[WF=CD$DDXX W8R>* /1M*U?4I_B+KNCW,\;V5K:6\UNB1
M;2I<OG)R23\H_P *ZJN$TRZ@B^+/BB:29%B32K-V9FP%4>823[8YKL--U.QU
MG3XK_3KJ*ZM)02DL395L'!_4$4 53-)_PD^S^V+80+9DMINU?,W;Q^^W9SMP
M0N,8YZT\>(=%:2WC&KV!>Y8I HN4S*P."%&?F((QQWKEFBM_^%Y%?+BS+X;;
MS!@?/_I Z^O%<*+6PA^!-Q>1PVZ3)J^Y)E4!E(OL#![84_D: /=:I?VQIG]H
M#3_[1M/MI) M_.7S"<9QMSGIS5BZ\[[)-]GQYWEMY>>F[''ZUYCX-U/POK'@
MOP_I^J/')K-A=JS632%;E;U6.7*@ACR68D\8))Z&@#T:[UC2["=(+S4;2WF?
M&V.:=48Y.!@$]S3[C4K&SE6*YO;>&1U9U2255)51EB 3T !)/:O/?#\UK<:5
MX_T_Q"8UN1?W+W:S8R;=D'E-S_#L "_2LG2;"5M4^%D6N0))?FPN_-6=07($
M2% V>I QUZ$4 >K6^KZ;=:<=0M]0M)K(9)N8YE:,8Z_,#CBHO^$@T7[.]Q_:
M]AY",$>0W*;58] 3G /M7FUI:6D]MXVT]=2&E#_A(XFMYT4%89_W+(2IX(,@
M&1WJOXCO-6NO GCS3=:L+5=6LK>!I[NRSY5TAY5L'E6"KR/3';% 'K)O[,7H
MLOM=N+MEWK 9!O(]=N<XKB])\;-I^B^*M3\27L)BTK59[6(H@CW*J(511DY8
MDGN3S5;4-9TN[^*?@U[:_MI5-G>*'20$$LL15<],GTZ_G6#>$2?#GXIA"&(U
M>[) YQ\D?^!H ]23Q!I!TZ&^?4[)+>7A9#<+M+8R0#G!(Y_*JFM>+]%T/3;2
M^N+^W:&\FCAMF652)2S 9!Z;0#DGH *YF]U_1I/$_AU(+JRCNO[/F>+4IYLP
MQI\@=% 8*[G ZGY0#UZ5QUE=VH^%6D#[3&RV?B>,S$L!Y2?;&(+?W1CGM0!Z
MX;P7.NV#6NN6?V62W=OL2A&>XZ;9%;.<#GH"#FK<NL:7!?+92ZC:1W;D*L#S
MJ')/0!<YR:XZ^DM)OC!X;N+9H7\[2[L^8F#Y@!CP<CJ.N*YS3Y(;[X'>(+/5
ML'68'NQ>(W^L^V&1FC/J6),>W\ * /5;G5]-LI)([K4+2!XXC,ZRS*I6,$ L
M03PN2!GIR*FM;NVOK6.ZM+B*XMY!N26)PZL/4$<&O-],L _Q2T5-6@AEU$>%
M0UR74$F82H"Q]3G=S6M\+?+7P[J<,.T0PZS>I&B]$7S20!Z#F@#K&U;34O)+
M-M0M!<QH7>$S+O50,DE<Y QSFF)KFD263WJ:I9-:(=K3K<(44^A;. :Y/QJ[
M>'?$VA^+H8))44MIEZD2Y>2.7F/\I0H_X'6/X8LK_3]=N_!-[&&@-Q'K.]%Q
M&(6.]XU]A<* !W4F@#NOMRPZY>33:[9_88K17:S(0-#R296?.=I&!R,<5RVN
M>/?MO@A-=\-7]N,7L43J5$C^6\_E@D9^3(RPR*L6"0Q_&K65C5%9]%MV<* "
M3YKY)]^GZ5PT-U:3?L]:;:^?$TL5U;K-&'&Y,WG1AVZ'\J /:+35=.O[BX@L
M[^UN)K=ML\<,RNT1]& /!^M4O$GB73O"VE-?ZC.D:EA'&A8 R.3@ ?U]!DUS
M<4%M9?&V*&VBB@5_#C92-0H.VX4+P/09J;XLE4^']S(Y 1+NT9F/10+B/)-
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MR30!ZY!K.EW5[]BM]2LY;L1B7R(YU9]AY#;0<XY'/O4]ZY2QG87"6Q$;8GD
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M 2P4#+@==N21GH<>]8%U=6UI\;;=KF:.(3>'S'&78#>_VD?*/4^PKDFOC!X
M\;0VTA>YA\07,UQ;Q$&7[.+A#(=I[;,]1@C- 'K=CJ^F:F\J6&HVET\6/,6"
M97*9Z9P>*(=9TNXOVL8-1M);Q 2T"3J9!C@Y4'/%<!<-HVM/<ZUX;U^?5=?_
M +'N(K;[.\7R*4)7S%15(^?;@-SGMP<0>&[CPMXBLO"DR:[<3:C8,GV?3XVA
M26"0+MD5D5 VP '=G@@=^* /4R<#)Z52L]8TS4)GALM1M+F5!N=(9E=E'J0#
MTKG/BE]N'PWUDZ>DCRB-3(L?WC%O7S /^ ;OPS6?XC,&I:_X$O\ 09(WF-T6
M5X<8-D8R9,X_A^X/J1WH ?+XGG\0^(=9T;0M?LK*YL%A%H28Y5NI&4NX8')*
M@ #Y,$')SVKNX]_EKYA4R8&XJ.,]\5Q/A5XV^)GCQ592PDL<@'I^XKN* "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH ***Q_$GB73O"VE&_U&=(U+".)"P!D<G  _J>PR: +,>B:3#?
M&^BTNR2[)R9UMT$A/^]C-3WEA9ZA"(;VT@N8@=VR:,.N?7!KE+KQ1+!X^T^V
M&IV?]@W&F3W3.-NT%&0;C)G&.3TQ74P:E8W6GC4+>]MY;(J6%Q'*K1E1U.X'
M&* %DT^RFMTMY;.W>"/[D;1*57Z#&!3?[+T_S4E^P6OF( %?R5RH'3!QQ18Z
MII^J)(^GWUM=K&VUS!*KA3Z'!X-<UXZUW5M"F\/C39K=%U+58=/E$T)?:'W'
M<,,.1MZ4 .\9^$Y-8\,7&EZ)::=;S7$L+N\G[H8CD5_X5).=N/QKH[+3K2SA
M806-K:F49E2! %8^^ ,_B*YC4?$6K>'/%6AZ;J#VE]9:Q*UNCPPM%+#(!D$C
M<P9?7ICWKI;W6-,TV18[[4;2U=QE5GG5"><<9/K0 #2-,6)XAIUH(W(+((%P
MQ'0D8YI_]FV&8#]BMLV_^H/E+^Z_W>./PI;S4;+3XEEO;RWMHV.%::0("<9P
M"3Z4PZOIHLX;PZA:"UG(6*;SEV2$G "MG!R?2@ ;2-,9%1M.M"B$LJF!< DY
M)''<T^/3[**Y-S'9VZ3GK*L2AC^.,U"FMZ3)9R7B:G9-:QR&)YEG4HK@XVEL
MX!R1Q7/^$_$-UK/BCQ1:/?6UY96,MNMI);J NUX]YY!.3DXZ]NU '36VG6-E
M++):6=O!),=TK11*I<^K$#G\:1=-L5OVOULK87C#:;@1+YA'INQFGW=]::?#
MYUY=0VT6=N^:0(,^F35*_P#$.F6/A^;6OMEM)9QQ-(DBS+MDP"<*V<$G&* -
M2J5UHVEWMPMQ=Z;9SSKC;)+ KL/H2,USGA+4=5UZ+3-:36[2YLKFS5[RQ5$)
MMYF4,%1EY&,D$/D\5#=ZSKS_ !/_ .$9M;VSALVTK^T!)):%W!\WR]GWP,=\
MT =E-;P7,)AGACEB/5)%#*?P-5SI.FF 0'3[3R0=PC\E=N?7&.M<Q_PE.J:'
MXPL-!\11VLD&J!A8:A:HT8,B\F.1&9L'D8(.#Z>FW9W@BO=7FNM=LY[6*12L
M0")]B7;RKMGG)R><4 7&TK3G$8;3[5A%_JP85.SOQQQ3YM.L;B[BNY[*WEN8
M?]7,\2LZ?1B,C\*B@UK2KDS"#4[.4P1K++LG5O+1AE6;!X!'()[4^QU33]42
M1]/OK:[6-MKF"57"GT.#P: 'O86<ET+I[2!KA<8E,8+C\<9I@TK3AOQ86HWR
M"5_W*_,XZ,>.3[]:BAUW2+AYTAU6QD:!#),$N$)C4=6;!X'N:J>'O%FD>)=,
MDO["\A:&-Y W[P955=E#L.JAMNX9[&@#0;3;+S)9DL[47$BD&4P@DY'.>Y'K
MS4>CZ3;Z+IZV=JJJF]Y"$0*-S,6.%' &3P.PQ3[/5M-U'S?L.H6MSY6/,\F9
M7V9Z9P>*CAU[1[B9(8=5L9)9%=T1+A"6520Q !Y (()[8- $SZ;8R7#7#V5L
MTS#!D:)2Q&,=<9Z<4S^QM+\KRO[-L_+SNV>0N,^N,4MGJVFZB[I9:A:W+H S
M+#,KE0>A.#5R@!J(D<:I&JJBC"JHP /05 FG6,=\]]'9VZW<@P\ZQ*)&'H6Q
MDU9HH JW&F:?=W,=S<6-M-<1?ZN62)69/H2,BG2V%G/<+<36D$DR8VR/&"PQ
MZ$C-6** *7]CZ8$D3^SK/;)]]?(7#?7CFI8+"SM;9K:WM((8&SNBCC"J<]<@
M<58HH J6^EZ?:"(6UA:P^2&$7EPJNP-]X# XS@9QUI8=-L+=9%ALK:,2C$@2
M)5WCT.!S5JB@"J=,L"ENAL;8K;', ,2XB/JO'R_A2G3[(V\MN;.W,$K%Y(_*
M7:[$Y)(Q@G-6:* *QTZQ:X2X:SMS,F-LAB7<N.F#C(I'TS3Y+Y;Y[&V:\486
MX,2F0?1L9JU10!6?3K&2Y-P]G;M.>#*T2ENF.N,]*=;6-I9!A:VL, ;EA%&%
MS]<5/10 UXTE4+(BNH(8!AGD'(/U! /X4>6GFF78OF%=I?'./3/I3J* *ZV%
MFET;I;2!;D]9A& Y_'&:C;2=-="CZ?:,C.9"IA4@L>K=.I]:N44 55TVP2=9
MTLK99E "R")0P &!@XSTJ>:&*XA>&>))8G&&1U#*P]"#UI]% %0Z7IYE24V-
MKYB !7\E<J!P #CBG0Z=8VZ2)!96\22C$BI$JAQ[X'-6:* *]G86>G0>18VD
M%M%G=Y<$81<^N!1<Z?97I4W5I!.5^[YL8;'TR*L44 5K;3K&S8M:V5O QX)B
MB52?R%)>:98:CY?VVRMKGRSE//B5]I]LCBK5% $%Q96EY&D=S;0SHC!E66,,
M%(Z$ ]#4<FEZ?,)!)8VKB1_,?="IW-C&3QR<=ZMT4 5Y+&TFLS9R6L#VI&TP
M-&"A'IMZ4EMI]E9'-K9V\!VA/W407Y1T' Z#TJS10!'/!#<PO#/$DL3C#)(H
M96'H0>M10:=96MH;2WL[>*V.<PQQ*J'/7Y0,59HH KVUC:6086MK!!N^]Y48
M7/UQ3;G3;"\D$EU96T[@8#2Q*Q ^I%6J* (+:SM;-2MK;0P*>HB0*#^5-DTZ
MQEN/M$EG;O/C'F-$I;TZXS5FB@"O;6-G9;OLMK!!O^]Y487/UQ3;?3;&TN9K
MFVLK:&>;F66.)59_]X@9/XU:HH K#3K%;\WXL[<7C+M-P(E\PCTW8SBI!;6X
MNC=""+[05V&78-Y7TSUQ[5+10!5ATS3[>\DO(;&VCNI/OS)$H=OJP&32Q:?9
M07#7$-G;QS-G=(D2ACGKD@9JS10!4@TK3K6X-Q;V%K#.PP9(X55B/J!FK=%%
M %2UTO3[$R&SL;6W,O\ K##"J;_K@<T^VL+.R+&UM(("WWC%&%S]<"K%% $-
MS:V][ 8+JWBGA."8Y4#*?P-1OIEA)YF^RMF\P*'W1*=P7[N>.<=O2K5% %/^
MR=-S&?[/M,Q<1_N5^3G/'''-69H8KB)HIXDEC;[R.H8'Z@T^B@"D='TPJBG3
MK/:GW!Y"_+]..*EBT^R@G>>*TMXYGSND2,!FSUR<9-6** *4&C:7:N'M]-LX
M6#F0&.!5(8\%N!U]Z>^FV,M\E])96SW:#"3M$ID4>@;&15JB@#C[;PI-)XZU
MG6-3LM-N;"]B@CA1R9'C,089*LF.=W8\8[UU<]K;W5LUM<0130,,-%(@92/0
M@\5+10!4_LK3OLD=I]@M?LT?W(?)78OT7&!2KIFGK,DRV-L)4 ".(EW+CI@X
MXJU10!2;1M+>>6=]-LVFFQYDA@4L^"",G'." >?2GW>FV%^8C>65M<F([HS-
M$K[#ZC(XJU10!7ET^RFN%N);2"2=,;9&C!88Z8.,TV/3-/A658K&V191MD"Q
M* X]#QR*M44 ,BBC@B2*&-(XT&%1% "CT '2H9=.L9KV.\ELK>2ZB&(YVB4N
M@]FQD59HH K7FFV.HJBWUE;W2H<J)XE<*?49'%+/I]E=+&MQ:6\RQ_<$D88+
M],CBK%% %3^R]/\ .,WV&U\TC!?R5W$8QC./3BF?V+I6P)_9EEM!R%\A<9]>
ME7J* *G]EZ?YQF^PVOFD8+^2N[&,8SCTXIG]C:7Y1B_LVS\LG<4\A<9]<8J]
M10! ;*U+P.;:'? ,0MY8S&,8^7TX]*=':V\4LLL<$223$&5U0 OCID]_QJ6B
M@"M9Z=8Z<'%E96]L)&W.((E3<?4X')I(=-L;:[ENX+*VBN9O]9,D2J[_ %8#
M)_&K5% !56TTRPT]Y'LK&VMFD.7,,2H6/O@<U:HH JPZ;86\YGALK:.8YS(D
M2AN?<"K5%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %<3\6&5/ ,\CD*B7EHS,>B@7$>2?:NVIDT
M,5Q"\,\:2Q.,,CJ&5AZ$'K0!P6H-8:G\7?#SAK>ZA_LJZ9#D.I(D09'KT/Y5
MR1N_[,\+ZI-&\D6EV7C:4W9MT#>3;A\YVD$8#E#C!Z5[&=,L#*DIL;;S$ "O
MY2Y4#@ '%+#IUC;I(D-G;QI*,2*D2@./? YH Y?PW%X?NO%5YK&DZW)JUY<6
MB1W,L<L31!0?DW>6H&_KC/. ?:LSXL^0Z^#XIY3&C>([7<1*8R%VODA@01C/
M4'BN\L[&ST^#R+*U@MHL[O+AC"+GUP*2YTZQO'#W5G;SL!@-+$K$#\10!Y?X
MI@M=%\?>%KWP[=R7VL7%V+::TGN6NR+5O]9("Y9HL>H(SGOS6OX9GMY-9\>:
M?X@,8F:]:203D -8F,+&>?X  WL"3W-=U;6%G9Y^RVD$&[KY487/Y4VZTRPO
M9HYKNQMKB6+_ %;RQ*Y3Z$CB@#R?PQ??V=IO@:SU=X[;5Q8W4EO?:A(52& L
M,+MR SE-F,D;0#UZ'(5]/N/A5% \T$QM_$P4[B 45KL_]\Y&3VXKW.>SM;IH
MFN+:&9HFWQF1 Q1O49Z&HGTK3I%*O86K*7,A#0J06/5NG4^M '"Z^UAX?^(W
MA998+:QT:;[4P946.+[8RJ%9\<;BN0"?4U-X,NK"3XD>.X[2>W;?/:2!8G!W
M?N!N(QU^;.?>NWN+"SN[3[)<VD$UM@#R9(PR<=/E/%+;V=K:%C;6T,)?&XQQ
MA=V!@9QZ  #V% '&ZI=/:_&/1?MQVZ?-I4T5DS_=%T9 6'^\8P /QK)MH&M1
M\4)(2%T9U+08/R"?[,3.1V^\1GW!KTB[LK6_@,%Y;0W$).3'-&'4GZ&D-C9F
MT6T-K ;91@0^6-@'^[TH Q_ I5OA_P"'"I!']F6W(_ZY+7.37,$7[0">9-&G
M_%,E?F8#G[3G'UQ7?6]K;VD?EVT$4*9SMC0*,_057ET?3)I6DETZTDD8Y9G@
M4DGW.* .!\3.GC'X@>&-.TAQ<PZ->?;]0NHCNCAVXV1[AP68_P /4#FJ,D-I
MY?Q;B$</EK'NV8& ?LG7'KG/XUZM%#%!&(X8TCC'144 #\!5;^R=-_>?\2^T
M_>??_<K\W.>>.>: /,=4AL]'^&/A;5[:W2"W#:>^IW5M"K2& +DLQ(.X!RK<
M@T>(XM.N]&\3ZSX8UJXU?5I]*$=Q);2QL@B# X/EJ,2;-^.^ ?:O5([2VAMS
M;Q6\20$$&-4 4@]>.E-L["STZ'R;*T@MHL[MD$81<^N!0!R^D:GX.\0ZEHNH
M:5);W-]%;,MLMO)\UM"RC<)$!^4<!?F'!/%>?6VH"'X/:8D<BR0V6N>9J\"'
M+):B\D+;U'(!^7KVSVS7M%IIUC8-*UG9V]N96W2&&)4WGU.!R:?':6T0E$=O
M$@F8M*%0#>3U+>I^M '%:Q MW\4_"]UIS1R*]E=#4&C(97MBJ^7N[$%SQZ\^
ME<_X1T?0+KX27TMXL%NI>_BDOHT7S($:5U)#=AMQQTQ7J%KI>GV4,D-I8VL$
M4GWTBA5%;Z@#FG1:=8P0R0Q65O'%)]]$B4*WU&.: .*\.:GJNG>)KK3O$WV&
MYE@TS[3'K5M\BRVZOC$J]%;)+#'&-V.]=O97MMJ-E#>6<Z3VTZ!XY8SE64]"
M*9;:986<4D5K8VT$<O\ K$BB50_U '-3PPQ6\*0P1)%%&H5$10JJ!T  Z"@!
M]%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
< !1110 4444 %%%% !1110 4444 %%%% '__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover Page - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Sep. 03, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-K<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentAnnualReport', window );">Document Annual Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Jun. 30,  2025<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--06-30<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-35647<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">LIFEVANTAGE CORP<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">90-0224471<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">3300 N. Triumph Blvd<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Suite 700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Lehi<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">UT<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">84043<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">801<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">432-9000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, par value $0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">LFVN<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityWellKnownSeasonedIssuer', window );">Entity Well-known Seasoned Issuer</a></td>
<td class="text">No<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityVoluntaryFilers', window );">Entity Voluntary Filers</a></td>
<td class="text">No<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_IcfrAuditorAttestationFlag', window );">ICFR Auditor Attestation Flag</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityPublicFloat', window );">Entity Public Float</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 220.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,691,009<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentsIncorporatedByReferenceTextBlock', window );">Documents Incorporated by Reference</a></td>
<td class="text">Portions of the registrant&#8217;s definitive proxy statement to be filed subsequent to the date hereof with the Securities and Exchange Commission pursuant to Regulation 14A in connection with the registrant&#8217;s fiscal year 2026 annual meeting of stockholders are incorporated by reference into Part III of this report. Such definitive proxy statement will be filed with the Commission not later than 120 days after the end of the registrant&#8217;s fiscal year ended June 30, 2025.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000849146<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2025<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">FY<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFinStmtErrorCorrectionFlag', window );">Document Financial Statement Error Correction [Flag]</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentAnnualReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an annual report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentAnnualReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFinStmtErrorCorrectionFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates whether any of the financial statement period in the filing include a restatement due to error correction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection w<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFinStmtErrorCorrectionFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentsIncorporatedByReferenceTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Documents incorporated by reference.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentsIncorporatedByReferenceTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityPublicFloat">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityPublicFloat</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityVoluntaryFilers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityVoluntaryFilers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityWellKnownSeasonedIssuer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityWellKnownSeasonedIssuer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_IcfrAuditorAttestationFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_IcfrAuditorAttestationFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Audit Information<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lfvn_AuditorInformationAbstract', window );"><strong>Auditor Information [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorName', window );">Auditor Name</a></td>
<td class="text">Deloitte & Touche LLP<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorLocation', window );">Auditor Location</a></td>
<td class="text">Salt Lake City, Utah<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorFirmId', window );">Auditor Firm ID</a></td>
<td class="text">34<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorFirmId">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>PCAOB issued Audit Firm Identifier</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorFirmId</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:nonemptySequenceNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorLocation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorLocation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:internationalNameItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:internationalNameItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lfvn_AuditorInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Auditor Information</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lfvn_AuditorInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lfvn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONSOLIDATED BALANCE SHEETS - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 20,201<span></span>
</td>
<td class="nump">$ 16,886<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable</a></td>
<td class="nump">3,294<span></span>
</td>
<td class="nump">2,949<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxesReceivable', window );">Income tax receivable</a></td>
<td class="nump">635<span></span>
</td>
<td class="nump">313<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventory</a></td>
<td class="nump">20,669<span></span>
</td>
<td class="nump">15,055<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid expenses and other</a></td>
<td class="nump">6,095<span></span>
</td>
<td class="nump">2,443<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">50,894<span></span>
</td>
<td class="nump">37,646<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsNoncurrentAbstract', window );"><strong>Non-current assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="nump">6,207<span></span>
</td>
<td class="nump">7,813<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Right-of-use assets</a></td>
<td class="nump">8,041<span></span>
</td>
<td class="nump">9,569<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Intangible assets, net</a></td>
<td class="nump">245<span></span>
</td>
<td class="nump">323<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxAssetsNet', window );">Deferred income tax asset</a></td>
<td class="nump">5,970<span></span>
</td>
<td class="nump">4,268<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other long-term assets</a></td>
<td class="nump">601<span></span>
</td>
<td class="nump">680<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">TOTAL ASSETS</a></td>
<td class="nump">71,958<span></span>
</td>
<td class="nump">60,299<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">4,600<span></span>
</td>
<td class="nump">5,853<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedSalesCommissionCurrent', window );">Commissions payable</a></td>
<td class="nump">7,237<span></span>
</td>
<td class="nump">6,569<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedIncomeTaxesCurrent', window );">Income tax payable</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">202<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Lease liabilities</a></td>
<td class="nump">1,867<span></span>
</td>
<td class="nump">1,811<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Other accrued expenses</a></td>
<td class="nump">13,513<span></span>
</td>
<td class="nump">7,874<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">27,217<span></span>
</td>
<td class="nump">22,309<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Long-term lease liabilities</a></td>
<td class="nump">9,811<span></span>
</td>
<td class="nump">11,801<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other long-term liabilities</a></td>
<td class="nump">289<span></span>
</td>
<td class="nump">198<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">37,317<span></span>
</td>
<td class="nump">34,308<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and contingencies &#8212; Note 14</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders&#8217; equity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred stock &#8212; par value $0.0001 per share, 5,000 shares authorized, no shares issued or outstanding</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock &#8212; par value $0.0001 per share, 40,000 shares authorized and 12,429 and 12,510 issued and outstanding as of June&#160;30, 2025 and 2024, respectively</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapitalCommonStock', window );">Additional paid-in capital</a></td>
<td class="nump">139,962<span></span>
</td>
<td class="nump">136,644<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="num">(104,147)<span></span>
</td>
<td class="num">(108,738)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive loss</a></td>
<td class="num">(1,175)<span></span>
</td>
<td class="num">(1,916)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total stockholders&#8217; equity</a></td>
<td class="nump">34,641<span></span>
</td>
<td class="nump">25,991<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">TOTAL LIABILITIES AND STOCKHOLDERS&#8217; EQUITY</a></td>
<td class="nump">$ 71,958<span></span>
</td>
<td class="nump">$ 60,299<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481990/310-10-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedIncomeTaxesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all currently due domestic and foreign income tax obligations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedIncomeTaxesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedSalesCommissionCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred through that date and payable for sales commissions. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 8<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedSalesCommissionCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of accumulated increase (decrease) in equity from transaction and other event and circumstance from nonowner source.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-14A<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-11<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 815<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480870/815-30-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapitalCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapitalCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset recognized for present right to economic benefit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478671/942-235-S50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 64<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481620/480-10-55-64<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 944<br> -SubTopic 605<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477548/944-605-55-14<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 944<br> -SubTopic 605<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477548/944-605-55-11<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 49<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-49<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 19: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 20: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 25: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 26: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 35: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 37: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset recognized for present right to economic benefit, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 22: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsNoncurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsNoncurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalent. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479887/480-10-S45-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (01)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480244/480-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482525/740-10-45-4<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482525/740-10-45-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount due within one year of the balance sheet date (or one operating cycle, if longer) from tax authorities as of the balance sheet date representing refunds of overpayments or recoveries based on agreed-upon resolutions of disputes.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482686/350-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized for present obligation requiring transfer or otherwise providing economic benefit to others.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 64<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481620/480-10-55-64<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(21))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 18: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(14))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 30: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br><br>Reference 31: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 944<br> -SubTopic 605<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477548/944-605-55-14<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 944<br> -SubTopic 605<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477548/944-605-55-11<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(21))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-5<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 22: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479887/480-10-S45-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (01)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480244/480-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(21))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-7A<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 360<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478451/942-360-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated undistributed earnings (deficit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480990/946-20-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 15: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 16: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480418/310-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONSOLIDATED BALANCE SHEETS (Parenthetical) - $ / shares<br></strong></div></th>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionAbstract', window );"><strong>Statement of Financial Position [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value (dollars per share)</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized (in shares)</a></td>
<td class="nump">5,000,000<span></span>
</td>
<td class="nump">5,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock, shares issued (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, shares outstanding (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (dollars per share)</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized (in shares)</a></td>
<td class="nump">40,000,000<span></span>
</td>
<td class="nump">40,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued (in shares)</a></td>
<td class="nump">12,429,000<span></span>
</td>
<td class="nump">12,510,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding (in shares)</a></td>
<td class="nump">12,429,000<span></span>
</td>
<td class="nump">12,510,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued for nonredeemable preferred shares and preferred shares redeemable solely at option of issuer. Includes, but is not limited to, preferred shares issued, repurchased, and held as treasury shares. Excludes preferred shares classified as debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME - USD ($)<br> shares in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementAbstract', window );"><strong>Income Statement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerProductAndServiceExtensibleList', window );">Revenue from Contract with Customer, Product and Service [Extensible Enumeration]</a></td>
<td class="text">Product [Member]<span></span>
</td>
<td class="text">Product [Member]<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue, net</a></td>
<td class="nump">$ 228,530<span></span>
</td>
<td class="nump">$ 200,164<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Cost of sales</a></td>
<td class="nump">44,864<span></span>
</td>
<td class="nump">41,440<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Gross profit</a></td>
<td class="nump">183,666<span></span>
</td>
<td class="nump">158,724<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Operating expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lfvn_CommissionAndIncentives', window );">Commissions and incentives</a></td>
<td class="nump">102,260<span></span>
</td>
<td class="nump">85,920<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpense', window );">Selling, general and administrative</a></td>
<td class="nump">69,207<span></span>
</td>
<td class="nump">68,472<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Total operating expenses</a></td>
<td class="nump">171,467<span></span>
</td>
<td class="nump">154,392<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating income</a></td>
<td class="nump">12,199<span></span>
</td>
<td class="nump">4,332<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpenseAbstract', window );"><strong>Other income (expense):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestRevenueExpenseNet', window );">Interest income, net</a></td>
<td class="nump">431<span></span>
</td>
<td class="nump">430<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other expense, net</a></td>
<td class="num">(387)<span></span>
</td>
<td class="num">(412)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpense', window );">Total other income, net</a></td>
<td class="nump">44<span></span>
</td>
<td class="nump">18<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Income before income taxes</a></td>
<td class="nump">12,243<span></span>
</td>
<td class="nump">4,350<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax expense</a></td>
<td class="num">(2,438)<span></span>
</td>
<td class="num">(1,413)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">$ 9,805<span></span>
</td>
<td class="nump">$ 2,937<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Net income per share:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic (dollars per share)</a></td>
<td class="nump">$ 0.80<span></span>
</td>
<td class="nump">$ 0.24<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted (dollars per share)</a></td>
<td class="nump">$ 0.75<span></span>
</td>
<td class="nump">$ 0.23<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract', window );"><strong>Weighted-average shares outstanding:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Basic (in shares)</a></td>
<td class="nump">12,251<span></span>
</td>
<td class="nump">12,458<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment', window );">Diluted (in shares)</a></td>
<td class="nump">12,987<span></span>
</td>
<td class="nump">12,986<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract', window );"><strong>Other comprehensive income (loss), net of tax:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax', window );">Foreign currency translation adjustment</a></td>
<td class="nump">$ 741<span></span>
</td>
<td class="num">$ (555)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss), net of tax:</a></td>
<td class="nump">741<span></span>
</td>
<td class="num">(555)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest', window );">Comprehensive income</a></td>
<td class="nump">$ 10,546<span></span>
</td>
<td class="nump">$ 2,382<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lfvn_CommissionAndIncentives">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Expenses related to commissions and other incentives earned by independent distributors. Commission and incentive expenses include sales commissions paid to our independent distributors, special incentives, costs for incentive trip and other rewards</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lfvn_CommissionAndIncentives</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lfvn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-19<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481175/810-10-55-4K<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-4A<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-11<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-4<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(2)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(2)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 924<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479941/924-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476148/220-40-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 9<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-9<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 17<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480336/718-10-65-17<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-52<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-15<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-7<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-2<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-10<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-7<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (f)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481538/470-20-65-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 9<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-9<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 17<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480336/718-10-65-17<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-52<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-15<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-7<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-2<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-7<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (f)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481538/470-20-65-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GrossProfit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 16: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-31<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GrossProfit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-4<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-21<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-14<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478671/942-235-S50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 14: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-31<br><br>Reference 15: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 16: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-4<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-21<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-14<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-10<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -SubTopic 20<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482659/740-20-45-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -SubTopic 10<br> -Topic 235<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestRevenueExpenseNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of interest income (expense) classified as operating and nonoperating.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestRevenueExpenseNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-4<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-21<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-14<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(k)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479857/480-10-S50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479887/480-10-S45-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (24)(d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480244/480-10-S99-3A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 9<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-9<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 17<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480336/718-10-65-17<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 19: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 34: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 38: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 39: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 40: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 41: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 42: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 43: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 44: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 45: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 46: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 47: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 48: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (f)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481538/470-20-65-4<br><br>Reference 49: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-4<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-14<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-31<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 220<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-10A<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481674/830-30-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481694/830-30-45-17<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-4<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-5<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481694/830-30-45-20<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -SubTopic 10<br> -Topic 220<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482739/220-10-55-15<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-4A<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-4<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-14<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-41<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-42<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-7<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 924<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479941/924-10-S99-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-5<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-40<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerProductAndServiceExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates product and service for revenue from satisfaction of performance obligation by transferring promised product and service to customer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-5<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479777/606-10-55-91<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerProductAndServiceExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-18<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-11<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-4<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-14<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476148/220-40-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The sum of dilutive potential common shares or units used in the calculation of the diluted per-share or per-unit computation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF STOCKHOLDERS&#8217; EQUITY - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>Common Stock</div></th>
<th class="th"><div>Additional Paid-In&#160;Capital</div></th>
<th class="th"><div>Accumulated Deficit</div></th>
<th class="th"><div>Accumulated Other Comprehensive Income (Loss)</div></th>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Beginning balances (in shares) at Jun. 30, 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,622,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balances at Jun. 30, 2023</a></td>
<td class="nump">$ 34,649<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">$ 134,314<span></span>
</td>
<td class="num">$ (98,305)<span></span>
</td>
<td class="num">$ (1,361)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation</a></td>
<td class="nump">3,280<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,280<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans', window );">Common stock issued under employee stock purchase plan (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">64,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan', window );">Common stock issued under employee stock purchase plan</a></td>
<td class="nump">$ 271<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">271<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures', window );">Common stock issued under equity award plans (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,007,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation', window );">Shares canceled or surrendered as payment of tax withholding and other (in shares)</a></td>
<td class="num">(200,000)<span></span>
</td>
<td class="num">(206,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation', window );">Shares canceled or surrendered as payment of tax withholding and other</a></td>
<td class="num">$ (1,221)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,221)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue', window );">Repurchase of company stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(6,430)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodShares', window );">Repurchase of company stock (in shares)</a></td>
<td class="num">(1,000,000.0)<span></span>
</td>
<td class="num">(977,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodValue', window );">Repurchase of company stock</a></td>
<td class="num">$ (6,430)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DividendsCash', window );">Cash dividends</a></td>
<td class="num">(6,940)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(6,940)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax', window );">Foreign currency translation adjustment</a></td>
<td class="num">(555)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(555)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">$ 2,937<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,937<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Ending balances (in shares) at Jun. 30, 2024</a></td>
<td class="nump">12,510,000<span></span>
</td>
<td class="nump">12,510,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balances at Jun. 30, 2024</a></td>
<td class="nump">$ 25,991<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">136,644<span></span>
</td>
<td class="num">(108,738)<span></span>
</td>
<td class="num">(1,916)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation</a></td>
<td class="nump">5,702<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,702<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans', window );">Common stock issued under employee stock purchase plan (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">44,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan', window );">Common stock issued under employee stock purchase plan</a></td>
<td class="nump">$ 280<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">280<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures', window );">Common stock issued under equity award plans (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">376,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation', window );">Shares canceled or surrendered as payment of tax withholding and other (in shares)</a></td>
<td class="num">(200,000)<span></span>
</td>
<td class="num">(202,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation', window );">Shares canceled or surrendered as payment of tax withholding and other</a></td>
<td class="num">$ (2,664)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,664)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue', window );">Repurchase of company stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3,147)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodShares', window );">Repurchase of company stock (in shares)</a></td>
<td class="num">(300,000)<span></span>
</td>
<td class="num">(299,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodValue', window );">Repurchase of company stock</a></td>
<td class="num">$ (3,147)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DividendsCash', window );">Cash dividends</a></td>
<td class="num">(2,067)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,067)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax', window );">Foreign currency translation adjustment</a></td>
<td class="nump">741<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">741<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">$ 9,805<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,805<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Ending balances (in shares) at Jun. 30, 2025</a></td>
<td class="nump">12,429,000<span></span>
</td>
<td class="nump">12,429,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balances at Jun. 30, 2025</a></td>
<td class="nump">$ 34,641<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">$ 139,962<span></span>
</td>
<td class="num">$ (104,147)<span></span>
</td>
<td class="num">$ (1,175)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease to equity for grantee's tax withholding obligation for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480483/718-10-35-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsCash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of paid and unpaid cash dividends declared for classes of stock, for example, but not limited to, common and preferred.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -SubTopic 405<br> -Topic 942<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477787/942-405-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsCash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInStockholdersEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-4<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-21<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-14<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(k)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479857/480-10-S50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479887/480-10-S45-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (24)(d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480244/480-10-S99-3A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 9<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-9<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 17<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480336/718-10-65-17<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 19: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 34: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 38: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 39: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 40: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 41: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 42: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 43: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 44: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 45: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 46: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 47: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 48: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (f)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481538/470-20-65-4<br><br>Reference 49: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 220<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-10A<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares used to settle grantee's tax withholding obligation for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period as a result of an employee stock purchase plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period related to Restricted Stock Awards, net of any shares forfeited.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate change in value for stock issued during the period as a result of employee stock purchase plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of stock that has been repurchased and retired during the period. The excess of the purchase price over par value can be charged against retained earnings (once the excess is fully allocated to additional paid in capital).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedAndRetiredDuringPeriodValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedDuringPeriodShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased during the period and have not been retired and are not held in treasury. Some state laws may govern the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478448/946-505-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedDuringPeriodShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedDuringPeriodValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of stock that has been repurchased during the period and has not been retired and is not held in treasury. Some state laws may mandate the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-11<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478009/946-205-45-4<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478448/946-505-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedDuringPeriodValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 15: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 16: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480418/310-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Cash Flows from Operating Activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">$ 9,805<span></span>
</td>
<td class="nump">$ 2,937<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net income to net cash provided by operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">3,156<span></span>
</td>
<td class="nump">3,581<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation</a></td>
<td class="nump">5,702<span></span>
</td>
<td class="nump">3,280<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense', window );">Non-cash operating lease expense</a></td>
<td class="nump">1,440<span></span>
</td>
<td class="nump">1,287<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfPropertyPlantEquipment', window );">(Gain) loss on disposal of fixed assets</a></td>
<td class="num">(4)<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfFinancingCosts', window );">Amortization of deferred financing fees</a></td>
<td class="nump">32<span></span>
</td>
<td class="nump">7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxesAndTaxCredits', window );">Deferred income tax</a></td>
<td class="num">(1,703)<span></span>
</td>
<td class="num">(1,277)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in operating assets and liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">Accounts receivable</a></td>
<td class="num">(242)<span></span>
</td>
<td class="num">(1,424)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInIncomeTaxesReceivable', window );">Income tax receivable</a></td>
<td class="num">(322)<span></span>
</td>
<td class="num">(71)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInInventories', window );">Inventory</a></td>
<td class="num">(5,216)<span></span>
</td>
<td class="nump">662<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidExpense', window );">Prepaid expenses and other</a></td>
<td class="num">(3,603)<span></span>
</td>
<td class="nump">2,280<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets', window );">Other long-term assets</a></td>
<td class="nump">72<span></span>
</td>
<td class="num">(55)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayable', window );">Accounts payable</a></td>
<td class="num">(1,295)<span></span>
</td>
<td class="nump">2,301<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable', window );">Income tax payable</a></td>
<td class="num">(201)<span></span>
</td>
<td class="nump">202<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedLiabilities', window );">Other accrued expenses</a></td>
<td class="nump">6,037<span></span>
</td>
<td class="num">(176)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingLeaseLiability', window );">Lease liabilities</a></td>
<td class="num">(1,843)<span></span>
</td>
<td class="num">(1,586)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities', window );">Other liabilities</a></td>
<td class="nump">63<span></span>
</td>
<td class="nump">247<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net Cash Provided by Operating Activities</a></td>
<td class="nump">11,878<span></span>
</td>
<td class="nump">12,197<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Cash Flows from Investing Activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Purchase of equipment</a></td>
<td class="num">(1,371)<span></span>
</td>
<td class="num">(2,245)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment', window );">Proceeds from sale of fixed assets</a></td>
<td class="nump">4<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net Cash Used in Investing Activities</a></td>
<td class="num">(1,367)<span></span>
</td>
<td class="num">(2,245)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Cash Flows from Financing Activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfFinancingCosts', window );">Payment of deferred financing fees</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(97)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForRepurchaseOfCommonStock', window );">Repurchase of company stock</a></td>
<td class="num">(3,147)<span></span>
</td>
<td class="num">(6,430)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfDividends', window );">Payment of cash dividends</a></td>
<td class="num">(2,067)<span></span>
</td>
<td class="num">(6,940)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation', window );">Shares purchased as payment of tax withholding and other</a></td>
<td class="num">(2,664)<span></span>
</td>
<td class="num">(1,221)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lfvn_ProceedsFromIssuanceOfCommonStockUnderEmployeeStockPurchasePlan', window );">Proceeds from common stock issued under employee stock purchase plan</a></td>
<td class="nump">280<span></span>
</td>
<td class="nump">271<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net Cash Used in Financing Activities</a></td>
<td class="num">(7,598)<span></span>
</td>
<td class="num">(14,417)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Foreign Currency Effect on Cash</a></td>
<td class="nump">402<span></span>
</td>
<td class="num">(254)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Increase (Decrease) in Cash and Cash Equivalents</a></td>
<td class="nump">3,315<span></span>
</td>
<td class="num">(4,719)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash and Cash Equivalents &#8212; beginning of period</a></td>
<td class="nump">16,886<span></span>
</td>
<td class="nump">21,605<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash and Cash Equivalents &#8212; end of period</a></td>
<td class="nump">20,201<span></span>
</td>
<td class="nump">16,886<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowInformationAbstract', window );"><strong>SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestPaidNet', window );">Cash paid for interest</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">21<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxesPaid', window );">Cash paid for income taxes</a></td>
<td class="nump">$ 4,918<span></span>
</td>
<td class="nump">$ 2,306<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lfvn_ProceedsFromIssuanceOfCommonStockUnderEmployeeStockPurchasePlan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Proceeds From Issuance of Common Stock Under Employee Stock Purchase Plan</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lfvn_ProceedsFromIssuanceOfCommonStockUnderEmployeeStockPurchasePlan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lfvn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfFinancingCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense attributable to debt issuance costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfFinancingCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalent, and cash and cash equivalent restricted to withdrawal or usage; attributable to continuing operation. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-8<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash and cash equivalent, and cash and cash equivalent restricted to withdrawal or usage; including effect from exchange rate change and including, but not limited to, discontinued operation. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -SubTopic 230<br> -Topic 830<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477401/830-230-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxesAndTaxCredits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) and income tax credits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxesAndTaxCredits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476148/220-40-50-12<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 49<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-49<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476148/220-40-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from effect of exchange rate change on cash and cash equivalent, and cash and cash equivalent restricted to withdrawal or usage; held in foreign currency; attributable to continuing operation. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 230<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477401/830-230-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnSaleOfPropertyPlantEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) on sale or disposal of property, plant and equipment assets, including oil and gas property and timber property.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnSaleOfPropertyPlantEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before refund, of cash paid to foreign, federal, state, and local jurisdictions as income tax.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-2A<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 23<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-23<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-22<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-25<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the period in the amount due for taxes based on the reporting entity's earnings or attributable to the entity's income earning process (business presence) within a given jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInIncomeTaxesReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in income taxes receivable, which represents the amount due from tax authorities for refunds of overpayments or recoveries of income taxes paid.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInIncomeTaxesReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInInventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInInventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in obligation for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -SubTopic 20<br> -Topic 842<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherNoncurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in noncurrent operating liabilities classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the amount of outstanding money paid in advance for goods or services that bring economic benefits for future periods.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-17<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activity, including, but not limited to, discontinued operation. Financing activity includes, but is not limited to, obtaining resource from owner and providing return on, and return of, their investment; borrowing money and repaying amount borrowed, or settling obligation; and obtaining and paying for other resource obtained from creditor on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activity, including, but not limited to, discontinued operation. Investing activity includes, but is not limited to, making and collecting loan, acquiring and disposing of debt and equity instruments, property, plant, and equipment, and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activity, including, but not limited to, discontinued operation. Operating activity includes, but is not limited to, transaction, adjustment, and change in value not defined as investing or financing activity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-25<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-4<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-21<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-14<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(k)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479857/480-10-S50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479887/480-10-S45-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (24)(d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480244/480-10-S99-3A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 9<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-9<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 17<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480336/718-10-65-17<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 19: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 34: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 38: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 39: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 40: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 41: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 42: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 43: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 44: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 45: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 46: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 47: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 48: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (f)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481538/470-20-65-4<br><br>Reference 49: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of periodic reduction over lease term of carrying amount of right-of-use asset from operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRepurchaseOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to reacquire common stock during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRepurchaseOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDividends">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash outflow in the form of capital distributions and dividends to common shareholders, preferred shareholders and noncontrolling interests.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDividends</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfFinancingCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for loan and debt issuance costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfFinancingCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the sale of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>The Company<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock', window );">The Company</a></td>
<td class="text">The Company<div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">LifeVantage Corporation (the &#8220;Company&#8221; or &#8220;we&#8221; or &#8220;our&#8221; or &#8220;us&#8221;) is a company focused on nutrigenomics, the study of how nutrition and naturally occurring compounds affect human genes to support good health. The Company is dedicated to helping people achieve their health, wellness, and financial goals. The Company provides quality, scientifically validated products to customers and independent consultants as well as a financially rewarding commission-based direct sales opportunity to its independent consultants. LifeVantage sells its products in the United States, Mexico, Japan, Australia, Hong Kong, Canada, Thailand, the United Kingdom, the Netherlands, Germany, Taiwan, Austria, Spain, Ireland, Belgium, New Zealand, and Singapore.  On June 30, 2025, the Company ceased operations in the Philippines and closed that marke</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">t.</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Company engages in the identification, research, development, formulation and sale of advanced nutrigenomic activators, dietary supplements, weight management products, pre- and pro-biotics, skin and hair care products and nootropics. The Company&#8217;s line of scientifically validated dietary supplements includes its flagship Protandim</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174; </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">family of products, its LifeVantage</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> line of dietary supplements that include the MindBody GLP-1 System</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#8482;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">,</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">  </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Omega+, ProBio, IC Bright</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">, the Rise AM &amp; Reset PM System</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">, D3+, and Daily Wellness, and PhysIQ</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#8482;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> Fat Burn and Prebiotic dietary supplements. TrueScience</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174; </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">is the Company&#8217;s line of skin and hair care products and Liquid Collagen. The Company also markets and sells Petandim</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">, its companion pet supplement formulated to combat oxidative stress in dogs; and AXIO</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">, its nootropic energy drink mixes.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Company was incorporated in Colorado in June 1988 under the name Andraplex Corporation. The Company changed its corporate name to Yaak River Resources, Inc. in January 1992, and subsequently changed it again in October 2004 to Lifeline Therapeutics, Inc. In October 2004 and March 2005, the Company acquired all of the outstanding common stock of Lifeline Nutraceuticals Corporation. In November 2006, the Company changed its name to LifeVantage Corporation.</span></div>In March 2018, the Company reincorporated from the state of Colorado to the state of Delaware. All outstanding shares of common stock, options and share units of the Colorado corporation were converted into an equivalent share, option or share unit of the Delaware corporation and the par value of the Company&#8217;s common stock was adjusted to $0.0001.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480424/946-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480424/946-10-50-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 810<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/810/tableOfContent<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480922/205-10-S99-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481034/205-10-S45-5<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/205/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SignificantAccountingPoliciesTextBlock', window );">Summary of Significant Accounting Policies</a></td>
<td class="text">Summary of Significant Accounting Policies<div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Consolidation</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries. All significant intercompany accounts and transactions are eliminated in consolidation. </span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Company prepares the consolidated financial statements and related disclosures in conformity with accounting principles generally accepted in the United States of America (&#8220;GAAP&#8221;). In preparing these statements, the Company is required to use estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ materially from those estimates and assumptions. On an ongoing basis, the Company reviews its estimates, including, but not limited to, those related to inventory valuation and obsolescence, sales returns, income taxes and tax valuation reserves, transfer pricing methodology and positions, impairment of assets, stock-based compensation, and loss contingencies.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Foreign Currency Translation</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">A portion of the Company&#8217;s business operations occurs outside the United States.&#160;The local currency of each of the Company&#8217;s subsidiaries generally is its functional currency.&#160;All assets and liabilities are translated into U.S. Dollars at exchange rates existing at the balance sheet dates, revenue and expenses are translated at weighted-average exchange rates and stockholders&#8217; equity is recorded at historical exchange rates.&#160;The resulting foreign currency translation adjustments are recorded as a separate component of stockholders&#8217; equity in the consolidated balance sheets and as a component of comprehensive income. Transaction gains and losses are included in other expense, net in the consolidated statements of operations and comprehensive income.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Fair Value of Financial Instruments</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Company accounts for assets and liabilities using a hierarchy of valuation techniques based on whether the inputs to those valuation techniques are observable or unobservable. Observable inputs reflect market data obtained from independent </span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">sources, while unobservable inputs reflect the Company&#8217;s market assumptions. These two types of inputs have created the fair-value hierarchy below. This hierarchy requires the Company to minimize the use of unobservable inputs and to use observable market data, if available, when determining fair value.</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 1&#8212;Quoted prices for identical instruments in active markets; </span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 2&#8212;Quoted prices for similar instruments in active markets, quoted prices for identical or similar instruments in markets that are not active, and model-derived valuations in which all significant inputs and significant value drivers are observable in active markets; and</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 3&#8212;Valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Our financial instruments, consisting primarily of cash and cash equivalents, accounts receivable, and accounts payable, approximate fair value due to their short-term nature. </span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Cash and Cash Equivalents</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Company considers only its monetary liquid assets with original maturities of three months or less to be cash equivalents.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Accounts Receivable</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s accounts receivable for the fiscal years ended June&#160;30, 2025 and 2024 consist primarily of credit card receivables. Based on the Company&#8217;s verification process for customer credit cards and historical information available, management has determined that an allowance for doubtful accounts on credit card sales related to its customer sales as of June&#160;30, 2025 or 2024 is not necessary. There was </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">no b</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">ad debt expense for the fiscal years ended June&#160;30, 2025 and 2024. </span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Inventory</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Inventory consisted of (in thousands):</span></div><div style="margin-bottom:8pt;margin-top:13pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:38.724%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.394%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.394%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.394%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.398%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="21" style="border-bottom:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">June&#160;30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="9" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">17,739&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">85.8&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">11,841&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">78.7&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2,930&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">14.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3,214&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">21.3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total inventory</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">20,669&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">15,055&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Inventories are carried at the lower of cost or net realizable value, using the first-in, first-out method, which includes a reduction in inventory values of </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">$0.5 million</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> and $1.3 million at June&#160;30, 2025 and 2024, respectively, related to obsolete and slow-moving inventory. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Reserves of inventories consist of the following (in thousands):</span></div><div style="margin-bottom:8pt;margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:62.150%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.908%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.910%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Years ended June&#160;30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Beginning balance</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,301&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,292&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Additions</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">214&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">901&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Write-offs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(1,049)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(892)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Ending balance</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">466&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,301&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Property and Equipment</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment are recorded at cost and depreciated using the straight-line method over the following useful lives:</span></div><div style="margin-bottom:8pt;margin-top:13pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:80.891%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.909%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Years</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Equipment (includes computer hardware and software)</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3 - 5</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Furniture and fixtures</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">5</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Vehicles</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">5</span></td></tr></table></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Leasehold improvements are depreciated over the shorter of estimated useful life of the related asset or the lease term.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The cost of normal maintenance and repairs is charged to expense as incurred. When an asset is sold or otherwise disposed of, the cost and associated accumulated depreciation are removed from the accounts and the resulting gain or loss is recognized in the consolidated statements of operations and comprehensive income in other expense, net. Significant expenditures that increase the useful life of an asset are capitalized and depreciated over the estimated useful life of the asset. Property and equipment are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of such assets may not be recoverable.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Intangible Assets</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Intangible assets are stated at cost less accumulated amortization. Finite-lived intangible assets are amortized over their related useful lives, using a straight-line method, consistent with the underlying expected future cash flows related to the specific intangible asset. Finite-lived intangible assets are reviewed for impairment whenever events or changes in circumstances exist that indicate the carrying amount of an asset may not be recoverable. When indicators of impairment exist, an estimate of undiscounted net cash flows is used in measuring whether the carrying amount of the asset or related asset group is recoverable. Measurement of the amount of impairment, if any, is based upon the difference between the asset&#8217;s carrying value and estimated fair value. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Indefinite-lived intangible assets are not amortized; however, they are tested at least annually for impairment or more frequently if events or changes in circumstances exist that may indicate impairment. An impairment loss is recognized if the carrying amount of the asset exceeds its fair value. Annual impairment tests on intangible assets were completed for the fiscal years ended June&#160;30, 2025 and 2024, resulting in no impairment charges.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Impairment of Long-Lived Assets</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to guidance established for impairment or disposal of assets, the Company assesses impairment whenever events or changes in circumstances indicate that the carrying amount of a long-lived asset may not be recoverable. When an assessment for impairment of long-lived assets, long-lived assets to be disposed of, and certain identifiable intangibles related to those assets is performed, the Company is required to compare the net carrying value of long-lived assets on the lowest level at which cash flows can be determined on a consistent basis to the related estimates of future undiscounted net cash flows for such assets. If the net carrying value exceeds the net cash flows, then an impairment is recognized to reduce the carrying value to the estimated fair value, generally equal to the future discounted net cash flow. For the fiscal years ended June&#160;30, 2025 and 2024, management has concluded that there are no indications of impairment.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Concentration of Credit Risk</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Accounting guidance for financial instruments requires disclosure of significant concentrations of credit risk regardless of the degree of such risk. Financial instruments with significant credit risk include cash and cash equivalents. At June&#160;30, 2025, the Company</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> had $17.0 million in cash and cash equivalent accounts at one financial institution and $3.2 million i</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">n other financial institutions. As of June&#160;30, 2025 and 2024, and during the years then ended, the Company&#8217;s cash balances exceeded federally insured limits.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Commissions and Incentives</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Commissions and incentives expenses are the Company&#8217;s most significant expenses and are classified as operating expenses. Commissions and incentives expenses include sales commissions paid to the Company&#8217;s independent consultants, special incentives, costs for incentive trips and other rewards. Commissions and incentives expenses do not include any amounts the Company pays to its independent consultants for personal purchases. Commissions paid to independent consultants on personal purchases are considered a sales discount and are reported as a reduction to net revenue.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Shipping and Handling</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Shipping and handling costs associated with inbound freight and freight out to customers, including independent consultants, are included in cost of sales. Shipping and handling fees charged to all customers are included in sales.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Research and Development Costs</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Company expenses all costs related to research and development activities as incurred. Research and development expenses for the fiscal years ended June&#160;30, 2025 and 2024 were </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">$1.4 million and</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> $0.7 million, respectively.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Leases</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Company accounts for leases in accordance with Accounting Standards Codification (&#8220;ASC&#8221;) 842. The Company reviews all contracts and determines if the arrangement is or contains a lease, at inception. Operating leases are included in right-of-use (&#8220;ROU&#8221;) assets, current lease liabilities and long-term lease liabilities on the consolidated balance sheets. The Company does not have any finance leases.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Operating lease ROU assets represent the Company&#8217;s right to use an underlying asset for the lease term and lease liabilities represent the Company&#8217;s obligation to make lease payments arising from the lease. ROU assets and lease liabilities are recognized at the lease commencement date based on the estimated present value of lease payments over the lease term. The Company uses its estimated incremental borrowing rate based on the information available at the commencement date in determining the present value of future payments. The operating lease ROU asset also includes any upfront lease payments made and excludes lease incentives and initial direct costs incurred. The Company&#8217;s lease terms may include options to extend or terminate the lease when it is reasonably certain that the Company will exercise that option. Lease expense for minimum lease payments is recognized on a straight-line basis over the lease term. Leases with a term of 12 months or less are not recorded on the balance sheet. The Company&#8217;s lease agreements do not contain any residual value guarantees.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Stock-Based Compensation</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognizes stock-based compensation by measuring the cost of services to be rendered based on the grant date fair value of the equity award. The Company recognizes stock-based compensation, net of any estimated forfeitures, over the period an employee is required to provide service in exchange for the award, generally referred to as the requisite service period. The Company estimates forfeitures based on historical information and other management assumptions. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Black-Scholes option pricing model is used to estimate the fair value of stock options and options under the Company&#8217;s 2019 Employee Stock Purchase Plan. The determination of the fair value of options is affected by the Company&#8217;s stock price and a number of assumptions, including expected volatility, expected life, risk-free interest rate and expected dividends. The Company uses historical data for estimating the expected volatility and expected life of stock options required in the Black-Scholes model. The risk-free interest rate assumption is based on observed interest rates appropriate for the expected terms of the stock options. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of restricted stock grants, including performance restricted stock units that include non-market based performance conditions, is based on the closing market price of the Company&#8217;s stock on the date of grant less the Company&#8217;s expected dividend yield. The Company recognizes compensation costs for awards with performance conditions when it concludes it is probable that the performance conditions will be achieved. The Company reassesses the probability of vesting at each balance sheet date and adjusts compensation costs accordingly.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Income Taxes</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Income taxes are accounted for under the asset and liability method. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases and operating loss and tax credit carry forwards. Deferred tax assets and liabilities are measured using statutory tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled, updated as needed for changes in corporate tax rates. The effect on deferred tax assets and liabilities from a change in tax rates is recognized in income in the period that includes the effective date of the change. The Company recognizes tax liabilities or benefits from an uncertain position only if it is more likely than not that the position will be sustained upon examination by taxing authorities based on the technical merits of the issue. The amount recognized would be the largest liability or benefit that the Company believes has greater than a 50% likelihood of being realized upon settlement.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Income Per Share</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Basic income per common share is computed by dividing net income by the weighted-average number of common shares outstanding during the period, less unvested restricted stock awards. Diluted income per common share is computed by dividing net income by the weighted-average common shares and potentially dilutive common share equivalents using the treasury stock method.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">For the fiscal years ended June&#160;30, 2025 and 2024, the effects of approximately 30,000</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> and</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> 13,000 common shares, respectively, issuable upon exercise of options and non-vested shares of restricted stock, are not included in the computations as their effect was anti-dilutive.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The following is a reconciliation of net income per share and the weighted-average common shares outstanding for purposes of computing basic and diluted net income per share (in thousands, except per share amounts):</span></div><div style="margin-bottom:8pt;margin-top:13pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:62.150%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.908%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.910%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Years ended June&#160;30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Numerator:</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">9,805&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2,937&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Denominator:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Basic weighted-average common shares outstanding</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">12,251&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">12,458&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Effect of dilutive securities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Stock awards and options</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">736&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">528&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Diluted weighted-average common shares outstanding</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">12,987&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">12,986&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Net income per share, basic</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">0.80&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">0.24&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Net income per share, diluted</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">0.75&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">0.23&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">New Accounting Pronouncements</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In November 2023, the Financial Accounting Standards Board (&#8220;FASB&#8221;) issued Accounting Standards Update (&#8220;ASU&#8221;) 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures (ASU 2023-07), expanding segment disclosure requirements. The amendments require enhanced disclosure for certain segment items and required disclosure on how management uses reported measures to assess segment performance. The amendments do not change how segments are determined, aggregated, or how thresholds are applied to determine reportable segments. ASU 2023-07 is effective for the Company&#8217;s annual periods beginning July 1, 2024, and for interim periods beginning July 1, 2025, with early adoption permitted. The Company adopted ASU 2023-07 for the fiscal year beginning July 1, 2024. See Note 13 for expanded segment disclosures.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In December 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures (&#8220;ASU 2023-09&#8221;). The guidance requires disclosure of disaggregated income taxes paid, prescribes standardized categories for the components of the effective tax rate reconciliation, and modifies other income tax-related disclosures. ASU 2023-09 is effective for the Company&#8217;s annual periods beginning July 1, 2025, with early adoption permitted. The Company is currently evaluating the potential effect that the updated standard will have on its financial statement disclosures.   </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In November 2024, the FASB issued ASU 2024-03, Income Statement&#8212;Reporting Comprehensive Income&#8212;Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses (&#8220;ASU 2024-03&#8221;). The guidance requires disclosure of specified information about certain costs and expenses at each interim and annual reporting period. ASU 2024-03 is effective for the Company&#8217;s annual periods beginning July 1, 2027, with early adoption permitted. The Company is currently evaluating the potential effect that the updated standard will have on its financial statement disclosures.   </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Other recently issued accounting pronouncements did not or are not believed by management to have a material impact on the Company&#8217;s present or future financial statements.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/235/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483426/235-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerTextBlock', window );">Revenue</a></td>
<td class="text">Revenue<div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Revenue is recognized when control of the promised goods or services are transferred to the customer, in an amount that reflects the consideration the Company expects to be entitled to in exchange for those goods or services. Sales, value add, and other taxes the Company collects concurrent with revenue-producing activities are excluded from revenue.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Company generates the majority of its revenue through product sales to customers. These products include the Protandim</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174; </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">line of dietary supplements, the LifeVantage</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> line of dietary supplements that include the MindBody GLP-1 System</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#8482;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">, Omega+, ProBio, IC Bright</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">, the Rise AM &amp; Reset PM System</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">, D3+, and Daily Wellness, PhysIQ</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#8482;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> Fat Burn and Prebiotic dietary supplements, TrueScience</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> skin and hair care products and Liquid Collagen, Petandim</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">, our companion pet supplement formulated to combat oxidative stress in dogs, and AXIO</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#160;nootropic energy drink mixes. The Company ships most of its product directly to the consumer and receives substantially all payment for product sales in the form of credit card receipts. Revenue from direct product sales to customers is recognized upon shipment, which is when passage of title and risk of loss occurs. For items sold in packs and bundles, the Company determines the standalone selling price at contract inception for each distinct good and then allocates the transaction price on a relative standalone selling price basis. Any discounts are accounted for as a direct reduction to the transaction price. Shipping and handling revenue is recognized upon shipment when the performance obligation is completed.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Company also charges amounts to independent consultants to attend events that it holds. Tickets to events are sold as standalone items or included within packs. For event tickets sold in packs, the Company allocates a portion of the transaction price to the ticket on a relative standalone selling price basis, adjusted for the probability of the tickets being redeemed for attendance at a future event. Any discounts are accounted for as a direct reduction to the transaction price. Fee revenue associated with ticket sales is recorded in the month that the event is held, which is when the Company has performed its obligations under the contract.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Deferred Revenue</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Company launched its Rewards Circle loyalty program in the United States, Australia, New Zealand, and Japan in March 2023 and in Canada, Europe, and Mexico in February 2024.  Contract liabilities, recorded as deferred revenue, include these loyalty program credit deferrals with certain customers which are accounted for as a reduction in the transaction price and are generally recognized as credits are redeemed for additional products at a later date.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Company also records deferred revenue when cash payments are received or due in advance of performance, including amounts which are refundable. The Company pre-sells tickets to its events. When cash payments are received in advance of events, the cash received is recorded to deferred revenue until the event is held, at which time the Company has performed its obligations under the contract and the revenue is recognized.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> Deferred revenue is included in accrued expenses in the consolidated balance sheets.  The balance of deferred revenue related to contract liabilities, each less than twelve months, was $0.7 million and $0.9 million as of June&#160;30, 2025 and 2024, respectively. The contract liabilities impact to revenue for the years ended June&#160;30, 2025 and 2024 was an increase of $0.2 million and a decrease of $26,000, respectively.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Sales Returns and Allowances</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Estimated returns are recorded when product is shipped. Subject to some exceptions based on local regulations, the Company&#8217;s return policy is to provide a full refund for product returned within 30 days. After 30 days of purchase, only unopened product that is in a resalable and restockable condition may be returned within twelve months of purchase and shall receive a 100% refund, less a 10% handling and restocking fee and any shipping and handling costs. The Company establishes a refund liability reserve, and an asset reserve for its right to recover products, based on historical experience. The returns asset reserve and returns liability reserve are evaluated on a quarterly basis. As of June&#160;30, 2025 and 2024, the Company&#8217;s return liability reserve, net was </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">$0.2 million </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">and $0.1 million, respectively.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Reserves for sales returns consist of the following (in thousands):</span></div><div style="margin-bottom:8pt;margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:62.150%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.908%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.910%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Years ended June&#160;30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Beginning balance</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">133&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">129&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Additions</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2,759&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,622&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Returns</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(2,655)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(1,618)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Ending balance</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">237&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">133&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-7<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-10<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-15<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-12<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-12<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-12<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-12<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-12<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-13<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Topic 606<br> -Publisher FASB<br> -URI https://asc.fasb.org/606/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property and Equipment, Net<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock', window );">Property and Equipment, Net</a></td>
<td class="text">Property and Equipment, Net<div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment, net consist of (in thousands):</span></div><div style="margin-bottom:8pt;margin-top:13pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:62.150%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.908%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.910%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">June&#160;30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Equipment (includes computer hardware and software)</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">16,998&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">15,766&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Furniture and fixtures</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,469&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,466&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">5,101&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">5,040&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Vehicles</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">51&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">51&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated depreciation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(17,412)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(14,510)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total property and equipment, net</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">6,207&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">7,813&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Depreciation expense totaled </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">$3.1 million and</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> $3.4 million for the fiscal years ended June&#160;30, 2025 and 2024, respectively.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/360/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -SubTopic 360<br> -Topic 958<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477798/958-360-50-6<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -SubTopic 360<br> -Topic 958<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477798/958-360-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -SubTopic 360<br> -Topic 958<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477798/958-360-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Intangible Assets, Net<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsDisclosureTextBlock', window );">Intangible Assets, Net</a></td>
<td class="text">Intangible Assets, Net<div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Intangible assets, net consist of (in thousands):</span></div><div style="margin-bottom:8pt;margin-top:13pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:62.150%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.908%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.910%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">June&#160;30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Patent costs</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2,330&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(2,252)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total finite-lived intangible assets, net</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">78&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Trademarks and other indefinite-lived intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">245&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">245&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total intangible assets, net</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">245&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">323&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">During the fiscal year ended June&#160;30, 2025, the patents included in intangible assets related to Protandim</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> Nrf2 Synergizer</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> reached expiration and entered the public domain. Amortization expense totaled </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">$0.1 million and</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> $0.1 million for the fiscal years ended June&#160;30, 2025 and 2024, respectively. As of June&#160;30, 2025, the remaining weighted-average amortization period for finite-lived intangible assets is zero years. There is </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">no a</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">nnual estimated amortization expense expected in the succeeding fiscal year.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all or part of the information related to intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/350-30/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-4<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 985<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481283/985-20-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 985<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/985-20/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other Accrued Expenses<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Payables and Accruals [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock', window );">Other Accrued Expenses</a></td>
<td class="text">Other Accrued Expenses<div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Other accrued expenses consist of (in thousands):</span></div><div style="margin-bottom:8pt;margin-top:13pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:62.150%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.908%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.910%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Accrued incentive compensation</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">5,325&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,521&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Accrued severance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">90&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Other taxes payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2,189&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2,258&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Accrued payable to vendors</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">459&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">434&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Deferred revenue</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">711&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">860&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Accrued incentives and promotions to consultants</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3,284&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,454&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Accrued other expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,540&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,257&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total other accrued expenses</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">13,513&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">7,874&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for accounts payable, accrued expenses, and other liabilities that are classified as current at the end of the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 720<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483384/720-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Long-Term Debt<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureTextBlock', window );">Long-Term Debt</a></td>
<td class="text">Long-Term Debt<div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">On March&#160;30, 2016,</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> t</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">he Company entered into a loan agreement (the &#8220;2016 Loan Agreement&#8221;) and a security agreement (the &#8220;2016 Security Agreement&#8221;). The 2016 Loan Agreement provides for a term loan in an aggregate principal amount of $10.0 million </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">(</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">the &#8220;2016 Term Loan&#8221;) and a revolving loan facility in an aggregate principal amount not to exceed $2.0 million (the &#8220;2016 Revolving Loan,&#8221; and collectively with the 2016 Term Loan, the 2016 Loan Agreement, and the 2016 Security Agreement, and together with the amendments described below, the &#8220;2016 Credit Facility&#8221;). The 2016 Credit Facility was subsequently amended, among other things, to increase the available borrowing under the revolving loan facility to $5.0 million. On March 31, 2024, the 2016 Credit Facility reached the maturity date and was terminated. As of March 31, 2024, there was no balance outstanding under the 2016 Credit Facility.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">On April 12, 2024, the Company entered into a Loan Agreement (the &#8220;Loan Agreement&#8221;) with Bank of America, N.A., as Lender (the &#8220;Lender&#8221;). In connection with the Loan Agreement and on the same date, the Company, Lifeline Nutraceuticals Corporation, as Guarantor (the &#8220;Guarantor&#8221;), and the Lender also entered into a Continuing and Unconditional Guaranty (the &#8220;Continuing and Unconditional Guaranty&#8221;) and a Security and Pledge Agreement (the &#8220;Security and Pledge Agreement&#8221;). The Loan Agreement provides for a revolving line of credit in an aggregate principal amount not to exceed</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">$5.0 million (the &#8220;Line of Credit&#8221; and collectively with the Loan Agreement, Continuing and Unconditional Guaranty, and the Security and Pledge Agreement, the &#8220;2024 Credit Facility&#8221;). </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In the event the Company borrows under the Line of Credit, interest will be payable commencing May 31, 2024, and then on the last day of each month thereafter until payment in full of all principal outstanding under the Line of Credit, with all unpaid principal and interest due on April 12, 2027 (the &#8220;Expiration Date&#8221;). The Line of Credit will bear interest at a rate per year equal to the sum of (i) the greater of the Term SOFR Daily Floating Rate (as defined in the Loan Agreement) or </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">0.00%</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">, plus (ii) 2.00%. Amounts under the Line of Credit may be repaid and re-borrowed from time to time until the Expiration Date. As of June&#160;30, 2025, the effective interest rate is 6.45%.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s obligations under the Loan Agreement are secured by a security interest in substantially all of the assets of the Company and the Guarantor, and by a pledge of the membership interests of the Company&#8217;s subsidiaries, as further provided for in the Security and Pledge Agreement. Pursuant to the Continuing and Unconditional Guaranty, the Guarantor guarantees and promises to pay promptly to the Lender all indebtedness of the Company when due. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Loan Agreement contains customary covenants, both affirmative and negative, that, among other things, restrict the Company&#8217;s ability to deal with the Company&#8217;s assets outside of the ordinary course, incur additional indebtedness, grant liens on the Company's assets, make certain investments, purchase or otherwise acquire all or substantially all the assets or equity interests of other companies, and enter into consolidations, mergers or other combinations. The Loan Agreement requires that the Company maintain specified financial ratios and satisfy certain financial condition tests. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Loan Agreement contains certain customary events of default, including, among other things, failure of the Company to make required payments under the Loan Agreement, certain breaches of representations made by the Company or the Guarantor, insolvency or bankruptcy of the Company or the Guarantor, failure to have an enforceable first lien or security interest in any property given as security for the Loan Agreement, or failure of the Company to comply with covenants set forth in the Loan Agreement. If an event of default occurs under the Loan Agreement, the obligation of the Lender to make any additional credit available to the Company may be terminated and the amounts outstanding may become immediately due and payable in the discretion of the Lender, provided that in the event of insolvency or bankruptcy of the Company or the Guarantor, all debts outstanding under the Loan Agreement will automatically become due and payable. Upon the occurrence of any default or after maturity, all amounts outstanding under the Loan Agreement will, at the option of the Lender, bear interest at a rate which is 2.00% higher than the rate of interest otherwise provided under the Loan Agreement. </span></div>As of June&#160;30, 2025, the Company was in compliance with its financial covenants under the 2024 Credit Facility.  As of June&#160;30, 2025, there was no balance outstanding on the 2024 Credit Facility.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-8A<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(c))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481544/470-10-50-6<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481544/470-10-50-6<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 405<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477092/405-40-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 405<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477092/405-40-50-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 405<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477092/405-40-50-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 405<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477092/405-40-50-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 405<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477092/405-40-50-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 470<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/470/tableOfContent<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1C<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1C<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1C<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1I<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1I<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1I<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">Stockholders' Equity</a></td>
<td class="text">Stockholders&#8217; Equity<div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">During the fiscal years ended June&#160;30, 2025 and 2024, the Company issued zero shares of common stock as a result of the exercise of options. During the fiscal years ended June&#160;30, 2025 and 2024, the Company issued </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">0.4 million and</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> 1.0 million shares, respectively, under the Company&#8217;s equity incentive plans. During the fiscal years ended June&#160;30, 2025 and 2024, 0.2 million</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> and</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> 0.2 million shares, respectively, of restricted stock were canceled or surrendered as payment of tax withholding upon vesting.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> During the fiscal years ended </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">June&#160;30, 2025 and 2024</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">, the Company sold 44,000 and 0.1 million shares under its 2019 Employee Stock Purchase Plan, respectively. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">On November&#160;27, 2017, the Company&#8217;s board approved a stock repurchase program, which was subsequently amended on February&#160;1, 2019. Under the currently approved stock repurchase program, the Company is authorized to purchase up to $60&#160;million through December 31, 2026. The stock repurchase program permits the Company to purchase shares from time to time through a variety of methods, including in the open market, through privately negotiated transactions or other means as determined by the Company&#8217;s management, in accordance with applicable securities laws. As part of the stock repurchase program, the Company may enter into a pre-arranged stock repurchase plan which operates in accordance with guidelines specified under Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. Accordingly, any transactions under such stock repurchase plan would be completed in accordance with the terms of the plan, including specified price, volume, and timing conditions. T</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">he stock repurchase program may be suspended or discontinued at any time. During the year ended June&#160;30, 2025, the Company purchased 0.3 million&#160;shares of its common stock at an aggregate purchase price of $3.1 million under this repurchase program. During the fiscal year ended June&#160;30, 2024, the Company purchased 1.0 million&#160;shares of its common stock at an aggregate purchase price of $6.4 million under this repurchase program. At&#160;June&#160;30, 2025, there is&#160;$17.3 million&#160;remaining under this stock repurch</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">ase program.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">On August 30, 2023, the board approved a stockholder rights agreement (the &#8220;Rights Plan&#8221;) and declared a dividend of one right for each outstanding share of common stock to stockholders of record on September 11, 2023. Each right entitled holders to purchase one newly issued share of preferred stock at an exercise price of $20 per right, subject to adjustment. Initially, the rights were not exercisable and traded with shares of the Company&#8217;s common stock.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In general, the rights became exercisable following a public announcement that a person had acquired 12% (or, in the case of passive investors, 20%) or more of the outstanding shares of the Company&#8217;s common stock. If a person became an acquiring </span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">person, each holder of rights (except the acquiring person) would have the right to purchase, for the purchase price, a number of shares of the Company&#8217;s common stock at a 50% discount to the then-current trading price. Rather than allowing the rights to be exercised in those circumstances, the board had the right to exchange each right, other than the rights owned by the acquiring person, for a share of the Company&#8217;s common stock. The agreement provided for exceptions and additional terms for other certain situations and circumstances.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Rights Plan was intended to protect the interests of the Company and its stockholders by reducing the likelihood that any entity, person or group gains control of the Company through open-market accumulation or other means without payment of an adequate control premium and expired on August 28, 2024. There was no impact to the Company&#8217;s Consolidated Financial Statements.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s Certificate of Incorporation authorizes the designation and issuance of shares of preferred stock. However, as of June&#160;30, 2025, no shares of preferred stock have been designated by the Board nor are any shares of preferred stock outstanding.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Dividends</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Company paid quarterly cash dividends of $0.04 per share of common stock to stockholders of record in September 2024, December 2024 and March 2025, and </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">$0.045</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> per share of common stock to stockholders of record in June 2025 which were in the aggregate amount of </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">$2.1 million, or $0.165</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> per share of common stock for the fiscal year ended June&#160;30, 2025</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">. </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Company paid a one-time cash dividend of $0.40</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">per share of common stock to stockholders of record in September 2023, quarterly cash dividends of $0.035 per share of common stock to stockholders of record in September 2023, December 2023 and March 2024, and $0.04 per share of common stock to stockholders of record in June 2024 which were in the aggregate amount of </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">$6.9 million, or </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">$0.545</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">per share of common stock for the fiscal year ended </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">June&#160;30, 2024. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The declaration of dividends is subject to the discretion of the board and will depend upon various factors, including the Company&#8217;s earnings, financial condition, restrictions imposed by any indebtedness that may be outstanding, cash requirements, future prospects, and other factors deemed relevant by the board.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-8A<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-14<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477968/946-235-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477968/946-235-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478448/946-505-50-6<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480237/815-40-50-6<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/505/tableOfContent<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-14<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-14<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 16<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-16<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-18<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-18<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-18<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-Based Compensation<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-Based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock', window );">Share-Based Compensation</a></td>
<td class="text">Stock-Based Compensation<div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Long-Term Incentive Plans</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Equity-Settled Plans</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Company adopted, and the stockholders approved, the 2017 Long-Term Incentive Plan (the &#8220;2017 Plan&#8221;), effective February&#160;16, 2017, to provide incentives to eligible employees, directors, and consultants. T</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">he initial share pool approved was 650,000 shares. On November 9, 2023, the stockholders approved amendments to the 2017 Plan to increase the number of shares of the Company&#8217;s common stock that are available for issuance under the 2017 plan by </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">1,138,000</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> shares. </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">As of&#160;June&#160;30, 2025, a maximum of&#160;5,105,000&#160;shares of the Company&#8217;s common stock can be issued under the 2017 Plan in connection with the grant of awards which is calculated as the sum of (i)&#160;4,630,000&#160;shares and (ii) up to&#160;475,000&#160;shares previously reserved for issuance under the Company&#8217;s prior 2010 Long Term Incentive Plan, including shares returned upon cancellation, termination or forfeiture of awards that were previously granted under that plan. Outstanding stock options awarded under the 2017 Plan have exercise prices of&#160;$4.44&#160;per share, vest over a&#160;<span style="-sec-ix-hidden:f-495">three&#160;year</span> vesting period, and have a contractual term of ten years. Awards expire in accordance with the terms of each award and, upon expiration of the award, the shares subject to the award are added back to the 2017 Plan. As of June&#160;30, 2025, under the 2017 Plan, there were stock option awards outstanding, net of awards expired, for an aggregate of 0.1 million shares of the Company&#8217;s common stock.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Employee Stock Purchase Plan</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">General.</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;The Company&#8217;s 2019 Employee Stock Purchase Plan (&#8220;ESPP&#8221;) was adopted by the board in September 2018 and the Company&#8217;s stockholders approved it in November 2018.  In August 2024, the board approved an amendment to the ESPP to increase the share reserve thereunder by 0.4 million shares, which amendment and increase was approved by the Company&#8217;s stockholders in November 2024. The ESPP is intended to qualify under Section 423 of the Internal Revenue Code.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Share Reserve.</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;The Company has reserved 0.8 million shares of its common stock for issuance under the ESPP. As of June&#160;30, 2025, 0.4 million shares were available for issuance. The number of shares reserved under the ESPP will automatically be adjusted in the event of a stock split, stock dividend or a reverse stock split (including an adjustment to the per-purchase period share limit).</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Purchase Price.</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;Employees may purchase each share of common stock under the ESPP at a price equal to 85% of the lower of the fair market values of the stock as of the beginning or the end of the six-month offering periods. An employee&#8217;s contributions to the ESPP are limited to 15% of the compensation, and up to a maximum of 3,000 shares may be purchased by </span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">an employee during any offering period. A participant shall not be granted an option under the ESPP if such option would permit the participant&#8217;s rights to purchase stock to accrue at a rate exceeding $25,000 fair market value of stock for each calendar year in which such option is outstanding at any time.&#160;</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Offering Periods.</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;Unless otherwise determined by the compensation committee, the ESPP will be operated through a series of successive six-month offering periods, which will begin each year on March 1 and September 1.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">During the fiscal years ended June&#160;30, 2025 and 2024, 44,000 and 0.1 million shares of common stock were purchased under the ESPP, respectively. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Stock-Based Compensation</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In accordance with accounting guidance for stock-based compensation, payments in equity instruments for goods or services are accounted for by the fair value method. For the fiscal year ended June&#160;30, 2025 and 2024, stock-based compensation of $5.7 million</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> and $3.3 million, respectively, was reflected as an increase to additional paid in capital. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">At June&#160;30, 2025, there was $3.5 million of unrecognized compensation cost related to non-vested stock-based compensation arrangements under the 2017 Plan, based on management&#8217;s estimate of the shares that will ultimately vest. The Company expects to recognize such costs over a weighted-average period of 1.43 years. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Stock Options</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">There were no stock option grants during the fiscal years ended June&#160;30, 2025 and 2024. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The following is a summary of stock option activity for the fiscal years ended June&#160;30, 2025 and 2024:</span></div><div style="margin-bottom:8pt;margin-top:13pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:38.724%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.394%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.394%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.394%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.398%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Options (in thousands)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Weighted<br/>Average<br/>Exercise&#160;Price</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Weighted<br/>Average&#160;Remaining<br/>Contractual Term (in years)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Aggregate Intrinsic Value (in thousands)</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at June 30, 2023</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">72&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">4.44&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Expired or Canceled</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at June 30, 2024</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">72&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">4.44&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Expired or Canceled</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at June 30, 2025</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">72&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">4.44&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2.59</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">618&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Exercisable at June 30, 2025</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">72&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">4.44&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2.59</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">618&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:8pt;margin-top:3pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Restricted Stock Awards</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The following is a summary of restricted stock award activity during the fiscal years ended June&#160;30, 2025 and 2024:</span></div><div style="margin-bottom:8pt;margin-top:13pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:61.418%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.908%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.910%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Shares<br/>(in thousands)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Weighted Average Grant Date Fair Value</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Nonvested at June 30, 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">117&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3.85&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">392&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">4.74&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Vested </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(117)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3.85&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Nonvested at June 30, 2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">392&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">4.74&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">58&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">13.54&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(294)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">4.77&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Nonvested at June 30, 2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">156&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">7.92&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center;text-indent:22.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.836%"><tr><td style="width:1.0%"></td><td style="width:2.679%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:95.121%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">(1)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">Includes 125,732 shares of restricted stock that were granted in exchange for the cancellation of 48,026 shares of stock units and 77,706 shares of performance restricted stock units on November 6, 2023.</span></div></td></tr></table></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The total vesting date fair value of restricted shares that vested during the fiscal years ended June 30, 2025 and 2024 w</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">as $4.4 million and</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> $0.7 million, respectively.  </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Restricted Stock Units</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The following is a summary of restricted stock units activity during the fiscal years ended June&#160;30, 2025 and 2024:</span></div><div style="margin-bottom:8pt;margin-top:13pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:61.418%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.908%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.910%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Number of Units (in thousands)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Weighted Average Grant Date Fair Value</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Nonvested at June 30, 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">538&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">4.90&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">214&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">4.90&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(331)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">5.05&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(84)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">4.48&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Nonvested at June 30, 2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">337&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">4.86&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">224&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10.08&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(224)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">4.87&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(47)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">6.12&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Nonvested at June 30, 2025</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">290&#160;</span></td><td style="border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">8.68&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center;text-indent:22.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.836%"><tr><td style="width:1.0%"></td><td style="width:2.679%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:95.121%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">(1)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">Includes 48,026 shares of restricted stock units that were canceled in exchange for restricted stock awards on November 6, 2023.</span></div></td></tr></table></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The total vesting date fair value of restricted stock units that vested during the fiscal years ended June 30, 2025 and 2024 was $2.6 million and $1.9 million, respectively. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Performance Restricted Stock Units</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">During the fiscal years ended June 30, 2025 and 2024 , the Company awarded performance restricted stock units (the &#8220;FY 2025 PRSUs&#8221; and &#8220;FY 2024 PRSUs,&#8221; respectively) to certain employees (the &#8220;Recipients&#8221;). Each performance restricted stock unit represents a contingent right for the Recipients to receive a distribution of shares of common stock of the Company equal to 0% to 200% of the target number of performance restricted stock units subject to the award. The actual number of shares distributed will be based on the Company&#8217;s achievement of specified financial performance metrics. For FY 2025 PRSUs, the performance period for 50% of the FY 2025 PRSUs ended on June&#160;30, 2025, the performance period for 30% of the FY 2025 PRSUs ends on June 30, 2026, and the performance period for the remaining 20% of the FY 2025 PRSUs ends on June 30, 2027. For FY 2024 PRSUs, the performance period for 50% of the FY 2024 PRSUs ended on June 30, 2024, the performance period for 30% of the FY 2024 PRSUs ended on June&#160;30, 2025, and the performance period for the remaining 20% of the FY </span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">2024 PRSUs ends on June 30, 2026. The financial performance metrics for the fiscal year ended June&#160;30, 2025, were deemed achieved at the 200.00% achievement level. The financial performance metrics for the fiscal year ended June 30, 2024, were deemed achieved at the 0% achievement level. The FY 2025 PRSUs and FY 2024 PRSUs will vest only to the extent the specified financial performance criteria are achieved and subject to the Recipient&#8217;s continued service with the Company, as follows: (i) a portion of the earned award will vest on the first anniversary of the grant date and (ii) an additional portion of the earned award will vest thereafter in a series of quarterly installments. The fair values of the performance restricted stock units are based on the grant date fair value which is the closing price of the Company's common stock on the date of grant.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The following is a summary of performance restricted stock units activity during the fiscal years ended June&#160;30, 2025 and 2024:</span></div><div style="margin-bottom:8pt;margin-top:13pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:61.418%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.908%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.910%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Number of Units (in thousands)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Weighted Average Grant Date Fair Value</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Nonvested at June 30, 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">492&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">4.24&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">350&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">4.89&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(284)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">4.24&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(274)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">4.68&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Nonvested at June 30, 2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">284&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">4.62&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">509&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">8.30&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(94)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">4.24&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(45)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">6.67&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Nonvested at June 30, 2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">654&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">7.40&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center;text-indent:22.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.836%"><tr><td style="width:1.0%"></td><td style="width:2.679%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:95.121%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">(1)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">Includes 77,706 shares of performance restricted stock units that were canceled in exchange for restricted stock awards on November 6, 2023.</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">(2)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">Includes shares added based on achievement of performance goals in excess of target.</span></div></td></tr></table></div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The total vesting date fair value of performance restricted stock units that vested during the fiscal years ended June 30, 2025 and 2024 was approximately $1.1 million</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> and</span> $1.6 million, respectively.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (l)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/718/tableOfContent<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other Expense, Net<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherIncomeAndExpensesAbstract', window );"><strong>Other Income and Expenses [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock', window );">Other Expense, Net</a></td>
<td class="text">Other Expense, Net<div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Other expense, net consists of the following (in thousands):</span></div><div style="margin-bottom:8pt;margin-top:13pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:62.150%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.908%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.910%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Years ended June&#160;30,</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency transaction loss, net</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(380)</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(429)</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Other income (expense), net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;Total other expense, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(387)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(412)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherIncomeAndExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherIncomeAndExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for other income or other expense items (both operating and nonoperating). Sources of nonoperating income or nonoperating expense that may be disclosed, include amounts earned from dividends, interest on securities, profits (losses) on securities, net and miscellaneous other income or income deductions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 720<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/720/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Topic 610<br> -Publisher FASB<br> -URI https://asc.fasb.org/610/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">Income Taxes</a></td>
<td class="text">Income Taxes<div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The income tax expense for the fiscal years ended June&#160;30, 2025 and 2024 consists of the following (in thousands):</span></div><div style="margin-bottom:8pt;margin-top:13pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:62.150%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.908%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.910%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Years ended June 30,</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Income before income taxes:</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Domestic</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10,397&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2,940&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">International</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,846&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,410&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td style="border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">12,243&#160;</span></td><td style="border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">4,350&#160;</span></td><td style="border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Current taxes:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Federal</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2,925&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,457&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">State</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">708&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">246&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">491&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">984&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total current income tax provision</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">4,124&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2,687&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Deferred taxes:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Federal</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(1,464)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(1,281)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">State</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(341)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(151)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">119&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">158&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total deferred income tax provision</span></td><td style="border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(1,686)</span></td><td style="border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(1,274)</span></td><td style="border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Net income tax provision</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2,438&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,413&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The effective income tax rate for the fiscal years ended June&#160;30, 2025 and 2024 differs from the U.S. Federal statutory income tax rate due to the following:</span></div><div style="margin-bottom:8pt;margin-top:13pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:62.150%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.908%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.910%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Years ended June 30,</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Federal statutory income tax rate</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">21.0&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">21.0&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">State income taxes, net of federal benefit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Foreign tax rate difference</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">8.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Tax return to provision true-up</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(4.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Limit on future stock compensation due to 162(m)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">4.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Foreign withholding tax</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">0.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Other differences</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Revalue of deferred for change in federal tax rate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">0.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">0.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Permanent differences:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212; stock-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(6.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(8.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212; current year section 162(m) limitation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">0.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">7.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212; foreign derived intangible income deduction</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(1.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(0.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212; tax credits</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(4.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(12.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212; meals and entertainment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212; removal of additional permanent reinvestment assertions</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212; change in uncertain tax positions</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212; accrual for foreign tax audits</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">7.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212; other permanent differences</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Change in valuation allowance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Net income tax provision </span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">19.9&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">32.5&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The components of the deferred tax assets and liabilities as of June&#160;30, 2025 and 2024 are as follows (in thousands):</span></div><div style="margin-bottom:8pt;margin-top:13pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:62.150%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.908%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.910%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Federal, state, and foreign net operating loss carryovers</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">234&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">271&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Stock option compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">628&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">360&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Section 174 costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2,798&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2,578&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Lease liability</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2,798&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3,223&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Accrued vacation, allowance for returns, bonuses&#160;&amp; other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2,819&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2,119&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Gross deferred tax asset</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">9,277&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">8,551&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Patents and trademarks</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(16)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(30)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Property&#160;&amp; equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(239)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(798)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Right of use asset</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(1,942)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(2,263)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(468)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(472)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Gross deferred tax liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(2,665)</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(3,563)</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Less: valuation allowance</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(642)</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(720)</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax assets, net</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">5,970&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">4,268&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Company has adopted accounting guidance for uncertain tax positions (&#8220;UTPs&#8221;) which provides that in order to recognize an uncertain tax benefit, the taxpayer must be more likely than not of sustaining the position. The measurement of the benefit is calculated as the largest amount that is more than 50% likely to be realized upon recognition of the benefit. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In the fiscal year ended June&#160;30, 2024, the Company began recording a withholding tax obligation on certain rebalanced commission payments to the U.S. parent company it had not obtained treaty rates for. The withholding tax recorded in the fiscal year ended June&#160;30, 2024 has been reversed during the fiscal year ended June&#160;30, 2025 as the Company no longer expects to pay that liability</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Company has been undergoing income tax audits in foreign jurisdictions. For the fiscal year ended June&#160;30, 2025, the Company accrued a total $0.4 million related to foreign income tax audits. In fiscal year 2025, the Company made payments or deemed payments totaling $0.4 million related to these foreign income tax audits. The UTP related to foreign tax audits is now zero. The Company does not have any other foreign tax audits as of June&#160;30, 2025.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The change in the liability for uncertain tax positions were as follows (in thousands):</span></div><div style="margin-bottom:8pt;margin-top:8pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:62.204%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.882%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.884%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Years ended June&#160;30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Beginning balance</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">389&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Gross increases - tax positions in prior year</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">51&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Gross decreases - tax positions in prior year</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(53)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Gross increases - tax positions in current year</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">389&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Settlement</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(381)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Currency adjustment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Ending balance</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">389&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In fiscal year 2022, the Company removed its permanent reinvestment assertion in Japan. In fiscal year 2024, the Company removed its permanent reinvestment assertions in Taiwan and Australia and recorded the tax effects of that change. In fiscal year 2025, the Company removed its permanent reinvestment assertion on all other entities. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The tax years open for examination by the Internal Revenue Service (&#8220;IRS&#8221;) include returns for fiscal years June 30, 2021 through present and the open tax years by state tax authorities include returns for fiscal years June 30, 2020 through present. In addition, the IRS and state tax authorities may examine net operating losses (&#8220;NOLs&#8221;) for any previous years if utilized by the Company.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The change in the valuation allowance were as follows (in thousands):</span></div><div style="margin-bottom:8pt;margin-top:8pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:62.150%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.908%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.910%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Years ended June&#160;30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Beginning balance</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">720&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">704&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Increases</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(78)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Ending balance</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">642&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">720&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The change in valuation allowance during the fiscal year ended </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">June&#160;30, 2025</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> related to current year income in entities with a full valuation allowance along with a change to the United States valuation allowance based on the Company converting from a blended rate to a state-by-state provision. During the fiscal year ended June&#160;30, 2024, the change in valuation allowance related to current year income in entities with a full valuation allowance along with a change to the United States valuation allowance based on updated projections and changes to the blended rate.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">As of June&#160;30, 2025, the Company had utilized all of its Federal NOL carry-forwards.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> As of June&#160;30, 2025, state NOLs were $4.8 million and foreign NOLs were $0.4 million.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The total recognized tax benefit from settlement of stock-based awards for the fiscal years ended June&#160;30, 2025 and 2024, was $0.8 million and $0.2 million, respectively.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Company has reflected all changes in tax laws including the changes resulting from expiring Tax Cuts and Jobs Act provisions. The Company will reflect the changes from the One Big Beautiful Bill Act in fiscal year 2026, when the law was enacted.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Company conducts its business globally. As a result, the Company and its subsidiaries file income tax returns in the U.S. federal jurisdiction and various state and foreign jurisdictions, and are subject to examination for the open tax years of June 30, 2021 through June 30, 2025.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income tax.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 740<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477617/942-740-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 740<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478822/944-740-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12C<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12B<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 270<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477891/740-270-50-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.5.Q1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480990/946-20-50-13<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/740/tableOfContent<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-14<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-21<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-17<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482603/740-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeasesTextBlock', window );">Leases</a></td>
<td class="text">Leases<div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Company has operating leases for current corporate offices and certain equipment. These leases have remaining terms of approximately <span style="-sec-ix-hidden:f-748">one</span> to 6.5 years. As of June&#160;30, 2025, the weighted average remaining lease term and weighted average discount rate for operating leases was 5.91 years and 3.17%, respectively. As of June&#160;30, 2024, the weighted average remaining lease term and weighted average discount rate for operating leases was 6.90 years and 3.46%, respectively.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The components of lease expense for the fiscal years ended June&#160;30, 2025 and 2024, were as follows (in thousands):</span></div><div style="margin-bottom:8pt;margin-top:8pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:62.150%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.908%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.910%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Years ended June 30,</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease expense</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease cost</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,881&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,913&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Variable lease cost</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">154&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">174&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Short-term lease cost</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">47&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total lease expense</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2,046&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2,134&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Supplemental cash flow information related to operating leases was as follows (in thousands):</span></div><div style="margin-bottom:8pt;margin-top:8pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:62.150%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.908%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.910%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2025</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash outflows from operating leases</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2,284&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2,187&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Right-of-use assets obtained in exchange for lease obligations</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2,475&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Maturity of lease liabilities at June&#160;30, 2025 are as follows (in thousands):</span></div><div style="margin-bottom:8pt;margin-top:8pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:80.159%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.909%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Year ended June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2,214&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2,195&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2028</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2,073&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2029</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,772&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2030</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,817&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2,805&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">12,876&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Less: imputed interest</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(1,198)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Present value of lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">11,678&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeasesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/842-20/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeasesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Information<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingDisclosureTextBlock', window );">Segment Information</a></td>
<td class="text">Segment Information<div style="margin-bottom:8pt;margin-top:3pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Company operates in a single operating segment by selling products directly to customers through an international network of independent consultants that operates in an integrated manner from market to market. The Company manages its business primarily by managing its international network of independent consultants through similar commission plans. Most products available to customers in the United States are available to customers across all markets.  These products are purchased through third-party manufacturers by the US Corporate office and sold to each international market. Pricing for all products is determined at the US Corporate office. Accordingly, for disclosure purposes, the Company has a single reporting segment, which is reported on the Company&#8217;s consolidated financial statements.</span></div><div style="margin-bottom:8pt;margin-top:3pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Chief Operating Decision Maker (&#8220;CODM&#8221;) is the Company&#8217;s Chief Executive Officer. The CODM regularly reviews consolidated financial information and performance used to make decisions about the Company as a whole and without distinguishing or grouping of operations based on asset type, revenue, geographic location, tenant or other factors.  </span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The CODM evaluates performance through consolidated financial budget-to-actual variances on a monthly and quarterly basis and allocates resources based on net income as reported in the consolidated statements of operations. The measure of segment assets is reported on the balance sheet as total consolidated assets. Total expenditures for long-lived assets are reported on the consolidated statements of cash flows.</span></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The following table presents the Company&#8217;s segment revenue and expenses and segment net income for the fiscal years ended June 30, 2025 and 2024 (in thousands):</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:62.150%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.908%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.910%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Years ended June&#160;30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Revenue, net</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">228,530&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">200,164&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Cost of sales</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(44,864)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(41,440)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Consultant commissions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(95,920)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(80,900)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Consultant incentives, promotions, and recognition</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(6,340)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(5,020)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Labor and benefits</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(31,216)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(27,202)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Stock compensation</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(5,702)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(3,280)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Events</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(3,791)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(4,321)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(3,156)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(3,581)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Credit card and bank processing fees</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(6,694)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(6,051)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Other segment items</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(19,035)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(24,449)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Interest income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">466&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">451&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(35)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(21)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Income tax expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(2,438)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(1,413)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">9,805&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2,937&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">(1) Other general and administrative expenses include legal, professional services, rent, utilities, and other miscellaneous expenses.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the Company&#8217;s long-lived assets for its most significant geographic markets (in thousands):</span></div><div style="margin-bottom:8pt;margin-top:13pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:62.150%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.908%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.910%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">June&#160;30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">18,446&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">19,216&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Foreign:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Japan</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,901&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,925&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Other foreign markets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">472&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">612&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total foreign markets</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2,373&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2,537&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total long-lived assets</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">20,819&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">21,753&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Company has identified two major markets with revenues exceeding 10% of consolidated total revenue: United States and Japan.  There are 16 other markets, each of which individually is less than 10% of consolidated total revenue. Sales are recorded in the market in which the transaction occurred. The following table presents the Company&#8217;s revenue disaggregated by these markets (in thousands):</span></div><div style="margin-bottom:8pt;margin-top:13pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:62.150%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.908%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.910%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Years ended June&#160;30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">178,442&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">145,679&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Foreign:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Japan</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">25,394&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">26,989&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Other foreign markets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">24,694&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">27,496&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total foreign markets</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">50,088&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">54,485&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total revenue, net</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">228,530&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">200,164&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Major Products</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s revenue for the fiscal year ended June 30, 2025 is largely attributed to three product lines, Protandim</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">, LifeVantage</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">, and TrueScience</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">. On a combined basis, these three product lines represent approximately </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">87.6% o</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">f the Company&#8217;s total net revenue for the fiscal year ended June&#160;30, 2025. Total revenue for the fiscal year ended June&#160;30, 2024 was largely attributed to two product lines, Protandim</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> and TrueScience</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">, which on a combined basis represented approximately 80.1% of total net revenue for that fiscal year. The following table shows revenue by product line for the fiscal years ended June&#160;30, 2025 and 2024 (in thousands):</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:62.243%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.788%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.936%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Years ended June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Protandim</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">&#174; </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">product line</span></div></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">95,328&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">104,135&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">LifeVantage</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">&#174; </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">product line</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">56,225&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">15,675&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">TrueScience</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">&#174; </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">product line</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">48,712&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">56,252&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">AXIO</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> product line</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">15,312&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">13,375&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">PhysIQ</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">&#8482;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> product line</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">5,102&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3,827&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Petandim</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> product line</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2,117&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2,398&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Other</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">5,734&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">4,502&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total revenue, net</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">228,530&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">200,164&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">(1) Other revenue includes shipping and handling revenue, event related revenue, and other revenues impracticable to allocate to a specific product line.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-21<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-21<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-31<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-15<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-42<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 12: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 54<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-54<br><br>Reference 13: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 47<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47<br><br>Reference 14: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 54<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-54<br><br>Reference 15: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 47<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47<br><br>Reference 16: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 54<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-54<br><br>Reference 17: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 47<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 34<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-34<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 26C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-26C<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 26B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-26B<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-40<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/280/tableOfContent<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 26<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-26<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-41<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">Commitments and Contingencies</a></td>
<td class="text">Commitments and Contingencies<div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contingencies</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Company accounts for contingent liabilities in accordance with ASC 450, </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contingencies</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">. This guidance requires management to assess potential contingent liabilities that may exist as of the date of the financial statements to determine the probability and amount of loss that may have occurred, which inherently involves an exercise of judgment. If the assessment of a contingency indicates that it is probable that a material loss has been incurred and the amount of the liability can be estimated, </span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">then the estimated liability would be accrued in the Company&#8217;s financial statements. If the assessment indicates that a potential material loss contingency is not probable but is reasonably possible, or is probable but cannot be estimated, then the nature of the contingent liability, and an estimate of the range of possible losses, if determinable and material, would be disclosed. For loss contingencies considered remote, no accrual or disclosures are generally made. Management has assessed potential contingent liabilities as of June&#160;30, 2025, and based on the assessment there are no probable loss contingencies requiring accrual or disclosures within its financial statements.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Legal Accruals</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In addition to commitments and obligations in the ordinary course of business, from time to time, the Company is subject to various claims, pending and potential legal actions, investigations relating to governmental laws and regulations and other matters arising out of the normal conduct of its business. Management assesses contingencies to determine the degree of probability and range of possible loss for potential accrual in the consolidated financial statements. An estimated loss contingency is accrued in the consolidated financial statements if it is probable that a liability has been incurred and the amount of the loss can be reasonably estimated. Because evaluating legal claims and litigation results are inherently unpredictable and unfavorable results could occur, assessing contingencies is highly subjective and requires judgments about future events. When evaluating contingencies, management may be unable to provide a meaningful estimate due to a number of factors, including the procedural status of the matter in question, the presence of complex or novel legal theories, and/or the ongoing discovery and development of information important to the matters. In addition, damage amounts claimed or asserted against the Company may be unsupported, exaggerated, or unrelated to possible outcomes, and as such are not meaningful indicators of a potential liability. Management regularly reviews contingencies to determine the adequacy of financial statement accruals and related disclosures. The amount of ultimate loss may differ from these estimates. It is possible that cash flows or results of operations could be materially affected in any particular period by the unfavorable publicity or resolution of one or more of these contingencies. Whether any losses finally determined in any claim, action, investigation or proceeding or publicity related to such could reasonably have a material effect on the Company's business, financial condition, results of operations or cash flows will depend on a number of variables, including: the timing and amount of such losses; the structure and type of any remedies; the significance of the impact of any such losses, damages or remedies may have on the consolidated financial statements; and the unique facts and circumstances of the particular matter that may give rise to additional factors.</span></div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Other Matters</span>.   The Company may become involved in other litigation and regulatory matters incidental to its business and the matters disclosed in this annual report on Form 10-K, including, but not limited to, product liability claims, regulatory actions, employment matters and commercial disputes. The Company intends to defend itself in any such matters and does not currently believe that the outcome of any such matters will have a material adverse effect on the Company's business, financial condition, results of operations and cash flows.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 405<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/405-30/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 440<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482648/440-10-50-4<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 450<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/450/tableOfContent<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 954<br> -SubTopic 440<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478522/954-440-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 440<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482648/440-10-50-4<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 440<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/440/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Subsequent Events<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventsAbstract', window );"><strong>Subsequent Events [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventsTextBlock', window );">Subsequent Events</a></td>
<td class="text"><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Note 15 &#8212; Subsequent Events</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">On September 3, 2025, the Company entered into an Asset Purchase Agreement to acquire critical assets of a Global Organics Merchants, LLC, dba LoveBiome.  The transaction is expected to close by mid-October 2025, subject to satisfaction of customary closing conditions and regulatory requirements.  The Company has not yet determined the accounting purchase price allocation of the purchase consideration described above, which includes evaluating the fair value of the acquired assets and the valuation of contingent consideration to be transferred.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 855<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/855/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 855<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483399/855-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Insider Trading Arrangements<br> shares in Thousands</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Jun. 30, 2025 </div>
<div>shares</div>
</th>
<th class="th">
<div>Jun. 30, 2025 </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TradingArrByIndTable', window );"><strong>Trading Arrangements, by Individual</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_NonRule10b51ArrAdoptedFlag', window );">Non-Rule 10b5-1 Arrangement Adopted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_Rule10b51ArrTrmntdFlag', window );">Rule 10b5-1 Arrangement Terminated</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_NonRule10b51ArrTrmntdFlag', window );">Non-Rule 10b5-1 Arrangement Terminated</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_IndividualAxis=lfvn_MichaelBeindorffMember', window );">Michael Beindorff [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TradingArrByIndTable', window );"><strong>Trading Arrangements, by Individual</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_MtrlTermsOfTrdArrTextBlock', window );">Material Terms of Trading Arrangement</a></td>
<td class="text"><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">As previously reported, on February 10, 2025, Michael Beindorff, a director, adopted a sales plan designed to comply with Rule 10b5-1 under the Exchange Act. The sales plan, which Mr. Beindorff adopted in compliance with restrictions imposed by our Insider Trading Policy, provided for sales of shares of LifeVantage Corporation common stock owned by Mr. Beindorff. Total sales on Mr. Beindorff&#8217;s behalf under the sales plan were limited to 1,000 shares per month, beginning in May 2025 and continuing through October 2026, and up to a maximum of 18,000 shares could be sold under the plan. On May 12, 2025, Mr. Beindorff terminated this 10b5-1 plan.</span></div><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TrdArrIndName', window );">Name</a></td>
<td class="text">Michael Beindorff<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TrdArrIndTitle', window );">Title</a></td>
<td class="text">director<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_Rule10b51ArrAdoptedFlag', window );">Rule 10b5-1 Arrangement Adopted</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TrdArrAdoptionDate', window );">Adoption Date</a></td>
<td class="text">February 10, 2025<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TrdArrExpirationDate', window );">Expiration Date</a></td>
<td class="text">October 2026<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TrdArrSecuritiesAggAvailAmt', window );">Aggregate Available</a></td>
<td class="nump">18<span></span>
</td>
<td class="nump">18<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_MtrlTermsOfTrdArrTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_MtrlTermsOfTrdArrTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_NonRule10b51ArrAdoptedFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_NonRule10b51ArrAdoptedFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_NonRule10b51ArrTrmntdFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_NonRule10b51ArrTrmntdFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_Rule10b51ArrAdoptedFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_Rule10b51ArrAdoptedFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_Rule10b51ArrTrmntdFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_Rule10b51ArrTrmntdFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_TradingArrByIndTable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 2<br> -Subparagraph A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_TradingArrByIndTable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_TrdArrAdoptionDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 2<br> -Subparagraph B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_TrdArrAdoptionDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_TrdArrExpirationDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 2<br> -Subparagraph C<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_TrdArrExpirationDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_TrdArrIndName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 2<br> -Subparagraph A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_TrdArrIndName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_TrdArrIndTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 2<br> -Subparagraph A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_TrdArrIndTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_TrdArrSecuritiesAggAvailAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 2<br> -Subparagraph D<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_TrdArrSecuritiesAggAvailAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_IndividualAxis=lfvn_MichaelBeindorffMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_IndividualAxis=lfvn_MichaelBeindorffMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Insider Trading Policies and Procedures<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_InsiderTradingPoliciesProcLineItems', window );"><strong>Insider Trading Policies and Procedures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_InsiderTrdPoliciesProcAdoptedFlag', window );">Insider Trading Policies and Procedures Adopted</a></td>
<td class="text">true<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_InsiderTradingPoliciesProcLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection b<br> -Paragraph 1<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16<br> -Subsection J<br> -Paragraph a<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_InsiderTradingPoliciesProcLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_InsiderTrdPoliciesProcAdoptedFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection b<br> -Paragraph 1<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16<br> -Subsection J<br> -Paragraph a<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_InsiderTrdPoliciesProcAdoptedFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cybersecurity Risk Management and Strategy Disclosure<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems', window );"><strong>Cybersecurity Risk Management, Strategy, and Governance [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock', window );">Cybersecurity Risk Management Processes for Assessing, Identifying, and Managing Threats [Text Block]</a></td>
<td class="text"><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We have implemented and maintain a cybersecurity risk management program through our security steering committee, which is designed to assess risks from cybersecurity threats, monitor our information systems for potential vulnerabilities, and test those systems pursuant to our cybersecurity policies, processes, and practices, which are integrated into our overall risk management program. The members of our security steering committee represent the following functional areas: cybersecurity and infrastructure; corporate risk and privacy; personnel; and finance and fraud management. The security steering committee collaborates with and manages third parties, as appropriate, to assess the effectiveness of our cybersecurity prevention and response systems and processes. These third parties may include cybersecurity assessors, consultants, and other external cybersecurity experts to assist in the identification, verification, and validation of cybersecurity risks, as well as to support associated mitigation plans when necessary. To protect our information systems from cybersecurity threats, we also ask our employees to take periodic cybersecurity training and we use various security tools that are designed to help identify, escalate, investigate, resolve, and recover from security incidents in a timely manner.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We have not identified risks from known cybersecurity threats to the business, including as a result of any prior cybersecurity incidents, that have materially affected or are reasonably likely to materially affect our Company, including our business strategy, results of operations, or financial condition. See our risk factor &#8220;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">We are subject to evolving laws, policies, and contractual obligations related to data privacy and security, including cybersecurity, and our actual or perceived failure to comply with such obligations or perceived failure to maintain the integrity of our data could expose us to data loss or litigation, harm our reputation, subject us to significant fines and liability, or otherwise affect our business, prospects, financial condition, and operating results.</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; in Part I, Item 1A. (&#8220;Risk Factors&#8221;) for additional details regarding cybersecurity risks and potential impacts on our business.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskManagementProcessesIntegratedFlag', window );">Cybersecurity Risk Management Processes Integrated [Flag]</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskManagementProcessesIntegratedTextBlock', window );">Cybersecurity Risk Management Processes Integrated [Text Block]</a></td>
<td class="text">We have implemented and maintain a cybersecurity risk management program through our security steering committee, which is designed to assess risks from cybersecurity threats, monitor our information systems for potential vulnerabilities, and test those systems pursuant to our cybersecurity policies, processes, and practices, which are integrated into our overall risk management program.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskManagementThirdPartyEngagedFlag', window );">Cybersecurity Risk Management Third Party Engaged [Flag]</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag', window );">Cybersecurity Risk Third Party Oversight and Identification Processes [Flag]</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag', window );">Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Flag]</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock', window );">Cybersecurity Risk Board of Directors Oversight [Text Block]</a></td>
<td class="text">Our board is actively involved in the assessment, oversight and management of the material risks that could affect the Company.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock', window );">Cybersecurity Risk Board Committee or Subcommittee Responsible for Oversight [Text Block]</a></td>
<td class="text">Our board has delegated to the audit committee the oversight responsibility for risks and incidents relating to cybersecurity threats, including compliance with disclosure requirements, cooperation with law enforcement, and related effects on financial and other risks.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock', window );">Cybersecurity Risk Process for Informing Board Committee or Subcommittee Responsible for Oversight [Text Block]</a></td>
<td class="text">Our board has delegated to the audit committee the oversight responsibility for risks and incidents relating to cybersecurity threats, including compliance with disclosure requirements, cooperation with law enforcement, and related effects on financial and other risks. The audit committee reports any material or notable cybersecurity incidents, findings and recommendations, as appropriate, to the full board for consideration. Our Chief Information and Innovation Officer (&#8220;CIIO&#8221;) also presents to the audit committee and to the board, as appropriate, any updates, changes, or improvements on the Company&#8217;s cybersecurity risk management program.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskRoleOfManagementTextBlock', window );">Cybersecurity Risk Role of Management [Text Block]</a></td>
<td class="text">Our board has delegated to the audit committee the oversight responsibility for risks and incidents relating to cybersecurity threats, including compliance with disclosure requirements, cooperation with law enforcement, and related effects on financial and other risks. The audit committee reports any material or notable cybersecurity incidents, findings and recommendations, as appropriate, to the full board for consideration. Our Chief Information and Innovation Officer (&#8220;CIIO&#8221;) also presents to the audit committee and to the board, as appropriate, any updates, changes, or improvements on the Company&#8217;s cybersecurity risk management program.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag', window );">Cybersecurity Risk Management Positions or Committees Responsible [Flag]</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock', window );">Cybersecurity Risk Management Positions or Committees Responsible [Text Block]</a></td>
<td class="text">Our Chief Information and Innovation Officer (&#8220;CIIO&#8221;) also presents to the audit committee and to the board, as appropriate, any updates, changes, or improvements on the Company&#8217;s cybersecurity risk management program.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock', window );">Cybersecurity Risk Management Expertise of Management Responsible [Text Block]</a></td>
<td class="text">Our CIIO, with over 40 years of experience in IT and operational technology security, has the primary responsibility of overseeing our cybersecurity risk management program and assessing and managing any material risks related to cybersecurity threats.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock', window );">Cybersecurity Risk Process for Informing Management or Committees Responsible [Text Block]</a></td>
<td class="text">Our Chief Information and Innovation Officer (&#8220;CIIO&#8221;) also presents to the audit committee and to the board, as appropriate, any updates, changes, or improvements on the Company&#8217;s cybersecurity risk management program.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag', window );">Cybersecurity Risk Management Positions or Committees Responsible Report to Board [Flag]</a></td>
<td class="text">true<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection c<br> -Paragraph 1<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection c<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection c<br> -Paragraph 1<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection c<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection c<br> -Paragraph 2<br> -Subparagraph i<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection c<br> -Paragraph 2<br> -Subparagraph i<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection c<br> -Paragraph 2<br> -Subparagraph i<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection c<br> -Paragraph 2<br> -Subparagraph i<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>i:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection c<br> -Paragraph 2<br> -Subparagraph iii<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection c<br> -Paragraph 2<br> -Subparagraph iii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>i:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection c<br> -Paragraph 2<br> -Subparagraph i<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection c<br> -Paragraph 2<br> -Subparagraph i<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection b<br> -Paragraph 1<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection b<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskManagementProcessesIntegratedFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection b<br> -Paragraph 1<br> -Subparagraph i<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection b<br> -Paragraph 1<br> -Subparagraph i<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskManagementProcessesIntegratedFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>i:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskManagementProcessesIntegratedTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection b<br> -Paragraph 1<br> -Subparagraph i<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection b<br> -Paragraph 1<br> -Subparagraph i<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskManagementProcessesIntegratedTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>i:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskManagementThirdPartyEngagedFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection b<br> -Paragraph 1<br> -Subparagraph ii<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection b<br> -Paragraph 1<br> -Subparagraph ii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskManagementThirdPartyEngagedFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>i:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection b<br> -Paragraph 2<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection b<br> -Paragraph 2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>i:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection c<br> -Paragraph 1<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection c<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection c<br> -Paragraph 2<br> -Subparagraph ii<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection c<br> -Paragraph 2<br> -Subparagraph ii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskRoleOfManagementTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection c<br> -Paragraph 2<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection c<br> -Paragraph 2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskRoleOfManagementTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection b<br> -Paragraph 1<br> -Subparagraph iii<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection b<br> -Paragraph 1<br> -Subparagraph iii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>i:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies (Policies)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConsolidationPolicyTextBlock', window );">Consolidation</a></td>
<td class="text"><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Consolidation</span></div>The consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries. All significant intercompany accounts and transactions are eliminated in consolidation.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of Estimates</a></td>
<td class="text"><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Company prepares the consolidated financial statements and related disclosures in conformity with accounting principles generally accepted in the United States of America (&#8220;GAAP&#8221;). In preparing these statements, the Company is required to use estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ materially from those estimates and assumptions. On an ongoing basis, the Company reviews its estimates, including, but not limited to, those related to inventory valuation and obsolescence, sales returns, income taxes and tax valuation reserves, transfer pricing methodology and positions, impairment of assets, stock-based compensation, and loss contingencies.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock', window );">Foreign Currency Translation</a></td>
<td class="text"><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Foreign Currency Translation</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">A portion of the Company&#8217;s business operations occurs outside the United States.&#160;The local currency of each of the Company&#8217;s subsidiaries generally is its functional currency.&#160;All assets and liabilities are translated into U.S. Dollars at exchange rates existing at the balance sheet dates, revenue and expenses are translated at weighted-average exchange rates and stockholders&#8217; equity is recorded at historical exchange rates.&#160;The resulting foreign currency translation adjustments are recorded as a separate component of stockholders&#8217; equity in the consolidated balance sheets and as a component of comprehensive income. Transaction gains and losses are included in other expense, net in the consolidated statements of operations and comprehensive income.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueOfFinancialInstrumentsPolicy', window );">Fair Value of Financial Instruments</a></td>
<td class="text"><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Fair Value of Financial Instruments</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Company accounts for assets and liabilities using a hierarchy of valuation techniques based on whether the inputs to those valuation techniques are observable or unobservable. Observable inputs reflect market data obtained from independent </span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">sources, while unobservable inputs reflect the Company&#8217;s market assumptions. These two types of inputs have created the fair-value hierarchy below. This hierarchy requires the Company to minimize the use of unobservable inputs and to use observable market data, if available, when determining fair value.</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 1&#8212;Quoted prices for identical instruments in active markets; </span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 2&#8212;Quoted prices for similar instruments in active markets, quoted prices for identical or similar instruments in markets that are not active, and model-derived valuations in which all significant inputs and significant value drivers are observable in active markets; and</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 3&#8212;Valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable.</span></div>Our financial instruments, consisting primarily of cash and cash equivalents, accounts receivable, and accounts payable, approximate fair value due to their short-term nature.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock', window );">Cash and Cash Equivalents</a></td>
<td class="text"><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Cash and Cash Equivalents</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Company considers only its monetary liquid assets with original maturities of three months or less to be cash equivalents.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReceivablesPolicyTextBlock', window );">Accounts Receivable</a></td>
<td class="text"><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Accounts Receivable</span></div>The Company&#8217;s accounts receivable for the fiscal years ended June&#160;30, 2025 and 2024 consist primarily of credit card receivables. Based on the Company&#8217;s verification process for customer credit cards and historical information available, management has determined that an allowance for doubtful accounts on credit card sales related to its customer sales as of June&#160;30, 2025 or 2024 is not necessary.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryPolicyTextBlock', window );">Inventories</a></td>
<td class="text">Inventories are carried at the lower of cost or net realizable value, using the first-in, first-out method<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock', window );">Property and Equipment</a></td>
<td class="text"><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Property and Equipment</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment are recorded at cost and depreciated using the straight-line method over the following useful lives:</span></div><div style="margin-bottom:8pt;margin-top:13pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:80.891%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.909%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Years</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Equipment (includes computer hardware and software)</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3 - 5</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Furniture and fixtures</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">5</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Vehicles</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">5</span></td></tr></table></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Leasehold improvements are depreciated over the shorter of estimated useful life of the related asset or the lease term.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The cost of normal maintenance and repairs is charged to expense as incurred. When an asset is sold or otherwise disposed of, the cost and associated accumulated depreciation are removed from the accounts and the resulting gain or loss is recognized in the consolidated statements of operations and comprehensive income in other expense, net. Significant expenditures that increase the useful life of an asset are capitalized and depreciated over the estimated useful life of the asset. Property and equipment are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of such assets may not be recoverable.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsFiniteLivedPolicy', window );">Intangible Assets</a></td>
<td class="text"><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Intangible Assets</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Intangible assets are stated at cost less accumulated amortization. Finite-lived intangible assets are amortized over their related useful lives, using a straight-line method, consistent with the underlying expected future cash flows related to the specific intangible asset. Finite-lived intangible assets are reviewed for impairment whenever events or changes in circumstances exist that indicate the carrying amount of an asset may not be recoverable. When indicators of impairment exist, an estimate of undiscounted net cash flows is used in measuring whether the carrying amount of the asset or related asset group is recoverable. Measurement of the amount of impairment, if any, is based upon the difference between the asset&#8217;s carrying value and estimated fair value. </span></div>Indefinite-lived intangible assets are not amortized; however, they are tested at least annually for impairment or more frequently if events or changes in circumstances exist that may indicate impairment. An impairment loss is recognized if the carrying amount of the asset exceeds its fair value.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock', window );">Impairment of Long-Lived Assets</a></td>
<td class="text"><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Impairment of Long-Lived Assets</span></div>Pursuant to guidance established for impairment or disposal of assets, the Company assesses impairment whenever events or changes in circumstances indicate that the carrying amount of a long-lived asset may not be recoverable. When an assessment for impairment of long-lived assets, long-lived assets to be disposed of, and certain identifiable intangibles related to those assets is performed, the Company is required to compare the net carrying value of long-lived assets on the lowest level at which cash flows can be determined on a consistent basis to the related estimates of future undiscounted net cash flows for such assets. If the net carrying value exceeds the net cash flows, then an impairment is recognized to reduce the carrying value to the estimated fair value, generally equal to the future discounted net cash flow.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskCreditRisk', window );">Concentration of Credit Risk</a></td>
<td class="text"><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Concentration of Credit Risk</span></div>Accounting guidance for financial instruments requires disclosure of significant concentrations of credit risk regardless of the degree of such risk. Financial instruments with significant credit risk include cash and cash equivalents.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommissionsExpensePolicyPolicyTextBlock', window );">Commissions and Incentives</a></td>
<td class="text"><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Commissions and Incentives</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Commissions and incentives expenses are the Company&#8217;s most significant expenses and are classified as operating expenses. Commissions and incentives expenses include sales commissions paid to the Company&#8217;s independent consultants, special incentives, costs for incentive trips and other rewards. Commissions and incentives expenses do not include any amounts the Company pays to its independent consultants for personal purchases. Commissions paid to independent consultants on personal purchases are considered a sales discount and are reported as a reduction to net revenue.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock', window );">Shipping and Handling, Revenue And Deferred Revenue</a></td>
<td class="text"><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Shipping and Handling</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Shipping and handling costs associated with inbound freight and freight out to customers, including independent consultants, are included in cost of sales. Shipping and handling fees charged to all customers are included in sales.</span></div>Revenue<div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Revenue is recognized when control of the promised goods or services are transferred to the customer, in an amount that reflects the consideration the Company expects to be entitled to in exchange for those goods or services. Sales, value add, and other taxes the Company collects concurrent with revenue-producing activities are excluded from revenue.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Company generates the majority of its revenue through product sales to customers. These products include the Protandim</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174; </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">line of dietary supplements, the LifeVantage</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> line of dietary supplements that include the MindBody GLP-1 System</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#8482;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">, Omega+, ProBio, IC Bright</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">, the Rise AM &amp; Reset PM System</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">, D3+, and Daily Wellness, PhysIQ</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#8482;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> Fat Burn and Prebiotic dietary supplements, TrueScience</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> skin and hair care products and Liquid Collagen, Petandim</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">, our companion pet supplement formulated to combat oxidative stress in dogs, and AXIO</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#160;nootropic energy drink mixes. The Company ships most of its product directly to the consumer and receives substantially all payment for product sales in the form of credit card receipts. Revenue from direct product sales to customers is recognized upon shipment, which is when passage of title and risk of loss occurs. For items sold in packs and bundles, the Company determines the standalone selling price at contract inception for each distinct good and then allocates the transaction price on a relative standalone selling price basis. Any discounts are accounted for as a direct reduction to the transaction price. Shipping and handling revenue is recognized upon shipment when the performance obligation is completed.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Company also charges amounts to independent consultants to attend events that it holds. Tickets to events are sold as standalone items or included within packs. For event tickets sold in packs, the Company allocates a portion of the transaction price to the ticket on a relative standalone selling price basis, adjusted for the probability of the tickets being redeemed for attendance at a future event. Any discounts are accounted for as a direct reduction to the transaction price. Fee revenue associated with ticket sales is recorded in the month that the event is held, which is when the Company has performed its obligations under the contract.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Deferred Revenue</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Company launched its Rewards Circle loyalty program in the United States, Australia, New Zealand, and Japan in March 2023 and in Canada, Europe, and Mexico in February 2024.  Contract liabilities, recorded as deferred revenue, include these loyalty program credit deferrals with certain customers which are accounted for as a reduction in the transaction price and are generally recognized as credits are redeemed for additional products at a later date.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Company also records deferred revenue when cash payments are received or due in advance of performance, including amounts which are refundable. The Company pre-sells tickets to its events. When cash payments are received in advance of events, the cash received is recorded to deferred revenue until the event is held, at which time the Company has performed its obligations under the contract and the revenue is recognized.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> Deferred revenue is included in accrued expenses in the consolidated balance sheets.  The balance of deferred revenue related to contract liabilities, each less than twelve months, was $0.7 million and $0.9 million as of June&#160;30, 2025 and 2024, respectively. The contract liabilities impact to revenue for the years ended June&#160;30, 2025 and 2024 was an increase of $0.2 million and a decrease of $26,000, respectively.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpensePolicy', window );">Research and Development Costs</a></td>
<td class="text"><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Research and Development Costs</span></div>The Company expenses all costs related to research and development activities as incurred.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeasesPolicyTextBlock', window );">Leases</a></td>
<td class="text"><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Leases</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Company accounts for leases in accordance with Accounting Standards Codification (&#8220;ASC&#8221;) 842. The Company reviews all contracts and determines if the arrangement is or contains a lease, at inception. Operating leases are included in right-of-use (&#8220;ROU&#8221;) assets, current lease liabilities and long-term lease liabilities on the consolidated balance sheets. The Company does not have any finance leases.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Operating lease ROU assets represent the Company&#8217;s right to use an underlying asset for the lease term and lease liabilities represent the Company&#8217;s obligation to make lease payments arising from the lease. ROU assets and lease liabilities are recognized at the lease commencement date based on the estimated present value of lease payments over the lease term. The Company uses its estimated incremental borrowing rate based on the information available at the commencement date in determining the present value of future payments. The operating lease ROU asset also includes any upfront lease payments made and excludes lease incentives and initial direct costs incurred. The Company&#8217;s lease terms may include options to extend or terminate the lease when it is reasonably certain that the Company will exercise that option. Lease expense for minimum lease payments is recognized on a straight-line basis over the lease term. Leases with a term of 12 months or less are not recorded on the balance sheet. The Company&#8217;s lease agreements do not contain any residual value guarantees.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy', window );">Stock-Based Compensation</a></td>
<td class="text"><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Stock-Based Compensation</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognizes stock-based compensation by measuring the cost of services to be rendered based on the grant date fair value of the equity award. The Company recognizes stock-based compensation, net of any estimated forfeitures, over the period an employee is required to provide service in exchange for the award, generally referred to as the requisite service period. The Company estimates forfeitures based on historical information and other management assumptions. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Black-Scholes option pricing model is used to estimate the fair value of stock options and options under the Company&#8217;s 2019 Employee Stock Purchase Plan. The determination of the fair value of options is affected by the Company&#8217;s stock price and a number of assumptions, including expected volatility, expected life, risk-free interest rate and expected dividends. The Company uses historical data for estimating the expected volatility and expected life of stock options required in the Black-Scholes model. The risk-free interest rate assumption is based on observed interest rates appropriate for the expected terms of the stock options. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of restricted stock grants, including performance restricted stock units that include non-market based performance conditions, is based on the closing market price of the Company&#8217;s stock on the date of grant less the Company&#8217;s expected dividend yield. The Company recognizes compensation costs for awards with performance conditions when it concludes it is probable that the performance conditions will be achieved. The Company reassesses the probability of vesting at each balance sheet date and adjusts compensation costs accordingly.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxPolicyTextBlock', window );">Income Taxes</a></td>
<td class="text"><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Income Taxes</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Income taxes are accounted for under the asset and liability method. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases and operating loss and tax credit carry forwards. Deferred tax assets and liabilities are measured using statutory tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled, updated as needed for changes in corporate tax rates. The effect on deferred tax assets and liabilities from a change in tax rates is recognized in income in the period that includes the effective date of the change. The Company recognizes tax liabilities or benefits from an uncertain position only if it is more likely than not that the position will be sustained upon examination by taxing authorities based on the technical merits of the issue. The amount recognized would be the largest liability or benefit that the Company believes has greater than a 50% likelihood of being realized upon settlement.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerSharePolicyTextBlock', window );">Income Per Share</a></td>
<td class="text"><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Income Per Share</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Basic income per common share is computed by dividing net income by the weighted-average number of common shares outstanding during the period, less unvested restricted stock awards. Diluted income per common share is computed by dividing net income by the weighted-average common shares and potentially dilutive common share equivalents using the treasury stock method.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingPolicyPolicyTextBlock', window );">Segment Information</a></td>
<td class="text"><div style="margin-bottom:8pt;margin-top:3pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Company operates in a single operating segment by selling products directly to customers through an international network of independent consultants that operates in an integrated manner from market to market. The Company manages its business primarily by managing its international network of independent consultants through similar commission plans. Most products available to customers in the United States are available to customers across all markets.  These products are purchased through third-party manufacturers by the US Corporate office and sold to each international market. Pricing for all products is determined at the US Corporate office. Accordingly, for disclosure purposes, the Company has a single reporting segment, which is reported on the Company&#8217;s consolidated financial statements.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">New Accounting Pronouncements</a></td>
<td class="text"><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">New Accounting Pronouncements</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In November 2023, the Financial Accounting Standards Board (&#8220;FASB&#8221;) issued Accounting Standards Update (&#8220;ASU&#8221;) 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures (ASU 2023-07), expanding segment disclosure requirements. The amendments require enhanced disclosure for certain segment items and required disclosure on how management uses reported measures to assess segment performance. The amendments do not change how segments are determined, aggregated, or how thresholds are applied to determine reportable segments. ASU 2023-07 is effective for the Company&#8217;s annual periods beginning July 1, 2024, and for interim periods beginning July 1, 2025, with early adoption permitted. The Company adopted ASU 2023-07 for the fiscal year beginning July 1, 2024. See Note 13 for expanded segment disclosures.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In December 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures (&#8220;ASU 2023-09&#8221;). The guidance requires disclosure of disaggregated income taxes paid, prescribes standardized categories for the components of the effective tax rate reconciliation, and modifies other income tax-related disclosures. ASU 2023-09 is effective for the Company&#8217;s annual periods beginning July 1, 2025, with early adoption permitted. The Company is currently evaluating the potential effect that the updated standard will have on its financial statement disclosures.   </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In November 2024, the FASB issued ASU 2024-03, Income Statement&#8212;Reporting Comprehensive Income&#8212;Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses (&#8220;ASU 2024-03&#8221;). The guidance requires disclosure of specified information about certain costs and expenses at each interim and annual reporting period. ASU 2024-03 is effective for the Company&#8217;s annual periods beginning July 1, 2027, with early adoption permitted. The Company is currently evaluating the potential effect that the updated standard will have on its financial statement disclosures.   </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Other recently issued accounting pronouncements did not or are not believed by management to have a material impact on the Company&#8217;s present or future financial statements.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommissionsExpensePolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for commissions incurred in relation to revenue generating activities or operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommissionsExpensePolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskCreditRisk">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for credit risk. Includes, but is not limited to, policy for entering into master netting arrangement or similar agreement to mitigate credit risk of financial instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-21<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-21<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskCreditRisk</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483426/235-10-50-4<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerSharePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerSharePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueOfFinancialInstrumentsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for determining the fair value of financial instruments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueOfFinancialInstrumentsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/830/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for recognizing and measuring the impairment of long-lived assets. An entity also may disclose its accounting policy for long-lived assets to be sold. This policy excludes goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.CC)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480091/360-10-S99-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 05<br> -Paragraph 4<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482338/360-10-05-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 20<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-20<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-19<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482525/740-10-45-25<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(h)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-17<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-9<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482525/740-10-45-28<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsFiniteLivedPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for finite-lived intangible assets. This accounting policy also might address: (1) the amortization method used; (2) the useful lives of such assets; and (3) how the entity assesses and measures impairment of such assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483426/235-10-50-4<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/350-30/tableOfContent<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 926<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483154/926-20-50-5<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 920<br> -SubTopic 350<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478609/920-350-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 920<br> -SubTopic 350<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478609/920-350-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 920<br> -SubTopic 350<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478609/920-350-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsFiniteLivedPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 330<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483080/330-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483489/210-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483426/235-10-50-4<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 912<br> -SubTopic 330<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478411/912-330-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 330<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/330/tableOfContent<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 330<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483080/330-10-50-4<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 6<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 270<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482989/270-10-45-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeLeasesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for leasing arrangement entered into by lessee.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeLeasesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -SubTopic 360<br> -Topic 958<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477798/958-360-50-6<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -SubTopic 360<br> -Topic 958<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477798/958-360-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReceivablesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for receivable. Includes, but is not limited to, accounts receivable and financing receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481962/310-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481569/310-20-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481962/310-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481962/310-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481962/310-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReceivablesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpensePolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 730<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 05<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483044/730-10-05-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpensePolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for revenue from contract with customer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-17<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-19<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-18<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-18<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-20<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-20<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-20<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-20<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -SubTopic 10<br> -Topic 235<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483426/235-10-50-4<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Topic 606<br> -Publisher FASB<br> -URI https://asc.fasb.org/606/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for segment reporting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-41<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-29<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-29<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-29<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 47<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-29<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 54<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-54<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 36<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-36<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 47<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-29<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 29<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-29<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-29<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(v)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479953/718-10-S50-5<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479953/718-10-S50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479953/718-10-S50-4<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479953/718-10-S50-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.C.Q3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479830/718-10-S99-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.1.Q5)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479830/718-10-S99-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.3.Q2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479830/718-10-S99-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.2.Q6)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479830/718-10-S99-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/718/tableOfContent<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478671/942-235-S50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 275<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-12<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 275<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-9<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 275<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482836/275-10-55-6<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 275<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-6<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 275<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-4<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock', window );">Schedule of Components of Inventory</a></td>
<td class="text"><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Inventory consisted of (in thousands):</span></div><div style="margin-bottom:8pt;margin-top:13pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:38.724%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.394%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.394%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.394%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.398%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="21" style="border-bottom:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">June&#160;30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="9" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">17,739&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">85.8&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">11,841&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">78.7&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2,930&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">14.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3,214&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">21.3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total inventory</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">20,669&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">15,055&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Reserves of inventories consist of the following (in thousands):</span></div><div style="margin-bottom:8pt;margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:62.150%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.908%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.910%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Years ended June&#160;30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Beginning balance</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,301&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,292&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Additions</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">214&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">901&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Write-offs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(1,049)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(892)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Ending balance</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">466&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,301&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentTextBlock', window );">Schedule of Property and Equipment</a></td>
<td class="text"><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment are recorded at cost and depreciated using the straight-line method over the following useful lives:</span></div><div style="margin-bottom:8pt;margin-top:13pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:80.891%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.909%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Years</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Equipment (includes computer hardware and software)</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3 - 5</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Furniture and fixtures</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">5</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Vehicles</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">5</span></td></tr></table></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment, net consist of (in thousands):</span></div><div style="margin-bottom:8pt;margin-top:13pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:62.150%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.908%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.910%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">June&#160;30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Equipment (includes computer hardware and software)</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">16,998&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">15,766&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Furniture and fixtures</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,469&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,466&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">5,101&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">5,040&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Vehicles</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">51&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">51&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated depreciation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(17,412)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(14,510)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total property and equipment, net</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">6,207&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">7,813&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Summary of Computation of Net Income Per Share</a></td>
<td class="text"><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The following is a reconciliation of net income per share and the weighted-average common shares outstanding for purposes of computing basic and diluted net income per share (in thousands, except per share amounts):</span></div><div style="margin-bottom:8pt;margin-top:13pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:62.150%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.908%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.910%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Years ended June&#160;30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Numerator:</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">9,805&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2,937&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Denominator:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Basic weighted-average common shares outstanding</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">12,251&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">12,458&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Effect of dilutive securities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Stock awards and options</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">736&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">528&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Diluted weighted-average common shares outstanding</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">12,987&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">12,986&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Net income per share, basic</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">0.80&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">0.24&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Net income per share, diluted</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">0.75&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">0.23&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock', window );">Schedule of Long-lived Assets by Geographic Areas</a></td>
<td class="text"><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the Company&#8217;s long-lived assets for its most significant geographic markets (in thousands):</span></div><div style="margin-bottom:8pt;margin-top:13pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:62.150%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.908%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.910%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">June&#160;30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">18,446&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">19,216&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Foreign:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Japan</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,901&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,925&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Other foreign markets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">472&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">612&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total foreign markets</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2,373&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2,537&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total long-lived assets</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">20,819&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">21,753&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of long-lived assets, excluding financial instruments, long-term customer relationships of a financial institution, mortgage rights, deferred policy acquisition costs, and deferred tax assets, by geographic areas located in the entity's country of domicile and foreign countries in which the entity holds assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-41<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(c))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483489/210-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfInventoryCurrentTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueTableTextBlock', window );">Schedule of Disaggregation of Revenue</a></td>
<td class="text"><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Reserves for sales returns consist of the following (in thousands):</span></div><div style="margin-bottom:8pt;margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:62.150%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.908%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.910%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Years ended June&#160;30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Beginning balance</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">133&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">129&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Additions</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2,759&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,622&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Returns</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(2,655)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(1,618)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Ending balance</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">237&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">133&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property and Equipment, Net (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentTextBlock', window );">Schedule of Property and Equipment</a></td>
<td class="text"><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment are recorded at cost and depreciated using the straight-line method over the following useful lives:</span></div><div style="margin-bottom:8pt;margin-top:13pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:80.891%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.909%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Years</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Equipment (includes computer hardware and software)</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3 - 5</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Furniture and fixtures</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">5</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Vehicles</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">5</span></td></tr></table></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment, net consist of (in thousands):</span></div><div style="margin-bottom:8pt;margin-top:13pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:62.150%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.908%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.910%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">June&#160;30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Equipment (includes computer hardware and software)</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">16,998&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">15,766&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Furniture and fixtures</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,469&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,466&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">5,101&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">5,040&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Vehicles</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">51&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">51&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated depreciation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(17,412)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(14,510)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total property and equipment, net</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">6,207&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">7,813&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Intangible Assets, Net (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock', window );">Schedule of Intangible Assets, Net</a></td>
<td class="text"><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Intangible assets, net consist of (in thousands):</span></div><div style="margin-bottom:8pt;margin-top:13pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:62.150%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.908%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.910%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">June&#160;30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Patent costs</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2,330&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(2,252)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total finite-lived intangible assets, net</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">78&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Trademarks and other indefinite-lived intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">245&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">245&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total intangible assets, net</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">245&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">323&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 40<br> -SubTopic 30<br> -Topic 350<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482640/350-30-55-40<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other Accrued Expenses (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Payables and Accruals [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock', window );">Schedule of Other Accrued Expenses</a></td>
<td class="text"><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Other accrued expenses consist of (in thousands):</span></div><div style="margin-bottom:8pt;margin-top:13pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:62.150%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.908%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.910%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Accrued incentive compensation</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">5,325&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,521&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Accrued severance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">90&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Other taxes payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2,189&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2,258&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Accrued payable to vendors</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">459&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">434&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Deferred revenue</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">711&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">860&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Accrued incentives and promotions to consultants</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3,284&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,454&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Accrued other expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,540&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,257&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total other accrued expenses</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">13,513&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">7,874&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of accrued liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-Based Compensation (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-Based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock', window );">Summary of Stock Option Activity</a></td>
<td class="text"><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The following is a summary of stock option activity for the fiscal years ended June&#160;30, 2025 and 2024:</span></div><div style="margin-bottom:8pt;margin-top:13pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:38.724%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.394%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.394%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.394%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.398%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Options (in thousands)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Weighted<br/>Average<br/>Exercise&#160;Price</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Weighted<br/>Average&#160;Remaining<br/>Contractual Term (in years)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Aggregate Intrinsic Value (in thousands)</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at June 30, 2023</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">72&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">4.44&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Expired or Canceled</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at June 30, 2024</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">72&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">4.44&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Expired or Canceled</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at June 30, 2025</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">72&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">4.44&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2.59</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">618&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Exercisable at June 30, 2025</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">72&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">4.44&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2.59</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">618&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock', window );">Schedule of Nonvested Restricted Shares</a></td>
<td class="text"><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The following is a summary of restricted stock award activity during the fiscal years ended June&#160;30, 2025 and 2024:</span></div><div style="margin-bottom:8pt;margin-top:13pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:61.418%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.908%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.910%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Shares<br/>(in thousands)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Weighted Average Grant Date Fair Value</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Nonvested at June 30, 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">117&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3.85&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">392&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">4.74&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Vested </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(117)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3.85&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Nonvested at June 30, 2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">392&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">4.74&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">58&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">13.54&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(294)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">4.77&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Nonvested at June 30, 2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">156&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">7.92&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center;text-indent:22.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.836%"><tr><td style="width:1.0%"></td><td style="width:2.679%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:95.121%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">(1)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">Includes 125,732 shares of restricted stock that were granted in exchange for the cancellation of 48,026 shares of stock units and 77,706 shares of performance restricted stock units on November 6, 2023.</span></div></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfUnvestedRestrictedStockUnitsRollForwardTableTextBlock', window );">Schedule of Unvested Restricted Stock Units Roll Forward</a></td>
<td class="text"><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The following is a summary of restricted stock units activity during the fiscal years ended June&#160;30, 2025 and 2024:</span></div><div style="margin-bottom:8pt;margin-top:13pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:61.418%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.908%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.910%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Number of Units (in thousands)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Weighted Average Grant Date Fair Value</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Nonvested at June 30, 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">538&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">4.90&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">214&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">4.90&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(331)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">5.05&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(84)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">4.48&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Nonvested at June 30, 2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">337&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">4.86&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">224&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10.08&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(224)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">4.87&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(47)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">6.12&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Nonvested at June 30, 2025</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">290&#160;</span></td><td style="border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">8.68&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center;text-indent:22.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.836%"><tr><td style="width:1.0%"></td><td style="width:2.679%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:95.121%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">(1)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">Includes 48,026 shares of restricted stock units that were canceled in exchange for restricted stock awards on November 6, 2023.</span></div></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock', window );">Summary of Nonvested Restricted Stock Units</a></td>
<td class="text"><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The following is a summary of performance restricted stock units activity during the fiscal years ended June&#160;30, 2025 and 2024:</span></div><div style="margin-bottom:8pt;margin-top:13pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:61.418%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.908%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.910%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Number of Units (in thousands)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Weighted Average Grant Date Fair Value</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Nonvested at June 30, 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">492&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">4.24&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">350&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">4.89&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(284)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">4.24&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(274)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">4.68&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Nonvested at June 30, 2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">284&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">4.62&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">509&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">8.30&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(94)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">4.24&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(45)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">6.67&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Nonvested at June 30, 2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">654&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">7.40&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center;text-indent:22.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.836%"><tr><td style="width:1.0%"></td><td style="width:2.679%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:95.121%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">(1)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">Includes 77,706 shares of performance restricted stock units that were canceled in exchange for restricted stock awards on November 6, 2023.</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">(2)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">Includes shares added based on achievement of performance goals in excess of target.</span></div></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the changes in outstanding nonvested restricted stock shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Subparagraph (c)<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the changes in outstanding nonvested restricted stock units.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfUnvestedRestrictedStockUnitsRollForwardTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the change in restricted stock units (RSUs).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfUnvestedRestrictedStockUnitsRollForwardTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other Expense, Net (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherIncomeAndExpensesAbstract', window );"><strong>Other Income and Expenses [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock', window );">Schedule of Other Expense, Net</a></td>
<td class="text"><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Other expense, net consists of the following (in thousands):</span></div><div style="margin-bottom:8pt;margin-top:13pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:62.150%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.908%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.910%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Years ended June&#160;30,</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency transaction loss, net</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(380)</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(429)</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Other income (expense), net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;Total other expense, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(387)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(412)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherIncomeAndExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherIncomeAndExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of non-operating income or non-operating expense that may include amounts earned from dividends, interest on securities, gains (losses) on securities sold, equity earnings of unconsolidated affiliates, net gain (loss) on sales of business, interest expense and other miscellaneous income or expense items.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock', window );">Schedule of Components of Income Tax Expense</a></td>
<td class="text"><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The income tax expense for the fiscal years ended June&#160;30, 2025 and 2024 consists of the following (in thousands):</span></div><div style="margin-bottom:8pt;margin-top:13pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:62.150%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.908%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.910%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Years ended June 30,</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Income before income taxes:</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Domestic</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10,397&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2,940&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">International</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,846&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,410&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td style="border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">12,243&#160;</span></td><td style="border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">4,350&#160;</span></td><td style="border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Current taxes:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Federal</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2,925&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,457&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">State</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">708&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">246&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">491&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">984&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total current income tax provision</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">4,124&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2,687&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Deferred taxes:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Federal</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(1,464)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(1,281)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">State</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(341)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(151)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">119&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">158&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total deferred income tax provision</span></td><td style="border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(1,686)</span></td><td style="border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(1,274)</span></td><td style="border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Net income tax provision</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2,438&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,413&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock', window );">Schedule of The Effective Income Tax Rate Differs from the U.S. Federal Statutory Income Tax Rate</a></td>
<td class="text"><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The effective income tax rate for the fiscal years ended June&#160;30, 2025 and 2024 differs from the U.S. Federal statutory income tax rate due to the following:</span></div><div style="margin-bottom:8pt;margin-top:13pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:62.150%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.908%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.910%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Years ended June 30,</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Federal statutory income tax rate</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">21.0&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">21.0&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">State income taxes, net of federal benefit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Foreign tax rate difference</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">8.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Tax return to provision true-up</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(4.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Limit on future stock compensation due to 162(m)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">4.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Foreign withholding tax</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">0.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Other differences</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Revalue of deferred for change in federal tax rate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">0.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">0.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Permanent differences:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212; stock-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(6.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(8.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212; current year section 162(m) limitation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">0.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">7.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212; foreign derived intangible income deduction</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(1.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(0.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212; tax credits</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(4.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(12.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212; meals and entertainment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212; removal of additional permanent reinvestment assertions</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212; change in uncertain tax positions</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212; accrual for foreign tax audits</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">7.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212; other permanent differences</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Change in valuation allowance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Net income tax provision </span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">19.9&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">32.5&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock', window );">Schedule of The Components of the Deferred Tax Assets and Liabilities</a></td>
<td class="text"><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The components of the deferred tax assets and liabilities as of June&#160;30, 2025 and 2024 are as follows (in thousands):</span></div><div style="margin-bottom:8pt;margin-top:13pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:62.150%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.908%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.910%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Federal, state, and foreign net operating loss carryovers</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">234&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">271&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Stock option compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">628&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">360&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Section 174 costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2,798&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2,578&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Lease liability</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2,798&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3,223&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Accrued vacation, allowance for returns, bonuses&#160;&amp; other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2,819&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2,119&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Gross deferred tax asset</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">9,277&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">8,551&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Patents and trademarks</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(16)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(30)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Property&#160;&amp; equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(239)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(798)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Right of use asset</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(1,942)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(2,263)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(468)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(472)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Gross deferred tax liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(2,665)</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(3,563)</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Less: valuation allowance</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(642)</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(720)</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax assets, net</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">5,970&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">4,268&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SummaryOfValuationAllowanceTextBlock', window );">Summary of Valuation Allowance</a></td>
<td class="text"><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The change in the valuation allowance were as follows (in thousands):</span></div><div style="margin-bottom:8pt;margin-top:8pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:62.150%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.908%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.910%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Years ended June&#160;30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Beginning balance</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">720&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">704&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Increases</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(78)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Ending balance</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">642&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">720&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12A<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SummaryOfValuationAllowanceTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of valuation allowances to reduce deferred tax assets to net realizable value, including identification of the deferred tax asset more likely than not will not be fully realized and the corresponding amount of the valuation allowance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SummaryOfValuationAllowanceTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeaseCostTableTextBlock', window );">Schedule of Lease, Cost</a></td>
<td class="text"><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The components of lease expense for the fiscal years ended June&#160;30, 2025 and 2024, were as follows (in thousands):</span></div><div style="margin-bottom:8pt;margin-top:8pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:62.150%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.908%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.910%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Years ended June 30,</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease expense</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease cost</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,881&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,913&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Variable lease cost</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">154&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">174&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Short-term lease cost</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">47&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total lease expense</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2,046&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2,134&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Supplemental cash flow information related to operating leases was as follows (in thousands):</span></div><div style="margin-bottom:8pt;margin-top:8pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:62.150%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.908%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.910%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2025</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash outflows from operating leases</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2,284&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2,187&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Right-of-use assets obtained in exchange for lease obligations</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2,475&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock', window );">Schedule of Lessee, Operating Lease, Liability, Maturity</a></td>
<td class="text"><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Maturity of lease liabilities at June&#160;30, 2025 are as follows (in thousands):</span></div><div style="margin-bottom:8pt;margin-top:8pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:80.159%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.909%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Year ended June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2,214&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2,195&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2028</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2,073&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2029</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,772&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2030</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,817&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2,805&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">12,876&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Less: imputed interest</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(1,198)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Present value of lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">11,678&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCostTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCostTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Information (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock', window );">Schedule of Segment Reporting Information, by Segment</a></td>
<td class="text"><div style="text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The following table presents the Company&#8217;s segment revenue and expenses and segment net income for the fiscal years ended June 30, 2025 and 2024 (in thousands):</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:62.150%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.908%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.910%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Years ended June&#160;30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Revenue, net</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">228,530&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">200,164&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Cost of sales</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(44,864)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(41,440)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Consultant commissions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(95,920)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(80,900)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Consultant incentives, promotions, and recognition</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(6,340)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(5,020)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Labor and benefits</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(31,216)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(27,202)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Stock compensation</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(5,702)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(3,280)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Events</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(3,791)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(4,321)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(3,156)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(3,581)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Credit card and bank processing fees</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(6,694)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(6,051)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Other segment items</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(19,035)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(24,449)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Interest income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">466&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">451&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(35)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(21)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Income tax expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(2,438)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(1,413)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">9,805&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2,937&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">(1) Other general and administrative expenses include legal, professional services, rent, utilities, and other miscellaneous expenses.</span></div>The following table shows revenue by product line for the fiscal years ended June&#160;30, 2025 and 2024 (in thousands):<div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:62.243%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.788%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.936%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Years ended June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Protandim</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">&#174; </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">product line</span></div></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">95,328&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">104,135&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">LifeVantage</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">&#174; </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">product line</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">56,225&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">15,675&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">TrueScience</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">&#174; </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">product line</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">48,712&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">56,252&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">AXIO</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> product line</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">15,312&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">13,375&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">PhysIQ</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">&#8482;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> product line</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">5,102&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3,827&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Petandim</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> product line</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2,117&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2,398&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Other</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">5,734&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">4,502&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total revenue, net</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">228,530&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">200,164&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">(1) Other revenue includes shipping and handling revenue, event related revenue, and other revenues impracticable to allocate to a specific product line.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock', window );">Schedule of Long-lived Assets by Geographic Areas</a></td>
<td class="text"><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the Company&#8217;s long-lived assets for its most significant geographic markets (in thousands):</span></div><div style="margin-bottom:8pt;margin-top:13pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:62.150%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.908%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.910%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">June&#160;30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">18,446&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">19,216&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Foreign:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Japan</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,901&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,925&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Other foreign markets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">472&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">612&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total foreign markets</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2,373&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2,537&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total long-lived assets</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">20,819&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">21,753&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock', window );">Revenue from External Customers by Geographic Areas</a></td>
<td class="text">The following table presents the Company&#8217;s revenue disaggregated by these markets (in thousands):<div style="margin-bottom:8pt;margin-top:13pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:62.150%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.908%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.910%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Years ended June&#160;30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">178,442&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">145,679&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Foreign:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Japan</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">25,394&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">26,989&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Other foreign markets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">24,694&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">27,496&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total foreign markets</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">50,088&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">54,485&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total revenue, net</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">228,530&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">200,164&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of long-lived assets, excluding financial instruments, long-term customer relationships of a financial institution, mortgage rights, deferred policy acquisition costs, and deferred tax assets, by geographic areas located in the entity's country of domicile and foreign countries in which the entity holds assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-41<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of revenue from external customers by geographic areas attributed to the entity's country of domicile and to foreign countries from which the entity derives revenue.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-41<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 25<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-25<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>The Company (Details) - $ / shares<br></strong></div></th>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Mar. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (dollars per share)</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies - Narrative (Details)<br> shares in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Jun. 30, 2025 </div>
<div>USD ($) </div>
<div>lease </div>
<div>region </div>
<div>shares</div>
</th>
<th class="th">
<div>Jun. 30, 2024 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lfvn_SummaryOfSignificantAccountingPoliciesTextualAbstract', window );"><strong>Summary of Significant Accounting Policies Additional Information [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProvisionForDoubtfulAccounts', window );">Recorded bad debt expense</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryAdjustments', window );">Reduction in inventory</a></td>
<td class="nump">500,000<span></span>
</td>
<td class="nump">1,300,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill', window );">Impairment of intangible assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="nump">$ 1,400,000<span></span>
</td>
<td class="nump">$ 700,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lfvn_NumberOfFinanceLeases', window );">Number of finance leases | lease</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Number of antidilutive securities (in shares) | shares</a></td>
<td class="nump">30<span></span>
</td>
<td class="nump">13<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lfvn_NumberOfGeographicSegments', window );">Number of geographic segments | region</a></td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByTypeAxis=lfvn_CashAccountsHeldPrimarilyAtFinancialInstitutionMember', window );">Cash Accounts Held Primarily At Financial Institution</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lfvn_SummaryOfSignificantAccountingPoliciesTextualAbstract', window );"><strong>Summary of Significant Accounting Policies Additional Information [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskCreditRiskFinancialInstrumentMaximumExposure', window );">Concentration of credit risk</a></td>
<td class="nump">$ 17,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByTypeAxis=lfvn_CashAccountsHeldatOtherFinancialInstitutionsMember', window );">Cash Accounts Held at Other Financial Institutions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lfvn_SummaryOfSignificantAccountingPoliciesTextualAbstract', window );"><strong>Summary of Significant Accounting Policies Additional Information [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskCreditRiskFinancialInstrumentMaximumExposure', window );">Concentration of credit risk</a></td>
<td class="nump">$ 3,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lfvn_NumberOfFinanceLeases">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of Finance Leases</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lfvn_NumberOfFinanceLeases</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lfvn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lfvn_NumberOfGeographicSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of geographic segments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lfvn_NumberOfGeographicSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lfvn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lfvn_SummaryOfSignificantAccountingPoliciesTextualAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Summary of significant accounting policies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lfvn_SummaryOfSignificantAccountingPoliciesTextualAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lfvn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskCreditRiskFinancialInstrumentMaximumExposure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Maximum amount of loss due to credit risk that, based on the gross fair value of the financial instrument, the entity would incur if parties to the financial instruments that make up the concentration failed completely to perform according to the terms of the contracts and the collateral or other security, if any, for the amount due proved to be of no value to the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-21<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskCreditRiskFinancialInstrumentMaximumExposure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of an intangible asset (excluding goodwill) to fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482686/350-30-45-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476148/220-40-50-21<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of inventory reserves for last-in first-out (LIFO) and other inventory valuation methods.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483080/330-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProvisionForDoubtfulAccounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense (reversal of expense) for expected credit loss on accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479319/326-20-50-13<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476148/220-40-50-22<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProvisionForDoubtfulAccounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-18<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-14<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 985<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481283/985-20-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 730<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482916/730-10-50-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 912<br> -SubTopic 730<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479532/912-730-25-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByTypeAxis=lfvn_CashAccountsHeldPrimarilyAtFinancialInstitutionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByTypeAxis=lfvn_CashAccountsHeldPrimarilyAtFinancialInstitutionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByTypeAxis=lfvn_CashAccountsHeldatOtherFinancialInstitutionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByTypeAxis=lfvn_CashAccountsHeldatOtherFinancialInstitutionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies - Inventory (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryNetAbstract', window );"><strong>Components of Inventory</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryFinishedGoods', window );">Finished goods</a></td>
<td class="nump">$ 17,739<span></span>
</td>
<td class="nump">$ 11,841<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryRawMaterials', window );">Raw materials</a></td>
<td class="nump">2,930<span></span>
</td>
<td class="nump">3,214<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Total inventory</a></td>
<td class="nump">$ 20,669<span></span>
</td>
<td class="nump">$ 15,055<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lfvn_InventoryFinishedGoodsPercentOfTotalInventory', window );">Finished goods</a></td>
<td class="nump">85.80%<span></span>
</td>
<td class="nump">78.70%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lfvn_RawMaterialsPercentOfTotalInventory', window );">Raw materials</a></td>
<td class="nump">14.20%<span></span>
</td>
<td class="nump">21.30%<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lfvn_InventoryPercentOfTotalInventory', window );">Total inventory</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lfvn_InventoryFinishedGoodsPercentOfTotalInventory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Inventory, Finished Goods, Percent Of Total Inventory</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lfvn_InventoryFinishedGoodsPercentOfTotalInventory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lfvn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lfvn_InventoryPercentOfTotalInventory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Inventory, Percent Of Total Inventory</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lfvn_InventoryPercentOfTotalInventory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lfvn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lfvn_RawMaterialsPercentOfTotalInventory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Raw Materials, Percent Of Total Inventory</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lfvn_RawMaterialsPercentOfTotalInventory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lfvn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryFinishedGoods">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before valuation and LIFO reserves of completed merchandise or goods expected to be sold within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryFinishedGoods</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryRawMaterials">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before valuation and LIFO reserves of raw materials expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryRawMaterials</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies - Schedule Of Inventory Valuation Reserve (Details) - SEC Schedule, 12-09, Reserve, Inventory - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MovementInValuationAllowancesAndReservesRollForward', window );"><strong>SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesBalance', window );">Beginning balance</a></td>
<td class="nump">$ 1,301<span></span>
</td>
<td class="nump">$ 1,292<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense', window );">Additions</a></td>
<td class="nump">214<span></span>
</td>
<td class="nump">901<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesDeductions', window );">Write-offs</a></td>
<td class="num">(1,049)<span></span>
</td>
<td class="num">(892)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesBalance', window );">Ending balance</a></td>
<td class="nump">$ 466<span></span>
</td>
<td class="nump">$ 1,301<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MovementInValuationAllowancesAndReservesRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MovementInValuationAllowancesAndReservesRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesBalance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of valuation and qualifying accounts and reserves.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-5<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09(Column B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-4<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09(Column E))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowancesAndReservesBalance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in valuation and qualifying accounts and reserves from charge to cost and expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-5<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09(Column C)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesDeductions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in valuation and qualifying accounts and reserves.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-5<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09(Column D))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowancesAndReservesDeductions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesTypeAxis=us-gaap_InventoryValuationReserveMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowancesAndReservesTypeAxis=us-gaap_InventoryValuationReserveMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies - Property and Equipment (Details)<br></strong></div></th>
<th class="th"><div>Jun. 30, 2025</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember', window );">Furniture and fixtures</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Estimated service lives of property and equipment</a></td>
<td class="text">5 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_VehiclesMember', window );">Vehicles</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Estimated service lives of property and equipment</a></td>
<td class="text">5 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum | Equipment (includes computer hardware and software)</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Estimated service lives of property and equipment</a></td>
<td class="text">3 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum | Equipment (includes computer hardware and software)</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Estimated service lives of property and equipment</a></td>
<td class="text">5 years<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-7A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_VehiclesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_VehiclesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_EquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_EquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies - Computation of Net Income Per Share (Details) - USD ($)<br> $ / shares in Units, shares in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract', window );"><strong>Numerator:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">$ 9,805<span></span>
</td>
<td class="nump">$ 2,937<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract', window );"><strong>Denominator:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Basic weighted-average common shares outstanding (in shares)</a></td>
<td class="nump">12,251<span></span>
</td>
<td class="nump">12,458<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DilutiveSecuritiesAbstract', window );"><strong>Effect of dilutive securities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements', window );">Stock awards and options (in shares)</a></td>
<td class="nump">736<span></span>
</td>
<td class="nump">528<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Diluted weighted-average common shares outstanding (in shares)</a></td>
<td class="nump">12,987<span></span>
</td>
<td class="nump">12,986<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Income per share, basic (dollars per share)</a></td>
<td class="nump">$ 0.80<span></span>
</td>
<td class="nump">$ 0.24<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Income per share, diluted (dollars per share)</a></td>
<td class="nump">$ 0.75<span></span>
</td>
<td class="nump">$ 0.23<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DilutiveSecuritiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DilutiveSecuritiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 9<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-9<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 17<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480336/718-10-65-17<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-52<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-15<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-7<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-2<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-10<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-7<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (f)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481538/470-20-65-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 9<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-9<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 17<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480336/718-10-65-17<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-52<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-15<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-7<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-2<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-7<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (f)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481538/470-20-65-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480454/718-10-45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-22<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-23<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-28A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-4<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-21<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-14<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(k)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479857/480-10-S50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479887/480-10-S45-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (24)(d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480244/480-10-S99-3A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 9<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-9<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 17<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480336/718-10-65-17<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 19: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 34: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 38: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 39: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 40: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 41: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 42: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 43: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 44: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 45: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 46: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 47: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 48: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (f)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481538/470-20-65-4<br><br>Reference 49: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 16<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-16<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies - Segment Information (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Revenues from External Customers and Long-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NoncurrentAssets', window );">Long-lived assets</a></td>
<td class="nump">$ 20,819<span></span>
</td>
<td class="nump">$ 21,753<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Revenues from External Customers and Long-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NoncurrentAssets', window );">Long-lived assets</a></td>
<td class="nump">18,446<span></span>
</td>
<td class="nump">19,216<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_JP', window );">Japan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Revenues from External Customers and Long-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NoncurrentAssets', window );">Long-lived assets</a></td>
<td class="nump">$ 1,901<span></span>
</td>
<td class="nump">$ 1,925<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Long-lived assets other than financial instruments, long-term customer relationships of a financial institution, mortgage and other servicing rights, deferred policy acquisition costs, and deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-41<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_JP">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_JP</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue - Narrative (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Jun. 30, 2025 </div>
<div>USD ($) </div>
<div>region </div>
<div>productLine</div>
</th>
<th class="th">
<div>Jun. 30, 2024 </div>
<div>USD ($) </div>
<div>productLine</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lfvn_MoneyBackGuaranteePeriod', window );">Money back guarantee period</a></td>
<td class="text">30 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lfvn_HandlingAndRestockingFeePercentage', window );">Handling and restocking fee, percentage</a></td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lfvn_ReturnLiabilityReserve', window );">Return liability reserve</a></td>
<td class="nump">$ 200<span></span>
</td>
<td class="nump">$ 100<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lfvn_NumberOfGeographicSegments', window );">Number of geographic segments | region</a></td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lfvn_NumberOfProductLines', window );">Number of product lines | productLine</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityCurrent', window );">Deferred revenue</a></td>
<td class="nump">$ 711<span></span>
</td>
<td class="nump">$ 860<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityRevenueRecognized', window );">Increase in revenue from recognition of deferred revenue</a></td>
<td class="nump">$ 200<span></span>
</td>
<td class="num">$ (26)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_ProductConcentrationRiskMember', window );">Product concentration risk | Revenue benchmark | Protandim and TrueScience Product Line</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk</a></td>
<td class="nump">87.60%<span></span>
</td>
<td class="nump">80.10%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lfvn_HandlingAndRestockingFeePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Handling and Restocking Fee, Percentage</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lfvn_HandlingAndRestockingFeePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lfvn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lfvn_MoneyBackGuaranteePeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Money Back Guarantee Period</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lfvn_MoneyBackGuaranteePeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lfvn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lfvn_NumberOfGeographicSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of geographic segments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lfvn_NumberOfGeographicSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lfvn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lfvn_NumberOfProductLines">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number Of Product Lines</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lfvn_NumberOfProductLines</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lfvn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lfvn_ReturnLiabilityReserve">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Return Liability Reserve</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lfvn_ReturnLiabilityReserve</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lfvn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskPercentage1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-42<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 275<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-18<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 275<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-18<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 275<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-20<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 275<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-18<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 275<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-18<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 275<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-18<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskPercentage1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-11<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479837/606-10-45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-8<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479837/606-10-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityRevenueRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized that was previously included in balance of obligation to transfer good or service to customer for which consideration from customer has been received or is due.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityRevenueRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_ProductConcentrationRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByTypeAxis=us-gaap_ProductConcentrationRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=lfvn_ProtandimandTrueScienceProductLineMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=lfvn_ProtandimandTrueScienceProductLineMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue - Sales Return (Details) - Sales Returns and Allowances - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MovementInValuationAllowancesAndReservesRollForward', window );"><strong>SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesBalance', window );">Beginning balance</a></td>
<td class="nump">$ 133<span></span>
</td>
<td class="nump">$ 129<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense', window );">Additions</a></td>
<td class="nump">2,759<span></span>
</td>
<td class="nump">1,622<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesDeductions', window );">Returns</a></td>
<td class="num">(2,655)<span></span>
</td>
<td class="num">(1,618)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesBalance', window );">Ending balance</a></td>
<td class="nump">$ 237<span></span>
</td>
<td class="nump">$ 133<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MovementInValuationAllowancesAndReservesRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MovementInValuationAllowancesAndReservesRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesBalance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of valuation and qualifying accounts and reserves.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-5<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09(Column B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-4<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09(Column E))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowancesAndReservesBalance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in valuation and qualifying accounts and reserves from charge to cost and expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-5<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09(Column C)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesDeductions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in valuation and qualifying accounts and reserves.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-5<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09(Column D))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowancesAndReservesDeductions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesTypeAxis=us-gaap_SalesReturnsAndAllowancesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowancesAndReservesTypeAxis=us-gaap_SalesReturnsAndAllowancesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue - Major Products (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue, net</a></td>
<td class="nump">$ 228,530<span></span>
</td>
<td class="nump">$ 200,164<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=lfvn_ProtandimMember', window );">Protandim&#174; product line</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue, net</a></td>
<td class="nump">95,328<span></span>
</td>
<td class="nump">104,135<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=lfvn_LifeVantageTrueScienceSkinCareRegimenMember', window );">LifeVantage&#174; product line</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue, net</a></td>
<td class="nump">56,225<span></span>
</td>
<td class="nump">15,675<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ProductAndServiceOtherMember', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue, net</a></td>
<td class="nump">$ 5,734<span></span>
</td>
<td class="nump">$ 4,502<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-4<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-14<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-41<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-42<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-7<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 924<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479941/924-10-S99-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-5<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-40<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=lfvn_ProtandimMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=lfvn_ProtandimMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=lfvn_LifeVantageTrueScienceSkinCareRegimenMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=lfvn_LifeVantageTrueScienceSkinCareRegimenMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_ProductAndServiceOtherMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_ProductAndServiceOtherMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property and Equipment, Net (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Accumulated depreciation</a></td>
<td class="num">$ (17,412)<span></span>
</td>
<td class="num">$ (14,510)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Total property and equipment, net</a></td>
<td class="nump">6,207<span></span>
</td>
<td class="nump">7,813<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation expense</a></td>
<td class="nump">3,100<span></span>
</td>
<td class="nump">3,400<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_EquipmentMember', window );">Equipment (includes computer hardware and software)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, gross</a></td>
<td class="nump">16,998<span></span>
</td>
<td class="nump">15,766<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember', window );">Furniture and fixtures</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, gross</a></td>
<td class="nump">1,469<span></span>
</td>
<td class="nump">1,466<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember', window );">Leasehold improvements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, gross</a></td>
<td class="nump">5,101<span></span>
</td>
<td class="nump">5,040<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_VehiclesMember', window );">Vehicles</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, gross</a></td>
<td class="nump">$ 51<span></span>
</td>
<td class="nump">$ 51<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Depreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-18<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-11<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-24<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476148/220-40-50-12<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476148/220-40-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Depreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-7A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-7A<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 360<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478451/942-360-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_EquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_EquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_VehiclesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_VehiclesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Intangible Assets, Net (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems', window );"><strong>Indefinite-lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Total intangible assets, net</a></td>
<td class="nump">$ 245<span></span>
</td>
<td class="nump">$ 323<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization of intangible assets</a></td>
<td class="nump">$ 100<span></span>
</td>
<td class="nump">100<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1', window );">Definite-lived intangible assets weighted-average amortization period</a></td>
<td class="text">0 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract', window );"><strong>Finite-Lived Intangible Assets, Amortization Expense, Maturity Schedule [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths', window );">2024</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo', window );">2025</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksMember', window );">Trademarks</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems', window );"><strong>Indefinite-lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill', window );">Trademarks and other indefinite-lived intangible assets</a></td>
<td class="nump">245<span></span>
</td>
<td class="nump">245<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_PatentsMember', window );">Patents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Patent costs</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">2,330<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated amortization</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(2,252)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Total finite-lived intangible assets, net</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 78<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-18<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-11<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-24<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476148/220-40-50-12<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 40<br> -SubTopic 30<br> -Topic 350<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482640/350-30-55-40<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482686/350-30-45-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476148/220-40-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 40<br> -SubTopic 30<br> -Topic 350<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482640/350-30-55-40<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480265/350-10-S45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 40<br> -SubTopic 30<br> -Topic 350<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482640/350-30-55-40<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 985<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481283/985-20-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 40<br> -SubTopic 30<br> -Topic 350<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482640/350-30-55-40<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 985<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481283/985-20-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 40<br> -SubTopic 30<br> -Topic 350<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482640/350-30-55-40<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480265/350-10-S45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 928<br> -SubTopic 340<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478859/928-340-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 31<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479876/805-20-55-31<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 20<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479876/805-20-55-20<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 20<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479876/805-20-55-20<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 38<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479876/805-20-55-38<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 31<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479876/805-20-55-31<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 38<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479876/805-20-55-38<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 38<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479876/805-20-55-38<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 38<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479876/805-20-55-38<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 38<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479876/805-20-55-38<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 38<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479876/805-20-55-38<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 31<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479876/805-20-55-31<br><br>Reference 12: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 31<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479876/805-20-55-31<br><br>Reference 13: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 31<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479876/805-20-55-31<br><br>Reference 14: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 31<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479876/805-20-55-31<br><br>Reference 15: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 31<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479876/805-20-55-31<br><br>Reference 16: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 31<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479876/805-20-55-31<br><br>Reference 17: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 31<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479876/805-20-55-31<br><br>Reference 18: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479876/805-20-55-31<br><br>Reference 19: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 29<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479876/805-20-55-29<br><br>Reference 20: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 29<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479876/805-20-55-29<br><br>Reference 21: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 20<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479876/805-20-55-20<br><br>Reference 22: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 20<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479876/805-20-55-20<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479876/805-20-55-14<br><br>Reference 24: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479876/805-20-55-14<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479876/805-20-55-14<br><br>Reference 26: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479876/805-20-55-14<br><br>Reference 27: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479876/805-20-55-14<br><br>Reference 28: http://www.xbrl.org/2003/role/exampleRef<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 40<br> -SubTopic 30<br> -Topic 350<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482640/350-30-55-40<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482686/350-30-45-1<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-3<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 985<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481283/985-20-50-2<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 926<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483154/926-20-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 926<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483154/926-20-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Remaining amortization period of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 926<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483154/926-20-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 38<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479876/805-20-55-38<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 31<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479876/805-20-55-31<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479876/805-20-55-31<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479876/805-20-55-14<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479876/805-20-55-14<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479876/805-20-55-14<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 40<br> -SubTopic 30<br> -Topic 350<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482640/350-30-55-40<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482686/350-30-45-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-3<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 40<br> -SubTopic 30<br> -Topic 350<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482640/350-30-55-40<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480265/350-10-S45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482686/350-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_PatentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_PatentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Other Accrued Expenses (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Payables and Accruals [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedBonusesCurrentAndNoncurrent', window );">Accrued incentive compensation</a></td>
<td class="nump">$ 5,325<span></span>
</td>
<td class="nump">$ 1,521<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedEmployeeBenefitsCurrentAndNoncurrent', window );">Accrued severance</a></td>
<td class="nump">5<span></span>
</td>
<td class="nump">90<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TaxesPayableCurrent', window );">Other taxes payable</a></td>
<td class="nump">2,189<span></span>
</td>
<td class="nump">2,258<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lfvn_AccruedPayableToVendors', window );">Accrued payable to vendors</a></td>
<td class="nump">459<span></span>
</td>
<td class="nump">434<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityCurrent', window );">Deferred revenue</a></td>
<td class="nump">711<span></span>
</td>
<td class="nump">860<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedMarketingCostsCurrent', window );">Accrued incentives and promotions to consultants</a></td>
<td class="nump">3,284<span></span>
</td>
<td class="nump">1,454<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAccruedLiabilitiesCurrent', window );">Accrued other expenses</a></td>
<td class="nump">1,540<span></span>
</td>
<td class="nump">1,257<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Total other accrued expenses</a></td>
<td class="nump">$ 13,513<span></span>
</td>
<td class="nump">$ 7,874<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lfvn_AccruedPayableToVendors">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accrued Payable to Vendors</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lfvn_AccruedPayableToVendors</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lfvn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedBonusesCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable for incentive compensation awarded to employees and directors or earned by them based on the terms of one or more relevant arrangements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedBonusesCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedEmployeeBenefitsCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations, excluding pension and other postretirement benefits, incurred through that date and payable for perquisites provided to employees pertaining to services received from them.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedEmployeeBenefitsCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedMarketingCostsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred through that date and payable for the marketing, trade and selling of the entity's goods and services. Marketing costs would include expenditures for planning and executing the conception, pricing, promotion, and distribution of ideas, goods, and services; costs of public relations and corporate promotions; and obligations incurred and payable for sales discounts, rebates, price protection programs, etc. offered to customers and under government programs. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedMarketingCostsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-11<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479837/606-10-45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-8<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479837/606-10-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxesPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable for statutory income, sales, use, payroll, excise, real, property and other taxes. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxesPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Long-Term Debt (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Apr. 01, 2021</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Apr. 12, 2024</div></th>
<th class="th"><div>Mar. 30, 2016</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lfvn_CommonStockDividendsPerShareCashPaidOneTimeDividend', window );">One time dividend (dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.40<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility | Line of Credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage', window );">Debt instrument, effective interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6.45%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=lfvn_March2016RevolvingLoanMember', window );">March 2016 Revolving Loan | Revolving Credit Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Maximum borrowing capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,000,000.0<span></span>
</td>
<td class="nump">$ 2,000,000.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate</a></td>
<td class="nump">2.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lfvn_DebtInstrumentFloorInterestRate', window );">Floor interest rate</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCredit', window );">Long-Term Line of Credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=lfvn_March2016TermLoanMember', window );">March 2016 Term Loan | Secured Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Maximum borrowing capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,000,000.0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lfvn_CommonStockDividendsPerShareCashPaidOneTimeDividend">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Common Stock, Dividends, Per Share, Cash Paid, One Time Dividend</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lfvn_CommonStockDividendsPerShareCashPaidOneTimeDividend</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lfvn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lfvn_DebtInstrumentFloorInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Floor Interest Rate</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lfvn_DebtInstrumentFloorInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lfvn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage points added to the reference rate to compute the variable rate on the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentBasisSpreadOnVariableRate1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Effective interest rate for the funds borrowed under the debt agreement considering interest compounding and original issue discount or premium.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482949/835-30-55-8<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482900/835-30-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateEffectivePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(f))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481544/470-10-50-6<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481544/470-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=lfvn_March2016RevolvingLoanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=lfvn_March2016RevolvingLoanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=lfvn_March2016TermLoanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=lfvn_March2016TermLoanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_SecuredDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_SecuredDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>77
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="8">3 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Mar. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Mar. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Aug. 30, 2023</div></th>
<th class="th"><div>Feb. 17, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation', window );">Shares canceled or surrendered as payment of tax withholding and other (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">200,000<span></span>
</td>
<td class="nump">200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StockRepurchaseProgramAuthorizedAmount1', window );">Repurchase common stock amount authorized (up to)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 60,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodShares', window );">Stock repurchased during period (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">300,000<span></span>
</td>
<td class="nump">1,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForRepurchaseOfCommonStock', window );">Payments for repurchase of common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,147,000<span></span>
</td>
<td class="nump">$ 6,430,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1', window );">Remaining authorized amount of common stock repurchase program</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 17,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DividendsCommonStockCash', window );">Cash dividend, common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,100,000<span></span>
</td>
<td class="nump">$ 6,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockDividendsPerShareCashPaid', window );">Cash dividend, common stock (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.045<span></span>
</td>
<td class="nump">$ 0.04<span></span>
</td>
<td class="nump">$ 0.04<span></span>
</td>
<td class="nump">$ 0.04<span></span>
</td>
<td class="nump">$ 0.04<span></span>
</td>
<td class="nump">$ 0.035<span></span>
</td>
<td class="nump">$ 0.035<span></span>
</td>
<td class="nump">$ 0.035<span></span>
</td>
<td class="nump">$ 0.165<span></span>
</td>
<td class="nump">$ 0.545<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lfvn_CommonStockDividendsPerShareCashPaidOneTimeDividend', window );">One time dividend (dollars per share)</a></td>
<td class="nump">$ 0.40<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight', window );">Number of rights</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price of rights (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lfvn_ClassOfWarrantOrRightPercentOfCommonStockAcquisitionThatMakesRightsExercisable', window );">Percent of common stock acquisition that makes rights exercisable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lfvn_ClassOfWarrantOrRightPercentOfCommonStockAcquisitionThatMakesRightsExercisablePassiveInvestors', window );">Percent of common stock acquisition that makes rights exercisable, passive investors</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lfvn_ClassOfWarrantsOrRightDiscount', window );">Discount percent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=lfvn_EmployeeStockPurchasePlanMember', window );">ESPP</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans', window );">Common stock issued under employee stock purchase plan (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">44,000<span></span>
</td>
<td class="nump">100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember', window );">Restricted Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures', window );">Restricted common stock to employees (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">400,000<span></span>
</td>
<td class="nump">1,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember', window );">Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lfvn_StockIssuedDuringPeriodSharesStockOptionsAndWarrantsExercised', window );">Common stock issued (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures', window );">Restricted common stock to employees (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">376,000<span></span>
</td>
<td class="nump">1,007,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation', window );">Shares canceled or surrendered as payment of tax withholding and other (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">202,000<span></span>
</td>
<td class="nump">206,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans', window );">Common stock issued under employee stock purchase plan (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">44,000<span></span>
</td>
<td class="nump">64,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodShares', window );">Stock repurchased during period (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">299,000<span></span>
</td>
<td class="nump">977,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lfvn_ClassOfWarrantOrRightPercentOfCommonStockAcquisitionThatMakesRightsExercisable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Class of Warrant or Right, Percent Of Common Stock Acquisition That Makes Rights Exercisable</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lfvn_ClassOfWarrantOrRightPercentOfCommonStockAcquisitionThatMakesRightsExercisable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lfvn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lfvn_ClassOfWarrantOrRightPercentOfCommonStockAcquisitionThatMakesRightsExercisablePassiveInvestors">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Class of Warrant or Right, Percent Of Common Stock Acquisition That Makes Rights Exercisable, Passive Investors</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lfvn_ClassOfWarrantOrRightPercentOfCommonStockAcquisitionThatMakesRightsExercisablePassiveInvestors</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lfvn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lfvn_ClassOfWarrantsOrRightDiscount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Class Of Warrants Or Right, Discount</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lfvn_ClassOfWarrantsOrRightDiscount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lfvn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lfvn_CommonStockDividendsPerShareCashPaidOneTimeDividend">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Common Stock, Dividends, Per Share, Cash Paid, One Time Dividend</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lfvn_CommonStockDividendsPerShareCashPaidOneTimeDividend</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lfvn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lfvn_StockIssuedDuringPeriodSharesStockOptionsAndWarrantsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Exercise of options and warrants, shares</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lfvn_StockIssuedDuringPeriodSharesStockOptionsAndWarrantsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lfvn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StockRepurchaseProgramAuthorizedAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount authorized for purchase of share under share repurchase plan. Includes, but is not limited to, repurchase of stock and unit of ownership.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 505<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481520/505-30-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StockRepurchaseProgramAuthorizedAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>srt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-8A<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479857/480-10-S50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 6: http://www.xbrl.org/2003/role/recommendedDisclosureRef<br> -Topic 272<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483014/272-10-45-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 272<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482987/272-10-50-1<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-14<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-18<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of securities into which each warrant or right may be converted. For example, but not limited to, each warrant may be converted into two shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockDividendsPerShareCashPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate dividends paid during the period for each share of common stock outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockDividendsPerShareCashPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsCommonStockCash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of paid and unpaid common stock dividends declared with the form of settlement in cash.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsCommonStockCash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRepurchaseOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to reacquire common stock during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRepurchaseOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares used to settle grantee's tax withholding obligation for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period as a result of an employee stock purchase plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period related to Restricted Stock Awards, net of any shares forfeited.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount remaining authorized for purchase of share under share repurchase plan. Includes, but is not limited to, repurchase of stock and unit of ownership.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedDuringPeriodShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased during the period and have not been retired and are not held in treasury. Some state laws may govern the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478448/946-505-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedDuringPeriodShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=lfvn_EmployeeStockPurchasePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=lfvn_EmployeeStockPurchasePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>78
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-Based Compensation - Equity-Settled Plans, Narrative (Details) - $ / shares<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Nov. 09, 2023</div></th>
<th class="th"><div>Feb. 16, 2017</div></th>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Feb. 02, 2018</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Company's common stock purchased in aggregate (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">72,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">72,000<span></span>
</td>
<td class="nump">72,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=lfvn_TwoThousandAndTenLongTermIncentivePlanMember', window );">2010 Long-Term Incentive Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Maximum common stock issued under Long-Term Incentive Plan (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">475,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=lfvn_TwoThousandSeventeenLongTermIncentivePlanMember', window );">2017 Long-Term Incentive Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized', window );">Number of additional shares authorized</a></td>
<td class="nump">1,138,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">650,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Maximum common stock issued under Long-Term Incentive Plan (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,105,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Exercise price of outstanding stock options (dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4.44<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Company's common stock purchased in aggregate (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=lfvn_TwoThousandSeventeenLongTermIncentivePlanExcludingTwoThousandAndTenLongTermIncentivePlanMember', window );">2017 Long Term Incentive Plan Excluding 2010 Long Term Incentive Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Maximum common stock issued under Long-Term Incentive Plan (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,630,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lfvn_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsOutstandingContractualTerm', window );">Contractual term of stock options granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lfvn_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsOutstandingContractualTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Contractual Term</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lfvn_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsOutstandingContractualTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lfvn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(v)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (l)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 1D<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480483/718-10-35-1D<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480483/718-10-35-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of additional shares authorized for issuance under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares authorized for issuance under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average grant-date fair value of non-vested options outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=lfvn_TwoThousandAndTenLongTermIncentivePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=lfvn_TwoThousandAndTenLongTermIncentivePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=lfvn_TwoThousandSeventeenLongTermIncentivePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=lfvn_TwoThousandSeventeenLongTermIncentivePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=lfvn_TwoThousandSeventeenLongTermIncentivePlanExcludingTwoThousandAndTenLongTermIncentivePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=lfvn_TwoThousandSeventeenLongTermIncentivePlanExcludingTwoThousandAndTenLongTermIncentivePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>79
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-Based Compensation - Employee Stock Purchase Plan, Narrative (Details) - ESPP - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Aug. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Number of shares of common stock subject for purchase</a></td>
<td class="nump">800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">400,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Number of shares available for issuance</a></td>
<td class="nump">400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent', window );">Purchase price of stock fair market value</a></td>
<td class="nump">85.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate', window );">Maximum percentage of employee compensation</a></td>
<td class="nump">15.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee', window );">Maximum number of shares that can be purchased during any offering period</a></td>
<td class="nump">3,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lfvn_ShareBasedCompensationArrangementByShareBasedPaymentAwardAmountInExcessOfFairMarketValueOfStockForOptionNotToBeGranted', window );">Amount in excess of fair market value of stock for option not to be granted</a></td>
<td class="nump">$ 25,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lfvn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOfferingPeriod', window );">Offering period</a></td>
<td class="text">6 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans', window );">Common stock issued under employee stock purchase plan (in shares)</a></td>
<td class="nump">44,000<span></span>
</td>
<td class="nump">100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lfvn_ShareBasedCompensationArrangementByShareBasedPaymentAwardAmountInExcessOfFairMarketValueOfStockForOptionNotToBeGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share-Based Compensation Arrangement By Share-Based Payment Award, Amount In Excess Of Fair Market Value Of Stock For Option Not To Be Granted</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lfvn_ShareBasedCompensationArrangementByShareBasedPaymentAwardAmountInExcessOfFairMarketValueOfStockForOptionNotToBeGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lfvn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lfvn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOfferingPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share-Based Compensation Arrangement By Share-Based Payment Award, Offering Period</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lfvn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOfferingPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lfvn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate number of common shares reserved for future issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockCapitalSharesReservedForFutureIssuance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(v)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (l)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 1D<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480483/718-10-35-1D<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480483/718-10-35-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The highest percentage of annual salary that an employee is permitted to utilize with respect to the plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The highest quantity of shares an employee can purchase under the plan per period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Purchase price of common stock expressed as a percentage of its fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period as a result of an employee stock purchase plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=lfvn_EmployeeStockPurchasePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=lfvn_EmployeeStockPurchasePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>80
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-Based Compensation - Stock-Based Compensation, Narrative (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation</a></td>
<td class="nump">$ 5,702<span></span>
</td>
<td class="nump">$ 3,280<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember', window );">Restricted Stock | 2010 and 2017 Long Term Incentive Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized', window );">Unrecognized compensation cost</a></td>
<td class="nump">$ 3,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Period for recognition of unrecognized compensation cost</a></td>
<td class="text">1 year 5 months 4 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480483/718-10-35-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cost not yet recognized for nonvested award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(v)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (l)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 1D<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480483/718-10-35-1D<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480483/718-10-35-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=lfvn_TwoThousandAndTenAndTwoThousandSeventeenLongTermIncentivePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=lfvn_TwoThousandAndTenAndTwoThousandSeventeenLongTermIncentivePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>81
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-Based Compensation - Stock Options, Narrative (Details) - shares<br></strong></div></th>
<th class="th" colspan="4">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Options granted (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_VestingAxis=us-gaap_ShareBasedCompensationAwardTrancheOneMember', window );">Vesting on January 1, 2019 | Employee Stock Option</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage', window );">Vesting right percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">33.33%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_VestingAxis=us-gaap_ShareBasedCompensationAwardTrancheTwoMember', window );">Vesting on the last day of each fiscal quarter following January 1, 2019 | Employee Stock Option</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage', window );">Vesting right percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8.33%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(v)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (l)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 1D<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480483/718-10-35-1D<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480483/718-10-35-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of vesting of award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VestingAxis=us-gaap_ShareBasedCompensationAwardTrancheOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VestingAxis=us-gaap_ShareBasedCompensationAwardTrancheOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VestingAxis=us-gaap_ShareBasedCompensationAwardTrancheTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VestingAxis=us-gaap_ShareBasedCompensationAwardTrancheTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>82
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-Based Compensation - Stock Options (Details) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward', window );"><strong>Options (in thousands)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Outstanding beginning balance (in shares)</a></td>
<td class="nump">72,000<span></span>
</td>
<td class="nump">72,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Granted (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercised (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod', window );">Forfeited (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod', window );">Expired or Canceled (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Outstanding ending balance (in shares)</a></td>
<td class="nump">72,000<span></span>
</td>
<td class="nump">72,000<span></span>
</td>
<td class="nump">72,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber', window );">Exercisable (in shares)</a></td>
<td class="nump">72,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward', window );"><strong>Weighted Average Exercise&#160;Price</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Outstanding beginning balance (dollars per share)</a></td>
<td class="nump">$ 4.44<span></span>
</td>
<td class="nump">$ 4.44<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Granted (dollars per share)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Exercised (dollars per share)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice', window );">Forfeited (dollars per share)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice', window );">Expired or Canceled (dollars per share)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Outstanding ending balance (dollars per share)</a></td>
<td class="nump">4.44<span></span>
</td>
<td class="nump">$ 4.44<span></span>
</td>
<td class="nump">$ 4.44<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice', window );">Exercisable (dollars per share)</a></td>
<td class="nump">$ 4.44<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lfvn_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermAbstract', window );"><strong>Weighted Average&#160;Remaining Contractual Term (in years)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Outstanding</a></td>
<td class="text">2 years 7 months 2 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1', window );">Exercisable</a></td>
<td class="text">2 years 7 months 2 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract', window );"><strong>Aggregate Intrinsic Value (in thousands)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue', window );">Exercised</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Outstanding</a></td>
<td class="nump">618<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1', window );">Exercisable</a></td>
<td class="nump">$ 618<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lfvn_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term [Abstract]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lfvn_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lfvn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of options or other stock instruments for which the right to exercise has lapsed under the terms of the plan agreements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which option holders acquired shares when converting their stock options into shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees could have acquired the underlying shares with respect to stock options of the plan that expired.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 718<br> -SubTopic 10<br> -Subparagraph (e)(1)<br> -Name Accounting Standards Codification<br> -Paragraph 2<br> -Section 50<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>83
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-Based Compensation - Restricted Shares (Details) - $ / shares<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Nov. 03, 2023</div></th>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember', window );">Restricted Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward', window );"><strong>Shares</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Nonvested beginning period (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">392,000<span></span>
</td>
<td class="nump">117,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">58,000<span></span>
</td>
<td class="nump">392,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Vested (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(294,000)<span></span>
</td>
<td class="num">(117,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod', window );">Forfeited (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Nonvested ending period (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">156,000<span></span>
</td>
<td class="nump">392,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward', window );"><strong>Weighted Average Grant Date Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Nonvested beginning period (dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4.74<span></span>
</td>
<td class="nump">$ 3.85<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Granted (dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13.54<span></span>
</td>
<td class="nump">4.74<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue', window );">Vested (dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.77<span></span>
</td>
<td class="nump">3.85<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue', window );">Forfeited (dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Nonvested ending period (dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7.92<span></span>
</td>
<td class="nump">$ 4.74<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lfvn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInExchange', window );">Granted in exchange (in shares)</a></td>
<td class="nump">125,732<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted Stock Units (RSUs)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward', window );"><strong>Shares</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Nonvested beginning period (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">337,000<span></span>
</td>
<td class="nump">538,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">224,000<span></span>
</td>
<td class="nump">214,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Vested (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(224,000)<span></span>
</td>
<td class="num">(331,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod', window );">Forfeited (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(47,000)<span></span>
</td>
<td class="num">(84,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Nonvested ending period (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">290,000<span></span>
</td>
<td class="nump">337,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward', window );"><strong>Weighted Average Grant Date Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Nonvested beginning period (dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4.86<span></span>
</td>
<td class="nump">$ 4.90<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Granted (dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.08<span></span>
</td>
<td class="nump">4.90<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue', window );">Vested (dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.87<span></span>
</td>
<td class="nump">5.05<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue', window );">Forfeited (dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6.12<span></span>
</td>
<td class="nump">4.48<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Nonvested ending period (dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8.68<span></span>
</td>
<td class="nump">$ 4.86<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lfvn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsCancelledInPeriod', window );">Cancelled in period (in shares)</a></td>
<td class="nump">48,026<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lfvn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsCancelledInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Cancelled In Period</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lfvn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsCancelledInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lfvn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lfvn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInExchange">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Exchange</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lfvn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInExchange</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lfvn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>84
<FILENAME>R58.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-Based Compensation - Restricted Stock, Narrative (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember', window );">Restricted Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue', window );">Fair value of vested awards</a></td>
<td class="nump">$ 4.4<span></span>
</td>
<td class="nump">$ 0.7<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted Stock Units (RSUs)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue', window );">Fair value of vested awards</a></td>
<td class="nump">$ 2.6<span></span>
</td>
<td class="nump">$ 1.9<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of share-based awards for which the grantee gained the right by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(v)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (l)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 1D<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480483/718-10-35-1D<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480483/718-10-35-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>85
<FILENAME>R59.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-Based Compensation - Performance Restricted Stock Units, Narrative (Details) - Performance Restricted Stock Units - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lfvn_SharebasedCompensationArrangementbySharebasedPaymentAwardDistributionPercentage', window );">Distribution percentage of target number of Performance Stock Units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue', window );">Fair value of vested awards</a></td>
<td class="nump">$ 1,100<span></span>
</td>
<td class="nump">$ 1,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=lfvn_PerformanceStockUnitsMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lfvn_SharebasedCompensationArrangementbySharebasedPaymentAwardDistributionPercentage', window );">Distribution percentage of target number of Performance Stock Units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=lfvn_PerformanceStockUnitsMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lfvn_SharebasedCompensationArrangementbySharebasedPaymentAwardDistributionPercentage', window );">Distribution percentage of target number of Performance Stock Units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">200.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lfvn_SharebasedCompensationArrangementbySharebasedPaymentAwardDistributionPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share-based Compensation Arrangement by Share-based Payment Award, Distribution Percentage</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lfvn_SharebasedCompensationArrangementbySharebasedPaymentAwardDistributionPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lfvn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of share-based awards for which the grantee gained the right by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(v)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (l)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 1D<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480483/718-10-35-1D<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480483/718-10-35-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=lfvn_PerformanceStockUnitsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=lfvn_PerformanceStockUnitsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>86
<FILENAME>R60.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-Based Compensation - Performance Restricted Stock Units (Details) - Performance Restricted Stock Units - $ / shares<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Nov. 03, 2023</div></th>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lfvn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsCancelledInPeriod', window );">Cancelled in period (in shares)</a></td>
<td class="nump">77,706<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward', window );"><strong>Shares</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Nonvested beginning period (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">284,000<span></span>
</td>
<td class="nump">492,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">509,000<span></span>
</td>
<td class="nump">350,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Vested (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(94,000)<span></span>
</td>
<td class="num">(284,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod', window );">Forfeited (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(45,000)<span></span>
</td>
<td class="num">(274,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Nonvested ending period (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">654,000<span></span>
</td>
<td class="nump">284,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward', window );"><strong>Weighted Average Grant Date Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Nonvested beginning period (dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4.62<span></span>
</td>
<td class="nump">$ 4.24<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Granted (dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8.30<span></span>
</td>
<td class="nump">4.89<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue', window );">Vested (dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.24<span></span>
</td>
<td class="nump">4.24<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue', window );">Forfeited (dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6.67<span></span>
</td>
<td class="nump">4.68<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Nonvested ending period (dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7.40<span></span>
</td>
<td class="nump">$ 4.62<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lfvn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsCancelledInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Cancelled In Period</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lfvn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsCancelledInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lfvn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(v)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (l)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 1D<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480483/718-10-35-1D<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480483/718-10-35-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=lfvn_PerformanceStockUnitsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=lfvn_PerformanceStockUnitsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>87
<FILENAME>R61.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other Expense, Net (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherIncomeAndExpensesAbstract', window );"><strong>Other Income and Expenses [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax', window );">Foreign currency transaction loss, net</a></td>
<td class="num">$ (380)<span></span>
</td>
<td class="num">$ (429)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lfvn_OtherMiscellaneousIncomeExpensesNet', window );">Other income (expense), net</a></td>
<td class="num">(7)<span></span>
</td>
<td class="nump">17<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Total other expense, net</a></td>
<td class="num">$ (387)<span></span>
</td>
<td class="num">$ (412)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lfvn_OtherMiscellaneousIncomeExpensesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Other Miscellaneous Income (Expenses), Net</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lfvn_OtherMiscellaneousIncomeExpensesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lfvn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of realized and unrealized gain (loss) from foreign currency transaction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482014/830-20-35-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481956/830-20-45-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481926/830-20-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481839/830-10-45-17<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (o)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476148/220-40-50-22<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyTransactionGainLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherIncomeAndExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherIncomeAndExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-4A<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>88
<FILENAME>R62.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Income Tax Expense (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterestAbstract', window );"><strong>Income before income taxes:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic', window );">Domestic</a></td>
<td class="nump">$ 10,397<span></span>
</td>
<td class="nump">$ 2,940<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign', window );">International</a></td>
<td class="nump">1,846<span></span>
</td>
<td class="nump">1,410<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Income before income taxes</a></td>
<td class="nump">12,243<span></span>
</td>
<td class="nump">4,350<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract', window );"><strong>Current taxes:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CurrentFederalTaxExpenseBenefit', window );">Federal</a></td>
<td class="nump">2,925<span></span>
</td>
<td class="nump">1,457<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CurrentStateAndLocalTaxExpenseBenefit', window );">State</a></td>
<td class="nump">708<span></span>
</td>
<td class="nump">246<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CurrentForeignTaxExpenseBenefit', window );">Foreign</a></td>
<td class="nump">491<span></span>
</td>
<td class="nump">984<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CurrentIncomeTaxExpenseBenefit', window );">Total current income tax provision</a></td>
<td class="nump">4,124<span></span>
</td>
<td class="nump">2,687<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract', window );"><strong>Deferred taxes:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredFederalIncomeTaxExpenseBenefit', window );">Federal</a></td>
<td class="num">(1,464)<span></span>
</td>
<td class="num">(1,281)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit', window );">State</a></td>
<td class="num">(341)<span></span>
</td>
<td class="num">(151)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredForeignIncomeTaxExpenseBenefit', window );">Foreign</a></td>
<td class="nump">119<span></span>
</td>
<td class="nump">158<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Total deferred income tax provision</a></td>
<td class="num">(1,686)<span></span>
</td>
<td class="num">(1,274)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Net income tax provision</a></td>
<td class="nump">$ 2,438<span></span>
</td>
<td class="nump">$ 1,413<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentFederalTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current national tax expense (benefit) for non-US (United States of America) jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentFederalTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentForeignTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentForeignTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentStateAndLocalTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current state and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentStateAndLocalTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFederalIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred national tax expense (benefit) for non-US (United States of America) jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFederalIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredForeignIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredForeignIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred state and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of earnings or loss from continuing operations before income taxes that is attributable to domestic operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-10A<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-4<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-21<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-14<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478671/942-235-S50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 14: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-31<br><br>Reference 15: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 16: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterestAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterestAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of earnings or loss from continuing operations before income taxes that is attributable to foreign operations, which is defined as Income or Loss generated from operations located outside the entity's country of domicile.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-10A<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-4<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-21<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-14<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-10<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -SubTopic 20<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482659/740-20-45-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -SubTopic 10<br> -Topic 235<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>89
<FILENAME>R63.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Effective Income Tax Rate (Details)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract', window );"><strong>The effective income tax rate differs from the U.S. Federal statutory income tax rate</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate', window );">Federal statutory income tax rate</a></td>
<td class="nump">21.00%<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes', window );">State income taxes, net of federal benefit</a></td>
<td class="nump">3.40%<span></span>
</td>
<td class="nump">1.20%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential', window );">Foreign tax rate difference</a></td>
<td class="num">(0.40%)<span></span>
</td>
<td class="nump">8.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lfvn_EffectiveIncomeTaxRateReconciliationTaxReturnToProvisionsTrueUp', window );">Tax return to provision true-up</a></td>
<td class="nump">0.40%<span></span>
</td>
<td class="num">(4.30%)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lfvn_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseLimitationOnFutureStockBasedCompensationExpensePercent', window );">Limit on future stock compensation due to 162(m)</a></td>
<td class="nump">4.00%<span></span>
</td>
<td class="nump">2.80%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lfvn_EffectiveIncomeTaxRateReconciliationForeignWithholdingTaxPercent', window );">Foreign withholding tax</a></td>
<td class="nump">0.80%<span></span>
</td>
<td class="nump">2.60%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments', window );">Other differences</a></td>
<td class="nump">0.70%<span></span>
</td>
<td class="nump">1.60%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate', window );">Revalue of deferred for change in federal tax rate</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lfvn_PermanentDifferencesAbstract', window );"><strong>Permanent differences:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost', window );">&#8212; stock-based compensation</a></td>
<td class="num">(6.20%)<span></span>
</td>
<td class="num">(8.30%)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lfvn_EffectiveIncomeTaxRateReconciliationCurrentYearSection162mLimitationPercent', window );">&#8212; current year section 162(m) limitation</a></td>
<td class="nump">0.90%<span></span>
</td>
<td class="nump">7.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationFdiiPercent', window );">&#8212; foreign derived intangible income deduction</a></td>
<td class="num">(1.40%)<span></span>
</td>
<td class="num">(0.70%)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits', window );">&#8212; tax credits</a></td>
<td class="num">(4.80%)<span></span>
</td>
<td class="num">(12.10%)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseMealsAndEntertainment', window );">&#8212; meals and entertainment</a></td>
<td class="nump">0.60%<span></span>
</td>
<td class="nump">1.30%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lfvn_EffectiveIncomeTaxRateReconciliationRemovalOfPermanentReinvestmentAssertion', window );">&#8212; removal of additional permanent reinvestment assertions</a></td>
<td class="nump">0.60%<span></span>
</td>
<td class="nump">1.20%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lfvn_EffectiveIncomeTaxRateReconciliationChangeInUncertainTaxPositions', window );">&#8212; change in uncertain tax positions</a></td>
<td class="num">(0.40%)<span></span>
</td>
<td class="nump">1.20%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationTaxSettlementsForeign', window );">&#8212; accrual for foreign tax audits</a></td>
<td class="nump">0.40%<span></span>
</td>
<td class="nump">7.70%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther', window );">&#8212; other permanent differences</a></td>
<td class="nump">0.70%<span></span>
</td>
<td class="nump">1.80%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance', window );">Change in valuation allowance</a></td>
<td class="num">(0.40%)<span></span>
</td>
<td class="nump">0.50%<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations', window );">Net income tax provision</a></td>
<td class="nump">19.90%<span></span>
</td>
<td class="nump">32.50%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lfvn_EffectiveIncomeTaxRateReconciliationChangeInUncertainTaxPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Effective Income Tax Rate Reconciliation, Change In UncertainTax Positions</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lfvn_EffectiveIncomeTaxRateReconciliationChangeInUncertainTaxPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lfvn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lfvn_EffectiveIncomeTaxRateReconciliationCurrentYearSection162mLimitationPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Effective Income Tax Rate Reconciliation, Current Year Section 162(m) Limitation, Percent</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lfvn_EffectiveIncomeTaxRateReconciliationCurrentYearSection162mLimitationPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lfvn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lfvn_EffectiveIncomeTaxRateReconciliationForeignWithholdingTaxPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Effective Income Tax Rate Reconciliation, Foreign Withholding Tax, Percent</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lfvn_EffectiveIncomeTaxRateReconciliationForeignWithholdingTaxPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lfvn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lfvn_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseLimitationOnFutureStockBasedCompensationExpensePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Effective Income Tax Rate Reconciliation, Nondeductible Expense, Limitation On Future Stock Based Compensation Expense, Percent</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lfvn_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseLimitationOnFutureStockBasedCompensationExpensePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lfvn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lfvn_EffectiveIncomeTaxRateReconciliationRemovalOfPermanentReinvestmentAssertion">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Effective Income Tax Rate Reconciliation, Removal Of Permanent Reinvestment Assertion</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lfvn_EffectiveIncomeTaxRateReconciliationRemovalOfPermanentReinvestmentAssertion</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lfvn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lfvn_EffectiveIncomeTaxRateReconciliationTaxReturnToProvisionsTrueUp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Effective income tax rate reconciliation tax return to provisions true up.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lfvn_EffectiveIncomeTaxRateReconciliationTaxReturnToProvisionsTrueUp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lfvn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lfvn_PermanentDifferencesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Permanent differences.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lfvn_PermanentDifferencesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lfvn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of domestic federal statutory tax rate applicable to pretax income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.1.Q1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the valuation allowance for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12A<br> -Subparagraph (a)(6)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12A<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the income tax rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12A<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12A<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationFdiiPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of reported income tax benefit from difference to income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operations, attributable to foreign-derived intangible income (FDII).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12A<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12A<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationFdiiPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to statutory income tax expense (benefit) outside of the country of domicile.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12A<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12A<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseMealsAndEntertainment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to meals and entertainment expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12A<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12A<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseMealsAndEntertainment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other nondeductible expenses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12A<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12A<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to nondeductible expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12A<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12A<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (b)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to state and local income tax expense (benefit), net of federal tax expense (benefit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12A<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12A<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to tax credits. Including, but not limited to, research credit, foreign tax credit, investment tax credit, and other tax credits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12A<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12A<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12A<br> -Subparagraph (a)(5)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12A<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationTaxSettlementsForeign">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to foreign income tax settlement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (b)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationTaxSettlementsForeign</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>90
<FILENAME>R64.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Income Taxes - Deferred Tax Assets and Liabilities (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComponentsOfDeferredTaxAssetsAbstract', window );"><strong>Deferred tax assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards', window );">Federal, state, and foreign net operating loss carryovers</a></td>
<td class="nump">$ 234<span></span>
</td>
<td class="nump">$ 271<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost', window );">Stock option compensation</a></td>
<td class="nump">628<span></span>
</td>
<td class="nump">360<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment', window );">Section 174 costs</a></td>
<td class="nump">2,798<span></span>
</td>
<td class="nump">2,578<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lfvn_DeferredTaxAssetsLeasingArrangements', window );">Lease liability</a></td>
<td class="nump">2,798<span></span>
</td>
<td class="nump">3,223<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals', window );">Accrued vacation, allowance for returns, bonuses&#160;&amp; other</a></td>
<td class="nump">2,819<span></span>
</td>
<td class="nump">2,119<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsGross', window );">Gross deferred tax asset</a></td>
<td class="nump">9,277<span></span>
</td>
<td class="nump">8,551<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesAbstract', window );"><strong>Deferred tax liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets', window );">Patents and trademarks</a></td>
<td class="num">(16)<span></span>
</td>
<td class="num">(30)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment', window );">Property&#160;&amp; equipment</a></td>
<td class="num">(239)<span></span>
</td>
<td class="num">(798)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesLeasingArrangements', window );">Right of use asset</a></td>
<td class="num">(1,942)<span></span>
</td>
<td class="num">(2,263)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesOther', window );">Other</a></td>
<td class="num">(468)<span></span>
</td>
<td class="num">(472)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilities', window );">Gross deferred tax liabilities</a></td>
<td class="num">(2,665)<span></span>
</td>
<td class="num">(3,563)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Less: valuation allowance</a></td>
<td class="num">(642)<span></span>
</td>
<td class="num">(720)<span></span>
</td>
<td class="num">$ (704)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsLiabilitiesNet', window );">Deferred tax assets, net</a></td>
<td class="nump">$ 5,970<span></span>
</td>
<td class="nump">$ 4,268<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lfvn_DeferredTaxAssetsLeasingArrangements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred Tax Assets, Leasing Arrangements</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lfvn_DeferredTaxAssetsLeasingArrangements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lfvn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComponentsOfDeferredTaxAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComponentsOfDeferredTaxAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary difference from in-process research and development cost acquired in business combination or from joint venture formation or both.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, without jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from share-based compensation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from reserves and accruals.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences from intangible assets other than goodwill.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesLeasingArrangements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences from leasing arrangements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesLeasingArrangements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences from property, plant, and equipment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>91
<FILENAME>R65.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Narrative (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lfvn_UnrecognizedTaxPositionIncreaseResultingFromForeignTaxAudits', window );">Increase resulting from foreign tax audits</a></td>
<td class="nump">$ 400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount', window );">Tax benefit from settlement of stock based awards</a></td>
<td class="nump">800<span></span>
</td>
<td class="nump">$ 200<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember', window );">State and Local Jurisdiction</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Net operating loss carryforwards</a></td>
<td class="nump">4,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_ForeignCountryMember', window );">Foreign Tax Authority</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Net operating loss carryforwards</a></td>
<td class="nump">$ 400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lfvn_UnrecognizedTaxPositionIncreaseResultingFromForeignTaxAudits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Unrecognized Tax Position, Increase Resulting From Foreign Tax Audits</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lfvn_UnrecognizedTaxPositionIncreaseResultingFromForeignTaxAudits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lfvn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to expense for award under share-based payment arrangement. Excludes expense determined to be nondeductible upon grant or after for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 718<br> -SubTopic 740<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479176/718-740-35-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (b)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLossCarryforwardsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLossCarryforwardsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_ForeignCountryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_ForeignCountryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>92
<FILENAME>R66.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Schedule of Unrecognized Tax Benefit (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward', window );"><strong>Unrecognized Tax Benefits [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Unrecognized Tax Benefits, Beginning Balance</a></td>
<td class="nump">$ 389<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions', window );">Gross increases - tax positions in prior year</a></td>
<td class="nump">51<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions', window );">Gross decreases - tax positions in prior year</a></td>
<td class="num">(53)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions', window );">Gross increases - tax positions in current year</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">389<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities', window );">Settlement</a></td>
<td class="num">(381)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromForeignCurrencyTranslation', window );">Currency adjustment</a></td>
<td class="num">(6)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Unrecognized Tax Benefits, Ending Balance</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 389<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of unrecognized tax benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 217<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-217<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-15A<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482525/740-10-45-10B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromForeignCurrencyTranslation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in unrecognized tax benefits resulting from foreign currency translation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-15A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromForeignCurrencyTranslation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in unrecognized tax benefits resulting from tax positions taken in prior period tax returns.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 217<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-217<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-15A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in unrecognized tax benefits resulting from settlements with taxing authorities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 217<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-217<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-15A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in unrecognized tax benefits resulting from tax positions that have been or will be taken in current period tax return.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 217<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-217<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-15A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in unrecognized tax benefits resulting from tax positions taken in prior period tax returns.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 217<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-217<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-15A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>93
<FILENAME>R67.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Deferred Tax Assets, Valuation Allowance Schedule (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MovementInValuationAllowancesAndReservesRollForward', window );"><strong>SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Beginning balance</a></td>
<td class="nump">$ 720<span></span>
</td>
<td class="nump">$ 704<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount', window );">Increases</a></td>
<td class="num">(78)<span></span>
</td>
<td class="nump">16<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Ending balance</a></td>
<td class="nump">$ 642<span></span>
</td>
<td class="nump">$ 720<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MovementInValuationAllowancesAndReservesRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MovementInValuationAllowancesAndReservesRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the valuation allowance for a specified deferred tax asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>94
<FILENAME>R68.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Leases - Narrative (Details)<br></strong></div></th>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1', window );">Weighted average remaining lease term</a></td>
<td class="text">5 years 10 months 28 days<span></span>
</td>
<td class="text">6 years 10 months 24 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent', window );">Weighted average discount rate</a></td>
<td class="nump">3.17%<span></span>
</td>
<td class="nump">3.46%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseTermOfContract', window );">Lease term</a></td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseTermOfContract', window );">Lease term</a></td>
<td class="text">6 years 6 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeLeaseDescriptionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7A<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-7A<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeLeaseDescriptionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseTermOfContract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Term of lessee's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseTermOfContract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average discount rate for operating lease calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>95
<FILENAME>R69.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases - Schedule of Lease Cost (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseCost', window );">Operating lease cost</a></td>
<td class="nump">$ 1,881<span></span>
</td>
<td class="nump">$ 1,913<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_VariableLeaseCost', window );">Variable lease cost</a></td>
<td class="nump">154<span></span>
</td>
<td class="nump">174<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermLeaseCost', window );">Short-term lease cost</a></td>
<td class="nump">11<span></span>
</td>
<td class="nump">47<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeaseCost', window );">Total lease expense</a></td>
<td class="nump">$ 2,046<span></span>
</td>
<td class="nump">$ 2,134<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lease cost recognized by lessee for lease contract.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of short-term lease cost, excluding expense for lease with term of one month or less.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of variable lease cost, excluded from lease liability, recognized when obligation for payment is incurred for finance and operating leases.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>96
<FILENAME>R70.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases - Supplemental Cash Flow Information (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeasePayments', window );">Operating cash outflows from operating leases</a></td>
<td class="nump">$ 2,284<span></span>
</td>
<td class="nump">$ 2,187<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability', window );">Right-of-use assets obtained in exchange for lease obligations</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 2,475<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasePayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-5<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasePayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in right-of-use asset obtained in exchange for operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>97
<FILENAME>R71.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Leases - Maturity of Lease Liabilities (Details)<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Jun. 30, 2025 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths', window );">2026</a></td>
<td class="nump">$ 2,214<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo', window );">2027</a></td>
<td class="nump">2,195<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree', window );">2028</a></td>
<td class="nump">2,073<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour', window );">2029</a></td>
<td class="nump">1,772<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive', window );">2030</a></td>
<td class="nump">1,817<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive', window );">Thereafter</a></td>
<td class="nump">2,805<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue', window );">Total</a></td>
<td class="nump">12,876<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount', window );">Less: imputed interest</a></td>
<td class="num">(1,198)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Present value of lease liabilities</a></td>
<td class="nump">$ 11,678<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-4<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease due after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-4<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-4<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-4<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-4<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-4<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-4<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>98
<FILENAME>R72.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Information - Schedule of Segment Revenue and Expense (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue, net</a></td>
<td class="nump">$ 228,530<span></span>
</td>
<td class="nump">$ 200,164<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Cost of sales</a></td>
<td class="num">(44,864)<span></span>
</td>
<td class="num">(41,440)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock compensation</a></td>
<td class="num">(5,702)<span></span>
</td>
<td class="num">(3,280)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="num">(3,156)<span></span>
</td>
<td class="num">(3,581)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax expense</a></td>
<td class="num">(2,438)<span></span>
</td>
<td class="num">(1,413)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">9,805<span></span>
</td>
<td class="nump">2,937<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=lfvn_ReportableSegmentMember', window );">Reportable Segment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue, net</a></td>
<td class="nump">228,530<span></span>
</td>
<td class="nump">200,164<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Cost of sales</a></td>
<td class="num">(44,864)<span></span>
</td>
<td class="num">(41,440)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lfvn_ConsultantCommissions', window );">Consultant commissions</a></td>
<td class="num">(95,920)<span></span>
</td>
<td class="num">(80,900)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lfvn_ConsultantIncentivesPromotionsAndRecognitionExpense', window );">Consultant incentives, promotions, and recognition</a></td>
<td class="num">(6,340)<span></span>
</td>
<td class="num">(5,020)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LaborAndRelatedExpense', window );">Labor and benefits</a></td>
<td class="num">(31,216)<span></span>
</td>
<td class="num">(27,202)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock compensation</a></td>
<td class="num">(5,702)<span></span>
</td>
<td class="num">(3,280)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lfvn_EventsExpense', window );">Events</a></td>
<td class="num">(3,791)<span></span>
</td>
<td class="num">(4,321)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="num">(3,156)<span></span>
</td>
<td class="num">(3,581)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lfvn_CreditCardAndBankingProcessingFees', window );">Credit card and bank processing fees</a></td>
<td class="num">(6,694)<span></span>
</td>
<td class="num">(6,051)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingOtherItemAmount', window );">Other segment items</a></td>
<td class="num">(19,035)<span></span>
</td>
<td class="num">(24,449)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIncomeInterest', window );">Interest income</a></td>
<td class="nump">466<span></span>
</td>
<td class="nump">451<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpenseNonoperating', window );">Interest expense</a></td>
<td class="num">(35)<span></span>
</td>
<td class="num">(21)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax expense</a></td>
<td class="num">(2,438)<span></span>
</td>
<td class="num">(1,413)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">$ 9,805<span></span>
</td>
<td class="nump">$ 2,937<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lfvn_ConsultantCommissions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Consultant Commissions</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lfvn_ConsultantCommissions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lfvn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lfvn_ConsultantIncentivesPromotionsAndRecognitionExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Consultant Incentives, Promotions And Recognition Expense</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lfvn_ConsultantIncentivesPromotionsAndRecognitionExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lfvn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lfvn_CreditCardAndBankingProcessingFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Credit Card And Banking Processing Fees</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lfvn_CreditCardAndBankingProcessingFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lfvn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lfvn_EventsExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Events Expense</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lfvn_EventsExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lfvn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-4A<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-11<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-4<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(2)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(2)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 924<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479941/924-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476148/220-40-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476148/220-40-50-12<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 49<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-49<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476148/220-40-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-4<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-21<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-14<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-10<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -SubTopic 20<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482659/740-20-45-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -SubTopic 10<br> -Topic 235<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpenseNonoperating">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of interest expense classified as nonoperating.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-4<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-14<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpenseNonoperating</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIncomeInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(7)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIncomeInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LaborAndRelatedExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for salary, wage, profit sharing; incentive and equity-based compensation; and other employee benefit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-21<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(14)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LaborAndRelatedExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-4<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-21<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-14<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(k)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479857/480-10-S50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479887/480-10-S45-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (24)(d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480244/480-10-S99-3A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 9<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-9<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 17<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480336/718-10-65-17<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 19: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 34: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 38: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 39: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 40: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 41: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 42: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 43: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 44: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 45: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 46: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 47: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 48: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (f)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481538/470-20-65-4<br><br>Reference 49: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-4<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-14<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-41<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-42<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-7<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 924<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479941/924-10-S99-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-5<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-40<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingOtherItemAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of other expense (income) and loss (gain) calculated as difference between segment revenue and separately disclosed expense category to arrive at segment profit (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 26C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-26C<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 26B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-26B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingOtherItemAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=lfvn_ReportableSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=lfvn_ReportableSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>99
<FILENAME>R73.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Segment Information - Schedule of Long-Lived Assets (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Revenues from External Customers and Long-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NoncurrentAssets', window );">Long-lived assets</a></td>
<td class="nump">$ 20,819<span></span>
</td>
<td class="nump">$ 21,753<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Revenues from External Customers and Long-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NoncurrentAssets', window );">Long-lived assets</a></td>
<td class="nump">18,446<span></span>
</td>
<td class="nump">19,216<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=us-gaap_NonUsMember', window );">Total foreign markets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Revenues from External Customers and Long-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NoncurrentAssets', window );">Long-lived assets</a></td>
<td class="nump">2,373<span></span>
</td>
<td class="nump">2,537<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_JP', window );">Japan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Revenues from External Customers and Long-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NoncurrentAssets', window );">Long-lived assets</a></td>
<td class="nump">1,901<span></span>
</td>
<td class="nump">1,925<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=lfvn_OtherForeignMember', window );">Other foreign markets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Revenues from External Customers and Long-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NoncurrentAssets', window );">Long-lived assets</a></td>
<td class="nump">$ 472<span></span>
</td>
<td class="nump">$ 612<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Long-lived assets other than financial instruments, long-term customer relationships of a financial institution, mortgage and other servicing rights, deferred policy acquisition costs, and deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-41<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=us-gaap_NonUsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=us-gaap_NonUsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_JP">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_JP</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=lfvn_OtherForeignMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=lfvn_OtherForeignMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>100
<FILENAME>R74.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Information - Narrative (Details)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Jun. 30, 2025 </div>
<div>region </div>
<div>productLine </div>
<div>segment</div>
</th>
<th class="th">
<div>Jun. 30, 2024 </div>
<div>productLine</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lfvn_NumberOfProductLines', window );">Number of product lines | productLine</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lfvn_NumberOfGeographicSegments', window );">Number of geographic segments | region</a></td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfOperatingSegments', window );">Number of operating segments | segment</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=lfvn_ProtandimandTrueScienceProductLineMember', window );">Protandim and TrueScience Product Line | Revenue benchmark | Product concentration risk</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk</a></td>
<td class="nump">87.60%<span></span>
</td>
<td class="nump">80.10%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lfvn_NumberOfGeographicSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of geographic segments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lfvn_NumberOfGeographicSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lfvn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lfvn_NumberOfProductLines">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number Of Product Lines</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lfvn_NumberOfProductLines</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lfvn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskPercentage1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-42<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 275<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-18<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 275<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-18<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 275<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-20<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 275<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-18<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 275<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-18<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 275<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-18<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskPercentage1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfOperatingSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 49<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-49<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-18<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfOperatingSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=lfvn_ProtandimandTrueScienceProductLineMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=lfvn_ProtandimandTrueScienceProductLineMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_ProductConcentrationRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByTypeAxis=us-gaap_ProductConcentrationRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>101
<FILENAME>R75.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Information - Schedule Of Revenue Disaggregation By Market (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue, net</a></td>
<td class="nump">$ 228,530<span></span>
</td>
<td class="nump">$ 200,164<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue, net</a></td>
<td class="nump">178,442<span></span>
</td>
<td class="nump">145,679<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=us-gaap_NonUsMember', window );">Total foreign markets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue, net</a></td>
<td class="nump">50,088<span></span>
</td>
<td class="nump">54,485<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_JP', window );">Japan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue, net</a></td>
<td class="nump">25,394<span></span>
</td>
<td class="nump">26,989<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=lfvn_OtherForeignMember', window );">Other foreign markets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue, net</a></td>
<td class="nump">$ 24,694<span></span>
</td>
<td class="nump">$ 27,496<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-4<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-14<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-41<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-42<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-7<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 924<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479941/924-10-S99-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-5<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-40<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=us-gaap_NonUsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=us-gaap_NonUsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_JP">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_JP</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=lfvn_OtherForeignMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=lfvn_OtherForeignMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>102
<FILENAME>R76.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Information - Schedule of Major Products Lines (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue, net</a></td>
<td class="nump">$ 228,530<span></span>
</td>
<td class="nump">$ 200,164<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=lfvn_ProtandimMember', window );">Protandim&#174; product line</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue, net</a></td>
<td class="nump">95,328<span></span>
</td>
<td class="nump">104,135<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=lfvn_LifeVantageTrueScienceSkinCareRegimenMember', window );">LifeVantage&#174; product line</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue, net</a></td>
<td class="nump">56,225<span></span>
</td>
<td class="nump">15,675<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=lfvn_TrueScienceProductLineMember', window );">TrueScience&#174; product line</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue, net</a></td>
<td class="nump">48,712<span></span>
</td>
<td class="nump">56,252<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=lfvn_AXIOProductLineMember', window );">AXIO&#174; product line</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue, net</a></td>
<td class="nump">15,312<span></span>
</td>
<td class="nump">13,375<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=lfvn_PhysIQProductLineMember', window );">PhysIQ&#8482; product line</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue, net</a></td>
<td class="nump">5,102<span></span>
</td>
<td class="nump">3,827<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=lfvn_PetandimProductLineMember', window );">Petandim&#174; product line</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue, net</a></td>
<td class="nump">2,117<span></span>
</td>
<td class="nump">2,398<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ProductAndServiceOtherMember', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue, net</a></td>
<td class="nump">$ 5,734<span></span>
</td>
<td class="nump">$ 4,502<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-4<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-14<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-41<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-42<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-7<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 924<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479941/924-10-S99-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-5<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-40<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=lfvn_ProtandimMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=lfvn_ProtandimMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=lfvn_LifeVantageTrueScienceSkinCareRegimenMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=lfvn_LifeVantageTrueScienceSkinCareRegimenMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=lfvn_TrueScienceProductLineMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=lfvn_TrueScienceProductLineMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=lfvn_AXIOProductLineMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=lfvn_AXIOProductLineMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=lfvn_PhysIQProductLineMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=lfvn_PhysIQProductLineMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=lfvn_PetandimProductLineMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=lfvn_PetandimProductLineMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_ProductAndServiceOtherMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_ProductAndServiceOtherMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>103
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>104
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>106
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>148</ContextCount>
  <ElementCount>404</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>50</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>8</UnitCount>
  <MyReports>
    <Report instance="lfvn-20250630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0000001 - Document - Cover Page</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.lifevantage.com/role/CoverPage</Role>
      <ShortName>Cover Page</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="lfvn-20250630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>0000002 - Document - Audit Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.lifevantage.com/role/AuditInformation</Role>
      <ShortName>Audit Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="lfvn-20250630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>9952151 - Statement - CONSOLIDATED BALANCE SHEETS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.lifevantage.com/role/CONSOLIDATEDBALANCESHEETS</Role>
      <ShortName>CONSOLIDATED BALANCE SHEETS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="lfvn-20250630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>9952152 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.lifevantage.com/role/CONSOLIDATEDBALANCESHEETSParenthetical</Role>
      <ShortName>CONSOLIDATED BALANCE SHEETS (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="lfvn-20250630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>9952153 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.lifevantage.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOME</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="lfvn-20250630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>9952154 - Statement - CONSOLIDATED STATEMENTS OF STOCKHOLDERS??? EQUITY</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.lifevantage.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF STOCKHOLDERS??? EQUITY</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="lfvn-20250630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>9952155 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.lifevantage.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF CASH FLOWS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="lfvn-20250630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>9952156 - Disclosure - The Company</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.lifevantage.com/role/TheCompany</Role>
      <ShortName>The Company</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="lfvn-20250630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>9952157 - Disclosure - Summary of Significant Accounting Policies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.lifevantage.com/role/SummaryofSignificantAccountingPolicies</Role>
      <ShortName>Summary of Significant Accounting Policies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="lfvn-20250630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>9952158 - Disclosure - Revenue</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.lifevantage.com/role/Revenue</Role>
      <ShortName>Revenue</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="lfvn-20250630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>9952159 - Disclosure - Property and Equipment, Net</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.lifevantage.com/role/PropertyandEquipmentNet</Role>
      <ShortName>Property and Equipment, Net</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="lfvn-20250630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>9952160 - Disclosure - Intangible Assets, Net</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.lifevantage.com/role/IntangibleAssetsNet</Role>
      <ShortName>Intangible Assets, Net</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="lfvn-20250630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>9952161 - Disclosure - Other Accrued Expenses</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.lifevantage.com/role/OtherAccruedExpenses</Role>
      <ShortName>Other Accrued Expenses</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="lfvn-20250630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>9952162 - Disclosure - Long-Term Debt</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.lifevantage.com/role/LongTermDebt</Role>
      <ShortName>Long-Term Debt</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="lfvn-20250630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>9952163 - Disclosure - Stockholders' Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.lifevantage.com/role/StockholdersEquity</Role>
      <ShortName>Stockholders' Equity</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="lfvn-20250630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>9952164 - Disclosure - Share-Based Compensation</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.lifevantage.com/role/ShareBasedCompensation</Role>
      <ShortName>Share-Based Compensation</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="lfvn-20250630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>9952165 - Disclosure - Other Expense, Net</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.lifevantage.com/role/OtherExpenseNet</Role>
      <ShortName>Other Expense, Net</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="lfvn-20250630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>9952166 - Disclosure - Income Taxes</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.lifevantage.com/role/IncomeTaxes</Role>
      <ShortName>Income Taxes</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="lfvn-20250630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>9952167 - Disclosure - Leases</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.lifevantage.com/role/Leases</Role>
      <ShortName>Leases</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="lfvn-20250630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>9952168 - Disclosure - Segment Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.lifevantage.com/role/SegmentInformation</Role>
      <ShortName>Segment Information</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="lfvn-20250630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>9952169 - Disclosure - Commitments and Contingencies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.lifevantage.com/role/CommitmentsandContingencies</Role>
      <ShortName>Commitments and Contingencies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="lfvn-20250630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>9952170 - Disclosure - Subsequent Events</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.lifevantage.com/role/SubsequentEvents</Role>
      <ShortName>Subsequent Events</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>22</Position>
    </Report>
    <Report instance="lfvn-20250630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>995445 - Disclosure - Insider Trading Arrangements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements</Role>
      <ShortName>Insider Trading Arrangements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>23</Position>
    </Report>
    <Report instance="lfvn-20250630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>995447 - Disclosure - Insider Trading Policies and Procedures</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc</Role>
      <ShortName>Insider Trading Policies and Procedures</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>24</Position>
    </Report>
    <Report instance="lfvn-20250630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>995550 - Disclosure - Cybersecurity Risk Management and Strategy Disclosure</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure</Role>
      <ShortName>Cybersecurity Risk Management and Strategy Disclosure</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>25</Position>
    </Report>
    <Report instance="lfvn-20250630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>9955511 - Disclosure - Summary of Significant Accounting Policies (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesPolicies</Role>
      <ShortName>Summary of Significant Accounting Policies (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://www.lifevantage.com/role/SummaryofSignificantAccountingPolicies</ParentRole>
      <Position>26</Position>
    </Report>
    <Report instance="lfvn-20250630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>9955512 - Disclosure - Summary of Significant Accounting Policies (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesTables</Role>
      <ShortName>Summary of Significant Accounting Policies (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.lifevantage.com/role/SummaryofSignificantAccountingPolicies</ParentRole>
      <Position>27</Position>
    </Report>
    <Report instance="lfvn-20250630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>9955513 - Disclosure - Revenue (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.lifevantage.com/role/RevenueTables</Role>
      <ShortName>Revenue (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.lifevantage.com/role/Revenue</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="lfvn-20250630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>9955514 - Disclosure - Property and Equipment, Net (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.lifevantage.com/role/PropertyandEquipmentNetTables</Role>
      <ShortName>Property and Equipment, Net (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.lifevantage.com/role/PropertyandEquipmentNet</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="lfvn-20250630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>9955515 - Disclosure - Intangible Assets, Net (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.lifevantage.com/role/IntangibleAssetsNetTables</Role>
      <ShortName>Intangible Assets, Net (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.lifevantage.com/role/IntangibleAssetsNet</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="lfvn-20250630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>9955516 - Disclosure - Other Accrued Expenses (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.lifevantage.com/role/OtherAccruedExpensesTables</Role>
      <ShortName>Other Accrued Expenses (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.lifevantage.com/role/OtherAccruedExpenses</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="lfvn-20250630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>9955517 - Disclosure - Share-Based Compensation (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.lifevantage.com/role/ShareBasedCompensationTables</Role>
      <ShortName>Share-Based Compensation (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.lifevantage.com/role/ShareBasedCompensation</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="lfvn-20250630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>9955518 - Disclosure - Other Expense, Net (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.lifevantage.com/role/OtherExpenseNetTables</Role>
      <ShortName>Other Expense, Net (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.lifevantage.com/role/OtherExpenseNet</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="lfvn-20250630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>9955519 - Disclosure - Income Taxes (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.lifevantage.com/role/IncomeTaxesTables</Role>
      <ShortName>Income Taxes (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.lifevantage.com/role/IncomeTaxes</ParentRole>
      <Position>34</Position>
    </Report>
    <Report instance="lfvn-20250630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>9955520 - Disclosure - Leases (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.lifevantage.com/role/LeasesTables</Role>
      <ShortName>Leases (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.lifevantage.com/role/Leases</ParentRole>
      <Position>35</Position>
    </Report>
    <Report instance="lfvn-20250630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>9955521 - Disclosure - Segment Information (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.lifevantage.com/role/SegmentInformationTables</Role>
      <ShortName>Segment Information (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.lifevantage.com/role/SegmentInformation</ParentRole>
      <Position>36</Position>
    </Report>
    <Report instance="lfvn-20250630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>9955522 - Disclosure - The Company (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.lifevantage.com/role/TheCompanyDetails</Role>
      <ShortName>The Company (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.lifevantage.com/role/TheCompany</ParentRole>
      <Position>37</Position>
    </Report>
    <Report instance="lfvn-20250630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>9955523 - Disclosure - Summary of Significant Accounting Policies - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails</Role>
      <ShortName>Summary of Significant Accounting Policies - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>38</Position>
    </Report>
    <Report instance="lfvn-20250630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>9955524 - Disclosure - Summary of Significant Accounting Policies - Inventory (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesInventoryDetails</Role>
      <ShortName>Summary of Significant Accounting Policies - Inventory (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>39</Position>
    </Report>
    <Report instance="lfvn-20250630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>9955525 - Disclosure - Summary of Significant Accounting Policies - Schedule Of Inventory Valuation Reserve (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesScheduleOfInventoryValuationReserveDetails</Role>
      <ShortName>Summary of Significant Accounting Policies - Schedule Of Inventory Valuation Reserve (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>40</Position>
    </Report>
    <Report instance="lfvn-20250630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>9955526 - Disclosure - Summary of Significant Accounting Policies - Property and Equipment (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesPropertyandEquipmentDetails</Role>
      <ShortName>Summary of Significant Accounting Policies - Property and Equipment (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>41</Position>
    </Report>
    <Report instance="lfvn-20250630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>9955527 - Disclosure - Summary of Significant Accounting Policies - Computation of Net Income Per Share (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesComputationofNetIncomePerShareDetails</Role>
      <ShortName>Summary of Significant Accounting Policies - Computation of Net Income Per Share (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>42</Position>
    </Report>
    <Report instance="lfvn-20250630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>9955528 - Disclosure - Summary of Significant Accounting Policies - Segment Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesSegmentInformationDetails</Role>
      <ShortName>Summary of Significant Accounting Policies - Segment Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>43</Position>
    </Report>
    <Report instance="lfvn-20250630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>9955529 - Disclosure - Revenue - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.lifevantage.com/role/RevenueNarrativeDetails</Role>
      <ShortName>Revenue - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>44</Position>
    </Report>
    <Report instance="lfvn-20250630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>9955530 - Disclosure - Revenue - Sales Return (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.lifevantage.com/role/RevenueSalesReturnDetails</Role>
      <ShortName>Revenue - Sales Return (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>45</Position>
    </Report>
    <Report instance="lfvn-20250630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>9955531 - Disclosure - Revenue - Major Products (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.lifevantage.com/role/RevenueMajorProductsDetails</Role>
      <ShortName>Revenue - Major Products (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>46</Position>
    </Report>
    <Report instance="lfvn-20250630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>9955532 - Disclosure - Property and Equipment, Net (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.lifevantage.com/role/PropertyandEquipmentNetDetails</Role>
      <ShortName>Property and Equipment, Net (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.lifevantage.com/role/PropertyandEquipmentNetTables</ParentRole>
      <Position>47</Position>
    </Report>
    <Report instance="lfvn-20250630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>9955533 - Disclosure - Intangible Assets, Net (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.lifevantage.com/role/IntangibleAssetsNetDetails</Role>
      <ShortName>Intangible Assets, Net (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.lifevantage.com/role/IntangibleAssetsNetTables</ParentRole>
      <Position>48</Position>
    </Report>
    <Report instance="lfvn-20250630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>9955534 - Disclosure - Other Accrued Expenses (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.lifevantage.com/role/OtherAccruedExpensesDetails</Role>
      <ShortName>Other Accrued Expenses (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.lifevantage.com/role/OtherAccruedExpensesTables</ParentRole>
      <Position>49</Position>
    </Report>
    <Report instance="lfvn-20250630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>9955535 - Disclosure - Long-Term Debt (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.lifevantage.com/role/LongTermDebtDetails</Role>
      <ShortName>Long-Term Debt (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.lifevantage.com/role/LongTermDebt</ParentRole>
      <Position>50</Position>
    </Report>
    <Report instance="lfvn-20250630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>9955536 - Disclosure - Stockholders' Equity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.lifevantage.com/role/StockholdersEquityDetails</Role>
      <ShortName>Stockholders' Equity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.lifevantage.com/role/StockholdersEquity</ParentRole>
      <Position>51</Position>
    </Report>
    <Report instance="lfvn-20250630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>9955537 - Disclosure - Share-Based Compensation - Equity-Settled Plans, Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.lifevantage.com/role/ShareBasedCompensationEquitySettledPlansNarrativeDetails</Role>
      <ShortName>Share-Based Compensation - Equity-Settled Plans, Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>52</Position>
    </Report>
    <Report instance="lfvn-20250630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>9955538 - Disclosure - Share-Based Compensation - Employee Stock Purchase Plan, Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.lifevantage.com/role/ShareBasedCompensationEmployeeStockPurchasePlanNarrativeDetails</Role>
      <ShortName>Share-Based Compensation - Employee Stock Purchase Plan, Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>53</Position>
    </Report>
    <Report instance="lfvn-20250630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>9955539 - Disclosure - Share-Based Compensation - Stock-Based Compensation, Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.lifevantage.com/role/ShareBasedCompensationStockBasedCompensationNarrativeDetails</Role>
      <ShortName>Share-Based Compensation - Stock-Based Compensation, Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>54</Position>
    </Report>
    <Report instance="lfvn-20250630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>9955540 - Disclosure - Share-Based Compensation - Stock Options, Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.lifevantage.com/role/ShareBasedCompensationStockOptionsNarrativeDetails</Role>
      <ShortName>Share-Based Compensation - Stock Options, Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>55</Position>
    </Report>
    <Report instance="lfvn-20250630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>9955541 - Disclosure - Share-Based Compensation - Stock Options (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.lifevantage.com/role/ShareBasedCompensationStockOptionsDetails</Role>
      <ShortName>Share-Based Compensation - Stock Options (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>56</Position>
    </Report>
    <Report instance="lfvn-20250630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>9955542 - Disclosure - Share-Based Compensation - Restricted Shares (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.lifevantage.com/role/ShareBasedCompensationRestrictedSharesDetails</Role>
      <ShortName>Share-Based Compensation - Restricted Shares (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>57</Position>
    </Report>
    <Report instance="lfvn-20250630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R58.htm</HtmlFileName>
      <LongName>9955543 - Disclosure - Share-Based Compensation - Restricted Stock, Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.lifevantage.com/role/ShareBasedCompensationRestrictedStockNarrativeDetails</Role>
      <ShortName>Share-Based Compensation - Restricted Stock, Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>58</Position>
    </Report>
    <Report instance="lfvn-20250630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R59.htm</HtmlFileName>
      <LongName>9955544 - Disclosure - Share-Based Compensation - Performance Restricted Stock Units, Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.lifevantage.com/role/ShareBasedCompensationPerformanceRestrictedStockUnitsNarrativeDetails</Role>
      <ShortName>Share-Based Compensation - Performance Restricted Stock Units, Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>59</Position>
    </Report>
    <Report instance="lfvn-20250630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R60.htm</HtmlFileName>
      <LongName>9955545 - Disclosure - Share-Based Compensation - Performance Restricted Stock Units (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.lifevantage.com/role/ShareBasedCompensationPerformanceRestrictedStockUnitsDetails</Role>
      <ShortName>Share-Based Compensation - Performance Restricted Stock Units (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>60</Position>
    </Report>
    <Report instance="lfvn-20250630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R61.htm</HtmlFileName>
      <LongName>9955546 - Disclosure - Other Expense, Net (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.lifevantage.com/role/OtherExpenseNetDetails</Role>
      <ShortName>Other Expense, Net (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.lifevantage.com/role/OtherExpenseNetTables</ParentRole>
      <Position>61</Position>
    </Report>
    <Report instance="lfvn-20250630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R62.htm</HtmlFileName>
      <LongName>9955547 - Disclosure - Income Taxes - Income Tax Expense (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.lifevantage.com/role/IncomeTaxesIncomeTaxExpenseDetails</Role>
      <ShortName>Income Taxes - Income Tax Expense (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>62</Position>
    </Report>
    <Report instance="lfvn-20250630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R63.htm</HtmlFileName>
      <LongName>9955548 - Disclosure - Income Taxes - Effective Income Tax Rate (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.lifevantage.com/role/IncomeTaxesEffectiveIncomeTaxRateDetails</Role>
      <ShortName>Income Taxes - Effective Income Tax Rate (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>63</Position>
    </Report>
    <Report instance="lfvn-20250630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R64.htm</HtmlFileName>
      <LongName>9955549 - Disclosure - Income Taxes - Deferred Tax Assets and Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.lifevantage.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails</Role>
      <ShortName>Income Taxes - Deferred Tax Assets and Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>64</Position>
    </Report>
    <Report instance="lfvn-20250630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R65.htm</HtmlFileName>
      <LongName>9955550 - Disclosure - Income Taxes - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.lifevantage.com/role/IncomeTaxesNarrativeDetails</Role>
      <ShortName>Income Taxes - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>65</Position>
    </Report>
    <Report instance="lfvn-20250630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R66.htm</HtmlFileName>
      <LongName>9955551 - Disclosure - Income Taxes - Schedule of Unrecognized Tax Benefit (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.lifevantage.com/role/IncomeTaxesScheduleofUnrecognizedTaxBenefitDetails</Role>
      <ShortName>Income Taxes - Schedule of Unrecognized Tax Benefit (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>66</Position>
    </Report>
    <Report instance="lfvn-20250630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R67.htm</HtmlFileName>
      <LongName>9955552 - Disclosure - Income Taxes - Deferred Tax Assets, Valuation Allowance Schedule (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.lifevantage.com/role/IncomeTaxesDeferredTaxAssetsValuationAllowanceScheduleDetails</Role>
      <ShortName>Income Taxes - Deferred Tax Assets, Valuation Allowance Schedule (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>67</Position>
    </Report>
    <Report instance="lfvn-20250630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R68.htm</HtmlFileName>
      <LongName>9955553 - Disclosure - Leases - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.lifevantage.com/role/LeasesNarrativeDetails</Role>
      <ShortName>Leases - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>68</Position>
    </Report>
    <Report instance="lfvn-20250630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R69.htm</HtmlFileName>
      <LongName>9955554 - Disclosure - Leases - Schedule of Lease Cost (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.lifevantage.com/role/LeasesScheduleofLeaseCostDetails</Role>
      <ShortName>Leases - Schedule of Lease Cost (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>69</Position>
    </Report>
    <Report instance="lfvn-20250630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R70.htm</HtmlFileName>
      <LongName>9955555 - Disclosure - Leases - Supplemental Cash Flow Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.lifevantage.com/role/LeasesSupplementalCashFlowInformationDetails</Role>
      <ShortName>Leases - Supplemental Cash Flow Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>70</Position>
    </Report>
    <Report instance="lfvn-20250630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R71.htm</HtmlFileName>
      <LongName>9955556 - Disclosure - Leases - Maturity of Lease Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.lifevantage.com/role/LeasesMaturityofLeaseLiabilitiesDetails</Role>
      <ShortName>Leases - Maturity of Lease Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>71</Position>
    </Report>
    <Report instance="lfvn-20250630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R72.htm</HtmlFileName>
      <LongName>9955557 - Disclosure - Segment Information - Schedule of Segment Revenue and Expense (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.lifevantage.com/role/SegmentInformationScheduleofSegmentRevenueandExpenseDetails</Role>
      <ShortName>Segment Information - Schedule of Segment Revenue and Expense (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>72</Position>
    </Report>
    <Report instance="lfvn-20250630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R73.htm</HtmlFileName>
      <LongName>9955558 - Disclosure - Segment Information - Schedule of Long-Lived Assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.lifevantage.com/role/SegmentInformationScheduleofLongLivedAssetsDetails</Role>
      <ShortName>Segment Information - Schedule of Long-Lived Assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>73</Position>
    </Report>
    <Report instance="lfvn-20250630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R74.htm</HtmlFileName>
      <LongName>9955559 - Disclosure - Segment Information - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.lifevantage.com/role/SegmentInformationNarrativeDetails</Role>
      <ShortName>Segment Information - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>74</Position>
    </Report>
    <Report instance="lfvn-20250630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R75.htm</HtmlFileName>
      <LongName>9955560 - Disclosure - Segment Information - Schedule Of Revenue Disaggregation By Market (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.lifevantage.com/role/SegmentInformationScheduleOfRevenueDisaggregationByMarketDetails</Role>
      <ShortName>Segment Information - Schedule Of Revenue Disaggregation By Market (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>75</Position>
    </Report>
    <Report instance="lfvn-20250630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R76.htm</HtmlFileName>
      <LongName>9955561 - Disclosure - Segment Information - Schedule of Major Products Lines (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.lifevantage.com/role/SegmentInformationScheduleofMajorProductsLinesDetails</Role>
      <ShortName>Segment Information - Schedule of Major Products Lines (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>76</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="10-K" isDefinitelyFs="true" isUsgaap="true" original="lfvn-20250630.htm">lfvn-20250630.htm</File>
    <File>lfvn-20250630.xsd</File>
    <File>lfvn-20250630_cal.xml</File>
    <File>lfvn-20250630_def.xml</File>
    <File>lfvn-20250630_lab.xml</File>
    <File>lfvn-20250630_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="1">http://fasb.org/srt/2025</BaseTaxonomy>
    <BaseTaxonomy items="722">http://fasb.org/us-gaap/2025</BaseTaxonomy>
    <BaseTaxonomy items="15">http://xbrl.sec.gov/cyd/2025</BaseTaxonomy>
    <BaseTaxonomy items="39">http://xbrl.sec.gov/dei/2025</BaseTaxonomy>
    <BaseTaxonomy items="11">http://xbrl.sec.gov/ecd/2025</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>109
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "lfvn-20250630.htm": {
   "nsprefix": "lfvn",
   "nsuri": "http://www.lifevantage.com/20250630",
   "dts": {
    "inline": {
     "local": [
      "lfvn-20250630.htm"
     ]
    },
    "schema": {
     "local": [
      "lfvn-20250630.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2024-01-31/types.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-roles-2025.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-types-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-roles-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-types-2025.xsd",
      "https://xbrl.sec.gov/country/2025/country-2025.xsd",
      "https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd",
      "https://xbrl.sec.gov/cyd/2025/cyd-af-2025.xsd",
      "https://xbrl.sec.gov/cyd/2025/cyd-af-sub-2025.xsd",
      "https://xbrl.sec.gov/dei/2025/dei-2025.xsd",
      "https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd",
      "https://xbrl.sec.gov/stpr/2025/stpr-2025.xsd"
     ]
    },
    "calculationLink": {
     "local": [
      "lfvn-20250630_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "lfvn-20250630_def.xml"
     ]
    },
    "labelLink": {
     "local": [
      "lfvn-20250630_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "lfvn-20250630_pre.xml"
     ]
    }
   },
   "keyStandard": 367,
   "keyCustom": 37,
   "axisStandard": 19,
   "axisCustom": 0,
   "memberStandard": 30,
   "memberCustom": 20,
   "hidden": {
    "total": 11,
    "http://fasb.org/us-gaap/2025": 7,
    "http://xbrl.sec.gov/dei/2025": 4
   },
   "contextCount": 148,
   "entityCount": 1,
   "segmentCount": 50,
   "elementCount": 681,
   "unitCount": 8,
   "baseTaxonomies": {
    "http://fasb.org/us-gaap/2025": 722,
    "http://xbrl.sec.gov/dei/2025": 39,
    "http://xbrl.sec.gov/cyd/2025": 15,
    "http://xbrl.sec.gov/ecd/2025": 11,
    "http://fasb.org/srt/2025": 1
   },
   "report": {
    "R1": {
     "role": "http://www.lifevantage.com/role/CoverPage",
     "longName": "0000001 - Document - Cover Page",
     "shortName": "Cover Page",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "lfvn-20250630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "lfvn-20250630.htm",
      "first": true,
      "unique": true
     }
    },
    "R2": {
     "role": "http://www.lifevantage.com/role/AuditInformation",
     "longName": "0000002 - Document - Audit Information",
     "shortName": "Audit Information",
     "isDefault": "false",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "2",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "dei:AuditorName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "lfvn-20250630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "dei:AuditorName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "lfvn-20250630.htm",
      "first": true,
      "unique": true
     }
    },
    "R3": {
     "role": "http://www.lifevantage.com/role/CONSOLIDATEDBALANCESHEETS",
     "longName": "9952151 - Statement - CONSOLIDATED BALANCE SHEETS",
     "shortName": "CONSOLIDATED BALANCE SHEETS",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "3",
     "firstAnchor": {
      "contextRef": "c-6",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "lfvn-20250630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-6",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "lfvn-20250630.htm",
      "first": true,
      "unique": true
     }
    },
    "R4": {
     "role": "http://www.lifevantage.com/role/CONSOLIDATEDBALANCESHEETSParenthetical",
     "longName": "9952152 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)",
     "shortName": "CONSOLIDATED BALANCE SHEETS (Parenthetical)",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "parenthetical",
     "menuCat": "Statements",
     "order": "4",
     "firstAnchor": {
      "contextRef": "c-6",
      "name": "us-gaap:PreferredStockParOrStatedValuePerShare",
      "unitRef": "usdPerShare",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "us-gaap:PreferredStockParOrStatedValuePerShare",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "lfvn-20250630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-6",
      "name": "us-gaap:PreferredStockParOrStatedValuePerShare",
      "unitRef": "usdPerShare",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "us-gaap:PreferredStockParOrStatedValuePerShare",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "lfvn-20250630.htm",
      "first": true,
      "unique": true
     }
    },
    "R5": {
     "role": "http://www.lifevantage.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOME",
     "longName": "9952153 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME",
     "shortName": "CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "5",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "lfvn-20250630.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:GrossProfit",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "lfvn-20250630.htm",
      "unique": true
     }
    },
    "R6": {
     "role": "http://www.lifevantage.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY",
     "longName": "9952154 - Statement - CONSOLIDATED STATEMENTS OF STOCKHOLDERS\u2019 EQUITY",
     "shortName": "CONSOLIDATED STATEMENTS OF STOCKHOLDERS\u2019 EQUITY",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "6",
     "firstAnchor": {
      "contextRef": "c-9",
      "name": "us-gaap:CommonStockSharesOutstanding",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "lfvn-20250630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-9",
      "name": "us-gaap:CommonStockSharesOutstanding",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "lfvn-20250630.htm",
      "first": true,
      "unique": true
     }
    },
    "R7": {
     "role": "http://www.lifevantage.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
     "longName": "9952155 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS",
     "shortName": "CONSOLIDATED STATEMENTS OF CASH FLOWS",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "7",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:NetIncomeLoss",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "lfvn-20250630.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "lfvn-20250630.htm",
      "unique": true
     }
    },
    "R8": {
     "role": "http://www.lifevantage.com/role/TheCompany",
     "longName": "9952156 - Disclosure - The Company",
     "shortName": "The Company",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "8",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "lfvn-20250630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "lfvn-20250630.htm",
      "first": true,
      "unique": true
     }
    },
    "R9": {
     "role": "http://www.lifevantage.com/role/SummaryofSignificantAccountingPolicies",
     "longName": "9952157 - Disclosure - Summary of Significant Accounting Policies",
     "shortName": "Summary of Significant Accounting Policies",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "9",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "lfvn-20250630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "lfvn-20250630.htm",
      "first": true,
      "unique": true
     }
    },
    "R10": {
     "role": "http://www.lifevantage.com/role/Revenue",
     "longName": "9952158 - Disclosure - Revenue",
     "shortName": "Revenue",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "10",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:RevenueFromContractWithCustomerTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "lfvn-20250630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:RevenueFromContractWithCustomerTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "lfvn-20250630.htm",
      "first": true,
      "unique": true
     }
    },
    "R11": {
     "role": "http://www.lifevantage.com/role/PropertyandEquipmentNet",
     "longName": "9952159 - Disclosure - Property and Equipment, Net",
     "shortName": "Property and Equipment, Net",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "11",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "lfvn-20250630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "lfvn-20250630.htm",
      "first": true,
      "unique": true
     }
    },
    "R12": {
     "role": "http://www.lifevantage.com/role/IntangibleAssetsNet",
     "longName": "9952160 - Disclosure - Intangible Assets, Net",
     "shortName": "Intangible Assets, Net",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "12",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:IntangibleAssetsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "lfvn-20250630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:IntangibleAssetsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "lfvn-20250630.htm",
      "first": true,
      "unique": true
     }
    },
    "R13": {
     "role": "http://www.lifevantage.com/role/OtherAccruedExpenses",
     "longName": "9952161 - Disclosure - Other Accrued Expenses",
     "shortName": "Other Accrued Expenses",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "13",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "lfvn-20250630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "lfvn-20250630.htm",
      "first": true,
      "unique": true
     }
    },
    "R14": {
     "role": "http://www.lifevantage.com/role/LongTermDebt",
     "longName": "9952162 - Disclosure - Long-Term Debt",
     "shortName": "Long-Term Debt",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "14",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "lfvn-20250630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "lfvn-20250630.htm",
      "first": true,
      "unique": true
     }
    },
    "R15": {
     "role": "http://www.lifevantage.com/role/StockholdersEquity",
     "longName": "9952163 - Disclosure - Stockholders' Equity",
     "shortName": "Stockholders' Equity",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "15",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "lfvn-20250630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "lfvn-20250630.htm",
      "first": true,
      "unique": true
     }
    },
    "R16": {
     "role": "http://www.lifevantage.com/role/ShareBasedCompensation",
     "longName": "9952164 - Disclosure - Share-Based Compensation",
     "shortName": "Share-Based Compensation",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "16",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "lfvn-20250630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "lfvn-20250630.htm",
      "first": true,
      "unique": true
     }
    },
    "R17": {
     "role": "http://www.lifevantage.com/role/OtherExpenseNet",
     "longName": "9952165 - Disclosure - Other Expense, Net",
     "shortName": "Other Expense, Net",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "17",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:OtherIncomeAndOtherExpenseDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "lfvn-20250630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:OtherIncomeAndOtherExpenseDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "lfvn-20250630.htm",
      "first": true,
      "unique": true
     }
    },
    "R18": {
     "role": "http://www.lifevantage.com/role/IncomeTaxes",
     "longName": "9952166 - Disclosure - Income Taxes",
     "shortName": "Income Taxes",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "18",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "lfvn-20250630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "lfvn-20250630.htm",
      "first": true,
      "unique": true
     }
    },
    "R19": {
     "role": "http://www.lifevantage.com/role/Leases",
     "longName": "9952167 - Disclosure - Leases",
     "shortName": "Leases",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "19",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "lfvn-20250630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "lfvn-20250630.htm",
      "first": true,
      "unique": true
     }
    },
    "R20": {
     "role": "http://www.lifevantage.com/role/SegmentInformation",
     "longName": "9952168 - Disclosure - Segment Information",
     "shortName": "Segment Information",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "20",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "lfvn-20250630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "lfvn-20250630.htm",
      "first": true,
      "unique": true
     }
    },
    "R21": {
     "role": "http://www.lifevantage.com/role/CommitmentsandContingencies",
     "longName": "9952169 - Disclosure - Commitments and Contingencies",
     "shortName": "Commitments and Contingencies",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "21",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "lfvn-20250630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "lfvn-20250630.htm",
      "first": true,
      "unique": true
     }
    },
    "R22": {
     "role": "http://www.lifevantage.com/role/SubsequentEvents",
     "longName": "9952170 - Disclosure - Subsequent Events",
     "shortName": "Subsequent Events",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "22",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "lfvn-20250630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "lfvn-20250630.htm",
      "first": true,
      "unique": true
     }
    },
    "R23": {
     "role": "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements",
     "longName": "995445 - Disclosure - Insider Trading Arrangements",
     "shortName": "Insider Trading Arrangements",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "23",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "ecd:NonRule10b51ArrAdoptedFlag",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "lfvn-20250630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "ecd:NonRule10b51ArrAdoptedFlag",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "lfvn-20250630.htm",
      "first": true,
      "unique": true
     }
    },
    "R24": {
     "role": "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc",
     "longName": "995447 - Disclosure - Insider Trading Policies and Procedures",
     "shortName": "Insider Trading Policies and Procedures",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "24",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "ecd:InsiderTrdPoliciesProcAdoptedFlag",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "a",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "lfvn-20250630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "ecd:InsiderTrdPoliciesProcAdoptedFlag",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "a",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "lfvn-20250630.htm",
      "first": true,
      "unique": true
     }
    },
    "R25": {
     "role": "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure",
     "longName": "995550 - Disclosure - Cybersecurity Risk Management and Strategy Disclosure",
     "shortName": "Cybersecurity Risk Management and Strategy Disclosure",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "25",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "cyd:CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "lfvn-20250630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "cyd:CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "lfvn-20250630.htm",
      "first": true,
      "unique": true
     }
    },
    "R26": {
     "role": "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesPolicies",
     "longName": "9955511 - Disclosure - Summary of Significant Accounting Policies (Policies)",
     "shortName": "Summary of Significant Accounting Policies (Policies)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "policies",
     "menuCat": "Policies",
     "order": "26",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ConsolidationPolicyTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "lfvn-20250630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ConsolidationPolicyTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "lfvn-20250630.htm",
      "first": true,
      "unique": true
     }
    },
    "R27": {
     "role": "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesTables",
     "longName": "9955512 - Disclosure - Summary of Significant Accounting Policies (Tables)",
     "shortName": "Summary of Significant Accounting Policies (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "27",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "lfvn-20250630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "lfvn-20250630.htm",
      "first": true,
      "unique": true
     }
    },
    "R28": {
     "role": "http://www.lifevantage.com/role/RevenueTables",
     "longName": "9955513 - Disclosure - Revenue (Tables)",
     "shortName": "Revenue (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "28",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:DisaggregationOfRevenueTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "lfvn-20250630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:DisaggregationOfRevenueTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "lfvn-20250630.htm",
      "first": true,
      "unique": true
     }
    },
    "R29": {
     "role": "http://www.lifevantage.com/role/PropertyandEquipmentNetTables",
     "longName": "9955514 - Disclosure - Property and Equipment, Net (Tables)",
     "shortName": "Property and Equipment, Net (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "29",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "lfvn-20250630.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R30": {
     "role": "http://www.lifevantage.com/role/IntangibleAssetsNetTables",
     "longName": "9955515 - Disclosure - Intangible Assets, Net (Tables)",
     "shortName": "Intangible Assets, Net (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "30",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "lfvn-20250630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "lfvn-20250630.htm",
      "first": true,
      "unique": true
     }
    },
    "R31": {
     "role": "http://www.lifevantage.com/role/OtherAccruedExpensesTables",
     "longName": "9955516 - Disclosure - Other Accrued Expenses (Tables)",
     "shortName": "Other Accrued Expenses (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "31",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "lfvn-20250630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "lfvn-20250630.htm",
      "first": true,
      "unique": true
     }
    },
    "R32": {
     "role": "http://www.lifevantage.com/role/ShareBasedCompensationTables",
     "longName": "9955517 - Disclosure - Share-Based Compensation (Tables)",
     "shortName": "Share-Based Compensation (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "32",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "lfvn-20250630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "lfvn-20250630.htm",
      "first": true,
      "unique": true
     }
    },
    "R33": {
     "role": "http://www.lifevantage.com/role/OtherExpenseNetTables",
     "longName": "9955518 - Disclosure - Other Expense, Net (Tables)",
     "shortName": "Other Expense, Net (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "33",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "lfvn-20250630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "lfvn-20250630.htm",
      "first": true,
      "unique": true
     }
    },
    "R34": {
     "role": "http://www.lifevantage.com/role/IncomeTaxesTables",
     "longName": "9955519 - Disclosure - Income Taxes (Tables)",
     "shortName": "Income Taxes (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "34",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "lfvn-20250630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "lfvn-20250630.htm",
      "first": true,
      "unique": true
     }
    },
    "R35": {
     "role": "http://www.lifevantage.com/role/LeasesTables",
     "longName": "9955520 - Disclosure - Leases (Tables)",
     "shortName": "Leases (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "35",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:LeaseCostTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "lfvn-20250630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:LeaseCostTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "lfvn-20250630.htm",
      "first": true,
      "unique": true
     }
    },
    "R36": {
     "role": "http://www.lifevantage.com/role/SegmentInformationTables",
     "longName": "9955521 - Disclosure - Segment Information (Tables)",
     "shortName": "Segment Information (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "36",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "lfvn-20250630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "lfvn-20250630.htm",
      "first": true,
      "unique": true
     }
    },
    "R37": {
     "role": "http://www.lifevantage.com/role/TheCompanyDetails",
     "longName": "9955522 - Disclosure - The Company (Details)",
     "shortName": "The Company (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "37",
     "firstAnchor": {
      "contextRef": "c-6",
      "name": "us-gaap:CommonStockParOrStatedValuePerShare",
      "unitRef": "usdPerShare",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "us-gaap:CommonStockParOrStatedValuePerShare",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "lfvn-20250630.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-30",
      "name": "us-gaap:CommonStockParOrStatedValuePerShare",
      "unitRef": "usdPerShare",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "lfvn-20250630.htm",
      "unique": true
     }
    },
    "R38": {
     "role": "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails",
     "longName": "9955523 - Disclosure - Summary of Significant Accounting Policies - Narrative (Details)",
     "shortName": "Summary of Significant Accounting Policies - Narrative (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "38",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ProvisionForDoubtfulAccounts",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "us-gaap:ProvisionForDoubtfulAccounts",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "lfvn-20250630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ProvisionForDoubtfulAccounts",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "us-gaap:ProvisionForDoubtfulAccounts",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "lfvn-20250630.htm",
      "first": true,
      "unique": true
     }
    },
    "R39": {
     "role": "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesInventoryDetails",
     "longName": "9955524 - Disclosure - Summary of Significant Accounting Policies - Inventory (Details)",
     "shortName": "Summary of Significant Accounting Policies - Inventory (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "39",
     "firstAnchor": {
      "contextRef": "c-6",
      "name": "us-gaap:InventoryFinishedGoods",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "lfvn-20250630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-6",
      "name": "us-gaap:InventoryFinishedGoods",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "lfvn-20250630.htm",
      "first": true,
      "unique": true
     }
    },
    "R40": {
     "role": "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesScheduleOfInventoryValuationReserveDetails",
     "longName": "9955525 - Disclosure - Summary of Significant Accounting Policies - Schedule Of Inventory Valuation Reserve (Details)",
     "shortName": "Summary of Significant Accounting Policies - Schedule Of Inventory Valuation Reserve (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "40",
     "firstAnchor": {
      "contextRef": "c-31",
      "name": "us-gaap:ValuationAllowancesAndReservesBalance",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "lfvn-20250630.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-32",
      "name": "us-gaap:ValuationAllowancesAndReservesBalance",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "lfvn-20250630.htm",
      "unique": true
     }
    },
    "R41": {
     "role": "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesPropertyandEquipmentDetails",
     "longName": "9955526 - Disclosure - Summary of Significant Accounting Policies - Property and Equipment (Details)",
     "shortName": "Summary of Significant Accounting Policies - Property and Equipment (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "41",
     "firstAnchor": {
      "contextRef": "c-38",
      "name": "us-gaap:PropertyPlantAndEquipmentUsefulLife",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "lfvn-20250630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-38",
      "name": "us-gaap:PropertyPlantAndEquipmentUsefulLife",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "lfvn-20250630.htm",
      "first": true,
      "unique": true
     }
    },
    "R42": {
     "role": "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesComputationofNetIncomePerShareDetails",
     "longName": "9955527 - Disclosure - Summary of Significant Accounting Policies - Computation of Net Income Per Share (Details)",
     "shortName": "Summary of Significant Accounting Policies - Computation of Net Income Per Share (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "42",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:NetIncomeLoss",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "lfvn-20250630.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "lfvn-20250630.htm",
      "unique": true
     }
    },
    "R43": {
     "role": "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesSegmentInformationDetails",
     "longName": "9955528 - Disclosure - Summary of Significant Accounting Policies - Segment Information (Details)",
     "shortName": "Summary of Significant Accounting Policies - Segment Information (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "43",
     "firstAnchor": {
      "contextRef": "c-6",
      "name": "us-gaap:NoncurrentAssets",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LongLivedAssetsByGeographicAreasTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "lfvn-20250630.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R44": {
     "role": "http://www.lifevantage.com/role/RevenueNarrativeDetails",
     "longName": "9955529 - Disclosure - Revenue - Narrative (Details)",
     "shortName": "Revenue - Narrative (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "44",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "lfvn:MoneyBackGuaranteePeriod",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "lfvn-20250630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "lfvn:MoneyBackGuaranteePeriod",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "lfvn-20250630.htm",
      "first": true,
      "unique": true
     }
    },
    "R45": {
     "role": "http://www.lifevantage.com/role/RevenueSalesReturnDetails",
     "longName": "9955530 - Disclosure - Revenue - Sales Return (Details)",
     "shortName": "Revenue - Sales Return (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "45",
     "firstAnchor": {
      "contextRef": "c-42",
      "name": "us-gaap:ValuationAllowancesAndReservesBalance",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DisaggregationOfRevenueTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "lfvn-20250630.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-43",
      "name": "us-gaap:ValuationAllowancesAndReservesBalance",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DisaggregationOfRevenueTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "lfvn-20250630.htm",
      "unique": true
     }
    },
    "R46": {
     "role": "http://www.lifevantage.com/role/RevenueMajorProductsDetails",
     "longName": "9955531 - Disclosure - Revenue - Major Products (Details)",
     "shortName": "Revenue - Major Products (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "46",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "lfvn-20250630.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R47": {
     "role": "http://www.lifevantage.com/role/PropertyandEquipmentNetDetails",
     "longName": "9955532 - Disclosure - Property and Equipment, Net (Details)",
     "shortName": "Property and Equipment, Net (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "47",
     "firstAnchor": {
      "contextRef": "c-6",
      "name": "us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "lfvn-20250630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-6",
      "name": "us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "lfvn-20250630.htm",
      "first": true,
      "unique": true
     }
    },
    "R48": {
     "role": "http://www.lifevantage.com/role/IntangibleAssetsNetDetails",
     "longName": "9955533 - Disclosure - Intangible Assets, Net (Details)",
     "shortName": "Intangible Assets, Net (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "48",
     "firstAnchor": {
      "contextRef": "c-6",
      "name": "us-gaap:IntangibleAssetsNetExcludingGoodwill",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "lfvn-20250630.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:AmortizationOfIntangibleAssets",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "lfvn-20250630.htm",
      "unique": true
     }
    },
    "R49": {
     "role": "http://www.lifevantage.com/role/OtherAccruedExpensesDetails",
     "longName": "9955534 - Disclosure - Other Accrued Expenses (Details)",
     "shortName": "Other Accrued Expenses (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "49",
     "firstAnchor": {
      "contextRef": "c-6",
      "name": "us-gaap:AccruedBonusesCurrentAndNoncurrent",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "lfvn-20250630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-6",
      "name": "us-gaap:AccruedBonusesCurrentAndNoncurrent",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "lfvn-20250630.htm",
      "first": true,
      "unique": true
     }
    },
    "R50": {
     "role": "http://www.lifevantage.com/role/LongTermDebtDetails",
     "longName": "9955535 - Disclosure - Long-Term Debt (Details)",
     "shortName": "Long-Term Debt (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "50",
     "firstAnchor": {
      "contextRef": "c-73",
      "name": "lfvn:CommonStockDividendsPerShareCashPaidOneTimeDividend",
      "unitRef": "usdPerShare",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "lfvn-20250630.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-62",
      "name": "us-gaap:DebtInstrumentInterestRateEffectivePercentage",
      "unitRef": "number",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "4",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "lfvn-20250630.htm",
      "unique": true
     }
    },
    "R51": {
     "role": "http://www.lifevantage.com/role/StockholdersEquityDetails",
     "longName": "9955536 - Disclosure - Stockholders' Equity (Details)",
     "shortName": "Stockholders' Equity (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "51",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "lfvn-20250630.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-67",
      "name": "srt:StockRepurchaseProgramAuthorizedAmount1",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "lfvn-20250630.htm",
      "unique": true
     }
    },
    "R52": {
     "role": "http://www.lifevantage.com/role/ShareBasedCompensationEquitySettledPlansNarrativeDetails",
     "longName": "9955537 - Disclosure - Share-Based Compensation - Equity-Settled Plans, Narrative (Details)",
     "shortName": "Share-Based Compensation - Equity-Settled Plans, Narrative (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "52",
     "firstAnchor": {
      "contextRef": "c-6",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "lfvn-20250630.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-82",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "lfvn-20250630.htm",
      "unique": true
     }
    },
    "R53": {
     "role": "http://www.lifevantage.com/role/ShareBasedCompensationEmployeeStockPurchasePlanNarrativeDetails",
     "longName": "9955538 - Disclosure - Share-Based Compensation - Employee Stock Purchase Plan, Narrative (Details)",
     "shortName": "Share-Based Compensation - Employee Stock Purchase Plan, Narrative (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "53",
     "firstAnchor": {
      "contextRef": "c-86",
      "name": "us-gaap:CommonStockCapitalSharesReservedForFutureIssuance",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "lfvn-20250630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-86",
      "name": "us-gaap:CommonStockCapitalSharesReservedForFutureIssuance",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "lfvn-20250630.htm",
      "first": true,
      "unique": true
     }
    },
    "R54": {
     "role": "http://www.lifevantage.com/role/ShareBasedCompensationStockBasedCompensationNarrativeDetails",
     "longName": "9955539 - Disclosure - Share-Based Compensation - Stock-Based Compensation, Narrative (Details)",
     "shortName": "Share-Based Compensation - Stock-Based Compensation, Narrative (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "54",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "lfvn-20250630.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-87",
      "name": "us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "lfvn-20250630.htm",
      "unique": true
     }
    },
    "R55": {
     "role": "http://www.lifevantage.com/role/ShareBasedCompensationStockOptionsNarrativeDetails",
     "longName": "9955540 - Disclosure - Share-Based Compensation - Stock Options, Narrative (Details)",
     "shortName": "Share-Based Compensation - Stock Options, Narrative (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "55",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "lfvn-20250630.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R56": {
     "role": "http://www.lifevantage.com/role/ShareBasedCompensationStockOptionsDetails",
     "longName": "9955541 - Disclosure - Share-Based Compensation - Stock Options (Details)",
     "shortName": "Share-Based Compensation - Stock Options (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "56",
     "firstAnchor": {
      "contextRef": "c-7",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "lfvn-20250630.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "lfvn-20250630.htm",
      "unique": true
     }
    },
    "R57": {
     "role": "http://www.lifevantage.com/role/ShareBasedCompensationRestrictedSharesDetails",
     "longName": "9955542 - Disclosure - Share-Based Compensation - Restricted Shares (Details)",
     "shortName": "Share-Based Compensation - Restricted Shares (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "57",
     "firstAnchor": {
      "contextRef": "c-91",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:NonvestedRestrictedStockSharesActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "lfvn-20250630.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-90",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:NonvestedRestrictedStockSharesActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "lfvn-20250630.htm",
      "unique": true
     }
    },
    "R58": {
     "role": "http://www.lifevantage.com/role/ShareBasedCompensationRestrictedStockNarrativeDetails",
     "longName": "9955543 - Disclosure - Share-Based Compensation - Restricted Stock, Narrative (Details)",
     "shortName": "Share-Based Compensation - Restricted Stock, Narrative (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "58",
     "firstAnchor": {
      "contextRef": "c-63",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "lfvn-20250630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-63",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "lfvn-20250630.htm",
      "first": true,
      "unique": true
     }
    },
    "R59": {
     "role": "http://www.lifevantage.com/role/ShareBasedCompensationPerformanceRestrictedStockUnitsNarrativeDetails",
     "longName": "9955544 - Disclosure - Share-Based Compensation - Performance Restricted Stock Units, Narrative (Details)",
     "shortName": "Share-Based Compensation - Performance Restricted Stock Units, Narrative (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "59",
     "firstAnchor": {
      "contextRef": "c-103",
      "name": "lfvn:SharebasedCompensationArrangementbySharebasedPaymentAwardDistributionPercentage",
      "unitRef": "number",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "lfvn-20250630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-103",
      "name": "lfvn:SharebasedCompensationArrangementbySharebasedPaymentAwardDistributionPercentage",
      "unitRef": "number",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "lfvn-20250630.htm",
      "first": true,
      "unique": true
     }
    },
    "R60": {
     "role": "http://www.lifevantage.com/role/ShareBasedCompensationPerformanceRestrictedStockUnitsDetails",
     "longName": "9955545 - Disclosure - Share-Based Compensation - Performance Restricted Stock Units (Details)",
     "shortName": "Share-Based Compensation - Performance Restricted Stock Units (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "60",
     "firstAnchor": {
      "contextRef": "c-95",
      "name": "lfvn:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsCancelledInPeriod",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "lfvn-20250630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-95",
      "name": "lfvn:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsCancelledInPeriod",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "lfvn-20250630.htm",
      "first": true,
      "unique": true
     }
    },
    "R61": {
     "role": "http://www.lifevantage.com/role/OtherExpenseNetDetails",
     "longName": "9955546 - Disclosure - Other Expense, Net (Details)",
     "shortName": "Other Expense, Net (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "61",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ForeignCurrencyTransactionGainLossBeforeTax",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "us-gaap:ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "lfvn-20250630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ForeignCurrencyTransactionGainLossBeforeTax",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "us-gaap:ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "lfvn-20250630.htm",
      "first": true,
      "unique": true
     }
    },
    "R62": {
     "role": "http://www.lifevantage.com/role/IncomeTaxesIncomeTaxExpenseDetails",
     "longName": "9955547 - Disclosure - Income Taxes - Income Tax Expense (Details)",
     "shortName": "Income Taxes - Income Tax Expense (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "62",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "lfvn-20250630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "lfvn-20250630.htm",
      "first": true,
      "unique": true
     }
    },
    "R63": {
     "role": "http://www.lifevantage.com/role/IncomeTaxesEffectiveIncomeTaxRateDetails",
     "longName": "9955548 - Disclosure - Income Taxes - Effective Income Tax Rate (Details)",
     "shortName": "Income Taxes - Effective Income Tax Rate (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "63",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
      "unitRef": "number",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "lfvn-20250630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
      "unitRef": "number",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "lfvn-20250630.htm",
      "first": true,
      "unique": true
     }
    },
    "R64": {
     "role": "http://www.lifevantage.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails",
     "longName": "9955549 - Disclosure - Income Taxes - Deferred Tax Assets and Liabilities (Details)",
     "shortName": "Income Taxes - Deferred Tax Assets and Liabilities (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "64",
     "firstAnchor": {
      "contextRef": "c-6",
      "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwards",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "lfvn-20250630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-6",
      "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwards",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "lfvn-20250630.htm",
      "first": true,
      "unique": true
     }
    },
    "R65": {
     "role": "http://www.lifevantage.com/role/IncomeTaxesNarrativeDetails",
     "longName": "9955550 - Disclosure - Income Taxes - Narrative (Details)",
     "shortName": "Income Taxes - Narrative (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "65",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "lfvn:UnrecognizedTaxPositionIncreaseResultingFromForeignTaxAudits",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "lfvn-20250630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "lfvn:UnrecognizedTaxPositionIncreaseResultingFromForeignTaxAudits",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "lfvn-20250630.htm",
      "first": true,
      "unique": true
     }
    },
    "R66": {
     "role": "http://www.lifevantage.com/role/IncomeTaxesScheduleofUnrecognizedTaxBenefitDetails",
     "longName": "9955551 - Disclosure - Income Taxes - Schedule of Unrecognized Tax Benefit (Details)",
     "shortName": "Income Taxes - Schedule of Unrecognized Tax Benefit (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "66",
     "firstAnchor": {
      "contextRef": "c-7",
      "name": "us-gaap:UnrecognizedTaxBenefits",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "lfvn-20250630.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-13",
      "name": "us-gaap:UnrecognizedTaxBenefits",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "lfvn-20250630.htm",
      "unique": true
     }
    },
    "R67": {
     "role": "http://www.lifevantage.com/role/IncomeTaxesDeferredTaxAssetsValuationAllowanceScheduleDetails",
     "longName": "9955552 - Disclosure - Income Taxes - Deferred Tax Assets, Valuation Allowance Schedule (Details)",
     "shortName": "Income Taxes - Deferred Tax Assets, Valuation Allowance Schedule (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "67",
     "firstAnchor": {
      "contextRef": "c-7",
      "name": "us-gaap:DeferredTaxAssetsValuationAllowance",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:SummaryOfValuationAllowanceTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "lfvn-20250630.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:SummaryOfValuationAllowanceTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "lfvn-20250630.htm",
      "unique": true
     }
    },
    "R68": {
     "role": "http://www.lifevantage.com/role/LeasesNarrativeDetails",
     "longName": "9955553 - Disclosure - Leases - Narrative (Details)",
     "shortName": "Leases - Narrative (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "68",
     "firstAnchor": {
      "contextRef": "c-6",
      "name": "us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "lfvn-20250630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-6",
      "name": "us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "lfvn-20250630.htm",
      "first": true,
      "unique": true
     }
    },
    "R69": {
     "role": "http://www.lifevantage.com/role/LeasesScheduleofLeaseCostDetails",
     "longName": "9955554 - Disclosure - Leases - Schedule of Lease Cost (Details)",
     "shortName": "Leases - Schedule of Lease Cost (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "69",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:OperatingLeaseCost",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LeaseCostTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "lfvn-20250630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:OperatingLeaseCost",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LeaseCostTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "lfvn-20250630.htm",
      "first": true,
      "unique": true
     }
    },
    "R70": {
     "role": "http://www.lifevantage.com/role/LeasesSupplementalCashFlowInformationDetails",
     "longName": "9955555 - Disclosure - Leases - Supplemental Cash Flow Information (Details)",
     "shortName": "Leases - Supplemental Cash Flow Information (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "70",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:OperatingLeasePayments",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LeaseCostTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "lfvn-20250630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:OperatingLeasePayments",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LeaseCostTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "lfvn-20250630.htm",
      "first": true,
      "unique": true
     }
    },
    "R71": {
     "role": "http://www.lifevantage.com/role/LeasesMaturityofLeaseLiabilitiesDetails",
     "longName": "9955556 - Disclosure - Leases - Maturity of Lease Liabilities (Details)",
     "shortName": "Leases - Maturity of Lease Liabilities (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "71",
     "firstAnchor": {
      "contextRef": "c-6",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "lfvn-20250630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-6",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "lfvn-20250630.htm",
      "first": true,
      "unique": true
     }
    },
    "R72": {
     "role": "http://www.lifevantage.com/role/SegmentInformationScheduleofSegmentRevenueandExpenseDetails",
     "longName": "9955557 - Disclosure - Segment Information - Schedule of Segment Revenue and Expense (Details)",
     "shortName": "Segment Information - Schedule of Segment Revenue and Expense (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "72",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "lfvn-20250630.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-115",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "lfvn-20250630.htm",
      "unique": true
     }
    },
    "R73": {
     "role": "http://www.lifevantage.com/role/SegmentInformationScheduleofLongLivedAssetsDetails",
     "longName": "9955558 - Disclosure - Segment Information - Schedule of Long-Lived Assets (Details)",
     "shortName": "Segment Information - Schedule of Long-Lived Assets (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "73",
     "firstAnchor": {
      "contextRef": "c-6",
      "name": "us-gaap:NoncurrentAssets",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LongLivedAssetsByGeographicAreasTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "lfvn-20250630.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-123",
      "name": "us-gaap:NoncurrentAssets",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LongLivedAssetsByGeographicAreasTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "lfvn-20250630.htm",
      "unique": true
     }
    },
    "R74": {
     "role": "http://www.lifevantage.com/role/SegmentInformationNarrativeDetails",
     "longName": "9955559 - Disclosure - Segment Information - Narrative (Details)",
     "shortName": "Segment Information - Narrative (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "74",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "lfvn:NumberOfProductLines",
      "unitRef": "productline",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "lfvn-20250630.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R75": {
     "role": "http://www.lifevantage.com/role/SegmentInformationScheduleOfRevenueDisaggregationByMarketDetails",
     "longName": "9955560 - Disclosure - Segment Information - Schedule Of Revenue Disaggregation By Market (Details)",
     "shortName": "Segment Information - Schedule Of Revenue Disaggregation By Market (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "75",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "lfvn-20250630.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-125",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "lfvn-20250630.htm",
      "unique": true
     }
    },
    "R76": {
     "role": "http://www.lifevantage.com/role/SegmentInformationScheduleofMajorProductsLinesDetails",
     "longName": "9955561 - Disclosure - Segment Information - Schedule of Major Products Lines (Details)",
     "shortName": "Segment Information - Schedule of Major Products Lines (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "76",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "lfvn-20250630.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-139",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "lfvn-20250630.htm",
      "unique": true
     }
    }
   },
   "tag": {
    "lfvn_AXIOProductLineMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.lifevantage.com/20250630",
     "localname": "AXIOProductLineMember",
     "presentation": [
      "http://www.lifevantage.com/role/SegmentInformationScheduleofMajorProductsLinesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "AXIO\u00ae product line",
        "label": "AXIO Product Line [Member]",
        "documentation": "AXIO Product Line"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccountingPoliciesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AccountingPoliciesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accounting Policies [Abstract]",
        "label": "Accounting Policies [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock",
     "presentation": [
      "http://www.lifevantage.com/role/OtherAccruedExpenses"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other Accrued Expenses",
        "label": "Accounts Payable, Accrued Liabilities, and Other Liabilities Disclosure, Current [Text Block]",
        "documentation": "The entire disclosure for accounts payable, accrued expenses, and other liabilities that are classified as current at the end of the reporting period."
       }
      }
     },
     "auth_ref": [
      "r500"
     ]
    },
    "us-gaap_AccountsPayableCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AccountsPayableCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.lifevantage.com/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.lifevantage.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Accounts payable",
        "label": "Accounts Payable, Current",
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r42",
      "r909"
     ]
    },
    "us-gaap_AccountsReceivableNetCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AccountsReceivableNetCurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.lifevantage.com/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.lifevantage.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accounts receivable",
        "label": "Accounts Receivable, after Allowance for Credit Loss, Current",
        "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current."
       }
      }
     },
     "auth_ref": [
      "r1145"
     ]
    },
    "us-gaap_AccruedBonusesCurrentAndNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AccruedBonusesCurrentAndNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.lifevantage.com/role/OtherAccruedExpensesDetails": {
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.lifevantage.com/role/OtherAccruedExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued incentive compensation",
        "label": "Accrued Bonuses",
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable for incentive compensation awarded to employees and directors or earned by them based on the terms of one or more relevant arrangements."
       }
      }
     },
     "auth_ref": [
      "r105"
     ]
    },
    "us-gaap_AccruedEmployeeBenefitsCurrentAndNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AccruedEmployeeBenefitsCurrentAndNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.lifevantage.com/role/OtherAccruedExpensesDetails": {
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.lifevantage.com/role/OtherAccruedExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued severance",
        "label": "Accrued Employee Benefits",
        "documentation": "Carrying value as of the balance sheet date of obligations, excluding pension and other postretirement benefits, incurred through that date and payable for perquisites provided to employees pertaining to services received from them."
       }
      }
     },
     "auth_ref": [
      "r105"
     ]
    },
    "us-gaap_AccruedIncomeTaxesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AccruedIncomeTaxesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.lifevantage.com/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.lifevantage.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Income tax payable",
        "label": "Accrued Income Taxes, Current",
        "documentation": "Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all currently due domestic and foreign income tax obligations."
       }
      }
     },
     "auth_ref": [
      "r45",
      "r103"
     ]
    },
    "us-gaap_AccruedLiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AccruedLiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.lifevantage.com/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 5.0
      },
      "http://www.lifevantage.com/role/OtherAccruedExpensesDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.lifevantage.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.lifevantage.com/role/OtherAccruedExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other accrued expenses",
        "totalLabel": "Total other accrued expenses",
        "label": "Accrued Liabilities, Current",
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r45"
     ]
    },
    "us-gaap_AccruedMarketingCostsCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AccruedMarketingCostsCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.lifevantage.com/role/OtherAccruedExpensesDetails": {
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://www.lifevantage.com/role/OtherAccruedExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Accrued incentives and promotions to consultants",
        "label": "Accrued Marketing Costs, Current",
        "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for the marketing, trade and selling of the entity's goods and services. Marketing costs would include expenditures for planning and executing the conception, pricing, promotion, and distribution of ideas, goods, and services; costs of public relations and corporate promotions; and obligations incurred and payable for sales discounts, rebates, price protection programs, etc. offered to customers and under government programs. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": []
    },
    "lfvn_AccruedPayableToVendors": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.lifevantage.com/20250630",
     "localname": "AccruedPayableToVendors",
     "crdr": "credit",
     "calculation": {
      "http://www.lifevantage.com/role/OtherAccruedExpensesDetails": {
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.lifevantage.com/role/OtherAccruedExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued payable to vendors",
        "label": "Accrued Payable to Vendors",
        "documentation": "Accrued Payable to Vendors"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccruedSalesCommissionCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AccruedSalesCommissionCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.lifevantage.com/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.lifevantage.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Commissions payable",
        "label": "Accrued Sales Commission, Current",
        "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for sales commissions. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r45",
      "r823"
     ]
    },
    "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment",
     "crdr": "credit",
     "calculation": {
      "http://www.lifevantage.com/role/PropertyandEquipmentNetDetails": {
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.lifevantage.com/role/PropertyandEquipmentNetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Accumulated depreciation",
        "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment",
        "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services."
       }
      }
     },
     "auth_ref": [
      "r31",
      "r169",
      "r679"
     ]
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
     "crdr": "credit",
     "calculation": {
      "http://www.lifevantage.com/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.lifevantage.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Accumulated other comprehensive loss",
        "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax",
        "documentation": "Amount, after tax, of accumulated increase (decrease) in equity from transaction and other event and circumstance from nonowner source."
       }
      }
     },
     "auth_ref": [
      "r16",
      "r17",
      "r65",
      "r176",
      "r675",
      "r711",
      "r712",
      "r1218"
     ]
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AccumulatedOtherComprehensiveIncomeMember",
     "presentation": [
      "http://www.lifevantage.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accumulated Other Comprehensive Income (Loss)",
        "label": "AOCI Attributable to Parent [Member]",
        "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners."
       }
      }
     },
     "auth_ref": [
      "r2",
      "r9",
      "r17",
      "r563",
      "r566",
      "r614",
      "r707",
      "r708",
      "r1062",
      "r1063",
      "r1064",
      "r1128",
      "r1129",
      "r1130",
      "r1131"
     ]
    },
    "ecd_Additional402vDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "Additional402vDisclosureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Additional 402(v) Disclosure",
        "label": "Additional 402(v) Disclosure [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r988"
     ]
    },
    "us-gaap_AdditionalPaidInCapitalCommonStock": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AdditionalPaidInCapitalCommonStock",
     "crdr": "credit",
     "calculation": {
      "http://www.lifevantage.com/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.lifevantage.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Additional paid-in capital",
        "label": "Additional Paid in Capital, Common Stock",
        "documentation": "Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital."
       }
      }
     },
     "auth_ref": [
      "r57"
     ]
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AdditionalPaidInCapitalMember",
     "presentation": [
      "http://www.lifevantage.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Additional Paid-In\u00a0Capital",
        "label": "Additional Paid-in Capital [Member]",
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders."
       }
      }
     },
     "auth_ref": [
      "r728",
      "r1128",
      "r1129",
      "r1130",
      "r1131",
      "r1219",
      "r1272"
     ]
    },
    "ecd_AdjToCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AdjToCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Adjustment to Compensation, Amount",
        "label": "Adjustment to Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r1001"
     ]
    },
    "ecd_AdjToCompAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AdjToCompAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Adjustment to Compensation:",
        "label": "Adjustment to Compensation [Axis]"
       }
      }
     },
     "auth_ref": [
      "r1001"
     ]
    },
    "ecd_AdjToNonPeoNeoCompFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AdjToNonPeoNeoCompFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Adjustment to Non-PEO NEO Compensation Footnote",
        "label": "Adjustment to Non-PEO NEO Compensation Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1001"
     ]
    },
    "ecd_AdjToPeoCompFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AdjToPeoCompFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Adjustment To PEO Compensation, Footnote",
        "label": "Adjustment To PEO Compensation, Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1001"
     ]
    },
    "us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "presentation": [
      "http://www.lifevantage.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Adjustments to reconcile net income to net cash provided by operating activities:",
        "label": "Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity, Noncash Item [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation",
     "crdr": "debit",
     "presentation": [
      "http://www.lifevantage.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Shares canceled or surrendered as payment of tax withholding and other",
        "label": "Share-Based Payment Arrangement, Decrease for Tax Withholding Obligation",
        "documentation": "Amount of decrease to equity for grantee's tax withholding obligation for award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r1202"
     ]
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue",
     "crdr": "credit",
     "presentation": [
      "http://www.lifevantage.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY",
      "http://www.lifevantage.com/role/ShareBasedCompensationStockBasedCompensationNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock-based compensation",
        "label": "APIC, Share-Based Payment Arrangement, Increase for Cost Recognition",
        "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r453"
     ]
    },
    "ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AggtChngPnsnValInSummryCompstnTblForAplblYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table",
        "label": "Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table [Member]"
       }
      }
     },
     "auth_ref": [
      "r1046"
     ]
    },
    "ecd_AggtErrCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AggtErrCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregate Erroneous Compensation Amount",
        "label": "Aggregate Erroneous Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r959",
      "r970",
      "r980",
      "r1013"
     ]
    },
    "ecd_AggtErrCompNotYetDeterminedTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AggtErrCompNotYetDeterminedTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregate Erroneous Compensation Not Yet Determined",
        "label": "Aggregate Erroneous Compensation Not Yet Determined [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r962",
      "r973",
      "r983",
      "r1016"
     ]
    },
    "ecd_AggtPnsnAdjsSvcCstMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AggtPnsnAdjsSvcCstMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregate Pension Adjustments Service Cost",
        "label": "Aggregate Pension Adjustments Service Cost [Member]"
       }
      }
     },
     "auth_ref": [
      "r1047"
     ]
    },
    "ecd_AllAdjToCompMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AllAdjToCompMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "All Adjustments to Compensation",
        "label": "All Adjustments to Compensation [Member]"
       }
      }
     },
     "auth_ref": [
      "r1001"
     ]
    },
    "ecd_AllExecutiveCategoriesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AllExecutiveCategoriesMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "All Executive Categories",
        "label": "All Executive Categories [Member]"
       }
      }
     },
     "auth_ref": [
      "r1008"
     ]
    },
    "ecd_AllIndividualsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AllIndividualsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure",
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure",
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements",
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "All Individuals",
        "label": "All Individuals [Member]"
       }
      }
     },
     "auth_ref": [
      "r963",
      "r974",
      "r984",
      "r1008",
      "r1017",
      "r1021",
      "r1029"
     ]
    },
    "ecd_AllTradingArrangementsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AllTradingArrangementsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "All Trading Arrangements",
        "label": "All Trading Arrangements [Member]"
       }
      }
     },
     "auth_ref": [
      "r1027"
     ]
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://www.lifevantage.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amendment Flag",
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AmortizationOfFinancingCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AmortizationOfFinancingCosts",
     "crdr": "debit",
     "calculation": {
      "http://www.lifevantage.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 17.0
      }
     },
     "presentation": [
      "http://www.lifevantage.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amortization of deferred financing fees",
        "label": "Amortization of Debt Issuance Costs",
        "documentation": "Amount of amortization expense attributable to debt issuance costs."
       }
      }
     },
     "auth_ref": [
      "r74",
      "r390",
      "r1111",
      "r1225"
     ]
    },
    "us-gaap_AmortizationOfIntangibleAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AmortizationOfIntangibleAssets",
     "crdr": "debit",
     "presentation": [
      "http://www.lifevantage.com/role/IntangibleAssetsNetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amortization of intangible assets",
        "label": "Amortization of Intangible Assets",
        "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets."
       }
      }
     },
     "auth_ref": [
      "r6",
      "r197",
      "r326",
      "r333",
      "r820",
      "r824",
      "r825",
      "r827",
      "r829"
     ]
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "presentation": [
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Number of antidilutive securities (in shares)",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount",
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented."
       }
      }
     },
     "auth_ref": [
      "r248"
     ]
    },
    "us-gaap_Assets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "Assets",
     "crdr": "debit",
     "calculation": {
      "http://www.lifevantage.com/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.lifevantage.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "TOTAL ASSETS",
        "label": "Assets",
        "documentation": "Amount of asset recognized for present right to economic benefit."
       }
      }
     },
     "auth_ref": [
      "r101",
      "r114",
      "r172",
      "r208",
      "r211",
      "r212",
      "r251",
      "r264",
      "r289",
      "r293",
      "r307",
      "r359",
      "r360",
      "r361",
      "r362",
      "r363",
      "r364",
      "r365",
      "r366",
      "r367",
      "r557",
      "r559",
      "r579",
      "r665",
      "r666",
      "r671",
      "r756",
      "r844",
      "r845",
      "r857",
      "r909",
      "r924",
      "r925",
      "r937",
      "r1169",
      "r1170",
      "r1230"
     ]
    },
    "us-gaap_AssetsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AssetsAbstract",
     "presentation": [
      "http://www.lifevantage.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "ASSETS",
        "label": "Assets [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AssetsCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AssetsCurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.lifevantage.com/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.lifevantage.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total current assets",
        "label": "Assets, Current",
        "documentation": "Amount of asset recognized for present right to economic benefit, classified as current."
       }
      }
     },
     "auth_ref": [
      "r164",
      "r179",
      "r208",
      "r211",
      "r212",
      "r307",
      "r359",
      "r360",
      "r361",
      "r362",
      "r363",
      "r364",
      "r365",
      "r366",
      "r367",
      "r557",
      "r559",
      "r579",
      "r909",
      "r1169",
      "r1170",
      "r1230"
     ]
    },
    "us-gaap_AssetsCurrentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AssetsCurrentAbstract",
     "presentation": [
      "http://www.lifevantage.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Current assets",
        "label": "Assets, Current [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AssetsNoncurrentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AssetsNoncurrentAbstract",
     "presentation": [
      "http://www.lifevantage.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Non-current assets",
        "label": "Assets, Noncurrent [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_AuditorFirmId": {
     "xbrltype": "nonemptySequenceNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AuditorFirmId",
     "presentation": [
      "http://www.lifevantage.com/role/AuditInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Auditor Firm ID",
        "label": "Auditor Firm ID",
        "documentation": "PCAOB issued Audit Firm Identifier"
       }
      }
     },
     "auth_ref": [
      "r942",
      "r943",
      "r966"
     ]
    },
    "lfvn_AuditorInformationAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.lifevantage.com/20250630",
     "localname": "AuditorInformationAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Information [Abstract]",
        "documentation": "Auditor Information"
       }
      }
     },
     "auth_ref": []
    },
    "dei_AuditorLocation": {
     "xbrltype": "internationalNameItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AuditorLocation",
     "presentation": [
      "http://www.lifevantage.com/role/AuditInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Auditor Location",
        "label": "Auditor Location"
       }
      }
     },
     "auth_ref": [
      "r942",
      "r943",
      "r966"
     ]
    },
    "dei_AuditorName": {
     "xbrltype": "internationalNameItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AuditorName",
     "presentation": [
      "http://www.lifevantage.com/role/AuditInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Auditor Name",
        "label": "Auditor Name"
       }
      }
     },
     "auth_ref": [
      "r942",
      "r943",
      "r966"
     ]
    },
    "ecd_AwardExrcPrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardExrcPrice",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Exercise Price",
        "label": "Award Exercise Price"
       }
      }
     },
     "auth_ref": [
      "r1024"
     ]
    },
    "ecd_AwardGrantDateFairValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardGrantDateFairValue",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value as of Grant Date",
        "label": "Award Grant Date Fair Value"
       }
      }
     },
     "auth_ref": [
      "r1025"
     ]
    },
    "ecd_AwardTmgDiscLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardTmgDiscLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing Disclosures [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r1020"
     ]
    },
    "ecd_AwardTmgHowMnpiCnsdrdTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardTmgHowMnpiCnsdrdTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award Timing, How MNPI Considered",
        "label": "Award Timing, How MNPI Considered [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1020"
     ]
    },
    "ecd_AwardTmgMethodTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardTmgMethodTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award Timing Method",
        "label": "Award Timing Method [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1020"
     ]
    },
    "ecd_AwardTmgMnpiCnsdrdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardTmgMnpiCnsdrdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award Timing MNPI Considered",
        "label": "Award Timing MNPI Considered [Flag]"
       }
      }
     },
     "auth_ref": [
      "r1020"
     ]
    },
    "ecd_AwardTmgMnpiDiscTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardTmgMnpiDiscTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award Timing MNPI Disclosure",
        "label": "Award Timing MNPI Disclosure [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1020"
     ]
    },
    "ecd_AwardTmgPredtrmndFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardTmgPredtrmndFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award Timing Predetermined",
        "label": "Award Timing Predetermined [Flag]"
       }
      }
     },
     "auth_ref": [
      "r1020"
     ]
    },
    "us-gaap_AwardTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AwardTypeAxis",
     "presentation": [
      "http://www.lifevantage.com/role/ShareBasedCompensationPerformanceRestrictedStockUnitsDetails",
      "http://www.lifevantage.com/role/ShareBasedCompensationPerformanceRestrictedStockUnitsNarrativeDetails",
      "http://www.lifevantage.com/role/ShareBasedCompensationRestrictedSharesDetails",
      "http://www.lifevantage.com/role/ShareBasedCompensationRestrictedStockNarrativeDetails",
      "http://www.lifevantage.com/role/ShareBasedCompensationStockBasedCompensationNarrativeDetails",
      "http://www.lifevantage.com/role/ShareBasedCompensationStockOptionsNarrativeDetails",
      "http://www.lifevantage.com/role/StockholdersEquityDetails",
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award Type [Axis]",
        "label": "Award Type [Axis]",
        "documentation": "Information by type of award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r457",
      "r458",
      "r459",
      "r461",
      "r462",
      "r463",
      "r464",
      "r465",
      "r466",
      "r467",
      "r468",
      "r469",
      "r470",
      "r471",
      "r472",
      "r473",
      "r474",
      "r475",
      "r476",
      "r477",
      "r478",
      "r481",
      "r482",
      "r483",
      "r484",
      "r485"
     ]
    },
    "ecd_AwardUndrlygSecuritiesAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardUndrlygSecuritiesAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Underlying Securities",
        "label": "Award Underlying Securities Amount"
       }
      }
     },
     "auth_ref": [
      "r1023"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardsCloseToMnpiDiscIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Name",
        "label": "Awards Close in Time to MNPI Disclosures, Individual Name"
       }
      }
     },
     "auth_ref": [
      "r1022"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardsCloseToMnpiDiscTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Awards Close in Time to MNPI Disclosures",
        "label": "Awards Close in Time to MNPI Disclosures [Table]"
       }
      }
     },
     "auth_ref": [
      "r1021"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardsCloseToMnpiDiscTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Awards Close in Time to MNPI Disclosures, Table",
        "label": "Awards Close in Time to MNPI Disclosures [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1021"
     ]
    },
    "lfvn_CashAccountsHeldPrimarilyAtFinancialInstitutionMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.lifevantage.com/20250630",
     "localname": "CashAccountsHeldPrimarilyAtFinancialInstitutionMember",
     "presentation": [
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash Accounts Held Primarily At Financial Institution",
        "label": "Cash Accounts Held Primarily At Financial Institution [Member]",
        "documentation": "Cash Accounts Held Primarily At Financial Institution [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "lfvn_CashAccountsHeldatOtherFinancialInstitutionsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.lifevantage.com/20250630",
     "localname": "CashAccountsHeldatOtherFinancialInstitutionsMember",
     "presentation": [
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash Accounts Held at Other Financial Institutions",
        "label": "Cash Accounts Held at Other Financial Institutions [Member]",
        "documentation": "Cash Accounts Held At Other Financial Institutions [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "crdr": "debit",
     "calculation": {
      "http://www.lifevantage.com/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.lifevantage.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash and cash equivalents",
        "label": "Cash and Cash Equivalent",
        "documentation": "Amount of cash and cash equivalent. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate."
       }
      }
     },
     "auth_ref": [
      "r19",
      "r167",
      "r821"
     ]
    },
    "us-gaap_CashAndCashEquivalentsPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CashAndCashEquivalentsPolicyTextBlock",
     "presentation": [
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Cash and Cash Equivalents",
        "label": "Cash and Cash Equivalents, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value."
       }
      }
     },
     "auth_ref": [
      "r20"
     ]
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "crdr": "debit",
     "presentation": [
      "http://www.lifevantage.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Cash and Cash Equivalents \u2014 beginning of period",
        "periodEndLabel": "Cash and Cash Equivalents \u2014 end of period",
        "label": "Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation",
        "documentation": "Amount of cash and cash equivalent, and cash and cash equivalent restricted to withdrawal or usage; attributable to continuing operation. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate."
       }
      }
     },
     "auth_ref": [
      "r19",
      "r79",
      "r205"
     ]
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "crdr": "debit",
     "calculation": {
      "http://www.lifevantage.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.lifevantage.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Increase (Decrease) in Cash and Cash Equivalents",
        "label": "Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Period Increase (Decrease), Including Exchange Rate Effect and Discontinued Operation",
        "documentation": "Amount of increase (decrease) in cash and cash equivalent, and cash and cash equivalent restricted to withdrawal or usage; including effect from exchange rate change and including, but not limited to, discontinued operation. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate."
       }
      }
     },
     "auth_ref": [
      "r1",
      "r79"
     ]
    },
    "ecd_ChangedPeerGroupFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ChangedPeerGroupFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Changed Peer Group, Footnote",
        "label": "Changed Peer Group, Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r999"
     ]
    },
    "ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year",
        "label": "Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year [Member]"
       }
      }
     },
     "auth_ref": [
      "r996"
     ]
    },
    "ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested",
        "label": "Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested [Member]"
       }
      }
     },
     "auth_ref": [
      "r994"
     ]
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CityAreaCode",
     "presentation": [
      "http://www.lifevantage.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "City Area Code",
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ClassOfStockLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ClassOfStockLineItems",
     "presentation": [
      "http://www.lifevantage.com/role/StockholdersEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Class of Stock [Line Items]",
        "label": "Class of Stock [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r173",
      "r174",
      "r175",
      "r253",
      "r400",
      "r407",
      "r408",
      "r409",
      "r411",
      "r414",
      "r419",
      "r421",
      "r561",
      "r722",
      "r723",
      "r724",
      "r725",
      "r858",
      "r1051",
      "r1113",
      "r1116"
     ]
    },
    "us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1",
     "presentation": [
      "http://www.lifevantage.com/role/StockholdersEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Exercise price of rights (in dollars per share)",
        "label": "Class of Warrant or Right, Exercise Price of Warrants or Rights",
        "documentation": "Exercise price per share or per unit of warrants or rights outstanding."
       }
      }
     },
     "auth_ref": [
      "r208",
      "r215",
      "r422"
     ]
    },
    "us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight",
     "presentation": [
      "http://www.lifevantage.com/role/StockholdersEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of rights",
        "label": "Class of Warrant or Right, Number of Securities Called by Each Warrant or Right",
        "documentation": "Number of securities into which each warrant or right may be converted. For example, but not limited to, each warrant may be converted into two shares."
       }
      }
     },
     "auth_ref": []
    },
    "lfvn_ClassOfWarrantOrRightPercentOfCommonStockAcquisitionThatMakesRightsExercisable": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.lifevantage.com/20250630",
     "localname": "ClassOfWarrantOrRightPercentOfCommonStockAcquisitionThatMakesRightsExercisable",
     "presentation": [
      "http://www.lifevantage.com/role/StockholdersEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Percent of common stock acquisition that makes rights exercisable",
        "label": "Class of Warrant or Right, Percent Of Common Stock Acquisition That Makes Rights Exercisable",
        "documentation": "Class of Warrant or Right, Percent Of Common Stock Acquisition That Makes Rights Exercisable"
       }
      }
     },
     "auth_ref": []
    },
    "lfvn_ClassOfWarrantOrRightPercentOfCommonStockAcquisitionThatMakesRightsExercisablePassiveInvestors": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.lifevantage.com/20250630",
     "localname": "ClassOfWarrantOrRightPercentOfCommonStockAcquisitionThatMakesRightsExercisablePassiveInvestors",
     "presentation": [
      "http://www.lifevantage.com/role/StockholdersEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Percent of common stock acquisition that makes rights exercisable, passive investors",
        "label": "Class of Warrant or Right, Percent Of Common Stock Acquisition That Makes Rights Exercisable, Passive Investors",
        "documentation": "Class of Warrant or Right, Percent Of Common Stock Acquisition That Makes Rights Exercisable, Passive Investors"
       }
      }
     },
     "auth_ref": []
    },
    "lfvn_ClassOfWarrantsOrRightDiscount": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.lifevantage.com/20250630",
     "localname": "ClassOfWarrantsOrRightDiscount",
     "presentation": [
      "http://www.lifevantage.com/role/StockholdersEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Discount percent",
        "label": "Class Of Warrants Or Right, Discount",
        "documentation": "Class Of Warrants Or Right, Discount"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_CoSelectedMeasureAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "CoSelectedMeasureAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Company Selected Measure Amount",
        "label": "Company Selected Measure Amount"
       }
      }
     },
     "auth_ref": [
      "r1000"
     ]
    },
    "ecd_CoSelectedMeasureName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "CoSelectedMeasureName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Company Selected Measure Name",
        "label": "Company Selected Measure Name"
       }
      }
     },
     "auth_ref": [
      "r1000"
     ]
    },
    "lfvn_CommissionAndIncentives": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.lifevantage.com/20250630",
     "localname": "CommissionAndIncentives",
     "crdr": "debit",
     "calculation": {
      "http://www.lifevantage.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOME": {
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.lifevantage.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOME"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Commissions and incentives",
        "label": "Commission And Incentives",
        "documentation": "Expenses related to commissions and other incentives earned by independent distributors. Commission and incentive expenses include sales commissions paid to our independent distributors, special incentives, costs for incentive trip and other rewards"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CommissionsExpensePolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CommissionsExpensePolicyPolicyTextBlock",
     "presentation": [
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Commissions and Incentives",
        "label": "Commissions Expense, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for commissions incurred in relation to revenue generating activities or operations."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CommitmentsAndContingencies": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CommitmentsAndContingencies",
     "crdr": "credit",
     "calculation": {
      "http://www.lifevantage.com/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.lifevantage.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Commitments and contingencies \u2014 Note 14",
        "label": "Commitments and Contingencies",
        "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur."
       }
      }
     },
     "auth_ref": [
      "r51",
      "r107",
      "r672",
      "r743"
     ]
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Commitments and Contingencies Disclosure [Abstract]",
        "label": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "presentation": [
      "http://www.lifevantage.com/role/CommitmentsandContingencies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Commitments and Contingencies",
        "label": "Commitments and Contingencies Disclosure [Text Block]",
        "documentation": "The entire disclosure for commitments and contingencies."
       }
      }
     },
     "auth_ref": [
      "r89",
      "r351",
      "r352",
      "r803",
      "r1160",
      "r1165"
     ]
    },
    "us-gaap_CommonStockCapitalSharesReservedForFutureIssuance": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CommonStockCapitalSharesReservedForFutureIssuance",
     "presentation": [
      "http://www.lifevantage.com/role/ShareBasedCompensationEmployeeStockPurchasePlanNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of shares of common stock subject for purchase",
        "label": "Common Stock, Capital Shares Reserved for Future Issuance",
        "documentation": "Aggregate number of common shares reserved for future issuance."
       }
      }
     },
     "auth_ref": [
      "r56"
     ]
    },
    "us-gaap_CommonStockDividendsPerShareCashPaid": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CommonStockDividendsPerShareCashPaid",
     "presentation": [
      "http://www.lifevantage.com/role/StockholdersEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash dividend, common stock (in dollars per share)",
        "label": "Common Stock, Dividends, Per Share, Cash Paid",
        "documentation": "Aggregate dividends paid during the period for each share of common stock outstanding."
       }
      }
     },
     "auth_ref": [
      "r94"
     ]
    },
    "lfvn_CommonStockDividendsPerShareCashPaidOneTimeDividend": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://www.lifevantage.com/20250630",
     "localname": "CommonStockDividendsPerShareCashPaidOneTimeDividend",
     "presentation": [
      "http://www.lifevantage.com/role/LongTermDebtDetails",
      "http://www.lifevantage.com/role/StockholdersEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "One time dividend (dollars per share)",
        "label": "Common Stock, Dividends, Per Share, Cash Paid, One Time Dividend",
        "documentation": "Common Stock, Dividends, Per Share, Cash Paid, One Time Dividend"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CommonStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CommonStockMember",
     "presentation": [
      "http://www.lifevantage.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY",
      "http://www.lifevantage.com/role/StockholdersEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common Stock",
        "label": "Common Stock [Member]",
        "documentation": "Stock that is subordinate to all other stock of the issuer."
       }
      }
     },
     "auth_ref": [
      "r927",
      "r928",
      "r929",
      "r931",
      "r932",
      "r933",
      "r934",
      "r1128",
      "r1129",
      "r1131",
      "r1219",
      "r1270",
      "r1272"
     ]
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CommonStockParOrStatedValuePerShare",
     "presentation": [
      "http://www.lifevantage.com/role/CONSOLIDATEDBALANCESHEETSParenthetical",
      "http://www.lifevantage.com/role/TheCompanyDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Common stock, par value (dollars per share)",
        "label": "Common Stock, Par or Stated Value Per Share",
        "documentation": "Face amount or stated value per share of common stock."
       }
      }
     },
     "auth_ref": [
      "r56"
     ]
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CommonStockSharesAuthorized",
     "presentation": [
      "http://www.lifevantage.com/role/CONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Common stock, shares authorized (in shares)",
        "label": "Common Stock, Shares Authorized",
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws."
       }
      }
     },
     "auth_ref": [
      "r56",
      "r744"
     ]
    },
    "us-gaap_CommonStockSharesIssued": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CommonStockSharesIssued",
     "presentation": [
      "http://www.lifevantage.com/role/CONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Common stock, shares issued (in shares)",
        "label": "Common Stock, Shares, Issued",
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury."
       }
      }
     },
     "auth_ref": [
      "r56"
     ]
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CommonStockSharesOutstanding",
     "presentation": [
      "http://www.lifevantage.com/role/CONSOLIDATEDBALANCESHEETSParenthetical",
      "http://www.lifevantage.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Common stock, shares outstanding (in shares)",
        "periodStartLabel": "Beginning balances (in shares)",
        "periodEndLabel": "Ending balances (in shares)",
        "label": "Common Stock, Shares, Outstanding",
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation."
       }
      }
     },
     "auth_ref": [
      "r10",
      "r56",
      "r744",
      "r762",
      "r1272",
      "r1273"
     ]
    },
    "us-gaap_CommonStockValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CommonStockValue",
     "crdr": "credit",
     "calculation": {
      "http://www.lifevantage.com/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.lifevantage.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Common stock \u2014 par value $0.0001 per share, 40,000 shares authorized and 12,429 and 12,510 issued and outstanding as of June\u00a030, 2025 and 2024, respectively",
        "label": "Common Stock, Value, Issued",
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity."
       }
      }
     },
     "auth_ref": [
      "r56",
      "r398",
      "r404",
      "r674",
      "r909"
     ]
    },
    "ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "CompActuallyPaidVsCoSelectedMeasureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Compensation Actually Paid vs. Company Selected Measure",
        "label": "Compensation Actually Paid vs. Company Selected Measure [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1005"
     ]
    },
    "ecd_CompActuallyPaidVsNetIncomeTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "CompActuallyPaidVsNetIncomeTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Compensation Actually Paid vs. Net Income",
        "label": "Compensation Actually Paid vs. Net Income [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1004"
     ]
    },
    "ecd_CompActuallyPaidVsOtherMeasureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "CompActuallyPaidVsOtherMeasureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Compensation Actually Paid vs. Other Measure",
        "label": "Compensation Actually Paid vs. Other Measure [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1006"
     ]
    },
    "ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "CompActuallyPaidVsTotalShareholderRtnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Compensation Actually Paid vs. Total Shareholder Return",
        "label": "Compensation Actually Paid vs. Total Shareholder Return [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1003"
     ]
    },
    "us-gaap_ComponentsOfDeferredTaxAssetsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ComponentsOfDeferredTaxAssetsAbstract",
     "presentation": [
      "http://www.lifevantage.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Deferred tax assets:",
        "label": "Components of Deferred Tax Assets [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract",
     "presentation": [
      "http://www.lifevantage.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "The components of the deferred tax assets and liabilities",
        "label": "Components of Deferred Tax Assets and Liabilities [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ComponentsOfIncomeTaxExpenseBenefitContinuingOperationsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ComponentsOfIncomeTaxExpenseBenefitContinuingOperationsAbstract",
     "presentation": [
      "http://www.lifevantage.com/role/IncomeTaxesIncomeTaxExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Components of income tax expense (benefit)",
        "label": "Components of Income Tax Expense (Benefit), Continuing Operations [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
     "crdr": "credit",
     "calculation": {
      "http://www.lifevantage.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOME": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.lifevantage.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOME"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Comprehensive income",
        "label": "Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest",
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners."
       }
      }
     },
     "auth_ref": [
      "r41",
      "r99",
      "r182",
      "r184",
      "r190",
      "r663",
      "r684"
     ]
    },
    "us-gaap_ConcentrationRiskBenchmarkDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ConcentrationRiskBenchmarkDomain",
     "presentation": [
      "http://www.lifevantage.com/role/RevenueMajorProductsDetails",
      "http://www.lifevantage.com/role/RevenueNarrativeDetails",
      "http://www.lifevantage.com/role/SegmentInformationNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Concentration Risk Benchmark [Domain]",
        "label": "Concentration Risk Benchmark [Domain]",
        "documentation": "The denominator in a calculation of a disclosed concentration risk percentage."
       }
      }
     },
     "auth_ref": [
      "r255",
      "r301",
      "r716",
      "r717",
      "r802",
      "r1135",
      "r1136",
      "r1137",
      "r1138",
      "r1139"
     ]
    },
    "us-gaap_ConcentrationRiskByBenchmarkAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ConcentrationRiskByBenchmarkAxis",
     "presentation": [
      "http://www.lifevantage.com/role/RevenueMajorProductsDetails",
      "http://www.lifevantage.com/role/RevenueNarrativeDetails",
      "http://www.lifevantage.com/role/SegmentInformationNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Concentration Risk Benchmark [Axis]",
        "label": "Concentration Risk Benchmark [Axis]",
        "documentation": "Information by benchmark of concentration risk."
       }
      }
     },
     "auth_ref": [
      "r255",
      "r301",
      "r716",
      "r717",
      "r802",
      "r1135",
      "r1136",
      "r1137",
      "r1138",
      "r1139"
     ]
    },
    "us-gaap_ConcentrationRiskByTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ConcentrationRiskByTypeAxis",
     "presentation": [
      "http://www.lifevantage.com/role/RevenueMajorProductsDetails",
      "http://www.lifevantage.com/role/RevenueNarrativeDetails",
      "http://www.lifevantage.com/role/SegmentInformationNarrativeDetails",
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Concentration Risk Type [Axis]",
        "label": "Concentration Risk Type [Axis]",
        "documentation": "Information by type of concentration risk, for example, but not limited to, asset, liability, net assets, geographic, customer, employees, supplier, lender."
       }
      }
     },
     "auth_ref": [
      "r255",
      "r301",
      "r716",
      "r717",
      "r802",
      "r1135",
      "r1136",
      "r1137",
      "r1138",
      "r1139"
     ]
    },
    "us-gaap_ConcentrationRiskCreditRisk": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ConcentrationRiskCreditRisk",
     "presentation": [
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Concentration of Credit Risk",
        "label": "Concentration Risk, Credit Risk, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for credit risk. Includes, but is not limited to, policy for entering into master netting arrangement or similar agreement to mitigate credit risk of financial instrument."
       }
      }
     },
     "auth_ref": [
      "r577",
      "r578"
     ]
    },
    "us-gaap_ConcentrationRiskCreditRiskFinancialInstrumentMaximumExposure": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ConcentrationRiskCreditRiskFinancialInstrumentMaximumExposure",
     "crdr": "debit",
     "presentation": [
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Concentration of credit risk",
        "label": "Concentration Risk, Credit Risk, Financial Instrument, Maximum Exposure",
        "documentation": "Maximum amount of loss due to credit risk that, based on the gross fair value of the financial instrument, the entity would incur if parties to the financial instruments that make up the concentration failed completely to perform according to the terms of the contracts and the collateral or other security, if any, for the amount due proved to be of no value to the entity."
       }
      }
     },
     "auth_ref": [
      "r1222"
     ]
    },
    "us-gaap_ConcentrationRiskLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ConcentrationRiskLineItems",
     "presentation": [
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Concentration Risk [Line Items]",
        "label": "Concentration Risk [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r255",
      "r256",
      "r802",
      "r835",
      "r1135",
      "r1136",
      "r1137",
      "r1138",
      "r1139"
     ]
    },
    "us-gaap_ConcentrationRiskPercentage1": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ConcentrationRiskPercentage1",
     "presentation": [
      "http://www.lifevantage.com/role/RevenueMajorProductsDetails",
      "http://www.lifevantage.com/role/RevenueNarrativeDetails",
      "http://www.lifevantage.com/role/SegmentInformationNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Concentration risk",
        "label": "Concentration Risk, Percentage",
        "documentation": "For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the \"benchmark\" (or denominator) in the equation, this concept represents the concentration percentage derived from the division."
       }
      }
     },
     "auth_ref": [
      "r255",
      "r301",
      "r1135",
      "r1136",
      "r1137",
      "r1138",
      "r1139"
     ]
    },
    "us-gaap_ConcentrationRiskTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ConcentrationRiskTable",
     "presentation": [
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Concentration Risk [Table]",
        "label": "Concentration Risk [Table]",
        "documentation": "Disclosure of information about concentration risk. Includes, but is not limited to, percentage of concentration risk and benchmark serving as denominator in calculation of percentage of concentration risk."
       }
      }
     },
     "auth_ref": [
      "r255",
      "r256",
      "r802",
      "r835",
      "r1135",
      "r1136",
      "r1137",
      "r1138",
      "r1139"
     ]
    },
    "us-gaap_ConcentrationRiskTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ConcentrationRiskTypeDomain",
     "presentation": [
      "http://www.lifevantage.com/role/RevenueMajorProductsDetails",
      "http://www.lifevantage.com/role/RevenueNarrativeDetails",
      "http://www.lifevantage.com/role/SegmentInformationNarrativeDetails",
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Concentration Risk Type [Domain]",
        "label": "Concentration Risk Type [Domain]",
        "documentation": "For an entity that discloses a concentration risk as a percentage of some financial balance or benchmark, identifies the type (for example, asset, liability, net assets, geographic, customer, employees, supplier, lender) of the concentration."
       }
      }
     },
     "auth_ref": [
      "r255",
      "r301",
      "r716",
      "r717",
      "r802",
      "r1135",
      "r1136",
      "r1137",
      "r1138",
      "r1139"
     ]
    },
    "us-gaap_ConsolidationPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ConsolidationPolicyTextBlock",
     "presentation": [
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Consolidation",
        "label": "Consolidation, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary."
       }
      }
     },
     "auth_ref": [
      "r40",
      "r831"
     ]
    },
    "lfvn_ConsultantCommissions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.lifevantage.com/20250630",
     "localname": "ConsultantCommissions",
     "crdr": "debit",
     "calculation": {
      "http://www.lifevantage.com/role/SegmentInformationScheduleofSegmentRevenueandExpenseDetails": {
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.lifevantage.com/role/SegmentInformationScheduleofSegmentRevenueandExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Consultant commissions",
        "label": "Consultant Commissions",
        "documentation": "Consultant Commissions"
       }
      }
     },
     "auth_ref": []
    },
    "lfvn_ConsultantIncentivesPromotionsAndRecognitionExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.lifevantage.com/20250630",
     "localname": "ConsultantIncentivesPromotionsAndRecognitionExpense",
     "crdr": "debit",
     "calculation": {
      "http://www.lifevantage.com/role/SegmentInformationScheduleofSegmentRevenueandExpenseDetails": {
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.lifevantage.com/role/SegmentInformationScheduleofSegmentRevenueandExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Consultant incentives, promotions, and recognition",
        "label": "Consultant Incentives, Promotions And Recognition Expense",
        "documentation": "Consultant Incentives, Promotions And Recognition Expense"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ContractWithCustomerLiabilityCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ContractWithCustomerLiabilityCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.lifevantage.com/role/OtherAccruedExpensesDetails": {
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.lifevantage.com/role/OtherAccruedExpensesDetails",
      "http://www.lifevantage.com/role/RevenueNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred revenue",
        "label": "Contract with Customer, Liability, Current",
        "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current."
       }
      }
     },
     "auth_ref": [
      "r424",
      "r425",
      "r427",
      "r446"
     ]
    },
    "us-gaap_ContractWithCustomerLiabilityRevenueRecognized": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ContractWithCustomerLiabilityRevenueRecognized",
     "crdr": "credit",
     "presentation": [
      "http://www.lifevantage.com/role/RevenueNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Increase in revenue from recognition of deferred revenue",
        "label": "Contract with Customer, Liability, Revenue Recognized",
        "documentation": "Amount of revenue recognized that was previously included in balance of obligation to transfer good or service to customer for which consideration from customer has been received or is due."
       }
      }
     },
     "auth_ref": [
      "r447"
     ]
    },
    "us-gaap_CostOfGoodsAndServicesSold": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CostOfGoodsAndServicesSold",
     "crdr": "debit",
     "calculation": {
      "http://www.lifevantage.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOME": {
       "parentTag": "us-gaap_GrossProfit",
       "weight": -1.0,
       "order": 2.0
      },
      "http://www.lifevantage.com/role/SegmentInformationScheduleofSegmentRevenueandExpenseDetails": {
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.lifevantage.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOME",
      "http://www.lifevantage.com/role/SegmentInformationScheduleofSegmentRevenueandExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cost of sales",
        "negatedTerseLabel": "Cost of sales",
        "label": "Cost of Product and Service Sold",
        "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities."
       }
      }
     },
     "auth_ref": [
      "r68",
      "r69",
      "r624",
      "r825",
      "r830",
      "r902",
      "r1105"
     ]
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cover [Abstract]",
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "lfvn_CreditCardAndBankingProcessingFees": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.lifevantage.com/20250630",
     "localname": "CreditCardAndBankingProcessingFees",
     "crdr": "debit",
     "calculation": {
      "http://www.lifevantage.com/role/SegmentInformationScheduleofSegmentRevenueandExpenseDetails": {
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0,
       "order": 9.0
      }
     },
     "presentation": [
      "http://www.lifevantage.com/role/SegmentInformationScheduleofSegmentRevenueandExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Credit card and bank processing fees",
        "label": "Credit Card And Banking Processing Fees",
        "documentation": "Credit Card And Banking Processing Fees"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CreditFacilityAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CreditFacilityAxis",
     "presentation": [
      "http://www.lifevantage.com/role/LongTermDebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Credit Facility [Axis]",
        "label": "Credit Facility [Axis]",
        "documentation": "Information by type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing."
       }
      }
     },
     "auth_ref": [
      "r358",
      "r1168"
     ]
    },
    "us-gaap_CreditFacilityDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CreditFacilityDomain",
     "presentation": [
      "http://www.lifevantage.com/role/LongTermDebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Credit Facility [Domain]",
        "label": "Credit Facility [Domain]",
        "documentation": "Type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing."
       }
      }
     },
     "auth_ref": [
      "r358",
      "r1168"
     ]
    },
    "us-gaap_CurrentFederalTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CurrentFederalTaxExpenseBenefit",
     "crdr": "debit",
     "calculation": {
      "http://www.lifevantage.com/role/IncomeTaxesIncomeTaxExpenseDetails": {
       "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.lifevantage.com/role/IncomeTaxesIncomeTaxExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Federal",
        "label": "Current Federal Tax Expense (Benefit)",
        "documentation": "Amount of current federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current national tax expense (benefit) for non-US (United States of America) jurisdiction."
       }
      }
     },
     "auth_ref": [
      "r1054",
      "r1113",
      "r1120",
      "r1217"
     ]
    },
    "dei_CurrentFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CurrentFiscalYearEndDate",
     "presentation": [
      "http://www.lifevantage.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Current Fiscal Year End Date",
        "label": "Current Fiscal Year End Date",
        "documentation": "End date of current fiscal year in the format --MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CurrentForeignTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CurrentForeignTaxExpenseBenefit",
     "crdr": "debit",
     "calculation": {
      "http://www.lifevantage.com/role/IncomeTaxesIncomeTaxExpenseDetails": {
       "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.lifevantage.com/role/IncomeTaxesIncomeTaxExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Foreign",
        "label": "Current Foreign Tax Expense (Benefit)",
        "documentation": "Amount of current foreign income tax expense (benefit) pertaining to income (loss) from continuing operations."
       }
      }
     },
     "auth_ref": [
      "r1054",
      "r1113",
      "r1120"
     ]
    },
    "us-gaap_CurrentIncomeTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CurrentIncomeTaxExpenseBenefit",
     "crdr": "debit",
     "calculation": {
      "http://www.lifevantage.com/role/IncomeTaxesIncomeTaxExpenseDetails": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.lifevantage.com/role/IncomeTaxesIncomeTaxExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total current income tax provision",
        "label": "Current Income Tax Expense (Benefit)",
        "documentation": "Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations."
       }
      }
     },
     "auth_ref": [
      "r539",
      "r1113",
      "r1120"
     ]
    },
    "us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract",
     "presentation": [
      "http://www.lifevantage.com/role/IncomeTaxesIncomeTaxExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Current taxes:",
        "label": "Current Income Tax Expense (Benefit), Continuing Operations [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CurrentStateAndLocalTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CurrentStateAndLocalTaxExpenseBenefit",
     "crdr": "debit",
     "calculation": {
      "http://www.lifevantage.com/role/IncomeTaxesIncomeTaxExpenseDetails": {
       "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.lifevantage.com/role/IncomeTaxesIncomeTaxExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "State",
        "label": "Current State and Local Tax Expense (Benefit)",
        "documentation": "Amount of current state and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction."
       }
      }
     },
     "auth_ref": [
      "r1054",
      "r1113",
      "r1120",
      "r1217"
     ]
    },
    "cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2025",
     "localname": "CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Board Committee or Subcommittee Responsible for Oversight [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r951",
      "r1040"
     ]
    },
    "cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2025",
     "localname": "CybersecurityRiskBoardOfDirectorsOversightTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Board of Directors Oversight [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r951",
      "r1040"
     ]
    },
    "cyd_CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2025",
     "localname": "CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management Expertise of Management Responsible [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r953",
      "r1042"
     ]
    },
    "cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2025",
     "localname": "CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management Positions or Committees Responsible [Flag]"
       }
      }
     },
     "auth_ref": [
      "r953",
      "r1042"
     ]
    },
    "cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2025",
     "localname": "CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management Positions or Committees Responsible Report to Board [Flag]"
       }
      }
     },
     "auth_ref": [
      "r955",
      "r1044"
     ]
    },
    "cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2025",
     "localname": "CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management Positions or Committees Responsible [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r953",
      "r1042"
     ]
    },
    "cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2025",
     "localname": "CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management Processes for Assessing, Identifying, and Managing Threats [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r946",
      "r1035"
     ]
    },
    "cyd_CybersecurityRiskManagementProcessesIntegratedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2025",
     "localname": "CybersecurityRiskManagementProcessesIntegratedFlag",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management Processes Integrated [Flag]"
       }
      }
     },
     "auth_ref": [
      "r947",
      "r1036"
     ]
    },
    "cyd_CybersecurityRiskManagementProcessesIntegratedTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2025",
     "localname": "CybersecurityRiskManagementProcessesIntegratedTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management Processes Integrated [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r947",
      "r1036"
     ]
    },
    "cyd_CybersecurityRiskManagementStrategyAndGovernanceAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2025",
     "localname": "CybersecurityRiskManagementStrategyAndGovernanceAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management, Strategy, and Governance [Abstract]"
       }
      }
     },
     "auth_ref": [
      "r945",
      "r1034"
     ]
    },
    "cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2025",
     "localname": "CybersecurityRiskManagementStrategyAndGovernanceLineItems",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management, Strategy, and Governance [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r945",
      "r1034"
     ]
    },
    "cyd_CybersecurityRiskManagementStrategyAndGovernanceTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2025",
     "localname": "CybersecurityRiskManagementStrategyAndGovernanceTable",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management, Strategy, and Governance [Table]"
       }
      }
     },
     "auth_ref": [
      "r945",
      "r1034"
     ]
    },
    "cyd_CybersecurityRiskManagementThirdPartyEngagedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2025",
     "localname": "CybersecurityRiskManagementThirdPartyEngagedFlag",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management Third Party Engaged [Flag]"
       }
      }
     },
     "auth_ref": [
      "r948",
      "r1037"
     ]
    },
    "cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2025",
     "localname": "CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Flag]"
       }
      }
     },
     "auth_ref": [
      "r950",
      "r1039"
     ]
    },
    "cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2025",
     "localname": "CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r950",
      "r1039"
     ]
    },
    "cyd_CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2025",
     "localname": "CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Process for Informing Board Committee or Subcommittee Responsible for Oversight [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r951",
      "r1040"
     ]
    },
    "cyd_CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2025",
     "localname": "CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Process for Informing Management or Committees Responsible [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r954",
      "r1043"
     ]
    },
    "cyd_CybersecurityRiskRoleOfManagementTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2025",
     "localname": "CybersecurityRiskRoleOfManagementTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Role of Management [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r952",
      "r1041"
     ]
    },
    "cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2025",
     "localname": "CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Third Party Oversight and Identification Processes [Flag]"
       }
      }
     },
     "auth_ref": [
      "r949",
      "r1038"
     ]
    },
    "us-gaap_DebtDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DebtDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt Disclosure [Abstract]",
        "label": "Debt Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DebtDisclosureTextBlock",
     "presentation": [
      "http://www.lifevantage.com/role/LongTermDebt"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Long-Term Debt",
        "label": "Debt Disclosure [Text Block]",
        "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants."
       }
      }
     },
     "auth_ref": [
      "r90",
      "r208",
      "r210",
      "r344",
      "r345",
      "r346",
      "r347",
      "r348",
      "r357",
      "r358",
      "r368",
      "r374",
      "r375",
      "r376",
      "r377",
      "r378",
      "r379",
      "r384",
      "r391",
      "r392",
      "r393",
      "r561",
      "r593"
     ]
    },
    "us-gaap_DebtInstrumentAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DebtInstrumentAxis",
     "presentation": [
      "http://www.lifevantage.com/role/LongTermDebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt Instrument [Axis]",
        "label": "Debt Instrument [Axis]",
        "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities."
       }
      }
     },
     "auth_ref": [
      "r15",
      "r44",
      "r45",
      "r102",
      "r106",
      "r369",
      "r370",
      "r371",
      "r372",
      "r373",
      "r375",
      "r380",
      "r381",
      "r382",
      "r383",
      "r385",
      "r386",
      "r387",
      "r388",
      "r389",
      "r390",
      "r852",
      "r853",
      "r854",
      "r855",
      "r856",
      "r907",
      "r1113",
      "r1114",
      "r1117",
      "r1122",
      "r1161",
      "r1162",
      "r1163",
      "r1224",
      "r1226",
      "r1239"
     ]
    },
    "us-gaap_DebtInstrumentBasisSpreadOnVariableRate1": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DebtInstrumentBasisSpreadOnVariableRate1",
     "presentation": [
      "http://www.lifevantage.com/role/LongTermDebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Basis spread on variable rate",
        "label": "Debt Instrument, Basis Spread on Variable Rate",
        "documentation": "Percentage points added to the reference rate to compute the variable rate on the debt instrument."
       }
      }
     },
     "auth_ref": []
    },
    "lfvn_DebtInstrumentFloorInterestRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.lifevantage.com/20250630",
     "localname": "DebtInstrumentFloorInterestRate",
     "presentation": [
      "http://www.lifevantage.com/role/LongTermDebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Floor interest rate",
        "label": "Debt Instrument, Floor Interest Rate",
        "documentation": "Debt Instrument, Floor Interest Rate"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtInstrumentInterestRateEffectivePercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DebtInstrumentInterestRateEffectivePercentage",
     "presentation": [
      "http://www.lifevantage.com/role/LongTermDebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt instrument, effective interest rate",
        "label": "Debt Instrument, Interest Rate, Effective Percentage",
        "documentation": "Effective interest rate for the funds borrowed under the debt agreement considering interest compounding and original issue discount or premium."
       }
      }
     },
     "auth_ref": [
      "r47",
      "r394",
      "r593",
      "r594",
      "r907"
     ]
    },
    "us-gaap_DebtInstrumentNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DebtInstrumentNameDomain",
     "presentation": [
      "http://www.lifevantage.com/role/LongTermDebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt Instrument, Name [Domain]",
        "label": "Debt Instrument, Name [Domain]",
        "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities."
       }
      }
     },
     "auth_ref": [
      "r15",
      "r369",
      "r370",
      "r371",
      "r372",
      "r373",
      "r375",
      "r380",
      "r381",
      "r382",
      "r383",
      "r385",
      "r386",
      "r387",
      "r388",
      "r389",
      "r390",
      "r852",
      "r853",
      "r854",
      "r855",
      "r856",
      "r907",
      "r1113",
      "r1114",
      "r1117",
      "r1122",
      "r1161",
      "r1162",
      "r1163",
      "r1224",
      "r1226",
      "r1239"
     ]
    },
    "us-gaap_DeferredFederalIncomeTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DeferredFederalIncomeTaxExpenseBenefit",
     "crdr": "debit",
     "calculation": {
      "http://www.lifevantage.com/role/IncomeTaxesIncomeTaxExpenseDetails": {
       "parentTag": "us-gaap_DeferredIncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.lifevantage.com/role/IncomeTaxesIncomeTaxExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Federal",
        "label": "Deferred Federal Income Tax Expense (Benefit)",
        "documentation": "Amount of deferred federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred national tax expense (benefit) for non-US (United States of America) jurisdiction."
       }
      }
     },
     "auth_ref": [
      "r1113",
      "r1120",
      "r1216",
      "r1217"
     ]
    },
    "us-gaap_DeferredForeignIncomeTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DeferredForeignIncomeTaxExpenseBenefit",
     "crdr": "debit",
     "calculation": {
      "http://www.lifevantage.com/role/IncomeTaxesIncomeTaxExpenseDetails": {
       "parentTag": "us-gaap_DeferredIncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.lifevantage.com/role/IncomeTaxesIncomeTaxExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Foreign",
        "label": "Deferred Foreign Income Tax Expense (Benefit)",
        "documentation": "Amount of deferred foreign income tax expense (benefit) pertaining to income (loss) from continuing operations."
       }
      }
     },
     "auth_ref": [
      "r1113",
      "r1120",
      "r1216"
     ]
    },
    "us-gaap_DeferredIncomeTaxAssetsNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DeferredIncomeTaxAssetsNet",
     "crdr": "debit",
     "calculation": {
      "http://www.lifevantage.com/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.lifevantage.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred income tax asset",
        "label": "Deferred Income Tax Assets, Net",
        "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting."
       }
      }
     },
     "auth_ref": [
      "r507",
      "r508"
     ]
    },
    "us-gaap_DeferredIncomeTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DeferredIncomeTaxExpenseBenefit",
     "crdr": "debit",
     "calculation": {
      "http://www.lifevantage.com/role/IncomeTaxesIncomeTaxExpenseDetails": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.lifevantage.com/role/IncomeTaxesIncomeTaxExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total deferred income tax provision",
        "label": "Deferred Income Tax Expense (Benefit)",
        "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations."
       }
      }
     },
     "auth_ref": [
      "r6",
      "r122",
      "r1113",
      "r1120"
     ]
    },
    "us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract",
     "presentation": [
      "http://www.lifevantage.com/role/IncomeTaxesIncomeTaxExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Deferred taxes:",
        "label": "Deferred Income Tax Expense (Benefit), Continuing Operations [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredIncomeTaxLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DeferredIncomeTaxLiabilities",
     "crdr": "credit",
     "calculation": {
      "http://www.lifevantage.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsLiabilitiesNet",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.lifevantage.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTotalLabel": "Gross deferred tax liabilities",
        "label": "Deferred Tax Liabilities, Gross",
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences."
       }
      }
     },
     "auth_ref": [
      "r52",
      "r53",
      "r104",
      "r531"
     ]
    },
    "us-gaap_DeferredIncomeTaxesAndTaxCredits": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DeferredIncomeTaxesAndTaxCredits",
     "crdr": "debit",
     "calculation": {
      "http://www.lifevantage.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 11.0
      }
     },
     "presentation": [
      "http://www.lifevantage.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred income tax",
        "label": "Deferred Income Taxes and Tax Credits",
        "documentation": "Amount of deferred income tax expense (benefit) and income tax credits."
       }
      }
     },
     "auth_ref": [
      "r82"
     ]
    },
    "us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DeferredStateAndLocalIncomeTaxExpenseBenefit",
     "crdr": "debit",
     "calculation": {
      "http://www.lifevantage.com/role/IncomeTaxesIncomeTaxExpenseDetails": {
       "parentTag": "us-gaap_DeferredIncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.lifevantage.com/role/IncomeTaxesIncomeTaxExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "State",
        "label": "Deferred State and Local Income Tax Expense (Benefit)",
        "documentation": "Amount of deferred state and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction."
       }
      }
     },
     "auth_ref": [
      "r1113",
      "r1120",
      "r1216",
      "r1217"
     ]
    },
    "us-gaap_DeferredTaxAssetsGross": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DeferredTaxAssetsGross",
     "crdr": "debit",
     "calculation": {
      "http://www.lifevantage.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsLiabilitiesNet",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.lifevantage.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Gross deferred tax asset",
        "label": "Deferred Tax Assets, Gross",
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards."
       }
      }
     },
     "auth_ref": [
      "r532"
     ]
    },
    "us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DeferredTaxAssetsInProcessResearchAndDevelopment",
     "crdr": "debit",
     "calculation": {
      "http://www.lifevantage.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.lifevantage.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Section 174 costs",
        "label": "Deferred Tax Asset, In-Process Research and Development",
        "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary difference from in-process research and development cost acquired in business combination or from joint venture formation or both."
       }
      }
     },
     "auth_ref": [
      "r1214"
     ]
    },
    "lfvn_DeferredTaxAssetsLeasingArrangements": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.lifevantage.com/20250630",
     "localname": "DeferredTaxAssetsLeasingArrangements",
     "crdr": "debit",
     "calculation": {
      "http://www.lifevantage.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.lifevantage.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Lease liability",
        "label": "Deferred Tax Assets, Leasing Arrangements",
        "documentation": "Deferred Tax Assets, Leasing Arrangements"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredTaxAssetsLiabilitiesNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DeferredTaxAssetsLiabilitiesNet",
     "crdr": "debit",
     "calculation": {
      "http://www.lifevantage.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.lifevantage.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Deferred tax assets, net",
        "label": "Deferred Tax Assets, Net",
        "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, without jurisdictional netting."
       }
      }
     },
     "auth_ref": [
      "r1209"
     ]
    },
    "us-gaap_DeferredTaxAssetsOperatingLossCarryforwards": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DeferredTaxAssetsOperatingLossCarryforwards",
     "crdr": "debit",
     "calculation": {
      "http://www.lifevantage.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.lifevantage.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Federal, state, and foreign net operating loss carryovers",
        "label": "Deferred Tax Assets, Operating Loss Carryforwards",
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards."
       }
      }
     },
     "auth_ref": [
      "r1214"
     ]
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost",
     "crdr": "debit",
     "calculation": {
      "http://www.lifevantage.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.lifevantage.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Stock option compensation",
        "label": "Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-Based Compensation Cost",
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from share-based compensation."
       }
      }
     },
     "auth_ref": [
      "r1214"
     ]
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals",
     "crdr": "debit",
     "calculation": {
      "http://www.lifevantage.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.lifevantage.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Accrued vacation, allowance for returns, bonuses\u00a0&amp; other",
        "label": "Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals",
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from reserves and accruals."
       }
      }
     },
     "auth_ref": [
      "r1214"
     ]
    },
    "us-gaap_DeferredTaxAssetsValuationAllowance": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DeferredTaxAssetsValuationAllowance",
     "crdr": "credit",
     "calculation": {
      "http://www.lifevantage.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsLiabilitiesNet",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.lifevantage.com/role/IncomeTaxesDeferredTaxAssetsValuationAllowanceScheduleDetails",
      "http://www.lifevantage.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Less: valuation allowance",
        "periodStartLabel": "Beginning balance",
        "periodEndLabel": "Ending balance",
        "label": "Deferred Tax Assets, Valuation Allowance",
        "documentation": "Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized."
       }
      }
     },
     "auth_ref": [
      "r533"
     ]
    },
    "us-gaap_DeferredTaxLiabilitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DeferredTaxLiabilitiesAbstract",
     "presentation": [
      "http://www.lifevantage.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Deferred tax liabilities:",
        "label": "Deferred Tax Liabilities, Gross [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets",
     "crdr": "credit",
     "calculation": {
      "http://www.lifevantage.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.lifevantage.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Patents and trademarks",
        "label": "Deferred Tax Liabilities, Intangible Assets",
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from intangible assets other than goodwill."
       }
      }
     },
     "auth_ref": [
      "r1214"
     ]
    },
    "us-gaap_DeferredTaxLiabilitiesLeasingArrangements": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DeferredTaxLiabilitiesLeasingArrangements",
     "crdr": "credit",
     "calculation": {
      "http://www.lifevantage.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.lifevantage.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Right of use asset",
        "label": "Deferred Tax Liabilities, Leasing Arrangements",
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from leasing arrangements."
       }
      }
     },
     "auth_ref": [
      "r1214"
     ]
    },
    "us-gaap_DeferredTaxLiabilitiesOther": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DeferredTaxLiabilitiesOther",
     "crdr": "credit",
     "calculation": {
      "http://www.lifevantage.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.lifevantage.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Other",
        "label": "Deferred Tax Liabilities, Other",
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences classified as other."
       }
      }
     },
     "auth_ref": [
      "r1214"
     ]
    },
    "us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DeferredTaxLiabilitiesPropertyPlantAndEquipment",
     "crdr": "credit",
     "calculation": {
      "http://www.lifevantage.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.lifevantage.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Property\u00a0&amp; equipment",
        "label": "Deferred Tax Liabilities, Property, Plant and Equipment",
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from property, plant, and equipment."
       }
      }
     },
     "auth_ref": [
      "r1214"
     ]
    },
    "us-gaap_Depreciation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "Depreciation",
     "crdr": "debit",
     "presentation": [
      "http://www.lifevantage.com/role/PropertyandEquipmentNetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Depreciation expense",
        "label": "Depreciation",
        "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation."
       }
      }
     },
     "auth_ref": [
      "r6",
      "r30",
      "r196",
      "r824",
      "r825",
      "r827",
      "r829"
     ]
    },
    "us-gaap_DepreciationDepletionAndAmortization": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DepreciationDepletionAndAmortization",
     "crdr": "debit",
     "calculation": {
      "http://www.lifevantage.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.lifevantage.com/role/SegmentInformationScheduleofSegmentRevenueandExpenseDetails": {
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://www.lifevantage.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.lifevantage.com/role/SegmentInformationScheduleofSegmentRevenueandExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Depreciation and amortization",
        "negatedTerseLabel": "Depreciation and amortization",
        "label": "Depreciation, Depletion and Amortization",
        "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets."
       }
      }
     },
     "auth_ref": [
      "r6",
      "r198",
      "r251",
      "r269",
      "r293",
      "r824",
      "r844",
      "r845"
     ]
    },
    "us-gaap_DilutiveSecuritiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DilutiveSecuritiesAbstract",
     "presentation": [
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesComputationofNetIncomePerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Effect of dilutive securities:",
        "label": "Dilutive Securities, Effect on Basic Earnings Per Share [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DisaggregationOfRevenueLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DisaggregationOfRevenueLineItems",
     "presentation": [
      "http://www.lifevantage.com/role/RevenueSalesReturnDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Disaggregation of Revenue [Line Items]",
        "label": "Disaggregation of Revenue [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r444",
      "r445",
      "r860",
      "r861",
      "r862",
      "r863",
      "r864",
      "r865",
      "r866"
     ]
    },
    "us-gaap_DisaggregationOfRevenueTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DisaggregationOfRevenueTable",
     "presentation": [
      "http://www.lifevantage.com/role/RevenueSalesReturnDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Disaggregation of Revenue [Table]",
        "label": "Disaggregation of Revenue [Table]",
        "documentation": "Disclosure of information about disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor."
       }
      }
     },
     "auth_ref": [
      "r444",
      "r445",
      "r860",
      "r861",
      "r862",
      "r863",
      "r864",
      "r865",
      "r866"
     ]
    },
    "us-gaap_DisaggregationOfRevenueTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DisaggregationOfRevenueTableTextBlock",
     "presentation": [
      "http://www.lifevantage.com/role/RevenueTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Disaggregation of Revenue",
        "label": "Disaggregation of Revenue [Table Text Block]",
        "documentation": "Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor."
       }
      }
     },
     "auth_ref": [
      "r1173"
     ]
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
     "presentation": [
      "http://www.lifevantage.com/role/ShareBasedCompensation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share-Based Compensation",
        "label": "Share-Based Payment Arrangement [Text Block]",
        "documentation": "The entire disclosure for share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r451",
      "r456",
      "r486",
      "r487",
      "r489",
      "r868"
     ]
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share-based Payment Arrangement [Abstract]",
        "label": "Share-Based Payment Arrangement [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DividendsCash": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DividendsCash",
     "crdr": "debit",
     "presentation": [
      "http://www.lifevantage.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Cash dividends",
        "label": "Dividends, Cash",
        "documentation": "Amount of paid and unpaid cash dividends declared for classes of stock, for example, but not limited to, common and preferred."
       }
      }
     },
     "auth_ref": [
      "r4",
      "r94"
     ]
    },
    "us-gaap_DividendsCommonStockCash": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DividendsCommonStockCash",
     "crdr": "debit",
     "presentation": [
      "http://www.lifevantage.com/role/StockholdersEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash dividend, common stock",
        "label": "Dividends, Common Stock, Cash",
        "documentation": "Amount of paid and unpaid common stock dividends declared with the form of settlement in cash."
       }
      }
     },
     "auth_ref": [
      "r94"
     ]
    },
    "dei_DocumentAnnualReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentAnnualReport",
     "presentation": [
      "http://www.lifevantage.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Annual Report",
        "label": "Document Annual Report",
        "documentation": "Boolean flag that is true only for a form used as an annual report."
       }
      }
     },
     "auth_ref": [
      "r942",
      "r943",
      "r966"
     ]
    },
    "dei_DocumentFinStmtErrorCorrectionFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentFinStmtErrorCorrectionFlag",
     "presentation": [
      "http://www.lifevantage.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Financial Statement Error Correction [Flag]",
        "label": "Document Financial Statement Error Correction [Flag]",
        "documentation": "Indicates whether any of the financial statement period in the filing include a restatement due to error correction."
       }
      }
     },
     "auth_ref": [
      "r942",
      "r943",
      "r966",
      "r1009"
     ]
    },
    "dei_DocumentFiscalPeriodFocus": {
     "xbrltype": "fiscalPeriodItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentFiscalPeriodFocus",
     "presentation": [
      "http://www.lifevantage.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Fiscal Period Focus",
        "label": "Document Fiscal Period Focus",
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalYearFocus": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentFiscalYearFocus",
     "presentation": [
      "http://www.lifevantage.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Fiscal Year Focus",
        "label": "Document Fiscal Year Focus",
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://www.lifevantage.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Period End Date",
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentTransitionReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentTransitionReport",
     "presentation": [
      "http://www.lifevantage.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Transition Report",
        "label": "Document Transition Report",
        "documentation": "Boolean flag that is true only for a form used as a transition report."
       }
      }
     },
     "auth_ref": [
      "r987"
     ]
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentType",
     "presentation": [
      "http://www.lifevantage.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Type",
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "presentation": [
      "http://www.lifevantage.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Documents Incorporated by Reference",
        "label": "Documents Incorporated by Reference [Text Block]",
        "documentation": "Documents incorporated by reference."
       }
      }
     },
     "auth_ref": [
      "r940"
     ]
    },
    "ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year",
        "label": "Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year [Member]"
       }
      }
     },
     "auth_ref": [
      "r998"
     ]
    },
    "us-gaap_EarningsPerShareAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EarningsPerShareAbstract",
     "presentation": [
      "http://www.lifevantage.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOME"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net income per share:",
        "label": "Earnings Per Share [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EarningsPerShareBasic": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EarningsPerShareBasic",
     "presentation": [
      "http://www.lifevantage.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOME",
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesComputationofNetIncomePerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Basic (dollars per share)",
        "terseLabel": "Income per share, basic (dollars per share)",
        "label": "Earnings Per Share, Basic",
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r158",
      "r191",
      "r227",
      "r228",
      "r229",
      "r230",
      "r231",
      "r232",
      "r233",
      "r234",
      "r238",
      "r240",
      "r245",
      "r246",
      "r247",
      "r250",
      "r396",
      "r490",
      "r551",
      "r556",
      "r574",
      "r575",
      "r664",
      "r685",
      "r834"
     ]
    },
    "us-gaap_EarningsPerShareBasicAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EarningsPerShareBasicAbstract",
     "presentation": [
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesComputationofNetIncomePerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Reconciliation of earnings per share and the weighted-average common shares outstanding for purposes of computing basic and diluted net income per share",
        "label": "Earnings Per Share, Basic [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EarningsPerShareDiluted": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EarningsPerShareDiluted",
     "presentation": [
      "http://www.lifevantage.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOME",
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesComputationofNetIncomePerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Diluted (dollars per share)",
        "verboseLabel": "Income per share, diluted (dollars per share)",
        "label": "Earnings Per Share, Diluted",
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r158",
      "r191",
      "r227",
      "r228",
      "r229",
      "r230",
      "r231",
      "r232",
      "r233",
      "r234",
      "r240",
      "r245",
      "r246",
      "r247",
      "r250",
      "r396",
      "r490",
      "r551",
      "r556",
      "r574",
      "r575",
      "r664",
      "r685",
      "r834"
     ]
    },
    "us-gaap_EarningsPerSharePolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EarningsPerSharePolicyTextBlock",
     "presentation": [
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Income Per Share",
        "label": "Earnings Per Share, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements."
       }
      }
     },
     "auth_ref": [
      "r22",
      "r23",
      "r249"
     ]
    },
    "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "crdr": "debit",
     "calculation": {
      "http://www.lifevantage.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.lifevantage.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Foreign Currency Effect on Cash",
        "label": "Effect of Exchange Rate on Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation",
        "documentation": "Amount of increase (decrease) from effect of exchange rate change on cash and cash equivalent, and cash and cash equivalent restricted to withdrawal or usage; held in foreign currency; attributable to continuing operation. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate."
       }
      }
     },
     "auth_ref": [
      "r585"
     ]
    },
    "us-gaap_EffectiveIncomeTaxRateContinuingOperations": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EffectiveIncomeTaxRateContinuingOperations",
     "calculation": {
      "http://www.lifevantage.com/role/IncomeTaxesEffectiveIncomeTaxRateDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.lifevantage.com/role/IncomeTaxesEffectiveIncomeTaxRateDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net income tax provision",
        "label": "Effective Income Tax Rate Reconciliation, Percent",
        "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations."
       }
      }
     },
     "auth_ref": [
      "r511",
      "r871"
     ]
    },
    "us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract",
     "presentation": [
      "http://www.lifevantage.com/role/IncomeTaxesEffectiveIncomeTaxRateDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "The effective income tax rate differs from the U.S. Federal statutory income tax rate",
        "label": "Effective Income Tax Rate Reconciliation, Percent [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
     "calculation": {
      "http://www.lifevantage.com/role/IncomeTaxesEffectiveIncomeTaxRateDetails": {
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.lifevantage.com/role/IncomeTaxesEffectiveIncomeTaxRateDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Federal statutory income tax rate",
        "label": "Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent",
        "documentation": "Percentage of domestic federal statutory tax rate applicable to pretax income (loss)."
       }
      }
     },
     "auth_ref": [
      "r208",
      "r214",
      "r511",
      "r542",
      "r871"
     ]
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance",
     "calculation": {
      "http://www.lifevantage.com/role/IncomeTaxesEffectiveIncomeTaxRateDetails": {
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0,
       "order": 18.0
      }
     },
     "presentation": [
      "http://www.lifevantage.com/role/IncomeTaxesEffectiveIncomeTaxRateDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Change in valuation allowance",
        "label": "Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent",
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the valuation allowance for deferred tax assets."
       }
      }
     },
     "auth_ref": [
      "r518",
      "r871",
      "r1113",
      "r1121",
      "r1205"
     ]
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate",
     "calculation": {
      "http://www.lifevantage.com/role/IncomeTaxesEffectiveIncomeTaxRateDetails": {
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://www.lifevantage.com/role/IncomeTaxesEffectiveIncomeTaxRateDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Revalue of deferred for change in federal tax rate",
        "label": "Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Percent",
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the income tax rates."
       }
      }
     },
     "auth_ref": [
      "r516",
      "r871",
      "r1113",
      "r1121",
      "r1205"
     ]
    },
    "lfvn_EffectiveIncomeTaxRateReconciliationChangeInUncertainTaxPositions": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.lifevantage.com/20250630",
     "localname": "EffectiveIncomeTaxRateReconciliationChangeInUncertainTaxPositions",
     "calculation": {
      "http://www.lifevantage.com/role/IncomeTaxesEffectiveIncomeTaxRateDetails": {
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0,
       "order": 15.0
      }
     },
     "presentation": [
      "http://www.lifevantage.com/role/IncomeTaxesEffectiveIncomeTaxRateDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "\u2014 change in uncertain tax positions",
        "label": "Effective Income Tax Rate Reconciliation, Change In UncertainTax Positions",
        "documentation": "Effective Income Tax Rate Reconciliation, Change In UncertainTax Positions"
       }
      }
     },
     "auth_ref": []
    },
    "lfvn_EffectiveIncomeTaxRateReconciliationCurrentYearSection162mLimitationPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.lifevantage.com/20250630",
     "localname": "EffectiveIncomeTaxRateReconciliationCurrentYearSection162mLimitationPercent",
     "calculation": {
      "http://www.lifevantage.com/role/IncomeTaxesEffectiveIncomeTaxRateDetails": {
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://www.lifevantage.com/role/IncomeTaxesEffectiveIncomeTaxRateDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "\u2014 current year section 162(m) limitation",
        "label": "Effective Income Tax Rate Reconciliation, Current Year Section 162(m) Limitation, Percent",
        "documentation": "Effective Income Tax Rate Reconciliation, Current Year Section 162(m) Limitation, Percent"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationFdiiPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EffectiveIncomeTaxRateReconciliationFdiiPercent",
     "calculation": {
      "http://www.lifevantage.com/role/IncomeTaxesEffectiveIncomeTaxRateDetails": {
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": -1.0,
       "order": 11.0
      }
     },
     "presentation": [
      "http://www.lifevantage.com/role/IncomeTaxesEffectiveIncomeTaxRateDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "\u2014 foreign derived intangible income deduction",
        "label": "Effective Income Tax Rate Reconciliation, FDII, Percent",
        "documentation": "Percentage of reported income tax benefit from difference to income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operations, attributable to foreign-derived intangible income (FDII)."
       }
      }
     },
     "auth_ref": [
      "r871",
      "r1205",
      "r1207"
     ]
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential",
     "calculation": {
      "http://www.lifevantage.com/role/IncomeTaxesEffectiveIncomeTaxRateDetails": {
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.lifevantage.com/role/IncomeTaxesEffectiveIncomeTaxRateDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Foreign tax rate difference",
        "label": "Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Percent",
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to statutory income tax expense (benefit) outside of the country of domicile."
       }
      }
     },
     "auth_ref": [
      "r512",
      "r515",
      "r871",
      "r1113",
      "r1121",
      "r1205"
     ]
    },
    "lfvn_EffectiveIncomeTaxRateReconciliationForeignWithholdingTaxPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.lifevantage.com/20250630",
     "localname": "EffectiveIncomeTaxRateReconciliationForeignWithholdingTaxPercent",
     "calculation": {
      "http://www.lifevantage.com/role/IncomeTaxesEffectiveIncomeTaxRateDetails": {
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.lifevantage.com/role/IncomeTaxesEffectiveIncomeTaxRateDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Foreign withholding tax",
        "label": "Effective Income Tax Rate Reconciliation, Foreign Withholding Tax, Percent",
        "documentation": "Effective Income Tax Rate Reconciliation, Foreign Withholding Tax, Percent"
       }
      }
     },
     "auth_ref": []
    },
    "lfvn_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseLimitationOnFutureStockBasedCompensationExpensePercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.lifevantage.com/20250630",
     "localname": "EffectiveIncomeTaxRateReconciliationNondeductibleExpenseLimitationOnFutureStockBasedCompensationExpensePercent",
     "calculation": {
      "http://www.lifevantage.com/role/IncomeTaxesEffectiveIncomeTaxRateDetails": {
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": -1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.lifevantage.com/role/IncomeTaxesEffectiveIncomeTaxRateDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Limit on future stock compensation due to 162(m)",
        "label": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Limitation On Future Stock Based Compensation Expense, Percent",
        "documentation": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Limitation On Future Stock Based Compensation Expense, Percent"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseMealsAndEntertainment": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EffectiveIncomeTaxRateReconciliationNondeductibleExpenseMealsAndEntertainment",
     "calculation": {
      "http://www.lifevantage.com/role/IncomeTaxesEffectiveIncomeTaxRateDetails": {
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0,
       "order": 13.0
      }
     },
     "presentation": [
      "http://www.lifevantage.com/role/IncomeTaxesEffectiveIncomeTaxRateDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "\u2014 meals and entertainment",
        "label": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Meals and Entertainment, Percent",
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to meals and entertainment expense."
       }
      }
     },
     "auth_ref": [
      "r1113",
      "r1121",
      "r1205",
      "r1207"
     ]
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther",
     "calculation": {
      "http://www.lifevantage.com/role/IncomeTaxesEffectiveIncomeTaxRateDetails": {
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0,
       "order": 17.0
      }
     },
     "presentation": [
      "http://www.lifevantage.com/role/IncomeTaxesEffectiveIncomeTaxRateDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "\u2014 other permanent differences",
        "label": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Percent",
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other nondeductible expenses."
       }
      }
     },
     "auth_ref": [
      "r871",
      "r1113",
      "r1121",
      "r1205",
      "r1207"
     ]
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost",
     "calculation": {
      "http://www.lifevantage.com/role/IncomeTaxesEffectiveIncomeTaxRateDetails": {
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0,
       "order": 9.0
      }
     },
     "presentation": [
      "http://www.lifevantage.com/role/IncomeTaxesEffectiveIncomeTaxRateDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "\u2014 stock-based compensation",
        "label": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-Based Payment Arrangement, Percent",
        "documentation": "Percentage of difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to nondeductible expense for share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r871",
      "r1113",
      "r1121",
      "r1205",
      "r1207"
     ]
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EffectiveIncomeTaxRateReconciliationOtherAdjustments",
     "calculation": {
      "http://www.lifevantage.com/role/IncomeTaxesEffectiveIncomeTaxRateDetails": {
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://www.lifevantage.com/role/IncomeTaxesEffectiveIncomeTaxRateDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other differences",
        "label": "Effective Income Tax Rate Reconciliation, Other Adjustments, Percent",
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments."
       }
      }
     },
     "auth_ref": [
      "r871",
      "r1113",
      "r1121",
      "r1205",
      "r1206"
     ]
    },
    "lfvn_EffectiveIncomeTaxRateReconciliationRemovalOfPermanentReinvestmentAssertion": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.lifevantage.com/20250630",
     "localname": "EffectiveIncomeTaxRateReconciliationRemovalOfPermanentReinvestmentAssertion",
     "calculation": {
      "http://www.lifevantage.com/role/IncomeTaxesEffectiveIncomeTaxRateDetails": {
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0,
       "order": 14.0
      }
     },
     "presentation": [
      "http://www.lifevantage.com/role/IncomeTaxesEffectiveIncomeTaxRateDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "\u2014 removal of additional permanent reinvestment assertions",
        "label": "Effective Income Tax Rate Reconciliation, Removal Of Permanent Reinvestment Assertion",
        "documentation": "Effective Income Tax Rate Reconciliation, Removal Of Permanent Reinvestment Assertion"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount",
     "crdr": "debit",
     "presentation": [
      "http://www.lifevantage.com/role/IncomeTaxesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Tax benefit from settlement of stock based awards",
        "label": "Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-Based Payment Arrangement, Amount",
        "documentation": "Amount of difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to expense for award under share-based payment arrangement. Excludes expense determined to be nondeductible upon grant or after for award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r1203",
      "r1205",
      "r1206"
     ]
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes",
     "calculation": {
      "http://www.lifevantage.com/role/IncomeTaxesEffectiveIncomeTaxRateDetails": {
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.lifevantage.com/role/IncomeTaxesEffectiveIncomeTaxRateDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "State income taxes, net of federal benefit",
        "label": "Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent",
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to state and local income tax expense (benefit), net of federal tax expense (benefit)."
       }
      }
     },
     "auth_ref": [
      "r514",
      "r871",
      "r1113",
      "r1121",
      "r1205"
     ]
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EffectiveIncomeTaxRateReconciliationTaxCredits",
     "calculation": {
      "http://www.lifevantage.com/role/IncomeTaxesEffectiveIncomeTaxRateDetails": {
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": -1.0,
       "order": 12.0
      }
     },
     "presentation": [
      "http://www.lifevantage.com/role/IncomeTaxesEffectiveIncomeTaxRateDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "\u2014 tax credits",
        "label": "Effective Income Tax Rate Reconciliation, Tax Credit, Percent",
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to tax credits. Including, but not limited to, research credit, foreign tax credit, investment tax credit, and other tax credits."
       }
      }
     },
     "auth_ref": [
      "r517",
      "r519",
      "r1113",
      "r1121",
      "r1205"
     ]
    },
    "lfvn_EffectiveIncomeTaxRateReconciliationTaxReturnToProvisionsTrueUp": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.lifevantage.com/20250630",
     "localname": "EffectiveIncomeTaxRateReconciliationTaxReturnToProvisionsTrueUp",
     "calculation": {
      "http://www.lifevantage.com/role/IncomeTaxesEffectiveIncomeTaxRateDetails": {
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.lifevantage.com/role/IncomeTaxesEffectiveIncomeTaxRateDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Tax return to provision true-up",
        "label": "Effective Income Tax Rate Reconciliation Tax Return To Provisions True Up",
        "documentation": "Effective income tax rate reconciliation tax return to provisions true up."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationTaxSettlementsForeign": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EffectiveIncomeTaxRateReconciliationTaxSettlementsForeign",
     "calculation": {
      "http://www.lifevantage.com/role/IncomeTaxesEffectiveIncomeTaxRateDetails": {
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0,
       "order": 16.0
      }
     },
     "presentation": [
      "http://www.lifevantage.com/role/IncomeTaxesEffectiveIncomeTaxRateDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "\u2014 accrual for foreign tax audits",
        "label": "Effective Income Tax Rate Reconciliation, Tax Settlement, Foreign, Percent",
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to foreign income tax settlement."
       }
      }
     },
     "auth_ref": [
      "r1113",
      "r1121",
      "r1205",
      "r1206"
     ]
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized",
     "crdr": "debit",
     "presentation": [
      "http://www.lifevantage.com/role/ShareBasedCompensationStockBasedCompensationNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Unrecognized compensation cost",
        "label": "Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount",
        "documentation": "Amount of cost not yet recognized for nonvested award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r488"
     ]
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1",
     "presentation": [
      "http://www.lifevantage.com/role/ShareBasedCompensationStockBasedCompensationNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Period for recognition of unrecognized compensation cost",
        "label": "Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition",
        "documentation": "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r488"
     ]
    },
    "us-gaap_EmployeeStockOptionMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EmployeeStockOptionMember",
     "presentation": [
      "http://www.lifevantage.com/role/ShareBasedCompensationStockOptionsNarrativeDetails",
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Employee Stock Option",
        "label": "Share-Based Payment Arrangement, Option [Member]",
        "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time."
       }
      }
     },
     "auth_ref": [
      "r1175",
      "r1176",
      "r1177",
      "r1178",
      "r1179",
      "r1180",
      "r1181",
      "r1182",
      "r1183",
      "r1184",
      "r1185",
      "r1187",
      "r1188",
      "r1189",
      "r1190",
      "r1191",
      "r1192",
      "r1193",
      "r1194",
      "r1195",
      "r1196",
      "r1197",
      "r1198",
      "r1199",
      "r1200",
      "r1201"
     ]
    },
    "lfvn_EmployeeStockPurchasePlanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.lifevantage.com/20250630",
     "localname": "EmployeeStockPurchasePlanMember",
     "presentation": [
      "http://www.lifevantage.com/role/ShareBasedCompensationEmployeeStockPurchasePlanNarrativeDetails",
      "http://www.lifevantage.com/role/StockholdersEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "ESPP",
        "label": "Employee Stock Purchase Plan [Member]",
        "documentation": "Employee Stock Purchase Plan [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://www.lifevantage.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Address Line One",
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://www.lifevantage.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Address Line Two",
        "label": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://www.lifevantage.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, City or Town",
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://www.lifevantage.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Postal Zip Code",
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://www.lifevantage.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, State or Province",
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://www.lifevantage.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Central Index Key",
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r939"
     ]
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCommonStockSharesOutstanding",
     "presentation": [
      "http://www.lifevantage.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Common Stock, Shares Outstanding",
        "label": "Entity Common Stock, Shares Outstanding",
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCurrentReportingStatus": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCurrentReportingStatus",
     "presentation": [
      "http://www.lifevantage.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Current Reporting Status",
        "label": "Entity Current Reporting Status",
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://www.lifevantage.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Emerging Growth Company",
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r939"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://www.lifevantage.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity File Number",
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityFilerCategory": {
     "xbrltype": "filerCategoryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityFilerCategory",
     "presentation": [
      "http://www.lifevantage.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Filer Category",
        "label": "Entity Filer Category",
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": [
      "r939"
     ]
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://www.lifevantage.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Incorporation, State or Country Code",
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInteractiveDataCurrent": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityInteractiveDataCurrent",
     "presentation": [
      "http://www.lifevantage.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Interactive Data Current",
        "label": "Entity Interactive Data Current",
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)."
       }
      }
     },
     "auth_ref": [
      "r1049"
     ]
    },
    "dei_EntityPublicFloat": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityPublicFloat",
     "crdr": "credit",
     "presentation": [
      "http://www.lifevantage.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Public Float",
        "label": "Entity Public Float",
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://www.lifevantage.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Registrant Name",
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r939"
     ]
    },
    "dei_EntityShellCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityShellCompany",
     "presentation": [
      "http://www.lifevantage.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Shell Company",
        "label": "Entity Shell Company",
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r939"
     ]
    },
    "dei_EntitySmallBusiness": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntitySmallBusiness",
     "presentation": [
      "http://www.lifevantage.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Small Business",
        "label": "Entity Small Business",
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)."
       }
      }
     },
     "auth_ref": [
      "r939"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://www.lifevantage.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Tax Identification Number",
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r939"
     ]
    },
    "dei_EntityVoluntaryFilers": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityVoluntaryFilers",
     "presentation": [
      "http://www.lifevantage.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Voluntary Filers",
        "label": "Entity Voluntary Filers",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityWellKnownSeasonedIssuer",
     "presentation": [
      "http://www.lifevantage.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Well-known Seasoned Issuer",
        "label": "Entity Well-known Seasoned Issuer",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A."
       }
      }
     },
     "auth_ref": [
      "r1050"
     ]
    },
    "us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EntityWideInformationRevenueFromExternalCustomerLineItems",
     "presentation": [
      "http://www.lifevantage.com/role/RevenueMajorProductsDetails",
      "http://www.lifevantage.com/role/RevenueNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Revenue from External Customer [Line Items]",
        "label": "Revenue from External Customer [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_EqtyAwrdsAdjFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "EqtyAwrdsAdjFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity Awards Adjustments, Footnote",
        "label": "Equity Awards Adjustments, Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r992"
     ]
    },
    "ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity Awards Adjustments, Excluding Value Reported in Compensation Table",
        "label": "Equity Awards Adjustments, Excluding Value Reported in the Compensation Table [Member]"
       }
      }
     },
     "auth_ref": [
      "r1045"
     ]
    },
    "ecd_EqtyAwrdsAdjsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "EqtyAwrdsAdjsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity Awards Adjustments",
        "label": "Equity Awards Adjustments [Member]"
       }
      }
     },
     "auth_ref": [
      "r1045"
     ]
    },
    "ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "EqtyAwrdsInSummryCompstnTblForAplblYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table",
        "label": "Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table [Member]"
       }
      }
     },
     "auth_ref": [
      "r1045"
     ]
    },
    "us-gaap_EquipmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EquipmentMember",
     "presentation": [
      "http://www.lifevantage.com/role/PropertyandEquipmentNetDetails",
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesPropertyandEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Equipment (includes computer hardware and software)",
        "terseLabel": "Equipment (includes computer hardware and software)",
        "label": "Equipment [Member]",
        "documentation": "Tangible personal property used to produce goods and services."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EquityAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity [Abstract]",
        "label": "Equity [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EquityComponentDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EquityComponentDomain",
     "presentation": [
      "http://www.lifevantage.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY",
      "http://www.lifevantage.com/role/StockholdersEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity Component [Domain]",
        "label": "Equity Component [Domain]",
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc."
       }
      }
     },
     "auth_ref": [
      "r10",
      "r156",
      "r157",
      "r158",
      "r186",
      "r187",
      "r188",
      "r222",
      "r223",
      "r224",
      "r226",
      "r233",
      "r235",
      "r237",
      "r252",
      "r308",
      "r309",
      "r342",
      "r395",
      "r423",
      "r490",
      "r540",
      "r541",
      "r548",
      "r549",
      "r550",
      "r552",
      "r555",
      "r556",
      "r562",
      "r563",
      "r564",
      "r565",
      "r566",
      "r567",
      "r568",
      "r569",
      "r570",
      "r571",
      "r573",
      "r586",
      "r588",
      "r589",
      "r590",
      "r591",
      "r592",
      "r595",
      "r597",
      "r614",
      "r683",
      "r707",
      "r708",
      "r709",
      "r728",
      "r781"
     ]
    },
    "ecd_EquityValuationAssumptionDifferenceFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "EquityValuationAssumptionDifferenceFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity Valuation Assumption Difference, Footnote",
        "label": "Equity Valuation Assumption Difference, Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1002"
     ]
    },
    "ecd_ErrCompAnalysisTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ErrCompAnalysisTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Erroneous Compensation Analysis",
        "label": "Erroneous Compensation Analysis [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r959",
      "r970",
      "r980",
      "r1013"
     ]
    },
    "ecd_ErrCompRecoveryTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ErrCompRecoveryTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Erroneously Awarded Compensation Recovery",
        "label": "Erroneously Awarded Compensation Recovery [Table]"
       }
      }
     },
     "auth_ref": [
      "r956",
      "r967",
      "r977",
      "r1010"
     ]
    },
    "lfvn_EventsExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.lifevantage.com/20250630",
     "localname": "EventsExpense",
     "crdr": "debit",
     "calculation": {
      "http://www.lifevantage.com/role/SegmentInformationScheduleofSegmentRevenueandExpenseDetails": {
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://www.lifevantage.com/role/SegmentInformationScheduleofSegmentRevenueandExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Events",
        "label": "Events Expense",
        "documentation": "Events Expense"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_ExecutiveCategoryAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ExecutiveCategoryAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Executive Category:",
        "label": "Executive Category [Axis]"
       }
      }
     },
     "auth_ref": [
      "r1008"
     ]
    },
    "us-gaap_FairValueOfFinancialInstrumentsPolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FairValueOfFinancialInstrumentsPolicy",
     "presentation": [
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Fair Value of Financial Instruments",
        "label": "Fair Value of Financial Instruments, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for determining the fair value of financial instruments."
       }
      }
     },
     "auth_ref": [
      "r1221"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization",
     "crdr": "credit",
     "calculation": {
      "http://www.lifevantage.com/role/IntangibleAssetsNetDetails": {
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.lifevantage.com/role/IntangibleAssetsNetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Accumulated amortization",
        "label": "Finite-Lived Intangible Assets, Accumulated Amortization",
        "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life."
       }
      }
     },
     "auth_ref": [
      "r170",
      "r314",
      "r332",
      "r820"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths",
     "crdr": "debit",
     "presentation": [
      "http://www.lifevantage.com/role/IntangibleAssetsNetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2024",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year One",
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r334",
      "r816",
      "r820"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo",
     "crdr": "debit",
     "presentation": [
      "http://www.lifevantage.com/role/IntangibleAssetsNetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2025",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Two",
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r334",
      "r816",
      "r820"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis",
     "presentation": [
      "http://www.lifevantage.com/role/IntangibleAssetsNetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Finite-Lived Intangible Assets by Major Class [Axis]",
        "label": "Finite-Lived Intangible Assets by Major Class [Axis]",
        "documentation": "Information by major type or class of finite-lived intangible assets."
       }
      }
     },
     "auth_ref": [
      "r325",
      "r327",
      "r328",
      "r329",
      "r331",
      "r332",
      "r336",
      "r337",
      "r625",
      "r626",
      "r715",
      "r816",
      "r820",
      "r875",
      "r876",
      "r877",
      "r878",
      "r879",
      "r880",
      "r881",
      "r882",
      "r883",
      "r884",
      "r885",
      "r886",
      "r887",
      "r888",
      "r889",
      "r890",
      "r891",
      "r892",
      "r893",
      "r894",
      "r895",
      "r896",
      "r897",
      "r898",
      "r899",
      "r900",
      "r901"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract",
     "presentation": [
      "http://www.lifevantage.com/role/IntangibleAssetsNetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Finite-Lived Intangible Assets, Amortization Expense, Maturity Schedule [Abstract]",
        "label": "Finite-Lived Intangible Assets, Amortization Expense, Maturity Schedule [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FiniteLivedIntangibleAssetsGross": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FiniteLivedIntangibleAssetsGross",
     "crdr": "debit",
     "calculation": {
      "http://www.lifevantage.com/role/IntangibleAssetsNetDetails": {
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.lifevantage.com/role/IntangibleAssetsNetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Patent costs",
        "label": "Finite-Lived Intangible Assets, Gross",
        "documentation": "Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life."
       }
      }
     },
     "auth_ref": [
      "r314",
      "r332",
      "r626",
      "r820"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FiniteLivedIntangibleAssetsLineItems",
     "presentation": [
      "http://www.lifevantage.com/role/IntangibleAssetsNetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Finite-Lived Intangible Assets [Line Items]",
        "label": "Finite-Lived Intangible Assets [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r325",
      "r332",
      "r336",
      "r337",
      "r340",
      "r625",
      "r816",
      "r820",
      "r875",
      "r876",
      "r877",
      "r878",
      "r879",
      "r880",
      "r881",
      "r882",
      "r883",
      "r884",
      "r885",
      "r886",
      "r887",
      "r888",
      "r889",
      "r890",
      "r891",
      "r892",
      "r893",
      "r894",
      "r895",
      "r896",
      "r897",
      "r898",
      "r899",
      "r900",
      "r901"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain",
     "presentation": [
      "http://www.lifevantage.com/role/IntangibleAssetsNetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Finite-Lived Intangible Assets, Major Class Name [Domain]",
        "label": "Finite-Lived Intangible Assets, Major Class Name [Domain]",
        "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company."
       }
      }
     },
     "auth_ref": [
      "r325",
      "r327",
      "r328",
      "r329",
      "r331",
      "r332",
      "r336",
      "r337",
      "r715",
      "r816",
      "r820",
      "r875",
      "r876",
      "r877",
      "r878",
      "r879",
      "r880",
      "r881",
      "r882",
      "r883",
      "r884",
      "r885",
      "r886",
      "r887",
      "r888",
      "r889",
      "r890",
      "r891",
      "r892",
      "r893",
      "r894",
      "r895",
      "r896",
      "r897",
      "r898",
      "r899",
      "r900",
      "r901"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FiniteLivedIntangibleAssetsNet",
     "crdr": "debit",
     "calculation": {
      "http://www.lifevantage.com/role/IntangibleAssetsNetDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.lifevantage.com/role/IntangibleAssetsNetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total finite-lived intangible assets, net",
        "label": "Finite-Lived Intangible Assets, Net",
        "documentation": "Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life."
       }
      }
     },
     "auth_ref": [
      "r625",
      "r1156"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1",
     "presentation": [
      "http://www.lifevantage.com/role/IntangibleAssetsNetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Definite-lived intangible assets weighted-average amortization period",
        "label": "Finite-Lived Intangible Assets, Remaining Amortization Period",
        "documentation": "Remaining amortization period of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r625"
     ]
    },
    "us-gaap_ForeignCountryMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ForeignCountryMember",
     "presentation": [
      "http://www.lifevantage.com/role/IncomeTaxesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Foreign Tax Authority",
        "label": "Foreign Tax Jurisdiction [Member]",
        "documentation": "Designated foreign jurisdiction entitled to levy and collect income tax outside country of domicile."
       }
      }
     },
     "auth_ref": [
      "r511",
      "r512"
     ]
    },
    "us-gaap_ForeignCurrencyTransactionGainLossBeforeTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ForeignCurrencyTransactionGainLossBeforeTax",
     "crdr": "credit",
     "calculation": {
      "http://www.lifevantage.com/role/OtherExpenseNetDetails": {
       "parentTag": "us-gaap_OtherNonoperatingIncomeExpense",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.lifevantage.com/role/OtherExpenseNetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Foreign currency transaction loss, net",
        "label": "Gain (Loss), Foreign Currency Transaction, before Tax",
        "documentation": "Amount, before tax, of realized and unrealized gain (loss) from foreign currency transaction."
       }
      }
     },
     "auth_ref": [
      "r195",
      "r581",
      "r582",
      "r583",
      "r584",
      "r778"
     ]
    },
    "us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock",
     "presentation": [
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Foreign Currency Translation",
        "label": "Foreign Currency Transactions and Translations Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy."
       }
      }
     },
     "auth_ref": [
      "r580"
     ]
    },
    "ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Forgone Recovery due to Disqualification of Tax Benefits, Amount",
        "label": "Forgone Recovery due to Disqualification of Tax Benefits, Amount"
       }
      }
     },
     "auth_ref": [
      "r963",
      "r974",
      "r984",
      "r1017"
     ]
    },
    "ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ForgoneRecoveryDueToExpenseOfEnforcementAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Forgone Recovery due to Expense of Enforcement, Amount",
        "label": "Forgone Recovery due to Expense of Enforcement, Amount"
       }
      }
     },
     "auth_ref": [
      "r963",
      "r974",
      "r984",
      "r1017"
     ]
    },
    "ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ForgoneRecoveryDueToViolationOfHomeCountryLawAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Forgone Recovery due to Violation of Home Country Law, Amount",
        "label": "Forgone Recovery due to Violation of Home Country Law, Amount"
       }
      }
     },
     "auth_ref": [
      "r963",
      "r974",
      "r984",
      "r1017"
     ]
    },
    "ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ForgoneRecoveryExplanationOfImpracticabilityTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Forgone Recovery, Explanation of Impracticability",
        "label": "Forgone Recovery, Explanation of Impracticability [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r963",
      "r974",
      "r984",
      "r1017"
     ]
    },
    "ecd_ForgoneRecoveryIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ForgoneRecoveryIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Name",
        "label": "Forgone Recovery, Individual Name"
       }
      }
     },
     "auth_ref": [
      "r963",
      "r974",
      "r984",
      "r1017"
     ]
    },
    "ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year",
        "label": "Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year [Member]"
       }
      }
     },
     "auth_ref": [
      "r997"
     ]
    },
    "us-gaap_FurnitureAndFixturesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FurnitureAndFixturesMember",
     "presentation": [
      "http://www.lifevantage.com/role/PropertyandEquipmentNetDetails",
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesPropertyandEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Furniture and fixtures",
        "label": "Furniture and Fixtures [Member]",
        "documentation": "Equipment commonly used in offices and stores that have no permanent connection to the structure of a building or utilities. Examples include, but are not limited to, desks, chairs, tables, and bookcases."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_GainLossOnSaleOfPropertyPlantEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "GainLossOnSaleOfPropertyPlantEquipment",
     "crdr": "credit",
     "calculation": {
      "http://www.lifevantage.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 14.0
      }
     },
     "presentation": [
      "http://www.lifevantage.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "(Gain) loss on disposal of fixed assets",
        "label": "Gain (Loss) on Disposition of Property Plant Equipment",
        "documentation": "Amount of gain (loss) on sale or disposal of property, plant and equipment assets, including oil and gas property and timber property."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Goodwill and Intangible Assets Disclosure [Abstract]",
        "label": "Goodwill and Intangible Assets Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_GrossProfit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "GrossProfit",
     "crdr": "credit",
     "calculation": {
      "http://www.lifevantage.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOME": {
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.lifevantage.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOME"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Gross profit",
        "label": "Gross Profit",
        "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity."
       }
      }
     },
     "auth_ref": [
      "r66",
      "r70",
      "r113",
      "r208",
      "r211",
      "r212",
      "r307",
      "r359",
      "r360",
      "r361",
      "r362",
      "r363",
      "r364",
      "r365",
      "r366",
      "r367",
      "r579",
      "r838",
      "r844",
      "r1134",
      "r1141",
      "r1142",
      "r1143",
      "r1144",
      "r1169"
     ]
    },
    "lfvn_HandlingAndRestockingFeePercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.lifevantage.com/20250630",
     "localname": "HandlingAndRestockingFeePercentage",
     "presentation": [
      "http://www.lifevantage.com/role/RevenueNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Handling and restocking fee, percentage",
        "label": "Handling and Restocking Fee, Percentage",
        "documentation": "Handling and Restocking Fee, Percentage"
       }
      }
     },
     "auth_ref": []
    },
    "dei_IcfrAuditorAttestationFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "IcfrAuditorAttestationFlag",
     "presentation": [
      "http://www.lifevantage.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "ICFR Auditor Attestation Flag",
        "label": "ICFR Auditor Attestation Flag"
       }
      }
     },
     "auth_ref": [
      "r942",
      "r943",
      "r966"
     ]
    },
    "us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ImpairmentOfIntangibleAssetsExcludingGoodwill",
     "crdr": "debit",
     "presentation": [
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Impairment of intangible assets",
        "label": "Impairment of Intangible Assets (Excluding Goodwill)",
        "documentation": "The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of an intangible asset (excluding goodwill) to fair value."
       }
      }
     },
     "auth_ref": [
      "r6",
      "r193",
      "r326",
      "r339"
     ]
    },
    "us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock",
     "presentation": [
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Impairment of Long-Lived Assets",
        "label": "Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for recognizing and measuring the impairment of long-lived assets. An entity also may disclose its accounting policy for long-lived assets to be sold. This policy excludes goodwill and intangible assets."
       }
      }
     },
     "auth_ref": [
      "r0",
      "r88"
     ]
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic",
     "crdr": "credit",
     "calculation": {
      "http://www.lifevantage.com/role/IncomeTaxesIncomeTaxExpenseDetails": {
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.lifevantage.com/role/IncomeTaxesIncomeTaxExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Domestic",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Domestic",
        "documentation": "The portion of earnings or loss from continuing operations before income taxes that is attributable to domestic operations."
       }
      }
     },
     "auth_ref": [
      "r208",
      "r213",
      "r510"
     ]
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
     "crdr": "credit",
     "calculation": {
      "http://www.lifevantage.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOME": {
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.lifevantage.com/role/IncomeTaxesIncomeTaxExpenseDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.lifevantage.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOME",
      "http://www.lifevantage.com/role/IncomeTaxesIncomeTaxExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Income before income taxes",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest",
        "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest."
       }
      }
     },
     "auth_ref": [
      "r67",
      "r109",
      "r113",
      "r665",
      "r667",
      "r681",
      "r826",
      "r828",
      "r830",
      "r838",
      "r844",
      "r1134",
      "r1141",
      "r1142",
      "r1143",
      "r1144"
     ]
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterestAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterestAbstract",
     "presentation": [
      "http://www.lifevantage.com/role/IncomeTaxesIncomeTaxExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Income before income taxes:",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign",
     "crdr": "credit",
     "calculation": {
      "http://www.lifevantage.com/role/IncomeTaxesIncomeTaxExpenseDetails": {
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.lifevantage.com/role/IncomeTaxesIncomeTaxExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "International",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Foreign",
        "documentation": "The portion of earnings or loss from continuing operations before income taxes that is attributable to foreign operations, which is defined as Income or Loss generated from operations located outside the entity's country of domicile."
       }
      }
     },
     "auth_ref": [
      "r208",
      "r213",
      "r510"
     ]
    },
    "us-gaap_IncomeStatementAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncomeStatementAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income Statement [Abstract]",
        "label": "Income Statement [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeTaxAuthorityAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncomeTaxAuthorityAxis",
     "presentation": [
      "http://www.lifevantage.com/role/IncomeTaxesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income Tax Authority [Axis]",
        "label": "Income Tax Jurisdiction [Axis]",
        "documentation": "Information by income tax jurisdiction."
       }
      }
     },
     "auth_ref": [
      "r204",
      "r511",
      "r512",
      "r523",
      "r536",
      "r871",
      "r1213"
     ]
    },
    "us-gaap_IncomeTaxAuthorityDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncomeTaxAuthorityDomain",
     "presentation": [
      "http://www.lifevantage.com/role/IncomeTaxesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income Tax Authority [Domain]",
        "label": "Income Tax Jurisdiction [Domain]",
        "documentation": "Income tax jurisdiction."
       }
      }
     },
     "auth_ref": [
      "r204",
      "r511",
      "r512",
      "r523",
      "r536",
      "r871",
      "r1213"
     ]
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncomeTaxDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income Tax Disclosure [Abstract]",
        "label": "Income Tax Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncomeTaxDisclosureTextBlock",
     "presentation": [
      "http://www.lifevantage.com/role/IncomeTaxes"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Income Taxes",
        "label": "Income Tax Disclosure [Text Block]",
        "documentation": "The entire disclosure for income tax."
       }
      }
     },
     "auth_ref": [
      "r208",
      "r214",
      "r503",
      "r511",
      "r520",
      "r521",
      "r522",
      "r528",
      "r535",
      "r543",
      "r545",
      "r546",
      "r547",
      "r670",
      "r714",
      "r727",
      "r871"
     ]
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncomeTaxExpenseBenefit",
     "crdr": "debit",
     "calculation": {
      "http://www.lifevantage.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOME": {
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0,
       "order": 2.0
      },
      "http://www.lifevantage.com/role/SegmentInformationScheduleofSegmentRevenueandExpenseDetails": {
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0,
       "order": 13.0
      },
      "http://www.lifevantage.com/role/IncomeTaxesIncomeTaxExpenseDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.lifevantage.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOME",
      "http://www.lifevantage.com/role/IncomeTaxesIncomeTaxExpenseDetails",
      "http://www.lifevantage.com/role/SegmentInformationScheduleofSegmentRevenueandExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Income tax expense",
        "totalLabel": "Net income tax provision",
        "negatedTerseLabel": "Income tax expense",
        "label": "Income Tax Expense (Benefit)",
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations."
       }
      }
     },
     "auth_ref": [
      "r115",
      "r123",
      "r208",
      "r236",
      "r237",
      "r251",
      "r272",
      "r293",
      "r509",
      "r511",
      "r544",
      "r686",
      "r826",
      "r828",
      "r830",
      "r871"
     ]
    },
    "us-gaap_IncomeTaxPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncomeTaxPolicyTextBlock",
     "presentation": [
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Income Taxes",
        "label": "Income Tax, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements."
       }
      }
     },
     "auth_ref": [
      "r185",
      "r505",
      "r506",
      "r528",
      "r529",
      "r534",
      "r538",
      "r721"
     ]
    },
    "us-gaap_IncomeTaxesPaid": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncomeTaxesPaid",
     "crdr": "credit",
     "presentation": [
      "http://www.lifevantage.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Cash paid for income taxes",
        "label": "Income Taxes Paid",
        "documentation": "Amount, before refund, of cash paid to foreign, federal, state, and local jurisdictions as income tax."
       }
      }
     },
     "auth_ref": [
      "r21",
      "r81",
      "r1112",
      "r1211",
      "r1212"
     ]
    },
    "us-gaap_IncomeTaxesReceivable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncomeTaxesReceivable",
     "crdr": "debit",
     "calculation": {
      "http://www.lifevantage.com/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.lifevantage.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income tax receivable",
        "label": "Income Taxes Receivable, Current",
        "documentation": "Carrying amount due within one year of the balance sheet date (or one operating cycle, if longer) from tax authorities as of the balance sheet date representing refunds of overpayments or recoveries based on agreed-upon resolutions of disputes."
       }
      }
     },
     "auth_ref": [
      "r100",
      "r1057"
     ]
    },
    "us-gaap_IncreaseDecreaseInAccountsPayable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncreaseDecreaseInAccountsPayable",
     "crdr": "debit",
     "calculation": {
      "http://www.lifevantage.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.lifevantage.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Accounts payable",
        "label": "Increase (Decrease) in Accounts Payable",
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "us-gaap_IncreaseDecreaseInAccountsReceivable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncreaseDecreaseInAccountsReceivable",
     "crdr": "credit",
     "calculation": {
      "http://www.lifevantage.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.lifevantage.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Accounts receivable",
        "label": "Increase (Decrease) in Accounts Receivable",
        "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncreaseDecreaseInAccruedIncomeTaxesPayable",
     "crdr": "debit",
     "calculation": {
      "http://www.lifevantage.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://www.lifevantage.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income tax payable",
        "label": "Increase (Decrease) in Income Taxes Payable",
        "documentation": "The increase (decrease) during the period in the amount due for taxes based on the reporting entity's earnings or attributable to the entity's income earning process (business presence) within a given jurisdiction."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "us-gaap_IncreaseDecreaseInAccruedLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncreaseDecreaseInAccruedLiabilities",
     "crdr": "debit",
     "calculation": {
      "http://www.lifevantage.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.lifevantage.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other accrued expenses",
        "label": "Increase (Decrease) in Accrued Liabilities",
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "us-gaap_IncreaseDecreaseInIncomeTaxesReceivable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncreaseDecreaseInIncomeTaxesReceivable",
     "crdr": "credit",
     "calculation": {
      "http://www.lifevantage.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://www.lifevantage.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Income tax receivable",
        "label": "Increase (Decrease) in Income Taxes Receivable",
        "documentation": "The increase (decrease) during the reporting period in income taxes receivable, which represents the amount due from tax authorities for refunds of overpayments or recoveries of income taxes paid."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "us-gaap_IncreaseDecreaseInInventories": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncreaseDecreaseInInventories",
     "crdr": "credit",
     "calculation": {
      "http://www.lifevantage.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 16.0
      }
     },
     "presentation": [
      "http://www.lifevantage.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Inventory",
        "label": "Increase (Decrease) in Inventories",
        "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "presentation": [
      "http://www.lifevantage.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Changes in operating assets and liabilities:",
        "label": "Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity, Increase (Decrease) in Operating Capital [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncreaseDecreaseInOperatingLeaseLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncreaseDecreaseInOperatingLeaseLiability",
     "crdr": "debit",
     "calculation": {
      "http://www.lifevantage.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 9.0
      }
     },
     "presentation": [
      "http://www.lifevantage.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Lease liabilities",
        "label": "Increase (Decrease) in Operating Lease Liability",
        "documentation": "Amount of increase (decrease) in obligation for operating lease."
       }
      }
     },
     "auth_ref": [
      "r1053",
      "r1110"
     ]
    },
    "us-gaap_IncreaseDecreaseInOtherNoncurrentAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncreaseDecreaseInOtherNoncurrentAssets",
     "crdr": "credit",
     "calculation": {
      "http://www.lifevantage.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://www.lifevantage.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Other long-term assets",
        "label": "Increase (Decrease) in Other Noncurrent Assets",
        "documentation": "Amount of increase (decrease) in noncurrent assets classified as other."
       }
      }
     },
     "auth_ref": [
      "r1110"
     ]
    },
    "us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncreaseDecreaseInOtherNoncurrentLiabilities",
     "crdr": "debit",
     "calculation": {
      "http://www.lifevantage.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 15.0
      }
     },
     "presentation": [
      "http://www.lifevantage.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Other liabilities",
        "label": "Increase (Decrease) in Other Noncurrent Liabilities",
        "documentation": "Amount of increase (decrease) in noncurrent operating liabilities classified as other."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncreaseDecreaseInPrepaidExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncreaseDecreaseInPrepaidExpense",
     "crdr": "credit",
     "calculation": {
      "http://www.lifevantage.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 12.0
      }
     },
     "presentation": [
      "http://www.lifevantage.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Prepaid expenses and other",
        "label": "Increase (Decrease) in Prepaid Expense",
        "documentation": "The increase (decrease) during the reporting period in the amount of outstanding money paid in advance for goods or services that bring economic benefits for future periods."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncreaseDecreaseInStockholdersEquityRollForward",
     "presentation": [
      "http://www.lifevantage.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
        "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncrementalCommonSharesAttributableToShareBasedPaymentArrangements",
     "calculation": {
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesComputationofNetIncomePerShareDetails": {
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesComputationofNetIncomePerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock awards and options (in shares)",
        "label": "Incremental Common Shares Attributable to Dilutive Effect of Share-Based Payment Arrangements",
        "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method."
       }
      }
     },
     "auth_ref": [
      "r241",
      "r242",
      "r243",
      "r247",
      "r455"
     ]
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IndefiniteLivedIntangibleAssetsByMajorClassAxis",
     "presentation": [
      "http://www.lifevantage.com/role/IntangibleAssetsNetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Indefinite-lived Intangible Assets [Axis]",
        "label": "Indefinite-Lived Intangible Assets [Axis]",
        "documentation": "Information by type or class of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit."
       }
      }
     },
     "auth_ref": [
      "r325",
      "r330",
      "r335",
      "r820",
      "r875",
      "r876",
      "r877",
      "r886",
      "r887",
      "r901"
     ]
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IndefiniteLivedIntangibleAssetsByMajorClassLineItems",
     "presentation": [
      "http://www.lifevantage.com/role/IntangibleAssetsNetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Indefinite-lived Intangible Assets [Line Items]",
        "label": "Indefinite-Lived Intangible Assets [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r325",
      "r335",
      "r340",
      "r820",
      "r875",
      "r876",
      "r877",
      "r886",
      "r887",
      "r901"
     ]
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IndefiniteLivedIntangibleAssetsExcludingGoodwill",
     "crdr": "debit",
     "presentation": [
      "http://www.lifevantage.com/role/IntangibleAssetsNetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trademarks and other indefinite-lived intangible assets",
        "label": "Indefinite-Lived Intangible Assets (Excluding Goodwill)",
        "documentation": "Amount of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit."
       }
      }
     },
     "auth_ref": [
      "r314",
      "r335",
      "r820"
     ]
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IndefiniteLivedIntangibleAssetsMajorClassNameDomain",
     "presentation": [
      "http://www.lifevantage.com/role/IntangibleAssetsNetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Indefinite-lived Intangible Assets, Major Class Name [Domain]",
        "label": "Indefinite-Lived Intangible Assets, Major Class Name [Domain]",
        "documentation": "The major class of indefinite-lived intangible asset (for example, trade names, etc. but not all-inclusive), excluding goodwill. A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of the company."
       }
      }
     },
     "auth_ref": [
      "r325",
      "r330",
      "r335",
      "r820",
      "r875",
      "r876",
      "r877",
      "r886",
      "r887",
      "r901"
     ]
    },
    "ecd_IndividualAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "IndividualAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure",
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure",
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements",
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Individual:",
        "label": "Individual [Axis]"
       }
      }
     },
     "auth_ref": [
      "r963",
      "r974",
      "r984",
      "r1008",
      "r1017",
      "r1021",
      "r1029"
     ]
    },
    "ecd_InsiderTradingArrLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "InsiderTradingArrLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Arrangements [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r1027"
     ]
    },
    "ecd_InsiderTradingPoliciesProcLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "InsiderTradingPoliciesProcLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Policies and Procedures [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r944",
      "r1033"
     ]
    },
    "ecd_InsiderTrdPoliciesProcAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "InsiderTrdPoliciesProcAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Insider Trading Policies and Procedures Adopted",
        "label": "Insider Trading Policies and Procedures Adopted [Flag]"
       }
      }
     },
     "auth_ref": [
      "r944",
      "r1033"
     ]
    },
    "ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "InsiderTrdPoliciesProcNotAdoptedTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Insider Trading Policies and Procedures Not Adopted",
        "label": "Insider Trading Policies and Procedures Not Adopted [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r944",
      "r1033"
     ]
    },
    "us-gaap_IntangibleAssetsDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IntangibleAssetsDisclosureTextBlock",
     "presentation": [
      "http://www.lifevantage.com/role/IntangibleAssetsNet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Intangible Assets, Net",
        "label": "Intangible Assets Disclosure [Text Block]",
        "documentation": "The entire disclosure for all or part of the information related to intangible assets."
       }
      }
     },
     "auth_ref": [
      "r324",
      "r338",
      "r341",
      "r815",
      "r816"
     ]
    },
    "us-gaap_IntangibleAssetsFiniteLivedPolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IntangibleAssetsFiniteLivedPolicy",
     "presentation": [
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Intangible Assets",
        "label": "Intangible Assets, Finite-Lived, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for finite-lived intangible assets. This accounting policy also might address: (1) the amortization method used; (2) the useful lives of such assets; and (3) how the entity assesses and measures impairment of such assets."
       }
      }
     },
     "auth_ref": [
      "r621",
      "r622",
      "r623",
      "r625",
      "r832",
      "r1148"
     ]
    },
    "us-gaap_IntangibleAssetsNetExcludingGoodwill": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IntangibleAssetsNetExcludingGoodwill",
     "crdr": "debit",
     "calculation": {
      "http://www.lifevantage.com/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.lifevantage.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.lifevantage.com/role/IntangibleAssetsNetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Intangible assets, net",
        "terseLabel": "Total intangible assets, net",
        "label": "Intangible Assets, Net (Excluding Goodwill)",
        "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges."
       }
      }
     },
     "auth_ref": [
      "r325",
      "r1156",
      "r1157"
     ]
    },
    "us-gaap_InterestExpenseNonoperating": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "InterestExpenseNonoperating",
     "crdr": "debit",
     "calculation": {
      "http://www.lifevantage.com/role/SegmentInformationScheduleofSegmentRevenueandExpenseDetails": {
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0,
       "order": 12.0
      }
     },
     "presentation": [
      "http://www.lifevantage.com/role/SegmentInformationScheduleofSegmentRevenueandExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Interest expense",
        "label": "Interest Expense, Nonoperating",
        "documentation": "Amount of interest expense classified as nonoperating."
       }
      }
     },
     "auth_ref": [
      "r268",
      "r826",
      "r830",
      "r1067"
     ]
    },
    "us-gaap_InterestPaidNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "InterestPaidNet",
     "crdr": "credit",
     "presentation": [
      "http://www.lifevantage.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash paid for interest",
        "label": "Interest Paid, Excluding Capitalized Interest, Operating Activity",
        "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount."
       }
      }
     },
     "auth_ref": [
      "r200",
      "r202",
      "r203"
     ]
    },
    "us-gaap_InterestRevenueExpenseNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "InterestRevenueExpenseNet",
     "crdr": "credit",
     "calculation": {
      "http://www.lifevantage.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOME": {
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.lifevantage.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOME"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Interest income, net",
        "label": "Interest Income (Expense), Operating and Nonoperating",
        "documentation": "Amount of interest income (expense) classified as operating and nonoperating."
       }
      }
     },
     "auth_ref": [
      "r251",
      "r264",
      "r293"
     ]
    },
    "us-gaap_InventoryAdjustments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "InventoryAdjustments",
     "crdr": "credit",
     "presentation": [
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Reduction in inventory",
        "label": "Inventory Adjustments",
        "documentation": "Amount of inventory reserves for last-in first-out (LIFO) and other inventory valuation methods."
       }
      }
     },
     "auth_ref": [
      "r29",
      "r1060"
     ]
    },
    "us-gaap_InventoryCurrentTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "InventoryCurrentTable",
     "presentation": [
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesScheduleOfInventoryValuationReserveDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Inventory, Current [Table]",
        "label": "Inventory, Current [Table]",
        "documentation": "Disclosure of information about inventory expected to be sold or consumed within one year or operating cycle, if longer."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_InventoryFinishedGoods": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "InventoryFinishedGoods",
     "crdr": "debit",
     "calculation": {
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesInventoryDetails": {
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesInventoryDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Finished goods",
        "label": "Inventory, Finished Goods, Gross",
        "documentation": "Amount before valuation and LIFO reserves of completed merchandise or goods expected to be sold within one year or operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r1058"
     ]
    },
    "lfvn_InventoryFinishedGoodsPercentOfTotalInventory": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.lifevantage.com/20250630",
     "localname": "InventoryFinishedGoodsPercentOfTotalInventory",
     "calculation": {
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesInventoryDetails": {
       "parentTag": "lfvn_InventoryPercentOfTotalInventory",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesInventoryDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Finished goods",
        "label": "Inventory, Finished Goods, Percent Of Total Inventory",
        "documentation": "Inventory, Finished Goods, Percent Of Total Inventory"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_InventoryLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "InventoryLineItems",
     "presentation": [
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesScheduleOfInventoryValuationReserveDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Inventory [Line Items]",
        "label": "Inventory [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_InventoryNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "InventoryNet",
     "crdr": "debit",
     "calculation": {
      "http://www.lifevantage.com/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 4.0
      },
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesInventoryDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.lifevantage.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesInventoryDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Inventory",
        "totalLabel": "Total inventory",
        "label": "Inventory, Net",
        "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r178",
      "r822",
      "r909"
     ]
    },
    "us-gaap_InventoryNetAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "InventoryNetAbstract",
     "presentation": [
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesInventoryDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Components of Inventory",
        "label": "Inventory, Net [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "lfvn_InventoryPercentOfTotalInventory": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.lifevantage.com/20250630",
     "localname": "InventoryPercentOfTotalInventory",
     "calculation": {
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesInventoryDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesInventoryDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total inventory",
        "label": "Inventory, Percent Of Total Inventory",
        "documentation": "Inventory, Percent Of Total Inventory"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_InventoryPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "InventoryPolicyTextBlock",
     "presentation": [
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Inventories",
        "label": "Inventory, Policy [Policy Text Block]",
        "documentation": "Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost."
       }
      }
     },
     "auth_ref": [
      "r116",
      "r166",
      "r177",
      "r311",
      "r312",
      "r313",
      "r620",
      "r833"
     ]
    },
    "us-gaap_InventoryRawMaterials": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "InventoryRawMaterials",
     "crdr": "debit",
     "calculation": {
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesInventoryDetails": {
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesInventoryDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Raw materials",
        "label": "Inventory, Raw Materials, Gross",
        "documentation": "Amount before valuation and LIFO reserves of raw materials expected to be sold, or consumed within one year or operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r1059"
     ]
    },
    "us-gaap_InventoryValuationReserveMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "InventoryValuationReserveMember",
     "presentation": [
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesScheduleOfInventoryValuationReserveDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "SEC Schedule, 12-09, Reserve, Inventory",
        "label": "SEC Schedule, 12-09, Reserve, Inventory [Member]",
        "documentation": "Reserve to reduce inventory to lower of cost or net realizable value."
       }
      }
     },
     "auth_ref": [
      "r1115",
      "r1123",
      "r1124",
      "r1125",
      "r1126",
      "r1127"
     ]
    },
    "us-gaap_InvestmentIncomeInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "InvestmentIncomeInterest",
     "crdr": "credit",
     "calculation": {
      "http://www.lifevantage.com/role/SegmentInformationScheduleofSegmentRevenueandExpenseDetails": {
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0,
       "order": 11.0
      }
     },
     "presentation": [
      "http://www.lifevantage.com/role/SegmentInformationScheduleofSegmentRevenueandExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Interest income",
        "label": "Investment Income, Interest",
        "documentation": "Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities."
       }
      }
     },
     "auth_ref": [
      "r251",
      "r267",
      "r293",
      "r844",
      "r1066"
     ]
    },
    "country_JP": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/country/2025",
     "localname": "JP",
     "presentation": [
      "http://www.lifevantage.com/role/SegmentInformationScheduleOfRevenueDisaggregationByMarketDetails",
      "http://www.lifevantage.com/role/SegmentInformationScheduleofLongLivedAssetsDetails",
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesSegmentInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Japan",
        "label": "JAPAN"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LaborAndRelatedExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LaborAndRelatedExpense",
     "crdr": "debit",
     "calculation": {
      "http://www.lifevantage.com/role/SegmentInformationScheduleofSegmentRevenueandExpenseDetails": {
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.lifevantage.com/role/SegmentInformationScheduleofSegmentRevenueandExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Labor and benefits",
        "label": "Labor and Related Expense",
        "documentation": "Amount of expense for salary, wage, profit sharing; incentive and equity-based compensation; and other employee benefit."
       }
      }
     },
     "auth_ref": [
      "r661",
      "r828",
      "r1065"
     ]
    },
    "us-gaap_LeaseCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LeaseCost",
     "crdr": "debit",
     "calculation": {
      "http://www.lifevantage.com/role/LeasesScheduleofLeaseCostDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.lifevantage.com/role/LeasesScheduleofLeaseCostDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total lease expense",
        "label": "Lease, Cost",
        "documentation": "Amount of lease cost recognized by lessee for lease contract."
       }
      }
     },
     "auth_ref": [
      "r603",
      "r908"
     ]
    },
    "us-gaap_LeaseCostTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LeaseCostTableTextBlock",
     "presentation": [
      "http://www.lifevantage.com/role/LeasesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Lease, Cost",
        "label": "Lease, Cost [Table Text Block]",
        "documentation": "Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income."
       }
      }
     },
     "auth_ref": [
      "r1228"
     ]
    },
    "us-gaap_LeaseholdImprovementsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LeaseholdImprovementsMember",
     "presentation": [
      "http://www.lifevantage.com/role/PropertyandEquipmentNetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Leasehold improvements",
        "label": "Leasehold Improvements [Member]",
        "documentation": "Additions or improvements to assets held under a lease arrangement."
       }
      }
     },
     "auth_ref": [
      "r87",
      "r612"
     ]
    },
    "us-gaap_LeasesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LeasesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Leases [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LesseeLeaseDescriptionLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LesseeLeaseDescriptionLineItems",
     "presentation": [
      "http://www.lifevantage.com/role/LeasesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Lessee, Lease, Description [Line Items]",
        "label": "Lessee, Lease, Description [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r602",
      "r613"
     ]
    },
    "us-gaap_LesseeLeaseDescriptionTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LesseeLeaseDescriptionTable",
     "presentation": [
      "http://www.lifevantage.com/role/LeasesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Lessee, Lease, Description [Table]",
        "label": "Lessee, Lease, Description [Table]",
        "documentation": "Disclosure of information about lessee's leases."
       }
      }
     },
     "auth_ref": [
      "r602",
      "r613"
     ]
    },
    "us-gaap_LesseeLeasesPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LesseeLeasesPolicyTextBlock",
     "presentation": [
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Leases",
        "label": "Lessee, Leases [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for leasing arrangement entered into by lessee."
       }
      }
     },
     "auth_ref": [
      "r601"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
     "presentation": [
      "http://www.lifevantage.com/role/LeasesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Lessee, Operating Lease, Liability, Maturity",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Maturity [Table Text Block]",
        "documentation": "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position."
       }
      }
     },
     "auth_ref": [
      "r1229"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDue",
     "crdr": "credit",
     "calculation": {
      "http://www.lifevantage.com/role/LeasesMaturityofLeaseLiabilitiesDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      },
      "http://www.lifevantage.com/role/LeasesMaturityofLeaseLiabilitiesDetails_1": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.lifevantage.com/role/LeasesMaturityofLeaseLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total",
        "label": "Lessee, Operating Lease, Liability, to be Paid",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease."
       }
      }
     },
     "auth_ref": [
      "r611",
      "r1114",
      "r1122",
      "r1239"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive",
     "crdr": "credit",
     "calculation": {
      "http://www.lifevantage.com/role/LeasesMaturityofLeaseLiabilitiesDetails": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.lifevantage.com/role/LeasesMaturityofLeaseLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Thereafter",
        "label": "Lessee, Operating Lease, Liability, to be Paid, after Year Five",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease due after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r611",
      "r1114",
      "r1122",
      "r1239"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
     "crdr": "credit",
     "calculation": {
      "http://www.lifevantage.com/role/LeasesMaturityofLeaseLiabilitiesDetails": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.lifevantage.com/role/LeasesMaturityofLeaseLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2026",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year One",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r611",
      "r1114",
      "r1122",
      "r1239"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFive",
     "crdr": "credit",
     "calculation": {
      "http://www.lifevantage.com/role/LeasesMaturityofLeaseLiabilitiesDetails": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.lifevantage.com/role/LeasesMaturityofLeaseLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2030",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Five",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r611",
      "r1114",
      "r1122",
      "r1239"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFour",
     "crdr": "credit",
     "calculation": {
      "http://www.lifevantage.com/role/LeasesMaturityofLeaseLiabilitiesDetails": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.lifevantage.com/role/LeasesMaturityofLeaseLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2029",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Four",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r611",
      "r1114",
      "r1122",
      "r1239"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree",
     "crdr": "credit",
     "calculation": {
      "http://www.lifevantage.com/role/LeasesMaturityofLeaseLiabilitiesDetails": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.lifevantage.com/role/LeasesMaturityofLeaseLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2028",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Three",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r611",
      "r1114",
      "r1122",
      "r1239"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo",
     "crdr": "credit",
     "calculation": {
      "http://www.lifevantage.com/role/LeasesMaturityofLeaseLiabilitiesDetails": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.lifevantage.com/role/LeasesMaturityofLeaseLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2027",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Two",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r611",
      "r1114",
      "r1122",
      "r1239"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount",
     "crdr": "credit",
     "calculation": {
      "http://www.lifevantage.com/role/LeasesMaturityofLeaseLiabilitiesDetails_1": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.lifevantage.com/role/LeasesMaturityofLeaseLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Less: imputed interest",
        "label": "Lessee, Operating Lease, Liability, Undiscounted Excess Amount",
        "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease."
       }
      }
     },
     "auth_ref": [
      "r611"
     ]
    },
    "us-gaap_LesseeOperatingLeaseTermOfContract": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LesseeOperatingLeaseTermOfContract",
     "presentation": [
      "http://www.lifevantage.com/role/LeasesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Lease term",
        "label": "Lessee, Operating Lease, Term of Contract",
        "documentation": "Term of lessee's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r1227"
     ]
    },
    "us-gaap_LesseeOperatingLeasesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LesseeOperatingLeasesTextBlock",
     "presentation": [
      "http://www.lifevantage.com/role/Leases"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Leases",
        "label": "Lessee, Operating Leases [Text Block]",
        "documentation": "The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability."
       }
      }
     },
     "auth_ref": [
      "r596"
     ]
    },
    "us-gaap_Liabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "Liabilities",
     "crdr": "credit",
     "calculation": {
      "http://www.lifevantage.com/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.lifevantage.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total liabilities",
        "label": "Liabilities",
        "documentation": "Amount of liability recognized for present obligation requiring transfer or otherwise providing economic benefit to others."
       }
      }
     },
     "auth_ref": [
      "r15",
      "r44",
      "r45",
      "r46",
      "r49",
      "r50",
      "r51",
      "r54",
      "r208",
      "r211",
      "r212",
      "r307",
      "r359",
      "r360",
      "r361",
      "r362",
      "r363",
      "r364",
      "r365",
      "r366",
      "r367",
      "r558",
      "r559",
      "r560",
      "r579",
      "r742",
      "r837",
      "r857",
      "r937",
      "r1169",
      "r1230",
      "r1231"
     ]
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LiabilitiesAndStockholdersEquity",
     "crdr": "credit",
     "calculation": {
      "http://www.lifevantage.com/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.lifevantage.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "TOTAL LIABILITIES AND STOCKHOLDERS\u2019 EQUITY",
        "label": "Liabilities and Equity",
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any."
       }
      }
     },
     "auth_ref": [
      "r61",
      "r108",
      "r677",
      "r909",
      "r924",
      "r925",
      "r1113",
      "r1119",
      "r1147",
      "r1223"
     ]
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "presentation": [
      "http://www.lifevantage.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "LIABILITIES AND STOCKHOLDERS\u2019 EQUITY",
        "label": "Liabilities and Equity [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.lifevantage.com/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.lifevantage.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total current liabilities",
        "label": "Liabilities, Current",
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r46",
      "r165",
      "r208",
      "r211",
      "r212",
      "r307",
      "r359",
      "r360",
      "r361",
      "r362",
      "r363",
      "r364",
      "r365",
      "r366",
      "r367",
      "r558",
      "r559",
      "r560",
      "r579",
      "r909",
      "r1169",
      "r1230",
      "r1231"
     ]
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LiabilitiesCurrentAbstract",
     "presentation": [
      "http://www.lifevantage.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Current liabilities",
        "label": "Liabilities, Current [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "lfvn_LifeVantageTrueScienceSkinCareRegimenMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.lifevantage.com/20250630",
     "localname": "LifeVantageTrueScienceSkinCareRegimenMember",
     "presentation": [
      "http://www.lifevantage.com/role/RevenueMajorProductsDetails",
      "http://www.lifevantage.com/role/SegmentInformationScheduleofMajorProductsLinesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "LifeVantage\u00ae product line",
        "label": "LifeVantage TrueScience Skin Care Regimen [Member]",
        "documentation": "LifeVantage TrueScience Skin Care Regimen [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LineOfCredit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LineOfCredit",
     "crdr": "credit",
     "presentation": [
      "http://www.lifevantage.com/role/LongTermDebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Long-Term Line of Credit",
        "label": "Long-Term Line of Credit",
        "documentation": "The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement."
       }
      }
     },
     "auth_ref": [
      "r15",
      "r106",
      "r1240"
     ]
    },
    "us-gaap_LineOfCreditFacilityLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LineOfCreditFacilityLineItems",
     "presentation": [
      "http://www.lifevantage.com/role/LongTermDebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Line of Credit Facility [Line Items]",
        "label": "Line of Credit Facility [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r358",
      "r1113",
      "r1117",
      "r1168"
     ]
    },
    "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LineOfCreditFacilityMaximumBorrowingCapacity",
     "crdr": "credit",
     "presentation": [
      "http://www.lifevantage.com/role/LongTermDebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Maximum borrowing capacity",
        "label": "Line of Credit Facility, Maximum Borrowing Capacity",
        "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility."
       }
      }
     },
     "auth_ref": [
      "r43",
      "r48"
     ]
    },
    "us-gaap_LineOfCreditFacilityTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LineOfCreditFacilityTable",
     "presentation": [
      "http://www.lifevantage.com/role/LongTermDebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Line of Credit Facility [Table]",
        "label": "Line of Credit Facility [Table]",
        "documentation": "Disclosure of information about short-term and long-term contractual arrangements with lender under which borrowing can occur up to maximum amount. Includes, but is not limited to, letter of credit, standby letter of credit, and revolving credit arrangement."
       }
      }
     },
     "auth_ref": [
      "r43",
      "r48",
      "r358",
      "r1113",
      "r1117",
      "r1168"
     ]
    },
    "us-gaap_LineOfCreditMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LineOfCreditMember",
     "presentation": [
      "http://www.lifevantage.com/role/LongTermDebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Line of Credit",
        "label": "Line of Credit [Member]",
        "documentation": "A contractual arrangement with a lender under which borrowings can be made up to a specific amount at any point in time, and under which borrowings outstanding may be either short-term or long-term, depending upon the particulars."
       }
      }
     },
     "auth_ref": []
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://www.lifevantage.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Local Phone Number",
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LongLivedAssetsByGeographicAreasTableTextBlock",
     "presentation": [
      "http://www.lifevantage.com/role/SegmentInformationTables",
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Long-lived Assets by Geographic Areas",
        "label": "Long-Lived Assets by Geographic Areas [Table Text Block]",
        "documentation": "Tabular disclosure of long-lived assets, excluding financial instruments, long-term customer relationships of a financial institution, mortgage rights, deferred policy acquisition costs, and deferred tax assets, by geographic areas located in the entity's country of domicile and foreign countries in which the entity holds assets."
       }
      }
     },
     "auth_ref": [
      "r84"
     ]
    },
    "us-gaap_LongtermDebtTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LongtermDebtTypeAxis",
     "presentation": [
      "http://www.lifevantage.com/role/LongTermDebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Long-term Debt, Type [Axis]",
        "label": "Long-Term Debt, Type [Axis]",
        "documentation": "Information by type of long-term debt."
       }
      }
     },
     "auth_ref": [
      "r15",
      "r1161",
      "r1162",
      "r1163"
     ]
    },
    "us-gaap_LongtermDebtTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LongtermDebtTypeDomain",
     "presentation": [
      "http://www.lifevantage.com/role/LongTermDebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Long-term Debt, Type [Domain]",
        "label": "Long-Term Debt, Type [Domain]",
        "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer."
       }
      }
     },
     "auth_ref": [
      "r15",
      "r32",
      "r1161",
      "r1162",
      "r1163"
     ]
    },
    "lfvn_March2016RevolvingLoanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.lifevantage.com/20250630",
     "localname": "March2016RevolvingLoanMember",
     "presentation": [
      "http://www.lifevantage.com/role/LongTermDebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "March 2016 Revolving Loan",
        "label": "March 2016 Revolving Loan [Member]",
        "documentation": "March 2016 Revolving Loan [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "lfvn_March2016TermLoanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.lifevantage.com/20250630",
     "localname": "March2016TermLoanMember",
     "presentation": [
      "http://www.lifevantage.com/role/LongTermDebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "March 2016 Term Loan",
        "label": "March 2016 Term Loan [Member]",
        "documentation": "March 2016 Term Loan [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "srt_MaximumMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "MaximumMember",
     "presentation": [
      "http://www.lifevantage.com/role/LeasesNarrativeDetails",
      "http://www.lifevantage.com/role/ShareBasedCompensationPerformanceRestrictedStockUnitsNarrativeDetails",
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesPropertyandEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Maximum",
        "label": "Maximum [Member]",
        "documentation": "Upper limit of the provided range."
       }
      }
     },
     "auth_ref": [
      "r125",
      "r127",
      "r129",
      "r130",
      "r132",
      "r149",
      "r151",
      "r152",
      "r154",
      "r155",
      "r259",
      "r353",
      "r354",
      "r355",
      "r356",
      "r450",
      "r482",
      "r483",
      "r484",
      "r499",
      "r576",
      "r619",
      "r705",
      "r706",
      "r713",
      "r734",
      "r735",
      "r786",
      "r788",
      "r790",
      "r791",
      "r793",
      "r797",
      "r798",
      "r800",
      "r801",
      "r813",
      "r814",
      "r850",
      "r858",
      "r867",
      "r872",
      "r873",
      "r874",
      "r903",
      "r904",
      "r905",
      "r906",
      "r919",
      "r1171",
      "r1232",
      "r1233",
      "r1234",
      "r1235",
      "r1236",
      "r1237"
     ]
    },
    "ecd_MeasureAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "MeasureAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Measure:",
        "label": "Measure [Axis]"
       }
      }
     },
     "auth_ref": [
      "r1000"
     ]
    },
    "ecd_MeasureName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "MeasureName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Name",
        "label": "Measure Name"
       }
      }
     },
     "auth_ref": [
      "r1000"
     ]
    },
    "lfvn_MichaelBeindorffMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.lifevantage.com/20250630",
     "localname": "MichaelBeindorffMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Michael Beindorff [Member]",
        "documentation": "Michael Beindorff"
       }
      }
     },
     "auth_ref": []
    },
    "srt_MinimumMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "MinimumMember",
     "presentation": [
      "http://www.lifevantage.com/role/LeasesNarrativeDetails",
      "http://www.lifevantage.com/role/ShareBasedCompensationPerformanceRestrictedStockUnitsNarrativeDetails",
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesPropertyandEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Minimum",
        "label": "Minimum [Member]",
        "documentation": "Lower limit of the provided range."
       }
      }
     },
     "auth_ref": [
      "r125",
      "r127",
      "r129",
      "r130",
      "r132",
      "r149",
      "r151",
      "r152",
      "r154",
      "r155",
      "r259",
      "r353",
      "r354",
      "r355",
      "r356",
      "r450",
      "r482",
      "r483",
      "r484",
      "r499",
      "r576",
      "r619",
      "r705",
      "r706",
      "r713",
      "r734",
      "r735",
      "r786",
      "r788",
      "r790",
      "r791",
      "r793",
      "r797",
      "r798",
      "r800",
      "r801",
      "r813",
      "r814",
      "r850",
      "r858",
      "r867",
      "r872",
      "r873",
      "r874",
      "r903",
      "r904",
      "r905",
      "r919",
      "r1171",
      "r1232",
      "r1233",
      "r1234",
      "r1235",
      "r1236",
      "r1237"
     ]
    },
    "ecd_MnpiDiscTimedForCompValFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "MnpiDiscTimedForCompValFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "MNPI Disclosure Timed for Compensation Value",
        "label": "MNPI Disclosure Timed for Compensation Value [Flag]"
       }
      }
     },
     "auth_ref": [
      "r1020"
     ]
    },
    "lfvn_MoneyBackGuaranteePeriod": {
     "xbrltype": "durationItemType",
     "nsuri": "http://www.lifevantage.com/20250630",
     "localname": "MoneyBackGuaranteePeriod",
     "presentation": [
      "http://www.lifevantage.com/role/RevenueNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Money back guarantee period",
        "label": "Money Back Guarantee Period",
        "documentation": "Money Back Guarantee Period"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_MovementInValuationAllowancesAndReservesRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "MovementInValuationAllowancesAndReservesRollForward",
     "presentation": [
      "http://www.lifevantage.com/role/IncomeTaxesDeferredTaxAssetsValuationAllowanceScheduleDetails",
      "http://www.lifevantage.com/role/RevenueSalesReturnDetails",
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesScheduleOfInventoryValuationReserveDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]",
        "label": "SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]",
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_MtrlTermsOfTrdArrTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "MtrlTermsOfTrdArrTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Material Terms of Trading Arrangement",
        "label": "Material Terms of Trading Arrangement [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1028"
     ]
    },
    "ecd_NamedExecutiveOfficersFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "NamedExecutiveOfficersFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Named Executive Officers, Footnote",
        "label": "Named Executive Officers, Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1001"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "crdr": "debit",
     "calculation": {
      "http://www.lifevantage.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.lifevantage.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net Cash Used in Financing Activities",
        "label": "Cash Provided by (Used in) Financing Activity, Including Discontinued Operation",
        "documentation": "Amount of cash inflow (outflow) from financing activity, including, but not limited to, discontinued operation. Financing activity includes, but is not limited to, obtaining resource from owner and providing return on, and return of, their investment; borrowing money and repaying amount borrowed, or settling obligation; and obtaining and paying for other resource obtained from creditor on long-term credit."
       }
      }
     },
     "auth_ref": [
      "r201"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "presentation": [
      "http://www.lifevantage.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Cash Flows from Financing Activities:",
        "label": "Cash Provided by (Used in) Financing Activity, Including Discontinued Operation [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "crdr": "debit",
     "calculation": {
      "http://www.lifevantage.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.lifevantage.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net Cash Used in Investing Activities",
        "label": "Cash Provided by (Used in) Investing Activity, Including Discontinued Operation",
        "documentation": "Amount of cash inflow (outflow) from investing activity, including, but not limited to, discontinued operation. Investing activity includes, but is not limited to, making and collecting loan, acquiring and disposing of debt and equity instruments, property, plant, and equipment, and other productive assets."
       }
      }
     },
     "auth_ref": [
      "r201"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "presentation": [
      "http://www.lifevantage.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Cash Flows from Investing Activities:",
        "label": "Cash Provided by (Used in) Investing Activity, Including Discontinued Operation [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "calculation": {
      "http://www.lifevantage.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.lifevantage.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net Cash Provided by Operating Activities",
        "label": "Cash Provided by (Used in) Operating Activity, Including Discontinued Operation",
        "documentation": "Amount of cash inflow (outflow) from operating activity, including, but not limited to, discontinued operation. Operating activity includes, but is not limited to, transaction, adjustment, and change in value not defined as investing or financing activity."
       }
      }
     },
     "auth_ref": [
      "r79",
      "r80",
      "r82"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "presentation": [
      "http://www.lifevantage.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Cash Flows from Operating Activities:",
        "label": "Cash Provided by (Used in) Operating Activity, Including Discontinued Operation [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetIncomeLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "NetIncomeLoss",
     "crdr": "credit",
     "calculation": {
      "http://www.lifevantage.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOME": {
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.lifevantage.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 13.0
      },
      "http://www.lifevantage.com/role/SegmentInformationScheduleofSegmentRevenueandExpenseDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.lifevantage.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.lifevantage.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOME",
      "http://www.lifevantage.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY",
      "http://www.lifevantage.com/role/SegmentInformationScheduleofSegmentRevenueandExpenseDetails",
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesComputationofNetIncomePerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net income",
        "terseLabel": "Net income",
        "label": "Net Income (Loss) Attributable to Parent",
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent."
       }
      }
     },
     "auth_ref": [
      "r71",
      "r82",
      "r110",
      "r158",
      "r163",
      "r180",
      "r183",
      "r188",
      "r208",
      "r211",
      "r212",
      "r216",
      "r225",
      "r229",
      "r230",
      "r231",
      "r232",
      "r233",
      "r236",
      "r237",
      "r244",
      "r307",
      "r359",
      "r360",
      "r361",
      "r362",
      "r363",
      "r364",
      "r365",
      "r366",
      "r367",
      "r396",
      "r399",
      "r401",
      "r405",
      "r490",
      "r551",
      "r556",
      "r575",
      "r579",
      "r682",
      "r763",
      "r779",
      "r780",
      "r826",
      "r828",
      "r830",
      "r935",
      "r1169"
     ]
    },
    "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "NetIncomeLossAvailableToCommonStockholdersBasicAbstract",
     "presentation": [
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesComputationofNetIncomePerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Numerator:",
        "label": "Net Income (Loss) Available to Common Stockholders, Basic [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "presentation": [
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "New Accounting Pronouncements",
        "label": "New Accounting Pronouncements, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_NonGaapMeasureDescriptionTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "NonGaapMeasureDescriptionTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-GAAP Measure Description",
        "label": "Non-GAAP Measure Description [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1000"
     ]
    },
    "ecd_NonNeosMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "NonNeosMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-NEOs",
        "label": "Non-NEOs [Member]"
       }
      }
     },
     "auth_ref": [
      "r963",
      "r974",
      "r984",
      "r1008",
      "r1017"
     ]
    },
    "ecd_NonPeoNeoAvgCompActuallyPaidAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "NonPeoNeoAvgCompActuallyPaidAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-PEO NEO Average Compensation Actually Paid Amount",
        "label": "Non-PEO NEO Average Compensation Actually Paid Amount"
       }
      }
     },
     "auth_ref": [
      "r991"
     ]
    },
    "ecd_NonPeoNeoAvgTotalCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "NonPeoNeoAvgTotalCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-PEO NEO Average Total Compensation Amount",
        "label": "Non-PEO NEO Average Total Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r990"
     ]
    },
    "ecd_NonPeoNeoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "NonPeoNeoMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-PEO NEO",
        "label": "Non-PEO NEO [Member]"
       }
      }
     },
     "auth_ref": [
      "r1008"
     ]
    },
    "ecd_NonRule10b51ArrAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "NonRule10b51ArrAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-Rule 10b5-1 Arrangement Adopted",
        "label": "Non-Rule 10b5-1 Arrangement Adopted [Flag]"
       }
      }
     },
     "auth_ref": [
      "r1028"
     ]
    },
    "ecd_NonRule10b51ArrTrmntdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "NonRule10b51ArrTrmntdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-Rule 10b5-1 Arrangement Terminated",
        "label": "Non-Rule 10b5-1 Arrangement Terminated [Flag]"
       }
      }
     },
     "auth_ref": [
      "r1028"
     ]
    },
    "us-gaap_NonUsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "NonUsMember",
     "presentation": [
      "http://www.lifevantage.com/role/SegmentInformationScheduleOfRevenueDisaggregationByMarketDetails",
      "http://www.lifevantage.com/role/SegmentInformationScheduleofLongLivedAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total foreign markets",
        "label": "Non-US [Member]",
        "documentation": "Countries excluding the United States of America (US)."
       }
      }
     },
     "auth_ref": [
      "r1274",
      "r1275",
      "r1276",
      "r1277"
     ]
    },
    "us-gaap_NoncurrentAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "NoncurrentAssets",
     "crdr": "debit",
     "presentation": [
      "http://www.lifevantage.com/role/SegmentInformationScheduleofLongLivedAssetsDetails",
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesSegmentInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Long-lived assets",
        "label": "Long-Lived Assets",
        "documentation": "Long-lived assets other than financial instruments, long-term customer relationships of a financial institution, mortgage and other servicing rights, deferred policy acquisition costs, and deferred tax assets."
       }
      }
     },
     "auth_ref": [
      "r300"
     ]
    },
    "us-gaap_NonoperatingIncomeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "NonoperatingIncomeExpense",
     "crdr": "credit",
     "calculation": {
      "http://www.lifevantage.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOME": {
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.lifevantage.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOME"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total other income, net",
        "label": "Nonoperating Income (Expense)",
        "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business)."
       }
      }
     },
     "auth_ref": [
      "r73"
     ]
    },
    "us-gaap_NonoperatingIncomeExpenseAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "NonoperatingIncomeExpenseAbstract",
     "presentation": [
      "http://www.lifevantage.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOME"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Other income (expense):",
        "label": "Nonoperating Income (Expense) [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "NonvestedRestrictedStockSharesActivityTableTextBlock",
     "presentation": [
      "http://www.lifevantage.com/role/ShareBasedCompensationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Nonvested Restricted Shares",
        "label": "Nonvested Restricted Stock Shares Activity [Table Text Block]",
        "documentation": "Tabular disclosure of the changes in outstanding nonvested restricted stock shares."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "lfvn_NumberOfFinanceLeases": {
     "xbrltype": "integerItemType",
     "nsuri": "http://www.lifevantage.com/20250630",
     "localname": "NumberOfFinanceLeases",
     "presentation": [
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of finance leases",
        "label": "Number of Finance Leases",
        "documentation": "Number of Finance Leases"
       }
      }
     },
     "auth_ref": []
    },
    "lfvn_NumberOfGeographicSegments": {
     "xbrltype": "integerItemType",
     "nsuri": "http://www.lifevantage.com/20250630",
     "localname": "NumberOfGeographicSegments",
     "presentation": [
      "http://www.lifevantage.com/role/RevenueNarrativeDetails",
      "http://www.lifevantage.com/role/SegmentInformationNarrativeDetails",
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of geographic segments",
        "label": "Number Of Geographic Segments",
        "documentation": "Number of geographic segments."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NumberOfOperatingSegments": {
     "xbrltype": "integerItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "NumberOfOperatingSegments",
     "presentation": [
      "http://www.lifevantage.com/role/SegmentInformationNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of operating segments",
        "label": "Number of Operating Segments",
        "documentation": "Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues."
       }
      }
     },
     "auth_ref": [
      "r845",
      "r1140"
     ]
    },
    "lfvn_NumberOfProductLines": {
     "xbrltype": "integerItemType",
     "nsuri": "http://www.lifevantage.com/20250630",
     "localname": "NumberOfProductLines",
     "presentation": [
      "http://www.lifevantage.com/role/RevenueNarrativeDetails",
      "http://www.lifevantage.com/role/SegmentInformationNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of product lines",
        "label": "Number Of Product Lines",
        "documentation": "Number Of Product Lines"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingExpenses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OperatingExpenses",
     "crdr": "debit",
     "calculation": {
      "http://www.lifevantage.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOME": {
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.lifevantage.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOME"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total operating expenses",
        "label": "Operating Expenses",
        "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense."
       }
      }
     },
     "auth_ref": [
      "r830"
     ]
    },
    "us-gaap_OperatingExpensesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OperatingExpensesAbstract",
     "presentation": [
      "http://www.lifevantage.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOME"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Operating expenses:",
        "label": "Operating Expenses [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingIncomeLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OperatingIncomeLoss",
     "crdr": "credit",
     "calculation": {
      "http://www.lifevantage.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOME": {
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.lifevantage.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOME"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Operating income",
        "label": "Operating Income (Loss)",
        "documentation": "The net result for the period of deducting operating expenses from operating revenues."
       }
      }
     },
     "auth_ref": [
      "r113",
      "r826",
      "r830",
      "r838",
      "r1134",
      "r1141",
      "r1142",
      "r1143",
      "r1144"
     ]
    },
    "us-gaap_OperatingLeaseCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OperatingLeaseCost",
     "crdr": "debit",
     "calculation": {
      "http://www.lifevantage.com/role/LeasesScheduleofLeaseCostDetails": {
       "parentTag": "us-gaap_LeaseCost",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.lifevantage.com/role/LeasesScheduleofLeaseCostDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating lease cost",
        "label": "Operating Lease, Cost",
        "documentation": "Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability."
       }
      }
     },
     "auth_ref": [
      "r604",
      "r908"
     ]
    },
    "us-gaap_OperatingLeaseLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OperatingLeaseLiability",
     "crdr": "credit",
     "calculation": {
      "http://www.lifevantage.com/role/LeasesMaturityofLeaseLiabilitiesDetails_1": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.lifevantage.com/role/LeasesMaturityofLeaseLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Present value of lease liabilities",
        "label": "Operating Lease, Liability",
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease."
       }
      }
     },
     "auth_ref": [
      "r599"
     ]
    },
    "us-gaap_OperatingLeaseLiabilityCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OperatingLeaseLiabilityCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.lifevantage.com/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.lifevantage.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Lease liabilities",
        "label": "Operating Lease, Liability, Current",
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current."
       }
      }
     },
     "auth_ref": [
      "r599"
     ]
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.lifevantage.com/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.lifevantage.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Long-term lease liabilities",
        "label": "Operating Lease, Liability, Noncurrent",
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent."
       }
      }
     },
     "auth_ref": [
      "r599"
     ]
    },
    "us-gaap_OperatingLeasePayments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OperatingLeasePayments",
     "crdr": "credit",
     "presentation": [
      "http://www.lifevantage.com/role/LeasesSupplementalCashFlowInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating cash outflows from operating leases",
        "label": "Operating Lease, Payments",
        "documentation": "Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use."
       }
      }
     },
     "auth_ref": [
      "r600",
      "r607"
     ]
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OperatingLeaseRightOfUseAsset",
     "crdr": "debit",
     "calculation": {
      "http://www.lifevantage.com/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.lifevantage.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Right-of-use assets",
        "label": "Operating Lease, Right-of-Use Asset",
        "documentation": "Amount of lessee's right to use underlying asset under operating lease."
       }
      }
     },
     "auth_ref": [
      "r598"
     ]
    },
    "us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OperatingLeaseRightOfUseAssetAmortizationExpense",
     "crdr": "debit",
     "calculation": {
      "http://www.lifevantage.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.lifevantage.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-cash operating lease expense",
        "label": "Operating Lease, Right-of-Use Asset, Periodic Reduction",
        "documentation": "Amount of periodic reduction over lease term of carrying amount of right-of-use asset from operating lease."
       }
      }
     },
     "auth_ref": [
      "r1111"
     ]
    },
    "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OperatingLeaseWeightedAverageDiscountRatePercent",
     "presentation": [
      "http://www.lifevantage.com/role/LeasesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted average discount rate",
        "label": "Operating Lease, Weighted Average Discount Rate, Percent",
        "documentation": "Weighted average discount rate for operating lease calculated at point in time."
       }
      }
     },
     "auth_ref": [
      "r610",
      "r908"
     ]
    },
    "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1",
     "presentation": [
      "http://www.lifevantage.com/role/LeasesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted average remaining lease term",
        "label": "Operating Lease, Weighted Average Remaining Lease Term",
        "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r609",
      "r908"
     ]
    },
    "us-gaap_OperatingLossCarryforwards": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OperatingLossCarryforwards",
     "crdr": "debit",
     "presentation": [
      "http://www.lifevantage.com/role/IncomeTaxesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Net operating loss carryforwards",
        "label": "Operating Loss Carryforwards",
        "documentation": "Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws."
       }
      }
     },
     "auth_ref": [
      "r537"
     ]
    },
    "us-gaap_OperatingLossCarryforwardsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OperatingLossCarryforwardsLineItems",
     "presentation": [
      "http://www.lifevantage.com/role/IncomeTaxesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating Loss Carryforwards [Line Items]",
        "label": "Operating Loss Carryforwards [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r537"
     ]
    },
    "us-gaap_OperatingLossCarryforwardsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OperatingLossCarryforwardsTable",
     "presentation": [
      "http://www.lifevantage.com/role/IncomeTaxesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating Loss Carryforwards [Table]",
        "label": "Operating Loss Carryforwards [Table]",
        "documentation": "Disclosure of information about operating loss carryforward. Includes, but is not limited to, tax authority, amount and expiration date of operating loss carryforward, and likelihood of utilization."
       }
      }
     },
     "auth_ref": [
      "r537"
     ]
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Organization, Consolidation and Presentation of Financial Statements [Abstract]",
        "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
     "presentation": [
      "http://www.lifevantage.com/role/TheCompany"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "The Company",
        "label": "Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]",
        "documentation": "The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure."
       }
      }
     },
     "auth_ref": [
      "r98",
      "r159",
      "r160",
      "r161",
      "r718",
      "r719"
     ]
    },
    "us-gaap_OtherAccruedLiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OtherAccruedLiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.lifevantage.com/role/OtherAccruedExpensesDetails": {
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.lifevantage.com/role/OtherAccruedExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued other expenses",
        "label": "Other Accrued Liabilities, Current",
        "documentation": "Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r45"
     ]
    },
    "us-gaap_OtherAssetsNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OtherAssetsNoncurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.lifevantage.com/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.lifevantage.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other long-term assets",
        "label": "Other Assets, Noncurrent",
        "documentation": "Amount of noncurrent assets classified as other."
       }
      }
     },
     "auth_ref": [
      "r171"
     ]
    },
    "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax",
     "crdr": "credit",
     "calculation": {
      "http://www.lifevantage.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOME": {
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.lifevantage.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOME",
      "http://www.lifevantage.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Foreign currency translation adjustment",
        "terseLabel": "Foreign currency translation adjustment",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax",
        "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature."
       }
      }
     },
     "auth_ref": [
      "r3",
      "r683"
     ]
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OtherComprehensiveIncomeLossNetOfTax",
     "crdr": "credit",
     "calculation": {
      "http://www.lifevantage.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOME": {
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.lifevantage.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOME"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Other comprehensive income (loss), net of tax:",
        "label": "Other Comprehensive Income (Loss), Net of Tax",
        "documentation": "Amount after tax and reclassification adjustments of other comprehensive income (loss)."
       }
      }
     },
     "auth_ref": [
      "r10",
      "r14",
      "r181",
      "r184",
      "r189",
      "r233",
      "r586",
      "r587",
      "r592",
      "r662",
      "r683",
      "r1062",
      "r1063"
     ]
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract",
     "presentation": [
      "http://www.lifevantage.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOME"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Other comprehensive income (loss), net of tax:",
        "label": "Other Comprehensive Income (Loss), Net of Tax [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "lfvn_OtherForeignMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.lifevantage.com/20250630",
     "localname": "OtherForeignMember",
     "presentation": [
      "http://www.lifevantage.com/role/SegmentInformationScheduleOfRevenueDisaggregationByMarketDetails",
      "http://www.lifevantage.com/role/SegmentInformationScheduleofLongLivedAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other foreign markets",
        "label": "Other Foreign [Member]",
        "documentation": "Other Foreign"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherIncomeAndExpensesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OtherIncomeAndExpensesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other Income and Expenses [Abstract]",
        "label": "Other Income and Expenses [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OtherIncomeAndOtherExpenseDisclosureTextBlock",
     "presentation": [
      "http://www.lifevantage.com/role/OtherExpenseNet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other Expense, Net",
        "label": "Other Income and Other Expense Disclosure [Text Block]",
        "documentation": "The entire disclosure for other income or other expense items (both operating and nonoperating). Sources of nonoperating income or nonoperating expense that may be disclosed, include amounts earned from dividends, interest on securities, profits (losses) on securities, net and miscellaneous other income or income deductions."
       }
      }
     },
     "auth_ref": [
      "r1055",
      "r1204"
     ]
    },
    "us-gaap_OtherLiabilitiesNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OtherLiabilitiesNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.lifevantage.com/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.lifevantage.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other long-term liabilities",
        "label": "Other Liabilities, Noncurrent",
        "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r50"
     ]
    },
    "lfvn_OtherMiscellaneousIncomeExpensesNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.lifevantage.com/20250630",
     "localname": "OtherMiscellaneousIncomeExpensesNet",
     "crdr": "credit",
     "calculation": {
      "http://www.lifevantage.com/role/OtherExpenseNetDetails": {
       "parentTag": "us-gaap_OtherNonoperatingIncomeExpense",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.lifevantage.com/role/OtherExpenseNetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other income (expense), net",
        "label": "Other Miscellaneous Income (Expenses), Net",
        "documentation": "Other Miscellaneous Income (Expenses), Net"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherNonoperatingIncomeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OtherNonoperatingIncomeExpense",
     "crdr": "credit",
     "calculation": {
      "http://www.lifevantage.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOME": {
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0,
       "order": 2.0
      },
      "http://www.lifevantage.com/role/OtherExpenseNetDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.lifevantage.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOME",
      "http://www.lifevantage.com/role/OtherExpenseNetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Other expense, net",
        "totalLabel": "Total other expense, net",
        "label": "Other Nonoperating Income (Expense)",
        "documentation": "Amount of income (expense) related to nonoperating activities, classified as other."
       }
      }
     },
     "auth_ref": [
      "r75",
      "r902"
     ]
    },
    "ecd_OtherPerfMeasureAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "OtherPerfMeasureAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other Performance Measure, Amount",
        "label": "Other Performance Measure, Amount"
       }
      }
     },
     "auth_ref": [
      "r1000"
     ]
    },
    "ecd_OutstandingAggtErrCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "OutstandingAggtErrCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Outstanding Aggregate Erroneous Compensation Amount",
        "label": "Outstanding Aggregate Erroneous Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r961",
      "r972",
      "r982",
      "r1015"
     ]
    },
    "ecd_OutstandingRecoveryCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "OutstandingRecoveryCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Compensation Amount",
        "label": "Outstanding Recovery Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r964",
      "r975",
      "r985",
      "r1018"
     ]
    },
    "ecd_OutstandingRecoveryIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "OutstandingRecoveryIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Name",
        "label": "Outstanding Recovery, Individual Name"
       }
      }
     },
     "auth_ref": [
      "r964",
      "r975",
      "r985",
      "r1018"
     ]
    },
    "us-gaap_PatentsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PatentsMember",
     "presentation": [
      "http://www.lifevantage.com/role/IntangibleAssetsNetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Patents",
        "label": "Patents [Member]",
        "documentation": "Exclusive legal right granted by the government to the owner of the patent to exploit an invention or a process for a period of time specified by law."
       }
      }
     },
     "auth_ref": [
      "r1149",
      "r1150",
      "r1151",
      "r1152",
      "r1154",
      "r1156",
      "r1158",
      "r1159"
     ]
    },
    "ecd_PayVsPerformanceDisclosureLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PayVsPerformanceDisclosureLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Pay vs Performance Disclosure [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r989"
     ]
    },
    "us-gaap_PayablesAndAccrualsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PayablesAndAccrualsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Payables and Accruals [Abstract]",
        "label": "Payables and Accruals [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PaymentsForRepurchaseOfCommonStock": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PaymentsForRepurchaseOfCommonStock",
     "crdr": "credit",
     "calculation": {
      "http://www.lifevantage.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.lifevantage.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.lifevantage.com/role/StockholdersEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Repurchase of company stock",
        "terseLabel": "Payments for repurchase of common stock",
        "label": "Payments for Repurchase of Common Stock",
        "documentation": "The cash outflow to reacquire common stock during the period."
       }
      }
     },
     "auth_ref": [
      "r78"
     ]
    },
    "us-gaap_PaymentsOfDividends": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PaymentsOfDividends",
     "crdr": "credit",
     "calculation": {
      "http://www.lifevantage.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.lifevantage.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Payment of cash dividends",
        "label": "Payments of Dividends",
        "documentation": "Cash outflow in the form of capital distributions and dividends to common shareholders, preferred shareholders and noncontrolling interests."
       }
      }
     },
     "auth_ref": [
      "r78"
     ]
    },
    "us-gaap_PaymentsOfFinancingCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PaymentsOfFinancingCosts",
     "crdr": "credit",
     "calculation": {
      "http://www.lifevantage.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.lifevantage.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Payment of deferred financing fees",
        "label": "Payments of Financing Costs",
        "documentation": "The cash outflow for loan and debt issuance costs."
       }
      }
     },
     "auth_ref": [
      "r18"
     ]
    },
    "us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PaymentsRelatedToTaxWithholdingForShareBasedCompensation",
     "crdr": "credit",
     "calculation": {
      "http://www.lifevantage.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.lifevantage.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Shares purchased as payment of tax withholding and other",
        "label": "Payment, Tax Withholding, Share-Based Payment Arrangement",
        "documentation": "Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r199"
     ]
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "crdr": "credit",
     "calculation": {
      "http://www.lifevantage.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.lifevantage.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Purchase of equipment",
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets."
       }
      }
     },
     "auth_ref": [
      "r77"
     ]
    },
    "ecd_PeerGroupIssuersFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PeerGroupIssuersFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Peer Group Issuers, Footnote",
        "label": "Peer Group Issuers, Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r999"
     ]
    },
    "ecd_PeerGroupTotalShareholderRtnAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PeerGroupTotalShareholderRtnAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Peer Group Total Shareholder Return Amount",
        "label": "Peer Group Total Shareholder Return Amount"
       }
      }
     },
     "auth_ref": [
      "r999"
     ]
    },
    "ecd_PeoActuallyPaidCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PeoActuallyPaidCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "PEO Actually Paid Compensation Amount",
        "label": "PEO Actually Paid Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r991"
     ]
    },
    "ecd_PeoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PeoMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "PEO",
        "label": "PEO [Member]"
       }
      }
     },
     "auth_ref": [
      "r1008"
     ]
    },
    "ecd_PeoName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PeoName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "PEO Name",
        "label": "PEO Name"
       }
      }
     },
     "auth_ref": [
      "r1001"
     ]
    },
    "ecd_PeoTotalCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PeoTotalCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "PEO Total Compensation Amount",
        "label": "PEO Total Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r990"
     ]
    },
    "lfvn_PerformanceStockUnitsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.lifevantage.com/20250630",
     "localname": "PerformanceStockUnitsMember",
     "presentation": [
      "http://www.lifevantage.com/role/ShareBasedCompensationPerformanceRestrictedStockUnitsDetails",
      "http://www.lifevantage.com/role/ShareBasedCompensationPerformanceRestrictedStockUnitsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Performance Restricted Stock Units",
        "label": "Performance Stock Units [Member]",
        "documentation": "Performance Stock Units [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "lfvn_PermanentDifferencesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.lifevantage.com/20250630",
     "localname": "PermanentDifferencesAbstract",
     "presentation": [
      "http://www.lifevantage.com/role/IncomeTaxesEffectiveIncomeTaxRateDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Permanent differences:",
        "label": "Permanent Differences [Abstract]",
        "documentation": "Permanent differences."
       }
      }
     },
     "auth_ref": []
    },
    "lfvn_PetandimProductLineMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.lifevantage.com/20250630",
     "localname": "PetandimProductLineMember",
     "presentation": [
      "http://www.lifevantage.com/role/SegmentInformationScheduleofMajorProductsLinesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Petandim\u00ae product line",
        "label": "Petandim Product Line [Member]",
        "documentation": "Petandim Product Line"
       }
      }
     },
     "auth_ref": []
    },
    "lfvn_PhysIQProductLineMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.lifevantage.com/20250630",
     "localname": "PhysIQProductLineMember",
     "presentation": [
      "http://www.lifevantage.com/role/SegmentInformationScheduleofMajorProductsLinesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "PhysIQ\u2122 product line",
        "label": "PhysIQ Product Line [Member]",
        "documentation": "PhysIQ Product Line"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PlanNameAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PlanNameAxis",
     "presentation": [
      "http://www.lifevantage.com/role/ShareBasedCompensationEmployeeStockPurchasePlanNarrativeDetails",
      "http://www.lifevantage.com/role/ShareBasedCompensationEquitySettledPlansNarrativeDetails",
      "http://www.lifevantage.com/role/ShareBasedCompensationStockBasedCompensationNarrativeDetails",
      "http://www.lifevantage.com/role/StockholdersEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Plan Name [Axis]",
        "label": "Plan Name [Axis]",
        "documentation": "Information by plan name for share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r1175",
      "r1176",
      "r1177",
      "r1178",
      "r1179",
      "r1180",
      "r1181",
      "r1182",
      "r1183",
      "r1184",
      "r1185",
      "r1187",
      "r1188",
      "r1189",
      "r1190",
      "r1191",
      "r1192",
      "r1193",
      "r1194",
      "r1195",
      "r1196",
      "r1197",
      "r1198",
      "r1199",
      "r1200",
      "r1201"
     ]
    },
    "us-gaap_PlanNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PlanNameDomain",
     "presentation": [
      "http://www.lifevantage.com/role/ShareBasedCompensationEmployeeStockPurchasePlanNarrativeDetails",
      "http://www.lifevantage.com/role/ShareBasedCompensationEquitySettledPlansNarrativeDetails",
      "http://www.lifevantage.com/role/ShareBasedCompensationStockBasedCompensationNarrativeDetails",
      "http://www.lifevantage.com/role/StockholdersEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Plan Name [Domain]",
        "label": "Plan Name [Domain]",
        "documentation": "Plan name for share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r1175",
      "r1176",
      "r1177",
      "r1178",
      "r1179",
      "r1180",
      "r1181",
      "r1182",
      "r1183",
      "r1184",
      "r1185",
      "r1187",
      "r1188",
      "r1189",
      "r1190",
      "r1191",
      "r1192",
      "r1193",
      "r1194",
      "r1195",
      "r1196",
      "r1197",
      "r1198",
      "r1199",
      "r1200",
      "r1201"
     ]
    },
    "ecd_PnsnAdjsPrrSvcCstMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PnsnAdjsPrrSvcCstMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pension Adjustments Prior Service Cost",
        "label": "Pension Adjustments Prior Service Cost [Member]"
       }
      }
     },
     "auth_ref": [
      "r992"
     ]
    },
    "ecd_PnsnAdjsSvcCstMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PnsnAdjsSvcCstMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pension Adjustments Service Cost",
        "label": "Pension Adjustments Service Cost [Member]"
       }
      }
     },
     "auth_ref": [
      "r1048"
     ]
    },
    "ecd_PnsnBnftsAdjFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PnsnBnftsAdjFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pension Benefits Adjustments, Footnote",
        "label": "Pension Benefits Adjustments, Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r991"
     ]
    },
    "us-gaap_PreferredStockParOrStatedValuePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PreferredStockParOrStatedValuePerShare",
     "presentation": [
      "http://www.lifevantage.com/role/CONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Preferred stock, par value (dollars per share)",
        "label": "Preferred Stock, Par or Stated Value Per Share",
        "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer."
       }
      }
     },
     "auth_ref": [
      "r55",
      "r407"
     ]
    },
    "us-gaap_PreferredStockSharesAuthorized": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PreferredStockSharesAuthorized",
     "presentation": [
      "http://www.lifevantage.com/role/CONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Preferred stock, shares authorized (in shares)",
        "label": "Preferred Stock, Shares Authorized",
        "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws."
       }
      }
     },
     "auth_ref": [
      "r55",
      "r744"
     ]
    },
    "us-gaap_PreferredStockSharesIssued": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PreferredStockSharesIssued",
     "presentation": [
      "http://www.lifevantage.com/role/CONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Preferred stock, shares issued (in shares)",
        "label": "Preferred Stock, Shares Issued",
        "documentation": "Number of shares issued for nonredeemable preferred shares and preferred shares redeemable solely at option of issuer. Includes, but is not limited to, preferred shares issued, repurchased, and held as treasury shares. Excludes preferred shares classified as debt."
       }
      }
     },
     "auth_ref": [
      "r55",
      "r407"
     ]
    },
    "us-gaap_PreferredStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PreferredStockSharesOutstanding",
     "presentation": [
      "http://www.lifevantage.com/role/CONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Preferred stock, shares outstanding (in shares)",
        "label": "Preferred Stock, Shares Outstanding",
        "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased."
       }
      }
     },
     "auth_ref": [
      "r55",
      "r744",
      "r762",
      "r1272",
      "r1273"
     ]
    },
    "us-gaap_PreferredStockValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PreferredStockValue",
     "crdr": "credit",
     "calculation": {
      "http://www.lifevantage.com/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.lifevantage.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Preferred stock \u2014 par value $0.0001 per share, 5,000 shares authorized, no shares issued or outstanding",
        "label": "Preferred Stock, Value, Issued",
        "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity."
       }
      }
     },
     "auth_ref": [
      "r55",
      "r398",
      "r403",
      "r673",
      "r909"
     ]
    },
    "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PrepaidExpenseAndOtherAssetsCurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.lifevantage.com/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.lifevantage.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Prepaid expenses and other",
        "label": "Prepaid Expense and Other Assets, Current",
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r1061"
     ]
    },
    "lfvn_ProceedsFromIssuanceOfCommonStockUnderEmployeeStockPurchasePlan": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.lifevantage.com/20250630",
     "localname": "ProceedsFromIssuanceOfCommonStockUnderEmployeeStockPurchasePlan",
     "crdr": "debit",
     "calculation": {
      "http://www.lifevantage.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.lifevantage.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Proceeds from common stock issued under employee stock purchase plan",
        "label": "Proceeds From Issuance of Common Stock Under Employee Stock Purchase Plan",
        "documentation": "Proceeds From Issuance of Common Stock Under Employee Stock Purchase Plan"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ProceedsFromSaleOfPropertyPlantAndEquipment",
     "crdr": "debit",
     "calculation": {
      "http://www.lifevantage.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.lifevantage.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Proceeds from sale of fixed assets",
        "label": "Proceeds from Sale of Property, Plant, and Equipment",
        "documentation": "The cash inflow from the sale of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale."
       }
      }
     },
     "auth_ref": [
      "r76"
     ]
    },
    "us-gaap_ProductAndServiceOtherMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ProductAndServiceOtherMember",
     "presentation": [
      "http://www.lifevantage.com/role/RevenueMajorProductsDetails",
      "http://www.lifevantage.com/role/SegmentInformationScheduleofMajorProductsLinesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other",
        "label": "Product and Service, Other [Member]",
        "documentation": "Article or substance produced by nature, labor or machinery and act of providing assistance, classified as other."
       }
      }
     },
     "auth_ref": [
      "r1173",
      "r1174"
     ]
    },
    "us-gaap_ProductConcentrationRiskMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ProductConcentrationRiskMember",
     "presentation": [
      "http://www.lifevantage.com/role/RevenueMajorProductsDetails",
      "http://www.lifevantage.com/role/RevenueNarrativeDetails",
      "http://www.lifevantage.com/role/SegmentInformationNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Product concentration risk",
        "label": "Product Concentration Risk [Member]",
        "documentation": "Reflects the percentage that revenues during the period from a specified product are to a specified benchmark, such as total net revenues, segment revenues or product line revenues. May also reflect the percentage contribution the product made to operating results. Risk is materially adverse effects of a loss of sales of a significant product or line of products, which could occur upon loss of rights to sell, distribute or license others; loss of patent or copyright protection; or technological obsolescence."
       }
      }
     },
     "auth_ref": [
      "r1137"
     ]
    },
    "srt_ProductOrServiceAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "ProductOrServiceAxis",
     "presentation": [
      "http://www.lifevantage.com/role/RevenueMajorProductsDetails",
      "http://www.lifevantage.com/role/RevenueNarrativeDetails",
      "http://www.lifevantage.com/role/SegmentInformationNarrativeDetails",
      "http://www.lifevantage.com/role/SegmentInformationScheduleofMajorProductsLinesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Product and Service [Axis]",
        "label": "Product and Service [Axis]",
        "documentation": "Information by product and service, or group of similar products and similar services."
       }
      }
     },
     "auth_ref": [
      "r134",
      "r135",
      "r136",
      "r137",
      "r138",
      "r139",
      "r153",
      "r297",
      "r624",
      "r698",
      "r699",
      "r700",
      "r701",
      "r702",
      "r703",
      "r704",
      "r818",
      "r825",
      "r828",
      "r830",
      "r859",
      "r860",
      "r918",
      "r919",
      "r920",
      "r923",
      "r926",
      "r1052",
      "r1056",
      "r1068",
      "r1069",
      "r1070",
      "r1071",
      "r1072",
      "r1073",
      "r1074",
      "r1075",
      "r1076",
      "r1077",
      "r1078",
      "r1079",
      "r1080",
      "r1081",
      "r1082",
      "r1083",
      "r1084",
      "r1085",
      "r1086",
      "r1087",
      "r1088",
      "r1089",
      "r1090",
      "r1091",
      "r1092",
      "r1093",
      "r1094",
      "r1095",
      "r1096",
      "r1097",
      "r1098",
      "r1099",
      "r1100",
      "r1101",
      "r1102",
      "r1103",
      "r1104",
      "r1106",
      "r1107",
      "r1108",
      "r1109",
      "r1166",
      "r1167",
      "r1241",
      "r1242",
      "r1243",
      "r1244",
      "r1245",
      "r1246",
      "r1247",
      "r1248",
      "r1249",
      "r1250",
      "r1251",
      "r1252",
      "r1253",
      "r1254",
      "r1255",
      "r1256",
      "r1257",
      "r1258",
      "r1259",
      "r1260",
      "r1261",
      "r1262",
      "r1263",
      "r1264",
      "r1265",
      "r1266",
      "r1267",
      "r1268",
      "r1269"
     ]
    },
    "srt_ProductsAndServicesDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "ProductsAndServicesDomain",
     "presentation": [
      "http://www.lifevantage.com/role/RevenueMajorProductsDetails",
      "http://www.lifevantage.com/role/RevenueNarrativeDetails",
      "http://www.lifevantage.com/role/SegmentInformationNarrativeDetails",
      "http://www.lifevantage.com/role/SegmentInformationScheduleofMajorProductsLinesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Product and Service [Domain]",
        "label": "Product and Service [Domain]",
        "documentation": "Product or service, or a group of similar products or similar services."
       }
      }
     },
     "auth_ref": [
      "r134",
      "r135",
      "r136",
      "r137",
      "r138",
      "r139",
      "r153",
      "r297",
      "r624",
      "r698",
      "r699",
      "r700",
      "r701",
      "r702",
      "r703",
      "r704",
      "r818",
      "r825",
      "r828",
      "r830",
      "r859",
      "r860",
      "r918",
      "r919",
      "r920",
      "r923",
      "r926",
      "r1052",
      "r1056",
      "r1068",
      "r1069",
      "r1070",
      "r1071",
      "r1072",
      "r1073",
      "r1074",
      "r1075",
      "r1076",
      "r1077",
      "r1078",
      "r1079",
      "r1080",
      "r1081",
      "r1082",
      "r1083",
      "r1084",
      "r1085",
      "r1086",
      "r1087",
      "r1088",
      "r1089",
      "r1090",
      "r1091",
      "r1092",
      "r1093",
      "r1094",
      "r1095",
      "r1096",
      "r1097",
      "r1098",
      "r1099",
      "r1100",
      "r1101",
      "r1102",
      "r1103",
      "r1104",
      "r1106",
      "r1107",
      "r1108",
      "r1109",
      "r1166",
      "r1167",
      "r1241",
      "r1242",
      "r1243",
      "r1244",
      "r1245",
      "r1246",
      "r1247",
      "r1248",
      "r1249",
      "r1250",
      "r1251",
      "r1252",
      "r1253",
      "r1254",
      "r1255",
      "r1256",
      "r1257",
      "r1258",
      "r1259",
      "r1260",
      "r1261",
      "r1262",
      "r1263",
      "r1264",
      "r1265",
      "r1266",
      "r1267",
      "r1268",
      "r1269"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PropertyPlantAndEquipmentAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Property, Plant and Equipment [Abstract]",
        "label": "Property, Plant and Equipment [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PropertyPlantAndEquipmentByTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PropertyPlantAndEquipmentByTypeAxis",
     "presentation": [
      "http://www.lifevantage.com/role/PropertyandEquipmentNetDetails",
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesPropertyandEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Property, Plant and Equipment by Type [Axis]",
        "label": "Long-Lived Tangible Asset [Axis]",
        "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale."
       }
      }
     },
     "auth_ref": [
      "r8",
      "r612"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PropertyPlantAndEquipmentDisclosureTextBlock",
     "presentation": [
      "http://www.lifevantage.com/role/PropertyandEquipmentNet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Property and Equipment, Net",
        "label": "Property, Plant and Equipment Disclosure [Text Block]",
        "documentation": "The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections."
       }
      }
     },
     "auth_ref": [
      "r86",
      "r119",
      "r120",
      "r121"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentGross": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PropertyPlantAndEquipmentGross",
     "crdr": "debit",
     "calculation": {
      "http://www.lifevantage.com/role/PropertyandEquipmentNetDetails": {
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.lifevantage.com/role/PropertyandEquipmentNetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Property and equipment, gross",
        "label": "Property, Plant and Equipment, Gross",
        "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures."
       }
      }
     },
     "auth_ref": [
      "r87",
      "r168",
      "r680"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PropertyPlantAndEquipmentLineItems",
     "presentation": [
      "http://www.lifevantage.com/role/PropertyandEquipmentNetDetails",
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesPropertyandEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Property, Plant and Equipment [Line Items]",
        "label": "Property, Plant and Equipment [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r612"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PropertyPlantAndEquipmentNet",
     "crdr": "debit",
     "calculation": {
      "http://www.lifevantage.com/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 2.0
      },
      "http://www.lifevantage.com/role/PropertyandEquipmentNetDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.lifevantage.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.lifevantage.com/role/PropertyandEquipmentNetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Property and equipment, net",
        "totalLabel": "Total property and equipment, net",
        "label": "Property, Plant and Equipment, Net",
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures."
       }
      }
     },
     "auth_ref": [
      "r8",
      "r612",
      "r669",
      "r680",
      "r909"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PropertyPlantAndEquipmentPolicyTextBlock",
     "presentation": [
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Property and Equipment",
        "label": "Property, Plant and Equipment, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections."
       }
      }
     },
     "auth_ref": [
      "r8",
      "r119",
      "r120",
      "r678"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PropertyPlantAndEquipmentTextBlock",
     "presentation": [
      "http://www.lifevantage.com/role/PropertyandEquipmentNetTables",
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Schedule of Property and Equipment",
        "label": "Property, Plant and Equipment [Table Text Block]",
        "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PropertyPlantAndEquipmentTypeDomain",
     "presentation": [
      "http://www.lifevantage.com/role/PropertyandEquipmentNetDetails",
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesPropertyandEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Property, Plant and Equipment, Type [Domain]",
        "label": "Long-Lived Tangible Asset [Domain]",
        "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software."
       }
      }
     },
     "auth_ref": [
      "r87",
      "r612"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentUsefulLife": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PropertyPlantAndEquipmentUsefulLife",
     "presentation": [
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesPropertyandEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Estimated service lives of property and equipment",
        "label": "Property, Plant and Equipment, Useful Life",
        "documentation": "Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment."
       }
      }
     },
     "auth_ref": []
    },
    "lfvn_ProtandimMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.lifevantage.com/20250630",
     "localname": "ProtandimMember",
     "presentation": [
      "http://www.lifevantage.com/role/RevenueMajorProductsDetails",
      "http://www.lifevantage.com/role/SegmentInformationScheduleofMajorProductsLinesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Protandim\u00ae product line",
        "label": "Protandim [Member]",
        "documentation": "Protandim [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "lfvn_ProtandimandTrueScienceProductLineMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.lifevantage.com/20250630",
     "localname": "ProtandimandTrueScienceProductLineMember",
     "presentation": [
      "http://www.lifevantage.com/role/RevenueNarrativeDetails",
      "http://www.lifevantage.com/role/SegmentInformationNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Protandim and TrueScience Product Line",
        "label": "Protandim and TrueScience Product Line [Member]",
        "documentation": "Protandim and TrueScience Product Line [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ProvisionForDoubtfulAccounts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ProvisionForDoubtfulAccounts",
     "crdr": "debit",
     "presentation": [
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Recorded bad debt expense",
        "label": "Accounts Receivable, Credit Loss Expense (Reversal)",
        "documentation": "Amount of expense (reversal of expense) for expected credit loss on accounts receivable."
       }
      }
     },
     "auth_ref": [
      "r192",
      "r194",
      "r310"
     ]
    },
    "ecd_PvpTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PvpTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pay vs Performance Disclosure",
        "label": "Pay vs Performance Disclosure [Table]"
       }
      }
     },
     "auth_ref": [
      "r989"
     ]
    },
    "ecd_PvpTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PvpTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pay vs Performance Disclosure, Table",
        "label": "Pay vs Performance [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r989"
     ]
    },
    "srt_RangeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "RangeAxis",
     "presentation": [
      "http://www.lifevantage.com/role/LeasesNarrativeDetails",
      "http://www.lifevantage.com/role/ShareBasedCompensationPerformanceRestrictedStockUnitsNarrativeDetails",
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesPropertyandEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statistical Measurement [Axis]",
        "label": "Statistical Measurement [Axis]",
        "documentation": "Information by statistical measurement. Includes, but is not limited to, minimum, maximum, weighted average, arithmetic average, and median."
       }
      }
     },
     "auth_ref": [
      "r125",
      "r127",
      "r129",
      "r130",
      "r132",
      "r149",
      "r151",
      "r152",
      "r154",
      "r155",
      "r259",
      "r353",
      "r354",
      "r355",
      "r356",
      "r449",
      "r450",
      "r482",
      "r483",
      "r484",
      "r489",
      "r499",
      "r576",
      "r617",
      "r618",
      "r619",
      "r705",
      "r706",
      "r713",
      "r734",
      "r735",
      "r786",
      "r788",
      "r790",
      "r791",
      "r793",
      "r797",
      "r798",
      "r800",
      "r801",
      "r813",
      "r814",
      "r850",
      "r858",
      "r867",
      "r872",
      "r873",
      "r874",
      "r903",
      "r904",
      "r905",
      "r906",
      "r919",
      "r929",
      "r1164",
      "r1171",
      "r1220",
      "r1233",
      "r1234",
      "r1235",
      "r1236",
      "r1237"
     ]
    },
    "srt_RangeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "RangeMember",
     "presentation": [
      "http://www.lifevantage.com/role/LeasesNarrativeDetails",
      "http://www.lifevantage.com/role/ShareBasedCompensationPerformanceRestrictedStockUnitsNarrativeDetails",
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesPropertyandEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statistical Measurement [Domain]",
        "label": "Statistical Measurement [Domain]",
        "documentation": "Statistical measurement. Includes, but is not limited to, minimum, maximum, weighted average, arithmetic average, and median."
       }
      }
     },
     "auth_ref": [
      "r125",
      "r127",
      "r129",
      "r130",
      "r132",
      "r149",
      "r151",
      "r152",
      "r154",
      "r155",
      "r259",
      "r353",
      "r354",
      "r355",
      "r356",
      "r449",
      "r450",
      "r482",
      "r483",
      "r484",
      "r489",
      "r499",
      "r576",
      "r617",
      "r618",
      "r619",
      "r705",
      "r706",
      "r713",
      "r734",
      "r735",
      "r786",
      "r788",
      "r790",
      "r791",
      "r793",
      "r797",
      "r798",
      "r800",
      "r801",
      "r813",
      "r814",
      "r850",
      "r858",
      "r867",
      "r872",
      "r873",
      "r874",
      "r903",
      "r904",
      "r905",
      "r906",
      "r919",
      "r929",
      "r1164",
      "r1171",
      "r1220",
      "r1233",
      "r1234",
      "r1235",
      "r1236",
      "r1237"
     ]
    },
    "lfvn_RawMaterialsPercentOfTotalInventory": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.lifevantage.com/20250630",
     "localname": "RawMaterialsPercentOfTotalInventory",
     "calculation": {
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesInventoryDetails": {
       "parentTag": "lfvn_InventoryPercentOfTotalInventory",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesInventoryDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Raw materials",
        "label": "Raw Materials, Percent Of Total Inventory",
        "documentation": "Raw Materials, Percent Of Total Inventory"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ReceivablesPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ReceivablesPolicyTextBlock",
     "presentation": [
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Accounts Receivable",
        "label": "Receivable [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for receivable. Includes, but is not limited to, accounts receivable and financing receivable."
       }
      }
     },
     "auth_ref": [
      "r303",
      "r304",
      "r305",
      "r306",
      "r1146"
     ]
    },
    "us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward",
     "presentation": [
      "http://www.lifevantage.com/role/IncomeTaxesScheduleofUnrecognizedTaxBenefitDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Unrecognized Tax Benefits [Roll Forward]",
        "label": "Unrecognized Tax Benefits [Roll Forward]",
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_RecoveryOfErrCompDisclosureLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "RecoveryOfErrCompDisclosureLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Recovery of Erroneously Awarded Compensation Disclosure [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r956",
      "r967",
      "r977",
      "r1010"
     ]
    },
    "lfvn_ReportableSegmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.lifevantage.com/20250630",
     "localname": "ReportableSegmentMember",
     "presentation": [
      "http://www.lifevantage.com/role/SegmentInformationScheduleofSegmentRevenueandExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Reportable Segment",
        "label": "Reportable Segment [Member]",
        "documentation": "Reportable Segment"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ResearchAndDevelopmentExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ResearchAndDevelopmentExpense",
     "crdr": "debit",
     "presentation": [
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Research and development",
        "label": "Research and Development Expense",
        "documentation": "Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity."
       }
      }
     },
     "auth_ref": [
      "r502",
      "r816",
      "r826",
      "r827",
      "r844",
      "r1238"
     ]
    },
    "us-gaap_ResearchAndDevelopmentExpensePolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ResearchAndDevelopmentExpensePolicy",
     "presentation": [
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Research and Development Costs",
        "label": "Research and Development Expense, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process."
       }
      }
     },
     "auth_ref": [
      "r501"
     ]
    },
    "ecd_RestatementDateAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "RestatementDateAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restatement Determination Date:",
        "label": "Restatement Determination Date [Axis]"
       }
      }
     },
     "auth_ref": [
      "r957",
      "r968",
      "r978",
      "r1011"
     ]
    },
    "ecd_RestatementDeterminationDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "RestatementDeterminationDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restatement Determination Date",
        "label": "Restatement Determination Date"
       }
      }
     },
     "auth_ref": [
      "r958",
      "r969",
      "r979",
      "r1012"
     ]
    },
    "ecd_RestatementDoesNotRequireRecoveryTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "RestatementDoesNotRequireRecoveryTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restatement does not require Recovery",
        "label": "Restatement Does Not Require Recovery [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r965",
      "r976",
      "r986",
      "r1019"
     ]
    },
    "us-gaap_RestrictedStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "RestrictedStockMember",
     "presentation": [
      "http://www.lifevantage.com/role/ShareBasedCompensationRestrictedSharesDetails",
      "http://www.lifevantage.com/role/ShareBasedCompensationRestrictedStockNarrativeDetails",
      "http://www.lifevantage.com/role/ShareBasedCompensationStockBasedCompensationNarrativeDetails",
      "http://www.lifevantage.com/role/StockholdersEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restricted Stock",
        "verboseLabel": "Restricted Shares",
        "label": "Restricted Stock [Member]",
        "documentation": "Stock including a provision that prohibits sale or substantive sale of an equity instrument for a specified period of time or until specified performance conditions are met."
       }
      }
     },
     "auth_ref": [
      "r1133",
      "r1175",
      "r1176",
      "r1177",
      "r1178",
      "r1179",
      "r1180",
      "r1181",
      "r1182",
      "r1183",
      "r1184",
      "r1185",
      "r1187",
      "r1188",
      "r1189",
      "r1190",
      "r1191",
      "r1192",
      "r1193",
      "r1194",
      "r1195",
      "r1196",
      "r1197",
      "r1198",
      "r1199",
      "r1200",
      "r1201"
     ]
    },
    "us-gaap_RestrictedStockUnitsRSUMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "RestrictedStockUnitsRSUMember",
     "presentation": [
      "http://www.lifevantage.com/role/ShareBasedCompensationRestrictedSharesDetails",
      "http://www.lifevantage.com/role/ShareBasedCompensationRestrictedStockNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restricted Stock Units (RSUs)",
        "label": "Restricted Stock Units (RSUs) [Member]",
        "documentation": "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met."
       }
      }
     },
     "auth_ref": [
      "r1175",
      "r1176",
      "r1177",
      "r1178",
      "r1179",
      "r1180",
      "r1181",
      "r1182",
      "r1183",
      "r1184",
      "r1185",
      "r1187",
      "r1188",
      "r1189",
      "r1190",
      "r1191",
      "r1192",
      "r1193",
      "r1194",
      "r1195",
      "r1196",
      "r1197",
      "r1198",
      "r1199",
      "r1200",
      "r1201"
     ]
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "RetainedEarningsAccumulatedDeficit",
     "crdr": "credit",
     "calculation": {
      "http://www.lifevantage.com/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.lifevantage.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Accumulated deficit",
        "label": "Retained Earnings (Accumulated Deficit)",
        "documentation": "Amount of accumulated undistributed earnings (deficit)."
       }
      }
     },
     "auth_ref": [
      "r58",
      "r94",
      "r676",
      "r710",
      "r712",
      "r726",
      "r745",
      "r909"
     ]
    },
    "us-gaap_RetainedEarningsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "RetainedEarningsMember",
     "presentation": [
      "http://www.lifevantage.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accumulated Deficit",
        "label": "Retained Earnings [Member]",
        "documentation": "Accumulated undistributed earnings (deficit)."
       }
      }
     },
     "auth_ref": [
      "r156",
      "r157",
      "r158",
      "r222",
      "r223",
      "r224",
      "r226",
      "r233",
      "r235",
      "r237",
      "r308",
      "r309",
      "r342",
      "r395",
      "r490",
      "r540",
      "r541",
      "r548",
      "r549",
      "r550",
      "r552",
      "r555",
      "r556",
      "r562",
      "r564",
      "r565",
      "r567",
      "r573",
      "r595",
      "r597",
      "r707",
      "r709",
      "r728",
      "r1272"
     ]
    },
    "lfvn_ReturnLiabilityReserve": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.lifevantage.com/20250630",
     "localname": "ReturnLiabilityReserve",
     "crdr": "credit",
     "presentation": [
      "http://www.lifevantage.com/role/RevenueNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Return liability reserve",
        "label": "Return Liability Reserve",
        "documentation": "Return Liability Reserve"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RevenueFromContractWithCustomerAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "RevenueFromContractWithCustomerAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Revenue from Contract with Customer [Abstract]",
        "label": "Revenue from Contract with Customer [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "RevenueFromContractWithCustomerExcludingAssessedTax",
     "crdr": "credit",
     "calculation": {
      "http://www.lifevantage.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOME": {
       "parentTag": "us-gaap_GrossProfit",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.lifevantage.com/role/SegmentInformationScheduleofSegmentRevenueandExpenseDetails": {
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.lifevantage.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOME",
      "http://www.lifevantage.com/role/RevenueMajorProductsDetails",
      "http://www.lifevantage.com/role/SegmentInformationScheduleOfRevenueDisaggregationByMarketDetails",
      "http://www.lifevantage.com/role/SegmentInformationScheduleofMajorProductsLinesDetails",
      "http://www.lifevantage.com/role/SegmentInformationScheduleofSegmentRevenueandExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Revenue, net",
        "label": "Revenue from Contract with Customer, Excluding Assessed Tax",
        "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise."
       }
      }
     },
     "auth_ref": [
      "r111",
      "r112",
      "r251",
      "r265",
      "r266",
      "r287",
      "r293",
      "r297",
      "r299",
      "r301",
      "r443",
      "r444",
      "r445",
      "r624",
      "r826",
      "r830"
     ]
    },
    "us-gaap_RevenueFromContractWithCustomerPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "RevenueFromContractWithCustomerPolicyTextBlock",
     "presentation": [
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Shipping and Handling, Revenue And Deferred Revenue",
        "label": "Revenue from Contract with Customer [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for revenue from contract with customer."
       }
      }
     },
     "auth_ref": [
      "r124",
      "r435",
      "r436",
      "r437",
      "r438",
      "r439",
      "r440",
      "r441",
      "r442",
      "r817"
     ]
    },
    "us-gaap_RevenueFromContractWithCustomerProductAndServiceExtensibleList": {
     "xbrltype": "enumerationSetItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "RevenueFromContractWithCustomerProductAndServiceExtensibleList",
     "presentation": [
      "http://www.lifevantage.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOME"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Revenue from Contract with Customer, Product and Service [Extensible Enumeration]",
        "label": "Revenue from Contract with Customer, Product and Service [Extensible Enumeration]",
        "documentation": "Indicates product and service for revenue from satisfaction of performance obligation by transferring promised product and service to customer."
       }
      }
     },
     "auth_ref": [
      "r859",
      "r860"
     ]
    },
    "us-gaap_RevenueFromContractWithCustomerTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "RevenueFromContractWithCustomerTextBlock",
     "presentation": [
      "http://www.lifevantage.com/role/Revenue"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Revenue",
        "label": "Revenue from Contract with Customer [Text Block]",
        "documentation": "The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts."
       }
      }
     },
     "auth_ref": [
      "r124",
      "r426",
      "r428",
      "r429",
      "r430",
      "r431",
      "r432",
      "r433",
      "r434",
      "r445",
      "r448"
     ]
    },
    "us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "RevenueFromExternalCustomersByGeographicAreasTableTextBlock",
     "presentation": [
      "http://www.lifevantage.com/role/SegmentInformationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Revenue from External Customers by Geographic Areas",
        "label": "Revenue from External Customers by Geographic Areas [Table Text Block]",
        "documentation": "Tabular disclosure of revenue from external customers by geographic areas attributed to the entity's country of domicile and to foreign countries from which the entity derives revenue."
       }
      }
     },
     "auth_ref": [
      "r83"
     ]
    },
    "us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "RevenuesFromExternalCustomersAndLongLivedAssetsLineItems",
     "presentation": [
      "http://www.lifevantage.com/role/SegmentInformationScheduleofLongLivedAssetsDetails",
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesSegmentInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Revenues from External Customers and Long-Lived Assets [Line Items]",
        "label": "Revenues from External Customers and Long-Lived Assets [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RevolvingCreditFacilityMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "RevolvingCreditFacilityMember",
     "presentation": [
      "http://www.lifevantage.com/role/LongTermDebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Revolving Credit Facility",
        "label": "Revolving Credit Facility [Member]",
        "documentation": "Arrangement in which loan proceeds can continuously be obtained following repayments, but the total amount borrowed cannot exceed a specified maximum amount."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability",
     "crdr": "debit",
     "presentation": [
      "http://www.lifevantage.com/role/LeasesSupplementalCashFlowInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Right-of-use assets obtained in exchange for lease obligations",
        "label": "Right-of-Use Asset Obtained in Exchange for Operating Lease Liability",
        "documentation": "Amount of increase in right-of-use asset obtained in exchange for operating lease liability."
       }
      }
     },
     "auth_ref": [
      "r608",
      "r908"
     ]
    },
    "ecd_Rule10b51ArrAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "Rule10b51ArrAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Rule 10b5-1 Arrangement Adopted",
        "label": "Rule 10b5-1 Arrangement Adopted [Flag]"
       }
      }
     },
     "auth_ref": [
      "r1028"
     ]
    },
    "ecd_Rule10b51ArrTrmntdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "Rule10b51ArrTrmntdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Rule 10b5-1 Arrangement Terminated",
        "label": "Rule 10b5-1 Arrangement Terminated [Flag]"
       }
      }
     },
     "auth_ref": [
      "r1028"
     ]
    },
    "us-gaap_SalesReturnsAndAllowancesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SalesReturnsAndAllowancesMember",
     "presentation": [
      "http://www.lifevantage.com/role/RevenueSalesReturnDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Sales Returns and Allowances",
        "label": "Sales Returns and Allowances [Member]",
        "documentation": "A revision in the estimated reserve needed for product returns and price or other concessions granted to customers."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SalesRevenueNetMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SalesRevenueNetMember",
     "presentation": [
      "http://www.lifevantage.com/role/RevenueMajorProductsDetails",
      "http://www.lifevantage.com/role/RevenueNarrativeDetails",
      "http://www.lifevantage.com/role/SegmentInformationNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Revenue benchmark",
        "label": "Revenue Benchmark [Member]",
        "documentation": "Revenue from sale of product and rendering of service and other sources of income, when it serves as benchmark in concentration of risk calculation."
       }
      }
     },
     "auth_ref": [
      "r301",
      "r1136",
      "r1137"
     ]
    },
    "us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfAccruedLiabilitiesTableTextBlock",
     "presentation": [
      "http://www.lifevantage.com/role/OtherAccruedExpensesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Other Accrued Expenses",
        "label": "Schedule of Accrued Liabilities [Table Text Block]",
        "documentation": "Tabular disclosure of the components of accrued liabilities."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
     "presentation": [
      "http://www.lifevantage.com/role/IncomeTaxesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Schedule of Components of Income Tax Expense",
        "label": "Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]",
        "documentation": "Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years."
       }
      }
     },
     "auth_ref": [
      "r1215"
     ]
    },
    "us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
     "presentation": [
      "http://www.lifevantage.com/role/IncomeTaxesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Schedule of The Components of the Deferred Tax Assets and Liabilities",
        "label": "Schedule of Deferred Tax Assets and Liabilities [Table Text Block]",
        "documentation": "Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets."
       }
      }
     },
     "auth_ref": [
      "r1209"
     ]
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
     "presentation": [
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Summary of Computation of Net Income Per Share",
        "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]",
        "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations."
       }
      }
     },
     "auth_ref": [
      "r1132"
     ]
    },
    "us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
     "presentation": [
      "http://www.lifevantage.com/role/IncomeTaxesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Schedule of The Effective Income Tax Rate Differs from the U.S. Federal Statutory Income Tax Rate",
        "label": "Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]",
        "documentation": "Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations."
       }
      }
     },
     "auth_ref": [
      "r513",
      "r871",
      "r1205"
     ]
    },
    "us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable",
     "presentation": [
      "http://www.lifevantage.com/role/RevenueMajorProductsDetails",
      "http://www.lifevantage.com/role/RevenueNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Revenue from External Customers by Products and Services [Table]",
        "label": "Segment Reporting, Revenue from External Customer, Product and Service [Table]",
        "documentation": "Disclosure of information about revenue from external customer by product and service when not provided as part of reportable operating segment information."
       }
      }
     },
     "auth_ref": [
      "r27"
     ]
    },
    "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfFiniteLivedIntangibleAssetsTable",
     "presentation": [
      "http://www.lifevantage.com/role/IntangibleAssetsNetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Finite-Lived Intangible Assets [Table]",
        "label": "Intangible Asset, Finite-Lived [Table]",
        "documentation": "Disclosure of information about finite-lived intangible asset. Excludes indefinite-lived intangible asset."
       }
      }
     },
     "auth_ref": [
      "r325",
      "r332",
      "r336",
      "r337",
      "r340",
      "r625",
      "r816",
      "r820",
      "r875",
      "r876",
      "r877",
      "r878",
      "r879",
      "r880",
      "r881",
      "r882",
      "r883",
      "r884",
      "r885",
      "r886",
      "r887",
      "r888",
      "r889",
      "r890",
      "r891",
      "r892",
      "r893",
      "r894",
      "r895",
      "r896",
      "r897",
      "r898",
      "r899",
      "r900",
      "r901"
     ]
    },
    "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
     "presentation": [
      "http://www.lifevantage.com/role/IntangibleAssetsNetTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Intangible Assets, Net",
        "label": "Schedule of Finite-Lived Intangible Assets [Table Text Block]",
        "documentation": "Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment."
       }
      }
     },
     "auth_ref": [
      "r820",
      "r1155"
     ]
    },
    "us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfIndefiniteLivedIntangibleAssetsTable",
     "presentation": [
      "http://www.lifevantage.com/role/IntangibleAssetsNetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Indefinite-Lived Intangible Assets [Table]",
        "label": "Intangible Asset, Indefinite-Lived [Table]",
        "documentation": "Disclosure of information about indefinite-lived intangible asset. Excludes finite-lived intangible asset."
       }
      }
     },
     "auth_ref": [
      "r325",
      "r335",
      "r340",
      "r820",
      "r875",
      "r876",
      "r877",
      "r886",
      "r887",
      "r901"
     ]
    },
    "us-gaap_ScheduleOfInventoryCurrentTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfInventoryCurrentTableTextBlock",
     "presentation": [
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Schedule of Components of Inventory",
        "label": "Schedule of Inventory, Current [Table Text Block]",
        "documentation": "Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process."
       }
      }
     },
     "auth_ref": [
      "r7",
      "r62",
      "r63",
      "r64"
     ]
    },
    "us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock",
     "presentation": [
      "http://www.lifevantage.com/role/ShareBasedCompensationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Summary of Nonvested Restricted Stock Units",
        "label": "Schedule of Nonvested Restricted Stock Units Activity [Table Text Block]",
        "documentation": "Tabular disclosure of the changes in outstanding nonvested restricted stock units."
       }
      }
     },
     "auth_ref": [
      "r96"
     ]
    },
    "us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock",
     "presentation": [
      "http://www.lifevantage.com/role/OtherExpenseNetTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Other Expense, Net",
        "label": "Schedule of Other Nonoperating Income (Expense) [Table Text Block]",
        "documentation": "Tabular disclosure of the components of non-operating income or non-operating expense that may include amounts earned from dividends, interest on securities, gains (losses) on securities sold, equity earnings of unconsolidated affiliates, net gain (loss) on sales of business, interest expense and other miscellaneous income or expense items."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfPropertyPlantAndEquipmentTable",
     "presentation": [
      "http://www.lifevantage.com/role/PropertyandEquipmentNetDetails",
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesPropertyandEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Property, Plant and Equipment [Table]",
        "label": "Property, Plant and Equipment [Table]",
        "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation."
       }
      }
     },
     "auth_ref": [
      "r8",
      "r612"
     ]
    },
    "us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable",
     "presentation": [
      "http://www.lifevantage.com/role/SegmentInformationScheduleofLongLivedAssetsDetails",
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesSegmentInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Revenues from External Customers and Long-Lived Assets [Table]",
        "label": "Schedule of Revenues from External Customers and Long-Lived Assets [Table]",
        "documentation": "Disclosure of information about revenue from external customer and long-lived asset by geographical area. Long-lived asset excludes financial instrument, customer relationship with financial institution, mortgage and other servicing right, deferred policy acquisition cost, and deferred tax asset."
       }
      }
     },
     "auth_ref": [
      "r28",
      "r66"
     ]
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTable",
     "presentation": [
      "http://www.lifevantage.com/role/SegmentInformationNarrativeDetails",
      "http://www.lifevantage.com/role/SegmentInformationScheduleOfRevenueDisaggregationByMarketDetails",
      "http://www.lifevantage.com/role/SegmentInformationScheduleofMajorProductsLinesDetails",
      "http://www.lifevantage.com/role/SegmentInformationScheduleofSegmentRevenueandExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Segment Reporting Information, by Segment [Table]",
        "label": "Schedule of Segment Reporting Information, by Segment [Table]",
        "documentation": "Disclosure of information about profit (loss) and total assets by reportable segment."
       }
      }
     },
     "auth_ref": [
      "r24",
      "r25",
      "r26"
     ]
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTextBlock",
     "presentation": [
      "http://www.lifevantage.com/role/SegmentInformationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Segment Reporting Information, by Segment",
        "label": "Schedule of Segment Reporting Information, by Segment [Table Text Block]",
        "documentation": "Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss."
       }
      }
     },
     "auth_ref": [
      "r24",
      "r25",
      "r26"
     ]
    },
    "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable",
     "presentation": [
      "http://www.lifevantage.com/role/ShareBasedCompensationEmployeeStockPurchasePlanNarrativeDetails",
      "http://www.lifevantage.com/role/ShareBasedCompensationEquitySettledPlansNarrativeDetails",
      "http://www.lifevantage.com/role/ShareBasedCompensationPerformanceRestrictedStockUnitsDetails",
      "http://www.lifevantage.com/role/ShareBasedCompensationPerformanceRestrictedStockUnitsNarrativeDetails",
      "http://www.lifevantage.com/role/ShareBasedCompensationRestrictedSharesDetails",
      "http://www.lifevantage.com/role/ShareBasedCompensationRestrictedStockNarrativeDetails",
      "http://www.lifevantage.com/role/ShareBasedCompensationStockBasedCompensationNarrativeDetails",
      "http://www.lifevantage.com/role/ShareBasedCompensationStockOptionsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]",
        "label": "Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]",
        "documentation": "Disclosure of information about share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r452",
      "r454",
      "r457",
      "r458",
      "r459",
      "r461",
      "r462",
      "r463",
      "r464",
      "r465",
      "r466",
      "r467",
      "r468",
      "r469",
      "r470",
      "r471",
      "r472",
      "r473",
      "r474",
      "r475",
      "r476",
      "r477",
      "r478",
      "r480",
      "r481",
      "r482",
      "r483",
      "r484",
      "r485",
      "r489"
     ]
    },
    "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
     "presentation": [
      "http://www.lifevantage.com/role/ShareBasedCompensationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Summary of Stock Option Activity",
        "label": "Share-Based Payment Arrangement, Option, Activity [Table Text Block]",
        "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r12",
      "r95"
     ]
    },
    "us-gaap_ScheduleOfStockByClassTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfStockByClassTable",
     "presentation": [
      "http://www.lifevantage.com/role/StockholdersEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Stock by Class [Table]",
        "label": "Stock, Class of Stock [Table]",
        "documentation": "Disclosure of information about stock by class. Includes, but is not limited to, common, convertible, and preferred stocks."
       }
      }
     },
     "auth_ref": [
      "r33",
      "r34",
      "r35",
      "r36",
      "r37",
      "r38",
      "r92",
      "r93",
      "r94",
      "r173",
      "r174",
      "r175",
      "r253",
      "r407",
      "r408",
      "r409",
      "r411",
      "r414",
      "r419",
      "r421",
      "r561",
      "r722",
      "r723",
      "r724",
      "r725",
      "r858",
      "r1051",
      "r1113",
      "r1116"
     ]
    },
    "us-gaap_ScheduleOfUnvestedRestrictedStockUnitsRollForwardTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfUnvestedRestrictedStockUnitsRollForwardTableTextBlock",
     "presentation": [
      "http://www.lifevantage.com/role/ShareBasedCompensationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Unvested Restricted Stock Units Roll Forward",
        "label": "Schedule of Unvested Restricted Stock Units Roll Forward [Table Text Block]",
        "documentation": "Tabular disclosure of the change in restricted stock units (RSUs)."
       }
      }
     },
     "auth_ref": [
      "r1186"
     ]
    },
    "us-gaap_SecuredDebtMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SecuredDebtMember",
     "presentation": [
      "http://www.lifevantage.com/role/LongTermDebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Secured Debt",
        "label": "Secured Debt [Member]",
        "documentation": "Collateralized debt obligation backed by, for example, but not limited to, pledge, mortgage or other lien on the entity's assets."
       }
      }
     },
     "auth_ref": []
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "Security12bTitle",
     "presentation": [
      "http://www.lifevantage.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Title of 12(b) Security",
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r938"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://www.lifevantage.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Security Exchange Name",
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r941"
     ]
    },
    "us-gaap_SegmentDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SegmentDomain",
     "presentation": [
      "http://www.lifevantage.com/role/SegmentInformationScheduleofSegmentRevenueandExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Segments [Domain]",
        "label": "Segments [Domain]",
        "documentation": "Components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity."
       }
      }
     },
     "auth_ref": [
      "r111",
      "r112",
      "r113",
      "r114",
      "r251",
      "r261",
      "r264",
      "r265",
      "r266",
      "r267",
      "r268",
      "r269",
      "r270",
      "r271",
      "r272",
      "r273",
      "r274",
      "r275",
      "r277",
      "r278",
      "r279",
      "r287",
      "r288",
      "r289",
      "r290",
      "r291",
      "r293",
      "r294",
      "r295",
      "r301",
      "r315",
      "r316",
      "r317",
      "r318",
      "r319",
      "r320",
      "r321",
      "r322",
      "r323",
      "r340",
      "r349",
      "r350",
      "r553",
      "r554",
      "r687",
      "r688",
      "r689",
      "r690",
      "r691",
      "r692",
      "r693",
      "r694",
      "r695",
      "r696",
      "r697",
      "r841",
      "r844",
      "r845",
      "r851",
      "r922",
      "r1241",
      "r1242",
      "r1243",
      "r1244",
      "r1245",
      "r1246",
      "r1247",
      "r1248",
      "r1249",
      "r1250",
      "r1251",
      "r1252",
      "r1253",
      "r1254",
      "r1255",
      "r1256",
      "r1257",
      "r1258",
      "r1259",
      "r1260",
      "r1261",
      "r1262",
      "r1263",
      "r1264",
      "r1265",
      "r1266",
      "r1267",
      "r1268",
      "r1269"
     ]
    },
    "srt_SegmentGeographicalDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "SegmentGeographicalDomain",
     "presentation": [
      "http://www.lifevantage.com/role/SegmentInformationScheduleOfRevenueDisaggregationByMarketDetails",
      "http://www.lifevantage.com/role/SegmentInformationScheduleofLongLivedAssetsDetails",
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesSegmentInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Geographical [Domain]",
        "label": "Geographical [Domain]",
        "documentation": "Geographical area."
       }
      }
     },
     "auth_ref": [
      "r126",
      "r128",
      "r131",
      "r133",
      "r140",
      "r141",
      "r142",
      "r143",
      "r144",
      "r145",
      "r146",
      "r147",
      "r148",
      "r150",
      "r151",
      "r152",
      "r256",
      "r299",
      "r300",
      "r627",
      "r628",
      "r629",
      "r630",
      "r631",
      "r632",
      "r633",
      "r634",
      "r635",
      "r636",
      "r637",
      "r638",
      "r639",
      "r640",
      "r641",
      "r642",
      "r643",
      "r644",
      "r645",
      "r646",
      "r647",
      "r648",
      "r649",
      "r650",
      "r651",
      "r652",
      "r653",
      "r654",
      "r655",
      "r656",
      "r657",
      "r658",
      "r659",
      "r660",
      "r665",
      "r666",
      "r667",
      "r668",
      "r731",
      "r732",
      "r733",
      "r787",
      "r789",
      "r792",
      "r794",
      "r797",
      "r799",
      "r800",
      "r801",
      "r804",
      "r805",
      "r806",
      "r807",
      "r808",
      "r809",
      "r810",
      "r811",
      "r812",
      "r819",
      "r835",
      "r859",
      "r861",
      "r910",
      "r911",
      "r912",
      "r913",
      "r914",
      "r915",
      "r916",
      "r917",
      "r921",
      "r929",
      "r1241",
      "r1242",
      "r1243",
      "r1245",
      "r1246",
      "r1247",
      "r1248",
      "r1249",
      "r1250",
      "r1251",
      "r1252",
      "r1253",
      "r1254",
      "r1255",
      "r1256",
      "r1257",
      "r1258",
      "r1259",
      "r1260",
      "r1261",
      "r1262",
      "r1263",
      "r1264",
      "r1265",
      "r1266",
      "r1267",
      "r1268",
      "r1269"
     ]
    },
    "us-gaap_SegmentReportingAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SegmentReportingAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Reporting [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SegmentReportingDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SegmentReportingDisclosureTextBlock",
     "presentation": [
      "http://www.lifevantage.com/role/SegmentInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Segment Information",
        "label": "Segment Reporting Disclosure [Text Block]",
        "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments."
       }
      }
     },
     "auth_ref": [
      "r114",
      "r251",
      "r260",
      "r261",
      "r262",
      "r263",
      "r264",
      "r276",
      "r278",
      "r279",
      "r291",
      "r292",
      "r293",
      "r294",
      "r295",
      "r297",
      "r298",
      "r301",
      "r839",
      "r842",
      "r843",
      "r844",
      "r846",
      "r848",
      "r849"
     ]
    },
    "us-gaap_SegmentReportingInformationLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SegmentReportingInformationLineItems",
     "presentation": [
      "http://www.lifevantage.com/role/SegmentInformationNarrativeDetails",
      "http://www.lifevantage.com/role/SegmentInformationScheduleOfRevenueDisaggregationByMarketDetails",
      "http://www.lifevantage.com/role/SegmentInformationScheduleofMajorProductsLinesDetails",
      "http://www.lifevantage.com/role/SegmentInformationScheduleofSegmentRevenueandExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Segment Reporting Information [Line Items]",
        "label": "Segment Reporting Information [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SegmentReportingOtherItemAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SegmentReportingOtherItemAmount",
     "crdr": "debit",
     "calculation": {
      "http://www.lifevantage.com/role/SegmentInformationScheduleofSegmentRevenueandExpenseDetails": {
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://www.lifevantage.com/role/SegmentInformationScheduleofSegmentRevenueandExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Other segment items",
        "label": "Segment Reporting, Other Segment Item, Amount",
        "documentation": "Amount of other expense (income) and loss (gain) calculated as difference between segment revenue and separately disclosed expense category to arrive at segment profit (loss)."
       }
      }
     },
     "auth_ref": [
      "r251",
      "r278",
      "r279",
      "r293",
      "r844"
     ]
    },
    "us-gaap_SegmentReportingPolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SegmentReportingPolicyPolicyTextBlock",
     "presentation": [
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Segment Information",
        "label": "Segment Reporting, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for segment reporting."
       }
      }
     },
     "auth_ref": [
      "r280",
      "r281",
      "r282",
      "r283",
      "r284",
      "r285",
      "r286",
      "r296",
      "r299",
      "r840",
      "r841",
      "r847"
     ]
    },
    "us-gaap_SellingGeneralAndAdministrativeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SellingGeneralAndAdministrativeExpense",
     "crdr": "debit",
     "calculation": {
      "http://www.lifevantage.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOME": {
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.lifevantage.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOME"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Selling, general and administrative",
        "label": "Selling, General and Administrative Expense",
        "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc."
       }
      }
     },
     "auth_ref": [
      "r72",
      "r825",
      "r826",
      "r827",
      "r830",
      "r1105"
     ]
    },
    "us-gaap_ShareBasedCompensation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensation",
     "crdr": "debit",
     "calculation": {
      "http://www.lifevantage.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 3.0
      },
      "http://www.lifevantage.com/role/SegmentInformationScheduleofSegmentRevenueandExpenseDetails": {
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.lifevantage.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.lifevantage.com/role/SegmentInformationScheduleofSegmentRevenueandExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Stock-based compensation",
        "negatedTerseLabel": "Stock compensation",
        "label": "Share-Based Payment Arrangement, Noncash Expense",
        "documentation": "Amount of noncash expense for share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "lfvn_ShareBasedCompensationArrangementByShareBasedPaymentAwardAmountInExcessOfFairMarketValueOfStockForOptionNotToBeGranted": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.lifevantage.com/20250630",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAmountInExcessOfFairMarketValueOfStockForOptionNotToBeGranted",
     "crdr": "debit",
     "presentation": [
      "http://www.lifevantage.com/role/ShareBasedCompensationEmployeeStockPurchasePlanNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amount in excess of fair market value of stock for option not to be granted",
        "label": "Share-Based Compensation Arrangement By Share-Based Payment Award, Amount In Excess Of Fair Market Value Of Stock For Option Not To Be Granted",
        "documentation": "Share-Based Compensation Arrangement By Share-Based Payment Award, Amount In Excess Of Fair Market Value Of Stock For Option Not To Be Granted"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1",
     "presentation": [
      "http://www.lifevantage.com/role/ShareBasedCompensationEquitySettledPlansNarrativeDetails",
      "http://www.lifevantage.com/role/ShareBasedCompensationStockOptionsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Vesting period",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period",
        "documentation": "Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition."
       }
      }
     },
     "auth_ref": [
      "r868"
     ]
    },
    "lfvn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsCancelledInPeriod": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.lifevantage.com/20250630",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsCancelledInPeriod",
     "presentation": [
      "http://www.lifevantage.com/role/ShareBasedCompensationPerformanceRestrictedStockUnitsDetails",
      "http://www.lifevantage.com/role/ShareBasedCompensationRestrictedSharesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cancelled in period (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Cancelled In Period",
        "documentation": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Cancelled In Period"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod",
     "presentation": [
      "http://www.lifevantage.com/role/ShareBasedCompensationPerformanceRestrictedStockUnitsDetails",
      "http://www.lifevantage.com/role/ShareBasedCompensationRestrictedSharesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Forfeited (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period",
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r474"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue",
     "presentation": [
      "http://www.lifevantage.com/role/ShareBasedCompensationPerformanceRestrictedStockUnitsDetails",
      "http://www.lifevantage.com/role/ShareBasedCompensationRestrictedSharesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Forfeited (dollars per share)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value",
        "documentation": "Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event."
       }
      }
     },
     "auth_ref": [
      "r474"
     ]
    },
    "lfvn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInExchange": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.lifevantage.com/20250630",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInExchange",
     "presentation": [
      "http://www.lifevantage.com/role/ShareBasedCompensationRestrictedSharesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Granted in exchange (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Exchange",
        "documentation": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Exchange"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod",
     "presentation": [
      "http://www.lifevantage.com/role/ShareBasedCompensationPerformanceRestrictedStockUnitsDetails",
      "http://www.lifevantage.com/role/ShareBasedCompensationRestrictedSharesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Granted (in shares)",
        "verboseLabel": "Granted (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period",
        "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan)."
       }
      }
     },
     "auth_ref": [
      "r472"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "presentation": [
      "http://www.lifevantage.com/role/ShareBasedCompensationPerformanceRestrictedStockUnitsDetails",
      "http://www.lifevantage.com/role/ShareBasedCompensationRestrictedSharesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Granted (dollars per share)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan)."
       }
      }
     },
     "auth_ref": [
      "r472"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
     "presentation": [
      "http://www.lifevantage.com/role/ShareBasedCompensationPerformanceRestrictedStockUnitsDetails",
      "http://www.lifevantage.com/role/ShareBasedCompensationRestrictedSharesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Nonvested beginning period (in shares)",
        "periodEndLabel": "Nonvested ending period (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number",
        "documentation": "The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date."
       }
      }
     },
     "auth_ref": [
      "r469",
      "r470"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward",
     "presentation": [
      "http://www.lifevantage.com/role/ShareBasedCompensationPerformanceRestrictedStockUnitsDetails",
      "http://www.lifevantage.com/role/ShareBasedCompensationRestrictedSharesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Shares",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]",
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue",
     "presentation": [
      "http://www.lifevantage.com/role/ShareBasedCompensationPerformanceRestrictedStockUnitsDetails",
      "http://www.lifevantage.com/role/ShareBasedCompensationRestrictedSharesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Nonvested beginning period (dollars per share)",
        "periodEndLabel": "Nonvested ending period (dollars per share)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value",
        "documentation": "Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options."
       }
      }
     },
     "auth_ref": [
      "r469",
      "r470"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward",
     "presentation": [
      "http://www.lifevantage.com/role/ShareBasedCompensationPerformanceRestrictedStockUnitsDetails",
      "http://www.lifevantage.com/role/ShareBasedCompensationRestrictedSharesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted Average Grant Date Fair Value",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod",
     "presentation": [
      "http://www.lifevantage.com/role/ShareBasedCompensationPerformanceRestrictedStockUnitsDetails",
      "http://www.lifevantage.com/role/ShareBasedCompensationRestrictedSharesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Vested (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period",
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r473"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue",
     "crdr": "debit",
     "presentation": [
      "http://www.lifevantage.com/role/ShareBasedCompensationPerformanceRestrictedStockUnitsNarrativeDetails",
      "http://www.lifevantage.com/role/ShareBasedCompensationRestrictedStockNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair value of vested awards",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value",
        "documentation": "Fair value of share-based awards for which the grantee gained the right by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash."
       }
      }
     },
     "auth_ref": [
      "r476"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue",
     "presentation": [
      "http://www.lifevantage.com/role/ShareBasedCompensationPerformanceRestrictedStockUnitsDetails",
      "http://www.lifevantage.com/role/ShareBasedCompensationRestrictedSharesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Vested (dollars per share)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value",
        "documentation": "The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement."
       }
      }
     },
     "auth_ref": [
      "r473"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems",
     "presentation": [
      "http://www.lifevantage.com/role/ShareBasedCompensationEmployeeStockPurchasePlanNarrativeDetails",
      "http://www.lifevantage.com/role/ShareBasedCompensationEquitySettledPlansNarrativeDetails",
      "http://www.lifevantage.com/role/ShareBasedCompensationPerformanceRestrictedStockUnitsDetails",
      "http://www.lifevantage.com/role/ShareBasedCompensationPerformanceRestrictedStockUnitsNarrativeDetails",
      "http://www.lifevantage.com/role/ShareBasedCompensationRestrictedSharesDetails",
      "http://www.lifevantage.com/role/ShareBasedCompensationRestrictedStockNarrativeDetails",
      "http://www.lifevantage.com/role/ShareBasedCompensationStockBasedCompensationNarrativeDetails",
      "http://www.lifevantage.com/role/ShareBasedCompensationStockOptionsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r452",
      "r454",
      "r457",
      "r458",
      "r459",
      "r461",
      "r462",
      "r463",
      "r464",
      "r465",
      "r466",
      "r467",
      "r468",
      "r469",
      "r470",
      "r471",
      "r472",
      "r473",
      "r474",
      "r475",
      "r476",
      "r477",
      "r478",
      "r480",
      "r481",
      "r482",
      "r483",
      "r484",
      "r485",
      "r489"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate",
     "presentation": [
      "http://www.lifevantage.com/role/ShareBasedCompensationEmployeeStockPurchasePlanNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Maximum percentage of employee compensation",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Maximum Employee Subscription Rate",
        "documentation": "The highest percentage of annual salary that an employee is permitted to utilize with respect to the plan."
       }
      }
     },
     "auth_ref": [
      "r39"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee",
     "presentation": [
      "http://www.lifevantage.com/role/ShareBasedCompensationEmployeeStockPurchasePlanNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Maximum number of shares that can be purchased during any offering period",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Maximum Number of Shares Per Employee",
        "documentation": "The highest quantity of shares an employee can purchase under the plan per period."
       }
      }
     },
     "auth_ref": [
      "r39"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized",
     "presentation": [
      "http://www.lifevantage.com/role/ShareBasedCompensationEquitySettledPlansNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of additional shares authorized",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Additional Shares Authorized",
        "documentation": "Number of additional shares authorized for issuance under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r1202"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized",
     "presentation": [
      "http://www.lifevantage.com/role/ShareBasedCompensationEquitySettledPlansNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Maximum common stock issued under Long-Term Incentive Plan (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized",
        "documentation": "Number of shares authorized for issuance under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r869"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant",
     "presentation": [
      "http://www.lifevantage.com/role/ShareBasedCompensationEmployeeStockPurchasePlanNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of shares available for issuance",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant",
        "documentation": "The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable."
       }
      }
     },
     "auth_ref": [
      "r39"
     ]
    },
    "lfvn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOfferingPeriod": {
     "xbrltype": "durationItemType",
     "nsuri": "http://www.lifevantage.com/20250630",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOfferingPeriod",
     "presentation": [
      "http://www.lifevantage.com/role/ShareBasedCompensationEmployeeStockPurchasePlanNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Offering period",
        "label": "Share-Based Compensation Arrangement By Share-Based Payment Award, Offering Period",
        "documentation": "Share-Based Compensation Arrangement By Share-Based Payment Award, Offering Period"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract",
     "presentation": [
      "http://www.lifevantage.com/role/ShareBasedCompensationStockOptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregate Intrinsic Value (in thousands)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber",
     "presentation": [
      "http://www.lifevantage.com/role/ShareBasedCompensationStockOptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Exercisable (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number",
        "documentation": "The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan."
       }
      }
     },
     "auth_ref": [
      "r463"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice",
     "presentation": [
      "http://www.lifevantage.com/role/ShareBasedCompensationStockOptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Exercisable (dollars per share)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price",
        "documentation": "The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan."
       }
      }
     },
     "auth_ref": [
      "r463"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue",
     "crdr": "debit",
     "presentation": [
      "http://www.lifevantage.com/role/ShareBasedCompensationStockOptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Exercised",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period, Intrinsic Value",
        "documentation": "Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares."
       }
      }
     },
     "auth_ref": [
      "r476"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod",
     "presentation": [
      "http://www.lifevantage.com/role/ShareBasedCompensationStockOptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Expired or Canceled (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Expirations in Period",
        "documentation": "Number of options or other stock instruments for which the right to exercise has lapsed under the terms of the plan agreements."
       }
      }
     },
     "auth_ref": [
      "r468"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod",
     "presentation": [
      "http://www.lifevantage.com/role/ShareBasedCompensationStockOptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Forfeited (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period",
        "documentation": "The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan."
       }
      }
     },
     "auth_ref": [
      "r467"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
     "presentation": [
      "http://www.lifevantage.com/role/ShareBasedCompensationStockOptionsDetails",
      "http://www.lifevantage.com/role/ShareBasedCompensationStockOptionsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Options granted (in shares)",
        "terseLabel": "Granted (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross",
        "documentation": "Gross number of share options (or share units) granted during the period."
       }
      }
     },
     "auth_ref": [
      "r465"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue",
     "crdr": "debit",
     "presentation": [
      "http://www.lifevantage.com/role/ShareBasedCompensationStockOptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Outstanding",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value",
        "documentation": "Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding."
       }
      }
     },
     "auth_ref": [
      "r39"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
     "presentation": [
      "http://www.lifevantage.com/role/ShareBasedCompensationEquitySettledPlansNarrativeDetails",
      "http://www.lifevantage.com/role/ShareBasedCompensationStockOptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Company's common stock purchased in aggregate (in shares)",
        "periodStartLabel": "Outstanding beginning balance (in shares)",
        "periodEndLabel": "Outstanding ending balance (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number",
        "documentation": "Number of options outstanding, including both vested and non-vested options."
       }
      }
     },
     "auth_ref": [
      "r461",
      "r462"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward",
     "presentation": [
      "http://www.lifevantage.com/role/ShareBasedCompensationStockOptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Options (in thousands)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward]",
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice",
     "presentation": [
      "http://www.lifevantage.com/role/ShareBasedCompensationStockOptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Outstanding beginning balance (dollars per share)",
        "periodEndLabel": "Outstanding ending balance (dollars per share)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price",
        "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan."
       }
      }
     },
     "auth_ref": [
      "r461",
      "r462"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward",
     "presentation": [
      "http://www.lifevantage.com/role/ShareBasedCompensationStockOptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted Average Exercise\u00a0Price",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "presentation": [
      "http://www.lifevantage.com/role/ShareBasedCompensationPerformanceRestrictedStockUnitsDetails",
      "http://www.lifevantage.com/role/ShareBasedCompensationPerformanceRestrictedStockUnitsNarrativeDetails",
      "http://www.lifevantage.com/role/ShareBasedCompensationRestrictedSharesDetails",
      "http://www.lifevantage.com/role/ShareBasedCompensationRestrictedStockNarrativeDetails",
      "http://www.lifevantage.com/role/ShareBasedCompensationStockBasedCompensationNarrativeDetails",
      "http://www.lifevantage.com/role/ShareBasedCompensationStockOptionsNarrativeDetails",
      "http://www.lifevantage.com/role/StockholdersEquityDetails",
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award Type [Domain]",
        "label": "Award Type [Domain]",
        "documentation": "Award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r457",
      "r458",
      "r459",
      "r461",
      "r462",
      "r463",
      "r464",
      "r465",
      "r466",
      "r467",
      "r468",
      "r469",
      "r470",
      "r471",
      "r472",
      "r473",
      "r474",
      "r475",
      "r476",
      "r477",
      "r478",
      "r481",
      "r482",
      "r483",
      "r484",
      "r485"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice",
     "presentation": [
      "http://www.lifevantage.com/role/ShareBasedCompensationStockOptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Exercised (dollars per share)",
        "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price",
        "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares."
       }
      }
     },
     "auth_ref": [
      "r466"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice",
     "presentation": [
      "http://www.lifevantage.com/role/ShareBasedCompensationStockOptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Expired or Canceled (dollars per share)",
        "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price",
        "documentation": "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options of the plan that expired."
       }
      }
     },
     "auth_ref": [
      "r468"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice",
     "presentation": [
      "http://www.lifevantage.com/role/ShareBasedCompensationStockOptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Forfeited (dollars per share)",
        "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price",
        "documentation": "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated."
       }
      }
     },
     "auth_ref": [
      "r467"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice",
     "presentation": [
      "http://www.lifevantage.com/role/ShareBasedCompensationStockOptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Granted (dollars per share)",
        "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price",
        "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options."
       }
      }
     },
     "auth_ref": [
      "r465"
     ]
    },
    "us-gaap_ShareBasedCompensationAwardTrancheOneMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationAwardTrancheOneMember",
     "presentation": [
      "http://www.lifevantage.com/role/ShareBasedCompensationStockOptionsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Vesting on January 1, 2019",
        "label": "Share-Based Payment Arrangement, Tranche One [Member]",
        "documentation": "First portion of award under share-based payment arrangement differentiated by vesting feature, including, but not limited to, performance measure or service period."
       }
      }
     },
     "auth_ref": [
      "r1175",
      "r1176",
      "r1177",
      "r1178",
      "r1179",
      "r1180",
      "r1181",
      "r1182",
      "r1183",
      "r1184",
      "r1185",
      "r1187",
      "r1188",
      "r1189",
      "r1190",
      "r1191",
      "r1192",
      "r1193",
      "r1194",
      "r1195",
      "r1196",
      "r1197",
      "r1198",
      "r1199",
      "r1200",
      "r1201"
     ]
    },
    "us-gaap_ShareBasedCompensationAwardTrancheTwoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationAwardTrancheTwoMember",
     "presentation": [
      "http://www.lifevantage.com/role/ShareBasedCompensationStockOptionsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Vesting on the last day of each fiscal quarter following January 1, 2019",
        "label": "Share-Based Payment Arrangement, Tranche Two [Member]",
        "documentation": "Second portion of award under share-based payment arrangement differentiated by vesting feature, including, but not limited to, performance measure or service period."
       }
      }
     },
     "auth_ref": [
      "r1175",
      "r1176",
      "r1177",
      "r1178",
      "r1179",
      "r1180",
      "r1181",
      "r1182",
      "r1183",
      "r1184",
      "r1185",
      "r1187",
      "r1188",
      "r1189",
      "r1190",
      "r1191",
      "r1192",
      "r1193",
      "r1194",
      "r1195",
      "r1196",
      "r1197",
      "r1198",
      "r1199",
      "r1200",
      "r1201"
     ]
    },
    "us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationOptionAndIncentivePlansPolicy",
     "presentation": [
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Stock-Based Compensation",
        "label": "Share-Based Payment Arrangement [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost."
       }
      }
     },
     "auth_ref": [
      "r451",
      "r460",
      "r479",
      "r480",
      "r481",
      "r482",
      "r485",
      "r491",
      "r492",
      "r493",
      "r494",
      "r495",
      "r496",
      "r497",
      "r498"
     ]
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage",
     "presentation": [
      "http://www.lifevantage.com/role/ShareBasedCompensationStockOptionsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Vesting right percentage",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Rights, Percentage",
        "documentation": "Percentage of vesting of award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r1175"
     ]
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1",
     "crdr": "debit",
     "presentation": [
      "http://www.lifevantage.com/role/ShareBasedCompensationStockOptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Exercisable",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value",
        "documentation": "Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable."
       }
      }
     },
     "auth_ref": [
      "r39"
     ]
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1",
     "presentation": [
      "http://www.lifevantage.com/role/ShareBasedCompensationStockOptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Exercisable",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term",
        "documentation": "Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r39"
     ]
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue",
     "presentation": [
      "http://www.lifevantage.com/role/ShareBasedCompensationEquitySettledPlansNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Exercise price of outstanding stock options (dollars per share)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Option, Nonvested, Weighted Average Exercise Price",
        "documentation": "Weighted average grant-date fair value of non-vested options outstanding."
       }
      }
     },
     "auth_ref": [
      "r1202"
     ]
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2",
     "presentation": [
      "http://www.lifevantage.com/role/ShareBasedCompensationStockOptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Outstanding",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term",
        "documentation": "Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r97"
     ]
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent",
     "presentation": [
      "http://www.lifevantage.com/role/ShareBasedCompensationEmployeeStockPurchasePlanNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Purchase price of stock fair market value",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Purchase Price of Common Stock, Percent",
        "documentation": "Purchase price of common stock expressed as a percentage of its fair value."
       }
      }
     },
     "auth_ref": [
      "r1202"
     ]
    },
    "lfvn_SharebasedCompensationArrangementbySharebasedPaymentAwardDistributionPercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.lifevantage.com/20250630",
     "localname": "SharebasedCompensationArrangementbySharebasedPaymentAwardDistributionPercentage",
     "presentation": [
      "http://www.lifevantage.com/role/ShareBasedCompensationPerformanceRestrictedStockUnitsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Distribution percentage of target number of Performance Stock Units",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Distribution Percentage",
        "documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Distribution Percentage"
       }
      }
     },
     "auth_ref": []
    },
    "lfvn_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsOutstandingContractualTerm": {
     "xbrltype": "durationItemType",
     "nsuri": "http://www.lifevantage.com/20250630",
     "localname": "SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsOutstandingContractualTerm",
     "presentation": [
      "http://www.lifevantage.com/role/ShareBasedCompensationEquitySettledPlansNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Contractual term of stock options granted",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Contractual Term",
        "documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Contractual Term"
       }
      }
     },
     "auth_ref": []
    },
    "lfvn_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.lifevantage.com/20250630",
     "localname": "SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermAbstract",
     "presentation": [
      "http://www.lifevantage.com/role/ShareBasedCompensationStockOptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted Average\u00a0Remaining Contractual Term (in years)",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term [Abstract]",
        "documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SharesPaidForTaxWithholdingForShareBasedCompensation",
     "presentation": [
      "http://www.lifevantage.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY",
      "http://www.lifevantage.com/role/StockholdersEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Shares canceled or surrendered as payment of tax withholding and other (in shares)",
        "terseLabel": "Shares canceled or surrendered as payment of tax withholding and other (in shares)",
        "label": "Share-Based Payment Arrangement, Shares Withheld for Tax Withholding Obligation",
        "documentation": "Number of shares used to settle grantee's tax withholding obligation for award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r1202"
     ]
    },
    "us-gaap_ShortTermLeaseCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShortTermLeaseCost",
     "crdr": "debit",
     "calculation": {
      "http://www.lifevantage.com/role/LeasesScheduleofLeaseCostDetails": {
       "parentTag": "us-gaap_LeaseCost",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.lifevantage.com/role/LeasesScheduleofLeaseCostDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Short-term lease cost",
        "label": "Short-Term Lease, Cost",
        "documentation": "Amount of short-term lease cost, excluding expense for lease with term of one month or less."
       }
      }
     },
     "auth_ref": [
      "r605",
      "r908"
     ]
    },
    "us-gaap_SignificantAccountingPoliciesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SignificantAccountingPoliciesTextBlock",
     "presentation": [
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Summary of Significant Accounting Policies",
        "label": "Significant Accounting Policies [Text Block]",
        "documentation": "The entire disclosure for all significant accounting policies of the reporting entity."
       }
      }
     },
     "auth_ref": [
      "r206",
      "r207"
     ]
    },
    "us-gaap_StateAndLocalJurisdictionMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StateAndLocalJurisdictionMember",
     "presentation": [
      "http://www.lifevantage.com/role/IncomeTaxesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "State and Local Jurisdiction",
        "label": "State and Local Jurisdiction [Member]",
        "documentation": "Designated state or local jurisdiction entitled to levy and collect income tax."
       }
      }
     },
     "auth_ref": [
      "r511"
     ]
    },
    "us-gaap_StatementBusinessSegmentsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StatementBusinessSegmentsAxis",
     "presentation": [
      "http://www.lifevantage.com/role/SegmentInformationScheduleofSegmentRevenueandExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Segments [Axis]",
        "label": "Segments [Axis]",
        "documentation": "Information by business segments."
       }
      }
     },
     "auth_ref": [
      "r111",
      "r112",
      "r113",
      "r114",
      "r162",
      "r251",
      "r261",
      "r264",
      "r265",
      "r266",
      "r267",
      "r268",
      "r269",
      "r270",
      "r271",
      "r272",
      "r273",
      "r274",
      "r275",
      "r277",
      "r278",
      "r279",
      "r287",
      "r288",
      "r289",
      "r290",
      "r291",
      "r293",
      "r294",
      "r295",
      "r301",
      "r315",
      "r316",
      "r317",
      "r318",
      "r319",
      "r320",
      "r321",
      "r322",
      "r323",
      "r340",
      "r343",
      "r349",
      "r350",
      "r553",
      "r554",
      "r687",
      "r688",
      "r689",
      "r690",
      "r691",
      "r692",
      "r693",
      "r694",
      "r695",
      "r696",
      "r697",
      "r841",
      "r844",
      "r845",
      "r851",
      "r922",
      "r1241",
      "r1242",
      "r1243",
      "r1244",
      "r1245",
      "r1246",
      "r1247",
      "r1248",
      "r1249",
      "r1250",
      "r1251",
      "r1252",
      "r1253",
      "r1254",
      "r1255",
      "r1256",
      "r1257",
      "r1258",
      "r1259",
      "r1260",
      "r1261",
      "r1262",
      "r1263",
      "r1264",
      "r1265",
      "r1266",
      "r1267",
      "r1268",
      "r1269"
     ]
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StatementEquityComponentsAxis",
     "presentation": [
      "http://www.lifevantage.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY",
      "http://www.lifevantage.com/role/StockholdersEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity Components [Axis]",
        "label": "Equity Components [Axis]",
        "documentation": "Information by component of equity."
       }
      }
     },
     "auth_ref": [
      "r10",
      "r56",
      "r59",
      "r60",
      "r156",
      "r157",
      "r158",
      "r186",
      "r187",
      "r188",
      "r222",
      "r223",
      "r224",
      "r226",
      "r233",
      "r235",
      "r237",
      "r252",
      "r308",
      "r309",
      "r342",
      "r395",
      "r423",
      "r490",
      "r540",
      "r541",
      "r548",
      "r549",
      "r550",
      "r552",
      "r555",
      "r556",
      "r562",
      "r563",
      "r564",
      "r565",
      "r566",
      "r567",
      "r568",
      "r569",
      "r570",
      "r571",
      "r573",
      "r586",
      "r588",
      "r589",
      "r590",
      "r591",
      "r592",
      "r595",
      "r597",
      "r614",
      "r683",
      "r707",
      "r708",
      "r709",
      "r728",
      "r781"
     ]
    },
    "srt_StatementGeographicalAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "StatementGeographicalAxis",
     "presentation": [
      "http://www.lifevantage.com/role/SegmentInformationScheduleOfRevenueDisaggregationByMarketDetails",
      "http://www.lifevantage.com/role/SegmentInformationScheduleofLongLivedAssetsDetails",
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesSegmentInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Geographical [Axis]",
        "label": "Geographical [Axis]",
        "documentation": "Information by geographical components."
       }
      }
     },
     "auth_ref": [
      "r126",
      "r128",
      "r131",
      "r133",
      "r140",
      "r141",
      "r142",
      "r143",
      "r144",
      "r145",
      "r146",
      "r147",
      "r148",
      "r150",
      "r151",
      "r152",
      "r256",
      "r299",
      "r300",
      "r627",
      "r628",
      "r629",
      "r630",
      "r631",
      "r632",
      "r633",
      "r634",
      "r635",
      "r636",
      "r637",
      "r638",
      "r639",
      "r640",
      "r641",
      "r642",
      "r643",
      "r644",
      "r645",
      "r646",
      "r647",
      "r648",
      "r649",
      "r650",
      "r651",
      "r652",
      "r653",
      "r654",
      "r655",
      "r656",
      "r657",
      "r658",
      "r659",
      "r660",
      "r665",
      "r666",
      "r667",
      "r668",
      "r731",
      "r732",
      "r733",
      "r787",
      "r789",
      "r792",
      "r794",
      "r797",
      "r799",
      "r800",
      "r801",
      "r804",
      "r805",
      "r806",
      "r807",
      "r808",
      "r809",
      "r810",
      "r811",
      "r812",
      "r819",
      "r835",
      "r859",
      "r861",
      "r910",
      "r911",
      "r912",
      "r913",
      "r914",
      "r915",
      "r916",
      "r917",
      "r921",
      "r929",
      "r1241",
      "r1242",
      "r1243",
      "r1245",
      "r1246",
      "r1247",
      "r1248",
      "r1249",
      "r1250",
      "r1251",
      "r1252",
      "r1253",
      "r1254",
      "r1255",
      "r1256",
      "r1257",
      "r1258",
      "r1259",
      "r1260",
      "r1261",
      "r1262",
      "r1263",
      "r1264",
      "r1265",
      "r1266",
      "r1267",
      "r1268",
      "r1269"
     ]
    },
    "us-gaap_StatementLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StatementLineItems",
     "presentation": [
      "http://www.lifevantage.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statement [Line Items]",
        "label": "Statement [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r222",
      "r223",
      "r224",
      "r252",
      "r397",
      "r398",
      "r400",
      "r402",
      "r597",
      "r624",
      "r720",
      "r729",
      "r730",
      "r736",
      "r737",
      "r738",
      "r739",
      "r740",
      "r741",
      "r744",
      "r747",
      "r748",
      "r749",
      "r750",
      "r751",
      "r752",
      "r753",
      "r754",
      "r755",
      "r757",
      "r758",
      "r759",
      "r760",
      "r761",
      "r764",
      "r765",
      "r766",
      "r767",
      "r768",
      "r769",
      "r770",
      "r771",
      "r772",
      "r773",
      "r774",
      "r775",
      "r776",
      "r777",
      "r781",
      "r828",
      "r830",
      "r930",
      "r1271"
     ]
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StatementOfCashFlowsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statement of Cash Flows [Abstract]",
        "label": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StatementOfFinancialPositionAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statement of Financial Position [Abstract]",
        "label": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StatementOfStockholdersEquityAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statement of Stockholders' Equity [Abstract]",
        "label": "Statement of Stockholders' Equity [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StatementTable",
     "presentation": [
      "http://www.lifevantage.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statement [Table]",
        "label": "Statement [Table]",
        "documentation": "Presentation of information about comprehensive income, income, other comprehensive income, financial position, cash flows, and shareholders' equity."
       }
      }
     },
     "auth_ref": [
      "r222",
      "r223",
      "r224",
      "r252",
      "r302",
      "r397",
      "r398",
      "r400",
      "r402",
      "r597",
      "r624",
      "r720",
      "r729",
      "r730",
      "r736",
      "r737",
      "r738",
      "r739",
      "r740",
      "r741",
      "r744",
      "r747",
      "r748",
      "r749",
      "r750",
      "r751",
      "r752",
      "r753",
      "r754",
      "r755",
      "r757",
      "r758",
      "r759",
      "r760",
      "r761",
      "r764",
      "r765",
      "r766",
      "r767",
      "r768",
      "r769",
      "r770",
      "r771",
      "r772",
      "r773",
      "r774",
      "r775",
      "r776",
      "r777",
      "r781",
      "r828",
      "r830",
      "r930",
      "r1271"
     ]
    },
    "ecd_StkPrcOrTsrEstimationMethodTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "StkPrcOrTsrEstimationMethodTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock Price or TSR Estimation Method",
        "label": "Stock Price or TSR Estimation Method [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r960",
      "r971",
      "r981",
      "r1014"
     ]
    },
    "us-gaap_StockAppreciationRightsSARSMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StockAppreciationRightsSARSMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock Appreciation Rights (SARs)",
        "label": "Stock Appreciation Rights (SARs) [Member]",
        "documentation": "Right to receive cash or shares equal to appreciation of predetermined number of grantor's shares during predetermined time period."
       }
      }
     },
     "auth_ref": [
      "r1175",
      "r1176",
      "r1177",
      "r1178",
      "r1179",
      "r1180",
      "r1181",
      "r1182",
      "r1183",
      "r1184",
      "r1185",
      "r1187",
      "r1188",
      "r1189",
      "r1190",
      "r1191",
      "r1192",
      "r1193",
      "r1194",
      "r1195",
      "r1196",
      "r1197",
      "r1198",
      "r1199",
      "r1200",
      "r1201"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans",
     "presentation": [
      "http://www.lifevantage.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY",
      "http://www.lifevantage.com/role/ShareBasedCompensationEmployeeStockPurchasePlanNarrativeDetails",
      "http://www.lifevantage.com/role/StockholdersEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common stock issued under employee stock purchase plan (in shares)",
        "label": "Stock Issued During Period, Shares, Employee Stock Purchase Plans",
        "documentation": "Number of shares issued during the period as a result of an employee stock purchase plan."
       }
      }
     },
     "auth_ref": [
      "r10",
      "r55",
      "r56",
      "r94"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures",
     "presentation": [
      "http://www.lifevantage.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY",
      "http://www.lifevantage.com/role/StockholdersEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Common stock issued under equity award plans (in shares)",
        "terseLabel": "Restricted common stock to employees (in shares)",
        "label": "Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures",
        "documentation": "Number of shares issued during the period related to Restricted Stock Awards, net of any shares forfeited."
       }
      }
     },
     "auth_ref": [
      "r10",
      "r55",
      "r56",
      "r94"
     ]
    },
    "lfvn_StockIssuedDuringPeriodSharesStockOptionsAndWarrantsExercised": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.lifevantage.com/20250630",
     "localname": "StockIssuedDuringPeriodSharesStockOptionsAndWarrantsExercised",
     "presentation": [
      "http://www.lifevantage.com/role/StockholdersEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common stock issued (in shares)",
        "label": "Stock Issued During Period Shares Stock Options and Warrants Exercised",
        "documentation": "Exercise of options and warrants, shares"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised",
     "presentation": [
      "http://www.lifevantage.com/role/ShareBasedCompensationStockOptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Exercised (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period",
        "documentation": "Number of share options (or share units) exercised during the current period."
       }
      }
     },
     "auth_ref": [
      "r10",
      "r55",
      "r56",
      "r94",
      "r466"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StockIssuedDuringPeriodValueEmployeeStockPurchasePlan",
     "crdr": "credit",
     "presentation": [
      "http://www.lifevantage.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common stock issued under employee stock purchase plan",
        "label": "Stock Issued During Period, Value, Employee Stock Purchase Plan",
        "documentation": "Aggregate change in value for stock issued during the period as a result of employee stock purchase plan."
       }
      }
     },
     "auth_ref": [
      "r10",
      "r55",
      "r56",
      "r94"
     ]
    },
    "srt_StockRepurchaseProgramAuthorizedAmount1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "StockRepurchaseProgramAuthorizedAmount1",
     "crdr": "credit",
     "presentation": [
      "http://www.lifevantage.com/role/StockholdersEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Repurchase common stock amount authorized (up to)",
        "label": "Share Repurchase Program, Authorized, Amount",
        "documentation": "Amount authorized for purchase of share under share repurchase plan. Includes, but is not limited to, repurchase of stock and unit of ownership."
       }
      }
     },
     "auth_ref": [
      "r1172"
     ]
    },
    "us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1",
     "crdr": "credit",
     "presentation": [
      "http://www.lifevantage.com/role/StockholdersEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Remaining authorized amount of common stock repurchase program",
        "label": "Share Repurchase Program, Remaining Authorized, Amount",
        "documentation": "Amount remaining authorized for purchase of share under share repurchase plan. Includes, but is not limited to, repurchase of stock and unit of ownership."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockRepurchasedAndRetiredDuringPeriodValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StockRepurchasedAndRetiredDuringPeriodValue",
     "crdr": "debit",
     "presentation": [
      "http://www.lifevantage.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Repurchase of company stock",
        "label": "Stock Repurchased and Retired During Period, Value",
        "documentation": "Equity impact of the value of stock that has been repurchased and retired during the period. The excess of the purchase price over par value can be charged against retained earnings (once the excess is fully allocated to additional paid in capital)."
       }
      }
     },
     "auth_ref": [
      "r10",
      "r55",
      "r56",
      "r94"
     ]
    },
    "us-gaap_StockRepurchasedDuringPeriodShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StockRepurchasedDuringPeriodShares",
     "presentation": [
      "http://www.lifevantage.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY",
      "http://www.lifevantage.com/role/StockholdersEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Repurchase of company stock (in shares)",
        "terseLabel": "Stock repurchased during period (in shares)",
        "label": "Stock Repurchased During Period, Shares",
        "documentation": "Number of shares that have been repurchased during the period and have not been retired and are not held in treasury. Some state laws may govern the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock."
       }
      }
     },
     "auth_ref": [
      "r10",
      "r55",
      "r56",
      "r94",
      "r725",
      "r781",
      "r795"
     ]
    },
    "us-gaap_StockRepurchasedDuringPeriodValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StockRepurchasedDuringPeriodValue",
     "crdr": "debit",
     "presentation": [
      "http://www.lifevantage.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Repurchase of company stock",
        "label": "Stock Repurchased During Period, Value",
        "documentation": "Equity impact of the value of stock that has been repurchased during the period and has not been retired and is not held in treasury. Some state laws may mandate the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock."
       }
      }
     },
     "auth_ref": [
      "r10",
      "r55",
      "r56",
      "r94",
      "r728",
      "r781",
      "r795",
      "r936"
     ]
    },
    "us-gaap_StockholdersEquity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StockholdersEquity",
     "crdr": "credit",
     "calculation": {
      "http://www.lifevantage.com/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.lifevantage.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.lifevantage.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total stockholders\u2019 equity",
        "periodStartLabel": "Beginning balances",
        "periodEndLabel": "Ending balances",
        "label": "Equity, Attributable to Parent",
        "documentation": "Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest."
       }
      }
     },
     "auth_ref": [
      "r56",
      "r59",
      "r60",
      "r85",
      "r746",
      "r762",
      "r782",
      "r783",
      "r909",
      "r937",
      "r1113",
      "r1118",
      "r1119",
      "r1147",
      "r1223",
      "r1272"
     ]
    },
    "us-gaap_StockholdersEquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StockholdersEquityAbstract",
     "presentation": [
      "http://www.lifevantage.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Stockholders\u2019 equity",
        "label": "Equity, Attributable to Parent [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockholdersEquityNoteDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StockholdersEquityNoteDisclosureTextBlock",
     "presentation": [
      "http://www.lifevantage.com/role/StockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Stockholders' Equity",
        "label": "Equity [Text Block]",
        "documentation": "The entire disclosure for equity."
       }
      }
     },
     "auth_ref": [
      "r91",
      "r406",
      "r408",
      "r410",
      "r411",
      "r412",
      "r413",
      "r414",
      "r415",
      "r416",
      "r417",
      "r418",
      "r420",
      "r423",
      "r561",
      "r572",
      "r784",
      "r785",
      "r796"
     ]
    },
    "us-gaap_SubsequentEventsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SubsequentEventsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Events [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SubsequentEventsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SubsequentEventsTextBlock",
     "presentation": [
      "http://www.lifevantage.com/role/SubsequentEvents"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Subsequent Events",
        "label": "Subsequent Events [Text Block]",
        "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business."
       }
      }
     },
     "auth_ref": [
      "r615",
      "r616"
     ]
    },
    "lfvn_SummaryOfSignificantAccountingPoliciesTextualAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.lifevantage.com/20250630",
     "localname": "SummaryOfSignificantAccountingPoliciesTextualAbstract",
     "presentation": [
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Summary of Significant Accounting Policies Additional Information [Abstract]",
        "label": "Summary of Significant Accounting Policies (Textual) [Abstract]",
        "documentation": "Summary of significant accounting policies."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SummaryOfValuationAllowanceTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SummaryOfValuationAllowanceTextBlock",
     "presentation": [
      "http://www.lifevantage.com/role/IncomeTaxesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Summary of Valuation Allowance",
        "label": "Summary of Valuation Allowance [Table Text Block]",
        "documentation": "Tabular disclosure of valuation allowances to reduce deferred tax assets to net realizable value, including identification of the deferred tax asset more likely than not will not be fully realized and the corresponding amount of the valuation allowance."
       }
      }
     },
     "auth_ref": [
      "r1210"
     ]
    },
    "us-gaap_SupplementalCashFlowInformationAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SupplementalCashFlowInformationAbstract",
     "presentation": [
      "http://www.lifevantage.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION",
        "label": "Supplemental Cash Flow Information [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_TabularListTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TabularListTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Tabular List, Table",
        "label": "Tabular List [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1007"
     ]
    },
    "us-gaap_TaxesPayableCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "TaxesPayableCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.lifevantage.com/role/OtherAccruedExpensesDetails": {
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.lifevantage.com/role/OtherAccruedExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other taxes payable",
        "label": "Taxes Payable, Current",
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable for statutory income, sales, use, payroll, excise, real, property and other taxes. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r44",
      "r45"
     ]
    },
    "ecd_TotalShareholderRtnAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TotalShareholderRtnAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total Shareholder Return Amount",
        "label": "Total Shareholder Return Amount"
       }
      }
     },
     "auth_ref": [
      "r999"
     ]
    },
    "ecd_TotalShareholderRtnVsPeerGroupTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TotalShareholderRtnVsPeerGroupTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total Shareholder Return Vs Peer Group",
        "label": "Total Shareholder Return Vs Peer Group [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1006"
     ]
    },
    "us-gaap_TrademarksMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "TrademarksMember",
     "presentation": [
      "http://www.lifevantage.com/role/IntangibleAssetsNetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trademarks",
        "label": "Trademarks [Member]",
        "documentation": "Rights acquired through registration of a trademark to gain or protect exclusive use of a business name, symbol or other device or style."
       }
      }
     },
     "auth_ref": [
      "r820",
      "r876",
      "r1149",
      "r1150",
      "r1151",
      "r1152",
      "r1153",
      "r1154",
      "r1156",
      "r1157",
      "r1158",
      "r1159"
     ]
    },
    "ecd_TradingArrAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TradingArrAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trading Arrangement:",
        "label": "Trading Arrangement [Axis]"
       }
      }
     },
     "auth_ref": [
      "r1027"
     ]
    },
    "ecd_TradingArrByIndTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TradingArrByIndTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trading Arrangements, by Individual",
        "label": "Trading Arrangements, by Individual [Table]"
       }
      }
     },
     "auth_ref": [
      "r1029"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "TradingSymbol",
     "presentation": [
      "http://www.lifevantage.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trading Symbol",
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_TrdArrAdoptionDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TrdArrAdoptionDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Adoption Date",
        "label": "Trading Arrangement Adoption Date"
       }
      }
     },
     "auth_ref": [
      "r1030"
     ]
    },
    "ecd_TrdArrDuration": {
     "xbrltype": "durationItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TrdArrDuration",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Arrangement Duration",
        "label": "Trading Arrangement Duration"
       }
      }
     },
     "auth_ref": [
      "r1031"
     ]
    },
    "ecd_TrdArrExpirationDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TrdArrExpirationDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Expiration Date",
        "label": "Trading Arrangement Expiration Date"
       }
      }
     },
     "auth_ref": [
      "r1031"
     ]
    },
    "ecd_TrdArrIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TrdArrIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Name",
        "label": "Trading Arrangement, Individual Name"
       }
      }
     },
     "auth_ref": [
      "r1029"
     ]
    },
    "ecd_TrdArrIndTitle": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TrdArrIndTitle",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Title",
        "label": "Trading Arrangement, Individual Title"
       }
      }
     },
     "auth_ref": [
      "r1029"
     ]
    },
    "ecd_TrdArrSecuritiesAggAvailAmt": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TrdArrSecuritiesAggAvailAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregate Available",
        "label": "Trading Arrangement, Securities Aggregate Available Amount"
       }
      }
     },
     "auth_ref": [
      "r1032"
     ]
    },
    "ecd_TrdArrTerminationDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TrdArrTerminationDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Termination Date",
        "label": "Trading Arrangement Termination Date"
       }
      }
     },
     "auth_ref": [
      "r1030"
     ]
    },
    "lfvn_TrueScienceProductLineMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.lifevantage.com/20250630",
     "localname": "TrueScienceProductLineMember",
     "presentation": [
      "http://www.lifevantage.com/role/SegmentInformationScheduleofMajorProductsLinesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "TrueScience\u00ae product line",
        "label": "TrueScience Product Line [Member]",
        "documentation": "TrueScience Product Line"
       }
      }
     },
     "auth_ref": []
    },
    "lfvn_TwoThousandAndTenAndTwoThousandSeventeenLongTermIncentivePlanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.lifevantage.com/20250630",
     "localname": "TwoThousandAndTenAndTwoThousandSeventeenLongTermIncentivePlanMember",
     "presentation": [
      "http://www.lifevantage.com/role/ShareBasedCompensationStockBasedCompensationNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2010 and 2017 Long Term Incentive Plan",
        "label": "Two Thousand And Ten and Two Thousand Seventeen Long Term Incentive Plan [Member]",
        "documentation": "Two Thousand And Ten and Two Thousand Seventeen Long Term Incentive Plan"
       }
      }
     },
     "auth_ref": []
    },
    "lfvn_TwoThousandAndTenLongTermIncentivePlanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.lifevantage.com/20250630",
     "localname": "TwoThousandAndTenLongTermIncentivePlanMember",
     "presentation": [
      "http://www.lifevantage.com/role/ShareBasedCompensationEquitySettledPlansNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "2010 Long-Term Incentive Plan",
        "label": "Two Thousand And Ten Long Term Incentive Plan [Member]",
        "documentation": "Two thousand and ten long term incentive plan."
       }
      }
     },
     "auth_ref": []
    },
    "lfvn_TwoThousandSeventeenLongTermIncentivePlanExcludingTwoThousandAndTenLongTermIncentivePlanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.lifevantage.com/20250630",
     "localname": "TwoThousandSeventeenLongTermIncentivePlanExcludingTwoThousandAndTenLongTermIncentivePlanMember",
     "presentation": [
      "http://www.lifevantage.com/role/ShareBasedCompensationEquitySettledPlansNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2017 Long Term Incentive Plan Excluding 2010 Long Term Incentive Plan",
        "label": "Two Thousand Seventeen Long Term Incentive Plan, Excluding Two Thousand And Ten Long Term Incentive Plan [Member]",
        "documentation": "Two Thousand Seventeen Long Term Incentive Plan, Excluding Two Thousand And Ten Long Term Incentive Plan [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "lfvn_TwoThousandSeventeenLongTermIncentivePlanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.lifevantage.com/20250630",
     "localname": "TwoThousandSeventeenLongTermIncentivePlanMember",
     "presentation": [
      "http://www.lifevantage.com/role/ShareBasedCompensationEquitySettledPlansNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2017 Long-Term Incentive Plan",
        "label": "Two Thousand Seventeen Long Term Incentive Plan [Member]",
        "documentation": "Two Thousand Seventeen Long Term Incentive Plan [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "country_US": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/country/2025",
     "localname": "US",
     "presentation": [
      "http://www.lifevantage.com/role/SegmentInformationScheduleOfRevenueDisaggregationByMarketDetails",
      "http://www.lifevantage.com/role/SegmentInformationScheduleofLongLivedAssetsDetails",
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesSegmentInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "United States",
        "label": "UNITED STATES"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_UndrlygSecurityMktPriceChngPct": {
     "xbrltype": "pureItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "UndrlygSecurityMktPriceChngPct",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Underlying Security Market Price Change",
        "label": "Underlying Security Market Price Change, Percent"
       }
      }
     },
     "auth_ref": [
      "r1026"
     ]
    },
    "us-gaap_UnrecognizedTaxBenefits": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "UnrecognizedTaxBenefits",
     "crdr": "credit",
     "presentation": [
      "http://www.lifevantage.com/role/IncomeTaxesScheduleofUnrecognizedTaxBenefitDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Unrecognized Tax Benefits, Beginning Balance",
        "periodEndLabel": "Unrecognized Tax Benefits, Ending Balance",
        "label": "Unrecognized Tax Benefits",
        "documentation": "Amount of unrecognized tax benefits."
       }
      }
     },
     "auth_ref": [
      "r504",
      "r524",
      "r870"
     ]
    },
    "us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromForeignCurrencyTranslation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "UnrecognizedTaxBenefitsDecreasesResultingFromForeignCurrencyTranslation",
     "crdr": "debit",
     "presentation": [
      "http://www.lifevantage.com/role/IncomeTaxesScheduleofUnrecognizedTaxBenefitDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Currency adjustment",
        "label": "Unrecognized Tax Benefits, Decrease Resulting from Foreign Currency Translation",
        "documentation": "Amount of decrease in unrecognized tax benefits resulting from foreign currency translation."
       }
      }
     },
     "auth_ref": [
      "r1208"
     ]
    },
    "us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions",
     "crdr": "debit",
     "presentation": [
      "http://www.lifevantage.com/role/IncomeTaxesScheduleofUnrecognizedTaxBenefitDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Gross decreases - tax positions in prior year",
        "label": "Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions",
        "documentation": "Amount of decrease in unrecognized tax benefits resulting from tax positions taken in prior period tax returns."
       }
      }
     },
     "auth_ref": [
      "r525",
      "r870"
     ]
    },
    "us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities",
     "crdr": "debit",
     "presentation": [
      "http://www.lifevantage.com/role/IncomeTaxesScheduleofUnrecognizedTaxBenefitDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Settlement",
        "label": "Unrecognized Tax Benefits, Decrease Resulting from Settlements with Taxing Authorities",
        "documentation": "Amount of decrease in unrecognized tax benefits resulting from settlements with taxing authorities."
       }
      }
     },
     "auth_ref": [
      "r527",
      "r870"
     ]
    },
    "us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions",
     "crdr": "credit",
     "presentation": [
      "http://www.lifevantage.com/role/IncomeTaxesScheduleofUnrecognizedTaxBenefitDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Gross increases - tax positions in current year",
        "label": "Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions",
        "documentation": "Amount of increase in unrecognized tax benefits resulting from tax positions that have been or will be taken in current period tax return."
       }
      }
     },
     "auth_ref": [
      "r526",
      "r870"
     ]
    },
    "us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions",
     "crdr": "credit",
     "presentation": [
      "http://www.lifevantage.com/role/IncomeTaxesScheduleofUnrecognizedTaxBenefitDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Gross increases - tax positions in prior year",
        "label": "Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions",
        "documentation": "Amount of increase in unrecognized tax benefits resulting from tax positions taken in prior period tax returns."
       }
      }
     },
     "auth_ref": [
      "r525",
      "r870"
     ]
    },
    "lfvn_UnrecognizedTaxPositionIncreaseResultingFromForeignTaxAudits": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.lifevantage.com/20250630",
     "localname": "UnrecognizedTaxPositionIncreaseResultingFromForeignTaxAudits",
     "crdr": "credit",
     "presentation": [
      "http://www.lifevantage.com/role/IncomeTaxesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Increase resulting from foreign tax audits",
        "label": "Unrecognized Tax Position, Increase Resulting From Foreign Tax Audits",
        "documentation": "Unrecognized Tax Position, Increase Resulting From Foreign Tax Audits"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_UseOfEstimates": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "UseOfEstimates",
     "presentation": [
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Use of Estimates",
        "label": "Use of Estimates, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles."
       }
      }
     },
     "auth_ref": [
      "r117",
      "r118",
      "r254",
      "r257",
      "r258",
      "r259",
      "r665",
      "r667",
      "r836"
     ]
    },
    "us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ValuationAllowanceDeferredTaxAssetChangeInAmount",
     "crdr": "credit",
     "presentation": [
      "http://www.lifevantage.com/role/IncomeTaxesDeferredTaxAssetsValuationAllowanceScheduleDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Increases",
        "label": "Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount",
        "documentation": "Amount of increase (decrease) in the valuation allowance for a specified deferred tax asset."
       }
      }
     },
     "auth_ref": [
      "r530"
     ]
    },
    "us-gaap_ValuationAllowancesAndReservesBalance": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ValuationAllowancesAndReservesBalance",
     "crdr": "credit",
     "presentation": [
      "http://www.lifevantage.com/role/RevenueSalesReturnDetails",
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesScheduleOfInventoryValuationReserveDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Beginning balance",
        "periodEndLabel": "Ending balance",
        "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves, Amount",
        "documentation": "Amount of valuation and qualifying accounts and reserves."
       }
      }
     },
     "auth_ref": [
      "r209",
      "r217",
      "r221"
     ]
    },
    "us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ValuationAllowancesAndReservesChargedToCostAndExpense",
     "crdr": "credit",
     "presentation": [
      "http://www.lifevantage.com/role/RevenueSalesReturnDetails",
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesScheduleOfInventoryValuationReserveDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Additions",
        "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves, Additions, Charge to Cost and Expense",
        "documentation": "Amount of increase in valuation and qualifying accounts and reserves from charge to cost and expense."
       }
      }
     },
     "auth_ref": [
      "r209",
      "r218"
     ]
    },
    "us-gaap_ValuationAllowancesAndReservesDeductions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ValuationAllowancesAndReservesDeductions",
     "crdr": "debit",
     "presentation": [
      "http://www.lifevantage.com/role/RevenueSalesReturnDetails",
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesScheduleOfInventoryValuationReserveDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Write-offs",
        "negatedLabel": "Returns",
        "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves, Deduction",
        "documentation": "Amount of decrease in valuation and qualifying accounts and reserves."
       }
      }
     },
     "auth_ref": [
      "r209",
      "r220"
     ]
    },
    "us-gaap_ValuationAllowancesAndReservesDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ValuationAllowancesAndReservesDomain",
     "presentation": [
      "http://www.lifevantage.com/role/RevenueSalesReturnDetails",
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesScheduleOfInventoryValuationReserveDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "SEC Schedule, 12-09, Valuation Allowances and Reserves [Domain]",
        "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves [Domain]",
        "documentation": "Valuation and qualifying accounts and reserves."
       }
      }
     },
     "auth_ref": [
      "r209",
      "r217",
      "r218",
      "r219",
      "r220",
      "r221"
     ]
    },
    "us-gaap_ValuationAllowancesAndReservesTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ValuationAllowancesAndReservesTypeAxis",
     "presentation": [
      "http://www.lifevantage.com/role/RevenueSalesReturnDetails",
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesScheduleOfInventoryValuationReserveDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "SEC Schedule, 12-09, Valuation Allowances and Reserves Type [Axis]",
        "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves Type [Axis]",
        "documentation": "Information by valuation and qualifying accounts and reserves."
       }
      }
     },
     "auth_ref": [
      "r209",
      "r217",
      "r218",
      "r219",
      "r220",
      "r221"
     ]
    },
    "us-gaap_VariableLeaseCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "VariableLeaseCost",
     "crdr": "debit",
     "calculation": {
      "http://www.lifevantage.com/role/LeasesScheduleofLeaseCostDetails": {
       "parentTag": "us-gaap_LeaseCost",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.lifevantage.com/role/LeasesScheduleofLeaseCostDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Variable lease cost",
        "label": "Variable Lease, Cost",
        "documentation": "Amount of variable lease cost, excluded from lease liability, recognized when obligation for payment is incurred for finance and operating leases."
       }
      }
     },
     "auth_ref": [
      "r606",
      "r908"
     ]
    },
    "us-gaap_VehiclesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "VehiclesMember",
     "presentation": [
      "http://www.lifevantage.com/role/PropertyandEquipmentNetDetails",
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesPropertyandEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Vehicles",
        "label": "Vehicles [Member]",
        "documentation": "Equipment used primarily for road transportation."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_VestingAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "VestingAxis",
     "presentation": [
      "http://www.lifevantage.com/role/ShareBasedCompensationStockOptionsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Vesting [Axis]",
        "label": "Vesting [Axis]",
        "documentation": "Information by vesting schedule of award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r1175",
      "r1176",
      "r1177",
      "r1178",
      "r1179",
      "r1180",
      "r1181",
      "r1182",
      "r1183",
      "r1184",
      "r1185",
      "r1187",
      "r1188",
      "r1189",
      "r1190",
      "r1191",
      "r1192",
      "r1193",
      "r1194",
      "r1195",
      "r1196",
      "r1197",
      "r1198",
      "r1199",
      "r1200",
      "r1201"
     ]
    },
    "us-gaap_VestingDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "VestingDomain",
     "presentation": [
      "http://www.lifevantage.com/role/ShareBasedCompensationStockOptionsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Vesting [Domain]",
        "label": "Vesting [Domain]",
        "documentation": "Vesting schedule of award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r1175",
      "r1176",
      "r1177",
      "r1178",
      "r1179",
      "r1180",
      "r1181",
      "r1182",
      "r1183",
      "r1184",
      "r1185",
      "r1187",
      "r1188",
      "r1189",
      "r1190",
      "r1191",
      "r1192",
      "r1193",
      "r1194",
      "r1195",
      "r1196",
      "r1197",
      "r1198",
      "r1199",
      "r1200",
      "r1201"
     ]
    },
    "ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year",
        "label": "Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year [Member]"
       }
      }
     },
     "auth_ref": [
      "r995"
     ]
    },
    "us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "WeightedAverageNumberDilutedSharesOutstandingAdjustment",
     "presentation": [
      "http://www.lifevantage.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOME"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Diluted (in shares)",
        "label": "Weighted Average Number of Shares Outstanding, Diluted, Adjustment",
        "documentation": "The sum of dilutive potential common shares or units used in the calculation of the diluted per-share or per-unit computation."
       }
      }
     },
     "auth_ref": [
      "r1132"
     ]
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "calculation": {
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesComputationofNetIncomePerShareDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesComputationofNetIncomePerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Diluted weighted-average common shares outstanding (in shares)",
        "label": "Weighted Average Number of Shares Outstanding, Diluted",
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period."
       }
      }
     },
     "auth_ref": [
      "r239",
      "r247"
     ]
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "WeightedAverageNumberOfSharesOutstandingAbstract",
     "presentation": [
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesComputationofNetIncomePerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Denominator:",
        "label": "Weighted Average Number of Shares Outstanding, Diluted [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "calculation": {
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesComputationofNetIncomePerShareDetails": {
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.lifevantage.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOME",
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesComputationofNetIncomePerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Basic (in shares)",
        "terseLabel": "Basic weighted-average common shares outstanding (in shares)",
        "label": "Weighted Average Number of Shares Outstanding, Basic",
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period."
       }
      }
     },
     "auth_ref": [
      "r238",
      "r247"
     ]
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "WeightedAverageNumberOfSharesOutstandingBasicAbstract",
     "presentation": [
      "http://www.lifevantage.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOME"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted-average shares outstanding:",
        "label": "Weighted Average Number of Shares Outstanding, Basic [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested",
        "label": "Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested [Member]"
       }
      }
     },
     "auth_ref": [
      "r993"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "05",
   "Paragraph": "4",
   "SubTopic": "10",
   "Topic": "360",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482338/360-10-05-4"
  },
  "r1": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "SubTopic": "230",
   "Topic": "830",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477401/830-230-45-1"
  },
  "r2": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10A",
   "SubTopic": "10",
   "Topic": "220",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-10A"
  },
  "r3": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10A",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "220",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-10A"
  },
  "r4": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "SubTopic": "405",
   "Topic": "942",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477787/942-405-45-2"
  },
  "r5": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r6": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(b)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r7": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "SubTopic": "10",
   "Topic": "210",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483489/210-10-50-1"
  },
  "r8": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "SubTopic": "10",
   "Topic": "360",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-1"
  },
  "r9": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(c)(3)",
   "SubTopic": "10",
   "Topic": "810",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-1A"
  },
  "r10": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "SubTopic": "10",
   "Topic": "505",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-2"
  },
  "r11": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "SubTopic": "10",
   "Topic": "718",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r12": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "SubTopic": "10",
   "Topic": "718",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r13": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Subparagraph": "(c)",
   "Paragraph": "2",
   "SubTopic": "10",
   "Topic": "718",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r14": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "15",
   "SubTopic": "10",
   "Topic": "220",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482739/220-10-55-15"
  },
  "r15": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(22))",
   "SubTopic": "10",
   "Topic": "210",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r16": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "220",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-14"
  },
  "r17": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "220",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-14A"
  },
  "r18": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-15"
  },
  "r19": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-4"
  },
  "r20": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-1"
  },
  "r21": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-2"
  },
  "r22": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "260",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1"
  },
  "r23": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "260",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-2"
  },
  "r24": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "280",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r25": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "280",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "25",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-25"
  },
  "r26": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "280",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "30",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r27": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "280",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "40",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-40"
  },
  "r28": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "280",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "41",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-41"
  },
  "r29": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "330",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483080/330-10-50-1"
  },
  "r30": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "360",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-1"
  },
  "r31": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "360",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-1"
  },
  "r32": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "470",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481544/470-10-50-5"
  },
  "r33": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481142/505-10-45-2"
  },
  "r34": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-10"
  },
  "r35": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-3"
  },
  "r36": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-4"
  },
  "r37": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-5"
  },
  "r38": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-8"
  },
  "r39": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r40": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-1"
  },
  "r41": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "55",
   "Paragraph": "4K",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481175/810-10-55-4K"
  },
  "r42": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(19)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r43": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(19)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r44": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r45": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r46": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(21))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r47": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(22)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r48": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(22)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r49": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r50": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(24))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r51": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(25))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r52": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(26)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r53": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(26)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r54": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(26))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r55": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(28))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r56": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(29))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r57": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r58": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r59": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r60": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(31))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r61": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(32))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r62": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(6)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r63": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(6)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r64": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(6)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r65": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-11"
  },
  "r66": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r67": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(10))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r68": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(2)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r69": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(2)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r70": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r71": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r72": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r73": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r74": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r75": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r76": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "12",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-12"
  },
  "r77": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "13",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-13"
  },
  "r78": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "15",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-15"
  },
  "r79": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-24"
  },
  "r80": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-25"
  },
  "r81": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-25"
  },
  "r82": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r83": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "41",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-41"
  },
  "r84": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "41",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-41"
  },
  "r85": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 4.E)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480418/310-10-S99-2"
  },
  "r86": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "360",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/360/tableOfContent"
  },
  "r87": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-1"
  },
  "r88": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 5.CC)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480091/360-10-S99-2"
  },
  "r89": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "440",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/440/tableOfContent"
  },
  "r90": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "470",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/470/tableOfContent"
  },
  "r91": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/505/tableOfContent"
  },
  "r92": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-6"
  },
  "r93": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-7"
  },
  "r94": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.3-04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480008/505-10-S99-1"
  },
  "r95": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r96": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r97": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "718",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Section": "50",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r98": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "810",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/810/tableOfContent"
  },
  "r99": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "19",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-19"
  },
  "r100": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(10))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r101": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(11))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r102": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(13))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r103": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(15)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r104": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(15)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r105": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(15)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r106": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(16))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r107": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r108": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r109": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(15))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r110": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r111": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r112": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r113": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r114": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r115": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "SubTopic": "20",
   "Topic": "740",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482659/740-20-45-2"
  },
  "r116": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "270",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482989/270-10-45-6"
  },
  "r117": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-1"
  },
  "r118": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-1"
  },
  "r119": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "SubTopic": "360",
   "Topic": "958",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477798/958-360-50-1"
  },
  "r120": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "SubTopic": "360",
   "Topic": "958",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477798/958-360-50-6"
  },
  "r121": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "SubTopic": "360",
   "Topic": "958",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477798/958-360-50-7"
  },
  "r122": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(b)",
   "SubTopic": "10",
   "Topic": "740",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-9"
  },
  "r123": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h))",
   "SubTopic": "10",
   "Topic": "235",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r124": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Topic": "606",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/606/tableOfContent"
  },
  "r125": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "12",
   "Paragraph": "Column A",
   "Footnote": "2",
   "Publisher": "SEC"
  },
  "r126": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "12",
   "Paragraph": "Column C",
   "Footnote": "5",
   "Publisher": "SEC"
  },
  "r127": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "12A",
   "Paragraph": "Column A",
   "Footnote": "2",
   "Publisher": "SEC"
  },
  "r128": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "12A",
   "Paragraph": "Column C",
   "Footnote": "4",
   "Publisher": "SEC"
  },
  "r129": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "12B",
   "Paragraph": "Column A",
   "Subparagraph": "(a)",
   "Footnote": "4",
   "Publisher": "SEC"
  },
  "r130": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "12B",
   "Paragraph": "Column A",
   "Subparagraph": "(b)",
   "Footnote": "4",
   "Publisher": "SEC"
  },
  "r131": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "12B",
   "Paragraph": "Column C",
   "Footnote": "2",
   "Publisher": "SEC"
  },
  "r132": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "14",
   "Paragraph": "Column A",
   "Footnote": "2",
   "Publisher": "SEC"
  },
  "r133": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "14",
   "Paragraph": "Column F",
   "Footnote": "7",
   "Publisher": "SEC"
  },
  "r134": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "17",
   "Paragraph": "Column A",
   "Publisher": "SEC"
  },
  "r135": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "17",
   "Paragraph": "Column B",
   "Publisher": "SEC"
  },
  "r136": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "17",
   "Paragraph": "Column C",
   "Publisher": "SEC"
  },
  "r137": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "17",
   "Paragraph": "Column D",
   "Publisher": "SEC"
  },
  "r138": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "17",
   "Paragraph": "Column E",
   "Publisher": "SEC"
  },
  "r139": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "17",
   "Paragraph": "Column F",
   "Publisher": "SEC"
  },
  "r140": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "28",
   "Paragraph": "Column A",
   "Footnote": "2",
   "Publisher": "SEC"
  },
  "r141": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "28",
   "Paragraph": "Column B",
   "Publisher": "SEC"
  },
  "r142": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "28",
   "Paragraph": "Column C",
   "Publisher": "SEC"
  },
  "r143": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "28",
   "Paragraph": "Column D",
   "Publisher": "SEC"
  },
  "r144": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "28",
   "Paragraph": "Column E",
   "Publisher": "SEC"
  },
  "r145": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "28",
   "Paragraph": "Column F",
   "Publisher": "SEC"
  },
  "r146": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "28",
   "Paragraph": "Column G",
   "Publisher": "SEC"
  },
  "r147": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "28",
   "Paragraph": "Column H",
   "Publisher": "SEC"
  },
  "r148": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "28",
   "Paragraph": "Column I",
   "Publisher": "SEC"
  },
  "r149": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "29",
   "Paragraph": "Column A",
   "Footnote": "3",
   "Publisher": "SEC"
  },
  "r150": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "29",
   "Paragraph": "Column A",
   "Footnote": "4",
   "Publisher": "SEC"
  },
  "r151": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "29",
   "Paragraph": "Column B",
   "Publisher": "SEC"
  },
  "r152": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "29",
   "Paragraph": "Column C",
   "Publisher": "SEC"
  },
  "r153": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Staff Accounting Bulletin (SAB)",
   "Number": "Topic 11",
   "Section": "L",
   "Publisher": "SEC"
  },
  "r154": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Staff Accounting Bulletin (SAB)",
   "Number": "Topic 5",
   "Section": "Y",
   "Paragraph": "Question 2",
   "Publisher": "SEC"
  },
  "r155": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Staff Accounting Bulletin (SAB)",
   "Number": "Topic 5",
   "Section": "Y",
   "Paragraph": "Question 4",
   "Publisher": "SEC"
  },
  "r156": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "105",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479343/105-10-65-6"
  },
  "r157": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "105",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "9",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479343/105-10-65-9"
  },
  "r158": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "105",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "9",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479343/105-10-65-9"
  },
  "r159": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "205",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/205/tableOfContent"
  },
  "r160": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "205",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S45",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481034/205-10-S45-5"
  },
  "r161": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "205",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480922/205-10-S99-3"
  },
  "r162": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-1"
  },
  "r163": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-7"
  },
  "r164": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-1"
  },
  "r165": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-5"
  },
  "r166": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483489/210-10-50-1"
  },
  "r167": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r168": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(13))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r169": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(14))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r170": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(16))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r171": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r172": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r173": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(27)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r174": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(28))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r175": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(29))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r176": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30)(a)(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r177": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(6)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r178": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r179": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r180": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1A"
  },
  "r181": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1A",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1A"
  },
  "r182": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1A",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1A"
  },
  "r183": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1B"
  },
  "r184": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1B"
  },
  "r185": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-1"
  },
  "r186": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-4"
  },
  "r187": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-5"
  },
  "r188": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-6"
  },
  "r189": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(21))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r190": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r191": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(25))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r192": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r193": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-21"
  },
  "r194": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r195": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(o)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r196": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-6"
  },
  "r197": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-6"
  },
  "r198": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-6"
  },
  "r199": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "15",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-15"
  },
  "r200": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "17",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-17"
  },
  "r201": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-24"
  },
  "r202": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-25"
  },
  "r203": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-2"
  },
  "r204": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-2A"
  },
  "r205": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-8"
  },
  "r206": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/235/tableOfContent"
  },
  "r207": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483426/235-10-50-1"
  },
  "r208": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480738/235-10-S50-1"
  },
  "r209": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480738/235-10-S50-5"
  },
  "r210": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r211": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(g)(1)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r212": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r213": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r214": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r215": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h)(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r216": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(k)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r217": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "4",
   "Subparagraph": "(SX 210.12-09(Column B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-4"
  },
  "r218": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "4",
   "Subparagraph": "(SX 210.12-09(Column C)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-4"
  },
  "r219": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "4",
   "Subparagraph": "(SX 210.12-09(Column C)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-4"
  },
  "r220": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "4",
   "Subparagraph": "(SX 210.12-09(Column D))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-4"
  },
  "r221": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "4",
   "Subparagraph": "(SX 210.12-09(Column E))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-4"
  },
  "r222": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "23",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-23"
  },
  "r223": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-24"
  },
  "r224": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-5"
  },
  "r225": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1"
  },
  "r226": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1"
  },
  "r227": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1"
  },
  "r228": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1"
  },
  "r229": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-11"
  },
  "r230": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-11"
  },
  "r231": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-3"
  },
  "r232": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-4"
  },
  "r233": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-6"
  },
  "r234": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-7"
  },
  "r235": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-7"
  },
  "r236": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-8"
  },
  "r237": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-9"
  },
  "r238": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-10"
  },
  "r239": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "16",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-16"
  },
  "r240": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-2"
  },
  "r241": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-22"
  },
  "r242": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "23",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-23"
  },
  "r243": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-28A"
  },
  "r244": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "60B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-60B"
  },
  "r245": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "60B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-60B"
  },
  "r246": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-7"
  },
  "r247": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1"
  },
  "r248": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1"
  },
  "r249": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1"
  },
  "r250": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482635/260-10-55-15"
  },
  "r251": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "270",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482964/270-10-50-1"
  },
  "r252": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483014/272-10-45-1"
  },
  "r253": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482987/272-10-50-1"
  },
  "r254": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "275",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-12"
  },
  "r255": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "275",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-20"
  },
  "r256": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "275",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-20"
  },
  "r257": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "275",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-4"
  },
  "r258": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "275",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-6"
  },
  "r259": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "275",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-9"
  },
  "r260": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/280/tableOfContent"
  },
  "r261": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-15"
  },
  "r262": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-21"
  },
  "r263": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-21"
  },
  "r264": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r265": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r266": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r267": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r268": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r269": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r270": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r271": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r272": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r273": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(j)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r274": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "25",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-25"
  },
  "r275": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "25",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-25"
  },
  "r276": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "26",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-26"
  },
  "r277": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "26A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-26A"
  },
  "r278": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "26B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-26B"
  },
  "r279": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "26C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-26C"
  },
  "r280": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "29",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-29"
  },
  "r281": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "29",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-29"
  },
  "r282": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "29",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-29"
  },
  "r283": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "29",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-29"
  },
  "r284": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "29",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-29"
  },
  "r285": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "29",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-29"
  },
  "r286": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "29",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-29"
  },
  "r287": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r288": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r289": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r290": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r291": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-31"
  },
  "r292": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r293": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(ee)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r294": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r295": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "34",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-34"
  },
  "r296": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "36",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-36"
  },
  "r297": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "40",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-40"
  },
  "r298": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "41",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-41"
  },
  "r299": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "41",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-41"
  },
  "r300": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "41",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-41"
  },
  "r301": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "42",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-42"
  },
  "r302": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481990/310-10-45-13"
  },
  "r303": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481962/310-10-50-2"
  },
  "r304": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481962/310-10-50-2"
  },
  "r305": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481962/310-10-50-2"
  },
  "r306": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "310",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481569/310-20-50-1"
  },
  "r307": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3"
  },
  "r308": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-4"
  },
  "r309": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "5",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-5"
  },
  "r310": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-13"
  },
  "r311": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "330",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/330/tableOfContent"
  },
  "r312": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "330",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483080/330-10-50-1"
  },
  "r313": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "330",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483080/330-10-50-4"
  },
  "r314": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480265/350-10-S45-1"
  },
  "r315": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r316": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r317": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r318": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r319": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r320": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r321": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r322": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r323": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r324": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/350-30/tableOfContent"
  },
  "r325": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482686/350-30-45-1"
  },
  "r326": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482686/350-30-45-2"
  },
  "r327": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r328": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r329": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r330": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r331": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r332": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2"
  },
  "r333": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2"
  },
  "r334": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2"
  },
  "r335": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2"
  },
  "r336": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2"
  },
  "r337": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2"
  },
  "r338": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-3"
  },
  "r339": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-3"
  },
  "r340": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-3"
  },
  "r341": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-4"
  },
  "r342": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476166/350-60-65-1"
  },
  "r343": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-3"
  },
  "r344": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r345": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r346": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r347": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r348": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r349": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482017/420-10-50-1"
  },
  "r350": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 5.P.4.d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479823/420-10-S99-2"
  },
  "r351": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "440",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482648/440-10-50-4"
  },
  "r352": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "440",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482648/440-10-50-4"
  },
  "r353": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-4"
  },
  "r354": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-9"
  },
  "r355": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480102/450-20-S99-1"
  },
  "r356": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.Y.Q4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480102/450-20-S99-1"
  },
  "r357": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481544/470-10-50-6"
  },
  "r358": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481544/470-10-50-6"
  },
  "r359": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r360": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r361": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r362": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r363": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r364": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r365": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r366": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r367": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r368": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r369": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r370": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r371": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r372": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r373": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r374": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r375": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r376": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r377": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1C",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1C"
  },
  "r378": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1C",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1C"
  },
  "r379": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1C",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1C"
  },
  "r380": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1D",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1D"
  },
  "r381": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1D",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1D"
  },
  "r382": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1D",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1D"
  },
  "r383": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1E"
  },
  "r384": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1E"
  },
  "r385": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1E"
  },
  "r386": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1E"
  },
  "r387": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1F"
  },
  "r388": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1F"
  },
  "r389": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1F"
  },
  "r390": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1F"
  },
  "r391": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1I",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1I"
  },
  "r392": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1I",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1I"
  },
  "r393": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1I",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1I"
  },
  "r394": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-6"
  },
  "r395": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(f)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481538/470-20-65-4"
  },
  "r396": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(f)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481538/470-20-65-4"
  },
  "r397": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479887/480-10-S45-1"
  },
  "r398": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479887/480-10-S45-2"
  },
  "r399": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479887/480-10-S45-3"
  },
  "r400": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479857/480-10-S50-1"
  },
  "r401": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479857/480-10-S50-3"
  },
  "r402": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480244/480-10-S99-1"
  },
  "r403": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(01)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480244/480-10-S99-1"
  },
  "r404": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(01)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480244/480-10-S99-1"
  },
  "r405": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3A",
   "Subparagraph": "(24)(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480244/480-10-S99-3A"
  },
  "r406": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r407": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r408": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r409": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r410": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r411": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r412": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r413": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-14"
  },
  "r414": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-14"
  },
  "r415": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-14"
  },
  "r416": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "16",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-16"
  },
  "r417": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-18"
  },
  "r418": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-18"
  },
  "r419": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-18"
  },
  "r420": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-18"
  },
  "r421": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-2"
  },
  "r422": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-3"
  },
  "r423": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.3-04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480008/505-10-S99-1"
  },
  "r424": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479837/606-10-45-1"
  },
  "r425": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479837/606-10-45-2"
  },
  "r426": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-10"
  },
  "r427": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-11"
  },
  "r428": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-12"
  },
  "r429": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-12"
  },
  "r430": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-12"
  },
  "r431": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-12"
  },
  "r432": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-12"
  },
  "r433": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-13"
  },
  "r434": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-15"
  },
  "r435": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-17"
  },
  "r436": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-18"
  },
  "r437": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-18"
  },
  "r438": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "19",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-19"
  },
  "r439": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-20"
  },
  "r440": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-20"
  },
  "r441": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-20"
  },
  "r442": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-20"
  },
  "r443": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-4"
  },
  "r444": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-5"
  },
  "r445": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-7"
  },
  "r446": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-8"
  },
  "r447": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-8"
  },
  "r448": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-9"
  },
  "r449": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r450": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480576/715-80-50-5"
  },
  "r451": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/718/tableOfContent"
  },
  "r452": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480483/718-10-35-1D"
  },
  "r453": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480483/718-10-35-2"
  },
  "r454": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480483/718-10-35-3"
  },
  "r455": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480454/718-10-45-1"
  },
  "r456": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r457": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r458": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r459": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r460": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r461": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r462": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r463": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r464": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r465": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r466": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r467": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r468": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r469": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r470": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r471": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r472": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r473": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r474": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r475": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r476": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r477": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r478": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r479": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r480": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r481": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r482": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r483": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r484": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r485": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(v)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r486": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r487": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r488": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r489": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(l)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r490": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "17",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480336/718-10-65-17"
  },
  "r491": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479953/718-10-S50-2"
  },
  "r492": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479953/718-10-S50-3"
  },
  "r493": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479953/718-10-S50-4"
  },
  "r494": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479953/718-10-S50-5"
  },
  "r495": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 14.C.Q3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479830/718-10-S99-1"
  },
  "r496": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 14.D.1.Q5)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479830/718-10-S99-1"
  },
  "r497": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 14.D.2.Q6)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479830/718-10-S99-1"
  },
  "r498": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 14.D.3.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479830/718-10-S99-1"
  },
  "r499": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "720",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483359/720-20-50-1"
  },
  "r500": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "720",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483384/720-30-45-1"
  },
  "r501": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "730",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "05",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483044/730-10-05-1"
  },
  "r502": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "730",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482916/730-10-50-1"
  },
  "r503": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/740/tableOfContent"
  },
  "r504": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482525/740-10-45-10B"
  },
  "r505": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482525/740-10-45-25"
  },
  "r506": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482525/740-10-45-28"
  },
  "r507": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482525/740-10-45-4"
  },
  "r508": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482525/740-10-45-6"
  },
  "r509": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-10"
  },
  "r510": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-10A"
  },
  "r511": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12"
  },
  "r512": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12"
  },
  "r513": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12A"
  },
  "r514": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12A",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12A"
  },
  "r515": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12A",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12A"
  },
  "r516": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12A",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12A"
  },
  "r517": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12A",
   "Subparagraph": "(a)(5)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12A"
  },
  "r518": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12A",
   "Subparagraph": "(a)(6)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12A"
  },
  "r519": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12A",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12A"
  },
  "r520": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12B"
  },
  "r521": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12C"
  },
  "r522": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-14"
  },
  "r523": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-15"
  },
  "r524": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-15A"
  },
  "r525": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15A",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-15A"
  },
  "r526": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15A",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-15A"
  },
  "r527": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15A",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-15A"
  },
  "r528": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "17",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-17"
  },
  "r529": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "19",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-19"
  },
  "r530": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-2"
  },
  "r531": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-2"
  },
  "r532": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-2"
  },
  "r533": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-2"
  },
  "r534": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-20"
  },
  "r535": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-21"
  },
  "r536": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "23",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-23"
  },
  "r537": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-3"
  },
  "r538": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-9"
  },
  "r539": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-9"
  },
  "r540": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482615/740-10-65-8"
  },
  "r541": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(d)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482615/740-10-65-8"
  },
  "r542": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 6.I.1.Q1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479360/740-10-S99-1"
  },
  "r543": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 6.I.5.Q1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479360/740-10-S99-1"
  },
  "r544": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479360/740-10-S99-1"
  },
  "r545": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 11.C)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479360/740-10-S99-2"
  },
  "r546": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "270",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477891/740-270-50-1"
  },
  "r547": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482603/740-30-50-2"
  },
  "r548": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r549": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r550": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r551": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r552": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r553": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-1"
  },
  "r554": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-2"
  },
  "r555": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476176/805-60-65-1"
  },
  "r556": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476176/805-60-65-1"
  },
  "r557": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-25"
  },
  "r558": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-25"
  },
  "r559": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-3"
  },
  "r560": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-3"
  },
  "r561": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-8A"
  },
  "r562": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r563": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r564": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r565": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r566": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r567": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(i)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r568": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480870/815-30-50-2"
  },
  "r569": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480870/815-30-50-2"
  },
  "r570": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480870/815-30-50-2"
  },
  "r571": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480870/815-30-50-2"
  },
  "r572": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480237/815-40-50-6"
  },
  "r573": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r574": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r575": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r576": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r577": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-21"
  },
  "r578": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-21"
  },
  "r579": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-28"
  },
  "r580": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/830/tableOfContent"
  },
  "r581": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481839/830-10-45-17"
  },
  "r582": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482014/830-20-35-1"
  },
  "r583": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481956/830-20-45-1"
  },
  "r584": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481926/830-20-50-1"
  },
  "r585": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "230",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477401/830-230-45-1"
  },
  "r586": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-17"
  },
  "r587": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20"
  },
  "r588": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20"
  },
  "r589": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20"
  },
  "r590": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20"
  },
  "r591": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20"
  },
  "r592": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481674/830-30-50-1"
  },
  "r593": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482925/835-30-45-2"
  },
  "r594": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482900/835-30-50-1"
  },
  "r595": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479832/842-10-65-8"
  },
  "r596": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/842-20/tableOfContent"
  },
  "r597": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "12A",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479165/842-20-35-12A"
  },
  "r598": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479041/842-20-45-1"
  },
  "r599": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479041/842-20-45-1"
  },
  "r600": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479041/842-20-45-5"
  },
  "r601": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-1"
  },
  "r602": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-3"
  },
  "r603": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4"
  },
  "r604": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4"
  },
  "r605": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4"
  },
  "r606": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4"
  },
  "r607": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(g)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4"
  },
  "r608": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(g)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4"
  },
  "r609": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(g)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4"
  },
  "r610": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(g)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4"
  },
  "r611": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-6"
  },
  "r612": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-7A"
  },
  "r613": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-7A"
  },
  "r614": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "848",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483550/848-10-65-2"
  },
  "r615": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "855",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/855/tableOfContent"
  },
  "r616": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "855",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483399/855-10-50-2"
  },
  "r617": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r618": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481420/860-30-50-7"
  },
  "r619": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "910",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482546/910-10-50-6"
  },
  "r620": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "912",
   "SubTopic": "330",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478411/912-330-50-1"
  },
  "r621": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "920",
   "SubTopic": "350",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478609/920-350-50-1"
  },
  "r622": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "920",
   "SubTopic": "350",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478609/920-350-50-1"
  },
  "r623": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "920",
   "SubTopic": "350",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478609/920-350-50-4"
  },
  "r624": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "924",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 11.L)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479941/924-10-S99-1"
  },
  "r625": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "926",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483154/926-20-50-5"
  },
  "r626": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "928",
   "SubTopic": "340",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478859/928-340-50-1"
  },
  "r627": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478934/932-220-50-1"
  },
  "r628": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-18"
  },
  "r629": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-18"
  },
  "r630": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-18"
  },
  "r631": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "19",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-19"
  },
  "r632": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-20"
  },
  "r633": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-20"
  },
  "r634": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "23",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-23"
  },
  "r635": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "23",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-23"
  },
  "r636": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "23",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-23"
  },
  "r637": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "23",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-23"
  },
  "r638": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "23",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-23"
  },
  "r639": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "23",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-23"
  },
  "r640": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-28"
  },
  "r641": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-28"
  },
  "r642": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-31"
  },
  "r643": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-31"
  },
  "r644": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-31"
  },
  "r645": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-31"
  },
  "r646": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-31"
  },
  "r647": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-31"
  },
  "r648": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-5"
  },
  "r649": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-5"
  },
  "r650": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-5"
  },
  "r651": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-5"
  },
  "r652": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-5"
  },
  "r653": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-5"
  },
  "r654": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-6"
  },
  "r655": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-7"
  },
  "r656": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-8"
  },
  "r657": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-8"
  },
  "r658": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-8"
  },
  "r659": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "280",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478657/932-280-50-1"
  },
  "r660": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478988/932-323-50-1"
  },
  "r661": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(14)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r662": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r663": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(24))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r664": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(27))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r665": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478671/942-235-S50-1"
  },
  "r666": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-05(b)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477314/942-235-S99-1"
  },
  "r667": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477314/942-235-S99-1"
  },
  "r668": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-05(b)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477314/942-235-S99-1"
  },
  "r669": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478451/942-360-50-1"
  },
  "r670": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "740",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477617/942-740-50-1"
  },
  "r671": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r672": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r673": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(21))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r674": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r675": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r676": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r677": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r678": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(8)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r679": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(8)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r680": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r681": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(11))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r682": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r683": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r684": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r685": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r686": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r687": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r688": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r689": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column C))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r690": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column D))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r691": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column E))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r692": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column F))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r693": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column G))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r694": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column H))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r695": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column I))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r696": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column J))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r697": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column K))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r698": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2"
  },
  "r699": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2"
  },
  "r700": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column C))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2"
  },
  "r701": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column D))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2"
  },
  "r702": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column E))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2"
  },
  "r703": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column F))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2"
  },
  "r704": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4E",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4E"
  },
  "r705": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r706": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r707": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r708": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(f)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r709": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r710": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r711": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r712": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(h)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r713": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.W.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479583/944-40-S99-1"
  },
  "r714": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "740",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478822/944-740-50-1"
  },
  "r715": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "805",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478072/944-805-50-1"
  },
  "r716": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "825",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477351/944-825-50-1B"
  },
  "r717": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "825",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477351/944-825-50-1B"
  },
  "r718": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480424/946-10-50-1"
  },
  "r719": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480424/946-10-50-2"
  },
  "r720": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r721": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(h)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r722": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r723": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(2)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r724": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(2)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r725": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r726": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-11"
  },
  "r727": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-13"
  },
  "r728": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478009/946-205-45-4"
  },
  "r729": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478009/946-205-45-6"
  },
  "r730": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477796/946-210-45-4"
  },
  "r731": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-1"
  },
  "r732": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-2"
  },
  "r733": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6"
  },
  "r734": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6"
  },
  "r735": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6"
  },
  "r736": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r737": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r738": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r739": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r740": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(13)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r741": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(13)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r742": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(14))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r743": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(15))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r744": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(16)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r745": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r746": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r747": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(2)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r748": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(2)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r749": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r750": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r751": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r752": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r753": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r754": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r755": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(e))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r756": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r757": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r758": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r759": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r760": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(e))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r761": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.6-05(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-2"
  },
  "r762": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.6-05(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-2"
  },
  "r763": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479105/946-220-45-7"
  },
  "r764": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r765": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r766": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r767": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r768": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r769": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r770": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r771": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r772": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r773": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r774": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r775": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r776": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r777": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r778": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r779": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r780": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(1)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r781": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r782": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r783": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r784": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477968/946-235-50-2"
  },
  "r785": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477968/946-235-50-2"
  },
  "r786": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-1"
  },
  "r787": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column C)(Footnote 5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-1"
  },
  "r788": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-2"
  },
  "r789": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-12A(Column C)(Footnote 4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-2"
  },
  "r790": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3"
  },
  "r791": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3"
  },
  "r792": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3"
  },
  "r793": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-6"
  },
  "r794": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column F)(Footnote 7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-6"
  },
  "r795": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-2"
  },
  "r796": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-6"
  },
  "r797": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "948",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478322/948-310-S50-2"
  },
  "r798": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "948",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-29(Column A)(Footnote 3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479628/948-310-S99-1"
  },
  "r799": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "948",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-29(Column A)(Footnote 4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479628/948-310-S99-1"
  },
  "r800": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "948",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-29(Column B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479628/948-310-S99-1"
  },
  "r801": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "948",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-29(Column C))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479628/948-310-S99-1"
  },
  "r802": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "954",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478785/954-310-50-2"
  },
  "r803": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "954",
   "SubTopic": "440",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478522/954-440-50-1"
  },
  "r804": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r805": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r806": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column C))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r807": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column D))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r808": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column E))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r809": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column F))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r810": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column G))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r811": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column H))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r812": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column I))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r813": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "976",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477332/976-310-50-1"
  },
  "r814": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "978",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479230/978-310-50-1"
  },
  "r815": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "985",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/985-20/tableOfContent"
  },
  "r816": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "985",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481283/985-20-50-2"
  },
  "r817": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(e)",
   "SubTopic": "10",
   "Topic": "235",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483426/235-10-50-4"
  },
  "r818": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "13H",
   "Subparagraph": "(a)",
   "SubTopic": "40",
   "Topic": "944",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-13H"
  },
  "r819": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "13H",
   "Subparagraph": "(b)",
   "SubTopic": "40",
   "Topic": "944",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-13H"
  },
  "r820": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "40",
   "SubTopic": "30",
   "Topic": "350",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482640/350-30-55-40"
  },
  "r821": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-1"
  },
  "r822": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-1"
  },
  "r823": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "8",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-8"
  },
  "r824": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-12"
  },
  "r825": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476153/220-40-55-11"
  },
  "r826": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476153/220-40-55-14"
  },
  "r827": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "18",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476153/220-40-55-18"
  },
  "r828": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "21",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476153/220-40-55-21"
  },
  "r829": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476153/220-40-55-24"
  },
  "r830": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476153/220-40-55-4"
  },
  "r831": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483426/235-10-50-4"
  },
  "r832": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483426/235-10-50-4"
  },
  "r833": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483426/235-10-50-4"
  },
  "r834": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "52",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482635/260-10-55-52"
  },
  "r835": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "275",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "18",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482836/275-10-55-18"
  },
  "r836": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "275",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482836/275-10-55-6"
  },
  "r837": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r838": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-31"
  },
  "r839": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "47",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-47"
  },
  "r840": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "47",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-47"
  },
  "r841": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "47",
   "Subparagraph": "(bb)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-47"
  },
  "r842": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "47",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-47"
  },
  "r843": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "47",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-47"
  },
  "r844": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "48",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-48"
  },
  "r845": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "49",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-49"
  },
  "r846": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "54",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-54"
  },
  "r847": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "54",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-54"
  },
  "r848": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "54",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-54"
  },
  "r849": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "54",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-54"
  },
  "r850": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "12A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481933/310-10-55-12A"
  },
  "r851": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482548/350-20-55-24"
  },
  "r852": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r853": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69B"
  },
  "r854": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69C"
  },
  "r855": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69E",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69E"
  },
  "r856": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69F",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69F"
  },
  "r857": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "64",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481620/480-10-55-64"
  },
  "r858": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r859": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-5"
  },
  "r860": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479777/606-10-55-91"
  },
  "r861": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479777/606-10-55-91"
  },
  "r862": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479777/606-10-55-91"
  },
  "r863": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479777/606-10-55-91"
  },
  "r864": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479777/606-10-55-91"
  },
  "r865": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479777/606-10-55-91"
  },
  "r866": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479777/606-10-55-91"
  },
  "r867": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480547/715-80-55-8"
  },
  "r868": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r869": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r870": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "217",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482663/740-10-55-217"
  },
  "r871": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "231",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482663/740-10-55-231"
  },
  "r872": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-8"
  },
  "r873": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "43",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479303/805-10-55-43"
  },
  "r874": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "47",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479303/805-10-55-47"
  },
  "r875": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-14"
  },
  "r876": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "14",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-14"
  },
  "r877": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "14",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-14"
  },
  "r878": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "14",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-14"
  },
  "r879": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "14",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-14"
  },
  "r880": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "20",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-20"
  },
  "r881": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "20",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-20"
  },
  "r882": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "20",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-20"
  },
  "r883": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "20",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-20"
  },
  "r884": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "29",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-29"
  },
  "r885": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "29",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-29"
  },
  "r886": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "31",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-31"
  },
  "r887": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "31",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-31"
  },
  "r888": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "31",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-31"
  },
  "r889": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "31",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-31"
  },
  "r890": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "31",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-31"
  },
  "r891": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "31",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-31"
  },
  "r892": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "31",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-31"
  },
  "r893": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "31",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-31"
  },
  "r894": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "31",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-31"
  },
  "r895": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "31",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-31"
  },
  "r896": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "38",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-38"
  },
  "r897": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "38",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-38"
  },
  "r898": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "38",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-38"
  },
  "r899": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "38",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-38"
  },
  "r900": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "38",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-38"
  },
  "r901": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "38",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-38"
  },
  "r902": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4A",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4A"
  },
  "r903": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "103",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-103"
  },
  "r904": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "107",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107"
  },
  "r905": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "107",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107"
  },
  "r906": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "107",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107"
  },
  "r907": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482949/835-30-55-8"
  },
  "r908": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "53",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479589/842-20-55-53"
  },
  "r909": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481372/852-10-55-10"
  },
  "r910": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-17"
  },
  "r911": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-21"
  },
  "r912": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "29",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-29"
  },
  "r913": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-3"
  },
  "r914": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477916/932-235-55-2"
  },
  "r915": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477916/932-235-55-4"
  },
  "r916": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477916/932-235-55-5"
  },
  "r917": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477916/932-235-55-6"
  },
  "r918": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479401/944-30-55-2"
  },
  "r919": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-29F"
  },
  "r920": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "9C",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-9C"
  },
  "r921": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "9C",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-9C"
  },
  "r922": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "9C",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-9C"
  },
  "r923": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "9E",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-9E"
  },
  "r924": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "605",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477548/944-605-55-11"
  },
  "r925": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "605",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477548/944-605-55-14"
  },
  "r926": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "18",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480078/944-80-55-18"
  },
  "r927": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-1"
  },
  "r928": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6"
  },
  "r929": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477439/946-210-55-1"
  },
  "r930": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477802/946-310-45-1"
  },
  "r931": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-1"
  },
  "r932": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-2"
  },
  "r933": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3"
  },
  "r934": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-6"
  },
  "r935": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479168/946-830-55-10"
  },
  "r936": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479168/946-830-55-11"
  },
  "r937": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479168/946-830-55-12"
  },
  "r938": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r939": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r940": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r941": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r942": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-K",
   "Number": "249",
   "Section": "310"
  },
  "r943": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Number": "249",
   "Section": "220",
   "Subsection": "f"
  },
  "r944": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16",
   "Subsection": "J",
   "Paragraph": "a"
  },
  "r945": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K"
  },
  "r946": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "b",
   "Paragraph": "1"
  },
  "r947": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "b",
   "Paragraph": "1",
   "Subparagraph": "i"
  },
  "r948": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "b",
   "Paragraph": "1",
   "Subparagraph": "ii"
  },
  "r949": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "b",
   "Paragraph": "1",
   "Subparagraph": "iii"
  },
  "r950": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "b",
   "Paragraph": "2"
  },
  "r951": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "c",
   "Paragraph": "1"
  },
  "r952": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "c",
   "Paragraph": "2"
  },
  "r953": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "c",
   "Paragraph": "2",
   "Subparagraph": "i"
  },
  "r954": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "c",
   "Paragraph": "2",
   "Subparagraph": "ii"
  },
  "r955": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "c",
   "Paragraph": "2",
   "Subparagraph": "iii"
  },
  "r956": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1"
  },
  "r957": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i"
  },
  "r958": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "A"
  },
  "r959": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "B"
  },
  "r960": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "C"
  },
  "r961": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "D"
  },
  "r962": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "E"
  },
  "r963": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "ii"
  },
  "r964": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "iii"
  },
  "r965": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "2"
  },
  "r966": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Number": "249",
   "Section": "240",
   "Subsection": "f"
  },
  "r967": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a"
  },
  "r968": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1"
  },
  "r969": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "i"
  },
  "r970": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "ii"
  },
  "r971": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iii"
  },
  "r972": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iv"
  },
  "r973": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "v"
  },
  "r974": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "2"
  },
  "r975": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "3"
  },
  "r976": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "b"
  },
  "r977": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a"
  },
  "r978": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1"
  },
  "r979": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "i"
  },
  "r980": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "ii"
  },
  "r981": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iii"
  },
  "r982": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iv"
  },
  "r983": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "v"
  },
  "r984": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "2"
  },
  "r985": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "3"
  },
  "r986": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "b"
  },
  "r987": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r988": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v"
  },
  "r989": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "1"
  },
  "r990": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "ii"
  },
  "r991": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii"
  },
  "r992": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "B",
   "Clause": "1",
   "Subclause": "ii"
  },
  "r993": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "i"
  },
  "r994": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "ii"
  },
  "r995": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "iii"
  },
  "r996": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "iv"
  },
  "r997": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "v"
  },
  "r998": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "vi"
  },
  "r999": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iv"
  },
  "r1000": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "vi"
  },
  "r1001": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "3"
  },
  "r1002": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "4"
  },
  "r1003": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "i"
  },
  "r1004": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "ii"
  },
  "r1005": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "iii"
  },
  "r1006": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "iv"
  },
  "r1007": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "6"
  },
  "r1008": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "6",
   "Subparagraph": "i"
  },
  "r1009": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w"
  },
  "r1010": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1"
  },
  "r1011": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i"
  },
  "r1012": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "A"
  },
  "r1013": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "B"
  },
  "r1014": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "C"
  },
  "r1015": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "D"
  },
  "r1016": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "E"
  },
  "r1017": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "ii"
  },
  "r1018": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "iii"
  },
  "r1019": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "2"
  },
  "r1020": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "1"
  },
  "r1021": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2"
  },
  "r1022": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "A"
  },
  "r1023": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "C"
  },
  "r1024": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "D"
  },
  "r1025": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "E"
  },
  "r1026": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "F"
  },
  "r1027": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a"
  },
  "r1028": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "1"
  },
  "r1029": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "A"
  },
  "r1030": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "B"
  },
  "r1031": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "C"
  },
  "r1032": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "D"
  },
  "r1033": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "b",
   "Paragraph": "1"
  },
  "r1034": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106"
  },
  "r1035": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "b",
   "Paragraph": "1"
  },
  "r1036": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "b",
   "Paragraph": "1",
   "Subparagraph": "i"
  },
  "r1037": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "b",
   "Paragraph": "1",
   "Subparagraph": "ii"
  },
  "r1038": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "b",
   "Paragraph": "1",
   "Subparagraph": "iii"
  },
  "r1039": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "b",
   "Paragraph": "2"
  },
  "r1040": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "c",
   "Paragraph": "1"
  },
  "r1041": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "c",
   "Paragraph": "2"
  },
  "r1042": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "c",
   "Paragraph": "2",
   "Subparagraph": "i"
  },
  "r1043": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "c",
   "Paragraph": "2",
   "Subparagraph": "ii"
  },
  "r1044": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "c",
   "Paragraph": "2",
   "Subparagraph": "iii"
  },
  "r1045": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "402",
   "Number": "229",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1"
  },
  "r1046": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "A",
   "Number": "229"
  },
  "r1047": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "B",
   "Clause": "1",
   "Number": "229"
  },
  "r1048": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "B",
   "Clause": "1",
   "Subclause": "i",
   "Number": "229"
  },
  "r1049": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "405"
  },
  "r1050": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "405"
  },
  "r1051": {
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483014/272-10-45-3"
  },
  "r1052": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(a)",
   "SubTopic": "40",
   "Topic": "220",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r1053": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(g)(1)",
   "SubTopic": "20",
   "Topic": "842",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4"
  },
  "r1054": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "740",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-9"
  },
  "r1055": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Topic": "610",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/610/tableOfContent"
  },
  "r1056": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Staff Accounting Bulletin (SAB)",
   "Number": "Topic 5",
   "Section": "Y",
   "Paragraph": "Question 2",
   "Publisher": "SEC"
  },
  "r1057": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(3)(a)(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r1058": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(6)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r1059": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(6)(a)(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r1060": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r1061": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r1062": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-4"
  },
  "r1063": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-5"
  },
  "r1064": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-6"
  },
  "r1065": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r1066": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(7)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r1067": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r1068": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-21"
  },
  "r1069": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-21"
  },
  "r1070": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-21"
  },
  "r1071": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-21"
  },
  "r1072": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-21"
  },
  "r1073": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-21"
  },
  "r1074": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-21"
  },
  "r1075": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-21"
  },
  "r1076": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-21"
  },
  "r1077": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(j)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-21"
  },
  "r1078": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(k)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-21"
  },
  "r1079": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(l)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-21"
  },
  "r1080": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(m)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-21"
  },
  "r1081": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r1082": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r1083": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r1084": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r1085": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r1086": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r1087": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r1088": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r1089": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(j)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r1090": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(k)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r1091": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(l)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r1092": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(m)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r1093": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(n)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r1094": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(o)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r1095": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(p)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r1096": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(q)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r1097": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(r)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r1098": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(s)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r1099": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(t)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r1100": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(u)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r1101": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-30"
  },
  "r1102": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-31"
  },
  "r1103": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-32"
  },
  "r1104": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "33",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-33"
  },
  "r1105": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-6"
  },
  "r1106": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-6"
  },
  "r1107": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-6"
  },
  "r1108": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-6"
  },
  "r1109": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-6"
  },
  "r1110": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r1111": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r1112": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-2A"
  },
  "r1113": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480738/235-10-S50-1"
  },
  "r1114": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480738/235-10-S50-4"
  },
  "r1115": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480738/235-10-S50-5"
  },
  "r1116": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r1117": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(f))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r1118": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(g)(1)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r1119": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r1120": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r1121": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r1122": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-04(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-3"
  },
  "r1123": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "4",
   "Subparagraph": "(SX 210.12-09(Column B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-4"
  },
  "r1124": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "4",
   "Subparagraph": "(SX 210.12-09(Column C)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-4"
  },
  "r1125": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "4",
   "Subparagraph": "(SX 210.12-09(Column C)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-4"
  },
  "r1126": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "4",
   "Subparagraph": "(SX 210.12-09(Column D))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-4"
  },
  "r1127": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "4",
   "Subparagraph": "(SX 210.12-09(Column E))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-4"
  },
  "r1128": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "23",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-23"
  },
  "r1129": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-24"
  },
  "r1130": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-5"
  },
  "r1131": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-6"
  },
  "r1132": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1"
  },
  "r1133": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1"
  },
  "r1134": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "270",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482964/270-10-50-1"
  },
  "r1135": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "275",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-18"
  },
  "r1136": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "275",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-18"
  },
  "r1137": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "275",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-18"
  },
  "r1138": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "275",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-18"
  },
  "r1139": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "275",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-18"
  },
  "r1140": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-18"
  },
  "r1141": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r1142": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r1143": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(ee)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r1144": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r1145": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481990/310-10-45-2"
  },
  "r1146": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481962/310-10-50-2"
  },
  "r1147": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3"
  },
  "r1148": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/350-30/tableOfContent"
  },
  "r1149": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482686/350-30-45-1"
  },
  "r1150": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r1151": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r1152": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r1153": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r1154": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r1155": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2"
  },
  "r1156": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2"
  },
  "r1157": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2"
  },
  "r1158": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2"
  },
  "r1159": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2"
  },
  "r1160": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "405",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/405-30/tableOfContent"
  },
  "r1161": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r1162": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r1163": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r1164": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "410",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481931/410-30-50-10"
  },
  "r1165": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "450",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/450/tableOfContent"
  },
  "r1166": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-9"
  },
  "r1167": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480102/450-20-S99-1"
  },
  "r1168": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481544/470-10-50-6"
  },
  "r1169": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r1170": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r1171": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r1172": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "505",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481520/505-30-50-4"
  },
  "r1173": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-5"
  },
  "r1174": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479777/606-10-55-91"
  },
  "r1175": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1176": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1177": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1178": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1179": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1180": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1181": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1182": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1183": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1184": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1185": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1186": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1187": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1188": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1189": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1190": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1191": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1192": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1193": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1194": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1195": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1196": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1197": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1198": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1199": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1200": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1201": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(v)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1202": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-4"
  },
  "r1203": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "740",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479176/718-740-35-2"
  },
  "r1204": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "720",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/720/tableOfContent"
  },
  "r1205": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12"
  },
  "r1206": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12"
  },
  "r1207": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12A",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12A"
  },
  "r1208": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-15A"
  },
  "r1209": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-2"
  },
  "r1210": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-2"
  },
  "r1211": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-22"
  },
  "r1212": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "23",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-23"
  },
  "r1213": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-3"
  },
  "r1214": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-6"
  },
  "r1215": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-9"
  },
  "r1216": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-9"
  },
  "r1217": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479360/740-10-S99-1"
  },
  "r1218": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "815",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480870/815-30-50-2"
  },
  "r1219": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r1220": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r1221": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-1"
  },
  "r1222": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-21"
  },
  "r1223": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-28"
  },
  "r1224": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482925/835-30-45-2"
  },
  "r1225": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482925/835-30-45-3"
  },
  "r1226": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482900/835-30-50-1"
  },
  "r1227": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-3"
  },
  "r1228": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4"
  },
  "r1229": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-6"
  },
  "r1230": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481404/852-10-50-7"
  },
  "r1231": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481404/852-10-50-7"
  },
  "r1232": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r1233": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r1234": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r1235": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4"
  },
  "r1236": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4"
  },
  "r1237": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4"
  },
  "r1238": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "912",
   "SubTopic": "730",
   "Name": "Accounting Standards Codification",
   "Section": "25",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479532/912-730-25-1"
  },
  "r1239": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "942",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477314/942-235-S99-2"
  },
  "r1240": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(16)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r1241": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479432/944-30-50-2B"
  },
  "r1242": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4B"
  },
  "r1243": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4B"
  },
  "r1244": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4C"
  },
  "r1245": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4D",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4D"
  },
  "r1246": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4G",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4G"
  },
  "r1247": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r1248": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r1249": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r1250": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r1251": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1252": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1253": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1254": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1255": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1256": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(5)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1257": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(6)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1258": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1259": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r1260": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r1261": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r1262": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r1263": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r1264": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r1265": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7B"
  },
  "r1266": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7B"
  },
  "r1267": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7B",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7B"
  },
  "r1268": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480109/944-80-50-2"
  },
  "r1269": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480109/944-80-50-2"
  },
  "r1270": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478009/946-205-45-4"
  },
  "r1271": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479105/946-220-45-3"
  },
  "r1272": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r1273": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r1274": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-1"
  },
  "r1275": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-2"
  },
  "r1276": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3"
  },
  "r1277": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-6"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>110
<FILENAME>0000849146-25-000068-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0000849146-25-000068-xbrl.zip
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M1(E4KXO\34OP\C-O4*Z;QN@_ 5!+ P04    " #!@"1;'B;.H><"  !-"0
M'@   &5X,C,Q9&5L;VET=&5C;VYS96YT,#8S,#(P+FAT;=U6;6_:,!#^OE]Q
MHUK[A;1Y)0PHTD9IQ<9H!73].#G)A7@--G(,+?OUN\1!W=:7;=(V5>.#==;=
M<_?<$Y]Q+]/+O-_+D"7]%[V7E@4G,EXO46B(%3*-":P++A9PE6!Q#9951PWD
M:JOX(M/@VFX 5U)=\PTS?LUUCOU=GMZ1V?>.JB*]2";;?B_A&^#)<8.GON/9
M:8)1V$[\($W:T>L6"SS;B5)D[2CXY#0(2N$&4^AMCL>-)1=6AF7]CN\>AL%*
M=V]XHK..8]NO&E5HOY=*H:F>(KPQ39I[R33>:HOE?"$Z54L- ]VY8YE+U=FS
MJU^W]%@I6_)\VSF8\R46,,$;F,HE$P?- A5/34S!OR#1(6;5]L:P#2E%S@7N
MV%/SQ'=XF_&(DY;>H?,]V8=IQJ0KJL:C+3XSU+]1TBV5')Q/9L/)',Y/830Y
M&5X,::'M='@VFLV'T^$)7%R^'8\&\&8P.+^<S$>3,S@=33_\(27^8K_^@R?G
M"B&6HBCG54O0&0(7L50KJ9CF4D"T!84I*A1QZ8(I+GBA:^=,TX!7LSZ1Q2%X
MGF>Y@6L[7M/8;KOEAK7MM%X'.]NVO58=X[0]O^74=A@XME_;03LL;282L_=]
MUP^!BIY*M829U3:^DO&CG&I*H6.WG&^@'L@4Y%I19]2GAJ2ZIF:X(F"$:G_/
M:=E=JEW>3$T*RBDSW6"U/BD73,2<Y?25ZE)%F7#,4_S(A&8+I-OM3L$=2TQ3
MC#7?H,#B*<!!03K3.1%4@3Z-5C('N4'U36'#FSB1!JL5,E72HX]3EGDCQ)I"
MIJ:U7=..;;U_BF0J587>4C) D9 >[]8"C12>;;0X_)5#_GE=:)YN?W?>OX?]
MPP'8W_/#;E&M<(*YY%HC[.]Y[2[,Y3K.L GC\<7_V/F,Y1K&[)I. M?;)EQJ
MECUOP@].Z"-WZ-/Z__#?OY(%+^>@8X9]@_=> SM@)+66RXY]!V%1(?.UO@_Y
MR0.B7LUSYJAZ1GT%4$L#!!0    ( ,& )%ON.ZDD%0@  /4E   >    97@S
M,3%C96]S96,S,#)C97)T:69I8V%T:6\N:'1M[5KQ4]LZ$O[]_@H=S/7!3!+B
MA! (E)D4TFOF=8 )Z7N]GVX46R8:;,M/DA-R?_W[5G)((-"7#CV:]JXS#;:U
M6NUJ/WV[DGTRMFER>C(6/#K]V\G?JU5VKL(B%9EEH1;<BH@51F8W[/=(F%M6
MK9929RJ?:7DSMJQ1;[38[TK?R@GW[5;:1)S.]9SL^?N3/3?(R4A%L].32$Z8
MC-YNR:@Y$OMANQ6TZ^W]N'UT6#]J-L5A>Q3S9KO>:O\[V$)7B/L^QLX2\78K
ME5EU+&C\SGZCUF[E]G@J(SON!/7Z/[:<Z.E)K#*+\33Z^TNO9D69%7>VRA-Y
MDW6<2UN^Z[PY5(G2G>VZ^W=,+=68IS*9=7X9RE08=B&F;*!2GOU2,4++V,L8
M^1\!<V"9NYUZ:]M0D<A,S*T/&F1O[_.'_KO^D#6#6O#0V&6?N;Z!VU;EG2-H
M7;(ZQ#0+_?IFG_4&P_[[_EEWV+^\8)?OV=6@?W'6O^I^9+W/O;-/P_YO/3R&
M1&_PK%L;X,?5I\'UI^[%D TOV37L'O2'_=XU?#C[T+WX9X]USX9L\.DC'@5-
M7@WV=_@NZUZ<LZ"U$^WZ^TUVKWO-NN>75\/>.7ODJ8M;L]Z@V T_]-AU=_"N
M>]&[KEY^_MC[E_,;+8UZO;$.*H/]_+^Z=O:?]*Y?8==63$3&!C7V7L:BPD*A
MK8QGS(ZY?;/=.CQ>U_KCG$<1V*Z:B-AV&HU::[[09!8A>IVJ?_;Z7@:UN0^O
M.O##"0F<ZWTVYA/!M)A(,45^L&-I6#?+"IZP@<B5MDQE[+W2*0OJU5^9BME'
MA.4WGEE^(Y Y-&2XE2I#;(Y^@M@T-B<V[[A!1##]Z8S=9FJ:B.@&"\*%2/O8
M1 IC9PKY'?JYS!C/9JS(K"X$3$?&=\D?0>,LQ9V6"&O,0SS23*72,JN\W(I
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M>B1=&H[]CW![?SH6<"<ZWJY=;]68F_M"@HC.(5U$+@.X^2C9>88=_JU(RH.
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M<P>@4[;VV= B():(O$47&B JA7ZYRTN?>KSX#5+YZ[Z(.K)?8OT!4$L#!!0
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MH5@,(Q%G#1 Y'^ZZ6):50EI:7;]IF_W%9O+15-,2OMG4)#,7V/^Z+0A:TQ5
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M3?XT=S\2CG _P:?V5U02:K4:4:_LI2?DOT""!<;&FYRE2C$IPCG:?+V-E8R
MH6P(J/2Q(Y@V!IN4FWQSV2H6M-B+0 7&@J:' 1 :&TD3+K%Q^;W4+O0K!%;<
ME5*X$%ZXQ'C*K)-1W_F\@]S0+S+I%E$E2(LZ>7H:!AAX9R;)K*\:1_:IV-U'
M7QA@-N6@ATJ7]54_^?'T5F2Y&UU"_Y:!:R=)_)K<G/#*Q)M_/N!Z3Z]V+ \\
M)W8-[8 9VF=X1%/>PCX';^U KHKU>,E[O<\&(;$\LO;28M=79&YHEQ!-U,4M
M5O"ZY$[BO-]!$$L*Z'M+/+VR'L8WO)[8_940;] W; H3&5Y=Z>M+!_Y1;1DB
M;XK:DJ9D-TZNK\"]L;0 NVBN\F9NZF*\%1=/+#D+Z9GCP:0_N;NMCS!:\EPV
MR!'82VO4N+)"TWBY66YXM2R91\J7[%RH2.7H2S]_GKM7?$8QG]MQBUE]8W0(
M< YCA[&&[@X.VFD/K:!>+IZ-N!=#352>"N).W] +PQ$.[=@U>OPSKN[ZI!AW
M\)\?7SW_!_[[\]M??_GA_P!02P,$%     @ P8 D6U)"R&= D@( SS\: !$
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MB[M3$UMR"0G%8_E@Z\-!N]GN=GN]O<Z]L%VM]<5"96MMXGO6/;S8,'M#%.J
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M\ (F*O!-[ORQQACR$OZ,B>V.![^"THR73D+I2E*A.UV'JEPBYPT\#\PV)TI
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MAFW0?!T3+V,P$]72W6H,DH"(LF$*L++(:<7Y&+C8]_4MG0< 1&W,. %B:FC
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M)1[2!:D:G$^)%I&B%.=<IZ%&W8+LZ41<MR![-GER.QG,<\GWD[$9]WRS Z\
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M[6O#-IX4H)'TE0:]>,Q&- F8M(4S.5_-@3[&*-D +&B-OM[T=?!+DKK$233
M)3(D=0)[X8 J+*@1'!P+IJ&6,QE-06#Z>HCOS'IZ& XDUN7,.=P)J=D#H]"
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MU ;'SDF>&8(1I-/PTO;T9A##@P>[G1^8Z\)N#_J&O8'^ID N34*,>43);7;
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MJ8&\'5=#P\,&.N?J$0G0^$@,I\Z;]#OLDQXD$X/D0-X*BJ=BS_NW#;M[GN"
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MJU>OQ[>^I<K:BELDO6LY5V'O#^J_!F+2TE.=*-^W],VZSI'QS<O2NI"G6;K
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M]Y&LT!V#0-XW /!X[Y?T &?Z$L,6CS\ZEFE@O=[O+KU^O1Y::(7O.;5]F@A
M-?(___MTE,S3R](U>3L'=JJ8\ ^A&?&R3B=\4;F:>R-747VI0NRS;H1EA# .
M*HK'5>GT<AX$9=W]GGNVK_<<.BB]^%\'"_%#( $_DE!_W];E/M\)!SEXW]O
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M^Q70G)$?K1OFL?PW6';''B0;FIW%@&;-EB*YT@FL200$*7*8D$?R-T'VYY?
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MJQ8@NE_6*!(;U_QA+#"$W<ZK$:$9SVR@!]CGO21Y1.5T_M%;3#[E3I<W#6#
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MKSVX&T)>::,_.G%H]D6R/ZU3AN-KS&MB%^95M^O7)%RDX9A<\W1I=2.MS'(
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M>EPS@RRPE5>04M,ZL\)Y@#LF4I(4/7Z49.F:*=>YZ%3 LG37U8Y>4M*V6U6
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M[Y1C.>25Z2Z##"H,<L0:,!ACDH=%W(G^^&WR]_P?P1BE U]K%_4X74L7E*A
M,:X$GM%<5K6BOJ7['+J&?D?/HP=&# K(^"$-PHT.0NZ(=4"CW0VX3]YWO./T
M=?K^@#WWHO3T;B-F8AC![>+ =E&,Q*I66+W9T?[F9)\E*.AP3_*EV-,+XI!%
M(_7W>V/88/\"CN3G9+>D=>A*;]D>40)['=[%6OR:*LPK-JB>YR!4B7#5OYX]
M#XDJ78'2OOF]N'[?6P_F[\EU2-N1JBP!3F*M <"J:!95?23R1))VF9;Y7Z;&
MA$\ IE \F M73(\B//YY1<*3%R-?=I1:FU72+=Q,5O+(S*3!+9,B)=5X&%M>
M0@C8OU(_"%<E:U'V5#.D">=B0=AY7)KPX'I2Y$WOEK0$#FE QBSPK3F@C$/=
M"QPZN6\W40WRZ8BS64;@N[@R(D)FLA:SQ"LO@T*.<PDFJ/-->B=?X(H?);Z)
M6G#/=9_--<<T1QY]3W]4+58[CE2P9^=!&V_.^<QR*MH;1+[A%:MIQI=5F5Z/
M>7=E9-?XLBDGH=2%7TO'FP5RKX\;Z;A_I64+37OZZ.2;D2*GN4;G0FMTM@A[
M!):^>.U+',AAYS2?MB@BY?;0\'&SG-7T99W.<<V(1265KTN:>+]"2:NP=I0=
M8,D_'<Q-['(-XPHY,J(ODN<79YH9ZG73AKJ5/^A%Q](2W*=\SB@4TL.Z%VP_
M2**;;\.1H6 7=/]QM5K1:L#R,JUY##VW@_M8H)$L0W\<#!4-Z_X]C+O(IXX7
M4K_UCZX+2<[VCG:\*WX/;>-[NRL:<T<KQ7W4']P"L>#J66")&XSY_D,. YF$
MA4;1 ^B1+?$&CI >%@[! @*MU,+TC!P>;]%)1_BS%<Q?Z1$3X(YZ(XIM 8<#
MB#&#A;4U,@W1R?.)B)+M^4LR:$J^7X]WM>.W"K"2$7P? =8G^QI@#<%5;@'1
MO=O/?$A_GZV8Y]TK.^0I-+ D;'59%$+M5&)>I75>D<"H6ZVNG9(,H$:CXR^
MQ&X2U9'W@K@EYPMH=)PM*E%>T%@;5GCJ&F6(RAUK7Z_ (9"XPDPP[],Z;;.V
ML#(%[U8VDYGC+I21!6P +E\SMUB3H9-GOA#&OB-*@*-*98/I"AHT7W!G5\&@
M@8L9S@*M;MV*4QL1GG>^8##7IIU*&<O2*KHY_F-7-.MLT7V#B\%*";/Y]N[R
MN, 8R\NCPDV7WSY^VI/0H]V(**__T]V 3+HK<O($:)B__4^-.&B&_)KTN.8A
M@ :LQ04:/ _?'7;LGG<L1X$G,!2+QESG= X=@PT$M2@7A>&$<69%,T'*3K5(
MUX<=^D0[-!R Y'#C ;BEP*W3O05N'<[">]TO1I$G$/5N;4=(/J?+:Z\@7P$J
M!-@:_P\F!>XH+KR?JO\T<6PA]92A>:TWO"WU!3K!/LIZ-I$\.HS#PAW+][:=
M]CJ N-62"^0$O8 :\P,CX(H$LKAMG""N^+\<[K&B$I:1?CS. A ,W]'\7H28
M"+9)+\H>%V /,!%U(7IYHV@_;R,M!9/ \<!+$3@\96P9AL!DA%][P1/I8<!9
MD0[%BF_K?WZ]K_XG.T:?"\0GR@E" KJ^GZ5EPS$8239$_$D@5%V)^OB,$TI@
M)9L:[1"@*,+?D/QN2%/180K,%)1;RR4U,20QA$&#W/7R._@BCZ .07RSVOEU
M9*!(=;T_19R6R1LATQM)[P(I,*QJ%^!,'%R5,GRM,03B"1YI!_C+H]H$"'OL
MW12QN@[:U@I9/3%27[]P9GTE$31C(S,*Y.569WL$1)&\5FM]N\@1^II3<&?9
M/=X""(@+)H7<AQ/BZK[W4L;;A[&)(TVUR(M+N>!GH:185_/N2N/IWC:>,3@J
MTW)=I%-':_.2-&SM4[-GD[VG/KMQ@@'!=_'RK)-A\WJD1-[NQ%@'T 4%0NH1
M 2@15+P'/4* *C@JM9LI%@;=M 1"KU@VQ'D;CU7E.D"H-88XM<M954-.^9P!
MKQWI"PU7::"1-1MWI)U;!UI+VF+)$&]#!\S"S3>;3S"XN//=8<PB'68N-NP"
M3 Y>[CU;]ET)<>](8T^ /_+28>R0!9?? ]Q@6?A.(<>2P_DLD^3B-8JC@U28
M.D0\0X7%]+,60D$N<3&6$[GO,I<N9X< QWUO/1FQ6'"PE.+F$@X+*9F)C9D!
MRI<YTZ'4;,9<84!K PE6Z@98V)R_E>.CN=81A^H5Y3C0TI;K(RJ'/?](>VZY
M^A6Y1<L"[9&J5;>.A(D(K&Y%4.*EW@5D6O$6#S)KQ:RYL\I0 1W[MN/2P4Y3
M+</9'6;/\Z5@3??:N[O9M+=MAE[ =O0@N,_3YQ+$6)0_@[:8\-6A/GF4_QMF
M16-<*EL2:F*'RB-R*:H%ZYJN_>];7G50Y +43#F#Z/2^8J2FE0E%'I=FWMCA
M6EHYW($D],/0%OA5)PB7EYQ"#8? =CAMK.)"+0C^U[!:\AL;1"O:2.3">",]
M-<_822T*#80EH>=S<FV:'R&[C,8P%_6 5M+MOZP(/*I4L>0MX(A*?633T@ 8
M$Z7UOKF8I:1$)Z[EC;-G0%/_V>9,(\C D<Y!8!>6P7#*MJ;#YHH81M=')('Q
MGX>JV!'2  "T,XY0I"JPDJA5&(-;0BI<N8WL9'MN]$[#N:7'Z%X7T(TV*/!M
MQA2.7?PU5_Z)B;-=T_#T&,D].#]9RG^E=" ZC%1 'LQ6Z25]<Y:R+V>H7@E-
M,C4E#VM1<Y7%5/!L1=LH&(>OT_"6L^AQG&SW>/!8S*2O^][JEUTACK@7Z<4:
M[27H6_4>KMSNJ&^-78 .KB"M/7PZ9=)%*^2(S\-X+4?&-=UH93#Z1D:@A_)@
M'%'+(OA ?LQ<@.?OL]SOZEX]R/U=5TY));5Q;RS;N5X'4-D<XF)1KIV)*PGR
M/HOJ047OFZC"LH Z9JDT3P09B'=*ZAB$]\'!K(6#05OB%#02M%0FQ\TZ'^_L
MVN/<\>%0'P[UC@YUM_[*7SKL..3-1&M?D35ZO-? DPLI@@6C$#R_;CBG:I?(
M6@W@LWT<)^V1=?2*B$):G;UA@)K3R7J#R$-B/ (2"7P%W?)+A$.M9C*Z^(6?
MT;S)F#*]W'P/N\;OPY.N+.GTSA]CWS/W+ND^:Z6#5;QO*X?PD&:2F64ICF%8
M+4)4PE^LDR)GJN\>.$(@6$-'U%/IOIA&Q#L&[V@ZW^1C1E:.<YJ0GE0"GDZ1
M0W:>PFQ+.Y#1%M=481V9<_/NZ54^<0GK7#E!^XCR\!148*>H\UX/@B)!;&FO
M]?1OFR Y*Y+?Y#G"@OK^1KI/B'"R,$"]=64D+8P6?X4PJ,?JH,*[=!(KDYRB
M70Q7>7/T/_ZOT],GWQU=Y<T0!4Q'76(7.RQ.<137OZ_B5@]M"1E-&R5/EM!C
M+P'Q;WI,5LT]KUYW.AS&"*_;P)=Y5CFU?K>0&9Y;:GR)RU%!DI%X13#42=7H
M)4;[ HH])IE>2K=+YD B*2Q;'4U6=?!0_;5E=J=,:@UC.);44,78K;MGYI[N
M:V;N506V)9QH[B1!*_X;6RPA1[?/A_SW0*3'A=?1R8ZDC3%&#(F.8NK*=,/W
M0F">'$F17F6&7;<T;Z0RQ9'Q.-FS+63HTX8+)U\C%5-F%H <&I=O[*ZW5C)-
MKRI&007NPT,MA]9R/-[76HX==3-AP6;>D9J[:I%^M;9;]0*-?3V:(>[LUA/1
MX^3[D-4JF;H65%',624W40]4AX.Y%4K3XYKS/ F]Y)88+J+Q)<\W:!\)L@N
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MX=O%;"SRUA"M%PTUR- KH-25>_K=&(TON-(&;\8>*P%JDM)!@WMQI6%O=3M
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MU9?K)*MA>W2JJ#1YF"!#W1G9)?<VE_'I\!;^>8=+\2Z7XB_YGVV>\3T('M@
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M>(X+NL%G@6(P<!)((U;/^XC@)'XA81,3]^$MP=/MEG":*Z9A7TDX/CQXY%M
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M0BFA-$; (T-S]#P@X3#M=Q7([P)9!SQ<%LK;J[)Q$>O<-8IU Y-QGY;))S!
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MGLABA%_8M9:R5B,ZL-BR56,BP@FOP<CCW;_B\9AV#+^,4XO=)HR96'*^3OD
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MAX_,GRF.U6BGR]X[2BL(A,IANC1@\OE9]?:N96C/)>5$B,.+->W@<_P4-NX
M@]7@J4KI9@&BH)1?+6<EQ+T7TG5;UG,ZY=NH:H8< R)/HC$+E<K.7=F1-94
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MI'<X"<%)'-_A)*X[5G[%^T:$THOWVGT34;=$I2NL'U5S;*?-%KHJ"=2C>X/
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MT_A1,9+>DTAZT'D?IB&OIWW4&\^U"FJLDL1,=/_H'O2X,RKL=%%BS7^B)4(
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MLG1]\7UG)\''OK[%/AG\10!Z41$].E<BR,(H:@E"*TI9;RG^PI:K.+;19Y1
M82(BBU?8B8GE/#5H.!L4AA-@B:0\R/$?8C\PA_ GUAFZ*!PK9)/QC+!UAFB=
MZS,MR5<)+&@5N=__[/%5:H8#;WBFD2>A!#-9YXXY.17>'0+,S7D/^X04^0^P
MX; Z]-K_J LJ=Y.9WC WJ0PLJ6C8XAE7YP,&:.3UZ+26M^,[@W/LEA0-8@9[
MO58O E,X" 4BD25]'B^*L*:F]"?^')VR=.Z@F\^99WBB%3^H4GO7E=3;X(RM
M,@HD8\C1Y1?90)Q=\(! @XU<YSPPR$BSMH:E0U]","(:Z_?V4(*S9[SC_+/$
ML*)1\G!,0L>[3T:-AC%4/0WMF4!I3)$^R#HT?>E) R@GP4T"L 0:]QGA^VTX
M9%Z3)QLE>8@@*EL8/P6[$*2N@1,^(A:JD257<[",*YF.,;\"H7L&@!LT"PU,
M80@1$7E-]8<">+H2K\Q*H/N0:$Q:V1!_L)@!"5_M\DEY1E59[5B92V^9V1B#
M>!OI9'RT.9A\/["+&MQNKO,O)L6\K\6!->8DKMG!KL- @ <TM: ?J4<W6J]$
M@P;?8JQ@PLI^8GY-M0OF="RZ"QAJ:S/J9O TVR^"QB1X! ;\S:@B>E2TR(R=
M1%6T<%K 5]MSC%-PR-"@P76S)M?QI DHF/R01$7V2BR"V9#-)U&#NAVWE)!_
MCD&B8T\$ 1EBY&'$\$Q?J3/LD]ZAV,_* ^.OA8&,QX$636QOU>^)!L]B8D=&
MD(]X#)*,QJ5?/!OR3FO6(<HJ#:=PNP:FM0 11"L$(_ 7VVQ)J(XQ02+J7V.A
MI-TVYB_&ECI#C.OS8E)TK'4"0\"^H41S Q/ 87<OZ3BKW<G:EE9SVTWQ*=+8
MX'C<&,ZR)&X'V9DK4GN[;(W_MCGBT$R%]AY>UDV9ATS5VCD<N=.C=LSL4E:D
MT":#3:*:JCI)ECWLFG(5H"C:5S)^PTB4T\I ZHD]:[(^[TN/:%<WN9V>@[U!
MQ,<,.RVI\533%ZUFP9<K\#R*7-/>_COJ&D@=1Q^]6-)+P=:%95"(O! ,8M,7
MW: !-/J"-H#:",<MEA"M%#[]@)U'PI?)H,N:%,X-;.R7L9CR#GH@T(.'=]"#
MZXZ5U2CD@'$#]$I%V4TXYE/A_^@AM,L]" H[:.J<E6IMX7=S2=>G'>AQ9.L%
MJ(]$PBKLEHU?B&'C9&@V0%=_4>N1FGMS"-YPMEY=3*X0>[B]O+N^+Z/4QT+'
M-5PT$DTO(.2@3 -F77T>E=#W_3*G$39JDAPL%\W ']YBB56C25PA#4<DZSG%
M4*GT+FS 7$/<7@F0M2)??=*O]K#W6]WF&@=WKY[-I&?_*NY\?3./DMU/GGW
MQ#>#*)E&0#XS> QNN<Y8*(:5NL8]<,-[Z-3OA;&=.YVSD3D)C'L2D2OB L$4
M#4DHC\TONW=C:SS68!P3;([);;W$\7A)LE?N.#NI(D\<A.SX [2R>+OF[J+V
MD$)SF@3!'E7>S%#=1V#D*B?EN^($L&*=6B]ZZ!72F7"!VN)B<3!TL?R"&^G=
M7Z]A:%@NA0,?'IB &C^RV^[PZRT9@/'V^ZV::IOS3IB=TID35I!=]F!-'*_F
M+(P1^F\S%[,4,4$+L</[;34P3_3'.D[_N>:B8#'<BR(7>3[-U\N9H_W%/IL9
M*!_198VKQ)ZD@:7 O2$9;71>#VB?#'):6]('[,+ZWBJ[\0-\P:J\F=T5!:\A
MJ>QSNU:ADY%#$H()[?I8!/M]Y;/&*S_/93J?U T**B9O_- 9W) &NJWQ+21?
M5$A^8>%RE"IVOO>,VL7 1>#T&*[!8:L.]K/6U1XUX)NPKB9A->R3FHF(*QR@
M2Z'*"<W)%)+H#U;VE:EY1%9%<MM:X8=IYC(\5W&Q^X%QYYL@<ZTMQ$:MA';I
ME]@L"G.#/D!R#F-NN@(OBCD<P-QT[1%&O@#-\KY:MO'1E&;QIC(KTKVR0EUL
M3B+P-MKTT&)Q<U3:U1PSE;WF'G)I2^;GCAOI2( 63S<9^:+1LH%7#N4&'D.L
MH;XSG+40<A03+ 70[A9W.W*@0Y?,I9ZVSCH^QC__*_R<UPL/4?Q9KGW"+NS1
MP>&!A[7A,T5K%#PT.IWT@=APO$=3@1VCTP;;.!CJYGWEVH,3-.:6;\>1>^.\
M*23(3-;LH>;ON5 >:\T(:R5^Q;=QWC259A_;9T;10?B"NF&B<[IV6HB1C&PD
M+$"87]I#!!C(Q*$;^VRPI\J.%O5)4KI[YINZ[%JQ<T\Y+XB)8 MT@\HB#G%1
M28Z0.Z7,Y^#YYG7##YN:PPNSZ3E.W ).(^1V8TUZ&)_Q3OJ/H OR#9,;F(/J
MC2KIPZY VR>ZH7!#NT$V+[6UX=(9TR?%4!+15+@>Q8$2!Q<3.)6:F7)8]>:R
M1+2&FF&ES1K5Z.O\2AL 6,9OJYLA"\J&U_5.]>A[#^I4PSGL6+12LC#22.T[
M8"FNM$O$KR*L'V"^:4[&A.(5*T@_?!0OIRU=BLS"0;N=6@J]$8[.*;MI+[UF
M^\2PJPG&BU<>T>VJP"FO1 B>X+#QGL3PW/!ASX:=C+Q,E?>OP\KU"X4L\^;G
M2@+=OC@ZMKU+UIJ-ZGTGT= Q%V^)4'R>^#_^$*/5IX*5Y;,23Z&6+DX5&Q%G
M"!>+LM^['QF-2W9)D@&WT$56]JQ7K'(_D22VKD9$TONM0L/8G?.7?3(D0O01
MB<5.^Z>4 ZK;-M3BMHRD>/P#T"X13:A&[F+INH*"(W+A/*N1.#;U966),F*\
M:@1H)Z<$G524!N;$.#<ABQ/W!GY$UN;%&)7JYPS< V0_O09EZEK.&R=U[YB^
M39B;:59*WAJSD7@!I'\]?'CO<?*EG_F:D_VJF1TE9ZO*P2+\EVON1N[Z#74?
MEF1-80>\S!KPB8X.CNX/4!Z\#;9L 94B&]\+)'_CL6W5&!@>#QU.$<+YM%AV
M6JQBX_71VU>QQM29-%&?!,M$O.52^8<%-""LKLDP[FK>Z[\Q^&L<<YI5,X;<
M,6X@PWA,^H&5S\$AGLW_WO@85I3/, XL'"8<BG81W&(ZZ&QG7([M_# \Y\@1
M<.FDEC>B!(F6'U[;91QC;ARR5/*<G39 :BYG_"%;GPE53M%R=?6\K&/<O+]O
M?0-F7=Z0D0VO2 5NGFA>%,O&,[P%C@I-YHCC$AJ\*.F/X9"P9^STJ?:R;ARZ
MX>G5FP*] X)N*?0/1<A@#:NW'Q>NP,$CWWDE";RQOJP3ZIL[]PQPHT,MT2Z'
MWT9Q4A%BRY6D6Q9%&SH!]?#;L)S>$1$"0V\XVU]A01IBNHS;G) SR#%)]<C6
M1HO$Z>%>_.D0+^A6X"*)$&D(U8\0'?$'PI_@X9GJW5]3QFN9M8II"9V#TNDE
M_K32W!(_&%/;7G"$ 5>R)E:ID&CIZC-H+&#!?N#$%72UMJ=4%U-*39HZ6S.B
M-A?,?\*<+@\*A9GA$8@_)Z2WWD53:9E1F'%8'] D2&UD6KEYS:C90%(L0R@X
MI(KIHJ(86SU:;S/\5VQYQA/<4 ,<:GYQ184(CC'FI X^SC@Q?U2)W*+K)AV;
MV<9-.>.C)!0R##4;.WFB'TRP*>,7IB7E)=AT@Q,GIA'Q!H^WMNZ'C5N! \CH
M!<(2G%!^"7M:-/- ?^7C5XFC.7,B+<0X!_PM^8[H!?NKFG&@W"7Q2=BX&WZ+
M<PA+53JP1DVX+OG8;OB[T%TOL0-Q3B379'7TL(M'KXZ'[7U57Y8NQX5\A_P0
MY,>/=\B/3P_-8W.XP+\," Z]\':MX-EMA_5.^R0^;\9(Y772247!8I\)Q )P
MO GBA3F1(!S ]C4FFYP$!E@VNY0!IT\S#UM,C\M=D\R0-$5D!WD\(GDPJRV/
MKU8=30R#/@+#T8Q#K.;+&A PU><5C.3<\'@Q:^_P:"3\*ORAZ39,N"X,[J*1
MOIS05I2[=EE(AYR1Q<LNZB)G7\!>0)HYY3+CH'Q?";9'>]RFYYED"]L(Q>&$
MJ^C@#<G>3^:[?W2PHWSWK\%[;)#?#EUGS,H]X?5U1I#DG<\Q&F3UD-A9/-@+
M2F%_7D;U%A@J3 FBG\"PB&+J4Y]6(F6#E3)UJDOTF6=ECQO;P.PW7Q$'53_O
M!L$!(0BH4DJ^,7A?#9A"&+0]^2<%Z*8G9P@B2$W-JJIJE"%FG\_35!JCE\:=
M!Q8>X^%:4L+R0<T6BVXXQI@)@V1&&$.2<BNAK[5A6#EQJUH">BF9B(R]8/+X
MDWE-[IY QN ^-1FO1IDFU>4+0P'_("\2WMW6+Y9X2'#R6ZHGU#<.CX7X&)T!
M%B0=F;<T$<" A!B%=HRL33">(/9JJ<*3HP1[+,1SIK>UY:EL@5B:T:<A.&<5
MJR+(QZPXD7]H&!,"=6LQCO&B=%,^)^@X3<<;+@(O[>9EO=O%E3,SZGX%M."*
MC*\%'^%SHX^,#8Z=(!FO-6([#3@+*S:+UFS5$Z_0)PR?[8@:M/B8OI7]KW5C
MV@"4'L#<*3%P,C)#]_#:1I*+R55\3=0(;F5)B1#;]6<+B5M*E/-O%99A2G)7
MKR'SC)S0X/"#0-+(((*&(6!AT31Q#H;N&\3:^%][C;@Y1H$L/J"($]T#"F1R
M),A1.E-+Z;7;BUSK$$HS)6C%,'LV.>^YJ#(_HSAET?JS"FF4010B8O+O>3+6
MB<_VD]=4]@[/(2D=73:4J)7TSZQQ:+E1P65\M5,KO4KVI1$>LR[[A22(1WN5
MX#B 4X^SO^OGZB6^V_!@C8Y3O_A''FO#X2I?H=@-FWM"<JJNKKE#_EQ?.LJ1
M#T_XZQZU8\\;\1S(:W%&F,;7?4",6.#FQF0[E7&YN9Z(F]%96BH^]\I3FD@J
M^(S63KU/.:63,U->&1%,%&R?S['&N]^N>,H@P_+$@- "FMX)>^ 'RKOK@M^H
MT&B)@&B&:8/)\K36O/$09&^:K,(D*9CHAEC7:)1,.0DYNL^ ,MP&9R5LO3D$
M!3"1S@6$%0T!<M7US?0\8\8DH@;0(>@Q=/L7A[(\M?![]DR9=XF+$73!HN.O
MN>J<IJ,$WWL/4^EV=/G+^Q BZSU;/0WZQ8()UB,687*%?0P9B)(W!4RA77I[
MWTC(_4^S]CR99(2,W>D8E6@NZZS)F9P;F[<(D!_D6++-,VY;@SPNEJLQ_K/]
M$O_ZNP<'X#>4I8&K1#,@5#A(V>0"=^3Q88KX@ <<\"[0%(!UZ@HO5<!&E?N+
M5FO/V0XB82IZZSY5&18MJ?E&MXS;!GC=^. R!OE>906EZHTJHFQ(% O>L\6F
MY6/D:&(]RX'R(Y[0J6]:]Q\+A#\FB(;1R3Y8S;92 &X7$90N$L/DT=TXR;H4
MV%_(:\>TYC6<5=0ZR-X>RU0[GH>EFQ*+N'JE#7RM1)BUCT_9CGJ.M734LK31
MIJP&FY$_'>57#%GZQ]H 0="27[QYJ_-Y&=6Q!A@#$C(.RJ>#.1[RL&T<=#DE
M%S5XU@76SMJ^I8I7SD>Y0%]Q>X9X0F$T0R M4=(P)I*[\J(Q&S_%GR$W7S';
M;O&+-A%&VX!<];2"N$BN9=:# @*V?]KI'VGX./S/Y(P>)QP&V,J(9_\[6/G*
M3"=]A*?53'(X;YUR/9K&$!GE>C9K81=-5NH*,!^%N%LYMV/0I,^*%AL@D3@Y
M4F'<\DA!F-%CCM0,6=^^(X$J9#;:\G8L9#VE!J@U&4"BGX2-US+*N[83)MMM
MIYT2(Y0ATV29KZQOS-YA\(^%:01+.L9+%M>8U'_Q6YI[=JV2@"H7!H:K=$JA
MP40DM?0VH*<G=H;3@A '-'X[C=YT@]MQ94YBEUV,$S(Q?^DK]U__<?C@X/'Q
M0:JH/]P1>7)XM'_/>P<;XEHSB 0,VGQ%RE'@9>6+.LUF%AADD&3S.=+T=+1(
M#O8/KW@&>]]$;QG=D<24V)&@DSNDB3>LI>BI<#FG:,^Y:UHH@K W!_[!K29#
MS3!"R)M0)GJI@_U'5[R1VD&^[(S/XO@([>HN2GW9!]Z<!KO#/7C<PZ,[W,/'
MU,OL:K8Y*#XQOZG-W>U*Z^E(R[]GB!]V0+W*VCS[YQB5/GLH3&C/*C_#T,U#
M;7.''_)24^QD[O3)=3H2J5YF[?!-837* '*%_B5'952E$RZT;8./YX ,;Q(K
M/W6B#;(!>Z=JGW"?2_PD)E-T,N0!">G!T:<X_>(?R0,+VDYJJA^4VBZ"4Q=C
MH^ :%;72P4@W1L:Z@^G9RN*](] >;3)N_C%0&@G9I+]H+<U& 7U1Y;X84D2<
MTXS*$WB^/*D$:>OT#4.&[PJFH.O96[@D+G"$"A$]J92((4*I+[FW"6Z&SS2H
M8_25C'MHS.5J"15#PEC$#0^2=-+S=[T5="UR_=SRWFTP4-J1[;4N%J0QD7A%
M,24/4MXO1=Q3J.2QPN33"%06@S-'7<?3LJ8&W%B/LM_4;EAP=B!P*^@C1!8Q
MKE5L>EZ/(:4*V=K.*2EWTW%_,[/->L'*G:]E?>2$HB4EOGOU99^)!<(@7:A#
M-U[%LW]POU"WKFRRMAPT:>7!+3 YR"2,12?4(<J$(4)R.<*^@)%E0R;!-Q%O
MF?N(Y7@0HF]XDL 5"E'KM*=E$17IM-](V+ODMAX9^&&5>!UOT]OD2F:I(2D
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M*/5ET)DA_6Q44BX@R"@0X9SWV!^]X0O<WF.%HAH6'[%%=WQ^_S["H8I<:'Z
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MLY:^!?=W!_NPG [Q5.*KI7KFZKUM>^/@0GYVR!GS&^QW1P=TO2N?>NVYC!?
MVH/,-7C"_,L41?GUL:P++#$LB[),%4B*CSI<HG22TBD4Z+C8+1.G4,YMPQ\]
M5HN88(5^@<@XR?BB4A*1C9%"&!B/OD)<%KBW4ZXP(WV-IV@DWW>^YN)Y4HIZ
MZ2J%^V33:;_H@WB+;WSA'#&L9'I(Y'ZQZQ73!H$.Q]\'WFM1] MJ#I KT&+F
MY$1D^GG;R  J07\=C,*/M,#OC1S7UV5B/-X-)D9U,Y&1,7G.K?\[75C^3;%A
M4X&MH9)6SB#;.;.$"IS%G/4LJ04':<H-C<RS(=!'!BJ$7HJ<P!7DO)!X78>V
M;B.##"ZY2 1HYV4)7P0*4V5%Y4X=/XI<28H'TN-4*"X=""MH@UI 1/.P+CQC
M;+;(Y@IZXL_&-:&MHYV<$CB'4)=URX)YK!KGR0MGA0HLE;V7/ PO.F3[D.65
ML<5+?0U<^1JB+]LEIVELC_D8%V"-I:,"&L17QI21<J=7TG,Z_9'X#+T2IG-0
M>=.P;U4^@_>OI$E2L./=.8?;RQ+[S" XH&'CQ97A:>HU/2:NQ(YB]GP0BQ2C
MS)P_+\!K+SHA_^(XM>TXF\.7#>IZOJ&&FM-<'E-DP)06"Y7R<(BV)2@M.HS<
M5R6_Y<+\B$RW+'BBEMB %]IM !"/A@HX^DY!E?U$G4-58PLH.E6!8\1#+,)%
M/";H4#1*?(,KJER9?11:1L)&PAV+ Y]N$"P$=V[J61,&@G8RYU]Z>F[!SJ0^
MI*BS)#0?V:7JYVUMBA)" 5E;K.AR@1GP+PAAZ>EU+UWVOB+2;R\ILW;A?9\V
MNW=PST-=LV:2P3?W7G\HG9$</3B*24O6/N8=>Y7U&_=]=7,[$H.3]14#)?QR
MY7@I2*)]Q+"H7$AF!05EH*17XOI7W.D%^-N(0.3ZJV-+JBN7$'&VHA/GFUP\
M812;A*DOTFQ9DCBA(J"EB+-9D_5Y3YH:FB'"LT+R7>%:<B>DJ6$0C)#7#\HY
MPGSOQ1WO\"F"3SG<57S*MQ\KOR5\V.P#8*N8:@I6H=O26!"!-0<)=OER&L38
M(>:O*V0UIRH3;9)&M+!]EHJEZ5=>^JI3[44K' U.3Q"BLSGS#6Z4U2O+'4LN
M,0JDV718C%G;S<;6*]Y0EC5FY&2QW3$: \[OEFJ6Y1BL8$9KD2R_<+EU4J2M
M0O/6!;,XPKO@H#E5L2K,93/EB!]X(1\W(*E0??212K;X0U@V'&NNI> L].@:
M@>6$A-#E+HNB-7[4FB&T;;DXCG2(ZV :5:M1JE43#/F',R>AG+X^0A+L"%AH
M7*149VQE5VB_<%CZIB'7GQ\:MEWK[-Z\FOQ28.+A#0Z)WJSID7L6%LNB+^<L
M@(%P<_KN2.H_6Y_@M>7AF@:KKELFPT;.EBA/ZC +29"-??5ZBVGS&N)OAP;"
M#OMN6YH%4@>;^@YIOH:SH:]IBHX]=+YJYEDUBLW4Q:'VL4D6W?KXD?!VJT X
M;-[V 8 5=6"J2&'#T*/>*'$AO2=L7OM! F_;%EQ/Y)47N5@EKP^RQ3\>7:3P
MFG^LQY=I4-39Z<CQER"2;D<?TS+_[''J),>"M*#J!+$>'U:O9E2X+*;,I"3G
M):Y2SH.S.::2I*C5(P.KW3V>*ZQF_2")4?%N%'E&T(?O,"JDPUUQ_WE-?8'J
M0X1 4+P+WHXA^8^]ID5>(-ML.X:(T%P/CJ:RPC=Z,YTV[LZSCC6:$_:,.=-(
MASD2UZ!)Z['G33M9;=.";VDU#[5/K)/#=05G!TG]Q3*%87%I>,C%%T8WXOF$
MFZVU363P7L0!NS'Q16>9X&]Q1:FE\0SO-/P\-&SLQ;[(2%.:R7S+JV&N;XG4
M%';;KNE):#A=WR5!1)?-HYD1_6R;AL2HG4YD.A%O-%OI&3/)D+0?!R+=M(>D
M 8_V6:!%,OE1N15N+V0U^LW).S?E2D>=B 68>0E\4^[.\95T&F8VHHW4).-H
MWM27K$\0#:!Q93<S5D5I04U/<5K0)Y\W/5_(*XMJ\,87B5B5_'$1LP</<\YQ
MRGFT^Y ?@.B <3O)[F@(RG:!_;P"(^,0@+AHZ)^IKYMT@]UD1SGSDJDSG8S*
M12V3S*KKG JQZIK(AP*Y'C1.W+Q"QTZ%0]T?^"!3'//.U'V88;H+V3^:I2LL
M//MH7M2Y!_<"]:652LR>Q.N;B<$NXH,6Z+XB,0=^T1-\KS, TYZ#!1,BOKDY
M ^<<"M N&(B+^?'R0G<H@<M//'!=_$#Q% KRKT%X0]L6LY5.E=>T"X=<Q)[)
M%)Y8=>XUWL%\=AWKA^\G3\=5^' N+Z5HKG*"GMP(0XE ],W#S53<>E3X06IY
M2]8SW9L%$5)@E=/JA>#RL9S$O!^DOS#FK/-W]P.M"Y,+^-9$J;/%X?= @(PN
MI ]/^R0BRXB(T?$V*#J,D4&$,\R%0WDMGB<Q1^_ZFM[BC4>.66R-NRB<H+'$
MLO!!1(O3K!>\_'J#<Q3SJ^"P?Q?Q ;0L?UDWY8Z+1CP3%$1*GF2'< BK1=R0
MRN&P8]QX[3)EYES;4D16XA^_UOWWYTU]V6%G34VT6SOO8V)-=;B T4.!,9QS
M&6)<+(B:E1A>B$,R,M*((W4D8?=ZVRP,=D5FR(!Y3HL*;0I#P<*6'S.B06+;
MM%(U.F5QIF']0>+C*&0JC - #Z2H8'TZ](Q=5,EH[UIOOW;#@+<!7+T4VT D
MFZ9/9."OWW4T?>UIT0$/+I-OH%"&<B6B<CXC<#<M7WM:J#/,NT$%.^AU8^<!
MI<Z(5*55;$T=V >BH!J>:L8X(78Z:U).X5RBNIQW4_JUI[3$P+Y&7$=9[F%>
M>5(6[3G#Y!H'OC0&:8SB:5=MYQ8T[YI-R?"0BSQ(<<;O)NYK3QSV:8!KTI*Z
MG.P732*)P]+V.8R9[$N_;2>KD-^>AXJ4,;5WD_<M.G8CTYARFLX+(*5B%5--
MNIGD05.O&,I$7T(.3S:F8H8G60-.[%W?]=>?15\C7G'NH<262PXJ;&P@$).6
M2%V+"[*HE%[5YB>(&9'4%C-.DG&=KJ;EG4/S;?8AHXL%E<B=\^ONIZ'V&Z 8
M&[?,.NEIR-KSNSG[!@>?Y$>9W8]P#@SV6-]['+%1>9?SE7?S\]5#ZJ8&"[=H
MN3EOTY1(1SZ:4,[*H!WM23F2-?4HCXR-")2(]_14=SP*WR3^%C%231#[%!GU
MTDY7H7!"=:7-R<M_-TCDT:Y"(F]#%KE:#5*D&TJDZ\HS6Q.R6HJ6_*TFI7>[
MC/%K%1B!YV4]@5?VV4NKLQL0%^?P;81FE0+,D@R,+7XLLFE3CUR&<SP.,1F^
M717[.64>-I6LUYJZ4@6Y?@<UC]?5G' T<U>')++RP= (44VYF/0B;A*8$#8.
M,^6@/V13UTRH]H2:O%QJ1I .,D%Z((#4+BS&U%^QKR0_TR&P@E([^%\C,ZS8
M63]!<BBGAG2D]!_[M2)X"U&38RL'U4+#4^.2"-4O70P?MQ(8#2)B"'KL(_JS
M<;2A&Y)K%EW-TYF7F1X;15M>(NA"P7@9WB8E4SY40?[9.R14<PXYK&T2.68?
M7?&XC$4R,F*Y6U"GH#!E^?*\P&-$W F95ZP@\E5WN30 RS8K ]C07S](!G)Y
M:]N,T1@S[ I=[""C1AV4%H5IUI\?$WPP8G_I8YK1J&A.28_@RWMKM TC(@K(
ME&!&<^;T 16JIM>3^KT47]OX]].:FA55<IF1,;2(">/,AXJ.MZ\[8%D/WH&K
MXC63G,1S$02AUX 37+GT%:5(<"^O4=7F8_C%TRT$X[O.\!'0$C3+&TVEX#K#
MTC4A>3:=*IA,VN%TBV=L8TF&T+(18![-X9<R@41E#;='##%LLFG%AX KS^NL
MC.3:(HR8G!$PL,1&DO=*JT--Z!>N"9KO#*[VYW8E=)W\U9%>9GEW]QEPC%LP
MX^_JZ"U%'J-AD,NYRTHPNVY9@,TLIC+Z'7G.TJE!NZ"9*R"=F$%>_^WTZ=[A
MHP2!!8Z0'H-)#%*@1=OT1/RD/J*'+@S-(UID.OCD.QYY3G_UUKLM8'PR)@@D
MA"OURTZM/OOH$VK-#(\&IECRY.<J!%14_E&X[I)R0DI>2L!%;8>&K$O.T5 3
M3I(>LRVF[Q43&70@>(T5:([@L0OV+EA;T)Q26NP1X(-:-5[$XJ' $U";T><X
M=;?!K?YM0[-!D,\D;)U2HP;"@)TWO&0MLQ:LU-4O"^<4KB1DD9T@0%LU9CPY
MA(=K>Q;YJ[L^B*C-WUJT5@C\!_]U0NX):PW<1(=R<;0V^]9K:N6%Z\@EPB7)
MS3%!7X^5!CW(,F*B2*Q&5>PDLPP;ZP<H&0!N9P$6^@$Q+?^F_RMH-*D0226<
M4[ KI20>.J6"2DQ'=8&@(P*[;KHNQOJ],0N894<.>MZW"%"&\2E7+7'_H2M,
M!WI[SAU<+<P+DFXU^FMTLI1-@"1C0I#L/QUD&H.3-50J$QBP\"F6X AZ&ED6
MW=[ES?[.J*)LDW!C*7.'$8;246I#>QC,2F5H6YT#;H2X:C9Y%H)R48@\SL(W
M&3:YMA"\?+K.>E@)4;,([=C!^IEB24>4)GO6KAY(Q(R.A3\4UMC[T#$X9?(X
M0\K)VBIR9Y1DI?OB^^;U936G0NW:3;[,.HXNR:\T)FF]X:E;MWW$-'AA1C@=
M?EX -8G.^::.=!CJCHRHAKB>#Y=HZ8+F_<C+C.S-$-J.'</79?]ZL!OL7Z?O
MGKW\K_\X?'#P^/!GXL@X/'J<_/KJ[;.SUR_^]NQI<O;NY/ES\#%?OGSVZMW9
M+ANJ5_6HI;WN?#[:G?E,#I_XJ7SR]Y^?O3U[]N37MZ?O_OZY7F4D3O6M9Y ?
M(4>62O*2?J)V:?S4#W\B[KJ7H4T<=_699.;C=RX^_%35U2M,QG * *_ZULW@
M!?8.?TBJ;('OLLI_>K*:8,A&I\<*KQ\N_T:[:)_7S0FUFH'U.,6E#<,"_SRI
M<OHP_//=.:IIM._@)C^78'5^H/4VVSM^^(//+.8G'?\*'\"UTVR)Y:>F=S_L
MVA;[LJ-["M^>4V_6^O#].!PI98OY6H_PO,SF/R3<B0X&XT/WTZSXX/(]NKL^
MU2-#S>'R_^>/T;/\2802A4D"HAK[ !R;&*8#"(SASHM FLEBR/SAMG-<#,<3
M#04X_)%78(,=AB/2F,2=D%S_XE:]Z*X=KT]/\R&UKR!#KC#-6<2O?-&7F#&G
M))EO<2 Z8]&$DF]9PEPZ@*.;6[X1&7#-Y'OZ$7XK)H33N6""7DK#H#.!RL?C
M@[>_-@7HK2Z(PM8W=&X95/1%J%^DBT7,L*-XJG@L]#A^&KP9NYJS)O-=M8]-
MJRT]+;]G<9%-5X]%0JYRY6/#^\?."=$/F7?;_S)+_!VRM2)S[NH9RN1=;X'?
M.V!_?]N0(7 -G$G.@XN^GCY_:TAB>=FT-G&:FA6[D9-CL(2$R#:$M]QDIPO0
MT^ (Z<%@.7S&4(8!?$T!.%A!L/MR"B Y*#Q3."BN,[B'RJ\>#9)V0F,_SW"5
MT5"1/BL5&$K,#T0E6,R$,C=$]$5*77 1!UL[ _U-$3U^FF!..?Q$6F[@ ^2!
M=FC-A/&D:I&0>AV7S/(6FN 6AABSS*J6,^@^93ZR:XG>K],^N%'[M,6V89<C
M%6-@VU&SJ4]9JO**IYH97$&YCH0Y!.,([?H-'ZJ)ATP;BJWU)68R&5,(8/#$
M*J44J PC+A4!6:=U&([MZ'W\/6#^Z3)"2:',*\1,,?!I!V/W[PR?.;Y5\!F8
M%^WXII6KCB#8F7\K/X]A-^7J1!(>KYNW<(+"63HI5R\HJ?"N'G[J+5'(-V#>
M-EG2&>SP8$J/@D.(530U:[ KC2?TOD+IFE&;H8W5(1<2BO=QU3D16I)Z>#+Y
M+2O4D?0P"_]>/M]#A2?BU-1!T-0*U84'GR?[]43I.,-#;6B4':WJ4JEEI!"\
M;G?/'.=-R&&9$36X\FA^/7CAQESO1IK(0;.N4T$-)@H(7J:@0+M&N30"315S
MQPBT)NLR=<WH.SJG=L"CR0X$)7IEHE9#?#Y2687J_!J7@7V$35_R(8.V^L^U
MT$LB[?BTG/Z"8[WV+%WT^[)NZ;JVMN!S_>#<]LHVI\/'W[7EC$#@@NU;5,M(
M!^).866&_>+!.%LP!Z%O>DB*?A.0V</'>+BB1Y><ILDI>!7)X<E^\GLOT1'H
M\2.E#M.&F#N8I])2SHTX2'&WAB_Y#O!N(Z>Z/3V^I^1-=$8DS.V%X<\N)QL_
MXX3\&=4I7L^>JI*:#R_6LB#WCH=9D-=>V*C@0BN5%BR5.I42*&Y@29M:KV["
M-*5IXKJJP&1Y[1H6-$/:* ?2>+C-SS.E/K*64#!8FZ4C9>/-)8XK-,& -:!
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M.:W2,:28\=D//"^X)5N&^AW@QHO2%@:DMOX5A,441Z0C"N*<@159:,$XU,T
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MZ"B7/@;S7A+PT*7JUEF@D,,.?%\HL9U !A-4J#L)>T.0>1-#78!"N:?).Z
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MARB=/0$\+@;2DG>]H?#A0PBOB>K6I7I1#\;A1G%DC4,77@6DL((^_!$X20^
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MZA6$5J/>^KF^I1KY\0B>V!/1FM:*U<_)6N.1Y,Z4\7"J9OAJNFYZFYXF/&^
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M/V?VBI)AI=F,FZ;>KSU_99*<B\T-9/M:9G3H5#C8%^Y$AD.6B,!V U=U@?V
MFZD<4HMORJ4IJKO87UMJIY"+2Q<EH4#^^?Z5U)%'C\2J=SX?&\_VANF:/%&"
M>IN+C(LN1/@UZM]GKROX&?%H1E#1%U4CWX>-:]E-+F$3,6..Q%]!F*NY,G1!
M/H18ARJC*'GONIB]FB9K8%4E02:>"M^/DAZLC;#&08S&%CD_L1"!\OO@ZSW4
MK_.)1[=!XCE\G<SF@//'^' .A;NAJ:8T3=W]<&&!C,K@G$U!]+KZ03Q!P9&4
M_.2@Z[D#=6D0YER!",L180L/EV)K$-=#X483\(J^Q;10#>8HX L1PKFX#1;=
M]"GS1N5[X)B F4 -T2"?1%3' W_S/#[B*/?Q#H-;H$U8T]8QNGV 5B*M7H1<
M+$,RG'M@(24C]",CM3#J'A8XGJP@1,[3_&P0XKM@1O")QP@3?_03V:XA-JOE
M3#U5O_$6-$J8%[$BSH,("@(*K6K>=O@E+J]"9 SR9Z7'56D!?(I*NXT5&E<R
M9<@SBP>C)AI/1>,UJQJ-]_*T0KT8L5_;"?H\KVX=IVRO*RB6;3OM\U/82D7A
M2.?FRU#6P/\/!B'V'Z'X5SX[T0IF,B:?['Z]D3G6_]3 0OE,&;I(8BMMNV=X
MA/IZW@4@BD"KI6E$_H*LZM4C,^8VZ?#PZ0[+GV56*P:P70VEUX>Y#%12'RSC
M%<9)(KA664<_]ZVO @2#U;)KRKZ^E2KZ0X"MC+,.\[..]*S3 ).KO9;U&O>I
MBH#!IUC3]%+!*F^*024D!$F3E#V/5/@L#!0#3F!S>M9!.C02V1CCB0[LA#V0
M6&)4[]G#7$8[&=DC&C([?2A4!U^AOJ!#QTB"/,T=5XHPU$7I I^$Y0CKJF:%
M3+D>!AW[PO.[*CLW7\\4?L7B?,KL)Z<&AMK#?U-5H8Q &'V/@I6<*A2K2BAF
M);K@94Z#\>2=FZLJ",I)E)WKZKK,B'XZ*15VZ#B@N%K0 T!RRH("I ZS:XB
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M))4*=G2$45V22@^7R@IB=^R_&<(/ VHOB3X,?:E.:9Z<<Q!.D@VWD]:[,\C
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M%)2E$ZQ@"Z$JJE4G'<Q#=^5VC%:5'*7></I8";FU4EOV:!V%G@^0S.>CZ7J
M:<F#.C8RYSI(7#*I1W&;CDMQ8KKF07ZV')65[[":7^QT X0R=RX+RT-PU-1)
ML O1J&Z=J'5E4L (%KU2<49JE/^0- VW1[9CE'3_XD,%,GK(RI%W&:N0CR&;
M(Q?WX;!5X>??IR]2F4P]#0-N_YWUVG[#P31D=)3<,^4Y^"&+G-/%'"?524 S
M*\P)=6#8-HFON5TQ"WM;9[P,-0ZR5Y$;7C?5T"8Z)F33T<'[Z7; "C _)+OF
MR%10F7G$0^2_HT]$SX0S")EO4!9DNT-ON=QSF<G(TM69E"2C5":$?NYM=IE
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MR9.>DF" 4B9Y(A@3'Z>31)Z$RPR[%%*0.JP ]#X?T(L%]V&W*(3#*"T-'_
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M3XL;!RT5;00_8>W3J]R/QJ1Y,I/&.,,,+*\*RRT#R[L RRW;D5[@QC$6Z(A
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M&H:!+X,DPMS;6Q%BSA/>)OV(!<OK$_5@]90W1BBLFGJ+F_@!F;?-69FWQ\D
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M@[^X=^_\P/^6C.#^'B:A(R4OD6*]/?L5%1#XURM'NN_4J''09\XKTA#Z>P=
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M9=P7+]P<9QI@;K?46FMK^2EUQ/7O_@$[-9E&F!+-,YJITYQ4%#?@F0*<HA'
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M(GS\/G8HCOIN,ZYXF(:INX#+7$9X"82G>HYAI"J(=8DGN[KM<;;%$YY *YC
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ML%0;*Z6_.^Z5@'U(K[/->$;F!S/._\E<)R.YJU[?HFG5#K<%^HWM9$SPF_M
M>3E04K)N !Q>_-#!OR$7N-C<.MZ_-+@)8\];J&U/PS$S HO=CZ+5>/#2?T:V
MDR%(&QF"M+&=("V!Z(E.'\H!1F.6?S&3C>^_;(8<]49EAK<TNA<=K5G,G)3&
M1:.7;ZD]#&^1F\JSJ>6S=XIM,+[S62!Y9L%&Q]'J\Y,FPD!358>?;#U.I]+W
MV9N_SJH/LMGIV)^C@U8S#\*OVTJYE&V)OYNVZ8%N1[VK%K4B7F<R<DE'Q:\)
MAMQ]R$L\*7[-(^>Q'MNK>LH*K3C$IM\1F?*VEJTWS_KUCMII] IJ9;[_2>Q;
M;263M6K%K+V0"*N!DH \+\Q=BI414EJC-WL!1CXP%R7-_>C9\3%C3GPGPD5,
M7PF1L776[[8N<G;AWC\J[OV._G4=1:+(@192QIR&C.GL1<:T0<;4U6ZSJ'$9
M4L8<MXSI[%+&=,[ZG>Y%I^RH>& 94^8!=6L>Z%%_CVK34D96!AT>"4EM84D
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M23JG*[BWNJ9, .QCDA(\IU;DV$6U\ )I9ECQ,I#J&+SC^Q6.1B%]%"['/-/
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MV*9O!-\FUQ@3!?9T0(Y<&=GR6TF9:]U%MYGWP%QR2BP4-KU*"ALXED+GJK+
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MV+U00(INH:*Y+Y].)IJ.AGR>.HUR#'<CR(2]KQ.;*XY6.I)6]C".1 Q!'7+
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M);<'W".,ZJXS><&1DQ\X69>*?'T78S\XW--Y]3AC&?S?FWL)_W7ASR/^MN.
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M.#LJ'LO$1M[C<JLER.YBJXD7\QB6POJ]?7(^P*JPU0*Z?G^GHH@Z@(')X$9
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M"CG"L<;9HL?NL9)4_W&<-8:Y]+#,U\29&24]<E 4E9*7.+(WQW%<6:5@"=C
MJRC4XH%6@!J];6Q\\B;ZXZUI^1O;>'UC.72G]*:WV<=C5.(9.UO"TGGLA9X"
M^YD'+*;3@3Y2,681>/!_,WHQ#V<, ')_SW^OZH.)HA7^-!S(A=_O>I0,2O>T
MVJ-V?S]2%;&HRR]*W_NHOU/,8M@%^(ND\7]Z:B^)N)D8#7@SE&3 _[\?NDS9
M_,0+W^8BBMNXSM"\1CZC'U*]:.R/<U-,C\&^TZ$/7,'_->8(@7DC<(C*%V@
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M:0P*3IIEML5."\/_?&@ G#UCK"^&?TK[\]R)?Z 9F=8SB:=V?@.2^ 9;<Q9
M]91;/JX,C[S#U2-7((Y/O_WP<T%\/\DFWO(PI?!DA'AR +,K[>F 5^P2>QKC
MGO*6;;2G/F"'OV&KL+<S!*^($M)3%#RRM&''7$Y$8I,W6+>-ERC_,](DHBN\
MJ#*-D0[YN;&HM@''(+T/ R:%_\N=^]+](DBT$C_;[_X% !\M(?-X^E#\XL$A
MTCOK27I'#)!HH$W )[@''VKE\H_'0&HKPAO'&R^4[HACX/8Z+?6_9W5",\1T
M;!3H\]"'BWU?>K+=.1S@ZP#EIL%/9VMRA<,RL?UP[ENF97BHI2TMFZ3G&$1)
MOCQAD YO67*M(3U#@S[M&9Z!N;9,(*=%76;<1I_^!)2+K_Z3GK2;28*.V.I6
M1C(7__E,YO2WV_,.BA-YD0%8$V-JR@MCHJCF7)OH^E09R3+L31UI8TU?JO^M
M3H:]XS(=SX8/N<P@B@]?7("WK$B\)$NJE@6+,X()2;0&&J++Y[]J$\;! 9+$
MO _X=_BX;%;L9Q[BV[*O,Z=2G,/+'U?P$J63R;9IOII*6V>]IQ#)(YMIX7H;
MEYIP[G)I@?1B-@L?;4'^"JW-FN;.?Z?S1O@3Z$P0CZRC25K$6U,B,3; 7G^"
M8 UPY%5FXW<^6=Q9/^]6E@FP>8/ U7LSUXEB$DB)^Y%'ULJ@SW=8R\/R/=R*
M,C536(A+>&.&'M)T@EO3WFP\&&TC#2/\P1[=']D$.P>46& <&T]IF%!(4<A0
MB.:N-$%>T*EA%/AX)+ES0IFQ%R3CW?HW/N%?_)WW[)7?HK7%<)(/@V<$?&@T
MF,K%\*%;VZEY.>%Z3KR]D8+<D>[=P6\<9JB.?24>IDC&NA40:KQFN3=3!_(D
MIUW];4NMVG6Z6BM.=W*!T\4>#X/IL+[3G9S_=%4\72T?<MX^W1S?KR*78'GO
M73_XCG[;O$ ::==0D $RPG78L*PEQV@<(N>PN5+'F9>BA./&2SC.7G:Q-Q!Y
MH?*UXVHRI'0Y!C,16EJ4L08ES2:B**/MT&ID-%+MVRT9X7[(:E"1K"J#,*<D
MX1["I*.: -:]MIK:Q;'$CVEW<& !.MHI7:)*I[HTM>'*D^RK9:LTM:T:.^!E
M;0I4VJO.GQ^->C.YKQ<T&KUD&S)^%/6TO!,T<%TT<"!B50,-C)$&IG)^Y$0S
M-%"3+M-Z@?9/P[.H8;M;GA44+-3<.;@+%'! "D1P3!% 'L<G@..CN@JX+L7E
M&^TIW07,.%CC4@(S=,",25LPXU:4^<>5ZP5WU(E^(O<[J7EO%W#\ />CD$2?
M_UXDGP*27Y&.*S"C!/<KA1GC86^FY<-EG=;\VLKTOM/<O[T>K)-J(^JO\FF_
MV5<O7*Z"+1P0&$?;B6.Y-U/ZPX+PZQGJ?,Y0Y%.K_BT(51#JF>7W\82J(*'*
M:LW]2AH@U,YW8GX,-QN6S ^2?V'X*VEINR^2Y; 310Q)53,5)@J)E J14G%B
M@D!7>@UF4JI+!'>O>/N-A/>;*F!/0KN41;IAL*3\CM9?;#-%T4-1='X[.5;\
MU7BETP,KJU8JJE:*WMU6<**KHJ"M\\:@CZ8MC9HM^LG>R O0UI7/Z/R&?]^Y
MR[O0)W0Z"B:*S[$N" >I.!+YR7LE8+(X<VBZ<U@QM6C*2^A3,E+:SRF.RDCI
M C<X(&DI\CPL__ );2'TP/'F$Y9(4ZSYZ'I9CO'9,N:6;06O%8;!C4=M&R'9
MUMPM02EME9NU44H)X3I&X:I-1BTAEA*]L4XN)XZ!];L1A![\=T=)U[B@QGA<
M4&/<,=]CM.NDQ,OF ,&:>R,H+.>J4,.5J[46TZN2Z56C+5BU<7H50_)]=?$5
M*^ [XE?6AP-Y-&VA,WAX<%$%"D;'NK:7KY_;53YW,_Y@UD+HB.$[Q[J+CRR-
M:Y/2B?UW3BD+$UXPX04[LM'U7A4T<HK]%I(O\,3O+\1^)K_#XU?5_60Z]4'+
MW?5!G\RONN5- YXT.8HG-9H!>T,4B=K&]Q>W,B%.J<-ZVA:;6DR]8,2FUZT
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MYAWTI5"ZHN8E?(M('.TQ0Y*<'+>)(Z<AF>3)(XS5;.E*Q3R(*LP)""(2XR>
M3 6])Y37%W/N>R<M#@H8\I8\./A(9(G%NE0B;$KK470]3(5*"8%XP0/I'5D8
M(> 6>3;LD)TO0P.&*O2YR.<8%L!#_- .& --Z9.ALX%%6(L@YN&ALS2>78]^
MCFY:4&Y.U=(^/U!\7_9$8=\KH!IX*,=?T-,X=G$M/%)2815S1*9E2.42=7O
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M]XJH(\,W&$_R )T\\FR1EX,,!'2!OT(#2!>/-T^>$8>(.![;2DH<H_&8)D/
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M/?KN)4C(M64]10<+#AO@]"E,ZI035"(AX\B:\:5DT&&/A:&F-S@^8U@HTC
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M%I1.V\[X%W#Y]]7N,-0>G^+X([R/<WA9*^3YH-1:%WNLJTO-N'H,<916+(-
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M[+B/[P<CR %RZ;ILSVF;L^G723T=?AP/ZS"W\TR7N\06+<9&PXSSL JTO[Z
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M&"5-M-*P,<\5/%<7N'H9-@'5,(MD+9#ALTAVU]%MA3<2<.,$DO7@'&U/B=L
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M3@=E'V2>CH^!#CCK05837S$7P=6L$^<96NLRRZQU4MZ1Y>ET8<!]>3I=-#%
MA\T-T#R5/)U.FGF@U>868NU?V84'5#X6D$*2D1L3!\<U@?1%62P8K3[V/)V&
M.NXBS:';J5I&3D(6!9C1=8Q\#A 8 20_IE@3E-?XH/']*-JI=E)"EW:J7238
MPPW?M;X-G\>+BSO(=WF>9U]R;87WZUEMGUC;E^$DYE%AS!L7'7"I' %.@4PF
M%B!YS(5[J]"WSL3M#/)1A@9VL4#[5>,!WRQ_(<^WVDVTP.4=R@B-$I&3 (,E
MTTTY3_*4&2&75(PPR='/#\7;?& M3X[%!T&*0[IN_GY>G%>37WG+5Z67(\=+
MK@G!4) M"R<EG4O!@9/")I;H#;>]Y%/TLIJG2?C]$^.0KH]_PZ_CT[/3[V;3
M69C'V7@9P*XCWT>!>Z%12=#:DG]<RX4]<@-%>27(#'/!]=(0N8>U/$VZ[YL4
M/8R.V75=UX\O>H,O%CH*-FKM2J*5Y%A;EM-;[$4$=#+G$$I(VAT8V]<NY@?=
M]T*+AO?1E]?L6^6&+%M#OJKYW[DV"JBI3K_A[(^\6"8\K1H1D,UV?EWY^W3Q
M8?K+>6943J.(QI#'$D&$4D E6< I1$#4Q:B0H[]9KGQ?NL7@^)\,^1\+1QHV
M/MYMR6]*R9<MG&D-T<8:!5(EUE:(R8##@B"=CC[$:#Q+_?+\.J ?Q.U;BWTU
M6=YBX$ 63"HK!: 5"92. = @!Z.*<))EKM.@LVT.:2S$OHV) 52ZMA'S,"D^
MY[,E;_ZTO_R>#9_79W+/-DL^G,P>@[;V8&6 C$[9\P'#7DH02I4LA6#&M1Y.
M?TR9/4FC=0DC>%-[9&OFP24?(=+9(0+S+OCF#8R>8&9/%Y;VE]G31=F'DMES
M?9PX8TEP8P5(B9I.KT+^IJ!SS#%AI>.^(+:^U;\&X/'G]G3BP+25+OJZT-A*
M$/=,#M]D33VE"/6QGOTD&NU DZ[1JZ%T_%CX*XJ2AF4!/&D/RJ. 0)8W%.V%
MX[8$G0;O1W@PO'T@=^K :=M%M3W0]<9TTU7F$(LI,B9<O>&K=HV-$)Q6P(-S
MA2>N#+.-^78GD -TQ7O7\;2U@GI(L;F6CY@S=XG3<@2KU<0J<? ^UI>+ZQ"T
MT@9;1W:.*R][%]MM:TWT<#%_@_6;H'DJ>=F=-'-_SNXV8AV@62;F7 +!R#$M
M6WN33ZQC!B&EM*6&JK%U;MP!V!9]Z;B+-'OOGUC_[=CL+3$O/,L,6.!TX.D@
MP&=&IA9RS[,6A=\<9+]I6\7N8/:>W]U)F?=V6^Q9$ST8"L_2?Y[-%\LS\,/T
MLAE5G<CU:G(UG?A6IMJ[?#[L(;_/LR_CF,_O)-[E./UXKK_S5B8I.YFL0RC2
M!'KI?)WC56OH8\@,2Y*R>05HWVLZ0*.WWTCH09&DAY?@^Q7:.<B[I?V]?<]2
ML"0(6O35WS^?SA>_3Q?_)R]6RZN]KGS"0*OAY,T*3EN+SN <CY!*-,&*2+]J
MW0&JM\4\.=H?!BUZ, U[6]CYZ[T<0/W]#>>CXFPQR5E(IG90L>1=(ZOC@:61
M"KWE0;1.VQUVA3_>C,,AT%JW>< \AHN&;_UF+ZQ[2N\Y"QLM[W R%9+E2FFA
M )VI^5C$<2^S!(E)DD.HO%$'TW;T]>%E*I3(1#*ZSG"O[3H-TEF%)#[M8K:B
M9.]"Z[&B3S%3H0M+^\M4Z*+L0\E46+4<7(9X9%+%^>! .CK9%-<,0N$)I&4E
M%)V1V=;W(E<>__@CW9WT/VVCAQX,W!6457QG$S ]Q;FO =E/F'MKM=RMWAUD
MVKNBC70Q:5N[YA2R$V.D/91Y!.,51R$T6;2M)ZX/H. '0MS]Z+>+*(=+TEAN
M5+27T7[W9I)7$52C0G1,!Y"\CC@.EL[01"N/BI7"7>9H!VHP?!>\X7W#'12Y
M63[%SEH8KJ?$%:@?_IRNH&8TJA2M:.], 50. 0(:.NE"+ IU%"XTKW38'-YQ
M$V8[+?2PPUS/.C*,Z\ $@V2QSMH(9 %EKP$UL]YZ5U)F/_);^[(<M]?%/KH7
M;)-@M,F:?N2W=LIO[423(1(%M]'Q8\EOM0ZML8%#L)Q.=\4,;=:*UN:2%(*.
MBS3\O.V#X6VG_-:#HVT7U?9Y%W4965X9"#J;(I@*0&Y,;9<N5;T/1M"9>6ZM
M#B6UCN6L!7. -SR]ZWK=G<].BCJD=G)W#2S!:%.T]7TTSH,J& !#S<D)/"+'
MH-$UCW8WQ'^ /.TY]+TOY?=%Y%LI-!MT!+NZEG=UMM1\U0D,/^:13_1_$CWD
MFM%>FR*18<XT&*.<*LE%%+T<W:T7\C2IO5<Z[,,Z?6".R;+=R_S5Y/R5_=ML
M.I^/M#7::V% ..% .1; EVA!.DPQ1(O>MS84>EC&T^3W'JFPYTR1*W5#RSX>
MS9-$UCV@S_R0C19U.*DA0D14+'M GAFH:#-X8QCDHK+&.KA.'LPHK->'EQKB
MT"G& P,A':NYZP$<-Q8P1VFCJ*YL\QX@3S UI M+^TL-Z:+L0TD-N1YZ45Q'
ME$CVO+'D_4;GP+O$ZX(""9(%Y*VG*1U9D+\3!^X-\G?1Q6,)DFZRIA]!_DY!
M_DXT&2):NHV.'PM_K?>%S/8,J NYAEF3:ZA5G1)A46IO"YK!_:B#X6VG(/_!
MT;:+:@=K8F&L-$97N\;5,20N2 C%:>#&6!6%<-:TCK4><Q.+3CK>J(E%%P7U
M$ ^] >KOI)7YN_=_7X%SP:7(T(!FLM2+-$-F"+UH66CG>10^F];.Q[V ?K"H
MH<(.*?+X\K_.QHMOKR:TMK.E5-\L/N79AT\XN2B$N2AT>C<].?EU.JO_T8BV
M>!2FI%I>1>\.I]T?F2:G36:RH@NMM3D]AUWA ?*]9U?Z< ET2+>JFZ]V-8@\
M,"F)RA&TJ--JO/(0.,M05%$<D46N#F9&=-?%/:*79 "6#O]";4&Q1W7T7+\#
M&6D7:Y=Y#B74)$S$",XDA!@L:K+96"@'<Q/6<6T_WJ2]O$D[$.R0)HL]N,Y_
M+/7Q?9U6&(L!)1FGY/0H,E"!%NS!6B.2)(N5R=;YX$.M[<>+M)<7:0>"'=+4
ML@?725HH>7QUJ5JR8M!$\,EP4,*6FAYH 94N1DM-.\KC.91N+>_'Z[27UVDW
MFC6<BS:\,9M\=54E@G8UW39F4^-S%ES6*DA4+N#!3,'<S5\Z2"W\,]>4NIR>
M?<DS_'@^?^P%+G(=5[;L9G;UY4&K;4@R .>*' ^1$]'3(J!62?#LE!:/T+?M
M(H)'M#\^FC!1;Q1\5+[OYN(829E8X,*3QY+J0.1$FI4Z@? 8B@[2!_\(@[$/
MKOL1O7N'0/X#?)$[,?=1O;W7 PL/"\+**#5*VHB=SJ 4S^"*0/!DWFGKHR2[
MY]&\PAT7_^,]/LSWN$\./^+HV<."X"QYS8R!8"()(JI$7R4)43/4K$2MS$ =
M.(9?_(^7^3!?YCXY_!@C>&>S/']8"E%G9W@)('APH'PMG@RN0/2&*>U#],V+
MM ]CY3]>X\-\C7MC[^.,&3XL@\Q$+)X;*(G7<")+X.H(C&*45\AH&\/6+>H/
M8=T[C6#I;P'/<1+SR<F5N+8,RA>K/.A8DS!35J0?4]\U4=!:4[LL/%0@.#3H
M1[0Y[A;T.V@V-'0A>E[GA2/U\FO\5#^,-F:ODBP2Q'(DCPF"M((.A&-)%\F*
M37K/I+^)^0?G#X +:PWMP6NZ:P)T?P, 'GK00#7>#R_R<&J]D_5*U :%Q)TZ
M_8U+<$(9$-YYP6-4O'VQ\LZH#Z?6NZ3LHBT&M%'53!0.@B=3V7(1N8X!C6]>
M*O\$:[V[L+3',0 =E'V8M=Y2:D'' YT2F050060(FLRF*#$GQ4,HJ;57<V2U
MWITX<&^M=Q==/)9:V4W6]*/6NU.M=R>:#%$TNXV.'PU_12XEQP@Y)0E*,(0@
M$<'GDD+@JE@S>.>;@^%MIUKOPZ-M!]4.5^O-N=?!D5T3B@+EL("+,@*37N3@
MBT[-S<=CKO7NI./-:KT[*&CP6F\1I> >+3A6YW674F_=,(&.)D2%6KG0.OGC
M*=1Z-V31#@I[5&E+UV^)ES,M+Z]2M,B2U<D[N1@/RI+)C+PX>H><RBE[+LK!
M- _>::4'R/^>7>O#)]3:37F8T"?A+]/9:;VPN&MKZ"\4VO7!?89&=Q+"X81*
MI9?2.T&'/Y-U/#7W9 L8#8)CD<D[%T7K1GG'%"I5$J/D@?R 2.^JBKD.LB^%
MOM)6E^1IOVD^D.P)ADJ[L+2_4&D791]FJ-3$H"/+!-YX<F"3(%O-EAKHRTDJ
MC)A]ZQJE(PN5=N+ _;.O.NCBL82:-EG3CU!IM]E776@RR.RK+73\6/@;BW5"
M"P$\B1K@RX&\9">!?NQ#"@D#'[S>]F!XVVWVU:'1MHMJ&])UF4%SQ5>X]!!6
MX1.EZRT;)H@L&E"N3N-TV@(R%9PBQX_IS=*?[GG( ?KPO:MPVH/\&P9#Y[/%
MZ%T5QO)MT5K7]E0<I"2K5BFN(12K0 FOO76%^[11-(D^]<J>0]]=[C?7'O@T
M[;#M9=XPO?([B(N):AO Z&(R;4*!]KO"P];-#L*_J;X=)-=P9[\)QT;TNB94
M(CKR45FD/402+76Q:#E&$?)&D91]*W#-,=]>?UT$UEAOOY&D3L].5T!8+L8Y
M7P"MIB,@< &A-D!6*43C1&)!I ::N_;0X8[DG<0^;2&SQL?F;_CU"A"ABQ:J
MT/GM>*G73PX"Q@P^V( :/>-YH_K2AY1W]:&/4'E;RZRU+;P\U,,]!W]8,^KN
MQ;A&V</9*OA^,>2.K+;@65" .=ESB7@E%3@>I3>>.(IJ(_NY,; #M+G[B;/N
M7:N/JB/R_7> CD3N/ .[/$N1T7M>O :76$E&9GIG#V9&V=.[5-[I$N+P";5V
MHS^(2^6A[Y(/X KYP&^.,Y,RV3K3GC-Z';0*M3Q1 XJD2F26H7.'LED=X,VQ
M+<YS2R<<1QU!62_ ">00C?*6\X+!_+@Y'I:E_=T<=U'V8=X<EVAC2"K225)J
MA[+HP)'O#X$D6**,3I36;_N1W1QWXL"]-\===/%8;MXV6=./F^-.-\>=:#+$
M%=PV.GXL_!4I.\>\@X*^OMV1C&QN/6@E,3M+?FO>*(9XE+SM='-\<+3MHMHA
M;XZ+-JDHLF484V3:^$!6C:P3>B7SF(/5/FW6+>;X;XX[J7#3F^,N\F\8HQJ\
M#XU7)<<@.3AE&2A3& 03$F3ME8K1L8QA(YX-"/H >=N/KW+0;'A4D=D[)V*H
MD(+//$!M#P<JTCGD0RKU6"JY1#+IAY^3_&.TXTY._>$2Z%%5Q]T<55)LXBIS
MA*QJCU1E,P2F!?"0LK*N:(&/IR#NJ8UV[,32O8UV[$*Q1_4NW9R\%T3)VG!R
M>6JM;H@*0FVYFA77+&M6QR<_FE?IB8UV/,PW:0>"/>+F]*-B$$T,#*Q(CE3@
M7!UJSVB=7FN36<KB\?2[?6*C'0_S1=J!8(^Q,?R5I4:V/&!) 3XCV=RY@,\V
M@%$Z>"F$POQXWJ6G-]KQ,%^GW6CV.-NTKXQ9[WFJ;:-H>4;5:4^!OD()Q13I
MZ%?T^\=CY!WY:$=/A#2A<$B,UWFCC@/R%(%Q8WAA2DOS>/:^IS/:\<##1+U1
M\%&9[!W&5P2=Z' @KY_1:FNE 8+3D4'D,@FNF+3-&[T>PKH?T;MW".0_P!>Y
M$W,?<>3J84$XJZ4K40/7SH-B-D(0UD! *YPS]9KV\5@]/T8['L5[W">'']51
MW'4LGB97TG.?(=$F1NHT%GRLHVL=D]EY'K-]/%<^/T8['L7+W">''V,$;[/A
M>)R'P'1$B,73EB9* -0\@RD>D\N,,7$PM1P_1CL^@=>X-_8^SICA!C(0JGBC
M,NA0JPLP27".!U &C16*(U./YPWNZANWKE!\-:$O\P?\FILTL[WOX]K4%VX,
MN%'YX)O/N3YD\O'U=#Y_3D_\5LZWD_EE](U%R8TD3S?'VJJ 5T;&Y" [DW/$
M:'SSSK(;P-KU95__B/,J'QYTB<XJL,:1%5'?R,"] 9N289&+(%/K]_ !2$,5
MZ[7FQ,W#IJ7D#Z7&[OM[^^QL\6DZHUWQO+L.G5C)*0%&8B)3M#APVD4040O,
M+BC:6AJ3Z&XD^ZJZ:ZKK:7.9]Q"BNXUJ5;JP":Z>"N/68=I/<5L+O3U(A1V$
M/B0IO DL8A+ I;2@@K80$F.0T I+CBQ:;'W*#$N&!RK&AN1"%UGW$;M?D+W[
M;))>TU^>_/O9;#Q/XU@%?-&_4C 44DB(4M0U6PTA*P5%JCHH6@2OF[>LO1_2
M\#YU&]W==&X;"KZ'0ACRD,DYFCR?GDT6LV\7[<&DL>3Y6C",EJH,G;:88@3+
M<BF:>9<-;TR&NW <"0-V%G'K:M"_3V8Y3C].QO^=$ZWU[72^%"LM?I;)R7Z7
MYW0>D=7T*\EG!7XIDC1>S$=!%EE48K615FUT2U9XH#608$1VB,8D?N/V?$T9
MWRXHAF=&7V[)L KI80-9+YB142&DPB1DKARHVH*-P-:F@X5>F) +#\.Y[L=#
MF<:2[\'8>%EGQ-7@T??]]!T=@N^(XY,X/ADO WQWA_U>?HUY3M[9UU_RA%2T
M>'9:=\U1*)F@&P0;M0=%V@.'(4 JAI<<DBK-&^JW7L/Q\6^O6EY[(]XZB/NZ
M[L!-XK=K/JE-Z'83F(VBMJ])=SDO'_@BS^-L_'F%^()3)IB8,4(2HAY( @%K
M;9"TBJPE:9)N7B[S *1=][.[/_X\AL1D+%P[!SJS6"=B\EK(3G:=*\S9:*(K
MK4N[[X$S5)2V)0=N[BNMI+WOZ.SU5N=",329Y,"%S*!B$>"T26"L*J8(KP1N
M=(0=^FR&9MJ[<]I"%RGVV*1_$QC'-VVAD_#7=.O?1G(]*I(IET7D":+R9/^H
MJ,'7]K8JZZQD,#[K9A-3]CYMH87^N@BLUVD+4G-?7/9@@J^MO6VM1,L!M!>A
MED%9N]D-Z>.8MM!)[&NG+7216:_3%KAP-K%L@5LGR3S("#Z9:N[3H4#'@(MZ
M(Q/Q<4Q;V%IY6\NL!Y_^_%R_]"GK ?\AST[?E.=D-LTP+D:I2"%9(C/!+1MK
MT/'NI-4@L]3!HI4LMO;2'T8UO-_=OVW<3 N]Q@,KMAN95^]RE>!5X'QD8\"*
MF-A<ZN"7F,"7($%J3Z^+T?2[UAVLNV(\+@[UJJ$>=IY[\;X8SV,-'M70TVKP
MQTC4&5+2UEK-X.@?#. *.D@\6,^4D-:%(1EU!\8GQ*A=-318I._]N;O_:K)L
MU;F,7JZZ=D_+ZG?O\I<\.<LX22^_UFCF+N' 71[7:)Q$JP6WFB9Q\<S/TUEE
MTQ5@5WAJH\*B(X18C:DH+:!7]>:<\^6UA\76=].;X&HX$6+]TW[YMOKE>3C%
M)1N3%QZ$J<TXE-/T%@D!@LQ-;VUPEK'6HN@.<[ I#ZW9<\\<AUY4M.]XY;6,
ME67B_=F<!#>?KU8T/P\B""Y9G?*&R_D#3$AP@?9OZ92WJ+B49:-!>5T3A=8!
M.H")#OVPX:X\HB9:Z2.[[!S+19OL#<#T-83A*I#]))@V5-1-"NPLY=Y57W10
MW.0$7'ER/CWMKZ'V2I?):,L1E9+X^%3^0!KI4!KO(MS6.6/GNUO=Q5:85E$I
MQW2.NC!POEKR/FOPFB FI71).2N5-IN;N>8!>ZBLW%[FT\8"ZR$\LS+H:R;9
M1<3HG^/%I^=G\\7T-,]>?HTG9XD.L6?D+=+_:CK:*'!MM;$%DJG)CS)JP.02
MF("B$+N%4*WG26X!<V],Z<_B[%M9/?#K^72^>%/^-IVF^;-)>I]G7\8QS]]/
M3](HIB*R$82'U^D9Q3C +!-X$8776-#;UF&9]6B.D"V-1-_ZY"#FUO15G"R>
M3T]/Q_-ZI-)"O4)6>((L<KV+9 AH)0=6+-)/# _";'1NW/GQ1Z3=1C)LV$'F
M!J)7DQK2&W_)\[<DE>FR\IKX]^X\H_D\W6\9.AIE13:/DW6^341B(>=T]"D/
MQDN?<G3D I6..M_XX<?+B'[DWT.3DM<8IK,ELA.RER\"BB.5BZ^$!95JYPBG
M#;C:F%]GD^@@\YFEUE&LNY$<$44:BGRP3A<CGH+DS@8(M'710KF@A2('GGV2
M)7,TS2\"[T9RA$1H(/+;1- [G2 OOU07^8*2/.J4D&4(LJ:F%"5HF=9!B9%Q
M95 $LYD]<.UCCTB3.\KLMO;,KJ_QB_QYEN-YGC]]?9*7DIVD9Z=UZ?]]SC M
M5&$Q"##<T7XC5<TY<W5Z;3;.:^=%:IT3L@FN(R)&;^JX31F[F\DXRVF\>%Y'
M+$[2+SCY@Z1 )DLM!:FU;3G/1\8'I1C3P#BYK$HD#02)D\&"B?F,7,O-HDD/
M/^N(&-"'=&\KWS6*%']?_[)=4UWUJOQ'.)N981(<>@?*I#H2,#LP0F1G>'1%
M-K]9NA_2$7&D#R7<YHC?O55%[=AUGI50B\I>319Y1C^AC<NQY8!(46P=/.$R
M>$EKSEQ;5C29L+KUQ<(Z+$?(BB9BOR-PM',X\0+(RN3Y?3J97N0:C8+-)B>;
M0-M "P[)0$V%A1"P)(]6:=[:<;P'SE&RHHWP[R!&NYXV*W"K2M)1EL8; @?>
MU1B'L@BH50&/Y/!&+;)5K0>HKX%RE(387>AWD&'G7M:_Y]6^52N=1YXYD21&
M8$49HB8Z\(K,')&$C1&#2*&URW$-P!$J?GL!WZ%N.7SZYNOIY./K\9><ZDW9
M8MY3UN::I_2?K+G)\AKE:*ZN).?U3O(E?>1L@B<7]Y'S99NC:U NZ<=3(1E:
M#=8943MDD]^AB4/6$RA4MI38NAGAMEC;Y7)V1'">):88%]Q8 \+%2"\J,G!.
M6-!1HT415+[I!#=,Z]P&\5 9GH-P;WW69^_*W'<":*TY^Y[+]+<\_3C#SY_&
M$4^6>4S%*9D1!5@;):A"9E_P&*#F,$7#761QH\3K!VKVU@+8?Z)G_P28ME9$
MXQ+<U2%T%=)%GM0&H!I6Q*\%,GQ]?"-%3?N2\F 4D(FAM=E!5,6!L@+)U!0*
M0G:H0[0JY(U"-(>E^GLJZX?4?!?A-M1X/&]:./K[^Y&0+ :G:?LR0M2!  *"
MX7YYY<2UUY[I^]*WYCG^]>/TR\^K3SS7\.J;2P5?/F_8<NU&@I_N)+4>TO%^
MGT[^/E]EGB)G/@KK(=8!TTK8!$%J"\X*(:)EFFC9VB^^?/QCUN>NTNSAA?SW
MMZ/@;>$V6XC.("CT$GS."5 55H.T1O'[#+)N+^2_OQT^K+&UN*<[R:IU N3R
MBF75MG.UFA"LU^2"@-%UX+O2=:2L<)6$7@811)$WG.$U]YRW/_OQJ:F%D'H8
MD$?+BF>S69TVLS3G1QA+Y$Y[$$(Q4$P*\'7>=K*&$Z'02MDZM'P3P_#*W8O/
MO9/HUYZB_0<<6W2)W.!3^PHH#M(]<J-8M1 ZJT!6LX@Z@<IU&ZGO?_3D1$=M
MT,BG4N1M1,B1RSJ0;#FC)-*AA?2M<"XS,BP#TZUWG<=>Y-V%/2V*O+NHZ!!B
M?&]GTW06%V]FJQJ1I<MJ:%<U7F$]8VOS71/!E9Q!%*-2*+S$TJ(_Y5W/WG]D
MKR==3QO*O'$89X7G:J70RD':!%3#2-Y:(,-'\G;7T6V%-Q+P8-K7T>40,4 N
MF1RE1-MFX.@ A0E6<JGB9KV3#DOK]P3Q!E)Z%[FV=D )U0(G) [ZYP.=+>_C
M.$]B7H&MY^;*X](ABX1U@'&I9K;R!I!+!HG3MA>]3S&%A^S73D\<-BC42#O3
MOD7;2UGNLDILMCS2WHWG?_SR[1<"^ND49W^<,UX[P56,$(VJ;;GT,C$\ ;EQ
MF2G.D9?63=L?PG3L9D$ONNDA$'(;WP6ZBP-M WP]]7MY"-M^6L"TU>B#=&F@
MCAX:PSR(4V0;BY4%;$BTZ=91VRA<!.M*XD*@E-@ZWW\_='F@?<Q^V=)%"WVT
M#\*3/%\%&7_/%TU2H@B\T,D+6'//E24CS+G@@?O$3& )>6S=*N).(,/'6]OJ
MZV9P8V=A#V.:?*#_=,G\;'(QV2L@HHM:J$S':A*I!G\5+XC%B=95'_? ><(&
MR58:Z:&'P"UH%=CJS=@$VE!FR"6L@[% ME/A0]384?Y#V!U7(!JN,Y/<$\1"
M$(OWX MGP")WK";J"=/[?M(W-;I;&[TSHXO8>V#$RAN_A?!B)$T)D1E62YD4
MH=.F@(_,0DI)6A:"4[*UZWL_H@.P.K95WK0WR3>T/):1F]_/*H0WY4JH9CYB
M2*:0D@%$<G4^![T*Z+%VS)*,9YDPW1Q\O"8 =M>G'VA=T#:W96TD.(0QN>HX
MCQ\S'Y&6<G"U"QH3JSDL+DD#G*DH40D>1.O"L/OP'!$?FHN_=0C\@JN7"8$7
M/5I'):,0RBJH05A:+[G8P1+*Y 6Y4IHGIEBG=_[V,XY(TRVEV4?2U@K9]XD4
ME\"P-L1Q""F6 @IEAH!60]0,HS2Z:-$ZI60MF"/B0UO!K_48ARL6_5[F\V(\
MQX\?9_GCRKW^#6=_Y$4OI:,;/K/O0M)MECYD5E@4='[H7*!((T&)H"!X[@"E
MRT9)GK(VC5_A0\T*R[;(Z+(%R6I#UUS[26N2AW,EI6CI1$VM6S(_]JRP+NQI
MD176146'D!5V3S638=Y62UXO6TIK'@$1'83$>2I6T?HV2D%\O)6?/6E]LW+/
M#M(?KMQS U!/KMRSBZ(V*_?<0LK#48"33>B0_'LG:B%5+6ICJB;.9*%KA895
M&[4I."S5;U?NV5[S'83;3[FG9UXBE^2H<^-I3<( :E%OGF-BY-*9=+-$Z2C*
M/3L)_G:Y9Q>I]5SN67B@,P=KXP%RQU5QQ,=:.(.JQ,**MN1^M79X#Z_<<QM]
M[BK-?LH]G;:R1.7 DRL.*D0&]'<"F%9*LY*3NG=F]N,J]^PD[MOEGEUD-4"Y
MIXKD7T@3(#E-K@=/"0(:!5&B+D+5\5";72L<6KGG-FIJ(:0>(H?;S-HQ)>CD
M; '.:R.UA.)\M(+1WOED/!>Q]<WA\0Q&VL4?[UM9>ZPAO>SJ]AO^YW1VD;->
MY=97W[KU#^J_==V&BQPRS*B#<(+5]HA%(2@9"@3G/%CF2DR>A8+VB809C5+<
M"CHX2S6<EMU+'**M][K::VX8_>]'F'%K]C0I/NV@HD,(,]Y9;Y6M#D$; 5'9
M:J5C(?$Q"<8XADQJS\U&HU^.O?BTBZX?*C[M(O/!R@\W ?6$BD\[Z6BC.L1M
M!#R8]E,TT5CEP7L;0#$5P5GR")3PM5N6XFZSBI##TGK7XM/V2N\BU]Z*3U=N
MGA%&$  +:=E\.FH$%(+,?B9-\<D[8S8; GCC@P^EE+23K.\L)=U"4*V3(U^3
M&?^/<S/^2E7K^S_&D^<X(P_G8V7W"B?WD?N\[*!&SI5RCH-SF,B--Y99'<F?
MVTRA'1[ZZ)7=EX!;O[WWUC2GC*$8Q2#FQ*NI*ZH'GX$K$6W4P:3D-]+\8R@1
MWUK5S438,.BU!/;L/_[_[JYFM6$8!M_W+@;_)8XO@^V60RE[@N%?6@@=+&S0
MMY^T;.M2)VN:>(/L$D(.DBS)D>POSE=O4XL4\@%Z)'N!4@,65;B2,9IP%X2@
MBCKE^:2@#HI??327.RWCJ:BN;NR.;?V0VF15J"238 D4$"0"MT@Y#Z\-7? @
M(R\,FS8[1Q2L/I0Y')<&<S8[:F=3Z'J U"HA+:-",L*9A:X0P0W+N2:VC%1J
M)0HQM6\:4['^@&9Q7AK2V3RG9\=@3D-]AS\^2X"5T52N)#!&I&1D@F@.RWLN
M%64,NCVNJ\Q[;#_9L^8LR.[O-!<6LZ;.@2ZX@0$;S4AD,6"-P;^JEI#-2DH3
M*QLIS[T-^W]PIB4;LK\=K-PX4P_I#\YW^$L-+\77O7\Q3;L]-,?+\-'@AP,H
MKDL<YT_Y<B[[*L1HAKD+@2!0\GC7--]4;'HY=O7X1P4NZ0(V>[<SH;D/^X-_
M>H[QZX?(SEIC%6A'*A$/2:4%W!D:)3.P5(BNF-0"#,O_N_E[*0J]JI[!&:,K
MIY%I]O$8+]:TX?;F#5!+ P04    " #!@"1;.+(GV3,A 0#3>@L %0   &QF
M=FXM,C R-3 V,S!?;&%B+GAM;-2]>W/<.)(O^O]^"MZ>B#GN"&&:#_ UL[LG
M9-GN];FVI6.K>\\>QXT*/"5.ET@M2<G6?/H+\%'%4E61  JD/!'=EE1%(C-_
M9": 1#[^]7]^OUL[CZRLLB+_MY^\O[@_.2PG!<WRFW_[Z;?K=R#YZ7_^^[_\
MR[_^/P#\G]>?/SAO"O)PQ_+:N2@9JAEUOF7UK5/?,N<_B_*/[!$Y5VM4\Z*\
M ^#?F]LNBONG,KNYK1W?]</^LO[;\J^12V+N<1_0T*< $M<#.$U]@!!/,/,2
MUV/T[.:OB<=P&HG+8H9< )F+04H1 5$8(A(1/_8Y:P9=9_D??Y7_8%0Q1XB7
M5\V?__;3;5W?__677[Y]^_:7[[A<_Z4H;W[Q73?XI;_ZI^[R[WO7?PN:J[TT
M37]IOMU<6F6'+A3#>K_\GX\?OI!;=H= EE<URHDD4&5_K9H//Q0$U0WJDWPY
M1Z^0?X'^,B _ IX/ N\OWROZT[__B^.T<)3%FGUFW)$_?_O\_BC)]!=YQ2\Y
MNY'/]HJ564&_U*BL/R#,UH+[9K3ZZ9[]VT]5=G>_9OUGMR7CAX==E^7.J)++
M5'+I19++/QTC]LL)[%OBM][GU0)SC;B?;/$XANDG:^Q>"PO!YF=X0.9DEML7
MZFU.EWIW-Z1.9GU^CFV]%D6-U@N\%ELR Y;7\H,/XK>.C!QHQ)@V=#K3/6"5
M?:]93EEK+7>&=C+Z;S^)WU9K_IBOWG+.2)T]LO=B>KQCU^C[9\':9T:*G&3K
MK#'E%P]E*>;&_V*H_"(O+G(O\N\^9'=9W7POWA,BOE]!-PH\UXL 9:Z8\B+*
M 4H3"FB0D)!Y&"8Q7=4;75BQ'/SVI6>[X6T>QG[20+(^8A%*5A4/)6GG4L&L
M7$>T_/_[G_^4^)[_-X>TW#A/@AVG:OEQ!$.O[GYVUAN>_O67K;@+/IOU#XOX
M6@OL#9-.RZ4CV'0DG\XNHV=.QZHC>76^[#Z.+<-G3L?R"ST7VBT\FP]_R.>S
MP^$/_)P*LL/;6JY#B_(YF 69#<QV/I"C [DE$,;0;:R]=7J_[+V?YV4O/"K)
MQ$/MKOA%4F;W-=C1/UX6=_.B5!?SOM+MTQ="_N04)66EV/T= &RCT \5N$'H
M?G51W-T5^9>Z('^\R1XS*B;/2HS\Y1:5[ )5MU<HHZL4(<)B$@$8\ ! UR4
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M $J# ! _%O"%/L<,Z:SN->G//"UON0'KPWYLYZMD0W&G;0JRVH)_1NCT+-(
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M9<X<3,&P9%VTR2]J<$S!>6Z#C,<QC4ENUUAO6/OS?=Y1KZ[0D_1]K.+$<Y,
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MOHM("&CL"TN%4@_@($$ QR1Q*0T)BK7J-Z@2GCW0JV%#S^0H@Z9F:>: 0L_
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MS+C561IO/9.T@5IRYO2LR?E]Z#9R&O9&RZ(NB+=&Y.."N)O%0,Z/OUZ$I"7
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M(H_'P*5I2%F24+%_T&KQ,TYOYLU#0[U1@X:^,V1 M\K,.&Z*CAA[:&AZ5$:
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M3B7!%1M(/+_+3,$OUDA646L2,#YL^A2E20AYY!(04T\>S'@8(!@RP*($)W&
MD4="';T^2&5F=6YH;I*"U+H7:4"DIL\G"ZZGQB8R:ZOOJ$R6M/8PC465=53,
MYSHZ?K%^I:DWW6;D7581M&Y=XN_$9]7*\Q**PQ0!',9"-:GG I32!% NU-1G
MD8L\KEIPZBB5F56SI^NTA+MC+:<AK5Y_ZCA&X[II37(]W3026JLJU:101L6I
MCH^Z6(VJ2<&&I:JF+S[%^R3^N2X?V!>2,<'V5>NYD1K?;;SBD(24QAC$">-B
MZPDY0!PE,KLP%G-JZL'$P"TU074I?U63HC]@Q.DX<3X8>JZFT-1Q:5G$R-37
M-0;/28ZP*9Q,/&06\3K5=78:;H9^-47YU1QN4X.]@"=.4;[#+CK5FPU,Z8>,
ML]^1>%ENV(#$ES^R_ *5[#.[R<2KU+W7D'MNF 08N$Q&B6%Y.,D""J*8,N(E
MF"9(J:J#+N&Y/0U;3DX[ M#!4L&6SH20GCD=,+%C%"0;CN3#Z1@QL:@Z@&D8
MU9F ,[.K%@'4,ZT&*(Q:5YWQEC.P!E+NV%B3^\U\.Y\98=FCS#ZHKHIU1IZV
MO>3B*&(>DT5R(E<L4WGB@Q0A#\2Q[XEE*DEA$NA%?1PG-GM0QZ82Y98'/0_/
M"%!J;AX[PNO9R2U-YVM+=)Z^>M.R6?+YC!!:U/$S+?!S[X_"'2>DQ++ZMJ#;
M-U(W)W;W]IE7-KM9H@UI@US89Q*/ZZ E8?64[X"<SE>KZJ<@UFFYL,_&7#X9
M]K!0![-ACUQJ-BV^>RCSK)95,W+Z+OLN?ZNZ)5_@14G(2 Q"EHII,4@P0#'D
M( XI\GTLYDKDZYQ['"<ULQYN"#=[:]Z1UIL51W!2FQ7M2*^GF+N"]U1GB#B8
M%L[2M#A":-%I<5K@Y].BPAUF&MS:!7'O^?>L6K&$QPF-(? CF>[*" *8AS[P
MB8]9XJ$TP:F.TNZ,OLQ\*2YSODIRFD>3NT"H::6Q>$8SI()DVJIW4 )+VK8[
M]J(*=E"LYSIU^")#-6I*%*^\('(]WPT!CXD+8!Q"D*0H!53H3> F8JL8<IW.
M8^VP6HJCWR3L^O+Z_(-S_N7+V^LOFCK32JVH+-JR:&K)>)5H?=78X=>63K2#
M+JL,.X+L:<'NMX81I.26T0=9NOA3D3^RJF;TL_BWS&1AM>8D_S<Q?57GI,X>
M^S(.VTV)%\9A0H6:1$&  )1NE-1%"0@PPC"B,4=Z(3(G<3/S+-5UAI>!)1OF
MG"UW7;1)PY]FX.I)CT!-A1<#5D_S>[940'5ZYKJ"+O,X>JP 92O>]B1>EHW-
MM0';7AROE4%MEH%H4W7%2OZ]0"479)DL]-[YNU8Q\3 ,& <H# B B<] (JUA
MY =N0&D4LTBSY(P!%[,[FAO@#Z3VVZC ,(ZOHJF;%S-- W>HO,&@<?6L3NL3
MD)BU], X!S] ]0 EB-0* *@-9>C#RX3Y8Q_$F&+T6KQ3F3" [:KP_*XHZ^P?
M#0MOOTMNV"?QBEU_8^M']K'(Z]MJE:9Q'(GM#B">+Q9O<> #["9B!\3]&,=^
M'/E<JR7-:>S,O'H3KR;4]/R=AJZB=W QS#0]B U?H&',V7+F-*PU%5G:>M9#
M)KM"MY<CP1OZ#D8K^-AR0I[&S+*.2BO [3DS[8RJ'PI^72*:Y3=?GNYPL5[%
MC+ABX^F#,/$@@*$7 <10 % *?9<@&N! R=FY-_+,1JBCY;3$U(.\=Z4?MRPG
MR:1G)!3%T0K?/LBZ4<CV[DB+A6D?%& 8FGWX@OD+UK\3CW$5I=S#7I@ /Q#Z
M I-$=NKF#,00^1$.XT#\/U>]>LG _+-\.E^Y^@9!M7E]3ESTE-2H6+UDZ65J
MU0_!>(%2]0WY'[92_1"<4PK5[XPS4YG,8]7.VLY6LI]NV81U5DTES^M;U&V5
MJM\;1\^1$FB_BO'K-ZAF[U!6_H[6#VSE\L +><P!ARP"D/@)2#TW %[(8M^-
MD.L%GM7ZF4M)-K.M;+E9H);F8F_"*?ZA'_SYFGN=CE7?G"B^V;4-'$C;U5"N
MA;S;TIS=2S16E;,1W)&2.U)TIY%]P>*<2S_.I:IV+B;7#^"0>\''J5WG<W$&
M]2;PJJQ77]B-Y.!75MR4Z/XV(VC]IKA#6;[RB0>Q[&(5!A #2 ,7X(#[P(_#
M*.%Q&+LD4IE,1ZG,/+$-"3I?6Y**(47CX(S/+]9$UK/U>M(JFU<E:<9,G1A@
M8.;$7UL3-S[V(N9&2;Q>]=4N/K6V4%%5%Z@LGWA12G-1M=U6$J%]!)$ A(BY
M +HA!6F(8A#"U/-Y[ 6AKU3I0)'>S*HYV(0*\LX.?;,^-5/XJ:T)+:*BI[TG
M 7)"S:%1,:T7'3I,[86J#HV*?KSLT/AM9LK_EG,F@Q>V94(_BQG^,Y,RB7U[
ML[*XN)4+B_?Y&\9963(J+FH=[G(1T*X]UNOBFVR-L H"DJ1^ZH,X@CZ  4M!
MBOP0!(@ASV=)#,-4+P#!,H>S!R>TO,C]R&-/W$$]=3W+8OOAJ%FB%P1<SW)M
M&!U4/'8DK\XNLV?.]IGT##?7MBP[&YZ=#=-G<C-)K%9;FPE62Y;2-G>+6M:9
MH'UNB><B<TJQ>3'^\U19&C,_\&,(:)**#10/8H 2'P,/>S0DU(T(TS3!QTC-
M;DN'E<Q-2L4?0$?-!MJ06,^8;445MJ>-R)HU,FM*0JL5V@^0>8'RZ\>%/5Q;
M?>1Z_?"!MWF=U4_GE(IWH+H0OUZ6U\6W?)42'WLXC$ ,$[F[\EV0LEBV@8 )
M(\2+B:>4ZCA"8^8=54O5Z<B*R5;^592.)*T>8' ,G^E0 PM2:ZX[3 36"D&8
M$,DH&.'8F(N%)4P(-0Q0F+K4L,9J<7=?Y(W?D^_-S^<Y'73P.\=572)2KYCO
M)SQT$<"14$K(J0L2UF2;8"^)>,H(1'J3J0$7L\^SU[?,(1N^9"I$+3ZA_5JY
M%FMEU*Z593:O<6EFDP>@-E_/#*J>?;C80?+0CD.B.&#)^=HS9;,\K#DDMHK'
M&G"P;&E9<XCV"L^>,)1!\;9/#S)]^Y*_RW*YE6A"+:H5XSZ/F1N#F% FPZE#
MD 2( 2_F,9:=6$*U#.SC)&9>2K0TI=;PEJJS;LAJ5!8[C,RX%;$CKYZ1V(K:
M$6R#HDX75:-<VLDBFQ5&TQ9=K_S9J%2CA<X.W[E<2;-1SG>*EXU?:;8\^L3J
M"U3=7I7%8T89??WT6R7/@C?^YR[);6=U!%TJL]8!(10#Z",7H#")0$BB)$8^
M\;PHTEL=Z3,QOT-7\..\6Q??JK;WVO; 9,O,7_460@90JZV#YH5/<QDD<>LY
MD;$^KR0S3I;_O _ATYGTX:X?FF#N-UE%VG9FXO)-.[-9%DGF>%E:(QDPL.@2
MR1R@YRND$T8R=9 ^BJFI*,4^\N\/5=T$O*P\!.,H# .0<I("2#$&*888^)10
M/V2("I.E<YA]B,C,BZ3/3):HE1J1R?\Z^KKNT0/8J+I&3Y-8URW:47,&Y&QZ
M08\+8\T#>H#$PM[/XT+N>SY'KC7M$-?$K7QF]S(]*[]I@LYD8X[S.UDN=!5[
MJ1>[$0,X\"F S.< )R$$ ?&P'Z+(C[&[RMD-JL662J=MW"A9I5<V;5_9/>+J
MP15-P&K5LN)DLAN);DNY<?#4=-8&%H;MYEK)-Y3/NAC>_@O)Q)G3LF&S#9V2
MO-::THU36[A%G9+H^PWKU&XSG8IW,S7E"F]=R*[;VX.YE 1I&*,8)'X* >0I
M @C!!+B)ZS$8!U& E3IV:-"<>:)^GK1<G3EB$:0[44\CISIO6\5#=QI_!H6S
M)6^Y8*N!O-9F^FF*"T_\RA#LKP/4;STE\NR2O_U.FI@)&4MQF<LM@OQ?AJH_
MHK5<?FP+[L@OSG.Z^\'@RI4?1U[B\13X7)[6$!@!S'P$_,2'#'./<ZB56SH#
MCS/;G'=%R;*;O&L629Z<5@2GD"T'JEN3^#.[CTC-6+TP\'K&K8>8.SV[;11:
MA_E9\Z^S9>5L6%ZLO4(>"#W[<.>&;7OWK4/$=FC:+&A;#4^SR^$+A*C- O'A
M,+5Y2)D>O#>5A]K7]G-6_?'Z:5,L-X$!\A*6 A8@F3L;I@![B0]0R#S*&(]"
MI)5=,$)K9M.[0]F1I,T+"H\AIF9!+>&@Z?(U@\#@;'M2.&MGV,<I+7Q6/2GR
M_IGT]"WZ_3 ^%?D5*SZQXOSQ1IYZGY/Z :W73[)VP_E=K=H78V*8N0^:BQQ<
MO;UT/HG_^RSAW33ECIVF),64?T(;HW$5M@R/G@K;14:KS8:BS$;M-J;&7JSM
MAJ*0P_8;JK>8=J?:KV?Z^<MOFSZJD'D,IP!%D *(B0<0\B- D ]3%.& $JT*
M?:/49C\X.5C4]Y6@7VE6G!@'36V&M@:%GH*/HC!#@PXE,:VUKAJCM7#W*@6Q
M]QM8J=RD/V<_MQJ_MYG_'QG:]20JSMV*P\V^WCXZ*SU6?^G.&3J>U*=N5:BF
MI_ 94-)=C:L#-$/7+$WYC:9U51J+3>^:0@^G>=U;#<)&YZL<<B'#T-;K;?&0
M%?8X1!Y% #(62%\L%VL(' *QF&!N&"&.:*(<C+H@XW-;K9Z>C-ZX;R@ZK\2O
M3=TKU67(X@]SW-K]R(](\[QZL;)5V_?@?5^YZ@=]]AH!Q3_H.V 6IOQCO@MZ
ML= O\$!&(ZR7Y&>YN.T70'DG&OPEZ)LY&W[+2T:*FSS[1Y,>\YKEC(L]SAM&
MRB:$76R 'M8R_N2=0/@+J^MUPW_UGUE]*ZZ78:(/]6U1-G&BJR"A49I&!/#(
M3=MU!L8$ 1HBEP4QC* 7&42.665RF3BS+1=Z?@R[ST/-[[$\O$9+@2&;3>Y>
MS^B9T[/J;%AM,P,&S#K?!+=.RZXSX->>7V46&"WY8>SRMJC?9A98G_MYYB%B
M6I3@[1TK;\28OY;%M_I63B$H?UK%;A2B!$8@@<@',$U<@#Q/^H!=0A#B7N(3
MO<($!^G,O-WJ<O5[TDY+V^F(ZY8G.(S4N-FS*+^> 3,4W:!0P:A@)Q0K.#SN
MP@4+1H7;+UHP?KFIBHIQ[HJ\<0HW*[GJ\J&N:I3+?*D5Y5X8>GX$4HH(@%$*
MA<["% 0RI!9!S +DZFGJ&+EE%+;EH#VA.&NW6&+OM.5"5W-' 5158%NP&.FQ
M,2(&"JTBZ EZ/3K\PNJM(NJ^EBO=97@>*XLN7_+?JC;R]A+7*,OE!JR/YWI7
ME$=Z+*P2S!-&J0OB4/I<4\( @C$$,I0*N\@/2*)W6FO.R]QGN9(S4'#P();A
M76V2HF-/>E99'XG)B[(M(B"^7F<WS<Y8,P?GE">B>!2\#,Z:!\4]Q(*M-FK?
MN1P@_':(\+/6+MO.+A;/D4_'R-8I\PF<+'L&?3ID>R?4%H9<N-U+Y\H:6.BV
M>L(JI$$2,^8#XLFV+7+)A&F*04I($& 2^EZLE2U@G<,%#M#%XO1_5++VDUQ;
M5$T\R+VX_!:UJ?H.NKDI&Z^4_B'5? ^.82^* P\"C.4T1WT*,(LQB"AT?>(E
M08SB57NV]J5&9?U/\/B><ZO\$ =4'<S$SB-O?D/KIK#*#_30XA %'DH8B .(
M /0Y%?N5B +?<Z.8QY[00:][:&]S^D_SR'I>C1X8ZY[;C_>TU-8M+XK_XB>[
MF_.Z =MG3LOX#]!-: K3E^X*=)2_?X[N/E/P6NO2,TG((/[O-K]YG[^377O.
MJTO^>U7G-V_$,NZJ+/^K?/O?]=/YMY)6XF.QD+MX+.E_E5TDJVI H.'X<R]P
M-F7?MVV_Q&919NK)3D=-K:$F48\[5\*6EVWGR>[0_KSM@+%M+W91/#)9QU%>
MI!%/: K]N 5>"G4](SL?X!8#DVU 9Q:L:$ITN>C%$V'9"6<\=2Q]7_F;+L[G
M799_J>_JMV59E!=%6;*F7-*[-;I98>92E/@1B$F0B*T#0R#Q0@3<""<T]MV$
M1TI[/C5R,]NWGH&NCF*&UH[80=3M6J9AQ]GRXWR5'"GF(2JB.>TXMXN1GC6R
M"H^6%UU=:B,ONL+PBWG1U44=>M$U[C((<_X/L6Q:RT/R-J6Y('_(HW3&NIXN
MZ(:M0NAZ./9\D'#L >BY"4!^$,M((LB#A,&0*-D!17HS&X*>@::.0+EAP>&R
M[?;]A@N- %,%",>5?P9@]+1_!Y,M=><=VW;WL8Z)1JRL76S,0EQ/Q4@O&%5=
MXM$84H5AE@O]5)=I)V)3XS;]W=[[O,K$E=<E;=J79*RZ*@ORJ:C/:7'?Q!=J
MYGLI#SBSF>OX<*Y+U/C->FZ:UU>RQ.B#/!47G#D=:^H;-774IG=FLP"F9_X,
ML)HA!TP;"*.-E3J5Q792VH(/MT[Z-YL=J9T34CXP^O;N?ET\,=:'(;:UHVIA
MFSX)0=L_5B&'!.$( B_Q.8!Q2D :1 @$//$0)2[S?:W"N1JT9[8J'2=.Q62Y
M ^TFC3H@JGG59X)&SW[TJ/1<.#T;]CS=!G):\F'K4%[4.VT R7._L\D0IE4]
MJ1@ZSVKV(7N4,0"[)0/??N\*NO]:%/1;MEZO(H;=$$((PL03FRZ,?("3E('4
MY5Y,."&>JU7K29>!F0V)G&K9'2K_:"?9HLGTRC8\@K5D4GRP*879QBWI%@35
M!%W-YLP)I>["90-8PXJS7SOTU88=I^?G^(&I0>%0,RBL51'5)+]P25$S</;K
MBQJ.8^ .^IB16\36KYG0Q:+D7.F 9>3.^=[]CIZS(3A][*$LKH9KXG2QS=P1
M>^);<CR,RS/J;#ARZW(.AG'>=YP*$Y<::,X5*WE1WLE%\;8@3?<^N3BF 0HQ
M\&,6 AC%(<"4IF)#$'I)D*:1FWC*'M010C-/V@/*PPJL@])(&JHWAI>"N;&$
M@I[-&0(P+ AE8'G&Q-<P/Y9@,+-!QG#HF20%&4?MTMC]RQDG!2EV+)3*]<:]
M78_G]Z $<\Q( B+H$0!3E((DXA%@?N@%*4DB8<&TF[A:R00R:T@VB-8]ZP(&
MG6(05F@<1SB*8@HY]86Q!\1#+H"4I "CQ 5N #%E8NN6(D\_ZM86DL8!M*^?
M!\U6,^%'XM2%@8L!1300NU^6 (12"F#H<=]W>>(2KAL :Q<][5C6MSOQJW,!
MI[:#?9GDO$-9>6=VT_)T!+37N?>%$_1TA#[0BW>NY+RF>UTE0Q2*\DWQ@&O^
ML#XG1-; K58DPB%,A&V,N;"2$&,QS6!.0>(ED0\]Y,48ZDTS8^1FGV8^,R*A
MH4*]J4,9KAWV7<:Q:OK'1R%34VU;,&A[P!L*8EM 6/:(\)J=.1<EHUGM?"BJ
MRGG;PN&\^BQ/#BIDTPFE(K(E91\EM:BRJPC]7-F5[C',.".WC#ZLV24?=O=^
MGY/BCEVC[]WC[QSLU_+]V)X1<^9C%G("W,3WY)(3@I3'"$0DXIBZD+B8ZMF"
M$[B9W53TO,G WBUW\J^6OZ9^SEL3ZW'*,U S+@OAJF=[= !U7G7,_>Q\;?AS
M9NFG90$G6QDH)W"R;*[)Z9#M9958&-+ $7C]K;B^+1XJL8CZPF2'4,;R#T5^
M<\W*N_=-EXGLD5V)5WCCN!_<<9[3ZR.7][Y$'X60>V)7!%.9B8L)P! AD+"(
MQ E*(*'JOL1Y>9W9'>F[7NQ(\HZD[VP8<"0'SO;<2USG'KU.PV4W\X-5<'K^
M.(]+ST0++IR>#6?#^=%G<C9X>#NW"A'$]<=O-''$SOQ4-7RY/\[3-7,'_SA/
M6<^_O SNHR[JF5E8SLN]#)8[CO*%2!HZ0<1 G]!=U[^-AX$+H0=HBF, >0P!
MIGX O!A2E*8$N[Y6$8WAX',?_4F]D[2,6K3MH*#HQS"43?- 3U4L?:?$ ?YM
M.2&&0R_K=#@@U)Z3X= UQA[$>U;63W)(&8TGDU_OY;S4A/H^;7>O'@DB&@<$
MQ%[J A@$+L"ISP E7LHC2GCD,VUOHA+IV=T%/2--F-R&"VVWHAJ.RBY&Z]AH
MJFW'P5FS'JAWL3EKX_>?G*_=SUFV^+H@V'- JI%=VAFI!<8!QZ3>_?J)/E>L
MT*O3L+EA[IGU[:5ZXLU6BG%5-19 4P_?7EHN-K#'M%&2RW:4Q9)8]A@?)JGL
M?VDV(;[)JK[(F-B877)YF)(_L&>^W#A-:4PX!SQEB9@-W10D+@I &KHL]+$7
MQI&2ATB+ZLQ:,G3R[O(C/^DXTIL5U<!4FQ*M0Z2GAT<1F=7+K26TI?E/C>:B
MDY\6#,]G/KV;37-/'EE5R^FT]7V_%UMDF?B^HABAR$6>K V( 8PB!C!/(Y *
M:\$3/_"2,-#+,3E,:&;;T)-QLH:J;H[($7#4%-^&R'JZOJ78G6^=.3U1FWD=
MXV)9R]\X0F;A/(UQ8??S,2:N-YS<&6=EV32YZ.O 9JSJDSK$JOAYXL?SOU?,
MA4GJ>QZ(0@0!E &<"408Q(BD!$9))'/&NL8YBE/_J3PIZ<%N2Q_-Y;.X11[W
MRBU@O4DJTUP)G(R\XBIA$33-5A =:\UA^8"YL_V4,HL+"%MXV%I<G,S/L@L/
M6_#M+4JL#6P8H-ZFW!XYJ;\H\CK+'[+\IBN>7>35.:Z$\I-Z%6"$*0E]P%RY
MI$D#!%+NQH#%09P@GR#$8LWP=6-F9O<-=JPY-?K.JK]J1A&;8ZQF[);!3<_*
M]8"-!0:=.5O>G"USSM>>/8L[J-,QLA7$;,[(LB'.)P.V%P!]^HAF1DX6_&S+
MW*[7Q3>9$S PNXT9;2N$OL_/[V2$YLI-N8<8IV(Y1ST 95F %"<)2/S$]R@1
M2Q\>ZNS6=!F8?1?7-733LV/:,*I9KSG!T;-9&TZ<#2NRJ^)@N=:P(Q=J7:?%
M5WUO/&'+6N[L62Q37"S9*6WRBUHG4W">VR3C<4XJ;;0Q@:PO@+)BC%)*O$@\
M"-G7$(E_4N(QX,+03<,H\>,@T%M-':4U^V*IF_/%6LFY1T_2OV94N^@ 2FH6
MQ8KD>J:CKTNT7>[(#5U'UGIMHN.2V:U$=(#.2]0=.B[ND2I#(S?HZ6V3L%$^
MK7[[L@HI\^,XB(";LAA F421)HD'W##R0Q)05ZBORII@.^3,L[S,8FY*!J!:
M=:8?B#NN:69"Z*G4;Y_>7[]]XWRY/K]^^^5T%=IG>>2\L[NX597NCZV6#(9:
M1!WV6>_?^P/?F!Y<M.N8?CWS/M^TR[I ]UF-UIL]:9P2)M;!&&"YVX=0K(M3
M/\" \!3!U(V]%&K.5.K$Y]_G-[-])>O\%YOF<5TC/^GW7&^=-)I>  V$5<]#
MYD!-<]JC?W_H3DCJ0F8DBA<Y6S/G$]OL_,7G%ZBZ=9J,N"9O\\EY]5O;Q^OG
M08>^<U)GCYD,-#JPNI;/8WMI)]XL?@)]5*T=T"@37OC(1A>0_4,<[1'T@X[>
M/%):79:7]6WYMLQOJBMZF6_:.7RJY>??JL]\361CA^MZ+?.4WA6E25L9"Z1F
MGOK?9%+5<EHYL@EF4_#O+2IE-8G*N4(9=<06=[>]25[4[87?LDI6'.)K1KI^
M)]>%U+6=YE2\Z5%@TG?&QF,:-X\O\(0TSW\6?CB6P\8L8FL4<&:#_F*A:A;!
M&@:YV1S6Y@GZT>#2E9>X/HU=#X0<4MG@A@'LQCX(:!3Y*7:#,( VSLN/<C#_
MZ7A'^<]_\B+W;W]&=_=_<YA9$+DNN*<<B9\&F.4#\-%@\[D/PR>1F/7H^SCU
M'^"@>Q(:M6/MZ6$,<L _HV\?A;:6&5I779^*2]Y,BS)X*!=OPM/*31%#S(/
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M%M77<4&?*^G$U:;Y]>P>9;0+>1-[G\:?UUJ!30A(Z/EQRA! "6=BEQ*$ .,
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MSJ#LZ::.H*PA5MTR*O7T>/5*%M(P" D0BQ4&8.(SD.*0RL;%&/DX3<6B1KD
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M5EV+)MIL10=1?XK(,^<\Z2]?6(VJ]CRS<E];^E[>8<;?]Y=',VK9>JY?^_S
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M- YX.D>BP0)F/ECPS\Y$\,L3F*AVF&& FW9'+?@KU.:9U1CX.]WMJ?5T@EL
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M6F-@RDI_:AGVET..O5Z9M)UF !/Z,*VT=.@_&[UR]](Z##P.. 4SQ]?\4WO
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MD92DD)3CJ* "DU@8SUX6X4APTYJ*2I*!BB6A" RLH[ZJIEXAS @2)A0-LS_
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MZLNJ#F!Q'J1"TA0K)0IM"Z<"\US?ZB/"(GW%#Z(XL,IL.+;XP*)4@T,U/-0
MM)>C SZ<%Z)+J(-)$( PD/B<HL!)=@X6&TUP3I'1E9J3SSC87[(I9V(S$D3?
M/TPK,5M4JU)M6]G8FF3G%AI87K;PD4;@I^]_05L< #;;6798F'$^.0&T['J8
M@'[WVLD'1*F;!7AV]?&,0EM"=^Q$ZY?</-L?BT()4Q"\Z1__H(_0!V7HF<Z:
M&177RT]*FH&KQL6^,G>UG8<GA5))1),4)Z'I61E$#.N3,<:1C$@1B2S*9 K+
MF?& U>"Y-"UT5*W!=Z?YE1H#F*_;QT;8>;Y'9B[0-%XCUYT/:$"B702OD*FS
M;;=@@^3^2QO?CC__N$?N>?*6^\!H5-^Y1Q;N>])]+GUA<6V;/-!F1Z=!%F0T
MP&$N4DP*:C(*<X(SIIA6CRJB,:@ZZ"B4@8VCCL>TA>J6W'R<0W:ZZV*ZG5WH
MMB2[E]8>(\EW9>T.C+<IK#U&YLFZVJ,/.TXBW-A.=T4W$_!!S<SPF)M%M:RV
MN8)M^F>UM=FEX(P2$N,BY SKN[\)CG&*TRCG<<QRGF>@]H,7XC-T*D\G%;:+
M'7#*WH4\MU,*(W(2IC[.Y!-[ODQY9H>OT7T78C/N5#\_K#L8^.=I63?%U_0?
MO.95G>@X"8@D0JD0AX$I5,Y8C+414F"1%Y'2%[8@R@GLMK8+8/"+U_77KQ\?
MO\(4T1X/[/2*.UU ATO;.G0-R:,N.$Z")]'>6WQ423U.V+[@G7C*,0EPI^2X
MSDKEA&9I$2JL.%.8J%QB*I,")TR1/"J4+%+0M(Y#$ ,?\P?5[0Z)NT?X8B=?
MEU$+DS$@H?"TN9.T^,J).P0P;L+;20(/LME./PD/+?PZE^7L]>FK$JO2%/K_
M<UD'S&^^S9_NA757G/Y5!I8Q#5QIZ*;N;HT ^H65_U3+-J/SYINQ".WC"V=X
M<CZXX(\=,"&TY(1'KYT]M4[1A3-+CQ9:L".Q&U>P?,/MI&S+3#\LGMET/A%)
MG!9QSG#!]4E)<I5AEJH(:V,S$DD24,%!%^>=U0>6W77![.\--.#)N,L'NT/1
MF3J8*%H3!CX)CQ+@Z1#<77O4\^\H6?M'W_&''/U5BB]OY]IRK9-;:[,J2CD)
M<Y%AE8:F.%T)3!75@A5D@D9%H#@'F9N'( 86)P,0;2$ZF9M'^&+I)KJ(6IAX
M 0F%^WA.TN++;7,(8%Q/S$D"#YPKIY_TVBYBZ[?[^?7 6=.D<]8]@K>X5/6<
MUD=MT]R]U-U^/RW*0DV7*_WA_*9,%8>2U]]5R9Y4W5#X ULJTW6X;CH\D6D>
M*Q$D6 6I*<$0 69,A#A+A I8SEE*)*@P]%V0-;"":5%1$OUT:?'9^^#79>TS
MWO'FNGO2=]MG=MSIID?0,8^[H?-JW<&[0RIJIE<O-;&HI?8*=>B]0FN*44MR
MT_@;&:([_<$'[P#R1MLX;'.1L8EZ#WU+WF@C+5NBO!5V/MRQZ[LF4T+Q,,)%
M$A28%(S@/ HICA6A-%&A$(E5?5 ?D+%=LDY7SZ/<<7'+#GT1!9-[H6MVD'OI
M41!OZ)[MOZ7V/NLFC*;_^5+5X\YNYTN]OU,^4TWTI>Y$/XD9T51E&8Y3$W7,
M28BY%"D.,JEB&8:*P88WG@,XL)#>:T6F#0%A(K<PP3S+*3LA]4D_3& ;R.W4
MPRWL=@"B]\D#MH1ZDN2SX$:5:EOB]R7<^CW7CD8+\<]OBYE^HVI,@DUD/:)Y
MQ A)<*1B?0#'/,$T#$)<Y%3E(8M($C!@_\23P ;/-.B"_O.?M"&1_16I&@5H
M:Z.3_+*\WGGA 4S.&SA7Z'JY+*=\M:PG&"T7^EK5Y$$.D*UPGDQOO8Y. AJY
MT=$Y@@^[')U] QYDK2<-?5C6PXGV!Q)=S\T@(JU&7$:V@1<>*9RS=X$_/>#+
MC$XT+S6SOMP&K,&Y>SZ".RACW2))'GCJ>?*9,Y.<8L%P:*.%AYT9T8T8NR]R
M@1N>GW=2\'TG1?U_[5?9]$IJTPG8DYHHFL9IK!)<!+'$A J%69H$6&8J"9,D
MS7@""J$-@N5(6K#NU&;\XRU8!_^X]_T!N+O?DNNC>Z^;=BOKG6M0W^3)].V=
MFP]Z*-[Z="E[QW%\#_%0;#[J\!T,F&O3FFLIM=!4[7\^3^<JG# A%0MRA7-5
M1)CD18%Y8=ICJU@0&NE_1U83ZGNA#*Q?V_8N+<2K]0_(P#:MXZ&];([QJ5]/
M>J,>>&5T)=RAQ4T/81<TNCFVZLCM;GH(.VQZT_>P/[&,)MH\"CC+"EQPE6.B
M3/TJ90PSGH6"9$$21?12L8S>4BP?_UA<+I;1!6()HMZC6/81[D4LHT'$,GI[
ML8P@8ADYBN7Z!']0E;X@BV_ZIO5!?5>SQ8LYHS_^,(>YFE J0J+?PR1+ TQD
M3G&>FT[RE(99( )"&'!J32^\P1VO:^BUKT!NX4/G3_;QS.ZFX8T/,)'=84 '
M,&HA^YP^:4&@M^F3?;!&GCYI0?;A]$F;EQRK-(58/:_J>M ZJ<(8ZJ7ZIE?>
M=+-HO8,J8ZP("HI)E-7M=@I,DX3B@&6D2)*8)0345MX:\L#G<P>/-C-K!Y-U
M;Y>?/B^J"IC+9\]<.ZTP",M@&N+Z[N;V9&S&^V@J,,&^2DRMX8Y;?0IEQT%A
M*GB!X=I[?5G,I9(K_9C^BEIE]HMBLTJK.6W.J'+)IG.CZ":,I$5!"X)S%H:8
M)$)?SDG.L,SS* [B6&1Y M$\7K$;6#O5\=_HK^C9P*Z/9=6%[K_9E_VVV.FL
M-V,V\+)BW0!L!]FU872%?MELT [&;]0*#,S1$9N"V>/V[MJ#@=GJTB@,#N2"
M2%=USZ;RTZ+4F)A99";$/YT_Z5\<3]:=$)*%&>$%ED0Q4U698*9,5ET:!Z&4
M!6,AF\S5DSEB'H'Q+" N5LJ -LK@ "-8$*5"@NF/:*9-Q$6)JKH[E*SCQZQ"
M+VW(9%'4/1C_V*)>JX-%;5.:N41U.0C4AG3:I32F893$,8X3XS>3*<<\#&.<
MR#A,M TOLP*4]CC8]ES8*>K?;5\ 8<8!N>T>13PZG;;=B1I+-9.HT%MA3L\.
MVNB.SZ9/_9V\W"*&CFSR&1"$HC!^O,^124?#>:YKN9U1=R^J9"8*^%GIE3<3
M,O41*=:#;<,P9_KHP30)$DS"4&$:IBE.4I4JFF9,'U8057<6XL!Z[?-B_H3U
M>\]H9A! LQ:#J0)F?)]GG9TV\LH0F.K9@$8U[)V9MEOX_C2*-:F>U,=Y>*/J
M"FOR]Q6#_8NNP<&_+V:K^9*5S;B-:B(YS:.L8#B7*L!$9#G.>21PP60:4":D
ME%;CK$]"&"<HN ':#&6QE/#3;+&- UY K%,,T)I.A]#?"5HN"/OMKSARR.\$
M08?AOE,/.DQFO-<'#IMK2?TPU3=4+;)";=L6:DD+*(DS3.-487V>)CA/&<$L
M)FDHT]!4.-J%^<["&CS$MP&.Y!;Z?P+&$?9RJE_^O%(/D\,MV1VP-L440 8
M9C'Z8H3;',:CW\%_>!J\:$-:[]#%W@7&&[AH0\?.L$6K%QSKKO6E8C&OB[^+
MC?.L]8[]K.:JF"YO%EHMSE?:#FD-DL5\^V5&)([SO,BQ8H)C0@**>:25F,G
M3F3,<R$#6*["A1@-KNJV^!D72&=*B&IP1#_Q!DOH>.P+=\+NVC$B=V&J=)>M
MG6C!QS5;6_3^<H6V&*(MBH/4L'EBEZ_"] NQ&;>&W0_K#LK=/2WK.)?V2$\?
MR(#:\5LH;4NX6"U9VYXWP+&UX&Y&GHB&J9&FLF*@QCX6%+D/MGVK)C<61!V,
MNO7>_N6^7&A17;[>Z\U<FH#<OU;3.AUK<[QQD<LL27(<1B3#)),"\ZP(, ]R
MDLL@3.,,5.IU%N+ @KF&?X5J#)H0]QH'\!7"GH]V9H)7[@#O5)<R!GS(6Q/K
MZ1@_#V_4@]J:_/VCV/Y%5__D@WJ:FJ7FRR_L64T"SF*5D!#+(%"82)Y@EK,0
MJY1)&A01302P;F$7P#C>R2U,9(!"G9-[/+'U3;I3ZN2:M"72P3-YG)(+')-[
M"X[LESQ.SJ%;\L1SKG/M1&F""A]4\]_;>9VXN TM-.UE)BG)2"Q"CF/"4WV]
MCQ+CGJ182I5E29RE19ZL\U+LSEU+R Y9*#!A;'*29YNP(*O!0F??V7'1[LSU
MR1G'^7@-8/33&H6_F)X.#:>V:+2]H7S.S ,1[FV*GAW4D>?J@5AQ.&D/]CK\
M$OQU^<_[4MR5CU7YL5I.G^O;]2]J^6TAP?/!;=8:.MW)-.!IQU68_)JO#VB+
M"FIPL;\G6S'G_*79-U]@6L"&)0,,#H<0[73)M@(PVHT;0F[W^@UZSS&!57Q3
M<C53=\5:>2S6B0B-PZWUMM5C/+??=4XIBUB08VG^CZ@DT\8YB7#,8U5D+./,
MKJCX,C2&UA<M4L:3UIR+FTSU+PI8-N#(9SMC8GCN ;7* >.Z*&VJP5JL_M(.
MYD6#C-2\C#>^<AS=D!@WR_$B1AWD.5ZVVJ69CHNJNF%E^5HLRKJ#V41?79)4
MJ0"K4"2FNS3#G*@4YW&21H0SSI6"A2Y/ QL\*JFU#]J*TTS#1Z*+@&N2XP'7
M[-2/'T[ 5$PGK=&0?V-%_@7)C*<H\Y[%> #HC=(73Q%\.F_QY!MNPJQ%8E%>
MSV4[:7?3+R'/$U.NB.,HC#&)@PSS,.,X#?.<%6$1)X%T*)XY#LW!,>%0'E/#
MKEW?;3(!4(!/<,I.>"\@W$EPM\2V$/WW1>@GR9/$G@ RJK3V$[HOJ6>>=LAX
MO)FQJKHK?F.FE&5Y5]9MQMI:S7I<]O-B7M\PK\6_5M-J:JXOC]_8\A?V3U4U
M/<D^_M"/3RMC!=SKQ>JJON^JTAM<30+."RJ#!.<\,],'XQ0S*1DF01Y)$N:R
M"'.;2\8(N X=/VSP-/:TJ#%%57UQ9UM<S2R<)7HVV#;=(2NDMOA>H9<&8S1=
MHPQ(5QQXG_L5U3O;/9BVJ_$VV]9B;IPL-3J;FF9T5Z &?]0X8SH4($,"JFEH
M^T:BC]T];>E M^]O3P%)K.]G;]W28-_+'L/R:\?A>F^&[L HC)?C.PXO=[*$
M1P)Y0<"Q%J19BTE=]=AM>?.X.!Q3M2V(K29)%->=27 F0X%)(BEFA8IQP!)2
MD#@261Q"'(R7HS1*<((U_=;KVNIF+)=[=;6'70#$,D?CK4.8L\%MHX*;6NO]
M!DP?IK-5W;RDZ2]A%/J9LFW?45$O+/09,+T,H?%CJ5X8>#3,ZF?E]S;4ML[L
MK&[G^MR8+N1$*UC.]1F-(T+-!+Z082Z+#(<DX)G,J$Q2\3[&UNXB/K!F7@^_
MN*S-Q1@;F#&:!D(4.!347)C30A^:L<(1#P*51 E+B661X7O>0B>7^;_/)EJ&
M_-[AQ@"#A*/-!6XH,ME-#4W_#D-_C^_"NQ_KNX?V_Y+!O<<W8[S1O"?@.WAL
M/ZA"E:62C^Q'DQUFNDU,YT][=R]%<LES3#(:8L(%PWE %.9"R5Q$)$VYU2 '
M:X@#'^"?=YK 6 X M&>7A?O2-Q-@FG8-O:ZP7,_Z;#&PN\\X<@;@!/3-(3=7
MWN6<@CGA(%3WNM*L%AK/(0:A:\>M!7KQO5VGV@GJ9G!K:\M)Q9*0*8JCW&2=
MQ$F 653$F 8BHUFD\I0HUTZ/XY P3@1\ _8]VN>'V_K6)KK;+KUS*WW[#?Q;
M&>HG]^+=V^J'F/\O,==/;LEX%OMI%!R;P3^_S!:O2GU5Y?>I4,<1_[*HXS>J
M&?U6/2X:E^7F[S>+:OEEL?R'6IIFR4_SZ?\H.6&9MNBS+,))&J68%+D9/:,*
M7(A(,)+G0:0?@C2&'PK3@2\)O\[+#2B39+'5=$(C ^P1/]ANV9T\[V(/W,^9
MHQUR-^BNCQ6#G_[M$KVJ)=JB>(6NGQ<KK[WBA^:FK[[Q@^$Y;@_YH=E]T$]^
M<(!N.G]]%]HTOE&F>[W^[XW^Y51?KTDBL]R4/@E*38=R4N!<FEIY6J0AIU'!
MDABBNL\!'%@#;R[?VS9;,+5[EF%VVM,G&QP=-=N.6*I)!C#^B!:\/\5F2Z@G
M_706W*AJQI;X?6UA_1Z\W/;FFSGNY+U2Y=_*Q>KETQQ<9=NSQ,#2VT)&!C2J
M89LKW6(Y7T":3_6QH%]Z/5(/$]H^P@<HG;6@T:EBMF_=T0IE+8CKUL?:/.YV
M]GY9F0E>=\6FNN6K>FI\VB2C!<V"%-/$)$FP+,$L5 G.XYR&212E*@6UICH)
M:6!Y;>":+*=M)5G5@H8=NZ=Y97?>>N$ 3&:WQ&_KR+Z>(QY\OIXES-/!>AK.
MJ"?J67+WC]+S+SA6CJFJ4NI$0_WV<EE]6*E_*%8^_K&8**HXR=(,IP5),$GB
M'+."4:Q8SF.6)$'(09-^@/ '%G3]N63 >C(@_^S$?$"NP(2_0>2J(_J'DS&6
M"\05,F-:KI!!R,^L[0M9X:MR#0A]W)(V-]8<U+HY+N/0*%;^]^/B7BV,,\#!
M8#_Q^L Z04-=5<O:R?:X0/<?[W9B.RZ&^RDVG#?:/7  )O^VQ ]@O)^AU:V?
M[(DUQ^LGVT_43C_9,X]>$-'GY\,X?#^,TP9K[E;+:LGF9@;7;\J4QBAY_5UK
MCB?UH)[9=*Y_;[I,FR:7*S9[5.5S-)&D"%1D?&])%&!"E, \H"&.5*I(S 0G
M!:@^Y0UH&%C'=#!RB.2/O)V B/[[W:31(_N;V'V'L"NT)@VUM*$-<:A#'3+D
M>0[PO\W6^ STCTS!^ '_M]FBHX'_-T+%[8PS?=<;)&>SQ1^L'@IC6CE4JORN
MJD>]Z/6/:341DF597@B<UV63D<@Q5WF.12H%5T&B[[,IY%BR SOP2?+UXPU:
M]Y.Z0F&$ WJ%-IBA+6IM6Y$&.62P0[\;_(!]U2UY;7=F^.<@4,T/QSRPDH;Q
MPI->M00ZJBJ$,6)?>P'??F]ILKO5#'OZ\\C@$1%*R;,\P"(*S# (XW&/BQ@G
M29PE)(DH"_A[+$L\2]G :G-3\B87LQDK*_2BRB:W]MVDUD(_!8"9_A[P?=?&
MNV/QW!'[?J !/.]V.]]]9B^4KO\E>;^.V_E6=7SV",*]TH^EU C?SN7C=#FS
MGEJV^]; QU,-P][!O$?1>;^R.S$P5?Q8,KE7'G:EM:J<?I_*VL_12R?(?7R<
M)">O\=Y2HSF+CY/0]1&?> (N YNTD#I9LQ;9;XN9?O=A.;]^7MH*Q9EE!I:2
M;581JN&C#@+ZMK9<E?-S"<]@QIR7+8\\@0F;!W: ),Z24"<1/+?V:#)I2617
M2&U?N70HP:?I?+I4GZ??3<+E4G\)4SY3367H7J?\+ E99&8$QBQ6F)"48"8B
MAK-(LB0.8LX5*(G# 8>AW6"=KOI;1#9ERA>,)+#GLN4%;%C> :]*';8UZ. :
MGT,>CC2' ,P3[T,([#%XHPD$8!:='C\ 7PIN:3RH:JD-=V/Z&0.^]@Y;6A='
M7AU8C70@H@_*C$.;SAO?@4'@/^W-B&-4GS<=+B08)OO]M'KS;Y^AR\DZ.+;>
M:!9!#S%=*Z#O,;@4?5GHB_'BBUK\HDQ>J*T$[;TVL/1H:-BD#'WY>&<O*?N4
MG9>2"XB"24B''O1[ \R30)P@P4D8]M<:31!.$-$5@E./7%;T]VE1JNG3_,30
M^TFA\B*-2(1#+KE)/XHPC17#!>.I"GAJ0B:P3G]V@"$?HE.?OA:\6^'?&:;9
M&:_^&0&3R$T18(M IQAP/2H#_=1B<3J0XUP,:$>VYY+ ,T#?I##0CA&GR@,M
MWQXY-GN8OJ)MXG(ZKZ:B";"E-,^U;HEQ&J9:KT0QP;20*8[3A!4D+E(:9J/$
M6L]A^JZ3%P?9FH%CGSX9/GHL\W@BXH: =Q.1M&7R6T<8S^+Y[Q$QM&6WMPB@
M-4!'O6]F!-Q6U4K)#RN][%,32*R7WG2Q,,_<:U'[II&[UX(V*5A&\Y"F6,3<
MV(IICGFF0AP5"4NE5&E2%""=[H+%P/KZICL5:5KCAE9S$Q10+4;MWUY:G-"+
M?A^HVIVX;ZFVA^8I4"77O&KP00U"F_2/&J<KM,:JG6BSQ@O=]_$5KFDOX8LO
M+>J$P[@:\A(V'6B_BQ:[[-JK+>5UF=Y4'>TIR[3NHMH2Q5D:!IC(-,0Y5QQ3
MF<9I((I<QI%#2TUK!*R$[N*&F/6$'A.Q6&F18L9;[78C/L]/V*78#WLN[V+<
M06*H!KW.I'N^&Y^'^R;78VMVG+HAVR]P0?K3%_8,SWXR+PWM1M8@''*?:G+.
M>X^=*8%)Y+G,IUXBW1*?N@1=EO=4KS1^VE.7@*-93SL/#.0>JD[=7^K_JPL(
MYM*<Z@:9#PM3T33)BD+FE#!,@SS"),P*3%4:X#1+\R*/.8D#O\.!') <6&AK
MP&UE3 ,06%@TR,9X\@L-S&Z89H%PVK_WY@)6C.6X<4'Q??EL+F RV%US":QA
M6Q!]43^6CW^HV7?URV*^_%9-2$13PD.&DSS0:M94/%$54,P2Q@K*\DPF5@;-
MI8@,K$KU%Y\.TY3H@*-V^G$,/L%TH%.;HKNY1S?WI3P9N5_1 1KOLG'1*6:Y
M=C ZN1[\UO3Q7\O7ZS]*65W+_ZY@23A'7AU8@[3E:TT[9K3MZ6/9O/ 4O><O
M5Q>2"E,")ZGTG*S30Y33->O8>J-=MGJ(Z5ZY^AYS/?6UD)H\^-OGEW+QO;$]
MV@^+RB!3(J>8%"3#A.F?:*(/]H RDH>AE!D'1=9[8 TL>1O(:-H!#3W-3W/*
M]L#V0C_T3%Z3WH7J418!U'D[74]#&OD /4ORX1EY_A6'NK%Y-?]Y7BR-7G#H
MZ'?B]8&%\EY?>TS.1)M@M'-6N/3S.\6$\^>C!_IA0FE'^@#=_,Y0ZE84=F+-
M\8K!^HG:*0([\ZAC*'!:L:>GTH3.]*[>%0_JNYJOM.T[5[=+]5Q-A,AB%14Y
M)G4$D.E#-&<!QW&4AVF>1V'(86,OS@ <6')WP9N87XL ^MV@@&H<@([&LSRT
MC/IYY PPV'<94^!!/DM*?<7VSH$;-Z1G2?Q!),_V/?@9W,F@,O-TOJORU?CV
M &7;IU<8/A6ID\((+,WNH?O\R>N'9)B@=F"B-5 $80'HQ#U/H=.AV[/L:.?N
M>=*Z1Z_%TYZ&3NTFKINNAM/Y2H-M/5.+>77-J[K3X40&I(@#$N,B9N9TSG+,
MHXAC04/!BRR*XD*X%:4X8 /YY)TJ53;Y*$LS \BR;M('FRW/[G%8!SS6#P=<
M'=:T7*$M<FB+'?I]C9_/<_]R+@TU'0N R=L.SH*S[.Q,+8<E8>JN'C9^,V-5
M=5?\QDRD<'E7UDEW]TI_NOI?19-27"<Z7HM_K:;5U !^_,:6O[!_JJI^N/KX
M0S^NS2 ^4Q,:"<7C(,4L$023S.1*I#S'2A8D+5(:AXE5!XH!<!O<^5#C9<QT
MT4W$9EO<3%>Y)7HVV*&R1@^I+7YVRG.(3>M7IF^\%3#E6N-I]J#%5 L"JL%?
MH?4&W16HS91OLK8[&".#,JIQ;MZJT,?WL$%R(>IF:K78O]>-VD'R?6^8]1$Y
M($N;(], J,_!((V#^BP< N0H9^. O%J?E4."<+TJ\.6VV6$G(RV42F9*,JSB
M3&(2A_H@3/1/-$P*)M-(7P9 J8*G  WMF--@.^U1K^I\5L?,OY.\LC7F+^<
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M)SYUV-.]QSX+#<1\T798[&IN_C%??_NV6NASH'KL1E2L:2<.<0'SF  ]B0[
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MS=4A=&- V0=1K&7V%0HQ)SQM0,,:D*.PA/T*CLUT=M.1NKK([:S=F" 84XE
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MR9P:TYU><;+.=(,"[;>F&W[PPJE,NB79:U)5CW)5:3KU[M>6PZQ "%' 8EP
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MAK^._]Q\!QBG2KZW8>UE9=<[@&J=/N]"(USOU_8$S?^UJ==-[LRLB(5$2$)
M,20 EG$*,,PA2)&@1*>V)-CJ?L6%B< 6M0WH!.WI>@2KF?$,#9:=D33OX-J%
MR'9,/5/;UG/83-BM]8B%%]>D]1Q(+KU9SZ[E9K%TX_[67FX/]4V'_UI4WT7]
MIA]&5<\(3M59&@L@BCA75HKF@"8L!G&<HZPL19FPU*'/OBE](YV[N+7^/RK=
MV&@EI:6!,D91%C)!A!7*UHL2P!PC@%@N0<J25% H:&(['24@@';8=?&A0,"9
M67.O8+BYN6]?1_T1\"I*4A#C=M!)Y^SN IOM8)26LZMHRYL_\VT+AB>3;4QV
M4C-M"\93TVS]ON<ZK8]B/2OS,F4(4I#BF $HBQ30 G*0$I@(3%,*8^FI+DN1
M"Q[+/*C#$KLZ+.M!X8.@2<)BR7(,A"XM4:"5 .MBMJPH2L@(E"G#-OE;OB!S
MGJK^, EL9O;6%QAV-G:P/&VXCL]?+=J>A*%KSS2IEU%KMB>T<6W9_CN.<4UQ
MIQ?Z+!YT@T$]TEVNJOO&&G_8]A5+($MBIKQ2ALH40*R<5"P(!.H072:<ZSYM
MF56\TH!HZ OBEH5HRT.TQ\0%;=J,\#2,/7I&R=+9NAP@^S"AA<2^PG\F)*<-
MZUF <!2NLWG7U8O:9HOO&BAOUM]6U?R_@L]HEG/,=8UIGB/E$H@,8$(RD":8
MQI00HHYEMG[4$,$)/*F^ZJ&91'G5MBY21XPM"]&K^;+[6\N.1B-8FOH)OO"Q
M]11VY2 -,'T']2UMGYZ"B8S>?(5!8A-["R:"'_L+1F\Y&H"N+O7=JMJ-KOPD
M7Z_N[U?+AN ,9P7*"4E )H2^WTPH("06@*<8(2QARM/"+A(S3G2"&(RG\;0&
M /)"Q+!0V+&R#0AF "54.5QY6?"RP#'A5EUQ/<'G[F[U#$1J/XJJIT@J)@(!
M:6A"O<)C:4;WD3G\C;7T6_/JT98:"^O+GHX3G-:F&@-P9%?-WW2M8KGFJP>W
M&I;]-P-K<T_*J7[E0,)A_;Q<.#M=/%6[8B:K0^7**9$NJ%LY6&[BJI53HAS7
MK)Q\REY/="+"-5MOR&+QJ'N;_%YOZ\AV^8^&FF.R5F!=.LS7Z7AIFK9$W^N_
M1;N*1',],T)H7/-\@V.GB\:X>&Y>82NYD\H:$9A,B6W$W5=KJ_?<#AMJM4IW
MQ7DCVO]]O[QFS5CI^K-@8OY=IWC.XCSA$"EO.4L0 3 1 B 42R!R7&#,$*90
MV!TW3,@&/W#T))6_W-.T\X^-P#/SD+T!XF0+>NK1JY[^3[K%\!:@S^, 6;O)
M-A)[<I2-2$[J*MN \-19MGK7U3IT'>1O5HLY>]QM;CE'G!<9!@*G*8!YS@#)
MLQ*4)4FS7.8P32UO<\^1"AY_[ G/;1/[SH)CJO&7"VRKY=NI#BW-Z&OWOT&J
M.L8$]*;49\A,K,C#PAXK[\CSKCVNNV+6[0U%4RQ5SRA)"&)J"Y>D9$IA,Z6P
MN"P!ET668BI12HVJ3\<(!7;FN_[._5"2W=U92]VVO_49L(85V"<$=@KL*KU#
M;^MAT2YH;7UFX8D[6P^+=]S8>N1Y?VUF;T5UKP->RW5%V'J69EB@C*M]EDM=
M(9I"0(J\ $F!44DIY;$Z)EC$J<=)!E;@AF*D7KR_O+_L$ZS,MEV_"-CI[]F>
MLIJ!-B#=LA"VG>QI<0,VDGU"\-E;R)X&P*1Y[)DW[?1_(;\OW0M_/NDZE&W1
MSRS5 QQ%D0!.*%)G<Y(!FF8"I#+C(I,<H=)HH+%/I@+;D)Z858VC5]"'3<US
M06EGC(QJ&G\>GDK4?XB1<L9P'X*OV$;_M^;U%_=!#KA[B1_&>#L)@6"[X>B5
MFUTD+K*XV4F\TIIDKPF!3K\;!5G;<91U_7JQ4GO@ZM?EPUQW16X: )A>!9U?
M(?1E:CO[MJ&LHYJW\_NFT^2O'V_>[X^[-K__&0!C_-;'#PYVMMX4@J[+A\]A
MWX.2ND_\/KWLM&._!T4[FOT]_/3%W8?:^4MS+O924C^+[V*Y$>\4ZV]_*,U9
MDL7K3;U>W2LE^OGQIEKIPA]="O1%5-_G3-3M;YC+.,/*?P1%64( B=3)40D&
M:<8$$7D!99):9:.'X#*PT>B8:CL0]6Q%6[YTLX>>LZ:$H^=M5(,F_(YF!^)G
M_SJ6;NO3M/FK:/A;7?4?:O\[^3-TD\#HO[F11QZ?J^N1?Y@'VB$%(.;82[:/
M1^RU^&8YC^.40U#DJ  PD04@.<Y F2>LD$D<%]BJ3/ $#2MS:U\=N(N(N30\
M/X6)F?&[4%([T[43\J %NL=VL.>E\=4#]@2%:1N_GA?QJ-OKP*.. ?OY4F>C
M5H+/UUUWTE(=6WDB,&!(Z/ ;3@$2F02,)ESY41PSLWNU\R1"!^1UG9D./3<D
M+8/RQW@8!N$ODM(RZ'X@8("6K.>%\152/R8P;0C]K(!'(?/S3]II7)/'4CW.
M_O=FEC->R!)* +DD ,:9TK T5Z<10@A/"2>R-.HPM5LRL$;]+WD@YSMAG!-S
M6''<F+=3E/^]OKG^>+E:'+,Z<,KO'FZUH/N7G0+L+37)#_Z8]?X'?N*_N&TA
MG\6:*"7A;TFU5%M3?<W8YGZST,F+;X2<L_EZ1H@HT[1D@&+) <R8;JXF$X#*
M/)6%)&5"B5UNU3C1X%E6>R0CWM*TVVL,@#/;>_R"8:=B/>VH)QZ]V@>FH^_1
M(S07UM->94!PTKW+'("G>YG%FVZFX!>UO'9*/RUUB_)/\J )Q;8#Q4QD6"E]
MH5S*F*I-L(#J<)=E&-"4Q4D!*2Q%[M"[S(RZD2I<W+GLE6;FIVBAV(E6RXC/
MZX=531;::Y/S'THQ2%V+M65ZIB&\9D;#(UI.AD/3[R=FZ5*I!J%Y<RNH0-HV
M(VI;RFSY\6='[.3W9$L,B4YJ3^R >&I3+-]V2"OY53W^+56&X;/XOEI\UWDK
M*[+L#F>09$CR/%?^!(T!I"P&&!9461:29W%2,DQRXUR1(4J!/>R&=*1I1UOB
MD:9ND8$P"-2P4? JOIT=."OY^+G6$@*+S I?4+BE2UP B5WZ@XF8@SD-@PM,
MEZA@(L=!]H'1"VX^T%XOV(^*=5)_:UKHW*[ZOK'B8(;A[>JU>D19S>]S+OC/
MC[_5@K]?;@-]U[K_;#/2Z9K6;5)H A..<BA!44(!8)F5 '.AO"=.,EI*2"2Q
M'+$2FN7P1[&= #H'H.K9UDWXNO"[_GO];UHZW;.OX5W?>:ZV(6RR9?Q_[/RR
MX)_<S*-[29_1;@_8<:X_TY;=_8I=]?>:W>AF[].]TBQ'VL_>W4-T;#]>11T&
M3<>QZ&LOA,<HZ51X>_(]@[,[J=<Z%?A/_=W)Z#JFS^AYW)J[3_+=?$D40V1Q
MTYVKMN9$0HS57B%!1O4LF3B7@,3*:88L30M"9":3TBH;QH!H8/]YRX(^/&Z9
MB'HN3/3?'4\S\^P;)3L3ZP$@^P02"XE]Y8.8D)PVO<,"A*-L#9MW[3-@_UF]
M7?)WU>]D\4F^_<_Z\?J/BM>_5,NU,E&OOU?\G]6GS;KFRDPM^6_+[_6:=R<I
MP_Q8U_4#VXI_"E(!L>31.S*OFF;P[=RX_VQT*6*76/I+19;KQKN(7J^44ZK^
MJ-^+UM_(.B*5B#3K:[)LFO_H-"PE@*C7 QT,_<$_;&^F0M[._H0%W>/!V =\
M3DG SD0G2Q&^%);]!.*+U[(W=V]_"+;1XUQ>*ZMZMZH>KW_,:U-;=O+EP(9J
M2S/JB1H>3,]+.VXZ+A;4SBX<RZA<$471DR8/2N.DIJ=7G$P'!P7:5[#A!\/-
M4U.G(MZ.WZ +\?:'+NT1IXM]7J_J]4R=."A-8@8(3 L LZ($A/,$% C'/,UP
MSE%I%\WRSV3P^-5?_X+2)/U[V] 4T*;^C>TQX7\\F^57,COA/"_REG;'>+3;
M <=1Q_+5Z5K%7?G:,\U_<X-WPNEPE@R^N-EQ;@"[3)9SI.1PPZI#5'VCK?\K
M%IRLFZEVVR/G^V6]GJ\WS4"E/DF8")BG90+*I.0 HCP'..4<2))!ELNXS(4T
MOG>UIQ_8\6HBS=M6<9JE2!U VAF/N]C)/EL6=Y0.:!M<WH;%T,ZVVL/G<M?K
M@*/%#7!8/-WNA4_@>GTIKG87QNZH#%XC.RP[W>6RN\P'5\X7+!/.66\"C.J$
M_4%]]L7V.5'/"IJ07/G?0%*8 \@R"!"E)9 EP4RB-(<P@%M^CIW@#GA#>'M3
MK$DV ]R:=#VA(%=J1<522-L4WXN^@3^GVP>NH=SK%GH=S&NXVWM>/-<0Y3&X
M)G27S[+RXASC,=!<7.#1->U;2G9M[][-:[6D#BZ_7?)FK  MXC1&60FXCD9
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MJC&M'\F]>+.Z)_.ELF8XAX3&0"K;!6#.$J#.9$3Y=I"CG)5<)-#&F;.D']C
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MU_[F*67&!8+!?!BK!:=+=G&1\R"3Q6F!BUVT=BZ)KA 4? 933HERS91QE3&
MF2@!144&,E(B+!$L:6;9+_H,I8E=L6XHT;RA[=X$]1QLUJZ7*Q27N%LMS:NH
MI1K$OSHEEG^?ZH#*<_E1IT0=\)U./NZ:$M.E@HOZLV!B_ET7C<\(YR6F"((R
M4?H*88D!A5"=JK*,4YS1(J&936CJ))7 T::NDD$7?%1;FK;I,*? ,=//BT6V
MT\Y=W8:R3#N"5]'K355Y+=(8%,Q;8LPI&A-GQ@R(>9P:,_2PFV8.CLW>#L-I
M_J/>UI,9IFE&DB)7FRS$N@M# C"+<\!RC!A#*$\(LE%:6P8"Z_/VXKH?$5AM
MYT$M- ^-UVFGW]80FZE^2.#LK,*6DZBA=N+V?S=4JWFB.0'YLQ6N2'@R(];D
M)[4PKN \-3[.Z[@FI2\V^OCP1;!--5_/Q:XS=RZ2,B/:;9!Q J"D&"#U44">
M(<F1Q!@C:.?PGR<6W.=OJ^6:'C =$U&]Y<*R-\0 9F8FQ0\.=L:CIQGMB%Y%
M/2K+;G#+\4B7,&TX1^7WE@Y_EM#$N?%C A\GRH^^\3Q)NK^H!]?U>UT6,U_Q
M7ZI57<\PX8AB$@/$"@2@$!!@03#0U9PQR]-<0,LN,@&X#&YB.M+1G:9]22@A
MQ"?*.4\*E&: )+HY0!E3=?R#!9 D0P653)3,Z@SXS!_(P>/\Y25^%K/]XIG!
MMMMH?.:ZMHQ'\Z9:4[&N_T8Q_P)R%<:1?>[DA0$._QS9#.,0^TY-'2+E<(%Y
MS5BU:0@UO1M7OXLE7U7U+$4Q2C*9@91Q98L9S-71/BD!D[% C,*L3!/C_@=G
MB 0VIAW5Z*$EJ[,IO[>$+2[6SN%C</7H06H[J]8+?+,3^'=O EM<&GH0W.U^
MT $ N[O $<D&K_W.O3O=#=\(]P>7>6//.IB:7]7CW](X*71,X,-J>QTM<9:E
M)!: ,BJ4J2E*@"DO !<EA+P4,DV-W+XA(H%-34,UTF3;"WU-V$+GSB%C8&0\
MR&MG9$Z)ZI*Q<$YF"SOC078W.^.&@9VI&1%NT-2<>W<Z4S/"_8&I&7O6+8;P
M6Y. 7Z_G]V0MU-DR%IG@1#=P4JX,+)$$.)'J@)E@96%B)FC&[8[_AP2"G]Q_
MZXI >H)VY\(G:)@=Z=PEM#,I3T6[BFY6BSE[C+YV_QNDW_QIZ3R=B)XL/NEA
MYK1@3\\A9YYRV-=-FKQ]%O>K[V3Q2:ICRSW132,^BWG35+XYW]2UJ!I[3SC-
M*2]3D!'$ <QB!&@90Z#<@%3DE!8QAL:^@$?& OL/?:_(JN5&:P/A?*XIJW][
MZ%E3_WW'6T1ZYFS<>Y\?R\ ]>:9/8&=_S'M1=JQ&GYK.=]U'V><VVK+[3-_$
MPGUZIF_CYG)-^XWL7+4 0 ZZ=S[I3><2!D#IP(T,L;Z;Z]E%[>I/<MM*:D8$
M0J)4AUR(,5+_2"! F$F0DYCE,LUY@G.'5FHG2!GIXL4-U?IHN-JIV 6]U4Y!
M9>:<NDKN.G&U(=9,)!F5U-H5'9#%DS]ZBL*D3NF B$\]TZ%'76<+W&RH.DF\
M6ZS(>I8E22G4F0\D4,>;XD2= J'N;RB%1 7,,QX;^9@G5P_L*+;THI9@U%"T
M'1NP#\6PJETLH*4;9B&;PT2 $S)<, 5@?[6)._^?$.2XV_^IAUSSM=7O5.V0
M75>#_3D@LS@72:J4"8@\9;JA  98G=> E"PA,,EDF@F'76V Y#2[6\] U$WF
ML4WB/H^8V>9V*0"."=V=T!W5JVB?KL]T[E'AO"5UGZ<T<6KWJ,C'"=[CK]BW
M';JMB&YJ=%U5US_FM6EGH<.W F]Q';']5 S#W,<3 @ZKVV6RV6G7";&BKYJD
MAY#F>3F<^O0\66JR5CRG1=COMG/F">="I$JG*+\1[?^^7W:7GGNU%=W]YRS+
M"@*Q'C4I,0$P1QE M,A!DF=9&6<Y+A*KSCD6M .KVU[14I<H85VQ9(RBZ>87
M!!O;S; E'KWJV?A)IW@=%#W=C.#E4NAD*[F_\B=CRE,71=E"<J)4RGH)AYUU
MM2:+)G/KVVJA7OF\7EKT[CO]=NB=5A.-]JA&G\5Z4RVM^_&=D=U@\[U8;,M-
MV%%BNYUX4"BW'?GTDM/MS(,B'>S0PT\ZU@-L:"W^LU$NTUO=$+S>#6(G"2_S
MDG @D)X-R?28)@(I2 M&)">E5/]BE3)^CE)@5=S1C5K"EFG?9P$RVW*]B&VG
MBD<21U_#C)4?$\U7#O19.M-F,H^)>Y2///J"8S&QGG"L4YR5)5 'V.V]S(=5
M7;];56)^MVP+Q=FC\NJ7-6%-'O22-_^V:+.B^;\V[=7,1['^)-5./2N+6"2(
M8!!S'@.H( (D01!D"624,I10).SR>,(P&CP?J&,M8AUOT7K'3D2V_%B6)X?Y
M:+*$2*0( 9DD%$!1"D!SG@))A4R($(6@S*I._-D_F5M3Y#_-!S/;-9[_,]AM
M.>W0]0.&MS/'-<\_747]1^KYCO88;SI.[;$>[7AO9\*LI#X8>JQE#XJOKXKW
M,$Q.6Q<?%.BCZOFPU.R/KN\5$^K)77#M@V$'XN&70P9G&IK1B9AJ[;EAL)F(
M3H>Z@64G.]B-B[9_N#-XVOZ"OJL>?WS[@WW37_$CN1<SG&+!"XD!*J$$$";J
M3X(BD(HRI80FDL1&G67.$0A]G.M(1CW-2!,UOZD_B<FP+OJ0U/($9R>DU97]
MD"1.M_8G%YSLXGY(G/V[^\'G O52J$<*3M66),5\O=']W[JJT\%Q20A"Q-5!
M#"1)P=0)C>8 2<Q QC!)>893"%//C18\BS#%V4WSHPO]@P_!\OUY#0-*+_B3
M65HY@U8!M6FO@#VI]AL&O)P)68$^RU1]!GRS_[*:$ 3Z.-8="D+QX9AM7:WX
MAJW5^>B+J+ZK]9KS55=-6B929GF< I@07?8'2^5',JK^E$F69D3YE-@F\C1$
M++!/V5"RS*X>@L;,D/L2V,[H=E2;B$M'5UG1)GSCK\S61D1?:=A#I*;-QS80
M^B@QV^2="^=D?R9__$J4=LS)HIY)@26+"P*$COA#ED! $X@!3@G.$D09*Z3C
MH.Q].L']/44LNN^I.<['/@#&3'<O%M8V*K.=D*T%WE+TWA!I4"[?@[(/:#S/
MI.Q38IX=E7WR88>JWIMOC_7[_]>IO([S=-L&I*4ZV(D$<"P)@!050.VA&2!<
MECG*$QVW,:[0/4,D\$[:4OWK7Q!$Z=^CAVZO4>\:1F@&\1E635]26VZG#<&H
MWU6; *E#RXYS(EO4G'H0W:U^] 0$GJH_1T0:K.0\]^YT59DCW!]46(X]Z[;U
M?Y@3.E\T[4-GF<RD3"D&(J=(^>PL 2A.E??.B61%D5$BZ6RM4XS,MON]M:UL
MRI:"96;98D?/;IO?!\%L<W<4S<YP?#"0QWK[/L&YITU[?^5)M^H3(CW=H$\]
M<M&!]_6J&:M3M87-\_K?_9&7)BS."ZK@$3HECA. :,J R.)<,LX)9%9-^8?)
MA=ZJ.WO-]JE'E2+O=!(^AYG56=@#$FZGX0/"D:8<[C0\(J3?\_ Y8L]Q(AX1
M_,R9>.PMUZUQ*3[)UY7@\_4[HKL8K!]_)3_F]YO[GU=5M?ICOKQ[31[4?UD_
MSG!10(D9!Y+K[LE(2H Q4Q8 %Y"K?Q1Q(FSTWH9X8"O0D8UH3S=B'6';7=8"
M3]-M. Q*MOOTLFFAU?(1]8Q<13UR6UZBUV/(.>SG]A!XV_ M2$_L$=B#<NPR
M.*QAG_YSLZQU/E%]4U5?OK/7];K;% U+5\Z\'MHQT)E3!SEXM;XLT_-XV]BD
MVBUKBQ*6<R ,6P%/\ENZ T:B>W0-#*1T2H ZM^9DV4\C0NVG/HT]ZMBD<ED)
MMKI;SO\K^"WY\;-8"CG7W;W;2K7ZLZ@W"UWR_4[QW<U5:R_4U-,WJ[KI$%?/
M!!59FJ0"$)+% )8Y!9@Q]:\BR90?D'&,I<W6[X>MP!:@"2KKF:\M3Q%H:UA[
MZOI^O4VU7D>/@EC>G'GZ,&8^Q/1PVQF<??Z:OFL]AU?1MDQVRV.D5:R? =AE
M.#0O;1GUV,+3*W"^6G_Z86K:EJ%>@3QJ->IW=9?+#+$F2SZ_/XY=YY21E!8,
ME*FD !9E"3#B J"LQ(A@1JA%P]&S9(([0RW=O_XE*:'[C<99D$SN-'R(;NL'
MM20OO]<X*[C-S88/ !SO-DX!X>MV8TRLX?N-LV]/>,,Q)L'A'<?HTXYIN'J*
M\F?QH#[A-YTV]693*8/76KEVN/*,Q47,"Y[JQN0I@#B/ :&2@SS)1":3A!.>
M]LVTS/RX<:)&/\[#=EIVIFE'O6D5N;I_(,O'=JSY!5.NQL$L"(0I)PD@2#=L
MP82K/V4YP"F'C")(*;(J.?0$Y04E!0UDU8Z#B#<LZ,QA[6*%!-/,C?4+D=U>
MT**S1SQJJ6]3;%L&/&;2&@OK*_=UG."TV:K& !SEEYJ_Z9I,QI6#N9ROQ8?Y
M=]WF19GTNSE="-W@=UW_2OZUJEXO2%WK\HHW*SVN=J:L7)%PF@,I90(@548#
M9QB"G*&\*&,HLLPJ4=2!A\ &9,<16&B6HAU/4<N4#A<KMJ*&KZ:8)_K:LF;H
M35WR <QL3&!8[8S.'J(?_"'JD [GC(FW9#E[#B9.I7.&Z#C1SGTIQTX:?=_'
MKA7D;I(S2@1GDB: HT(9K2(I 8KC%,19D2>EH.H :UEJ=9:6C18Y3J;M!\=W
M/5=M)UZ?A\G,M'@1W<Z [&3N:08993TJF:]6 &?I/,^4^W/BGAUG?_8%^TNU
M7]?50L^SJC_)VXI?5]6N)9/AO=KY%8+?MK?IP\ULLZ;E_8DZ>_.;M0$DQB_7
M_(!@IY5&\GON5F4FJ],MV\"RDUVTC8NV?]=F\+1K$$9]6OWU/FP;7$A1%J3D
M)< I$P F6/TI*1D@D$@N>8(R2.SB!$])!(\+= 3-&E^8XF)ZY+]$6MLCOI6@
M#B?Z<[)X.\$?$9CXQ'Y.P.,3^MDG[7?"SYN%2&*:)[IK,U\]K 5_MR!WIMO@
MF=<#:Y6F&FFR(#FP^AT'YKO?.>G'MSX/@MLIV(C,T5=-WM->-R*<TT9W;LW)
M=KD1H?:WN+%'W?:WUZ3^=KWD^G_>_F<S_TX6.CGH>OV:5-6C<F!^)XN-F/$,
M0E0B!I*DQ #JJ#@1N01Q+F)U8$2<8ZL$<2.J@?55$V^JA9MA5&+'AMU&: :@
MV=[H'18[;=XBTOQAQX&_#=-*0$][J!G-2;=5*QB>[K1V+P?J '2NG</'C;[X
M_"2OMZ-(V_#\]6;];57I;(Z9)!BA)"X!A90#",L8T +K44 8<I+0E.;<RGT.
MQVM@"]0R\&1R:WLA%Y$M$YZ;^USPY0P=_)?Q/2Q/"@8M>T8Z]NR^YDZ [@XQ
MNA[_FOX;\UR.\U0]>"[@]&6UV[D<<NO..AY(.GJ.J_O[U;*YF>U2GU 6P[3@
MRIZS0EEVFD" .8E!FA">"!JGI"RMO,2G%$)[A V]J"%HZ00>86'H\%TBH:5S
MMR=<@!K LY+X\N*.UI_68SLGWI%W=O;!B3TQ[1NN']\O___JKJXW4A"*OO=7
M\ ,D4<3*O/2E[=MFFC1-7R<(TD[2Z&;4A_WW"T+7C[&S@LJT23-IB.*Y]XYP
MAP/G5O6IT;51E?+.RSLMC.36:U[5BHS4NR@.(B)QG,H\[#8)8X@CGD*"9(*6
MY&F4T!AS+M,RNZUDGJ!OOB%-/V[!=BE?,=PX0=LB+M?*UK0MH&>,$0NKI3F=
M^J()_3_AQ6^0OCE&X=JYG"WLGY'8.09CM2S/]?FN1;&5[/SI=ZD/K;=K_O>J
M"M;ISWW)\T.:,+(+HQ *2I1T(D-PE\4,,BKRB*$P0SBV*Y-]\7D;IX,: 1A
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M.'VCA\-1:TETH'9N$J]2C$2L!^NM %4S\M$E#KD(S44,AN,P#OM3 -/\@6]
MF^9@[AX.C<4:9PVA\?MB'F]QQ*IH+"=F<%_?*"-F<%%E$,X$:XM.&!YJ[7<X
M2N[2TH,1W-!'/Y+9G5Q7BR]YN?[^=H9U3$NJWN&7&@6KEV_(3'(O!0B]N7P-
M B:=0*,)J&K*C'RH5O^P>VHW/3TXY<?*_,X=U8C]78#I#>T%:^WYZXRK_*Z.
MHGM3_DIW;V7=1-*1(KXHT(F5VA)3@T-=" ->.(SH_8-UNH>@Z4&">M!&C>'4
M3@ =&#NO2!KSCU/R#B]XE=<OO\7962T5^,MBD?Z8SF83[K3@14C2X@%!\4+W
MO0D"O#7T9Q,8NO:^U^-T]>"T-\96<W%TH;)>7"Q\%96XVMQ$..^#04\(B'7,
MA/403*D&8#3"2QV":/WJMYN:'IS\QH!JQ/H.--668WG-HPDO2M ][<#X4BMA
M@P//I8188C3(,K/X4!^L@^Z[^PCIP:]O?<\=S? .4'-._T0[5;)DC,BLL\ZB
M)BN/D;W'BF VH%,Q/M0Q]W#_K(<[JJ$W]B1&=N"POYYBF,ZFZVE>D>&_J8C\
MM)@1TU?5"5A_OV(-*\F[DA%,KG-K)'T)@DER YCR@4>,LO5#Q+ZTC6M"#YZQ
M,8B(NC![MG9V.X+F% M..@E,U/&LHCAPBI1SE"I+G6E;LK4^VDW-N"[_,/+?
M#;)C1-$%K"Y?A=_B]_JJ=Q5*S6ASU>LFU]J:S Q@<0ELR0YEYN0UM+:D[Z>D
M&S@=)>D=3_%',+T7\"S/<GJ/,^+/XO/GZ6I%@KG:CJWCEWP +FM55F8"T-G:
M I7'[(RT/#5_['B(H'&OON&@U$@$/2%J*^/@<BL,!6>E, BN5H0['< %GJ$(
MPSV/#M.#/5Z.0--=8L:UPX=%TI&L[P)%-X.JE_RZ[+<ZB<)HE.1KLJR(2XQ4
MK*^Y"N1N^H26<<$?*KLY/JQ]FZ)Q0T4#X:FA$'IP_<]/QUU>36(6(J= E*M2
M$Q+"9JI<S:1#K[.I(R$>:JA_A&*Z2\RX@:-A%=.1K.\ 0_?LP"F=F$5&'BXY
M'RH02S#1H4#ODV.:9VU:@^= U R6%3(0:HYD=@?AIAT*="M\:H7SO(A,7BL*
M<F)C!I=\ <XPD6]K56J.GD>)&F=^^3AWV8&BZ$ 5;<+Q6\S:VHECV6D3R0M-
M0M1>L1Z"\DA*5>7L=0CVP8&S!S^"W$O-.%/.AT93&^9W *.M34PRJ_D)Y&LZ
M%PLHS4L-VQ:0,FL;LI"RM'X\VUJ^&^?^)&'')S&[@ZML$YE8;QH!UIJFQ;SJ
MTCR/=2LRA""2T!"SS722&(*WS@+/+BMOHQ*\=:CQ 7*Z<>V'PU$K873AZC_
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M.TH<W<+KU6IU1GO))24M90 3@H"-AXQ,9LC"RB*C2MZVSG#93<W8T:\18'6
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MG;I^RS68.M%6&F/($T+K)2A=''B%FIR7*)-S)N3F2?!WB!@Y@^%XP>[NAW8
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MB^VTZ.X*(%VHVA>9UH[3C<#IS[-\$0%Z]KGVR_JO\Q=L&;-(6 PP79/@4C*
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M0R7KN"D21*R;%5+57AX27$$2BM8ZEM;O],-?!H-9.WU"_$E"/+(K.G%@N>X
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MB\V'?[\^)RIJJP-Z**S.Z98E PHL4-!$)P5:EEO'D!^BI]O"_*<@XJ[QTT@
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MHST0M)1#%\"Z751WO^N,/)$=H#,I6;1UZ"8#G^E/29*QZ7E)Z%LWC]B+L/U
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M:)OW7!YW^N'U.;I?5)NAHN>YOJMG<3W].EU_OW6^Z*06;U@"ODEB,4J!YRJ
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MT'JX-Y]6JXT8T7&.('A-#D!)^A\].0TZ1<NBD[EY1=P !?6#W9:#('% $74
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MBTF 2@+I*\(7+[7(0.EI,:W'J.Q$8+O+ZU?3V72%OT^_XIV/O<B;//.1!V]
M>T$6PJR $+@';5F*AB>1;.O*U_;4C9L6#(>IAR^SF^JK@T3T$7Y^^;X>K_3R
M+"R7Z^NR4I*@+%U!U(I=S&GU5B<P(2NOG# ^M&[HWH&\7JZWVR+D=K5_('7U
MC<0KQMZ$+Y>52JZ8$[YHR#&OIU%ZLF?B44B&2<E@@VY]1NQ(XKB(' PJVT/R
M8+UU ,MWE+M>W7\H(@^+\R!5[=ODGFP7Z:ML/1?)6YE*ZQN$&P1T"ZG#57T[
MM]Q;[AV YA%!7251C@NAM*:,QYEUJRZ'("P'CXQCT($YU?HV81NZ>KE/&.L<
MW4]!?8/NHI"=DE/66@8&,PDL6@,A,P><\QAU*MPU'_3R%$W=^K,]4; ]S'97
M2=\0NU:3OEY[GK!0LO#9 $41IHK/0U3" :(Q/#OA1/,FLMVI'-?GC0G#%FKK
MYV;@$4;7)>GH+18K*:ZM"YZS=^ 8EQ"YE(HIEU7S'1F/4S3N[<"8N-M5'1W<
M$%R%)J]G&<M3X0G+WB9F+'"M$10J#;%$02)D6*33(39_!+ ;A>,ZO3&*=\WU
MUL&1_ 1/=U)]+P5F2IK &4%&)^-Z<B%E4LD&@8(2MMPZ@]V1Q%X*>>W1,C^>
MZOI'YKT5 V50*4]1<++)@JHCR4)! 498)QE]6[#U!HP]R!P7H8/"9C>('JS#
M#F#Z<1$RUGDLE[4FG3P&'^J.S>Q!!<GJCH\$/L80=39*L=9I\FT:N@;8X4J?
M-]1 !PC:P2"OXFK,(J"N&QB('U \VFJ?&;R7T=H<.&XWV'V8<[B[:F!/A_%^
M2NP?J#^&EUS&YA.GBRT%&60Z*D YJ\!K94$D1C]B&*UKG</L2F/7KK(!:G:#
MZ6$J[ *B=^H$=WFRBO+!D@+PZ$F .7/P11=(W$3'A50JM:[C;$/7N-6<XR74
MS774 >ZN%S_K:7.3PTE&DSD7$8RR]6DN8^!##:G129^99AE;G]:/4S1NB^CQ
ML-90+QV@[)&"Z'NL<72='':]<W^]_X]/4C(&H[? N*/H.GH.(28/6@H6O<=L
MS!$+UX^1NA4N]>GC\AB:[!NPK\[7K\ZO\;C9$_SR?%%UM7Z/_A4_G*>$6(^&
M5Z2!</;?&!;+*Q68G K%(4""H%-",J2O"H,B=: 8OE 2>,26PA8L;64 YED;
MP-&1T;>AW".(-_AM]?$O//N*?\QGJ\_+28W":]4#I).J/L1R$ -]JYTO/%E'
M2<(1[6 +BKMMW#@^^':X;&^,A)/#?97RQ[_F$U>,U\(G2GF]!V6XAE@SA"!1
MYAR$#:'U^^:]".VV+^3$4+Z/WCN>3KK>X/4BI<4YY@V'ARS,?NS7M7KNM37)
MK8:2AN^U)%MGAJ\_-9Q=X4YISY@3I'MK* ;.=4U[3=JX=YX7Q9EH?L'R"#D-
M7MM7H?XRGYV33*_L[\U\EBZ^F: S.M@L@$S,@')1@E<J @O19FFT]<WG\SU-
MU<@C'1KAXYZG\2VUT<$)>VFTY$GFWQ%_P1F6Z>I^UA0WP>40*&X(&922M9TT
M<BA,9*E\D*D,!+1MR!MY)L.PB&NNGPZ@]S%\P^5&;B\OK<>C958+$ KK<I%(
MX8.B$SUFI4,TEJRH]970/62,/%9A("@=*N^QUQ5O3&'#P<?YORB2F"^6$R&]
M+%%+$"E5'H0DZ:0(Q1O!*>YD/OFG@J3'/F#D>0F-T=!,E!UXD/MV9/P^#7%Z
M-EU]OX2XH90@^QPA<5>7(3@+(1#8767/,1&M'F!IYY-TC5O*'LK'--=(!RC;
M&,L?8?$?7%&R^W*^_'$ 3S+&7'BL%T.Y#A8Q=5&;5N B8U$HPVQJW5+X&#WC
MUH<'#H(.UT 7 ]2N)\N7MC']D4U,/(\F<,H=2LZ40(A<-R((#UY[*:60FIO6
M"SP?IV@K3-E3PU1#+?3CH^YCA%GF/$E&1FWK D #3@<&RECO)&96<NMBZ&%(
M<J>&I#:R;_8$J7U!\O?Y[--'7'SY%>,A8Z?N^S6M"I!/DMBH\+C^_7>O.I&@
M8^N00U%THHB&<W#<&^#:*H/"84BMC>Q^2@Z>DCZ=X=ORDK W7;T*:1VV772_
M%ADM0V/ E$C';.((03L#'GTR-3U ;'TL/4C,N,7%!ABX,Q2]B=@[.(>J;%[/
M2"+GZU5/]8&(0N]M+A(2VG4_*G$@;29>I(W192Z;;\BZ2\6XB&FDWCNC#@^2
M=7=HN?;> U6@<[AXD*F^]XBUB21[!BY00)\31ME\S.I#M(SO:P[1\:.0V5/@
M8]<!*0U,GP7CYCU^G9]]I7SP]WF8;1[W1.^BYEE#3NON=_K#.U>@)H)9>L.U
MED\%*D]^2D^8V%>)\R$DV@TT:BQXC0>5I96&1] BDV12[8N4](?2/"8C?5$B
M[H:*FQ\P[MW3@( X0(X=G"\W3]RU][0R5 ?IP+/Z8$41D+W@&0R=O2$8$XUJ
M7:^[2\6X<!DF&CE0UMVA96-"$J5F(=0N)EU'PY$=11EDW4M$N7VV*<MA\=)#
M%'*H;A^%RAZ"[@ L/T[*F\Q<+B?2* S9$J -'A1+$;P/Y#:S3\P5J[5H_:#G
M48)Z@L\^^IX/)?P.D/0!T_FBKMJ(EYL:F=;)>2N)@5J,%-X ?6LAI<Q229FG
MYC>6=X@8]XAJCIC#A-P!2FJ!<[4I<%[;,&N3XR01(>IUO8B90KLB()2B&$LB
ME=Q\;^$]=(S;+C-,.'.PO#O$S,:.1 K%\A(!<YUL*B5E!2(B>!YMB9Z+J%JW
M\=U/R<A%N8,U_ 1D]A!W#Z"Y9DX;5TG48_#< /I(KM)GRB %RT 97W0\8Q2A
M.6#N4-$76/;1[2,U_ST$W1E4+CWO[S_F4*3$E JQ@+8N@\J1F.'(("B7/,_>
MAM)Z /6C!(W;QC?0*=5, YW"Z8_P;?KE_,LO\\5B_E<-^,.?])/5]TFN0:#F
M# KSKK;9,X@)%2#SA2NG4Y2M&X5WH:^_^Z8]8;$%X)KHJ /\W2RC_A*6T^4'
MHB7DM[-_A<6T&NO[L$(^0469AF(<C"JECH6($)CE8+,2R+)%5EK7A+:EK;_*
M8AO<#:*;L6\K;C+UZFP^7[R>T>_&Y:HR,W'><QM]!LMK(<-3GAI,3H I:,Q<
MH<'M[K*>^*#^\K?#0--<N&,#Y>7\RY?Y[,-JGO[SZ_3K-.,L+]_AXL-G$O#+
ML/S\+DS)$/#C] M>_GQB,O)L#0=E#/''A8(@4P1G>?+6F?K68ROP[/'A_85:
M#0 UM!*Z.P&OF\MOI6!:3;\B<9QPW7PW$<0.%R1$D:,!I70"KQ!!1(%!2I1<
MM$X+=R)PW!<6QSH+6VJI PA>%]M$&ZU%?=#(3:$ ,CL!0:A0M_$XR74UGR%3
MR'$?4QPGB-])QAT/35C[Y<_S,]+)LJX47GT_H%/YX5_6JE]Y2W(;=2U??,)5
ML[M)E)IA!$_I&"B)'B)R.I_0:5Z4T,FU[LB\24&[71EK.?[R?3T"]:*<PF,M
MH5&^F5S2A&)>;<(F*)F\7K2LB.9[SQXA9]PZP %Z?WC-Q6$B[^"(^4 *P'IT
M7HB'XKH_YS/Z]F*>O8V"QZ S&%?;W5PD<055O\I"L:B#5*U;3Q\EJ)=]%0>J
M_3:<FNF@ T#=XN'R;B"$;(L-D&2=Q1B< U\GB"HF>.'&Q*Q:3]6\EY"1 =1.
MT?/64N\ .M>2RLT=4"[<F6@*,*E$W45:-U:1A&*H'5<9*9%L?3C?(:*'4^L@
MQ=YYE7Z(E#N R8N_PB+_N*1&$[)VQ+OE@M7>6P%.Z@+U\;R/V3(N6_<'W2"@
MEZT-;8^D_67< 4#65:A?PA)SM1N<+3?J6(39I[7[7?[R_>K?O O?U\])*L=7
M;,_RN[,PN]8^[I/TEOL()63*,5V)0%^L6Z\*%NV2,*U=T1!\C.O-#H#5[9AI
M;!UW@//W2+G,-*TP7_?FTA>>#7ESEW@DJ=95CUYYT/6F,1)[Q;:^#+Z7D)%#
MK='Q<:=-]U!E=8"X2WFLS3=S9S7/$6RTLC[C-^!5]B L!N9Y\KYY<GC]\\>]
MJ!OJX-U;PAVAX]):"--D(@&XS8YLQ')R[R'7_6(N$ =:\=97(CV==?MK\@%(
M["'6L>]J+R<UKFWDW?DB?29O6_G9N#^1,HNJW@$J6Q_.U'MGP15YPY)3L8E8
MW.Y>]HD/Z@,)^RAP/I T.W 7:X^Y\9]7=SF%'"?7DH$VB<[8$#PX77M6=% D
M-_16M"Y9WTO(N-?V0QTOA\M\;)>R)OWU<GF.^=?SQ73VZ6+=RSJ66ZY_^/;/
MJJ4ZV>C?H<9[=54;+M*4XKP).LV8R\2:%V1[%B7XI!20W3GE)":9^58.YR R
M1GZ!=C@&YJ,HI .?]2BSMT+\=2+Q!E=ORZOYHN"TKA%83IP3*(,H$*VG2"#6
M/M!"B02)WU@NC9+6-_9O!Q,]\ONW9G@=1XL]P';-66W*(B8^AF]U(FF]<*_;
M*N:+^W/EB>#:LIKMBJSIG!$\0%0E@1;&)R%5<,U?NNQ#Y[AYX #@'%I7/>#Q
M,0-\,,PELTN2LT095$F:S*Z8!%X4 =X@UT*%Z+#]??1>I(X;/A[993;2V(C
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MK/_X%PGEQR- /D%O92A2@DE\W6;.(; <P&:7<M&Z&&S]=J0E_2,/+>K 1,8
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ME%P+.@ =$U:2,$L(K=L7;A#P7!KN=@+!O)5&.H#3_H*[8GN6;_4GB:*D82B
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M;>@6'S9NP6X   TBY0ZBV35+=&3/Z9@D_<P^W>!HDJ)P)J4(Z.K]NXL(P?$
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MU/5;[Q,6R2@@'ZK!LR>8C=^I=9AN3J,O^[=")K>:?KVZ,'U/$4>;[NS'?_<
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MSV  :23/[H#Q>E:?^4^_XO(="7.^WKRUGC&[WF)QL=E\71><8%WKZR3A7Z9
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M=P%RH(#'K@\0%ZLPR],O],?'Q3E^2%.<)=PP5X/(31*L(XH<!*_/%RCP4]Y
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M:6\N:'1M4$L! A0#%     @ P8 D6[1@1N 4"   D"4  !X
M ( !&1   &5X,S$R8V9O<V5C,S R8V5R=&EF:6-A=&EO+FAT;5!+ 0(4 Q0
M   ( ,& )%O&O)G[9@0  - .   >              "  6D8  !E>#,R,6-E
M;W-E8SDP-F-E<G1I9FEC871I;RYH=&U02P$"% ,4    " #!@"1;_<L4374$
M  !B$   '@              @ $+'0  97@S,C)C9F]S96,Y,#9C97)T:69I
M8V%T:6\N:'1M4$L! A0#%     @ P8 D6R39SJ =*P  ^ID  !@
M     ( !O"$  &EN<VED97)T<F%D:6YG<&]L:6-Y+FAT;5!+ 0(4 Q0    (
M ,& )%M20LAG0)(" ,\_&@ 1              "  0]-  !L9G9N+3(P,C4P
M-C,P+FAT;5!+ 0(4 Q0    ( ,& )%ND@K&1:Q$  /['   1
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M! !L9G9N+3(P,C4P-C,P7W!R92YX;6Q02P4&      T #0"8 P  6#P%

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>111
<FILENAME>lfvn-20250630_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:country="http://xbrl.sec.gov/country/2025"
  xmlns:cyd="http://xbrl.sec.gov/cyd/2025"
  xmlns:dei="http://xbrl.sec.gov/dei/2025"
  xmlns:ecd="http://xbrl.sec.gov/ecd/2025"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:lfvn="http://www.lifevantage.com/20250630"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2025"
  xmlns:us-gaap="http://fasb.org/us-gaap/2025"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="lfvn-20250630.xsd" xlink:type="simple"/>
    <context id="c-1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c-2">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-3">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
        </entity>
        <period>
            <instant>2025-09-03</instant>
        </period>
    </context>
    <context id="c-4">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">lfvn:MichaelBeindorffMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c-5">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">lfvn:MichaelBeindorffMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c-6">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c-7">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c-8">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c-9">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-10">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-11">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-12">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-13">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-14">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c-15">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c-16">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c-17">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c-18">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c-19">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c-20">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c-21">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c-22">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c-23">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c-24">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c-25">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c-26">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c-27">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c-28">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c-29">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
        </entity>
        <period>
            <instant>2018-03-31</instant>
        </period>
    </context>
    <context id="c-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:InventoryValuationReserveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c-32">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:InventoryValuationReserveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-33">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:InventoryValuationReserveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c-34">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:InventoryValuationReserveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c-35">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:InventoryValuationReserveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c-36">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c-37">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c-38">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c-39">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:VehiclesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c-40">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">lfvn:CashAccountsHeldPrimarilyAtFinancialInstitutionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c-41">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">lfvn:CashAccountsHeldatOtherFinancialInstitutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c-42">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:SalesReturnsAndAllowancesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c-43">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:SalesReturnsAndAllowancesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-44">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:SalesReturnsAndAllowancesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c-45">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:SalesReturnsAndAllowancesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c-46">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:SalesReturnsAndAllowancesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c-47">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c-48">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c-49">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c-50">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c-51">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c-52">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:VehiclesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c-53">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:PatentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c-54">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:PatentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c-55">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c-56">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c-57">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">lfvn:March2016TermLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2016-03-30</instant>
        </period>
    </context>
    <context id="c-58">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">lfvn:March2016RevolvingLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2016-03-30</instant>
        </period>
    </context>
    <context id="c-59">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">lfvn:March2016RevolvingLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-04-12</instant>
        </period>
    </context>
    <context id="c-60">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">lfvn:March2016RevolvingLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c-61">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">lfvn:March2016RevolvingLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-04-01</endDate>
        </period>
    </context>
    <context id="c-62">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c-63">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c-64">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c-65">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">lfvn:EmployeeStockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c-66">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">lfvn:EmployeeStockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c-67">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
        </entity>
        <period>
            <instant>2022-02-17</instant>
        </period>
    </context>
    <context id="c-68">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
        </entity>
        <period>
            <instant>2023-08-30</instant>
        </period>
    </context>
    <context id="c-69">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="c-70">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
        </entity>
        <period>
            <startDate>2024-10-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-71">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-72">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
        </entity>
        <period>
            <startDate>2025-04-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c-73">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
        </entity>
        <period>
            <startDate>2023-09-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-74">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
        </entity>
        <period>
            <startDate>2023-10-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-75">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-76">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-77">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c-78">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">lfvn:TwoThousandSeventeenLongTermIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-07-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="c-79">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">lfvn:TwoThousandSeventeenLongTermIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-11-09</startDate>
            <endDate>2023-11-09</endDate>
        </period>
    </context>
    <context id="c-80">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">lfvn:TwoThousandSeventeenLongTermIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c-81">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">lfvn:TwoThousandSeventeenLongTermIncentivePlanExcludingTwoThousandAndTenLongTermIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-02-02</instant>
        </period>
    </context>
    <context id="c-82">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">lfvn:TwoThousandAndTenLongTermIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-02-02</instant>
        </period>
    </context>
    <context id="c-83">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">lfvn:TwoThousandSeventeenLongTermIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c-84">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">lfvn:TwoThousandSeventeenLongTermIncentivePlanExcludingTwoThousandAndTenLongTermIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-02-16</startDate>
            <endDate>2017-02-16</endDate>
        </period>
    </context>
    <context id="c-85">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">lfvn:EmployeeStockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-08-31</instant>
        </period>
    </context>
    <context id="c-86">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">lfvn:EmployeeStockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c-87">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">lfvn:TwoThousandAndTenAndTwoThousandSeventeenLongTermIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c-88">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">lfvn:TwoThousandAndTenAndTwoThousandSeventeenLongTermIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c-89">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-90">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-91">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c-92">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c-93">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-11-03</startDate>
            <endDate>2023-11-03</endDate>
        </period>
    </context>
    <context id="c-94">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-11-03</startDate>
            <endDate>2023-11-03</endDate>
        </period>
    </context>
    <context id="c-95">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">lfvn:PerformanceStockUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-11-03</startDate>
            <endDate>2023-11-03</endDate>
        </period>
    </context>
    <context id="c-96">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-97">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c-98">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c-99">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c-100">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c-101">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">lfvn:PerformanceStockUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="c-102">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">lfvn:PerformanceStockUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="c-103">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">lfvn:PerformanceStockUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="c-104">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">lfvn:PerformanceStockUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-105">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">lfvn:PerformanceStockUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c-106">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">lfvn:PerformanceStockUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c-107">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">lfvn:PerformanceStockUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c-108">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">lfvn:PerformanceStockUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c-109">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c-110">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c-111">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c-112">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c-113">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c-114">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c-115">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lfvn:ReportableSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c-116">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lfvn:ReportableSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c-117">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c-118">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c-119">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:JP</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c-120">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:JP</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c-121">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">lfvn:OtherForeignMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c-122">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">lfvn:OtherForeignMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c-123">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c-124">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c-125">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c-126">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c-127">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:JP</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c-128">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:JP</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c-129">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">lfvn:OtherForeignMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c-130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">lfvn:OtherForeignMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c-131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c-132">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c-133">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lfvn:ProtandimandTrueScienceProductLineMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c-134">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lfvn:ProtandimandTrueScienceProductLineMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c-135">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lfvn:ProtandimMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c-136">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lfvn:ProtandimMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c-137">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lfvn:LifeVantageTrueScienceSkinCareRegimenMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c-138">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lfvn:LifeVantageTrueScienceSkinCareRegimenMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c-139">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lfvn:TrueScienceProductLineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c-140">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lfvn:TrueScienceProductLineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c-141">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lfvn:AXIOProductLineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c-142">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lfvn:AXIOProductLineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c-143">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lfvn:PhysIQProductLineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c-144">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lfvn:PhysIQProductLineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c-145">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lfvn:PetandimProductLineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c-146">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lfvn:PetandimProductLineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c-147">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c-148">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <unit id="usdPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="number">
        <measure>pure</measure>
    </unit>
    <unit id="lease">
        <measure>lfvn:lease</measure>
    </unit>
    <unit id="region">
        <measure>lfvn:region</measure>
    </unit>
    <unit id="productline">
        <measure>lfvn:productLine</measure>
    </unit>
    <unit id="segment">
        <measure>lfvn:segment</measure>
    </unit>
    <dei:EntityCentralIndexKey contextRef="c-1" id="f-33">0000849146</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag contextRef="c-1" id="f-34">false</dei:AmendmentFlag>
    <dei:DocumentFiscalYearFocus contextRef="c-1" id="f-35">2025</dei:DocumentFiscalYearFocus>
    <dei:DocumentFiscalPeriodFocus contextRef="c-1" id="f-36">FY</dei:DocumentFiscalPeriodFocus>
    <us-gaap:RevenueFromContractWithCustomerProductAndServiceExtensibleList contextRef="c-1" id="f-140">http://fasb.org/us-gaap/2025#ProductMember</us-gaap:RevenueFromContractWithCustomerProductAndServiceExtensibleList>
    <us-gaap:RevenueFromContractWithCustomerProductAndServiceExtensibleList contextRef="c-8" id="f-141">http://fasb.org/us-gaap/2025#ProductMember</us-gaap:RevenueFromContractWithCustomerProductAndServiceExtensibleList>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1 contextRef="c-83" id="f-495">P3Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage contextRef="c-109" decimals="4" id="f-618" unitRef="number">0.3333</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage contextRef="c-110" decimals="4" id="f-619" unitRef="number">0.0833</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage>
    <us-gaap:LesseeOperatingLeaseTermOfContract contextRef="c-113" id="f-748">P1Y</us-gaap:LesseeOperatingLeaseTermOfContract>
    <us-gaap:NumberOfOperatingSegments
      contextRef="c-1"
      decimals="INF"
      id="f-852"
      unitRef="segment">1</us-gaap:NumberOfOperatingSegments>
    <dei:DocumentType contextRef="c-1" id="f-1">10-K</dei:DocumentType>
    <dei:DocumentAnnualReport contextRef="c-1" id="f-2">true</dei:DocumentAnnualReport>
    <dei:DocumentPeriodEndDate contextRef="c-1" id="f-4">2025-06-30</dei:DocumentPeriodEndDate>
    <dei:CurrentFiscalYearEndDate contextRef="c-1" id="f-3">--06-30</dei:CurrentFiscalYearEndDate>
    <dei:DocumentTransitionReport contextRef="c-1" id="f-5">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber contextRef="c-1" id="f-6">001-35647</dei:EntityFileNumber>
    <dei:EntityRegistrantName contextRef="c-1" id="f-7">LIFEVANTAGE CORP</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="c-1" id="f-8">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber contextRef="c-1" id="f-9">90-0224471</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="c-1" id="f-10">3300 N. Triumph Blvd</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="c-1" id="f-11">Suite 700</dei:EntityAddressAddressLine2>
    <dei:EntityAddressPostalZipCode contextRef="c-1" id="f-12">84043</dei:EntityAddressPostalZipCode>
    <dei:EntityAddressCityOrTown contextRef="c-1" id="f-13">Lehi</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="c-1" id="f-14">UT</dei:EntityAddressStateOrProvince>
    <dei:CityAreaCode contextRef="c-1" id="f-15">801</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="c-1" id="f-16">432-9000</dei:LocalPhoneNumber>
    <dei:Security12bTitle contextRef="c-1" id="f-17">Common Stock, par value $0.0001</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="c-1" id="f-18">LFVN</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="c-1" id="f-19">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityWellKnownSeasonedIssuer contextRef="c-1" id="f-20">No</dei:EntityWellKnownSeasonedIssuer>
    <dei:EntityVoluntaryFilers contextRef="c-1" id="f-21">No</dei:EntityVoluntaryFilers>
    <dei:EntityCurrentReportingStatus contextRef="c-1" id="f-22">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent contextRef="c-1" id="f-23">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory contextRef="c-1" id="f-24">Accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness contextRef="c-1" id="f-25">true</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany contextRef="c-1" id="f-26">false</dei:EntityEmergingGrowthCompany>
    <dei:IcfrAuditorAttestationFlag contextRef="c-1" id="f-27">true</dei:IcfrAuditorAttestationFlag>
    <dei:DocumentFinStmtErrorCorrectionFlag contextRef="c-1" id="f-28">false</dei:DocumentFinStmtErrorCorrectionFlag>
    <dei:EntityShellCompany contextRef="c-1" id="f-29">false</dei:EntityShellCompany>
    <dei:EntityPublicFloat contextRef="c-2" decimals="-5" id="f-30" unitRef="usd">220000000.0</dei:EntityPublicFloat>
    <dei:EntityCommonStockSharesOutstanding contextRef="c-3" decimals="INF" id="f-31" unitRef="shares">12691009</dei:EntityCommonStockSharesOutstanding>
    <dei:DocumentsIncorporatedByReferenceTextBlock contextRef="c-1" id="f-32">Portions of the registrant&#x2019;s definitive proxy statement to be filed subsequent to the date hereof with the Securities and Exchange Commission pursuant to Regulation 14A in connection with the registrant&#x2019;s fiscal year 2026 annual meeting of stockholders are incorporated by reference into Part III of this report. Such definitive proxy statement will be filed with the Commission not later than 120 days after the end of the registrant&#x2019;s fiscal year ended June 30, 2025.</dei:DocumentsIncorporatedByReferenceTextBlock>
    <cyd:CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock contextRef="c-1" id="f-37">&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We have implemented and maintain a cybersecurity risk management program through our security steering committee, which is designed to assess risks from cybersecurity threats, monitor our information systems for potential vulnerabilities, and test those systems pursuant to our cybersecurity policies, processes, and practices, which are integrated into our overall risk management program. The members of our security steering committee represent the following functional areas: cybersecurity and infrastructure; corporate risk and privacy; personnel; and finance and fraud management. The security steering committee collaborates with and manages third parties, as appropriate, to assess the effectiveness of our cybersecurity prevention and response systems and processes. These third parties may include cybersecurity assessors, consultants, and other external cybersecurity experts to assist in the identification, verification, and validation of cybersecurity risks, as well as to support associated mitigation plans when necessary. To protect our information systems from cybersecurity threats, we also ask our employees to take periodic cybersecurity training and we use various security tools that are designed to help identify, escalate, investigate, resolve, and recover from security incidents in a timely manner.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We have not identified risks from known cybersecurity threats to the business, including as a result of any prior cybersecurity incidents, that have materially affected or are reasonably likely to materially affect our Company, including our business strategy, results of operations, or financial condition. See our risk factor &#x201c;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;We are subject to evolving laws, policies, and contractual obligations related to data privacy and security, including cybersecurity, and our actual or perceived failure to comply with such obligations or perceived failure to maintain the integrity of our data could expose us to data loss or litigation, harm our reputation, subject us to significant fines and liability, or otherwise affect our business, prospects, financial condition, and operating results.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x201d; in Part I, Item 1A. (&#x201c;Risk Factors&#x201d;) for additional details regarding cybersecurity risks and potential impacts on our business.&lt;/span&gt;&lt;/div&gt;</cyd:CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock>
    <cyd:CybersecurityRiskManagementProcessesIntegratedTextBlock contextRef="c-1" id="f-38">We have implemented and maintain a cybersecurity risk management program through our security steering committee, which is designed to assess risks from cybersecurity threats, monitor our information systems for potential vulnerabilities, and test those systems pursuant to our cybersecurity policies, processes, and practices, which are integrated into our overall risk management program.</cyd:CybersecurityRiskManagementProcessesIntegratedTextBlock>
    <cyd:CybersecurityRiskManagementProcessesIntegratedFlag contextRef="c-1" id="f-39">true</cyd:CybersecurityRiskManagementProcessesIntegratedFlag>
    <cyd:CybersecurityRiskManagementThirdPartyEngagedFlag contextRef="c-1" id="f-40">true</cyd:CybersecurityRiskManagementThirdPartyEngagedFlag>
    <cyd:CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag contextRef="c-1" id="f-41">true</cyd:CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag>
    <cyd:CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag contextRef="c-1" id="f-42">false</cyd:CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag>
    <cyd:CybersecurityRiskBoardOfDirectorsOversightTextBlock contextRef="c-1" id="f-43">Our board is actively involved in the assessment, oversight and management of the material risks that could affect the Company.</cyd:CybersecurityRiskBoardOfDirectorsOversightTextBlock>
    <cyd:CybersecurityRiskRoleOfManagementTextBlock contextRef="c-1" id="f-46">Our board has delegated to the audit committee the oversight responsibility for risks and incidents relating to cybersecurity threats, including compliance with disclosure requirements, cooperation with law enforcement, and related effects on financial and other risks. The audit committee reports any material or notable cybersecurity incidents, findings and recommendations, as appropriate, to the full board for consideration. Our Chief Information and Innovation Officer (&#x201c;CIIO&#x201d;) also presents to the audit committee and to the board, as appropriate, any updates, changes, or improvements on the Company&#x2019;s cybersecurity risk management program.</cyd:CybersecurityRiskRoleOfManagementTextBlock>
    <cyd:CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock contextRef="c-1" id="f-44">Our board has delegated to the audit committee the oversight responsibility for risks and incidents relating to cybersecurity threats, including compliance with disclosure requirements, cooperation with law enforcement, and related effects on financial and other risks. The audit committee reports any material or notable cybersecurity incidents, findings and recommendations, as appropriate, to the full board for consideration. Our Chief Information and Innovation Officer (&#x201c;CIIO&#x201d;) also presents to the audit committee and to the board, as appropriate, any updates, changes, or improvements on the Company&#x2019;s cybersecurity risk management program.</cyd:CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock>
    <cyd:CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock contextRef="c-1" id="f-45">Our board has delegated to the audit committee the oversight responsibility for risks and incidents relating to cybersecurity threats, including compliance with disclosure requirements, cooperation with law enforcement, and related effects on financial and other risks.</cyd:CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock>
    <cyd:CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock contextRef="c-1" id="f-48">Our Chief Information and Innovation Officer (&#x201c;CIIO&#x201d;) also presents to the audit committee and to the board, as appropriate, any updates, changes, or improvements on the Company&#x2019;s cybersecurity risk management program.</cyd:CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock>
    <cyd:CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock contextRef="c-1" id="f-47">Our Chief Information and Innovation Officer (&#x201c;CIIO&#x201d;) also presents to the audit committee and to the board, as appropriate, any updates, changes, or improvements on the Company&#x2019;s cybersecurity risk management program.</cyd:CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock>
    <cyd:CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag contextRef="c-1" id="f-49">true</cyd:CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag>
    <cyd:CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag contextRef="c-1" id="f-50">true</cyd:CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag>
    <cyd:CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock contextRef="c-1" id="f-51">Our CIIO, with over 40 years of experience in IT and operational technology security, has the primary responsibility of overseeing our cybersecurity risk management program and assessing and managing any material risks related to cybersecurity threats.</cyd:CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock>
    <ecd:NonRule10b51ArrAdoptedFlag contextRef="c-1" id="f-52">false</ecd:NonRule10b51ArrAdoptedFlag>
    <ecd:NonRule10b51ArrTrmntdFlag contextRef="c-1" id="f-53">false</ecd:NonRule10b51ArrTrmntdFlag>
    <ecd:Rule10b51ArrTrmntdFlag contextRef="c-1" id="f-54">false</ecd:Rule10b51ArrTrmntdFlag>
    <ecd:MtrlTermsOfTrdArrTextBlock contextRef="c-4" id="f-55">&lt;div style="text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As previously reported, on February 10, 2025, Michael Beindorff, a director, adopted a sales plan designed to comply with Rule 10b5-1 under the Exchange Act. The sales plan, which Mr. Beindorff adopted in compliance with restrictions imposed by our Insider Trading Policy, provided for sales of shares of LifeVantage Corporation common stock owned by Mr. Beindorff. Total sales on Mr. Beindorff&#x2019;s behalf under the sales plan were limited to 1,000 shares per month, beginning in May 2025 and continuing through October 2026, and up to a maximum of 18,000 shares could be sold under the plan. On May 12, 2025, Mr. Beindorff terminated this 10b5-1 plan.&lt;/span&gt;&lt;/div&gt;</ecd:MtrlTermsOfTrdArrTextBlock>
    <ecd:TrdArrAdoptionDate contextRef="c-4" id="f-56">February 10, 2025</ecd:TrdArrAdoptionDate>
    <ecd:TrdArrIndName contextRef="c-4" id="f-57">Michael Beindorff</ecd:TrdArrIndName>
    <ecd:TrdArrIndTitle contextRef="c-4" id="f-58">director</ecd:TrdArrIndTitle>
    <ecd:Rule10b51ArrAdoptedFlag contextRef="c-4" id="f-59">true</ecd:Rule10b51ArrAdoptedFlag>
    <ecd:TrdArrExpirationDate contextRef="c-4" id="f-60">October 2026</ecd:TrdArrExpirationDate>
    <ecd:TrdArrSecuritiesAggAvailAmt contextRef="c-5" decimals="-3" id="f-61" unitRef="shares">18000</ecd:TrdArrSecuritiesAggAvailAmt>
    <ecd:InsiderTrdPoliciesProcAdoptedFlag contextRef="c-1" id="f-62">true</ecd:InsiderTrdPoliciesProcAdoptedFlag>
    <dei:AuditorFirmId contextRef="c-1" id="f-63">34</dei:AuditorFirmId>
    <dei:AuditorName contextRef="c-1" id="f-64">Deloitte &amp; Touche LLP</dei:AuditorName>
    <dei:AuditorLocation contextRef="c-1" id="f-65">Salt Lake City, Utah</dei:AuditorLocation>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c-6" decimals="-3" id="f-66" unitRef="usd">20201000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c-7" decimals="-3" id="f-67" unitRef="usd">16886000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:AccountsReceivableNetCurrent contextRef="c-6" decimals="-3" id="f-68" unitRef="usd">3294000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent contextRef="c-7" decimals="-3" id="f-69" unitRef="usd">2949000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:IncomeTaxesReceivable contextRef="c-6" decimals="-3" id="f-70" unitRef="usd">635000</us-gaap:IncomeTaxesReceivable>
    <us-gaap:IncomeTaxesReceivable contextRef="c-7" decimals="-3" id="f-71" unitRef="usd">313000</us-gaap:IncomeTaxesReceivable>
    <us-gaap:InventoryNet contextRef="c-6" decimals="-3" id="f-72" unitRef="usd">20669000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet contextRef="c-7" decimals="-3" id="f-73" unitRef="usd">15055000</us-gaap:InventoryNet>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent contextRef="c-6" decimals="-3" id="f-74" unitRef="usd">6095000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent contextRef="c-7" decimals="-3" id="f-75" unitRef="usd">2443000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:AssetsCurrent contextRef="c-6" decimals="-3" id="f-76" unitRef="usd">50894000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent contextRef="c-7" decimals="-3" id="f-77" unitRef="usd">37646000</us-gaap:AssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="c-6" decimals="-3" id="f-78" unitRef="usd">6207000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="c-7" decimals="-3" id="f-79" unitRef="usd">7813000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:OperatingLeaseRightOfUseAsset contextRef="c-6" decimals="-3" id="f-80" unitRef="usd">8041000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset contextRef="c-7" decimals="-3" id="f-81" unitRef="usd">9569000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill contextRef="c-6" decimals="-3" id="f-82" unitRef="usd">245000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill contextRef="c-7" decimals="-3" id="f-83" unitRef="usd">323000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:DeferredIncomeTaxAssetsNet contextRef="c-6" decimals="-3" id="f-84" unitRef="usd">5970000</us-gaap:DeferredIncomeTaxAssetsNet>
    <us-gaap:DeferredIncomeTaxAssetsNet contextRef="c-7" decimals="-3" id="f-85" unitRef="usd">4268000</us-gaap:DeferredIncomeTaxAssetsNet>
    <us-gaap:OtherAssetsNoncurrent contextRef="c-6" decimals="-3" id="f-86" unitRef="usd">601000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent contextRef="c-7" decimals="-3" id="f-87" unitRef="usd">680000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:Assets contextRef="c-6" decimals="-3" id="f-88" unitRef="usd">71958000</us-gaap:Assets>
    <us-gaap:Assets contextRef="c-7" decimals="-3" id="f-89" unitRef="usd">60299000</us-gaap:Assets>
    <us-gaap:AccountsPayableCurrent contextRef="c-6" decimals="-3" id="f-90" unitRef="usd">4600000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent contextRef="c-7" decimals="-3" id="f-91" unitRef="usd">5853000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccruedSalesCommissionCurrent contextRef="c-6" decimals="-3" id="f-92" unitRef="usd">7237000</us-gaap:AccruedSalesCommissionCurrent>
    <us-gaap:AccruedSalesCommissionCurrent contextRef="c-7" decimals="-3" id="f-93" unitRef="usd">6569000</us-gaap:AccruedSalesCommissionCurrent>
    <us-gaap:AccruedIncomeTaxesCurrent contextRef="c-6" decimals="-3" id="f-94" unitRef="usd">0</us-gaap:AccruedIncomeTaxesCurrent>
    <us-gaap:AccruedIncomeTaxesCurrent contextRef="c-7" decimals="-3" id="f-95" unitRef="usd">202000</us-gaap:AccruedIncomeTaxesCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent contextRef="c-6" decimals="-3" id="f-96" unitRef="usd">1867000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent contextRef="c-7" decimals="-3" id="f-97" unitRef="usd">1811000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:AccruedLiabilitiesCurrent contextRef="c-6" decimals="-3" id="f-98" unitRef="usd">13513000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent contextRef="c-7" decimals="-3" id="f-99" unitRef="usd">7874000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent contextRef="c-6" decimals="-3" id="f-100" unitRef="usd">27217000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent contextRef="c-7" decimals="-3" id="f-101" unitRef="usd">22309000</us-gaap:LiabilitiesCurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent contextRef="c-6" decimals="-3" id="f-102" unitRef="usd">9811000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent contextRef="c-7" decimals="-3" id="f-103" unitRef="usd">11801000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent contextRef="c-6" decimals="-3" id="f-104" unitRef="usd">289000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent contextRef="c-7" decimals="-3" id="f-105" unitRef="usd">198000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:Liabilities contextRef="c-6" decimals="-3" id="f-106" unitRef="usd">37317000</us-gaap:Liabilities>
    <us-gaap:Liabilities contextRef="c-7" decimals="-3" id="f-107" unitRef="usd">34308000</us-gaap:Liabilities>
    <us-gaap:CommitmentsAndContingencies contextRef="c-6" id="f-108" unitRef="usd" xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies contextRef="c-7" id="f-109" unitRef="usd" xsi:nil="true"/>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="c-7"
      decimals="INF"
      id="f-110"
      unitRef="usdPerShare">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="c-6"
      decimals="INF"
      id="f-111"
      unitRef="usdPerShare">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized contextRef="c-7" decimals="INF" id="f-112" unitRef="shares">5000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized contextRef="c-6" decimals="INF" id="f-113" unitRef="shares">5000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesOutstanding contextRef="c-7" decimals="INF" id="f-114" unitRef="shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesIssued contextRef="c-6" decimals="INF" id="f-115" unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesIssued contextRef="c-7" decimals="INF" id="f-116" unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding contextRef="c-6" decimals="INF" id="f-117" unitRef="shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockValue contextRef="c-6" decimals="-3" id="f-118" unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockValue contextRef="c-7" decimals="-3" id="f-119" unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="c-7"
      decimals="INF"
      id="f-120"
      unitRef="usdPerShare">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="c-6"
      decimals="INF"
      id="f-121"
      unitRef="usdPerShare">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized contextRef="c-7" decimals="INF" id="f-122" unitRef="shares">40000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized contextRef="c-6" decimals="INF" id="f-123" unitRef="shares">40000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued contextRef="c-6" decimals="INF" id="f-124" unitRef="shares">12429000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding contextRef="c-6" decimals="INF" id="f-125" unitRef="shares">12429000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesOutstanding contextRef="c-7" decimals="INF" id="f-126" unitRef="shares">12510000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued contextRef="c-7" decimals="INF" id="f-127" unitRef="shares">12510000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockValue contextRef="c-6" decimals="-3" id="f-128" unitRef="usd">1000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue contextRef="c-7" decimals="-3" id="f-129" unitRef="usd">1000</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapitalCommonStock contextRef="c-6" decimals="-3" id="f-130" unitRef="usd">139962000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:AdditionalPaidInCapitalCommonStock contextRef="c-7" decimals="-3" id="f-131" unitRef="usd">136644000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="c-6" decimals="-3" id="f-132" unitRef="usd">-104147000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="c-7" decimals="-3" id="f-133" unitRef="usd">-108738000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax contextRef="c-6" decimals="-3" id="f-134" unitRef="usd">-1175000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax contextRef="c-7" decimals="-3" id="f-135" unitRef="usd">-1916000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockholdersEquity contextRef="c-6" decimals="-3" id="f-136" unitRef="usd">34641000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-7" decimals="-3" id="f-137" unitRef="usd">25991000</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="c-6" decimals="-3" id="f-138" unitRef="usd">71958000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="c-7" decimals="-3" id="f-139" unitRef="usd">60299000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-1" decimals="-3" id="f-142" unitRef="usd">228530000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-8" decimals="-3" id="f-143" unitRef="usd">200164000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:CostOfGoodsAndServicesSold contextRef="c-1" decimals="-3" id="f-144" unitRef="usd">44864000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold contextRef="c-8" decimals="-3" id="f-145" unitRef="usd">41440000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:GrossProfit contextRef="c-1" decimals="-3" id="f-146" unitRef="usd">183666000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit contextRef="c-8" decimals="-3" id="f-147" unitRef="usd">158724000</us-gaap:GrossProfit>
    <lfvn:CommissionAndIncentives contextRef="c-1" decimals="-3" id="f-148" unitRef="usd">102260000</lfvn:CommissionAndIncentives>
    <lfvn:CommissionAndIncentives contextRef="c-8" decimals="-3" id="f-149" unitRef="usd">85920000</lfvn:CommissionAndIncentives>
    <us-gaap:SellingGeneralAndAdministrativeExpense contextRef="c-1" decimals="-3" id="f-150" unitRef="usd">69207000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense contextRef="c-8" decimals="-3" id="f-151" unitRef="usd">68472000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:OperatingExpenses contextRef="c-1" decimals="-3" id="f-152" unitRef="usd">171467000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses contextRef="c-8" decimals="-3" id="f-153" unitRef="usd">154392000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingIncomeLoss contextRef="c-1" decimals="-3" id="f-154" unitRef="usd">12199000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="c-8" decimals="-3" id="f-155" unitRef="usd">4332000</us-gaap:OperatingIncomeLoss>
    <us-gaap:InterestRevenueExpenseNet contextRef="c-1" decimals="-3" id="f-156" unitRef="usd">431000</us-gaap:InterestRevenueExpenseNet>
    <us-gaap:InterestRevenueExpenseNet contextRef="c-8" decimals="-3" id="f-157" unitRef="usd">430000</us-gaap:InterestRevenueExpenseNet>
    <us-gaap:OtherNonoperatingIncomeExpense contextRef="c-1" decimals="-3" id="f-158" unitRef="usd">-387000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense contextRef="c-8" decimals="-3" id="f-159" unitRef="usd">-412000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense contextRef="c-1" decimals="-3" id="f-160" unitRef="usd">44000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense contextRef="c-8" decimals="-3" id="f-161" unitRef="usd">18000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c-1" decimals="-3" id="f-162" unitRef="usd">12243000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c-8" decimals="-3" id="f-163" unitRef="usd">4350000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-1" decimals="-3" id="f-164" unitRef="usd">2438000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-8" decimals="-3" id="f-165" unitRef="usd">1413000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:NetIncomeLoss contextRef="c-1" decimals="-3" id="f-166" unitRef="usd">9805000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-8" decimals="-3" id="f-167" unitRef="usd">2937000</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-1"
      decimals="2"
      id="f-168"
      unitRef="usdPerShare">0.80</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-8"
      decimals="2"
      id="f-169"
      unitRef="usdPerShare">0.24</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-1"
      decimals="2"
      id="f-170"
      unitRef="usdPerShare">0.75</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-8"
      decimals="2"
      id="f-171"
      unitRef="usdPerShare">0.23</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-1" decimals="-3" id="f-172" unitRef="shares">12251000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-8" decimals="-3" id="f-173" unitRef="shares">12458000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment contextRef="c-1" decimals="-3" id="f-174" unitRef="shares">12987000</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
    <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment contextRef="c-8" decimals="-3" id="f-175" unitRef="shares">12986000</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax contextRef="c-1" decimals="-3" id="f-176" unitRef="usd">741000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax contextRef="c-8" decimals="-3" id="f-177" unitRef="usd">-555000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax contextRef="c-1" decimals="-3" id="f-178" unitRef="usd">741000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax contextRef="c-8" decimals="-3" id="f-179" unitRef="usd">-555000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest contextRef="c-1" decimals="-3" id="f-180" unitRef="usd">10546000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest contextRef="c-8" decimals="-3" id="f-181" unitRef="usd">2382000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:CommonStockSharesOutstanding contextRef="c-9" decimals="-3" id="f-182" unitRef="shares">12622000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity contextRef="c-9" decimals="-3" id="f-183" unitRef="usd">1000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-10" decimals="-3" id="f-184" unitRef="usd">134314000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-11" decimals="-3" id="f-185" unitRef="usd">-98305000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-12" decimals="-3" id="f-186" unitRef="usd">-1361000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-13" decimals="-3" id="f-187" unitRef="usd">34649000</us-gaap:StockholdersEquity>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c-14" decimals="-3" id="f-188" unitRef="usd">3280000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c-8" decimals="-3" id="f-189" unitRef="usd">3280000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans contextRef="c-15" decimals="-3" id="f-190" unitRef="shares">64000</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan contextRef="c-14" decimals="-3" id="f-191" unitRef="usd">271000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan contextRef="c-8" decimals="-3" id="f-192" unitRef="usd">271000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures contextRef="c-15" decimals="-3" id="f-193" unitRef="shares">1007000</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures>
    <us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation contextRef="c-15" decimals="-3" id="f-194" unitRef="shares">206000</us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation contextRef="c-14" decimals="-3" id="f-195" unitRef="usd">1221000</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation contextRef="c-8" decimals="-3" id="f-196" unitRef="usd">1221000</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:StockRepurchasedDuringPeriodShares contextRef="c-15" decimals="-3" id="f-197" unitRef="shares">977000</us-gaap:StockRepurchasedDuringPeriodShares>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodValue contextRef="c-16" decimals="-3" id="f-198" unitRef="usd">6430000</us-gaap:StockRepurchasedAndRetiredDuringPeriodValue>
    <us-gaap:StockRepurchasedDuringPeriodValue contextRef="c-8" decimals="-3" id="f-199" unitRef="usd">6430000</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:DividendsCash contextRef="c-16" decimals="-3" id="f-200" unitRef="usd">6940000</us-gaap:DividendsCash>
    <us-gaap:DividendsCash contextRef="c-8" decimals="-3" id="f-201" unitRef="usd">6940000</us-gaap:DividendsCash>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax contextRef="c-17" decimals="-3" id="f-202" unitRef="usd">-555000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax contextRef="c-8" decimals="-3" id="f-203" unitRef="usd">-555000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:NetIncomeLoss contextRef="c-16" decimals="-3" id="f-204" unitRef="usd">2937000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-8" decimals="-3" id="f-205" unitRef="usd">2937000</us-gaap:NetIncomeLoss>
    <us-gaap:CommonStockSharesOutstanding contextRef="c-18" decimals="-3" id="f-206" unitRef="shares">12510000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity contextRef="c-18" decimals="-3" id="f-207" unitRef="usd">1000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-19" decimals="-3" id="f-208" unitRef="usd">136644000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-20" decimals="-3" id="f-209" unitRef="usd">-108738000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-21" decimals="-3" id="f-210" unitRef="usd">-1916000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-7" decimals="-3" id="f-211" unitRef="usd">25991000</us-gaap:StockholdersEquity>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c-22" decimals="-3" id="f-212" unitRef="usd">5702000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c-1" decimals="-3" id="f-213" unitRef="usd">5702000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans contextRef="c-23" decimals="-3" id="f-214" unitRef="shares">44000</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan contextRef="c-22" decimals="-3" id="f-215" unitRef="usd">280000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan contextRef="c-1" decimals="-3" id="f-216" unitRef="usd">280000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures contextRef="c-23" decimals="-3" id="f-217" unitRef="shares">376000</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures>
    <us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation contextRef="c-23" decimals="-3" id="f-218" unitRef="shares">202000</us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation contextRef="c-22" decimals="-3" id="f-219" unitRef="usd">2664000</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation contextRef="c-1" decimals="-3" id="f-220" unitRef="usd">2664000</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:StockRepurchasedDuringPeriodShares contextRef="c-23" decimals="-3" id="f-221" unitRef="shares">299000</us-gaap:StockRepurchasedDuringPeriodShares>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodValue contextRef="c-24" decimals="-3" id="f-222" unitRef="usd">3147000</us-gaap:StockRepurchasedAndRetiredDuringPeriodValue>
    <us-gaap:StockRepurchasedDuringPeriodValue contextRef="c-1" decimals="-3" id="f-223" unitRef="usd">3147000</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:DividendsCash contextRef="c-24" decimals="-3" id="f-224" unitRef="usd">2067000</us-gaap:DividendsCash>
    <us-gaap:DividendsCash contextRef="c-1" decimals="-3" id="f-225" unitRef="usd">2067000</us-gaap:DividendsCash>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax contextRef="c-25" decimals="-3" id="f-226" unitRef="usd">741000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax contextRef="c-1" decimals="-3" id="f-227" unitRef="usd">741000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:NetIncomeLoss contextRef="c-24" decimals="-3" id="f-228" unitRef="usd">9805000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-1" decimals="-3" id="f-229" unitRef="usd">9805000</us-gaap:NetIncomeLoss>
    <us-gaap:CommonStockSharesOutstanding contextRef="c-26" decimals="-3" id="f-230" unitRef="shares">12429000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity contextRef="c-26" decimals="-3" id="f-231" unitRef="usd">1000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-27" decimals="-3" id="f-232" unitRef="usd">139962000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-28" decimals="-3" id="f-233" unitRef="usd">-104147000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-29" decimals="-3" id="f-234" unitRef="usd">-1175000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-6" decimals="-3" id="f-235" unitRef="usd">34641000</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss contextRef="c-1" decimals="-3" id="f-236" unitRef="usd">9805000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-8" decimals="-3" id="f-237" unitRef="usd">2937000</us-gaap:NetIncomeLoss>
    <us-gaap:DepreciationDepletionAndAmortization contextRef="c-1" decimals="-3" id="f-238" unitRef="usd">3156000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization contextRef="c-8" decimals="-3" id="f-239" unitRef="usd">3581000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:ShareBasedCompensation contextRef="c-1" decimals="-3" id="f-240" unitRef="usd">5702000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation contextRef="c-8" decimals="-3" id="f-241" unitRef="usd">3280000</us-gaap:ShareBasedCompensation>
    <us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense contextRef="c-1" decimals="-3" id="f-242" unitRef="usd">1440000</us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense>
    <us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense contextRef="c-8" decimals="-3" id="f-243" unitRef="usd">1287000</us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense>
    <us-gaap:GainLossOnSaleOfPropertyPlantEquipment contextRef="c-1" decimals="-3" id="f-244" unitRef="usd">4000</us-gaap:GainLossOnSaleOfPropertyPlantEquipment>
    <us-gaap:GainLossOnSaleOfPropertyPlantEquipment contextRef="c-8" decimals="-3" id="f-245" unitRef="usd">-2000</us-gaap:GainLossOnSaleOfPropertyPlantEquipment>
    <us-gaap:AmortizationOfFinancingCosts contextRef="c-1" decimals="-3" id="f-246" unitRef="usd">32000</us-gaap:AmortizationOfFinancingCosts>
    <us-gaap:AmortizationOfFinancingCosts contextRef="c-8" decimals="-3" id="f-247" unitRef="usd">7000</us-gaap:AmortizationOfFinancingCosts>
    <us-gaap:DeferredIncomeTaxesAndTaxCredits contextRef="c-1" decimals="-3" id="f-248" unitRef="usd">-1703000</us-gaap:DeferredIncomeTaxesAndTaxCredits>
    <us-gaap:DeferredIncomeTaxesAndTaxCredits contextRef="c-8" decimals="-3" id="f-249" unitRef="usd">-1277000</us-gaap:DeferredIncomeTaxesAndTaxCredits>
    <us-gaap:IncreaseDecreaseInAccountsReceivable contextRef="c-1" decimals="-3" id="f-250" unitRef="usd">242000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable contextRef="c-8" decimals="-3" id="f-251" unitRef="usd">1424000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInIncomeTaxesReceivable contextRef="c-1" decimals="-3" id="f-252" unitRef="usd">322000</us-gaap:IncreaseDecreaseInIncomeTaxesReceivable>
    <us-gaap:IncreaseDecreaseInIncomeTaxesReceivable contextRef="c-8" decimals="-3" id="f-253" unitRef="usd">71000</us-gaap:IncreaseDecreaseInIncomeTaxesReceivable>
    <us-gaap:IncreaseDecreaseInInventories contextRef="c-1" decimals="-3" id="f-254" unitRef="usd">5216000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories contextRef="c-8" decimals="-3" id="f-255" unitRef="usd">-662000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInPrepaidExpense contextRef="c-1" decimals="-3" id="f-256" unitRef="usd">3603000</us-gaap:IncreaseDecreaseInPrepaidExpense>
    <us-gaap:IncreaseDecreaseInPrepaidExpense contextRef="c-8" decimals="-3" id="f-257" unitRef="usd">-2280000</us-gaap:IncreaseDecreaseInPrepaidExpense>
    <us-gaap:IncreaseDecreaseInOtherNoncurrentAssets contextRef="c-1" decimals="-3" id="f-258" unitRef="usd">-72000</us-gaap:IncreaseDecreaseInOtherNoncurrentAssets>
    <us-gaap:IncreaseDecreaseInOtherNoncurrentAssets contextRef="c-8" decimals="-3" id="f-259" unitRef="usd">55000</us-gaap:IncreaseDecreaseInOtherNoncurrentAssets>
    <us-gaap:IncreaseDecreaseInAccountsPayable contextRef="c-1" decimals="-3" id="f-260" unitRef="usd">-1295000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccountsPayable contextRef="c-8" decimals="-3" id="f-261" unitRef="usd">2301000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable contextRef="c-1" decimals="-3" id="f-262" unitRef="usd">-201000</us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable>
    <us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable contextRef="c-8" decimals="-3" id="f-263" unitRef="usd">202000</us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable>
    <us-gaap:IncreaseDecreaseInAccruedLiabilities contextRef="c-1" decimals="-3" id="f-264" unitRef="usd">6037000</us-gaap:IncreaseDecreaseInAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccruedLiabilities contextRef="c-8" decimals="-3" id="f-265" unitRef="usd">-176000</us-gaap:IncreaseDecreaseInAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInOperatingLeaseLiability contextRef="c-1" decimals="-3" id="f-266" unitRef="usd">-1843000</us-gaap:IncreaseDecreaseInOperatingLeaseLiability>
    <us-gaap:IncreaseDecreaseInOperatingLeaseLiability contextRef="c-8" decimals="-3" id="f-267" unitRef="usd">-1586000</us-gaap:IncreaseDecreaseInOperatingLeaseLiability>
    <us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities contextRef="c-1" decimals="-3" id="f-268" unitRef="usd">63000</us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities>
    <us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities contextRef="c-8" decimals="-3" id="f-269" unitRef="usd">247000</us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="c-1" decimals="-3" id="f-270" unitRef="usd">11878000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="c-8" decimals="-3" id="f-271" unitRef="usd">12197000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment contextRef="c-1" decimals="-3" id="f-272" unitRef="usd">1371000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment contextRef="c-8" decimals="-3" id="f-273" unitRef="usd">2245000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment contextRef="c-1" decimals="-3" id="f-274" unitRef="usd">4000</us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment>
    <us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment contextRef="c-8" decimals="-3" id="f-275" unitRef="usd">0</us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="c-1" decimals="-3" id="f-276" unitRef="usd">-1367000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="c-8" decimals="-3" id="f-277" unitRef="usd">-2245000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:PaymentsOfFinancingCosts contextRef="c-1" decimals="-3" id="f-278" unitRef="usd">0</us-gaap:PaymentsOfFinancingCosts>
    <us-gaap:PaymentsOfFinancingCosts contextRef="c-8" decimals="-3" id="f-279" unitRef="usd">97000</us-gaap:PaymentsOfFinancingCosts>
    <us-gaap:PaymentsForRepurchaseOfCommonStock contextRef="c-1" decimals="-3" id="f-280" unitRef="usd">3147000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:PaymentsForRepurchaseOfCommonStock contextRef="c-8" decimals="-3" id="f-281" unitRef="usd">6430000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:PaymentsOfDividends contextRef="c-1" decimals="-3" id="f-282" unitRef="usd">2067000</us-gaap:PaymentsOfDividends>
    <us-gaap:PaymentsOfDividends contextRef="c-8" decimals="-3" id="f-283" unitRef="usd">6940000</us-gaap:PaymentsOfDividends>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation contextRef="c-1" decimals="-3" id="f-284" unitRef="usd">2664000</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation contextRef="c-8" decimals="-3" id="f-285" unitRef="usd">1221000</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <lfvn:ProceedsFromIssuanceOfCommonStockUnderEmployeeStockPurchasePlan contextRef="c-1" decimals="-3" id="f-286" unitRef="usd">280000</lfvn:ProceedsFromIssuanceOfCommonStockUnderEmployeeStockPurchasePlan>
    <lfvn:ProceedsFromIssuanceOfCommonStockUnderEmployeeStockPurchasePlan contextRef="c-8" decimals="-3" id="f-287" unitRef="usd">271000</lfvn:ProceedsFromIssuanceOfCommonStockUnderEmployeeStockPurchasePlan>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="c-1" decimals="-3" id="f-288" unitRef="usd">-7598000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="c-8" decimals="-3" id="f-289" unitRef="usd">-14417000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-1" decimals="-3" id="f-290" unitRef="usd">402000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-8" decimals="-3" id="f-291" unitRef="usd">-254000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect contextRef="c-1" decimals="-3" id="f-292" unitRef="usd">3315000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect contextRef="c-8" decimals="-3" id="f-293" unitRef="usd">-4719000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-7" decimals="-3" id="f-294" unitRef="usd">16886000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-13" decimals="-3" id="f-295" unitRef="usd">21605000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-6" decimals="-3" id="f-296" unitRef="usd">20201000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-7" decimals="-3" id="f-297" unitRef="usd">16886000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:InterestPaidNet contextRef="c-1" decimals="-3" id="f-298" unitRef="usd">2000</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet contextRef="c-8" decimals="-3" id="f-299" unitRef="usd">21000</us-gaap:InterestPaidNet>
    <us-gaap:IncomeTaxesPaid contextRef="c-1" decimals="-3" id="f-300" unitRef="usd">4918000</us-gaap:IncomeTaxesPaid>
    <us-gaap:IncomeTaxesPaid contextRef="c-8" decimals="-3" id="f-301" unitRef="usd">2306000</us-gaap:IncomeTaxesPaid>
    <us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock contextRef="c-1" id="f-302">The Company&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;LifeVantage Corporation (the &#x201c;Company&#x201d; or &#x201c;we&#x201d; or &#x201c;our&#x201d; or &#x201c;us&#x201d;) is a company focused on nutrigenomics, the study of how nutrition and naturally occurring compounds affect human genes to support good health. The Company is dedicated to helping people achieve their health, wellness, and financial goals. The Company provides quality, scientifically validated products to customers and independent consultants as well as a financially rewarding commission-based direct sales opportunity to its independent consultants. LifeVantage sells its products in the United States, Mexico, Japan, Australia, Hong Kong, Canada, Thailand, the United Kingdom, the Netherlands, Germany, Taiwan, Austria, Spain, Ireland, Belgium, New Zealand, and Singapore.  On June 30, 2025, the Company ceased operations in the Philippines and closed that marke&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;t.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company engages in the identification, research, development, formulation and sale of advanced nutrigenomic activators, dietary supplements, weight management products, pre- and pro-biotics, skin and hair care products and nootropics. The Company&#x2019;s line of scientifically validated dietary supplements includes its flagship Protandim&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;&#xae; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;family of products, its LifeVantage&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt; line of dietary supplements that include the MindBody GLP-1 System&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;&#x2122;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;  &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Omega+, ProBio, IC Bright&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, the Rise AM &amp;amp; Reset PM System&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, D3+, and Daily Wellness, and PhysIQ&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;&#x2122;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Fat Burn and Prebiotic dietary supplements. TrueScience&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;&#xae; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;is the Company&#x2019;s line of skin and hair care products and Liquid Collagen. The Company also markets and sells Petandim&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, its companion pet supplement formulated to combat oxidative stress in dogs; and AXIO&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, its nootropic energy drink mixes.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company was incorporated in Colorado in June 1988 under the name Andraplex Corporation. The Company changed its corporate name to Yaak River Resources, Inc. in January 1992, and subsequently changed it again in October 2004 to Lifeline Therapeutics, Inc. In October 2004 and March 2005, the Company acquired all of the outstanding common stock of Lifeline Nutraceuticals Corporation. In November 2006, the Company changed its name to LifeVantage Corporation.&lt;/span&gt;&lt;/div&gt;In March 2018, the Company reincorporated from the state of Colorado to the state of Delaware. All outstanding shares of common stock, options and share units of the Colorado corporation were converted into an equivalent share, option or share unit of the Delaware corporation and the par value of the Company&#x2019;s common stock was adjusted to $0.0001.</us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="c-30"
      decimals="INF"
      id="f-303"
      unitRef="usdPerShare">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:SignificantAccountingPoliciesTextBlock contextRef="c-1" id="f-304">Summary of Significant Accounting Policies&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Consolidation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries. All significant intercompany accounts and transactions are eliminated in consolidation. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Use of Estimates&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company prepares the consolidated financial statements and related disclosures in conformity with accounting principles generally accepted in the United States of America (&#x201c;GAAP&#x201d;). In preparing these statements, the Company is required to use estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ materially from those estimates and assumptions. On an ongoing basis, the Company reviews its estimates, including, but not limited to, those related to inventory valuation and obsolescence, sales returns, income taxes and tax valuation reserves, transfer pricing methodology and positions, impairment of assets, stock-based compensation, and loss contingencies.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Foreign Currency Translation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A portion of the Company&#x2019;s business operations occurs outside the United States.&#160;The local currency of each of the Company&#x2019;s subsidiaries generally is its functional currency.&#160;All assets and liabilities are translated into U.S. Dollars at exchange rates existing at the balance sheet dates, revenue and expenses are translated at weighted-average exchange rates and stockholders&#x2019; equity is recorded at historical exchange rates.&#160;The resulting foreign currency translation adjustments are recorded as a separate component of stockholders&#x2019; equity in the consolidated balance sheets and as a component of comprehensive income. Transaction gains and losses are included in other expense, net in the consolidated statements of operations and comprehensive income.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Fair Value of Financial Instruments&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company accounts for assets and liabilities using a hierarchy of valuation techniques based on whether the inputs to those valuation techniques are observable or unobservable. Observable inputs reflect market data obtained from independent &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;sources, while unobservable inputs reflect the Company&#x2019;s market assumptions. These two types of inputs have created the fair-value hierarchy below. This hierarchy requires the Company to minimize the use of unobservable inputs and to use observable market data, if available, when determining fair value.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Level 1&#x2014;Quoted prices for identical instruments in active markets; &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Level 2&#x2014;Quoted prices for similar instruments in active markets, quoted prices for identical or similar instruments in markets that are not active, and model-derived valuations in which all significant inputs and significant value drivers are observable in active markets; and&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Level 3&#x2014;Valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our financial instruments, consisting primarily of cash and cash equivalents, accounts receivable, and accounts payable, approximate fair value due to their short-term nature. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Cash and Cash Equivalents&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company considers only its monetary liquid assets with original maturities of three months or less to be cash equivalents.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Accounts Receivable&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s accounts receivable for the fiscal years ended June&#160;30, 2025 and 2024 consist primarily of credit card receivables. Based on the Company&#x2019;s verification process for customer credit cards and historical information available, management has determined that an allowance for doubtful accounts on credit card sales related to its customer sales as of June&#160;30, 2025 or 2024 is not necessary. There was &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;no b&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;ad debt expense for the fiscal years ended June&#160;30, 2025 and 2024. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Inventory&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Inventory consisted of (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:13pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:38.724%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.394%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.394%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.394%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.398%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="21" style="border-bottom:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June&#160;30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finished goods&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,739&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;85.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,841&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;78.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Raw materials&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,930&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,214&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total inventory&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,669&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,055&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Inventories are carried at the lower of cost or net realizable value, using the first-in, first-out method, which includes a reduction in inventory values of &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$0.5 million&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and $1.3 million at June&#160;30, 2025 and 2024, respectively, related to obsolete and slow-moving inventory. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Reserves of inventories consist of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:3pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:62.150%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:16.908%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:16.910%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Years ended June&#160;30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Beginning balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,301&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,292&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Additions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;214&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;901&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Write-offs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,049)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(892)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Ending balance&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;466&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,301&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Property and Equipment&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Property and equipment are recorded at cost and depreciated using the straight-line method over the following useful lives:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:13pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:80.891%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:16.909%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equipment (includes computer hardware and software)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3 - 5&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Furniture and fixtures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vehicles&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Leasehold improvements are depreciated over the shorter of estimated useful life of the related asset or the lease term.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The cost of normal maintenance and repairs is charged to expense as incurred. When an asset is sold or otherwise disposed of, the cost and associated accumulated depreciation are removed from the accounts and the resulting gain or loss is recognized in the consolidated statements of operations and comprehensive income in other expense, net. Significant expenditures that increase the useful life of an asset are capitalized and depreciated over the estimated useful life of the asset. Property and equipment are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of such assets may not be recoverable.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Intangible Assets&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Intangible assets are stated at cost less accumulated amortization. Finite-lived intangible assets are amortized over their related useful lives, using a straight-line method, consistent with the underlying expected future cash flows related to the specific intangible asset. Finite-lived intangible assets are reviewed for impairment whenever events or changes in circumstances exist that indicate the carrying amount of an asset may not be recoverable. When indicators of impairment exist, an estimate of undiscounted net cash flows is used in measuring whether the carrying amount of the asset or related asset group is recoverable. Measurement of the amount of impairment, if any, is based upon the difference between the asset&#x2019;s carrying value and estimated fair value. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Indefinite-lived intangible assets are not amortized; however, they are tested at least annually for impairment or more frequently if events or changes in circumstances exist that may indicate impairment. An impairment loss is recognized if the carrying amount of the asset exceeds its fair value. Annual impairment tests on intangible assets were completed for the fiscal years ended June&#160;30, 2025 and 2024, resulting in no impairment charges.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Impairment of Long-Lived Assets&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Pursuant to guidance established for impairment or disposal of assets, the Company assesses impairment whenever events or changes in circumstances indicate that the carrying amount of a long-lived asset may not be recoverable. When an assessment for impairment of long-lived assets, long-lived assets to be disposed of, and certain identifiable intangibles related to those assets is performed, the Company is required to compare the net carrying value of long-lived assets on the lowest level at which cash flows can be determined on a consistent basis to the related estimates of future undiscounted net cash flows for such assets. If the net carrying value exceeds the net cash flows, then an impairment is recognized to reduce the carrying value to the estimated fair value, generally equal to the future discounted net cash flow. For the fiscal years ended June&#160;30, 2025 and 2024, management has concluded that there are no indications of impairment.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Concentration of Credit Risk&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accounting guidance for financial instruments requires disclosure of significant concentrations of credit risk regardless of the degree of such risk. Financial instruments with significant credit risk include cash and cash equivalents. At June&#160;30, 2025, the Company&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt; had $17.0 million in cash and cash equivalent accounts at one financial institution and $3.2 million i&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;n other financial institutions. As of June&#160;30, 2025 and 2024, and during the years then ended, the Company&#x2019;s cash balances exceeded federally insured limits.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Commissions and Incentives&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Commissions and incentives expenses are the Company&#x2019;s most significant expenses and are classified as operating expenses. Commissions and incentives expenses include sales commissions paid to the Company&#x2019;s independent consultants, special incentives, costs for incentive trips and other rewards. Commissions and incentives expenses do not include any amounts the Company pays to its independent consultants for personal purchases. Commissions paid to independent consultants on personal purchases are considered a sales discount and are reported as a reduction to net revenue.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Shipping and Handling&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Shipping and handling costs associated with inbound freight and freight out to customers, including independent consultants, are included in cost of sales. Shipping and handling fees charged to all customers are included in sales.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Research and Development Costs&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company expenses all costs related to research and development activities as incurred. Research and development expenses for the fiscal years ended June&#160;30, 2025 and 2024 were &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$1.4 million and&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt; $0.7 million, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Leases&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company accounts for leases in accordance with Accounting Standards Codification (&#x201c;ASC&#x201d;) 842. The Company reviews all contracts and determines if the arrangement is or contains a lease, at inception. Operating leases are included in right-of-use (&#x201c;ROU&#x201d;) assets, current lease liabilities and long-term lease liabilities on the consolidated balance sheets. The Company does not have any finance leases.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Operating lease ROU assets represent the Company&#x2019;s right to use an underlying asset for the lease term and lease liabilities represent the Company&#x2019;s obligation to make lease payments arising from the lease. ROU assets and lease liabilities are recognized at the lease commencement date based on the estimated present value of lease payments over the lease term. The Company uses its estimated incremental borrowing rate based on the information available at the commencement date in determining the present value of future payments. The operating lease ROU asset also includes any upfront lease payments made and excludes lease incentives and initial direct costs incurred. The Company&#x2019;s lease terms may include options to extend or terminate the lease when it is reasonably certain that the Company will exercise that option. Lease expense for minimum lease payments is recognized on a straight-line basis over the lease term. Leases with a term of 12 months or less are not recorded on the balance sheet. The Company&#x2019;s lease agreements do not contain any residual value guarantees.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Stock-Based Compensation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company recognizes stock-based compensation by measuring the cost of services to be rendered based on the grant date fair value of the equity award. The Company recognizes stock-based compensation, net of any estimated forfeitures, over the period an employee is required to provide service in exchange for the award, generally referred to as the requisite service period. The Company estimates forfeitures based on historical information and other management assumptions. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Black-Scholes option pricing model is used to estimate the fair value of stock options and options under the Company&#x2019;s 2019 Employee Stock Purchase Plan. The determination of the fair value of options is affected by the Company&#x2019;s stock price and a number of assumptions, including expected volatility, expected life, risk-free interest rate and expected dividends. The Company uses historical data for estimating the expected volatility and expected life of stock options required in the Black-Scholes model. The risk-free interest rate assumption is based on observed interest rates appropriate for the expected terms of the stock options. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair value of restricted stock grants, including performance restricted stock units that include non-market based performance conditions, is based on the closing market price of the Company&#x2019;s stock on the date of grant less the Company&#x2019;s expected dividend yield. The Company recognizes compensation costs for awards with performance conditions when it concludes it is probable that the performance conditions will be achieved. The Company reassesses the probability of vesting at each balance sheet date and adjusts compensation costs accordingly.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Income Taxes&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Income taxes are accounted for under the asset and liability method. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases and operating loss and tax credit carry forwards. Deferred tax assets and liabilities are measured using statutory tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled, updated as needed for changes in corporate tax rates. The effect on deferred tax assets and liabilities from a change in tax rates is recognized in income in the period that includes the effective date of the change. The Company recognizes tax liabilities or benefits from an uncertain position only if it is more likely than not that the position will be sustained upon examination by taxing authorities based on the technical merits of the issue. The amount recognized would be the largest liability or benefit that the Company believes has greater than a 50% likelihood of being realized upon settlement.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Income Per Share&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Basic income per common share is computed by dividing net income by the weighted-average number of common shares outstanding during the period, less unvested restricted stock awards. Diluted income per common share is computed by dividing net income by the weighted-average common shares and potentially dilutive common share equivalents using the treasury stock method.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the fiscal years ended June&#160;30, 2025 and 2024, the effects of approximately 30,000&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt; 13,000 common shares, respectively, issuable upon exercise of options and non-vested shares of restricted stock, are not included in the computations as their effect was anti-dilutive.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is a reconciliation of net income per share and the weighted-average common shares outstanding for purposes of computing basic and diluted net income per share (in thousands, except per share amounts):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:13pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:62.150%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:16.908%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:16.910%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Years ended June&#160;30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Numerator:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,805&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,937&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Denominator:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic weighted-average common shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,251&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,458&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effect of dilutive securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock awards and options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;736&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;528&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diluted weighted-average common shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,987&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,986&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income per share, basic&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.80&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income per share, diluted&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%"&gt;New Accounting Pronouncements&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In November 2023, the Financial Accounting Standards Board (&#x201c;FASB&#x201d;) issued Accounting Standards Update (&#x201c;ASU&#x201d;) 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures (ASU 2023-07), expanding segment disclosure requirements. The amendments require enhanced disclosure for certain segment items and required disclosure on how management uses reported measures to assess segment performance. The amendments do not change how segments are determined, aggregated, or how thresholds are applied to determine reportable segments. ASU 2023-07 is effective for the Company&#x2019;s annual periods beginning July 1, 2024, and for interim periods beginning July 1, 2025, with early adoption permitted. The Company adopted ASU 2023-07 for the fiscal year beginning July 1, 2024. See Note 13 for expanded segment disclosures.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In December 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures (&#x201c;ASU 2023-09&#x201d;). The guidance requires disclosure of disaggregated income taxes paid, prescribes standardized categories for the components of the effective tax rate reconciliation, and modifies other income tax-related disclosures. ASU 2023-09 is effective for the Company&#x2019;s annual periods beginning July 1, 2025, with early adoption permitted. The Company is currently evaluating the potential effect that the updated standard will have on its financial statement disclosures.   &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In November 2024, the FASB issued ASU 2024-03, Income Statement&#x2014;Reporting Comprehensive Income&#x2014;Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses (&#x201c;ASU 2024-03&#x201d;). The guidance requires disclosure of specified information about certain costs and expenses at each interim and annual reporting period. ASU 2024-03 is effective for the Company&#x2019;s annual periods beginning July 1, 2027, with early adoption permitted. The Company is currently evaluating the potential effect that the updated standard will have on its financial statement disclosures.   &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other recently issued accounting pronouncements did not or are not believed by management to have a material impact on the Company&#x2019;s present or future financial statements.&lt;/span&gt;&lt;/div&gt;</us-gaap:SignificantAccountingPoliciesTextBlock>
    <us-gaap:ConsolidationPolicyTextBlock contextRef="c-1" id="f-305">&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Consolidation&lt;/span&gt;&lt;/div&gt;The consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries. All significant intercompany accounts and transactions are eliminated in consolidation.</us-gaap:ConsolidationPolicyTextBlock>
    <us-gaap:UseOfEstimates contextRef="c-1" id="f-306">&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Use of Estimates&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company prepares the consolidated financial statements and related disclosures in conformity with accounting principles generally accepted in the United States of America (&#x201c;GAAP&#x201d;). In preparing these statements, the Company is required to use estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ materially from those estimates and assumptions. On an ongoing basis, the Company reviews its estimates, including, but not limited to, those related to inventory valuation and obsolescence, sales returns, income taxes and tax valuation reserves, transfer pricing methodology and positions, impairment of assets, stock-based compensation, and loss contingencies.&lt;/span&gt;&lt;/div&gt;</us-gaap:UseOfEstimates>
    <us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock contextRef="c-1" id="f-307">&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Foreign Currency Translation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A portion of the Company&#x2019;s business operations occurs outside the United States.&#160;The local currency of each of the Company&#x2019;s subsidiaries generally is its functional currency.&#160;All assets and liabilities are translated into U.S. Dollars at exchange rates existing at the balance sheet dates, revenue and expenses are translated at weighted-average exchange rates and stockholders&#x2019; equity is recorded at historical exchange rates.&#160;The resulting foreign currency translation adjustments are recorded as a separate component of stockholders&#x2019; equity in the consolidated balance sheets and as a component of comprehensive income. Transaction gains and losses are included in other expense, net in the consolidated statements of operations and comprehensive income.&lt;/span&gt;&lt;/div&gt;</us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock>
    <us-gaap:FairValueOfFinancialInstrumentsPolicy contextRef="c-1" id="f-308">&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Fair Value of Financial Instruments&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company accounts for assets and liabilities using a hierarchy of valuation techniques based on whether the inputs to those valuation techniques are observable or unobservable. Observable inputs reflect market data obtained from independent &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;sources, while unobservable inputs reflect the Company&#x2019;s market assumptions. These two types of inputs have created the fair-value hierarchy below. This hierarchy requires the Company to minimize the use of unobservable inputs and to use observable market data, if available, when determining fair value.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Level 1&#x2014;Quoted prices for identical instruments in active markets; &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Level 2&#x2014;Quoted prices for similar instruments in active markets, quoted prices for identical or similar instruments in markets that are not active, and model-derived valuations in which all significant inputs and significant value drivers are observable in active markets; and&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Level 3&#x2014;Valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable.&lt;/span&gt;&lt;/div&gt;Our financial instruments, consisting primarily of cash and cash equivalents, accounts receivable, and accounts payable, approximate fair value due to their short-term nature.</us-gaap:FairValueOfFinancialInstrumentsPolicy>
    <us-gaap:CashAndCashEquivalentsPolicyTextBlock contextRef="c-1" id="f-309">&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Cash and Cash Equivalents&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company considers only its monetary liquid assets with original maturities of three months or less to be cash equivalents.&lt;/span&gt;&lt;/div&gt;</us-gaap:CashAndCashEquivalentsPolicyTextBlock>
    <us-gaap:ReceivablesPolicyTextBlock contextRef="c-1" id="f-310">&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Accounts Receivable&lt;/span&gt;&lt;/div&gt;The Company&#x2019;s accounts receivable for the fiscal years ended June&#160;30, 2025 and 2024 consist primarily of credit card receivables. Based on the Company&#x2019;s verification process for customer credit cards and historical information available, management has determined that an allowance for doubtful accounts on credit card sales related to its customer sales as of June&#160;30, 2025 or 2024 is not necessary.</us-gaap:ReceivablesPolicyTextBlock>
    <us-gaap:ProvisionForDoubtfulAccounts contextRef="c-8" decimals="INF" id="f-311" unitRef="usd">0</us-gaap:ProvisionForDoubtfulAccounts>
    <us-gaap:ProvisionForDoubtfulAccounts contextRef="c-1" decimals="INF" id="f-312" unitRef="usd">0</us-gaap:ProvisionForDoubtfulAccounts>
    <us-gaap:ScheduleOfInventoryCurrentTableTextBlock contextRef="c-1" id="f-313">&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Inventory consisted of (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:13pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:38.724%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.394%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.394%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.394%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.398%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="21" style="border-bottom:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June&#160;30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finished goods&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,739&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;85.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,841&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;78.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Raw materials&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,930&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,214&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total inventory&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,669&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,055&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Reserves of inventories consist of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:3pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:62.150%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:16.908%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:16.910%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Years ended June&#160;30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Beginning balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,301&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,292&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Additions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;214&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;901&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Write-offs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,049)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(892)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Ending balance&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;466&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,301&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfInventoryCurrentTableTextBlock>
    <us-gaap:InventoryFinishedGoods contextRef="c-6" decimals="-3" id="f-314" unitRef="usd">17739000</us-gaap:InventoryFinishedGoods>
    <lfvn:InventoryFinishedGoodsPercentOfTotalInventory contextRef="c-6" decimals="3" id="f-315" unitRef="number">0.858</lfvn:InventoryFinishedGoodsPercentOfTotalInventory>
    <us-gaap:InventoryFinishedGoods contextRef="c-7" decimals="-3" id="f-316" unitRef="usd">11841000</us-gaap:InventoryFinishedGoods>
    <lfvn:InventoryFinishedGoodsPercentOfTotalInventory contextRef="c-7" decimals="3" id="f-317" unitRef="number">0.787</lfvn:InventoryFinishedGoodsPercentOfTotalInventory>
    <us-gaap:InventoryRawMaterials contextRef="c-6" decimals="-3" id="f-318" unitRef="usd">2930000</us-gaap:InventoryRawMaterials>
    <lfvn:RawMaterialsPercentOfTotalInventory contextRef="c-6" decimals="3" id="f-319" unitRef="number">0.142</lfvn:RawMaterialsPercentOfTotalInventory>
    <us-gaap:InventoryRawMaterials contextRef="c-7" decimals="-3" id="f-320" unitRef="usd">3214000</us-gaap:InventoryRawMaterials>
    <lfvn:RawMaterialsPercentOfTotalInventory contextRef="c-7" decimals="3" id="f-321" unitRef="number">0.213</lfvn:RawMaterialsPercentOfTotalInventory>
    <us-gaap:InventoryNet contextRef="c-6" decimals="-3" id="f-322" unitRef="usd">20669000</us-gaap:InventoryNet>
    <lfvn:InventoryPercentOfTotalInventory contextRef="c-6" decimals="INF" id="f-323" unitRef="number">1.000</lfvn:InventoryPercentOfTotalInventory>
    <us-gaap:InventoryNet contextRef="c-7" decimals="-3" id="f-324" unitRef="usd">15055000</us-gaap:InventoryNet>
    <lfvn:InventoryPercentOfTotalInventory contextRef="c-7" decimals="INF" id="f-325" unitRef="number">1.000</lfvn:InventoryPercentOfTotalInventory>
    <us-gaap:InventoryPolicyTextBlock contextRef="c-1" id="f-326">Inventories are carried at the lower of cost or net realizable value, using the first-in, first-out method</us-gaap:InventoryPolicyTextBlock>
    <us-gaap:InventoryAdjustments contextRef="c-6" decimals="-5" id="f-327" unitRef="usd">500000</us-gaap:InventoryAdjustments>
    <us-gaap:InventoryAdjustments contextRef="c-7" decimals="-5" id="f-328" unitRef="usd">1300000</us-gaap:InventoryAdjustments>
    <us-gaap:ValuationAllowancesAndReservesBalance contextRef="c-31" decimals="-3" id="f-329" unitRef="usd">1301000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesBalance contextRef="c-32" decimals="-3" id="f-330" unitRef="usd">1292000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense contextRef="c-33" decimals="-3" id="f-331" unitRef="usd">214000</us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense>
    <us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense contextRef="c-34" decimals="-3" id="f-332" unitRef="usd">901000</us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense>
    <us-gaap:ValuationAllowancesAndReservesDeductions contextRef="c-33" decimals="-3" id="f-333" unitRef="usd">1049000</us-gaap:ValuationAllowancesAndReservesDeductions>
    <us-gaap:ValuationAllowancesAndReservesDeductions contextRef="c-34" decimals="-3" id="f-334" unitRef="usd">892000</us-gaap:ValuationAllowancesAndReservesDeductions>
    <us-gaap:ValuationAllowancesAndReservesBalance contextRef="c-35" decimals="-3" id="f-335" unitRef="usd">466000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesBalance contextRef="c-31" decimals="-3" id="f-336" unitRef="usd">1301000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:PropertyPlantAndEquipmentPolicyTextBlock contextRef="c-1" id="f-337">&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Property and Equipment&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Property and equipment are recorded at cost and depreciated using the straight-line method over the following useful lives:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:13pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:80.891%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:16.909%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equipment (includes computer hardware and software)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3 - 5&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Furniture and fixtures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vehicles&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Leasehold improvements are depreciated over the shorter of estimated useful life of the related asset or the lease term.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The cost of normal maintenance and repairs is charged to expense as incurred. When an asset is sold or otherwise disposed of, the cost and associated accumulated depreciation are removed from the accounts and the resulting gain or loss is recognized in the consolidated statements of operations and comprehensive income in other expense, net. Significant expenditures that increase the useful life of an asset are capitalized and depreciated over the estimated useful life of the asset. Property and equipment are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of such assets may not be recoverable.&lt;/span&gt;&lt;/div&gt;</us-gaap:PropertyPlantAndEquipmentPolicyTextBlock>
    <us-gaap:PropertyPlantAndEquipmentTextBlock contextRef="c-1" id="f-338">&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Property and equipment are recorded at cost and depreciated using the straight-line method over the following useful lives:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:13pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:80.891%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:16.909%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equipment (includes computer hardware and software)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3 - 5&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Furniture and fixtures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vehicles&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Property and equipment, net consist of (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:13pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:62.150%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:16.908%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:16.910%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June&#160;30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equipment (includes computer hardware and software)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,998&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,766&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Furniture and fixtures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,469&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,466&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Leasehold improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,101&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,040&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vehicles&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated depreciation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(17,412)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14,510)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total property and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,207&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,813&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:PropertyPlantAndEquipmentTextBlock>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="c-36" id="f-339">P3Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="c-37" id="f-340">P5Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="c-38" id="f-341">P5Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="c-39" id="f-342">P5Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:IntangibleAssetsFiniteLivedPolicy contextRef="c-1" id="f-343">&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Intangible Assets&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Intangible assets are stated at cost less accumulated amortization. Finite-lived intangible assets are amortized over their related useful lives, using a straight-line method, consistent with the underlying expected future cash flows related to the specific intangible asset. Finite-lived intangible assets are reviewed for impairment whenever events or changes in circumstances exist that indicate the carrying amount of an asset may not be recoverable. When indicators of impairment exist, an estimate of undiscounted net cash flows is used in measuring whether the carrying amount of the asset or related asset group is recoverable. Measurement of the amount of impairment, if any, is based upon the difference between the asset&#x2019;s carrying value and estimated fair value. &lt;/span&gt;&lt;/div&gt;Indefinite-lived intangible assets are not amortized; however, they are tested at least annually for impairment or more frequently if events or changes in circumstances exist that may indicate impairment. An impairment loss is recognized if the carrying amount of the asset exceeds its fair value.</us-gaap:IntangibleAssetsFiniteLivedPolicy>
    <us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill contextRef="c-8" decimals="INF" id="f-344" unitRef="usd">0</us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill>
    <us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill contextRef="c-1" decimals="INF" id="f-345" unitRef="usd">0</us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill>
    <us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock contextRef="c-1" id="f-346">&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Impairment of Long-Lived Assets&lt;/span&gt;&lt;/div&gt;Pursuant to guidance established for impairment or disposal of assets, the Company assesses impairment whenever events or changes in circumstances indicate that the carrying amount of a long-lived asset may not be recoverable. When an assessment for impairment of long-lived assets, long-lived assets to be disposed of, and certain identifiable intangibles related to those assets is performed, the Company is required to compare the net carrying value of long-lived assets on the lowest level at which cash flows can be determined on a consistent basis to the related estimates of future undiscounted net cash flows for such assets. If the net carrying value exceeds the net cash flows, then an impairment is recognized to reduce the carrying value to the estimated fair value, generally equal to the future discounted net cash flow.</us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock>
    <us-gaap:ConcentrationRiskCreditRisk contextRef="c-1" id="f-347">&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Concentration of Credit Risk&lt;/span&gt;&lt;/div&gt;Accounting guidance for financial instruments requires disclosure of significant concentrations of credit risk regardless of the degree of such risk. Financial instruments with significant credit risk include cash and cash equivalents.</us-gaap:ConcentrationRiskCreditRisk>
    <us-gaap:ConcentrationRiskCreditRiskFinancialInstrumentMaximumExposure contextRef="c-40" decimals="-5" id="f-348" unitRef="usd">17000000.0</us-gaap:ConcentrationRiskCreditRiskFinancialInstrumentMaximumExposure>
    <us-gaap:ConcentrationRiskCreditRiskFinancialInstrumentMaximumExposure contextRef="c-41" decimals="-5" id="f-349" unitRef="usd">3200000</us-gaap:ConcentrationRiskCreditRiskFinancialInstrumentMaximumExposure>
    <us-gaap:CommissionsExpensePolicyPolicyTextBlock contextRef="c-1" id="f-350">&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Commissions and Incentives&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Commissions and incentives expenses are the Company&#x2019;s most significant expenses and are classified as operating expenses. Commissions and incentives expenses include sales commissions paid to the Company&#x2019;s independent consultants, special incentives, costs for incentive trips and other rewards. Commissions and incentives expenses do not include any amounts the Company pays to its independent consultants for personal purchases. Commissions paid to independent consultants on personal purchases are considered a sales discount and are reported as a reduction to net revenue.&lt;/span&gt;&lt;/div&gt;</us-gaap:CommissionsExpensePolicyPolicyTextBlock>
    <us-gaap:RevenueFromContractWithCustomerPolicyTextBlock contextRef="c-1" id="f-351">&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Shipping and Handling&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Shipping and handling costs associated with inbound freight and freight out to customers, including independent consultants, are included in cost of sales. Shipping and handling fees charged to all customers are included in sales.&lt;/span&gt;&lt;/div&gt;Revenue&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenue is recognized when control of the promised goods or services are transferred to the customer, in an amount that reflects the consideration the Company expects to be entitled to in exchange for those goods or services. Sales, value add, and other taxes the Company collects concurrent with revenue-producing activities are excluded from revenue.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company generates the majority of its revenue through product sales to customers. These products include the Protandim&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;&#xae; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;line of dietary supplements, the LifeVantage&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt; line of dietary supplements that include the MindBody GLP-1 System&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;&#x2122;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, Omega+, ProBio, IC Bright&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, the Rise AM &amp;amp; Reset PM System&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, D3+, and Daily Wellness, PhysIQ&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;&#x2122;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Fat Burn and Prebiotic dietary supplements, TrueScience&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt; skin and hair care products and Liquid Collagen, Petandim&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, our companion pet supplement formulated to combat oxidative stress in dogs, and AXIO&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;nootropic energy drink mixes. The Company ships most of its product directly to the consumer and receives substantially all payment for product sales in the form of credit card receipts. Revenue from direct product sales to customers is recognized upon shipment, which is when passage of title and risk of loss occurs. For items sold in packs and bundles, the Company determines the standalone selling price at contract inception for each distinct good and then allocates the transaction price on a relative standalone selling price basis. Any discounts are accounted for as a direct reduction to the transaction price. Shipping and handling revenue is recognized upon shipment when the performance obligation is completed.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company also charges amounts to independent consultants to attend events that it holds. Tickets to events are sold as standalone items or included within packs. For event tickets sold in packs, the Company allocates a portion of the transaction price to the ticket on a relative standalone selling price basis, adjusted for the probability of the tickets being redeemed for attendance at a future event. Any discounts are accounted for as a direct reduction to the transaction price. Fee revenue associated with ticket sales is recorded in the month that the event is held, which is when the Company has performed its obligations under the contract.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Deferred Revenue&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company launched its Rewards Circle loyalty program in the United States, Australia, New Zealand, and Japan in March 2023 and in Canada, Europe, and Mexico in February 2024.  Contract liabilities, recorded as deferred revenue, include these loyalty program credit deferrals with certain customers which are accounted for as a reduction in the transaction price and are generally recognized as credits are redeemed for additional products at a later date.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company also records deferred revenue when cash payments are received or due in advance of performance, including amounts which are refundable. The Company pre-sells tickets to its events. When cash payments are received in advance of events, the cash received is recorded to deferred revenue until the event is held, at which time the Company has performed its obligations under the contract and the revenue is recognized.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Deferred revenue is included in accrued expenses in the consolidated balance sheets.  The balance of deferred revenue related to contract liabilities, each less than twelve months, was $0.7 million and $0.9 million as of June&#160;30, 2025 and 2024, respectively. The contract liabilities impact to revenue for the years ended June&#160;30, 2025 and 2024 was an increase of $0.2 million and a decrease of $26,000, respectively.&lt;/span&gt;&lt;/div&gt;</us-gaap:RevenueFromContractWithCustomerPolicyTextBlock>
    <us-gaap:ResearchAndDevelopmentExpensePolicy contextRef="c-1" id="f-352">&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Research and Development Costs&lt;/span&gt;&lt;/div&gt;The Company expenses all costs related to research and development activities as incurred.</us-gaap:ResearchAndDevelopmentExpensePolicy>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c-1" decimals="-5" id="f-353" unitRef="usd">1400000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c-8" decimals="-5" id="f-354" unitRef="usd">700000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:LesseeLeasesPolicyTextBlock contextRef="c-1" id="f-355">&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Leases&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company accounts for leases in accordance with Accounting Standards Codification (&#x201c;ASC&#x201d;) 842. The Company reviews all contracts and determines if the arrangement is or contains a lease, at inception. Operating leases are included in right-of-use (&#x201c;ROU&#x201d;) assets, current lease liabilities and long-term lease liabilities on the consolidated balance sheets. The Company does not have any finance leases.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Operating lease ROU assets represent the Company&#x2019;s right to use an underlying asset for the lease term and lease liabilities represent the Company&#x2019;s obligation to make lease payments arising from the lease. ROU assets and lease liabilities are recognized at the lease commencement date based on the estimated present value of lease payments over the lease term. The Company uses its estimated incremental borrowing rate based on the information available at the commencement date in determining the present value of future payments. The operating lease ROU asset also includes any upfront lease payments made and excludes lease incentives and initial direct costs incurred. The Company&#x2019;s lease terms may include options to extend or terminate the lease when it is reasonably certain that the Company will exercise that option. Lease expense for minimum lease payments is recognized on a straight-line basis over the lease term. Leases with a term of 12 months or less are not recorded on the balance sheet. The Company&#x2019;s lease agreements do not contain any residual value guarantees.&lt;/span&gt;&lt;/div&gt;</us-gaap:LesseeLeasesPolicyTextBlock>
    <lfvn:NumberOfFinanceLeases contextRef="c-1" decimals="INF" id="f-356" unitRef="lease">0</lfvn:NumberOfFinanceLeases>
    <us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy contextRef="c-1" id="f-357">&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Stock-Based Compensation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company recognizes stock-based compensation by measuring the cost of services to be rendered based on the grant date fair value of the equity award. The Company recognizes stock-based compensation, net of any estimated forfeitures, over the period an employee is required to provide service in exchange for the award, generally referred to as the requisite service period. The Company estimates forfeitures based on historical information and other management assumptions. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Black-Scholes option pricing model is used to estimate the fair value of stock options and options under the Company&#x2019;s 2019 Employee Stock Purchase Plan. The determination of the fair value of options is affected by the Company&#x2019;s stock price and a number of assumptions, including expected volatility, expected life, risk-free interest rate and expected dividends. The Company uses historical data for estimating the expected volatility and expected life of stock options required in the Black-Scholes model. The risk-free interest rate assumption is based on observed interest rates appropriate for the expected terms of the stock options. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair value of restricted stock grants, including performance restricted stock units that include non-market based performance conditions, is based on the closing market price of the Company&#x2019;s stock on the date of grant less the Company&#x2019;s expected dividend yield. The Company recognizes compensation costs for awards with performance conditions when it concludes it is probable that the performance conditions will be achieved. The Company reassesses the probability of vesting at each balance sheet date and adjusts compensation costs accordingly.&lt;/span&gt;&lt;/div&gt;</us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy>
    <us-gaap:IncomeTaxPolicyTextBlock contextRef="c-1" id="f-358">&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Income Taxes&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Income taxes are accounted for under the asset and liability method. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases and operating loss and tax credit carry forwards. Deferred tax assets and liabilities are measured using statutory tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled, updated as needed for changes in corporate tax rates. The effect on deferred tax assets and liabilities from a change in tax rates is recognized in income in the period that includes the effective date of the change. The Company recognizes tax liabilities or benefits from an uncertain position only if it is more likely than not that the position will be sustained upon examination by taxing authorities based on the technical merits of the issue. The amount recognized would be the largest liability or benefit that the Company believes has greater than a 50% likelihood of being realized upon settlement.&lt;/span&gt;&lt;/div&gt;</us-gaap:IncomeTaxPolicyTextBlock>
    <us-gaap:EarningsPerSharePolicyTextBlock contextRef="c-1" id="f-359">&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Income Per Share&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Basic income per common share is computed by dividing net income by the weighted-average number of common shares outstanding during the period, less unvested restricted stock awards. Diluted income per common share is computed by dividing net income by the weighted-average common shares and potentially dilutive common share equivalents using the treasury stock method.&lt;/span&gt;&lt;/div&gt;</us-gaap:EarningsPerSharePolicyTextBlock>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="c-1" decimals="-3" id="f-360" unitRef="shares">30000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="c-8" decimals="-3" id="f-361" unitRef="shares">13000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock contextRef="c-1" id="f-362">&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is a reconciliation of net income per share and the weighted-average common shares outstanding for purposes of computing basic and diluted net income per share (in thousands, except per share amounts):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:13pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:62.150%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:16.908%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:16.910%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Years ended June&#160;30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Numerator:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,805&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,937&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Denominator:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic weighted-average common shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,251&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,458&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effect of dilutive securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock awards and options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;736&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;528&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diluted weighted-average common shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,987&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,986&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income per share, basic&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.80&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income per share, diluted&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:NetIncomeLoss contextRef="c-1" decimals="-3" id="f-363" unitRef="usd">9805000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-8" decimals="-3" id="f-364" unitRef="usd">2937000</us-gaap:NetIncomeLoss>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-1" decimals="-3" id="f-365" unitRef="shares">12251000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-8" decimals="-3" id="f-366" unitRef="shares">12458000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements contextRef="c-1" decimals="-3" id="f-367" unitRef="shares">736000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements contextRef="c-8" decimals="-3" id="f-368" unitRef="shares">528000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="c-1" decimals="-3" id="f-369" unitRef="shares">12987000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="c-8" decimals="-3" id="f-370" unitRef="shares">12986000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-1"
      decimals="2"
      id="f-371"
      unitRef="usdPerShare">0.80</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-8"
      decimals="2"
      id="f-372"
      unitRef="usdPerShare">0.24</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-1"
      decimals="2"
      id="f-373"
      unitRef="usdPerShare">0.75</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-8"
      decimals="2"
      id="f-374"
      unitRef="usdPerShare">0.23</us-gaap:EarningsPerShareDiluted>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock contextRef="c-1" id="f-375">&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%"&gt;New Accounting Pronouncements&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In November 2023, the Financial Accounting Standards Board (&#x201c;FASB&#x201d;) issued Accounting Standards Update (&#x201c;ASU&#x201d;) 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures (ASU 2023-07), expanding segment disclosure requirements. The amendments require enhanced disclosure for certain segment items and required disclosure on how management uses reported measures to assess segment performance. The amendments do not change how segments are determined, aggregated, or how thresholds are applied to determine reportable segments. ASU 2023-07 is effective for the Company&#x2019;s annual periods beginning July 1, 2024, and for interim periods beginning July 1, 2025, with early adoption permitted. The Company adopted ASU 2023-07 for the fiscal year beginning July 1, 2024. See Note 13 for expanded segment disclosures.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In December 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures (&#x201c;ASU 2023-09&#x201d;). The guidance requires disclosure of disaggregated income taxes paid, prescribes standardized categories for the components of the effective tax rate reconciliation, and modifies other income tax-related disclosures. ASU 2023-09 is effective for the Company&#x2019;s annual periods beginning July 1, 2025, with early adoption permitted. The Company is currently evaluating the potential effect that the updated standard will have on its financial statement disclosures.   &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In November 2024, the FASB issued ASU 2024-03, Income Statement&#x2014;Reporting Comprehensive Income&#x2014;Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses (&#x201c;ASU 2024-03&#x201d;). The guidance requires disclosure of specified information about certain costs and expenses at each interim and annual reporting period. ASU 2024-03 is effective for the Company&#x2019;s annual periods beginning July 1, 2027, with early adoption permitted. The Company is currently evaluating the potential effect that the updated standard will have on its financial statement disclosures.   &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other recently issued accounting pronouncements did not or are not believed by management to have a material impact on the Company&#x2019;s present or future financial statements.&lt;/span&gt;&lt;/div&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:RevenueFromContractWithCustomerTextBlock contextRef="c-1" id="f-376">Revenue&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenue is recognized when control of the promised goods or services are transferred to the customer, in an amount that reflects the consideration the Company expects to be entitled to in exchange for those goods or services. Sales, value add, and other taxes the Company collects concurrent with revenue-producing activities are excluded from revenue.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company generates the majority of its revenue through product sales to customers. These products include the Protandim&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;&#xae; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;line of dietary supplements, the LifeVantage&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt; line of dietary supplements that include the MindBody GLP-1 System&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;&#x2122;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, Omega+, ProBio, IC Bright&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, the Rise AM &amp;amp; Reset PM System&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, D3+, and Daily Wellness, PhysIQ&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;&#x2122;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Fat Burn and Prebiotic dietary supplements, TrueScience&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt; skin and hair care products and Liquid Collagen, Petandim&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, our companion pet supplement formulated to combat oxidative stress in dogs, and AXIO&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;nootropic energy drink mixes. The Company ships most of its product directly to the consumer and receives substantially all payment for product sales in the form of credit card receipts. Revenue from direct product sales to customers is recognized upon shipment, which is when passage of title and risk of loss occurs. For items sold in packs and bundles, the Company determines the standalone selling price at contract inception for each distinct good and then allocates the transaction price on a relative standalone selling price basis. Any discounts are accounted for as a direct reduction to the transaction price. Shipping and handling revenue is recognized upon shipment when the performance obligation is completed.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company also charges amounts to independent consultants to attend events that it holds. Tickets to events are sold as standalone items or included within packs. For event tickets sold in packs, the Company allocates a portion of the transaction price to the ticket on a relative standalone selling price basis, adjusted for the probability of the tickets being redeemed for attendance at a future event. Any discounts are accounted for as a direct reduction to the transaction price. Fee revenue associated with ticket sales is recorded in the month that the event is held, which is when the Company has performed its obligations under the contract.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Deferred Revenue&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company launched its Rewards Circle loyalty program in the United States, Australia, New Zealand, and Japan in March 2023 and in Canada, Europe, and Mexico in February 2024.  Contract liabilities, recorded as deferred revenue, include these loyalty program credit deferrals with certain customers which are accounted for as a reduction in the transaction price and are generally recognized as credits are redeemed for additional products at a later date.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company also records deferred revenue when cash payments are received or due in advance of performance, including amounts which are refundable. The Company pre-sells tickets to its events. When cash payments are received in advance of events, the cash received is recorded to deferred revenue until the event is held, at which time the Company has performed its obligations under the contract and the revenue is recognized.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Deferred revenue is included in accrued expenses in the consolidated balance sheets.  The balance of deferred revenue related to contract liabilities, each less than twelve months, was $0.7 million and $0.9 million as of June&#160;30, 2025 and 2024, respectively. The contract liabilities impact to revenue for the years ended June&#160;30, 2025 and 2024 was an increase of $0.2 million and a decrease of $26,000, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Sales Returns and Allowances&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Estimated returns are recorded when product is shipped. Subject to some exceptions based on local regulations, the Company&#x2019;s return policy is to provide a full refund for product returned within 30 days. After 30 days of purchase, only unopened product that is in a resalable and restockable condition may be returned within twelve months of purchase and shall receive a 100% refund, less a 10% handling and restocking fee and any shipping and handling costs. The Company establishes a refund liability reserve, and an asset reserve for its right to recover products, based on historical experience. The returns asset reserve and returns liability reserve are evaluated on a quarterly basis. As of June&#160;30, 2025 and 2024, the Company&#x2019;s return liability reserve, net was &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$0.2 million &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;and $0.1 million, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Reserves for sales returns consist of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:3pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:62.150%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:16.908%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:16.910%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Years ended June&#160;30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Beginning balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;133&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;129&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Additions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,759&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,622&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Returns&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,655)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,618)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Ending balance&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;237&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;133&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:RevenueFromContractWithCustomerTextBlock>
    <us-gaap:ContractWithCustomerLiabilityCurrent contextRef="c-6" decimals="-5" id="f-377" unitRef="usd">700000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:ContractWithCustomerLiabilityCurrent contextRef="c-7" decimals="-5" id="f-378" unitRef="usd">900000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:ContractWithCustomerLiabilityRevenueRecognized contextRef="c-1" decimals="-3" id="f-379" unitRef="usd">200000</us-gaap:ContractWithCustomerLiabilityRevenueRecognized>
    <us-gaap:ContractWithCustomerLiabilityRevenueRecognized contextRef="c-8" decimals="-3" id="f-380" unitRef="usd">-26000</us-gaap:ContractWithCustomerLiabilityRevenueRecognized>
    <lfvn:MoneyBackGuaranteePeriod contextRef="c-1" id="f-381">P30D</lfvn:MoneyBackGuaranteePeriod>
    <lfvn:HandlingAndRestockingFeePercentage contextRef="c-6" decimals="INF" id="f-382" unitRef="number">0.10</lfvn:HandlingAndRestockingFeePercentage>
    <lfvn:ReturnLiabilityReserve contextRef="c-6" decimals="-5" id="f-383" unitRef="usd">200000</lfvn:ReturnLiabilityReserve>
    <lfvn:ReturnLiabilityReserve contextRef="c-7" decimals="-5" id="f-384" unitRef="usd">100000</lfvn:ReturnLiabilityReserve>
    <us-gaap:DisaggregationOfRevenueTableTextBlock contextRef="c-1" id="f-385">&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Reserves for sales returns consist of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:3pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:62.150%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:16.908%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:16.910%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Years ended June&#160;30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Beginning balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;133&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;129&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Additions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,759&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,622&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Returns&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,655)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,618)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Ending balance&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;237&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;133&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:DisaggregationOfRevenueTableTextBlock>
    <us-gaap:ValuationAllowancesAndReservesBalance contextRef="c-42" decimals="-3" id="f-386" unitRef="usd">133000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesBalance contextRef="c-43" decimals="-3" id="f-387" unitRef="usd">129000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense contextRef="c-44" decimals="-3" id="f-388" unitRef="usd">2759000</us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense>
    <us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense contextRef="c-45" decimals="-3" id="f-389" unitRef="usd">1622000</us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense>
    <us-gaap:ValuationAllowancesAndReservesDeductions contextRef="c-44" decimals="-3" id="f-390" unitRef="usd">2655000</us-gaap:ValuationAllowancesAndReservesDeductions>
    <us-gaap:ValuationAllowancesAndReservesDeductions contextRef="c-45" decimals="-3" id="f-391" unitRef="usd">1618000</us-gaap:ValuationAllowancesAndReservesDeductions>
    <us-gaap:ValuationAllowancesAndReservesBalance contextRef="c-46" decimals="-3" id="f-392" unitRef="usd">237000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesBalance contextRef="c-42" decimals="-3" id="f-393" unitRef="usd">133000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock contextRef="c-1" id="f-394">Property and Equipment, Net&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Property and equipment, net consist of (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:13pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:62.150%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:16.908%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:16.910%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June&#160;30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equipment (includes computer hardware and software)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,998&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,766&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Furniture and fixtures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,469&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,466&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Leasehold improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,101&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,040&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vehicles&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated depreciation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(17,412)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14,510)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total property and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,207&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,813&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Depreciation expense totaled &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$3.1 million and&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt; $3.4 million for the fiscal years ended June&#160;30, 2025 and 2024, respectively.&lt;/span&gt;&lt;/div&gt;</us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-47" decimals="-3" id="f-395" unitRef="usd">16998000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-48" decimals="-3" id="f-396" unitRef="usd">15766000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-38" decimals="-3" id="f-397" unitRef="usd">1469000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-49" decimals="-3" id="f-398" unitRef="usd">1466000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-50" decimals="-3" id="f-399" unitRef="usd">5101000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-51" decimals="-3" id="f-400" unitRef="usd">5040000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-39" decimals="-3" id="f-401" unitRef="usd">51000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-52" decimals="-3" id="f-402" unitRef="usd">51000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment contextRef="c-6" decimals="-3" id="f-403" unitRef="usd">17412000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment contextRef="c-7" decimals="-3" id="f-404" unitRef="usd">14510000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="c-6" decimals="-3" id="f-405" unitRef="usd">6207000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="c-7" decimals="-3" id="f-406" unitRef="usd">7813000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:Depreciation contextRef="c-1" decimals="-5" id="f-407" unitRef="usd">3100000</us-gaap:Depreciation>
    <us-gaap:Depreciation contextRef="c-8" decimals="-5" id="f-408" unitRef="usd">3400000</us-gaap:Depreciation>
    <us-gaap:IntangibleAssetsDisclosureTextBlock contextRef="c-1" id="f-409">Intangible Assets, Net&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Intangible assets, net consist of (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:13pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:62.150%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:16.908%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:16.910%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June&#160;30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Patent costs&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,330&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,252)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total finite-lived intangible assets, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;78&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trademarks and other indefinite-lived intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;245&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;245&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total intangible assets, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;245&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;323&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the fiscal year ended June&#160;30, 2025, the patents included in intangible assets related to Protandim&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Nrf2 Synergizer&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt; reached expiration and entered the public domain. Amortization expense totaled &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$0.1 million and&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt; $0.1 million for the fiscal years ended June&#160;30, 2025 and 2024, respectively. As of June&#160;30, 2025, the remaining weighted-average amortization period for finite-lived intangible assets is zero years. There is &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;no a&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;nnual estimated amortization expense expected in the succeeding fiscal year.&lt;/span&gt;&lt;/div&gt;</us-gaap:IntangibleAssetsDisclosureTextBlock>
    <us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock contextRef="c-1" id="f-410">&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Intangible assets, net consist of (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:13pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:62.150%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:16.908%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:16.910%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June&#160;30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Patent costs&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,330&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,252)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total finite-lived intangible assets, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;78&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trademarks and other indefinite-lived intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;245&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;245&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total intangible assets, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;245&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;323&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="c-53" decimals="-3" id="f-411" unitRef="usd">0</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="c-54" decimals="-3" id="f-412" unitRef="usd">2330000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="c-53" decimals="-3" id="f-413" unitRef="usd">0</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="c-54" decimals="-3" id="f-414" unitRef="usd">2252000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet contextRef="c-53" decimals="-3" id="f-415" unitRef="usd">0</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsNet contextRef="c-54" decimals="-3" id="f-416" unitRef="usd">78000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill contextRef="c-55" decimals="-3" id="f-417" unitRef="usd">245000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill contextRef="c-56" decimals="-3" id="f-418" unitRef="usd">245000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill contextRef="c-6" decimals="-3" id="f-419" unitRef="usd">245000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill contextRef="c-7" decimals="-3" id="f-420" unitRef="usd">323000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:AmortizationOfIntangibleAssets contextRef="c-1" decimals="-5" id="f-421" unitRef="usd">100000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets contextRef="c-8" decimals="-5" id="f-422" unitRef="usd">100000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1 contextRef="c-6" id="f-423">P0D</us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo contextRef="c-6" decimals="-5" id="f-424" unitRef="usd">0</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths contextRef="c-6" decimals="-5" id="f-425" unitRef="usd">0</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths>
    <us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock contextRef="c-1" id="f-426">Other Accrued Expenses&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other accrued expenses consist of (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:13pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:62.150%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:16.908%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:16.910%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued incentive compensation&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,325&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,521&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued severance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;90&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other taxes payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,189&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,258&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued payable to vendors&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;459&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;434&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;711&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;860&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued incentives and promotions to consultants&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,284&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,454&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued other expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,540&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,257&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total other accrued expenses&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,513&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,874&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock>
    <us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock contextRef="c-1" id="f-427">&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other accrued expenses consist of (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:13pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:62.150%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:16.908%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:16.910%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued incentive compensation&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,325&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,521&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued severance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;90&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other taxes payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,189&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,258&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued payable to vendors&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;459&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;434&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;711&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;860&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued incentives and promotions to consultants&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,284&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,454&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued other expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,540&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,257&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total other accrued expenses&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,513&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,874&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock>
    <us-gaap:AccruedBonusesCurrentAndNoncurrent contextRef="c-6" decimals="-3" id="f-428" unitRef="usd">5325000</us-gaap:AccruedBonusesCurrentAndNoncurrent>
    <us-gaap:AccruedBonusesCurrentAndNoncurrent contextRef="c-7" decimals="-3" id="f-429" unitRef="usd">1521000</us-gaap:AccruedBonusesCurrentAndNoncurrent>
    <us-gaap:AccruedEmployeeBenefitsCurrentAndNoncurrent contextRef="c-6" decimals="-3" id="f-430" unitRef="usd">5000</us-gaap:AccruedEmployeeBenefitsCurrentAndNoncurrent>
    <us-gaap:AccruedEmployeeBenefitsCurrentAndNoncurrent contextRef="c-7" decimals="-3" id="f-431" unitRef="usd">90000</us-gaap:AccruedEmployeeBenefitsCurrentAndNoncurrent>
    <us-gaap:TaxesPayableCurrent contextRef="c-6" decimals="-3" id="f-432" unitRef="usd">2189000</us-gaap:TaxesPayableCurrent>
    <us-gaap:TaxesPayableCurrent contextRef="c-7" decimals="-3" id="f-433" unitRef="usd">2258000</us-gaap:TaxesPayableCurrent>
    <lfvn:AccruedPayableToVendors contextRef="c-6" decimals="-3" id="f-434" unitRef="usd">459000</lfvn:AccruedPayableToVendors>
    <lfvn:AccruedPayableToVendors contextRef="c-7" decimals="-3" id="f-435" unitRef="usd">434000</lfvn:AccruedPayableToVendors>
    <us-gaap:ContractWithCustomerLiabilityCurrent contextRef="c-6" decimals="-3" id="f-436" unitRef="usd">711000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:ContractWithCustomerLiabilityCurrent contextRef="c-7" decimals="-3" id="f-437" unitRef="usd">860000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:AccruedMarketingCostsCurrent contextRef="c-6" decimals="-3" id="f-438" unitRef="usd">3284000</us-gaap:AccruedMarketingCostsCurrent>
    <us-gaap:AccruedMarketingCostsCurrent contextRef="c-7" decimals="-3" id="f-439" unitRef="usd">1454000</us-gaap:AccruedMarketingCostsCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent contextRef="c-6" decimals="-3" id="f-440" unitRef="usd">1540000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent contextRef="c-7" decimals="-3" id="f-441" unitRef="usd">1257000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent contextRef="c-6" decimals="-3" id="f-442" unitRef="usd">13513000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent contextRef="c-7" decimals="-3" id="f-443" unitRef="usd">7874000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:DebtDisclosureTextBlock contextRef="c-1" id="f-444">Long-Term Debt&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On March&#160;30, 2016,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt; t&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;he Company entered into a loan agreement (the &#x201c;2016 Loan Agreement&#x201d;) and a security agreement (the &#x201c;2016 Security Agreement&#x201d;). The 2016 Loan Agreement provides for a term loan in an aggregate principal amount of $10.0 million &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;the &#x201c;2016 Term Loan&#x201d;) and a revolving loan facility in an aggregate principal amount not to exceed $2.0 million (the &#x201c;2016 Revolving Loan,&#x201d; and collectively with the 2016 Term Loan, the 2016 Loan Agreement, and the 2016 Security Agreement, and together with the amendments described below, the &#x201c;2016 Credit Facility&#x201d;). The 2016 Credit Facility was subsequently amended, among other things, to increase the available borrowing under the revolving loan facility to $5.0 million. On March 31, 2024, the 2016 Credit Facility reached the maturity date and was terminated. As of March 31, 2024, there was no balance outstanding under the 2016 Credit Facility.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On April 12, 2024, the Company entered into a Loan Agreement (the &#x201c;Loan Agreement&#x201d;) with Bank of America, N.A., as Lender (the &#x201c;Lender&#x201d;). In connection with the Loan Agreement and on the same date, the Company, Lifeline Nutraceuticals Corporation, as Guarantor (the &#x201c;Guarantor&#x201d;), and the Lender also entered into a Continuing and Unconditional Guaranty (the &#x201c;Continuing and Unconditional Guaranty&#x201d;) and a Security and Pledge Agreement (the &#x201c;Security and Pledge Agreement&#x201d;). The Loan Agreement provides for a revolving line of credit in an aggregate principal amount not to exceed&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$5.0 million (the &#x201c;Line of Credit&#x201d; and collectively with the Loan Agreement, Continuing and Unconditional Guaranty, and the Security and Pledge Agreement, the &#x201c;2024 Credit Facility&#x201d;). &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the event the Company borrows under the Line of Credit, interest will be payable commencing May 31, 2024, and then on the last day of each month thereafter until payment in full of all principal outstanding under the Line of Credit, with all unpaid principal and interest due on April 12, 2027 (the &#x201c;Expiration Date&#x201d;). The Line of Credit will bear interest at a rate per year equal to the sum of (i) the greater of the Term SOFR Daily Floating Rate (as defined in the Loan Agreement) or &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;0.00%&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, plus (ii) 2.00%. Amounts under the Line of Credit may be repaid and re-borrowed from time to time until the Expiration Date. As of June&#160;30, 2025, the effective interest rate is 6.45%.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s obligations under the Loan Agreement are secured by a security interest in substantially all of the assets of the Company and the Guarantor, and by a pledge of the membership interests of the Company&#x2019;s subsidiaries, as further provided for in the Security and Pledge Agreement. Pursuant to the Continuing and Unconditional Guaranty, the Guarantor guarantees and promises to pay promptly to the Lender all indebtedness of the Company when due. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Loan Agreement contains customary covenants, both affirmative and negative, that, among other things, restrict the Company&#x2019;s ability to deal with the Company&#x2019;s assets outside of the ordinary course, incur additional indebtedness, grant liens on the Company's assets, make certain investments, purchase or otherwise acquire all or substantially all the assets or equity interests of other companies, and enter into consolidations, mergers or other combinations. The Loan Agreement requires that the Company maintain specified financial ratios and satisfy certain financial condition tests. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Loan Agreement contains certain customary events of default, including, among other things, failure of the Company to make required payments under the Loan Agreement, certain breaches of representations made by the Company or the Guarantor, insolvency or bankruptcy of the Company or the Guarantor, failure to have an enforceable first lien or security interest in any property given as security for the Loan Agreement, or failure of the Company to comply with covenants set forth in the Loan Agreement. If an event of default occurs under the Loan Agreement, the obligation of the Lender to make any additional credit available to the Company may be terminated and the amounts outstanding may become immediately due and payable in the discretion of the Lender, provided that in the event of insolvency or bankruptcy of the Company or the Guarantor, all debts outstanding under the Loan Agreement will automatically become due and payable. Upon the occurrence of any default or after maturity, all amounts outstanding under the Loan Agreement will, at the option of the Lender, bear interest at a rate which is 2.00% higher than the rate of interest otherwise provided under the Loan Agreement. &lt;/span&gt;&lt;/div&gt;As of June&#160;30, 2025, the Company was in compliance with its financial covenants under the 2024 Credit Facility.  As of June&#160;30, 2025, there was no balance outstanding on the 2024 Credit Facility.</us-gaap:DebtDisclosureTextBlock>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity contextRef="c-57" decimals="INF" id="f-445" unitRef="usd">10000000.0</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity contextRef="c-58" decimals="INF" id="f-446" unitRef="usd">2000000.0</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity contextRef="c-59" decimals="INF" id="f-447" unitRef="usd">5000000.0</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCredit contextRef="c-60" decimals="INF" id="f-448" unitRef="usd">0</us-gaap:LineOfCredit>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity contextRef="c-59" decimals="INF" id="f-449" unitRef="usd">5000000.0</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <lfvn:DebtInstrumentFloorInterestRate
      contextRef="c-61"
      decimals="INF"
      id="f-450"
      unitRef="number">0.0000</lfvn:DebtInstrumentFloorInterestRate>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="c-61"
      decimals="INF"
      id="f-451"
      unitRef="number">0.0200</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentInterestRateEffectivePercentage contextRef="c-62" decimals="4" id="f-452" unitRef="number">0.0645</us-gaap:DebtInstrumentInterestRateEffectivePercentage>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="c-61"
      decimals="INF"
      id="f-453"
      unitRef="number">0.0200</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock contextRef="c-1" id="f-454">Stockholders&#x2019; Equity&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the fiscal years ended June&#160;30, 2025 and 2024, the Company issued zero shares of common stock as a result of the exercise of options. During the fiscal years ended June&#160;30, 2025 and 2024, the Company issued &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;0.4 million and&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt; 1.0 million shares, respectively, under the Company&#x2019;s equity incentive plans. During the fiscal years ended June&#160;30, 2025 and 2024, 0.2 million&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt; 0.2 million shares, respectively, of restricted stock were canceled or surrendered as payment of tax withholding upon vesting.&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt; During the fiscal years ended &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;June&#160;30, 2025 and 2024&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, the Company sold 44,000 and 0.1 million shares under its 2019 Employee Stock Purchase Plan, respectively. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On November&#160;27, 2017, the Company&#x2019;s board approved a stock repurchase program, which was subsequently amended on February&#160;1, 2019. Under the currently approved stock repurchase program, the Company is authorized to purchase up to $60&#160;million through December 31, 2026. The stock repurchase program permits the Company to purchase shares from time to time through a variety of methods, including in the open market, through privately negotiated transactions or other means as determined by the Company&#x2019;s management, in accordance with applicable securities laws. As part of the stock repurchase program, the Company may enter into a pre-arranged stock repurchase plan which operates in accordance with guidelines specified under Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. Accordingly, any transactions under such stock repurchase plan would be completed in accordance with the terms of the plan, including specified price, volume, and timing conditions. T&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;he stock repurchase program may be suspended or discontinued at any time. During the year ended June&#160;30, 2025, the Company purchased 0.3 million&#160;shares of its common stock at an aggregate purchase price of $3.1 million under this repurchase program. During the fiscal year ended June&#160;30, 2024, the Company purchased 1.0 million&#160;shares of its common stock at an aggregate purchase price of $6.4 million under this repurchase program. At&#160;June&#160;30, 2025, there is&#160;$17.3 million&#160;remaining under this stock repurch&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;ase program.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On August 30, 2023, the board approved a stockholder rights agreement (the &#x201c;Rights Plan&#x201d;) and declared a dividend of one right for each outstanding share of common stock to stockholders of record on September 11, 2023. Each right entitled holders to purchase one newly issued share of preferred stock at an exercise price of $20 per right, subject to adjustment. Initially, the rights were not exercisable and traded with shares of the Company&#x2019;s common stock.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In general, the rights became exercisable following a public announcement that a person had acquired 12% (or, in the case of passive investors, 20%) or more of the outstanding shares of the Company&#x2019;s common stock. If a person became an acquiring &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;person, each holder of rights (except the acquiring person) would have the right to purchase, for the purchase price, a number of shares of the Company&#x2019;s common stock at a 50% discount to the then-current trading price. Rather than allowing the rights to be exercised in those circumstances, the board had the right to exchange each right, other than the rights owned by the acquiring person, for a share of the Company&#x2019;s common stock. The agreement provided for exceptions and additional terms for other certain situations and circumstances.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Rights Plan was intended to protect the interests of the Company and its stockholders by reducing the likelihood that any entity, person or group gains control of the Company through open-market accumulation or other means without payment of an adequate control premium and expired on August 28, 2024. There was no impact to the Company&#x2019;s Consolidated Financial Statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s Certificate of Incorporation authorizes the designation and issuance of shares of preferred stock. However, as of June&#160;30, 2025, no shares of preferred stock have been designated by the Board nor are any shares of preferred stock outstanding.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Dividends&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company paid quarterly cash dividends of $0.04 per share of common stock to stockholders of record in September 2024, December 2024 and March 2025, and &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$0.045&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt; per share of common stock to stockholders of record in June 2025 which were in the aggregate amount of &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$2.1 million, or $0.165&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt; per share of common stock for the fiscal year ended June&#160;30, 2025&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company paid a one-time cash dividend of $0.40&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;per share of common stock to stockholders of record in September 2023, quarterly cash dividends of $0.035 per share of common stock to stockholders of record in September 2023, December 2023 and March 2024, and $0.04 per share of common stock to stockholders of record in June 2024 which were in the aggregate amount of &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$6.9 million, or &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$0.545&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;per share of common stock for the fiscal year ended &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;June&#160;30, 2024. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The declaration of dividends is subject to the discretion of the board and will depend upon various factors, including the Company&#x2019;s earnings, financial condition, restrictions imposed by any indebtedness that may be outstanding, cash requirements, future prospects, and other factors deemed relevant by the board.&lt;/span&gt;&lt;/div&gt;</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <lfvn:StockIssuedDuringPeriodSharesStockOptionsAndWarrantsExercised contextRef="c-15" decimals="-3" id="f-455" unitRef="shares">0</lfvn:StockIssuedDuringPeriodSharesStockOptionsAndWarrantsExercised>
    <lfvn:StockIssuedDuringPeriodSharesStockOptionsAndWarrantsExercised contextRef="c-23" decimals="0" id="f-456" unitRef="shares">0</lfvn:StockIssuedDuringPeriodSharesStockOptionsAndWarrantsExercised>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures contextRef="c-63" decimals="-5" id="f-457" unitRef="shares">400000</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures contextRef="c-64" decimals="-5" id="f-458" unitRef="shares">1000000.0</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures>
    <us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation contextRef="c-1" decimals="-3" id="f-459" unitRef="shares">200000</us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation>
    <us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation contextRef="c-8" decimals="0" id="f-460" unitRef="shares">200000</us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans contextRef="c-65" decimals="-3" id="f-461" unitRef="shares">44000</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans contextRef="c-66" decimals="-5" id="f-462" unitRef="shares">100000</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
    <srt:StockRepurchaseProgramAuthorizedAmount1 contextRef="c-67" decimals="INF" id="f-463" unitRef="usd">60000000</srt:StockRepurchaseProgramAuthorizedAmount1>
    <us-gaap:StockRepurchasedDuringPeriodShares contextRef="c-1" decimals="-5" id="f-464" unitRef="shares">300000</us-gaap:StockRepurchasedDuringPeriodShares>
    <us-gaap:PaymentsForRepurchaseOfCommonStock contextRef="c-1" decimals="-5" id="f-465" unitRef="usd">3100000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:StockRepurchasedDuringPeriodShares contextRef="c-8" decimals="-5" id="f-466" unitRef="shares">1000000.0</us-gaap:StockRepurchasedDuringPeriodShares>
    <us-gaap:PaymentsForRepurchaseOfCommonStock contextRef="c-8" decimals="-5" id="f-467" unitRef="usd">6400000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1 contextRef="c-6" decimals="-5" id="f-468" unitRef="usd">17300000</us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight
      contextRef="c-68"
      decimals="INF"
      id="f-469"
      unitRef="shares">1</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight
      contextRef="c-68"
      decimals="INF"
      id="f-470"
      unitRef="shares">1</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="c-68"
      decimals="INF"
      id="f-471"
      unitRef="usdPerShare">20</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <lfvn:ClassOfWarrantOrRightPercentOfCommonStockAcquisitionThatMakesRightsExercisable
      contextRef="c-68"
      decimals="INF"
      id="f-472"
      unitRef="number">0.12</lfvn:ClassOfWarrantOrRightPercentOfCommonStockAcquisitionThatMakesRightsExercisable>
    <lfvn:ClassOfWarrantOrRightPercentOfCommonStockAcquisitionThatMakesRightsExercisablePassiveInvestors
      contextRef="c-68"
      decimals="INF"
      id="f-473"
      unitRef="number">0.20</lfvn:ClassOfWarrantOrRightPercentOfCommonStockAcquisitionThatMakesRightsExercisablePassiveInvestors>
    <lfvn:ClassOfWarrantsOrRightDiscount
      contextRef="c-68"
      decimals="INF"
      id="f-474"
      unitRef="number">0.50</lfvn:ClassOfWarrantsOrRightDiscount>
    <us-gaap:CommonStockDividendsPerShareCashPaid
      contextRef="c-69"
      decimals="INF"
      id="f-475"
      unitRef="usdPerShare">0.04</us-gaap:CommonStockDividendsPerShareCashPaid>
    <us-gaap:CommonStockDividendsPerShareCashPaid
      contextRef="c-70"
      decimals="INF"
      id="f-476"
      unitRef="usdPerShare">0.04</us-gaap:CommonStockDividendsPerShareCashPaid>
    <us-gaap:CommonStockDividendsPerShareCashPaid
      contextRef="c-71"
      decimals="INF"
      id="f-477"
      unitRef="usdPerShare">0.04</us-gaap:CommonStockDividendsPerShareCashPaid>
    <us-gaap:CommonStockDividendsPerShareCashPaid
      contextRef="c-72"
      decimals="INF"
      id="f-478"
      unitRef="usdPerShare">0.045</us-gaap:CommonStockDividendsPerShareCashPaid>
    <us-gaap:DividendsCommonStockCash contextRef="c-1" decimals="-5" id="f-479" unitRef="usd">2100000</us-gaap:DividendsCommonStockCash>
    <us-gaap:CommonStockDividendsPerShareCashPaid
      contextRef="c-1"
      decimals="INF"
      id="f-480"
      unitRef="usdPerShare">0.165</us-gaap:CommonStockDividendsPerShareCashPaid>
    <lfvn:CommonStockDividendsPerShareCashPaidOneTimeDividend
      contextRef="c-73"
      decimals="INF"
      id="f-481"
      unitRef="usdPerShare">0.40</lfvn:CommonStockDividendsPerShareCashPaidOneTimeDividend>
    <us-gaap:CommonStockDividendsPerShareCashPaid
      contextRef="c-74"
      decimals="INF"
      id="f-482"
      unitRef="usdPerShare">0.035</us-gaap:CommonStockDividendsPerShareCashPaid>
    <us-gaap:CommonStockDividendsPerShareCashPaid
      contextRef="c-75"
      decimals="INF"
      id="f-483"
      unitRef="usdPerShare">0.035</us-gaap:CommonStockDividendsPerShareCashPaid>
    <us-gaap:CommonStockDividendsPerShareCashPaid
      contextRef="c-76"
      decimals="INF"
      id="f-484"
      unitRef="usdPerShare">0.035</us-gaap:CommonStockDividendsPerShareCashPaid>
    <us-gaap:CommonStockDividendsPerShareCashPaid
      contextRef="c-77"
      decimals="INF"
      id="f-485"
      unitRef="usdPerShare">0.04</us-gaap:CommonStockDividendsPerShareCashPaid>
    <us-gaap:DividendsCommonStockCash contextRef="c-8" decimals="-5" id="f-486" unitRef="usd">6900000</us-gaap:DividendsCommonStockCash>
    <us-gaap:CommonStockDividendsPerShareCashPaid
      contextRef="c-8"
      decimals="INF"
      id="f-487"
      unitRef="usdPerShare">0.545</us-gaap:CommonStockDividendsPerShareCashPaid>
    <us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock contextRef="c-1" id="f-488">Stock-Based Compensation&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Long-Term Incentive Plans&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Equity-Settled Plans&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company adopted, and the stockholders approved, the 2017 Long-Term Incentive Plan (the &#x201c;2017 Plan&#x201d;), effective February&#160;16, 2017, to provide incentives to eligible employees, directors, and consultants. T&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;he initial share pool approved was 650,000 shares. On November 9, 2023, the stockholders approved amendments to the 2017 Plan to increase the number of shares of the Company&#x2019;s common stock that are available for issuance under the 2017 plan by &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,138,000&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt; shares. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of&#160;June&#160;30, 2025, a maximum of&#160;5,105,000&#160;shares of the Company&#x2019;s common stock can be issued under the 2017 Plan in connection with the grant of awards which is calculated as the sum of (i)&#160;4,630,000&#160;shares and (ii) up to&#160;475,000&#160;shares previously reserved for issuance under the Company&#x2019;s prior 2010 Long Term Incentive Plan, including shares returned upon cancellation, termination or forfeiture of awards that were previously granted under that plan. Outstanding stock options awarded under the 2017 Plan have exercise prices of&#160;$4.44&#160;per share, vest over a&#160;&lt;span style="-sec-ix-hidden:f-495"&gt;three&#160;year&lt;/span&gt; vesting period, and have a contractual term of ten years. Awards expire in accordance with the terms of each award and, upon expiration of the award, the shares subject to the award are added back to the 2017 Plan. As of June&#160;30, 2025, under the 2017 Plan, there were stock option awards outstanding, net of awards expired, for an aggregate of 0.1 million shares of the Company&#x2019;s common stock.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Employee Stock Purchase Plan&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;General.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;The Company&#x2019;s 2019 Employee Stock Purchase Plan (&#x201c;ESPP&#x201d;) was adopted by the board in September 2018 and the Company&#x2019;s stockholders approved it in November 2018.  In August 2024, the board approved an amendment to the ESPP to increase the share reserve thereunder by 0.4 million shares, which amendment and increase was approved by the Company&#x2019;s stockholders in November 2024. The ESPP is intended to qualify under Section 423 of the Internal Revenue Code.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Share Reserve.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;The Company has reserved 0.8 million shares of its common stock for issuance under the ESPP. As of June&#160;30, 2025, 0.4 million shares were available for issuance. The number of shares reserved under the ESPP will automatically be adjusted in the event of a stock split, stock dividend or a reverse stock split (including an adjustment to the per-purchase period share limit).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Purchase Price.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;Employees may purchase each share of common stock under the ESPP at a price equal to 85% of the lower of the fair market values of the stock as of the beginning or the end of the six-month offering periods. An employee&#x2019;s contributions to the ESPP are limited to 15% of the compensation, and up to a maximum of 3,000 shares may be purchased by &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;an employee during any offering period. A participant shall not be granted an option under the ESPP if such option would permit the participant&#x2019;s rights to purchase stock to accrue at a rate exceeding $25,000 fair market value of stock for each calendar year in which such option is outstanding at any time.&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Offering Periods.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;Unless otherwise determined by the compensation committee, the ESPP will be operated through a series of successive six-month offering periods, which will begin each year on March 1 and September 1.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the fiscal years ended June&#160;30, 2025 and 2024, 44,000 and 0.1 million shares of common stock were purchased under the ESPP, respectively. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Stock-Based Compensation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In accordance with accounting guidance for stock-based compensation, payments in equity instruments for goods or services are accounted for by the fair value method. For the fiscal year ended June&#160;30, 2025 and 2024, stock-based compensation of $5.7 million&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and $3.3 million, respectively, was reflected as an increase to additional paid in capital. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At June&#160;30, 2025, there was $3.5 million of unrecognized compensation cost related to non-vested stock-based compensation arrangements under the 2017 Plan, based on management&#x2019;s estimate of the shares that will ultimately vest. The Company expects to recognize such costs over a weighted-average period of 1.43 years. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Stock Options&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;There were no stock option grants during the fiscal years ended June&#160;30, 2025 and 2024. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is a summary of stock option activity for the fiscal years ended June&#160;30, 2025 and 2024:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:13pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:38.724%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.394%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.394%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.394%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.398%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Options (in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted&lt;br/&gt;Average&lt;br/&gt;Exercise&#160;Price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted&lt;br/&gt;Average&#160;Remaining&lt;br/&gt;Contractual Term (in years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Aggregate Intrinsic Value (in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding at June 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expired or Canceled&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding at June 30, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expired or Canceled&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding at June 30, 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.59&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;618&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercisable at June 30, 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.59&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;618&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:3pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Restricted Stock Awards&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is a summary of restricted stock award activity during the fiscal years ended June&#160;30, 2025 and 2024:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:13pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:61.418%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:16.908%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:16.910%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Shares&lt;br/&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted Average Grant Date Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Nonvested at June 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;117&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.85&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;392&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.74&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(117)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.85&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Nonvested at June 30, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;392&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.74&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.54&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(294)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.77&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Nonvested at June 30, 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;156&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.92&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-align:center;text-indent:22.5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.836%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:2.679%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:95.121%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:2pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;Includes 125,732 shares of restricted stock that were granted in exchange for the cancellation of 48,026 shares of stock units and 77,706 shares of performance restricted stock units on November 6, 2023.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The total vesting date fair value of restricted shares that vested during the fiscal years ended June 30, 2025 and 2024 w&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;as $4.4 million and&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt; $0.7 million, respectively.  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Restricted Stock Units&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is a summary of restricted stock units activity during the fiscal years ended June&#160;30, 2025 and 2024:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:13pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:61.418%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:16.908%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:16.910%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Number of Units (in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted Average Grant Date Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Nonvested at June 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;538&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.90&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;214&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.90&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(331)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.05&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(84)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.48&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Nonvested at June 30, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;337&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.86&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;224&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.08&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(224)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.87&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(47)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Nonvested at June 30, 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;290&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.68&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-align:center;text-indent:22.5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.836%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:2.679%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:95.121%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="margin-bottom:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;Includes 48,026 shares of restricted stock units that were canceled in exchange for restricted stock awards on November 6, 2023.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The total vesting date fair value of restricted stock units that vested during the fiscal years ended June 30, 2025 and 2024 was $2.6 million and $1.9 million, respectively. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Performance Restricted Stock Units&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the fiscal years ended June 30, 2025 and 2024 , the Company awarded performance restricted stock units (the &#x201c;FY 2025 PRSUs&#x201d; and &#x201c;FY 2024 PRSUs,&#x201d; respectively) to certain employees (the &#x201c;Recipients&#x201d;). Each performance restricted stock unit represents a contingent right for the Recipients to receive a distribution of shares of common stock of the Company equal to 0% to 200% of the target number of performance restricted stock units subject to the award. The actual number of shares distributed will be based on the Company&#x2019;s achievement of specified financial performance metrics. For FY 2025 PRSUs, the performance period for 50% of the FY 2025 PRSUs ended on June&#160;30, 2025, the performance period for 30% of the FY 2025 PRSUs ends on June 30, 2026, and the performance period for the remaining 20% of the FY 2025 PRSUs ends on June 30, 2027. For FY 2024 PRSUs, the performance period for 50% of the FY 2024 PRSUs ended on June 30, 2024, the performance period for 30% of the FY 2024 PRSUs ended on June&#160;30, 2025, and the performance period for the remaining 20% of the FY &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2024 PRSUs ends on June 30, 2026. The financial performance metrics for the fiscal year ended June&#160;30, 2025, were deemed achieved at the 200.00% achievement level. The financial performance metrics for the fiscal year ended June 30, 2024, were deemed achieved at the 0% achievement level. The FY 2025 PRSUs and FY 2024 PRSUs will vest only to the extent the specified financial performance criteria are achieved and subject to the Recipient&#x2019;s continued service with the Company, as follows: (i) a portion of the earned award will vest on the first anniversary of the grant date and (ii) an additional portion of the earned award will vest thereafter in a series of quarterly installments. The fair values of the performance restricted stock units are based on the grant date fair value which is the closing price of the Company's common stock on the date of grant.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is a summary of performance restricted stock units activity during the fiscal years ended June&#160;30, 2025 and 2024:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:13pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:61.418%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:16.908%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:16.910%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Number of Units (in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted Average Grant Date Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Nonvested at June 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;492&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;350&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.89&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(284)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(274)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.68&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Nonvested at June 30, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;284&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.62&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;509&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(94)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(45)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.67&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Nonvested at June 30, 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;654&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-align:center;text-indent:22.5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.836%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:2.679%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:95.121%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:2pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;Includes 77,706 shares of performance restricted stock units that were canceled in exchange for restricted stock awards on November 6, 2023.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:2pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;Includes shares added based on achievement of performance goals in excess of target.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The total vesting date fair value of performance restricted stock units that vested during the fiscal years ended June 30, 2025 and 2024 was approximately $1.1 million&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and&lt;/span&gt; $1.6 million, respectively.</us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized
      contextRef="c-78"
      decimals="INF"
      id="f-489"
      unitRef="shares">650000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized
      contextRef="c-79"
      decimals="INF"
      id="f-490"
      unitRef="shares">1138000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="c-80"
      decimals="INF"
      id="f-491"
      unitRef="shares">5105000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="c-81"
      decimals="INF"
      id="f-492"
      unitRef="shares">4630000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="c-82"
      decimals="INF"
      id="f-493"
      unitRef="shares">475000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="c-80"
      decimals="2"
      id="f-494"
      unitRef="usdPerShare">4.44</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue>
    <lfvn:SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsOutstandingContractualTerm contextRef="c-84" id="f-496">P10Y</lfvn:SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsOutstandingContractualTerm>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber contextRef="c-80" decimals="-5" id="f-497" unitRef="shares">100000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance contextRef="c-85" decimals="-5" id="f-498" unitRef="shares">400000</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="c-86"
      decimals="INF"
      id="f-499"
      unitRef="shares">800000</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="c-86"
      decimals="INF"
      id="f-500"
      unitRef="shares">400000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent
      contextRef="c-65"
      decimals="INF"
      id="f-501"
      unitRef="number">0.85</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate
      contextRef="c-86"
      decimals="INF"
      id="f-502"
      unitRef="number">0.15</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee
      contextRef="c-65"
      decimals="INF"
      id="f-503"
      unitRef="shares">3000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee>
    <lfvn:ShareBasedCompensationArrangementByShareBasedPaymentAwardAmountInExcessOfFairMarketValueOfStockForOptionNotToBeGranted contextRef="c-86" decimals="INF" id="f-504" unitRef="usd">25000</lfvn:ShareBasedCompensationArrangementByShareBasedPaymentAwardAmountInExcessOfFairMarketValueOfStockForOptionNotToBeGranted>
    <lfvn:ShareBasedCompensationArrangementByShareBasedPaymentAwardOfferingPeriod contextRef="c-65" id="f-505">P6M</lfvn:ShareBasedCompensationArrangementByShareBasedPaymentAwardOfferingPeriod>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans contextRef="c-65" decimals="-3" id="f-506" unitRef="shares">44000</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans contextRef="c-66" decimals="-5" id="f-507" unitRef="shares">100000</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c-1" decimals="-5" id="f-508" unitRef="usd">5700000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c-8" decimals="-5" id="f-509" unitRef="usd">3300000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized contextRef="c-87" decimals="-5" id="f-510" unitRef="usd">3500000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1 contextRef="c-88" id="f-511">P1Y5M4D</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross contextRef="c-1" decimals="INF" id="f-512" unitRef="shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross contextRef="c-8" decimals="INF" id="f-513" unitRef="shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="c-89"
      decimals="INF"
      id="f-514"
      unitRef="shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock contextRef="c-1" id="f-515">&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is a summary of stock option activity for the fiscal years ended June&#160;30, 2025 and 2024:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:13pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:38.724%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.394%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.394%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.394%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.398%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Options (in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted&lt;br/&gt;Average&lt;br/&gt;Exercise&#160;Price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted&lt;br/&gt;Average&#160;Remaining&lt;br/&gt;Contractual Term (in years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Aggregate Intrinsic Value (in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding at June 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expired or Canceled&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding at June 30, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expired or Canceled&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding at June 30, 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.59&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;618&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercisable at June 30, 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.59&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;618&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber contextRef="c-13" decimals="-3" id="f-516" unitRef="shares">72000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="c-13"
      decimals="2"
      id="f-517"
      unitRef="usdPerShare">4.44</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross contextRef="c-8" decimals="-3" id="f-518" unitRef="shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="c-8"
      decimals="2"
      id="f-519"
      unitRef="usdPerShare">0</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised contextRef="c-8" decimals="-3" id="f-520" unitRef="shares">0</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="c-8"
      decimals="2"
      id="f-521"
      unitRef="usdPerShare">0</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue contextRef="c-8" decimals="-3" id="f-522" unitRef="usd">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod contextRef="c-8" decimals="-3" id="f-523" unitRef="shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
      contextRef="c-8"
      decimals="2"
      id="f-524"
      unitRef="usdPerShare">0</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod contextRef="c-8" decimals="-3" id="f-525" unitRef="shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
      contextRef="c-8"
      decimals="2"
      id="f-526"
      unitRef="usdPerShare">0</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber contextRef="c-7" decimals="-3" id="f-527" unitRef="shares">72000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="c-7"
      decimals="2"
      id="f-528"
      unitRef="usdPerShare">4.44</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross contextRef="c-1" decimals="-3" id="f-529" unitRef="shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="c-1"
      decimals="2"
      id="f-530"
      unitRef="usdPerShare">0</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised contextRef="c-1" decimals="-3" id="f-531" unitRef="shares">0</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="c-1"
      decimals="2"
      id="f-532"
      unitRef="usdPerShare">0</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue contextRef="c-1" decimals="-3" id="f-533" unitRef="usd">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod contextRef="c-1" decimals="-3" id="f-534" unitRef="shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
      contextRef="c-1"
      decimals="2"
      id="f-535"
      unitRef="usdPerShare">0</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod contextRef="c-1" decimals="-3" id="f-536" unitRef="shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
      contextRef="c-1"
      decimals="2"
      id="f-537"
      unitRef="usdPerShare">0</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber contextRef="c-6" decimals="-3" id="f-538" unitRef="shares">72000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="c-6"
      decimals="2"
      id="f-539"
      unitRef="usdPerShare">4.44</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 contextRef="c-1" id="f-540">P2Y7M2D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue contextRef="c-6" decimals="-3" id="f-541" unitRef="usd">618000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber contextRef="c-6" decimals="-3" id="f-542" unitRef="shares">72000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
      contextRef="c-6"
      decimals="2"
      id="f-543"
      unitRef="usdPerShare">4.44</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1 contextRef="c-1" id="f-544">P2Y7M2D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 contextRef="c-6" decimals="-3" id="f-545" unitRef="usd">618000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1>
    <us-gaap:NonvestedRestrictedStockSharesActivityTableTextBlock contextRef="c-1" id="f-546">&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is a summary of restricted stock award activity during the fiscal years ended June&#160;30, 2025 and 2024:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:13pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:61.418%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:16.908%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:16.910%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Shares&lt;br/&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted Average Grant Date Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Nonvested at June 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;117&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.85&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;392&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.74&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(117)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.85&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Nonvested at June 30, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;392&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.74&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.54&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(294)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.77&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Nonvested at June 30, 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;156&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.92&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-align:center;text-indent:22.5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.836%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:2.679%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:95.121%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:2pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;Includes 125,732 shares of restricted stock that were granted in exchange for the cancellation of 48,026 shares of stock units and 77,706 shares of performance restricted stock units on November 6, 2023.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:NonvestedRestrictedStockSharesActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber contextRef="c-90" decimals="-3" id="f-547" unitRef="shares">117000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="c-90"
      decimals="2"
      id="f-548"
      unitRef="usdPerShare">3.85</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod contextRef="c-64" decimals="-3" id="f-549" unitRef="shares">392000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="c-64"
      decimals="2"
      id="f-550"
      unitRef="usdPerShare">4.74</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod contextRef="c-64" decimals="-3" id="f-551" unitRef="shares">117000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
      contextRef="c-64"
      decimals="2"
      id="f-552"
      unitRef="usdPerShare">3.85</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod contextRef="c-64" decimals="-3" id="f-553" unitRef="shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
      contextRef="c-64"
      decimals="2"
      id="f-554"
      unitRef="usdPerShare">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber contextRef="c-91" decimals="-3" id="f-555" unitRef="shares">392000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="c-91"
      decimals="2"
      id="f-556"
      unitRef="usdPerShare">4.74</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod contextRef="c-63" decimals="-3" id="f-557" unitRef="shares">58000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="c-63"
      decimals="2"
      id="f-558"
      unitRef="usdPerShare">13.54</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod contextRef="c-63" decimals="-3" id="f-559" unitRef="shares">294000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
      contextRef="c-63"
      decimals="2"
      id="f-560"
      unitRef="usdPerShare">4.77</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod contextRef="c-63" decimals="-3" id="f-561" unitRef="shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
      contextRef="c-63"
      decimals="2"
      id="f-562"
      unitRef="usdPerShare">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber contextRef="c-92" decimals="-3" id="f-563" unitRef="shares">156000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="c-92"
      decimals="2"
      id="f-564"
      unitRef="usdPerShare">7.92</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <lfvn:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInExchange
      contextRef="c-93"
      decimals="INF"
      id="f-565"
      unitRef="shares">125732</lfvn:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInExchange>
    <lfvn:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsCancelledInPeriod
      contextRef="c-94"
      decimals="INF"
      id="f-566"
      unitRef="shares">48026</lfvn:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsCancelledInPeriod>
    <lfvn:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsCancelledInPeriod
      contextRef="c-95"
      decimals="INF"
      id="f-567"
      unitRef="shares">77706</lfvn:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsCancelledInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue contextRef="c-63" decimals="-5" id="f-568" unitRef="usd">4400000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue contextRef="c-64" decimals="-5" id="f-569" unitRef="usd">700000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue>
    <us-gaap:ScheduleOfUnvestedRestrictedStockUnitsRollForwardTableTextBlock contextRef="c-1" id="f-570">&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is a summary of restricted stock units activity during the fiscal years ended June&#160;30, 2025 and 2024:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:13pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:61.418%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:16.908%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:16.910%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Number of Units (in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted Average Grant Date Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Nonvested at June 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;538&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.90&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;214&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.90&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(331)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.05&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(84)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.48&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Nonvested at June 30, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;337&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.86&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;224&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.08&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(224)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.87&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(47)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Nonvested at June 30, 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;290&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.68&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-align:center;text-indent:22.5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.836%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:2.679%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:95.121%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="margin-bottom:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;Includes 48,026 shares of restricted stock units that were canceled in exchange for restricted stock awards on November 6, 2023.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfUnvestedRestrictedStockUnitsRollForwardTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber contextRef="c-96" decimals="-3" id="f-571" unitRef="shares">538000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="c-96"
      decimals="2"
      id="f-572"
      unitRef="usdPerShare">4.90</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod contextRef="c-97" decimals="-3" id="f-573" unitRef="shares">214000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="c-97"
      decimals="2"
      id="f-574"
      unitRef="usdPerShare">4.90</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod contextRef="c-97" decimals="-3" id="f-575" unitRef="shares">331000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
      contextRef="c-97"
      decimals="2"
      id="f-576"
      unitRef="usdPerShare">5.05</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod contextRef="c-97" decimals="-3" id="f-577" unitRef="shares">84000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
      contextRef="c-97"
      decimals="2"
      id="f-578"
      unitRef="usdPerShare">4.48</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber contextRef="c-98" decimals="-3" id="f-579" unitRef="shares">337000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="c-98"
      decimals="2"
      id="f-580"
      unitRef="usdPerShare">4.86</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod contextRef="c-99" decimals="-3" id="f-581" unitRef="shares">224000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="c-99"
      decimals="2"
      id="f-582"
      unitRef="usdPerShare">10.08</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod contextRef="c-99" decimals="-3" id="f-583" unitRef="shares">224000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
      contextRef="c-99"
      decimals="2"
      id="f-584"
      unitRef="usdPerShare">4.87</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod contextRef="c-99" decimals="-3" id="f-585" unitRef="shares">47000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
      contextRef="c-99"
      decimals="2"
      id="f-586"
      unitRef="usdPerShare">6.12</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="c-100"
      decimals="-3"
      id="f-587"
      unitRef="shares">290000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="c-100"
      decimals="2"
      id="f-588"
      unitRef="usdPerShare">8.68</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <lfvn:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsCancelledInPeriod
      contextRef="c-94"
      decimals="INF"
      id="f-589"
      unitRef="shares">48026</lfvn:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsCancelledInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue contextRef="c-99" decimals="-5" id="f-590" unitRef="usd">2600000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue contextRef="c-97" decimals="-5" id="f-591" unitRef="usd">1900000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue>
    <lfvn:SharebasedCompensationArrangementbySharebasedPaymentAwardDistributionPercentage
      contextRef="c-101"
      decimals="INF"
      id="f-592"
      unitRef="number">0</lfvn:SharebasedCompensationArrangementbySharebasedPaymentAwardDistributionPercentage>
    <lfvn:SharebasedCompensationArrangementbySharebasedPaymentAwardDistributionPercentage
      contextRef="c-102"
      decimals="INF"
      id="f-593"
      unitRef="number">2</lfvn:SharebasedCompensationArrangementbySharebasedPaymentAwardDistributionPercentage>
    <lfvn:SharebasedCompensationArrangementbySharebasedPaymentAwardDistributionPercentage
      contextRef="c-102"
      decimals="INF"
      id="f-594"
      unitRef="number">2.0000</lfvn:SharebasedCompensationArrangementbySharebasedPaymentAwardDistributionPercentage>
    <lfvn:SharebasedCompensationArrangementbySharebasedPaymentAwardDistributionPercentage
      contextRef="c-103"
      decimals="INF"
      id="f-595"
      unitRef="number">0</lfvn:SharebasedCompensationArrangementbySharebasedPaymentAwardDistributionPercentage>
    <us-gaap:ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock contextRef="c-1" id="f-596">&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is a summary of performance restricted stock units activity during the fiscal years ended June&#160;30, 2025 and 2024:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:13pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:61.418%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:16.908%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:16.910%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Number of Units (in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted Average Grant Date Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Nonvested at June 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;492&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;350&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.89&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(284)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(274)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.68&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Nonvested at June 30, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;284&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.62&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;509&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(94)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(45)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.67&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Nonvested at June 30, 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;654&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-align:center;text-indent:22.5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.836%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:2.679%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:95.121%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:2pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;Includes 77,706 shares of performance restricted stock units that were canceled in exchange for restricted stock awards on November 6, 2023.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:2pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;Includes shares added based on achievement of performance goals in excess of target.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="c-104"
      decimals="-3"
      id="f-597"
      unitRef="shares">492000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="c-104"
      decimals="2"
      id="f-598"
      unitRef="usdPerShare">4.24</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="c-105"
      decimals="-3"
      id="f-599"
      unitRef="shares">350000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="c-105"
      decimals="2"
      id="f-600"
      unitRef="usdPerShare">4.89</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="c-105"
      decimals="-3"
      id="f-601"
      unitRef="shares">284000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
      contextRef="c-105"
      decimals="2"
      id="f-602"
      unitRef="usdPerShare">4.24</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="c-105"
      decimals="-3"
      id="f-603"
      unitRef="shares">274000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
      contextRef="c-105"
      decimals="2"
      id="f-604"
      unitRef="usdPerShare">4.68</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="c-106"
      decimals="-3"
      id="f-605"
      unitRef="shares">284000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="c-106"
      decimals="2"
      id="f-606"
      unitRef="usdPerShare">4.62</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="c-107"
      decimals="-3"
      id="f-607"
      unitRef="shares">509000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="c-107"
      decimals="2"
      id="f-608"
      unitRef="usdPerShare">8.30</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="c-107"
      decimals="-3"
      id="f-609"
      unitRef="shares">94000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
      contextRef="c-107"
      decimals="2"
      id="f-610"
      unitRef="usdPerShare">4.24</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="c-107"
      decimals="-3"
      id="f-611"
      unitRef="shares">45000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
      contextRef="c-107"
      decimals="2"
      id="f-612"
      unitRef="usdPerShare">6.67</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="c-108"
      decimals="-3"
      id="f-613"
      unitRef="shares">654000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="c-108"
      decimals="2"
      id="f-614"
      unitRef="usdPerShare">7.40</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <lfvn:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsCancelledInPeriod
      contextRef="c-95"
      decimals="INF"
      id="f-615"
      unitRef="shares">77706</lfvn:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsCancelledInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue contextRef="c-107" decimals="-3" id="f-616" unitRef="usd">1100000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue contextRef="c-105" decimals="-3" id="f-617" unitRef="usd">1600000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue>
    <us-gaap:OtherIncomeAndOtherExpenseDisclosureTextBlock contextRef="c-1" id="f-620">Other Expense, Net&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other expense, net consists of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:13pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:62.150%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:16.908%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:16.910%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Years ended June&#160;30,&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency transaction loss, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(380)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(429)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other income (expense), net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;Total other expense, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(387)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(412)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:OtherIncomeAndOtherExpenseDisclosureTextBlock>
    <us-gaap:ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock contextRef="c-1" id="f-621">&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other expense, net consists of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:13pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:62.150%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:16.908%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:16.910%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Years ended June&#160;30,&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency transaction loss, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(380)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(429)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other income (expense), net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;Total other expense, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(387)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(412)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock>
    <us-gaap:ForeignCurrencyTransactionGainLossBeforeTax contextRef="c-1" decimals="-3" id="f-622" unitRef="usd">-380000</us-gaap:ForeignCurrencyTransactionGainLossBeforeTax>
    <us-gaap:ForeignCurrencyTransactionGainLossBeforeTax contextRef="c-8" decimals="-3" id="f-623" unitRef="usd">-429000</us-gaap:ForeignCurrencyTransactionGainLossBeforeTax>
    <lfvn:OtherMiscellaneousIncomeExpensesNet contextRef="c-1" decimals="-3" id="f-624" unitRef="usd">-7000</lfvn:OtherMiscellaneousIncomeExpensesNet>
    <lfvn:OtherMiscellaneousIncomeExpensesNet contextRef="c-8" decimals="-3" id="f-625" unitRef="usd">17000</lfvn:OtherMiscellaneousIncomeExpensesNet>
    <us-gaap:OtherNonoperatingIncomeExpense contextRef="c-1" decimals="-3" id="f-626" unitRef="usd">-387000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense contextRef="c-8" decimals="-3" id="f-627" unitRef="usd">-412000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:IncomeTaxDisclosureTextBlock contextRef="c-1" id="f-628">Income Taxes&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The income tax expense for the fiscal years ended June&#160;30, 2025 and 2024 consists of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:13pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:62.150%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:16.908%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:16.910%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Years ended June 30,&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income before income taxes:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Domestic&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,397&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,940&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,846&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,410&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,243&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,350&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current taxes:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Federal&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,925&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,457&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;708&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;246&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;491&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;984&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total current income tax provision&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,124&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,687&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred taxes:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Federal&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,464)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,281)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(341)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(151)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;119&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;158&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total deferred income tax provision&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,686)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,274)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income tax provision&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,438&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,413&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The effective income tax rate for the fiscal years ended June&#160;30, 2025 and 2024 differs from the U.S. Federal statutory income tax rate due to the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:13pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:62.150%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:16.908%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:16.910%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Years ended June 30,&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Federal statutory income tax rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State income taxes, net of federal benefit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign tax rate difference&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Tax return to provision true-up&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Limit on future stock compensation due to 162(m)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign withholding tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other differences&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Revalue of deferred for change in federal tax rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Permanent differences:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014; stock-based compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014; current year section 162(m) limitation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014; foreign derived intangible income deduction&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014; tax credits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014; meals and entertainment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014; removal of additional permanent reinvestment assertions&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014; change in uncertain tax positions&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014; accrual for foreign tax audits&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014; other permanent differences&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Change in valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income tax provision &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The components of the deferred tax assets and liabilities as of June&#160;30, 2025 and 2024 are as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:13pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:62.150%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:16.908%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:16.910%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred tax assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Federal, state, and foreign net operating loss carryovers&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;234&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;271&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock option compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;628&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;360&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Section 174 costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,798&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,578&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Lease liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,798&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,223&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued vacation, allowance for returns, bonuses&#160;&amp;amp; other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,819&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,119&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross deferred tax asset&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,277&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,551&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred tax liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Patents and trademarks&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(16)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(30)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property&#160;&amp;amp; equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(239)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(798)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Right of use asset&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,942)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,263)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(468)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(472)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross deferred tax liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,665)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,563)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(642)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(720)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred tax assets, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,970&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,268&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has adopted accounting guidance for uncertain tax positions (&#x201c;UTPs&#x201d;) which provides that in order to recognize an uncertain tax benefit, the taxpayer must be more likely than not of sustaining the position. The measurement of the benefit is calculated as the largest amount that is more than 50% likely to be realized upon recognition of the benefit. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the fiscal year ended June&#160;30, 2024, the Company began recording a withholding tax obligation on certain rebalanced commission payments to the U.S. parent company it had not obtained treaty rates for. The withholding tax recorded in the fiscal year ended June&#160;30, 2024 has been reversed during the fiscal year ended June&#160;30, 2025 as the Company no longer expects to pay that liability&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has been undergoing income tax audits in foreign jurisdictions. For the fiscal year ended June&#160;30, 2025, the Company accrued a total $0.4 million related to foreign income tax audits. In fiscal year 2025, the Company made payments or deemed payments totaling $0.4 million related to these foreign income tax audits. The UTP related to foreign tax audits is now zero. The Company does not have any other foreign tax audits as of June&#160;30, 2025.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The change in the liability for uncertain tax positions were as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:62.204%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:16.882%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:16.884%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Years ended June&#160;30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Beginning balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;389&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross increases - tax positions in prior year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross decreases - tax positions in prior year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(53)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross increases - tax positions in current year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;389&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Settlement&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(381)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Currency adjustment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Ending balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;389&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In fiscal year 2022, the Company removed its permanent reinvestment assertion in Japan. In fiscal year 2024, the Company removed its permanent reinvestment assertions in Taiwan and Australia and recorded the tax effects of that change. In fiscal year 2025, the Company removed its permanent reinvestment assertion on all other entities. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The tax years open for examination by the Internal Revenue Service (&#x201c;IRS&#x201d;) include returns for fiscal years June 30, 2021 through present and the open tax years by state tax authorities include returns for fiscal years June 30, 2020 through present. In addition, the IRS and state tax authorities may examine net operating losses (&#x201c;NOLs&#x201d;) for any previous years if utilized by the Company.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The change in the valuation allowance were as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:62.150%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:16.908%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:16.910%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Years ended June&#160;30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Beginning balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;720&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;704&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Increases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(78)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Ending balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;642&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;720&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The change in valuation allowance during the fiscal year ended &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;June&#160;30, 2025&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt; related to current year income in entities with a full valuation allowance along with a change to the United States valuation allowance based on the Company converting from a blended rate to a state-by-state provision. During the fiscal year ended June&#160;30, 2024, the change in valuation allowance related to current year income in entities with a full valuation allowance along with a change to the United States valuation allowance based on updated projections and changes to the blended rate.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of June&#160;30, 2025, the Company had utilized all of its Federal NOL carry-forwards.&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt; As of June&#160;30, 2025, state NOLs were $4.8 million and foreign NOLs were $0.4 million.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The total recognized tax benefit from settlement of stock-based awards for the fiscal years ended June&#160;30, 2025 and 2024, was $0.8 million and $0.2 million, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has reflected all changes in tax laws including the changes resulting from expiring Tax Cuts and Jobs Act provisions. The Company will reflect the changes from the One Big Beautiful Bill Act in fiscal year 2026, when the law was enacted.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company conducts its business globally. As a result, the Company and its subsidiaries file income tax returns in the U.S. federal jurisdiction and various state and foreign jurisdictions, and are subject to examination for the open tax years of June 30, 2021 through June 30, 2025.&lt;/span&gt;&lt;/div&gt;</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock contextRef="c-1" id="f-629">&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The income tax expense for the fiscal years ended June&#160;30, 2025 and 2024 consists of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:13pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:62.150%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:16.908%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:16.910%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Years ended June 30,&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income before income taxes:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Domestic&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,397&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,940&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,846&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,410&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,243&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,350&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current taxes:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Federal&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,925&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,457&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;708&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;246&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;491&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;984&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total current income tax provision&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,124&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,687&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred taxes:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Federal&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,464)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,281)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(341)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(151)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;119&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;158&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total deferred income tax provision&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,686)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,274)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income tax provision&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,438&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,413&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic contextRef="c-1" decimals="-3" id="f-630" unitRef="usd">10397000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic contextRef="c-8" decimals="-3" id="f-631" unitRef="usd">2940000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign contextRef="c-1" decimals="-3" id="f-632" unitRef="usd">1846000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign contextRef="c-8" decimals="-3" id="f-633" unitRef="usd">1410000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c-1" decimals="-3" id="f-634" unitRef="usd">12243000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c-8" decimals="-3" id="f-635" unitRef="usd">4350000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:CurrentFederalTaxExpenseBenefit contextRef="c-1" decimals="-3" id="f-636" unitRef="usd">2925000</us-gaap:CurrentFederalTaxExpenseBenefit>
    <us-gaap:CurrentFederalTaxExpenseBenefit contextRef="c-8" decimals="-3" id="f-637" unitRef="usd">1457000</us-gaap:CurrentFederalTaxExpenseBenefit>
    <us-gaap:CurrentStateAndLocalTaxExpenseBenefit contextRef="c-1" decimals="-3" id="f-638" unitRef="usd">708000</us-gaap:CurrentStateAndLocalTaxExpenseBenefit>
    <us-gaap:CurrentStateAndLocalTaxExpenseBenefit contextRef="c-8" decimals="-3" id="f-639" unitRef="usd">246000</us-gaap:CurrentStateAndLocalTaxExpenseBenefit>
    <us-gaap:CurrentForeignTaxExpenseBenefit contextRef="c-1" decimals="-3" id="f-640" unitRef="usd">491000</us-gaap:CurrentForeignTaxExpenseBenefit>
    <us-gaap:CurrentForeignTaxExpenseBenefit contextRef="c-8" decimals="-3" id="f-641" unitRef="usd">984000</us-gaap:CurrentForeignTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit contextRef="c-1" decimals="-3" id="f-642" unitRef="usd">4124000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit contextRef="c-8" decimals="-3" id="f-643" unitRef="usd">2687000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:DeferredFederalIncomeTaxExpenseBenefit contextRef="c-1" decimals="-3" id="f-644" unitRef="usd">-1464000</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredFederalIncomeTaxExpenseBenefit contextRef="c-8" decimals="-3" id="f-645" unitRef="usd">-1281000</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit contextRef="c-1" decimals="-3" id="f-646" unitRef="usd">-341000</us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit contextRef="c-8" decimals="-3" id="f-647" unitRef="usd">-151000</us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredForeignIncomeTaxExpenseBenefit contextRef="c-1" decimals="-3" id="f-648" unitRef="usd">119000</us-gaap:DeferredForeignIncomeTaxExpenseBenefit>
    <us-gaap:DeferredForeignIncomeTaxExpenseBenefit contextRef="c-8" decimals="-3" id="f-649" unitRef="usd">158000</us-gaap:DeferredForeignIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit contextRef="c-1" decimals="-3" id="f-650" unitRef="usd">-1686000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit contextRef="c-8" decimals="-3" id="f-651" unitRef="usd">-1274000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-1" decimals="-3" id="f-652" unitRef="usd">2438000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-8" decimals="-3" id="f-653" unitRef="usd">1413000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock contextRef="c-1" id="f-654">&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The effective income tax rate for the fiscal years ended June&#160;30, 2025 and 2024 differs from the U.S. Federal statutory income tax rate due to the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:13pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:62.150%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:16.908%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:16.910%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Years ended June 30,&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Federal statutory income tax rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State income taxes, net of federal benefit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign tax rate difference&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Tax return to provision true-up&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Limit on future stock compensation due to 162(m)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign withholding tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other differences&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Revalue of deferred for change in federal tax rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Permanent differences:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014; stock-based compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014; current year section 162(m) limitation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014; foreign derived intangible income deduction&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014; tax credits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014; meals and entertainment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014; removal of additional permanent reinvestment assertions&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014; change in uncertain tax positions&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014; accrual for foreign tax audits&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014; other permanent differences&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Change in valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income tax provision &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate contextRef="c-1" decimals="INF" id="f-655" unitRef="number">0.210</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate contextRef="c-8" decimals="INF" id="f-656" unitRef="number">0.210</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes contextRef="c-1" decimals="3" id="f-657" unitRef="number">0.034</us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes contextRef="c-8" decimals="3" id="f-658" unitRef="number">0.012</us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential contextRef="c-1" decimals="3" id="f-659" unitRef="number">-0.004</us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential>
    <us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential contextRef="c-8" decimals="3" id="f-660" unitRef="number">0.080</us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential>
    <lfvn:EffectiveIncomeTaxRateReconciliationTaxReturnToProvisionsTrueUp contextRef="c-1" decimals="3" id="f-661" unitRef="number">0.004</lfvn:EffectiveIncomeTaxRateReconciliationTaxReturnToProvisionsTrueUp>
    <lfvn:EffectiveIncomeTaxRateReconciliationTaxReturnToProvisionsTrueUp contextRef="c-8" decimals="3" id="f-662" unitRef="number">-0.043</lfvn:EffectiveIncomeTaxRateReconciliationTaxReturnToProvisionsTrueUp>
    <lfvn:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseLimitationOnFutureStockBasedCompensationExpensePercent contextRef="c-1" decimals="3" id="f-663" unitRef="number">-0.040</lfvn:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseLimitationOnFutureStockBasedCompensationExpensePercent>
    <lfvn:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseLimitationOnFutureStockBasedCompensationExpensePercent contextRef="c-8" decimals="3" id="f-664" unitRef="number">-0.028</lfvn:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseLimitationOnFutureStockBasedCompensationExpensePercent>
    <lfvn:EffectiveIncomeTaxRateReconciliationForeignWithholdingTaxPercent contextRef="c-1" decimals="3" id="f-665" unitRef="number">0.008</lfvn:EffectiveIncomeTaxRateReconciliationForeignWithholdingTaxPercent>
    <lfvn:EffectiveIncomeTaxRateReconciliationForeignWithholdingTaxPercent contextRef="c-8" decimals="3" id="f-666" unitRef="number">0.026</lfvn:EffectiveIncomeTaxRateReconciliationForeignWithholdingTaxPercent>
    <us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments contextRef="c-1" decimals="3" id="f-667" unitRef="number">0.007</us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments>
    <us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments contextRef="c-8" decimals="3" id="f-668" unitRef="number">0.016</us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments>
    <us-gaap:EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate contextRef="c-1" decimals="3" id="f-669" unitRef="number">0.000</us-gaap:EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate contextRef="c-8" decimals="3" id="f-670" unitRef="number">0.000</us-gaap:EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost contextRef="c-1" decimals="3" id="f-671" unitRef="number">-0.062</us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost>
    <us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost contextRef="c-8" decimals="3" id="f-672" unitRef="number">-0.083</us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost>
    <lfvn:EffectiveIncomeTaxRateReconciliationCurrentYearSection162mLimitationPercent contextRef="c-1" decimals="3" id="f-673" unitRef="number">0.009</lfvn:EffectiveIncomeTaxRateReconciliationCurrentYearSection162mLimitationPercent>
    <lfvn:EffectiveIncomeTaxRateReconciliationCurrentYearSection162mLimitationPercent contextRef="c-8" decimals="3" id="f-674" unitRef="number">0.070</lfvn:EffectiveIncomeTaxRateReconciliationCurrentYearSection162mLimitationPercent>
    <us-gaap:EffectiveIncomeTaxRateReconciliationFdiiPercent contextRef="c-1" decimals="3" id="f-675" unitRef="number">0.014</us-gaap:EffectiveIncomeTaxRateReconciliationFdiiPercent>
    <us-gaap:EffectiveIncomeTaxRateReconciliationFdiiPercent contextRef="c-8" decimals="3" id="f-676" unitRef="number">0.007</us-gaap:EffectiveIncomeTaxRateReconciliationFdiiPercent>
    <us-gaap:EffectiveIncomeTaxRateReconciliationTaxCredits contextRef="c-1" decimals="3" id="f-677" unitRef="number">0.048</us-gaap:EffectiveIncomeTaxRateReconciliationTaxCredits>
    <us-gaap:EffectiveIncomeTaxRateReconciliationTaxCredits contextRef="c-8" decimals="3" id="f-678" unitRef="number">0.121</us-gaap:EffectiveIncomeTaxRateReconciliationTaxCredits>
    <us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseMealsAndEntertainment contextRef="c-1" decimals="3" id="f-679" unitRef="number">0.006</us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseMealsAndEntertainment>
    <us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseMealsAndEntertainment contextRef="c-8" decimals="3" id="f-680" unitRef="number">0.013</us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseMealsAndEntertainment>
    <lfvn:EffectiveIncomeTaxRateReconciliationRemovalOfPermanentReinvestmentAssertion contextRef="c-1" decimals="3" id="f-681" unitRef="number">0.006</lfvn:EffectiveIncomeTaxRateReconciliationRemovalOfPermanentReinvestmentAssertion>
    <lfvn:EffectiveIncomeTaxRateReconciliationRemovalOfPermanentReinvestmentAssertion contextRef="c-8" decimals="3" id="f-682" unitRef="number">0.012</lfvn:EffectiveIncomeTaxRateReconciliationRemovalOfPermanentReinvestmentAssertion>
    <lfvn:EffectiveIncomeTaxRateReconciliationChangeInUncertainTaxPositions contextRef="c-1" decimals="INF" id="f-683" unitRef="number">-0.004</lfvn:EffectiveIncomeTaxRateReconciliationChangeInUncertainTaxPositions>
    <lfvn:EffectiveIncomeTaxRateReconciliationChangeInUncertainTaxPositions contextRef="c-8" decimals="INF" id="f-684" unitRef="number">0.012</lfvn:EffectiveIncomeTaxRateReconciliationChangeInUncertainTaxPositions>
    <us-gaap:EffectiveIncomeTaxRateReconciliationTaxSettlementsForeign contextRef="c-1" decimals="INF" id="f-685" unitRef="number">0.004</us-gaap:EffectiveIncomeTaxRateReconciliationTaxSettlementsForeign>
    <us-gaap:EffectiveIncomeTaxRateReconciliationTaxSettlementsForeign contextRef="c-8" decimals="INF" id="f-686" unitRef="number">0.077</us-gaap:EffectiveIncomeTaxRateReconciliationTaxSettlementsForeign>
    <us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther contextRef="c-1" decimals="3" id="f-687" unitRef="number">0.007</us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther>
    <us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther contextRef="c-8" decimals="3" id="f-688" unitRef="number">0.018</us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther>
    <us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance contextRef="c-1" decimals="3" id="f-689" unitRef="number">-0.004</us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance contextRef="c-8" decimals="3" id="f-690" unitRef="number">0.005</us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations contextRef="c-1" decimals="3" id="f-691" unitRef="number">0.199</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations contextRef="c-8" decimals="3" id="f-692" unitRef="number">0.325</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock contextRef="c-1" id="f-693">&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The components of the deferred tax assets and liabilities as of June&#160;30, 2025 and 2024 are as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:13pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:62.150%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:16.908%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:16.910%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred tax assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Federal, state, and foreign net operating loss carryovers&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;234&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;271&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock option compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;628&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;360&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Section 174 costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,798&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,578&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Lease liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,798&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,223&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued vacation, allowance for returns, bonuses&#160;&amp;amp; other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,819&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,119&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross deferred tax asset&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,277&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,551&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred tax liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Patents and trademarks&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(16)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(30)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property&#160;&amp;amp; equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(239)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(798)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Right of use asset&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,942)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,263)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(468)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(472)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross deferred tax liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,665)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,563)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(642)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(720)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred tax assets, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,970&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,268&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards contextRef="c-6" decimals="-3" id="f-694" unitRef="usd">234000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards contextRef="c-7" decimals="-3" id="f-695" unitRef="usd">271000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost contextRef="c-6" decimals="-3" id="f-696" unitRef="usd">628000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost contextRef="c-7" decimals="-3" id="f-697" unitRef="usd">360000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost>
    <us-gaap:DeferredTaxAssetsInProcessResearchAndDevelopment contextRef="c-6" decimals="-3" id="f-698" unitRef="usd">2798000</us-gaap:DeferredTaxAssetsInProcessResearchAndDevelopment>
    <us-gaap:DeferredTaxAssetsInProcessResearchAndDevelopment contextRef="c-7" decimals="-3" id="f-699" unitRef="usd">2578000</us-gaap:DeferredTaxAssetsInProcessResearchAndDevelopment>
    <lfvn:DeferredTaxAssetsLeasingArrangements contextRef="c-6" decimals="-3" id="f-700" unitRef="usd">2798000</lfvn:DeferredTaxAssetsLeasingArrangements>
    <lfvn:DeferredTaxAssetsLeasingArrangements contextRef="c-7" decimals="-3" id="f-701" unitRef="usd">3223000</lfvn:DeferredTaxAssetsLeasingArrangements>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals contextRef="c-6" decimals="-3" id="f-702" unitRef="usd">2819000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals contextRef="c-7" decimals="-3" id="f-703" unitRef="usd">2119000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals>
    <us-gaap:DeferredTaxAssetsGross contextRef="c-6" decimals="-3" id="f-704" unitRef="usd">9277000</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxAssetsGross contextRef="c-7" decimals="-3" id="f-705" unitRef="usd">8551000</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets contextRef="c-6" decimals="-3" id="f-706" unitRef="usd">16000</us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets>
    <us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets contextRef="c-7" decimals="-3" id="f-707" unitRef="usd">30000</us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets>
    <us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment contextRef="c-6" decimals="-3" id="f-708" unitRef="usd">239000</us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment>
    <us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment contextRef="c-7" decimals="-3" id="f-709" unitRef="usd">798000</us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment>
    <us-gaap:DeferredTaxLiabilitiesLeasingArrangements contextRef="c-6" decimals="-3" id="f-710" unitRef="usd">1942000</us-gaap:DeferredTaxLiabilitiesLeasingArrangements>
    <us-gaap:DeferredTaxLiabilitiesLeasingArrangements contextRef="c-7" decimals="-3" id="f-711" unitRef="usd">2263000</us-gaap:DeferredTaxLiabilitiesLeasingArrangements>
    <us-gaap:DeferredTaxLiabilitiesOther contextRef="c-6" decimals="-3" id="f-712" unitRef="usd">468000</us-gaap:DeferredTaxLiabilitiesOther>
    <us-gaap:DeferredTaxLiabilitiesOther contextRef="c-7" decimals="-3" id="f-713" unitRef="usd">472000</us-gaap:DeferredTaxLiabilitiesOther>
    <us-gaap:DeferredIncomeTaxLiabilities contextRef="c-6" decimals="-3" id="f-714" unitRef="usd">2665000</us-gaap:DeferredIncomeTaxLiabilities>
    <us-gaap:DeferredIncomeTaxLiabilities contextRef="c-7" decimals="-3" id="f-715" unitRef="usd">3563000</us-gaap:DeferredIncomeTaxLiabilities>
    <us-gaap:DeferredTaxAssetsValuationAllowance contextRef="c-6" decimals="-3" id="f-716" unitRef="usd">642000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsValuationAllowance contextRef="c-7" decimals="-3" id="f-717" unitRef="usd">720000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsLiabilitiesNet contextRef="c-6" decimals="-3" id="f-718" unitRef="usd">5970000</us-gaap:DeferredTaxAssetsLiabilitiesNet>
    <us-gaap:DeferredTaxAssetsLiabilitiesNet contextRef="c-7" decimals="-3" id="f-719" unitRef="usd">4268000</us-gaap:DeferredTaxAssetsLiabilitiesNet>
    <lfvn:UnrecognizedTaxPositionIncreaseResultingFromForeignTaxAudits contextRef="c-1" decimals="-3" id="f-720" unitRef="usd">400000</lfvn:UnrecognizedTaxPositionIncreaseResultingFromForeignTaxAudits>
    <lfvn:UnrecognizedTaxPositionIncreaseResultingFromForeignTaxAudits contextRef="c-1" decimals="-3" id="f-721" unitRef="usd">400000</lfvn:UnrecognizedTaxPositionIncreaseResultingFromForeignTaxAudits>
    <us-gaap:UnrecognizedTaxBenefits contextRef="c-7" decimals="-3" id="f-722" unitRef="usd">389000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits contextRef="c-13" decimals="-3" id="f-723" unitRef="usd">0</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions contextRef="c-1" decimals="-3" id="f-724" unitRef="usd">51000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions contextRef="c-8" decimals="-3" id="f-725" unitRef="usd">0</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions contextRef="c-1" decimals="-3" id="f-726" unitRef="usd">53000</us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions contextRef="c-8" decimals="-3" id="f-727" unitRef="usd">0</us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions contextRef="c-1" decimals="-3" id="f-728" unitRef="usd">0</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions contextRef="c-8" decimals="-3" id="f-729" unitRef="usd">389000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities contextRef="c-1" decimals="-3" id="f-730" unitRef="usd">381000</us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities>
    <us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities contextRef="c-8" decimals="-3" id="f-731" unitRef="usd">0</us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities>
    <us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromForeignCurrencyTranslation contextRef="c-1" decimals="-3" id="f-732" unitRef="usd">6000</us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromForeignCurrencyTranslation>
    <us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromForeignCurrencyTranslation contextRef="c-8" decimals="-3" id="f-733" unitRef="usd">0</us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromForeignCurrencyTranslation>
    <us-gaap:UnrecognizedTaxBenefits contextRef="c-6" decimals="-3" id="f-734" unitRef="usd">0</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits contextRef="c-7" decimals="-3" id="f-735" unitRef="usd">389000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:SummaryOfValuationAllowanceTextBlock contextRef="c-1" id="f-736">&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The change in the valuation allowance were as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:62.150%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:16.908%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:16.910%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Years ended June&#160;30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Beginning balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;720&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;704&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Increases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(78)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Ending balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;642&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;720&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:SummaryOfValuationAllowanceTextBlock>
    <us-gaap:DeferredTaxAssetsValuationAllowance contextRef="c-7" decimals="-3" id="f-737" unitRef="usd">720000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsValuationAllowance contextRef="c-13" decimals="-3" id="f-738" unitRef="usd">704000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount contextRef="c-1" decimals="-3" id="f-739" unitRef="usd">-78000</us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount>
    <us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount contextRef="c-8" decimals="-3" id="f-740" unitRef="usd">16000</us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount>
    <us-gaap:DeferredTaxAssetsValuationAllowance contextRef="c-6" decimals="-3" id="f-741" unitRef="usd">642000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsValuationAllowance contextRef="c-7" decimals="-3" id="f-742" unitRef="usd">720000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:OperatingLossCarryforwards contextRef="c-111" decimals="-5" id="f-743" unitRef="usd">4800000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:OperatingLossCarryforwards contextRef="c-112" decimals="-5" id="f-744" unitRef="usd">400000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount contextRef="c-1" decimals="-5" id="f-745" unitRef="usd">800000</us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount>
    <us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount contextRef="c-8" decimals="-3" id="f-746" unitRef="usd">200000</us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount>
    <us-gaap:LesseeOperatingLeasesTextBlock contextRef="c-1" id="f-747">Leases&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has operating leases for current corporate offices and certain equipment. These leases have remaining terms of approximately &lt;span style="-sec-ix-hidden:f-748"&gt;one&lt;/span&gt; to 6.5 years. As of June&#160;30, 2025, the weighted average remaining lease term and weighted average discount rate for operating leases was 5.91 years and 3.17%, respectively. As of June&#160;30, 2024, the weighted average remaining lease term and weighted average discount rate for operating leases was 6.90 years and 3.46%, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The components of lease expense for the fiscal years ended June&#160;30, 2025 and 2024, were as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:62.150%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:16.908%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:16.910%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Years ended June 30,&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,881&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,913&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Variable lease cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;154&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;174&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Short-term lease cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total lease expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,046&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,134&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Supplemental cash flow information related to operating leases was as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:62.150%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:16.908%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:16.910%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 30, 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 30, 2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating cash outflows from operating leases&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,284&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,187&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Right-of-use assets obtained in exchange for lease obligations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,475&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Maturity of lease liabilities at June&#160;30, 2025 are as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:80.159%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:16.909%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,214&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,195&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2028&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,073&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2029&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,772&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2030&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,817&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,805&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,876&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: imputed interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,198)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Present value of lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,678&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:LesseeOperatingLeasesTextBlock>
    <us-gaap:LesseeOperatingLeaseTermOfContract contextRef="c-114" id="f-749">P6Y6M</us-gaap:LesseeOperatingLeaseTermOfContract>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1 contextRef="c-6" id="f-750">P5Y10M28D</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent contextRef="c-6" decimals="4" id="f-751" unitRef="number">0.0317</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1 contextRef="c-7" id="f-752">P6Y10M24D</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent contextRef="c-7" decimals="4" id="f-753" unitRef="number">0.0346</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:LeaseCostTableTextBlock contextRef="c-1" id="f-754">&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The components of lease expense for the fiscal years ended June&#160;30, 2025 and 2024, were as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:62.150%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:16.908%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:16.910%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Years ended June 30,&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,881&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,913&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Variable lease cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;154&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;174&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Short-term lease cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total lease expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,046&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,134&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Supplemental cash flow information related to operating leases was as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:62.150%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:16.908%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:16.910%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 30, 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 30, 2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating cash outflows from operating leases&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,284&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,187&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Right-of-use assets obtained in exchange for lease obligations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,475&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:LeaseCostTableTextBlock>
    <us-gaap:OperatingLeaseCost contextRef="c-1" decimals="-3" id="f-755" unitRef="usd">1881000</us-gaap:OperatingLeaseCost>
    <us-gaap:OperatingLeaseCost contextRef="c-8" decimals="-3" id="f-756" unitRef="usd">1913000</us-gaap:OperatingLeaseCost>
    <us-gaap:VariableLeaseCost contextRef="c-1" decimals="-3" id="f-757" unitRef="usd">154000</us-gaap:VariableLeaseCost>
    <us-gaap:VariableLeaseCost contextRef="c-8" decimals="-3" id="f-758" unitRef="usd">174000</us-gaap:VariableLeaseCost>
    <us-gaap:ShortTermLeaseCost contextRef="c-1" decimals="-3" id="f-759" unitRef="usd">11000</us-gaap:ShortTermLeaseCost>
    <us-gaap:ShortTermLeaseCost contextRef="c-8" decimals="-3" id="f-760" unitRef="usd">47000</us-gaap:ShortTermLeaseCost>
    <us-gaap:LeaseCost contextRef="c-1" decimals="-3" id="f-761" unitRef="usd">2046000</us-gaap:LeaseCost>
    <us-gaap:LeaseCost contextRef="c-8" decimals="-3" id="f-762" unitRef="usd">2134000</us-gaap:LeaseCost>
    <us-gaap:OperatingLeasePayments contextRef="c-1" decimals="-3" id="f-763" unitRef="usd">2284000</us-gaap:OperatingLeasePayments>
    <us-gaap:OperatingLeasePayments contextRef="c-8" decimals="-3" id="f-764" unitRef="usd">2187000</us-gaap:OperatingLeasePayments>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability contextRef="c-1" decimals="-3" id="f-765" unitRef="usd">0</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability contextRef="c-8" decimals="-3" id="f-766" unitRef="usd">2475000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock contextRef="c-1" id="f-767">&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Maturity of lease liabilities at June&#160;30, 2025 are as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:80.159%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:16.909%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,214&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,195&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2028&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,073&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2029&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,772&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2030&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,817&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,805&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,876&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: imputed interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,198)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Present value of lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,678&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths contextRef="c-6" decimals="-3" id="f-768" unitRef="usd">2214000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo contextRef="c-6" decimals="-3" id="f-769" unitRef="usd">2195000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree contextRef="c-6" decimals="-3" id="f-770" unitRef="usd">2073000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour contextRef="c-6" decimals="-3" id="f-771" unitRef="usd">1772000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive contextRef="c-6" decimals="-3" id="f-772" unitRef="usd">1817000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive contextRef="c-6" decimals="-3" id="f-773" unitRef="usd">2805000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue contextRef="c-6" decimals="-3" id="f-774" unitRef="usd">12876000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue>
    <us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount contextRef="c-6" decimals="-3" id="f-775" unitRef="usd">1198000</us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount>
    <us-gaap:OperatingLeaseLiability contextRef="c-6" decimals="-3" id="f-776" unitRef="usd">11678000</us-gaap:OperatingLeaseLiability>
    <us-gaap:SegmentReportingDisclosureTextBlock contextRef="c-1" id="f-777">Segment Information&lt;div style="margin-bottom:8pt;margin-top:3pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company operates in a single operating segment by selling products directly to customers through an international network of independent consultants that operates in an integrated manner from market to market. The Company manages its business primarily by managing its international network of independent consultants through similar commission plans. Most products available to customers in the United States are available to customers across all markets.  These products are purchased through third-party manufacturers by the US Corporate office and sold to each international market. Pricing for all products is determined at the US Corporate office. Accordingly, for disclosure purposes, the Company has a single reporting segment, which is reported on the Company&#x2019;s consolidated financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:3pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Chief Operating Decision Maker (&#x201c;CODM&#x201d;) is the Company&#x2019;s Chief Executive Officer. The CODM regularly reviews consolidated financial information and performance used to make decisions about the Company as a whole and without distinguishing or grouping of operations based on asset type, revenue, geographic location, tenant or other factors.  &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The CODM evaluates performance through consolidated financial budget-to-actual variances on a monthly and quarterly basis and allocates resources based on net income as reported in the consolidated statements of operations. The measure of segment assets is reported on the balance sheet as total consolidated assets. Total expenditures for long-lived assets are reported on the consolidated statements of cash flows.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:18pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:18pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The following table presents the Company&#x2019;s segment revenue and expenses and segment net income for the fiscal years ended June 30, 2025 and 2024 (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:62.150%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:16.908%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:16.910%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Years ended June&#160;30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Revenue, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;228,530&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;200,164&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost of sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(44,864)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(41,440)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Consultant commissions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(95,920)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(80,900)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Consultant incentives, promotions, and recognition&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,340)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,020)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Labor and benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(31,216)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(27,202)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,702)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,280)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Events&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,791)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,321)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,156)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,581)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Credit card and bank processing fees&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,694)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,051)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other segment items&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(19,035)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(24,449)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;466&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;451&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(35)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(21)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income tax expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,438)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,413)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,805&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,937&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;(1) Other general and administrative expenses include legal, professional services, rent, utilities, and other miscellaneous expenses.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the Company&#x2019;s long-lived assets for its most significant geographic markets (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:13pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:62.150%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:16.908%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:16.910%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June&#160;30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,446&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,216&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Japan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,901&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,925&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other foreign markets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;472&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;612&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total foreign markets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,373&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,537&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total long-lived assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,819&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,753&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has identified two major markets with revenues exceeding 10% of consolidated total revenue: United States and Japan.  There are 16 other markets, each of which individually is less than 10% of consolidated total revenue. Sales are recorded in the market in which the transaction occurred. The following table presents the Company&#x2019;s revenue disaggregated by these markets (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:13pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:62.150%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:16.908%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:16.910%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Years ended June&#160;30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;178,442&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;145,679&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Japan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,394&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,989&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other foreign markets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,694&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27,496&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total foreign markets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50,088&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54,485&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total revenue, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;228,530&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;200,164&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Major Products&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s revenue for the fiscal year ended June 30, 2025 is largely attributed to three product lines, Protandim&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, LifeVantage&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, and TrueScience&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. On a combined basis, these three product lines represent approximately &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;87.6% o&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;f the Company&#x2019;s total net revenue for the fiscal year ended June&#160;30, 2025. Total revenue for the fiscal year ended June&#160;30, 2024 was largely attributed to two product lines, Protandim&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and TrueScience&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, which on a combined basis represented approximately 80.1% of total net revenue for that fiscal year. The following table shows revenue by product line for the fiscal years ended June&#160;30, 2025 and 2024 (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:62.243%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:16.788%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.533%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:16.936%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="border-bottom:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Years ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Protandim&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;&#xae; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;product line&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;95,328&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;104,135&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;LifeVantage&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;&#xae; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;product line&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56,225&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,675&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;TrueScience&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;&#xae; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;product line&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48,712&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56,252&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;AXIO&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt; product line&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,312&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,375&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;PhysIQ&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;&#x2122;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt; product line&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,102&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,827&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Petandim&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt; product line&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,117&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,398&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,734&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,502&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total revenue, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;228,530&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;200,164&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(1) Other revenue includes shipping and handling revenue, event related revenue, and other revenues impracticable to allocate to a specific product line.&lt;/span&gt;&lt;/div&gt;</us-gaap:SegmentReportingDisclosureTextBlock>
    <us-gaap:SegmentReportingPolicyPolicyTextBlock contextRef="c-1" id="f-778">&lt;div style="margin-bottom:8pt;margin-top:3pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company operates in a single operating segment by selling products directly to customers through an international network of independent consultants that operates in an integrated manner from market to market. The Company manages its business primarily by managing its international network of independent consultants through similar commission plans. Most products available to customers in the United States are available to customers across all markets.  These products are purchased through third-party manufacturers by the US Corporate office and sold to each international market. Pricing for all products is determined at the US Corporate office. Accordingly, for disclosure purposes, the Company has a single reporting segment, which is reported on the Company&#x2019;s consolidated financial statements.&lt;/span&gt;&lt;/div&gt;</us-gaap:SegmentReportingPolicyPolicyTextBlock>
    <us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock contextRef="c-1" id="f-779">&lt;div style="text-indent:18pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The following table presents the Company&#x2019;s segment revenue and expenses and segment net income for the fiscal years ended June 30, 2025 and 2024 (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:62.150%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:16.908%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:16.910%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Years ended June&#160;30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Revenue, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;228,530&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;200,164&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost of sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(44,864)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(41,440)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Consultant commissions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(95,920)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(80,900)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Consultant incentives, promotions, and recognition&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,340)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,020)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Labor and benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(31,216)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(27,202)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,702)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,280)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Events&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,791)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,321)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,156)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,581)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Credit card and bank processing fees&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,694)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,051)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other segment items&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(19,035)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(24,449)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;466&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;451&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(35)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(21)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income tax expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,438)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,413)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,805&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,937&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;(1) Other general and administrative expenses include legal, professional services, rent, utilities, and other miscellaneous expenses.&lt;/span&gt;&lt;/div&gt;The following table shows revenue by product line for the fiscal years ended June&#160;30, 2025 and 2024 (in thousands):&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:62.243%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:16.788%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.533%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:16.936%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="border-bottom:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Years ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Protandim&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;&#xae; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;product line&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;95,328&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;104,135&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;LifeVantage&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;&#xae; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;product line&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56,225&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,675&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;TrueScience&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;&#xae; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;product line&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48,712&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56,252&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;AXIO&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt; product line&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,312&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,375&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;PhysIQ&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;&#x2122;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt; product line&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,102&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,827&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Petandim&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt; product line&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,117&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,398&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,734&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,502&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total revenue, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;228,530&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;200,164&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(1) Other revenue includes shipping and handling revenue, event related revenue, and other revenues impracticable to allocate to a specific product line.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-115" decimals="-3" id="f-780" unitRef="usd">228530000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-116" decimals="-3" id="f-781" unitRef="usd">200164000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:CostOfGoodsAndServicesSold contextRef="c-115" decimals="-3" id="f-782" unitRef="usd">44864000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold contextRef="c-116" decimals="-3" id="f-783" unitRef="usd">41440000</us-gaap:CostOfGoodsAndServicesSold>
    <lfvn:ConsultantCommissions contextRef="c-115" decimals="-3" id="f-784" unitRef="usd">95920000</lfvn:ConsultantCommissions>
    <lfvn:ConsultantCommissions contextRef="c-116" decimals="-3" id="f-785" unitRef="usd">80900000</lfvn:ConsultantCommissions>
    <lfvn:ConsultantIncentivesPromotionsAndRecognitionExpense contextRef="c-115" decimals="-3" id="f-786" unitRef="usd">6340000</lfvn:ConsultantIncentivesPromotionsAndRecognitionExpense>
    <lfvn:ConsultantIncentivesPromotionsAndRecognitionExpense contextRef="c-116" decimals="-3" id="f-787" unitRef="usd">5020000</lfvn:ConsultantIncentivesPromotionsAndRecognitionExpense>
    <us-gaap:LaborAndRelatedExpense contextRef="c-115" decimals="-3" id="f-788" unitRef="usd">31216000</us-gaap:LaborAndRelatedExpense>
    <us-gaap:LaborAndRelatedExpense contextRef="c-116" decimals="-3" id="f-789" unitRef="usd">27202000</us-gaap:LaborAndRelatedExpense>
    <us-gaap:ShareBasedCompensation contextRef="c-115" decimals="-3" id="f-790" unitRef="usd">5702000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation contextRef="c-116" decimals="-3" id="f-791" unitRef="usd">3280000</us-gaap:ShareBasedCompensation>
    <lfvn:EventsExpense contextRef="c-115" decimals="-3" id="f-792" unitRef="usd">3791000</lfvn:EventsExpense>
    <lfvn:EventsExpense contextRef="c-116" decimals="-3" id="f-793" unitRef="usd">4321000</lfvn:EventsExpense>
    <us-gaap:DepreciationDepletionAndAmortization contextRef="c-115" decimals="-3" id="f-794" unitRef="usd">3156000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization contextRef="c-116" decimals="-3" id="f-795" unitRef="usd">3581000</us-gaap:DepreciationDepletionAndAmortization>
    <lfvn:CreditCardAndBankingProcessingFees contextRef="c-115" decimals="-3" id="f-796" unitRef="usd">6694000</lfvn:CreditCardAndBankingProcessingFees>
    <lfvn:CreditCardAndBankingProcessingFees contextRef="c-116" decimals="-3" id="f-797" unitRef="usd">6051000</lfvn:CreditCardAndBankingProcessingFees>
    <us-gaap:SegmentReportingOtherItemAmount contextRef="c-115" decimals="-3" id="f-798" unitRef="usd">19035000</us-gaap:SegmentReportingOtherItemAmount>
    <us-gaap:SegmentReportingOtherItemAmount contextRef="c-116" decimals="-3" id="f-799" unitRef="usd">24449000</us-gaap:SegmentReportingOtherItemAmount>
    <us-gaap:InvestmentIncomeInterest contextRef="c-115" decimals="-3" id="f-800" unitRef="usd">466000</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InvestmentIncomeInterest contextRef="c-116" decimals="-3" id="f-801" unitRef="usd">451000</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InterestExpenseNonoperating contextRef="c-115" decimals="-3" id="f-802" unitRef="usd">35000</us-gaap:InterestExpenseNonoperating>
    <us-gaap:InterestExpenseNonoperating contextRef="c-116" decimals="-3" id="f-803" unitRef="usd">21000</us-gaap:InterestExpenseNonoperating>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-115" decimals="-3" id="f-804" unitRef="usd">2438000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-116" decimals="-3" id="f-805" unitRef="usd">1413000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:NetIncomeLoss contextRef="c-115" decimals="-3" id="f-806" unitRef="usd">9805000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-116" decimals="-3" id="f-807" unitRef="usd">2937000</us-gaap:NetIncomeLoss>
    <us-gaap:LongLivedAssetsByGeographicAreasTableTextBlock contextRef="c-1" id="f-808">&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the Company&#x2019;s long-lived assets for its most significant geographic markets (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:13pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:62.150%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:16.908%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:16.910%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June&#160;30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,446&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,216&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Japan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,901&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,925&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other foreign markets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;472&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;612&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total foreign markets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,373&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,537&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total long-lived assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,819&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,753&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:LongLivedAssetsByGeographicAreasTableTextBlock>
    <us-gaap:NoncurrentAssets contextRef="c-117" decimals="-3" id="f-809" unitRef="usd">18446000</us-gaap:NoncurrentAssets>
    <us-gaap:NoncurrentAssets contextRef="c-118" decimals="-3" id="f-810" unitRef="usd">19216000</us-gaap:NoncurrentAssets>
    <us-gaap:NoncurrentAssets contextRef="c-119" decimals="-3" id="f-811" unitRef="usd">1901000</us-gaap:NoncurrentAssets>
    <us-gaap:NoncurrentAssets contextRef="c-120" decimals="-3" id="f-812" unitRef="usd">1925000</us-gaap:NoncurrentAssets>
    <us-gaap:NoncurrentAssets contextRef="c-121" decimals="-3" id="f-813" unitRef="usd">472000</us-gaap:NoncurrentAssets>
    <us-gaap:NoncurrentAssets contextRef="c-122" decimals="-3" id="f-814" unitRef="usd">612000</us-gaap:NoncurrentAssets>
    <us-gaap:NoncurrentAssets contextRef="c-123" decimals="-3" id="f-815" unitRef="usd">2373000</us-gaap:NoncurrentAssets>
    <us-gaap:NoncurrentAssets contextRef="c-124" decimals="-3" id="f-816" unitRef="usd">2537000</us-gaap:NoncurrentAssets>
    <us-gaap:NoncurrentAssets contextRef="c-6" decimals="-3" id="f-817" unitRef="usd">20819000</us-gaap:NoncurrentAssets>
    <us-gaap:NoncurrentAssets contextRef="c-7" decimals="-3" id="f-818" unitRef="usd">21753000</us-gaap:NoncurrentAssets>
    <lfvn:NumberOfGeographicSegments contextRef="c-1" decimals="INF" id="f-819" unitRef="region">2</lfvn:NumberOfGeographicSegments>
    <us-gaap:RevenueFromExternalCustomersByGeographicAreasTableTextBlock contextRef="c-1" id="f-820">The following table presents the Company&#x2019;s revenue disaggregated by these markets (in thousands):&lt;div style="margin-bottom:8pt;margin-top:13pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:62.150%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:16.908%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:16.910%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Years ended June&#160;30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;178,442&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;145,679&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Japan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,394&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,989&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other foreign markets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,694&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27,496&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total foreign markets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50,088&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54,485&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total revenue, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;228,530&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;200,164&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:RevenueFromExternalCustomersByGeographicAreasTableTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-125" decimals="-3" id="f-821" unitRef="usd">178442000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-126" decimals="-3" id="f-822" unitRef="usd">145679000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-127" decimals="-3" id="f-823" unitRef="usd">25394000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-128" decimals="-3" id="f-824" unitRef="usd">26989000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-129" decimals="-3" id="f-825" unitRef="usd">24694000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-130" decimals="-3" id="f-826" unitRef="usd">27496000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-131" decimals="-3" id="f-827" unitRef="usd">50088000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-132" decimals="-3" id="f-828" unitRef="usd">54485000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-1" decimals="-3" id="f-829" unitRef="usd">228530000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-8" decimals="-3" id="f-830" unitRef="usd">200164000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <lfvn:NumberOfProductLines
      contextRef="c-1"
      decimals="INF"
      id="f-831"
      unitRef="productline">3</lfvn:NumberOfProductLines>
    <lfvn:NumberOfProductLines
      contextRef="c-1"
      decimals="INF"
      id="f-832"
      unitRef="productline">3</lfvn:NumberOfProductLines>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="c-133" decimals="3" id="f-833" unitRef="number">0.876</us-gaap:ConcentrationRiskPercentage1>
    <lfvn:NumberOfProductLines
      contextRef="c-8"
      decimals="INF"
      id="f-834"
      unitRef="productline">2</lfvn:NumberOfProductLines>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="c-134" decimals="3" id="f-835" unitRef="number">0.801</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-135" decimals="-3" id="f-836" unitRef="usd">95328000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-136" decimals="-3" id="f-837" unitRef="usd">104135000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-137" decimals="-3" id="f-838" unitRef="usd">56225000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-138" decimals="-3" id="f-839" unitRef="usd">15675000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-139" decimals="-3" id="f-840" unitRef="usd">48712000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-140" decimals="-3" id="f-841" unitRef="usd">56252000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-141" decimals="-3" id="f-842" unitRef="usd">15312000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-142" decimals="-3" id="f-843" unitRef="usd">13375000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-143" decimals="-3" id="f-844" unitRef="usd">5102000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-144" decimals="-3" id="f-845" unitRef="usd">3827000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-145" decimals="-3" id="f-846" unitRef="usd">2117000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-146" decimals="-3" id="f-847" unitRef="usd">2398000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-147" decimals="-3" id="f-848" unitRef="usd">5734000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-148" decimals="-3" id="f-849" unitRef="usd">4502000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-1" decimals="-3" id="f-850" unitRef="usd">228530000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-8" decimals="-3" id="f-851" unitRef="usd">200164000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock contextRef="c-1" id="f-853">Commitments and Contingencies&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Contingencies&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company accounts for contingent liabilities in accordance with ASC 450, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Contingencies&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. This guidance requires management to assess potential contingent liabilities that may exist as of the date of the financial statements to determine the probability and amount of loss that may have occurred, which inherently involves an exercise of judgment. If the assessment of a contingency indicates that it is probable that a material loss has been incurred and the amount of the liability can be estimated, &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;then the estimated liability would be accrued in the Company&#x2019;s financial statements. If the assessment indicates that a potential material loss contingency is not probable but is reasonably possible, or is probable but cannot be estimated, then the nature of the contingent liability, and an estimate of the range of possible losses, if determinable and material, would be disclosed. For loss contingencies considered remote, no accrual or disclosures are generally made. Management has assessed potential contingent liabilities as of June&#160;30, 2025, and based on the assessment there are no probable loss contingencies requiring accrual or disclosures within its financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Legal Accruals&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In addition to commitments and obligations in the ordinary course of business, from time to time, the Company is subject to various claims, pending and potential legal actions, investigations relating to governmental laws and regulations and other matters arising out of the normal conduct of its business. Management assesses contingencies to determine the degree of probability and range of possible loss for potential accrual in the consolidated financial statements. An estimated loss contingency is accrued in the consolidated financial statements if it is probable that a liability has been incurred and the amount of the loss can be reasonably estimated. Because evaluating legal claims and litigation results are inherently unpredictable and unfavorable results could occur, assessing contingencies is highly subjective and requires judgments about future events. When evaluating contingencies, management may be unable to provide a meaningful estimate due to a number of factors, including the procedural status of the matter in question, the presence of complex or novel legal theories, and/or the ongoing discovery and development of information important to the matters. In addition, damage amounts claimed or asserted against the Company may be unsupported, exaggerated, or unrelated to possible outcomes, and as such are not meaningful indicators of a potential liability. Management regularly reviews contingencies to determine the adequacy of financial statement accruals and related disclosures. The amount of ultimate loss may differ from these estimates. It is possible that cash flows or results of operations could be materially affected in any particular period by the unfavorable publicity or resolution of one or more of these contingencies. Whether any losses finally determined in any claim, action, investigation or proceeding or publicity related to such could reasonably have a material effect on the Company's business, financial condition, results of operations or cash flows will depend on a number of variables, including: the timing and amount of such losses; the structure and type of any remedies; the significance of the impact of any such losses, damages or remedies may have on the consolidated financial statements; and the unique facts and circumstances of the particular matter that may give rise to additional factors.&lt;/span&gt;&lt;/div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Other Matters&lt;/span&gt;.   The Company may become involved in other litigation and regulatory matters incidental to its business and the matters disclosed in this annual report on Form 10-K, including, but not limited to, product liability claims, regulatory actions, employment matters and commercial disputes. The Company intends to defend itself in any such matters and does not currently believe that the outcome of any such matters will have a material adverse effect on the Company's business, financial condition, results of operations and cash flows.</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <us-gaap:SubsequentEventsTextBlock contextRef="c-1" id="f-854">&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Note 15 &#x2014; Subsequent Events&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On September 3, 2025, the Company entered into an Asset Purchase Agreement to acquire critical assets of a Global Organics Merchants, LLC, dba LoveBiome.  The transaction is expected to close by mid-October 2025, subject to satisfaction of customary closing conditions and regulatory requirements.  The Company has not yet determined the accounting purchase price allocation of the purchase consideration described above, which includes evaluating the fair value of the acquired assets and the valuation of contingent consideration to be transferred.&lt;/span&gt;&lt;/div&gt;</us-gaap:SubsequentEventsTextBlock>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
